PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Rehm, J; Fischer, B; McKeganey, N				Rehm, Juergen; Fischer, Benedikt; McKeganey, Neil			Should heroin be prescribed to heroin misusers?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Rehm, Juergen; Fischer, Benedikt] Ctr Addict & Mental Hlth, Toronto, ON M5S 2S1, Canada; [Fischer, Benedikt] Univ Victoria, Ctr Addict Res British Columbia, Victoria, BC V8W 2Y2, Canada; [McKeganey, Neil] Univ Glasgow, Glasgow G11 6PW, Lanark, Scotland	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Victoria; University of Glasgow	Rehm, J (corresponding author), Ctr Addict & Mental Hlth, Toronto, ON M5S 2S1, Canada.	jtrehm@aol.com; n.mckeganey@lbss.gla.ac.uk	Rem, Jürgen/H-1309-2011	Fischer, B/0000-0002-2186-4030					0	12	12	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 12	2008	336	7635					70	71		10.1136/bmj.39421.593692.94	http://dx.doi.org/10.1136/bmj.39421.593692.94			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253BX	18187720	Green Accepted, Green Published			2022-12-28	WOS:000252494800024
J	Gibson, DG; Benders, GA; Andrews-Pfannkoch, C; Denisova, EA; Baden-Tillson, H; Zaveri, J; Stockwell, TB; Brownley, A; Thomas, DW; Algire, MA; Merryman, C; Young, L; Noskov, VN; Glass, JI; Venter, JC; Hutchison, CA; Smith, HO				Gibson, Daniel G.; Benders, Gwynedd A.; Andrews-Pfannkoch, Cynthia; Denisova, Evgeniya A.; Baden-Tillson, Holly; Zaveri, Jayshree; Stockwell, Timothy B.; Brownley, Anushka; Thomas, David W.; Algire, Mikkel A.; Merryman, Chuck; Young, Lei; Noskov, Vladimir N.; Glass, John I.; Venter, J. Craig; Hutchison, Clyde A., III; Smith, Hamilton O.			Complete chemical synthesis, assembly, and cloning of a Mycoplasma genitalium genome	SCIENCE			English	Article							TRANSFORMATION-ASSOCIATED RECOMBINATION; SELECTIVE ISOLATION; HOMOLOGOUS RECOMBINATION; YEAST; DNA; GENE; SEGMENTS; REGIONS; VIRUS; CELLS	We have synthesized a 582,970 - base pair Mycoplasma genitalium genome. This synthetic genome, named M. genitalium JCVI- 1.0, contains all the genes of wild- type M. genitalium G37 except MG408, which was disrupted by an antibiotic marker to block pathogenicity and to allow for selection. To identify the genome as synthetic, we inserted "watermarks" at intergenic sites known to tolerate transposon insertions. Overlapping "cassettes" of 5 to 7 kilobases ( kb), assembled from chemically synthesized oligonucleotides, were joined by in vitro recombination to produce intermediate assemblies of approximately 24 kb, 72 kb ("1/ 8 genome"), and 144 kb ("1/ 4 genome"), which were all cloned as bacterial artificial chromosomes in Escherichia coli. Most of these intermediate clones were sequenced, and clones of all four 1/ 4 genomes with the correct sequence were identified. The complete synthetic genome was assembled by transformation-associated recombination cloning in the yeast Saccharomyces cerevisiae, then isolated and sequenced. A clone with the correct sequence was identified. The methods described here will be generally useful for constructing large DNA molecules from chemically synthesized pieces and also from combinations of natural and synthetic DNA segments.	[Gibson, Daniel G.; Benders, Gwynedd A.; Andrews-Pfannkoch, Cynthia; Denisova, Evgeniya A.; Baden-Tillson, Holly; Zaveri, Jayshree; Stockwell, Timothy B.; Brownley, Anushka; Thomas, David W.; Algire, Mikkel A.; Merryman, Chuck; Young, Lei; Noskov, Vladimir N.; Glass, John I.; Venter, J. Craig; Hutchison, Clyde A., III; Smith, Hamilton O.] J Craig Venter Inst, Rockville, MD 20850 USA	J. Craig Venter Institute	Smith, HO (corresponding author), J Craig Venter Inst, Rockville, MD 20850 USA.	hsmith@jcvi.org	; Glass, John/A-6572-2015	Stockwell, Timothy/0000-0002-3595-4539; Glass, John/0000-0002-3784-5301				Arita M, 2004, BIOTECHNOL PROGR, V20, P1605, DOI 10.1021/bp049917i; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; COLMAN SD, 1990, MOL MICROBIOL, V4, P683, DOI 10.1111/j.1365-2958.1990.tb00638.x; Dhandayuthapani S, 2001, J BACTERIOL, V183, P5645, DOI 10.1128/JB.183.19.5645-5650.2001; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Heider D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-176; Holt RA, 2007, BIOESSAYS, V29, P580, DOI 10.1002/bies.20585; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Itaya M, 2005, P NATL ACAD SCI USA, V102, P15971, DOI 10.1073/pnas.0503868102; Itaya M, 2008, NAT METHODS, V5, P41, DOI 10.1038/NMETH1143; KNIGHT T, 2003, IDEMPOTENT VECTOR DE; Kodumal SJ, 2004, P NATL ACAD SCI USA, V101, P15573, DOI 10.1073/pnas.0406911101; Kouprina N, 2003, EMBO REP, V4, P257, DOI 10.1038/sj.embor.embor766; Kouprina Natalay, 2006, V349, P85; Larionov V, 1996, P NATL ACAD SCI USA, V93, P13925, DOI 10.1073/pnas.93.24.13925; Larionov V, 1997, P NATL ACAD SCI USA, V94, P7384, DOI 10.1073/pnas.94.14.7384; Lartigue C, 2007, SCIENCE, V317, P632, DOI 10.1126/science.1144622; Leem SH, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng029; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Marschall P, 1999, GENE THER, V6, P1634, DOI 10.1038/sj.gt.3300975; NEWLON CS, 1993, CURR OPIN GENET DEV, V3, P752, DOI 10.1016/S0959-437X(05)80094-2; Noskov VN, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.6.e32; SHENG Y, 1995, NUCLEIC ACIDS RES, V23, P1990, DOI 10.1093/nar/23.11.1990; Shimanovsky B., 2003, 5 INT WORKSH INF HID; Silverman G A, 1996, Methods Mol Biol, V54, P65; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; Yount B, 2002, J VIROL, V76, P11065, DOI 10.1128/JVI.76.21.11065-11078.2002; Zeng CJ, 2001, GENOMICS, V77, P27, DOI 10.1006/geno.2001.6616	31	759	903	7	348	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 29	2008	319	5867					1215	1220		10.1126/science.1151721	http://dx.doi.org/10.1126/science.1151721			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18218864				2022-12-28	WOS:000253530600035
J	Bolland, MJ; Barber, PA; Doughty, RN; Mason, B; Horne, A; Ames, R; Gamble, GD; Grey, A; Reid, IR				Bolland, Mark J.; Barber, P. Alan; Doughty, Robert N.; Mason, Barbara; Horne, Anne; Ames, Ruth; Gamble, Gregory D.; Grey, Andrew; Reid, Ian R.			Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; PLACEBO-CONTROLLED TRIAL; DIETARY CALCIUM; ELDERLY-WOMEN; VITAMIN-D; HEMODIALYSIS-PATIENTS; ARTERY CALCIFICATION; BLOOD-PRESSURE; MORTALITY; METAANALYSIS	Objective To determine the effect of calcium supplementation on myocardial infarction, stroke, and sudden death in healthy postmenopausal women. Design Randomised, placebo controlled trial. Setting Academic medical centre in an urban setting in New Zealand. Participants 1471 postmenopausal women (mean age 74): 732 were randomised to calcium supplementation and 739 to placebo. Main outcome measures Adverse cardiovascular events over five years: death, sudden death, myocardial infarction, angina, other chest pain, stroke, transient ischaemic attack, and a composite end point of myocardial infarction, stroke, or sudden death. Results Myocardial infarction was more commonly reported in the calcium group than in the placebo group (45 events in 31 women v19 events in 14 women, P=0.01). The composite end point of myocardial infarction, stroke, or sudden death was also more common in the calcium group (101 events in 69 women v 54 events in 42 women, P=0.008). After adjudication myocardial infarction remained more common in the calcium group (24 events in 21 women v 10 events in 10 women, relative risk 2.12, 95% confidence interval 1.01 to 4.47). For the composite end point 61 events were verified in 51 women in the calcium group and 36 events in 35 women in the placebo group (relative risk 1.47, 0.97 to 2.23). When unreported events were added from the national database of hospital admissions in New Zealand the relative risk of myocardial infarction was 1.49 (0.86 to 2.57) and that of the composite end point was 1.21 (0.84 to 1.74). The respective rate ratios were 1.67 (95% confidence intervals 0.98 to 2.87) and 1.43 (1.01 to 2.04); event rates: placebo 16.3/1000 person years, calcium 23.3/1000 person years. For stroke (including unreported events)the relative risk was 1.37 (0.83 to 2.28) and the rate ratio was 1.45 (0.88 to 2.49). Conclusion Calcium supplementation in healthy postmenopausal women is associated with upward trends in cardiovascular event rates. This potentially detrimental effect should be balanced against the likely benefits of calcium on bone. Trial registration Australian Clinical Trials Registry ACTRN 012605000242628.	[Bolland, Mark J.; Barber, P. Alan; Doughty, Robert N.; Mason, Barbara; Horne, Anne; Ames, Ruth; Gamble, Gregory D.; Grey, Andrew; Reid, Ian R.] Univ Auckland, Fac Med & Hlth Sci, Dept Med, Auckland 1, New Zealand	University of Auckland	Reid, IR (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Dept Med, Private Bag 92019, Auckland 1, New Zealand.	i.reid@auckland.ac.nz	Bolland, Mark J/A-7554-2008	Bolland, Mark J/0000-0003-0465-2674; Barber, P Alan/0000-0003-2469-9023; Horne, Anne/0000-0003-2783-7452; Reid, Ian/0000-0001-6021-5458; Gamble, Greg/0000-0003-0412-3203				Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Anavekar N, 2005, MED J AUSTRALIA, V183, P138, DOI 10.5694/j.1326-5377.2005.tb06958.x; ANGUS RM, 1989, J AM DIET ASSOC, V89, P209; Asmus HG, 2005, NEPHROL DIAL TRANSPL, V20, P1653, DOI 10.1093/ndt/gfh894; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Block GA, 2007, KIDNEY INT, V71, P438, DOI 10.1038/sj.ki.5002059; Block GA, 2005, KIDNEY INT, V68, P1815, DOI 10.1111/j.1523-1755.2005.00600.x; Bostick RM, 1999, AM J EPIDEMIOL, V149, P151, DOI 10.1093/oxfordjournals.aje.a009781; CHAPUY MC, 1994, BRIT MED J, V308, P1081, DOI 10.1136/bmj.308.6936.1081; Chapuy MC, 2002, OSTEOPOROSIS INT, V13, P257, DOI 10.1007/s001980200023; Chertow GM, 2002, KIDNEY INT, V62, P245, DOI 10.1046/j.1523-1755.2002.00434.x; DAWSON EB, 1978, AM J CLIN NUTR, V31, P1188, DOI 10.1093/ajcn/31.7.1188; DENKE MA, 1993, J NUTR, V123, P1047; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; GOVERS MJAP, 1993, GUT, V34, P365, DOI 10.1136/gut.34.3.365; Grant AM, 2005, LANCET, V365, P1621, DOI 10.1016/S0140-6736(05)63013-9; Griffith LE, 1999, AM J HYPERTENS, V12, P84, DOI 10.1016/S0895-7061(98)00224-6; Hsia J, 2007, CIRCULATION, V115, P846, DOI 10.1161/CIRCULATIONAHA.106.673491; Iso H, 1999, STROKE, V30, P1772, DOI 10.1161/01.STR.30.9.1772; Kelly KA, 1998, ENDOCRINOLOGY, V139, P2622, DOI 10.1210/en.139.5.2622; KNOX EG, 1973, LANCET, V1, P1465; Payne ME, 2007, FASEB J, V21, pA1072; PEDERSEN TR, 1994, LANCET, V344, P1383; Pletcher MJ, 2004, ARCH INTERN MED, V164, P1285, DOI 10.1001/archinte.164.12.1285; Prince RL, 2006, ARCH INTERN MED, V166, P869, DOI 10.1001/archinte.166.8.869; Reid IR, 2006, AM J MED, V119, P777, DOI 10.1016/j.amjmed.2006.02.038; Reid IR, 2005, J CLIN ENDOCR METAB, V90, P3824, DOI 10.1210/jc.2004-2205; REID IR, 1986, AUST NZ J MED, V16, P193, DOI 10.1111/j.1445-5994.1986.tb01147.x; Reid IR, 2002, AM J MED, V112, P343, DOI 10.1016/S0002-9343(01)01138-X; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Stevens LA, 2004, J AM SOC NEPHROL, V15, P770, DOI 10.1097/01.ASN.0000113243.24155.2F; Tang BMP, 2007, LANCET, V370, P657, DOI 10.1016/S0140-6736(07)61342-7; Zemel MB, 2000, FASEB J, V14, P1132, DOI 10.1096/fasebj.14.9.1132	33	465	482	0	37	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2008	336	7638					262	266		10.1136/bmj.39440.525752.BE	http://dx.doi.org/10.1136/bmj.39440.525752.BE			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	261TM	18198394	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000253102900039
J	Roy, SK; Hossain, MJ; Khatun, W; Chakraborty, B; Chowdhury, S; Begum, A; Mah-e-Muneer, S; Shafique, S; Khanam, M; Chowdhury, R				Roy, S. K.; Hossain, M. Jahangir; Khatun, Wajiha; Chakraborty, Barnali; Chowdhury, S.; Begum, Afroza; Mah-e-Muneer, Syeda; Shafique, Sohana; Khanam, Mansura; Chowdhury, R.			Zinc supplementation in children with cholera in Bangladesh: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PERSISTENT DIARRHEA; ORAL ZINC; IMPACT; DEFICIENCY; VACCINE; INFANTS	Objective To investigate the impact of zinc supplementation in children with cholera. Design Double blind, randomised, placebo controlled trial. Setting Dhaka Hospital, Bangladesh. Participants 179 children aged 3-14 years with watery diarrhoea and stool dark field examination positive for Vibrio cholerae and confirmed by stool culture. Intervention Children were randomised to receive 30 mg elemental zinc per day (n=90) or placebo (n=89) until recovery. All children received erythromycin suspension orally in a dose of 12.5 mg/kg every six hours for three days. Main outcome measures Duration of diarrhoea and stool output. Results 82 children in each group completed the study. More patients in the zinc group than in the control group recovered by two days (49% v 32%, P=0.032) and by three days (81% v 68%, P=0.03). Zinc supplemented patients had 12% shorter duration of diarrhoea than control patients (64.1 v 72.8 h, P=0.028) and 11% less stool output (1.6 v 1.8 kg/day, P=0.039). Conclusion Zinc supplementation significantly reduced the duration of diarrhoea and stool output in children with cholera. Children with cholera should be supplemented with zinc to reduce its duration and severity. Trial registration Clinical trials NCT00226616.	[Roy, S. K.; Hossain, M. Jahangir; Khatun, Wajiha; Chakraborty, Barnali; Chowdhury, S.; Begum, Afroza; Mah-e-Muneer, Syeda; Shafique, Sohana; Khanam, Mansura; Chowdhury, R.] Int Ctr Diarrhoeal Dis Res, Dhaka 1212, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR)	Roy, SK (corresponding author), Int Ctr Diarrhoeal Dis Res, 68 Shaheed Tajuddin Ahmed Sarani, Dhaka 1212, Bangladesh.	skroy@icddrb.org		Roy, Prof. S. K/0000-0001-5175-0731	Medical Research Council [G0500300] Funding Source: Medline; MRC [G0500300] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Albert MJ, 2003, J INFECT DIS, V187, P909, DOI 10.1086/368132; Bhutta ZA, 2000, AM J CLIN NUTR, V72, P1516; Dutta P, 2000, J TROP PEDIATRICS, V46, P259, DOI 10.1093/tropej/46.5.259; Karlsen TH, 2003, INFECT IMMUN, V71, P3909, DOI 10.1128/IAI.71.7.3909-3913.2003; KARLSEN TH, 2002, 11 INT C MUC IMM ORL; KHAN WA, 1995, T ROY SOC TROP MED H, V89, P103, DOI 10.1016/0035-9203(95)90675-4; KIRKWOOD B, 1998, ESSENTIALS MED STAT, P191; MOYNAHAN EJ, 1974, LANCET, V2, P399; Rabbani G. H., 2003, International handbook of foodborne pathogens, P217; ROTHBAUM RJ, 1982, AM J CLIN NUTR, V35, P595; Roy SK, 2006, J HEALTH POPUL NUTR, V24, P42; Roy SK, 1998, ACTA PAEDIATR, V87, P1235, DOI 10.1080/080352598750030898; Roy SK, 1997, ARCH DIS CHILD, V77, P196, DOI 10.1136/adc.77.3.196; ROY SK, 1992, J PEDIATR GASTR NUTR, V15, P289, DOI 10.1097/00005176-199210000-00010; SACHDEV HPS, 1990, ANN TROP PAEDIATR, V10, P63, DOI 10.1080/02724936.1990.11747411; World Health Organization (WHO), 2005, TREATM DIARRH MAN PH, P1	16	64	66	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2008	336	7638					266	268		10.1136/bmj.39416.646250.AE	http://dx.doi.org/10.1136/bmj.39416.646250.AE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	261TM	18184631	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000253102900040
J	Croce, CM				Croce, Carlo M.			Molecular origins of cancer: Oncogenes and cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							C-MYC ONCOGENE; HUMAN FOLLICULAR LYMPHOMA; CHRONIC MYELOID-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; CHRONIC LYMPHOCYTIC-LEUKEMIA; ABL TYROSINE KINASE; B-CELL LYMPHOMAS; TRANSGENIC MICE; CHROMOSOME TRANSLOCATIONS; GENE AMPLIFICATION		[Croce, Carlo M.] Ohio State Univ, Med Ctr, Human Canc Genet Program, Columbus, OH 43210 USA; [Croce, Carlo M.] Ohio State Univ, Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Croce, CM (corresponding author), Ohio State Univ, Med Ctr, Human Canc Genet Program, 385L Wiseman Hall,400 W 12th Ave, Columbus, OH 43210 USA.	carlo.croce@osumc.edu	Jackson, Benjamin L/C-4297-2012; Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647				Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; ALT FW, 1978, J BIOL CHEM, V253, P1357; ARRUSHDI A, 1983, SCIENCE, V222, P390, DOI 10.1126/science.6414084; Arteaga CL, 2002, ONCOLOGIST, V7, P31; Beaupre DM, 1999, J CLIN ONCOL, V17, P1071, DOI 10.1200/JCO.1999.17.3.1071; BISHOP JM, 1991, CELL, V64, P235, DOI 10.1016/0092-8674(91)90636-D; Calin GA, 2006, NEW ENGL J MED, V355, P533; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; CAPON DJ, 1983, NATURE, V302, P33, DOI 10.1038/302033a0; Casali PG, 2004, CANCER-AM CANCER SOC, V101, P2086, DOI 10.1002/cncr.20618; Cimmino A, 2006, P NATL ACAD SCI USA, V103, P2464, DOI 10.1073/pnas.0510793103; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; COWELL JK, 1982, ANNU REV GENET, V16, P21, DOI 10.1146/annurev.ge.16.120182.000321; CROCE CM, 1987, CELL, V49, P155, DOI 10.1016/0092-8674(87)90552-6; CROCE CM, 1979, P NATL ACAD SCI USA, V76, P3416, DOI 10.1073/pnas.76.7.3416; CROCE CM, 1983, P NATL ACAD SCI-BIOL, V80, P6922, DOI 10.1073/pnas.80.22.6922; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; ERIKSON J, 1981, NATURE, V294, P173, DOI 10.1038/294173a0; ERIKSON J, 1983, P NATL ACAD SCI-BIOL, V80, P7581, DOI 10.1073/pnas.80.24.7581; FAVERA RD, 1982, P NATL ACAD SCI USA, V79, P7824; FINGER LR, 1986, SCIENCE, V234, P982, DOI 10.1126/science.3490692; Frattini M, 2004, ONCOGENE, V23, P7436, DOI 10.1038/sj.onc.1207980; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Goldman JM, 2001, NEW ENGL J MED, V344, P1084, DOI 10.1056/NEJM200104053441409; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; Heinrich MC, 2002, J CLIN ONCOL, V20, P1692, DOI 10.1200/JCO.2002.20.6.1692; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Huebner K, 2001, NAT REV CANCER, V1, P214, DOI 10.1038/35106058; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Joensuu H, 2001, ANN MED, V33, P451, DOI 10.3109/07853890109002093; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; KAZIRO Y, 1991, ANNU REV BIOCHEM, V60, P349, DOI 10.1146/annurev.bi.60.070191.002025; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; KONOPKA JB, 1985, P NATL ACAD SCI USA, V82, P1810, DOI 10.1073/pnas.82.6.1810; LEDER A, 1986, CELL, V45, P485, DOI 10.1016/0092-8674(86)90280-1; MCCOY MS, 1983, NATURE, V302, P79, DOI 10.1038/302079a0; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Nakamura T, 2007, P NATL ACAD SCI USA, V104, P10980, DOI 10.1073/pnas.0704559104; Ohta M, 1996, CELL, V84, P587, DOI 10.1016/S0092-8674(00)81034-X; Ottmann OG, 2002, BLOOD, V100, P1965, DOI 10.1182/blood-2001-12-0181; Pawson T, 2007, ONCOGENE, V26, P1268, DOI 10.1038/sj.onc.1210255; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; Press MF, 1997, J CLIN ONCOL, V15, P2894, DOI 10.1200/JCO.1997.15.8.2894; Roche-Lestienne C, 2002, BLOOD, V100, P1014, DOI 10.1182/blood.V100.3.1014; Rodenhuis S, 1992, Semin Cancer Biol, V3, P241; Salgia R, 1998, J CLIN ONCOL, V16, P1207, DOI 10.1200/JCO.1998.16.3.1207; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tamborini E, 2004, GASTROENTEROLOGY, V127, P294, DOI 10.1053/j.gastro.2004.02.021; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; TSUJIMOTO Y, 1987, ONCOGENE, V2, P3; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; TSUJIMOTO Y, 1984, SCIENCE, V224, P1403, DOI 10.1126/science.6610211; TSUJIMOTO Y, 1986, P NATL ACAD SCI USA, V83, P5214, DOI 10.1073/pnas.83.14.5214; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang ZG, 1998, SCIENCE, V279, P1547; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025	71	665	721	6	110	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2008	358	5					502	511		10.1056/NEJMra072367	http://dx.doi.org/10.1056/NEJMra072367			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	256IW	18234754				2022-12-28	WOS:000252722900008
J	Wilbert-Lampen, U; Leistner, D; Greven, S; Pohl, T; Sper, S; Volker, C; Guthlin, D; Plasse, A; Knez, A; Kuchenhoff, H; Steinbeck, G				Wilbert-Lampen, Ute; Leistner, David; Greven, Sonja; Pohl, Tilmann; Sper, Sebastian; Voelker, Christoph; Guethlin, Denise; Plasse, Andrea; Knez, Andreas; Kuechenhoff, Helmut; Steinbeck, Gerhard			Cardiovascular events during World Cup Soccer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; EUROPEAN FOOTBALL CHAMPIONSHIP; SUDDEN CARDIAC DEATH; ENDOTHELIAL DYSFUNCTION; POTENTIAL LINK; VENTRICULAR ARRHYTHMIA; HORMONE CRH; MORTALITY; DISEASE; POPULATION	Background: The Federation Internationale de Football Association (FIFA) World Cup, held in Germany from June 9 to July 9, 2006, provided an opportunity to examine the relation between emotional stress and the incidence of cardiovascular events. Methods: Cardiovascular events occurring in patients in the greater Munich area were prospectively assessed by emergency physicians during the World Cup. We compared those events with events that occurred during the control period: May 1 to June 8 and July 10 to July 31, 2006, and May 1 to July 31 in 2003 and 2005. Results: Acute cardiovascular events were assessed in 4279 patients. On days of matches involving the German team, the incidence of cardiac emergencies was 2.66 times that during the control period (95% confidence interval [CI], 2.33 to 3.04; P<0.001); for men, the incidence was 3.26 times that during the control period (95% CI, 2.78 to 3.84; P<0.001), and for women, it was 1.82 times that during the control period (95% CI, 1.44 to 2.31; P<0.001). Among patients with coronary events on days when the German team played, the proportion with known coronary heart disease was 47.0%, as compared with 29.1% of patients with events during the control period. On those days, the highest average incidence of events was observed during the first 2 hours after the beginning of each match. A subanalysis of serious events during that period, as compared with the control period, showed an increase in the incidence of myocardial infarction with ST-segment elevation by a factor of 2.49 (95% CI, 1.47 to 4.23), of myocardial infarction without ST-segment elevation or unstable angina by a factor of 2.61 (95% CI, 2.22 to 3.08), and of cardiac arrhythmia causing major symptoms by a factor of 3.07 (95% CI, 2.32 to 4.06) (P<0.001 for all comparisons). Conclusions: Viewing a stressful soccer match more than doubles the risk of an acute cardiovascular event. In view of this excess risk, particularly in men with known coronary heart disease, preventive measures are urgently needed.	[Wilbert-Lampen, Ute; Leistner, David; Pohl, Tilmann; Sper, Sebastian; Voelker, Christoph; Plasse, Andrea; Knez, Andreas; Steinbeck, Gerhard] Univ Munich, Med Klin & Poliklin 1, D-81377 Munich, Germany; [Greven, Sonja; Guethlin, Denise; Kuechenhoff, Helmut] Univ Munich, Inst Stat, Stat Beratungslab, D-81377 Munich, Germany	University of Munich; University of Munich	Wilbert-Lampen, U (corresponding author), Univ Munich, Med Klin & Poliklin 1, Campus Grosshadern,Marchioninistr 15, D-81377 Munich, Germany.	ute.wilbert-lampen@med.uni-muenchen.de		Leistner, David/0000-0002-4351-420X; Kuchenhoff, Helmut/0000-0002-6372-2487				Akaike H, 1973, P 2 INT S INF THEOR, P267, DOI DOI 10.2307/2334537; [Anonymous], 2007, R LANG ENV STAT COMP; Berthier F, 2003, HEART, V89, P555, DOI 10.1136/heart.89.5.555; Brunekreef B, 2002, EPIDEMIOLOGY, V13, P491, DOI 10.1097/00001648-200207000-00022; Carroll D, 2002, BRIT MED J, V325, P1439, DOI 10.1136/bmj.325.7378.1439; Culic V, 2003, INT J CARDIOL, V90, P189, DOI 10.1016/S0167-5273(02)00563-6; Grima RS, 2005, REV ESP CARDIOL, V58, P587; Hemingway H, 2001, EUR HEART J, V22, P1082, DOI 10.1053/euhj.2000.2534; HUIKURI HV, 1994, CIRCULATION, V90, P121, DOI 10.1161/01.CIR.90.1.121; Kirkup W, 2003, J EPIDEMIOL COMMUN H, V57, P429, DOI 10.1136/jech.57.6.429; Lampert R, 2002, CIRCULATION, V106, P1800, DOI 10.1161/01.CIR.0000031733.51374.C1; Leor J, 1996, NEW ENGL J MED, V334, P413, DOI 10.1056/NEJM199602153340701; MEISEL SR, 1991, LANCET, V338, P660, DOI 10.1016/0140-6736(91)91234-L; Moecke H, 2000, ANAESTHESIST, V49, P211, DOI 10.1007/s001010050817; Schwartz J, 1999, EPIDEMIOLOGY, V10, P17, DOI 10.1097/00001648-199901000-00005; Strike PC, 2006, HEART, V92, P1035, DOI 10.1136/hrt.2005.077362; Tofler GH, 2006, CIRCULATION, V114, P1863, DOI 10.1161/CIRCULATIONAHA.105.596189; TOFLER GH, 1990, AM J CARDIOL, V66, P22, DOI 10.1016/0002-9149(90)90729-K; Toubiana L, 2001, BRIT MED J, V322, P1306, DOI 10.1136/bmj.322.7297.1306; Wilbert-Lampen U, 2007, ENDOTHELIUM-J ENDOTH, V14, P65, DOI 10.1080/10623320701346585; Wilbert-Lampen U, 2006, J CARDIOVASC PHARM, V47, P110, DOI 10.1097/01.fjc.0000196240.58641.d3; Wilbert-Lampen U, 2006, J PSYCHOSOM RES, V61, P453, DOI 10.1016/j.jpsychores.2006.07.001; Witte DR, 2000, BMJ-BRIT MED J, V321, P1552, DOI 10.1136/bmj.321.7276.1552; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd, DOI 10.1201/9781315370279	24	271	280	23	52	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2008	358	5					475	483		10.1056/NEJMoa0707427	http://dx.doi.org/10.1056/NEJMoa0707427			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	256IW	18234752				2022-12-28	WOS:000252722900005
J	Davies, PG				Davies, Peter G.			The treatment paradox - The interpretation of evidence	BRITISH MEDICAL JOURNAL			English	Letter									Keighley Rd Surg, Halifax, NS HX2 9LL, Canada		Davies, PG (corresponding author), Keighley Rd Surg, Halifax, NS HX2 9LL, Canada.							JENKINSON S, 2008, STUDENT BMJ; Spence D, 2008, BRIT MED J, V336, P100, DOI 10.1136/bmj.39454.622824.94	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 26	2008	336	7637					174	174		10.1136/bmj.39465.493090.3A	http://dx.doi.org/10.1136/bmj.39465.493090.3A			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259KT	18219016	Green Published			2022-12-28	WOS:000252938900018
J	Lubell, Y; Reyburn, H; Mbakilwa, H; Mwangi, R; Chonya, S; Whitty, CJM; Mills, A				Lubell, Yoel; Reyburn, Hugh; Mbakilwa, Hilda; Mwangi, Rose; Chonya, Semkini; Whitty, Christopher J. M.; Mills, Anne			The impact of response to the results of diagnostic tests for malaria: cost-benefit analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FEBRILE ILLNESS; MICROSCOPY; TANZANIA	Objective Rapid diagnostic tests for malaria seem cost effective in standard analyses, but these do not take account of clinicians' response to test results. This study tested the impact of clinicians' response to rapid diagnostic test or microscopy results on the costs and benefits of testing at different levels of malaria transmission and in different age groups. Design Cost-benefit analysis using a decision tree model and clinical data on the effectiveness of diagnostic tests for malaria, their costs, and clinicians' response to test results. Setting Tanzania. Methods Data were obtained from a clinical trial of 2425 patients carried out in three settings of varying transmission. Results At moderate and tow levels of malaria transmission, rapid diagnostic tests were more cost beneficial than microscopy, and both more so than presumptive treatment, but only where response was consistent with test results. At the levels of prescription of antimalarial drugs to patients with negative tests that have been found in observational studies and trials, neither test methodis likely to be cost beneficial, incurring costs 10-250% higher, depending on transmission rate, than would have been the case with fully consistent responses to all test results. Microscopy becomes more cost beneficial than rapid diagnostic tests when its sensitivity under operational conditions approaches that of rapid diagnostic tests. Conclusions Improving diagnostic methods, including rapid diagnostic tests, can reduce costs and enhance the benefits of effective antimalarial drugs, but only if the consistency of response to test results is also improved. Investing in methods to improve rational response to tests is essential. Economic evaluations of diagnostic tests should take into account whether clinicians' response is consistent with test results.	[Lubell, Yoel; Mills, Anne] Univ London London Sch Hyg & Trop Med, Hlth Econ & Financing Programme, Dept Publ Hlth & Policy, London WC1E 7HT, England; [Reyburn, Hugh; Whitty, Christopher J. M.] Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Med, London WC1E 7HT, England; [Mbakilwa, Hilda; Mwangi, Rose; Chonya, Semkini] Kilimanjaro Christian Med Ctr, Joint Malaria Programme, Moshi, Tanzania	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Kilimanjaro Christian Medical Centre	Lubell, Y (corresponding author), Univ London London Sch Hyg & Trop Med, Hlth Econ & Financing Programme, Dept Publ Hlth & Policy, Keppel St, London WC1E 7HT, England.	yoel.lubell@lshtm.ac.uk	Whitty, Christopher/C-7740-2012	Mills, Anne/0000-0001-9863-9950; Lubell, Yoel/0000-0002-0237-1070; Whitty, Christopher/0000-0002-6076-5027				Agnamey P, 2005, TROP MED INT HEALTH, V10, P926, DOI 10.1111/j.1365-3156.2005.01482.x; Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; Bell D, 2006, NAT REV MICROBIOL, pS7, DOI [10.1038/nrmico1525, 10.1038/nrmicro1525]; Coleman PG, 2004, AM J TROP MED HYG, V71, P196, DOI 10.4269/ajtmh.2004.71.196; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Foster S, 1998, ANN TROP MED PARASIT, V92, P391, DOI 10.1080/00034989859375; Garber AM, 1997, J HEALTH ECON, V16, P1, DOI 10.1016/S0167-6296(96)00506-1; Gold MR, 1996, COST EFFECTIVENESS H; Goodman CA, 2006, HEALTH POLICY PLANN, V21, P275, DOI 10.1093/heapol/czl011; Goodman CA, 2001, HEALTH ECON, V10, P731, DOI 10.1002/hec.621; Hamer DH, 2007, JAMA-J AM MED ASSOC, V297, P2227, DOI 10.1001/jama.297.20.2227; JONKMAN A, 1995, B WORLD HEALTH ORGAN, V73, P223; LUBELL Y, 2007, AM J TROP MED HYG  S, P77; Marsh K, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P241; MIN NC, 2000, SE ASIAN J TROP MED, V31, P238; *NAT MAL CONTR PRO, 2000, NAT GUID MAL TREATM; *NAT MAL CONTROL P, 2000, NAT GUID MAL TREATM; Rafael Maria E, 2006, Nature, V444 Suppl 1, P39, DOI 10.1038/nature05445; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; Rolland E, 2006, TROP MED INT HEALTH, V11, P398, DOI 10.1111/j.1365-3156.2006.01580.x; SHILLCUTT S, 2007, B WHO; WHO, 2006, GUID TREATM MAL; *WHO, 1996, TDRGEN961 WHO; *WHO, 2007, MAL RAP DIAGN TESTS; *WHO STAT INF SYST, 2007, WORLD HLTH STAT 2007; Wiseman V, 2006, PLOS MED, V3, P1844, DOI 10.1371/journal.pmed.0030373; *WORLD BANK, 2007, GNI PER CAP 2005; Zurovac D, 2006, ANN TROP MED PARASIT, V100, P283, DOI 10.1179/136485906X105633	29	113	113	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2008	336	7637					202	205		10.1136/bmj.39395.696065.47	http://dx.doi.org/10.1136/bmj.39395.696065.47			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259KT	18199700	Bronze, Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000252938900044
J	McMichael, AJ; Friel, S; Nyong, A; Corvalan, C				McMichael, A. J.; Friel, S.; Nyong, A.; Corvalan, C.			Global environmental change and health: impacts, inequalities, and the health sector	BRITISH MEDICAL JOURNAL			English	Editorial Material							CLIMATE-CHANGE; POPULATION HEALTH; BANGLADESH; CHALLENGE; AFRICA; ISSUES		[McMichael, A. J.; Friel, S.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Nyong, A.] Univ Jos, Ctr Environm Resources & Hazards Res, Dept Geog & Planning, Jos, Nigeria; [Corvalan, C.] WHO, CH-1211 Geneva, Switzerland	Australian National University; University of Jos; World Health Organization	McMichael, AJ (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia.	tony.mcmichael@anu.edu.au		Friel, Sharon/0000-0002-8345-5435				Abdalla Abdalla Ahmed, 2006, ENV DEGRADATION CONF, P87; Barrios S, 2006, J URBAN ECON, V60, P357, DOI 10.1016/j.jue.2006.04.005; BAYLIS M, 2005, EFFECTS CLIMATE CHAN; Burnett J, 2007, BMJ-BRIT MED J, V334, P671; Butler CD, 2005, SOCIAL INJUSTICE PUB, V318-36; Corvalan C, 2005, ECOSYSTEMS HUMAN WEL; DESANKER P, 2001, CLIMATE CHANGE 2001, P433; Desanker PV, 2001, CLIM RES, V17, P93, DOI 10.3354/cr017093; Earth System Science Partnership, GLOB ENV CHANG HUM H; FRUMKIN H, IN PRESS AM J PUBLIC; Haines A, 2006, LANCET, V367, P2101, DOI 10.1016/S0140-6736(06)68933-2; Hassan MM, 2005, SOC SCI MED, V61, P2201, DOI 10.1016/j.socscimed.2005.04.021; Hirji R, 2002, DEFINING MAINSTREAM; Hulme M, 2001, CLIM RES, V17, P145, DOI 10.3354/cr017145; *INT PAN CLIM CHAN, 2007, CLIM CHANG 2006 IMP; Karim M, 2000, WATER RES, V34, P304, DOI 10.1016/S0043-1354(99)00128-1; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; McMichael AJ, 2006, HEALTH PROMOT INT, V21, P15, DOI 10.1093/heapro/dal047; McMichael AJ, 2006, EUR J PUBLIC HEALTH, V16, P579, DOI 10.1093/eurpub/ckl102; Parry ML, 2004, GLOBAL ENVIRON CHANG, V14, P53, DOI 10.1016/j.gloenvcha.2003.10.008; Pruss-Ustun A., 2006, WORLD HEALTH; Stern Nicholas, 2006, STERN REV EC CLIMATE; *UN ENV PROGR, 2007, DARF POST CONFL ASS; United Nations, 2000, MILL DEV GOALS; *WHO UN JOINT MON, 2006, M MDG DRINK WAT SAN; World Health Organization, 2006, WHO HOUS EN DAT; Zhang JJ, 2007, ENVIRON HEALTH PERSP, V115, P848, DOI 10.1289/ehp.9479	27	189	192	2	37	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 26	2008	336	7637					191	194		10.1136/bmj.39392.473727.AD	http://dx.doi.org/10.1136/bmj.39392.473727.AD			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	259KT	18219041	Green Submitted, Green Published			2022-12-28	WOS:000252938900041
J	Saze, H; Shiraishi, A; Miura, A; Kakutani, T				Saze, Hidetoshi; Shiraishi, Akiko; Miura, Asuka; Kakutani, Tetsuji			Control of genic DNA methylation by a jmjC domain - Containing protein in Arabidopsis thaliana	SCIENCE			English	Article							NON-CG METHYLATION; MAINTENANCE; HETEROCHROMATIN; TRANSPOSONS; MUTATION; GENOME	Differential cytosine methylation of repeats and genes is important for coordination of genome stability and proper gene expression. Through genetic screen of mutants showing ectopic cytosine methylation in a genic region, we identified a jmjC- domain gene, IBM1 ( increase in bonsai methylation 1), in Arabidopsis thaliana. In addition to the ectopic cytosine methylation, the ibm1 mutations induced a variety of developmental phenotypes, which depend on methylation of histone H3 at lysine 9. Paradoxically, the developmental phenotypes of the ibm1 were enhanced by the mutation in the chromatin- remodeling gene DDM1 ( decrease in DNA methylation 1), which is necessary for keeping methylation and silencing of repeated heterochromatin loci. Our results demonstrate the importance of chromatin remodeling and histone modifications in the differential epigenetic control of repeats and genes.	[Saze, Hidetoshi; Shiraishi, Akiko; Miura, Asuka; Kakutani, Tetsuji] Natl Inst Genet, Dept Integrated Genet, Shizuoka 4118540, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Saze, H (corresponding author), Natl Inst Genet, Dept Integrated Genet, Yata 1111, Shizuoka 4118540, Japan.	hsaze@lab.nig.ac.jp	Hu, Ruogu/B-2203-2008; Saze, Hidetoshi/B-5922-2015	Saze, Hidetoshi/0000-0002-8647-1430				Bartee L, 2001, GENE DEV, V15, P1753, DOI 10.1101/gad.905701; Bender J, 2004, CURR OPIN PLANT BIOL, V7, P521, DOI 10.1016/j.pbi.2004.07.003; Brzeski J, 2003, J BIOL CHEM, V278, P823, DOI 10.1074/jbc.M209260200; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jacobsen SE, 2000, CURR BIOL, V10, P179, DOI 10.1016/S0960-9822(00)00324-9; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Johnson LM, 2007, CURR BIOL, V17, P379, DOI 10.1016/j.cub.2007.01.009; Kakutani T, 2004, COLD SPRING HARB SYM, V69, P139, DOI 10.1101/sqb.2004.69.139; Kakutani T, 1996, P NATL ACAD SCI USA, V93, P12406, DOI 10.1073/pnas.93.22.12406; Kankel MW, 2003, GENETICS, V163, P1109; Kato M, 2003, CURR BIOL, V13, P421, DOI 10.1016/S0960-9822(03)00106-4; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Malagnac F, 2002, EMBO J, V21, P6842, DOI 10.1093/emboj/cdf687; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Saze H, 2007, EMBO J, V26, P3641, DOI 10.1038/sj.emboj.7601788; Tompa R, 2002, CURR BIOL, V12, P65, DOI 10.1016/S0960-9822(01)00622-4; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	28	209	227	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2008	319	5862					462	465		10.1126/science.1150987	http://dx.doi.org/10.1126/science.1150987			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254HB	18218897				2022-12-28	WOS:000252576600038
J	Gerardot, BD; Brunner, D; Dalgarno, PA; Ohberg, P; Seidl, S; Kroner, M; Karrai, K; Stoltz, NG; Petroff, PM; Warburton, RJ				Gerardot, Brian D.; Brunner, Daniel; Dalgarno, Paul A.; Ohberg, Patrik; Seidl, Stefan; Kroner, Martin; Karrai, Khaled; Stoltz, Nick G.; Petroff, Pierre M.; Warburton, Richard J.			Optical pumping of a single hole spin in a quantum dot	NATURE			English	Article							ELECTRON-SPIN; COMPUTATION	The spin of an electron is a natural two- level system for realizing a quantum bit in the solid state(1-16). For an electron trapped in a semiconductor quantum dot, strong quantum confinement highly suppresses the detrimental effect of phonon- related spin relaxation(1-7). However, this advantage is offset by the hyperfine interaction between the electron spin and the 10(4) to 10(6) spins of the host nuclei in the quantum dot. Random fluctuations in the nuclear spin ensemble lead to fast spin decoherence in about ten nanoseconds(8-14). Spin- echo techniques have been used to mitigate the hyperfine interaction(14,15), but completely cancelling the effect is more attractive. In principle, polarizing all the nuclear spins can achieve this(16,17) but is very difficult to realize in practice(12,18,19). Exploring materials with zero- spin nuclei is another option, and carbon nanotubes(20), graphene quantum dots(21) and silicon have been proposed. An alternative is to use a semiconductor hole. Unlike an electron, a valence hole in a quantum dot has an atomic p orbital which conveniently goes to zero at the location of all the nuclei, massively suppressing the interaction with the nuclear spins. Furthermore, in a quantum dot with strong strain and strong quantization, the heavy hole with spin- 3/2 behaves as a spin-1/2 system and spin decoherence mechanisms are weak(22,23). We demonstrate here high fidelity ( about 99 per cent) initialization of a single hole spin confined to a self- assembled quantum dot by optical pumping. Our scheme works even at zero magnetic field, demonstrating a negligible hole spin hyperfine interaction. We determine a hole spin relaxation time at low field of about one millisecond. These results suggest a route to the realization of solid- state quantum networks(24) that can intra- convert the spin state with the polarization of a photon.	[Gerardot, Brian D.; Brunner, Daniel; Dalgarno, Paul A.; Ohberg, Patrik; Warburton, Richard J.] Heriot Watt Univ, Sch Engn & Phys Sci, Edinburgh EH14 4AS, Midlothian, Scotland; [Seidl, Stefan; Kroner, Martin; Karrai, Khaled] Univ Munich, Ctr Nanosci, D-90539 Munich, Germany; [Seidl, Stefan; Kroner, Martin; Karrai, Khaled] Univ Munich, Dept Phys, D-90539 Munich, Germany; [Stoltz, Nick G.; Petroff, Pierre M.] Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA	Heriot Watt University; University of Munich; University of Munich; University of California System; University of California Santa Barbara	Gerardot, BD (corresponding author), Heriot Watt Univ, Sch Engn & Phys Sci, Edinburgh EH14 4AS, Midlothian, Scotland.	b.d.gerardot@hw.ac.uk; r.j.warburton@hw.ac.uk	Gerardot, Brian D./AHB-1102-2022; Brunner, Daniel/J-3460-2012; Dalgarno, Paul/A-4065-2010; Öhberg, Patrik/C-8926-2013; Petroff, Pierre/M-9840-2019; Warburton, Richard/ABC-3609-2021; Gerardot, Brian D/D-2418-2009	Brunner, Daniel/0000-0002-4003-3056; Öhberg, Patrik/0000-0002-8780-4233; Gerardot, Brian D/0000-0002-0279-898X; Dalgarno, Paul/0000-0001-7701-373X	EPSRC [EP/E037992/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E037992/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		AMASHA S, 2006, MEASUREMENTS SPIN RE; Atature M, 2006, SCIENCE, V312, P551, DOI 10.1126/science.1126074; Bergmann K, 1998, REV MOD PHYS, V70, P1003, DOI 10.1103/RevModPhys.70.1003; Bracker AS, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047402; Braun PF, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.116601; Bulaev DV, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.076805; Burkard G, 1999, PHYS REV B, V59, P2070, DOI 10.1103/PhysRevB.59.2070; Coish WA, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.195340; DiVincenzo DP, 2000, FORTSCHR PHYS, V48, P771, DOI 10.1002/1521-3978(200009)48:9/11<771::AID-PROP771>3.0.CO;2-E; DREISER J, 2007, OPTICAL INVESTIGATIO; Elzerman JM, 2004, NATURE, V430, P431, DOI 10.1039/nature02693; Gerardot BD, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2743750; Greilich A, 2006, SCIENCE, V313, P341, DOI 10.1126/science.1128215; HEISS D, 2007, OBSERVATION EXTREMEL; Hogele A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.217401; Imamoglu A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.017402; Johnson AC, 2005, NATURE, V435, P925, DOI 10.1038/nature03815; Khaetskii AV, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.186802; Koppens FHL, 2005, SCIENCE, V309, P1346, DOI 10.1126/science.1113719; Kroutvar M, 2004, NATURE, V432, P81, DOI 10.1038/nature03008; Lai CW, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.167403; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Merkulov IA, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.205309; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Postma HWC, 2001, SCIENCE, V293, P76, DOI 10.1126/science.1061797; Smith JM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.197402; URBASZEK B, 2005, PHYS REV LETT, V90	30	333	335	1	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2008	451	7177					441	444		10.1038/nature06472	http://dx.doi.org/10.1038/nature06472			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	253YS	18216849	Bronze			2022-12-28	WOS:000252554100039
J	Kawai, T; Cosimi, AB; Spitzer, TR; Tolkoff-Rubin, N; Suthanthiran, M; Saidman, SL; Shaffer, J; Preffer, FI; Ding, RC; Sharma, V; Fishman, JA; Dey, B; Ko, DSC; Hertl, M; Goes, NB; Wong, WC; Williams, WW; Colvin, RB; Sykes, M; Sachs, DH				Kawai, Tatsuo; Cosimi, A. Benedict; Spitzer, Thomas R.; Tolkoff-Rubin, Nina; Suthanthiran, Manikkam; Saidman, Susan L.; Shaffer, Juanita; Preffer, Frederic I.; Ding, Ruchuang; Sharma, Vijay; Fishman, Jay A.; Dey, Bimalangshu; Ko, Dicken S. C.; Hertl, Martin; Goes, Nelson B.; Wong, Waichi; Williams, Winfred W., Jr.; Colvin, Robert B.; Sykes, Megan; Sachs, David H.			Brief report: HLA-mismatched renal transplantation without maintenance immunosuppression	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DONOR BONE-MARROW; ALLOGRAFT TOLERANCE; MIXED CHIMERISM; LYMPHOHEMATOPOIETIC CHIMERISM; CYNOMOLGUS MONKEYS; MULTIPLE-MYELOMA; BODY IRRADIATION; RECIPIENTS; INDUCTION; KIDNEY	Five patients with end-stage renal disease received combined bone marrow and kidney transplants from HLA single-haplotype mismatched living related donors, with the use of a nonmyeloablative preparative regimen. Transient chimerism and reversible capillary leak syndrome developed in all recipients. Irreversible humoral rejection occurred in one patient. In the other four recipients, it was possible to discontinue all immunosuppressive therapy 9 to 14 months after the transplantation, and renal function has remained stable for 2.0 to 5.3 years since transplantation. The T cells from these four recipients, tested in vitro, showed donor-specific unresponsiveness and in specimens from allograft biopsies, obtained after withdrawal of immunosuppressive therapy, there were high levels of P3 (FOXP3) messenger RNA (mRNA) but not granzyme B mRNA.	[Kawai, Tatsuo; Cosimi, A. Benedict; Tolkoff-Rubin, Nina; Fishman, Jay A.; Ko, Dicken S. C.; Hertl, Martin; Goes, Nelson B.; Wong, Waichi; Williams, Winfred W., Jr.] Massachusetts Gen Hosp, Transplantat Unit, Boston, MA 02114 USA; [Shaffer, Juanita; Sykes, Megan; Sachs, David H.] Massachusetts Gen Hosp, Transplantat Biol Res Ctr, Boston, MA 02114 USA; [Spitzer, Thomas R.; Dey, Bimalangshu] Massachusetts Gen Hosp, Dept Med, Bone Marrow Transplantat Program, Boston, MA 02114 USA; [Saidman, Susan L.; Preffer, Frederic I.; Colvin, Robert B.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Kawai, Tatsuo; Cosimi, A. Benedict; Spitzer, Thomas R.; Tolkoff-Rubin, Nina; Saidman, Susan L.; Shaffer, Juanita; Preffer, Frederic I.; Fishman, Jay A.; Dey, Bimalangshu; Ko, Dicken S. C.; Hertl, Martin; Goes, Nelson B.; Wong, Waichi; Williams, Winfred W., Jr.; Colvin, Robert B.; Sykes, Megan; Sachs, David H.] Harvard Univ, Sch Med, Boston, MA USA; [Suthanthiran, Manikkam; Ding, Ruchuang; Sharma, Vijay] New York Presbyterian Hosp Weill Cornell Med Ctr, Dept Med & Transplant Med, Div Nephrol, New York, NY USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Cornell University; NewYork-Presbyterian Hospital	Sachs, DH (corresponding author), Massachusetts Gen Hosp, Transplantat Biol Res Ctr, 149 13th St, Charlestown, MA 02129 USA.		Suthanthiran, Manikkam/AAL-9104-2020; Spitzer, Thomas/AAR-7652-2020		NIAID NIH HHS [R01 AI037692-09, R01 AI037692-10, N01 AI015416, U19 AI102405, R01 AI037692, R21 AI037692, R21 AI037692-06, N01AI15416] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI015416, U19AI102405, R21AI037692, R01AI037692] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BARBER WH, 1991, TRANSPLANTATION, V51, P70, DOI 10.1097/00007890-199101000-00011; Buhler LH, 2002, TRANSPLANTATION, V74, P1405, DOI 10.1097/01.TP.0000034627.37442.A4; Ciancio G, 2002, TRANSPLANTATION, V74, P488, DOI 10.1097/00007890-200208270-00010; Corry RJ, 1999, ANN SURG, V230, P372, DOI 10.1097/00000658-199909000-00010; Fuchimoto Y, 2000, J CLIN INVEST, V105, P1779, DOI 10.1172/JCI8721; Fudaba Y, 2006, AM J TRANSPLANT, V6, P2121, DOI 10.1111/j.1600-6143.2006.01434.x; Haas M, 2006, AM J TRANSPLANT, V6, P1829, DOI 10.1111/j.1600-6143.2006.01356.x; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Kawai T, 1999, TRANSPLANTATION, V68, P1767, DOI 10.1097/00007890-199912150-00022; Kawai T, 2004, AM J TRANSPLANT, V4, P1391, DOI 10.1111/j.1600-6143.2004.00523.x; KAWAI T, 1995, TRANSPLANTATION, V59, P256, DOI 10.1097/00007890-199501270-00018; Kimikawa M, 1997, TRANSPLANTATION, V64, P709, DOI 10.1097/00007890-199709150-00008; Kirk AD, 2005, TRANSPLANTATION, V80, P1051, DOI 10.1097/01.tp.0000174341.49741.8f; Lee I, 2005, J EXP MED, V201, P1037, DOI 10.1084/jem.20041709; Mengel M, 2005, AM J TRANSPLANT, V5, P1050, DOI 10.1111/j.1600-6143.2005.00788.x; Mezrich JD, 2003, TRANSPLANTATION, V76, P625, DOI 10.1097/01.TP.0000079926.80833.42; Millan TLT, 2002, TRANSPLANTATION, V73, P1386, DOI 10.1097/00007890-200205150-00005; MURRAY JE, 1960, SURGERY, V48, P272; Muthukumar T, 2005, NEW ENGL J MED, V353, P2342, DOI 10.1056/NEJMoa051907; Pascual M, 2002, NEW ENGL J MED, V346, P580, DOI 10.1056/NEJMra011295; Sayegh MH, 2004, NEW ENGL J MED, V351, P2761, DOI 10.1056/NEJMon043418; Sayegh MH, 1999, KIDNEY INT, V56, P1967, DOI 10.1046/j.1523-1755.1999.00751.x; SCHWARTZ DWM, 1995, VOX SANG, V68, P139, DOI 10.1111/j.1423-0410.1995.tb02571.x; Shapiro R, 2005, J AM COLL SURGEONS, V200, P505, DOI 10.1016/j.jamcollsurg.2004.12.024; SHARABI Y, 1989, J EXP MED, V169, P493, DOI 10.1084/jem.169.2.493; Spitzer TR, 1999, TRANSPLANTATION, V68, P480, DOI 10.1097/00007890-199908270-00006; Spitzer TR, 2001, BONE MARROW TRANSPL, V27, P893, DOI 10.1038/sj.bmt.1703015; Starzl TE, 1998, THEOR MED BIOETH, V19, P441, DOI 10.1023/A:1009924907775	28	787	842	0	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2008	358	4					353	361		10.1056/NEJMoa071074	http://dx.doi.org/10.1056/NEJMoa071074			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253GY	18216355	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000252507900005
J	Le May, MR; So, DY; Dionne, R; Glover, CA; Froeschl, MPV; Wells, GA; Davies, RF; Sherrard, HL; Maloney, J; Marquis, JF; O'Brien, ER; Trickett, J; Poirier, P; Ryan, SC; Ha, A; Joseph, PG; Labinaz, M				Le May, Michel R.; So, Derek Y.; Dionne, Richard; Glover, Chris A.; Froeschl, Michael P. V.; Wells, George A.; Davies, Richard F.; Sherrard, Heather L.; Maloney, Justin; Marquis, Jean-Francois; O'Brien, Edward R.; Trickett, John; Poirier, Pierre; Ryan, Sheila C.; Ha, Andrew; Joseph, Phil G.; Labinaz, Marino			A citywide protocol for primary PCI in ST-segment elevation myocardial infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; TO-BALLOON TIME; PRIMARY ANGIOPLASTY; IMMEDIATE THROMBOLYSIS; RANDOMIZED-TRIAL; UNITED-STATES; MORTALITY; TRANSPORT; THERAPY; STRATEGIES	Background: If primary percutaneous coronary intervention (PCI) is performed promptly, the procedure is superior to fibrinolysis in restoring flow to the infarct-related artery in patients with ST-segment elevation myocardial infarction. The benchmark for a timely PCI intervention has become a door-to-balloon time of less than 90 minutes. Whether regional strategies can be developed to achieve this goal is uncertain. Methods: We developed an integrated-metropolitan-area approach in which all patients with ST-segment elevation myocardial infarction were referred to a specialized center for primary PCI. We sought to determine whether there was a difference in door-to-balloon times between patients who were referred directly from the field by paramedics trained in the interpretation of electrocardiograms and patients who were referred by emergency department physicians. Results: Between May 1, 2005, and April 30, 2006, a total of 344 consecutive patients with ST-segment elevation myocardial infarction were referred for primary PCI: 135 directly from the field and 209 from emergency departments. Primary PCI was performed in 93.6% of patients. The median door-to-balloon time was shorter in patients referred from the field (69 minutes; interquartile range, 43 to 87) than in patients needing interhospital transfer (123 minutes; interquartile range, 101 to 153; P<0.001). Door-to-balloon times of less than 90 minutes were achieved in 79.7% of patients who were transferred from the field and in 11.9% of those transferred from emergency departments (P<0.001). Conclusions: Guideline door-to-balloon-times were more often achieved when trained paramedics independently triaged and transported patients directly to a designated primary PCI center than when patients were referred from emergency departments.	[Le May, Michel R.; So, Derek Y.; Glover, Chris A.; Froeschl, Michael P. V.; Wells, George A.; Davies, Richard F.; Sherrard, Heather L.; Marquis, Jean-Francois; O'Brien, Edward R.; Ryan, Sheila C.; Ha, Andrew; Joseph, Phil G.; Labinaz, Marino] Univ Ottawa, Inst Heart, Ottawa, ON, Canada; [Dionne, Richard; Maloney, Justin; Trickett, John] Univ Ottawa, Ottawa Base Hosp Program, Ottawa, ON, Canada; [Poirier, Pierre] Ottawa Paramedic Serv, Ottawa, ON, Canada	University of Ottawa; University of Ottawa Heart Institute; University of Ottawa	Le May, MR (corresponding author), Ottawa Heart Inst, 40 Ruskin St, Ottawa, ON K1Y 4W7, Canada.	mlemay@ottawaheart.ca	O'Brien, Edward R/J-6621-2013	O'Brien, Edward R/0000-0003-1039-9425				Andersen HR, 2003, NEW ENGL J MED, V349, P733, DOI 10.1056/NEJMoa025142; [Anonymous], 1986, LANCET, V1, P397; Antman EM, 2007, CIRCULATION, V115, pE411, DOI 10.1161/CIRCULATIONAHA.107.183508; Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014; Antman EM, 2005, CIRCULATION, V111, P2013; Berger PB, 1999, CIRCULATION, V100, P14, DOI 10.1161/01.CIR.100.1.14; Boersma E, 2006, EUR HEART J, V27, P779, DOI 10.1093/eurheartj/ehi810; Bradley EH, 2006, CIRCULATION, V113, P1079, DOI 10.1161/CIRCULATIONAHA.105.590133; Bradley EH, 2006, NEW ENGL J MED, V355, P2308, DOI 10.1056/NEJMsa063117; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; Canto JG, 2000, NEW ENGL J MED, V342, P1573, DOI 10.1056/NEJM200005253422106; De Luca G, 2004, CIRCULATION, V109, P1223, DOI 10.1161/01.CIR.0000121424.76486.20; Fox KAA, 2004, AM HEART J, V148, pS40, DOI 10.1016/j.ahj.2004.09.014; Grines CL, 2002, J AM COLL CARDIOL, V39, P1713, DOI 10.1016/S0735-1097(02)01870-3; Henry TD, 2006, J AM COLL CARDIOL, V47, P1339, DOI 10.1016/j.jacc.2005.05.101; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Keeley EC, 2006, LANCET, V367, P579, DOI 10.1016/S0140-6736(06)68148-8; Keeley EC, 2006, LANCET, V367, P1656; Labinaz M, 2006, CAN J CARDIOL, V22, P243, DOI 10.1016/S0828-282X(06)70904-7; Le May Michel R, 2006, CJEM, V8, P401; Le May MR, 2006, AM J CARDIOL, V98, P1329, DOI 10.1016/j.amjcard.2006.06.019; Le May MR, 2003, CIRCULATION, V108, P2624, DOI 10.1161/01.CIR.0000097120.26062.FE; McNamara RL, 2006, J AM COLL CARDIOL, V47, P2180, DOI 10.1016/j.jacc.2005.12.072; Nallamothu BK, 2005, CIRCULATION, V111, P761, DOI 10.1161/01.CIR.0000155258.44268.F8; Nallamothu BK, 2006, CIRCULATION, V113, P1189, DOI 10.1161/CIRCULATIONAHA.105.596346; OHMAN EM, 1990, CIRCULATION, V82, P781, DOI 10.1161/01.CIR.82.3.781; PASSAMANI E, 1985, NEW ENGL J MED, V312, P932; ROSS AM, 1993, NEW ENGL J MED, V329, P1615; So DYF, 2006, AM J CARDIOL, V97, P458, DOI 10.1016/j.amjcard.2005.08.069; The GUSTO Angiographic Investigators, 1994, NEW ENGL J MED, V330, P516; Van de Werf F, 2003, EUR HEART J, V24, P28, DOI 10.1016/S0195-668X(02)00618-8; Vermeer F, 1999, HEART, V82, P426, DOI 10.1136/hrt.82.4.426; Widimsky P, 2000, EUR HEART J, V21, P823, DOI 10.1053/euhj.1999.1993; Widimsky P, 2003, EUR HEART J, V24, P94, DOI 10.1016/S0195-668X(02)00468-2; Zijlstra F, 2003, EUR HEART J, V24, P21, DOI 10.1016/S0195-668X(02)00693-0	35	296	300	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2008	358	3					231	240		10.1056/NEJMoa073102	http://dx.doi.org/10.1056/NEJMoa073102			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	251LS	18199862				2022-12-28	WOS:000252375600004
J	Riser, SC; Johnson, KS				Riser, Stephen C.; Johnson, Kenneth S.			Net production of oxygen in the subtropical ocean	NATURE			English	Article							METABOLIC BALANCE; RESPIRATION; NITROGEN; WATER	The question of whether the plankton communities in low-utrient regions of the ocean, comprising 80% of the global ocean surface area, are net producers or consumers of oxygen and fixed carbon is a key uncertainty in the global carbon cycle(1,2). Direct measurements in bottle experiments indicate net oxygen consumption in the sunlit zone(3-6), whereas geochemical evidence suggests that the upper ocean is a net source of oxygen(2). One possible resolution to this conflict is that primary production in the gyres is episodic(1,2,6) and thus difficult to observe: in this model, oligotrophic regions would be net consumers of oxygen during most of the year, but strong, brief events with high primary production rates might produce enough fixed carbon and dissolved oxygen to yield net production as an average over the annual cycle. Here we examine the balance of oxygen production over three years at sites in the North and South Pacific subtropical gyres using the new technique of oxygen sensors deployed on profiling floats. We find that mixing events during early winter homogenize the upper water column and cause low oxygen concentrations. Oxygen then increases below the mixed layer at a nearly constant rate that is similar to independent measures of net community production. This continuous oxygen increase is consistent with an ecosystem that is a net producer of fixed carbon ( net autotrophic) throughout the year, with episodic events not required to sustain positive oxygen production.	[Riser, Stephen C.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Johnson, Kenneth S.] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA	University of Washington; University of Washington Seattle; Monterey Bay Aquarium Research Institute	Riser, SC (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	riser@ocean.washington.edu; johnson@mbari.org	Johnson, Kenneth S/F-9742-2011	Johnson, Kenneth S/0000-0001-5513-5584				ANDERSON LA, 1995, DEEP-SEA RES PT I, V42, P1675, DOI 10.1016/0967-0637(95)00072-E; Behrenfeld MJ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002299; del Giorgio PA, 2002, NATURE, V420, P379, DOI 10.1038/nature01165; delGiorgio PA, 1997, NATURE, V385, P148, DOI 10.1038/385148a0; Duarte CM, 1998, SCIENCE, V281, P234, DOI 10.1126/science.281.5374.234; DUARTE CM, 1999, SCIENCE, V284, P173; Emerson S, 2002, DEEP-SEA RES PT I, V49, P941, DOI 10.1016/S0967-0637(02)00004-3; Johnson KS, 2007, CHEM REV, V107, P623, DOI 10.1021/cr050354e; Karl DM, 2003, NATURE, V426, P32, DOI 10.1038/426032a; Keeling CD, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002227; Kortzinger A, 2004, SCIENCE, V306, P1337, DOI 10.1126/science.1102557; Letelier RM, 2000, J GEOPHYS RES-OCEANS, V105, P28723, DOI 10.1029/1999JC000306; Roemmich D, 2004, MAR TECHNOL SOC J, V38, P21, DOI 10.4031/002533204787522802; Roemmich D., 2001, OBSERVING OCEANS 21, P248; Scharek R, 1999, MAR ECOL PROG SER, V182, P55, DOI 10.3354/meps182055; Schlitzer R., 2006, OCEAN DATA VIEW; SHULENBERGER E, 1981, DEEP-SEA RES, V28, P901, DOI 10.1016/0198-0149(81)90009-1; WEISS RF, 1970, DEEP-SEA RES, V17, P721, DOI 10.1016/0011-7471(70)90037-9; Williams PJL, 2004, DEEP-SEA RES PT I, V51, P1563, DOI 10.1016/j.dsr.2004.07.001; WILLIAMS PJL, 1999, SCIENCE, V284, P173	20	151	156	5	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2008	451	7176					323	U5		10.1038/nature06441	http://dx.doi.org/10.1038/nature06441			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202655				2022-12-28	WOS:000252432100047
J	Parikh, NI; Pencina, MJ; Wang, TJ; Benjamin, EJ; Lanier, KJ; Levy, D; D'Agostino, RB; Kannel, WB; Vasan, RS				Parikh, Nisha I.; Pencina, Michael J.; Wang, Thomas J.; Benjamin, Emelia J.; Lanier, Katherine J.; Levy, Daniel; D'Agostino, Ralph B., Sr.; Kannel, William B.; Vasan, Ramachandran S.			A risk score for predicting near-term incidence of hypertension: The Framingham Heart Study	ANNALS OF INTERNAL MEDICINE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; BLOOD-PRESSURE; CIGARETTE-SMOKING; BODY-WEIGHT; PARENTAL HISTORY; ANALGESIC USE; NONHYPERTENSIVE PARTICIPANTS; CARDIOVASCULAR-DISEASE; ARTERIAL STIFFNESS; FAMILY-HISTORY	Background: Studies suggest that targeting high-risk, nonhypertensive individuals for treatment may delay hypertension onset, thereby possibly mitigating vascular complications. Risk stratification may facilitate cost-effective approaches to management. Objective: To develop a simple risk score for predicting hypertension incidence by using measures readily obtained in the physician's office. Design: Longitudinal cohort study. Setting: Framingham Heart Study, Framingham, Massachusetts. Patients: 1717 nonhypertensive white individuals 20 to 69 years of age (mean age, 42 years; 54% women), without diabetes and with both parents in the original cohort of the Framingham Heart Study, contributed 5814 person-examinations. Measurements: Scores were developed for predicting the 1-, 2- and 4-year risk for new-onset hypertension, and performance characteristics of the prediction algorithm were assessed by using calibration and discrimination measures. Parental hypertension was ascertained from examinations of the original cohort of the Framingham Heart Study. Results: During follow-up (median time over all person-examinations, 3.8 years), 796 persons (52% women) developed new-onset hypertension. In multivariable analyses, age, sex, systolic and diastolic blood pressure, body mass index, parental hypertension, and cigarette smoking were significant predictors of hypertension. According to the risk score based on these factors, the 4-year risk for incident hypertension was classified as low (<5%) in 34% of participants, medium (5% to 10%) in 19%, and high (>10%) in 47%. The c-statistic for the prediction model was 0.788, and calibration was very good. Limitations: The risk score findings may not be generalizable to persons of nonwhite race or ethnicity or to persons with diabetes. The risk score algorithm has not been validated in an independent cohort and is based on single measurements of risk factors and blood pressure. Conclusion: The hypertension risk prediction score can be used to estimate an individual's absolute risk for hypertension on short-term follow-up, and it represents a simple, office-based tool that may facilitate management of high-risk individuals with prehypertension.	[Vasan, Ramachandran S.] Framing Heart Study, Newark, NJ 07102 USA		Vasan, RS (corresponding author), Framing Heart Study, 73 Mt Ave, Suit 2, Newark, NJ 07102 USA.	vasan@bu.edu	Ramachandran, Vasan/Y-2527-2019; Levy, Daniel/ABF-6873-2021; Levy, Daniel/ABB-2752-2021; Benjamin, Emelia/E-7103-2011	Ramachandran, Vasan/0000-0001-7357-5970; Levy, Daniel/0000-0003-1843-8724; Pencina, Michael/0000-0001-5798-8855; Wang, Thomas/0000-0003-4063-6508; Benjamin, Emelia/0000-0003-4076-2336	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004334, ZIAHL006001, K23HL074077] Funding Source: NIH RePORTER	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Appel LJ, 2003, JAMA-J AM MED ASSOC, V289, P2083, DOI 10.1001/jama.289.16.2083; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Bakx JC, 1999, J CLIN EPIDEMIOL, V52, P531, DOI 10.1016/S0895-4356(99)00023-2; Benetos A, 2002, AM J HYPERTENS, V15, P1101, DOI 10.1016/S0895-7061(02)03029-7; BERGLUND G, 1975, ACTA MED SCAND, V198, P291; BORKAN GA, 1986, AM J EPIDEMIOL, V124, P410, DOI 10.1093/oxfordjournals.aje.a114411; BURKE GL, 1991, CIRCULATION, V84, P1176, DOI 10.1161/01.CIR.84.3.1176; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Chu N F, 1996, J Cardiovasc Risk, V3, P205, DOI 10.1097/00043798-199604000-00012; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; COMONIHUNTLEY J, 1989, ARCH INTERN MED, V149, P780; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cox D. R., 1984, ANAL SURVIVAL DATA; CRYER PE, 1976, NEW ENGL J MED, V295, P573, DOI 10.1056/NEJM197609092951101; CUPPLES LA, 1987, FRAMINGHAM HEART STU, P87; Curhan GC, 2002, ARCH INTERN MED, V162, P2204, DOI 10.1001/archinte.162.19.2204; Czernichow S, 2002, INT J OBESITY, V26, P1138, DOI 10.1038/sj.ijo.0802059; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; DAWBER TR, 1963, ANN NY ACAD SCI, V107, P539, DOI 10.1111/j.1749-6632.1963.tb13299.x; Dyer AR, 1999, J HUM HYPERTENS, V13, P13, DOI 10.1038/sj.jhh.1000740; Forman JP, 2007, ARCH INTERN MED, V167, P394, DOI 10.1001/archinte.167.4.394; France CR, 1998, PSYCHOPHYSIOLOGY, V35, P341, DOI 10.1017/S0048577298000833; Franco OH, 2005, HYPERTENSION, V46, P280, DOI 10.1161/01.HYP.0000173433.67426.9b; Franklin SS, 1997, CIRCULATION, V96, P308; Gambini G, 1997, G Ital Cardiol, V27, P1153; GRASSI G, 1994, CIRCULATION, V90, P248, DOI 10.1161/01.CIR.90.1.248; GRIMM RH, 1985, ARCH INTERN MED, V145, P1191, DOI 10.1001/archinte.145.7.1191; Halimi JM, 2002, J HYPERTENS, V20, P187, DOI 10.1097/00004872-200202000-00007; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; He JA, 2000, HYPERTENSION, V35, P544, DOI 10.1161/01.HYP.35.2.544; HOSMER DW, 1989, APPL LOGISTIC REGRES; HUBERT HB, 1987, AM J EPIDEMIOL, V125, P812, DOI 10.1093/oxfordjournals.aje.a114598; Imamura H, 1996, CLIN EXP PHARMACOL P, V23, P397, DOI 10.1111/j.1440-1681.1996.tb02748.x; Janzon E, 2004, J INTERN MED, V255, P266, DOI 10.1046/j.1365-2796.2003.01293.x; JOHN U, 2006, QJM, V99, P47; JOHNSON AG, 1994, ANN INTERN MED, V121, P289, DOI 10.7326/0003-4819-121-4-199408150-00011; Jones DW, 1996, AM J HYPERTENS, V9, pS50, DOI 10.1016/0895-7061(96)00183-5; Julius S, 2006, NEW ENGL J MED, V354, P1685, DOI 10.1056/NEJMoa060838; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kim JW, 2005, BLOOD PRESSURE, V14, P80, DOI 10.1080/08037050510008896; Kurth T, 2005, ARCH INTERN MED, V165, P1903, DOI 10.1001/archinte.165.16.1903; Lascaux-Lefebvre V, 1999, J HUM HYPERTENS, V13, P631, DOI 10.1038/sj.jhh.1000884; Lee DH, 2001, HYPERTENSION, V37, P194, DOI 10.1161/01.HYP.37.2.194; Lee JS, 2004, INT J OBESITY, V28, P391, DOI 10.1038/sj.ijo.0802568; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mahmud A, 2003, HYPERTENSION, V41, P183, DOI 10.1161/01.HYP.0000047464.66901.60; MANN SJ, 1991, JAMA-J AM MED ASSOC, V265, P2226, DOI 10.1001/jama.265.17.2226; Niskanen L, 2004, HYPERTENSION, V44, P859, DOI 10.1161/01.HYP.0000146691.51307.84; Okubo Y, 2004, DRUG ALCOHOL DEPEN, V73, P167, DOI 10.1016/j.drugalcdep.2003.10.005; Okubo Y, 2002, J HUM HYPERTENS, V16, P91, DOI 10.1038/sj.jhh.1001303; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; POPE JE, 1993, ARCH INTERN MED, V153, P477, DOI 10.1001/archinte.153.4.477; Radi S, 2004, J HUM HYPERTENS, V18, P487, DOI 10.1038/sj.jhh.1001682; Rebbeck TR, 1996, J CLIN EPIDEMIOL, V49, P727, DOI 10.1016/0895-4356(96)00015-7; Retnakaran R, 2005, CAN MED ASSOC J, V173, P885, DOI 10.1503/cmaj.045159; ROSNER B, 1983, AM J EPIDEMIOL, V117, P429, DOI 10.1093/oxfordjournals.aje.a113561; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Shirakawa T, 2006, HYPERTENS RES, V29, P81, DOI 10.1291/hypres.29.81; STAMLER R, 1979, JAMA-J AM MED ASSOC, V241, P43, DOI 10.1001/jama.241.1.43; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Tozawa M, 2001, HYPERTENS RES, V24, P93, DOI 10.1291/hypres.24.93; van der Sande MAB, 2001, B WORLD HEALTH ORGAN, V79, P321; Vasan RS, 2001, LANCET, V358, P1682, DOI 10.1016/S0140-6736(01)06710-1; VERDECCHIA P, 1995, J HYPERTENS, V13, P1209, DOI 10.1097/00004872-199510000-00016; Whelton PK, 1997, ARCH INTERN MED, V157, P657, DOI 10.1001/archinte.157.6.657; Wilsgaard T, 2000, ARCH INTERN MED, V160, P2847, DOI 10.1001/archinte.160.18.2847; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yeh CJ, 2001, J FORMOS MED ASSOC, V100, P668; Zhang HF, 2006, J HYPERTENS, V24, P1719, DOI 10.1097/01.hjh.0000242395.07473.92; ZINNER SH, 1971, NEW ENGL J MED, V284, P401, DOI 10.1056/NEJM197102252840801	72	197	211	4	50	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2008	148	2					102	110		10.7326/0003-4819-148-2-200801150-00005	http://dx.doi.org/10.7326/0003-4819-148-2-200801150-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254NZ	18195335				2022-12-28	WOS:000252594600003
J	Beaulieu, JM; Marion, S; Rodriguiz, RM; Medvedev, IO; Sotnikova, TD; Ghisi, V; Wetsel, WC; Lefkowitz, RJ; Gainetdinov, RR; Caron, MG				Beaulieu, Jean-Martin; Marion, Sebastien; Rodriguiz, Ramona M.; Medvedev, Ivan O.; Sotnikova, Tatyana D.; Ghisi, Valentina; Wetsel, William C.; Lefkowitz, Robert J.; Gainetdinov, Raul R.; Caron, Marc G.			A beta-arrestin 2 signaling complex mediates lithium action on Behavior	CELL			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; PROTEIN-COUPLED RECEPTORS; BETA-ARRESTIN; MOUSE-BRAIN; KINASE-B; IN-VIVO; MICE; ACTIVATION; DESENSITIZATION; PHOSPHORYLATION	Besides their role in desensitization, b-arrestin 1 and 2 promote the formation of signaling complexes allowing G protein-coupled receptors (GPCR) to signal independently from G proteins. Here we show that lithium, a pharmacological agent used for the management of psychiatric disorders such as bipolar disorder, schizophrenia, and depression, regulates Akt/glycogen synthase kinase 3 (GSK3) signaling and related behaviors in mice by disrupting a signaling complex composed of Akt, beta-arrestin 2, and protein phosphatase 2A. When administered to beta-arrestin 2 knockout mice, lithium fails to affect Akt/GSK3 signaling and induce behavioral changes associated with GSK3 inhibition as it does in normal animals. These results point toward a pharmacological approach to modulating GPCR function that affects the formation of beta-arrestin-mediated signaling complexes.	[Beaulieu, Jean-Martin; Marion, Sebastien; Medvedev, Ivan O.; Sotnikova, Tatyana D.; Ghisi, Valentina; Wetsel, William C.; Gainetdinov, Raul R.; Caron, Marc G.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Lefkowitz, Robert J.; Caron, Marc G.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Wetsel, William C.; Caron, Marc G.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Wetsel, William C.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Howard Hughes Medical Institute	Caron, MG (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	m.caron@cellbio.duke.edu	Sotnikova, Tatyana D/T-9992-2017; Lefkowitz, Robert/AAW-2649-2021; Beaulieu, Jean-Martin/A-7598-2008; Gainetdinov, Raul R/G-5875-2011	Beaulieu, Jean-Martin/0000-0002-0446-7447; Gainetdinov, Raul R/0000-0003-2951-6038; Marion, Sebastien/0000-0002-3302-3845	NIMH NIH HHS [MH-73853, MH-40159] Funding Source: Medline; NINDS NIH HHS [NS-19576] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073853, P50MH040159, P30MH040159, R37MH073853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019576] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Beaulieu JM, 2007, TRENDS PHARMACOL SCI, V28, P166, DOI 10.1016/j.tips.2007.02.006; Beaulieu JM, 2007, INT J NEUROPSYCHOPH, V10, P3, DOI 10.1017/S1461145706006857; Beaulieu JM, 2007, J NEUROSCI, V27, P881, DOI 10.1523/JNEUROSCI.5074-06.2007; Beaulieu JM, 2006, J BIOL CHEM, V281, P32072, DOI 10.1074/jbc.M606062200; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; BERRIDGE MJ, 1989, CELL, V59, P411, DOI 10.1016/0092-8674(89)90026-3; BIRCH NJ, 1974, LANCET, V2, P965; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Chalecka-Franaszek E, 1999, P NATL ACAD SCI USA, V96, P8745, DOI 10.1073/pnas.96.15.8745; COX C, 1971, NATURE, V232, P336, DOI 10.1038/232336a0; CRAWLEY J, 1980, PHARMACOL BIOCHEM BE, V13, P167, DOI 10.1016/0091-3057(80)90067-2; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Crowley JJ, 2004, PHARMACOL BIOCHEM BE, V78, P269, DOI 10.1016/j.pbb.2004.03.014; De Ferrari GV, 2003, MOL PSYCHIATR, V8, P195, DOI 10.1038/sj.mp.4001208; De Sarno P, 2002, NEUROPHARMACOLOGY, V43, P1158, DOI 10.1016/S0028-3908(02)00215-0; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Gainetdinov RR, 1999, NEURON, V24, P1029, DOI 10.1016/S0896-6273(00)81048-X; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gould TD, 2004, INT J NEUROPSYCHOPH, V7, P387, DOI 10.1017/S1461145704004535; Gould TD, 2007, NEUROPSYCHOPHARMACOL, V32, P2173, DOI 10.1038/sj.npp.1301338; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kim KM, 2001, J BIOL CHEM, V276, P37409, DOI 10.1074/jbc.M106728200; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Lavoie L, 1999, J BIOL CHEM, V274, P28279, DOI 10.1074/jbc.274.40.28279; Li XH, 2004, NEUROPSYCHOPHARMACOL, V29, P1426, DOI 10.1038/sj.npp.1300439; Li XH, 2007, INT J NEUROPSYCHOPH, V10, P7, DOI 10.1017/S1461145706006547; LOHSE MJ, 1989, P NATL ACAD SCI USA, V86, P3011, DOI 10.1073/pnas.86.9.3011; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Marion S, 2004, J BIOL CHEM, V279, P2945, DOI 10.1074/jbc.M308742200; Martinex A, 2006, NEUROBIOL AGING, V27, pS13; O'Brien WT, 2004, J NEUROSCI, V24, P6791, DOI 10.1523/JNEUROSCI.4753-03.2004; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Phiel CJ, 2001, ANNU REV PHARMACOL, V41, P789, DOI 10.1146/annurev.pharmtox.41.1.789; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Prickaerts J, 2006, J NEUROSCI, V26, P9022, DOI 10.1523/JNEUROSCI.5216-05.2006; Rajagopal K, 2006, P NATL ACAD SCI USA, V103, P16284, DOI 10.1073/pnas.0607583103; Ryves WJ, 2001, BIOCHEM BIOPH RES CO, V280, P720, DOI 10.1006/bbrc.2000.4169; SMITH DF, 1980, PSYCHOPHARMACOLOGY, V68, P315, DOI 10.1007/BF00428123; Valenstein M, 2006, AM J PSYCHIAT, V163, P1219, DOI 10.1176/appi.ajp.163.7.1219; Weisstaub NV, 2006, SCIENCE, V313, P536, DOI 10.1126/science.1123432; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613	52	273	285	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 11	2008	132	1					125	136		10.1016/j.cell.2007.11.041	http://dx.doi.org/10.1016/j.cell.2007.11.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IL	18191226	Bronze			2022-12-28	WOS:000253427600021
J	Yu, WQ; Gius, D; Onyango, P; Muldoon-Jacobs, K; Karp, J; Feinberg, AP; Cui, HM				Yu, Wenqiang; Gius, David; Onyango, Patrick; Muldoon-Jacobs, Kristi; Karp, Judith; Feinberg, Andrew P.; Cui, Hengmi			Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA	NATURE			English	Article							HUMAN CANCER; METHYLATION; CELLS; DNA; TRANSCRIPTION; INHIBITOR; PROTEINS; IGF2	Tumour suppressor genes ( TSGs) inhibiting normal cellular growth are frequently silenced epigenetically in cancer(1). DNA methylation is commonly associated with TSG silencing(1), yet mutations in the DNA methylation initiation and recognition machinery in carcinogenesis are unknown(2). An intriguing possible mechanism for gene regulation involves widespread non- coding RNAs such as microRNA, Piwi- interacting RNA and antisense RNAs3-5. Widespread sense - antisense transcripts have been systematically identified in mammalian cells(6), and global transcriptome analysis shows that up to 70% of transcripts have antisense partners and that perturbation of antisense RNA can alter the expression of the sense gene(7). For example, it has been shown that an antisense transcript not naturally occurring but induced by genetic mutation leads to gene silencing and DNA methylation, causing thalassaemia in a patient(8). Here we show that many TSGs have nearby antisense RNAs, and we focus on the role of one RNA in silencing p15, a cyclin- dependent kinase inhibitor implicated in leukaemia. We found an inverse relation between p15 antisense ( p15AS) and p15 sense expression in leukaemia. A p15AS expression construct induced p15 silencing in cis and in trans through heterochromatin formation but not DNA methylation; the silencing persisted after p15AS was turned off, although methylation and heterochromatin inhibitors reversed this process. The p15AS-induced silencing was Dicer- independent. Expression of exogenous p15AS in mouse embryonic stem cells caused p15 silencing and increased growth, through heterochromatin formation, as well as DNA methylation after differentiation of the embryonic stem cells. Thus, natural antisense RNA may be a trigger for heterochromatin formation and DNA methylation in TSG silencing in tumorigenesis.	[Yu, Wenqiang; Onyango, Patrick; Feinberg, Andrew P.; Cui, Hengmi] Johns Hopkins Univ, Sch Med, Ctr Epigenet, Baltimore, MD 21205 USA; [Yu, Wenqiang; Onyango, Patrick; Feinberg, Andrew P.; Cui, Hengmi] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Gius, David; Muldoon-Jacobs, Kristi] NCI, Radiat Oncol Branch, NIH, Bethesda, MD 20892 USA; [Karp, Judith] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; Johns Hopkins Medicine	Cui, HM (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Epigenet, 720 Rutland Ave, Baltimore, MD 21205 USA.	afeinberg@jhu.edu; hcui@jhmi.edu	Feinberg, Andrew/AAY-7666-2020	Feinberg, Andrew/0000-0002-8364-1991	NATIONAL CANCER INSTITUTE [ZIABC010544, R37CA054358, R01CA054358] Funding Source: NIH RePORTER; NCI NIH HHS [R37 CA054358, R01 CA054358, R37 CA054358-18] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Cui HM, 2002, CANCER RES, V62, P6442; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Gius D, 2004, CANCER CELL, V6, P361, DOI 10.1016/j.ccr.2004.08.029; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; JONES A, 1967, ECON BOT, V21, P163, DOI 10.1007/BF02897864; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lubbert M, 2003, LEUKEMIA, V17, P1762, DOI 10.1038/sj.leu.2403045; NOBORI T, 1994, NATURE, V368, P753, DOI 10.1038/368753a0; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rosok O, 2004, NAT BIOTECHNOL, V22, P104, DOI 10.1038/nbt925; Sakatani T, 2005, SCIENCE, V307, P1976, DOI 10.1126/science.1108080; Sandhu C, 1997, MOL CELL BIOL, V17, P2458, DOI 10.1128/MCB.17.5.2458; Ting AH, 2005, NAT GENET, V37, P906, DOI 10.1038/ng1611; Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157; Weinberg MS, 2006, RNA, V12, P256, DOI 10.1261/rna.2235106; Willingham AT, 2006, CELL, V125, P1215, DOI 10.1016/j.cell.2006.06.009; Wozniak RJ, 2007, ONCOGENE, V26, P77, DOI 10.1038/sj.onc.1209763	22	672	740	0	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2008	451	7175					202	U10		10.1038/nature06468	http://dx.doi.org/10.1038/nature06468			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249GA	18185590	Green Accepted			2022-12-28	WOS:000252214400045
J	Hazir, T; Fox, LM; Bin Nisar, Y; Fox, MP; Ashraf, YP; MacLeod, WB; Ramzan, A; Maqbool, S; Masood, T; Hussain, W; Murtaza, A; Khawar, N; Tariq, P; Asghar, R; Simon, JL; Thea, DM; Qazi, SA				Hazir, Tabish; Fox, LeAnne M.; Bin Nisar, Yasir; Fox, Matthew P.; Ashraf, Yusra Pervaiz; MacLeod, William B.; Ramzan, Afroze; Maqbool, Sajid; Masood, Tahir; Hussain, Waqar; Murtaza, Asifa; Khawar, Nadeem; Tariq, Parveen; Asghar, Rai; Simon, Jonathon L.; Thea, Donald M.; Qazi, Shamim A.		NO SHOTS Study Grp	Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: a randomised equivalency trial	LANCET			English	Article							ACUTE RESPIRATORY-INFECTIONS; ANTIMICROBIAL RESISTANCE; MULTICENTER; COMMUNITY; BACTERIAL; ETIOLOGY; PAKISTAN; IMPACT; DEATH; RISK	Background WHO case management guidelines for severe pneumonia involve referral to hospital for treatment with parenteral antibiotics. If equally as effective as parenteral treatment, home-based oral antibiotic treatment could reduce referral, admission, and treatment costs. Our aim was to determine whether home treatment with high-dose oral amoxicillin and inpatient treatment with parenteral ampicillin were equivalent for the treatment of severe pneumonia in children. Methods This randomised, open-label equivalency trial was done at seven study sites in Pakistan. 2037 children aged 3-59 months with severe pneumonia were randomly allocated to either initial hospitalisation and parenteral ampicillin (100 mg/kg per day in four doses) for 48 h, followed by 3 days of oral amoxicillin (80-90 mg/kg per day; n=1012) or to home-based treatment for 5 days with oral amoxicillin (80-90 mg/kg per day in two doses; n=1025). Follow-up assessments were done at 1, 3, 6, and 14 days after enrolment. The primary outcome was treatment failure (clinical deterioration) by day 6. Analyses were done per protocol and by intention to treat. This trial is registered, ISRCTN95821329. Findings In the per-protocol population, 36 individuals were excluded from the hospitalised group and 37 from the ambulatory group, mainly because of protocol violations or loss to follow-up. There were 87 (8.6%) treatment failures in the hospitalised group and 77 (7.5%) in the ambulatory group (risk difference 1 . 1%; 95% CI -1.3 to 3.5) by day 6. Five (0 . 2%) children died within 14 days of enrolment, one in the ambulatory group and four in the hospitalised group. In each case, treatment failure was declared before death and the antibiotic had been changed. None of the deaths were considered to be associated with treatment allocation; there were no serious adverse events reported in the trial. Interpretation Home treatment with high-dose oral amoxicillin is equivalent to currently recommended hospitalisation and parenteral ampicillin for treatment of severe pneumonia without underlying complications, suggesting that WHO recommendations for treatment of severe pneumonia need to be revised.	[Fox, LeAnne M.; Fox, Matthew P.; MacLeod, William B.; Simon, Jonathon L.; Thea, Donald M.] Boston Univ, Sch Publ Hlth, Ctr Int Hlth & Dev, Boston, MA 02118 USA; [Ramzan, Afroze] Natl Inst Child Hlth, Karachi, Pakistan; [Hazir, Tabish; Bin Nisar, Yasir; Ashraf, Yusra Pervaiz] Pakistan Inst Med Sci, Childrens Hosp, Islamabad, Pakistan; [Maqbool, Sajid; Masood, Tahir] Childrens Hosp, Lahore, Pakistan; [Hussain, Waqar] Sheikh Zayed Hosp, Lahore, Pakistan; [Murtaza, Asifa] Fed Govt Serv Hosp, Islamabad, Pakistan; [Khawar, Nadeem] Univ Peshawar, Khyber Med Coll, Pashawar, Pakistan; [Tariq, Parveen] Rawalpindi Med Coll, Rawalpindi, Pakistan; [Asghar, Rai] Rawalpindi Gen Hosp, Rawalpindi, Pakistan; [Qazi, Shamim A.] WHO, CH-1211 Geneva, Switzerland	Boston University; Pakistan Institute of Medical Sciences; University of Peshawar; National University of Sciences & Technology - Pakistan; Rawalpindi Medical College; Rawalpindi Medical College; World Health Organization	Thea, DM (corresponding author), Boston Univ, Sch Publ Hlth, Ctr Int Hlth & Dev, 85 E Concord St, Boston, MA 02118 USA.	dthea@bu.edu	Fox, Matthew/K-2004-2019; Nisar, Yasir Bin/AFO-2407-2022	Thea, Donald/0000-0002-6933-1030; MacLeod, William/0000-0001-8003-8874; Simon, Jonathon/0000-0001-6740-549X; Fox, Matthew/0000-0001-9887-0634				Addo-Yobo E, 2004, LANCET, V364, P1141, DOI 10.1016/S0140-6736(04)17100-6; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Cesar JA, 1999, BRIT MED J, V318, P1316, DOI 10.1136/bmj.318.7194.1316; Chantry CJ, 2007, BREASTFEED MED, V2, P63, DOI 10.1089/bfm.2007.0002; Chow SC, 2002, CONTROL CLIN TRIALS, V23, P515, DOI 10.1016/S0197-2456(02)00222-2; Craig WA, 1998, CLIN INFECT DIS, V26, P1, DOI 10.1086/516284; Fonseca W, 2003, ANTIMICROB AGENTS CH, V47, P997, DOI 10.1128/AAC.47.3.997-1001.2003; FORGIE IM, 1992, PEDIATR INFECT DIS J, V11, P466, DOI 10.1097/00006454-199206000-00009; GHAFOOR A, 1990, REV INFECT DIS, V12, pS907; HIETALA J, 1989, PEDIATR INFECT DIS J, V8, P683, DOI 10.1097/00006454-198910000-00004; Juven T, 2000, PEDIATR INFECT DIS J, V19, P293, DOI 10.1097/00006454-200004000-00006; KORPPI M, 1989, PEDIATR INFECT DIS J, V8, P687, DOI 10.1097/00006454-198910000-00005; Lieberthal AS, 2004, PEDIATRICS, V113, P1451, DOI 10.1542/peds.113.5.1451; MASTRO TD, 1991, LANCET, V337, P156, DOI 10.1016/0140-6736(91)90813-5; McCormick AW, 2003, NAT MED, V9, P424, DOI 10.1038/nm839; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Peterson S, 2004, LANCET, V363, P1955, DOI 10.1016/S0140-6736(04)16411-8; Qazi SA, 2002, ARCH DIS CHILD, V86, P113, DOI 10.1136/adc.86.2.113; Qazi SA, 1996, B WORLD HEALTH ORGAN, V74, P501; Renaud B, 2007, CLIN INFECT DIS, V44, P41, DOI 10.1086/509331; RODEWALD LE, 1993, J PEDIATR-US, V123, P143, DOI 10.1016/S0022-3476(05)81560-4; Sehgal V, 1997, Indian Pediatr, V34, P213; SHAH N, 1994, J TROP PEDIATRICS, V40, P201, DOI 10.1093/tropej/40.4.201; SHANN F, 1989, PEDIATR INFECT DIS J, V8, P852, DOI 10.1097/00006454-198912000-00005; Straus WL, 1998, LANCET, V352, P270, DOI 10.1016/S0140-6736(97)10294-X; TUPASI TE, 1988, J INFECT DIS, V157, P615, DOI 10.1093/infdis/157.4.615; *UNAIDS, 2001, AIDS EP UPD; *WHO, 1991, PROGR CONTR AC RESP; *WHO, 1993, BRONCH OTH MED TREAT; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0	31	115	126	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 5	2008	371	9606					49	56		10.1016/S0140-6736(08)60071-9	http://dx.doi.org/10.1016/S0140-6736(08)60071-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248YH	18177775				2022-12-28	WOS:000252192600030
J	Lenzer, J; Brownlee, S				Lenzer, Jeanne; Brownlee, Shannon			Medicine and the media - Doctor takes "march of shame" to atone for drug company payments	BRITISH MEDICAL JOURNAL			English	Editorial Material												jeanne.lenzer@gmail.com; shannon.brownlee@comcast.net							0	4	4	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 5	2008	336	7634					20	21		10.1136/bmj.39437.473576.0F	http://dx.doi.org/10.1136/bmj.39437.473576.0F			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	250UT	18174595	Green Published			2022-12-28	WOS:000252327500028
J	Snyder, SH				Snyder, Solomon H.			Seeking God in the brain - Efforts to localize higher brain functions	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA	Johns Hopkins University	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.							Collins Francis S, 2007, LANGUAGE GOD SCI PRE; Griffiths RR, 2006, PSYCHOPHARMACOLOGY, V187, P268, DOI 10.1007/s00213-006-0457-5; Linden D., 2007, ACCIDENTAL MIND BRAI; Snyder SH, 2005, P AM PHILOS SOC, V149, P141; Trimble M., 2007, SOUL BRAIN CEREBRAL	5	6	6	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2008	358	1					6	7		10.1056/NEJMp078206	http://dx.doi.org/10.1056/NEJMp078206			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	246TW	18172169				2022-12-28	WOS:000252031200002
J	Smith, TC; Ryan, MAK; Wingard, DL; Slymen, DJ; Sallis, JF; Kritz-Silverstein, D				Smith, Tyler C.; Ryan, Margaret A. K.; Wingard, Deborah L.; Slymen, Donald J.; Sallis, James F.; Kritz-Silverstein, Donna		Millennium Cohort Study Team	New onset and persistent symptoms of post-traumatic stress disorder self reported after deployment and combat exposures: prospective population based US military cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MENTAL-HEALTH PROBLEMS; GULF-WAR VETERANS; MILLENNIUM COHORT; IRAQ-WAR; PREVALENCE; VIETNAM; SERVICE; PTSD; CARE; AFGHANISTAN	Objective To describe new onset and persistence of self reported post-traumatic stress disorder symptoms in a large population based military cohort, many of whom were deployed in support of the wars in Iraq and Afghanistan. Design Prospective cohort analysis. Setting and participants Survey enrolment data from the millennium cohort (July 2001 to June 2003) obtained before the wars in Iraq and Afghanistan. Follow-up (June 2004 to February 2006) data on health outcomes collected from 50 184 participants. Main outcome measures Self reported post-traumatic stress disorder as measured by the posttraumatic stress disorder checklist-civilian version using Diagnostic and Statistical Manual of Mental Disorders, fourth edition criteria. Results More than 40% of the cohort were deployed between 2001 and 2006; between baseline and follow-up, 24% deployed for the first time in support of the wars in Iraq and Afghanistan. New incidence rates of 10-13 cases of post-traumatic stress disorder per 1000 person years occurred in the millennium cohort. New onset self reported post-traumatic stress disorder symptoms or diagnosis were identified in 7.6-8.7% of deployers; who reported combat exposures, 1.4-2.1% of deployers who did not report combat exposures, and 2.3-3.0% of non-deployers. Among those with self reported symptoms of post-traumatic stress disorder at baseline, deployment did not affect persistence of symptoms. Conclusions After adjustment for baseline characteristics, these prospective data indicate a threefold increase in new onset self reported post-traumatic stress disorder symptoms or diagnosis among deployed military personnel who reported combat exposures. The findings define the importance of post-traumatic stress disorder in this population and emphasise that specific combat exposures, rather than deployment itself, significantly affect the onset of symptoms of post-traumatic stress disorder after deployment.	[Smith, Tyler C.; Ryan, Margaret A. K.] US Dept Def, Ctr Deployment Hlth Res, Naval Hlth Res Ctr, San Diego, CA 92106 USA; [Smith, Tyler C.; Ryan, Margaret A. K.; Wingard, Deborah L.] Univ Calif San Diego, Div Epidemiol, Dept Family & Prevent Med, La Jolla, CA 92093 USA; [Slymen, Donald J.] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92108 USA; [Sallis, James F.] San Diego State Univ, Dept Psychol, San Diego, CA 92108 USA; [Kritz-Silverstein, Donna] Univ Calif San Diego, Div Epidemiol, Dept Family & Prevent Med, La Jolla, CA 92093 USA	United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC); University of California System; University of California San Diego; California State University System; San Diego State University; California State University System; San Diego State University; University of California System; University of California San Diego	Smith, TC (corresponding author), US Dept Def, Ctr Deployment Hlth Res, Naval Hlth Res Ctr, San Diego, CA 92106 USA.	tyler.c.smith@med.navy.mil	Sallis, James F/D-3001-2014	Sallis, James F/0000-0003-2555-9452				American Psychiatric Association, 1994, DIAGNOSTIC STAT MANU, V4th; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Brewin CR, 2005, J TRAUMA STRESS, V18, P53, DOI 10.1002/jts.20007; Dohrenwend BP, 2006, SCIENCE, V313, P979, DOI 10.1126/science.1128944; Eisen SA, 2004, MIL MED, V169, P896, DOI 10.7205/MILMED.169.11.896; ENGEL CC, 1993, J NERV MENT DIS, V181, P683, DOI 10.1097/00005053-199311000-00006; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Frueh BC, 2005, BRIT J PSYCHIAT, V186, P467, DOI 10.1192/bjp.186.6.467; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hyams KC, 1996, ANN INTERN MED, V125, P398, DOI 10.7326/0003-4819-125-5-199609010-00007; Jones E, 2003, BRIT J PSYCHIAT, V182, P158, DOI 10.1192/bjp.182.2.158; Jones E, 2002, BMJ-BRIT MED J, V324, P321, DOI 10.1136/bmj.324.7333.321; Kang HK, 2005, NEW ENGL J MED, V352, P1289, DOI 10.1056/NEJMp058024; Kang HK, 2003, AM J EPIDEMIOL, V157, P141, DOI 10.1093/aje/kwf187; Koenen KC, 2007, J TRAUMA STRESS, V20, P3, DOI 10.1002/jts.20191; Kulka R.A., 1990, TRAUMA VIETNAM WAR G; LeardMann CA, 2007, HUM VACCINES, V3, P245, DOI 10.4161/hv.4589; Magruder KM, 2005, GEN HOSP PSYCHIAT, V27, P169, DOI 10.1016/j.genhosppsych.2004.11.001; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Riddle JR, 2007, J CLIN EPIDEMIOL, V60, P192, DOI 10.1016/j.jclinepi.2006.04.008; Ryan MAK, 2007, J CLIN EPIDEMIOL, V60, P181, DOI 10.1016/j.jclinepi.2006.05.009; Smith B, 2007, ANN EPIDEMIOL, V17, P976, DOI 10.1016/j.annepidem.2007.07.102; Smith B, 2007, AM J EPIDEMIOL, V166, P1345, DOI 10.1093/aje/kwm212; Smith B, 2007, AM J PREV MED, V32, P347, DOI 10.1016/j.amepre.2006.12.015; Smith NB, 2001, INT J HYPERTHER, V17, P271, DOI 10.1080/02656730010025841; Smith TC, 2007, INT J ENVIRON HEAL R, V17, P271, DOI 10.1080/09603120701372243; Smith TC, 2007, ANN EPIDEMIOL, V17, P525, DOI 10.1016/j.annepidem.2006.12.002; Stretch RH, 1996, MIL MED, V161, P407, DOI 10.1093/milmed/161.7.407; Thompson WW, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-19; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Weathers F.W., 1993, ANN CONV INT SOC TRA; WEATHERS PW, 1993, ANN M INT SOC TRAUM; Wright KM, 2002, MIL MED, V167, P853, DOI 10.1093/milmed/167.10.853	35	468	476	0	36	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 16	2008	336	7640					366	371		10.1136/bmj.39430.638241.AE	http://dx.doi.org/10.1136/bmj.39430.638241.AE			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	268AP	18198395	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000253550600039
J	Meibom, A				Meibom, Anders			Geochemistry - The rise and fall of a great idea	SCIENCE			English	Editorial Material							CORE; OS		Museum Natl Hist Nat, Lab Etud Mat Extraterr, F-75005 Paris, France	Museum National d'Histoire Naturelle (MNHN)	Meibom, A (corresponding author), Museum Natl Hist Nat, Lab Etud Mat Extraterr, F-75005 Paris, France.	meibom@mnhn.fr		Meibom, Anders/0000-0002-4542-2819				Brandon AD, 1998, SCIENCE, V280, P1570, DOI 10.1126/science.280.5369.1570; Labrosse S, 2001, EARTH PLANET SC LETT, V190, P111, DOI 10.1016/S0012-821X(01)00387-9; Luguet A, 2008, SCIENCE, V319, P453, DOI 10.1126/science.1149868; Meibom A, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002602; Schersten A, 2004, NATURE, V427, P234, DOI 10.1038/nature02221; Smith AD, 2003, J GEODYN, V36, P469, DOI 10.1016/S0264-3707(02)00108-4	6	5	5	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2008	319	5862					418	419		10.1126/science.1153710	http://dx.doi.org/10.1126/science.1153710			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254HB	18218883				2022-12-28	WOS:000252576600024
J	Alonso-Coello, P; Garcia-Franco, AL; Guyatt, G; Moynihan, R				Alonso-Coello, Pablo; Lopez Garcia-Franco, Alberto; Guyatt, Gordon; Moynihan, Ray			Drugs for pre-osteoporosis: prevention or disease mongering?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VERTEBRAL FRACTURE RISK; POSTMENOPAUSAL WOMEN; RALOXIFENE; METAANALYSIS; ALENDRONATE		[Alonso-Coello, Pablo] Univ Autonoma Barcelona, Hosp St Pau, Dept Clin Epidemiol & Publ Hlth, Iberoamer Cochrane Ctr, Barcelona 08041, Spain; [Lopez Garcia-Franco, Alberto] Serv Madrileno Salud, Madrid, Spain; [Guyatt, Gordon] McMaster Univ, Fac Hlth Sci, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Guyatt, Gordon] McMaster Univ, Fac Hlth Sci, Dept Med, Hamilton, ON L8N 3Z5, Canada; [Moynihan, Ray] Univ Newcastle, Fac Hlth, Callaghan, NSW, Australia	Autonomous University of Barcelona; McMaster University; McMaster University; University of Newcastle	Alonso-Coello, P (corresponding author), Univ Autonoma Barcelona, Hosp St Pau, Dept Clin Epidemiol & Publ Hlth, Iberoamer Cochrane Ctr, Barcelona 08041, Spain.	palonso@santpau.es	Moynihan, Ray/ABC-3010-2020					[Anonymous], 1994, World Health Organ Tech Rep Ser, V843, P1; Barrett-Connor E, 2006, NEW ENGL J MED, V355, P125, DOI 10.1056/NEJMoa062462; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cummings SR, 2006, JAMA-J AM MED ASSOC, V296, P2601, DOI 10.1001/jama.296.21.2601; Deeks JJ, 2002, STAT MED, V21, P1575, DOI 10.1002/sim.1188; *DEP HHS, 2004, ODS POSTM SAF REV; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; *EUR MED AG, 2007, EMEA REC CHANG PROD; International Osteoporosis Foundation, KEY STAT N AM; Kanis JA, 2007, OSTEOPOROSIS INT, V18, P1033, DOI 10.1007/s00198-007-0343-y; Kanis JA, 2003, BONE, V33, P293, DOI 10.1016/S8756-3282(03)00200-X; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Miller PD, 2004, ARCH INTERN MED, V164, P1113, DOI 10.1001/archinte.164.10.1113; Moynihan R, 2002, BRIT MED J, V324, P886, DOI 10.1136/bmj.324.7342.886; Moynihan R, 2005, SELLING SICKNESS DRU; NELSON HD, 2001, OSTEOPOROSIS POSTMEN; O'Donnell S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005326.pub2; O'Neill TW, 2002, J BONE MINER RES, V17, P2214, DOI 10.1359/jbmr.2002.17.12.2214; Quandt SA, 2005, MAYO CLIN PROC, V80, P343, DOI 10.4065/80.3.343; Schousboe JT, 2005, ANN INTERN MED, V142, P734, DOI 10.7326/0003-4819-142-9-200505030-00008; SEEMAN E, 2007, J BONE MINER RE 1112; SIRIS ES, 2007, OSTEOPOROS INT  1030; STEVENSON M, 2007, HEALTH TECHNOL ASSES, P11; Valensi P, 2005, DIABETES METAB, V31, P606, DOI 10.1016/S1262-3636(07)70239-2	24	49	51	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 19	2008	336	7636					126	129		10.1136/bmj.39435.656250.AD	http://dx.doi.org/10.1136/bmj.39435.656250.AD			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	257SS	18202066	Green Submitted, Green Published			2022-12-28	WOS:000252819400029
J	Pihlstrom, BL; Fine, DH				Pihlstrom, Bruce L.; Fine, Daniel H.			Aggressive periodontitis in adolescents in Morocco	LANCET			English	Editorial Material							ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; LOCALIZED JUVENILE; JP2 CLONE; DETERMINANTS		[Pihlstrom, Bruce L.] Univ Minnesota, Sch Dent, Dept Prevent Sci, Minneapolis, MN 55455 USA; [Fine, Daniel H.] Univ Med & Dent New Jersey, Newark, NJ 07103 USA	University of Minnesota System; University of Minnesota Twin Cities; Rutgers State University New Brunswick; Rutgers State University Medical Center	Pihlstrom, BL (corresponding author), Univ Minnesota, Sch Dent, Dept Prevent Sci, Minneapolis, MN 55455 USA.	bpihls@umn.edu						Bueno LC, 1998, J PERIODONTOL, V69, P998, DOI 10.1902/jop.1998.69.9.998; Contreras A, 2000, ORAL MICROBIOL IMMUN, V15, P338, DOI 10.1034/j.1399-302x.2000.150513.x; Cortelli JR, 2005, J CLIN PERIODONTOL, V32, P860, DOI 10.1111/j.1600-051X.2005.00777.x; Fine DH, 2007, J CLIN MICROBIOL, V45, P3859, DOI 10.1128/JCM.00653-07; Haraszthy VI, 2000, J PERIODONTOL, V71, P912, DOI 10.1902/jop.2000.71.6.912; Haubek D, 2004, J DENT RES, V83, P767, DOI 10.1177/154405910408301006; HAUBEK D, 1995, J CLIN MICROBIOL, V33, P395, DOI 10.1128/JCM.33.2.395-401.1995; Haubek D, 2008, LANCET, V371, P237, DOI 10.1016/S0140-6736(08)60135-X; Haubek D, 2007, INFECT IMMUN, V75, P3080, DOI 10.1128/IAI.01734-06; Meng HX, 2007, PERIODONTOL 2000, V43, P133, DOI 10.1111/j.1600-0757.2006.00204.x; Mombelli A, 1999, J CLIN PERIODONTOL, V26, P505, DOI 10.1034/j.1600-051X.1999.260803.x; Van der Velden U, 2006, J CLIN PERIODONTOL, V33, P540, DOI 10.1111/j.1600-051X.2006.00953.x	12	7	7	1	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 19	2008	371	9608					188	189		10.1016/S0140-6736(08)60117-8	http://dx.doi.org/10.1016/S0140-6736(08)60117-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	252UK	18207006				2022-12-28	WOS:000252471900010
J	Prather, JF; Peters, S; Nowicki, S; Mooney, R				Prather, J. F.; Peters, S.; Nowicki, S.; Mooney, R.			Precise auditory-vocal mirroring in neurons for learned vocal communication	NATURE			English	Article							IDENTIFIED HVC NEURONS; ZEBRA FINCH; ACTION RECOGNITION; PREMOTOR CORTEX; EFFERENCE COPY; ADULT SONG; MECHANISMS; LANGUAGE; NUCLEUS; LESIONS	Brain mechanisms for communication must establish a correspondence between sensory and motor codes used to represent the signal. One idea is that this correspondence is established at the level of single neurons that are active when the individual performs a particular gesture or observes a similar gesture performed by another individual. Although neurons that display a precise auditory- vocal correspondence could facilitate vocal communication, they have yet to be identified. Here we report that a certain class of neurons in the swamp sparrow forebrain displays a precise auditory- vocal correspondence. We show that these neurons respond in a temporally precise fashion to auditory presentation of certain note sequences in this songbird's repertoire and to similar note sequences in other birds' songs. These neurons display nearly identical patterns of activity when the bird sings the same sequence, and disrupting auditory feedback does not alter this singing- related activity, indicating it is motor in nature. Furthermore, these neurons innervate striatal structures important for song learning, raising the possibility that singing- related activity in these cells is compared to auditory feedback to guide vocal learning.	[Prather, J. F.; Nowicki, S.; Mooney, R.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Peters, S.; Nowicki, S.] Duke Univ, Dept Biol, Durham, NC 27710 USA	Duke University; Duke University	Mooney, R (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	mooney@neuro.duke.edu	Nowicki, Stephen/Y-9690-2019; Galantucci, Bruno/E-5770-2010	Mooney, Richard/0000-0002-3308-1367	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002524] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC002524] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Arbib MA, 2005, BEHAV BRAIN SCI, V28, P105, DOI 10.1017/S0140525X05000038; BELL CC, 1981, SCIENCE, V214, P450, DOI 10.1126/science.7291985; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Farries MA, 2002, J NEUROSCI, V22, P3776; Fee MS, 2001, J NEUROSCI METH, V112, P83, DOI 10.1016/S0165-0270(01)00426-5; Ferrari PF, 2003, EUR J NEUROSCI, V17, P1703, DOI 10.1046/j.1460-9568.2003.02601.x; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gentner TQ, 2000, J NEUROBIOL, V42, P117, DOI 10.1002/(SICI)1097-4695(200001)42:1<117::AID-NEU11>3.0.CO;2-M; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hyman J, 2003, ANIM BEHAV, V65, P1179, DOI 10.1006/anbe.2003.2175; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; Kozhevnikov AA, 2007, J NEUROPHYSIOL, V97, P4271, DOI 10.1152/jn.00952.2006; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lewicki MS, 1996, J NEUROSCI, V16, P5854; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; MARLER P, 1981, SCIENCE, V213, P780, DOI 10.1126/science.213.4509.780; MARLER P, 1984, ANIM BEHAV, V32, P673, DOI 10.1016/S0003-3472(84)80143-8; MARLER P, 1964, SCIENCE, V146, P1483, DOI 10.1126/science.146.3650.1483; MARLER P, 1988, NATURE, V336, P770, DOI 10.1038/336770a0; MCCASLAND JS, 1981, P NATL ACAD SCI-BIOL, V78, P7815, DOI 10.1073/pnas.78.12.7815; Mooney R, 2005, J NEUROSCI, V25, P1952, DOI 10.1523/JNEUROSCI.3726-04.2005; Mooney R, 2001, P NATL ACAD SCI USA, V98, P12778, DOI 10.1073/pnas.221453298; Mooney R, 2000, J NEUROSCI, V20, P5420, DOI 10.1523/JNEUROSCI.20-14-05420.2000; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; Okanoya K, 1997, J NEUROBIOL, V33, P343; Perkel DJ, 2002, BRAIN RES BULL, V57, P529, DOI 10.1016/S0361-9230(01)00690-6; Poulet JFA, 2006, SCIENCE, V311, P518, DOI 10.1126/science.1120847; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Rosen MJ, 2003, NEURON, V39, P177, DOI 10.1016/S0896-6273(03)00357-X; Scharff C, 1998, J NEUROBIOL, V36, P81, DOI 10.1002/(SICI)1097-4695(199807)36:1<81::AID-NEU7>3.3.CO;2-8; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Troyer TW, 2000, J NEUROPHYSIOL, V84, P1204, DOI 10.1152/jn.2000.84.3.1204; Vargha-Khadem F, 2005, NAT REV NEUROSCI, V6, P131, DOI 10.1038/nrn1605; Wild JM, 2005, J COMP NEUROL, V483, P76, DOI 10.1002/cne.20403; Woolley SMN, 1997, J NEUROSCI, V17, P6380; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	43	277	281	1	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2008	451	7176					305	U2		10.1038/nature06492	http://dx.doi.org/10.1038/nature06492			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202651				2022-12-28	WOS:000252432100043
J	Goldstein, NE; Fischberg, D				Goldstein, Nathan E.; Fischberg, Daniel			Update in palliative medicine	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							OF-LIFE CARE; DOSE MORPHINE USE; HEART-FAILURE; RANDOMIZED-TRIAL; OPIOID USE; END; PNEUMONIA; SURVIVAL; GASTROENTEROSTOMY; MORTALITY		[Goldstein, Nathan E.] Mt Sinai Sch Med, Dept Geriatr & Adult Dev, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Goldstein, NE (corresponding author), Mt Sinai Sch Med, Dept Geriatr & Adult Dev, 1 Gustave Levy Pl,Box 1070, New York, NY 10029 USA.	nathan.goldstein@mssm.edu			NATIONAL INSTITUTE ON AGING [K23AG025933] Funding Source: NIH RePORTER; NIA NIH HHS [K23AG025933] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Agar MH., 2004, CLIN PRACT GUID QUAL, DOI 10.4135/9781848608191; Bercovitch M, 2004, CANCER-AM CANCER SOC, V101, P1473, DOI 10.1002/cncr.20485; Bercovitch M, 1999, CANCER-AM CANCER SOC, V86, P871, DOI 10.1002/(SICI)1097-0142(19990901)86:5<871::AID-CNCR25>3.0.CO;2-L; BOAS RA, 1982, BRIT J ANAESTH, V54, P501, DOI 10.1093/bja/54.5.501; Campbell ML, 2006, CRIT CARE MED, V34, pS355, DOI 10.1097/01.CCM.0000237248.16818.E5; Campbell ML, 2003, CHEST, V123, P266, DOI 10.1378/chest.123.1.266; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Ferrante FM, 1996, ANESTH ANALG, V82, P91, DOI 10.1097/00000539-199601000-00016; GUDJONSSON B, 1987, CANCER, V60, P2284, DOI 10.1002/1097-0142(19871101)60:9<2284::AID-CNCR2820600930>3.0.CO;2-V; Hosono S, 2007, J GASTROENTEROL, V42, P283, DOI 10.1007/s00535-006-2003-y; Huehnergarth KV, 2005, AM J CARDIOL, V95, P1492, DOI 10.1016/j.amjcard.2005.02.022; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Levy WC, 2006, CIRCULATION, V113, P1424, DOI 10.1161/CIRCULATIONAHA.105.584102; Loeb M, 2006, JAMA-J AM MED ASSOC, V295, P2503, DOI 10.1001/jama.295.21.2503; Lynn J, 1997, New Horiz, V5, P56; Maggioni AP, 2005, J CARD FAIL, V11, P91, DOI 10.1016/j.cardfail.2004.05.004; Mann DL, 2004, CIRCULATION, V109, P1594, DOI 10.1161/01.CIR.0000124490.27666.B2; Marrie TJ, 2002, INFECT CONT HOSP EP, V23, P159, DOI 10.1086/502030; Muder RR, 1996, ARCH INTERN MED, V156, P2365, DOI 10.1001/archinte.156.20.2365; Norton SA, 2007, CRIT CARE MED, V35, P1530, DOI 10.1097/01.CCM.0000266533.06543.0C; Packer M, 1996, NEW ENGL J MED, V335, P1107, DOI 10.1056/NEJM199610103351504; Pitt B, 2000, LANCET, V355, P1582, DOI 10.1016/S0140-6736(00)02213-3; Portenoy RK, 2006, J PAIN SYMPTOM MANAG, V32, P532, DOI 10.1016/j.jpainsymman.2006.08.003; Teno JM, 2005, J AM GERIATR SOC, V53, P1905, DOI 10.1111/j.1532-5415.2005.53563.x; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; Teno JM, 2001, J PAIN SYMPTOM MANAG, V22, P738, DOI 10.1016/S0885-3924(01)00335-9; Thorns A, 2000, LANCET, V356, P398, DOI 10.1016/S0140-6736(00)02534-4; Tremont-Lukats IW, 2005, ANESTH ANALG, V101, P1738, DOI 10.1213/01.ANE.0000186348.86792.38; Twaddle ML, 2007, J PALLIAT MED, V10, P86, DOI 10.1089/jpm.2006.0048; VANDERSCHELLING GP, 1993, WORLD J SURG, V17, P128, DOI 10.1007/BF01655726	30	4	5	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2008	148	2					135	140		10.7326/0003-4819-148-2-200801150-00008	http://dx.doi.org/10.7326/0003-4819-148-2-200801150-00008			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254NZ	18195337				2022-12-28	WOS:000252594600006
J	Trejo-Gutierrez, JF; Larson, JM; Abril, A				Trejo-Gutierrez, Jorge F.; Larson, Jan M.; Abril, Andy			Shortness of breath, weak pulses - and a high ESR	LANCET			English	Editorial Material							GIANT-CELL ARTERITIS; AORTIC-ANEURYSM; DISSECTION		[Trejo-Gutierrez, Jorge F.] Mayo Clin, Div Cardiovasc Dis, Jacksonville, FL 32224 USA; [Larson, Jan M.] Mayo Clin, Dept Family Med, Jacksonville, FL 32224 USA; [Abril, Andy] Mayo Clin, Div Rheumatol, Jacksonville, FL 32224 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Trejo-Gutierrez, JF (corresponding author), Mayo Clin, Div Cardiovasc Dis, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	trejo.jorge@mayo.edu						EVANS JM, 1995, ANN INTERN MED, V122, P502, DOI 10.7326/0003-4819-122-7-199504010-00004; MARTIN JF, 1980, BRIT HEART J, V43, P487; Nuenninghoff DM, 2003, ARTHRITIS RHEUM-US, V48, P3522, DOI 10.1002/art.11353; STRACHAN RW, 1980, LANCET, V1, P194	4	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 12	2008	371	9607					176	176		10.1016/S0140-6736(08)60109-9	http://dx.doi.org/10.1016/S0140-6736(08)60109-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	252ND	18191688				2022-12-28	WOS:000252452300032
J	Palmer, TM; Stanton, ML; Young, TP; Goheen, JR; Pringle, RM; Karban, R				Palmer, Todd M.; Stanton, Maureen L.; Young, Truman P.; Goheen, Jacob R.; Pringle, Robert M.; Karban, Richard			Breakdown of an ant-plant mutualism follows the loss of large herbivores from an African Savanna	SCIENCE			English	Article							SWOLLEN-THORN ACACIAS; STABLE ISOTOPES; KENYA; COEXISTENCE; COMPETITION; ECOSYSTEM; LAIKIPIA; FOREST; GUILD	Mutualisms are key components of biodiversity and ecosystem function, yet the forces maintaining them are poorly understood. We investigated the effects of removing large mammals on an ant-Acacia mutualism in an African savanna. Ten years of large-herbivore exclusion reduced the nectar and housing provided by plants to ants, increasing antagonistic behavior by a mutualistic ant associate and shifting competitive dominance within the plant-ant community from this nectar-dependent mutualist to an antagonistic species that does not depend on plant rewards. Trees occupied by this antagonist suffered increased attack by stem-boring beetles, grew more slowly, and experienced doubled mortality relative to trees occupied by the mutualistic ant. These results show that large mammals maintain cooperation within a widespread symbiosis and suggest complex cascading effects of megafaunal extinction.	[Palmer, Todd M.; Goheen, Jacob R.] Univ Florida, Dept Zool, Gainesville, FL 32611 USA; [Palmer, Todd M.; Stanton, Maureen L.; Young, Truman P.] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA; [Stanton, Maureen L.] Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA; [Palmer, Todd M.; Stanton, Maureen L.; Young, Truman P.; Goheen, Jacob R.; Pringle, Robert M.] Mpala Res Ctr, Nanyuki, Kenya; [Young, Truman P.] Univ Calif Davis, Dept Plant Environm Sci, Davis, CA 95616 USA; [Goheen, Jacob R.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Pringle, Robert M.] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Karban, Richard] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA	State University System of Florida; University of Florida; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of British Columbia; Stanford University; University of California System; University of California Davis	Palmer, TM (corresponding author), Univ Florida, Dept Zool, Gainesville, FL 32611 USA.	tmpalmer@zoo.ufl.edu	Palmer, Todd/GRS-0639-2022; Stanton, Maureen L/E-1204-2012	Palmer, Todd/0000-0001-5710-9750				Brockerhoff EG, 2006, CAN J FOREST RES, V36, P263, DOI 10.1139/x06-013; BROWN WL, 1960, ECOLOGY, V41, P587, DOI 10.2307/1933346; Du Toit JT, 1999, BIODIVERS CONSERV, V8, P1643, DOI 10.1023/A:1008959721342; Frederickson ME, 2005, OECOLOGIA, V143, P387, DOI 10.1007/s00442-004-1817-7; HARDY RWF, 1975, SCIENCE, V188, P633, DOI 10.1126/science.188.4188.633; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; HOCKING B, 1970, T ROY ENT SOC LONDON, V122, P211; Huntzinger M, 2004, ECOLOGY, V85, P609, DOI 10.1890/03-3056; JANZEN DANIEL H., 1967, UNIV KANS SCI SCI BULL, V47, P315; JANZEN DH, 1972, ECOLOGY, V53, P885, DOI 10.2307/1934304; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Ottichilo WK, 2000, AFR J ECOL, V38, P202, DOI 10.1046/j.1365-2028.2000.00242.x; Palmer TM, 2000, OECOLOGIA, V123, P425, DOI 10.1007/s004420051030; Palmer TM, 2003, ECOLOGY, V84, P2843, DOI 10.1890/02-0528; Palmer TM, 2002, OECOLOGIA, V133, P372, DOI 10.1007/s00442-002-1026-1; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Pringle RM, 2007, P NATL ACAD SCI USA, V104, P193, DOI 10.1073/pnas.0609840104; Sachs JL, 2006, TRENDS ECOL EVOL, V21, P585, DOI 10.1016/j.tree.2006.06.018; Stanton ML, 1999, NATURE, V401, P578, DOI 10.1038/44119; Stanton ML, 2002, ECOL MONOGR, V72, P347, DOI 10.1890/0012-9615(2002)072[0347:CCTOIA]2.0.CO;2; Stapley L, 1998, OECOLOGIA, V115, P401, DOI 10.1007/s004420050534; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wheeler W.M., 1920, T AM PHIL SOC, V22, P235; Young T. P., 1997, African Journal of Range & Forage Science, V14, P94, DOI 10.1080/10220119.1997.9647929; Young TP, 1997, OECOLOGIA, V109, P98, DOI 10.1007/s004420050063; Young TP, 2003, OIKOS, V101, P171, DOI 10.1034/j.1600-0706.2003.12067.x	28	192	200	11	408	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2008	319	5860					192	195		10.1126/science.1151579	http://dx.doi.org/10.1126/science.1151579			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249RC	18187652				2022-12-28	WOS:000252246400038
J	Shimizu, H; Iwamoto, M; Konno, T; Nihei, A; Sasaki, YC; Oiki, S				Shimizu, Hirofumi; Iwamoto, Masayuki; Konno, Takashi; Nihei, Amiko; Sasaki, Yuji C.; Oiki, Shigetoshi			Global twisting motion of single molecular KcsA potassium channel upon Gating	CELL			English	Article							FULL-LENGTH KCSA; K+-CHANNEL; X-RAYS; STREPTOMYCES-LIVIDANS; INTRACELLULAR GATE; CRYSTAL-STRUCTURE; ENERGY LANDSCAPE; ACTIVATION; F-1-ATPASE; MECHANISM	Ion channels are signal transduction molecules that switch ion permeation pathways on and off (gating). Crystal structures of several kinds of potassium channels have revealed open and closed conformations, which provide static pictures of gating status. Here we studied KcsA potassium channels undergoing conformational changes at the single-molecule level. A KcsA channel with a gold nanocrystal attached was irradiated by white X-rays and motions of the diffraction spot from the nanocrystal were tracked in real time. Upon gating, the KcsA channels twisted around the axis of the pore. These conformational changes were prevented by an open-channel blocker, tetrabuthylammonium. Random clockwise and counterclockwise twisting in the range of several tens of degrees originated in the transmembrane domain and was transmitted to the cytoplasmic domain. This coupling suggests a mechanical interplay between the transmembrane and cytoplasmic domains.	[Shimizu, Hirofumi; Iwamoto, Masayuki; Konno, Takashi; Sasaki, Yuji C.; Oiki, Shigetoshi] Japan Sci & Technol Corp, CREST Sasaki Team, Tokyo 1900012, Japan; [Shimizu, Hirofumi; Iwamoto, Masayuki; Konno, Takashi; Oiki, Shigetoshi] Univ Fukui, Fac Med Sci, Dept Physiol & Mol Biophys, Fukui 9101193, Japan; [Sasaki, Yuji C.] Japan Synchrotron Radiat Res Inst, Hyogo 6795198, Japan; [Nihei, Amiko] Sll NanoTechnol Inc, Engn Grp, Chiba 2702222, Japan	Japan Science & Technology Agency (JST); University of Fukui; Japan Synchrotron Radiation Research Institute	Oiki, S (corresponding author), Japan Sci & Technol Corp, CREST Sasaki Team, Tokyo 1900012, Japan.	oiki-fki@umin.ac.jp	SASAKI, Yuji/N-6880-2016	SASAKI, Yuji/0000-0003-3403-237X; Iwamoto, Masayuki/0000-0001-9505-2652				Blunck R, 2006, J GEN PHYSIOL, V128, P569, DOI 10.1085/jgp.200609638; Bragg WH, 1913, P R SOC LOND A-CONTA, V88, P428, DOI 10.1098/rspa.1913.0040; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cortes DM, 2001, J GEN PHYSIOL, V117, P165, DOI 10.1085/jgp.117.2.165; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Faraldo-Gomez JD, 2007, J MOL BIOL, V365, P649, DOI 10.1016/j.jmb.2006.09.069; FRIEDRICH W, 1912, P BAV AC SCI, P303; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Iwamoto M, 2006, J BIOL CHEM, V281, P28379, DOI 10.1074/jbc.M602018200; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Johnson JP, 2001, NATURE, V412, P917, DOI 10.1038/35091089; Kelly BL, 2003, NAT STRUCT BIOL, V10, P280, DOI 10.1038/nsb908; KUO RL, 2003, WORLD J SURG ONCOL, V1, P1; LeMasurier M, 2001, J GEN PHYSIOL, V118, P303, DOI 10.1085/jgp.118.3.303; Lenaeus MJ, 2005, NAT STRUCT MOL BIOL, V12, P454, DOI 10.1038/nsmb929; Liu YS, 2001, NAT STRUCT BIOL, V8, P883, DOI 10.1038/nsb1001-883; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Okumura Y, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.021917; Okumura Y, 2005, THIN SOLID FILMS, V471, P91, DOI 10.1016/j.tsf.2004.04.033; Perozo E, 1998, NAT STRUCT BIOL, V5, P459, DOI 10.1038/nsb0698-459; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Phillips LR, 2003, NEURON, V37, P953, DOI 10.1016/S0896-6273(03)00155-7; Sasaki YC, 2000, PHYS REV E, V62, P3843, DOI 10.1103/PhysRevE.62.3843; Sasaki YC, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.248102; SCHREMPF H, 1995, EMBO J, V14, P5170, DOI 10.1002/j.1460-2075.1995.tb00201.x; Sigg D, 2003, P NATL ACAD SCI USA, V100, P7611, DOI 10.1073/pnas.1332409100; Sigg D, 2003, BIOPHYS J, V84, P3703, DOI 10.1016/S0006-3495(03)75099-1; Terada T, 1913, NATURE, V91, P213, DOI 10.1038/091213b0; Terada T, 1913, NATURE, V91, P135, DOI 10.1038/091135c0; Terada T., 1913, P TOKYO MATH PHYS SO, V7, P60; Thomas D. D, 1986, TECHNIQUES ANAL MEMB; Webster SM, 2004, NATURE, V428, P864, DOI 10.1038/nature02468; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zimmer J, 2006, BIOPHYS J, V90, P1752, DOI 10.1529/biophysj.105.071175	40	90	91	2	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2008	132	1					67	78		10.1016/j.cell.2007.11.040	http://dx.doi.org/10.1016/j.cell.2007.11.040			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IL	18191221	Bronze, Green Submitted			2022-12-28	WOS:000253427600016
J	Anderson, D				Anderson, David			Seymour Benzer (1921-2007) - Obituary	NATURE			English	Biographical-Item									CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Anderson, D (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol, 216-276, Pasadena, CA 91125 USA.	wuwei@caltech.edu							0	5	5	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2008	451	7175					139	139		10.1038/451139a	http://dx.doi.org/10.1038/451139a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249GA	18185579				2022-12-28	WOS:000252214400031
J	Lipsker, D; Kara, F				Lipsker, Dan; Kara, Fady			Retiform purpura	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lipsker, Dan; Kara, Fady] Hop Univ Strasbourg, F-67091 Strasbourg, France	CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Lipsker, D (corresponding author), Hop Univ Strasbourg, F-67091 Strasbourg, France.	dan.lipsker@chru-strasbourg.fr		Lipsker, Dan/0000-0003-4675-0336					0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2008	358	2					E1	E1		10.1056/NEJMicm073564	http://dx.doi.org/10.1056/NEJMicm073564			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249CJ	18184954				2022-12-28	WOS:000252204200010
J	Thakor, AS; Hiemstra, TF; Jayne, DRW				Thakor, Avnesh S.; Hiemstra, Thomas F.; Jayne, David R. W.			Anaemia, weight loss, and round shadows in the lungs	LANCET			English	Editorial Material							WEGENERS-GRANULOMATOSIS; VASCULITIS		[Thakor, Avnesh S.; Hiemstra, Thomas F.; Jayne, David R. W.] Univ Cambridge, Addenbrookes Hosp, Dept Renal Med, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Thakor, AS (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Renal Med, Hills Rd, Cambridge CB2 0QQ, England.	asthakor@hotmail.com		Jayne, David/0000-0002-1712-0637				Hagen EC, 1998, KIDNEY INT, V53, P743, DOI 10.1046/j.1523-1755.1998.00807.x; Pankhurst T, 2004, RHEUMATOLOGY, V43, P1532, DOI 10.1093/rheumatology/keh374; Reuter M, 1998, CHEST, V114, P500, DOI 10.1378/chest.114.2.500; Tatsis E, 1999, ARTHRITIS RHEUM-US, V42, P751, DOI 10.1002/1529-0131(199904)42:4<751::AID-ANR19>3.0.CO;2-D	4	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 5	2008	371	9606					88	88		10.1016/S0140-6736(08)60076-8	http://dx.doi.org/10.1016/S0140-6736(08)60076-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248YH	18177780				2022-12-28	WOS:000252192600035
J	Liu, JG; Diamond, J				Liu, Jianguo; Diamond, Jared			Science and government - Revolutionizing China's environmental protection	SCIENCE			English	Editorial Material									[Liu, Jianguo] Michigan State Univ, Dept Fisheries & Wildlife, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48823 USA; [Liu, Jianguo] Chinese Acad Sci, State Key Lab Urban & Reg Ecol, Shanghai, Peoples R China; [Liu, Jianguo] Fudan Univ, Shanghai 200433, Peoples R China; [Diamond, Jared] Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90095 USA	Michigan State University; Chinese Academy of Sciences; Fudan University; University of California System; University of California Los Angeles	Liu, JG (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48823 USA.	jliu@panda.msu.edu	Liu, Jianguo/G-5211-2015	Liu, Jianguo/0000-0001-6344-0087				[Anonymous], 2005, EC HUM WELL BEING SY; CHEN Q, 2007, YUE PAN ENV EC POLIC; Chinese Academy for Environmental Planning, 2006, CHIN GREEN NAT ACC S; *INT EN AG, 2006, CO2 EM FUEL COMB; Liu JG, 2005, NATURE, V435, P1179, DOI 10.1038/4351179a; Liu JG, 2007, SCIENCE, V317, P1513, DOI 10.1126/science.1144004; National Bureau of Statistics of China, 2004, CHIN STAT YB 2004; NDRC of China, 2006, OUTL 11 5 YEAR PLAN; *NETH ENV ASS AG M, 2007, GLOB CO2 EM; SEPA, 2006, CHIN 11 5 YEAR PLAN; World Bank, 2007, COST POLL CHIN; *YAL CTR ENV LAW P, 2006, ENV PERF MEAS PROJ	12	153	171	5	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2008	319	5859					37	38		10.1126/science.1150416	http://dx.doi.org/10.1126/science.1150416			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18174421				2022-12-28	WOS:000252084000015
J	Setiawan, J; Henning, T; Launhardt, R; Muller, A; Weise, P; Kurster, M				Setiawan, J.; Henning, Th.; Launhardt, R.; Mueller, A.; Weise, P.; Kuerster, M.			A young massive planet in a star-disk system	NATURE			English	Article							T-TAURI STARS; INNER DISK; GIANT; ACCRETION; HYDRAE; GAS; VARIABILITY; COMPANION; EVOLUTION; MODELS	There is a general consensus that planets form within disks of dust and gas around newly born stars(1,2). Details of their formation process, however, are still a matter of ongoing debate. The timescale of planet formation remains unclear, so the detection of planets around young stars with protoplanetary disks is potentially of great interest. Hitherto, no such planet has been found. Here we report the detection of a planet of mass (9.8 +/- 3.3) M-Jupiter around TW Hydrae (TW Hya), a nearby young star with an age of only 8-10 Myr that is surrounded by a well- studied circumstellar disk. It orbits the star with a period of 3.56 days at 0.04 AU, inside the inner rim of the disk. This demonstrates that planets can form within 10 Myr, before the disk has been dissipated by stellar winds and radiation.	[Setiawan, J.; Henning, Th.; Launhardt, R.; Mueller, A.; Weise, P.; Kuerster, M.] Max Planck Inst Astron, D-69117 Heidelberg, Germany	Max Planck Society	Setiawan, J (corresponding author), Max Planck Inst Astron, D-69117 Heidelberg, Germany.	setiawan@mpia.de; rlau@mpia.de	Henning, Thomas K/O-4372-2018	Henning, Thomas K/0000-0002-1493-300X; Mueller, Andre/0000-0002-9757-7951				Alencar SHP, 2002, ASTROPHYS J, V571, P378, DOI 10.1086/339878; Boss AP, 2005, ASTROPHYS J, V629, P535, DOI 10.1086/431457; Boss AP, 2001, ASTROPHYS J, V563, P367, DOI 10.1086/323694; Calvet N, 2002, ASTROPHYS J, V568, P1008, DOI 10.1086/339061; Carpenter JM, 2005, ASTRON J, V129, P1049, DOI 10.1086/427131; Chauvin G, 2005, ASTRON ASTROPHYS, V438, pL25, DOI 10.1051/0004-6361:200500116; Cieza L, 2007, ASTROPHYS J, V667, P308, DOI 10.1086/520698; Cumming A, 1999, ASTROPHYS J, V526, P890, DOI 10.1086/308020; Eisner JA, 2006, ASTROPHYS J, V637, pL133, DOI 10.1086/500689; Haisch KE, 2001, ASTROPHYS J, V553, pL153, DOI 10.1086/320685; HERBST W, 1988, ASTRON J, V96, P1949, DOI 10.1086/114941; Hughes AM, 2007, ASTROPHYS J, V664, P536, DOI 10.1086/518885; Kaufer A, 2000, P SOC PHOTO-OPT INS, V4008, P459, DOI 10.1117/12.395506; Krist JE, 2000, ASTROPHYS J, V538, P793, DOI 10.1086/309170; Kurster M, 1997, ASTRON ASTROPHYS, V320, P831; Matsuo T, 2007, ASTROPHYS J, V662, P1282, DOI 10.1086/517964; Mekkaden MV, 1998, ASTRON ASTROPHYS, V340, P135; Muzerolle J, 2000, ASTROPHYS J, V535, pL47, DOI 10.1086/312691; Pollack JB, 1996, ICARUS, V124, P62, DOI 10.1006/icar.1996.0190; Qi CH, 2004, ASTROPHYS J, V616, pL11, DOI 10.1086/421063; Ratzka T, 2007, ASTRON ASTROPHYS, V471, P173, DOI 10.1051/0004-6361:20077357; Rettig TW, 2004, ASTROPHYS J, V616, pL163, DOI 10.1086/426433; SAFRONOV VS, 1967, SOV ASTRON, V10, P650; Salyk C, 2007, ASTROPHYS J, V655, pL105, DOI 10.1086/512012; Setiawan J, 2007, ASTROPHYS J, V660, pL145, DOI 10.1086/518213; Setiawan J, 2003, ASTRON ASTROPHYS, V397, P1151, DOI 10.1051/0004-6361:20021559	29	122	122	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2008	451	7174					38	41		10.1038/nature06426	http://dx.doi.org/10.1038/nature06426			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247KZ	18172492				2022-12-28	WOS:000252079300027
J	Semenov, MV; Habas, R; MacDonald, BT; He, X				Semenov, Mikhail V.; Habas, Raymond; MacDonald, Bryan T.; He, Xi			SnapShot: Noncanonical Wnt signaling pathways	CELL			English	Editorial Material							CELL POLARITY; PROTEIN		[Semenov, Mikhail V.; MacDonald, Bryan T.; He, Xi] Harvard Univ, Sch Med, Childrens Hosp, F M Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Habas, Raymond] Univ Med & Dent New Jersey, Dept Biochem, Piscataway, NJ 08854 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Rutgers State University New Brunswick; Rutgers State University Medical Center	Semenov, MV (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, F M Kirby Neurobiol Ctr, Boston, MA 02115 USA.				NIGMS NIH HHS [R01 GM078172, R01 GM078172-07] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078172] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bovolenta P, 2006, DEVELOPMENT, V133, P4399, DOI 10.1242/dev.02592; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Salinas PC, 2007, TRENDS CELL BIOL, V17, P333, DOI 10.1016/j.tcb.2007.07.003; Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Tsai IC, 2007, DEV CELL, V12, P335, DOI 10.1016/j.devcel.2007.02.009; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Zhang X, 2007, NAT CELL BIOL, V9, P743, DOI 10.1038/ncb1603	9	241	253	2	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 28	2007	131	7							1378.e1	10.1016/j.cell.2007.12.011	http://dx.doi.org/10.1016/j.cell.2007.12.011			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GV	18160045	Bronze			2022-12-28	WOS:000252217200001
J	Lozier, MS; Leadbetter, S; Williams, RG; Roussenov, V; Reed, MSC; Moore, NJ				Lozier, M. Susan; Leadbetter, Susan; Williams, Richard G.; Roussenov, Vassil; Reed, Mark S. C.; Moore, Nathan J.			The spatial pattern and mechanisms of heat-content change in the North Atlantic	SCIENCE			English	Article							CLIMATE; OCEAN; OSCILLATION	The total heat gained by the North Atlantic Ocean over the past 50 years is equivalent to a basinwide increase in the flux of heat across the ocean surface of 0.4 +/- 0.05 watts per square meter. We show, however, that this basin has not warmed uniformly: Although the tropics and subtropics have warmed, the subpolar ocean has cooled. These regional differences require local surface heat flux changes ( +/- 4 watts per square meter) much larger than the basinwide average. Model investigations show that these regional differences can be explained by large- scale, decadal variability in wind and buoyancy forcing as measured by the North Atlantic Oscillation index. Whether the overall heat gain is due to anthropogenic warming is difficult to confirm because strong natural variability in this ocean basin is potentially masking such input at the present time.	[Lozier, M. Susan; Reed, Mark S. C.; Moore, Nathan J.] Duke Univ, Div Earth & Ocean Sci, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA; [Leadbetter, Susan; Williams, Richard G.; Roussenov, Vassil] Univ Liverpool, Dept Earth & Ocean Sci, Liverpool L69 3GP, Merseyside, England	Duke University; University of Liverpool	Lozier, MS (corresponding author), Duke Univ, Div Earth & Ocean Sci, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA.	mslozier@duke.edu; ric@liverpool.ac.uk	Williams, Richard G/K-4111-2016; Leadbetter, Susan/AAN-7922-2021; Kushnir, Yochanan/B-4472-2013; Leadbetter, Susan/B-8111-2008	Williams, Richard G/0000-0002-3180-7558; Leadbetter, Susan/0000-0002-8295-6465	Natural Environment Research Council [NE/D003245/1, NER/O/S/2003/00625, NE/D002478/1] Funding Source: researchfish; NERC [NE/D003245/1, NE/D002478/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Arbic BK, 2001, J CLIMATE, V14, P4091, DOI 10.1175/1520-0442(2001)014<4091:CWOAIW>2.0.CO;2; Bindoff NL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P385; BINDOFF NL, 1994, J PHYS OCEANOGR, V24, P1137, DOI 10.1175/1520-0485(1994)024<1137:DCCAOV>2.0.CO;2; BLECK R, 1990, J GEOPHYS RES-OCEANS, V95, P3273, DOI 10.1029/JC095iC03p03273; Boyer T. P., 2005, WORLD OCEAN DATABASE; Bryden HL, 1996, J CLIMATE, V9, P3162, DOI 10.1175/1520-0442(1996)009<3162:DCIWMC>2.0.CO;2; Curry R, 2003, NATURE, V426, P826, DOI 10.1038/nature02206; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; GILLETT NP, 2003, GEOPHYS MONOGR AM GE, V134; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Joyce TM, 1999, DEEP-SEA RES PT II, V46, P245, DOI 10.1016/S0967-0645(98)00102-7; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; LAZIER JRN, 1995, NATURAL CLIMATE VARI, P295; Leadbetter SJ, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029957; Levitus S, 2001, SCIENCE, V292, P267, DOI 10.1126/science.1058154; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; Levitus S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021592; Lozier MS, 1995, PROG OCEANOGR, V36, P1, DOI 10.1016/0079-6611(95)00013-5; Stephenson DB, 2006, CLIM DYNAM, V27, P401, DOI 10.1007/s00382-006-0140-x; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176	20	82	82	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2008	319	5864					800	803		10.1126/science.1146436	http://dx.doi.org/10.1126/science.1146436			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18174399				2022-12-28	WOS:000252963000058
J	Mettetal, JT; Muzzey, D; Gomez-Uribe, C; van Oudenaarden, A				Mettetal, Jerome T.; Muzzey, Dale; Gomez-Uribe, Carlos; van Oudenaarden, Alexander			The frequency dependence of osmo-adaptation in Saccharomyces cerevisiae	SCIENCE			English	Article							BACTERIAL CHEMOTAXIS; HIGH-OSMOLARITY; YEAST; STRESS; NETWORKS; GLYCEROL; ACCUMULATION; BIOLOGY; SYSTEMS; KINASE	The propagation of information through signaling cascades spans a wide range of time scales, including the rapid ligand- receptor interaction and the much slower response of downstream gene expression. To determine which dynamic range dominates a response, we used periodic stimuli to measure the frequency dependence of signal transduction in the osmo- adaptation pathway of Saccharomyces cerevisiae. We applied system identification methods to infer a concise predictive model. We found that the dynamics of the osmo- adaptation response are dominated by a fast-acting negative feedback through the kinase Hog1 that does not require protein synthesis. After large osmotic shocks, an additional, much slower, negative feedback through gene expression allows cells to respond faster to future stimuli.	[Mettetal, Jerome T.; Muzzey, Dale; Gomez-Uribe, Carlos; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA; [Muzzey, Dale] Harvard Univ, Sch Med, Grad Biophys Program, Boston, MA 02115 USA; [Gomez-Uribe, Carlos] MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT)	van Oudenaarden, A (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	avano@mit.edu	van Oudenaarden, Alexander/AAA-1705-2019		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R90DK071511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068957] Funding Source: NIH RePORTER; NIDDK NIH HHS [5 R90 DK071511-01, R90 DK071511] Funding Source: Medline; NIGMS NIH HHS [R01-GM068957, R01 GM068957-06, R01 GM068957-05, R01 GM068957] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERTYN J, 1994, MOL CELL BIOL, V14, P4135, DOI 10.1128/MCB.14.6.4135; [Anonymous], 1983, SIGNALS SYSTEMS; BLOCK SM, 1982, CELL, V31, P215, DOI 10.1016/0092-8674(82)90421-4; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Gennemark Peter, 2006, In Silico Biology, V6, P193; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Ingalls BP, 2004, J PHYS CHEM B, V108, P1143, DOI 10.1021/jp036567u; Kitano H, 2005, NAT BIOTECHNOL, V23, P961, DOI 10.1038/nbt1111; Klipp E, 2005, NAT BIOTECHNOL, V23, P975, DOI 10.1038/nbt1114; Krantz M, 2004, EUKARYOT CELL, V3, P1381, DOI 10.1128/EC.3.6.1381-1390.2004; Lipan O, 2005, P NATL ACAD SCI USA, V102, P7063, DOI 10.1073/pnas.0403790102; LUYTEN K, 1995, EMBO J, V14, P1360, DOI 10.1002/j.1460-2075.1995.tb07122.x; Posas F, 2000, J BIOL CHEM, V275, P17249, DOI 10.1074/jbc.M910016199; Proft M, 2004, CELL, V118, P351, DOI 10.1016/j.cell.2004.07.016; Reiser V, 1999, MOL BIOL CELL, V10, P1147, DOI 10.1091/mbc.10.4.1147; Samoilov M, 2002, J PHYS CHEM A, V106, P10205, DOI 10.1021/jp025846z; Savageau M, 1976, BIOCH SYSTEMS ANAL S; Slepchenko BM, 2003, TRENDS CELL BIOL, V13, P570, DOI 10.1016/j.tcb.2003.09.002; Sontag ED, 2005, EUR J CONTROL, V11, P396, DOI 10.3166/ejc.11.396-435; Tamas MJ, 1999, MOL MICROBIOL, V31, P1087, DOI 10.1046/j.1365-2958.1999.01248.x; Thorsen M, 2006, MOL BIOL CELL, V17, P4400, DOI 10.1091/mbc.E06-04-0315; Tyson JJ, 2001, NAT REV MOL CELL BIO, V2, P908, DOI 10.1038/35103078; Vance W, 2002, P NATL ACAD SCI USA, V99, P5816, DOI 10.1073/pnas.022049699; Westwick D. T., 2003, IDENTIFICATION NONLI; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649	25	256	261	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2008	319	5862					482	484		10.1126/science.1151582	http://dx.doi.org/10.1126/science.1151582			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254HB	18218902	Green Accepted			2022-12-28	WOS:000252576600043
J	Andang, M; Hjerling-Leffler, J; Moliner, A; Lundgren, TK; Castelo-Branco, G; Nanou, E; Pozas, E; Bryja, V; Halliez, S; Nishimaru, H; Wilbertz, J; Arenas, E; Koltzenburg, M; Charnay, P; El Manira, A; Ibanez, CF; Ernfors, P				Andang, Michael; Hjerling-Leffler, Jens; Moliner, Annalena; Lundgren, T. Kalle; Castelo-Branco, Goncalo; Nanou, Evanthia; Pozas, Ester; Bryja, Vitezslav; Halliez, Sophie; Nishimaru, Hiroshi; Wilbertz, Johannes; Arenas, Ernest; Koltzenburg, Martin; Charnay, Patrick; El Manira, Abdeljabbar; Ibanez, Carlos F.; Ernfors, Patrik			Histone H2AX-dependent GABA(A) receptor regulation of stem cell proliferation	NATURE			English	Article							DNA-DAMAGE; BOUNDARY CAP; H2AX; PHOSPHORYLATION; DIFFERENTIATION; EXPRESSION; HINDBRAIN; PHASE; ATM	Stem cell self- renewal implies proliferation under continued maintenance of multipotency. Small changes in numbers of stem cells may lead to large differences in differentiated cell numbers, resulting in significant physiological consequences. Proliferation is typically regulated in the G1 phase, which is associated with differentiation and cell cycle arrest(1). However, embryonic stem ( ES) cells may lack a G1 checkpoint(2,3). Regulation of proliferation in the 'DNA damage' S/G2 cell cycle checkpoint pathway is known for its role in the maintenance of chromatin structural integrity(4). Here we show that autocrine/paracrine gamma-aminobutyric acid ( GABA) signalling by means of GABA(A) receptors negatively controls ES cell and peripheral neural crest stem ( NCS) cell proliferation, preimplantation embryonic growth and proliferation in the boundary- cap stem cell niche, resulting in an attenuation of neuronal progenies from this stem cell niche. Activation of GABA(A) receptors leads to hyperpolarization, increased cell volume and accumulation of stem cells in S phase, thereby causing a rapid decrease in cell proliferation. GABA(A) receptors signal through S- phase checkpoint kinases of the phosphatidylinositol-3-OH kinase- related kinase family and the histone variant H2AX. This signalling pathway critically regulates proliferation independently of differentiation, apoptosis and overt damage to DNA. These results indicate the presence of a fundamentally different mechanism of proliferation control in these stem cells, in comparison with most somatic cells, involving proteins in the DNA damage checkpoint pathway.	[Andang, Michael; Hjerling-Leffler, Jens; Lundgren, T. Kalle; Pozas, Ester; Bryja, Vitezslav; Arenas, Ernest; Ernfors, Patrik] Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Neurobiol, S-17177 Stockholm, Sweden; [Moliner, Annalena; Castelo-Branco, Goncalo; Nanou, Evanthia; Nishimaru, Hiroshi; El Manira, Abdeljabbar; Ibanez, Carlos F.] Karolinska Inst, Dept Neurosci, Lab Mol Neurodev, S-17177 Stockholm, Sweden; [Wilbertz, Johannes] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Halliez, Sophie; Charnay, Patrick] Ecole Normale Super, INSERM, U784, F-75230 Paris 05, France; [Koltzenburg, Martin] UCL, Inst Child Hlth, Neural Plast Unit, London WC1E 6BT, England	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of London; University College London	Ernfors, P (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Neurobiol, S-17177 Stockholm, Sweden.	patrik.ernfors@ki.se	Arenas, Ernest/AAO-5231-2020; Castelo-Branco, Gonçalo/B-1635-2009; Bryja, Vítězslav/P-4217-2019; Hjerling-Leffler, Jens/B-3307-2008; Hjerling-Leffler, Jens/E-3775-2012; Castelo-Branco, Gonçalo/O-9162-2019; Bryja, Vít?zslav/H-1925-2014; Koltzenburg, Martin/C-1349-2008; Castelo-Branco, Goncalo/A-8357-2015; Halliez, Sophie/ABA-1356-2020; Lundgren, Kalle/E-9056-2015; Andäng, Michael/GRE-9898-2022	Arenas, Ernest/0000-0003-0197-6577; Castelo-Branco, Gonçalo/0000-0003-2247-9393; Bryja, Vítězslav/0000-0002-9136-5085; Hjerling-Leffler, Jens/0000-0002-4539-1776; Castelo-Branco, Gonçalo/0000-0003-2247-9393; Bryja, Vít?zslav/0000-0002-9136-5085; Koltzenburg, Martin/0000-0001-9181-5966; Halliez, Sophie/0000-0002-6173-9752; Lundgren, Kalle/0000-0001-6781-762X; Andang, Michael/0000-0002-2886-7891; Charnay, Patrick/0000-0002-3847-6042; Ernfors, Patrik/0000-0002-1140-3986; El Manira, Abdel/0000-0001-5920-9384	Medical Research Council [G0601943] Funding Source: Medline; MRC [G0601943] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALTMAN J, 1984, ADV ANAT EMBRYOL CEL, V85, P1; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Fernandez-Capetillo O, 2003, DEV CELL, V4, P497, DOI 10.1016/S1534-5807(03)00093-5; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Hammond EM, 2004, CANCER RES, V64, P6556, DOI 10.1158/0008-5472.CAN-04-1520; Hjerling-Leffler J, 2005, DEVELOPMENT, V132, P2623, DOI 10.1242/dev.01852; Ichijima Y, 2005, BIOCHEM BIOPH RES CO, V336, P807, DOI 10.1016/j.bbrc.2005.08.164; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522; Lundgren TK, 2006, J BIOL CHEM, V281, P29886, DOI 10.1074/jbc.M600473200; Maro GS, 2004, NAT NEUROSCI, V7, P930, DOI 10.1038/nn1299; MCGANN LE, 1988, CYTOMETRY, V9, P33, DOI 10.1002/cyto.990090106; McManus KJ, 2005, MOL BIOL CELL, V16, P5013, DOI 10.1091/mbc.E05-01-0065; SAVATIER P, 1994, ONCOGENE, V9, P809; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; Voiculescu O, 2000, GENESIS, V26, P123, DOI 10.1002/(SICI)1526-968X(200002)26:2<123::AID-GENE7>3.0.CO;2-O; Voiculescu O, 2001, DEVELOPMENT, V128, P4967; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhu L, 2001, CURR OPIN GENET DEV, V11, P91, DOI 10.1016/S0959-437X(00)00162-3	21	210	216	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2008	451	7177					460	U4		10.1038/nature06488	http://dx.doi.org/10.1038/nature06488			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	253YS	18185516	Bronze			2022-12-28	WOS:000252554100044
J	Jarvinen, TLN; Sievanen, H; Khan, KM; Heinonen, A; Kannus, P				Jarvinen, Teppo L. N.; Sievanen, Harri; Khan, Karim M.; Heinonen, Ari; Kannus, Pekka			Shifting the focus in fracture prevention from osteoporosis to falls	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Jarvinen, Teppo L. N.; Kannus, Pekka] Tampere Univ Hosp, Dept Trauma Musculoskeletal Surg & Rehabil, Div Orthopaed & Traumatol, Tampere 33520, Finland; [Sievanen, Harri; Kannus, Pekka] UKK Inst, Bone Res Grp, Tampere, Finland; [Khan, Karim M.] Univ British Columbia, Dept Family Practice, Vancouver, BC V5Z 1M9, Canada; [Khan, Karim M.] Univ British Columbia, Ctr Hip Hlth, Vancouver, BC V5Z 1M9, Canada; [Heinonen, Ari] Univ Jyvaskyla, Dept Hlth Sci, Jyvaskyla, Finland	Tampere University; Tampere University Hospital; UKK Institute; University of British Columbia; University of British Columbia; University of Jyvaskyla	Jarvinen, TLN (corresponding author), Tampere Univ Hosp, Dept Trauma Musculoskeletal Surg & Rehabil, Div Orthopaed & Traumatol, Tampere 33520, Finland.	teppo.jarvinen@uta.fi	Järvinen, Teppo/B-8189-2013; Heinonen, Ari/A-9199-2014; Heinonen, Ari/I-5292-2019	Järvinen, Teppo/0000-0003-3713-956X; Heinonen, Ari/0000-0002-3681-9953; Heinonen, Ari/0000-0002-3681-9953					0	273	286	0	14	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 19	2008	336	7636					124	126		10.1136/bmj.39428.470752.AD	http://dx.doi.org/10.1136/bmj.39428.470752.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	257SS	18202065	Green Published			2022-12-28	WOS:000252819400028
J	Brauman, JI				Brauman, John I.			Chemistry - Not so simple	SCIENCE			English	Editorial Material							DYNAMICS		[Brauman, John I.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University	Brauman, JI (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	brauman@stanford.edu						Anslyn E. V., 2006, MODERN PHYS ORGANIC; BERGSMA JP, 1987, J CHEM PHYS, V86, P1356, DOI 10.1063/1.452224; Chabinyc ML, 1998, SCIENCE, V279, P1882, DOI 10.1126/science.279.5358.1882; Elioff MS, 2003, SCIENCE, V302, P1940, DOI 10.1126/science.1090679; Liu KP, 2001, ANNU REV PHYS CHEM, V52, P139, DOI 10.1146/annurev.physchem.52.1.139; Mikosch J, 2008, SCIENCE, V319, P183, DOI 10.1126/science.1150238; Mikosch J, 2006, PHYS CHEM CHEM PHYS, V8, P2990, DOI 10.1039/b603109a	7	15	15	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2008	319	5860					168	168		10.1126/science.1152387	http://dx.doi.org/10.1126/science.1152387			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249RC	18187647				2022-12-28	WOS:000252246400029
J	James, RM; Cruickshank, ME; Siddiqui, N				James, R. M.; Cruickshank, M. E.; Siddiqui, N.		Guideline Dev Grp	Guidelines - Management of cervical cancer: summary of SIGN guidelines	BRITISH MEDICAL JOURNAL			English	Editorial Material									[James, R. M.] Scottish Intercollegiate Guidelines Network, Edinburgh EH2 1EN, Midlothian, Scotland; [Cruickshank, M. E.] Aberdeen Matern Hosp, Dept Obstet & Gynaecol, Aberdeen AB25 7ZD, Scotland; [Siddiqui, N.] Glasgow Royal Infirm, Dept Gynaecol Oncol, Glasgow G4 0SF, Lanark, Scotland	University of Aberdeen; University of Glasgow	James, RM (corresponding author), Scottish Intercollegiate Guidelines Network, 28 Thistle St, Edinburgh EH2 1EN, Midlothian, Scotland.	roberta.james@nhs.net		Cruickshank, Margaret/0000-0002-8893-8620				[Anonymous], 2002, INV POSTM BLEED; Bodurka-Bevers D, 2000, GYNECOL ONCOL, V78, P187, DOI 10.1006/gyno.2000.5860; Downing A, 2007, EUR J CANCER, V43, P363, DOI 10.1016/j.ejca.2006.04.019; Hong JH, 2004, INT J RADIAT ONCOL, V60, P249, DOI 10.1016/j.ijrobp.2004.02.044; Lim KCK, 2004, BJOG-INT J OBSTET GY, V111, P1444, DOI 10.1111/j.1471-0528.2004.00280.x; *NHMRC NAT BREAST, 2003, CLIN PRACT GUID PSYC; *SIGN, 2007, MAN CERV CANC; *SIGN, 2000, MAN GEN CHLAM TRACH; Slevin ML, 1996, BRIT J CANCER, V74, P1275, DOI 10.1038/bjc.1996.529	9	11	11	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 5	2008	336	7634					41	43		10.1136/bmj.39399.642894.AD	http://dx.doi.org/10.1136/bmj.39399.642894.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250UT	18174599	Green Published			2022-12-28	WOS:000252327500041
J	Anderson, DR; Kahn, SR; Rodger, MA; Kovacs, MJ; Morris, T; Hirsch, A; Lang, E; Stiell, I; Kovacs, G; Dreyer, J; Dennie, C; Cartier, Y; Barnes, D; Burton, E; Pleasance, S; Skedgel, C; O'Rouke, K; Wells, PS				Anderson, David R.; Kahn, Susan R.; Rodger, Marc A.; Kovacs, Michael J.; Morris, Tim; Hirsch, Andrew; Lang, Eddy; Stiell, Ian; Kovacs, George; Dreyer, Jon; Dennie, Carol; Cartier, Yannick; Barnes, David; Burton, Erica; Pleasance, Susan; Skedgel, Chris; O'Rouke, Keith; Wells, Philip S.			Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism - A Randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SIMPLE CLINICAL-MODEL; DEEP-VEIN THROMBOSIS; DIAGNOSTIC WORK-UP; D-DIMER; HEMORRHAGIC COMPLICATIONS; ANTICOAGULANT TREATMENT; SPIRAL CT; MANAGEMENT; ULTRASONOGRAPHY; PROBABILITY	Context Ventilation- perfusion ( (V) over dot/(Q) over dot.) lung scanning and computed tomographic pulmonary angiography ( CTPA) are widely used imaging procedures for the evaluation of patients with suspected pulmonary embolism. Ventilation- perfusion scanning has been largely replaced by CTPA in many centers despite limited comparative formal evaluations and concerns about CTPA's low sensitivity ( ie, chance of missing clinically important pulmonary embuli). Objectives To determine whether CTPA may be relied upon as a safe alternative to (V) over dot /(Q) over dot scanning as the initial pulmonary imaging procedure for excluding the diagnosis of pulmonary embolism in acutely symptomatic patients. Design, Setting, and Participants Randomized, single- blinded noninferiority clinical trial performed at 4 Canadian and 1 US tertiary care centers between May 2001 and April 2005 and involving 1417 patients considered likely to have acute pulmonary embolism based on a Wells clinical model score of 4.5 or greater or a positive D- dimer assay result. Intervention Patients were randomized to undergo either (V) over dot /(Q) over dot scanning or CTPA. Patients in whom pulmonary embolism was considered excluded did not receive antithrombotic therapy and were followed up for a 3- month period. Main Outcome Measure The primary outcome was the subsequent development of symptomatic pulmonary embolism or proximal deep vein thrombosis in patients in whom pulmonary embolism had initially been excluded. Results Seven hundred one patients were randomized to CTPA and 716 to (V) over dot/(Q) over dot scanning. Of these, 133 patients ( 19.2%) in the CTPA group vs 101 ( 14.2%) in the (V) over dot/(Q) over dot scan group were diagnosed as having pulmonary embolism in the initial evaluation period ( difference, 5.0%; 95% confidence interval [ CI], 1.1% to 8.9%) and were treated with anticoagulant therapy. Of those in whom pulmonary embolism was considered excluded, 2 of 561 patients ( 0.4%) randomized to CTPA vs 6 of 611 patients ( 1.0%) undergoing (V) over dot/(Q) over dot scanning developed venous thromboembolism in follow- up ( difference, - 0.6%; 95% CI, - 1.6% to 0.3%) including one patient with fatal pulmonary embolism in the (V) over dot/(Q) over dot group. Conclusions In this study, CTPA was not inferior to (V) over dot/(Q) over dot scanning in ruling out pulmonary embolism. However, significantly more patients were diagnosed with pulmonary embolism using the CTPA approach. Further research is required to determine whether all pulmonary emboli detected by CTPA should be managed with anticoagulant therapy.	Dalhousie Univ, Dept Med, Halifax, NS, Canada; Dalhousie Univ, Dept Emergency Med, Halifax, NS, Canada; Dalhousie Univ, Dept Radiol, Halifax, NS, Canada; McGill Univ, Dept Med, Montreal, PQ, Canada; McGill Univ, Dept Emergency Med, Montreal, PQ, Canada; Univ Western Ontario, Dept Med, London, ON, Canada; Univ Western Ontario, Dept Emergency Med, London, ON, Canada; Univ Ottawa, Dept Med, Ottawa, ON, Canada; Univ Ottawa, Dept Emergency Med, Ottawa, ON, Canada; Univ Ottawa, Dept Radiol, Ottawa, ON, Canada; Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA	Dalhousie University; Dalhousie University; Dalhousie University; McGill University; McGill University; Western University (University of Western Ontario); Western University (University of Western Ontario); University of Ottawa; University of Ottawa; University of Ottawa; University of California System; University of California San Diego	Anderson, DR (corresponding author), Queen Elizabeth 2 Hlth Sci Ctr, VGH Site,Room 430,Bethune Bldg,1278 Tower Rd, Halifax, NS B3H 2Y9, Canada.	david.anderson@dal.ca	Lang, Eddy/AAS-2080-2020; Skedgel, Chris/U-7173-2019; Kovacs, Michael/G-3315-2011; Lang, Eddy/I-4759-2014	Skedgel, Chris/0000-0003-4989-8846; Stiell, Ian/0000-0002-2583-6408; Rodger, Marc/0000-0001-8166-3487; Lang, Eddy/0000-0003-0850-4337; Anderson, David/0000-0003-0845-1722				Anderson DR, 2005, J EMERG MED, V29, P399, DOI 10.1016/j.jemermed.2005.05.010; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; BLACKWELDER WC, 1982, CONTROL CLIN TRIALS, V3, P345, DOI 10.1016/0197-2456(82)90024-1; Buller HR, 2004, CHEST, V126, p401S, DOI 10.1378/chest.126.3_suppl.401S; DISMUKE SE, 1986, JAMA-J AM MED ASSOC, V255, P2039, DOI 10.1001/jama.255.15.2039; Fedullo PF, 2003, NEW ENGL J MED, V349, P1247, DOI 10.1056/NEJMcp035442; Fraser JD, 2004, RADIOL CLIN N AM, V42, P279, DOI 10.1016/j.rcl.2004.01.001; Ghanima W, 2005, J THROMB HAEMOST, V3, P1926, DOI 10.1111/j.1538-7836.2005.01544.x; Ghaye B, 2001, RADIOLOGY, V219, P629, DOI 10.1148/radiology.219.3.r01jn32629; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Goldhaber SZ, 2004, LANCET, V363, P1295, DOI 10.1016/S0140-6736(04)16004-2; Kruip MJHA, 2002, ARCH INTERN MED, V162, P1631, DOI 10.1001/archinte.162.14.1631; Levine MN, 2004, CHEST, V126, p287S, DOI 10.1378/chest.126.3_suppl.287S; LEVINE MN, 1995, CHEST, V108, pS276, DOI 10.1378/chest.108.4_Supplement.276S; Mullins MD, 2000, ARCH INTERN MED, V160, P293, DOI 10.1001/archinte.160.3.293; Musset D, 2002, LANCET, V360, P1914, DOI 10.1016/S0140-6736(02)11914-3; Nijkeuter M, 2007, CHEST, V131, P517, DOI 10.1378/chest.05-2799; Perrier A, 2001, ANN INTERN MED, V135, P88, DOI 10.7326/0003-4819-135-2-200107170-00008; Prandoni P, 2002, THROMB HAEMOSTASIS, V88, P402; Rathbun SW, 2000, ANN INTERN MED, V132, P227, DOI 10.7326/0003-4819-132-3-200002010-00009; Schoepf UJ, 2004, CIRCULATION, V109, P2160, DOI 10.1161/01.CIR.0000128813.04325.08; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; STEIN PD, 1992, CIRCULATION, V85, P462, DOI 10.1161/01.CIR.85.2.462; Ten Wolde M, 2004, J THROMB HAEMOST, V2, P1110, DOI 10.1111/j.1538-7836.2004.00769.x; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172; van Strijen MJ, 2003, ANN INTERN MED, V139, P387, DOI 10.7326/0003-4819-138-4-200302180-00009; van Strijen MJL, 2005, J THROMB HAEMOST, V3, P622; van Strijen MJL, 2005, J THROMB HAEMOST, V3, P17, DOI 10.1111/j.1538-7836.2004.01064.x; van Strijen MJL, 2003, ANN INTERN MED, V138, P307, DOI 10.7326/0003-4819-138-4-200302180-00009; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416	33	399	410	0	19	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2007	298	23					2743	2753		10.1001/jama.298.23.2743	http://dx.doi.org/10.1001/jama.298.23.2743			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242HK	18165667				2022-12-28	WOS:000251716000019
J	Yu, D; Tan, AHM; Hu, X; Athanasopoulos, V; Simpson, N; Silva, DG; Hutloff, A; Giles, KM; Leedman, PJ; Lam, KP; Goodnow, CC; Vinuesa, CG				Yu, Di; Tan, Andy Hee-Meng; Hu, Xin; Athanasopoulos, Vicki; Simpson, Nicholas; Silva, Diego G.; Hutloff, Andreas; Giles, Keith M.; Leedman, Peter J.; Lam, Kong Peng; Goodnow, Christopher C.; Vinuesa, Carola G.			Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA	NATURE			English	Article							IMMUNE-RESPONSES; ICOS; HELPER; ACTIVATION; TOLERANCE; RECEPTOR; SIGNALS; STRESS; FAMILY; LIGAND	Immune responses are normally targeted against microbial pathogens and not self-antigens by mechanisms that are only partly understood. Here we define a newly discovered pathway that prevents autoimmunity by limiting the levels on T lymphocytes of a co-stimulatory receptor, the inducible T-cell co-stimulator (ICOS). In sanroque mice homozygous for an M199R mutation in the ROQ domain of Roquin (also known as Rc3h1)(1), increased Icos expression on T cells causes the accumulation of lymphocytes that is associated with a lupus-like autoimmune syndrome. Roquin normally limits Icos expression by promoting the degradation of Icos messenger RNA. A conserved segment in the unusually long ICOS 39 untranslated mRNA is essential for regulation by Roquin. This segment comprises a 47-base-pair minimal region complementary to T-cell-expressed microRNAs including miR-101, the repressive activity of which is disrupted by base-pair inversions predicted to abrogate miR-101 binding. These findings illuminate a critical post-transcriptional pathway within T cells that regulates lymphocyte accumulation and autoimmunity, and highlights the therapeutic potential of partially antagonising the ICOS pathway.	Australian Natl Univ, John Curtin Sch Med Res, Div Immunol & Genet, Canberra, ACT 2601, Australia; ASTAR, Inst Biomed Sci, Cellular & Mol Immunol Lab, Singapore 138673, Singapore; Australian Natl Univ, ARC Ctr Mol Genet Dev, Canberra, ACT 2601, Australia; Robert Koch Inst, D-13353 Berlin, Germany; Univ Western Australia, Med Res Ctr, Western Australian Inst Med Res, Lab Canc Med, Perth, WA 6000, Australia; Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6000, Australia; Australian Phenom Facil, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research; Agency for Science Technology & Research (A*STAR); Australian National University; Robert Koch Institute; University of Western Australia; University of Western Australia	Vinuesa, CG (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Div Immunol & Genet, Canberra, ACT 2601, Australia.	carola.vinuesa@anu.edu.au	Vinuesa, Carola G/B-1108-2010; Yu, Di/C-2163-2009; Goodnow, Christopher C/V-8108-2018; Lam, Kong-Peng/G-5374-2012; Hutloff, Andreas/D-1781-2014; Leedman, Peter J/O-4044-2014; Silva, Diego/GRF-5446-2022	Vinuesa, Carola G/0000-0001-9799-0298; Yu, Di/0000-0003-1721-8922; Goodnow, Christopher C/0000-0001-5296-6155; Hutloff, Andreas/0000-0002-0572-8151; Lam, Kong-Peng/0000-0002-1316-4333; Athanasopoulos, Vicki/0000-0002-5764-5948				Akiba H, 2005, J IMMUNOL, V175, P2340, DOI 10.4049/jimmunol.175.4.2340; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bossaller L, 2006, J IMMUNOL, V177, P4927, DOI 10.4049/jimmunol.177.7.4927; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Dong C, 2001, J IMMUNOL, V166, P3659, DOI 10.4049/jimmunol.166.6.3659; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; JACKSON RJ, 2007, SCI STKE, pRE1, DOI DOI 10.1126/STKE.3672007RE1; Jakymiw A, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1959; JANEWAY CA, 1994, CELL, V76, P275, DOI 10.1016/0092-8674(94)90335-2; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; LAFFERTY KJ, 1980, IMMUNOL REV, V51, P279, DOI 10.1111/j.1600-065X.1980.tb00325.x; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Mak TW, 2003, NAT IMMUNOL, V4, P765, DOI 10.1038/ni947; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; Newbury SF, 2006, EMBO REP, V7, P143, DOI 10.1038/sj.embor.7400628; Nurieva R, 2006, EMBO J, V25, P2623, DOI 10.1038/sj.emboj.7601146; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Scheu S, 2006, NAT IMMUNOL, V7, P644, DOI 10.1038/ni1338; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Suh WK, 2004, J IMMUNOL, V172, P5917, DOI 10.4049/jimmunol.172.10.5917; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Tordjman R, 2002, NAT IMMUNOL, V3, P477, DOI 10.1038/ni789; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Wong SC, 2003, BLOOD, V102, P1381, DOI 10.1182/blood-2002-08-2416; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582	30	325	348	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2007	450	7167					299	U15		10.1038/nature06253	http://dx.doi.org/10.1038/nature06253			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	18172933				2022-12-28	WOS:000250746200061
J	Steiner, MJ; Cates, W; Genuis, S				Steiner, Markus J.; Cates, Willard; Genuis, Stephen			Are condoms the answer to rising rates of non-HIV sexually transmitted infection?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Steiner, Markus J.; Cates, Willard] Family Hlth Int, Res Triangle Pk, NC 27709 USA; [Genuis, Stephen] Univ Alberta, Edmonton, AB T6K 4C1, Canada	University of Alberta	Steiner, MJ (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.	wcates@fhi.org; sgenuis@ualberta.ca							0	9	9	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 26	2008	336	7637					184	185		10.1136/bmj.39402.488727.AD	http://dx.doi.org/10.1136/bmj.39402.488727.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	259KT	18219036	Green Published			2022-12-28	WOS:000252938900037
J	Wilt, TJ; N'Dow, J				Wilt, Timothy J.; N'Dow, James			Benign prostatic hyperplasia. Part 2 - Management	BMJ-BRITISH MEDICAL JOURNAL			English	Review							FINASTERIDE		[Wilt, Timothy J.] Ctr Chron Dis Outcomes Res, Minneapolis, MN 55417 USA; [N'Dow, James] Univ Aberdeen, Acad Urol Unit, Aberdeen AB25 2ZD, Scotland	University of Aberdeen	Wilt, TJ (corresponding author), Ctr Chron Dis Outcomes Res, 1 Vet Dr 111-0, Minneapolis, MN 55417 USA.	tim.wilt@med.va.gov						*AM UR ASS, 2006, GUID MAN BEN PROST H; BARRY MJ, 1995, J UROLOGY, V154, P1770, DOI 10.1016/S0022-5347(01)66780-6; Bent S, 2006, NEW ENGL J MED, V354, P557, DOI 10.1056/NEJMoa053085; Chapple C, 2005, EUR UROL, V48, P5, DOI 10.1016/j.eururo.2005.02.024; Chapple CR, 2006, EUR UROL, V49, P651, DOI 10.1016/j.eururo.2006.02.018; EMBERTON M, 1995, BRIT J UROL, V75, P301, DOI 10.1111/j.1464-410X.1995.tb07341.x; *EUR ASS UR, GUID BEN PROST HYP; HELFAND M, 2007, BEN PROST HYP BPH MA; Hoffman R, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858; Hoffman RM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004135.pub2; LOURENCO T, IN PRESS HLTH TECHNO; McConnell JD, 2003, NEW ENGL J MED, V349, P2387, DOI 10.1056/NEJMoa030656; Reich O, 2006, EUR UROL, V49, P970, DOI 10.1016/j.eururo.2005.12.072; Ruggieri MR, 2005, J UROLOGY, V174, P1743, DOI 10.1097/01.ju.0000176460.62847.23; Speakman MJ, 2004, BJU INT, V93, P985, DOI 10.1111/j.1464-410X.2004.04765.x; T Brown C, 2007, BRIT MED J, V334, P25, DOI 10.1136/bmj.39010.551319.AE; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Wilt T, 1998, COCHRANE DB SYST REV; Wilt T, 2000, COCHRANE DB SYST REV; Wilt T, 2002, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD001423; Wilt TJ, 2008, BRIT MED J, V336, P146, DOI 10.1136/bmj.39421.685023.AE; WILT TJ, IN PRESS COCHRANE LI; Wilt TJ, 2002, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD002081, 10.1002/14651858.CD002081]	23	8	8	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2008	336	7637					206	210		10.1136/bmj.39433.670718.AD	http://dx.doi.org/10.1136/bmj.39433.670718.AD			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259KT	18219042	Green Published, Green Submitted			2022-12-28	WOS:000252938900045
J	Got, JL; Monteiller, V; Monteux, J; Hassani, R; Okubo, P				Got, Jean-Luc; Monteiller, Vadim; Monteux, Julien; Hassani, Riad; Okubo, Paul			Deformation and rupture of the oceanic crust may control growth of Hawaiian volcanoes	NATURE			English	Article							BENEATH KILAUEA VOLCANO; MAUNA-LOA; SOUTH FLANK; ISLANDS; MANTLE; LANDSLIDES; INSIGHTS; STRESS; FIELD	Hawaiian volcanoes are formed by the eruption of large quantities of basaltic magma related to hot- spot activity below the Pacific Plate(1,2). Despite the apparent simplicity of the parent process emission of magma onto the oceanic crust - the resulting edifices display some topographic complexity(3-5). Certain features, such as rift zones and large flank slides, are common to all Hawaiian volcanoes, indicating similarities in their genesis; however, the underlying mechanism controlling this process remains unknown(6,7). Here we use seismological investigations and finite-element mechanical modelling to show that the load exerted by large Hawaiian volcanoes can be sufficient to rupture the oceanic crust. This intense deformation, combined with the accelerated subsidence of the oceanic crust and the weakness of the volcanic edifice/ oceanic crust interface, may control the surface morphology of Hawaiian volcanoes, especially the existence of their giant flank instabilities(8-10). Further studies are needed to determine whether such processes occur in other active intraplate volcanoes.	[Got, Jean-Luc; Monteiller, Vadim; Hassani, Riad] Univ Savoie, Lab Geophys Interne & Tectonophys, F-73376 Le Bourget Du Lac, France; [Monteux, Julien] Ecole Normale Super Lyon, Lab Sci Terre, F-69364 Lyon, France; [Okubo, Paul] US Geol Survey, Hawaiian Volcano Observ, Hawaii Natl Pk, HI USA	Universite de Savoie; Ecole Normale Superieure de Lyon (ENS de LYON); United States Department of the Interior; United States Geological Survey	Got, JL (corresponding author), Univ Savoie, Lab Geophys Interne & Tectonophys, F-73376 Le Bourget Du Lac, France.	jlgot@univ-savoie.fr	GOT, Jean-Luc/AAE-6880-2021	Monteiller, Vadim/0000-0002-9926-3825; Monteux, Julien/0000-0002-1059-6165				Davis AS, 2006, B VOLCANOL, V68, P294, DOI 10.1007/s00445-005-0008-7; Denlinger RP, 1995, J GEOPHYS RES-SOL EA, V100, P24499, DOI 10.1029/95JB01479; DIETERICH JH, 1988, J GEOPHYS RES-SOLID, V93, P4258, DOI 10.1029/JB093iB05p04258; Got J.-L., 2003, Journal of Geophysical Research, V108, pESE5, DOI 10.1029/2002JB002060; GOT JL, 1994, J GEOPHYS RES-SOL EA, V99, P15375, DOI 10.1029/94JB00577; Hassani R, 1996, GEOLOGY, V24, P1095, DOI 10.1130/0091-7613(1996)024<1095:AETAWB>2.3.CO;2; Hassani R, 1997, J GEOPHYS RES-SOL EA, V102, P17951, DOI 10.1029/97JB01354; HILL DP, 1987, US GEOL SURV PROF PA, V1350, P903; JACKSON ED, 1975, EARTH PLANET SC LETT, V26, P145, DOI 10.1016/0012-821X(75)90082-5; Klein F.W., 1987, VOLCANISM HAWAII, P1019; LIPMAN PW, 1988, J GEOPHYS RES-SOLID, V93, P4279, DOI 10.1029/JB093iB05p04279; Lipman PW, 2006, J VOLCANOL GEOTH RES, V151, P73, DOI 10.1016/j.jvolgeores.2005.07.032; Mark RK., 1987, VOLCANISM HAWAII US, V1350, P101; Miklius A, 2003, NATURE, V421, P229, DOI 10.1038/421229a; Monteiller V, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003466; MOORE JG, 1994, ANNU REV EARTH PL SC, V22, P119, DOI 10.1146/annurev.ea.22.050194.001003; MOORE JG, 1989, J GEOPHYS RES-SOLID, V94, P17465, DOI 10.1029/JB094iB12p17465; Morgan JK, 2006, J VOLCANOL GEOTH RES, V151, P109, DOI 10.1016/j.jvolgeores.2005.07.025; MORGAN WJ, 1971, NATURE, V230, P42, DOI 10.1038/230042a0; Okubo PG, 1997, GEOLOGY, V25, P867, DOI 10.1130/0091-7613(1997)025<0867:ITCMSB>2.3.CO;2; OWEN S, 1995, SCIENCE, V267, P1328, DOI 10.1126/science.267.5202.1328; Pritchard ME, 2007, GEOPHYS J INT, V168, P419, DOI 10.1111/j.1365-246X.2006.03169.x; Schiffman P, 2006, J VOLCANOL GEOTH RES, V151, P217, DOI 10.1016/j.jvolgeores.2005.07.030; Swanson D.A., 1976, US GEOL SURV PROF PA, V963, P1; THURBER CH, 1984, SCIENCE, V223, P165, DOI 10.1126/science.223.4632.165; WATTS AB, 1989, J GEOPHYS RES-SOLID, V94, P10473, DOI 10.1029/JB094iB08p10473; WESSEL P, 1993, J GEOPHYS RES-SOL EA, V98, P12177, DOI 10.1029/93JB00523; WILSON JT, 1963, CAN J PHYS, V41, P863, DOI 10.1139/p63-094; Wolfe CJ, 2003, SCIENCE, V300, P478, DOI 10.1126/science.1082205	29	27	30	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2008	451	7177					453	456		10.1038/nature06481	http://dx.doi.org/10.1038/nature06481			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	253YS	18216852	Green Submitted, Bronze			2022-12-28	WOS:000252554100042
J	Sanchez-Lavega, A; Orton, GS; Hueso, R; Garcia-Melendo, E; Perez-Hoyos, S; Simon-Miller, A; Rojas, JF; Gomez, JM; Yanamandra-Fisher, P; Fletcher, L; Joels, J; Kemerer, J; Hora, J; Karkoschka, E; de Pater, I; Wong, MH; Marcus, PS; Pinilla-Alonso, N; Carvalho, F; Go, C; Parker, D; Salway, M; Valimberti, M; Wesley, A; Pujic, Z				Sanchez-Lavega, A.; Orton, G. S.; Hueso, R.; Garcia-Melendo, E.; Perez-Hoyos, S.; Simon-Miller, A.; Rojas, J. F.; Gomez, J. M.; Yanamandra-Fisher, P.; Fletcher, L.; Joels, J.; Kemerer, J.; Hora, J.; Karkoschka, E.; de Pater, I.; Wong, M. H.; Marcus, P. S.; Pinilla-Alonso, N.; Carvalho, F.; Go, C.; Parker, D.; Salway, M.; Valimberti, M.; Wesley, A.; Pujic, Z.			Depth of a strong jovian jet from a planetary-scale disturbance driven by storms	NATURE			English	Article							DEEP ZONAL WINDS; MOIST CONVECTION; NONLINEAR SIMULATIONS; 3-DIMENSIONAL MODEL; JUPITERS ATMOSPHERE; GIANT PLANETS; STABILITY; DYNAMICS; CASSINI; GALILEO	The atmospheres of the gas giant planets ( Jupiter and Saturn) contain jets that dominate the circulation at visible levels(1,2). The power source for these jets ( solar radiation, internal heat, or both) and their vertical structure below the upper cloud are major open questions in the atmospheric circulation and meteorology of giant planets(1-3). Several observations(1) and in situ measurements(4) found intense winds at a depth of 24 bar, and have been interpreted as supporting an internal heat source. This issue remains controversial(5), in part because of effects from the local meteorology(6). Here we report observations and modelling of two plumes in Jupiter's atmosphere that erupted at the same latitude as the strongest jet ( 23 degrees N). The plumes reached a height of 30 km above the surrounding clouds, moved faster than any other feature ( 169 m s(-1)), and left in their wake a turbulent planetary- scale disturbance containing red aerosols. On the basis of dynamical modelling, we conclude that the data are consistent only with a wind that extends well below the level where solar radiation is deposited.	[Sanchez-Lavega, A.; Hueso, R.; Perez-Hoyos, S.] Univ Basque Country, ETS Ingenieros, Dept Fis Aplicada 1, Bilbao 48013, Spain; [Orton, G. S.; Yanamandra-Fisher, P.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Garcia-Melendo, E.; Gomez, J. M.] Esteve Duran Observ Fdn, Seva 085330, Spain; [Simon-Miller, A.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Rojas, J. F.] Univ Basque Country, EUITI, Dept Fis Aplicada 1, Bilbao 48013, Spain; [Fletcher, L.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [Joels, J.] Principia Coll, Elsah, IL 62028 USA; [Kemerer, J.] Calif State Polytech Univ Pomona, Pomona, CA 91768 USA; [Hora, J.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Karkoschka, E.] Univ Arizona, Tucson, AZ 85721 USA; [de Pater, I.; Wong, M. H.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Marcus, P. S.] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA; [Pinilla-Alonso, N.] Telescopio Nazl Galileo Galilei, Santa Cruz De La Palma 38700, Spain; [Carvalho, F.] Ctr Estudos Universo, BR-17380000 Brotas, Brazil; [Go, C.] Univ San Carlos, Dept Phys, Cebu 6000, Philippines; [Parker, D.] Assoc Lunar & Planetary Observers, Coral Gables, FL 33156 USA; [Salway, M.] IcelnSpace, Wyoming, NSW 2250, Australia; [Valimberti, M.] Astron Soc Victoria, Melbourne, Vic 3001, Australia; [Wesley, A.] Math & Comp Sci, Murrumbateman 2582, Australia	University of Basque Country; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Basque Country; University of Oxford; California State University System; California State Polytechnic University Pomona; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Arizona; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of San Carlos	Sanchez-Lavega, A (corresponding author), Univ Basque Country, ETS Ingenieros, Dept Fis Aplicada 1, Alameda Urquijo S-N, Bilbao 48013, Spain.	agustin.sanchez@ehu.es	Sanchez-Lavega, Agustin/Z-3639-2019; Orton, Glenn/AAD-9862-2020; Hueso, Ricardo/Z-3277-2019; Simon, Amy/C-8020-2012; Fletcher, Leigh/D-6093-2011; Perez-Hoyos, Santiago/L-7543-2014; Palenzuela, Jose Felix Rojas/H-2782-2015; Pinilla-Alonso, Noemi/K-4361-2017; Garcia-Melendo, Enrique/AAH-5658-2020; Pinilla-Alonso, Noemi/B-8583-2008	Hueso, Ricardo/0000-0003-0169-123X; Simon, Amy/0000-0003-4641-6186; Fletcher, Leigh/0000-0001-5834-9588; Perez-Hoyos, Santiago/0000-0002-2587-4682; Palenzuela, Jose Felix Rojas/0000-0002-1102-5612; Pinilla-Alonso, Noemi/0000-0002-2770-7896; Sanchez-Lavega, Agustin/0000-0001-7234-7634; Hora, Joseph/0000-0002-5599-4650; Sanchez-Lavega, Agustin/0000-0001-7355-1522				Atkinson DH, 1998, J GEOPHYS RES-PLANET, V103, P22911, DOI 10.1029/98JE00060; Dowling TE, 1998, ICARUS, V132, P221, DOI 10.1006/icar.1998.5917; DOWLING TE, 1995, ICARUS, V117, P439, DOI 10.1006/icar.1995.1169; Garcia-Melendo E, 2005, ICARUS, V176, P272, DOI 10.1016/j.icarus.2005.02.012; Garcia-Melendo E, 2001, ICARUS, V152, P316, DOI 10.1006/icar.2001.6646; Hueso R, 2004, ICARUS, V172, P255, DOI 10.1016/j.icarus.2004.06.010; Hueso R, 2001, ICARUS, V151, P257, DOI 10.1006/icar.2000.6606; LAVEGA AS, 1987, ASTRON ASTROPHYS, V185, P315; LIMAYE SS, 1986, ICARUS, V65, P335, DOI 10.1016/0019-1035(86)90142-9; LINDAL GF, 1981, J GEOPHYS RES-SPACE, V86, P8721, DOI 10.1029/JA086iA10p08721; MAXWORTHY T, 1984, PLANET SPACE SCI, V32, P1053, DOI 10.1016/0032-0633(84)90062-X; Nakajima K, 2000, GEOPHYS RES LETT, V27, P3129, DOI 10.1029/2000GL011740; Peek B. M., 1958, PLANET JUPITER; Porco CC, 2003, SCIENCE, V299, P1541, DOI 10.1126/science.1079462; Rogers J. H., 1995, GIANT PLANET JUPITER; Sanchez-Lavega A., 2004, LECT NOTES ESSAYS AS, V1, P63; SANCHEZLAVEGA A, 1991, ICARUS, V94, P92, DOI 10.1016/0019-1035(91)90142-G; SANCHEZLAVEGA A, 1988, ICARUS, V76, P533, DOI 10.1016/0019-1035(88)90020-6; Showman AP, 2006, ICARUS, V182, P513, DOI 10.1016/j.icarus.2006.01.019; Showman AP, 2000, SCIENCE, V289, P1737; Simon AA, 1999, ICARUS, V141, P29, DOI 10.1006/icar.1999.6163; Simon-Miller AA, 2006, ICARUS, V180, P98, DOI 10.1016/j.icarus.2005.07.019; Vasavada AR, 2005, REP PROG PHYS, V68, P1935, DOI 10.1088/0034-4885/68/8/R06	25	71	71	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2008	451	7177					437	440		10.1038/nature06533	http://dx.doi.org/10.1038/nature06533			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	253YS	18216848	Bronze			2022-12-28	WOS:000252554100038
J	Horton, R				Horton, Richard			Maternal and child undernutrition: an urgent opportunity	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9	1	68	76	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 19	2008	371	9608					179	179		10.1016/S0140-6736(07)61869-8	http://dx.doi.org/10.1016/S0140-6736(07)61869-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	252UK	18207569				2022-12-28	WOS:000252471900004
J	Girard, TD; Kress, JP; Fuchs, BD; Thomason, JWW; Schweickert, WD; Pun, BT; Taichman, DB; Dunn, JG; Pohlman, AS; Kinniry, PA; Jackson, JC; Canonico, AE; Light, RW; Shintani, AK; Thompson, JL; Gordon, SM; Hall, JB; Dittus, RS; Bernard, GR; Ely, EW				Girard, Timothy D.; Kress, John P.; Fuchs, Barry D.; Thomason, Jason W. W.; Schweickert, William D.; Pun, Brenda T.; Taichman, Darren B.; Dunn, Jan G.; Pohlman, Anne S.; Kinniry, Paul A.; Jackson, James C.; Canonico, Angelo E.; Light, Richard W.; Shintani, Ayumi K.; Thompson, Jennifer L.; Gordon, Sharon M.; Hall, Jesse B.; Dittus, Robert S.; Bernard, Gordon R.; Ely, E. Wesley			Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial	LANCET			English	Article							CRITICALLY-ILL PATIENTS; CONFUSION ASSESSMENT METHOD; DAILY INTERRUPTION; RELIABILITY; ANALGESICS; INFUSIONS; VALIDITY; DELIRIUM; RISK; GUIDELINES	Background Approaches to removal of sedation and mechanical ventilation for critically ill patients vary widely. Our aim was to assess a protocol that paired spontaneous awakening trials (SATs)-ie, daily interruption of sedatives-with spontaneous breathing trials (SBTs). Methods In four tertiary-care hospitals, we randomly assigned 336 mechanically ventilated patients in intensive care to management with a daily SAT followed by an SBT (intervention group; n=168) or with sedation per usual care plus a daily SBT (control group; n=168). The primary endpoint was time breathing without assistance. Data were analysed by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00097630. Findings One patient in the intervention group did not begin their assigned treatment protocol because of withdrawal of consent and thus was excluded from analyses and lost to follow-up. Seven patients in the control group discontinued their assigned protocol, and two of these patients were lost to follow-up. Patients in the intervention group spent more days breathing without assistance during the 28-day study period than did those in the control group (14.7 days vs 11 . 6 days; mean difference 3 . 1 days, 95% CI 0.7 to 5.6; p=0.02) and were discharged from intensive care (median time in intensive care 9.1 days vs 12.9 days; p=0.01) and the hospital earlier (median time in the hospital 14.9 days vs 19.2 days; p=0.04). More patients in the intervention group self-extubated than in the control group (16 patients vs six patients; 6.0% difference, 95% CI 0. 6% to 11.8%; p=0.03), but the number of patients who required reintubation after self-extubation was similar (five patients vs three patients; 1. 2% difference, 95% CI -5.2% to 2.5%; p=0.47), as were total reintubation rates (13.8% vs 12 . 5%; 1. 3% difference, 95% CI -8.6% to 6 . 1%; p=0. 73). At any instant during the year after enrolment, patients in the intervention group were less likely to die than were patients in the control group (HR 0.68, 95% CI 0 .50 to 0. 92; p=0.01). For every seven patients treated with the intervention, one life as saved (number needed to treat was 7.4, 95% CI 4 . 2 to 35. 5). Interpretation Our results suggest that a wake up and breathe protocol that pairs daily spontaneous awakening trials (ie, interruption of sedatives) with daily spontaneous breathing trials results in better outcomes for mechanically ventilated patients in intensive care than current standard approaches and should become routine practice.	[Girard, Timothy D.; Thomason, Jason W. W.; Pun, Brenda T.; Jackson, James C.; Light, Richard W.; Gordon, Sharon M.; Dittus, Robert S.; Bernard, Gordon R.; Ely, E. Wesley] Vanderbilt Univ, Sch Med, Ctr Hlth Serv Res, Dept Med,Div Allergy Pulm & Crit Care Med, Nashville, TN 37232 USA; [Canonico, Angelo E.] St Thomas Hosp, Dept Med, Nashville, TN USA; [Dunn, Jan G.] St Thomas Hosp, St Thomas Res Inst, Nashville, TN USA; [Shintani, Ayumi K.; Thompson, Jennifer L.] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37232 USA; [Gordon, Sharon M.; Dittus, Robert S.; Ely, E. Wesley] Tennessee Valley Healthcare Syst, Dept Vet Affairs Med Ctr, VA Serv, VA Tennessee Valley Geriatr Res Educ & Clin Ctr, Nashville, TN USA; [Kress, John P.; Schweickert, William D.; Pohlman, Anne S.; Hall, Jesse B.] Univ Chicago, Dept Med, Sect Pulm & Crit Care, Chicago, IL 60637 USA; [Fuchs, Barry D.; Taichman, Darren B.; Kinniry, Paul A.] Univ Penn, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Philadelphia, PA 19104 USA	Vanderbilt University; Saint Thomas Hospital; Saint Thomas Hospital; Vanderbilt University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; University of Chicago; University of Pennsylvania	Girard, TD (corresponding author), Vanderbilt Univ, Sch Med, Ctr Hlth Serv Res, Dept Med,Div Allergy Pulm & Crit Care Med, 6th Floor MCE 6110, Nashville, TN 37232 USA.	timothy.girard@vanderbilt.edu	Girard, Timothy/I-3008-2019; Ely, E. Wesley/Z-2018-2019	Girard, Timothy/0000-0002-9833-4871; Ely, E. Wesley/0000-0003-3957-2172	NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007123] Funding Source: NIH RePORTER; NCRR NIH HHS [RR024975] Funding Source: Medline; NHLBI NIH HHS [HL007123] Funding Source: Medline; NIA NIH HHS [AG001023] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Brook AD, 1999, CRIT CARE MED, V27, P2609, DOI 10.1097/00003246-199912000-00001; Carson SS, 2006, CRIT CARE MED, V34, P1326, DOI 10.1097/01.CCM.0000215513.63207.7F; Cook DJ, 1998, ANN INTERN MED, V129, P433, DOI 10.7326/0003-4819-129-6-199809150-00002; Devlin JW, 2006, CRIT CARE MED, V34, P556, DOI 10.1097/01.CCM.0000199058.88904.D6; Dupont WD, 1997, CONTROL CLIN TRIALS, V18, P274, DOI 10.1016/S0197-2456(97)00074-3; Efron B., 1994, MONOGRAPHS STAT APPL; Ely EW, 2003, JAMA-J AM MED ASSOC, V289, P2983, DOI 10.1001/jama.289.22.2983; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Ely EW, 2001, CRIT CARE MED, V29, P1370, DOI 10.1097/00003246-200107000-00012; Ely EW, 1996, NEW ENGL J MED, V335, P1864, DOI 10.1056/NEJM199612193352502; Ely EW, 2002, CONFUSION ASSESSMENT; ESTEBAN A, 1995, NEW ENGL J MED, V332, P345, DOI 10.1056/NEJM199502093320601; Esteban A, 1997, AM J RESP CRIT CARE, V156, P459, DOI 10.1164/ajrccm.156.2.9610109; Esteban A, 2002, JAMA-J AM MED ASSOC, V287, P345, DOI 10.1001/jama.287.3.345; Heffner JE, 2000, NEW ENGL J MED, V342, P1520, DOI 10.1056/NEJM200005183422011; Hong JJ, 2000, NEW ENGL J MED, V343, P814; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jacobi J, 2002, CRIT CARE MED, V30, P119, DOI 10.1097/00003246-200201000-00020; Kollef MH, 1998, CHEST, V114, P541, DOI 10.1378/chest.114.2.541; Kollef MH, 1997, CRIT CARE MED, V25, P567, DOI 10.1097/00003246-199704000-00004; Kress JP, 2007, CRIT CARE MED, V35, P365, DOI 10.1097/01.CCM.0000254334.46406.B3; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Kress JP, 2003, AM J RESP CRIT CARE, V168, P1457, DOI 10.1164/rccm.200303-455OC; Lellouche F, 2006, AM J RESP CRIT CARE, V174, P894, DOI 10.1164/rccm.200511-1780OC; MacIntyre NR, 2001, CHEST, V120, p375S, DOI 10.1378/chest.120.6_suppl.375S; Marelich GP, 2000, CHEST, V118, P459, DOI 10.1378/chest.118.2.459; Martin J, 2007, CRIT CARE, V11, DOI 10.1186/cc6189; Mehta S, 2006, CRIT CARE MED, V34, P374, DOI 10.1097/01.CCM.0000196830.61965.F1; Novaes MAFP, 1999, INTENS CARE MED, V25, P1421, DOI 10.1007/s001340051091; Pandharipande P, 2006, ANESTHESIOLOGY, V104, P21, DOI 10.1097/00000542-200601000-00005; Payen JF, 2007, ANESTHESIOLOGY, V106, P687, DOI 10.1097/01.anes.0000264747.09017.da; Pinhu L, 2003, LANCET, V361, P332, DOI 10.1016/S0140-6736(03)12329-X; PUNTILLO KA, 1990, HEART LUNG, V19, P526; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Schoenfeld DA, 2002, CRIT CARE MED, V30, P1772, DOI 10.1097/00003246-200208000-00016; Schweickert WD, 2004, CRIT CARE MED, V32, P1272, DOI 10.1097/01.CCM.0000127263.54807.79; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; TANIOS MA, 2005, P AM THORAC SOC, V2, pA793; Weinert CR, 2007, CRIT CARE MED, V35, P393, DOI 10.1097/01.CCM.0000254339.18639.1D; WILSON WC, 1992, JAMA-J AM MED ASSOC, V267, P949	40	1222	1293	0	76	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 12	2008	371	9607					126	134		10.1016/S0140-6736(08)60105-1	http://dx.doi.org/10.1016/S0140-6736(08)60105-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	252ND	18191684				2022-12-28	WOS:000252452300027
J	Jacobson, PD				Jacobson, Peter D.			Transforming clinical practice guidelines into legislative mandates - Proceed with abundant caution	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; EXPERT CONSENSUS DOCUMENT; CORONARY-ARTERY-DISEASE; COMPUTED-TOMOGRAPHY; POSTMENOPAUSAL WOMEN; TASK-FORCE; HEART; PREVENTION; BENEFITS; ESTROGEN		Univ Michigan, Sch Publ Hlth, Ctr Law Eth & Hlth, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Jacobson, PD (corresponding author), Univ Michigan, Sch Publ Hlth, Ctr Law Eth & Hlth, 109 Observatory St, Ann Arbor, MI 48109 USA.	pdj@umich.edu						Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Atkins D, 2005, HEALTH AFFAIR, V24, P102, DOI 10.1377/hlthaff.24.1.102; DeMaria AN, 2006, J AM COLL CARDIOL, V48, P1109, DOI 10.1016/j.jacc.2006.08.007; GARZA JJ, 2007, COMMUNICATION   1210; Greenland P, 2007, J AM COLL CARDIOL, V49, P378, DOI 10.1016/j.jacc.2006.10.001; Grimes DA, 2002, LANCET, V359, P881, DOI 10.1016/S0140-6736(02)07948-5; Harris R, 2002, ANN INTERN MED, V137, P917, DOI 10.7326/0003-4819-137-11-200212030-00014; Lauer MS, 2007, JAMA-J AM MED ASSOC, V297, P1376, DOI 10.1001/jama.297.12.1376; MAZAFFARIAN D, 2005, JAMA-J AM MED ASSOC, V294, P2897; Mendelsohn ME, 2007, NEW ENGL J MED, V356, P2639, DOI 10.1056/NEJMe078072; Naghavi M, 2006, AM J CARDIOL, V98, p2H, DOI 10.1016/j.amjcard.2006.03.002; O'Rourke RA, 2000, J AM COLL CARDIOL, V36, P326, DOI 10.1016/S0735-1097(00)00831-7; Raine R, 2005, BMJ-BRIT MED J, V331, P631, DOI 10.1136/bmj.331.7517.631; Rettig R. A., 2007, FALSE HOPE BONE MARR; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schuijf JD, 2006, AM J CARDIOL, V98, P145, DOI 10.1016/j.amjcard.2006.01.092; Sirovich BE, 2003, JAMA-J AM MED ASSOC, V289, P1414, DOI 10.1001/jama.289.11.1414; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527	18	43	43	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2008	299	2					208	210		10.1001/jama.2007.12	http://dx.doi.org/10.1001/jama.2007.12			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UN	18182603				2022-12-28	WOS:000252182600021
J	Elshaug, AG; Moss, JR; Hiller, JE; Maddern, GJ				Elshaug, Adam G.; Moss, John R.; Hiller, Janet E.; Maddern, Guy J.			Change page - Upper airway surgery should not be first line treatment for obstructive sleep apnoea in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRACTICE PARAMETERS		[Elshaug, Adam G.; Moss, John R.; Hiller, Janet E.] Univ Adelaide, Discipline Publ Hlth, Adelaide, SA 5005, Australia; [Maddern, Guy J.] Queen Elizabeth Hosp, Woodville, SA 5011, Australia	University of Adelaide	Elshaug, AG (corresponding author), Univ Adelaide, Discipline Publ Hlth, Adelaide, SA 5005, Australia.	adam.elshaug@adelaide.edu.au	Elshaug, Adam G/A-5714-2008; Hiller, Janet E./A-5633-2008; Moss, John/B-2327-2010	Hiller, Janet E./0000-0002-8532-4033; Moss, John/0000-0003-4216-1761; Elshaug, Adam/0000-0002-4939-5379; Maddern, Guy/0000-0003-2064-181X				Elshaug AG, 2007, J EVAL CLIN PRACT, V13, P3, DOI 10.1111/j.1365-2753.2006.00793.x; Elshaug AG, 2007, SLEEP, V30, P461, DOI 10.1093/sleep/30.4.461; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Giles TL, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001106.pub2; *JOINT NORD PROJ, 2007, OBSTR SLEEP APN SYND; Kushida CA, 2006, SLEEP, V29, P375, DOI 10.1093/sleep/29.3.375; Lim J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004435.pub3; Morgenthaler TI, 2006, SLEEP, V29, P1031; Scottish Intercollegiate Guidelines Network, 2003, MAN OBSTR SLEEP APN; Sundaram S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001004.pub2; Young T, 2004, JAMA-J AM MED ASSOC, V291, P2013, DOI 10.1001/jama.291.16.2013	11	26	26	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 5	2008	336	7634					44	45		10.1136/bmj.39381.509213.AE	http://dx.doi.org/10.1136/bmj.39381.509213.AE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250UT	18174600	Green Published, Green Submitted			2022-12-28	WOS:000252327500042
J	Kinmonth, AL; Wareham, NJ; Hardeman, W; Sutton, S; Prevost, AT; Fanshawe, T; Williams, KM; Ekelund, U; Spiegelhalter, D; Griffin, SJ				Kinmonth, Ann-Louise; Wareham, Nicholas J.; Hardeman, Wendy; Sutton, Stephen; Prevost, A. Toby; Fanshawe, Tom; Williams, Kate M.; Ekelund, Ulf; Spiegelhalter, David; Griffin, Simon J.			Efficacy of a theory-based behavioural intervention to increase physical activity in an at-risk group in primary care (ProActive UK): a randomised trial	LANCET			English	Article							ENERGY-EXPENDITURE; GENERAL-PRACTICE; FAMILY-HISTORY; HEALTH; INDIVIDUALS; INACTIVITY; SETTINGS; IMPACT; CANCER	Background Declining physical activity is associated with a rising burden of global disease. Efforts to reverse this trend have not been successful. We aimed to assess the efficacy of a facilitated behavioural intervention to increase the physical activity of sedentary individuals at familial risk of diabetes. Methods We enrolled 365 sedentary adults who had a parental history of type 2 diabetes. They were recruited from either diabetes or family history registers at 20 general practice clinics in the UK. Eligible participants were randomly assigned to one of two intervention groups, or to a comparison group. All participants were posted a brief advice leaflet. One intervention group was offered a 1-year behaviour-change programme, to be delivered by trained facilitators in participants' homes, and the other the same programme by telephone. The programme was designed to alter behavioural determinants, as defined by the theory of planned behaviour, and to teach behaviour-change strategies. The principal outcome at 1 year was daytime physical activity, which was objectively measured as a ratio to resting energy expenditure. Analysis was by intention to treat. This study is registered as ISRCTN61323766. Findings Of 365 patients, we analysed primary endpoints for 321 (88%) for whom we had data after 1 year of follow-up. At 1 year, the physical-activity ratio of participants who received the intervention, by either delivery route, did not differ from the ratio in those who were given a brief advice leaflet. The mean difference in daytime physical-activity ratio, adjusted for baseline, was -0.04 (95% CI -0.16 to 0.08). The physical-activity ratio did not differ between participants who were delivered the intervention face-to-face or by telephone (mean difference -0.05; 95% CI -0.19 to 0.10). Interpretation A facilitated theory-based behavioural intervention was no more effective than an advice leaflet for promotion of physical activity in an at-risk group; therefore health-care providers should remain cautious about commissioning behavioural programmes into individual preventive health-care services.	[Kinmonth, Ann-Louise; Hardeman, Wendy; Sutton, Stephen; Prevost, A. Toby; Fanshawe, Tom; Williams, Kate M.] Univ Cambridge, Dept Publ Hlth & Primary Care, Gen Practice & Primary Care Res Unit, Cambridge CB2 0SR, England; [Wareham, Nicholas J.; Ekelund, Ulf; Griffin, Simon J.] MRC, Epidemiol Unit, Cambridge, England; [Spiegelhalter, David] MRC, Biostat Unit, Cambridge CB2 2BW, England	University of Cambridge; MRC Biostatistics Unit	Kinmonth, AL (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Gen Practice & Primary Care Res Unit, Cambridge CB2 0SR, England.	alk25@medschl.cam.ac.uk	Ekelund, Ulf/AAE-8471-2019; Hardeman, Wendy/H-1497-2012; Griffin, Simon J/K-3106-2013	Ekelund, Ulf/0000-0003-2115-9267; Griffin, Simon J/0000-0002-2157-4797; Hardeman, Wendy/0000-0002-6498-9407; Sutton, Stephen/0000-0003-1610-0404; Williams, Kate/0000-0002-6188-9363; Prevost, A. Toby/0000-0003-1723-0796	MRC [MC_U106179474, MC_U106179473, G0200391, MC_U105260557] Funding Source: UKRI; Medical Research Council [MC_U106179474, MC_U106179471, G0200391, MC_U105260557, MC_U106179473] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; Berg AO, 2002, ANN INTERN MED, V137, P205, DOI 10.7326/0003-4819-137-3-200208060-00014; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Dishman RK, 1996, MED SCI SPORT EXER, V28, P706, DOI 10.1097/00005768-199606000-00010; Eden KB, 2002, ANN INTERN MED, V137, P208, DOI 10.7326/0003-4819-137-3-200208060-00015; Erlichman J, 2002, Obes Rev, V3, P273, DOI 10.1046/j.1467-789X.2002.00078.x; GODIN G, 1985, Canadian Journal of Applied Sport Sciences, V10, P141; GRIFFIN SJ, 1999, ED PSYCHOSOCIAL INT; HAMMAN RF, 2002, EVIDENCE BASE DIABET, P75; Hardeman W, 2005, HEALTH EDUC RES, V20, P676, DOI 10.1093/her/cyh022; Hillsdon M, 2005, Cochrane Database Syst Rev, pCD003180; HILLSDON M, 2005, EFFECTIVENESS PUBL H; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; JENKINSON C, 1996, UKSF 36 ANAL INTERPR; Kinmonth AL, 1998, BMJ-BRIT MED J, V317, P1202, DOI 10.1136/bmj.317.7167.1202; LERMAN C, 1991, HEALTH PSYCHOL, V10, P259, DOI 10.1037/0278-6133.10.4.259; Marteau TM, 1996, BRIT J GEN PRACT, V46, P577; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; Michie S, 2004, PSYCHOL HEALTH, V19, P29, DOI 10.1080/0887044031000141199; MURRAY CJL, 1996, GLOAL BURDEN DIS; *NICE, 2006, NICE PUBL HLTH INT G; Samsa G, 1999, PHARMACOECONOMICS, V15, P141, DOI 10.2165/00019053-199915020-00003; Sargeant LA, 2000, INT J OBESITY, V24, P1333, DOI 10.1038/sj.ijo.0801383; Simons-Morton DG, 1998, AM J PREV MED, V15, P413, DOI 10.1016/S0749-3797(98)00078-6; Simons-Morton DG, 2001, JAMA-J AM MED ASSOC, V286, P677; van Sluijs EMF, 2006, J CLIN EPIDEMIOL, V59, P404, DOI 10.1016/j.jclinepi.2005.08.016; van Sluijs EMF, 2005, AM J PUBLIC HEALTH, V95, P1825, DOI 10.2105/AJPH.2004.044537; Wareham NJ, 2000, AM J EPIDEMIOL, V152, P132, DOI 10.1093/aje/152.2.132; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Wareham NJ, 1998, INT J OBESITY, V22, pS30; Wareham NJ, 2002, INT J EPIDEMIOL, V31, P168, DOI 10.1093/ije/31.1.168; Wareham NJ, 1997, BRIT J NUTR, V78, P889, DOI 10.1079/BJN19970207; WEINSTEIN ND, 1989, PRIM PREV P, V13, P142; White IR, 2005, STAT MED, V24, P993, DOI 10.1002/sim.1981; *WHO, 2002, WORLD HHLTH REP 2002; Williams K, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-48; Wing RR, 1998, DIABETES CARE, V21, P350, DOI 10.2337/diacare.21.3.350	39	142	144	2	40	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 5	2008	371	9606					41	48		10.1016/S0140-6736(08)60070-7	http://dx.doi.org/10.1016/S0140-6736(08)60070-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248YH	18177774				2022-12-28	WOS:000252192600029
J	Lemos, B; Araripe, LO; Hartl, DL				Lemos, Bernardo; Araripe, Luciana O.; Hartl, Daniel L.			Polymorphic Y chromosomes harbor cryptic variation with manifold functional consequences	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER HETEROCHROMATIN; GENE COPY NUMBER; SEX-CHROMOSOMES; MALE-STERILITY; MALE FITNESS; EVOLUTION; POPULATIONS; EXPRESSION; CHROMATIN; SIMULANS	The paucity of polymorphisms in single- copy genes on the Y chromosome of Drosophila contrasts with data indicating that this chromosome has polymorphic phenotypic effects on sex ratio, temperature sensitivity, behavior, and fitness. We show that the Y chromosome of D. melanogaster harbors substantial genetic diversity in the form of polymorphisms for genetic elements that differentially affect the expression of hundreds of X- linked and autosomal genes. The affected genes are more highly expressed in males, more meagerly expressed in females, and more highly divergent between species. Functionally, they affect microtubule stability, lipid and mitochondrial metabolism, and the thermal sensitivity of spermatogenesis. Our findings provide a mechanism for adaptive phenotypic variation associated with the Y chromosome.	[Lemos, Bernardo; Araripe, Luciana O.; Hartl, Daniel L.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University	Lemos, B (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	blemos@oeb.harvard.edu	Lemos, Bernardo/AAL-2429-2020	Lemos, Bernardo/0000-0001-6996-9483; O Araripe, Luciana/0000-0001-5878-1792	NIGMS NIH HHS [GM068465, GM065169] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068465, R01GM065169] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Carvalho AB, 2005, SCIENCE, V307, P108, DOI 10.1126/science.1101675; Carvalho AB, 2002, CURR OPIN GENET DEV, V12, P664, DOI 10.1016/S0959-437X(02)00356-8; Carvalho AB, 1997, GENETICS, V146, P891; Charlesworth D, 2005, CURR BIOL, V15, pR129, DOI 10.1016/j.cub.2005.02.011; Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P5677, DOI 10.1073/pnas.101456898; CLARK AG, 1990, GENETICS, V125, P527; David JR, 2005, J EVOLUTION BIOL, V18, P838, DOI 10.1111/j.1420-9101.2005.00914.x; DeFalco TJ, 2003, DEV CELL, V5, P205, DOI 10.1016/S1534-5807(03)00204-1; GATTI M, 1992, ANNU REV GENET, V26, P239, DOI 10.1146/annurev.ge.26.120192.001323; Huttunen S, 2003, BEHAV GENET, V33, P17, DOI 10.1023/A:1021095331850; Liu XW, 2007, J BIOL CHEM, V282, P20868, DOI 10.1074/jbc.M702547200; LYCKEGAARD EMS, 1991, MOL BIOL EVOL, V8, P458; LYCKEGAARD EMS, 1989, P NATL ACAD SCI USA, V86, P1944, DOI 10.1073/pnas.86.6.1944; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; Meiklejohn CD, 2003, P NATL ACAD SCI USA, V100, P9894, DOI 10.1073/pnas.1630690100; Montchamp-Moreau C, 2001, EVOLUTION, V55, P728, DOI 10.1554/0014-3820(2001)055[0728:TYCODS]2.0.CO;2; Murray J., 1910, REPORTS SCI EXPEDITI, P17; Ranz JM, 2003, SCIENCE, V300, P1742, DOI 10.1126/science.1085881; Repping S, 2003, NAT GENET, V35, P247, DOI 10.1038/ng1250; Rice WR, 1998, P NATL ACAD SCI USA, V95, P6217, DOI 10.1073/pnas.95.11.6217; Rohmer C, 2004, J EXP BIOL, V207, P2735, DOI 10.1242/jeb.01087; Schulze SR, 2007, ANNU REV ENTOMOL, V52, P171, DOI 10.1146/annurev.ento.51.110104.151007; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Smith CD, 2007, SCIENCE, V316, P1586, DOI 10.1126/science.1139815; Stoltenberg SF, 1997, ANIM BEHAV, V53, P853, DOI 10.1006/anbe.1996.0351; Talbert PB, 2006, NAT REV GENET, V7, P793, DOI 10.1038/nrg1920; Zurovcova M, 1999, GENETICS, V153, P1709	28	173	173	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2008	319	5859					91	93		10.1126/science.1148861	http://dx.doi.org/10.1126/science.1148861			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18174442				2022-12-28	WOS:000252084000038
J	Nash, DR; Als, TD; Maile, R; Jones, GR; Boomsma, JJ				Nash, David R.; Als, Thomas D.; Maile, Roland; Jones, Graeme R.; Boomsma, Jacobus J.			A mosaic of chemical coevolution in a large blue butterfly	SCIENCE			English	Article							HOST-ANT SPECIFICITY; MACULINEA-REBELI; LOCAL ADAPTATION; SOCIAL PARASITES; CUCULUS-CANORUS; CUCKOO; ALCON; CATERPILLARS; COLONIES	Mechanisms of recognition are essential to the evolution of mutualistic and parasitic interactions between species. One such example is the larval mimicry that Maculinea butterfly caterpillars use to parasitize Myrmica ant colonies. We found that the greater the match between the surface chemistry of Maculinea alcon and two of its host Myrmica species, the more easily ant colonies were exploited. The geographic patterns of surface chemistry indicate an ongoing coevolutionary arms race between the butterflies and Myrmica rubra, which has significant genetic differentiation between populations, but not between the butterflies and a second, sympatric host, Myrmica ruginodis, which has panmictic populations. Alternative hosts may therefore provide an evolutionary refuge for a parasite during periods of counteradaptation by their preferred hosts.	[Nash, David R.; Boomsma, Jacobus J.] Univ Copenhagen, Inst Biol, DK-2100 Copenhagen, Denmark; [Als, Thomas D.] Aarhus Univ, Dept Ecol & Genet, DK-8000 Aarhus C, Denmark; [Maile, Roland; Jones, Graeme R.] Univ Keele, Sch Chem, Keele ST5 5BG, Staffs, England	University of Copenhagen; Aarhus University; Keele University	Nash, DR (corresponding author), Univ Copenhagen, Inst Biol, Univ Pk 15, DK-2100 Copenhagen, Denmark.	DRNash@bi.ku.dk	Nash, David R./B-2916-2009; Boomsma, Jacobus J/M-2785-2014	Nash, David R./0000-0002-0462-6794; Boomsma, Jacobus J/0000-0002-3598-1609				Akino T, 1999, P ROY SOC B-BIOL SCI, V266, P1419, DOI 10.1098/rspb.1999.0796; Als TD, 2002, ECOL ENTOMOL, V27, P403, DOI 10.1046/j.1365-2311.2002.00427.x; Als TD, 2001, ANIM BEHAV, V62, P99, DOI 10.1006/anbe.2001.1716; D'Ettorre P, 2002, P ROY SOC B-BIOL SCI, V269, P1911, DOI 10.1098/rspb.2002.2110; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; DAVIES NB, 1989, J ANIM ECOL, V58, P207, DOI 10.2307/4995; DAVIES NB, 1989, J ANIM ECOL, V58, P225, DOI 10.2307/4996; Elmes Graham W., 1994, Memorabilia Zoologica, V48, P55; Elmes GW, 2004, ENTOMOL EXP APPL, V110, P53, DOI 10.1111/j.0013-8703.2004.00121.x; Elmes GW, 2002, OECOLOGIA, V130, P525, DOI 10.1007/s00442-001-0857-5; Foitzik S, 2003, BEHAV ECOL, V14, P80, DOI 10.1093/beheco/14.1.80; Gomulkiewicz R, 2000, AM NAT, V156, P156, DOI 10.1086/303382; Holldobler B., 1990, pi; Langmore NE, 2005, BEHAV ECOL, V16, P686, DOI 10.1093/beheco/ari041; Michener C.D., 2000, BEES WORLD, V1st, DOI DOI 10.7171/JBT.12-2303-004; Morgan AD, 2005, NATURE, V437, P253, DOI 10.1038/nature03913; Nuismer SL, 2006, EVOLUTION, V60, P24, DOI 10.1111/j.0014-3820.2006.tb01078.x; SEPPA P, 1995, HEREDITY, V74, P200, DOI 10.1038/hdy.1995.28; Thomas JA, 1998, P ROY SOC B-BIOL SCI, V265, P1895, DOI 10.1098/rspb.1998.0517; Thomas Jeremy, 1999, British Wildlife, V11, P22; Thompson J.N., 2005, INTERSPEC INTERACT; Thompson JN, 1999, AM NAT, V153, pS1, DOI 10.1086/303208; Tsutsui ND, 2004, ANN ZOOL FENN, V41, P713; Turillazzi S., 1996, NATURAL HIST EVOLUTI; van Swaay C. M., 1999, RED DATA BOOK EUROPE; Wright S., 1969, THEORY GENE FREQUENC, V2, P520; Wynhoff I, 1998, J INSECT CONSERV, V2, P47, DOI 10.1023/A:1009692723056	27	140	146	3	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2008	319	5859					88	90		10.1126/science.1149180	http://dx.doi.org/10.1126/science.1149180			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18174441				2022-12-28	WOS:000252084000037
J	van Deutekom, JC; Janson, AA; Ginjaar, IB; Frankhuizen, WS; Aartsma-Rus, A; Bremmer-Bout, M; den Dunnen, JT; Koop, K; van der Kooi, AJ; Goemans, NM; de Kimpe, SJ; Ekhart, PF; Venneker, EH; Platenburg, GJ; Verschuuren, JJ; van Ommen, GJB				van Deutekom, Judith C.; Janson, Anneke A.; Ginjaar, Ieke B.; Frankhuizen, Wendy S.; Aartsma-Rus, Annemieke; Bremmer-Bout, Mattie; den Dunnen, Johan T.; Koop, Klaas; van der Kooi, Anneke J.; Goemans, Nathalie M.; de Kimpe, Sjef J.; Ekhart, Peter F.; Venneker, Edna H.; Platenburg, Gerard J.; Verschuuren, Jan J.; van Ommen, Gert-Jan B.			Local dystrophin restoration with antisense oligonucleotide PRO051	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; SYSTEMIC DELIVERY; MUSCLE-BIOPSY; IN-VITRO; EXPRESSION; EXON; DMD; GENE; CELLS; DIFFERENTIATION	Background: Duchenne's muscular dystrophy is associated with severe, progressive muscle weakness and typically leads to death between the ages of 20 and 35 years. By inducing specific exon skipping during messenger RNA (mRNA) splicing, antisense compounds were recently shown to correct the open reading frame of the DMD gene and thus to restore dystrophin expression in vitro and in animal models in vivo. We explored the safety, adverse-event profile, and local dystrophin-restoring effect of a single, intramuscular dose of an antisense oligonucleotide, PRO051, in patients with this disease. Methods: Four patients, who were selected on the basis of their mutational status, muscle condition, and positive exon-skipping response to PRO051 in vitro, received a dose of 0.8 mg of PRO051 injected into the tibialis anterior muscle. A biopsy was performed 28 days later. Safety measures, composition of mRNA, and dystrophin expression were assessed. Results: PRO051 injection was not associated with clinically apparent adverse events. Each patient showed specific skipping of exon 51 and sarcolemmal dystrophin in 64 to 97% of myofibers. The amount of dystrophin in total protein extracts ranged from 3 to 12% of that found in the control specimen and from 17 to 35% of that of the control specimen in the quantitative ratio of dystrophin to laminin alpha 2. Conclusions: Intramuscular injection of antisense oligonucleotide PRO051 induced dystrophin synthesis in four patients with Duchenne's muscular dystrophy who had suitable mutations, suggesting that further studies might be feasible.	Prosensa BV, NL-2333 AL Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Human & Clin Genet, Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; Univ Louvain, Dept Pediat Neurol, Louvain, Belgium; Afforce Healthcare, The Hague, Netherlands	BioMarin Pharmaceutical Inc.; Prosensa; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam	van Deutekom, JC (corresponding author), Prosensa BV, Wassenaarseweg 72, NL-2333 AL Leiden, Netherlands.	j.vandeutekom@prosensa.nl	dunnen, johan den/ABH-4228-2020	dunnen, johan den/0000-0002-6304-1710; Verschuuren, Jan/0000-0002-4572-1501; van der Kooi, Anneke/0000-0002-5261-5512				Aartsma-Rus A, 2002, NEUROMUSCULAR DISORD, V12, pS71, DOI 10.1016/S0960-8966(02)00086-X; Aartsma-Rus A, 2005, OLIGONUCLEOTIDES, V15, P284, DOI 10.1089/oli.2005.15.284; Aartsma-Rus A, 2003, HUM MOL GENET, V12, P907, DOI 10.1093/hmg/ddg100; Aartsma-Rus A, 2004, AM J HUM GENET, V74, P83, DOI 10.1086/381039; Aartsma-Rus A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/mus.20586; Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; Cullen MJ, 1996, NEUROPATH APPL NEURO, V22, P30, DOI 10.1046/j.1365-2990.1996.1398013.x; Dorph C, 2001, J RHEUMATOL, V28, P1591; Eagle M, 2002, NEUROMUSCULAR DISORD, V12, P926, DOI 10.1016/S0960-8966(02)00140-2; Emery A.E.H., 1993, DUCHENNE MUSCULAR DY; ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0; Havenga MJE, 2002, J VIROL, V76, P4612, DOI 10.1128/JVI.76.9.4612-4620.2002; HOFFMAN EP, 1988, NEW ENGL J MED, V318, P1363, DOI 10.1056/NEJM198805263182104; JOHN J, 1984, INT J REHABIL RES, V7, P173, DOI 10.1097/00004356-198406000-00005; KOENIG M, 1989, AM J HUM GENET, V45, P498; Koop K, 2004, KIDNEY INT, V66, P2038, DOI 10.1111/j.1523-1755.2004.00976.x; Lu QL, 2005, P NATL ACAD SCI USA, V102, P198, DOI 10.1073/pnas.0406700102; Manzur AY, 2004, COCHRANE DB SYST REV, V2; McClorey G, 2006, GENE THER, V13, P1373, DOI 10.1038/sj.gt.3302800; Mercuri E, 2005, NEUROMUSCULAR DISORD, V15, P164, DOI 10.1016/j.nmd.2004.10.008; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; MOSER H, 1984, HUM GENET, V66, P17, DOI 10.1007/BF00275183; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; ROEST PAM, 1993, NEUROMUSCULAR DISORD, V3, P391, DOI 10.1016/0960-8966(93)90083-V; Roest PAM, 1996, NEUROMUSCULAR DISORD, V6, P195, DOI 10.1016/0960-8966(96)00006-5; Simonds AK, 1998, THORAX, V53, P949, DOI 10.1136/thx.53.11.949; Surono A, 2004, HUM GENE THER, V15, P749, DOI 10.1089/1043034041648444; Takeshima Y, 2001, BRAIN DEV-JPN, V23, P788, DOI 10.1016/S0387-7604(01)00326-6; van Deutekom JCT, 2001, HUM MOL GENET, V10, P1547, DOI 10.1093/hmg/10.15.1547; Yuan HP, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134946	30	615	683	0	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2007	357	26					2677	2686		10.1056/NEJMoa073108	http://dx.doi.org/10.1056/NEJMoa073108			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	245UO	18160687	Bronze			2022-12-28	WOS:000251964500006
J	Li, XL; Wang, XR; Zhang, L; Lee, SW; Dai, HJ				Li, Xiaolin; Wang, Xinran; Zhang, Li; Lee, Sangwon; Dai, Hongjie			Chemically derived, ultrasmooth graphene nanoribbon semiconductors	SCIENCE			English	Article							FIELD-EFFECT TRANSISTORS; WALLED CARBON NANOTUBES; GRAPHITE; CAPACITANCE; FILMS; OXIDE; GAS	We developed a chemical route to produce graphene nanoribbons ( GNR) with width below 10 nanometers, as well as single ribbons with varying widths along their lengths or containing lattice- defined graphene junctions for potential molecular electronics. The GNRs were solution-phase - derived, stably suspended in solvents with noncovalent polymer functionalization, and exhibited ultrasmooth edges with possibly well- defined zigzag or armchair- edge structures. Electrical transport experiments showed that, unlike single- walled carbon nanotubes, all of the sub - 10- nanometer GNRs produced were semiconductors and afforded graphene field effect transistors with on- off ratios of about 10(7) at room temperature.	[Li, Xiaolin; Wang, Xinran; Zhang, Li; Lee, Sangwon; Dai, Hongjie] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Li, Xiaolin; Wang, Xinran; Zhang, Li; Lee, Sangwon; Dai, Hongjie] Stanford Univ, Adv Mat Lab, Stanford, CA 94305 USA	Stanford University; Stanford University	Dai, HJ (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	hdai@stanford.edu	Wang, Xinran/E-8392-2010; Dai, Hongjie/ABC-4574-2021; Li, jiayu/H-3827-2014	Wang, Xinran/0000-0002-3975-1667; Li, jiayu/0000-0003-2639-213X				Areshkin DA, 2007, NANO LETT, V7, P204, DOI 10.1021/nl062132h; Barone V, 2006, NANO LETT, V6, P2748, DOI 10.1021/nl0617033; Berger C, 2004, J PHYS CHEM B, V108, P19912, DOI 10.1021/jp040650f; Berger C, 2006, SCIENCE, V312, P1191, DOI 10.1126/science.1125925; BOEHM HP, 1994, PURE APPL CHEM, V66, P1893, DOI 10.1351/pac199466091893; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; GREINKE RA, Patent No. 6416815; Han MY, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.206805; Ilani S, 2006, NAT PHYS, V2, P687, DOI 10.1038/nphys412; Javey A, 2003, NATURE, V424, P654, DOI 10.1038/nature01797; Li XL, 2007, J AM CHEM SOC, V129, P4890, DOI 10.1021/ja071114e; Liang GC, 2007, IEEE T ELECTRON DEV, V54, P677, DOI 10.1109/TED.2007.891872; Lueking AD, 2005, J PHYS CHEM B, V109, P12710, DOI 10.1021/jp0512199; Nakada K, 1996, PHYS REV B, V54, P17954, DOI 10.1103/PhysRevB.54.17954; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Ouyang Y, 2007, IEEE T ELECTRON DEV, V54, P2223, DOI 10.1109/TED.2007.902692; Rollings E, 2006, J PHYS CHEM SOLIDS, V67, P2172, DOI 10.1016/j.jpcs.2006.05.010; Schniepp HC, 2006, J PHYS CHEM B, V110, P8535, DOI 10.1021/jp060936f; Son YW, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.216803; Stankovich S, 2006, CARBON, V44, P3342, DOI 10.1016/j.carbon.2006.06.004; Star A, 2001, ANGEW CHEM INT EDIT, V40, P1721, DOI 10.1002/1521-3773(20010504)40:9<1721::AID-ANIE17210>3.0.CO;2-F; Tu R, 2007, NANO LETT, V7, P1561, DOI 10.1021/nl070378w; Yoon Y, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2769764; Yu AP, 2007, J PHYS CHEM C, V111, P7565, DOI 10.1021/jp071761s; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235	26	4053	4208	35	2556	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 29	2008	319	5867					1229	1232		10.1126/science.1150878	http://dx.doi.org/10.1126/science.1150878			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18218865				2022-12-28	WOS:000253530600039
J	Hom, G; Graham, RR; Modrek, B; Taylor, KE; Ortmann, W; Garnier, S; Lee, AT; Chung, SA; Ferreira, RC; Pant, PVK; Ballinger, DG; Kosoy, R; Demirci, FY; Kamboh, MI; Kao, AH; Tian, C; Gunnarsson, I; Bengtsson, AA; Rantapaa-Dahlqvist, S; Petri, M; Manzi, S; Seldin, MF; Ronnblom, L; Syvanen, AC; Criswell, LA; Gregersen, PK; Behrens, TW				Hom, Geoffrey; Graham, Robert R.; Modrek, Barmak; Taylor, Kimberly E.; Ortmann, Ward; Garnier, Sophie; Lee, Annette T.; Chung, Sharon A.; Ferreira, Ricardo C.; Pant, P. V. Krishna; Ballinger, Dennis G.; Kosoy, Roman; Demirci, F. Yesim; Kamboh, M. Ilyas; Kao, Amy H.; Tian, Chao; Gunnarsson, Iva; Bengtsson, Anders A.; Rantapaa-Dahlqvist, Solbritt; Petri, Michelle; Manzi, Susan; Seldin, Michael F.; Ronnblom, Lars; Syvanen, Ann-Christine; Criswell, Lindsey A.; Gregersen, Peter K.; Behrens, Timothy W.			Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; B-CELL DEVELOPMENT; TYROSINE KINASE; INCREASED RISK; INTERFERON; EXPRESSION; TOLERANCE; HAPLOTYPES; SUSCEPTIBILITY; POLYMORPHISMS	Background Systemic lupus erythematosus (SLE) is a clinically heterogeneous disease in which the risk of disease is influenced by complex genetic and environmental contributions. Alleles of HLA-DRB1, IRF5, and STAT4 are established susceptibility genes; there is strong evidence for the existence of additional risk loci. Methods We genotyped more than 500,000 single-nucleotide polymorphisms (SNPs) in DNA samples from 1311 case subjects with SLE and 1783 control subjects; all subjects were North Americans of European descent. Genotypes from 1557 additional control subjects were obtained from public data repositories. We measured the association between the SNPs and SLE after applying strict quality-control filters to reduce technical artifacts and to correct for the presence of population stratification. Replication of the top loci was performed in 793 case subjects and 857 control subjects from Sweden. Results Genetic variation in the region upstream from the transcription initiation site of the gene encoding B lymphoid tyrosine kinase (BLK) and C8orf13 (chromosome 8p23.1) was associated with disease risk in both the U.S. and Swedish case-control series (rs13277113; odds ratio, 1.39; P=1 x 10(-10)) and also with altered levels of messenger RNA in B-cell lines. In addition, variants on chromosome 16p11.22, near the genes encoding integrin alpha M (ITGAM, or CD11b) and integrin alpha X (ITGAX), were associated with SLE in the combined sample (rs11574637; odds ratio, 1.33; P=3 x 1 (-11)). Conclusions We identified and then confirmed through replication two new genetic loci for SLE: a promoter-region allele associated with reduced expression of BLK and increased expression of C8orf13 and variants in the ITGAM-ITGAX region.	[Hom, Geoffrey; Graham, Robert R.; Modrek, Barmak; Ortmann, Ward; Ferreira, Ricardo C.; Behrens, Timothy W.] Genentech Inc, San Francisco, CA 94080 USA; [Taylor, Kimberly E.; Chung, Sharon A.; Criswell, Lindsey A.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Garnier, Sophie; Ronnblom, Lars; Syvanen, Ann-Christine] Uppsala Univ, Uppsala, Sweden; [Lee, Annette T.; Gregersen, Peter K.] Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY USA; [Pant, P. V. Krishna; Ballinger, Dennis G.] Perlegen Sci, Mountain View, CA USA; [Kosoy, Roman; Tian, Chao; Seldin, Michael F.] Univ Calif Davis, Davis, CA 95616 USA; [Demirci, F. Yesim; Kamboh, M. Ilyas; Kao, Amy H.; Manzi, Susan] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Gunnarsson, Iva] Karolinska Univ Hosp, Karolinska Inst, Stockholm, Sweden; [Bengtsson, Anders A.] Univ Lund Hosp, S-22185 Lund, Sweden; [Rantapaa-Dahlqvist, Solbritt] Univ Umea Hosp, S-90185 Umea, Sweden; [Petri, Michelle] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Roche Holding; Genentech; University of California System; University of California San Francisco; Uppsala University; Northwell Health; University of California System; University of California Davis; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Karolinska Institutet; Karolinska University Hospital; Lund University; Skane University Hospital; Umea University; Johns Hopkins University	Behrens, TW (corresponding author), Genentech Inc, 1 DNA Way,45-3B, San Francisco, CA 94080 USA.	behrens.timothy@gene.com		Ferreira, Ricardo C./0000-0001-5733-3285; Kamboh, M. Ilyas/0000-0002-3453-1438; Garnier, Sophie/0000-0002-7492-1617; Rantapaa Dahlqvist, Solbritt/0000-0001-8259-3863; Demirci, F. Yesim/0000-0001-6907-9843	NCRR NIH HHS [M01-RR00052, 5-M01-RR00079] Funding Source: Medline; NHLBI NIH HHS [HL74165, HL54900] Funding Source: Medline; NIAID NIH HHS [N01-AI95386] Funding Source: Medline; NIAMS NIH HHS [K23-AR051044, P60 AR053308, AR43737, R01-AR046588, N01-AR1-2256, R01-AR44804, AR050267, K24-AR02175] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000079, M01RR000052] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054900, R01HL074165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI095386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR053308, K24AR002175, R01AR050267, R01AR044804, R01AR046588, N01AR012256, K23AR051044] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; Baechler EC, 2004, CURR OPIN IMMUNOL, V16, P801, DOI 10.1016/j.coi.2004.09.014; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Bauer JW, 2006, PLOS MED, V3, P2274, DOI 10.1371/journal.pmed.0030491; BUYON JP, 1988, CLIN IMMUNOL IMMUNOP, V46, P141, DOI 10.1016/0090-1229(88)90014-1; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Cornall RJ, 1998, CIBA F SYMP, V215, P21; Criswell LA, 2005, AM J HUM GENET, V76, P561, DOI 10.1086/429096; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Demirci FYK, 2007, ANN HUM GENET, V71, P308, DOI 10.1111/j.1469-1809.2006.00336.x; Devlin B, 2000, Biostatistics, V1, P369, DOI 10.1093/biostatistics/1.4.369; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Dunn MJ, 2001, PROTEOMICS, V1, P1; DYMECKI SM, 1992, J BIOL CHEM, V267, P4815; Ehirchiou D, 2007, J EXP MED, V204, P1519, DOI 10.1084/jem.20062292; Giglio S, 2001, AM J HUM GENET, V68, P874, DOI 10.1086/319506; GOLDBERG MA, 1976, ARTHRITIS RHEUM, V19, P129, DOI 10.1002/art.1780190201; Graham RR, 2007, EUR J HUM GENET, V15, P823, DOI 10.1038/sj.ejhg.5201827; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Graham RR, 2002, AM J HUM GENET, V71, P543, DOI 10.1086/342290; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Gunderson KL, 2006, METHOD ENZYMOL, V410, P359, DOI 10.1016/S0076-6879(06)10017-8; Hammerberg C, 1998, J EXP MED, V187, P1133, DOI 10.1084/jem.187.7.1133; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; HOCHBERG MC, 1997, DUBOIS LUPUS ERYTHEM, P49; Hsu TM, 2001, BIOTECHNIQUES, V31, P560, DOI 10.2144/01313rr01; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Kumar KR, 2006, SCIENCE, V312, P1665, DOI 10.1126/science.1125893; Lu HF, 1997, J CLIN INVEST, V99, P1340, DOI 10.1172/JCI119293; Mitchell MK, 2004, J URBAN HEALTH, V81, P301, DOI 10.1093/jurban/jth116; Miyagi T, 2007, J EXP MED, V204, P2383, DOI 10.1084/jem.20070401; Nath SK, 2004, CURR OPIN IMMUNOL, V16, P794, DOI 10.1016/j.coi.2004.09.007; Nemazee D, 2000, J EXP MED, V191, P1813, DOI 10.1084/jem.191.11.1813; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Ronnblom L, 2001, J EXP MED, V194, pF59, DOI 10.1084/jem.194.12.f59; Seligman VA, 2001, ARTHRITIS RHEUM, V44, P618, DOI 10.1002/1529-0131(200103)44:3<618::AID-ANR110>3.0.CO;2-R; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Sohn JH, 2003, NAT MED, V9, P206, DOI 10.1038/nm814; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Sugawara H, 2003, GENOMICS, V82, P238, DOI 10.1016/S0888-7543(03)00108-3; Texido G, 2000, MOL CELL BIOL, V20, P1227, DOI 10.1128/MCB.20.4.1227-1233.2000; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; Wakeland EK, 2001, IMMUNITY, V15, P397, DOI 10.1016/S1074-7613(01)00201-1; WASSERMAN R, 1995, J IMMUNOL, V155, P644; Watts GM, 2005, J IMMUNOL, V174, P3668, DOI 10.4049/jimmunol.174.6.3668	49	694	712	1	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2008	358	9					900	909		10.1056/NEJMoa0707865	http://dx.doi.org/10.1056/NEJMoa0707865			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266JD	18204098				2022-12-28	WOS:000253430200005
J	Albarede, F				Albarede, Francis			Rogue mantle helium and neon	SCIENCE			English	Article							SOUTHWEST INDIAN RIDGE; OCEAN ISLAND BASALTS; DIFFUSION KINETICS; HAWAIIAN BASALTS; HE-3/HE-4 RATIOS; ISOTOPES; CONSTRAINTS; SYSTEMATICS; MELT; HETEROGENEITY	The canonical model of helium isotope geochemistry describes the lower mantle as undegassed, but this view conflicts with evidence of recycled material in the source of ocean island basalts. Because mantle helium is efficiently extracted by magmatic activity, it cannot remain in fertile mantle rocks for long periods of time. Here, I suggest that helium with high (3)He/(4)He ratios, as well as neon rich in the solar component, diffused early in Earth's history from low- melting- point primordial material into residual refractory "reservoir" rocks, such as dunites. The difference in (3)He/(4)He ratios of ocean- island and mid- ocean ridge basalts and the preservation of solar neon are ascribed to the reservoir rocks being stretched and tapped to different extents during melting.	[Albarede, Francis] Ecole Normale Super, CNRS, UMR 5570, F-69007 Lyon, France; [Albarede, Francis] Univ Lyon 1, F-69007 Lyon, France	Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Albarede, F (corresponding author), Ecole Normale Super, CNRS, UMR 5570, F-69007 Lyon, France.	albarede@ens-lyon.fr	Albarede, Francis/A-8871-2011	Albarede, Francis/0000-0003-1994-1428				AGEE CB, 1995, J GEOPHYS RES-SOL EA, V100, P17725, DOI 10.1029/95JB00049; Allegre CJ, 1997, EARTH PLANET SC LETT, V150, P1, DOI 10.1016/S0012-821X(97)00072-1; ALLEGRE CJ, 1983, NATURE, V303, P762, DOI 10.1038/303762a0; ALLEGRE CJ, 1986, NATURE, V323, P123, DOI 10.1038/323123a0; Anderson DL, 1998, P NATL ACAD SCI USA, V95, P9087, DOI 10.1073/pnas.95.16.9087; Becker TW, 1999, EARTH PLANET SC LETT, V171, P351, DOI 10.1016/S0012-821X(99)00160-0; Blichert-Toft J, 1999, SCIENCE, V285, P879, DOI 10.1126/science.285.5429.879; CRAIG H, 1976, EARTH PLANET SC LETT, V31, P369, DOI 10.1016/0012-821X(76)90118-7; Ellam RM, 2004, EARTH PLANET SC LETT, V228, P511, DOI 10.1016/j.epsl.2004.10.020; Georgen JE, 2003, EARTH PLANET SC LETT, V206, P509, DOI 10.1016/S0012-821X(02)01106-8; GRAHAM D, 1990, NATURE, V347, P545, DOI 10.1038/347545a0; Graham DW, 2002, REV MINERAL GEOCHEM, V47, P247, DOI 10.2138/rmg.2002.47.8; Graham DW, 2006, NATURE, V440, P199, DOI 10.1038/nature04582; Hilton DR, 1999, EARTH PLANET SC LETT, V173, P53, DOI 10.1016/S0012-821X(99)00215-0; Hirth G, 1996, EARTH PLANET SC LETT, V144, P93, DOI 10.1016/0012-821X(96)00154-9; HONDA M, 1991, NATURE, V349, P149, DOI 10.1038/349149a0; HONDA M, 1993, LITHOS, V30, P257, DOI 10.1016/0024-4937(93)90039-F; KANEOKA I, 1980, SCIENCE, V208, P1366, DOI 10.1126/science.208.4450.1366; KANEOKA I, 1983, NATURE, V302, P698, DOI 10.1038/302698a0; KELEMEN PB, 1995, NATURE, V375, P747, DOI 10.1038/375747a0; KURZ MD, 1982, NATURE, V297, P43, DOI 10.1038/297043a0; Kurz MD, 2005, EARTH PLANET SC LETT, V232, P125, DOI 10.1016/j.epsl.2005.01.005; Lassiter JC, 1998, EARTH PLANET SC LETT, V164, P483, DOI 10.1016/S0012-821X(98)00240-4; Minshull TA, 1996, GEOPHYS J INT, V125, P139, DOI 10.1111/j.1365-246X.1996.tb06541.x; OHTANI E, 1986, NATURE, V322, P352, DOI 10.1038/322352a0; ONions RK, 1996, EARTH PLANET SC LETT, V139, P213, DOI 10.1016/0012-821X(96)00004-0; Parman SW, 2007, NATURE, V446, P900, DOI 10.1038/nature05691; Parman SW, 2005, NATURE, V437, P1140, DOI 10.1038/nature04215; Shuster DL, 2005, GEOCHIM COSMOCHIM AC, V69, P2349, DOI 10.1016/j.gca.2004.11.002; Shuster DL, 2004, EARTH PLANET SC LETT, V217, P19, DOI 10.1016/S0012-821X(03)00594-6; WYLLIE PJ, 1976, CONTRIB MINERAL PETR, V54, P79, DOI 10.1007/BF00372117	31	41	41	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2008	319	5865					943	945		10.1126/science.1150060	http://dx.doi.org/10.1126/science.1150060			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	262RM	18202257				2022-12-28	WOS:000253165700043
J	Hyrich, KL				Hyrich, Kimme L.			Change page - Patients with suspected rheumatoid arthritis should be referred early to rheumatology	BRITISH MEDICAL JOURNAL			English	Editorial Material							MANAGEMENT		[Hyrich, Kimme L.] Univ Manchester, ARC Epidemiol Unit, Manchester M13 9PT, Lancs, England	University of Manchester	Hyrich, KL (corresponding author), Univ Manchester, ARC Epidemiol Unit, Manchester M13 9PT, Lancs, England.	kimme.hyrich@manchester.ac.uk		Hyrich, Kimme/0000-0001-8242-9262	Arthritis Research UK [17552] Funding Source: Medline	Arthritis Research UK(Versus Arthritis)		Aletaha D, 2004, ANN RHEUM DIS, V63, P1269, DOI 10.1136/ard.2003.015131; AMETT FC, 1988, ARTHRITIS RHEUM, V31, P315; Anderson JJ, 2000, ARTHRITIS RHEUM, V43, P22, DOI 10.1002/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9; Combe B, 2007, ANN RHEUM DIS, V66, P34, DOI 10.1136/ard.2005.044354; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Finckh A, 2006, ARTHRIT RHEUM-ARTHR, V55, P864, DOI 10.1002/art.22353; Luqmani R, 2006, RHEUMATOLOGY, V45, P1167, DOI 10.1093/rheumatology/kel215a; Nell VPK, 2004, RHEUMATOLOGY, V43, P906, DOI 10.1093/rheumatology/keh199; Raza K, 2005, ARTHRITIS RES THER, V7, pR784, DOI 10.1186/ar1733; Singh JA, 2004, J RHEUMATOL, V31, P1281; van Dongen H, 2007, ARTHRITIS RHEUM-US, V56, P1424, DOI 10.1002/art.22525	11	16	16	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 26	2008	336	7637					215	216		10.1136/bmj.39381.597454.AE	http://dx.doi.org/10.1136/bmj.39381.597454.AE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259KT	18219044	Green Published			2022-12-28	WOS:000252938900047
J	Crowhurst, JC; Brown, JM; Goncharov, AF; Jacobsen, SD				Crowhurst, J. C.; Brown, J. M.; Goncharov, A. F.; Jacobsen, S. D.			Elasticity of (Mg,Fe)O through the spin transition of iron in the lower mantle	SCIENCE			English	Article							EARTHS LOWER MANTLE; SILICATE PEROVSKITE; POST-PEROVSKITE; MAGNESIOWUSTITE; SYSTEM	Changes in the electronic configuration of iron at high pressures toward a spin- paired state within host minerals ferropericlase and silicate perovskite may directly influence the seismic velocity structure of Earth's lower mantle. We measured the complete elastic tensor of ferropericlase, (Mg1-x,Fe-x)O ( x = 0.06), through the spin transition of iron, whereupon the elastic moduli exhibited up to 25% softening over an extended pressure range from 40 to 60 gigapascals. These results are fully consistent with a simple thermodynamic description of the transition. Examination of previous compression data shows that the magnitude of softening increases with iron content up to at least x = 0.20. Although the spin transition in (Mg,Fe)O is too broad to produce an abrupt seismic discontinuity in the lower mantle, the transition will produce a correlated negative anomaly for both compressional and shear velocities that extends throughout most, if not all, of the lower mantle.	[Crowhurst, J. C.] Lawrence Livermore Natl Lab, Chem Mat & Life Sci Directorate, Livermore, CA 94550 USA; [Brown, J. M.] Univ Washington, Seattle, WA 98195 USA; [Goncharov, A. F.] Carnegie Inst Washington, Geophys Lab, Washington, DC 20015 USA; [Jacobsen, S. D.] Northwestern Univ, Dept Earth & Planetary Sci, Evanston, IL 60208 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Washington; University of Washington Seattle; Carnegie Institution for Science; Northwestern University	Crowhurst, JC (corresponding author), Lawrence Livermore Natl Lab, Chem Mat & Life Sci Directorate, Livermore, CA 94550 USA.	crowhurst1@llnl.gov	Jacobsen, Steven/F-3443-2013; Goncharov, Alexander F./AAX-9943-2020	Jacobsen, Steven/0000-0002-9746-958X; Goncharov, Alexander F./0000-0002-6422-8819				Andrault D, 2001, J GEOPHYS RES-SOL EA, V106, P2079, DOI 10.1029/2000JB900362; Badro J, 2003, SCIENCE, V300, P789, DOI 10.1126/science.1081311; Bina CR, 1998, REV MINERAL, V37, P205; Fei YW, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030712; Fei YW, 1998, REV MINERAL, V37, P343; Goncharov AF, 2006, SCIENCE, V312, P1205, DOI 10.1126/science.1125622; Irifune T, 1998, SCIENCE, V279, P1698, DOI 10.1126/science.279.5357.1698; ITO E, 1989, J GEOPHYS RES-SOLID, V94, P10637, DOI 10.1029/JB094iB08p10637; Jackson JM, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004052; Kesson SE, 2002, PHYS EARTH PLANET IN, V131, P295, DOI 10.1016/S0031-9201(02)00063-8; Kobayashi Y, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023257; Lin JF, 2005, NATURE, V436, P377, DOI 10.1038/nature03825; Lin JF, 2007, SCIENCE, V317, P1740, DOI 10.1126/science.1144997; Lin JF, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028099; Murakami M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021956; Persson K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026621; Speziale S, 2005, P NATL ACAD SCI USA, V102, P17918, DOI 10.1073/pnas.0508919102; Sturhahn W, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022802; Tsuchiya T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.198501	19	139	145	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2008	319	5862					451	453		10.1126/science.1149606	http://dx.doi.org/10.1126/science.1149606			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254HB	18218893				2022-12-28	WOS:000252576600034
J	Smith, WR; Penberthy, LT; Bovbjerg, VE; McClish, DK; Roberts, JD; Dahman, B; Aisiku, IP; Levenson, JL; Roseff, SD				Smith, Wally R.; Penberthy, Lynne T.; Bovbjerg, Viktor E.; McClish, Donna K.; Roberts, John D.; Dahman, Bassarn; Aisiku, Imoigele P.; Levenson, James L.; Roseff, Susan D.			Daily assessment of pain in adults with sickle cell disease	ANNALS OF INTERNAL MEDICINE			English	Article							NITRIC-OXIDE BIOAVAILABILITY; HEALTH-CARE UTILIZATION; BELIEF MODEL; RISK-FACTORS; MANAGEMENT; ANEMIA; CHILDREN; ADOLESCENTS; HYDROXYUREA; ADHESION	Background: Researchers of sickle cell disease have traditionally used health care utilization as a proxy for pain and underlying vaso-occlusion. However, utilization may not completely reflect the amount of self-reported pain or acute, painful episodes (crises). Objective: To examine the prevalence of self-reported pain and the relationship among pain, crises, and utilization in adults with sickle cell disease. Design: Prospective cohort study. Setting: Academic and community practices in Virginia. Patients: 232 patients age 16 years or older with sickle cell disease. Measurements: Patients completed a daily diary for up to 6 months, recording their maximum pain (on a scale of 0 to 9); whether they were in a crisis (crisis day); and whether they used hospital, emergency, or unscheduled ambulatory care for pain on the, previous day (utilization day). Summary measures included both simple proportions and adjusted probabilities (for repeated measures within patients) of pain days, crisis days, and utilization days, as well as mean pain intensity. Results: Pain (with or without crisis or utilization of care) was reported on 54.5% of 31 017 analyzed patient-days (adjusted probability, 56%). Crises without utilization were reported on 12.7% of days and utilization on only 3.5% (unadjusted). In total, 29.3% of patients reported pain in greater than 95% of diary days, whereas only 14.2% reported pain in 5% or fewer diary days (adjusted). The frequency of home opiate use varied and independently predicted pain, crises, and utilization. Mean pain intensity on crisis days, noncrisis pain days, and total pain days increased as the percentage of pain days increased (P < 0.001). Intensity was significantly higher on utilization days (P < 0.001). However, utilization was not an independent predictor of crisis, after controlling for pain intensity. Limitations: The study was done in a single state. Patients did not always send in their diaries. Conclusion: Pain in adults with sickle cell disease is the rule rather than the exception and is far more prevalent and severe than previous large-scale studies have portrayed. It is mostly managed at home; therefore, its prevalence is probably underestimated by health care providers, resulting in misclassification, distorted communication, and undertreatment.	[Smith, Wally R.] Virginia Commonwealth Univ, Dept Internal Med, Div Quality Hlth Care, Richmond, VA 23298 USA	Virginia Commonwealth University	Smith, WR (corresponding author), Virginia Commonwealth Univ, Dept Internal Med, Div Quality Hlth Care, Box 980306, Richmond, VA 23298 USA.	wrsmith@vcu.edu			NHLBI NIH HHS [1R01HL64122-01A1] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064122] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allen KD, 2006, JCR-J CLIN RHEUMATOL, V12, P118, DOI 10.1097/01.rhu.0000221801.63880.3f; Anie Kofi A, 2003, Hematol J, V4, P71, DOI 10.1038/sj.thj.6200227; Ballas SK, 2005, HEMATOL ONCOL CLIN N, V19, P785, DOI 10.1016/j.hoc.2005.07.008; Baron Michael J, 2006, J Opioid Manag, V2, P277; BECKER MH, 1974, HEALTH EDUC QUART, V2, P409, DOI 10.1177/109019817400200407; Blum A, 2005, J THROMB THROMBOLYS, V19, P83, DOI 10.1007/s11239-005-1377-7; BOBO L, 1989, SOUTHERN MED J, V82, P9, DOI 10.1097/00007611-198901000-00004; Bunn HF, 1997, NEW ENGL J MED, V337, P762, DOI 10.1056/NEJM199709113371107; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; Charache S, 1995, CONTROL CLIN TRIALS, V16, P432, DOI 10.1016/S0197-2456(95)00098-4; CHEN MS, 1986, SOC PSYCHOL QUART, V49, P45, DOI 10.2307/2786856; Dampier C, 2004, J PEDIAT HEMATOL ONC, V26, P785; Dimcevski G, 2006, EUR J GASTROEN HEPAT, V18, P755, DOI 10.1097/01.meg.0000223903.70492.c5; El Nemer W, 2007, BLOOD, V109, P3544, DOI 10.1182/blood-2006-07-035139; Elander J, 2004, J PAIN SYMPTOM MANAG, V27, P156, DOI 10.1016/j.jpainsymman.2003.12.001; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Fuggle P, 1996, ARCH DIS CHILD, V75, P199, DOI 10.1136/adc.75.3.199; Gil KM, 2004, HEALTH PSYCHOL, V23, P267, DOI 10.1037/0278-6133.23.3.267; Gil KM, 2003, J PEDIATR PSYCHOL, V28, P363, DOI 10.1093/jpepsy/jsg026; Gil KM, 2000, CHILD HEALTH CARE, V29, P225, DOI 10.1207/S15326888CHC2904_1; Gladwin MT, 2003, CIRCULATION, V107, P271, DOI 10.1161/01.CIR.0000044943.12533.A8; Graido-Gonzalez E, 1998, BLOOD, V92, P2551, DOI 10.1182/blood.V92.7.2551.2551_2551_2555; HEBBEL RP, 1980, NEW ENGL J MED, V302, P992, DOI 10.1056/NEJM198005013021803; Hermann C, 2006, PAIN, V125, P278, DOI 10.1016/j.pain.2006.08.026; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; KAUL DK, 1989, P NATL ACAD SCI USA, V86, P3356, DOI 10.1073/pnas.86.9.3356; Kaul DK, 2000, AM J PHYSIOL-HEART C, V278, pH1799, DOI 10.1152/ajpheart.2000.278.6.H1799; Lefebvre JC, 2002, CLIN J PAIN, V18, P56, DOI 10.1097/00002508-200201000-00009; McClish DK, 2006, J WOMENS HEALTH, V15, P146, DOI 10.1089/jwh.2006.15.146; Michaels LA, 1998, BLOOD, V92, P3148, DOI 10.1182/blood.V92.9.3148.421k12_3148_3151; MURRAY N, 1988, BRIT MED J, V297, P452, DOI 10.1136/bmj.297.6646.452; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Porter LS, 1998, INT J BEHAV MED, V5, P185, DOI 10.1207/s15327558ijbm0503_1; Powars DR, 2005, MEDICINE, V84, P363, DOI 10.1097/01.md.0000189089.45003.52; Reese FL, 1997, ANN BEHAV MED, V19, P171, DOI 10.1007/BF02883334; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Sakhalkar VS, 2004, AM J HEMATOL, V76, P57, DOI 10.1002/ajh.20016; Serjeant GR, 1997, LANCET, V350, P725, DOI 10.1016/S0140-6736(97)07330-3; SERJEANT GR, 1993, BLOOD REV, V7, P137, DOI 10.1016/0268-960X(93)90001-K; Setty BNY, 2003, LANCET, V362, P1450, DOI 10.1016/S0140-6736(03)14689-2; SHAPIRO BS, 1995, PAIN, V61, P139, DOI 10.1016/0304-3959(94)00164-A; Shapiro BS, 1997, J PAIN SYMPTOM MANAG, V14, P168, DOI 10.1016/S0885-3924(97)00019-5; Smith WR, 2005, J NATL MED ASSOC, V97, P183; Steinberg MH, 2003, JAMA-J AM MED ASSOC, V289, P1645, DOI 10.1001/jama.289.13.1645; Steinberg MH, 1999, NEW ENGL J MED, V340, P1021, DOI 10.1056/NEJM199904013401307; Von Korff M, 2000, SPINE, V25, P3140, DOI 10.1097/00007632-200012150-00009; Wagner MC, 2004, J LAB CLIN MED, V144, P260, DOI 10.1016/j.lab.2004.08.004; Westerman MP, 1997, AM J HEMATOL, V54, P183, DOI 10.1002/(SICI)1096-8652(199703)54:3<183::AID-AJH2>3.0.CO;2-S; [No title captured]	50	372	376	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2008	148	2					94	101		10.7326/0003-4819-148-2-200801150-00004	http://dx.doi.org/10.7326/0003-4819-148-2-200801150-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254NZ	18195334				2022-12-28	WOS:000252594600002
J	Ke, YG; Lindsay, S; Chang, Y; Liu, Y; Yan, H				Ke, Yonggang; Lindsay, Stuart; Chang, Yung; Liu, Yan; Yan, Hao			Self-assembled water-soluble nucleic acid probe tiles for label-free RNA hybridization assays	SCIENCE			English	Article							DNA HYBRIDIZATION; MICROARRAY; PATTERNS; DESIGN	The DNA origami method, in which long, single- stranded DNA segments are folded into shapes by short staple segments, was used to create nucleic acid probe tiles that are molecular analogs of macroscopic DNA chips. One hundred trillion probe tiles were fabricated in one step and bear pairs of 20- nucleotide- long single- stranded DNA segments that act as probe sequences. These tiles can hybridize to their targets in solution and, after adsorption onto mica surfaces, can be examined by atomic force microscopy in order to quantify binding events, because the probe segments greatly increase in stiffness upon hybridization. The nucleic acid probe tiles have been used to study position-dependent hybridization on the nanoscale and have also been used for label- free detection of RNA.	[Ke, Yonggang; Lindsay, Stuart; Liu, Yan; Yan, Hao] Arizona State Univ, Ctr Single Mol Biophys, Tempe, AZ 85287 USA; [Chang, Yung] Arizona State Univ, Ctr Infect Dis & Vaccinol, Biodesign Inst, Tempe, AZ 85287 USA; [Ke, Yonggang; Lindsay, Stuart; Liu, Yan; Yan, Hao] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Lindsay, Stuart] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Lindsay, Stuart] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Yan, H (corresponding author), Arizona State Univ, Ctr Single Mol Biophys, Tempe, AZ 85287 USA.	hao.yan@asu.edu	Liu, Yan/K-1999-2014	Liu, Yan/0000-0003-0906-2606				Bustin S. A., 2004, REAL TIME PCR ESSENT; Chang Y, 1999, P NATL ACAD SCI USA, V96, P191, DOI 10.1073/pnas.96.1.191; Chhabra R, 2007, J AM CHEM SOC, V129, P10304, DOI 10.1021/ja072410u; Gao Y, 2006, NUCLEIC ACIDS RES, V34, P3370, DOI 10.1093/nar/gkl422; Jacobsen EA, 2006, J IMMUNOL, V176, P6831, DOI 10.4049/jimmunol.176.11.6831; Lund K, 2005, J AM CHEM SOC, V127, P17606, DOI 10.1021/ja0568446; Meldrum DR, 2001, SCIENCE, V292, P515, DOI 10.1126/science.292.5516.515; MUELLER UR, 2004, MICROARRAY TECHNOLOG; Park SH, 2006, ANGEW CHEM INT EDIT, V45, P735, DOI 10.1002/anie.200503797; Peterson AW, 2001, NUCLEIC ACIDS RES, V29, P5163, DOI 10.1093/nar/29.24.5163; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863; Zuker M, 1999, NATO ASI 3 HIGH TECH, V70, P11	17	375	400	3	264	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2008	319	5860					180	183		10.1126/science.1150082	http://dx.doi.org/10.1126/science.1150082			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249RC	18187649				2022-12-28	WOS:000252246400034
J	Sprung, CL; Annane, D; Keh, D; Moreno, R; Singer, M; Freivogel, K; Weiss, YG; Benbenishty, J; Kalenka, A; Forst, H; Laterre, PF; Reinhart, K; Cuthbertson, BH; Payen, D; Briegel, J				Sprung, Charles L.; Annane, Djillali; Keh, Didier; Moreno, Rui; Singer, Mervyn; Freivogel, Klaus; Weiss, Yoram G.; Benbenishty, Julie; Kalenka, Armin; Forst, Helmuth; Laterre, Pierre-Francois; Reinhart, Konrad; Cuthbertson, Brian H.; Payen, Didier; Briegel, Josef		CORTICUS Study Grp	Hydrocortisone therapy for patients with septic shock	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	103rd International Conference of the American-Thoracic-Society	MAY 18-23, 2007	San Francisco, CA	Amer Thorac Soc			LOW-DOSE HYDROCORTISONE; SEVERE SEPSIS; DOUBLE-BLIND; CORTICOSTEROIDS; CORTISOL; RECEPTOR; INSUFFICIENCY; METAANALYSIS; MANAGEMENT; MORTALITY	Background: Hydrocortisone is widely used in patients with septic shock even though a survival benefit has been reported only in patients who remained hypotensive after fluid and vasopressor resuscitation and whose plasma cortisol levels did not rise appropriately after the administration of corticotropin. Methods: In this multicenter, randomized, double-blind, placebo-controlled trial, we assigned 251 patients to receive 50 mg of intravenous hydrocortisone and 248 patients to receive placebo every 6 hours for 5 days; the dose was then tapered during a 6-day period. At 28 days, the primary outcome was death among patients who did not have a response to a corticotropin test. Results: Of the 499 patients in the study, 233 (46.7%) did not have a response to corticotropin (125 in the hydrocortisone group and 108 in the placebo group). At 28 days, there was no significant difference in mortality between patients in the two study groups who did not have a response to corticotropin (39.2% in the hydrocortisone group and 36.1% in the placebo group, P=0.69) or between those who had a response to corticotropin (28.8% in the hydrocortisone group and 28.7% in the placebo group, P=1.00). At 28 days, 86 of 251 patients in the hydrocortisone group (34.3%) and 78 of 248 patients in the placebo group (31.5%) had died (P=0.51). In the hydrocortisone group, shock was reversed more quickly than in the placebo group. However, there were more episodes of superinfection, including new sepsis and septic shock. Conclusions: Hydrocortisone did not improve survival or reversal of shock in patients with septic shock, either overall or in patients who did not have a response to corticotropin, although hydrocortisone hastened reversal of shock in patients in whom shock was reversed. (ClinicalTrials.gov number, NCT00147004.).	[Sprung, Charles L.; Weiss, Yoram G.; Benbenishty, Julie] Hadassah Hebrew Univ Med Ctr, Dept Anesthesiol & Crit Care Med, Gen Intens Care Unit, IL-91120 Jerusalem, Israel; [Annane, Djillali] UniverSud Paris, Univ Versailles, Raymond Poincare Hosp, Garches, France; [Keh, Didier] Charite Univ Med Berlin, Berlin, Germany; [Moreno, Rui] Ctr Hosp Lisboa Cent, Hosp St Antonio dos Capuchos, Lisbon, Portugal; [Singer, Mervyn] UCL, Bloomsbury Inst Intens Care Med, London, England; [Freivogel, Klaus] Analytica Int, Lorrach, Germany; [Kalenka, Armin] Heidelberg Univ, Klinikum Mannheim, Mannheim, Germany; [Forst, Helmuth] Zent Klinikum, Augsburg, Germany; [Laterre, Pierre-Francois] Catholic Univ Louvain, St Luc Univ Hosp, B-1200 Brussels, Belgium; [Reinhart, Konrad] Univ Jena, Jena, Germany; [Cuthbertson, Brian H.] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Scotland; [Payen, Didier] Denis Diderot Univ Paris, Hop Lariboisiere, Paris, France; [Briegel, Josef] Univ Munich Klinikum, Munich, Germany	Hebrew University of Jerusalem; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Centro Hospitalar de Lisboa Central, EPE; Universidade de Lisboa; University of London; University College London; Ruprecht Karls University Heidelberg; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Friedrich Schiller University of Jena; University of Aberdeen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Munich	Sprung, CL (corresponding author), Hadassah Hebrew Univ Med Ctr, Dept Anesthesiol & Crit Care Med, Gen Intens Care Unit, POB 12000, IL-91120 Jerusalem, Israel.	sprung@cc.huji.ac.il	Singer, Mervyn/Q-6142-2019; Josef, Briegel/ABF-3522-2021; Annane, Djillali/R-7947-2019; Benbenishty, Julie Sarah/AFK-9001-2022; Briegel, Josef/AAG-3774-2019; Singer, Mervyn/J-4425-2012	Singer, Mervyn/0000-0002-1042-6350; Briegel, Josef/0000-0003-2837-8008; Singer, Mervyn/0000-0002-1042-6350	Chief Scientist Office [HSRU1] Funding Source: researchfish	Chief Scientist Office		Abraham E, 2003, JAMA-J AM MED ASSOC, V290, P238, DOI 10.1001/jama.290.2.238; Absalom A, 1999, ANAESTHESIA, V54, P861; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Annane D, 2003, AM J RESP CRIT CARE, V168, P165, DOI 10.1164/rccm.2201087; Annane D, 2004, BMJ-BRIT MED J, V329, P480, DOI 10.1136/bmj.38181.482222.55; Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Arafah BM, 2006, J CLIN ENDOCR METAB, V91, P3725, DOI 10.1210/jc.2006-0674; AXELROD L, 2001, PRINCIPLES PRACTICE, P762; Bollaert PE, 1998, CRIT CARE MED, V26, P645, DOI 10.1097/00003246-199804000-00010; Briegel J, 1999, CRIT CARE MED, V27, P723, DOI 10.1097/00003246-199904000-00025; Cohen J, 2006, INTENS CARE MED, V32, P1901, DOI 10.1007/s00134-006-0389-x; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; CRONIN L, 1995, CRIT CARE MED, V23, P1430, DOI 10.1097/00003246-199508000-00019; De Jonghe B, 2002, JAMA-J AM MED ASSOC, V288, P2859, DOI 10.1001/jama.288.22.2859; Dellinger RP, 2003, CRIT CARE MED, V31, P946, DOI 10.1097/01.CCM.0000057403.73299.A6; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Dellinger RP, 2004, CRIT CARE MED, V32, P1448; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Hamrahian AH, 2004, NEW ENGL J MED, V350, P1629, DOI 10.1056/NEJMoa020266; Keh D, 2003, AM J RESP CRIT CARE, V167, P512, DOI 10.1164/rccm.200205-446OC; Laterre PF, 2004, CRIT CARE MED, V32, P2207, DOI 10.1097/01.CCM.0000145231.71605.D8; LEFERING R, 1995, CRIT CARE MED, V23, P1294, DOI 10.1097/00003246-199507000-00021; LEGALL JR, 1994, JAMA-J AM MED ASSOC, V271, P1321; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Matot I, 2001, INTENS CARE MED, V27, pS3, DOI 10.1007/PL00003795; Matot I, 2001, INTENS CARE MED, V27, pS128; Meduri GU, 2005, NEUROIMMUNOMODULAT, V12, P321, DOI 10.1159/000091126; Minneci PC, 2004, ANN INTERN MED, V141, P47, DOI 10.7326/0003-4819-141-1-200407060-00014; Moreno Rui, 2006, Curr Infect Dis Rep, V8, P346, DOI 10.1007/s11908-006-0044-2; Oppert M, 2005, CRIT CARE MED, V33, P2457, DOI 10.1097/01.CCM.0000186370.78639.23; Reves JG, 2005, MILLERS ANESTHESIA, P317; Russell JA, 2006, NEW ENGL J MED, V355, P2267; SAITO T, 1995, INTENS CARE MED, V21, P204, DOI 10.1007/BF01701473; SCHUMER W, 1976, ANN SURG, V184, P333, DOI 10.1097/00000658-197609000-00011; SILVERMAN HJ, 1993, CRIT CARE MED, V21, P31, DOI 10.1097/00003246-199301000-00010; SPRUNG CL, 1984, NEW ENGL J MED, V311, P1137, DOI 10.1056/NEJM198411013111801; Steinberg KP, 2006, NEW ENGL J MED, V354, P1671; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Warren BL, 2001, JAMA-J AM MED ASSOC, V286, P1869, DOI 10.1001/jama.286.15.1869; Warren BL, 2002, JAMA-J AM MED ASSOC, V287, P192	42	1383	1478	2	63	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2008	358	2					111	124		10.1056/NEJMoa071366	http://dx.doi.org/10.1056/NEJMoa071366			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	249CJ	18184957	Bronze			2022-12-28	WOS:000252204200003
J	Weidenspointner, G; Skinner, G; Jean, P; Knodlseder, J; von Ballmoos, P; Bignami, G; Diehl, R; Strong, AW; Cordier, B; Schanne, S; Winkler, C				Weidenspointner, Georg; Skinner, Gerry; Jean, Pierre; Knoedlseder, Juergen; von Ballmoos, Peter; Bignami, Giovanni; Diehl, Roland; Strong, Andrew W.; Cordier, Bertrand; Schanne, Stephane; Winkler, Christoph			An asymmetric distribution of positrons in the Galactic disk revealed by gamma-rays	NATURE			English	Article							ANNIHILATION RADIATION; SKY DISTRIBUTION; INNER GALAXY; BLACK-HOLE; MILKY-WAY; EMISSION; AL-26; SEARCH	Gamma- ray line radiation at 511 keV is the signature of electron positron annihilation. Such radiation has been known for 30 years to come from the general direction of the Galactic Centre(1), but the origin of the positrons has remained a mystery. Stellar nucleosynthesis(2-4), accreting compact objects(5-8), and even the annihilation of exotic dark- matter particles(9) have all been suggested. Here we report a distinct asymmetry in the 511- keV line emission coming from the inner Galactic disk ( similar to 10-50 degrees from the Galactic Centre). This asymmetry resembles an asymmetry in the distribution of low mass X- ray binaries with strong emission at photon energies >20 keV ('hard' LMXBs), indicating that they may be the dominant origin of the positrons. Although it had long been suspected that electron - positron pair plasmas may exist in X- ray binaries, it was not evident that many of the positrons could escape to lose energy and ultimately annihilate with electrons in the interstellar medium and thus lead to the emission of a narrow 511- keV line. For these models, our result implies that up to a few times 10(41) positrons escape per second from a typical hard LMXB. Positron production at this level from hard LMXBs in the Galactic bulge would reduce ( and possibly eliminate) the need for more exotic explanations, such as those involving dark matter.	[Weidenspointner, Georg; Skinner, Gerry; Jean, Pierre; Knoedlseder, Juergen; von Ballmoos, Peter; Bignami, Giovanni] UPS, CNRS, Ctr Etud Spatiale Rayonnements, Toulouse 4, France; [Weidenspointner, Georg; Diehl, Roland; Strong, Andrew W.] Max Planck Inst Extraterr Phys, D-85741 Garching, Germany; [Weidenspointner, Georg] MPI Halbleiterlab, D-81739 Munich, Germany; [Skinner, Gerry] NASA, CRESST, Greenbelt, MD 20771 USA; [Skinner, Gerry] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Skinner, Gerry] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Cordier, Bertrand; Schanne, Stephane] CEA Saclay, SAp, DAPNIA, DSM, F-91191 Gif Sur Yvette, France; [Winkler, Christoph] ESA, ESTEC, SCI SA, NL-2201 AZ Noordwijk, Netherlands; [Bignami, Giovanni] IUSS, I-27100 Pavia, Italy	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Max Planck Society; National Aeronautics & Space Administration (NASA); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland College Park; CEA; UDICE-French Research Universities; Universite Paris Saclay; European Space Agency; IUSS PAVIA	Weidenspointner, G (corresponding author), UPS, CNRS, Ctr Etud Spatiale Rayonnements, BP 44346, Toulouse 4, France.	Georg.Weidenspointner@hll.mpg.de	Diehl, Roland/K-4496-2016	Diehl, Roland/0000-0002-8337-9022; Knodlseder, Jurgen/0000-0002-0014-7809; Bignami, Giovanni/0000-0001-9582-2450; Jean, Pierre/0000-0002-1757-9560				Bazzano A, 2006, ASTROPHYS J, V649, pL9, DOI 10.1086/508171; Benjamin RA, 2005, ASTROPHYS J, V630, pL149, DOI 10.1086/491785; Bird AJ, 2007, ASTROPHYS J SUPPL S, V170, P175, DOI 10.1086/513148; Boehm C, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.101301; Cheng KS, 2006, ASTROPHYS J, V645, P1138, DOI 10.1086/504583; CLAYTON DD, 1973, NATURE-PHYS SCI, V244, P137, DOI 10.1038/physci244137b0; CLAYTON DD, 1974, APJ, V187, P101; De Cesare G, 2006, ADV SPACE RES-SERIES, V38, P1457, DOI 10.1016/j.asr.2005.01.015; Diehl R, 2006, ASTRON ASTROPHYS, V449, P1025, DOI 10.1051/0004-6361:20054301; GEHRELS N, 1991, ASTROPHYS J, V375, pL13, DOI 10.1086/186077; GILLARD W, ESA, V622; Grimm HJ, 2002, ASTRON ASTROPHYS, V391, P923, DOI 10.1051/0004-6361:20020826; Guessoum N, 2006, ASTRON ASTROPHYS, V457, P753, DOI 10.1051/0004-6361:20065240; Jean P, 2006, ASTRON ASTROPHYS, V445, P579, DOI 10.1051/0004-6361:20053765; Kinzer RL, 2001, ASTROPHYS J, V559, P282, DOI 10.1086/322371; Knodlseder J, 2005, ASTRON ASTROPHYS, V441, P513, DOI 10.1051/0004-6361:20042063; Knodlseder J, 1999, ASTRON ASTROPHYS, V344, P68; KNODLSEDER J, 2007, ESA, V622; LEVENTHAL M, 1978, ASTROPHYS J, V225, pL11, DOI 10.1086/182782; Milne PA, 2000, AIP CONF PROC, V510, P21; Pluschke S, 2001, ESA SP PUBL, V459, P55; PRANTZOS N, 1986, ASTROPHYS J, V307, P324, DOI 10.1086/164419; RAMATY R, 1979, NATURE, V278, P127, DOI 10.1038/278127a0; Robin AC, 2003, ASTRON ASTROPHYS, V409, P523, DOI 10.1051/0004-6361:20031117; SCHANNE S, IN PRESS ESA, V622; Teegarden BJ, 2006, ASTROPHYS J, V646, P965, DOI 10.1086/504967; Totani T, 2006, PUBL ASTRON SOC JPN, V58, P965, DOI 10.1093/pasj/58.6.965; Weidenspointner G, 2006, ASTRON ASTROPHYS, V450, P1013, DOI 10.1051/0004-6361:20054046; WEIDENSPOINTNER G, 2007, ESA, V622	29	168	168	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2008	451	7175					159	162		10.1038/nature06490	http://dx.doi.org/10.1038/nature06490			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249GA	18185581				2022-12-28	WOS:000252214400035
J	Cappellini, MD; Fiorelli, G				Cappellini, M. D.; Fiorelli, G.			Gluclose-6-phosphate dehydrogenase deficiency	LANCET			English	Review							SEVERE NEONATAL HYPERBILIRUBINEMIA; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; G6PD DEFICIENCY; PLASMODIUM-FALCIPARUM; ACUTE HEMOLYSIS; RED-CELLS; MOLECULAR CHARACTERIZATION; SEQUENCE-ANALYSIS; CANARY-ISLANDS; GENE	Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common human enzyme defect, being present in more than 400 million people worldwide. The global distribution of this disorder is remarkably similar to that of malaria, lending support to the so-called malaria protection hypothesis. G6PD deficiency is an X-linked, hereditary genetic defect due to mutations in the G6PD gene, which cause functional variants with many biochemical and clinical phenotypes. About 140 mutations have been described: most are single base changes, leading to aminoacid substitutions. The most frequent clinical manifestations of G6PD deficiency are neonatal jaundice, and acute haemolytic anaemia, which is usually triggered by an exogenous agent. Some G6PD variants cause chronic haemolysis, leading to congenital non-spherocytic haemolytic anaemia. The most effective management of G6PD deficiency is to prevent haemolysis by avoiding oxidative stress. Screening programmes for the disorder are undertaken, depending on the prevalence of G6PD deficiency in a particular community.	[Cappellini, M. D.; Fiorelli, G.] Univ Milan, Policlin Mangiagalli, Regina Elena Fdn IRCCS, Dept Internal Med, I-20122 Milan, Italy	University of Milan	Cappellini, MD (corresponding author), Univ Milan, Policlin Mangiagalli, Regina Elena Fdn IRCCS, Dept Internal Med, Via F Sforza 35, I-20122 Milan, Italy.	maria.cappellini@unimi.it	CAPPELLINI, MARIA DOMENICA/B-4475-2017	CAPPELLINI, MARIA DOMENICA/0000-0001-8676-6864				ALFINITO F, 1994, BRIT J HAEMATOL, V87, P148, DOI 10.1111/j.1365-2141.1994.tb04885.x; ANGLE CR, 1972, LANCET, V2, P134; [Anonymous], 1967, WHO TECH REP SER; ARESE P, 1990, SEMIN HEMATOL, V27, P1; ARESE P, 1986, GLUCOSE 6 PHOSPHATE, P45; ATAMNA H, 1994, MOL BIOCHEM PARASIT, V67, P79, DOI 10.1016/0166-6851(94)90098-1; BATTISTUZZI G, 1985, P NATL ACAD SCI USA, V82, P1465, DOI 10.1073/pnas.82.5.1465; Bayoumi RA, 1996, HUM HERED, V46, P136, DOI 10.1159/000154342; BELSEY MA, 1973, B WORLD HEALTH ORGAN, V48, P1; BERNSTEIN RE, 1963, CLIN CHIM ACTA, V8, P158, DOI 10.1016/0009-8981(63)90217-1; BEUTLER E, 1968, BLOOD, V31, P131, DOI 10.1182/blood.V31.2.131.131; BEUTLER E, 1992, ACTA HAEMATOL-BASEL, V87, P103; BEUTLER E, 1966, BLOOD-J HEMATOL, V28, P553, DOI 10.1182/blood.V28.4.553.553; BEUTLER E, 1989, BLOOD, V74, P2550; Beutler E, 1996, BLOOD REV, V10, P45, DOI 10.1016/S0268-960X(96)90019-3; BEUTLER E, 1994, BLOOD, V84, P3613, DOI 10.1182/blood.V84.11.3613.bloodjournal84113613; BEUTLER E, 1962, P NATL ACAD SCI USA, V48, P9, DOI 10.1073/pnas.48.1.9; BEUTLER E, 1990, SEMIN HEMATOL, V27, P137; BEUTLER E, 1959, BLOOD, V14, P103, DOI 10.1182/blood.V14.2.103.103; BIENZLE U, 1972, LANCET, V1, P107; Cabrera VM, 1996, HUM HERED, V46, P197, DOI 10.1159/000154353; Cappadoro M, 1998, BLOOD, V92, P2527, DOI 10.1182/blood.V92.7.2527.2527_2527_2534; Cappellini MD, 1999, BRIT J HAEMATOL, V104, P928; CAPPELLINI MD, 1994, HUM GENET, V93, P139, DOI 10.1007/BF00210598; Cappellini MD, 1996, BLOOD, V87, P3953, DOI 10.1182/blood.V87.9.3953.bloodjournal8793953; CARSON PE, 1956, SCIENCE, V124, P484, DOI 10.1126/science.124.3220.484-a; CHEN EY, 1991, GENOMICS, V10, P792, DOI 10.1016/0888-7543(91)90465-Q; Cheng YS, 1999, J BIOMED SCI, V6, P106, DOI 10.1159/000025377; CHOREMIS C, 1966, LANCET, V1, P269; CLARK IA, 1983, INFECT IMMUN, V39, P1; Cocco P, 1998, BLOOD, V91, P706, DOI 10.1182/blood.V91.2.706.706_706_709; CORCHIA C, 1995, J PEDIATR-US, V127, P807, DOI 10.1016/S0022-3476(95)70178-8; CROSBY WH, 1956, BLOOD, V11, P91; DERN RJ, 1954, J LAB CLIN MED, V44, P171; DEVITA G, 1989, AM J HUM GENET, V44, P233; DiMontemuros FM, 1997, HAEMATOLOGICA, V82, P440; Edwards Corwin Q, 2002, Clin Liver Dis, V6, P891, DOI 10.1016/S1089-3261(02)00050-8; FERMI C, 1905, ANN IGIENE SPERIMENT, V15, P76; Fiorelli G, 2000, BEST PRACT RES CL HA, V13, P39, DOI 10.1053/beha.1999.0056; FIORELLI G, 1989, ANN HUM GENET, V53, P229, DOI 10.1111/j.1469-1809.1989.tb01789.x; FISCHER TM, 1985, BRIT J HAEMATOL, V59, P159, DOI 10.1111/j.1365-2141.1985.tb02976.x; Frank JE, 2005, AM FAM PHYSICIAN, V72, P1277; Franze A, 1998, FEBS LETT, V437, P313, DOI 10.1016/S0014-5793(98)01259-9; GAETANI GD, 1974, P NATL ACAD SCI USA, V71, P3584, DOI 10.1073/pnas.71.9.3584; GANCZAKOWSKI M, 1995, AM J HUM GENET, V56, P294; GANGAROSSA S, 1995, ACTA HAEMATOL-BASEL, V93, P36; GREENE LS, 1993, YEARB PHYS ANTHROPOL, V36, P153; GUGGENMOOSHOLZMANN I, 1981, INT J EPIDEMIOL, V10, P16, DOI 10.1093/ije/10.1.16; HAFEZ M, 1986, J PEDIATR-US, V108, P558, DOI 10.1016/S0022-3476(86)80833-2; Hirono A, 1997, BLOOD, V89, P4624, DOI 10.1182/blood.V89.12.4624; Hirono A, 2002, BLOOD, V99, P1498, DOI 10.1182/blood.V99.4.1498; HIRONO A, 1989, P NATL ACAD SCI USA, V86, P10015, DOI 10.1073/pnas.86.24.10015; HOIBERG A, 1981, ARCH INTERN MED, V141, P1485, DOI 10.1001/archinte.141.11.1485; Jalloh A, 2004, TROP MED INT HEALTH, V9, P615, DOI 10.1111/j.1365-3156.2004.01237.x; Johnson LH, 2002, J PEDIATR-US, V140, P396, DOI 10.1067/mpd.2002.123098; Kaplan M, 1996, J PEDIATR-US, V128, P695, DOI 10.1016/S0022-3476(96)80138-7; Kaplan M, 1997, P NATL ACAD SCI USA, V94, P12128, DOI 10.1073/pnas.94.22.12128; Kaplan M, 1996, BRIT J HAEMATOL, V93, P822, DOI 10.1046/j.1365-2141.1996.d01-1745.x; Karimi M, 2003, HAEMATOLOGICA, V88, P346; KATTAMIS C A, 1969, Journal of Medical Genetics, V6, P34, DOI 10.1136/jmg.6.1.34; KURDIHAIDAR B, 1990, AM J HUM GENET, V47, P1013; Lee DH, 1996, AM J HEMATOL, V51, P174, DOI 10.1002/(SICI)1096-8652(199602)51:2<174::AID-AJH18>3.0.CO;2-I; Lim F, 2005, J CLIN PATHOL, V58, P317, DOI 10.1136/jcp.2004.017426; LOPEZ R, 1971, AM J DIS CHILD, V122, P66, DOI 10.1001/archpedi.1971.02110010102020; Luisada A, 1941, MEDICINE, V20, P229, DOI 10.1097/00005792-194105000-00003; LUZZATTO L, 1979, BLOOD, V54, P961; LUZZATTO L, 1979, LANCET, V1, P1183; LUZZATTO L, 1983, CIBA F SYMP, V94, P159; LUZZATTO L, 1969, SCIENCE, V164, P839, DOI 10.1126/science.164.3881.839; LUZZATTO L, 2006, HEMATOLOGY, V2, P63; LUZZATTO L, 1986, ETHNIC DIFFERENCES R, P385; LUZZATTO L, 1995, BLOOD PRINCIPLES PRA, P1897; LUZZATTO L, 1980, MODERN GENETIC CONCE, P257; MAESTRINI E, 1992, AM J HUM GENET, V50, P156; MAHENDRA P, 1992, BRIT MED J, V305, P760; Maisels MJ, 2004, PEDIATRICS, V114, P297; MARTIN SK, 1979, LANCET, V1, P524; MASON PJ, 1995, BLOOD, V85, P1377, DOI 10.1182/blood.V85.5.1377.bloodjournal8551377; Mason PJ, 1996, BRIT J HAEMATOL, V94, P585, DOI 10.1111/j.1365-2141.1996.tb00001.x; MATTHAY KK, 1981, CLIN HAEMATOL, V10, P31; MCCAFFREY RP, 1971, ANN INTERN MED, V74, P722, DOI 10.7326/0003-4819-74-5-722; MELONI T, 1983, ACTA HAEMATOL-BASEL, V70, P83, DOI 10.1159/000206700; MELONI T, 1992, ACTA HAEMATOL-BASEL, V87, P29; MILLER J, 1984, EXP PARASITOL, V57, P239, DOI 10.1016/0014-4894(84)90097-3; Motulsky AG, 1961, P C GENETIC POLYMORP, P159; Nair AK, 2003, J TROP PEDIATRICS, V49, P74, DOI 10.1093/tropej/49.2.74; Naylor CE, 1996, BLOOD, V87, P2974, DOI 10.1182/blood.V87.7.2974.bloodjournal8772974; NEWMAN TB, 1992, PEDIATRICS, V89, P809; NINFALI P, 1995, CELL BIOCHEM FUNCT, V13, P297, DOI 10.1002/cbf.290130412; Oo M, 1995, B WORLD HEALTH ORGAN, V73, P659; OPPENHEIM A, 1993, HUM GENET, V91, P293; PERKINS RP, 1971, AM J OBSTET GYNECOL, V111, P379, DOI 10.1016/0002-9378(71)90781-2; PERNG LI, 1992, HUM MOL GENET, V1, P205, DOI 10.1093/hmg/1.3.205; PERSICO MG, 1986, NUCLEIC ACIDS RES, V14, P2511, DOI 10.1093/nar/14.6.2511; PHILIPPE M, 1994, EUR J BIOCHEM, V226, P377, DOI 10.1111/j.1432-1033.1994.tb20062.x; Pinto FM, 1996, HUM BIOL, V68, P517; REYNOLDS GA, 1984, CELL, V38, P275, DOI 10.1016/0092-8674(84)90549-X; RINGELHAHN B, 1972, CLIN CHIM ACTA, V36, P272, DOI 10.1016/0009-8981(72)90193-3; ROTH EF, 1983, P NATL ACAD SCI-BIOL, V80, P298, DOI 10.1073/pnas.80.1.298; RUBINS J, 1977, JAMA-J AM MED ASSOC, V237, P797; RUSSEL B, 1965, HIST W PHILOS; Ruwende C, 1998, J MOL MED, V76, P581, DOI 10.1007/s001090050253; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Sampietro M, 1997, BRIT J HAEMATOL, V99, P437, DOI 10.1046/j.1365-2141.1997.4113228.x; SANSONE G., 1958, BOL SOC ITAL BIOL SPERIM, V34, P327; SANSONE G, 1958, FAVISMO; SCHILIRO G, 1979, CLIN GENET, V15, P183; Scopes DA, 1998, EUR J BIOCHEM, V251, P382, DOI 10.1046/j.1432-1327.1998.2510382.x; SEIDMAN DS, 1995, J PEDIATR-US, V127, P804, DOI 10.1016/S0022-3476(95)70177-X; SELROOS O, 1972, LANCET, V2, P284; Sgro M, 2006, CAN MED ASSOC J, V175, P587, DOI 10.1503/cmaj.060328; SHALEV O, 1984, BRIT MED J, V288, P179, DOI 10.1136/bmj.288.6412.179; Siddiqui T, 1998, MIL MED, V163, P434, DOI 10.1093/milmed/163.6.434; SZABO P, 1984, P NATL ACAD SCI-BIOL, V81, P7855, DOI 10.1073/pnas.81.24.7855; Tantular IS, 2003, TROP MED INT HEALTH, V8, P569, DOI 10.1046/j.1365-3156.2003.01055.x; TONIOLO D, 1991, GENE, V102, P197, DOI 10.1016/0378-1119(91)90078-P; TOWN M, 1992, HUM MOL GENET, V1, P171, DOI 10.1093/hmg/1.3.171; TRASK BJ, 1991, AM J HUM GENET, V48, P1; Tsai KJ, 1998, FEBS LETT, V436, P411, DOI 10.1016/S0014-5793(98)01174-0; TUGWELL P, 1973, LANCET, V1, P968; VALAES T, 1963, J PEDIATR-US, V63, P904, DOI 10.1016/S0022-3476(63)80221-8; Vulliamy T, 1997, BLOOD CELL MOL DIS, V23, P302, DOI 10.1006/bcmd.1997.0147; VULLIAMY TJ, 1991, P NATL ACAD SCI USA, V88, P8568, DOI 10.1073/pnas.88.19.8568; Vulliamy TJ, 1998, BRIT J HAEMATOL, V101, P670, DOI 10.1046/j.1365-2141.1998.00763.x; WALLER HD, 1957, KLIN WOCHENSCHR, V35, P1022, DOI 10.1007/BF01488728; [No title captured]	127	883	925	6	152	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 5	2008	371	9606					64	74		10.1016/S0140-6736(08)60073-2	http://dx.doi.org/10.1016/S0140-6736(08)60073-2			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248YH	18177777				2022-12-28	WOS:000252192600032
J	Farag, N; Reynolds, E; Lembo, A				Farag, Nadine; Reynolds, Eileen; Lembo, Anthony			Update: A 54-year-old woman with constipation-predominant irritable bowel syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		Lembo AJ, 2006, JAMA-J AM MED ASSOC, V295, P925, DOI 10.1001/jama.295.8.925; Lin HC, 2004, JAMA-J AM MED ASSOC, V292, P852, DOI 10.1001/jama.292.7.852; O'Mahony L, 2005, GASTROENTEROLOGY, V128, P541, DOI 10.1053/j.gastro.2004.11.050; *US FDA, 2007, FDA PUBL HLTH ADV TE	4	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2008	299	1					88	88		10.1001/jama.2007.63	http://dx.doi.org/10.1001/jama.2007.63			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247BL	18167409				2022-12-28	WOS:000252052000020
J	Hecht, GA				Hecht, Gail A.			Inflammatory bowel disease - Live transmission	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Illinois, Sect Digest Dis & Nutr, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Hecht, GA (corresponding author), Univ Illinois, Sect Digest Dis & Nutr, Chicago, IL 60680 USA.							Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Meduri GU, 1999, AM J RESP CRIT CARE, V160, P961, DOI 10.1164/ajrccm.160.3.9807080; Wu LC, 2005, SCIENCE, V309, P774, DOI 10.1126/science.1112422	4	24	24	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2008	358	5					528	530		10.1056/NEJMcibr0707718	http://dx.doi.org/10.1056/NEJMcibr0707718			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	256IW	18234759				2022-12-28	WOS:000252722900014
J	Hoge, CW; McGurk, D; Thomas, JL; Cox, AL; Engel, CC; Castro, CA				Hoge, Charles W.; McGurk, Dennis; Thomas, Jeffrey L.; Cox, Anthony L.; Engel, Charles C.; Castro, Carl A.			Mild traumatic brain injury in US Soldiers returning from Iraq	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; COLLEGIATE FOOTBALL PLAYERS; MENTAL-HEALTH PROBLEMS; GULF-WAR; AFGHANISTAN; CONCUSSION; DEPRESSION; DEPLOYMENT; ILLNESS; CARE	Background: An important medical concern of the Iraq war is the potential long-term effect of mild traumatic brain injury, or concussion, particularly from blast explosions. However, the epidemiology of combat-related mild traumatic brain injury is poorly understood. Methods: We surveyed 2525 U.S. Army infantry soldiers 3 to 4 months after their return from a year-long deployment to Iraq. Validated clinical instruments were used to compare soldiers reporting mild traumatic brain injury, defined as an injury with loss of consciousness or altered mental status (e.g., dazed or confused), with soldiers who reported other injuries. Results: Of 2525 soldiers, 124 (4.9%) reported injuries with loss of consciousness, 260 (10.3%) reported injuries with altered mental status, and 435 (17.2%) reported other injuries during deployment. Of those reporting loss of consciousness, 43.9% met criteria for post-traumatic stress disorder (PTSD), as compared with 27.3% of those reporting altered mental status, 16.2% with other injuries, and 9.1% with no injury. Soldiers with mild traumatic brain injury, primarily those who had loss of consciousness, were significantly more likely to report poor general health, missed workdays, medical visits, and a high number of somatic and postconcussive symptoms than were soldiers with other injuries. However, after adjustment for PTSD and depression, mild traumatic brain injury was no longer significantly associated with these physical health outcomes or symptoms, except for headache. Conclusions: Mild traumatic brain injury (i.e., concussion) occurring among soldiers deployed in Iraq is strongly associated with PTSD and physical health problems 3 to 4 months after the soldiers return home. PTSD and depression are important mediators of the relationship between mild traumatic brain injury and physical health problems.	[Hoge, Charles W.; McGurk, Dennis; Thomas, Jeffrey L.; Cox, Anthony L.; Castro, Carl A.] USA, Div Psychiat & Neurosci, Walter Reed Army Inst Res, Med Res & Mat Command, Silver Spring, MD 20910 USA; [Engel, Charles C.] Deployment Hlth Clin Ctr, Washington, DC USA; [Engel, Charles C.] Uniformed Serv Univ Hlth Sci, Washington, DC USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Hoge, CW (corresponding author), USA, Div Psychiat & Neurosci, Walter Reed Army Inst Res, Med Res & Mat Command, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	charles.hoge@us.army.mil		McGurk, Dennis/0000-0003-4126-5980; Engel, Charles/0000-0002-9232-3389				BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Barsky AJ, 1999, ANN INTERN MED, V130, P910, DOI 10.7326/0003-4819-130-11-199906010-00016; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; BLIESE PD, IN PRESS J CONSULT C; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Boscarino JA, 2004, ANN NY ACAD SCI, V1032, P141, DOI 10.1196/annals.1314.011; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; *DEF VET BRAIN INJ, 2006, CLIN PRACT GUID REC; *DEF VET BRAIN INJ, 3 QUEST DVBIC TBI SC; *DEP VET AFF, 2007, VHA DIR 2007 013 SCR; Engel C. C., 1999, STRATEGIES PROTECT H, P173; Engel CC, 2006, PHILOS T R SOC B, V361, P707, DOI 10.1098/rstb.2006.1829; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; Fisher ES, 1999, JAMA-J AM MED ASSOC, V281, P446, DOI 10.1001/jama.281.5.446; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; GLASSER R, 2008, WASHINGTON POST 0418, pB1; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2006, JAMA-J AM MED ASSOC, V296, P2678, DOI 10.1001/jama.296.22.2678-b; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Independent Review G. Rebuilding the Trust, 2007, REB TRUST REP REH CA; Jones E, 2002, BRIT MED J, V324, P397; Jones E, 2002, BMJ-BRIT MED J, V324, P321, DOI 10.1136/bmj.324.7333.321; Kang HK, 2003, AM J EPIDEMIOL, V157, P141, DOI 10.1093/aje/kwf187; Katon W, 2007, GEN HOSP PSYCHIAT, V29, P147, DOI 10.1016/j.genhosppsych.2006.11.005; Katon WJ, 2006, J TRAUMA STRESS, V19, P611, DOI 10.1002/jts.20147; Kroenke K, 2003, INT J METH PSYCH RES, V12, P34, DOI 10.1002/mpr.140; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; McAllister T. W., 2005, TXB TRAUMATIC BRAIN, P279; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; MEARES S, IN PRESS J NEUROL NE; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Nemeroff CB, 2006, J PSYCHIATR RES, V40, P1, DOI 10.1016/j.jpsychires.2005.07.005; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Peloso PM, 2004, J REHABIL MED, V36, P106, DOI 10.1080/16501960410023868; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Rona RJ, 2005, JAMA-J AM MED ASSOC, V293, P1257, DOI 10.1001/jama.293.10.1257; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Taber KH, 2007, J NEUROPSYCH CLIN N, V19, P100; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; *VET HLTH ADM, 2001, CLIN PRACT GUID POST; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Xydakis MS, 2005, OTOLARYNG HEAD NECK, V133, P497, DOI 10.1016/j.otohns.2005.07.003	50	2015	2040	3	326	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2008	358	5					453	463		10.1056/NEJMoa072972	http://dx.doi.org/10.1056/NEJMoa072972			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	256IW	18234750				2022-12-28	WOS:000252722900003
J	Page, KR; Zenilman, J				Page, Kathleen R.; Zenilman, Jonathan			Eosinophilia in a patient from South America	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LINKED-IMMUNOSORBENT-ASSAY; STRONGYLOIDES-STERCORALIS; BLOOD EOSINOPHILIA; INFECTION; DIAGNOSIS; REFUGEES; HYPERINFECTION; FILARIASIS; EFFICACY; ANTIGEN	Asymptomatic eosinophilia is a common finding in returning travelers and immigrants from parasite- endemic areas. We present a 49- year- old man from Guyana who immigrated to the United States 4 years prior to examination. He had persistent asymptomatic eosinophilia, and multiple stool examinations were negative for ova and parasites. Although the list of parasitic diseases associated with eosinophilia is extensive, the differential diagnosis of asymptomatic eosinophilia with negative stool evaluations is rather limited. We discuss herein elements of the clinical history and examination essential for evaluating eosinophilia in patients at risk of parasitic diseases and present a simple algorithm to guide diagnostic testing. Despite the importance of repeated stool examinations for the presence of ova and parasites, in practice this test is not sensitive. Serologic testing for chronic parasitic infections is often necessary. Most cases without a definitive diagnosis can be conservatively managed with serial monitoring or empirically treated with antihelminthic therapy, but patients with an absolute eosinophil count of more than 3000/mu L or more than 1500/mu L for more than 6 months are at risk of end organ damage and should be referred for specialized parasitic and/ or hematology consultation.	[Page, Kathleen R.; Zenilman, Jonathan] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Johns Hopkins University	Page, KR (corresponding author), 600 N Wolfe St,Phipps 524, Baltimore, MD 21287 USA.	kpage2@jhmi.edu						[Anonymous], 2007, Wkly Epidemiol Rec, V82, P361; BERK SL, 1987, ARCH INTERN MED, V147, P1257, DOI 10.1001/archinte.147.7.1257; Boatright MD, 2005, ARTHRITIS RHEUM, V52, P1336, DOI 10.1002/art.20882; *CDCP, PAR DIS; *CDCP, REC PRES TREATM SCHI; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; DAVIDSON RA, 1984, ARCH INTERN MED, V144, P321, DOI 10.1001/archinte.144.2.321; FRYATT RJ, 1990, TROP GEOGR MED, V42, P119; Gotuzzo E, 1999, AM J TROP MED HYG, V60, P146, DOI 10.4269/ajtmh.1999.60.146; GYORKOS TW, 1990, AM J EPIDEMIOL, V132, P257, DOI 10.1093/oxfordjournals.aje.a115655; HARLEY WB, 1994, CLIN INFECT DIS, V18, P627, DOI 10.1093/clinids/18.4.627; HARRIES AD, 1986, T ROY SOC TROP MED H, V80, P327, DOI 10.1016/0035-9203(86)90049-0; Hirata T, 2006, AM J TROP MED HYG, V74, P246, DOI 10.4269/ajtmh.2006.74.246; Igual-Adell R, 2004, EXPERT OPIN PHARMACO, V5, P2615, DOI 10.1517/14656566.5.12.2615; Karunajeewa H, 2006, J TRAVEL MED, V13, P84, DOI 10.1111/j.1708-8305.2006.00004.x; Keiser PB, 2004, CLIN MICROBIOL REV, V17, P208, DOI 10.1128/CMR.17.1.208-217.2004; KOBAYASHI J, 1994, DIAGN MICR INFEC DIS, V18, P19, DOI 10.1016/0732-8893(94)90129-5; Lammie Patrick J, 2004, Filaria J, V3, P9, DOI 10.1186/1475-2883-3-9; LIBMAN MD, 1993, CLIN INFECT DIS, V17, P353, DOI 10.1093/clinids/17.3.353; Lindo JF, 1996, AM J TROP MED HYG, V55, P474, DOI 10.4269/ajtmh.1996.55.474; Lo Re III V, 2003, AM J MED, V114, P217, DOI 10.1016/S0002-9343(02)01495-X; Loutfy MR, 2002, AM J TROP MED HYG, V66, P749, DOI 10.4269/ajtmh.2002.66.749; LUCAS SB, 1990, T ROY SOC TROP MED H, V84, P34, DOI 10.1016/0035-9203(90)90453-L; Moore TA, 1998, INFECT DIS CLIN N AM, V12, P503, DOI 10.1016/S0891-5520(05)70016-7; Muennig P, 1999, NEW ENGL J MED, V340, P773, DOI 10.1056/NEJM199903113401006; NUCCI M, 1995, CLIN INFECT DIS, V21, P675, DOI 10.1093/clinids/21.3.675; Nutman TB, 2006, CLIN INFECT DIS, V42, P368, DOI 10.1086/499247; NUTMAN TB, 1987, J INFECT DIS, V155, P309, DOI 10.1093/infdis/155.2.309; Pardo J, 2006, EMERG INFECT DIS, V12, P1587, DOI 10.3201/eid1210.060102; Pinto Pedro Luiz Silva, 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P109, DOI 10.1590/S0036-46651995000200004; Reddy M, 2007, JAMA-J AM MED ASSOC, V298, P1911, DOI 10.1001/jama.298.16.1911; Roman-Sanchez P, 2003, AM J TROP MED HYG, V69, P336, DOI 10.4269/ajtmh.2003.69.336; Safdar A, 2004, CANCER-AM CANCER SOC, V100, P1531, DOI 10.1002/cncr.20120; SATO Y, 1995, AM J TROP MED HYG, V53, P248, DOI 10.4269/ajtmh.1995.53.248; Schaffel R, 2001, AM J TROP MED HYG, V65, P346, DOI 10.4269/ajtmh.2001.65.346; SCHERMOLY MJ, 1988, ARCH INTERN MED, V148, P895, DOI 10.1001/archinte.148.4.895; Schulte C, 2002, CLIN INFECT DIS, V34, P407, DOI 10.1086/338026; Seet RCS, 2005, CLIN DIAGN LAB IMMUN, V12, P680, DOI 10.1128/CDLI.12.5.680-682.2005; Seybolt LM, 2006, CLIN INFECT DIS, V42, P363, DOI 10.1086/499238; Skiest DJ, 1997, AM J MED, V102, P449, DOI 10.1016/S0002-9343(97)00048-X; SMITH JD, 1976, ARCH DERMATOL, V112, P1161, DOI 10.1001/archderm.112.8.1161; Tefferi A, 2005, MAYO CLIN PROC, V80, P75; van Doorn HR, 2007, J CLIN MICROBIOL, V45, P438, DOI 10.1128/JCM.01735-06; Weerasooriya MV, 2003, ANN TROP MED PARASIT, V97, P179, DOI 10.1179/000349803235001624; Weil GJ, 2007, TRENDS PARASITOL, V23, P78, DOI 10.1016/j.pt.2006.12.001; Weil GJ, 1997, PARASITOL TODAY, V13, P401, DOI 10.1016/S0169-4758(97)01130-7; Wolfe MS, 1999, MED CLIN N AM, V83, P1019; Zaha Osamu, 2002, Journal of Infection and Chemotherapy, V8, P94	48	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 30	2008	299	4					437	444		10.1001/jama.2008.21	http://dx.doi.org/10.1001/jama.2008.21			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	256JK	18230781				2022-12-28	WOS:000252724500021
J	de Lucas, M; Daviere, JM; Rodriguez-Falcon, M; Pontin, M; Iglesias-Pedraz, JM; Lorrain, S; Fankhauser, C; Blazquez, MA; Titarenko, E; Prat, S				de Lucas, Miguel; Daviere, Jean-Michel; Rodriguez-Falcon, Mariana; Pontin, Mariela; Iglesias-Pedraz, Juan Manuel; Lorrain, Severine; Fankhauser, Christian; Blazquez, Miguel Angel; Titarenko, Elena; Prat, Salome			A molecular framework for light and gibberellin control of cell elongation	NATURE			English	Article							SIGNAL-TRANSDUCTION; PHYTOCHROME-B; TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; INDUCED DEGRADATION; PROTEIN; GENE; PLANTS; PHOTOMORPHOGENESIS; RGA	Cell elongation during seedling development is antagonistically regulated by light and gibberellins (GAs)(1,2). Light induces photomorphogenesis, leading to inhibition of hypocotyl growth, whereas GAs promote etiolated growth, characterized by increased hypocotyl elongation. The mechanism underlying this antagonistic interaction remains unclear. Here we report on the central role of the Arabidopsis thaliana nuclear transcription factor PIF4 ( encoded by PHYTOCHROME INTERACTING FACTOR 4)(3) in the positive control of genes mediating cell elongation and show that this factor is negatively regulated by the light photoreceptor phyB ( ref. 4) and by DELLA proteins that have a key repressor function in GA signalling(5). Our results demonstrate that PIF4 is destabilized by phyB in the light and that DELLAs block PIF4 transcriptional activity by binding the DNA- recognition domain of this factor. We show that GAs abrogate such repression by promoting DELLA destabilization, and therefore cause a concomitant accumulation of free PIF4 in the nucleus. Consistent with this model, intermediate hypocotyl lengths were observed in transgenic plants over- accumulating both DELLAs and PIF4. Destabilization of this factor by phyB, together with its inactivation by DELLAs, constitutes a protein interaction framework that explains how plants integrate both light and GA signals to optimize growth and development in response to changing environments.	[de Lucas, Miguel; Daviere, Jean-Michel; Rodriguez-Falcon, Mariana; Pontin, Mariela; Iglesias-Pedraz, Juan Manuel; Titarenko, Elena; Prat, Salome] CSIC, Ctr Nacl Biotecnol, Dept Genet Mol Plantas, Madrid 28049, Spain; [Lorrain, Severine; Fankhauser, Christian] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Blazquez, Miguel Angel] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Valencia 46022, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of Lausanne; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Prat, S (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Genet Mol Plantas, Campus Univ Autonoma Madrid,C Darwin 3, Madrid 28049, Spain.	sprat@cnb.uam.es	Fankhauser, Christian/C-4291-2018; Iglesias Pedraz, Juan Manuel/AAH-6075-2019; Fankhauser, Christian/ABE-8757-2021; Pedraz, Juan Manuel Iglesias/AAH-6067-2019; Blazquez, Miguel A/B-1495-2008; Prat, Salome/L-9240-2014; Iglesias-Pedraz, Juan Manuel/U-7205-2017	Fankhauser, Christian/0000-0003-4719-5901; Iglesias Pedraz, Juan Manuel/0000-0003-0070-8116; Fankhauser, Christian/0000-0003-4719-5901; Blazquez, Miguel A/0000-0001-5743-0448; Prat, Salome/0000-0003-2684-5485; Iglesias-Pedraz, Juan Manuel/0000-0003-0070-8116; De Lucas, Miguel/0000-0002-6544-6404				Achard P, 2007, PLANT PHYSIOL, V143, P1163, DOI 10.1104/pp.106.092254; Al-Sady B, 2006, MOL CELL, V23, P439, DOI 10.1016/j.molcel.2006.06.011; Alabadi D, 2004, PLANT PHYSIOL, V134, P1050, DOI 10.1104/pp.103.035451; Boter M, 2004, GENE DEV, V18, P1577, DOI 10.1101/gad.297704; Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dill A, 2001, P NATL ACAD SCI USA, V98, P14162, DOI 10.1073/pnas.251534098; Dill A, 2004, PLANT CELL, V16, P1392, DOI 10.1105/tpc.020958; Fu XD, 2002, PLANT CELL, V14, P3191, DOI 10.1105/tpc.006197; Fujimori T, 2004, PLANT CELL PHYSIOL, V45, P1078, DOI 10.1093/pcp/pch124; Huq E, 2004, SCIENCE, V305, P1937, DOI 10.1126/science.1099728; Huq E, 2003, PLANT J, V35, P660, DOI 10.1046/j.1365-313X.2003.01836.x; Huq E, 2002, EMBO J, V21, P2441, DOI 10.1093/emboj/21.10.2441; Huq E, 2000, PLANT J, V23, P461, DOI 10.1046/j.1365-313x.2000.00810.x; JEFFERSON RA, 1989, NATURE, V342, P837, DOI 10.1038/342837a0; Khanna R, 2004, PLANT CELL, V16, P3033, DOI 10.1105/tpc.104.025643; Kim JY, 2003, PLANT CELL, V15, P2399, DOI 10.1105/tpc.014498; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; LOGEMANN J, 1987, ANAL BIOCHEM, V163, P16, DOI 10.1016/0003-2697(87)90086-8; Martinez-Garcia JF, 2000, SCIENCE, V288, P859, DOI 10.1126/science.288.5467.859; McGinnis KM, 2003, PLANT CELL, V15, P1120, DOI 10.1105/tpc.010827; Nagy F, 2000, CURR OPIN PLANT BIOL, V3, P450, DOI 10.1016/S1369-5266(00)00112-6; Neff MM, 2000, GENE DEV, V14, P257; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; Oh E, 2007, PLANT CELL, V19, P1192, DOI 10.1105/tpc.107.050153; Oh E, 2006, PLANT J, V47, P124, DOI 10.1111/j.1365-313X.2006.02773.x; Peng J, 1997, PLANT PHYSIOL, V113, P1051, DOI 10.1104/pp.113.4.1051; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Quail PH, 2002, CURR OPIN CELL BIOL, V14, P180, DOI 10.1016/S0955-0674(02)00309-5; REED JW, 1993, PLANT CELL, V5, P147, DOI 10.1105/tpc.5.2.147; Shen Y, 2007, PLANT PHYSIOL, V145, P1043, DOI 10.1104/pp.107.105601; Sun TP, 2004, ANNU REV PLANT BIOL, V55, P197, DOI 10.1146/annurev.arplant.55.031903.141753; Ueguchi-Tanaka M, 2007, ANNU REV PLANT BIOL, V58, P183, DOI 10.1146/annurev.arplant.58.032806.103830; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x	36	830	850	19	298	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2008	451	7177					480	U11		10.1038/nature06520	http://dx.doi.org/10.1038/nature06520			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	253YS	18216857	Bronze			2022-12-28	WOS:000252554100048
J	Doyle, MW; Stanley, EH; Havlick, DG; Kaiser, MJ; Steinbach, G; Graf, WL; Galloway, GE; Riggsbee, JA				Doyle, Martin W.; Stanley, Emily H.; Havlick, David G.; Kaiser, Mark J.; Steinbach, George; Graf, William L.; Galloway, Gerald E.; Riggsbee, J. Adam			Environmental science - Aging infrastructure and ecosystem restoration	SCIENCE			English	Editorial Material							OFFSHORE OIL		[Doyle, Martin W.] Univ N Carolina, Chapel Hill, NC 27599 USA; [Stanley, Emily H.] Univ Wisconsin, Madison, WI USA; [Havlick, David G.] Univ Colorado, Colorado Springs, CO 80907 USA; [Kaiser, Mark J.] Louisiana State Univ, Ctr Energy Studies, Baton Rouge, LA 70803 USA; [Steinbach, George] Calif Artificial Reef Enhancement Program, Santa Barbara, CA USA; [Graf, William L.] Univ S Carolina, Columbia, SC 29208 USA; [Galloway, Gerald E.] Univ Maryland, College Pk, MD 20742 USA; [Riggsbee, J. Adam] Restorat Syst LLC, Raleigh, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of Wisconsin System; University of Wisconsin Madison; University of Colorado System; University of Colorado at Colorado Springs; Louisiana State University System; Louisiana State University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University System of Maryland; University of Maryland College Park	Doyle, MW (corresponding author), Univ N Carolina, Chapel Hill, NC 27599 USA.	mwdoyle@email.unc.edu		Stanley, Emily/0000-0003-4922-8121; Havlick, David/0000-0002-6230-1584				ASCE, 2005, REP CARD AM INFR; *ASCE, 2007, NAT INV DAMS; Bernhardt ES, 2005, SCIENCE, V308, P636, DOI 10.1126/science.1109769; Doyle MW, 2005, GEOMORPHOLOGY, V71, P227, DOI 10.1016/j.geomorph.2004.04.011; Galat DL, 1998, BIOSCIENCE, V48, P721, DOI 10.2307/1313335; *HEINZ CTR, 2002, STAT NAT EC; Ihara D. M., 2003, REINVESTING JOBS COM; *INT LEV POL REV C, 2006, NAT LEV CHALL; Kaiser MJ, 2005, OCEAN DEV INT LAW, V36, P119, DOI 10.1080/00908320590943990; Leslie M., 1996, CONSERVING BIODIVERS; Love MS, 2006, FISH B-NOAA, V104, P383; National Research Council, 2001, COMP WETL LOSS CLEAN; National Research Council (NRC), 2005, ASS MAN EC IMP PAV R; *NCPWI, 1988, FRAG FDN FIN REP PRE; Nilsson C, 2005, SCIENCE, V308, P405, DOI 10.1126/science.1107887; *NRC, 2006, PROGR REST EV; Patin S, 1999, ENV IMPACT OFFSHORE; Sammarco PW, 2004, MAR ECOL PROG SER, V280, P129, DOI 10.3354/meps280129; Schroeder DM, 2004, OCEAN COAST MANAGE, V47, P21, DOI 10.1016/j.ocecoaman.2004.03.002; TOBIN GA, 1995, WATER RESOUR BULL, V31, P359, DOI 10.1111/j.1752-1688.1995.tb04025.x; United States Environmental Protection Agency, 2002, CLEAN WAT DRINK WAT; *US FHA, 2007, FHA ANN HIGHW STAT; [No title captured]	23	76	76	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2008	319	5861					286	287		10.1126/science.1149852	http://dx.doi.org/10.1126/science.1149852			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252GY	18202277				2022-12-28	WOS:000252436200021
J	Grove, EA				Grove, Elizabeth A.			Neuroscience - Organizing the source of memory	SCIENCE			English	Editorial Material							MAMMALIAN CORTEX; CEREBRAL-CORTEX; HIPPOCAMPUS; NEOCORTEX		Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA	University of Chicago	Grove, EA (corresponding author), Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA.	egrove@bsd.uchicago.edu						Bulchand S, 2001, MECH DEVELOP, V100, P165, DOI 10.1016/S0925-4773(00)00515-3; Fernandes M, 2007, DEVELOPMENT, V134, P3789, DOI 10.1242/dev.004325; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Galceran J, 2000, DEVELOPMENT, V127, P469; Garel S, 2003, DEVELOPMENT, V130, P1903, DOI 10.1242/dev.00416; Lee SMK, 2000, DEVELOPMENT, V127, P457; Machon O, 2007, DEV BIOL, V311, P223, DOI 10.1016/j.ydbio.2007.08.038; Mangale VS, 2008, SCIENCE, V319, P304, DOI 10.1126/science.1151695; Miquelajauregui A, 2007, P NATL ACAD SCI USA, V104, P12919, DOI 10.1073/pnas.0609863104; Monuki ES, 2001, NEURON, V32, P591, DOI 10.1016/S0896-6273(01)00504-9; Nauta W., 1986, FUNDAMENTAL NEUROANA; O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010; Ragsdale CW, 2001, CURR OPIN NEUROBIOL, V11, P50, DOI 10.1016/S0959-4388(00)00173-2; Spemann Hans., 1924, ROUXS ARCH ENTW MECH, V100, P599, DOI 10.1007/BF02108133; Squire L. R., 1987, MEMORY BRAIN	15	10	10	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2008	319	5861					288	289		10.1126/science.1153743	http://dx.doi.org/10.1126/science.1153743			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252GY	18202278				2022-12-28	WOS:000252436200022
J	Montgomery, DR				Montgomery, David R.			Geology - Dreams of natural streams	SCIENCE			English	Editorial Material							EROSION; IMPACT; HUMANS		Univ Washington, Quaternary Res Ctr, Dept Earth & Space Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Montgomery, DR (corresponding author), Univ Washington, Quaternary Res Ctr, Dept Earth & Space Sci, Seattle, WA 98195 USA.	dave@ess.washington.edu						Collins BD, 2002, RESTOR ECOL, V10, P237, DOI 10.1046/j.1526-100X.2002.01023.x; HARWOOD K, 1993, EARTH SURF PROCESSES, V18, P741, DOI 10.1002/esp.3290180808; Leopold L.B., 1992, FLUVIAL PROCESSES GE; Montgomery D., 2007, SPELLING HANDWRITING; Montgomery D.R., 2003, KING FISH 1000 YEAR; Montgomery DR, 2007, P NATL ACAD SCI USA, V104, P13268, DOI 10.1073/pnas.0611508104; Rosgen D., 1996, APPL RIVER MORPHOLOG; Syvitski JPM, 2005, SCIENCE, V308, P376, DOI 10.1126/science.1109454; Walter RC, 2008, SCIENCE, V319, P299, DOI 10.1126/science.1151716; Wilkinson BH, 2007, GEOL SOC AM BULL, V119, P140, DOI 10.1130/B25899.1	10	52	52	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2008	319	5861					291	292		10.1126/science.1153480	http://dx.doi.org/10.1126/science.1153480			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252GY	18202281				2022-12-28	WOS:000252436200025
J	Ogawa, M; Shinohara, H; Sakagami, Y; Matsubayashi, Y				Ogawa, Mari; Shinohara, Hidefumi; Sakagami, Youji; Matsubayashi, Yoshikatsu			Arabidopsis CLV3 peptide directly binds CLV1 ectodomain	SCIENCE			English	Article							MERISTEM; KINASE; SHOOT		[Ogawa, Mari; Shinohara, Hidefumi; Sakagami, Youji; Matsubayashi, Yoshikatsu] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nagoya University	Matsubayashi, Y (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	matsu@agr.nagoya-u.ac.jp	MATSUBAYASHI, Yoshikatsu/AAA-9705-2019	Matsubayashi, Yoshikatsu/0000-0002-2669-2119; Ogawa-Ohnishi, Mari/0000-0002-7581-2607				Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Fletcher JC, 2000, CURR OPIN PLANT BIOL, V3, P23, DOI 10.1016/S1369-5266(99)00033-3; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Ito Y, 2006, SCIENCE, V313, P842, DOI 10.1126/science.1128436; Kondo T, 2006, SCIENCE, V313, P845, DOI 10.1126/science.1128439; Shinohara H, 2007, PLANT J, V52, P175, DOI 10.1111/j.1365-313X.2007.03204.x; Strabala TJ, 2006, PLANT PHYSIOL, V140, P1331, DOI 10.1104/pp.105.075515	7	356	381	4	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2008	319	5861					294	294		10.1126/science.1150083	http://dx.doi.org/10.1126/science.1150083			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252GY	18202283				2022-12-28	WOS:000252436200027
J	Lorenz, KA; Lynn, J; Dy, SM; Shugarman, LR; Wilkinson, A; Mularski, RA; Morton, SC; Hughes, RG; Hilton, LK; Maglione, M; Rhodes, SL; Rolon, C; Sun, VC; Shekelle, PG				Lorenz, Karl A.; Lynn, Joanne; Dy, Sydney M.; Shugarman, Lisa R.; Wilkinson, Anne; Mularski, Richard A.; Morton, Sally C.; Hughes, Ronda G.; Hilton, Lara K.; Maglione, Margaret; Rhodes, Shannon L.; Rolon, Cony; Sun, Virginia C.; Shekelle, Paul G.			Evidence for improving palliative care at the end of life: A systematic review	ANNALS OF INTERNAL MEDICINE			English	Review							QUALITY-OF-LIFE; OBSTRUCTIVE PULMONARY-DISEASE; RANDOMIZED CONTROLLED-TRIAL; CANCER-PATIENTS; DOUBLE-BLIND; AROMATHERAPY MASSAGE; HEART-FAILURE; ETHICS CONSULTATIONS; FAMILY SATISFACTION; TELEPHONE SUPPORT	Background: Many persons and their families are burdened by serious chronic illness in late life. How to best support quality of life is an important consideration for care. Purpose: To assess evidence about interventions to improve palliative and end-of-life care. Data Sources: English-language citations (January 1990 to November 2005) from MEDLINE, the Database of Abstracts of Reviews of Effects, the National Consensus Project for Quality Palliative Care bibliography, and November 2005 to January 2007 updates from expert reviews and literature surveillance. Study Selection: Systematic reviews that addressed "end of life," including terminal illness (for example, advanced cancer) and chronic, eventually fatal illness with ambiguous prognosis (for example, advanced dementia), and intervention studies (randomized and nonrandomized designs) that addressed pain, dyspnea, depression, advance care planning, continuity, and caregiving. Data Extraction: Single reviewers screened 24423 titles to find 6381 relevant abstracts and reviewed 1274 articles in detail to identify 33 high-quality systematic reviews and 89 relevant intervention studies. They synthesized the evidence by using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) classification. Data Synthesis: Strong evidence supports treating cancer pain with opioids, nonsteroidals, radionuclides, and radiotherapy; dyspnea from chronic lung disease with short-term opioids; and cancer-associated depression with psychotherapy, tricyclics, and selective serotonin reuptake inhibitors. Strong evidence supports multicomponent interventions to improve continuity in heart failure. Moderate evidence supports advance care planning led by skilled facilitators who engage key decision makers and interventions to alleviate caregiver burden. Weak evidence addresses cancer-related dyspnea management, and no evidence addresses noncancer pain, symptomatic dyspnea management in advanced heart failure, or short-acting antidepressants in terminal illness. No direct evidence addresses improving continuity for patients with dementia. Evidence was weak for improving caregiver burdens in cancer and was absent for heart failure. Limitations: Variable literature indexing for advanced chronic illness and end of life limited the comprehensiveness of searches, and heterogeneity was too great to do meta-analysis. Conclusion: Strong to moderate evidence supports interventions to improve important aspects of end-of-life care. Future research should quantify these effects and address the generalizability of insights across the conditions and settings of the last part of life. Many critical issues lack high-quality evidence.	[Lorenz, Karl A.] Vet Affairs Greater Los Angeles Hlthcare Syst, Vet Integrated Palliat Program, Div Gen Internal Med, Los Angeles, CA 90073 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Lorenz, KA (corresponding author), Vet Affairs Greater Los Angeles Hlthcare Syst, Vet Integrated Palliat Program, Div Gen Internal Med, 11031 Wilshire Blvd,Code 111-G, Los Angeles, CA 90073 USA.	karl.lorenz@med.va.gov		Sun, Virginia/0000-0003-3129-4235	NCI NIH HHS [K07-CA096 783] Funding Source: Medline; PHS HHS [290-02-0003] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K07CA096783] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abernethy AP, 2003, BRIT MED J, V327, P523, DOI 10.1136/bmj.327.7414.523; Acton GJ, 2001, RES NURS HEALTH, V24, P349, DOI 10.1002/nur.1036; Adams K., 2003, PRIORITY AREAS NATL; Ahrens T, 2003, AM J CRIT CARE, V12, P317, DOI 10.4037/ajcc2003.12.4.317; ANDERSON JP, 1994, J CLIN EPIDEMIOL, V47, P761, DOI 10.1016/0895-4356(94)90173-2; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Baggs Judith Gedney, 2002, Annu Rev Nurs Res, V20, P181; Bailey FA, 2005, ARCH INTERN MED, V165, P1722, DOI 10.1001/archinte.165.15.1722; Baker R, 2000, J AM GERIATR SOC, V48, pS61, DOI 10.1111/j.1532-5415.2000.tb03143.x; Benitez-Rosario MA, 2004, CANCER-AM CANCER SOC, V101, P2866, DOI 10.1002/cncr.20712; Bookbinder M, 2005, J PAIN SYMPTOM MANAG, V29, P529, DOI 10.1016/j.jpainsymman.2004.05.011; Booth S, 2004, RESP MED, V98, P66, DOI 10.1016/j.rmed.2003.08.008; Bruera E, 2003, PALLIATIVE MED, V17, P659, DOI 10.1191/0269216303pm826oa; Bruera E, 2004, J CLIN ONCOL, V22, P185, DOI 10.1200/JCO.2004.03.172; BRUERA E, 1993, ANN INTERN MED, V119, P906, DOI 10.7326/0003-4819-119-9-199311010-00007; Brumley Richard D, 2003, J Palliat Med, V6, P715, DOI 10.1089/109662103322515220; Bucher JA, 2001, CANCER PRACT, V9, P66, DOI 10.1046/j.1523-5394.2001.009002066.x; Burgio L, 2003, GERONTOLOGIST, V43, P568, DOI 10.1093/geront/43.4.568; Burns R, 2003, GERONTOLOGIST, V43, P547, DOI 10.1093/geront/43.4.547; Cameron JI, 2004, J PSYCHOSOM RES, V57, P137, DOI 10.1016/S0022-3999(03)00609-3; Campbell ML, 2004, CRIT CARE MED, V32, P1839, DOI 10.1097/01.CCM.0000138560.56577.88; CARR D, 2002, AHRQ PUBLICATION; Casarett D, 2005, JAMA-J AM MED ASSOC, V294, P211, DOI 10.1001/jama.294.2.211; Chochinov HM, 2005, J CLIN ONCOL, V23, P5520, DOI 10.1200/JCO.2005.08.391; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Cook AM, 2001, J PAIN SYMPTOM MANAG, V22, P797, DOI 10.1016/S0885-3924(01)00315-3; Coppola KM, 2001, ARCH INTERN MED, V161, P431, DOI 10.1001/archinte.161.3.431; Detmar SB, 2002, JAMA-J AM MED ASSOC, V288, P3027, DOI 10.1001/jama.288.23.3027; Eisdorfer C, 2003, GERONTOLOGIST, V43, P521, DOI 10.1093/geront/43.4.521; Engelhardt JB, 2006, AM J MANAG CARE, V12, P93; Field MJ, 1997, APPROACHING DEATH IM; Fox E, 1999, JAMA-J AM MED ASSOC, V282, P1638, DOI 10.1001/jama.282.17.1638; Furlan AD, 2006, CAN MED ASSOC J, V174, P1589, DOI 10.1503/cmaj.051528; Gillick M, 1999, J AM GERIATR SOC, V47, P227, DOI 10.1111/j.1532-5415.1999.tb04582.x; Gitlin LN, 2003, PSYCHOL AGING, V18, P361, DOI 10.1037/0882-7974.18.3.361; Gitlin LN, 2003, GERONTOLOGIST, V43, P532, DOI 10.1093/geront/43.4.532; Goldberg LR, 2003, AM HEART J, V146, P705, DOI 10.1016/S0002-8703(03)00393-4; Gomes B, 2006, BMJ-BRIT MED J, V332, P515, DOI 10.1136/bmj.38740.614954.55; GOODYER LI, 1995, BRIT J CLIN PRACT, V49, P173; Gorski Lisa A, 2003, Lippincotts Case Manag, V8, P265, DOI 10.1097/00129234-200311000-00009; Gottlieb S S, 1999, J Card Fail, V5, P188, DOI 10.1016/S1071-9164(99)90002-7; Grande GE, 2000, PALLIATIVE MED, V14, P375, DOI 10.1191/026921600701536200; Grande GE, 1999, BRIT MED J, V319, P1472, DOI 10.1136/bmj.319.7223.1472; Grosset AB, 2005, J PAIN SYMPTOM MANAG, V29, P584, DOI 10.1016/j.jpainsymman.2004.10.008; GUO B, 2004, ADV DIRECTIVES END O; Gutheil IA, 2005, HEALTH SOC WORK, V30, P107, DOI 10.1093/hsw/30.2.107; Gysels M., 2004, IMPROVING SUPPORTIVE; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; Hanks GW, 2002, BRIT J CANCER, V87, P733, DOI 10.1038/sj.bjc.6600522; Hanson LC, 1997, ANN INTERN MED, V126, P381, DOI 10.7326/0003-4819-126-5-199703010-00007; Hanson LC, 1997, J AM GERIATR SOC, V45, P1339, DOI 10.1111/j.1532-5415.1997.tb02933.x; Hanson LC, 2005, J PALLIAT MED, V8, P1207, DOI 10.1089/jpm.2005.8.1207; Heffner J E, 2001, J Cardiopulm Rehabil, V21, P387, DOI 10.1097/00008483-200111000-00008; Heffner JE, 1997, AM J RESP CRIT CARE, V155, P1055, DOI 10.1164/ajrccm.155.3.9116986; HIGGINSON IJ, 2000, ROLE PALLIATIVE CARE; Hogan C, 2001, HEALTH AFFAIR, V20, P188, DOI 10.1377/hlthaff.20.4.188; Holzapfel L, 2002, INTENS CARE MED, V28, P1309, DOI 10.1007/s00134-002-1370-y; Hughes SL, 2000, JAMA-J AM MED ASSOC, V284, P2877, DOI 10.1001/jama.284.22.2877; Jack B, 2003, PALLIATIVE MED, V17, P498, DOI 10.1191/0269216303pm794oa; Jennings AL, 2002, THORAX, V57, P939, DOI 10.1136/thorax.57.11.939; Jordhoy MS, 2001, J CLIN ONCOL, V19, P3884, DOI 10.1200/JCO.2001.19.18.3884; Karel MJ, 2004, PATIENT EDUC COUNS, V55, P22, DOI 10.1016/s0738-3991(03)00246-5; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; KNAUS WA, 1995, ANN INTERN MED, V122, P191, DOI 10.7326/0003-4819-122-3-199502010-00007; Knols R, 2005, J CLIN ONCOL, V23, P3830, DOI 10.1200/JCO.2005.02.148; Latimer EJ, 1998, J PAIN SYMPTOM MANAG, V16, P41, DOI 10.1016/S0885-3924(98)00027-X; Lee H, 2005, EUR J PAIN, V9, P437, DOI 10.1016/j.ejpain.2004.10.004; Levenson JW, 2000, J AM GERIATR SOC, V48, pS101, DOI 10.1111/j.1532-5415.2000.tb03119.x; Lewith GT, 2004, CHEST, V125, P1783, DOI 10.1378/chest.125.5.1783; Lilly CM, 2003, CRIT CARE MED, V31, pS394, DOI 10.1097/01.CCM.0000065279.77449.B4; Loeb M, 2006, JAMA-J AM MED ASSOC, V295, P2503, DOI 10.1001/jama.295.21.2503; Lorenz K, 2004, END OF LIFE CARE OUT; Lorenz Karl A, 2005, J Palliat Med, V8 Suppl 1, pS4; Lunney JR, 2003, JAMA-J AM MED ASSOC, V289, P2387, DOI 10.1001/jama.289.18.2387; Lynn J, 2000, J AM GERIATR SOC, V48, pS91, DOI 10.1111/j.1532-5415.2000.tb03147.x; Mahoney DF, 2003, GERONTOLOGIST, V43, P556, DOI 10.1093/geront/43.4.556; Mann WC, 1999, ARCH FAM MED, V8, P210, DOI 10.1001/archfami.8.3.210; Marinangeli F, 2004, J PAIN SYMPTOM MANAG, V27, P409, DOI 10.1016/j.jpainsymman.2003.10.006; Martell BA, 2007, ANN INTERN MED, V146, P116, DOI 10.7326/0003-4819-146-2-200701160-00006; Mazzocato C, 1999, ANN ONCOL, V10, P1511, DOI 10.1023/A:1008337624200; McAlister FA, 2004, J AM COLL CARDIOL, V44, P810, DOI 10.1016/j.jacc.2004.05.055; McDonald MV, 2005, J PAIN SYMPTOM MANAG, V29, P474, DOI 10.1016/j.jpainsymman.2004.08.018; MELIN AL, 1992, MED CARE, V30, P1004, DOI 10.1097/00005650-199211000-00004; Mercadante S, 2004, SUPPORT CARE CANCER, V12, P762, DOI 10.1007/s00520-004-0650-1; Mercadante S, 2002, EUR J CANCER, V38, P1358, DOI 10.1016/S0959-8049(02)00102-8; Molloy DW, 2000, JAMA-J AM MED ASSOC, V283, P1437, DOI 10.1001/jama.283.11.1437; Monteleoni C, 2004, BMJ-BRIT MED J, V329, P491, DOI 10.1136/bmj.329.7464.491; Morrison RS, 2005, J PALLIAT MED, V8, P1127, DOI 10.1089/jpm.2005.8.1127; Morrison RS, 2005, J AM GERIATR SOC, V53, P290, DOI 10.1111/j.1532-5415.2005.53116.x; Mularski RA, 2007, HEALTH SERV RES, V42, P1848, DOI 10.1111/j.1475-6773.2007.00721.x; *NAT CONS PROJ, NATL CONS PROJ QUAL; Pan CX, 2000, J PAIN SYMPTOM MANAG, V20, P374, DOI 10.1016/S0885-3924(00)00190-1; Patrick DL, 2003, ANN INTERN MED, V139, P410, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00006; Pearlman RA, 2005, ARCH INTERN MED, V165, P667, DOI 10.1001/archinte.165.6.667; Perry E, 2005, AM J KIDNEY DIS, V46, P111, DOI 10.1053/j.ajkd.2005.03.018; Philbin EF, 2000, AM J MED, V109, P443, DOI 10.1016/S0002-9343(00)00544-1; Phillips CO, 2004, JAMA-J AM MED ASSOC, V291, P1358, DOI 10.1001/jama.291.11.1358; Rabow MW, 2004, ARCH INTERN MED, V164, P83, DOI 10.1001/archinte.164.1.83; Ram FSF, 2005, RESP MED, V99, P135, DOI 10.1016/j.rmed.2004.10.009; Ram FSF, 2004, BMJ-BRIT MED J, V329, P315, DOI 10.1136/bmj.38159.650347.55; Ratner E, 2001, J AM GERIATR SOC, V49, P778, DOI 10.1046/j.1532-5415.2001.49155.x; Ringdal GI, 2004, PALLIATIVE MED, V18, P108, DOI 10.1191/0269216304pm878oa; Ringdal GI, 2002, J PAIN SYMPTOM MANAG, V24, P53, DOI 10.1016/S0885-3924(02)00417-7; Rodrigues P, 2004, PROSTATE CANCER P D, V7, P350, DOI 10.1038/sj.pcan.4500752; Roffe L, 2005, PSYCHO-ONCOLOGY, V14, P607, DOI 10.1002/pon.889; Salman GF, 2003, J GEN INTERN MED, V18, P213, DOI 10.1046/j.1525-1497.2003.20221.x; Sarna L, 1998, Oncol Nurs Forum, V25, P1041; Schneiderman LJ, 2000, CRIT CARE MED, V28, P3920, DOI 10.1097/00003246-200012000-00033; Schneiderman LJ, 2003, JAMA-J AM MED ASSOC, V290, P1166, DOI 10.1001/jama.290.9.1166; Schwartz CE, 2002, ARCH INTERN MED, V162, P1611, DOI 10.1001/archinte.162.14.1611; Shalowitz DI, 2006, ARCH INTERN MED, V166, P493, DOI 10.1001/archinte.166.5.493; SHUKLA V, 2006, 65 CAN COORD OFF HLT; Simmons SF, 2002, CLIN J PAIN, V18, P380, DOI 10.1097/00002508-200211000-00006; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Sittl R, 2003, CLIN THER, V25, P150, DOI 10.1016/S0149-2918(03)90019-1; Smeenk FWJM, 1998, NURS RES, V47, P129, DOI 10.1097/00006199-199805000-00003; Smeenk FWJM, 1998, BRIT MED J, V316, P1939, DOI 10.1136/bmj.316.7149.1939; Smith TJ, 2002, J CLIN ONCOL, V20, P4040, DOI 10.1200/JCO.2002.02.118; Soden K, 2004, PALLIATIVE MED, V18, P87, DOI 10.1191/0269216304pm874oa; Solano JP, 2006, J PAIN SYMPTOM MANAG, V31, P58, DOI 10.1016/j.jpainsymman.2005.06.007; Song MK, 2005, MED CARE, V43, P1049, DOI 10.1097/01.mlr.0000178192.10283.b4; Song MK, 2004, NURS OUTLOOK, V52, P118, DOI 10.1016/j.outlook.2003.10.014; Sorensen S, 2002, GERONTOLOGIST, V42, P356, DOI 10.1093/geront/42.3.356; Soskis CW, 1997, SOC WORK HEALTH CARE, V25, P107, DOI 10.1300/J010v25n01_11; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; Stephenson N L, 2000, Oncol Nurs Forum, V27, P67; Stuart Brad, 2003, J Palliat Med, V6, P671, DOI 10.1089/109662103768253849; Sultzer DL, 2001, J AM GERIATR SOC, V49, P1294, DOI 10.1046/j.1532-5415.2001.49256.x; Taylor SJC, 2005, BMJ-BRIT MED J, V331, P485, DOI 10.1136/bmj.38512.664167.8F; Teno J M, 2001, J Palliat Med, V4, P457, DOI 10.1089/109662101753381593; Teno JM, 2001, J PAIN SYMPTOM MANAG, V22, P752, DOI 10.1016/S0885-3924(01)00331-1; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; THOMAS K, 2004, CARING DYING HOME CO; Tolle SW, 1998, J AM GERIATR SOC, V46, P1097, DOI 10.1111/j.1532-5415.1998.tb06647.x; Tolle SW, 2000, NURS RES, V49, P310, DOI 10.1097/00006199-200011000-00003; Treece PD, 2004, CRIT CARE MED, V32, P1141, DOI 10.1097/01.CCM.0000125509.34805.0C; Tremont-Lukats IW, 2005, ANESTH ANALG, V101, P1738, DOI 10.1213/01.ANE.0000186348.86792.38; Walsh RA, 1998, BEHAV MED, V24, P61, DOI 10.1080/08964289809596382; Walsh SM, 2003, CANCER NURS, V26, P448; Weeks JC, 1998, JAMA-J AM MED ASSOC, V279, P1709, DOI 10.1001/jama.279.21.1709; Weiner P, 1999, CLIN CARDIOL, V22, P727, DOI 10.1002/clc.4960221110; Weisbord SD, 2003, NEPHROL DIAL TRANSPL, V18, P1345, DOI 10.1093/ndt/gfg105; Wenrich MD, 2003, J PAIN SYMPTOM MANAG, V25, P236, DOI 10.1016/S0885-3924(02)00694-2; Wilcock A, 2004, PALLIATIVE MED, V18, P287, DOI 10.1191/0269216304pm895oa; Wilkinson EK, 1999, PALLIATIVE MED, V13, P197, DOI 10.1191/026921699673563105; Wilkinson S, 1999, PALLIATIVE MED, V13, P409, DOI 10.1191/026921699678148345; WILSON DM, 2004, SYSTEMATIC REV END L; Windham BG, 2003, AM J MANAG CARE, V9, P447; Yin T, 2002, NURS RES, V51, P199, DOI 10.1097/00006199-200205000-00009; [No title captured]	150	398	407	1	195	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2008	148	2					147	159		10.7326/0003-4819-148-2-200801150-00010	http://dx.doi.org/10.7326/0003-4819-148-2-200801150-00010			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	254NZ	18195339				2022-12-28	WOS:000252594600008
J	Ijsselmuiden, C; Matlin, SA; Maiga, AH; Hasler, J; Pannenborg, O; Evans, T; Pang, T; Gardner, CA				Ijsselmuiden, Carel; Matlin, Stephen A.; Maiga, Alhacoum H.; Hasler, Julia; Pannenborg, Ok; Evans, Tim; Pang, Tikki; Gardner, Charles A.		2008 Global Ministerial Forum Res	From Mexico to Mali: a new course for global health	LANCET			English	Editorial Material							INNOVATION		[Gardner, Charles A.] WHO, New York, NY 10017 USA; [Ijsselmuiden, Carel] Council Hlth Res Dev, Geneva, Switzerland; [Matlin, Stephen A.] Global Forum Hlth Res, Geneva, Switzerland; [Maiga, Alhacoum H.] Govt Mali, Bamako, Mali; [Hasler, Julia] UNESCO, Paris, France; [Pannenborg, Ok] World Bank, Washington, DC 20433 USA; [Evans, Tim; Pang, Tikki] WHO, CH-1211 Geneva, Switzerland; [Gardner, Charles A.] Columbia Univ, Earth Inst, New York, NY USA	World Health Organization; The World Bank; World Health Organization; Columbia University	Gardner, CA (corresponding author), WHO, New York, NY 10017 USA.	cgardner@ei.columbia.edu						[Anonymous], 2005, GOING GROWTH SCI TEC; [Anonymous], MONITORING FINANCIAL; Cohen J, 2006, SCIENCE, V311, P162, DOI 10.1126/science.311.5758.162; *COUNC HLTH RES DE, 2007, COHRED STAT; Gardner CA, 2007, HEALTH AFFAIR, V26, P1052, DOI 10.1377/hlthaff.26.4.1052; *GLOB MIN FOR RES, 2007, CONS QUEST; Gonzalez Block Miguel A, 2003, Health Res Policy Syst, V1, P1, DOI 10.1186/1478-4505-1-1; Gulmezoglu AM, 2005, LANCET, V365, P1829, DOI 10.1016/S0140-6736(05)66589-0; Hamid M, 2005, LANCET, V366, P1758, DOI 10.1016/S0140-6736(05)67709-4; *HLTH RES MILL DEV, 2005, 8 HLTH RES MILL DEV; Juma C, 2005, UN MILLENNIUM PROJEC; Moran M, 2005, PLOS MED, V2, P828, DOI 10.1371/journal.pmed.0020302; Morel CM, 2005, SCIENCE, V309, P401, DOI 10.1126/science.1115538; *NAT SCI BOARD, 2006, SCI ENG IND 2006; *OECD, 2000, REC TRENDS OFF DEV A; *TDR TROPIKA NET, 2004, NEW WEB BAS RES POL; The Commission on Health Research for Development, 1990, HLTH RES ESS LINK EQ; WHO, 2004, REP MIN SUMM HLTH RE; *WHO, 2007, DRAFT GLOB STRAT PLA; *WHO AD HOC COMM H, 1996, INV HLTH RES DEV 199; Widdus R., 2004, COMBATING DIS ASS PO; *WORLD BANK, 1993, WORLD DEV REP 1993 I; World Health Organization, 2004, WORLD REP KNOWL BETT	23	12	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 12	2008	371	9607					91	93		10.1016/S0140-6736(08)60080-X	http://dx.doi.org/10.1016/S0140-6736(08)60080-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	252ND	18191667				2022-12-28	WOS:000252452300004
J	Loder, E; Rizzoli, P				Loder, Elizabeth; Rizzoli, Paul			Tension-type headache	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DOUBLE-BLIND; COMBINATION; PREVALENCE; AMITRIPTYLINE; PROPHYLAXIS; MEDICATION; TIZANIDINE; MIGRAINE; CAFFEINE; IMPACT		[Loder, Elizabeth] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Neurol,Div Headache & Pain, Boston, MA USA; [Loder, Elizabeth] Harvard Univ, Sch Med, Faulkner Hosp, Dept Neurol,Div Headache & Pain, Boston, MA USA; [Rizzoli, Paul] Faulkner Hosp, Graham Headache Ctr, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Loder, E (corresponding author), 1153 Ctr St,4970, Boston, MA 02130 USA.	eloder@partners.org						Ashina M, 2004, CEPHALALGIA, V24, P161, DOI 10.1111/j.1468-2982.2003.00644.x; Bendtsen L, 2000, CEPHALALGIA, V20, P603, DOI 10.1046/j.1468-2982.2000.00087.x; Bendtsen L, 2004, NEUROLOGY, V62, P1706, DOI 10.1212/01.WNL.0000127282.90920.8C; Bettucci Diego, 2006, J Headache Pain, V7, P34, DOI 10.1007/s10194-005-0251-5; Bigal ME, 2002, HEADACHE, V42, P575, DOI 10.1046/j.1526-4610.2002.02143.x; Diamond S, 2001, Curr Pain Headache Rep, V5, P472, DOI 10.1007/s11916-001-0060-8; Diener HC, 2005, CEPHALALGIA, V25, P776, DOI 10.1111/j.1468-2982.2005.00948.x; Dodick D, 2006, HEADACHE, V46, pS202, DOI 10.1111/j.1526-4610.2006.00604.x; Fernandez-de-las-Penas C, 2006, CLIN J PAIN, V22, P278, DOI 10.1097/01.ajp.0000173017.64741.86; FOGELHOLM R, 1992, HEADACHE, V32, P509, DOI 10.1111/j.1526-4610.1992.hed3210509.x; Fuller G, 2007, BRIT MED J, V334, P254, DOI 10.1136/bmj.39090.652847.DE; Goadsby P, 2004, BMJ-BRIT MED J, V329, P469, DOI 10.1136/bmj.329.7464.469; Holroyd KA, 2000, HEADACHE, V40, P3, DOI 10.1046/j.1526-4610.2000.00001.x; Holroyd KA, 2001, JAMA-J AM MED ASSOC, V285, P2208, DOI 10.1001/jama.285.17.2208; Jensen R, 1996, CEPHALALGIA, V16, P175, DOI 10.1046/j.1468-2982.1996.1603175.x; Laurell K, 2004, CEPHALALGIA, V24, P380, DOI 10.1111/j.1468-2982.2004.00681.x; Lyngberg AC, 2005, NEUROLOGY, V65, P580, DOI 10.1212/01.wnl.0000172918.74999.8a; MATHEW NT, 1981, HEADACHE, V21, P105, DOI 10.1111/j.1526-4610.1981.hed2103105.x; Melchart D, 2005, BMJ-BRIT MED J, V331, P376, DOI 10.1136/bmj.38512.405440.8F; MIGLIARDI JR, 1994, CLIN PHARMACOL THER, V56, P576, DOI 10.1038/clpt.1994.179; Ostergaard S, 1997, BMJ-BRIT MED J, V314, P1092, DOI 10.1136/bmj.314.7087.1092; Russell Michael Bjorn, 2006, J Headache Pain, V7, P119, DOI 10.1007/s10194-006-0299-x; Scher AI, 1998, HEADACHE, V38, P497, DOI 10.1046/j.1526-4610.1998.3807497.x; Scher AI, 2003, PAIN, V106, P81, DOI 10.1016/S0304-3959(03)00293-8; Scher Ann I, 2002, Curr Pain Headache Rep, V6, P486, DOI 10.1007/s11916-002-0068-8; Schulte-Mattler WJ, 2004, PAIN, V109, P110, DOI 10.1016/j.pain.2004.01.016; Schwartz BS, 1997, J OCCUP ENVIRON MED, V39, P320, DOI 10.1097/00043764-199704000-00009; Schwartz BS, 1998, JAMA-J AM MED ASSOC, V279, P381, DOI 10.1007/s11916-010-0146-2; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Silberstein SD, 2001, HEADACHE, V41, P953, DOI 10.1046/j.1526-4610.2001.01189.x; Steiner TJ, 1998, CEPHALALGIA, V18, P38, DOI 10.1046/j.1468-2982.1998.1801038.x; Steiner TJ, 2003, CEPHALALGIA, V23, P59, DOI 10.1046/j.1468-2982.2003.00470.x; Stetter F, 2002, APPL PSYCHOPHYS BIOF, V27, P45, DOI 10.1023/A:1014576505223; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x	34	33	37	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 12	2008	336	7635					88	92		10.1136/bmj.39412.705868.AD	http://dx.doi.org/10.1136/bmj.39412.705868.AD			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253BX	18187725	Green Published			2022-12-28	WOS:000252494800031
J	Wakim, LM; Waithman, J; van Rooijen, N; Heath, WR; Carbone, FR				Wakim, Linda M.; Waithman, Jason; van Rooijen, Nico; Heath, William R.; Carbone, Francis R.			Dendritic cell-induced memory T cell activation in nonlymphoid tissues	SCIENCE			English	Article							HERPES-SIMPLEX-VIRUS; IN-VIVO; SENSORY GANGLIA; LYMPH-NODE; INFECTIONS; MONOCYTES; TYPE-1; DIFFERENTIATION; GENERATION; RESPONSES	Secondary lymphoid organs are dominant sites of T cell activation, although many T cells are subsequently retained within peripheral tissues. Currently, these nonlymphoid compartments are viewed as sites only of effector T cell function, without the involvement of renewed induction of immunity via the interactions with professional antigen- presenting cells. We describe a method of reactivation of herpes simplex virus to examine the stimulation of tissue- resident T cells during secondary challenge. The results revealed that memory CD8(+) T cell responses can be initiated within peripheral tissues through a tripartite interaction that includes CD4(+) T cells and recruited dendritic cells. These findings lend evidence for the existence of a sophisticated T cell response mechanism in extra- lymphoid tissues that can act to control localized infection.	[Heath, William R.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Immunol, Melbourne, Vic 3050, Australia; [Wakim, Linda M.; Waithman, Jason; Carbone, Francis R.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [van Rooijen, Nico] Vrije Univ Amsterdam, Fac Med, Dept Mol Cell Biol, NL-1081 BT Amsterdam, Netherlands	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; Vrije Universiteit Amsterdam	Heath, WR (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Immunol, Melbourne, Vic 3050, Australia.	heath@wehi.edu.au; fcarbone@unimelb.edu.au	Carbone, Francis/ABF-2141-2020; Van Rooijen, Nico/Z-1578-2019	Heath, William/0000-0001-9670-259X; Wakim, Linda/0000-0003-1752-9579; Waithman, Jason/0000-0003-4940-0155				Bailey SL, 2007, NAT IMMUNOL, V8, P172, DOI 10.1038/ni1430; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Ely KH, 2003, J IMMUNOL, V170, P1423, DOI 10.4049/jimmunol.170.3.1423; Freeman ML, 2007, J IMMUNOL, V179, P322, DOI 10.4049/jimmunol.179.1.322; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Harris NL, 2002, J EXP MED, V195, P317, DOI 10.1084/jem.20011558; Hikono H, 2006, IMMUNOL REV, V211, P119, DOI 10.1111/j.0105-2896.2006.00385.x; Hogan RJ, 2001, J EXP MED, V193, P981, DOI 10.1084/jem.193.8.981; JENNINGS SR, 1991, CELL IMMUNOL, V133, P234, DOI 10.1016/0008-8749(91)90194-G; Khanna KM, 2003, IMMUNITY, V18, P593, DOI 10.1016/S1074-7613(03)00112-2; Le Borgne M, 2006, IMMUNITY, V24, P191, DOI 10.1016/j.immuni.2006.01.005; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Liu T, 2000, J EXP MED, V191, P1459, DOI 10.1084/jem.191.9.1459; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Moyron-Quiroz JE, 2006, IMMUNITY, V25, P643, DOI 10.1016/j.immuni.2006.08.022; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; STEVENS JG, 1971, SCIENCE, V173, P843, DOI 10.1126/science.173.3999.843; Tacke F, 2006, J EXP MED, V203, P583, DOI 10.1084/jem.20052119; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; TENSER RB, 1989, J VIROL, V63, P2861, DOI 10.1128/JVI.63.6.2861-2865.1989; van Lint AL, 2005, J VIROL, V79, P14843, DOI 10.1128/JVI.79.23.14843-14851.2005; van Panhuys N, 2005, TRENDS IMMUNOL, V26, P242, DOI 10.1016/j.it.2005.03.005; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Zammit DJ, 2005, IMMUNITY, V22, P561, DOI 10.1016/j.immuni.2005.03.005	25	325	353	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2008	319	5860					198	202		10.1126/science.1151869	http://dx.doi.org/10.1126/science.1151869			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249RC	18187654				2022-12-28	WOS:000252246400040
J	Bissler, JJ; McCormack, FX; Young, LR; Elwing, JM; Chuck, G; Leonard, JM; Schmithorst, VJ; Laor, T; Brody, AS; Bean, J; Salisbury, S; Franz, DN				Bissler, John J.; McCormack, Francis X.; Young, Lisa R.; Elwing, Jean M.; Chuck, Gail; Leonard, Jennifer M.; Schmithorst, Vincent J.; Laor, Tal; Brody, Alan S.; Bean, Judy; Salisbury, Shelia; Franz, David N.			Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RENAL-TRANSPLANT RECIPIENTS; TUMOR VOLUMETRY; CERVICAL-CANCER; RAPAMYCIN; THERAPY; PATHWAY; TARGET	Background: Angiomyolipomas in patients with the tuberous sclerosis complex or sporadic lymphangioleiomyomatosis are associated with mutations in tuberous sclerosis genes resulting in constitutive activation of the mammalian target of rapamycin (mTOR). The drug sirolimus suppresses mTOR signaling. Methods: We conducted a 24-month, nonrandomized, open-label trial to determine whether sirolimus reduces the angiomyolipoma volume in patients with the tuberous sclerosis complex or sporadic lymphangioleiomyomatosis. Sirolimus was administered for the first 12 months only. Serial magnetic resonance imaging of angiomyolipomas and brain lesions, computed tomography of lung cysts, and pulmonary-function tests were performed. Results: Of the 25 patients enrolled, 20 completed the 12-month evaluation, and 18 completed the 24-month evaluation. The mean (+/-SD) angiomyolipoma volume at 12 months was 53.2+/-26.6% of the baseline value (P<0.001) and at 24 months was 85.9+/-28.5% of the baseline value (P=0.005). At 24 months, five patients had a persistent reduction in the angiomyolipoma volume of 30% or more. During the period of sirolimus therapy, among patients with lymphangioleiomyomatosis, the mean forced expiratory volume in 1 second (FEV1) increased by 118+/-330 ml (P=0.06), the forced vital capacity (FVC) increased by 390+/-570 ml (P<0.001), and the residual volume decreased by 439+/-493 ml (P=0.02), as compared with baseline values. One year after sirolimus was discontinued, the FEV1 was 62+/-411 ml above the baseline value, the FVC was 346+/-712 ml above the baseline value, and the residual volume was 333+/-570 ml below the baseline value; cerebral lesions were unchanged. Five patients had six serious adverse events while receiving sirolimus, including diarrhea, pyelonephritis, stomatitis, and respiratory infections. Conclusions: Angiomyolipomas regressed somewhat during sirolimus therapy but tended to increase in volume after the therapy was stopped. Some patients with lymphangioleiomyomatosis had improvement in spirometric measurements and gas trapping that persisted after treatment. Suppression of mTOR signaling might constitute an ameliorative treatment in patients with the tuberous sclerosis complex or sporadic lymphangioleiomyomatosis. (ClinicalTrials.gov number, NCT00457808.).	[Bissler, John J.] Childrens Hosp, Med Ctr, Div Nephrol & Hypertens, Cincinnati, OH 45229 USA; [Young, Lisa R.] Childrens Hosp, Med Ctr, Div Pulm Med, Cincinnati, OH 45229 USA; [Chuck, Gail; Leonard, Jennifer M.; Franz, David N.] Childrens Hosp, Med Ctr, Div Neurol, Cincinnati, OH 45229 USA; [Schmithorst, Vincent J.; Laor, Tal; Brody, Alan S.] Childrens Hosp, Med Ctr, Div Radiol, Cincinnati, OH 45229 USA; [Bean, Judy; Salisbury, Shelia] Childrens Hosp, Med Ctr, Div Biostat, Cincinnati, OH 45229 USA; [McCormack, Francis X.; Young, Lisa R.; Elwing, Jean M.] Univ Cincinnati, Coll Med, Div Pulm & Crit Care, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Bissler, JJ (corresponding author), Childrens Hosp, Med Ctr, Div Nephrol & Hypertens, MLC 7022,3333 Burnet Ave, Cincinnati, OH 45229 USA.	john.bissler@cchmc.org	McCormack, Francis X./ABE-8398-2020	McCormack, Francis X./0000-0001-7168-9464; Bissler, John/0000-0001-9685-9183	NATIONAL CANCER INSTITUTE [R21CA103486] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR008084] Funding Source: NIH RePORTER; NCI NIH HHS [R21 CA103486-01, R21 CA103486, CA103486, R21 CA103486-02] Funding Source: Medline; NCRR NIH HHS [M01 RR008084, M01 RR08084] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Bissler JJ, 2004, KIDNEY INT, V66, P924, DOI 10.1111/j.1523-1755.2004.00838.x; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Brattstrom C, 1998, TRANSPLANT P, V30, P3950, DOI 10.1016/S0041-1345(98)01301-3; Brooks D, 2003, AM J RESP CRIT CARE, V167, P1287, DOI 10.1164/ajrccm.167.9.950; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Chapman AB, 2003, KIDNEY INT, V64, P1035, DOI 10.1046/j.1523-1755.2003.00185.x; Chen ACY, 2002, EUR J GYNAECOL ONCOL, V23, P401; Dickinson M, 1998, CLIN NEPHROL, V49, P281; Franz DN, 2001, AM J RESP CRIT CARE, V164, P661, DOI 10.1164/ajrccm.164.4.2011025; Franz DN, 2006, ANN NEUROL, V59, P490, DOI 10.1002/ana.20784; Galanis E, 2005, J CLIN ONCOL, V23, P5294, DOI 10.1200/JCO.2005.23.622; Groth CG, 1999, TRANSPLANTATION, V67, P1036, DOI 10.1097/00007890-199904150-00017; Guilbeau JM, 2002, ANN PHARMACOTHER, V36, P1391; Gylys-Morin VM, 2001, RADIOLOGY, V220, P696, DOI 10.1148/radiol.2203000461; Herry I, 2007, EUR J INTERN MED, V18, P76, DOI 10.1016/j.ejim.2006.07.017; Hong JC, 2000, TRANSPLANTATION, V69, P2085, DOI 10.1097/00007890-200005270-00019; Hyman MH, 2000, ARCH NEUROL-CHICAGO, V57, P662, DOI 10.1001/archneur.57.5.662; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; James K, 1999, J NATL CANCER I, V91, P523, DOI 10.1093/jnci/91.6.523; Kaplan MJ, 1999, ARCH DERMATOL, V135, P553, DOI 10.1001/archderm.135.5.553; Karbowniczek M, 2003, AM J RESP CRIT CARE, V167, P976, DOI 10.1164/rccm.200208-969OC; Kenerson HL, 2002, CANCER RES, V62, P5645; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Mayr NA, 1996, INT J RADIAT ONCOL, V35, P915, DOI 10.1016/0360-3016(96)00230-1; Mayr NA, 2006, AM J ROENTGENOL, V187, P65, DOI 10.2214/AJR.05.0039; Montalbano M, 2004, TRANSPLANTATION, V78, P264, DOI 10.1097/01.tp.0000128628.31556.b1; Roach ES, 2004, J CHILD NEUROL, V19, P643, DOI 10.1177/08830738040190090301; Ryu JH, 2006, AM J RESP CRIT CARE, V173, P105, DOI 10.1164/rccm.200409-1298OC; SHEPHERD CW, 1991, MAYO CLIN PROC, V66, P792, DOI 10.1016/S0025-6196(12)61196-3; Taveira-DaSilva AM, 2004, CHEST, V126, P1867, DOI 10.1378/chest.126.6.1867; Taveira-DaSilva Angelo M, 2006, Cancer Control, V13, P276; Vignot S, 2005, ANN ONCOL, V16, P525, DOI 10.1093/annonc/mdi113; Wienecke R, 2006, AM J KIDNEY DIS, V48, pE27, DOI 10.1053/j.ajkd.2006.05.018; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	35	877	922	1	69	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2008	358	2					140	151		10.1056/NEJMoa063564	http://dx.doi.org/10.1056/NEJMoa063564			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249CJ	18184959	Green Accepted, Bronze			2022-12-28	WOS:000252204200005
J	Rice, WR; Friberg, U				Rice, William R.; Friberg, Urban			Genetics - Functionally degenerate - Y not so?	SCIENCE			English	Editorial Material							EVOLUTION		[Rice, William R.; Friberg, Urban] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Rice, WR (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	rice@lifesci.ucsb.edu; friberg@lifesci.ucsb.edu	Friberg, Urban/H-4569-2011; Friberg, Urban/C-9412-2015	Friberg, Urban/0000-0001-6112-9586				Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167; Lemos B, 2008, SCIENCE, V319, P91, DOI 10.1126/science.1148861; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; RICE WR, 1984, EVOLUTION, V38, P735, DOI 10.1111/j.1558-5646.1984.tb00346.x; VOELKER RA, 1972, EVOLUTION, V26, P560, DOI 10.1111/j.1558-5646.1972.tb01964.x	5	7	7	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2008	319	5859					42	43		10.1126/science.1153482	http://dx.doi.org/10.1126/science.1153482			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18174425				2022-12-28	WOS:000252084000019
J	Gammon, BD; Gunarathne, A				Gammon, Brian D.; Gunarathne, Ashan			It's time to reappraise recruitment of South Asians to clinical trials	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gunarathne, Ashan] City Hosp, Univ Dept Med, Birmingham, W Midlands, England; [Gammon, Brian D.] Sandwell Gen Hosp, Sandwell Med Res Unit, Birmingham, W Midlands, England	University of Birmingham	Gunarathne, A (corresponding author), City Hosp, Univ Dept Med, Birmingham, W Midlands, England.	ashan@doctors.org.uk						[Anonymous], NATL STAT ONLINE UK; BALARAJAN R, 1991, BMJ-BRIT MED J, V302, P560, DOI 10.1136/bmj.302.6776.560; Bham Z, 2005, ETHNIC DIS, V15, P548; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Gill PS, HLTH CARE NEED ASSES; Hussain-Gambles M, 2004, HEALTH TECHNOL ASSES, V8, P1; Lip GYH, 2007, J HUM HYPERTENS, V21, P183, DOI 10.1038/sj.jhh.1002126; Vydelingum V, 2006, NURS INQ, V13, P23, DOI 10.1111/j.1440-1800.2006.00304.x	8	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 3	2008	336								46	10.1136/bmj.39416.697778.94	http://dx.doi.org/10.1136/bmj.39416.697778.94			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V21OB	18174601	Green Published			2022-12-28	WOS:000208215800015
J	Nestler, JE				Nestler, John E.			Metformin for the treatment of the polycystic ovary syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE MODIFICATION; INSULIN-RESISTANCE; DOUBLE-BLIND; METABOLIC SYNDROME; DIABETES-MELLITUS; OBESE WOMEN; PREVALENCE; PLACEBO; OVULATION	A 23- year- old woman with known polycystic ovary syndrome visits her family physician. She has taken oral contraceptive pills in the past but did not tolerate them and is not currently receiving any treatment. She has three or four menstrual periods per year and is not interested in becoming pregnant now, but she will be getting married in a year. She has heard that the polycystic ovary syndrome is associated with diabetes and is concerned because both her mother and father have type 2 diabetes. Her body-mass index ( the weight in kilograms divided by the square of the height in meters) is 32, her waist circumference is 38 in. ( 96.5 cm), her serum total testosterone level is elevated at 0.9 ng per milliliter ( 90 ng per deciliter, or 2.9 nmol per liter), her plasma high- density lipoprotein cholesterol level is 35 mg per deciliter ( 0.9 mmol per liter), and her triglyceride level is 190 mg per deciliter ( 2.1 mmol per liter). Her serum glucose level 2 hours after the ingestion of 75 g of dextrose is 138 mg per deciliter ( 7.7 mmol per liter). The physician wonders whether treatment with metformin would be beneficial and refers the patient to an endocrinologist.	Virginia Commonwealth Univ, Med Coll Virginia, Dept Internal Med, Div Endocrinol & Metab, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Nestler, JE (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Dept Internal Med, Div Endocrinol & Metab, POB 980111, Richmond, VA 23298 USA.	jnestler@mcvh-vcu.edu			FIC NIH HHS [D43TW007692] Funding Source: Medline; NICHD NIH HHS [R01 HD035629, R01HD035629] Funding Source: Medline; PHS HHS [K24D040237] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035629] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW007692] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Apridonidze T, 2005, J CLIN ENDOCR METAB, V90, P1929, DOI 10.1210/jc.2004-1045; Asuncion M, 2000, J CLIN ENDOCR METAB, V85, P2434, DOI 10.1210/jc.85.7.2434; Azziz R, 2001, J CLIN ENDOCR METAB, V86, P1626, DOI 10.1210/jc.86.4.1626; Bailey CJ, 1996, NEW ENGL J MED, V334, P574, DOI 10.1056/NEJM199602293340906; Baillargeon JP, 2007, FERTIL STERIL, V88, P886, DOI 10.1016/j.fertnstert.2006.12.055; Baillargeon JP, 2004, FERTIL STERIL, V82, P893, DOI 10.1016/j.fertnstert.2004.02.127; Baillargeon JP, 2006, J CLIN ENDOCR METAB, V91, P22, DOI 10.1210/jc.2005-1804; Baillargeon JP, 2005, J CLIN ENDOCR METAB, V90, P3863, DOI 10.1210/jc.2004-1958; Brettenthaler N, 2004, J CLIN ENDOCR METAB, V89, P3835, DOI 10.1210/jc.2003-031737; CHANG RJ, 1983, J CLIN ENDOCR METAB, V57, P356, DOI 10.1210/jcem-57-2-356; Cheang KI, 2006, GYNECOL ENDOCRINOL, V22, P595, DOI 10.1080/09513590601005847; Christian RC, 2003, J CLIN ENDOCR METAB, V88, P2562, DOI 10.1210/jc.2003-030334; Ciotta L, 1999, HUM REPROD, V14, P2951, DOI 10.1093/humrep/14.12.2951; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Diamanti-Kandarakis E, 2003, J CLIN ENDOCR METAB, V88, P1927, DOI 10.1210/jc.2002-021528; Diamanti-Kandarakis E, 1998, EUR J ENDOCRINOL, V138, P269, DOI 10.1530/eje.0.1380269; DUNAIF A, 1989, DIABETES, V38, P1165, DOI 10.2337/diabetes.38.9.1165; DUNAIF A, 1987, J CLIN ENDOCR METAB, V65, P499, DOI 10.1210/jcem-65-3-499; Ehrmann DA, 1999, DIABETES CARE, V22, P141, DOI 10.2337/diacare.22.1.141; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Garber AJ, 1997, AM J MED, V103, P491, DOI 10.1016/S0002-9343(97)00254-4; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Harborne L, 2003, J CLIN ENDOCR METAB, V88, P4116, DOI 10.1210/jc.2003-030424; Kelly CJG, 2002, J CLIN ENDOCR METAB, V87, P742, DOI 10.1210/jc.87.2.742; Knochenhauer ES, 1998, J CLIN ENDOCR METAB, V83, P3078, DOI 10.1210/jc.83.9.3078; Knowler WC, 2003, DIABETES CARE, V26, P977; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Legro RS, 2007, NEW ENGL J MED, V356, P551, DOI 10.1056/NEJMoa063971; Legro RS, 2005, J CLIN ENDOCR METAB, V90, P3236, DOI 10.1210/jc.2004-1843; Legro RS, 1999, J CLIN ENDOCR METAB, V84, P165, DOI 10.1210/jc.84.1.165; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; Lord JM, 2003, BRIT MED J, V327, P951, DOI 10.1136/bmj.327.7421.951; Moll E, 2006, BRIT MED J, V332, P1485, DOI 10.1136/bmj.38867.631551.55; Nestler JE, 1996, NEW ENGL J MED, V335, P617, DOI 10.1056/NEJM199608293350902; Nestler JE, 1998, J CLIN ENDOCR METAB, V83, P2001, DOI 10.1210/jc.83.6.2001; NESTLER JE, 1989, J CLIN ENDOCR METAB, V68, P1027, DOI 10.1210/jcem-68-6-1027; NESTLER JE, 1991, J CLIN ENDOCR METAB, V72, P83, DOI 10.1210/jcem-72-1-83; Nestler JE, 1998, NEW ENGL J MED, V338, P1876, DOI 10.1056/NEJM199806253382603; Nestler JE, 1997, SEMIN REPROD ENDOCR, V15, P111, DOI 10.1055/s-2007-1016294; Norman RJ, 2006, ENDOCRINE, V30, P35, DOI 10.1385/ENDO:30:1:35; Norman RJ, 2002, TRENDS ENDOCRIN MET, V13, P251, DOI 10.1016/S1043-2760(02)00612-4; Orio F, 2004, J CLIN ENDOCR METAB, V89, P4588, DOI 10.1210/jc.2003-031867; Palomba S, 2005, J CLIN ENDOCR METAB, V90, P4068, DOI 10.1210/jc.2005-0110; Paradisi G, 2001, CIRCULATION, V103, P1410, DOI 10.1161/01.CIR.103.10.1410; Penna IAA, 2005, HUM REPROD, V20, P2396, DOI 10.1093/humrep/dei104; *POL OV SYNDR WRIT, 2005, ENDOCR PRACT, V11, P126; PORETSKY L, 1991, ENDOCR REV, V12, P3, DOI 10.1210/edrv-12-1-3; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Rautio K, 2006, HUM REPROD, V21, P1400, DOI 10.1093/humrep/dei505; Salley KES, 2007, J CLIN ENDOCR METAB, V92, P4546, DOI 10.1210/jc.2007-1549; Sharma Susmeeta T, 2007, Endocr Pract, V13, P373; Solomon CG, 2002, J CLIN ENDOCR METAB, V87, P2013, DOI 10.1210/jc.87.5.2013; T Sharma S, 2006, BEST PRACT RES CL EN, V20, P245, DOI 10.1016/j.beem.2006.02.003; Talbott EO, 2004, J CLIN ENDOCR METAB, V89, P5454, DOI 10.1210/jc.2003-032237; Talbott EO, 2000, ARTERIOSCL THROM VAS, V20, P2414, DOI 10.1161/01.ATV.20.11.2414; Ting RZW, 2006, ARCH INTERN MED, V166, P1975, DOI 10.1001/archinte.166.18.1975	56	191	204	1	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2008	358	1					47	54		10.1056/NEJMct0707092	http://dx.doi.org/10.1056/NEJMct0707092			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	246TW	18172174	Green Published			2022-12-28	WOS:000252031200007
J	Williams, SG				Williams, Scott G.			Giving back	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												scott.williams@na.amedd.army.mil							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2007	298	23					2723	2724		10.1001/jama.298.23.2723	http://dx.doi.org/10.1001/jama.298.23.2723			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242HK	18165658				2022-12-28	WOS:000251716000001
J	Feng, HC; Shuda, M; Chang, Y; Moore, PS				Feng, Huichen; Shuda, Masahiro; Chang, Yuan; Moore, Patrick S.			Clonal integration of a polyomavirus in human Merkel cell carcinoma	SCIENCE			English	Article							PROTEIN PHOSPHATASE-2A; TUMOR-ANTIGEN; DNA-SEQUENCE; T-ANTIGENS; CANCER; SV40; GENE; IDENTIFICATION; SUBTRACTION; PRODUCT	Merkel cell carcinoma ( MCC) is a rare but aggressive human skin cancer that typically affects elderly and immunosuppressed individuals, a feature suggestive of an infectious origin. We studied MCC samples by digital transcriptome subtraction and detected a fusion transcript between a previously undescribed virus T antigen and a human receptor tyrosine phosphatase. Further investigation led to identification and sequence analysis of the 5387- base- pair genome of a previously unknown polyomavirus that we call Merkel cell polyomavirus ( MCV or MCPyV). MCV sequences were detected in 8 of 10 ( 80%) MCC tumors but only 5 of 59 ( 8%) control tissues from various body sites and 4 of 25 ( 16%) control skin tissues. In six of eight MCV- positive MCCs, viral DNA was integrated within the tumor genome in a clonal pattern, suggesting that MCV infection and integration preceded clonal expansion of the tumor cells. Thus, MCV may be a contributing factor in the pathogenesis of MCC.	[Feng, Huichen; Shuda, Masahiro; Chang, Yuan; Moore, Patrick S.] Univ Pittsburgh, Inst Canc, Mol Virol Program, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chang, Y (corresponding author), Univ Pittsburgh, Inst Canc, Mol Virol Program, 5117 Ctr Ave,Suite 1-8, Pittsburgh, PA 15213 USA.	yc70@pitt.edu; psm9@pitt.edu	Feng, Huichen/F-5502-2011; Chang, Yuan/F-4146-2011; Moore, Patrick/GVR-8294-2022; SHUDA, MASAHIRO/N-8239-2019; SHUDA, MASAHIRO/F-5505-2011; Moore, Patrick S./F-3960-2011	Feng, Huichen/0000-0003-3069-8174; Chang, Yuan/0000-0003-1125-4041; SHUDA, MASAHIRO/0000-0003-0595-2572; SHUDA, MASAHIRO/0000-0003-0595-2572; Moore, Patrick S./0000-0002-8132-858X	NCI NIH HHS [R33 CA120726, R33CA120726, R33 CA120726-02, R01 CA136806] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA197463, R01CA136806, R33CA120726] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Crandall KA, 2006, ADV EXP MED BIOL, V577, P46; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; Dilworth SM, 2002, NAT REV CANCER, V2, P951, DOI 10.1038/nrc946; DURST M, 1983, P NATL ACAD SCI-BIOL, V80, P3812, DOI 10.1073/pnas.80.12.3812; Engels EA, 2002, LANCET, V359, P497, DOI 10.1016/S0140-6736(02)07668-7; Feng HC, 2007, J VIROL, V81, P11332, DOI 10.1128/JVI.00875-07; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; GROSS L, 1953, P SOC EXP BIOL MED, V83, P414; Hollanderova D, 2003, INT J ONCOL, V23, P333; Lemos B, 2007, J INVEST DERMATOL, V127, P2100, DOI 10.1038/sj.jid.5700925; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; Parsonnet J, 1999, MICROBES AND MALIGNANCY, P3; PAWLITA M, 1985, VIROLOGY, V143, P196, DOI 10.1016/0042-6822(85)90108-4; PIPAS JM, 1992, J VIROL, V66, P3979, DOI 10.1128/JVI.66.7.3979-3985.1992; Pitterle DM, 1998, IN VIVO, V12, P643; Poulin DL, 2006, J CLIN ONCOL, V24, P4356, DOI 10.1200/JCO.2005.03.7101; Van Gele M, 2004, ONCOGENE, V23, P2732, DOI 10.1038/sj.onc.1207421; WALTER G, 1990, P NATL ACAD SCI USA, V87, P2521, DOI 10.1073/pnas.87.7.2521; Xu YH, 2003, GENOMICS, V81, P329, DOI 10.1016/S0888-7543(02)00043-5	22	2092	2139	2	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2008	319	5866					1096	1100		10.1126/science.1152586	http://dx.doi.org/10.1126/science.1152586			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264SW	18202256	Green Accepted			2022-12-28	WOS:000253311700045
J	Weiss, LA; Shen, YP; Korn, JM; Arking, DE; Miller, DT; Fossdal, R; Saemundsen, E; Stefansson, H; Ferreira, MAR; Green, T; Platt, OS; Ruderfer, DM; Walsh, CA; Altshuler, D; Chakravarti, A; Tanzi, RE; Stefansson, K; Santangelo, SL; Gusella, JF; Sklar, P; Wu, B; Daly, MJ				Weiss, Lauren A.; Shen, Yiping; Korn, Joshua M.; Arking, Dan E.; Miller, David T.; Fossdal, Ragnheidur; Saemundsen, Evald; Stefansson, Hreinn; Ferreira, Manuel A. R.; Green, Todd; Platt, Orah S.; Ruderfer, Douglas M.; Walsh, Christopher A.; Altshuler, David; Chakravarti, Aravinda; Tanzi, Rudolph E.; Stefansson, Kari; Santangelo, Susan L.; Gusella, James F.; Sklar, Pamela; Wu, Bai-Lin; Daly, Mark J.		Autism Consortium	Association between microdeletion and microduplication at 16p11.2 and autism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REARRANGEMENTS; DISORDERS; DUPLICATION; GENOME	Background: Autism spectrum disorder is a heritable developmental disorder in which chromosomal abnormalities are thought to play a role. Methods: As a first component of a genomewide association study of families from the Autism Genetic Resource Exchange (AGRE), we used two novel algorithms to search for recurrent copy-number variations in genotype data from 751 multiplex families with autism. Specific recurrent de novo events were further evaluated in clinical-testing data from Children's Hospital Boston and in a large population study in Iceland. Results: Among the AGRE families, we observed five instances of a de novo deletion of 593 kb on chromosome 16p11.2. Using comparative genomic hybridization, we observed the identical deletion in 5 of 512 children referred to Children's Hospital Boston for developmental delay, mental retardation, or suspected autism spectrum disorder, as well as in 3 of 299 persons with autism in an Icelandic population; the deletion was also carried by 2 of 18,834 unscreened Icelandic control subjects. The reciprocal duplication of this region occurred in 7 affected persons in AGRE families and 4 of the 512 children from Children's Hospital Boston. The duplication also appeared to be a high-penetrance risk factor. Conclusions: We have identified a novel, recurrent microdeletion and a reciprocal microduplication that carry substantial susceptibility to autism and appear to account for approximately 1% of cases. We did not identify other regions with similar aggregations of large de novo mutations. `	[Weiss, Lauren A.; Shen, Yiping; Korn, Joshua M.; Ferreira, Manuel A. R.; Green, Todd; Ruderfer, Douglas M.; Altshuler, David; Santangelo, Susan L.; Gusella, James F.; Sklar, Pamela; Daly, Mark J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA 02114 USA; [Weiss, Lauren A.; Shen, Yiping; Korn, Joshua M.; Miller, David T.; Green, Todd; Platt, Orah S.; Ruderfer, Douglas M.; Walsh, Christopher A.; Altshuler, David; Tanzi, Rudolph E.; Santangelo, Susan L.; Gusella, James F.; Sklar, Pamela; Wu, Bai-Lin; Daly, Mark J.] Harvard Univ, Sch Med, Autism Consortium, Boston, MA 02115 USA; [Weiss, Lauren A.; Platt, Orah S.; Walsh, Christopher A.; Altshuler, David; Tanzi, Rudolph E.; Santangelo, Susan L.; Gusella, James F.; Sklar, Pamela; Wu, Bai-Lin; Daly, Mark J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Weiss, Lauren A.; Platt, Orah S.; Walsh, Christopher A.; Altshuler, David; Tanzi, Rudolph E.; Santangelo, Susan L.; Gusella, James F.; Sklar, Pamela; Wu, Bai-Lin; Daly, Mark J.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Weiss, Lauren A.; Platt, Orah S.; Walsh, Christopher A.; Altshuler, David; Tanzi, Rudolph E.; Santangelo, Susan L.; Gusella, James F.; Sklar, Pamela; Wu, Bai-Lin; Daly, Mark J.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Weiss, Lauren A.; Platt, Orah S.; Walsh, Christopher A.; Altshuler, David; Tanzi, Rudolph E.; Santangelo, Susan L.; Gusella, James F.; Sklar, Pamela; Wu, Bai-Lin; Daly, Mark J.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Weiss, Lauren A.; Platt, Orah S.; Walsh, Christopher A.; Altshuler, David; Tanzi, Rudolph E.; Santangelo, Susan L.; Gusella, James F.; Sklar, Pamela; Wu, Bai-Lin; Daly, Mark J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Shen, Yiping; Miller, David T.; Platt, Orah S.; Walsh, Christopher A.; Wu, Bai-Lin] Harvard Univ, Sch Publ Hlth, Dept Lab Med, Childrens Hosp Boston, Boston, MA 02115 USA; [Shen, Yiping; Miller, David T.; Platt, Orah S.; Walsh, Christopher A.; Wu, Bai-Lin] Harvard Univ, Sch Publ Hlth, Div Genet, Childrens Hosp Boston, Boston, MA 02115 USA; [Santangelo, Susan L.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Weiss, Lauren A.; Korn, Joshua M.; Ferreira, Manuel A. R.; Green, Todd; Ruderfer, Douglas M.; Walsh, Christopher A.; Altshuler, David; Gusella, James F.; Sklar, Pamela; Daly, Mark J.] Harvard Univ, Broad Inst Harvard, Cambridge, MA 02138 USA; [Weiss, Lauren A.; Korn, Joshua M.; Ferreira, Manuel A. R.; Green, Todd; Ruderfer, Douglas M.; Walsh, Christopher A.; Altshuler, David; Gusella, James F.; Sklar, Pamela; Daly, Mark J.] Harvard Univ, MIT, Cambridge, MA 02139 USA; [Korn, Joshua M.] Harvard Univ, MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Korn, Joshua M.] Harvard Univ, Grad Program Biophys, Cambridge, MA 02139 USA; [Arking, Dan E.; Chakravarti, Aravinda] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Fossdal, Ragnheidur; Stefansson, Hreinn; Stefansson, Kari] deCODE Genet, Reykjavik, Iceland; [Saemundsen, Evald] State Diagnost & Counseling Ctr, Kopavogur, Iceland; [Ferreira, Manuel A. R.] Univ Queensland, Royal Brisbane Hosp, Queensland Inst Med Res, Herston, Qld, Australia	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Johns Hopkins University; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Queensland	Daly, MJ (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, 185 Cambridge St, Boston, MA 02114 USA.	mjdaly@chgr.mgh.harvard.edu	Ferreira, Manuel A R/D-3609-2013; Warfield, Simon/B-3352-2009; Altshuler, David M/A-4476-2009; Daly, Mark J/B-2453-2017; Ruderfer, Douglas M/M-5795-2016; Stefansson, Kari/AAE-7187-2019; Tanzi, Rudolph/AAE-9622-2019	Ferreira, Manuel A R/0000-0001-9059-1825; Warfield, Simon/0000-0002-7659-3880; Altshuler, David M/0000-0002-7250-4107; Daly, Mark J/0000-0002-0949-8752; Ruderfer, Douglas M/0000-0002-2365-386X; Tanzi, Rudolph/0000-0002-7032-1454; Stefansson, Hreinn/0000-0002-9331-6666; Graybiel, Ann/0000-0002-4326-7720	OMHHE CDC HHS [R01-MN071425-01A1] Funding Source: Medline	OMHHE CDC HHS		Ballif BC, 2007, NAT GENET, V39, P1071, DOI 10.1038/ng2107; Berg JS, 2007, GENET MED, V9, P427, DOI 10.1097/GIM.0b013e3180986192; Emanuel BS, 2001, NAT REV GENET, V2, P791, DOI 10.1038/35093500; Finelli P, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.016311; Fombonne E, 2005, J CLIN PSYCHIAT, V66, P3; Freitag CM, 2007, MOL PSYCHIATR, V12, P2, DOI 10.1038/sj.mp.4001896; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Ghebranious N, 2007, AM J MED GENET A, V143A, P1462, DOI 10.1002/ajmg.a.31837; Hernando C, 2002, J Med Genet, V39, pE24, DOI 10.1136/jmg.39.5.e24; KIM HG, IN PRESS AM J HUM GE; Lupski JR, 2007, NEW ENGL J MED, V356, P1169, DOI 10.1056/NEJMcibr067658; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Potocki L, 2007, AM J HUM GENET, V80, P633, DOI 10.1086/512864; Rosenberg C, 2006, J MED GENET, V43, P180, DOI 10.1136/jmg.2005.032268; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104	17	1188	1248	0	112	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2008	358	7					667	675		10.1056/NEJMoa075974	http://dx.doi.org/10.1056/NEJMoa075974			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262CX	18184952				2022-12-28	WOS:000253127700003
J	Chen, ES; Zhang, K; Nicolas, E; Cam, HP; Zofall, M; Grewal, SIS				Chen, Ee Sin; Zhang, Ke; Nicolas, Estelle; Cam, Hugh P.; Zofall, Martin; Grewal, Shiv I. S.			Cell cycle control of centromeric repeat transcription and heterochromatin assembly	NATURE			English	Article							RNA-POLYMERASE-II; FISSION YEAST; CHROMOSOME CONDENSATION; LYSINE-9 METHYLATION; EPIGENETIC CONTROL; UBIQUITIN LIGASE; CHROMATIN; PHOSPHORYLATION; RITS; MAINTENANCE	Heterochromatin in eukaryotic genomes regulates diverse chromosomal processes including transcriptional silencing(1). However, in Schizosaccharomyces pombe RNA polymerase II ( RNAPII) transcription of centromeric repeats is essential for RNA- interference- mediated heterochromatin assembly(2-5). Here we study heterochromatin dynamics during the cell cycle and its effect on RNAPII transcription. We describe a brief period during the S phase of the cell cycle in which RNAPII preferentially transcribes centromeric repeats. This period is enforced by heterochromatin, which restricts RNAPII accessibility at centromeric repeats for most of the cell cycle. RNAPII transcription during S phase is linked to loading of RNA interference and heterochromatin factors such as the Ago1 subunit of the RITS complex(6) and the Clr4 methyltransferase complex subunit Rik1 ( ref. 7). Moreover, Set2, an RNAPII- associated methyltransferase(8) that methylates histone H3 lysine 36 at repeat loci during S phase, acts in a pathway parallel to Clr4 to promote heterochromatin assembly. We also show that phosphorylation of histone H3 serine 10 alters heterochromatin during mitosis, correlating with recruitment of condensin that affects silencing of centromeric repeats. Our analyses suggest at least two distinct modes of heterochromatin targeting to centromeric repeats, whereby RNAPII transcription of repeats and chromodomain proteins bound to methylated histone H3 lysine 9 mediate recruitment of silencing factors. Together, these processes probably facilitate heterochromatin maintenance through successive cell divisions.	[Chen, Ee Sin; Zhang, Ke; Nicolas, Estelle; Cam, Hugh P.; Zofall, Martin; Grewal, Shiv I. S.] NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Grewal, SIS (corresponding author), NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	grewals@mail.nih.gov	Nicolas, Estelle/C-4425-2008	Nicolas, Estelle/0000-0003-0412-8477; Grewal, Shiv/0000-0002-4552-9261	NATIONAL CANCER INSTITUTE [Z01BC010523, ZIABC011208, ZIABC010523] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Alfa C, 1993, EXPT FISSION YEAST L; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hirano T, 2005, CURR BIOL, V15, pR265, DOI 10.1016/j.cub.2005.03.037; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Horn PJ, 2005, GENE DEV, V19, P1705, DOI 10.1101/gad.1328005; Jia ST, 2005, NAT CELL BIOL, V7, P1007, DOI 10.1038/ncb1300; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Kim SM, 2001, EMBO J, V20, P6115, DOI 10.1093/emboj/20.21.6115; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Meyer BJ, 2000, TRENDS GENET, V16, P247, DOI 10.1016/S0168-9525(00)02004-7; Morris SA, 2005, EUKARYOT CELL, V4, P1446, DOI 10.1128/EC.4.8.1446-1454.2005; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nakayama J, 2000, CELL, V101, P307, DOI 10.1016/S0092-8674(00)80840-5; Nicolas E, 2007, NAT STRUCT MOL BIOL, V14, P372, DOI 10.1038/nsmb1239; Oliveira RA, 2005, MOL CELL BIOL, V25, P8971, DOI 10.1128/MCB.25.20.8971-8984.2005; SAKA Y, 1994, EMBO J, V13, P4938, DOI 10.1002/j.1460-2075.1994.tb06821.x; Schramke V, 2005, NATURE, V435, P1275, DOI 10.1038/nature03652; Sutani T, 1999, GENE DEV, V13, P2271, DOI 10.1101/gad.13.17.2271; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Yamada T, 2005, MOL CELL, V20, P173, DOI 10.1016/j.molcel.2005.10.002; Zofall M, 2007, J BIOL CHEM, V282, P14065, DOI 10.1074/jbc.M700292200	30	284	289	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2008	451	7179					734	737		10.1038/nature06561	http://dx.doi.org/10.1038/nature06561			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HD	18216783				2022-12-28	WOS:000252929500045
J	Chaine, AS; Lyon, BE				Chaine, Alexis S.; Lyon, Bruce E.			Adaptive plasticity in female mate choice dampens sexual selection on male ornaments in the lark bunting	SCIENCE			English	Article								Theory on the evolution of ornamental male traits by sexual selection assumes consistency in selection over time. Temporal variation in female choice could dampen sexual selection, but scant information exists on the degree to which individual female preferences are flexible. Here we show that in lark buntings sexual selection on male traits varied dramatically across years and, in some cases, exhibited reversals in the direction of selection for a single trait. We show that these shifts are probably because of flexibility in mate choice by individual females and that they parallel shifts in the male traits that predict female reproductive success in a given year. Plasticity in choice and concomitant reversals in mating patterns across time may weaken the strength of sexual selection and could maintain genetic variation underlying multiple sexual ornaments.	[Chaine, Alexis S.; Lyon, Bruce E.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Chaine, Alexis S.] CNRS Moulis, Stn Ecol Expt, Lab Evolut & Divers Biol, USR 2936, F-09200 St Girons, France	University of California System; University of California Santa Cruz; Centre National de la Recherche Scientifique (CNRS)	Chaine, AS (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	alexis.chaine@ecoex-moulis.cnrs.fr	Lyon, Bruce E/E-8491-2011; Chaine, Alexis S/B-4062-2012					Alonzo SH, 2001, BEHAV ECOL SOCIOBIOL, V49, P176, DOI 10.1007/s002650000265; Andersson Malte, 1994; BAKKER TCM, 1995, J EVOLUTION BIOL, V8, P129, DOI 10.1046/j.1420-9101.1995.8020129.x; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; CHAINE A, 2006, THESIS U CALIFORNIA; Darwin C., 1871, P475; Ellner S, 1996, B MATH BIOL, V58, P103, DOI 10.1007/BF02458284; Gibson RM, 1996, TRENDS ECOL EVOL, V11, P468, DOI 10.1016/0169-5347(96)10050-1; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; Hill GE, 1999, BEHAV ECOL, V10, P48, DOI 10.1093/beheco/10.1.48; JANETOS AC, 1980, BEHAV ECOL SOCIOBIOL, V7, P107, DOI 10.1007/BF00299515; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.2307/2408842; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Mead LS, 2004, TRENDS ECOL EVOL, V19, P264, DOI 10.1016/j.tree.2004.03.003; Merila J, 2001, GENETICA, V112, P199, DOI 10.1023/A:1013391806317; O'Donald P., 1983, P53; Oh KP, 2006, P ROY SOC B-BIOL SCI, V273, P1913, DOI 10.1098/rspb.2006.3528; Qvarnstrom A, 2000, NATURE, V405, P344, DOI 10.1038/35012605; Qvarnstrom A, 2001, TRENDS ECOL EVOL, V16, P5, DOI 10.1016/S0169-5347(00)02030-9; REID ML, 1990, ANIM BEHAV, V40, P538, DOI 10.1016/S0003-3472(05)80534-2; SCHLUTER D, 1988, EVOLUTION, V42, P849, DOI [10.2307/2408904, 10.1111/j.1558-5646.1988.tb02507.x]; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439	23	215	215	1	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2008	319	5862					459	462		10.1126/science.1149167	http://dx.doi.org/10.1126/science.1149167			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254HB	18218896				2022-12-28	WOS:000252576600037
J	Lynch, AI; Boerwinkle, E; Davis, BR; Ford, CE; Eckfeldt, JH; Leiendecker-Foster, C; Arnett, DK				Lynch, Amy I.; Boerwinkle, Eric; Davis, Barry R.; Ford, Charles E.; Eckfeldt, John H.; Leiendecker-Foster, Catherine; Arnett, Donna K.			Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; POLYMORPHISMS; MARKERS; DESIGN; STROKE	Context The NPPA gene codes for the precursor of atrial natriuretic polypeptide, suggesting that NPPA may modulate the efficacy of some antihypertensive drugs. Objective To test whether participants with minor NPPA alleles in the T2238C or G664A variants had different rates of cardiovascular disease or blood pressure ( BP) changes than common allele homozygotes when treated with a diuretic vs other antihypertensive medications. Design, Setting, and Patients Post hoc analysis of 38 462 participants with hypertension from ALLHAT, a multicenter randomized clinical trial conducted in the United States and Canada. Genotyping was performed from February 2004 to January 2005. Intervention Participants were randomly assigned to receive a diuretic ( chlorthalidone; n= 13 860), a calcium antagonist ( amlodipine; n= 8174), an angiotensin-converting enzyme inhibitor ( lisinopril; n= 8233), or an alpha-blocker ( doxazosin; n= 8195). Main Outcome Measure The primary outcome measure was coronary heart disease ( CHD), defined as fatal CHD or nonfatal myocardial infarction ( mean follow- up, 4.9 years). Secondary outcomes were stroke, all- cause mortality, combined cardiovascular disease outcomes, and 6- month systolic and diastolic BP changes. Genotype x treatment interactions were tested where genotypes were modeled additively and dominantly. Results Depending on genotype, the event rates per 1000 person- years were 15.3 to 19.7 for CHO, 9.6 to 15.4 for stroke, and 27.4 to 30.7 for all- cause mortality. For the NPPA T2238C variant, lower event rates were found for the C allele carriers than for the TT homozygous individuals when comparing chlorthalidone and amlodipine ( CHD: CC= 0.86; TC= 0.90; TT= 1.09; P=. 03[ dominant model]; stroke: CC= 1.18; TC= 0.82; TT= 1.26; P=. 01 [ additive and dominant models]; all- cause mortality: CC= 0.87; TC= 0.98; TT= 1.12; P=. 05 [ dominant model]). Combined end points yielded similar results. Consistent with these clinical findings, 6- month changes in systolic BP for those with the CC genotype showed larger reductions with chlorthalidone (- 6.5 mm Hg) than with amlodipine (- 3.8 mm Hg), lisinopril (- 2.4 mm Hg), or doxazosin (- 3.8 mm Hg). Among those with the TT genotype, systolic BP differences between drugs were less ( range, - 5.4 to - 7.5 mm Hg; P value, <. 001 to .003 for interaction); diastolic BP showed similar results. We found no pharmacogenetic associations with the NPPA G664A variant. Conclusions The NPPA T2238C variant was associated with modification of antihypertensive medication effects on cardiovascular disease and BP. Minor C allele carriers experienced more favorable cardiovascular disease outcomes when randomized to receive a diuretic, whereas TT allele carriers had more favorable outcomes when randomized to receive a calcium channel blocker.	[Arnett, Donna K.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA; [Lynch, Amy I.; Eckfeldt, John H.; Leiendecker-Foster, Catherine] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Boerwinkle, Eric] Univ Texas Houston, Hlth Sci Ctr, Ctr Human Genet, Houston, TX USA; [Davis, Barry R.; Ford, Charles E.] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA	University of Alabama System; University of Alabama Birmingham; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Arnett, DK (corresponding author), Univ Alabama Birmingham, Dept Epidemiol, RPHB 220E,1530 3rd Ave S, Birmingham, AL USA.	arnett@ms.soph.uab.edu			NHLBI NIH HHS [R01 HL083498, HL63082, N01-HC-35130] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC035130] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083498, R01HL063082] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ACKERMANN U, 1986, CLIN CHEM, V32, P241; Alderman MH, 2003, HYPERTENSION, V42, P239, DOI 10.1161/01.HYP.0000086521.95630.5A; Arnett D. K., 2002, Pharmacogenomics Journal, V2, P309; Cadman PE, 2003, CURR OPIN NEPHROL HY, V12, P61, DOI 10.1097/00041552-200301000-00011; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P7; Cheng S, 1999, GENOME RES, V9, P936, DOI 10.1101/gr.9.10.936; Davis BR, 1996, AM J HYPERTENS, V9, P342, DOI 10.1016/0895-7061(96)00037-4; Dedoussis GVZ, 2006, J CLIN LAB ANAL, V20, P98, DOI 10.1002/jcla.20108; Deschepper CF, 2002, HYPERTENSION, V39, P332, DOI 10.1161/hy0202.102787; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Guo XQ, 2005, HYPERTENSION, V45, P799, DOI 10.1161/01.HYP.0000154786.17416.ea; Hardy G H, 2003, Yale J Biol Med, V76, P79; Houweling AC, 2005, CARDIOVASC RES, V67, P583, DOI 10.1016/j.cardiores.2005.06.013; JOHN SWM, 1995, SCIENCE, V267, P679, DOI 10.1126/science.7839143; KANFER A, 1989, CLIN NEPHROL, V32, P51; Kato N, 2000, CLIN SCI, V98, P251, DOI 10.1042/CS19990220; Kurland L, 2005, TRENDS PHARMACOL SCI, V26, P443, DOI 10.1016/j.tips.2005.07.008; Liguori A, 1994, Riv Eur Sci Med Farmacol, V16, P61; PETERSON B, 1994, CONTROL CLIN TRIALS, V15, P326; PETERSON B, 1993, CONTROL CLIN TRIALS, V14, P511, DOI 10.1016/0197-2456(93)90031-8; Rubattu S, 2004, STROKE, V35, P814, DOI 10.1161/01.STR.0000119381.52589.AB; Rubattu S, 2007, J HUM HYPERTENS, V21, P822, DOI 10.1038/sj.jhh.1002228; Rubattu S, 2006, J AM COLL CARDIOL, V48, P499, DOI 10.1016/j.jacc.2005.12.081; STEINHELPER ME, 1990, HYPERTENSION, V16, P301, DOI 10.1161/01.HYP.16.3.301; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600	26	75	86	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2008	299	3					296	307		10.1001/jama.299.3.296	http://dx.doi.org/10.1001/jama.299.3.296			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253DB	18212314	Bronze			2022-12-28	WOS:000252497800021
J	Shankar, AH; Jahari, AB; Sebayang, SK; Aditiawarman; Apriatni, M; Harefa, B; Muadz, H; Soesbandoro, SDA; Tjiong, R; Fachry, A; Shankar, AV; Atmarita; Prihatini, S; Sofia, G				Shankar, A. H.; Jahari, A. B.; Sebayang, S. K.; Aditiawarman; Apriatni, M.; Harefa, B.; Muadz, H.; Soesbandoro, S. D. A.; Tjiong, R.; Fachry, A.; Shankar, A. V.; Atmarita; Prihatini, S.; Sofia, G.		SUMMIT Study Grp	Effect of maternal multiple micronutrient supplementation on fetal loss and infant death in Indonesia: a double-blind cluster-randomised trial	LANCET			English	Article							BETA-CAROTENE SUPPLEMENTATION; VITAMIN-A SUPPLEMENTATION; PREGNANT-WOMEN; BIRTH-WEIGHT; MULTIMICRONUTRIENT SUPPLEMENTATION; ZINC SUPPLEMENTATION; LONGITUDINAL DATA; SINGLE MEGADOSE; POOR COUNTRIES; MOTHERS	Background Maternal nutrient supplementation in developing countries is generally restricted to provision of iron and folic acid (IFA). Change in practice toward supplementation with multiple micronutrients (MMN) has been hindered by little evidence of the effects of MMN on fetal loss and infant death. We assessed the effect of maternal supplementation with MMN, compared with IFA, on fetal loss and infant death in the setting of routine prenatal care services. Methods in a double-blind cluster-randomised trial in Lombok, Indonesia, we randomly assigned 262 midwives to distribute IFA (n=15 486) or MMN (n=15 804) supplements to 31290 pregnant women through government prenatal care services that were strengthened by training and community-based advocacy. Women obtained supplements, to be taken daily, every month from enrolment to 90 days post partum. The primary outcome was early infant mortality (deaths until 90 days post partum). Secondary outcomes were neonatal mortality, fetal loss (abortions and stillbirths), and low birthweight. Analysis was by intention to treat. The study is registered as an International Standard Randomised Controlled Trial, number ISRCTN34151616. Findings Infants of women consuming MMN supplements had an 18% reduction in early infant mortality compared with those of women given IFA (35 . 5 deaths per 1000 livebirths vs 43 per 1000; relative risk [RR] 0 . 82, 95% CI 0. 70-0.95, p=0 . 010). Infants whose mothers were undernourished (mid upper arm circumference <23 . 5 cm) or anaemic (haemoglobin <110 g/L) at enrolment had a reduction in early infant mortality of 25% (RR 0 . 75, 0.62-0.90, p=0. 0021) and 38% (RR 0 . 62, 0 . 49-0.78, p<0 . 0001), respectively. Combined fetal loss and neonatal deaths were reduced by 11% (RR 0 . 89, 0 . 81-1. 00, p=0 . 045), with significant effects in undernourished (RR 0 . 85, 0.73-0.98, p=0 . 022) or anaemic (RR 0 . 71, 0.58-0.87, p=0 . 0010) women. A cohort of 11101 infants weighed within 1 h of birth showed a 14% (RR 0 . 86, 0.73-1 .01, p=0.060) decreased risk of low birthweight for those in the MMN group, with a 33% (RR 0 . 67, 0 . 51-0 . 89, p=0. 0062) decrease for infants of women anaemic at enrolment. Interpretation Maternal MMN supplementation, as compared with IFA, can reduce early infant mortality, especially in undernourished and anaemic women. Maternal MMN supplementation might therefore be an important part of overall strengthening of prenatal-care programmes.	[Shankar, A. H.; Muadz, H.; Fachry, A.] Univ Mataram, SUMMIT Inst Dev, Gedung Pusat Penelitan Bahasa Kebudayaan P2BK, Mataram, Nusa Tenggara B, Indonesia; [Shankar, A. H.; Tjiong, R.] Helen Keller Int, Jakarta, Indonesia; [Shankar, A. H.; Shankar, A. V.] Johns Hopkins Univ, Baltimore, MD USA; [Jahari, A. B.; Prihatini, S.; Sofia, G.] Ctr Res & Dev Food & Nutr, Bogor, Indonesia; [Aditiawarman; Apriatni, M.; Harefa, B.] Helen Keller Int, SUMMIT, Mataram, Indonesia; [Soesbandoro, S. D. A.] Mataram Gen Hosp, Mataram, Indonesia; [Atmarita] Govt Indonesia, Minist Hlth, Directorate Community Nutr, Jakarta, Indonesia	Universitas Mataram; Johns Hopkins University; Ministry of Health - Indonesia	Shankar, AH (corresponding author), Univ Mataram, SUMMIT Inst Dev, Gedung Pusat Penelitan Bahasa Kebudayaan P2BK, Jalan Pendidikan 37, Mataram, Nusa Tenggara B, Indonesia.	ashankar@jhsph.edu	Sebayang, Susy/ABI-1686-2022					Allen LH, 2005, AM J CLIN NUTR, V81, p1206S; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; [Anonymous], 1972, World Health Organ Tech Rep Ser, V503, P1; Basu S, 2003, POSTGRAD MED J, V79, P397, DOI 10.1136/pmj.79.933.397; *BPS BAPP UNDP IND, 2001, IND HUM DEV REP 2001; *CENTR BUR STAT NA, 1998, IND DEM HLTH SURV 19; Christian P, 2005, LANCET, V366, P711, DOI 10.1016/S0140-6736(05)67166-8; Christian P, 2003, AM J CLIN NUTR, V78, P1194, DOI 10.1093/ajcn/78.6.1194; DEPEE S, 2002, BREASTFEEDING COMPLE; DEPEE S, 2004, NUTR HLTH TRENDS IND; Dijkhuizen MA, 2004, AM J CLIN NUTR, V80, P1299, DOI 10.1093/ajcn/80.5.1299; Fawzi WW, 2007, NEW ENGL J MED, V356, P1423, DOI 10.1056/NEJMoa064868; Fawzi WW, 1998, LANCET, V351, P1477, DOI 10.1016/S0140-6736(98)04197-X; Fawzi WW, 2003, CLIN INFECT DIS, V36, P1053, DOI 10.1086/374223; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Friis H, 2004, AM J CLIN NUTR, V80, P178; Goldenberg RL, 2003, J NUTR, V133, p1645S, DOI 10.1093/jn/133.5.1645S; Gupta P, 2007, ARCH PEDIAT ADOL MED, V161, P58, DOI 10.1001/archpedi.161.1.58; HABICHT JP, 1973, NUTR REP INT, V7, P533; Haider BA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004905; Heo M, 2005, J BIOPHARM STAT, V15, P513, DOI 10.1081/BIP-200056554; Heo M, 2005, STAT MED, V24, P911, DOI 10.1002/sim.1958; Hininger I, 2004, EUR J CLIN NUTR, V58, P52, DOI 10.1038/sj.ejcn.1601745; Huffman SL, 2005, LANCET, V366, P2001, DOI 10.1016/S0140-6736(05)67807-5; HUFFMAN SL, 1999, CASE PROMOTING MULTI; Kaestel P, 2005, EUR J CLIN NUTR, V59, P1081, DOI 10.1038/sj.ejcn.1602215; Keen CL, 2003, J NUTR, V133, p1597S, DOI 10.1093/jn/133.5.1597S; Ladipo OA, 2000, AM J CLIN NUTR, V72, p280S, DOI 10.1093/ajcn/72.1.280S; Lee E. W., 1992, SURVIVAL ANAL STATE, P237, DOI [DOI 10.1007/978-94-015-7983-4_14, 10.1007/978-94-015-7983-4_14]; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Malaba LC, 2005, AM J CLIN NUTR, V81, P454, DOI 10.1093/ajcn.81.2.454; Martines J, 2005, LANCET, V365, P1189, DOI 10.1016/S0140-6736(05)71882-1; Murphy MM, 2004, CLIN CHEM, V50, P1406, DOI 10.1373/clinchem.2004.032904; Nelson CM, 2000, J HEALTH POPUL NUTR, V18, P131; Osendarp SJM, 2003, J NUTR, V133, p817S; Osrin D, 2005, LANCET, V365, P955, DOI 10.1016/S0140-6736(05)71084-9; PENAROSAS JP, 2006, COCHRANE DB SYST REV, V19, P3; Ramakrishnan U, 2003, AM J CLIN NUTR, V77, P720, DOI 10.1093/ajcn/77.3.720; Rice AL, 1999, J NUTR, V129, P356, DOI 10.1093/jn/129.2.356; Roy SK, 1997, EUR J CLIN NUTR, V51, P302, DOI 10.1038/sj.ejcn.1600398; Scholl TO, 1997, AM J EPIDEMIOL, V146, P134, DOI 10.1093/oxfordjournals.aje.a009244; Shankar A, 1998, FASEB J, V12, pA818; Shrimpton R, 2005, LANCET, V366, P2001, DOI 10.1016/S0140-6736(05)67808-7; Shrimpton R, 2003, T ROY SOC TROP MED H, V97, P39, DOI 10.1016/S0035-9203(03)90015-0; Tomkins A, 2001, BRIT J NUTR, V85, pS93, DOI 10.1079/BJN2001358; *UN DEV PROGR, 2001, HUM DEV REP 2001; [UNICEF WHO UNU Study Team], 1999, COMP MULT MICR SUPPL; *UNICEF, 2001, STAT WORLDS CHILDR 2; *UNICEF WHO UNU, 2004, MULT MICRUPPL PREGN; *UNICEF WHO UNU ST, 2002, MULT MICR SUPPL PREG; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011; West KP, 1999, BMJ-BRIT MED J, V318, P570, DOI 10.1136/bmj.318.7183.570; World Health Organization, 1994, STAT CLASS DIS REL H; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; Zimmermann M, 2004, EUR J CLIN NUTR, V58, P979, DOI 10.1038/sj.ejcn.1601933	56	149	153	1	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 19	2008	371	9608					215	227						13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	252UK	18207017				2022-12-28	WOS:000252471900025
J	Walter, RC; Merritts, DJ				Walter, Robert C.; Merritts, Dorothy J.			Natural streams and the legacy of water-powered mills	SCIENCE			English	Article							SOIL-EROSION; SEDIMENT; RIVER; REDISTRIBUTION; RESTORATION; CESIUM-137; PHOSPHORUS; LOWLAND	Gravel- bedded streams are thought to have a characteristic meandering form bordered by a self-formed, fine- grained floodplain. This ideal guides a multibillion- dollar stream restoration industry. We have mapped and dated many of the deposits along mid- Atlantic streams that formed the basis for this widely accepted model. These data, as well as historical maps and records, show instead that before European settlement, the streams were small anabranching channels within extensive vegetated wetlands that accumulated little sediment but stored substantial organic carbon. Subsequently, 1 to 5 meters of slackwater sedimentation, behind tens of thousands of 17th- to 19th- century milldams, buried the presettlement wetlands with fine sediment. These findings show that most floodplains along mid- Atlantic streams are actually fill terraces, and historically incised channels are not natural archetypes for meandering streams.	[Walter, Robert C.; Merritts, Dorothy J.] Franklin & Marshall Coll, Dept Earth & Environm, Lancaster, PA 17604 USA	Franklin & Marshall College	Walter, RC (corresponding author), Franklin & Marshall Coll, Dept Earth & Environm, POB 3003, Lancaster, PA 17604 USA.	robert.walter@fandm.edu; dorothy.merritts@fandm.edu	Walter, Robert/AAD-7642-2020	Walter, Robert/0000-0001-8761-5355				Bernhardt ES, 2005, SCIENCE, V308, P636, DOI 10.1126/science.1109769; Brown A.G., 1997, ALLUVIAL GEOARCHAEOL; Butler DR, 2005, GEOMORPHOLOGY, V71, P48, DOI 10.1016/j.geomorph.2004.08.016; Cantelli A, 2004, WATER RESOUR RES, V40, DOI 10.1029/2003WR002940; Chow V.T., 1959, OPEN CHANNEL HYDRAUL; Collins BD, 2002, RESTOR ECOL, V10, P237, DOI 10.1046/j.1526-100X.2002.01023.x; Collins BD, 2001, WATER SCI APPL, V4, P227; COSTA JE, 1975, GEOL SOC AM BULL, V86, P1281, DOI 10.1130/0016-7606(1975)86&lt;1281:EOAOEA&gt;2.0.CO;2; Doyle MW, 2005, GEOMORPHOLOGY, V71, P227, DOI 10.1016/j.geomorph.2004.04.011; Gellis A. C., 2005, 20045056 USGS; Happ S. C., 1940, SOME PRINCIPLES ACCE; HART JF, 1995, AM J LEGAL HIST, V39, P1, DOI 10.2307/845747; Hart JF, 1998, J LEGAL STUD, V27, P455, DOI 10.1086/468027; HARTRANFT J, COMMUNICATION; Hilgartner WB, 2006, HOLOCENE, V16, P479, DOI 10.1191/0959683606hl938rp; Hunter B, 2005, WILLIAM MARY QUART, V62, P505, DOI 10.2307/3491533; JACOBSON RB, 1986, AM J SCI, V286, P617, DOI 10.2475/ajs.286.8.617; Kalm P., 1987, P KALMS TRAVELS N AM; Ketterer ME, 2002, ENVIRON SCI TECHNOL, V36, P1307, DOI 10.1021/es010826g; Laubel A, 2003, HYDROL PROCESS, V17, P3443, DOI 10.1002/hyp.1302; LEMON JT, 1967, WILLIAM MARY Q, V24, P501; Leopold LB, 2005, P AM PHILOS SOC, V149, P349; LEOPOLD LB, 1973, GEOL SOC AM BULL, V84, P1845, DOI 10.1130/0016-7606(1973)84<1845:RCCWTA>2.0.CO;2; LEOPOLD LB, 1953, 252 USGS; Malakoff D, 2004, SCIENCE, V305, P937, DOI 10.1126/science.305.5686.937; Montgomery DR, 2003, AM FISH S S, V37, P21; ODGAARD AJ, 1987, WATER RESOUR RES, V23, P1225, DOI 10.1029/WR023i007p01225; PIZZUTO JE, 1987, SEDIMENTOLOGY, V34, P301, DOI 10.1111/j.1365-3091.1987.tb00779.x; REYNODLS TS, 1983, STRONGER 100 MEN HIS; RITCHIE JC, 1990, J ENVIRON QUAL, V19, P215, DOI 10.2134/jeq1990.00472425001900020006x; RITCHIE JC, 1974, SOIL SCI SOC AM J, V38, P137, DOI 10.2136/sssaj1974.03615995003800010042x; Sekely AC, 2002, J SOIL WATER CONSERV, V57, P243; Stanley EH, 2002, BIOSCIENCE, V52, P693, DOI 10.1641/0006-3568(2002)052[0693:AGPONR]2.0.CO;2; Trimble SW, 2008, MAN INDUCED SOIL ERO; *US DEP STAT, 1841, COMP EN INH STAT US; Verstraeten G, 2000, PROG PHYS GEOG, V24, P219, DOI 10.1177/030913330002400204; Walling D. E., 1990, Land Degradation & Rehabilitation, V2, P161, DOI 10.1002/ldr.3400020302; WATSON JF, 1830, ANN PHILADELPHIA PEN; Wolman M. G., 1967, GEOGR ANN A, V49, P385, DOI DOI 10.2307/520904; Wolman M.G., 1957, US GEOLOGICAL SURVEY, P87, DOI [10.3133/pp282C, DOI 10.3133/PP282C]; Wolman MG, 1955, 271 USGS	41	575	582	4	231	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2008	319	5861					299	304		10.1126/science.1151716	http://dx.doi.org/10.1126/science.1151716			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252GY	18202284				2022-12-28	WOS:000252436200029
J	Srivastava, R				Srivastava, Ranjana			A bridge to nowhere - The troubled trek of foreign medical graduates	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	5	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2008	358	3					216	219		10.1056/NEJMp0708599	http://dx.doi.org/10.1056/NEJMp0708599			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	251LS	18199860				2022-12-28	WOS:000252375600002
J	Kearney, PM; Blackwell, L; Collins, R; Keech, A; Simes, J; Peto, R; Armitage, J; Baigent, C				Kearney, P. M.; Blackwell, L.; Collins, R.; Keech, A.; Simes, J.; Peto, R.; Armitage, J.; Baigent, C.		CTT Collaborators	Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis	LANCET			English	Article							CORONARY-HEART-DISEASE; PRIMARY PREVENTION; CARDIOVASCULAR-DISEASE; CARDIAC OUTCOMES; ATORVASTATIN; PRAVASTATIN; EVENTS; MULTICENTER; MORTALITY; MELLITUS	Background Although statin therapy reduces the risk of occlusive vascular events in people with diabetes mellitus, there is uncertainty about the effects on particular outcomes and whether such effects depend on the type of diabetes, lipid profile, or other factors. We undertook a prospective meta-analysis to help resolve these uncertainties. Methods We analysed data from 18 686 individuals with diabetes (1466 with type 1 and 17 220 with type 2) in the context of a further 71370 without diabetes in 14 randomised trials of statin therapy. Weighted estimates were obtained of effects on clinical outcomes per 1 . 0 mmol/L reduction in LDL cholesterol. Findings During a mean follow-up of 4.3 years, there were 3247 major vascular events in people with diabetes. There was a 9% proportional reduction in all-cause mortality per mmol/L reduction in LDL cholesterol in participants with diabetes (rate ratio [RR] 0.91, 99% CI 0.82-1.01; p=0.02), which was similar to the 13% reduction in those without diabetes (0 . 87, 0 . 82-0 . 92; p<0.0001). This finding reflected a significant reduction in vascular mortality (0 . 87, 0.76-1. 00; p=0.008) and no effect on non-vascular mortality (0 . 97, 0.82-1.16; p=0.7) in participants with diabetes. There was a significant 21% proportional reduction in major vascular events per mmol/L reduction in LDL cholesterol in people with diabetes (0 .79, 0.72-0.86; p<0.0001), which was similar to the effect observed in those without diabetes (0.79, 0.76-0.82; p<0.0001). In diabetic participants there were reductions in myocardial infarction or coronary death (0 . 78, 0.69-0.87; p<0.0001), coronary revascularisation (0 .75, 0.64-0.88; p<0.0001), and stroke (0 . 79, 0 . 67-0.93; p=0.0002). Among people with diabetes the proportional effects of statin therapy were similar irrespective of whether there was a prior history of vascular disease and irrespective of other baseline characteristics. After 5 years, 42 (95% CI 30-55) fewer people with diabetes had major vascular events per 1000 allocated statin therapy. Interpretation Statin therapy should be considered for all diabetic individuals who are at sufficiently high risk of vascular events.	CTT Secretariat, Clin Trial Serv Unit, Oxford OX3 7LF, England; CTT Secretariat, Epidemiol Studies Unit, Oxford OX3 7LF, England; Univ Sydney, NHMRC, Clin Trial Ctr, Sydney, NSW 2006, Australia	University of Oxford; University of Oxford; University of Sydney	Kearney, PM (corresponding author), CTT Secretariat, Clin Trial Serv Unit, Richard Doll Bldg,Old Rd Campus,Roosevelt Dr, Oxford OX3 7LF, England.		Simes, Robert John/P-1497-2014; Collins, Rory/ABA-8487-2020; Kearney, Patricia M/AAE-8501-2020	Varigos, John/0000-0001-6722-3135; Kearney, Patricia/0000-0001-9599-3540	Medical Research Council [MC_U137686849, MC_U137686853] Funding Source: Medline; MRC [MC_U137686853, MC_U137686849] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abramson J, 2007, LANCET, V369, P168, DOI 10.1016/S0140-6736(07)60084-1; *ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI DOI 10.1016/S1062-1458(03)00049-7; Amarenco P, 2006, NEW ENGL J MED, V355, P549; [Anonymous], 2005, DIABETES CARE, V28, pS4; [Anonymous], 1995, Am J Cardiol, V75, P1130; Armitage J, 2000, HEART, V84, P357, DOI 10.1136/heart.84.4.357; Athyros VG, 2002, CURR MED RES OPIN, V18, P220, DOI 10.1185/030079902125000787; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Campeau L, 1997, NEW ENGL J MED, V336, P153; CHEN ZM, 1991, BRIT MED J, V303, P276, DOI 10.1136/bmj.303.6797.276; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Collins R, 2003, LANCET, V361, P2005; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; *EARL BREAST CANC, 1990, TREATM EARL BREAST C, V1; GARCIA MJ, 1974, DIABETES, V23, P105, DOI 10.2337/diab.23.2.105; GISSI Prevenzione Investigators, 2000, ITAL HEART J, V1, P810; Holdaas H, 2003, LANCET, V361, P2024, DOI 10.1016/S0140-6736(03)13638-0; JACOBS D, 1992, CIRCULATION, V86, P1046, DOI 10.1161/01.CIR.86.3.1046; Knopp RH, 2006, DIABETES CARE, V29, P1478, DOI 10.2337/dc05-2415; Koren MJ, 2004, J AM COLL CARDIOL, V44, P1772, DOI 10.1016/j.jacc.2004.07.053; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levey AS, 2000, J AM SOC NEPHROL, V11, p115A; Mihaylova B, 2006, BMJ-BRIT MED J, V333, P1145, DOI 10.1136/bmj.38993.731725.BE; Nakamura H, 2006, LANCET, V368, P1155, DOI 10.1016/S0140-6736(06)69472-5; *NAT I HEALTHC CLI, 2006, STAT PREV CARD EV TE; NIKKILA EA, 1978, DIABETES, V27, P1078, DOI 10.2337/diab.27.11.1078; PEDERSEN TR, 1994, LANCET, V344, P1383; PYORALA K, 1987, DIABETES METAB REV, V3, P464; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Serruys PWJC, 2002, JAMA-J AM MED ASSOC, V287, P3215, DOI 10.1001/jama.287.24.3215; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Taskinen MR, 2002, ACTA DIABETOL, V39, pS29, DOI 10.1007/s005920200023; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988	41	1393	1440	0	50	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 12	2008	371	9607					117	125						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	252ND	18191683				2022-12-28	WOS:000252452300026
J	Gao, DC; Nolan, DJ; Mellick, AS; Bambino, K; McDonnell, K; Mittal, V				Gao, Dingcheng; Nolan, Daniel J.; Mellick, Albert S.; Bambino, Kathryn; McDonnell, Kevin; Mittal, Vivek			Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis	SCIENCE			English	Article							HEMATOPOIETIC STEM-CELLS; MARROW; RECRUITMENT; DORMANCY; GROWTH	Angiogenesis- mediated progression of micrometastasis to lethal macrometastasis is the major cause of death in cancer patients. Here, using mouse models of pulmonary metastasis, we identify bone marrow ( BM)- derived endothelial progenitor cells ( EPCs) as critical regulators of this angiogenic switch. We show that tumors induce expression of the transcription factor Id1 in the EPCs and that suppression of Id1 after metastatic colonization blocked EPC mobilization, caused angiogenesis inhibition, impaired pulmonary macrometastases, and increased survival of tumor- bearing animals. These findings establish the role of EPCs in metastatic progression in preclinical models and suggest that selective targeting of EPCs may merit investigation as a therapy for cancer patients with lung metastases.	[Gao, Dingcheng; Nolan, Daniel J.; Mellick, Albert S.; Bambino, Kathryn; McDonnell, Kevin; Mittal, Vivek] Cold Spring Harbor Lab, Canc Genome Res Ctr, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Mittal, V (corresponding author), Cold Spring Harbor Lab, Canc Genome Res Ctr, POB 100, Cold Spring Harbor, NY 11724 USA.	mittal@cshl.edu	Gao, Dingcheng/P-5889-2019	Mellick, Albert/0000-0002-0668-2706				Arroyo AG, 1996, CELL, V85, P997, DOI 10.1016/S0092-8674(00)81301-X; Beaudry P, 2005, CLIN CANCER RES, V11, P3514, DOI 10.1158/1078-0432.CCR-04-2271; Bertolini F, 2006, NAT REV CANCER, V6, P833, DOI 10.1039/nrc1971; Garmy-Susini B, 2005, J CLIN INVEST, V115, P1542, DOI 10.1172/JCI23445; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; HOLMGREN L, 1995, NAT MED, V1, P149, DOI 10.1038/nm0295-149; Jankovic V, 2007, P NATL ACAD SCI USA, V104, P1260, DOI 10.1073/pnas.0607894104; Jiang SG, 2004, P NATL ACAD SCI USA, V101, P16891, DOI 10.1073/pnas.0404398101; Jin H, 2006, J CLIN INVEST, V116, P652, DOI 10.1172/JCI24751; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kopp HG, 2006, CURR OPIN HEMATOL, V13, P175, DOI 10.1097/01.moh.0000219664.26528.da; Laitinen L, 1987, J HISTOCHEM CYTOCHEM, V35, P55, DOI 10.1177/35.1.3794309; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Naumov GN, 2006, CELL CYCLE, V5, P1779, DOI 10.4161/cc.5.16.3018; Nolan DJ, 2007, GENE DEV, V21, P1546, DOI 10.1101/gad.436307; Peters BA, 2005, NAT MED, V11, P261, DOI 10.1038/nm1200; Prindull GA, 2007, EXP HEMATOL, V35, P691, DOI 10.1016/j.exphem.2007.01.047; Ruzinova MB, 2003, CANCER CELL, V4, P277, DOI 10.1016/S1535-6108(03)00240-X; Townson JL, 2006, CELL CYCLE, V5, P1744, DOI 10.4161/cc.5.16.2864	20	514	550	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2008	319	5860					195	198		10.1126/science.1150224	http://dx.doi.org/10.1126/science.1150224			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249RC	18187653				2022-12-28	WOS:000252246400039
J	Kim, JSM; Zhen, M				Kim, Joanne S. M.; Zhen, Mei			Protons as intercellular messengers	CELL			English	Editorial Material							RECEPTOR	Muscle contractions are driven by neurotransmitters released at neuromuscular junctions. In this issue, Beg et al. ( 2008) report that protons, in the absence of neurotransmitters and neurons, can stimulate muscle contractions involved in the defecation cycle of the worm Caenorhabditis elegans. Their results identify protons as a new intercellular messenger and suggest that protonmediated intercellular communication may be a widespread phenomenon.	[Kim, Joanne S. M.; Zhen, Mei] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Kim, Joanne S. M.; Zhen, Mei] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Zhen, Mei] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Zhen, M (corresponding author), Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada.	zhen@mshri.on.ca	Zhen, Mei/A-4967-2012	Zhen, Mei/0000-0003-0086-9622				BEG AA, 2008, CELL; Branicky R, 2006, TRENDS GENET, V22, P571, DOI 10.1016/j.tig.2006.08.006; CROLL N A, 1975, P71, DOI 10.1016/S0065-308X(08)60319-X; Dal Santo P, 1999, CELL, V98, P757, DOI 10.1016/S0092-8674(00)81510-X; KAILA K, 1994, PROG NEUROBIOL, V42, P489, DOI 10.1016/0301-0082(94)90049-3; MAHNENSMITH RL, 1985, CIRC RES, V56, P773, DOI 10.1161/01.RES.56.6.773; Peters MA, 2007, CURR BIOL, V17, P1601, DOI 10.1016/j.cub.2007.08.031; Slepkov ER, 2007, BIOCHEM J, V401, P623, DOI 10.1042/BJ20061062; THOMAS JH, 1990, GENETICS, V124, P855; Vukicevic M, 2004, AM J PHYSIOL-CELL PH, V287, pC682, DOI 10.1152/ajpcell.00127.2004; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Zha XM, 2006, P NATL ACAD SCI USA, V103, P16556, DOI 10.1073/pnas.0608018103	12	5	5	2	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2008	132	1					21	22		10.1016/j.cell.2007.12.020	http://dx.doi.org/10.1016/j.cell.2007.12.020			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IL	18191215	Bronze			2022-12-28	WOS:000253427600010
J	Rafii, S; Lyden, D				Rafii, Shahin; Lyden, David			Cancer - A few to flip the angiogenic switch	SCIENCE			English	Editorial Material							ENDOTHELIAL PROGENITOR CELLS; MARROW; TUMORS; NEOVASCULARIZATION; RECRUITMENT; CONTRIBUTE; THERAPY		[Rafii, Shahin; Lyden, David] Columbia Univ, Howard Hughes Med Inst, Weill Cornell Med Coll, New York, NY 10065 USA	Columbia University; Cornell University; Howard Hughes Medical Institute	Rafii, S (corresponding author), Columbia Univ, Howard Hughes Med Inst, Weill Cornell Med Coll, New York, NY 10065 USA.	srafii@med.cornell.edu; dcl2001@med.cornell.edu			Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [R01 HL061849-03S1, P50 HL084936-040003, R01 HL075234-01, P50 HL084936-030003, R01 HL075234, R01 HL061849-02, R01 HL061849-03, P01 HL067839-040004, R01 HL061849-04, R21 HL083222, R01 HL075234-03, R01 HL075234-04, R21 HL083222-01, R21 HL083222-02, P01 HL067839-010004, P01 HL067839, R01 HL061849, P50 HL084936-010003, P01 HL067839-020004, R01 HL075234-02, R01 HL058707-03, R01 HL061849-05, R01 HL058707-04, P50 HL084936, P01 HL067839-050004, P01 HL067839-030004, P50 HL084936-020003] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL067839, P50HL084936, R01HL075234, R01HL061849, R21HL083222, R01HL058707] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aicher A, 2007, CIRC RES, V100, P581, DOI 10.1161/01.RES.0000259562.63718.35; Bertolini F, 2006, NAT REV CANCER, V6, P833, DOI 10.1039/nrc1971; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Duda DG, 2006, BLOOD, V107, P2774, DOI 10.1182/blood-2005-08-3210; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Gothert JR, 2004, BLOOD, V104, P1769, DOI 10.1182/blood-2003-11-3952; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Minami E, 2005, CIRCULATION, V112, P2951, DOI 10.1161/CIRCULATIONAHA.105.576017; Nolan DJ, 2007, GENE DEV, V21, P1546, DOI 10.1101/gad.436307; Peters BA, 2005, NAT MED, V11, P261, DOI 10.1038/nm1200; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Rafii S, 2002, NAT REV CANCER, V2, P826, DOI 10.1038/nrc925; RAFII S, 2006, NAT REV CANCER, V6, P835; Ruzinova MB, 2003, CANCER CELL, V4, P277, DOI 10.1016/S1535-6108(03)00240-X; Shaked Y, 2005, CANCER CELL, V7, P101, DOI 10.1016/j.ccr.2004.11.023; Shaked Y, 2006, SCIENCE, V313, P1785, DOI 10.1126/science.1127592; Spring H, 2005, P NATL ACAD SCI USA, V102, P18111, DOI 10.1073/pnas.0507158102; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471	19	57	61	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2008	319	5860					163	164		10.1126/science.1153615	http://dx.doi.org/10.1126/science.1153615			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249RC	18187643	Green Accepted			2022-12-28	WOS:000252246400025
J	Narayan, RL				Narayan, Rajeev L.			Spontaneous pneumothorax in tuberous sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Columbia Univ Coll Phys & Surg, New York, NY 10032 USA	Columbia University	Narayan, RL (corresponding author), Columbia Univ Coll Phys & Surg, 630 W 168th St, New York, NY 10032 USA.	RN2187@columbia.edu							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2008	358	2					177	177		10.1056/NEJMicm074098	http://dx.doi.org/10.1056/NEJMicm074098			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249CJ	18184963				2022-12-28	WOS:000252204200009
J	Steinbrook, R				Steinbrook, Robert			HIV in india - A downsized epidemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						Dandona L, 2007, LANCET, V370, P1811, DOI 10.1016/S0140-6736(07)61756-5; Steinbrook R, 2007, NEW ENGL J MED, V356, P1089, DOI 10.1056/NEJMp078009; Steinbrook R, 2007, NEW ENGL J MED, V356, P1197, DOI 10.1056/NEJMp078011; *UNAIDS, 2007, AIDS EP UPD; 2007, 2005 06 NAT FAM HLTH	5	15	15	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2008	358	2					107	109		10.1056/NEJMp0708474	http://dx.doi.org/10.1056/NEJMp0708474			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	249CJ	18184956				2022-12-28	WOS:000252204200002
J	Toudic, B; Garcia, P; Odin, C; Rabiller, P; Ecolivet, C; Collet, E; Bourges, P; McIntyre, GJ; Hollingsworth, MD; Breczewski, T				Toudic, Bertrand; Garcia, Pilar; Odin, Christophe; Rabiller, Philippe; Ecolivet, Claude; Collet, Eric; Bourges, Philippe; McIntyre, Garry J.; Hollingsworth, Mark D.; Breczewski, Tomasz			Hidden degrees of freedom in aperiodic materials	SCIENCE			English	Article							UREA INCLUSION-COMPOUNDS; NEUTRON-SCATTERING; CRYSTAL-GROWTH; COMPOUND; ADDUCTS; ORDER	Numerous crystalline materials, including those of bioorganic origin, comprise incommensurate sublattices whose mutual arrangement is described in a superspace framework exceeding three dimensions. We report direct observation by neutron diffraction of superspace symmetry breaking in a solid- solid phase transition of an incommensurate host- guest system: the channel inclusion compound of nonadecane/ urea. Strikingly, this phase transition generates a unit cell doubling that concerns only the modulation of one substructure by the other- an internal variable available only in superspace. This unanticipated pathway for degrees of freedom to rearrange leads to a second phase transition, which again is controlled by the higher dimensionality of superspace. These results reveal nature's capacity to explore the increased number of phases allowed in aperiodic crystals.	[Toudic, Bertrand; Garcia, Pilar; Odin, Christophe; Rabiller, Philippe; Ecolivet, Claude; Collet, Eric] Univ Rennes 1, IPR, F-35042 Rennes, France; [Toudic, Bertrand; Garcia, Pilar; Odin, Christophe; Rabiller, Philippe; Ecolivet, Claude; Collet, Eric] IPR, CNRS, UMR 6251, F-35042 Rennes, France; [Bourges, Philippe] Ctr Etud Saclay, CNRS, CEA, Lab Leon Brillouin, F-91191 Gif Sur Yvette, France; [McIntyre, Garry J.] Inst Max Von Laue Paul Langevin, F-38042 Grenoble 9, France; [Hollingsworth, Mark D.] Kansas State Univ, Dept Chem, Manhattan, KS 66506 USA; [Breczewski, Tomasz] Univ Basque Country, Fac Ciencias, E-48080 Bilbao, Spain	Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut Laue-Langevin (ILL); Kansas State University; University of Basque Country	Toudic, B (corresponding author), Univ Rennes 1, IPR, F-35042 Rennes, France.	bertrand.toudic@univ-rennes1.fr	ECOLIVET, Claude H/N-8640-2014; Garcia-Orduña, Pilar M/C-9844-2014; Toudic, Bertrand/N-6834-2014; Breczewski, Tomasz/H-8910-2015; McIntyre, Garry/AAL-3103-2020; Collet, Eric/O-9037-2019; RABILLER, Philippe/O-1623-2014	Garcia-Orduña, Pilar M/0000-0002-7063-1292; Collet, Eric/0000-0003-0810-7411; McIntyre, Garry/0000-0003-3722-0624				Abe E, 2004, NAT MATER, V3, P759, DOI 10.1038/nmat1244; Bourgeois L, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.025504; BRAUN DM, 2005, PHYS REV LETT, V95; CHATANI Y, 1977, ACTA CRYSTALLOGR B, V33, P309, DOI 10.1107/S0567740877003501; COPPENS P, 1995, ACTA CRYSTALLOGR B, V51, P402, DOI 10.1107/S0108768195003235; FORST R, 1990, ACTA CRYSTALLOGR B, V46, P70, DOI 10.1107/S0108768189009912; Gorbitz CH, 2007, CHEM-EUR J, V13, P1022, DOI 10.1002/chem.200601427; GUILLAUME F, 1990, J CHEM PHYS, V93, P3536, DOI 10.1063/1.458835; HARRIS KDM, 1990, J CHEM SOC FARADAY T, V86, P2985, DOI 10.1039/ft9908602985; Hollingsworth M. D., 1996, COMPREHENSIVE SUPRAM, V6, P177; Hollingsworth MD, 1996, SCIENCE, V273, P1355, DOI 10.1126/science.273.5280.1355; JANNER A, 1984, LECT NOTES PHYS, V201, P394; Janssen T, 2002, J PHYS-CONDENS MAT, V14, P12411, DOI 10.1088/0953-8984/14/47/314; Janssen T., 1995, INT TABLES CRYSTALLO, VC, P797; Janssen T., 2007, APERIODIC CRYSTALS M; Konig O, 1997, J AM CHEM SOC, V119, P10632, DOI 10.1021/ja971945s; Le Lann H, 2000, PHYS REV B, V62, P5442, DOI 10.1103/PhysRevB.62.5442; Lefort R, 1996, PHYS REV LETT, V77, P4027, DOI 10.1103/PhysRevLett.77.4027; LYNDENBELL RM, 1993, MOL PHYS, V79, P313, DOI 10.1080/00268979300101231; Macia E, 2006, REP PROG PHYS, V69, P397, DOI 10.1088/0034-4885/69/2/R03; Marti-Rujas J, 2004, J AM CHEM SOC, V126, P11124, DOI 10.1021/ja040117d; Mickelson W, 2003, SCIENCE, V300, P467, DOI 10.1126/science.1082346; MIDGLEY PA, 1993, PHYS REV LETT, V70, P678, DOI 10.1103/PhysRevLett.70.678; PEMBERTON RC, 1965, T FARADAY SOC, V61, P2112, DOI 10.1039/tf9656102112; SMIT B, 1995, NATURE, V374, P42, DOI 10.1038/374042a0; Toudic B, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.145503; vanSmaalen S, 1996, P ROY SOC A-MATH PHY, V452, P677, DOI 10.1098/rspa.1996.0034; Weber T, 1996, Z KRISTALLOGR, V211, P238, DOI 10.1524/zkri.1996.211.4.238	28	72	72	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2008	319	5859					69	71		10.1126/science.1146745	http://dx.doi.org/10.1126/science.1146745			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18174435				2022-12-28	WOS:000252084000031
J	Johnson, PA; Savage, H; Knuth, M; Gomberg, J; Marone, C				Johnson, Paul A.; Savage, Heather; Knuth, Matt; Gomberg, Joan; Marone, Chris			Effects of acoustic waves on stick-slip in granular media and implications for earthquakes	NATURE			English	Article							SEISMICITY; CALIFORNIA; FRICTION; STRESS	It remains unknown how the small strains induced by seismic waves can trigger earthquakes at large distances, in some cases thousands of kilometres from the triggering earthquake, with failure often occurring long after the waves have passed(1-6). Earthquake nucleation is usually observed to take place at depths of 10 - 20 km, and so static overburden should be large enough to inhibit triggering by seismic- wave stress perturbations. To understand the physics of dynamic triggering better, as well as the influence of dynamic stressing on earthquake recurrence, we have conducted laboratory studies of stick - slip in granular media with and without applied acoustic vibration. Glass beads were used to simulate granular fault zone material, sheared under constant normal stress, and subject to transient or continuous perturbation by acoustic waves. Here we show that small- magnitude failure events, corresponding to triggered aftershocks, occur when applied sound- wave amplitudes exceed several microstrain. These events are frequently delayed or occur as part of a cascade of small events. Vibrations also cause large slip events to be disrupted in time relative to those without wave perturbation. The effects are observed for many large- event cycles after vibrations cease, indicating a strain memory in the granular material. Dynamic stressing of tectonic faults may play a similar role in determining the complexity of earthquake recurrence.	[Johnson, Paul A.] Los Alamos Natl Lab, Geophys Grp EES11, Los Alamos, NM 87545 USA; [Savage, Heather; Knuth, Matt; Marone, Chris] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Savage, Heather] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Knuth, Matt] Univ Wisconsin, Dept Geol & Geophys, Madison, WI 53706 USA; [Gomberg, Joan] Univ Washington, Dept Earth & Space Sci, US Geol Survey, Seattle, WA 98195 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California Santa Cruz; University of Wisconsin System; University of Wisconsin Madison; United States Department of the Interior; United States Geological Survey; University of Washington; University of Washington Seattle	Johnson, PA (corresponding author), Los Alamos Natl Lab, Geophys Grp EES11, MS D443, Los Alamos, NM 87545 USA.	paj@lanl.gov		Johnson, Paul/0000-0002-0927-4003				Beeler NM, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001518; Brodsky EE, 2000, GEOPHYS RES LETT, V27, P2741, DOI 10.1029/2000GL011534; Brodsky EE, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003211; Felzer KR, 2006, NATURE, V441, P735, DOI 10.1038/nature04799; Freed AM, 2005, ANNU REV EARTH PL SC, V33, P335, DOI 10.1146/annurev.earth.33.092203.122505; Gomberg J, 2004, NATURE, V427, P621, DOI 10.1038/nature02335; Gomberg J, 2003, B SEISMOL SOC AM, V93, P118, DOI 10.1785/0120020075; Hartley RR, 2003, NATURE, V421, P928, DOI 10.1038/nature01394; HILL DP, 1993, SCIENCE, V260, P1617, DOI 10.1126/science.260.5114.1617; Hough SE, 2001, B SEISMOL SOC AM, V91, P1574, DOI 10.1785/0120000259; Mair K, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000516; Marone C, 1998, ANNU REV EARTH PL SC, V26, P643, DOI 10.1146/annurev.earth.26.1.643; Morgan JK, 1999, J GEOPHYS RES-SOL EA, V104, P2703, DOI 10.1029/1998JB900056; Nasuno S, 1998, PHYS REV E, V58, P2161, DOI 10.1103/PhysRevE.58.2161; Scholz C.H., 2002, MECH EARTHQUAKES FAU, DOI 10.1017/CBO9780511818516; Scholz CH, 2000, GEOLOGY, V28, P163, DOI 10.1130/0091-7613(2000)28<163:EFASSA>2.0.CO;2; ZOBACK MD, 1993, GEOLOGY, V21, P181, DOI 10.1130/0091-7613(1993)021<0181:EFNFFI>2.3.CO;2	17	149	156	3	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2008	451	7174					57	U5		10.1038/nature06440	http://dx.doi.org/10.1038/nature06440			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247KZ	18172496				2022-12-28	WOS:000252079300032
J	Vadas, P; Gold, M; Perelman, B; Liss, GM; Lack, G; Blyth, T; Simons, FER; Simons, KJ; Cass, D; Yeung, J				Vadas, Peter; Gold, Milton; Perelman, Boris; Liss, Gary M.; Lack, Gideon; Blyth, Thomas; Simons, F. Estelle R.; Simons, Keith J.; Cass, Dan; Yeung, Jupiter			Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHILDREN	Background: Platelet-activating factor (PAF) is an important mediator of anaphylaxis in animals, and interventions that block PAF prevent fatal anaphylaxis. The roles of PAF and PAF acetylhydrolase, the enzyme that inactivates PAF, in anaphylaxis in humans have not been reported. Methods: We measured serum PAF levels and PAF acetylhydrolase activity in 41 patients with anaphylaxis and in 23 control patients. Serum PAF acetylhydrolase activity was also measured in 9 patients with peanut allergy who had fatal anaphylaxis and compared with that in 26 nonallergic pediatric control patients, 49 nonallergic adult control patients, 63 children with mild peanut allergy, 24 patients with nonfatal anaphylaxis, 10 children who died of nonanaphylactic causes, 15 children with life-threatening asthma, and 19 children with non-life-threatening asthma. Results: Mean (+/-SD) serum PAF levels were significantly higher in patients with anaphylaxis (805+/-595 pg per milliliter) than in patients in the control groups (127+/-104 pg per milliliter, P<0.001 after log transformation) and were correlated with the severity of anaphylaxis. The proportion of subjects with elevated PAF levels increased from 4% in the control groups to 20% in the group with grade 1 anaphylaxis, 71% in the group with grade 2 anaphylaxis, and 100% in the group with grade 3 anaphylaxis (P<0.001). There was an inverse correlation between PAF levels and PAF acetylhydrolase activity (P<0.001). The proportion of patients with low PAF acetylhydrolase values increased with the severity of anaphylaxis (P<0.001 for all comparisons). Serum PAF acetylhydrolase activity was significantly lower in patients with fatal peanut anaphylaxis than in control patients (P values <0.001 for all comparisons). Conclusions: Serum PAF levels were directly correlated and serum PAF acetylhydrolase activity was inversely correlated with the severity of anaphylaxis. PAF acetylhydrolase activity was significantly lower in patients with fatal anaphylactic reactions to peanuts than in patients in any of the control groups. Failure of PAF acetylhydrolase to inactivate PAF may contribute to the severity of anaphylaxis.	St Michaels Hosp, Dept Med, Div Clin Immunol & Allergy, Toronto, ON M5B 1W8, Canada; St Michaels Hosp, Dept Emergency Med, Toronto, ON M5B 1W8, Canada; Hosp Sick Children, Dept Pediat, Div Immunol & Allergy, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Publ Hlth Sci, Gage Occupat & Environm Hlth Unit, Toronto, ON, Canada; St Marys Hosp, Imperial Coll, Dept Pediat Allergy, London, England; Univ Manitoba, Fac Med, Dept Pediat & Child Hlth, Winnipeg, MB, Canada; Univ Manitoba, Fac Pharm, Div Pharmaceut Sci, Winnipeg, MB R3T 2N2, Canada; Food Prod Assoc, Washington, DC USA	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Imperial College London; University of Manitoba; University of Manitoba	Vadas, P (corresponding author), St Michaels Hosp, Dept Med, Div Clin Immunol & Allergy, Carter Wing 8-161,30 Bond St, Toronto, ON M5B 1W8, Canada.	vadasp@smh.toronto.on.ca		Lack, Gideon/0000-0001-7350-4021	Medical Research Council [G0400503B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Ansley DM, 1997, J INVEST SURG, V10, P87, DOI 10.3109/08941939709032138; Bock SA, 2001, J ALLERGY CLIN IMMUN, V107, P191, DOI 10.1067/mai.2001.112031; Brown AFT, 2001, J ALLERGY CLIN IMMUN, V108, P861, DOI 10.1067/mai.2001.119028; Devenney I, 2000, ANN ALLERG ASTHMA IM, V85, P455, DOI 10.1016/S1081-1206(10)62571-9; Estelle F, 2006, J ALLERGY CLIN IMMUN, V117, P367, DOI 10.1016/j.jaci.2005.12.002; Finkelman FD, 2005, J ALLERGY CLIN IMMUN, V115, P449, DOI 10.1016/j.jaci.2004.12.1125; Ishii S, 1998, J EXP MED, V187, P1779, DOI 10.1084/jem.187.11.1779; Karasawa K, 2006, BBA-MOL CELL BIOL L, V1761, P1359, DOI 10.1016/j.bbalip.2006.06.017; MIWA M, 1988, J CLIN INVEST, V82, P1983, DOI 10.1172/JCI113818; Pumphrey R, 2004, CURR OPIN ALLERGY CL, V4, P285, DOI 10.1097/01.all.0000136762.89313.0b; SAMPSON HA, 1992, NEW ENGL J MED, V327, P380, DOI 10.1056/NEJM199208063270603; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Sarchielli P, 2004, CEPHALALGIA, V24, P623, DOI 10.1111/j.1468-2982.2003.00717.x; Schwartz Lawrence B, 2004, Novartis Found Symp, V257, P65; Simons FER, 2002, J ALLERGY CLIN IMMUN, V109, P171, DOI 10.1067/mai.2002.120758; STAFFORINI DM, 1990, J BIOL CHEM, V265, P9682; Stafforini DM, 2003, CRIT REV CL LAB SCI, V40, P643, DOI 10.1080/714037693; STAFFORINI DM, 1987, J BIOL CHEM, V262, P4215; Strait Richard, 2004, Novartis Found Symp, V257, P80; Vadas P., 2003, Journal of Allergy and Clinical Immunology, V111, pS206, DOI 10.1016/S0091-6749(03)80712-1	20	371	384	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2008	358	1					28	35		10.1056/NEJMoa070030	http://dx.doi.org/10.1056/NEJMoa070030			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	246TW	18172172				2022-12-28	WOS:000252031200005
J	Takai, H; Wang, RC; Takai, KK; Yang, H; de Lange, T				Takai, Hiroyuki; Wang, Richard C.; Takai, Kaori K.; Yang, Haijuan; de lange, Titia			TeI2 regulates the stability of PI3K-related protein kinases	CELL			English	Article							TELOMERE LENGTH REGULATION; SACCHAROMYCES-CEREVISIAE; ATAXIA-TELANGIECTASIA; C-ELEGANS; CAENORHABDITIS-ELEGANS; LIFE-SPAN; GENE; MTOR; CHECKPOINT; MOUSE	We report an unexpected role for Tel2 in the expression of all mammalian phosphatidylinositol 3-kinase-related protein kinases (PIKKs). Although Tel2 was identified as a budding yeast gene required for the telomere length maintenance, we found no obvious telomeric function for mammalian Tel2. Targeted gene deletion showed that mouse Tel2 is essential in embryonic development, embryonic stem (ES) cells, and embryonic fibroblasts. Conditional deletion of Tel2 from embryonic fibroblasts compromised their response to IR and UV, diminishing the activation of checkpoint kinases and their downstream effectors. The effects of Tel2 deletion correlated with significantly reduced protein levels for the PI3K-related kinases ataxia telangiectasia mutated (ATM), ATM and Rad3 related (ATR), DNA-dependent protein kinase catalytic subunit ataxia (DNA-PKcs). Tel2 deletion also elicited specific depletion of the mammalian target of rapamycin (mTOR), suppressor with morphological effect on genitalia 1 (SMG1), and transformation/transcription domain-associated protein (TRRAP), and curbed mTOR signaling, indicating that Tel2 affects all six mammalian PIKKs. While Tel2 deletion did not alter PIKK mRNA levels, in vivo pulse labeling experiments showed that Tel2 controls the stability of ATM and mTOR. Each of the PIKK family members associated with Tel2 in vivo and in vitro experiments indicated that Tel2 binds to part of the HEAT repeat segments of ATM and mTOR. These data identify Tel2 as a highly conserved regulator of PIKK stability.	[Takai, Hiroyuki; Wang, Richard C.; Takai, Kaori K.; de lange, Titia] Rockefeller Univ, Cell Biol & Genet Lab, New York, NY 10065 USA; [Yang, Haijuan] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Struct Biol Program, New York, NY 10065 USA	Rockefeller University; Memorial Sloan Kettering Cancer Center	de Lange, T (corresponding author), Rockefeller Univ, Cell Biol & Genet Lab, 1230 York Ave, New York, NY 10065 USA.	delange@rockefeller.edu	Wang, Richard/AAW-3066-2021; Takai, Hiroyuki/B-8352-2011; de Lange, Titia/B-8263-2011	Wang, Richard/0000-0003-4543-8295; de Lange, Titia/0000-0002-9267-367X	NCI NIH HHS [K08 CA164047, CA076027] Funding Source: Medline; NIGMS NIH HHS [GM07739] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K08CA164047, R01CA076027] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Ahmed S, 2001, CURR BIOL, V11, P1934, DOI 10.1016/S0960-9822(01)00604-2; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Badea TC, 2003, J NEUROSCI, V23, P2314; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Benard C, 2001, DEVELOPMENT, V128, P4045; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; Brown EJ, 2000, GENE DEV, V14, P397; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Collis SJ, 2007, NAT CELL BIOL, V9, P391, DOI 10.1038/ncb1555; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; GREENWELL PW, 1995, CELL, V82, P823, DOI 10.1016/0092-8674(95)90479-4; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; HARTMAN PS, 1982, GENETICS, V102, P159; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Herceg Z, 2005, CELL CYCLE, V4, P383, DOI 10.4161/cc.4.3.1546; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jiang N, 2003, J BIOL CHEM, V278, P21678, DOI 10.1074/jbc.M300286200; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; LAVIN MF, 1995, TRENDS BIOCHEM SCI, V20, P382, DOI 10.1016/S0968-0004(00)89083-0; LUSTIG AJ, 1986, P NATL ACAD SCI USA, V83, P1398, DOI 10.1073/pnas.83.5.1398; MORROW DM, 1995, CELL, V82, P831, DOI 10.1016/0092-8674(95)90480-8; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Ritchie KB, 1999, MOL CELL BIOL, V19, P6065; Runge KW, 1996, MOL CELL BIOL, V16, P3094; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Seibler J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm122; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shikata M, 2007, J BIOL CHEM, V282, P5346, DOI 10.1074/jbc.M607432200; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Silverman J, 2004, GENE DEV, V18, P2108, DOI 10.1101/gad.1216004; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Taniguchi M, 1998, NUCLEIC ACIDS RES, V26, P679, DOI 10.1093/nar/26.2.679; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; WATANABE K, 1995, J CELL BIOL, V130, P1207, DOI 10.1083/jcb.130.5.1207; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu LF, 2004, J CELL BIOL, V167, P819, DOI 10.1083/jcb.200408181; Ye JZS, 2004, NAT GENET, V36, P618, DOI 10.1038/ng1360	44	173	178	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 28	2007	131	7					1248	1259		10.1016/j.cell.2007.10.052	http://dx.doi.org/10.1016/j.cell.2007.10.052			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GV	18160036	Bronze			2022-12-28	WOS:000252217200015
J	Vonnegut, M				Vonnegut, Mark			Is quality improvement improving quality ?: A view from the doctor's office	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	10	10	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2007	357	26					2652	2653		10.1056/NEJMp0706425	http://dx.doi.org/10.1056/NEJMp0706425			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	245UO	18160683				2022-12-28	WOS:000251964500002
J	Wilson, CH; White, SA				Wilson, Colin H.; White, Steve A.			Small-bowel intussusception	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Freeman Rd Hosp, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England	Newcastle Freeman Hospital; Newcastle University - UK	Wilson, CH (corresponding author), Freeman Rd Hosp, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England.	c4moon@doctors.org.uk							0	0	0	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2007	357	26					E30	E30		10.1056/NEJMicm064904	http://dx.doi.org/10.1056/NEJMicm064904			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	245UO	18160681				2022-12-28	WOS:000251964500010
J	Holt, GR				Holt, G. Richard			Repair of facial fractures in the Iraq war combat theater	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								Objective: To determine the safety of definitive in- theater facial fracture repair on American military personnel wounded during Operation Iraqi Freedom. Methods: A retrospective review of all patients with head and neck trauma treated at the 322nd Expeditionary Medical Group/ Air Force Theater Hospital, Balad Air Base, Iraq, from May 7, 2005, through September 18, 2005, was performed. This study focused on the outcomes of wounded American military personnel whose facial fractures were definitively repaired in theater. The criteria used to determine candidacy for definitive in- theater facial fracture repair on American military personnel were ( 1) the fracture site was exposed through either a soft tissue wound or because of an adjacent surgical approach, ( 2) treatment would not delay evacuation from theater, and ( 3) treatment would allow the military member to remain in theater. Results: From May 2005 to September 2005, 207 patients were taken to the operating room and required 388 procedures. A total of 175 patients ( 85%) were operated on for traumatic injuries, and 52 of these patients required open reduction and internal fixation ( ORIF) of a facial fracture. Of the 52 patients who underwent an ORIF, 17 were American military personnel. Of the 17 American patients who were definitively treated for their facial fractures in theater, 16 were contacted and/ or followed up on the global military medical database. None of these patients developed an Acinetobacter baumannii infection or had a complication caused by the definitive in- theater ORIF. The range of follow- up was 2 months to 11 months, with a mean of 8.3 months. Conclusions: Definitive repair of facial fractures with ORIF on American military personnel in theater is advised when the aforementioned criteria are observed. An otolaryngologist is a crucial member of the head and neck trauma team.	Univ Texas Hlth Sci Ctr San Antonio, Dept Otolaryngol Head & Neck Surg, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Holt, GR (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Otolaryngol Head & Neck Surg, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	HoltG@uthscsa.edu						Berkowitz G, 2007, ENT TODAY        MAY, P12; *CTRP, 2004, MMWR-MORBID MORTAL W, V53, P1063; DORLAND P, 1982, DUST OFF ARMY AEROME, P115; Lopez MA, 2007, ARCH FACIAL PLAST S, V9, P400, DOI 10.1001/archfaci.9.6.400; PAGE T N, 1957, U S Armed Forces Med J, V8, P1195	5	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2007	298	24					2905	2906		10.1001/jama.298.24.2905	http://dx.doi.org/10.1001/jama.298.24.2905			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243RW	18163245				2022-12-28	WOS:000251816000023
J	Khan, MM				Khan, Murad M.			Keeping alive the "jazba"	BRITISH MEDICAL JOURNAL			English	Editorial Material									Aga Khan Univ, Dept Psychiat, Karachi 74800, Pakistan	Aga Khan University	Khan, MM (corresponding author), Aga Khan Univ, Dept Psychiat, Karachi 74800, Pakistan.		Khan, Murad/AAE-5134-2020						0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 21	2006	333	7573					864	864		10.1136/bmj.333.7573.864	http://dx.doi.org/10.1136/bmj.333.7573.864			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100ON	18232084	Green Published			2022-12-28	WOS:000241678500036
J	Bryce, J; Coitinho, D; Darnton-Hill, I; Pelletier, D; Pinstrup-Andersen, P				Bryce, Jennifer; Coitinho, Denise; Darnton-Hill, Ian; Pelletier, David; Pinstrup-Andersen, Per		Maternal & Child Undernutr Study G	Maternal and Child Undernutrition 4 - Maternal and child undernutrition: effective action at national level	LANCET			English	Article							NUTRITIONAL-STATUS; HEALTH-SERVICES; YOUNG-CHILDREN; MORTALITY; SURVIVAL; INTERVENTIONS; INFANTS; PROGRAM; AFRICA; IMPACT	80% of the world's undernourished children live in just 20 countries. Intensified nutrition action in these countries can lead to achievement of the first Millennium Development Goal (MDG) and greatly increase the chances of achieving goals for child and maternal mortality (MDGs 4 and 5). Despite isolated successes in specific countries or for interventions-eg, iodised salt and vitamin A supplementation-most countries with high rates of undernutrition are failing to reach undernourished mothers and children with effective interventions supported by appropriate policies. This paper reports on an assessment of actions addressing undernutrition in the countries with the highest burden of undernutrition, drawing on systematic reviews and best-practice reports. Seven key Challenges for addressing undernutrition at national level are defined and reported on: getting nutrition on the list of priorities, and keeping it there; doing the right things; not doing the wrong things; acting at scale; reaching those in need; data-based decisionmaking; and building strategic and operational capacity. Interventions with proven effectiveness that are selected by countries should be rapidly implemented at scale. The period from pregnancy to 24 months of age is a crucial window of opportunity for reducing undernutrition and its adverse effects. Programme efforts, as well as monitoring and assessment, should focus on this segment of the continuum of care. Nutrition resources should not be used to support actions unlikely to be effective in the context of country or local realities. Nutrition resources should not be used to support actions that have not been proven to have a direct effect on undernutrition, such as stand-alone growth monitoring or school feeding programmes. In addition to health and nutrition interventions, economic and social policies addressing poverty, trade, and agriculture that have been associated with rapid improvements in nutritional status should be implemented. There is a reservoir of important experience and expertise in individual countries about how to build commitment, develop and monitor nutrition programmes, move toward acting at scale, reform or phase-out ineffective programmes, and other challenges. This resource needs to be formalised, shared, and used as the basis for setting priorities in problem-solving research for nutrition.	[Bryce, Jennifer] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Coitinho, Denise] WHO, CH-1211 Geneva, Switzerland; [Darnton-Hill, Ian] UNICEF, New York, NY USA; [Pelletier, David; Pinstrup-Andersen, Per] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; World Health Organization; UNICEF; Cornell University	Bryce, J (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, 615 N Wolfe St, Baltimore, MD 21205 USA.	jbryce@jhsph.edu	Hallal, Pedro C/A-3249-2011	Hallal, Pedro C/0000-0003-1470-6461; Kirkwood, Betty/0000-0001-5274-6072	Medical Research Council [U1475000003] Funding Source: researchfish; Medical Research Council [G0400519, U.1475.00.004.00005.01 (85821), MC_U147585821, G0400519(71108)] Funding Source: Medline; MRC [MC_U147585821, G0400519] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aguayo VM, 2003, BRIT MED J, V326, P127, DOI 10.1136/bmj.326.7381.127; Allen L.H., 2001, WHAT WORKS REV EFFIC; Allen LH, GUIDELINES FOOD FORT; [Anonymous], DEM HLTH SURV; [Anonymous], EM DAT OFDA CRED INT; ASHWORTH A, IN PRESS J MAT CHILD; Barrett CB, 2005, FOOD AID 50 YEARS RE; BERG A, 1993, AM J CLIN NUTR, V57, P3, DOI 10.1093/ajcn/57.1.3; BHUTTA ZA, 2008, LANCET          0117, DOI DOI 10.1016/S0140-6736(07)61693-6; Birn AE, 2005, LANCET, V366, P514, DOI 10.1016/S0140-6736(05)66479-3; Bishai D, 2002, ECON DEV CULT CHANGE, V51, P37, DOI 10.1086/345361; *BRAZ MIN HLTH, 2005, AV PROGR BOLS AL 2 F; Bryce J, 2005, HEALTH POLICY PLANN, V20, pI5, DOI 10.1093/heapol/czi055; Bryce J, 2005, LANCET, V365, P2193, DOI 10.1016/S0140-6736(05)66777-3; Bryce J, 2003, LANCET, V362, P159, DOI 10.1016/S0140-6736(03)13870-6; Bryce J, 2006, LANCET, V368, P1067, DOI 10.1016/S0140-6736(06)69339-2; Carpenter KJ, 2005, J NUTR, V135, P675, DOI 10.1093/jn/135.4.675; CHOWDHURY N, 2006, 92 MTID INT FOOD POL; Darnton-Hill I, 1998, PUBLIC HEALTH NUTR, V1, P23, DOI 10.1079/PHN19980005; De Pee S., 2005, PREVENTIVE NUTR COMP, P689; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; GILLESPIE D, 2007, SCALING HLTH TECHNOL; Gitau R, 2005, PUBLIC HEALTH NUTR, V8, P837, DOI 10.1079/PHN2005746; GWATKIN DR, 2007, SOCIOECONOMIC DIFFER; Heaver R., 2005, STRENGTHENING COUNTR; Hossain SMM, 2005, HEALTH POLICY PLANN, V20, P35, DOI 10.1093/heapol/czi004; *INT BAB FOOD ACT, 2004, BREAK RUL STRETCH RU; *JOINT UN PROGR HI, REP GLOB AIDS EP 200; Knippenberg R, 2005, LANCET, V365, P1087, DOI 10.1016/S0140-6736(05)74233-1; Krause VM, 1998, J NUTR, V128, P860, DOI 10.1093/jn/128.5.860; Leroy JL, 2007, J NUTR, V137, P2311, DOI 10.1093/jn/137.10.2311; LEVINSON J, 2002, SEARCHING HOME I ISS; Marek T, 1999, HEALTH POLICY PLANN, V14, P382, DOI 10.1093/heapol/14.4.382; Martin-Prevel Y, 2000, B WORLD HEALTH ORGAN, V78, P108; Montagu D, 2002, HEALTH POLICY PLANN, V17, P121, DOI 10.1093/heapol/17.2.121; MORRIS SS, 2008, LANCET          0117, DOI DOI 10.1016/S0140-6736(07)61695-X; Orr J.B., 1936, FOOD HLTH INCOME; Palmer N, 2006, BMJ-BRIT MED J, V332, P718, DOI 10.1136/bmj.332.7543.718; PINSTRUPANDERSE.P, 2006, POVERTY INEQUALITY D; PINSTRUPANDERSE.P, 2000, SEEDS CONTENTION WOR; PINSTRUPANDERSE.P, RURAL INFRASTRUCTURE; PINSTRUPANDERSE.P, 2006, 26 C INT ASS AGR EC; PORTER R, PACKAGED FOODS COMPL; Powell-Jackson T, 2006, LANCET, V368, P1077, DOI 10.1016/S0140-6736(06)69338-0; Rivera JA, 2004, JAMA-J AM MED ASSOC, V291, P2563, DOI 10.1001/jama.291.21.2563; *ROCK FDN, ALL GREE REV AFR AGR; ROKZ D, 2000, WHO SOULD IMPLEMENT; Sachs J., 2001, MACROECONOMICS HLTH; Selwitz Robert H, LANCET, V369, P51, DOI [10.1016/s0140-6736(07)60031-2, DOI 10.1016/S0140-6736(07)60031-2, DOI 10.1016/S0140-6736(07)61690-0]; Sen Amartya, 1995, INEQUALITY REEXAMINE; SHARMA RR, INTRO ADVOCACY; SHEKAR M, 2005, MAINSTREAMING NUTR P; Shiffman J, 2007, AM J PUBLIC HEALTH, V97, P796, DOI 10.2105/AJPH.2006.095455; SHRIMPTON R, 2007, SCN NEWS, V34, P32; *SIPRI, 2007, SIPRI YB 2006 ARM DI; The World Bank, POVCALNET; Torlesse H, 2003, J NUTR, V133, P1320; TRUSSELL J, 1992, POP STUD-J DEMOG, V46, P285, DOI 10.1080/0032472031000146246; *UN C TRAD DEV, 2002, LEAST DEV COUNTR REP; *UN MILL PROJ 2005, 2005, HALV HUNG IT CAN BE; *UN STAND COMM NUT, 5 UN STAND COMM NUTR; UNICEF, MON SIT CHILDR WOM; UNICEF, 2007, STAT WORLDS CHILDR 2; UNICEF, 2005, ACC CHILD SURV DEV R; United Nations Children's Fund (UNICEF), 2007, VIT A SUPPL DEC PROG; Utting P, 2005, DEV PRACT, V15, P375, DOI 10.1080/09614520500075797; Victora CG, 2005, HEALTH POLICY PLANN, V20, pI18, DOI 10.1093/heapol/czi050; Victora CG, 2005, LANCET, V366, P1460, DOI 10.1016/S0140-6736(05)67599-X; Victora CG, 2004, LANCET, V364, P1541, DOI 10.1016/S0140-6736(04)17279-6; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; VICTORA CG, 2008, LANCET          0117, DOI DOI 10.1016/S0140-6736(07)61692-4; Webster J, 2007, HEALTH POLICY PLANN, V22, P277, DOI 10.1093/heapol/czm021; Welch RM, 2004, J EXP BOT, V55, P353, DOI 10.1093/jxb/erh064; *WHO, NAT HLTH ACC; *WHO, HLTH METR NETW; *WHO UNICEF, 2004, UNICEF WHO M JUN 17; *WORLD BANK, COUNTR CLASS; World Bank, 2006, REP NUTR CENTR DEV S; *WORLD BANK, 2007, WORLD DEV REP 2004 M	79	258	266	1	38	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 9	2008	371	9611					510	526		10.1016/S0140-6736(07)61694-8	http://dx.doi.org/10.1016/S0140-6736(07)61694-8			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262SV	18206224				2022-12-28	WOS:000253169200031
J	Mou, XZ; Sun, SL; Edwards, RA; Hodson, RE; Moran, MA				Mou, Xiaozhen; Sun, Shulei; Edwards, Robert A.; Hodson, Robert E.; Moran, Mary Ann			Bacterial carbon processing by generalist species in the coastal ocean	NATURE			English	Article							MARINE; GENES; BACTERIOPLANKTON; ASSEMBLAGES; SEQUENCE; IDENTIFICATION; BIOGEOGRAPHY; COMMUNITIES; MORTALITY; EVOLUTION	The assimilation and mineralization of dissolved organic carbon ( DOC) by marine bacterioplankton is a major process in the ocean carbon cycle(1). However, little information exists on the specific metabolic functions of participating bacteria and on whether individual taxa specialize on particular components of the marine DOC pool(2). Here we use experimental metagenomics to show that coastal communities are populated by taxa capable of metabolizing a wide variety of organic carbon compounds. Genomic DNA captured from bacterial community subsets metabolizing a single model component of the DOC pool ( either dimethylsulphoniopropionate or vanillate) showed substantial overlap in gene composition as well as a diversity of carbon- processing capabilities beyond the selected phenotypes. Our direct measure of niche breadth for bacterial functional assemblages indicates that, in accordance with ecological theory, heterogeneity in the composition and supply of organic carbon to coastal oceans may favour generalist bacteria. In the important interplay between microbial community structure and biogeochemical cycling, coastal heterotrophic communities may be controlled less by transient changes in the carbon reservoir that they process and more by factors such as trophic interactions and physical conditions.	[Mou, Xiaozhen; Sun, Shulei; Hodson, Robert E.; Moran, Mary Ann] Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA; [Edwards, Robert A.] San Diego State Univ, Dept Comp Sci, San Diego, CA 92182 USA	University System of Georgia; University of Georgia; California State University System; San Diego State University	Moran, MA (corresponding author), Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA.	mmoran@uga.edu	Mou, Xiaozhen/AAG-2806-2020; Moran, Mary Ann/B-6939-2012; Edwards, Robert/Q-1691-2019	Edwards, Robert/0000-0001-8383-8949; Moran, Mary Ann/0000-0002-0702-8167				Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Beardsley C, 2003, APPL ENVIRON MICROB, V69, P2624, DOI 10.1128/AEM.69.5.2624-2630.2003; Bouvier T, 2007, ENVIRON MICROBIOL, V9, P287, DOI 10.1111/j.1462-2920.2006.01137.x; Buchan A, 2000, APPL ENVIRON MICROB, V66, P4662, DOI 10.1128/AEM.66.11.4662-4672.2000; Button DK, 2004, APPL ENVIRON MICROB, V70, P5511, DOI 10.1128/AEM.70.9.5511-5521.2004; Crump BC, 1999, APPL ENVIRON MICROB, V65, P3192; DELONG EF, 1989, SCIENCE, V243, P1360, DOI 10.1126/science.2466341; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Doney SC, 2004, FRONT ECOL ENVIRON, V2, P457, DOI 10.2307/3868334; Edwards RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-57; Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544; Fuhrman JA, 2006, P NATL ACAD SCI USA, V103, P13104, DOI 10.1073/pnas.0602399103; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Hamasaki K, 2007, APPL ENVIRON MICROB, V73, P2787, DOI 10.1128/AEM.02111-06; Hewson I, 2006, MAR ECOL PROG SER, V311, P67, DOI 10.3354/meps311067; Howard EC, 2006, SCIENCE, V314, P649, DOI 10.1126/science.1130657; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kassen R, 2002, J EVOLUTION BIOL, V15, P173, DOI 10.1046/j.1420-9101.2002.00377.x; Kiene RP, 2000, J SEA RES, V43, P209, DOI 10.1016/S1385-1101(00)00023-X; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Moran MA, 1999, ESTUARIES, V22, P55, DOI 10.2307/1352927; Moran MA, 2004, NATURE, V432, P910, DOI 10.1038/nature03170; MORAN MA, 1994, LIMNOL OCEANOGR, V39, P762, DOI 10.4319/lo.1994.39.4.0762; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Rodriguez-Brito B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-162; Santos SR, 2004, ENVIRON MICROBIOL, V6, P754, DOI 10.1111/j.1462-2920.2004.00617.x; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Su ZC, 2006, NUCLEIC ACIDS RES, V34, P1050, DOI 10.1093/nar/gkj496; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Todd JD, 2007, SCIENCE, V315, P666, DOI 10.1126/science.1135370; Urbach E, 1999, APPL ENVIRON MICROB, V65, P1207; Vila M, 2004, APPL ENVIRON MICROB, V70, P4648, DOI 10.1128/AEM.70.8.4648-4657.2004; Yokokawa T, 2005, APPL ENVIRON MICROB, V71, P6799, DOI 10.1128/AEM.71.11.6799-6807.2005; Yutin N, 2007, ENVIRON MICROBIOL, V9, P1464, DOI 10.1111/j.1462-2920.2007.01265.x	37	224	241	6	117	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 7	2008	451	7179					708	U4		10.1038/nature06513	http://dx.doi.org/10.1038/nature06513			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HD	18223640				2022-12-28	WOS:000252929500039
J	Tonks, A				Tonks, Alison			Safer by design	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SYSTEMS					atonks@bmj.com						*DEP HLTH, 2003, DES PAT SAF; Elwyn G, 2005, BRIT MED J, V331, P302, DOI 10.1136/bmj.38562.690104.43; Fernando B, 2004, BMJ-BRIT MED J, V328, P1171, DOI 10.1136/bmj.328.7449.1171; Ferner RE, 2004, BRIT MED J, V328, P1172, DOI 10.1136/bmj.328.7449.1172; Grout JR, 2006, QUAL SAF HEALTH CARE, V15, pI44, DOI 10.1136/qshc.2005.016030; Koppel R, 2005, JAMA-J AM MED ASSOC, V293, P1197, DOI 10.1001/jama.293.10.1197; LERTZMAN R, ABSENT MINDED ERROR; *NAT PAT SAF AG, DES PAT SAF FUT AMB; *NHS INN, 2007, DEL INN AG 2006 2007; OAKESHOTT I, 2006, TIMES           0618; Reiling J, 2006, QUAL SAF HEALTH CARE, V15, pI34, DOI 10.1136/qshc.2006.019422; RUSSELL J, 2007, COLLABORATION LED NE; Toft B., 2001, EXTERNAL INQUIRY ADV; WILSON P, DESIGNING OUT MRSA N	14	6	6	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2008	336	7637					186	188		10.1136/bmj.39426.511759.AD	http://dx.doi.org/10.1136/bmj.39426.511759.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259KT	18219038	Green Published			2022-12-28	WOS:000252938900038
J	Rosasco-Nitcher, SE; Lan, WJ; Khorasanizadeh, S; Stukenberg, PT				Rosasco-Nitcher, Sara E.; Lan, Weijie; Khorasanizadeh, Sepideh; Stukenberg, P. Todd			Centromeric Aurora-B activation requires TD-60, microtubules, and substrate priming phosphorylation	SCIENCE			English	Article							CHROMOSOME SEGREGATION; MITOTIC CENTROMERE; CLEAVAGE FURROW; CENTRAL SPINDLE; REGULATES MCAK; INCENP BINDS; KINASE; HASPIN; TARGET; SITES	The chromosome passenger complex ( CPC) controls chromosome congression, kinetochore- microtubule attachments, and spindle checkpoint signaling during mitosis. Aurora- B kinase is the catalytic subunit of the CPC. To understand how a single kinase can regulate such diverse events, we have investigated the activation of Aurora- B and describe two distinct activation mechanisms. First, Aurora- B activation in vitro requires two cofactors, telophase disc-60kD ( TD-60) and microtubules. TD-60 is critical to localize both the CPC and Haspin kinase activity to centromeres and thus regulates Aurora- B at several levels. Second, Aurora- B substrates can inhibit kinase activation, and this is relieved by phosphorylation of these substrates by the centromeric kinases Plk1 and Haspin. These regulatory mechanisms suggest models for phosphorylation by Aurora- B of centromeric substrates at unaligned chromosomes and merotelic attachments.	[Rosasco-Nitcher, Sara E.; Lan, Weijie; Khorasanizadeh, Sepideh; Stukenberg, P. Todd] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia	Stukenberg, PT (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	pts7h@virginia.edu		Stukenberg, Todd/0000-0002-6788-2111	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063045] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM063045-06] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Bishop JD, 2002, J BIOL CHEM, V277, P27577, DOI 10.1074/jbc.C200307200; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Dai J, 2005, CELL CYCLE, V4, P665, DOI 10.4161/cc.4.5.1683; Dai J, 2006, DEV CELL, V11, P741, DOI 10.1016/j.devcel.2006.09.018; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Kaitna S, 2000, CURR BIOL, V10, P1172, DOI 10.1016/S0960-9822(00)00721-1; Kim JH, 1999, J CELL BIOL, V145, P1381, DOI 10.1083/jcb.145.7.1381; Knowlton AL, 2006, CURR BIOL, V16, P1705, DOI 10.1016/j.cub.2006.07.057; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; MACKAY AM, 1993, J CELL BIOL, V123, P373, DOI 10.1083/jcb.123.2.373; Mollinari C, 2003, DEV CELL, V5, P295, DOI 10.1016/S1534-5807(03)00205-3; Ohi R, 2004, MOL BIOL CELL, V15, P2895, DOI 10.1091/mbc.E04-02-0082; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Vagnarelli P, 2004, CHROMOSOMA, V113, P211, DOI 10.1007/s00412-004-0307-3; Wheatley SP, 2001, EXP CELL RES, V262, P122, DOI 10.1006/excr.2000.5088; Zhang X, 2007, MOL BIOL CELL, V18, P3264, DOI 10.1091/mbc.E07-01-0086	20	119	128	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2008	319	5862					469	472		10.1126/science.1148980	http://dx.doi.org/10.1126/science.1148980			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254HB	18218899				2022-12-28	WOS:000252576600040
J	Sliwa, K; Ansari, AA				Sliwa, Karen; Ansari, Aftab A.			Immunosuppression as therapy for congestive heart failure	LANCET			English	Editorial Material							APOPTOTIC CELLS; AUTOIMMUNITY; CLEARANCE; INFUSION		[Sliwa, Karen] Univ Witwatersrand, CH Baragwanath Hosp, Soweto Cardiovasc Res Unit, ZA-2013 Johannesburg, South Africa; [Ansari, Aftab A.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	University of Witwatersrand; Emory University	Sliwa, K (corresponding author), Univ Witwatersrand, CH Baragwanath Hosp, Soweto Cardiovasc Res Unit, ZA-2013 Johannesburg, South Africa.	Sliwa-hahnlek@mdh-africa.org		Sliwa, Karen/0000-0002-8272-0911				Albert ML, 2004, NAT REV IMMUNOL, V4, P223, DOI 10.1038/nri11308; Hanayama R, 2006, CURR DIRECT AUTOIMMU, V9, P162; Kleinclauss F, 2006, CELL DEATH DIFFER, V13, P41, DOI 10.1038/sj.cdd.4401699; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Maeda A, 2005, J IMMUNOL, V174, P5968, DOI 10.4049/jimmunol.174.10.5968; Mahoney JA, 2005, CURR OPIN IMMUNOL, V17, P583, DOI 10.1016/j.coi.2005.09.018; Mann DL, 2002, CIRC RES, V91, P988, DOI 10.1161/01.RES.0000043825.01705.1B; Mousa SA, 2007, EXPERT OPIN BIOL TH, V7, P617, DOI 10.1517/14712598.7.5.617; PARRILLO JE, 1989, NEW ENGL J MED, V321, P1061, DOI 10.1056/NEJM198910193211601; Sliwa K, 1998, LANCET, V351, P1091, DOI 10.1016/S0140-6736(97)09338-0; Torre-Amione G, 2008, LANCET, V371, P228, DOI 10.1016/S0140-6736(08)60134-8; Xia CQ, 2005, TRANSFUSION, V45, P181, DOI 10.1111/j.1537-2995.2004.04137.x	12	8	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 19	2008	371	9608					184	186		10.1016/S0140-6736(08)60115-4	http://dx.doi.org/10.1016/S0140-6736(08)60115-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	252UK	18207004				2022-12-28	WOS:000252471900008
J	Watts, G				Watts, Geoff			Getting the best from research funding	BRITISH MEDICAL JOURNAL			English	Editorial Material												geoff@scileg.freeserve.co.uk						Cooksey D., 2006, REV UK HLTH RES FUND; Department of Health, 2006, BEST RES BEST HLTH; *NIH RES, TRANSF HLTH RES 1 2; *ROYAL SOC, 2006, RESP COOKS REV UK HL; *U UK, 2007, TEST TIM UK HLTH RES	5	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 19	2008	336	7636					120	122		10.1136/bmj.39454.402813.AD	http://dx.doi.org/10.1136/bmj.39454.402813.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	257SS	18202063	Green Published			2022-12-28	WOS:000252819400026
J	Barbier, EB; Koch, EW; Silliman, BR; Hacker, SD; Wolanski, E; Primavera, J; Granek, EF; Polasky, S; Aswani, S; Cramer, LA; Stoms, DM; Kennedy, CJ; Bael, D; Kappel, CV; Perillo, GME; Reed, DJ				Barbier, Edward B.; Koch, Evamaria W.; Silliman, Brian R.; Hacker, Sally D.; Wolanski, Eric; Primavera, Jurgenne; Granek, Elise F.; Polasky, Stephen; Aswani, Shankar; Cramer, Lori A.; Stoms, David M.; Kennedy, Chris J.; Bael, David; Kappel, Carrie V.; Perillo, Gerardo M. E.; Reed, Denise J.			Coastal ecosystem-based management with nonlinear ecological functions and values	SCIENCE			English	Article							MANGROVE FORESTS; THAILAND	A common assumption is that ecosystem services respond linearly to changes in habitat size. This assumption leads frequently to an "all or none" choice of either preserving coastal habitats or converting them to human use. However, our survey of wave attenuation data from field studies of mangroves, salt marshes, seagrass beds, nearshore coral reefs, and sand dunes reveals that these relationships are rarely linear. By incorporating nonlinear wave attenuation in estimating coastal protection values of mangroves in Thailand, we show that the optimal land use option may instead be the integration of development and conservation consistent with ecosystem- based management goals. This result suggests that reconciling competing demands on coastal habitats should not always result in stark preservation- versus- conversion choices.	[Barbier, Edward B.; Kennedy, Chris J.] Univ Wyoming, Dept Econ & Finance, Laramie, WY 82071 USA; [Koch, Evamaria W.] Univ Maryland, Ctr Environm Sci, Horn Point Lab, Cambridge, MD 21613 USA; [Silliman, Brian R.] Univ Florida, Dept Zool, Gainesville, FL 32611 USA; [Hacker, Sally D.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Wolanski, Eric] James Cook Univ N Queensland, Australian Ctr Trop Freshwater Res, Townsville, Qld 4810, Australia; [Wolanski, Eric] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Primavera, Jurgenne] SE Asian Fisheries Dev Ctr, Dept Aquaculture, Iloilo 5021, Philippines; [Granek, Elise F.] Portland State Univ, Portland, OR 97207 USA; [Polasky, Stephen; Bael, David] Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA; [Aswani, Shankar] Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA; [Cramer, Lori A.] Oregon State Univ, Dept Sociol, Corvallis, OR 97331 USA; [Stoms, David M.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Kappel, Carrie V.] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; [Perillo, Gerardo M. E.] Inst Argentino Oceanog, Bahia Blanca, Buenos Aires, Argentina; [Reed, Denise J.] Univ New Orleans, Dept Earth & Environm Sci, New Orleans, LA 70148 USA	University of Wyoming; University System of Maryland; University of Maryland Center for Environmental Science; State University System of Florida; University of Florida; Oregon State University; James Cook University; Australian Institute of Marine Science; Southeast Asian Fisheries Development Center; Portland State University; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Santa Barbara; Oregon State University; University of California System; University of California Santa Barbara; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; University of Louisiana System; University of New Orleans	Barbier, EB (corresponding author), Univ Wyoming, Dept Econ & Finance, Laramie, WY 82071 USA.	ebarbier@uwyo.edu	Kennedy, Chris/B-3496-2008; Perillo, GME/AAV-3784-2021; Kappel, Carrie Vanessa/B-9534-2009; Polasky, Stephen/AAC-5341-2019	Perillo, GME/0000-0002-1200-5138; Kappel, Carrie Vanessa/0000-0003-2507-8042; Kennedy, Chris/0000-0002-0360-9116; Silliman, Brian/0000-0001-6360-650X				Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Barbier EB, 2003, CONTEMP ECON POLICY, V21, P59, DOI 10.1093/cep/21.1.59; Barbier EB, 2007, ECON POLICY, P178, DOI 10.1111/j.1468-0327.2007.00174.x; Brander LM, 2006, ENVIRON RESOUR ECON, V33, P223, DOI 10.1007/s10640-005-3104-4; Chua TE, 2006, COAST MANAGE, V34, P303, DOI 10.1080/08920750600686695; Farnsworth EJ, 1998, GLOBAL ECOL BIOGEOGR, V7, P15, DOI 10.2307/2997694; Gaston K.J., 2000, PATTERN PROCESS MACR, DOI [10.1002/9780470999592, DOI 10.1002/9780470999592]; Kareiva P, 2007, SCIENCE, V316, P1866, DOI 10.1126/science.1140170; Massel SR, 1999, FLUID DYN RES, V24, P219, DOI 10.1016/S0169-5983(98)00024-0; Mazda Y., 1997, MANGROVE SALT MARCHE, V1, P127, DOI DOI 10.1023/A:1009928003700; Mazda Yoshihiro, 2006, Wetlands Ecology and Management, V14, P365, DOI 10.1007/s11273-005-5388-0; McLeod K.L., 2005, SCI CONSENSUS STATEM; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING CU; Petersen JE, 2003, BIOSCIENCE, V53, P1181, DOI 10.1641/0006-3568(2003)053[1181:MEICEI]2.0.CO;2; Primavera JH, 2007, B MAR SCI, V80, P795; Saenger P., 1983, GLOBAL STATUS MANGRO; Sathirathai S, 2001, CONTEMP ECON POLICY, V19, P109, DOI 10.1093/cep/19.2.109; *UN ENV PROGR GPA, 2006, EC BAS MAN MARK ASS; United Nations Environment Programme, 2006, MAR COAST EC HUM WEL; Valiela I, 2001, BIOSCIENCE, V51, P807, DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2; WOLANSKI E, 2007, COASTAL PROTECTION A, P157	21	666	734	24	618	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2008	319	5861					321	323		10.1126/science.1150349	http://dx.doi.org/10.1126/science.1150349			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252GY	18202288				2022-12-28	WOS:000252436200035
J	Porter, P				Porter, Peggy			"Westernizing" women's risks? Breast cancer in lower-income countries	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SHANGHAI		[Porter, Peggy] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Porter, Peggy] Univ Washington, Sch Med, Seattle, WA USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Porter, P (corresponding author), Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.							Anderson BO, 2006, BREAST J, V12, pS3, DOI 10.1111/j.1075-122X.2006.00199.x; Cui XH, 2007, CANCER EPIDEM BIOMAR, V16, P1443, DOI 10.1158/1055-9965.EPI-07-0059; Curado MP, 2007, CANC INCIDENCE 5 CON, VIX; Thomas DB, 2002, JNCI-J NATL CANCER I, V94, P1445, DOI 10.1093/jnci/94.19.1445; World Cancer Research Fund/American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	5	344	356	1	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2008	358	3					213	216		10.1056/NEJMp0708307	http://dx.doi.org/10.1056/NEJMp0708307			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	251LS	18199859				2022-12-28	WOS:000252375600001
J	Vidula, H; Tian, L; Liu, K; Criqui, MH; Ferrucci, L; Pearce, WH; Greenland, P; Green, D; Tan, J; Garside, DB; Guralnik, J; Ridker, PM; Rifai, N; McDermott, MM				Vidula, Himabindu; Tian, Lu; Liu, Kiang; Criqui, Michael H.; Ferrucci, Luigi; Pearce, William H.; Greenland, Philip; Green, David; Tan, Jin; Garside, Daniel B.; Guralnik, Jack; Ridker, Paul M.; Rifai, Nader; McDermott, Mary M.			Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: A cohort study	ANNALS OF INTERNAL MEDICINE			English	Article							C-REACTIVE PROTEIN; AORTIC ENDOTHELIAL-CELLS; ANKLE BRACHIAL INDEX; ATHEROSCLEROTIC LESIONS; ASSOCIATION; SERUM; CHOLESTEROL; PREVALENCE; EXPRESSION; MARKER	Background: Traditional atherosclerotic risk factors predict long-term cardiovascular disease events but are poor predictors of near-term events. Objective: To determine whether elevated levels Of D-dimer and biomarkers of inflammation were more closely associated with near-term than long-term mortality in patients with lower-extremity peripheral arterial disease (PAD) and whether greater increases in biomarker levels were associated with higher mortality rates during the first year after the increase than during later years. Design: Prospective cohort study with a mean follow-up of 3.4 years. Setting: Academic medical center. Patients: 377 men and women with PAD. Measurements: Mortality within 1 year after biomarker measurement, 1 to 2 years after biomarker measurement, and 2 to 3 years after biomarker measurement. Cox regression analyses were used to evaluate associations of biomarkers levels and changes in biomarkers with cardiovascular and all-cause mortality. Hazard ratios were calculated for each 1-unit increase in log(1.5)(biomarker level). Analyses were adjusted for age, sex, race, comorbid conditions, ankle-brachial index, and other confounders. Results: Seventy-six patients (20%) died during follow-up. Higher levels Of D-dimer, C-reactive protein, and serum amyloid A were associated with higher all-cause mortality among patients who died within 1 year after biomarker measurement (hazard ratio, 1.20 [95% CI, 1.08 to 1.33], 1.13 [CI, 1.05 to 1.21], and 1.12 [CI, 1.04 to 1.20], respectively; P < 0.001, P < 0.001, and P = 0.003) and among patients who died 1 to 2 years after biomarker measurement (hazard ratio, 1.14 [Cl, 1.02 to 1.27], 1.15 [C], 1.06 to 1.24], and 1.13 [C], 1.04 to 1.24]; P = 0.022, P = 0.001, and P = 0.005]). However, higher levels of each biomarker were not associated with all-cause mortality for deaths occurring 2 to 3 years after biomarker measurement. Similar results were observed for cardiovascular mortality. Greater increases in each biomarker were associated with higher all-cause and cardiovascular mortality during the following year. Limitation: The small number of deaths limited the statistical power of the analyses. Conclusion: Among persons with PAD, circulating levels Of D-dimer and inflammatory markers are higher in the 1 to 2 years before death than in periods more remote from death. increasing levels of D-dimer and inflammatory biomarkers are independently associated with higher mortality in persons with PAD.			McDermott, MM (corresponding author), 750 N Lake Shore Dr,10th Floor, Chicago, IL 60611 USA.		Greenland, Philip/ABD-5528-2021		Intramural NIH HHS [Z99 AG999999] Funding Source: Medline; NCRR NIH HHS [RR-00048, M01 RR000048] Funding Source: Medline; NHLBI NIH HHS [R01 HL076298, R01-HL64739, R01 HL064739, R01-HL076298, R01-HL58099] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076298, R01HL064739, R01HL058099] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALLAIN CC, 1974, CLIN CHEM, V20, P470; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; DAVIES MJ, 1990, CIRCULATION, V82, P38; Devaraj S, 2004, J MOL CELL CARDIOL, V36, P405, DOI 10.1016/j.yjmcc.2003.12.005; FUSTER V, 1994, CIRCULATION, V90, P2126, DOI 10.1161/01.CIR.90.4.2126; Guralnik JM, 1995, NIH PUBLICATION, V95-4009; HIATT WR, 1995, CIRCULATION, V91, P1472, DOI 10.1161/01.CIR.91.5.1472; Ledue TB, 1998, ANN CLIN BIOCHEM, V35, P745, DOI 10.1177/000456329803500607; Li L, 2004, CIRC RES, V95, P877, DOI 10.1161/01.RES.0000147309.54227.42; Libby P, 2001, CIRCULATION, V104, P365, DOI 10.1161/01.CIR.104.3.365; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Lu KF, 2001, BIOMETRICS, V57, P1191, DOI 10.1111/j.0006-341X.2001.01191.x; McDermott MM, 2000, J VASC SURG, V32, P1164, DOI 10.1067/mva.2000.108640; McDermott MM, 2005, AM HEART J, V150, P276, DOI 10.1016/j.ahj.2004.09.032; McDermott MM, 2003, AM J CARDIOL, V92, P194, DOI 10.1016/S0002-9149(03)00537-X; McDermott MM, 2004, JAMA-J AM MED ASSOC, V292, P453, DOI 10.1001/jama.292.4.453; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; NEWMAN AB, 1993, CIRCULATION, V88, P837, DOI 10.1161/01.CIR.88.3.837; Shadman R, 2004, J AM COLL CARDIOL, V44, P618, DOI 10.1016/j.jacc.2004.04.044; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; SUGIUCHI H, 1995, CLIN CHEM, V41, P717; Torzewski J, 1998, ARTERIOSCL THROM VAS, V18, P1386, DOI 10.1161/01.ATV.18.9.1386; Wilson AM, 2006, INT J CARDIOL, V106, P291, DOI 10.1016/j.ijcard.2005.01.068	25	106	111	1	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2008	148	2					85	93		10.7326/0003-4819-148-2-200801150-00003	http://dx.doi.org/10.7326/0003-4819-148-2-200801150-00003			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254NZ	18195333	Green Accepted			2022-12-28	WOS:000252594600001
J	Levine, B; Kroemer, G				Levine, Beth; Kroemer, Guido			Autophagy in the pathogenesis of disease	CELL			English	Review							CELL-SURVIVAL; MOLECULAR-MECHANISMS; LIFE-SPAN; PROTEIN; BECLIN-1; NEURODEGENERATION; GROWTH; MACROAUTOPHAGY; TUMORIGENESIS; DEFICIENCY	Autophagy is a lysosomal degradation pathway that is essential for survival, differentiation, development, and homeostasis. Autophagy principally serves an adaptive role to protect organisms against diverse pathologies, including infections, cancer, neurodegeneration, aging, and heart disease. However, in certain experimental disease settings, the self-cannibalistic or, paradoxically, even the prosurvival functions of autophagy may be deleterious. This Review summarizes recent advances in understanding the physiological functions of autophagy and its possible roles in the causation and prevention of human diseases.	[Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Kroemer, Guido] Univ Paris 11, Paris, France; [Kroemer, Guido] INSERM, U848, F-94805 Villejuif, France	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm)	Levine, B (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	beth.levine@utsouthwestern.edu; kroemer@igr.fr	Kroemer, Guido/AAY-9859-2020; KROEMER, Guido/B-4263-2013	KROEMER, Guido/0000-0002-9334-4405	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA109618, R01 CA084254-10, R01 CA084254, R01 CA109618-05] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA084254, R01CA109618] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Askanas V, 2006, NEUROLOGY, V66, pS39, DOI 10.1212/01.wnl.0000192128.13875.1e; BAHRO M, 1987, J MOL CELL CARDIOL, V19, P1169, DOI 10.1016/S0022-2828(87)80527-8; Bassham DC, 2006, AUTOPHAGY, V2, P2, DOI 10.4161/auto.2092; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Bergamini E, 2005, EXPERT OPIN THER TAR, V9, P77, DOI 10.1517/14728222.9.1.77; Bolanos-Meade J, 2005, AM J HEMATOL, V78, P306, DOI 10.1002/ajh.20294; Cao Y, 2006, J BIOL CHEM, V281, P20483, DOI 10.1074/jbc.M602180200; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Criollo A, 2007, CELL DEATH DIFFER, V14, P1029, DOI 10.1038/sj.cdd.4402099; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Del Roso A, 2003, EXP GERONTOL, V38, P519, DOI 10.1016/S0531-5565(03)00002-0; Espert L, 2006, J CLIN INVEST, V116, P2161, DOI 10.1172/JCI26185; Felbor U, 2002, P NATL ACAD SCI USA, V99, P7883, DOI 10.1073/pnas.112632299; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Fukuda T, 2006, MOL THER, V14, P831, DOI 10.1016/j.ymthe.2006.08.009; Gozuacik D, 2006, AUTOPHAGY, V2, P74, DOI 10.4161/auto.2.2.2459; Grossmayer Gerhard E, 2005, Mod Rheumatol, V15, P383, DOI 10.1007/s10165-005-0430-x; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Hamacher-Brady A, 2006, J BIOL CHEM, V281, P29776, DOI 10.1074/jbc.M603783200; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Iwata J, 2006, J BIOL CHEM, V281, P4035, DOI 10.1074/jbc.M512283200; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; JIA K, 2007, CAENORHABDITIS ELEGA, V3, P21; Jia KL, 2007, AUTOPHAGY, V3, P597, DOI 10.4161/auto.4989; Jin SK, 2007, AUTOPHAGY, V3, P28, DOI 10.4161/auto.3269; Kamimoto T, 2006, J BIOL CHEM, V281, P4467, DOI 10.1074/jbc.M509409200; Kang C, 2007, GENE DEV, V21, P2161, DOI 10.1101/gad.1573107; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Koneri K, 2007, ANTICANCER RES, V27, P1453; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Li CY, 2006, J IMMUNOL, V177, P5163, DOI 10.4049/jimmunol.177.8.5163; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lucas GJA, 2006, J BONE MINER RES, V21, pP31, DOI 10.1359/JBMR.06S206; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Lunemann JD, 2007, ANN NEUROL, V61, P476, DOI 10.1002/ana.21115; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Marino G, 2007, J BIOL CHEM, V282, P18573, DOI 10.1074/jbc.M701194200; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; Massey DCO, 2007, AUTOPHAGY, V3, P649, DOI 10.4161/auto.5075; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Meijer Alfred J., 2006, Molecular Aspects of Medicine, V27, P411, DOI 10.1016/j.mam.2006.08.002; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Miracco C, 2007, INT J ONCOL, V30, P429; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Nair U, 2005, J BIOL CHEM, V280, P41785, DOI 10.1074/jbc.R500016200; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; Nishino Ichizo, 2006, Semin Pediatr Neurol, V13, P90, DOI 10.1016/j.spen.2006.06.004; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Perlmutter DH, 2006, AUTOPHAGY, V2, P258, DOI 10.4161/auto.2882; Pinkston JM, 2006, SCIENCE, V313, P971, DOI 10.1126/science.1121908; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Puls I, 2005, ANN NEUROL, V57, P687, DOI 10.1002/ana.20468; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Ravikumar B, 2005, NAT GENET, V37, P771, DOI 10.1038/ng1591; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Schmid D, 2007, IMMUNITY, V27, P11, DOI 10.1016/j.immuni.2007.07.004; Schwartz RA, 2007, J AM ACAD DERMATOL, V57, P189, DOI 10.1016/j.jaad.2007.05.004; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Shacka JJ, 2007, J NEUROSCI, V27, P2081, DOI 10.1523/JNEUROSCI.5577-06.2007; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; Takacs-Vellai K, 2005, CURR BIOL, V15, P1513, DOI 10.1016/j.cub.2005.07.035; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Terman A, 2005, CARDIOVASC RES, V68, P355, DOI 10.1016/j.cardiores.2005.08.014; Vesa J., 2002, Current Molecular Medicine (Hilversum), V2, P439, DOI 10.2174/1566524023362311; Williams A, 2006, CURR TOP DEV BIOL, V76, P89, DOI 10.1016/S0070-2153(06)76003-3; Yorimitsu T, 2007, TRENDS CELL BIOL, V17, P279, DOI 10.1016/j.tcb.2007.04.005; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Yue ZY, 2002, NEURON, V35, P921, DOI 10.1016/S0896-6273(02)00861-9; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang Y, 2007, AUTOPHAGY, V3, P337, DOI 10.4161/auto.4127; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	101	5258	5624	41	1444	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2008	132	1					27	42		10.1016/j.cell.2007.12.018	http://dx.doi.org/10.1016/j.cell.2007.12.018			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IL	18191218	Green Accepted, Bronze			2022-12-28	WOS:000253427600013
J	Idnurm, A; Walton, FJ; Floyd, A; Heitman, J				Idnurm, Alexander; Walton, Felicia J.; Floyd, Anna; Heitman, Joseph			Identification of the sex genes in an early diverged fungus	NATURE			English	Article							MATING-TYPE REGION; PHYCOMYCES-BLAKESLEEANUS; NEUROSPORA-CRASSA; EVOLUTION; LOCUS; RECOMBINATION; CHROMOSOMES; PHYLOGENY	Sex determination in fungi is controlled by a small, specialized region of the genome in contrast to the large sex- specific chromosomes of animals and some plants. Different gene combinations reside at these mating- type ( MAT) loci and confer sexual identity; invariably they encode homeodomain, alpha-box, or high mobility group ( HMG)- domain transcription factors(1). So far, MAT loci have been characterized from a single monophyletic clade of fungi, the Dikarya ( the ascomycetes and basidiomycetes)(2), and the ancestral state and evolutionary history of these loci have remained a mystery. Mating in the basal members of the kingdom has been less well studied, and even their precise taxonomic interrelationships are still obscure(3,4). Here we apply bioinformatic and genetic mapping to identify the sex- determining ( sex) region in Phycomyces blakesleeanus ( Zygomycota), which represents an early branch within the fungi. Each sex allele contains a single gene that encodes an HMG- domain protein, implicating the HMG- domain proteins as an earlier form of fungal MAT loci. Additionally, one allele also contains a copy of a unique, chromosome- specific repetitive element, suggesting a generalized mechanism for the earliest steps in the evolution of sex determination and sex chromosome structure in eukaryotes.	[Idnurm, Alexander; Walton, Felicia J.; Floyd, Anna; Heitman, Joseph] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Idnurm, Alexander] Univ Missouri, Sch Biol Sci, Kansas City, MO 64110 USA	Duke University; University of Missouri System; University of Missouri Kansas City	Heitman, J (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	heitm001@mc.duke.edu	Idnurm, Alexander/K-8558-2013; Heitman, Joseph/ABC-6006-2021; Idnurm, Alexander/GPX-9055-2022; Idnurm, Alexander/AAC-9614-2019	Idnurm, Alexander/0000-0001-5995-7040; Idnurm, Alexander/0000-0001-5995-7040; Pagliuca, Felicia/0000-0003-4589-1807				ALVAREZ MI, 1983, GENETICS, V105, P873; ALVAREZ MI, 1980, MOL GEN GENET, V179, P447, DOI 10.1007/BF00425475; Arnaise S, 2001, GENETICS, V159, P545; Bakkeren G, 2006, FUNGAL GENET BIOL, V43, P655, DOI 10.1016/j.fgb.2006.04.002; Blakeslee AF, 1904, SCIENCE, V19, P0864, DOI 10.1126/science.19.492.864; Blakeslee AF, 1904, P AM ACAD ARTS SCI, V40, P205, DOI DOI 10.2307/20021962; Burgeff H., 1914, FLORA, V107, P259, DOI [DOI 10.1016/S0367-1615(17)32823-9, 10.1016/S0367-1615(17)32823-9]; Burglin TR, 2003, DEV GENES EVOL, V213, P50, DOI 10.1007/s00427-002-0287-3; Butler G, 2004, P NATL ACAD SCI USA, V101, P1632, DOI 10.1073/pnas.0304170101; CERDAOLMEDO E, 1975, GENET RES, V25, P285, DOI 10.1017/S0016672300015718; Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697; ESLAVA AP, 1975, P NATL ACAD SCI USA, V72, P4076, DOI 10.1073/pnas.72.10.4076; ESLAVA AP, 1975, GENETICS, V80, P445; Ferreira AVB, 1998, GENETICS, V148, P1069; Fraser JA, 2004, PLOS BIOL, V2, P2243, DOI 10.1371/journal.pbio.0020384; Fraser JA, 2004, MOL MICROBIOL, V51, P299, DOI 10.1046/j.1365-2958.2003.03874.x; GAUGER WL, 1977, J GEN MICROBIOL, V101, P211, DOI 10.1099/00221287-101-2-211; GLASS NL, 1990, P NATL ACAD SCI USA, V87, P4912, DOI 10.1073/pnas.87.13.4912; GOVIND NS, 1986, J GEN MICROBIOL, V132, P2775; Heitman J., 2007, SEX FUNGI MOL DETERM; Idnurm A, 2006, P NATL ACAD SCI USA, V103, P4546, DOI 10.1073/pnas.0600633103; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Lee N, 1999, P NATL ACAD SCI USA, V96, P15026, DOI 10.1073/pnas.96.26.15026; Mehta BJ, 2001, GENETICS, V158, P635; Obraztsova IN, 2004, FUNGAL GENET BIOL, V41, P168, DOI 10.1016/j.fgb.2003.09.007; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; STABEN C, 1990, P NATL ACAD SCI USA, V87, P4917, DOI 10.1073/pnas.87.13.4917; White MM, 2006, MYCOLOGIA, V98, P872, DOI 10.3852/mycologia.98.6.872	29	114	118	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2008	451	7175					193	U8		10.1038/nature06453	http://dx.doi.org/10.1038/nature06453			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249GA	18185588				2022-12-28	WOS:000252214400043
J	Wheeler, DW; Carter, JJ; Murray, LJ; Degnan, BA; Dunling, CP; Salvador, R; Menon, DK; Gupta, AK				Wheeler, Daniel W.; Carter, Joseph J.; Murray, Louise J.; Degnan, Beverley A.; Dunling, Colin P.; Salvador, Raymond; Menon, David K.; Gupta, Arun K.			The effect of drug concentration expression on epinephrine dosing errors - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							HOSPITALIZED-PATIENTS; MEDICATION ERROR; EVENTS; ABILITY; DOCTORS; COSTS	Background: The expression of drug concentration as a ratio may cause dosing errors. Objective: To examine the effect of ratio expressions on drug administration. Design: Randomized, blinded, controlled study. Setting: Simulation center in an urban hospital. Participants: 28 physicians. Intervention: Participants managed a simulated pediatric acute anaphylaxis scenario by using epinephrine ampules labeled with mass concentration (1 mg in 1 mL) or a ratio (1 mL of a 1:1000 solution). Measurements: The amount of epinephrine given and the time taken to administer it. Results: Compared with providers using ampules with mass concentration labels, those using ratio labels gave more epinephrine (adjusted mean dose, 213 mu g above target [95% Cl, 76.4 to 350.1 mu g; P = 0.003), and took longer to do so (adjusted mean delay, 91 seconds, [Cl, 61.0 to 122.1 seconds]; P <= 0.0001). Limitations: Performance in simulated scenarios may not reflect clinical practice. in reality, ampule labels provide both expressions of concentration. Conclusion: The use of ratios to express drug concentration may be a source of drug administration error. Patient safety might be improved by expressing drug concentrations exclusively as mass concentration.	[Wheeler, Daniel W.; Carter, Joseph J.; Murray, Louise J.; Degnan, Beverley A.; Dunling, Colin P.; Salvador, Raymond; Menon, David K.; Gupta, Arun K.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge CB2 0QQ, England; [Wheeler, Daniel W.; Carter, Joseph J.; Murray, Louise J.; Degnan, Beverley A.; Dunling, Colin P.; Salvador, Raymond; Menon, David K.; Gupta, Arun K.] Benito Menni Ctr Assistencial Salut Mental Sant B, Barcelona, Spain	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Wheeler, DW (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Box 93,Hills Rd, Cambridge CB2 0QQ, England.	dww21@cam.ac.uk	Wheeler, Daniel/A-8690-2008; Wheeler, Daniel/L-8609-2019	Wheeler, Daniel/0000-0001-7692-6887; Salvador, Raymond/0000-0001-5557-1562				BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Bates DW, 1997, JAMA-J AM MED ASSOC, V277, P307, DOI 10.1001/jama.277.4.307; Chamberlain D, 2001, RESUSCITATION, V48, P241; Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301; Degnan BA, 2006, ANAESTHESIA, V61, P1155, DOI 10.1111/j.1365-2044.2006.04869.x; EDGAR TA, 1994, AM J HOSP PHARM, V51, P1335, DOI 10.1093/ajhp/51.10.1335; KELLY DA, 1983, BRIT MED J, V286, P1784, DOI 10.1136/bmj.286.6380.1784; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; Lesar TS, 2002, ANN PHARMACOTHER, V36, P1833; MULLER N, 1997, EUROPEAN DRUG INDEX; Oldridge GJ, 2004, INTERN MED J, V34, P316, DOI 10.1111/j.1445-5994.2004.00613.x; *R DEV COR TEAM, 1997, R LANG ENV STAT COMP; ROLFE S, 1995, BRIT MED J, V310, P1173, DOI 10.1136/bmj.310.6988.1173; SCRIMSHIRE JA, 1989, BRIT MED J, V298, P1494, DOI 10.1136/bmj.298.6686.1494; Wheeler DW, 2007, INT J CLIN PRACT, V61, P189, DOI 10.1111/j.1742-1241.2006.01273.x; Wheeler DW, 2004, DRUG SAFETY, V27, P729, DOI 10.2165/00002018-200427100-00003; Wheeler DW, 2004, J ROY SOC MED, V97, P380, DOI 10.1258/jrsm.97.8.380; Wheeler SJ, 2004, EUR J ANAESTH, V21, P929; *WHO, 2002, WHO TECHNICAL REPORT, V902	19	45	48	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	2008	148	1					11	14		10.7326/0003-4819-148-1-200801010-00003	http://dx.doi.org/10.7326/0003-4819-148-1-200801010-00003			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248JJ	18166759				2022-12-28	WOS:000252149300002
J	Milstein, A; Lee, TH				Milstein, Arnold; Lee, Thomas H.			Comparing physicians on efficiency	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Mercer Hlth & Benefits, San Francisco, CA USA; Pacific Business Grp Hlth, San Francisco, CA USA; Partners Healthcare, Boston, MA USA	Partners Healthcare System	Milstein, A (corresponding author), Mercer Hlth & Benefits, San Francisco, CA USA.								0	21	22	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2007	357	26					2649	2652		10.1056/NEJMp0706521	http://dx.doi.org/10.1056/NEJMp0706521			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	245UO	18160682				2022-12-28	WOS:000251964500001
J	Wendt, KS; Yoshida, K; Itoh, T; Bando, M; Koch, B; Schirghuber, E; Tsutsumi, S; Nagae, G; Ishihara, K; Mishiro, T; Yahata, K; Imamoto, F; Aburatani, H; Nakao, M; Imamoto, N; Maeshima, K; Shirahige, K; Peters, JM				Wendt, Kerstin S.; Yoshida, Keisuke; Itoh, Takehiko; Bando, Masashige; Koch, Birgit; Schirghuber, Erika; Tsutsumi, Shuichi; Nagae, Genta; Ishihara, Ko; Mishiro, Tsuyoshi; Yahata, Kazuhide; Imamoto, Fumio; Aburatani, Hiroyuki; Nakao, Mitsuyoshi; Imamoto, Naoko; Maeshima, Kazuhiro; Shirahige, Katsuhiko; Peters, Jan-Michael			Cohesin mediates transcriptional insulation by CCCTC-binding factor	NATURE			English	Article							SISTER-CHROMATID COHESION; DE-LANGE-SYNDROME; ENHANCER-BLOCKING ACTIVITY; HUMAN GENOME; NIPPED-B; CTCF-BINDING; SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; ROBERTS-SYNDROME; GENE-EXPRESSION	Cohesin complexes mediate sister- chromatid cohesion in dividing cells but may also contribute to gene regulation in postmitotic cells. How cohesin regulates gene expression is not known. Here we describe cohesin- binding sites in the human genome and show that most of these are associated with the CCCTC- binding factor ( CTCF), a zinc- finger protein required for transcriptional insulation. CTCF is dispensable for cohesin loading onto DNA, but is needed to enrich cohesin at specific binding sites. Cohesin enables CTCF to insulate promoters from distant enhancers and controls transcription at the H19/IGF2 ( insulin- like growth factor 2) locus. This role of cohesin seems to be independent of its role in cohesion. We propose that cohesin functions as a transcriptional insulator, and speculate that subtle deficiencies in this function contribute to 'cohesinopathies' such as Cornelia de Lange syndrome.	[Yoshida, Keisuke; Bando, Masashige; Shirahige, Katsuhiko] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Kanagawa 2268501, Japan; [Wendt, Kerstin S.; Koch, Birgit; Schirghuber, Erika; Peters, Jan-Michael] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Itoh, Takehiko] Mitsubishi Res Inst Inc, Adv Sci & Technol Res Ctr, Chiyoda Ku, Tokyo 1008141, Japan; [Tsutsumi, Shuichi; Aburatani, Hiroyuki] Univ Tokyo, Genome Sci Div, Adv Sci & Technol Res Ctr, Tokyo 1538904, Japan; [Yahata, Kazuhide; Imamoto, Fumio] Osaka Univ, Dept Mol Biol, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; [Ishihara, Ko; Mishiro, Tsuyoshi; Nakao, Mitsuyoshi] Kumamoto Univ, Dept Regenerat Med, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan; [Imamoto, Naoko; Maeshima, Kazuhiro] RIKEN, Cellular Dynam Lab, Wako, Saitama 3510198, Japan	Tokyo Institute of Technology; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Mitsubishi Research Institute; University of Tokyo; Osaka University; Kumamoto University; RIKEN	Shirahige, K (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, B2C4259, Kanagawa 2268501, Japan.	kshirahi@bio.titech.ac.jp; peters@imp.univie.ac.at	Nagae, Genta/H-6579-2019; Imamoto, Naoko/A-7458-2015; Nagae, Genta/AAN-1167-2021; Itoh, Takehiko/E-8873-2014	Nagae, Genta/0000-0002-2929-7990; Imamoto, Naoko/0000-0002-2886-3022; Itoh, Takehiko/0000-0002-6113-557X; Yoshida, Keisuke/0000-0002-5579-9716; Maeshima, Kazuhiro/0000-0003-3909-0341; Koch, Birgit/0000-0003-4683-3115; Shirahige, Katsuhiko/0000-0002-7862-1144	Austrian Science Fund FWF [F 3407] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bartolomei MS, 1997, ANNU REV GENET, V31, P493, DOI 10.1146/annurev.genet.31.1.493; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Benard CY, 2004, DEVELOPMENT, V131, P5947, DOI 10.1242/dev.01433; Burke LJ, 2005, EMBO J, V24, P3291, DOI 10.1038/sj.emboj.7600793; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Deardorff MA, 2007, AM J HUM GENET, V80, P485, DOI 10.1086/511888; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Dorsett D, 2005, DEVELOPMENT, V132, P4743, DOI 10.1242/dev.02064; Dorsett D, 2007, CHROMOSOMA, V116, P1, DOI 10.1007/s00412-006-0072-6; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Gerlich D, 2006, CURR BIOL, V16, P1571, DOI 10.1016/j.cub.2006.06.068; Glynn EF, 2004, PLOS BIOL, V2, P1325, DOI 10.1371/journal.pbio.0020259; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Horsfield JA, 2007, DEVELOPMENT, V134, P2639, DOI 10.1242/dev.002485; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Kugoh H, 1999, DNA Res, V6, P165, DOI 10.1093/dnares/6.3.165; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lee MP, 1997, NAT GENET, V15, P181, DOI 10.1038/ng0297-181; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; Liu CL, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-19; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Maeshima K, 2006, J CELL SCI, V119, P4442, DOI 10.1242/jcs.03207; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Moon H, 2005, EMBO REP, V6, P165, DOI 10.1038/sj.embor.7400334; Musio A, 2006, NAT GENET, V38, P528, DOI 10.1038/ng1779; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Recillas-Targa F, 2002, P NATL ACAD SCI USA, V99, P6883, DOI 10.1073/pnas.102179399; Rollins RA, 1999, GENETICS, V152, P577; Rollins RA, 2004, MOL CELL BIOL, V24, P3100, DOI 10.1128/MCB.24.8.3100-3111.2004; Schule B, 2005, AM J HUM GENET, V77, P1117, DOI 10.1086/498695; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Vega H, 2005, NAT GENET, V37, P468, DOI 10.1038/ng1548; Verni F, 2000, GENETICS, V154, P1693; Watrin E, 2006, CURR BIOL, V16, P863, DOI 10.1016/j.cub.2006.03.049; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Yahata K, 2007, J MOL BIOL, V374, P580, DOI 10.1016/j.jmb.2007.09.054; Zhang B, 2007, DEVELOPMENT, V134, P3191, DOI 10.1242/dev.005884	55	836	860	1	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2008	451	7180					796	U3		10.1038/nature06634	http://dx.doi.org/10.1038/nature06634			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	263BA	18235444				2022-12-28	WOS:000253191400035
J	Dzenis, Y				Dzenis, Yuris			Materials science - Structural nanocomposites	SCIENCE			English	Editorial Material							COMPOSITES; REINFORCEMENT		[Dzenis, Yuris] Univ Nebraska, Dept Engn Mech, Natl Nanofiber Facil, Lincoln, NE 68588 USA; [Dzenis, Yuris] Univ Nebraska, Nebraska Ctr Mat & Nanosci, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Dzenis, Y (corresponding author), Univ Nebraska, Dept Engn Mech, Natl Nanofiber Facil, Lincoln, NE 68588 USA.	ydzenis@unl.edu						Bekyarova E, 2007, LANGMUIR, V23, P3970, DOI 10.1021/la062743p; Coleman JN, 2006, ADV MATER, V18, P689, DOI 10.1002/adma.200501851; DZENIS Y, 2007, P 16 INT C COMP MAT; Gates TS, 2005, COMPOS SCI TECHNOL, V65, P2416, DOI 10.1016/j.compscitech.2005.06.009; Jones R.M., 1999, MECH COMPOS MATER, V2nd, DOI DOI 10.1201/9781498711067; Kalaitzidou K, 2007, CARBON, V45, P1446, DOI 10.1016/j.carbon.2007.03.029; Schulte K, 2007, COMPOS SCI TECHNOL, V67, P777, DOI 10.1016/j.compscitech.2006.08.020; Thostenson ET, 2005, COMPOS SCI TECHNOL, V65, P491, DOI 10.1016/j.compscitech.2004.11.003; 2007, COMPOS SCI TECHNOL, V65, P491	9	192	197	1	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2008	319	5862					419	420		10.1126/science.1151434	http://dx.doi.org/10.1126/science.1151434			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254HB	18218884	Green Published			2022-12-28	WOS:000252576600025
J	Lipan, O				Lipan, Ovidiu			Systems biology - Enlightening rhythms	SCIENCE			English	Editorial Material									Univ Richmond, Dept Phys, Richmond, VA 23173 USA	University of Richmond	Lipan, O (corresponding author), Univ Richmond, Dept Phys, Richmond, VA 23173 USA.	olipan@richmond.edu						[Anonymous], 1983, SIGNALS SYSTEMS; Dunlap J.C., 2004, CHRONOBIOLOGY BIOL T; Grilly C, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100168; Lipan O, 2005, P NATL ACAD SCI USA, V102, P7063, DOI 10.1073/pnas.0403790102; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; OHARA JG, 1987, IEE HIST TECHNOLOGY, V8; Shimizu-Sato S, 2002, NAT BIOTECHNOL, V20, P1041, DOI 10.1038/nbt734; Woese CR, 2004, MICROBIOL MOL BIOL R, V68, P173, DOI 10.1128/MMBR.68.2.173-186.2004	9	4	4	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2008	319	5862					417	418		10.1126/science.1154208	http://dx.doi.org/10.1126/science.1154208			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254HB	18218882				2022-12-28	WOS:000252576600023
J	Epstein, EH; Shepard, JAO; Flotte, TJ				Epstein, Ervin H.; Shepard, Jo-Anne O.; Flotte, Thomas J.			A woman with cutaneous basal-cell carcinomas and cysts of the jaws - The basal-cell nevus (Gorlin's) syndrome with multiple basal-cell carcinomas and odontogenic keratocysts.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHOTODYNAMIC THERAPY; HUMAN HOMOLOG; MUTATIONS; CANCER; TAZAROTENE; GENE		[Epstein, Ervin H.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Shepard, Jo-Anne O.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Flotte, Thomas J.] Massachusetts Gen Hosp, Dept Dermatopathol, Boston, MA 02114 USA; [Shepard, Jo-Anne O.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Flotte, Thomas J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Epstein, EH (corresponding author), Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA.							Aszterbaum M, 2007, J INVEST DERMATOL, V127, pS41; Bianchi L, 2004, BRIT J DERMATOL, V151, P148, DOI 10.1111/j.1365-2133.2004.06044.x; Carneiro BA, 2006, CANCER INVEST, V24, P396, DOI 10.1080/07357900600705474; Chapas Anne M, 2006, J Drugs Dermatol, V5, P3; GORLIN R, 2003, COMMUNICATION   0407; GORLIN RJ, 1987, MEDICINE, V66, P98, DOI 10.1097/00005792-198703000-00002; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kimonis VE, 1997, AM J MED GENET, V69, P299, DOI 10.1002/(SICI)1096-8628(19970331)69:3<299::AID-AJMG16>3.0.CO;2-M; Lauth M, 2007, CURR OPIN INVEST DR, V8, P457; Ling G, 2001, ONCOGENE, V20, P7770, DOI 10.1038/sj.onc.1204946; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Madan V, 2006, J AM ACAD DERMATOL, V55, pS86, DOI 10.1016/j.jaad.2005.12.004; Neuhaus Isaac M, 2005, Dermatol Ther, V18, P28, DOI 10.1111/j.1529-8019.2005.05006.x; Oseroff AR, 2005, ARCH DERMATOL, V141, P60, DOI 10.1001/archderm.141.1.60; PECK G L, 1987, Dermatologica (Basel), V175, P138; Peris K, 1999, NEW ENGL J MED, V341, P1767, DOI 10.1056/NEJM199912023412312; Reifenberger J, 1998, CANCER RES, V58, P1798; Reifenberger J, 2001, J INVEST DERMATOL, V116, P472, DOI 10.1046/j.1523-1747.2001.01279-2.x; Xie JW, 2001, P NATL ACAD SCI USA, V98, P9255, DOI 10.1073/pnas.151173398; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201	22	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2008	358	4					393	401		10.1056/NEJMcpc0707893	http://dx.doi.org/10.1056/NEJMcpc0707893			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253GY	18216361				2022-12-28	WOS:000252507900012
J	Heikens, GT; Amadi, BC; Manary, M; Rollins, N; Tomkins, A				Heikens, Geert Tom; Amadi, Beatrice C.; Manary, Mark; Rollins, Nigel; Tomkins, Andrew			Nutrition interventions need improved operational capacity	LANCET			English	Editorial Material							MALNOURISHED MALAWIAN CHILDREN; USE THERAPEUTIC FOOD; HOME-BASED THERAPY; TO-USE FOOD; SEVERE MALNUTRITION; CHALLENGES		[Heikens, Geert Tom] Univ Malawi, Coll Med, Dept Paediat, Blantyre 3, Malawi; [Manary, Mark] Univ Malawi, Coll Med, Dept Community Med, Blantyre 3, Malawi; [Amadi, Beatrice C.] Univ Teaching Hosp, Dept Paediat & Child Hlth, Lusaka, Zambia; [Manary, Mark] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Rollins, Nigel] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Ctr Maternal & Child Hlth, Durban, South Africa; [Tomkins, Andrew] UCL, Inst Child Hlth, Ctr Int Hlth & Dev, London, England	University of Malawi; University of Malawi; University of Zambia; Washington University (WUSTL); University of Kwazulu Natal; University of London; University College London	Heikens, GT (corresponding author), Univ Malawi, Coll Med, Dept Paediat, Blantyre 3, Malawi.	theikens@medcol.mw		Manary, Mark/0000-0003-2733-9568				Briend A, 1999, LANCET, V353, P1767, DOI 10.1016/S0140-6736(99)01078-8; Briend A, 2006, FOOD NUTR BULL, V27, pS3, DOI 10.1177/15648265060273S301; BRYCE J, LANCET, DOI DOI 10.1016/S0140-6736(07)61694-8; Bryce J, 2006, LANCET, V368, P1067, DOI 10.1016/S0140-6736(06)69339-2; Ciliberto MA, 2005, AM J CLIN NUTR, V81, P864, DOI 10.1093/ajcn/81.4.864; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; Heikens GT, 2007, PLOS MED, V4, P222, DOI 10.1371/journal.pmed.0040045; Heikens GT, 2007, LANCET, V369, P2159, DOI 10.1016/S0140-6736(07)61010-1; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Maitland K, 2006, PLOS MED, V3, P2431, DOI 10.1371/journal.pmed.0030500; Manary MJ, 2004, ARCH DIS CHILD, V89, P557, DOI 10.1136/adc.2003.034306; Murray CJL, 2007, LANCET, V370, P1018, DOI 10.1016/S0140-6736(07)61458-5; Sandige H, 2004, J PEDIATR GASTR NUTR, V39, P141, DOI 10.1097/00005176-200408000-00003; *WHO, 2006, WORLD HHLTH REP 2006; World Health Organization, 1999, MAN SEV MALN MAN PHY; [No title captured]	16	22	23	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 19	2008	371	9608					181	182		10.1016/S0140-6736(07)61691-2	http://dx.doi.org/10.1016/S0140-6736(07)61691-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	252UK	18207567				2022-12-28	WOS:000252471900006
J	Bauditz, J; Norman, K; Biering, H; Lochs, H; Pirlich, M				Bauditz, Juergen; Norman, Kristina; Biering, Henrik; Lochs, Herbert; Pirlich, Matthias			Lesson of the week - Severe weight loss caused by chewing gum	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DIARRHEA; SORBITOL; COMPLAINTS; ORIGIN		[Bauditz, Juergen; Norman, Kristina; Biering, Henrik; Lochs, Herbert; Pirlich, Matthias] Charite, Dept Gastroenterol Hepatol & Endocrinol, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Bauditz, J (corresponding author), Charite, Dept Gastroenterol Hepatol & Endocrinol, D-10117 Berlin, Germany.	juergen.bauditz@charite.de		Norman, Kristina/0000-0003-2029-9102				BADIGA MS, 1990, J AM COLL NUTR, V9, P578; BYTZER P, 1989, GUT, V30, P1379, DOI 10.1136/gut.30.10.1379; DILLS WL, 1989, ANNU REV NUTR, V9, P161, DOI 10.1146/annurev.nutr.9.1.161; EHERER AJ, 1992, GASTROENTEROLOGY, V103, P545, DOI 10.1016/0016-5085(92)90845-P; Goldstein R, 2000, ISRAEL MED ASSOC J, V2, P583; Greaves RRSH, 1996, LANCET, V348, P1488, DOI 10.1016/S0140-6736(96)08190-1; HYAMS JS, 1983, GASTROENTEROLOGY, V84, P30; JOHNSTON KR, 1994, AM J MED, V97, P185, DOI 10.1016/0002-9343(94)90029-9; LEDERLE FA, 1990, AM J MED, V89, P597, DOI 10.1016/0002-9343(90)90177-F; Lochs H, 2006, CLIN NUTR, V25, P180, DOI 10.1016/j.clnu.2006.02.007; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; RAVRY M J R, 1980, Journal of the American Medical Association, V244, P270, DOI 10.1001/jama.244.3.270; READ NW, 1980, GASTROENTEROLOGY, V78, P264	13	27	29	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 12	2008	336	7635					96	97		10.1136/bmj.39280.657350.BE	http://dx.doi.org/10.1136/bmj.39280.657350.BE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253BX	18187727	Green Published			2022-12-28	WOS:000252494800033
J	Beg, AA; Ernstrom, GG; Nix, P; Davis, MW; Jorgensen, EM				Beg, Asim A.; Ernstrom, Glen G.; Nix, Paola; Davis, M. Wayne; Jorgensen, Erik M.			Protons act as a transmitter for muscle contraction in C-elegans	CELL			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; CALCINEURIN HOMOLOGOUS PROTEIN; NA+/H+ EXCHANGER NHE1; GATED ION-CHANNEL; CAENORHABDITIS-ELEGANS; NERVOUS-SYSTEM; SYNAPTIC-TRANSMISSION; FAMILY; BINDING; PH	Muscle contraction is normally mediated by the release of neurotransmitters from motor neurons. Here we demonstrate that protons can act as a direct transmitter from intestinal cells to stimulate muscle contraction. During the C. elegans defecation motor program the posterior body muscles contract even in the absence of neuronal inputs or vesicular neurotransmission. In this study, we demonstrate that the space between the intestine and the muscle is acidified just prior to muscle contraction and that the release of caged protons is sufficient to induce muscle contraction. PBO-4 is a putative Na+/H+ ion exchanger expressed on the basolateral membrane of the intestine, juxtaposed to the posterior body muscles. In pbo-4 mutants the extracellular space is not acidified and the muscles fail to contract. The pbo-5 and pbo-6 genes encode subunits of a "cysloop'' proton-gated cation channel required for muscles to respond to acidification. In heterologous expression assays the PBO receptor is half-maximally activated at a pH of 6.8. The identification of the mechanisms for release and reception of proton signals establishes a highly unusual mechanism for intercellular communication.	[Beg, Asim A.; Jorgensen, Erik M.] Univ Utah, Howard Hughes Med Inst, Neurosci Program, Salt Lake City, UT 84112 USA; [Beg, Asim A.; Ernstrom, Glen G.; Nix, Paola; Davis, M. Wayne; Jorgensen, Erik M.] Univ Utah, Howard Hughes Med Inst, Dept Biol, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Jorgensen, EM (corresponding author), Univ Utah, Howard Hughes Med Inst, Neurosci Program, Salt Lake City, UT 84112 USA.	jorgensen@biology.utah.edu		Davis, Mikel/0000-0003-1867-1593	Howard Hughes Medical Institute Funding Source: Medline; NINDS NIH HHS [R37 NS034307, R37 NS034307-13] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034307] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aharonovitz O, 2000, J CELL BIOL, V150, P213, DOI 10.1083/jcb.150.1.213; Baranano DE, 2001, TRENDS NEUROSCI, V24, P99, DOI 10.1016/S0166-2236(00)01716-1; Bell SM, 1999, AM J PHYSIOL-CELL PH, V276, pC788, DOI 10.1152/ajpcell.1999.276.4.C788; BETZ H, 1990, NEURON, V5, P383, DOI 10.1016/0896-6273(90)90077-S; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Brachmann CB, 1998, YEAST, V14, P115; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; BRENNER S, 1974, GENETICS, V77, P71; CLARK SG, 1994, GENETICS, V137, P987; Counillon L, 2000, J BIOL CHEM, V275, P1, DOI 10.1074/jbc.275.1.1; COWAN WM, 2001, HOWARD HUGHES MED I; CROLL N A, 1975, P71, DOI 10.1016/S0065-308X(08)60319-X; Dal Santo P, 1999, CELL, V98, P757, DOI 10.1016/S0092-8674(00)81510-X; DELCASTILLO J, 1962, J CELL COMPAR PHYSL, V59, P35, DOI 10.1002/jcp.1030590105; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Espelt MV, 2005, J GEN PHYSIOL, V126, P379, DOI 10.1085/jgp.200509355; GIFFARD RG, 1990, BRAIN RES, V506, P339, DOI 10.1016/0006-8993(90)91276-M; Hyman SE, 2005, CURR BIOL, V15, pR154, DOI 10.1016/j.cub.2005.02.037; KAILA K, 1994, PROG NEUROBIOL, V42, P489, DOI 10.1016/0301-0082(94)90049-3; Kaila K., 1998, PH BRAIN FUNCTION; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Lin X, 1996, P NATL ACAD SCI USA, V93, P12631, DOI 10.1073/pnas.93.22.12631; MARUYAMA IN, 1995, NUCLEIC ACIDS RES, V23, P3796, DOI 10.1093/nar/23.18.3796; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nehrke K, 2002, J BIOL CHEM, V277, P29036, DOI 10.1074/jbc.M203200200; Norman KR, 2005, CELL, V123, P119, DOI 10.1016/j.cell.2005.08.001; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; ORLOWSKI J, 1993, J BIOL CHEM, V268, P16369; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; PALMA A, 1991, J MEMBRANE BIOL, V120, P67, DOI 10.1007/BF01868592; Pang TX, 2001, J BIOL CHEM, V276, P17367, DOI 10.1074/jbc.M100296200; PATON WDM, 1958, ANNU REV PHYSIOL, V20, P431, DOI 10.1146/annurev.ph.20.030158.002243; Peters MA, 2007, CURR BIOL, V17, P1601, DOI 10.1016/j.cub.2007.08.031; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; SMART TG, 1982, PROC R SOC SER B-BIO, V215, P327, DOI 10.1098/rspb.1982.0045; TAKEUCHI A, 1967, J PHYSIOL-LONDON, V191, P575, DOI 10.1113/jphysiol.1967.sp008269; THOMAS JH, 1990, GENETICS, V124, P855; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; Villmann C, 1997, J NEUROSCI, V17, P7634, DOI 10.1523/jneurosci.17-20-07634.1997; Wakabayashi S, 1997, BIOCHEMISTRY-US, V36, P12854, DOI 10.1021/bi9715472; Wakabayashi S, 2000, J BIOL CHEM, V275, P7942, DOI 10.1074/jbc.275.11.7942; WAKABAYASHI S, 1994, J BIOL CHEM, V269, P13710; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Zha XM, 2006, P NATL ACAD SCI USA, V103, P16556, DOI 10.1073/pnas.0608018103	49	95	108	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 11	2008	132	1					149	160		10.1016/j.cell.2007.10.058	http://dx.doi.org/10.1016/j.cell.2007.10.058			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IL	18191228	Green Accepted, Bronze			2022-12-28	WOS:000253427600023
J	Ron, D; Hubbard, SR				Ron, David; Hubbard, Stevan R.			How IRe1 reacts to ER stress	CELL			English	Editorial Material							UNFOLDED PROTEIN RESPONSE; MESSENGER-RNA; TRANSMEMBRANE PROTEIN; TRANSCRIPTION FACTOR; KINASE-ACTIVITY	The long-awaited structure of the effector portion of IRE1, the endoplasmic reticulum stress transducer, is published in this issue of Cell ( Lee et al., 2008). This structure provides new insight into the mysterious coupling of kinase and endoribonuclease activities in the oldest, most-conserved branch of the unfolded protein response in eukaryotes.	[Ron, David; Hubbard, Stevan R.] NYU, Sch Med, Kimmel Ctr Biol, Med Skirball Inst, New York, NY 10016 USA; [Ron, David] NYU, Sch Med, Dept Cell Biol, Dept Med, New York, NY 10016 USA; [Hubbard, Stevan R.] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA	New York University; New York University; New York University	Ron, D (corresponding author), NYU, Sch Med, Kimmel Ctr Biol, Med Skirball Inst, New York, NY 10016 USA.	ron@saturn.med.nyu.edu; hubbard@saturn.med.nyu.edu	Longo, Kenneth A/A-5631-2010	Ron, David/0000-0002-3014-5636; Hubbard, Stevan/0000-0002-2707-9383				Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; LEE KPK, 2008, CELL; MORI K, 1993, CELL, V74, P743; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	11	168	177	1	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 11	2008	132	1					24	26		10.1016/j.cell.2007.12.017	http://dx.doi.org/10.1016/j.cell.2007.12.017			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IL	18191217	Bronze			2022-12-28	WOS:000253427600012
J	Okie, S				Okie, Susan			Dr. Pou and the hurricane - Implications for patient care during disasters	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		[Anonymous], AHRQ PUBLICATION; BRADLEY CW, 2007, COMMUNICATION   1022; Deichmann R, 2007, CODE BLUE KATRINA PH; KONIGSMARK AR, 2006, US TODAY        0719, pA3; SCELFO J, 2007, NEWSWEEK        0903	5	37	38	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2008	358	1					1	5		10.1056/NEJMp0707917	http://dx.doi.org/10.1056/NEJMp0707917			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	246TW	18172168				2022-12-28	WOS:000252031200001
J	Larson, DM; Menssen, KM; Sharkey, SW; Duval, S; Schwartz, RS; Harris, J; Meland, JT; Unger, BT; Henry, TD				Larson, David M.; Menssen, Katie M.; Sharkey, Scott W.; Duval, Sue; Schwartz, Robert S.; Harris, James; Meland, Jeffrey T.; Unger, Barbara T.; Henry, Timothy D.			"False-positive" cardiac catheterization laboratory activation among patients with suspected ST-segment elevation myocardial infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERCUTANEOUS CORONARY INTERVENTION; TO-BALLOON TIME; THROMBOLYTIC THERAPY; ELECTROCARDIOGRAM; EMERGENCY; DIAGNOSIS; SYSTEM	Context Allowing the emergency department physician to activate the cardiac catheterization laboratory is a key strategy to reduce door- to- balloon times in patients with ST- segment elevation myocardial infarction ( STEMI). There are limited data on the frequency of "false- positive" catheterization laboratory activation in patients undergoing percutaneous coronary intervention for suspected STEMI. Objective To determine the prevalence, etiology, and outcomes of false- positive cardiac catheterization laboratory activation in patients with a suspected STEMI. Design, Setting, and Patients Prospective registry from a regional system that includes transfer of patients with STEMI from 30 community and rural hospitals with pretransfer catheterization laboratory activation for percutaneous coronary intervention at a tertiary cardiovascular center in Minnesota. A total of 1345 patients were enrolled from March 2003 to November 2006. Main Outcome Measure Prevalence of false- positive catheterization laboratory activation in patients with suspected STEMI by 3 criteria: no culprit coronary artery, no significant coronary artery disease, and negative cardiac biomarker results. Results Of the 1335 patients with suspected STEMI who underwent angiography, 187 ( 14%; 95% confidence interval [ CI], 12.2%- 16.0%) had no culprit coronary artery and 127 ( 9.5%; 95% CI, 8.0%- 11.2%) did not have significant coronary artery disease. Cardiac biomarker levels were negative in 11.2% ( 95% CI, 9.6%-13.0%) of patients. The combination of no culprit artery with negative cardiac biomarker results was present in 9.2% ( 95% CI, 7.7%- 10.9%) of patients. Thirty- day mortality was 2.7% ( 95% CI, 0.4%- 5.0%) without vs 4.6% ( 95% CI, 3.4%- 5.8%) with a culprit coronary artery ( P =. 33). Conclusions The frequency of false- positive cardiac catheterization laboratory activation for suspected STEMI is relatively common in community practice, depending on the definition of false- positive. Recent emphasis on rapid door- to- balloon times must also consider the consequences of false- positive catheterization laboratory activation.	Abbott NW Hosp, Minneapolis Heart Inst Fdn, Minneapolis, MN 55407 USA; Ridgeview Med Ctr, Dept Emergency Med, Waconia, MN USA; Riverwood Healthcare Ctr, Aitkin, MN USA; Northfield Hosp, Northfield, MN USA; Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA	Minneapolis Heart Institute Foundation; University of Minnesota System; University of Minnesota Twin Cities	Henry, TD (corresponding author), Abbott NW Hosp, Minneapolis Heart Inst Fdn, 920 E 28th St,Ste 40, Minneapolis, MN 55407 USA.	henry003@umn.edu	Duval, Susan/AAI-1874-2020	Duval, Sue/0000-0003-1025-8665				Adams RJ, 2004, CIRCULATION, V110, P2512, DOI 10.1161/01.CIR.0000134791.68010.FA; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Barbagelata A, 2006, J ELECTROCARDIOL, V39, pS73, DOI 10.1016/j.jelectrocard.2006.06.006; BLANKENSHIP JC, 1989, J AM COLL CARDIOL, V14, P1579, DOI 10.1016/0735-1097(89)90402-6; Boersma E, 1996, LANCET, V348, P771, DOI 10.1016/S0140-6736(96)02514-7; Bradley EH, 2006, NEW ENGL J MED, V355, P2308, DOI 10.1056/NEJMsa063117; Brady WJ, 2006, EMERG MED CLIN N AM, V24, P91, DOI 10.1016/j.emc.2005.08.004; Brady WJ, 2001, ACAD EMERG MED, V8, P349, DOI 10.1111/j.1553-2712.2001.tb02113.x; Brodie BR, 2006, J AM COLL CARDIOL, V47, P289, DOI 10.1016/j.jacc.2005.08.065; DEWOOD MA, 1980, NEW ENGL J MED, V303, P897, DOI 10.1056/NEJM198010163031601; Henry TD, 2005, AM HEART J, V150, P373, DOI 10.1016/j.ahj.2005.01.059; Henry TD, 2007, CIRCULATION, V116, P721, DOI 10.1161/CIRCULATIONAHA.107.694141; Jaffe AS, 2006, J AM COLL CARDIOL, V48, P1, DOI 10.1016/j.jacc.2006.02.056; KAHN JK, 1993, CLIN CARDIOL, V16, P67, DOI 10.1002/clc.4960160115; Khoury NE, 1996, ANN EMERG MED, V28, P289, DOI 10.1016/S0196-0644(96)70027-6; Laissy JP, 2005, RADIOLOGY, V237, P75, DOI 10.1148/radiol.2371041322; Mahajan N, 2006, INT J CARDIOL, V111, P442, DOI 10.1016/j.ijcard.2005.08.029; MILLER DH, 1987, ARCH INTERN MED, V147, P257, DOI 10.1001/archinte.147.2.257; Sharkey SW, 2005, CIRCULATION, V111, P472, DOI 10.1161/01.CIR.0000153801.51470.EB; SHARKEY SW, 1994, AM J CARDIOL, V73, P550, DOI 10.1016/0002-9149(94)90331-X; Steg PG, 2007, ARCH INTERN MED, V167, P68, DOI 10.1001/archinte.167.1.68; TOPOL EJ, 1995, CIRCULATION, V92, P2333, DOI 10.1161/01.CIR.92.8.2333; Turnipseed SD, 2006, ACAD EMERG MED, V13, P961, DOI 10.1197/j.aem.2006.04.014; Van de Werf F, 2006, LANCET, V367, P569, DOI 10.1016/S0140-6736(06)68147-6; Wang K, 2003, NEW ENGL J MED, V349, P2128, DOI 10.1056/NEJMra022580; Zimetbaum PJ, 2003, NEW ENGL J MED, V348, P933, DOI 10.1056/NEJMra022700	26	231	235	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2007	298	23					2754	2760		10.1001/jama.298.23.2754	http://dx.doi.org/10.1001/jama.298.23.2754			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242HK	18165668	Bronze			2022-12-28	WOS:000251716000020
J	Dixon, JB; O'Brien, PE; Playfair, J; Chapman, L; Schachter, LM; Skinner, S; Proietto, J; Bailey, M; Anderson, M				Dixon, John B.; O'Brien, Paul E.; Playfair, Julie; Chapman, Leon; Schachter, Linda M.; Skinner, Stewart; Proietto, Joseph; Bailey, Michael; Anderson, Margaret			Adjustable gastric banding and conventional therapy for type 2 diabetes - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WEIGHT-LOSS; RISK-FACTORS; LIFE-STYLE; OBESITY; HEALTH; ADULTS; MANAGEMENT; MELLITUS; OUTCOMES; TRENDS	Context Observational studies suggest that surgically induced loss of weight may be effective therapy for type 2 diabetes. Objective To determine if surgically induced weight loss results in better glycemic control and less need for diabetes medications than conventional approaches to weight loss and diabetes control. Design, Setting, and Participants Unblinded randomized controlled trial conducted from December 2002 through December 2006 at the University Obesity Research Center in Australia, with general community recruitment to established treatment programs. Participants were 60 obese patients ( BMI > 30 and < 40) with recently diagnosed ( < 2 years) type 2 diabetes. Interventions Conventional diabetes therapy with a focus on weight loss by lifestyle change vs laparoscopic adjustable gastric banding with conventional diabetes care. Main Outcome Measures Remission of type 2 diabetes ( fasting glucose level < 126 mg/ dL [ 7.0 mmol/ L] and glycated hemoglobin [ HbA(1c)] value < 6.2% while taking no glycemic therapy). Secondary measures included weight and components of the metabolic syndrome. Analysis was by intention- to- treat. Results Of the 60 patients enrolled, 55 ( 92%) completed the 2- year follow- up. Remission of type 2 diabetes was achieved by 22 ( 73%) in the surgical group and 4 ( 13%) in the conventional- therapy group. Relative risk of remission for the surgical group was 5.5 ( 95% confidence interval, 2.2- 14.0). Surgical and conventional- therapy groups lost a mean ( SD) of 20.7% ( 8.6%) and 1.7% ( 5.2%) of weight, respectively, at 2 years ( P <. 001). Remission of type 2 diabetes was related to weight loss ( R-2= 0.46, P <. 001) and lower baseline HbA(1c) levels ( combined R-2= 0.52, P <. 001). There were no serious complications in either group. Conclusions Participants randomized to surgical therapy were more likely to achieve remission of type 2 diabetes through greater weight loss. These results need to be confirmed in a larger, more diverse population and have long- term efficacy assessed. Trial Registration actr. org Identifier: ACTRN012605000159651	[Dixon, John B.; O'Brien, Paul E.; Playfair, Julie; Chapman, Leon; Schachter, Linda M.; Skinner, Stewart; Anderson, Margaret] Monash Univ, Ctr Obes Res & Educ, Melbourne, Vic 3004, Australia; [Bailey, Michael] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Proietto, Joseph] Univ Melbourne, Dept Med AH NH, Melbourne, Vic, Australia	Monash University; Monash University; University of Melbourne	Dixon, JB (corresponding author), Monash Univ, Sch Med, Alfred Hosp, Ctr Obes Res & Educ, Melbourne, Vic 3004, Australia.	john.dixon@med.monash.edu.au	Proietto, Joe/B-3780-2012; Bailey, Michael J/A-4499-2012; Dixon, John B/A-5318-2011	Bailey, Michael J/0000-0002-5551-1401; Dixon, John B/0000-0001-5391-4082				[Anonymous], 1995, Diabetes, V44, P1249; [Anonymous], 2007, DIABETES CARE, V30, pS4, DOI [10.2337/dc07-S004, DOI 10.2337/DC07-S004]; [Anonymous], 1996, DIABETES; Brandle M, 2003, DIABETES CARE, V26, P2300, DOI 10.2337/diacare.26.8.2300; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; Chapman AE, 2004, SURGERY, V135, P326, DOI 10.1016/S0039-6060(03)00392-1; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; Dargent J, 2004, OBES SURG, V14, P986, DOI 10.1381/0960892041719545; Dixon JB, 2002, DIABETES CARE, V25, P358, DOI 10.2337/diacare.25.2.358; Dixon JB, 2005, DIABETES CARE, V28, P472, DOI 10.2337/diacare.28.2.472; Favretti F, 2002, AM J SURG, V184, p38S, DOI 10.1016/S0002-9610(02)01178-9; Favretti F, 2007, OBES SURG, V17, P168, DOI 10.1007/s11695-007-9043-0; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Heine RJ, 2005, ANN INTERN MED, V143, P559, DOI 10.7326/0003-4819-143-8-200510180-00006; Khan MA, 2000, OBES RES, V8, P43, DOI 10.1038/oby.2000.7; Leibson CL, 2001, DIABETES CARE, V24, P1584, DOI 10.2337/diacare.24.9.1584; Mokdad AH, 2000, DIABETES CARE, V23, P1278, DOI 10.2337/diacare.23.9.1278; National Institutes of Health (USA), 1992, American Journal of Clinical Nutrition, V55, p615S; Norris SL, 2004, AM J MED, V117, P762, DOI 10.1016/j.amjmed.2004.05.024; O'Brien PE, 2006, ANN INTERN MED, V144, P625, DOI 10.7326/0003-4819-144-9-200605020-00005; O'Brien PE, 2005, OBES SURG, V15, P820, DOI 10.1381/0960892054222858; Oster G, 1999, AM J PUBLIC HEALTH, V89, P1536, DOI 10.2105/AJPH.89.10.1536; Ponce J, 2004, OBES SURG, V14, P1335, DOI 10.1381/0960892042583932; PORIES WJ, 1992, AM J CLIN NUTR, V55, P582; Schauer PR, 2003, ANN SURG, V238, P467, DOI 10.1097/01.sla.0000089851.41115.1b; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Snow V, 2005, ANN INTERN MED, V142, P525, DOI 10.7326/0003-4819-142-7-200504050-00011; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Sugerman HJ, 2003, ANN SURG, V237, P751, DOI 10.1097/00000658-200306000-00002; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; UK Prospective Diabetes Study Grp, 1999, DIABETES CARE, V22, P1125; *UKPDS GROUP, 1999, BMJ-BRIT MED J, V318, P29; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Weiner R, 2003, OBES SURG, V13, P427, DOI 10.1381/096089203765887787; Williamson DF, 2000, DIABETES CARE, V23, P1499, DOI 10.2337/diacare.23.10.1499; WING RR, 1987, DIABETES CARE, V10, P563, DOI 10.2337/diacare.10.5.563; Zimmet P, 2003, DIABETIC MED, V20, P693, DOI 10.1046/j.1464-5491.2003.01052.x; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	38	1008	1055	1	44	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2008	299	3					316	323		10.1001/jama.299.3.316	http://dx.doi.org/10.1001/jama.299.3.316			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253DB	18212316	Bronze			2022-12-28	WOS:000252497800023
J	Bijlsma, JWJ; Jacobs, JWG				Bijlsma, Johannes W. J.; Jacobs, Johannes W. G.			Glucocorticoid chronotherapy in rheumatoid arthritis	LANCET			English	Editorial Material							CONTROLLED CLINICAL-TRIAL; PREDNISONE THERAPY; TIGHT CONTROL; DOUBLE-BLIND; MANAGEMENT; METHOTREXATE; RECOMMENDATIONS; EFFICACY; PLACEBO		[Bijlsma, Johannes W. J.; Jacobs, Johannes W. G.] Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, NL-3508 GA Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Bijlsma, JWJ (corresponding author), Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, NL-3508 GA Utrecht, Netherlands.	j.w.j.bijlsma@umcutrecht.nl						Arvidson NG, 1997, ANN RHEUM DIS, V56, P27, DOI 10.1136/ard.56.1.27; Bakker MF, 2007, ANN RHEUM DIS, V66, P56, DOI 10.1136/ard.2007.078360; Bijlsma JWJ, 2007, ANN RHEUM DIS, V66, P1409, DOI 10.1136/ard.2007.076463; Buttgereit F, 2008, LANCET, V371, P205, DOI 10.1016/S0140-6736(08)60132-4; Combe B, 2007, ANN RHEUM DIS, V66, P34, DOI 10.1136/ard.2005.044354; Crofford LJ, 1997, J CLIN ENDOCR METAB, V82, P1279, DOI 10.1210/jc.82.4.1279; Da Silva JAP, 2006, ANN RHEUM DIS, V65, P285, DOI 10.1136/ard.2005.038638; Hoes JN, 2007, ANN RHEUM DIS, V66, P1560, DOI 10.1136/ard.2007.072157; Jacobs JWG, 2006, ARTHRITIS RHEUM, V54, P1422, DOI 10.1002/art.21809; Kirwan JR, 2007, COCHRANE DB SYST REV, V1; Maini RN, 2006, ARTHRITIS RHEUM-US, V54, P2817, DOI 10.1002/art.22033; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; Straub RH, 2007, ARTHRITIS RHEUM, V56, P399, DOI 10.1002/art.22368; van Everdingen AA, 2002, ANN INTERN MED, V136, P1, DOI 10.7326/0003-4819-136-1-200201010-00006; Verstappen SMM, 2007, ANN RHEUM DIS, V66, P1443, DOI 10.1136/ard.2007.071092	15	22	23	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 19	2008	371	9608					183	184		10.1016/S0140-6736(08)60114-2	http://dx.doi.org/10.1016/S0140-6736(08)60114-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	252UK	18207003				2022-12-28	WOS:000252471900007
J	Black, RE; Allen, LH; Bhutta, ZA; Caulfield, LE; de Onis, M; Ezzati, M; Mathers, C; Rivera, J				Black, Robert E.; Allen, Lindsay H.; Bhutta, Zulfiqar A.; Caulfield, Laura E.; de Onis, Mercedes; Ezzati, Majid; Mathers, Colin; Rivera, Juan		Maternal & Child Undernutr Study	Maternal and child undernutrition 1 - Maternal and child undernutrition: global and regional exposures and health consequences	LANCET			English	Review							VITAMIN-A SUPPLEMENTATION; CONTROLLED CLINICAL-TRIAL; CLUSTER-RANDOMIZED-TRIAL; YOUNG-CHILDREN; INFANT-MORTALITY; DOUBLE-BLIND; RISK-FACTORS; IRON SUPPLEMENTATION; ZINC SUPPLEMENTATION; DEVELOPING-COUNTRIES	Maternal and child undernutrition is highly prevalent in low-income and middle-income countries, resulting in substantial increases in mortality and overall disease burden. In this paper, we present new analyses to estimate the effects of the risks related to measures of undernutrition, as well as to suboptimum breastfeeding practices on mortality and disease. We estimated that stunting, severe wasting, and intrauterine growth restriction together were responsible for 2.2 million deaths and 21% of disability-adjusted life-years (DALYs) for children younger than 5 years. Deficiencies of vitamin A and zinc were estimated to be responsible for 0 . 6 million and 0 . 4 million deaths, respectively, and a combined 9 % of global childhood DALYs. Iron and iodine deficiencies resulted in few child deaths, and combined were responsible for about 0 . 2% of global childhood DALYs. Iron deficiency as a risk factor for maternal mortality added 115 000 deaths and 0.4% of global total DALYs. Suboptimum breastfeeding was estimated to be responsible for 1 . 4 million child deaths and 44 million DALYs (10% of DALYs in children younger than 5 years). In an analysis that accounted for co-exposure of these nutrition-related factors, they were together responsible for about 35% of child deaths and 11% of the total global disease burden. The high mortality and disease burden resulting from these nutrition-related factors make a compelling case for the urgent implementation of interventions to reduce their occurrence or ameliorate their consequences.	[Black, Robert E.; Caulfield, Laura E.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Allen, Lindsay H.] ARS, USDA, Western Human Nutr Res Ctr, Davis, CA USA; [Bhutta, Zulfiqar A.] Aga Khan Univ, Karachi, Pakistan; [de Onis, Mercedes; Mathers, Colin] WHO, CH-1211 Geneva, Switzerland; [Ezzati, Majid] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Rivera, Juan] Mexico Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; United States Department of Agriculture (USDA); Aga Khan University; World Health Organization; Harvard University; Harvard T.H. Chan School of Public Health; Instituto Nacional de Salud Publica	Black, RE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	rblack@jhsph.edu		Mathers, Colin/0000-0002-0617-6731; Black, Robert/0000-0001-9926-7984; Kirkwood, Betty/0000-0001-5274-6072	MRC [G0400519, MC_U147585821] Funding Source: UKRI; Medical Research Council [U1475000003] Funding Source: researchfish; Medical Research Council [U.1475.00.004.00005.01 (85821), G0400519(71108), G0400519, MC_U147585821] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ADAIR L, 1993, EUR J CLIN NUTR, V47, P42; Aggarwal R, 2007, PEDIATRICS, V119, P1120, DOI 10.1542/peds.2006-3481; AlAli FM, 1997, PUBLIC HEALTH, V111, P239, DOI 10.1016/S0033-3506(97)00041-3; Allen L H, 1994, SCN News, P21; ANDERSEN M, 1997, THESIS U COPENHAGEN; [Anonymous], 2002, NUTR TRANSITION DIET; Arifeen S, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e67; Assis AMO, 2005, EUR J CLIN NUTR, V59, P1317, DOI 10.1038/sj.ejcn.1602245; Bahl R, 2005, B WORLD HEALTH ORGAN, V83, P418; BARRETO ML, 1994, LANCET, V344, P228, DOI 10.1016/S0140-6736(94)92998-X; BEATON GH, 1993, 13 UN ADM COMM COORD; BECKER S, 1991, AM J CLIN NUTR, V53, P1499, DOI 10.1093/ajcn/53.6.1499; Bhargava A, 2001, J NUTR, V131, P758, DOI 10.1093/jn/131.3.758; Bhutta ZA, 1999, J PEDIATR-US, V135, P689, DOI 10.1016/S0022-3476(99)70086-7; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; BLACK RE, 1984, PEDIATRICS, V73, P799; BLEICHRODT N, 1994, DAMAGED BRAIN OF IODINE DEFICIENCY, P195; Branth PV, 2001, AM J CLIN NUTR, V73, P968; BRIEND A, 1988, BRIT MED J, V296, P879, DOI 10.1136/bmj.296.6626.879; Brooks WA, 2004, LANCET, V363, P1683, DOI 10.1016/S0140-6736(04)16252-1; Brooks WA, 2005, LANCET, V366, P999, DOI 10.1016/S0140-6736(05)67109-7; Brown Kenneth H., 2001, Food and Nutrition Bulletin, V22, P113; Brown KH, 2002, AM J CLIN NUTR, V75, P1062, DOI 10.1093/ajcn/75.6.1062; BROWN KH, 1989, PEDIATRICS, V83, P31; BROWN KH, 1998, COMPLEMENTARY FEEDIN; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Caulfield LE, 2004, AM J CLIN NUTR, V80, P193; Checkley W, 1998, AM J EPIDEMIOL, V148, P497, DOI 10.1093/oxfordjournals.aje.a009675; Checkley W, 2003, AM J EPIDEMIOL, V157, P166, DOI 10.1093/aje/kwf179; Christian P, 2003, AM J CLIN NUTR, V78, P1194, DOI 10.1093/ajcn/78.6.1194; CHRISTIAN P, 2007, P MICR FOR CONS CONT; Cnattingius R, 1998, OBSTET GYNECOL, V92, P501, DOI 10.1016/S0029-7844(98)00244-0; Collins S, 2006, LANCET, V368, P1992, DOI 10.1016/S0140-6736(06)69443-9; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; Cottrell G, 2007, AM J TROP MED HYG, V76, P849, DOI 10.4269/ajtmh.2007.76.849; Coutsoudis A, 2004, J INFECT DIS, V189, P2154, DOI 10.1086/420834; Coutsoudis A, 2001, AIDS, V15, P379, DOI 10.1097/00002030-200102160-00011; de Onis M, 1998, EUR J CLIN NUTR, V52, pS5; de Onis M, 2000, B WORLD HEALTH ORGAN, V78, P1222; de Onis M, 2004, INT J EPIDEMIOL, V33, P1260, DOI 10.1093/ije/dyh202; de Onis M, 2004, JAMA-J AM MED ASSOC, V291, P2600, DOI 10.1001/jama.291.21.2600; de Onis M, 2003, INT J EPIDEMIOL, V32, P518, DOI 10.1093/ije/dyg099; de Onis M, 2006, PUBLIC HEALTH NUTR, V9, P942, DOI 10.1017/PHN20062005; Dempsey JC, 2005, J MATERN-FETAL NEO M, V17, P179, DOI 10.1080/14767050500073456; DEWEY KG, SYSTEMATIC REV EFFIC; Edmond KM, 2006, PEDIATRICS, V117, pE380, DOI 10.1542/peds.2005-1496; Ezzati M, 2005, PLOS MED, V2, P404, DOI 10.1371/journal.pmed.0020133; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2; Ezzati M, 2004, COMP QUANTIFICATION; Fawzi WW, 2007, NEW ENGL J MED, V356, P1423, DOI 10.1056/NEJMoa064868; Fishman SM, 2004, COMP QUANTIFICATION, P39; GARENNE M, 1987, RISKS DYING ASS DIFF; Glinoer D, 2000, THYROID, V10, P871, DOI 10.1089/thy.2000.10.871; Gluckman PD, 1999, ACTA PAEDIATR, V88, P7; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Gwatkin DR., 2003, INITIAL COUNTRY LEVE; Haddad L, 2003, WORLD BANK ECON REV, V17, P107, DOI 10.1093/wber/lhg012; Harding R, 2000, CLIN EXP PHARMACOL P, V27, P114, DOI 10.1046/j.1440-1681.2000.03191.x; Harding R, 2000, CLIN EXP PHARMACOL P, V27, P965, DOI 10.1046/j.1440-1681.2000.03379.x; Holick MF, 2006, J CLIN INVEST, V116, P2062, DOI 10.1172/JCI29449; Humphrey JH, 1996, J PEDIATR-US, V128, P489, DOI 10.1016/S0022-3476(96)70359-1; Iannotti LL, 2006, AM J CLIN NUTR, V84, P1261, DOI 10.1093/ajcn/84.6.1261; Iliff PJ, 2005, AIDS, V19, P699, DOI 10.1097/01.aids.0000166093.16446.c9; *IZINCG, 2004, FOOD NUTR BULL, V25, pS130; Khatun UHF, 2001, ACTA PAEDIATR, V90, P376, DOI 10.1080/080352501750126159; Klemm R, 2007, P MICR FOR CONS CONT; KRAEMER K, 2007, NUTR ANEMIAS; Kramer M. S., 2001, Nutrition and health in developing countries, P57; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; KUMAR V, 1981, Indian Pediatrics, V18, P743; LANATA CF, 1992, ACTA PAEDIATR, V81, P32, DOI 10.1111/j.1651-2227.1992.tb12369.x; Lauer JA, 2006, PUBLIC HEALTH NUTR, V9, P673, DOI 10.1079/PHN2005891; Lauer JA, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-26; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Luxemburger C, 2001, AM J EPIDEMIOL, V154, P459, DOI 10.1093/aje/154.5.459; Mahalanabis D, 2004, AM J CLIN NUTR, V79, P430; Manzar S, 1999, PEDIATRICS, V104, P1169, DOI 10.1542/peds.104.5.1169; Martines J, 1998, LANCET, V352, P1257, DOI 10.1016/S0140-6736(98)02487-8; MARTORELL R, 1975, AM J DIS CHILD, V129, P1296, DOI 10.1001/archpedi.1975.02120480022007; MATA L, 1992, AM J TROP MED HYG, V47, P16, DOI 10.4269/ajtmh.1992.47.16; MCLEAN E, 2006, PRELIMINARY ESTIMATE; Menezes AMB, 2005, REV PANAM SALUD PUBL, V18, P439, DOI 10.1590/S1020-49892005001000007; MOLBAK K, 1994, J INFECT DIS, V169, P581, DOI 10.1093/infdis/169.3.581; Molbak K, 1997, AM J EPIDEMIOL, V146, P273, DOI 10.1093/oxfordjournals.aje.a009263; Moore SR, 2001, INT J EPIDEMIOL, V30, P1457, DOI 10.1093/ije/30.6.1457; Morris SS, 2004, LANCET, V364, P2030, DOI 10.1016/S0140-6736(04)17515-6; Mullany LC, 2006, LANCET, V367, P910, DOI 10.1016/S0140-6736(06)68381-5; Murray C.J.L., 2004, COMP QUANTIFICATION, V1, P257, DOI DOI 10.1007/S12263-011-0248-4; Onis M. de, 2006, Acta Paediatrica, V95, P76; PELLETIER DL, 1993, AM J PUBLIC HEALTH, V83, P1130, DOI 10.2105/AJPH.83.8.1130; Penny ME, 2005, LANCET, V365, P1863, DOI 10.1016/S0140-6736(05)66426-4; Prentice AM, 2005, ARCH DIS CHILD, V90, P429, DOI 10.1136/adc.2004.059030; RAHMATHULLAH L, 1990, NEW ENGL J MED, V323, P929, DOI 10.1056/NEJM199010043231401; Rahmathullah L, 2003, BMJ-BRIT MED J, V327, P254, DOI 10.1136/bmj.327.7409.254; RAMAKRISHNAN U, 1995, J NUTR, V125, P202; RASTOGI R, GLOBAL BURDEN IODINE; Rastogi R, GLOBAL BURDEN IRON D; Ray JG, 2007, EPIDEMIOLOGY, V18, P362, DOI 10.1097/01.ede.0000257063.77411.e9; Rice AL., 2004, COMP QUANTIFICATION, V1, P0211; Ronsmans C, 2006, LANCET, V368, P1516, DOI 10.1016/S0140-6736(06)69639-6; ROSS DA, 1993, LANCET, V342, P7, DOI 10.1016/0140-6736(93)91879-Q; ROSS DA, 1995, AM J PUBLIC HEALTH, V85, P1246, DOI 10.2105/AJPH.85.9.1246; ROWLAND MGM, 1988, AM J CLIN NUTR, V47, P134, DOI 10.1093/ajcn/47.1.134; ROWLAND MGM, 1977, BRIT J NUTR, V37, P441, DOI 10.1079/BJN19770047; Sachdev HPS, 2006, PUBLIC HEALTH NUTR, V9, P904, DOI 10.1017/PHN2005918; Sachdev HPS, 2005, PUBLIC HEALTH NUTR, V8, P117, DOI 10.1079/PHN2004677; Salomon JA, 2002, POPUL DEV REV, V28, P205, DOI 10.1111/j.1728-4457.2002.00205.x; Sazawal S, 2007, LANCET, V369, P927, DOI 10.1016/S0140-6736(07)60452-8; SCHLESINGER L, 1991, SEMIN PERINATOL, V15, P469; Scrimshaw NS, 1968, INTERACTIONS NUTR IN; Shankar AH, 1999, LANCET, V354, P203, DOI 10.1016/S0140-6736(98)08293-2; Shankar AH, 1998, AM J CLIN NUTR, V68, p447S, DOI 10.1093/ajcn/68.2.447S; Shrimpton R, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e75; SINKALA M, 2007, 14 C RETR OPP INF; SOMMER A, 1984, AM J CLIN NUTR, V40, P1090, DOI 10.1093/ajcn/40.5.1090; STAVE U, 1970, PHYSL PERINATAL PERI, P29; Stoltzfus RJ., 2004, COMP QUANTIFICATION, pp. 163; Taha TE, 2006, B WORLD HEALTH ORGAN, V84, P546, DOI 10.2471/BLT.05.027664; Tamura T, 2006, AM J CLIN NUTR, V83, P993, DOI 10.1093/ajcn/83.5.993; *TASK FORC HUNG, 2005, UN MILL PROJ 2005 HA; Thacher TD, 2006, ANN TROP PAEDIATR, V26, P1, DOI 10.1179/146532806X90556; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; Tielsch JM, 2007, LANCET, V370, P1230, DOI 10.1016/S0140-6736(07)61539-6; UN Department of Economic and Social Affairs Population Division, 2005, WORLD POP PROSP 2004; *UNAIDS WHO, 2006, UNAIDS WHO AIDS EP U; *UNICEF, CHILDR AIDS STOCK RE; United Nations Children's Fund and World Health Organization, 2004, LOW BIRTHW COUNTR RE; VICTORA CG, 1992, J NUTR, V122, P1105, DOI 10.1093/jn/122.5.1105; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7; Walker CF, 2004, ANNU REV NUTR, V24, P255, DOI 10.1146/annurev.nutr.23.011702.073054; WATERLOW JC, 1972, BRIT MED J, V3, P566, DOI 10.1136/bmj.3.5826.566; West KP, 1997, J NUTR, V127, P1957, DOI 10.1093/jn/127.10.1957; WEST KP, 1991, LANCET, V338, P67, DOI 10.1016/0140-6736(91)90070-6; West KP, 2002, J NUTR, V132, p2857S, DOI 10.1093/jn/132.9.2857S; West KP, 1999, BMJ-BRIT MED J, V318, P570, DOI 10.1136/bmj.318.7183.570; *WHO, 1995, WHO S, V73, P32; *WHO, 2006, GLOB TUB CONTR SURV; *WHO, 1997, HYP NEWB REV LIT; World Bank, 2006, REP NUTR CENTR DEV S; World Health Organization, 2006, WHO CHILD GROWTH STA; World Health Organization (WHO), 2006, WORLD HLTH REP 2006; Zimmermann M, 2004, EUR J CLIN NUTR, V58, P979, DOI 10.1038/sj.ejcn.1601933	144	3474	3590	13	453	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 19	2008	371	9608					243	260		10.1016/S0140-6736(07)61690-0	http://dx.doi.org/10.1016/S0140-6736(07)61690-0			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	252UK	18207566				2022-12-28	WOS:000252471900028
J	Wilt, TJ; N'Dow, J				Wilt, Timothy J.; N'Dow, James			Benign prostatic hyperplasia. Part 1 - Diagnosis	BRITISH MEDICAL JOURNAL			English	Review							URINARY-TRACT SYMPTOMS; QUALITY-OF-LIFE; NATURAL-HISTORY; RISK-FACTORS; PREVALENCE; COMMUNITY; MEN; RETENTION; SURGERY; CANCER		[Wilt, Timothy J.] Ctr Chron Dis Outcomes Res, Minneapolis, MN 55417 USA; [N'Dow, James] Univ Aberdeen, Acad Urol Unit, Aberdeen AB25 2ZD, Scotland	University of Aberdeen	Wilt, TJ (corresponding author), Ctr Chron Dis Outcomes Res, 1 Vet Dr 111-0, Minneapolis, MN 55417 USA.	tim.wilt@med.va.gov						*AM UR ASS, 2006, GUID MAN BEN PROST H; BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; BERRY SJ, 1984, J UROLOGY, V132, P474, DOI 10.1016/S0022-5347(17)49698-4; Brown CT, 2003, BJU INT, V91, P30, DOI 10.1046/j.1464-410X.2003.04013.x; *EUR ASS UR, 2004, GUID BEN PROST HYP; Fitzpatrick JM, 2006, BJU INT, V97, P3, DOI 10.1111/j.1464-410X.2006.06097.x; Foley CL, 2004, BJU INT, V93, P250, DOI 10.1111/j.1464-410X.2004.04595.x; GARRAWAY WM, 1991, LANCET, V338, P469, DOI 10.1016/0140-6736(91)90543-X; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Jacobsen SJ, 1997, J UROLOGY, V158, P481, DOI 10.1016/S0022-5347(01)64508-7; Kupelian V, 2006, ARCH INTERN MED, V166, P2381, DOI 10.1001/archinte.166.21.2381; McConnell JD, 2003, NEW ENGL J MED, V349, P2387, DOI 10.1056/NEJMoa030656; Meigs JB, 1999, J UROLOGY, V162, P376, DOI 10.1016/S0022-5347(05)68563-1; Platz EA, 2002, UROLOGY, V59, P877, DOI 10.1016/S0090-4295(01)01673-9; Schafer W, 2002, NEUROUROL URODYNAM, V21, P261, DOI 10.1002/nau.10066; Su L, 1996, J CLIN EPIDEMIOL, V49, P483, DOI 10.1016/0895-4356(96)00567-7; Sullivan J, 2003, BJU INT, V91, P201, DOI 10.1046/j.1464-410X.2003.04054.x; Trueman P, 1999, BJU INT, V83, P410; WASSON JH, 1995, NEW ENGL J MED, V332, P75, DOI 10.1056/NEJM199501123320202; WEI JT, 2007, NIH PUBLICATION, P43; Welch G, 2002, UROLOGY, V59, P245, DOI 10.1016/S0090-4295(01)01506-0; WILT TJ, 2006, BRIT MED J, V133, P1102; Young JM, 2000, BJU INT, V85, P1037, DOI 10.1046/j.1464-410x.2000.00659.x; Zucchetto A, 2005, INT J OBESITY, V29, P798, DOI 10.1038/sj.ijo.0802979	24	11	11	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 19	2008	336	7636					146	149		10.1136/bmj.39421.685023.AE	http://dx.doi.org/10.1136/bmj.39421.685023.AE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	257SS	18202067	Green Published, Green Submitted			2022-12-28	WOS:000252819400034
J	Pedraza, JM; Paulsson, J				Pedraza, Juan M.; Paulsson, Johan			Effects of molecular memory and bursting on fluctuations in gene expression	SCIENCE			English	Article							SINGLE-CELL; PROTEIN EXPRESSION; NOISE; NETWORKS; DIFFERENTIATION; STOCHASTICITY; TURNOVER; LEVEL; TIME	Many cellular components are present in such low numbers per cell that random births and deaths of individual molecules can cause substantial "noise" in concentrations. But biochemical events do not necessarily occur in single steps of individual molecules. Some processes are greatly randomized when synthesis or degradation occurs in large bursts of many molecules during a short time interval. Conversely, each birth or death of a macromolecule could involve several small steps, creating a memory between individual events. We present a generalized theory for stochastic gene expression, formulating the variance in protein abundance in terms of the randomness of the individual gene expression events. We show that common types of molecular mechanisms can produce gestation and senescence periods that reduce noise without requiring higher abundances, shorter lifetimes, or any concentration- dependent control loops. We also show that most single- cell experimental methods cannot distinguish between qualitatively different stochastic principles, although this in turn makes such methods better suited for identifying which components introduce fluctuations. Characterizing the random events that give rise to noise in concentrations instead requires dynamic measurements with single- molecule resolution.	[Pedraza, Juan M.; Paulsson, Johan] Harvard Univ, Dept Syst Biol, Boston, MA 02115 USA; [Paulsson, Johan] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Paulsson, J (corresponding author), Harvard Univ, Dept Syst Biol, Boston, MA 02115 USA.	johan_paulsson@hms.harvard.edu		Pedraza, Juan/0000-0002-1802-3337				Amir A, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100113; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; BERG OG, 1978, J THEOR BIOL, V71, P587, DOI 10.1016/0022-5193(78)90326-0; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Bortkewitsch L.v, 1898, MONATSHEFTE MATH PHY, V9, pA39; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Doan T, 2006, SCIENCE, V313, P530, DOI 10.1126/science.1126612; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Friedman N, 2005, PLOS BIOL, V3, P1261, DOI 10.1371/journal.pbio.0030238; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Hubner CG, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.093903; Korobkova EA, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.058105; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2001, Q REV BIOPHYS, V34, P1, DOI 10.1017/S0033583501003663; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Paulsson J, 2005, PHYS LIFE REV, V2, P157, DOI 10.1016/j.plrev.2005.03.003; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623	32	275	278	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2008	319	5861					339	343		10.1126/science.1144331	http://dx.doi.org/10.1126/science.1144331			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252GY	18202292				2022-12-28	WOS:000252436200041
J	Press, F				Press, Frank			Earth science and society	NATURE			English	Editorial Material								The unique set of challenges that face humankind today mean that it is more essential than ever that Earth scientists apply their understanding of the planet to benefit society and that society invite them to do so.	[Press, Frank] Natl Acad Sci, Washington, DC 20418 USA; [Press, Frank] MIT, Cambridge, MA 02139 USA	National Academies of Sciences, Engineering & Medicine; Massachusetts Institute of Technology (MIT)	Press, F (corresponding author), Law & Econ Consulting Grp, Washington Advisory Grp, Washington, DC USA.	fpress@theadvisorygroup.com						Barth KH, 2003, SOC STUD SCI, V33, P743, DOI 10.1177/0306312703335005; *COMM TECHN ISS RE, 2002, TECHN ISS REL COMPR; MOLINA MJ, 1974, NATURE, V249, P810, DOI 10.1038/249810a0; PEARCE F, 1992, NEW SCI, P81338; Richards PG, 1996, NATO ADV SCI INST SE, V303, P53; Solomon S., 2007, PHYS SCI BASIS WORKI	6	10	11	2	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2008	451	7176					301	303		10.1038/nature06595	http://dx.doi.org/10.1038/nature06595			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202650	Bronze			2022-12-28	WOS:000252432100042
J	Iams, JD; Romero, R; Culhane, JF; Goldenberg, RL				Iams, Jay D.; Romero, Roberto; Culhane, Jennifer F.; Goldenberg, Robert L.			Preterm birth 2 - Primary, secondary, and tertiary interventions to reduce the morbidity and mortality of preterm birth	LANCET			English	Review							RANDOMIZED CONTROLLED-TRIAL; ELECTIVE CERVICAL CERCLAGE; PLACEBO-CONTROLLED TRIAL; LOW-DOSE ASPIRIN; BACTERIAL VAGINOSIS; HIGH-RISK; PERIODONTAL-DISEASE; PREGNANT-WOMEN; PRENATAL-CARE; BED REST	Interventions to reduce the morbidity and mortality of preterm birth can be primary (directed to all women), secondary (aimed at eliminating or reducing existing risk), or tertiary (intended to improve outcomes for preterm infants). Most efforts so far have been tertiary interventions, such as regionalised care, and treatment with antenatal corticosteroids, tocolytic agents, and antibiotics. These measures have reduced perinatal morbidity and mortality; but the incidence of preterm birth is increasing. Advances in primary and secondary care, following strategies used for other complex health problems, such as cervical cancer, will be needed to prevent prematurity-related illness in infants and children.	[Iams, Jay D.] Ohio State Univ, Dept Obstet & Gynecol, Columbus, OH 43210 USA; [Romero, Roberto] NICHHD, Perinatol Res Branch, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Romero, Roberto] NICHHD, Perinatol Res Branch, NIH, Dept Hlth & Human Serv, Detroit, MI USA; [Romero, Roberto] Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI USA; [Culhane, Jennifer F.; Goldenberg, Robert L.] Drexel Univ, Coll Med, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA	University System of Ohio; Ohio State University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Wayne State University; Drexel University	Iams, JD (corresponding author), 1654 Upham Dr, Columbus, OH 43210 USA.	iams.1@osu.edu	Romero, Roberto/A-5268-2019	Romero, Roberto/0000-0002-4448-5121	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD002400] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD002400] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		*ACOG, 2001, OBSTET GYNECOL, V98, P708; ACOG Committee on Obstetric Practice, 2005, Obstet Gynecol, V106, P1143; Adams MM, 2000, JAMA-J AM MED ASSOC, V283, P1591, DOI 10.1001/jama.283.12.1591; ALEXANDER GRR, 2006, PRETERM BIRTH CAUSES, P636; Alfirevic Z, 2007, ULTRASOUND OBST GYN, V29, P47, DOI 10.1002/uog.3908; Althuisius S, 2002, ULTRASOUND OBST GYN, V20, P163, DOI 10.1046/j.1469-0705.2002.00770.x; Althuisius SM, 2003, AM J OBSTET GYNECOL, V189, P907, DOI 10.1067/S0002-9378(03)00718-X; Althuisius SM, 2001, AM J OBSTET GYNECOL, V185, P1106, DOI 10.1067/mob.2001.118655; Althuisius SM, 2000, AM J OBSTET GYNECOL, V183, P823, DOI 10.1067/mob.2000.108874; American College of Obstetricians and Gynecologists, 2005, Obstet Gynecol, V106, P665; American College of Obstetricians and Gynecologists Committee on Practice Bulletins, 2003, OBSTET GYNECOL, V101, P1039; Ananth CV, 2006, AM J OBSTET GYNECOL, V195, P643, DOI 10.1016/j.ajog.2006.05.022; Ancel PY, 2004, HUM REPROD, V19, P734, DOI 10.1093/humrep/deh107; ANDERSEN HF, 1990, AM J OBSTET GYNECOL, V163, P859, DOI 10.1016/0002-9378(90)91084-P; Andrews WW, 2006, AM J OBSTET GYNECOL, V194, P617, DOI 10.1016/j.ajog.2005.11.049; Andrews WW, 2003, OBSTET GYNECOL, V101, P847, DOI 10.1016/S0029-7844(03)00172-8; Anotayanonth S, 2004, Cochrane Database Syst Rev, pCD004352, DOI 10.1002/14651858.CD004352.pub2; Armstrong J, 2007, AM J OBSTET GYNECOL, V196, P194, DOI 10.1016/j.ajog.2006.12.022; Bailit JL, 2007, AM J OBSTET GYNECOL, V196, P219, DOI 10.1016/j.ajog.2006.12.021; BAKKETEIG LS, 1981, PRETERM LABOR, P17; BEHRMAN RE, 2006, COMMITTEE UNDERSTAND; Berghella V, 1999, AM J OBSTET GYNECOL, V181, P809, DOI 10.1016/S0002-9378(99)70306-6; Berghella V, 2005, OBSTET GYNECOL, V106, P181, DOI 10.1097/01.AOG.0000168435.17200.53; Berghella V, 2004, AM J OBSTET GYNECOL, V191, P1311, DOI 10.1016/j.ajog.2004.06.054; Berghella V, 2002, AM J OBSTET GYNECOL, V187, P747, DOI 10.1067/mob.2002.124289; Brown HL, 1999, AM J OBSTET GYNECOL, V180, P798, DOI 10.1016/S0002-9378(99)70650-2; BRYCE RL, 1991, BRIT J OBSTET GYNAEC, V98, P1001, DOI 10.1111/j.1471-0528.1991.tb15338.x; Burguet A, 2004, BJOG-INT J OBSTET GY, V111, P258, DOI 10.1046/j.1471-0528.2003.00037.x; Callaghan WM, 2006, PEDIATRICS, V118, P1566, DOI 10.1542/peds.2006-0860; Carey JC, 2000, NEW ENGL J MED, V342, P534, DOI 10.1056/NEJM200002243420802; Caritis S, 1998, NEW ENGL J MED, V338, P701, DOI 10.1056/NEJM199803123381101; Caritis S, 2006, AM J OBSTET GYNECOL, V195, pS2, DOI 10.1016/j.ajog.2006.10.003; *CDCP, 2006, SEX TRANSM DIS TREAT; COPPER RL, 1994, OBSTET GYNECOL, V84, P490; Crowther CA, 2002, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD001060; CZEIZEL AE, 1994, ARCH GYNECOL OBSTET, V255, P131; da Fonseca EB, 2003, AM J OBSTET GYNECOL, V188, P419, DOI 10.1067/mob.2003.41; DEPP R, 1993, AM J OBSTET GYNECOL, V169, P352; Deulofeut R, 2005, OBSTET GYNECOL, V105, P525, DOI 10.1097/01.AOG.0000154156.51578.50; DEVOE LD, 1995, AM J OBSTET GYNECOL, V173, P1120; Di Renzo GC, 1998, PRENAT NEONAT MED, V3, P147; Dodd JM, 2006, COCHRANE DB SYST REV, V1; Dodd JM, 2006, COCHRANE DB SYST REV, V1; Duley L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004659.pub2; Dyson DC, 1998, NEW ENGL J MED, V338, P15, DOI 10.1056/NEJM199801013380103; ELDER HA, 1971, AM J OBSTET GYNECOL, V111, P441, DOI 10.1016/0002-9378(71)90793-9; ESCHENBACH DA, 1991, AM J OBSTET GYNECOL, V164, P734, DOI 10.1016/0002-9378(91)90506-M; Espinoza J, 2006, AM J OBSTET GYNECOL, V194, P630, DOI 10.1016/j.ajog.2005.11.050; FIORE MC, 2000, TREATING TOBACCO USE; Fonseca EB, 2007, NEW ENGL J MED, V357, P462, DOI 10.1056/NEJMoa067815; Gichangi PB, 1997, AM J OBSTET GYNECOL, V177, P680, DOI 10.1016/S0002-9378(97)70164-9; Goldenberg RL, 2006, AM J OBSTET GYNECOL, V194, P650, DOI 10.1016/j.ajog.2006.01.004; Goldenberg RL, 2001, AM J OBSTET GYNECOL, V185, P643, DOI 10.1067/mob.2001.116752; Goldenberg RL, 1998, AM J PUBLIC HEALTH, V88, P233, DOI 10.2105/AJPH.88.2.233; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Goldenberg RL, 2006, AM J OBSTET GYNECOL, V195, P792, DOI 10.1016/j.ajog.2006.05.050; Grant A, 1996, BRIT J OBSTET GYNAEC, V103, P1197, DOI 10.1111/j.1471-0528.1996.tb09628.x; Groom KM, 2004, EUR J OBSTET GYN R B, V112, P158, DOI 10.1016/S0301-2115(03)00289-6; Guzman ER, 2001, ULTRASOUND OBST GYN, V18, P195, DOI 10.1046/j.0960-7692.2001.525.x; Guzman ER, 1998, ULTRASOUND OBST GYN, V12, P323, DOI 10.1046/j.1469-0705.1998.12050323.x; Haas JS, 2005, ARCH PEDIAT ADOL MED, V159, P58, DOI 10.1001/archpedi.159.1.58; Harnett EL, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.047; Hassan SS, 2001, AM J OBSTET GYNECOL, V184, P1325, DOI 10.1067/mob.2001.115119; Hauth JC, 1995, NEW ENGL J MED, V333, P1732, DOI 10.1056/NEJM199512283332603; Healy AJ, 2006, OBSTET GYNECOL, V107, P625, DOI 10.1097/01.AOG.0000201978.83607.96; Heath VCF, 1998, ULTRASOUND OBST GYN, V12, P312, DOI 10.1046/j.1469-0705.1998.12050312.x; Heijnen EMEW, 2007, LANCET, V369, P743, DOI 10.1016/S0140-6736(07)60360-2; HERRON MA, 1982, OBSTET GYNECOL, V59, P452; Higgins SP, 2004, AUST NZ J OBSTET GYN, V44, P228, DOI 10.1111/j.1479-828X.2004.00220.x; Hodnett E. D., 2003, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD000198; HOFMEYR GJ, 2006, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD001059.PUB2; HUESTON WJ, 1995, OBSTET GYNECOL, V86, P705, DOI 10.1016/0029-7844(95)00202-3; IAMS JD, 1995, AM J OBSTET GYNECOL, V172, P1097, DOI 10.1016/0002-9378(95)91469-2; IAMS JD, 1990, AM J PERINAT, V7, P170, DOI 10.1055/s-2007-999473; Iams JD, 1998, AM J OBSTET GYNECOL, V178, P1035, DOI 10.1016/S0002-9378(98)70544-7; Iams JD, 1996, NEW ENGL J MED, V334, P567, DOI 10.1056/NEJM199602293340904; Iams JD, 2001, AM J OBSTET GYNECOL, V184, P652, DOI 10.1067/mob.2001.111248; Jain T, 2004, NEW ENGL J MED, V350, P1639, DOI 10.1056/NEJMsa032073; Jakobsson M, 2007, OBSTET GYNECOL, V109, P309, DOI 10.1097/01.AOG.0000253239.87040.23; JOESOEF MR, 1995, AM J OBSTET GYNECOL, V173, P1527, DOI 10.1016/0002-9378(95)90644-4; JOSEPH KS, 2007, BMC PREGNANCY CHILDB, V28, P7; KEIRSE MJNC, 1990, BRIT J OBSTET GYNAEC, V97, P149, DOI 10.1111/j.1471-0528.1990.tb01740.x; Kekki M, 2001, OBSTET GYNECOL, V97, P643, DOI 10.1016/S0029-7844(01)01321-7; Kenyon SL, 2001, LANCET, V357, P979, DOI 10.1016/S0140-6736(00)04233-1; Kigozi GG, 2003, AM J OBSTET GYNECOL, V189, P1398, DOI 10.1067/S0002-9378(03)00777-4; King J, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001992.pub2; King JF, 2003, COCHRANE DB SYST REV, V1; Kiss H, 2004, BMJ-BRIT MED J, V329, P371, DOI 10.1136/bmj.38169.519653.EB; Kitzman H, 1997, JAMA-J AM MED ASSOC, V278, P644, DOI 10.1001/jama.278.8.644; Klebanoff MA, 2001, NEW ENGL J MED, V345, P487, DOI 10.1056/NEJMoa003329; KLEBANOFF MA, 1995, AM J OBSTET GYNECOL, V172, P1540, DOI 10.1016/0002-9378(95)90493-X; Klerman LV, 2001, AM J PUBLIC HEALTH, V91, P105; Kramer MS, 2003, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD000032; Kurkinen-Raty M, 2000, BRIT J OBSTET GYNAEC, V107, P1427, DOI 10.1111/j.1471-0528.2000.tb11660.x; Kurup M, 1999, AM J OBSTET GYNECOL, V181, P240, DOI 10.1016/S0002-9378(99)70542-9; Lamont RF, 2005, BJOG-INT J OBSTET GY, V112, P67, DOI 10.1111/j.1471-0528.2005.00589.x; Lamont RF, 2003, OBSTET GYNECOL, V101, P516, DOI 10.1016/S0029-7844(02)03054-5; Larsson PG, 2006, BJOG-INT J OBSTET GY, V113, P629, DOI 10.1111/j.1471-0528.2006.00946.x; LAUNER LJ, 1990, BRIT J OBSTET GYNAEC, V97, P62, DOI 10.1111/j.1471-0528.1990.tb01718.x; LAZAR P, 1984, BRIT J OBSTET GYNAEC, V91, P731, DOI 10.1111/j.1471-0528.1984.tb04841.x; Leitich H, 1999, AM J OBSTET GYNECOL, V181, P1465, DOI 10.1016/S0002-9378(99)70407-2; LEVENO KJ, 1986, OBSTET GYNECOL, V68, P434, DOI 10.1097/00006250-198609000-00031; Levine RJ, 1997, NEW ENGL J MED, V337, P69, DOI 10.1056/NEJM199707103370201; Lu MC, 2006, MATERN CHILD HLTH J, V10, pS107, DOI 10.1007/s10995-006-0118-7; Lumley J., 2004, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD001055.PUB2; Lumley J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-299; Mackenzie R, 2006, AM J OBSTET GYNECOL, V194, P1234, DOI 10.1016/j.ajog.2005.06.049; MACNAUGHTON MC, 1993, BRIT J OBSTET GYNAEC, V100, P516; Martensson A, 2004, ACTA AGR SCAND B-S P, V54, P1, DOI 10.1080/09064710410024417; Massett HA, 2003, AM J PREV MED, V24, P120, DOI 10.1016/S0749-3797(02)00572-X; Matijevic R, 2006, ACTA OBSTET GYN SCAN, V85, P1342, DOI 10.1080/00016340600935722; Mazaki-Tovi S, 2007, SEMIN PERINATOL, V31, P142, DOI 10.1053/j.semperi.2007.04.001; McDonald H, 2007, COCHRANE DB SYST REV, V1; McDonald HM, 1997, BRIT J OBSTET GYNAEC, V104, P1391, DOI 10.1111/j.1471-0528.1997.tb11009.x; MEIS PJ, 1995, AM J OBSTET GYNECOL, V173, P597, DOI 10.1016/0002-9378(95)90288-0; Meis PJ, 2003, NEW ENGL J MED, V348, P2379, DOI 10.1056/NEJMoa035140; Mercer B, 2005, AM J OBSTET GYNECOL, V193, P1175, DOI 10.1016/j.ajog.2005.05.040; Mercer BM, 1999, AM J OBSTET GYNECOL, V181, P1216, DOI 10.1016/S0002-9378(99)70111-0; Mercer BM, 1997, JAMA-J AM MED ASSOC, V278, P989, DOI 10.1001/jama.278.12.989; Michalowicz BS, 2006, NEW ENGL J MED, V355, P1885, DOI 10.1056/NEJMoa062249; Min JK, 2006, J OBSTET GYNAECOL CA, V28, P799, DOI 10.1016/S1701-2163(16)32246-0; Mittendorf R, 1997, LANCET, V350, P1517, DOI 10.1016/S0140-6736(97)24047-X; Moore S, 2004, BRIT DENT J, V197, P251, DOI 10.1038/sj.bdj.4811620; Moreau C, 2005, BJOG-INT J OBSTET GY, V112, P430, DOI 10.1111/j.1471-0528.2004.00478.x; MUELLERHEUBACH E, 1989, AM J OBSTET GYNECOL, V160, P1172, DOI 10.1016/0002-9378(89)90183-X; NAGEY DA, 1993, OBSTET GYNECOL, V82, P319; Nanda K, 2002, COCHRANE DB SYST REV, V4; Offenbacher S, 2006, OBSTET GYNECOL, V107, P29, DOI 10.1097/01.AOG.0000190212.87012.96; OLDS DL, 1986, PEDIATRICS, V77, P16; Olsen SF, 2000, BRIT J OBSTET GYNAEC, V107, P382, DOI 10.1111/j.1471-0528.2000.tb13235.x; OLSEN SF, 1992, LANCET, V339, P1003, DOI 10.1016/0140-6736(92)90533-9; Papatsonis D, 2005, COCHRANE DB SYST REV, V3; PAPIERNIK E, 1985, PEDIATRICS, V76, P154; Papiernik E, 2007, MATERN CHILD HLTH J, V11, P407, DOI 10.1007/s10995-007-0217-0; Patton PE, 2004, AM J OBSTET GYNECOL, V190, P1669, DOI 10.1016/j.ajog.2004.02.046; Petersen R, 2006, TOB CONTROL, V15, P30, DOI 10.1136/tc.2005.012187; Petrini JR, 2005, OBSTET GYNECOL, V105, P267, DOI 10.1097/01.AOG.0000150560.24297.4f; Phibbs CS, 2007, NEW ENGL J MED, V356, P2165, DOI 10.1056/NEJMsa065029; Pompeii LA, 2005, OBSTET GYNECOL, V106, P1279, DOI 10.1097/01.AOG.0000189080.76998.f8; Poston L, 2006, LANCET, V367, P1145, DOI 10.1016/S0140-6736(06)68433-X; Pretorius C, 2007, J PERINAT MED, V35, P93, DOI 10.1515/JPM.2007.039; Quinlivan JA, 2004, BJOG-INT J OBSTET GY, V111, P571, DOI 10.1111/j.1471-0528.2004.00146.x; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Ricketts SA, 2005, AM J PUBLIC HEALTH, V95, P1952, DOI 10.2105/AJPH.2004.047068; Riggs MA, 2004, CLIN OBSTET GYNECOL, V47, P796, DOI 10.1097/01.grf.0000141450.61310.81; Riskin A, 2004, BJOG-INT J OBSTET GY, V111, P1365, DOI 10.1111/j.1471-0528.2004.00268.x; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Romero R, 2004, AM J OBSTET GYNECOL, V190, P1509, DOI 10.1016/j.ajog.2004.01.002; ROMERO R, 1989, OBSTET GYNECOL, V73, P576; ROMERO R, 2004, PRETERM BIRTH, P28; Rosenstein I J, 2000, Infect Dis Obstet Gynecol, V8, P158, DOI 10.1155/S1064744900000211; Rumbold A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004227.pub2; Rumbold AR, 2006, NEW ENGL J MED, V354, P1796, DOI 10.1056/NEJMoa054186; RUSH RW, 1984, BRIT J OBSTET GYNAEC, V91, P724, DOI 10.1111/j.1471-0528.1984.tb04840.x; Rust OA, 2001, AM J OBSTET GYNECOL, V185, P1098, DOI 10.1067/mob.2001.118163; Sadler L, 2004, JAMA-J AM MED ASSOC, V291, P2100, DOI 10.1001/jama.291.17.2100; Sakai M, 2006, AM J OBSTET GYNECOL, V194, P14, DOI 10.1016/j.ajog.2005.06.014; Salihu Hamisu M, 2003, Matern Child Health J, V7, P219, DOI 10.1023/A:1027319517405; Sanchez-Ramos L, 2005, OBSTET GYNECOL, V105, P273, DOI 10.1097/01.AOG.0000150559.59531.b2; Saurel-Cubizolles MJ, 2004, J EPIDEMIOL COMMUN H, V58, P395, DOI 10.1136/jech.2003.008029; Shah NR, 2000, AM J OBSTET GYNECOL, V182, P465, DOI 10.1016/S0002-9378(00)70240-7; Shennan A, 2006, BJOG-INT J OBSTET GY, V113, P65, DOI 10.1111/j.1471-0528.2005.00788.x; SIBAI BM, 1993, NEW ENGL J MED, V329, P1213, DOI 10.1056/NEJM199310213291701; Smaill F., 2001, COCHRANE DB SYST REV, V2, DOI [DOI 10.1002/14651858.CD000490, 10.1002/14651858.CD000490]; Smuts CM, 2003, OBSTET GYNECOL, V101, P469, DOI 10.1016/S0029-7844(02)02585-1; Sosa C, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003581.pub2, DOI 10.1002/14651858.CD003581.PUB2]; Stamilio DM, 2007, AM J OBSTET GYNECOL, V196, P93, DOI 10.1016/j.ajog.2006.09.029; Taipale P, 1998, OBSTET GYNECOL, V92, P902, DOI 10.1016/S0029-7844(98)00346-9; To MS, 2004, LANCET, V363, P1849, DOI 10.1016/S0140-6736(04)16351-4; To MS, 2002, ULTRASOUND OBST GYN, V19, P475, DOI 10.1046/j.1469-0705.2002.00673.x; Towers CV, 2000, OBSTET GYNECOL, V95, P291, DOI 10.1016/S0029-7844(99)00528-1; Ugwumadu A, 2003, LANCET, V361, P983, DOI 10.1016/S0140-6736(03)12823-1; Ugwumadu A, 2006, OBSTET GYNECOL, V107, P863, DOI 10.1097/01.AOG.0000202399.13074.98; Vahratian A, 2004, AM J EPIDEMIOL, V160, P886, DOI 10.1093/aje/kwh305; VERGNES JN, 2007, AM J OBSTET GYNECOL, V196; Vermeulen GM, 1999, BRIT J OBSTET GYNAEC, V106, P652, DOI 10.1111/j.1471-0528.1999.tb08363.x; VILLAR J, 1992, NEW ENGL J MED, V327, P1266, DOI 10.1056/NEJM199210293271803; Wapner RJ, 2006, AM J OBSTET GYNECOL, V195, P633, DOI 10.1016/j.ajog.2006.03.087; Warner B, 2004, PEDIATRICS, V113, P35, DOI 10.1542/peds.113.1.35; White Deborah E, 2006, Health Care Women Int, V27, P777, DOI 10.1080/07399330600880335; Yeast JD, 1998, AM J OBSTET GYNECOL, V178, P131, DOI 10.1016/S0002-9378(98)70639-8; Yost NP, 2006, OBSTET GYNECOL, V107, P793, DOI 10.1097/01.AOG.0000206757.92602.b5	182	319	330	3	49	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 12	2008	371	9607					164	175		10.1016/S0140-6736(08)60108-7	http://dx.doi.org/10.1016/S0140-6736(08)60108-7			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	252ND	18191687				2022-12-28	WOS:000252452300031
J	Brunkhorst, FM; Engel, C; Bloos, F; Meier-Hellmann, A; Ragaller, M; Weiler, N; Moerer, O; Gruendling, M; Oppert, M; Grond, S; Olthoff, D; Jaschinski, U; John, S; Rossaint, R; Welte, T; Schaefer, M; Kern, P; Kuhnt, E; Kiehntopf, M; Hartog, C; Natanson, C; Loeffler, M; Reinhart, K				Brunkhorst, Frank M.; Engel, Christoph; Bloos, Frank; Meier-Hellmann, Andreas; Ragaller, Max; Weiler, Norbert; Moerer, Onnen; Gruendling, Matthias; Oppert, Michael; Grond, Stefan; Olthoff, Derk; Jaschinski, Ulrich; John, Stefan; Rossaint, Rolf; Welte, Tobias; Schaefer, Martin; Kern, Peter; Kuhnt, Evelyn; Kiehntopf, Michael; Hartog, Christiane; Natanson, Charles; Loeffler, Markus; Reinhart, Konrad		German Competence Network Sepsis	Intensive insulin therapy and pentastarch resuscitation in severe sepsis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HYDROXYETHYL STARCH; RENAL-FUNCTION; CRITICALLY-ILL; HYPOGLYCEMIA; REPLACEMENT; MULTICENTER; GELATIN; FAILURE; SURGERY; LESIONS	Background: The role of intensive insulin therapy in patients with severe sepsis is uncertain. Fluid resuscitation improves survival among patients with septic shock, but evidence is lacking to support the choice of either crystalloids or colloids. Methods: In a multicenter, two-by-two factorial trial, we randomly assigned patients with severe sepsis to receive either intensive insulin therapy to maintain euglycemia or conventional insulin therapy and either 10% pentastarch, a low-molecular-weight hydroxyethyl starch (HES 200/0.5), or modified Ringer's lactate for fluid resuscitation. The rate of death at 28 days and the mean score for organ failure were coprimary end points. Results: The trial was stopped early for safety reasons. Among 537 patients who could be evaluated, the mean morning blood glucose level was lower in the intensive-therapy group (112 mg per deciliter [6.2 mmol per liter]) than in the conventional-therapy group (151 mg per deciliter [8.4 mmol per liter], P<0.001). However, at 28 days, there was no significant difference between the two groups in the rate of death or the mean score for organ failure. The rate of severe hypoglycemia (glucose level, <= 40 mg per deciliter [2.2 mmol per liter]) was higher in the intensive-therapy group than in the conventional-therapy group (17.0% vs. 4.1%, P<0.001), as was the rate of serious adverse events (10.9% vs. 5.2%, P=0.01). HES therapy was associated with higher rates of acute renal failure and renal-replacement therapy than was Ringer's lactate. Conclusions: The use of intensive insulin therapy placed critically ill patients with sepsis at increased risk for serious adverse events related to hypoglycemia. As used in this study, HES was harmful, and its toxicity increased with accumulating doses. (ClinicalTrials.gov number, NCT00135473.).	[Brunkhorst, Frank M.; Bloos, Frank; Hartog, Christiane; Reinhart, Konrad] Univ Jena, Dept Anesthesiol & Intens Care Med, D-07747 Jena, Germany; [Kiehntopf, Michael] Univ Jena, Inst Clin Chem & Lab Med, D-07747 Jena, Germany; [Engel, Christoph; Loeffler, Markus] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany; [Kuhnt, Evelyn] Univ Leipzig, Coordinat Ctr Clin Trials, Leipzig, Germany; [Meier-Hellmann, Andreas] HELIOS Klin, Dept Anesthesiol & Intens Care Med, Erfurt, Germany; [Ragaller, Max] Tech Univ Dresden, Univ Hosp, Dept Anesthesiol & Intens Care Med, Dresden, Germany; [Weiler, Norbert] Univ Hosp Schleswig Holstein, Dept Anesthesiol & Intens Care Med, Kiel, Germany; [Moerer, Onnen] Univ Goettingen, Dept Anesthesiol & Intens Care Med, Gottingen, Germany; [Gruendling, Matthias] Univ Greifswald, Dept Anesthesiol & Intens Care Med, Greifswald, Germany; [Oppert, Michael] Univ Med Ctr, Charite, Dept Nephrol & Med Intens Care, Berlin, Germany; [Grond, Stefan] Univ Halle Wittenberg, Dept Anesthesiol & Intens Care Med, Halle, Germany; [Olthoff, Derk] Univ Hosp, Dept Anesthesiol & Intens Care Med, Leipzig, Germany; [Jaschinski, Ulrich] Klinikum Augsburg, Dept Anesthesiol & Crit Care Med, Augsburg, Germany; [John, Stefan] Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, Erlangen, Germany; [Rossaint, Rolf] Rhein Westfal TH Aachen, Univ Hosp Aachen, Dept Anesthesiol & Intens Care Med, Aachen, Germany; [Welte, Tobias] Otto von Guericke Univ, Dept Pulm & Crit Care Med, Magdeburg, Germany; [Welte, Tobias] Hannover Med Sch, Dept Pulm & Crit Care Med, D-30623 Hannover, Germany; [Schaefer, Martin] Staedt Klinikum Brandenburg, Dept Anesthesiol & Intens Care Med, Brandenburg, Germany; [Kern, Peter] Staedt Krankenhaus Dresden Friedrichstadt, Dept Anesthesiol & Intens Care Med, Dresden, Germany; [Natanson, Charles] NIH, Dept Crit Care Med, Bethesda, MD 20892 USA	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Leipzig University; Leipzig University; Helios Kliniken; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Gottingen; Ernst Moritz Arndt Universitat Greifswald; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Martin Luther University Halle Wittenberg; Leipzig University; Klinikum Augsburg; University of Erlangen Nuremberg; RWTH Aachen University; RWTH Aachen University Hospital; Otto von Guericke University; Hannover Medical School; Technische Universitat Dresden; Municipal Hospital Dresden; National Institutes of Health (NIH) - USA	Reinhart, K (corresponding author), Univ Jena, Dept Anesthesiol & Intens Care Med, Erlanger Allee 101, D-07747 Jena, Germany.	konrad.reinhart@med.uni-jena.de	Weiler, Norbert/E-5356-2010; Moerer, Onnen/K-6349-2019; Bloos, Frank/AAY-8265-2020	Bloos, Frank/0000-0002-0767-7941; Engel, Christoph/0000-0002-7247-282X; Brunkhorst, Frank Martin/0000-0002-8132-8651; Hartog, Christiane/0000-0003-1098-9775; Trips, Evelyn/0000-0002-6530-5855; Grundling, Matthias/0000-0001-8043-7293				Arellano R, 2005, ANESTH ANALG, V100, P1846, DOI 10.1213/01.ANE.0000152008.04333.53; Auwerda JJA, 2002, ANN INTERN MED, V137, P1013, DOI 10.7326/0003-4819-137-12-200212170-00037; Barron ME, 2004, ARCH SURG-CHICAGO, V139, P552, DOI 10.1001/archsurg.139.5.552; BAUER P, 1994, BIOMETRICS, V50, P1029, DOI 10.2307/2533441; Beyer R, 1997, BRIT J ANAESTH, V78, P44, DOI 10.1093/bja/78.1.44; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brunkhorst FM, 2005, INFECTION, V33, P19; Christidis C, 2001, J HEPATOL, V35, P726, DOI 10.1016/S0168-8278(01)00200-8; Cittanova ML, 1996, LANCET, V348, P1620, DOI 10.1016/S0140-6736(96)07588-5; Cryer PE, 2004, NEW ENGL J MED, V350, P2272, DOI 10.1056/NEJMra031354; Dellinger RP, 2004, CRIT CARE MED, V32, P1448; Egi M, 2006, ANESTHESIOLOGY, V105, P244, DOI 10.1097/00000542-200608000-00006; Haynes GR, 2004, ANESTHESIOLOGY, V101, P560, DOI 10.1097/00000542-200408000-00055; Hoffmann JN, 2002, ANESTHESIOLOGY, V97, P460, DOI 10.1097/00000542-200208000-00025; Jonville-Bera A, 2001, NEW ENGL J MED, V345, P622, DOI 10.1056/NEJM200108233450818; LEGENDRE C, 1993, LANCET, V342, P248, DOI 10.1016/0140-6736(93)92345-T; Liet Jean-Michel, 2003, Pediatr Crit Care Med, V4, P305, DOI 10.1097/01.PCC.0000074262.84240.1E; *MEDWATCH, 2004, WHAT IS SER ADV EV; Moreno R, 1999, INTENS CARE MED, V25, P686, DOI 10.1007/s001340050931; MORISAKI H, 1994, J APPL PHYSIOL, V77, P1507, DOI 10.1152/jappl.1994.77.3.1507; Perazella MA, 2003, AM J MED SCI, V325, P349, DOI 10.1097/00000441-200306000-00006; Pillebout E, 2005, AM J TRANSPLANT, V5, P1120, DOI 10.1111/j.1600-6143.2005.00852.x; ROBERTS I, 2004, COCHRANE DB SYST REV, V4; Sakr Y, 2007, BRIT J ANAESTH, V98, P216, DOI 10.1093/bja/ael333; Schmidt-Hieber M, 2006, EUR J HAEMATOL, V77, P83, DOI 10.1111/j.1600-0609.2006.00657.x; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Van den Berghe G, 2003, CRIT CARE MED, V31, P359, DOI 10.1097/01.CCM.0000045568.12881.10; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; van Rijen EAM, 1998, CLIN DIAGN LAB IMMUN, V5, P543, DOI 10.1128/CDLI.5.4.543-549.1998; Vogt N, 1999, ANAESTHESIA, V54, P121, DOI 10.1046/j.1365-2044.1999.00649.x; Wiedermann CJ, 2004, WIEN KLIN WOCHENSCHR, V116, P583, DOI 10.1007/s00508-004-0237-3; Wiesen P, 2005, ACTA ANAESTH BELG, V56, P257; Wilkes MM, 2001, ANN THORAC SURG, V72, P527, DOI 10.1016/S0003-4975(01)02745-X; Wilson M, 2007, DIABETES CARE, V30, P1005, DOI 10.2337/dc06-1964; Winkelmayer WC, 2003, KIDNEY INT, V64, P1046, DOI 10.1046/j.1523-1755.2003.00186.x	37	1951	2069	3	115	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2008	358	2					125	139		10.1056/NEJMoa070716	http://dx.doi.org/10.1056/NEJMoa070716			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249CJ	18184958	Green Submitted, Green Published			2022-12-28	WOS:000252204200004
J	Clem, RL; Celikel, T; Barth, AL				Clem, Roger L.; Celikel, Tansu; Barth, Alison L.			Ongoing in vivo experience triggers synaptic metaplasticity in the neocortex	SCIENCE			English	Article							LONG-TERM POTENTIATION; CA2+-PERMEABLE AMPA RECEPTORS; DEPENDENT PLASTICITY; VISUAL-CORTEX; LTP; ACTIVATION; SYNAPSES; NMDA; INTERNEURONS; INDUCTION	In vivo experience can occlude subsequent induction of long- term potentiation and enhance long- term depression of synaptic responses. Although a reduced capacity for synaptic strengthening may function to prevent excessive excitation, such an effect paradoxically implies that continued experience or training should not improve and may even degrade neural representations. In mice, we examined the effect of ongoing whisker stimulation on synaptic strengthening at layer 4-2/3 synapses in the barrel cortex. Although N- methyl- D- aspartate receptors were required to initiate strengthening, they subsequently suppressed further potentiation at these synapses in vitro and in vivo. Despite this transition, synaptic strengthening continued with additional sensory activity but instead required the activation of metabotropic glutamate receptors, suggesting a mechanism by which continued experience can result in increasing synaptic strength over time.	[Clem, Roger L.; Barth, Alison L.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Clem, Roger L.; Barth, Alison L.] Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Celikel, Tansu] Max Planck Inst Med Res, Dept Cell Physiol, D-69120 Heidelberg, Germany	Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Max Planck Society	Barth, AL (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	barth@cmu.edu	Celikel, Tansu/P-4235-2018		NIDA NIH HHS [DA017188-01, R01 DA017188] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017188] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Abraham WC, 1997, PROG NEUROBIOL, V52, P303, DOI 10.1016/S0301-0082(97)00018-X; Barth AL, 2004, J NEUROSCI, V24, P6466, DOI 10.1523/JNEUROSCI.4737-03.2004; Barth AL, 2001, NAT NEUROSCI, V4, P235, DOI 10.1038/85070; BASHIR ZI, 1993, NATURE, V363, P347, DOI 10.1038/363347a0; Bender VA, 2006, J NEUROSCI, V26, P4166, DOI 10.1523/JNEUROSCI.0176-06.2006; Celikel T, 2004, NAT NEUROSCI, V7, P534, DOI 10.1038/nn1222; Celikel T, 2007, P NATL ACAD SCI USA, V104, P1395, DOI 10.1073/pnas.0610267104; Clem RL, 2006, NEURON, V49, P663, DOI 10.1016/j.neuron.2006.01.019; D'Angelo E, 1999, J NEUROPHYSIOL, V81, P277, DOI 10.1152/jn.1999.81.1.277; Ge WP, 2006, SCIENCE, V312, P1533, DOI 10.1126/science.1124669; Glazewski S, 2007, J NEUROSCI, V27, P3910, DOI 10.1523/JNEUROSCI.0181-07.2007; Gu JG, 1996, NATURE, V381, P793, DOI 10.1038/381793a0; Hardingham N, 2003, J NEUROSCI, V23, P4428; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Lee OK, 2002, NEUROREPORT, V13, P685, DOI 10.1097/00001756-200204160-00030; Lu YM, 1997, J NEUROSCI, V17, P5196; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MCBAIN CJ, 1994, J NEUROSCI, V14, P4433; Perez Y, 2001, P NATL ACAD SCI USA, V98, P9401, DOI 10.1073/pnas.161493498; Petersen CCH, 1998, P NATL ACAD SCI USA, V95, P4732, DOI 10.1073/pnas.95.8.4732; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Sacchetti B, 2002, EUR J NEUROSCI, V15, P143, DOI 10.1046/j.0953-816x.2001.01844.x; Villarreal DM, 2002, NAT NEUROSCI, V5, P48, DOI 10.1038/nn776; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134	27	121	124	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2008	319	5859					101	104		10.1126/science.1143808	http://dx.doi.org/10.1126/science.1143808			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18174444				2022-12-28	WOS:000252084000041
J	Coppens, P				Coppens, Philip			Chemistry - A phase transition hidden in higher dimensions	SCIENCE			English	Editorial Material							UREA INCLUSION-COMPOUNDS; CRYSTAL; STORAGE		SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Coppens, P (corresponding author), SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA.	coppens@buffalo.edu						Atwood JL, 2002, SCIENCE, V298, P1000, DOI 10.1126/science.1077591; Atwood JL, 2002, SCIENCE, V296, P2367, DOI 10.1126/science.1072252; COPPENS P, 1995, ACTA CRYSTALLOGR B, V51, P402, DOI 10.1107/S0108768195003235; FORST R, 1987, ACTA CRYSTALLOGR B, V43, P187, DOI 10.1107/S0108768187098082; Harris KDM, 2007, SUPRAMOL CHEM, V19, P47, DOI 10.1080/10610270600977706; Hollingsworth MD, 1999, J AM CHEM SOC, V121, P9732, DOI 10.1021/ja9919534; Hollingsworth MD, 1996, SCIENCE, V273, P1355, DOI 10.1126/science.273.5280.1355; Hollingsworth MD, 2002, ANGEW CHEM INT EDIT, V41, P965, DOI 10.1002/1521-3773(20020315)41:6<965::AID-ANIE965>3.0.CO;2-Y; JANNER A, 1980, ACTA CRYSTALLOGR A, V36, P408, DOI 10.1107/S0567739480000897; MAKOVICKY E, 1981, STRUCT BOND, V46, P101; Rosi NL, 2003, SCIENCE, V300, P1127, DOI 10.1126/science.1083440; Toudic B, 2008, SCIENCE, V319, P69, DOI 10.1126/science.1146745; Van Smallen S., 1995, CRYSTALLOGR REV, V4, P79; Zheng SL, 2007, CHEM COMMUN, P2735, DOI 10.1039/b703378h	14	1	1	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2008	319	5859					41	42		10.1126/science.1153272	http://dx.doi.org/10.1126/science.1153272			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18174424				2022-12-28	WOS:000252084000018
J	Triggs, WJ; Cros, D				Triggs, William J.; Cros, Didier			A man with weakness in the hands - Multifocal motor neuropathy with conduction block	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MUSCULAR-ATROPHY; ANTIBODIES; FEDERATION; DIAGNOSIS; CRITERIA; PROTEIN; SITE; GM1		Univ Florida, McKnight Brain Inst, Gainesville, FL 32611 USA; Univ Florida, Dept Neurol, Gainesville, FL USA; Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Triggs, WJ (corresponding author), Univ Florida, McKnight Brain Inst, Gainesville, FL 32611 USA.							Attarian S, 2005, MUSCLE NERVE, V32, P710, DOI 10.1002/mus.20434; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; CHAMBERLAIN MA, 1970, ANN RHEUM DIS, V29, P609, DOI 10.1136/ard.29.6.609; Chaudhry V, 2003, MUSCLE NERVE, V27, P590, DOI 10.1002/mus.10365; Chaudhry V, 2006, NEUROLOGY, V67, P558, DOI 10.1212/01.wnl.0000233832.13749.ac; Delmont E, 2006, NEUROLOGY, V67, P592, DOI 10.1212/01.wnl.0000234063.51897.20; FEASBY TE, 1985, J NEUROL NEUROSUR PS, V48, P239, DOI 10.1136/jnnp.48.3.239; Geoghegan JM, 2004, J HAND SURG-BRIT EUR, V29B, P315, DOI 10.1016/j.jhsb.2004.02.009; Ghosh A, 2005, J NEUROL NEUROSUR PS, V76, P1264, DOI 10.1136/jnnp.2004.047688; Holloway, 2000, NEUROLOGY, V54, P539; Holloway RG, 1999, NEUROLOGY, V53, P1905, DOI 10.1212/WNL.53.9.1905; Kaji R, 2000, BRAIN, V123, P1602, DOI 10.1093/brain/123.8.1602; KAJI R, 1993, ANN NEUROL, V33, P152, DOI 10.1002/ana.410330204; Katz JS, 1997, NEUROLOGY, V48, P700, DOI 10.1212/WNL.48.3.700; Katz JS, 2002, NEUROLOGY, V58, P615, DOI 10.1212/WNL.58.4.615; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; Kornberg Andrew J., 1995, Annals of Neurology, V37, pS43; Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001; Nobile-Orazio E, 2001, J NEUROIMMUNOL, V115, P4, DOI 10.1016/S0165-5728(01)00266-1; Nobile-Orazio E, 2005, MUSCLE NERVE, V31, P663, DOI 10.1002/mus.20296; Nodera H, 2006, NEUROLOGY, V67, P280, DOI 10.1212/01.wnl.0000225048.20239.e4; Olney RK, 2003, MUSCLE NERVE, V27, P117, DOI 10.1002/mus.10317; Pestronk A, 1997, NEUROLOGY, V49, P1289, DOI 10.1212/WNL.49.5.1289; Pestronk A, 2003, J NEUROL NEUROSUR PS, V74, P485, DOI 10.1136/jnnp.74.4.485; PESTRONK A, 1988, ANN NEUROL, V24, P73, DOI 10.1002/ana.410240113; Ruegg SJ, 2004, NEUROLOGY, V63, P2178, DOI 10.1212/01.WNL.0000145706.04340.25; Stogbauer F, 2000, NEUROLOGY, V54, P546, DOI 10.1212/WNL.54.3.546; Taylor BV, 2004, J NEUROPATH EXP NEUR, V63, P129, DOI 10.1093/jnen/63.2.129; Taylor BV, 2000, MUSCLE NERVE, V23, P900, DOI 10.1002/(SICI)1097-4598(200006)23:6<900::AID-MUS9>3.0.CO;2-Y; Triggs WJ, 1999, NEUROLOGY, V53, P605, DOI 10.1212/WNL.53.3.605; TRIGGS WJ, 1992, BRAIN, V115, P1291, DOI 10.1093/brain/115.5.1291; Van den Berg-Vos RA, 2002, BRAIN, V125, P1875, DOI 10.1093/brain/awf193; van Schaik IN, 2006, EUR J NEUROL, V13, P802, DOI 10.1111/j.1468-1331.2006.01466.x; VANSCHAIK IN, 1995, NEUROLOGY, V45, P1570, DOI 10.1212/WNL.45.8.1570; Vucic S, 2005, NEUROLOGY, V64, P530, DOI 10.1212/01.WNL.0000150582.80346.2C; Vucic S, 2004, CLIN NEUROPHYSIOL, V115, P2323, DOI 10.1016/j.clinph.2004.05.003; Vucic S, 2004, NEUROLOGY, V63, P1264, DOI 10.1212/01.WNL.0000140497.85952.FA; Vucic S, 2006, BRAIN, V129, P2436, DOI 10.1093/brain/awl172; YOUNGER DS, 1990, NEUROLOGY, V40, P595, DOI 10.1212/WNL.40.4.595	39	2	2	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2007	357	26					2707	2715		10.1056/NEJMcpc0707069	http://dx.doi.org/10.1056/NEJMcpc0707069			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	245UO	18160691				2022-12-28	WOS:000251964500011
J	Black, L; Sade, RM				Black, Lee; Sade, Robert M.			Lethal injection and physicians - State law vs medical ethics	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Amer Med Assoc, Eth Grp, Chicago, IL 60610 USA; Med Univ S Carolina, Inst Human Values Hlth Care, Charleston, SC 29425 USA	American Medical Association; Medical University of South Carolina	Black, L (corresponding author), Amer Med Assoc, Eth Grp, 515 N State St, Chicago, IL 60610 USA.	lee.black@ama-assn.org						*AM MED ASS COUNC, RUL REV MEMB; *AM MED ASS COUNC, PHYS ADM OTH NON CLI; American Medical Association, 2006, COD MED ETH AM MED A, P19; Denno, 2002, OHIO ST LJ, V63, P63; Gawande A, 2006, NEW ENGL J MED, V354, P1221, DOI 10.1056/NEJMp068042; KOHLER J, 2006, ST LOUIS POST DISPAT, pA1; KOHLER J, 2006, ST LOUIS POST D 0813, pB1; LeGraw JM, 2002, HUM RIGHTS QUART, V24, P382, DOI 10.1353/hrq.2002.0027; WEIGL A, 2007, NEWS OBSERVER R 0217, pB5; WEINSTEIN H, 2007, LA TIMES        0126, pA16; 2007, NEWS OBSERVER   0331, pA24	11	12	12	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2007	298	23					2779	2781		10.1001/jama.298.23.2779	http://dx.doi.org/10.1001/jama.298.23.2779			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242HK	18165671				2022-12-28	WOS:000251716000023
J	Lacy, BE; Cash, BD				Lacy, Brian E.; Cash, Brooks D.			A 32-year-old woman with chronic abdominal pain	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IRRITABLE-BOWEL-SYNDROME; QUALITY-OF-LIFE; PLACEBO-CONTROLLED TRIAL; PROTON-PUMP INHIBITORS; FUNCTIONAL DYSPEPSIA; UNINVESTIGATED DYSPEPSIA; NONULCER DYSPEPSIA; DOUBLE-BLIND; PATHOPHYSIOLOGICAL MECHANISMS; GASTROINTESTINAL SYMPTOMS	Functional dyspepsia is a highly prevalent disorder that accounts for 5% of visits to primary care clinicians. It frequently coexists with other gastrointestinal tract disorders, including irritable bowel syndrome and gastroesophageal reflux disease. Symptoms of functional dyspepsia, including epigastric pain, early satiety, and postprandial nausea, are nonspecific, making its diagnosis difficult. Functional dyspepsia is a heterogeneous disorder involving a number of different pathophysiologic processes, culminating in both gastrointestinal sensory and motor dysfunction. Although functional dyspepsia does not impart any increased risks to long- term health, it significantly affects both individuals and society. The economic burden of evaluating and treating functional dyspepsia is estimated to be at least $1 billion per year, and patients with functional dyspepsia experience a markedly reduced quality of life. Using the case of Ms C, we apply an evidence- based approach to highlight current knowledge in the diagnosis, evaluation, and treatment of functional dyspepsia.	[Lacy, Brian E.] Dartmouth Coll, Hitchcock Med Ctr, Div Gastroenterol & Hepatol, Area 4C, Lebanon, NH 03756 USA; [Cash, Brooks D.] Bethesda Naval Med Ctr, Div Gastroenterol, Bethesda, MD USA	Dartmouth College	Lacy, BE (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Div Gastroenterol & Hepatol, Area 4C, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	brian.e.lacy@hitchcock.org						Abraham NS, 2004, ALIMENT PHARM THER, V19, P631, DOI 10.1111/j.1365-2036.2004.01878.x; AGREUS L, 1995, GASTROENTEROLOGY, V109, P671, DOI 10.1016/0016-5085(95)90373-9; Agreus L, 2001, AM J GASTROENTEROL, V96, P2905; Andrews CN, 2005, GASTROENTEROLOGY, V128, pA456, DOI 10.1053/j.gastro.2005.09.020; BARBERA R, 1995, DIGEST DIS SCI, V40, P1636, DOI 10.1007/BF02212683; Barbera R, 1995, EUR J GASTROEN HEPAT, V7, P1051, DOI 10.1097/00042737-199511000-00007; BEKHTI A, 1979, POSTGRAD MED J, V55, P30; Caballero-Plasencia AM, 1999, EUR J GASTROEN HEPAT, V11, P517, DOI 10.1097/00042737-199905000-00009; Calvert EL, 2002, GASTROENTEROLOGY, V123, P1778, DOI 10.1053/gast.2002.37071; Camilleri CE, 2006, AM J GASTROENTEROL, V101, P581, DOI 10.1111/j.1572-0241.2006.00481.x; Camilleri M, 1998, GASTROENTEROLOGY, V115, P747, DOI 10.1016/S0016-5085(98)70155-6; Castillo EJ, 2004, CLIN GASTROENTEROL H, V2, P985, DOI 10.1016/S1542-3565(04)00454-9; Chey WD, 2004, ALIMENT PHARM THER, V19, P1, DOI 10.1111/j.0953-0673.2004.01829.x; Chiba N, 1999, CAN J GASTROENTEROL, V13, P681; Corsetti M, 2004, AM J GASTROENTEROL, V99, P1152, DOI 10.1111/j.1572-0241.2004.30040.x; Cremonini F, 2004, ALIMENT PHARM THER, V20, P40, DOI 10.1111/j.1365-2036.2004.02184.x; Cremonini F, 2004, BEST PRACT RES CL GA, V18, P717, DOI 10.1016/j.bpg.2004.04.003; Danesh J, 2000, ARCH INTERN MED, V160, P1192, DOI 10.1001/archinte.160.8.1192; De Schepper HU, 2004, NEUROGASTROENT MOTIL, V16, P275, DOI 10.1111/j.1365-2982.2004.00497.x; Delgado-Aros S, 2004, GASTROENTEROLOGY, V127, P1685, DOI 10.1053/j.gastro.2004.09.006; El-Serag HB, 2004, ALIMENT PHARM THER, V19, P643, DOI 10.1111/j.1365-2036.2004.01897.x; El-Serag HB, 2003, ALIMENT PHARM THER, V18, P387, DOI 10.1046/j.1365-2036.2003.01706.x; Feinle C, 2001, GUT, V48, P347, DOI 10.1136/gut.48.3.347; Feinle-Bisset C, 2004, AM J GASTROENTEROL, V99, P170, DOI 10.1111/j.1572-0241.2004.04003.x; Feinle-Bisset Christine, 2003, Curr Treat Options Gastroenterol, V6, P289, DOI 10.1007/s11938-003-0021-x; Fischler B, 2003, GASTROENTEROLOGY, V124, P903, DOI 10.1053/gast.2003.50155; Ford AC, 2005, GASTROENTEROLOGY, V128, P1838, DOI 10.1053/j.gastro.2005.03.004; Ford AC, 2007, GUT, V56, P321, DOI 10.1136/gut.2006.099846; FUMAGALLI I, 1994, SCAND J GASTROENTERO, V29, P33, DOI 10.3109/00365529409090434; Gutierrez A, 2003, EUR J GASTROEN HEPAT, V15, P1175, DOI 10.1097/01.meg.0000085483.12407.05; Hallerback BI, 2002, ALIMENT PHARM THER, V16, P959, DOI 10.1046/j.1365-2036.2002.01236.x; Hammer J, 2004, GUT, V53, P666, DOI 10.1136/gut.2003.021857; Heikkinen M, 2003, ALIMENT PHARM THER, V18, P223, DOI 10.1046/j.1365-2036.2003.01685.x; Hojo M, 2005, J GASTROENTEROL, V40, P1036, DOI 10.1007/s00535-005-1687-8; Holtmann G, 2006, AM J GASTROENTEROL, V101, P593, DOI 10.1111/j.1572-0241.2006.00480.x; Holtmann G, 2006, NEW ENGL J MED, V354, P832, DOI 10.1056/NEJMoa052639; KNILLJONES RP, 1991, SCAND J GASTROENTERO, V26, P17, DOI 10.3109/00365529109109532; Laheij RJF, 2004, JAMA-J AM MED ASSOC, V292, P1955, DOI 10.1001/jama.292.16.1955; Leonard J, 2007, AM J GASTROENTEROL, V102, P2047, DOI 10.1111/j.1572-0241.2007.01275.x; Locke GR, 1998, BAILLIERE CLIN GASTR, V12, P435; Mayer EA, 2006, ALIMENT PHARM THER, V24, P919, DOI 10.1111/j.1365-2036.2006.03078.x; Meineche-Schmidt V, 2002, SCAND J GASTROENTERO, V37, P999, DOI 10.1080/003655202320378167; Mizuta Y, 2006, J GASTROENTEROL, V41, P1025, DOI 10.1007/s00535-006-1966-z; Moayyedi P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001960.pub3; Moayyedi P, 2006, JAMA-J AM MED ASSOC, V295, P1566, DOI 10.1001/jama.295.13.1566; Moayyedi P, 2004, GASTROENTEROLOGY, V127, P1329, DOI 10.1053/j.gastro.2004.08.026; Moayyedi P, 2003, ALIMENT PHARM THER, V17, P1215, DOI 10.1046/j.1365-2036.2003.01575.x; Moayyedi P, 2002, GUT, V50, P10, DOI 10.1136/gut.50.suppl_4.iv10; Muller-Lissner SA, 2001, ALIMENT PHARM THER, V15, P1655, DOI 10.1046/j.1365-2036.2001.01094.x; National Institute for Clinical Excellence, 2004, DYSP MAN DYSP AD PRI; Novick J, 2002, ALIMENT PHARM THER, V16, P1877, DOI 10.1046/j.1365-2036.2002.01372.x; Otaka M, 2005, ALIMENT PHARM THERAP, V21, P42, DOI 10.1111/j.1365-2036.2005.02473.x; Pilichiewicz AN, 2007, AM J GASTROENTEROL, V102, P1276, DOI 10.1111/j.1572-0241.2007.01142.x; PRIEBE WM, 1982, GASTROENTEROLOGY, V82, P16; Quartero AO, 1998, DIGEST DIS SCI, V43, P2028, DOI 10.1023/A:1018803129779; Redstone HA, 2001, ALIMENT PHARM THER, V15, P1291, DOI 10.1046/j.1365-2036.2001.01044.x; Saad RJ, 2006, ALIMENT PHARM THER, V24, P475, DOI 10.1111/j.1365-2036.2006.03005.x; Sawant Prabha, 2004, J Assoc Physicians India, V52, P626; Shaib Y, 2004, AM J GASTROENTEROL, V99, P2210, DOI 10.1111/j.1572-0241.2004.40052.x; Soo S, 2004, AM J GASTROENTEROL, V99, P1817, DOI 10.1111/j.1572-0241.2004.30086.x; Soo S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002301.pub5; Stanghellini V, 2002, AM J GASTROENTEROL, V97, P2738; Stanghellini V, 1996, GASTROENTEROLOGY, V110, P1036, DOI 10.1053/gast.1996.v110.pm8612991; Tabas G, 2004, AM J GASTROENTEROL, V99, P914, DOI 10.1111/j.1572-0241.2004.04127.x; Tack J, 2001, GASTROENTEROLOGY, V121, P526, DOI 10.1053/gast.2001.27180; Tack J, 2002, GASTROENTEROLOGY, V122, P1738, DOI 10.1053/gast.2002.33663; Tack J, 2004, GASTROENTEROLOGY, V127, P1239, DOI 10.1053/j.gastro.2004.05.030; TACK J, 2006, GASTROENTEROLOGY S1, V120, pA80; Tack J, 2006, GASTROENTEROLOGY, V130, P1466, DOI 10.1053/j.gastro.2005.11.059; Talley NJ, 2006, GUT, V55, P933, DOI 10.1136/gut.2005.078634; Talley NJ, 2007, CLIN GASTROENTEROL H, V5, P1175, DOI 10.1016/j.cgh.2007.05.015; Talley NJ, 2007, NAT CLIN PRACT GASTR, V4, P35, DOI 10.1038/ncpgasthep0685; TALLEY NJ, 1992, GASTROENTEROLOGY, V102, P1259; Talley NJ, 2003, AM J GASTROENTEROL, V98, P2454, DOI 10.1016/S0002-9270(03)00705-6; Talley NJ, 1999, GUT, V45, P37; Talley NJ, 2005, AM J GASTROENTEROL, V100, P2324, DOI 10.1111/j.1572-0241.2005.00225.x; TALLEY NJ, 1992, AM J EPIDEMIOL, V136, P165, DOI 10.1093/oxfordjournals.aje.a116483; Talley NJ, 1998, GASTROENTEROLOGY, V114, P582, DOI 10.1016/S0016-5085(98)70542-6; TALLEY NJ, 2006, ANN SCI M AM COLL GA; TALLEY NJ, 2002, GUT S3, V51; Thomson ABR, 2003, ALIMENT PHARM THER, V17, P1481, DOI 10.1046/j.1365-2036.2003.01646.x; Thumshim M, 2005, GASTROENTEROLOGY, V128, pA469; Thumshirn M, 2002, GUT               S1, V51, pi63, DOI [10.1136/gut.51.suppl_1.i63, DOI 10.1136/GUT.51.SUPPL_1.I63]; Traub RJ, 2002, NEUROSCIENCE, V113, P205, DOI 10.1016/S0306-4522(02)00170-7; Vakil N, 2006, GASTROENTEROLOGY, V131, P390, DOI 10.1053/j.gastro.2006.04.029; van Zanten SV, 2006, AM J GASTROENTEROL, V101, P2096, DOI 10.1111/j.1572-0241.2006.00751.x; van Zanten SJOV, 2005, CAN J GASTROENTEROL, V19, P285, DOI 10.1155/2005/674607; van Zanten SJOV, 2000, CAN MED ASSOC J, V162, pS3; von Arnim U, 2007, AM J GASTROENTEROL, V102, P1268, DOI 10.1111/j.1572-0241.2006.01183.x; Wang WH, 2007, CLIN GASTROENTEROL H, V5, P178, DOI 10.1016/j.cgh.2006.09.012; Yang YX, 2006, JAMA-J AM MED ASSOC, V296, P2947, DOI 10.1001/jama.296.24.2947	91	16	17	2	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2008	299	5					555	565		10.1001/jama.2007.51-a	http://dx.doi.org/10.1001/jama.2007.51-a			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258RB	18167396				2022-12-28	WOS:000252886100021
J	Alkhuzai, AH; Ahmad, IJ; Hweel, MJ; Ismail, TW; Hasan, HH; Younis, AR; Shawani, O; Al-Jaf, VM; Al-Alak, MM; Rasheed, LH; Hamid, SM; Al-Gasseer, N; Majeed, FA; Al Awqati, NA; Ali, MM; Boerma, JT; Mathers, C				Alkhuzai, Amir H.; Ahmad, Ihsan J.; Hweel, Mohammed J.; Ismail, Thakir W.; Hasan, Hanan H.; Younis, Abdul Rahman; Shawani, Osman; Al-Jaf, Vian M.; Al-Alak, Mahdi M.; Rasheed, Louay H.; Hamid, Suham M.; Al-Gasseer, Naeema; Majeed, Fazia A.; Al Awqati, Naira A.; Ali, Mohamed M.; Boerma, J. Ties; Mathers, Colin		Iraq Family Hlth Survey Study Grp	Violence-related mortality in Iraq from 2002 to 2006	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADULT MORTALITY	Background: Estimates of the death toll in Iraq from the time of the U.S.-led invasion in March 2003 until June 2006 have ranged from 47,668 (from the Iraq Body Count) to 601,027 (from a national survey). Results from the Iraq Family Health Survey (IFHS), which was conducted in 2006 and 2007, provide new evidence on mortality in Iraq. Methods: The IFHS is a nationally representative survey of 9345 households that collected information on deaths in the household since June 2001. We used multiple methods for estimating the level of underreporting and compared reported rates of death with those from other sources. Results: Interviewers visited 89.4% of 1086 household clusters during the study period; the household response rate was 96.2%. From January 2002 through June 2006, there were 1325 reported deaths. After adjustment for missing clusters, the overall rate of death per 1000 person-years was 5.31 (95% confidence interval [CI], 4.89 to 5.77); the estimated rate of violence-related death was 1.09 (95% CI, 0.81 to 1.50). When underreporting was taken into account, the rate of violence-related death was estimated to be 1.67 (95% uncertainty range, 1.24 to 2.30). This rate translates into an estimated number of violent deaths of 151,000 (95% uncertainty range, 104,000 to 223,000) from March 2003 through June 2006. Conclusions: Violence is a leading cause of death for Iraqi adults and was the main cause of death in men between the ages of 15 and 59 years during the first 3 years after the 2003 invasion. Although the estimated range is substantially lower than a recent survey-based estimate, it nonetheless points to a massive death toll, only one of the many health and human consequences of an ongoing humanitarian crisis.	[Ali, Mohamed M.; Boerma, J. Ties; Mathers, Colin] WHO, Dept Measurement & Hlth Informat Syst, CH-1211 Geneva, Switzerland; [Alkhuzai, Amir H.; Ahmad, Ihsan J.; Hweel, Mohammed J.; Ismail, Thakir W.; Hasan, Hanan H.] Fed Minist Hlth, Baghdad, Iraq; [Shawani, Osman] Kurdistan Minist Planning, Erbil, Iraq; [Younis, Abdul Rahman; Al-Jaf, Vian M.] Kurdistan Minist Hlth, Erbil, Iraq; [Al-Alak, Mahdi M.; Rasheed, Louay H.; Hamid, Suham M.] Cent Org Stat & Informat Technol, Baghdad, Iraq; [Al-Gasseer, Naeema; Majeed, Fazia A.; Al Awqati, Naira A.] WHO, Iraq Off, Amman, Jordan	World Health Organization; World Health Organization	Ali, MM (corresponding author), WHO, Dept Measurement & Hlth Informat Syst, CH-1211 Geneva, Switzerland.	alim@who.int		Mathers, Colin/0000-0002-0617-6731				Bicego, 1997, HLTH T REV S2, V7, P7; Brown V, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-9; Burnham G, 2006, LANCET, V368, P1421, DOI 10.1016/S0140-6736(06)69491-9; *COST KURD REG STA, 2007, FIND IR MULT IND CLU; *DEP EC SOC AFF, 1983, IND TECHN DEM EST MA; Effron B, 1993, INTRO BOOTSTRAP; Gakidou E, 2004, INT J EPIDEMIOL, V33, P710, DOI 10.1093/ije/dyh099; Gakidou E, 2006, DEMOGRAPHY, V43, P569, DOI 10.1353/dem.2006.0024; *MIN PLANN DEV COR, 2005, IR LIV COND SURV 200; SELTZER W, 1969, POP STUD-J DEMOG, V23, P395, DOI 10.1080/00324728.1969.10405293; TIMAEUS IM, 2001, BRASS TACKS ESSAYS M, P43; WHO (World Health Organization), 2005, WORLD HLTH STAT 2005	12	96	98	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2008	358	5					484	493		10.1056/NEJMsa0707782	http://dx.doi.org/10.1056/NEJMsa0707782			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	256IW	18184950				2022-12-28	WOS:000252722900006
J	Moore, CB; Bergstralh, DT; Duncan, JA; Lei, Y; Morrison, TE; Zimmermann, AG; Accavitti-Loper, MA; Madden, VJ; Sun, LJ; Ye, ZM; Lich, JD; Heise, MT; Chen, ZJ; Ting, JPY				Moore, Chris B.; Bergstralh, Daniel T.; Duncan, Joseph A.; Lei, Yu; Morrison, Thomas E.; Zimmermann, Albert G.; Accavitti-Loper, Mary A.; Madden, Victoria J.; Sun, Lijun; Ye, Zhengmao; Lich, John D.; Heise, Mark T.; Chen, Zhijian; Ting, Jenny P-Y.			NLRX1 is a regulator of mitochondrial antiviral immunity	NATURE			English	Article							NF-KAPPA-B; RIG-I; ADAPTER PROTEIN; LRR PROTEINS; RESPONSES; CATERPILLER; FAMILY; DEFENSE; PATHWAY; SIGNALS	The RIG- like helicase ( RLH) family of intracellular receptors detect viral nucleic acid and signal through the mitochondrial antiviral signalling adaptor MAVS ( also known as Cardif, VISA and IPS- 1) during a viral infection(1-6). MAVS activation leads to the rapid production of antiviral cytokines, including type 1 interferons. Although MAVS is vital to antiviral immunity, its regulation from within the mitochondria remains unknown. Here we describe human NLRX1, a highly conserved nucleotide- binding domain ( NBD)- and leucine- rich- repeat ( LRR)- containing family member ( known as NLR) that localizes to the mitochondrial outer membrane and interacts with MAVS. Expression of NLRX1 results in the potent inhibition of RLH- and MAVS- mediated interferon-beta promoter activity and in the disruption of virus- induced RLH-MAVS interactions. Depletion of NLRX1 with small interference RNA promotes virus- induced type I interferon production and decreases viral replication. This work identifies NLRX1 as a check against mitochondrial antiviral responses and represents an intersection of three ancient cellular processes: NLR signalling, intracellular virus detection and the use of mitochondria as a platform for anti- pathogen signalling. This represents a conceptual advance, in that NLRX1 is a modulator of pathogen- associated molecular pattern receptors rather than a receptor, and identifies a key therapeutic target for enhancing antiviral responses.	[Moore, Chris B.; Lei, Yu; Zimmermann, Albert G.; Ye, Zhengmao; Lich, John D.; Ting, Jenny P-Y.] Univ N Carolina, Dept Microbiol Immunol, Chapel Hill, NC 27599 USA; [Moore, Chris B.; Bergstralh, Daniel T.; Lei, Yu; Zimmermann, Albert G.; Ye, Zhengmao; Lich, John D.; Ting, Jenny P-Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Duncan, Joseph A.] Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC 27599 USA; [Morrison, Thomas E.; Heise, Mark T.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Morrison, Thomas E.; Heise, Mark T.] Univ N Carolina, Carolina Vaccine Inst, Chapel Hill, NC 27599 USA; [Madden, Victoria J.] Univ N Carolina, Dept Pathol, Chapel Hill, NC 27599 USA; [Accavitti-Loper, Mary A.] Univ Alabama, Birmingham, AL 35294 USA; [Sun, Lijun; Chen, Zhijian] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Alabama System; University of Alabama Birmingham; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Ting, JPY (corresponding author), Univ N Carolina, Dept Microbiol Immunol, Chapel Hill, NC 27599 USA.	jenny_ting@med.unc.edu	Chen, Zhijian/C-6039-2012; Sun, Lijun/ABD-4470-2021; Ariel, Pablo/AGJ-4118-2022; Lei, Yu Leo/ABF-1293-2020	Chen, Zhijian/0000-0002-8475-8251; Lei, Yu Leo/0000-0002-9868-9824; Bergstralh, Dan/0000-0003-1689-3715				Bruey JM, 2004, J BIOL CHEM, V279, P51897, DOI 10.1074/jbc.M406741200; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Harton JA, 2002, J IMMUNOL, V169, P4088, DOI 10.4049/jimmunol.169.8.4088; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Marathe R, 2003, MOL CELL, V11, P284, DOI 10.1016/S1097-2765(03)00072-8; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Meylan E, 2006, MOL CELL, V22, P561, DOI 10.1016/j.molcel.2006.05.012; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Ting JPY, 2005, ANNU REV IMMUNOL, V23, P387, DOI 10.1146/annurev.immunol.23.021704.115616; Williams KL, 2005, J BIOL CHEM, V280, P39914, DOI 10.1074/jbc.M502820200; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	25	430	457	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2008	451	7178					573	U8		10.1038/nature06501	http://dx.doi.org/10.1038/nature06501			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256OQ	18200010	Bronze			2022-12-28	WOS:000252739900042
J	Schermerhorn, ML; O'Malley, AJ; Jhaveri, A; Cotterill, P; Pomposelli, F; Landon, BE				Schermerhorn, Marc L.; O'Malley, A. James; Jhaveri, Ami; Cotterill, Philip; Pomposelli, Frank; Landon, Bruce E.			Endovascular vs. open repair of abdominal aortic aneurysms in the medicare population	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; EUROSTAR; OUTCOMES; COMPLICATIONS; EXPERIENCE; MORTALITY; REGISTRY	Background: Randomized trials have shown reductions in perioperative mortality and morbidity with endovascular repair of abdominal aortic aneurysm, as compared with open surgical repair. Longer-term survival rates, however, were similar for the two procedures. There are currently no long-term, population-based data from the comparison of these strategies. Methods: We studied perioperative rates of death and complications, long-term survival, rupture, and reinterventions after open as compared with endovascular repair of abdominal aortic aneurysm in propensity-score-matched cohorts of Medicare beneficiaries undergoing repair during the 2001-2004 period, with follow-up until 2005. Results: There were 22,830 matched patients undergoing open repair of abdominal aortic aneurysm in each cohort. The average age of the patients was 76 years, and approximately 20% were women. Perioperative mortality was lower after endovascular repair than after open repair (1.2% vs. 4.8%, P<0.001), and the reduction in mortality increased with age (2.1% difference for those 67 to 69 years old vs. 8.5% for those 85 years or older, P<0.001). Late survival was similar in the two cohorts, although the survival curves did not converge until after 3 years. By 4 years, rupture was more likely in the endovascular-repair cohort than in the open-repair cohort (1.8% vs. 0.5%, P<0.001), as was reintervention related to abdominal aortic aneurysm (9.0% vs. 1.7%, P<0.001), although most reinterventions were minor. In contrast, by 4 years, surgery for laparotomy-related complications was more likely among patients who had undergone open repair (9.7%, vs. 4.1% among those who had undergone endovascular repair; P<0.001), as was hospitalization without surgery for bowel obstruction or abdominal-wall hernia (14.2% vs. 8.1%, P<0.001). Conclusions: As compared with open repair, endovascular repair of abdominal aortic aneurysm is associated with lower short-term rates of death and complications. The survival advantage is more durable among older patients. Late reinterventions related to abdominal aortic aneurysm are more common after endovascular repair but are balanced by an increase in laparotomy-related reinterventions and hospitalizations after open surgery.	[Schermerhorn, Marc L.; Jhaveri, Ami; Pomposelli, Frank] Beth Israel Deaconess Med Ctr, Dept Surg, Div Vasc Surg, Boston, MA 02215 USA; [Landon, Bruce E.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [O'Malley, A. James; Landon, Bruce E.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Cotterill, Philip] Ctr Medicare & Medicaid Serv, Baltimore, MD USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Centers for Medicare & Medicaid Services	Schermerhorn, ML (corresponding author), Beth Israel Deaconess Med Ctr, Dept Surg, Div Vasc Surg, 110 Francis St, Boston, MA 02215 USA.	mscherm@bidmc.harvard.edu						Baldwin LM, 2006, MED CARE, V44, P745, DOI 10.1097/01.mlr.0000223475.70440.07; Biancari F, 2002, J VASC SURG, V35, P87, DOI 10.1067/mva.2002.119751; Blankensteijn JD, 2005, NEW ENGL J MED, V352, P2398, DOI 10.1056/NEJMoa051255; COCHRAN WG, 1973, SANKHYA SER A, V35, P417; Dillavou ED, 2006, J VASC SURG, V43, P446, DOI 10.1016/j.jvs.2005.11.017; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Greenhalgh RM, 2005, LANCET, V365, P2179, DOI 10.1016/S0140-6736(05)66627-5; Greenhalgh RM, 2004, LANCET, V364, P843, DOI 10.1016/S0140-6736(04)16979-1; Gu Xing S., 1993, J COMPUTATIONAL GRAP, V2, P405, DOI [DOI 10.1080/10618600.1993.10474623, DOI 10.7326/0003-4819-152-6-201003160-00008]; Hallett JW, 1997, J VASC SURG, V25, P277, DOI 10.1016/S0741-5214(97)70349-5; Harris PL, 2000, J VASC SURG, V32, P739, DOI 10.1067/mva.2000.109990; Laheij RJF, 2000, BRIT J SURG, V87, P1666, DOI 10.1046/j.1365-2168.2000.01661.x; Lee WA, 2004, J VASC SURG, V39, P491, DOI 10.1016/j.jvs.2003.12.001; Nowygrod R, 2006, J VASC SURG, V43, P205, DOI 10.1016/j.jvs.2005.11.002; Parodi J C, 1991, Ann Vasc Surg, V5, P491, DOI 10.1007/BF02015271; Prinssen M, 2004, NEW ENGL J MED, V351, P1607, DOI 10.1056/NEJMoa042002; Schermerhorn ML, 2002, J VASC SURG, V36, P1112, DOI 10.1067/mva.2002.129646; Zarins CK, 2005, J VASC SURG, V42, P1, DOI 10.1016/j.jvs.2005.05.012	18	556	591	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2008	358	5					464	474		10.1056/NEJMoa0707348	http://dx.doi.org/10.1056/NEJMoa0707348			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	256IW	18234751				2022-12-28	WOS:000252722900004
J	Shiber, JR; Carter, K				Shiber, Joseph R.; Carter, Kelly			Open mandibular fracture with malocclusion	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Shiber, Joseph R.; Carter, Kelly] Florida Emergency Phys, Orlando, FL 32751 USA		Shiber, JR (corresponding author), Florida Emergency Phys, Orlando, FL 32751 USA.	shiberj@bellsouth.net							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2008	358	5					512	512		10.1056/NEJMicm065053	http://dx.doi.org/10.1056/NEJMicm065053			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	256IW	18234755				2022-12-28	WOS:000252722900009
J	Warner, DA; Shine, R				Warner, D. A.; Shine, R.			The adaptive significance of temperature-dependent sex determination in a reptile	NATURE			English	Article							GECKO EUBLEPHARIS-MACULARIUS; LIZARD; ESTRADIOL; EVOLUTION; ECOLOGY; GROWTH	Understanding the mechanisms that determine an individual's sex remains a primary challenge for evolutionary biology. Chromosome- based systems ( genotypic sex determination) that generate roughly equal numbers of sons and daughters accord with theory(1), but the adaptive significance of environmental sex determination ( that is, when embryonic environmental conditions determine offspring sex, ESD) is a major unsolved problem(2,3). Theoretical models predict that selection should favour ESD over genotypic sex determination when the developmental environment differentially influences male versus female fitness ( that is, the Charnov - Bull model)(4), but empirical evidence for this hypothesis remains elusive in amniote vertebrates - the clade in which ESD is most prevalent(5). Here we provide the first substantial empirical support for this model by showing that incubation temperatures influence reproductive success of males differently than that of females in a short- lived lizard ( Amphibolurus muricatus, Agamidae) with temperature- dependent sex determination. We incubated eggs at a variety of temperatures, and de- confounded sex and incubation temperature by using hormonal manipulations to embryos. We then raised lizards in field enclosures and quantified their lifetime reproductive success. Incubation temperature affected reproductive success differently in males versus females in exactly the way predicted by theory: the fitness of each sex was maximized by the incubation temperature that produces that sex. Our results	[Warner, D. A.; Shine, R.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Sydney	Warner, DA (corresponding author), Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA.	dwarner@iastate.edu	Shine, Richard/B-8711-2008	Warner, Daniel/0000-0001-7231-7785				Austin JJ, 2006, MOL ECOL NOTES, V6, P194, DOI 10.1111/j.1471-8286.2005.01190.x; BULL JJ, 1989, EVOLUTION, V43, P1561, DOI 10.1111/j.1558-5646.1989.tb02605.x; CHARNOV EL, 1989, J THEOR BIOL, V139, P431, DOI 10.1016/S0022-5193(89)80063-3; CHARNOV EL, 1977, NATURE, V266, P828, DOI 10.1038/266828a0; Conover David O., 2004, P11; Fisher R.A., 1930, GENETICAL THEORY NAT; Freedberg S, 2006, BIOL LETTERS, V2, P378, DOI 10.1098/rsbl.2006.0454; GUTZKE WHN, 1988, NATURE, V332, P832, DOI 10.1038/332832a0; Harlow PS, 2000, AUSTRAL ECOL, V25, P640, DOI 10.1046/j.1442-9993.2000.01064.x; Janzen FJ, 2006, J EVOLUTION BIOL, V19, P1775, DOI 10.1111/j.1420-9101.2006.01138.x; JANZEN FJ, 1995, EVOLUTION, V49, P864, DOI 10.1111/j.1558-5646.1995.tb02322.x; JANZEN FJ, 1991, EVOLUTION, V45, P435, DOI 10.1111/j.1558-5646.1991.tb04417.x; JANZEN FJ, 1991, Q REV BIOL, V66, P149, DOI 10.1086/417143; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Schwartz TS, 2007, MOL ECOL NOTES, V7, P528, DOI 10.1111/j.1471-8286.2006.01644.x; Shine R, 1999, TRENDS ECOL EVOL, V14, P186, DOI 10.1016/S0169-5347(98)01575-4; SHINE R, 1995, NATURE, V378, P451, DOI 10.1038/378451a0; Shine R, 2007, ECOLOGY, V88, P1781, DOI 10.1890/06-2024.1; TOUSIGNANT A, 1994, J EXP ZOOL, V268, P17, DOI 10.1002/jez.1402680104; TOUSIGNANT A, 1995, J MORPHOL, V224, P159, DOI 10.1002/jmor.1052240205; Warner DA, 2005, EVOLUTION, V59, P2209; WARNER DA, IN PRESS ANIM BEHAV; Warner DA, 2007, OECOLOGIA, V154, P65, DOI 10.1007/s00442-007-0809-9; WENNSTROM KL, 1995, GEN COMP ENDOCR, V99, P316, DOI 10.1006/gcen.1995.1115; WIBBELS T, 1994, J ENDOCRINOL, V141, P295, DOI 10.1677/joe.0.1410295	25	242	250	2	232	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2008	451	7178					566	U5		10.1038/nature06519	http://dx.doi.org/10.1038/nature06519			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256OQ	18204437				2022-12-28	WOS:000252739900040
J	Koplan, KE; David, SP; Rigotti, NA				Koplan, Kate E.; David, Sean P.; Rigotti, Nancy A.			10-minute consultation - Smoking cessation	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Koplan, Kate E.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 01225 USA; [David, Sean P.] Brown Univ, Ctr Primary Care & Prevent, Brown Med Sch, Providence, RI 02912 USA; [Rigotti, Nancy A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Brown University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Koplan, KE (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 01225 USA.	kkoplan@partners.org		David, Sean/0000-0002-4922-2603					0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 26	2008	336	7637					217	217		10.1136/bmj.39248.531748.47	http://dx.doi.org/10.1136/bmj.39248.531748.47			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259KT	18219045	Green Published			2022-12-28	WOS:000252938900048
J	Huang, GN; Huso, DL; Bouyain, S; Tu, JC; McCorkell, KA; May, MJ; Zhu, YW; Lutz, M; Collins, S; Dehoff, M; Kang, S; Whartenby, K; Powell, J; Leahy, D; Worley, PF				Huang, Guo N.; Huso, David L.; Bouyain, Samuel; Tu, Jianchen; McCorkell, Kelly A.; May, Michael J.; Zhu, Yuwen; Lutz, Michael; Collins, Samuel; Dehoff, Marlin; Kang, Shin; Whartenby, Katharine; Powell, Jonathan; Leahy, Daniel; Worley, Paul F.			NFAT binding and regulation of T cell activation by the cytoplasmic scaffolding Homer proteins	SCIENCE			English	Article							CD28 COSTIMULATORY SIGNAL; CALCIUM; KINASE; AKT	T cell receptor ( TCR) and costimulatory receptor ( CD28) signals cooperate in activating T cells, although understanding of how these pathways are themselves regulated is incomplete. We found that Homer2 and Homer3, members of the Homer family of cytoplasmic scaffolding proteins, are negative regulators of T cell activation. This is achieved through binding of nuclear factor of activated T cells ( NFAT) and by competing with calcineurin. Homer-NFAT binding was also antagonized by active serine- threonine kinase AKT, thereby enhancing TCR signaling via calcineurin- dependent dephosphorylation of NFAT. This corresponded with changes in cytokine expression and an increase in effector- memory T cell populations in Homer- deficient mice, which also developed autoimmune- like pathology. These results demonstrate a further means by which costimulatory signals are regulated to control self- reactivity.	[Huang, Guo N.; Tu, Jianchen; Dehoff, Marlin; Kang, Shin; Worley, Paul F.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Huang, Guo N.] Johns Hopkins Univ, Sch Med, Program Biochem Cellular & Mol Biol, Baltimore, MD 21205 USA; [Huso, David L.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21205 USA; [Bouyain, Samuel; Leahy, Daniel] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [McCorkell, Kelly A.; May, Michael J.] Univ Penn, Dept Anim Biol, Philadelphia, PA 19104 USA; [Zhu, Yuwen] Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA; [Lutz, Michael; Collins, Samuel; Whartenby, Katharine; Powell, Jonathan] Johns Hopkins Univ, Sch Med, Dept Oncol Immunol Hematopoiesis, Baltimore, MD 21205 USA; [Worley, Paul F.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Pennsylvania; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Worley, PF (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	pworley@jhmi.edu	zhu, yuwen/C-9010-2011	Huang, Guo/0000-0002-4335-9123; May, Michael/0000-0002-2485-3716	NATIONAL CANCER INSTITUTE [R01CA098109, P30CA006973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA010309, R37DA010309, P50DA000266] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA098109, P30 CA006973] Funding Source: Medline; NIDA NIH HHS [P50 DA000266, DA10309, R01 DA010309, DA00266, R37 DA010309] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Beneken J, 2000, NEURON, V26, P143, DOI 10.1016/S0896-6273(00)81145-9; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; Duncan RS, 2005, EXP BIOL MED, V230, P527, DOI 10.1177/153537020523000803; Fagni Laurent, 2002, Sci STKE, V2002, pre8, DOI 10.1126/stke.2002.137.re8; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Huang CT, 2003, J IMMUNOL, V170, P3945, DOI 10.4049/jimmunol.170.8.3945; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; KOHN AD, 1995, EMBO J, V14, P4288, DOI 10.1002/j.1460-2075.1995.tb00103.x; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042	16	66	72	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2008	319	5862					476	481		10.1126/science.1151227	http://dx.doi.org/10.1126/science.1151227			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254HB	18218901	Green Accepted			2022-12-28	WOS:000252576600042
J	Bartali, B; Frongillo, EA; Guralnik, JM; Stipanuk, MH; Allore, HG; Cherubini, A; Bandinelli, S; Ferrucci, L; Gill, TM				Bartali, Benedetta; Frongillo, Edward A.; Guralnik, Jack M.; Stipanuk, Martha H.; Allore, Heather G.; Cherubini, Antonio; Bandinelli, Stefania; Ferrucci, Luigi; Gill, Thomas M.			Serum micronutrient concentrations and decline in physical function among older persons	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MINI-MENTAL-STATE; OXIDATIVE STRESS; VITAMIN-E; DISABILITY; HEALTH; PERFORMANCE; INCHIANTI; DAMAGE; AGE; ANTIOXIDANTS	Context Maintaining independence of older persons is a public health priority, and identifying the factors that contribute to decline in physical function is needed to prevent or postpone the disablement process. The potential deleterious effect of poor nutrition on decline in physical function in older persons is unclear. Objective To determine whether a low serum concentration of micronutrients is associated with subsequent decline in physical function among older men and women living in the community. Design, Setting, and Participants Longitudinal study of 698 community- living persons 65 years or older who were randomly selected from a population registry in Tuscany, Italy. Participants completed the baseline examination from November 1, 1998, through May 28, 2000, and the 3- year follow- up assessments from November 1, 2001, through March 30, 2003. Main Outcome Measure Decline in physical function was defined as a loss of at least 1 point in the Short Physical Performance Battery during the 3- year follow- up. Odds ratios ( ORs) were calculated for the lowest quartile of each nutrient using the other 3 quartiles combined as the reference group. Two additional and complementary analytical approaches were used to confirm the validity of the results. Results The mean decline in the Short Physical Performance Battery score was 1.1 point. In a logistic regression analysis that was adjusted for potential confounders, only a low concentration of vitamin E ( < 1.1 mu g/ mL [ < 24.9 mu mol/L]) was significantly associated with subsequent decline in physical function ( OR, 1.62; 95% confidence interval, 1.11- 2.36; P=. 01 for association of lowest alpha-tocopherol quartile with at least a 1- point decline in physical function). In a general linear model, the concentration of vitamin E at baseline, when analyzed as a continuous measure, was significantly associated with the Short Physical Performance Battery score at follow- up after adjustment for potential confounders and Short Physical Performance Battery score at baseline ( beta=.023; P=. 01). In a classification and regression tree analysis, age older than 81 years and vitamin E ( in participants aged 70- 80 years) were identified as the strongest determinants of decline in physical function ( physical decline in 84% and 60%, respectively; misclassification error rate, 0.33). Conclusions These results provide empirical evidence that a low serum concentration of vitamin E is associated with subsequent decline in physical function among community-living older adults. Clinical trials may be warranted to determine whether an optimal concentration of vitamin E reduces functional decline and the onset of disability in older persons.	[Bartali, Benedetta; Allore, Heather G.; Gill, Thomas M.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06504 USA; [Bartali, Benedetta; Frongillo, Edward A.; Stipanuk, Martha H.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Frongillo, Edward A.] Univ S Carolina, Arnold Sch Publ Hlth, Dept Hlth Promot Educ & Behav, Columbia, SC 29208 USA; [Guralnik, Jack M.] NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Ferrucci, Luigi] NIA, Longitudinal Studies Sect, Clin Res Branch, Bethesda, MD 20892 USA; [Cherubini, Antonio] Univ Perugia, Sch Med, Monteluce Policlin, Inst Gerontol & Geriatr, I-06100 Perugia, Italy; [Bandinelli, Stefania] Azienda Sanit Firenze, Florence, Italy	Yale University; Cornell University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Perugia; Azienda Sanitaria di Firenze	Bartali, B (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 20 York St,TMP 17B, New Haven, CT 06504 USA.	benedetta.bartali@yale.edu	Cherubini, Antonio/AAL-4632-2020; bandinelli, stefania/AAL-4570-2020; Gill, Thomas M./H-7043-2019	Gill, Thomas M./0000-0002-6450-0368; Cherubini, Antonio/0000-0003-0261-9897; Allore, Heather/0000-0001-7685-8175	NATIONAL INSTITUTE ON AGING [P30AG021342, ZIAAG001050, Z01AG000971, Z01AG000631, K24AG021507] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD009164] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 AG999999] Funding Source: Medline; NIA NIH HHS [K24 AG021507, K24AG021507, P30 AG021342, P30AG21342] Funding Source: Medline; NIMHD NIH HHS [R01 MD009164] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Allore H, 2005, J CLIN EPIDEMIOL, V58, P154, DOI 10.1016/j.jclinepi.2004.09.001; APPLEGATE WB, 1990, NEW ENGL J MED, V322, P1207; Bartali B, 2006, ARCH INTERN MED, V166, P2335, DOI 10.1001/archinte.166.21.2335; Bartali B, 2006, J GERONTOL A-BIOL, V61, P589, DOI 10.1093/gerona/61.6.589; Ble A, 2006, J GERONTOL A-BIOL, V61, P278, DOI 10.1093/gerona/61.3.278; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Cesari M, 2005, ARCH INTERN MED, V165, P2148, DOI 10.1001/archinte.165.18.2148; Cesari M, 2004, AM J CLIN NUTR, V79, P289; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Deeg DJH, 2002, J CLIN EPIDEMIOL, V55, P319, DOI 10.1016/S0895-4356(01)00475-9; Diaz MN, 1997, NEW ENGL J MED, V337, P408, DOI 10.1056/NEJM199708073370607; Ebrahim S, 1999, LANCET, V353, P1990, DOI 10.1016/S0140-6736(99)00195-6; Esposito K, 2004, JAMA-J AM MED ASSOC, V292, P1440, DOI 10.1001/jama.292.12.1440; Evans WJ, 2000, AM J CLIN NUTR, V72, p647S, DOI 10.1093/ajcn/72.2.647S; Fano G, 2001, J MUSCLE RES CELL M, V22, P345, DOI 10.1023/A:1013122805060; Ferrucci L, 2000, J AM GERIATR SOC, V48, P1618, DOI 10.1111/j.1532-5415.2000.tb03873.x; Finaud J, 2006, SPORTS MED, V36, P327, DOI 10.2165/00007256-200636040-00004; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Food and Nutrition Board, 2006, DIET REF INT ESS GUI; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Guralnik JM, 2002, AM J PUBLIC HEALTH, V92, P1244, DOI 10.2105/AJPH.92.8.1244; Guralnik JM, 1995, NIH PUBLICATION, V95-4009; Irwin M, 1999, ARCH INTERN MED, V159, P1701, DOI 10.1001/archinte.159.15.1701; LIU IY, 1989, AM J EPIDEMIOL, V130, P416, DOI 10.1093/oxfordjournals.aje.a115350; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Manton KG, 2006, P NATL ACAD SCI USA, V103, P18374, DOI 10.1073/pnas.0608483103; MathSoft, 1999, S PLUS 2000 GUID STA, V1; Mecocci P, 1999, FREE RADICAL BIO MED, V26, P303, DOI 10.1016/S0891-5849(98)00208-1; Ostir GV, 2002, J CLIN EPIDEMIOL, V55, P916, DOI 10.1016/S0895-4356(02)00436-5; Pahor M, 2006, J GERONTOL A-BIOL, V61, P1157; Perera S, 2006, J AM GERIATR SOC, V54, P743, DOI 10.1111/j.1532-5415.2006.00701.x; PETTE D, 1986, FED PROC, V45, P2910; Pisani P, 1997, INT J EPIDEMIOL, V26, pS152, DOI 10.1093/ije/26.suppl_1.S152; Radimer K, 2004, AM J EPIDEMIOL, V160, P339, DOI 10.1093/aje/kwh207; *SAS I INC, 2000, SAS PROC GUID COMP P; Snowdon DA, 1996, J GERONTOL A-BIOL, V51, pM10, DOI 10.1093/gerona/51A.1.M10; Traber MG, 1996, ANNU REV NUTR, V16, P321, DOI 10.1146/annurev.nu.16.070196.001541; Traber MG, 2000, LANCET, V355, P2013, DOI 10.1016/S0140-6736(00)02345-X; *US BUR CENS, 2000, ANN PROJ RES POP AG	39	81	85	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2008	299	3					308	315		10.1001/jama.299.3.308	http://dx.doi.org/10.1001/jama.299.3.308			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253DB	18212315	Green Accepted, Bronze			2022-12-28	WOS:000252497800022
J	Coates, AL				Coates, Allan L.			Guiding aerosol deposition in the lung	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DELIVERY		Univ Toronto, Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Coates, AL (corresponding author), Univ Toronto, Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada.							COATES AL, 2006, KENDIGS DISORDERS RE, P268; Dames P, 2007, NAT NANOTECHNOL, V2, P495, DOI 10.1038/nnano.2007.217; Koehler DR, 2005, J GENE MED, V7, P1409, DOI 10.1002/jgm.797; Laube BL, 2000, CHEST, V118, P1069, DOI 10.1378/chest.118.4.1069; SMALDONE GC, 1991, AM REV RESPIR DIS, V143, P727, DOI 10.1164/ajrccm/143.4_Pt_1.727	5	23	24	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2008	358	3					304	305		10.1056/NEJMcibr0707489	http://dx.doi.org/10.1056/NEJMcibr0707489			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	251LS	18199871				2022-12-28	WOS:000252375600015
J	Mani, A; Lee, DA				Mani, Aparna; Lee, David A.			Leukemic gingival infiltration	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mani, Aparna; Lee, David A.] Georgetown Univ, Med Ctr, Washington, DC 20007 USA	Georgetown University	Mani, A (corresponding author), Georgetown Univ, Med Ctr, Washington, DC 20007 USA.	am2@georgetown.edu							0	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2008	358	3					274	274		10.1056/NEJMicm066017	http://dx.doi.org/10.1056/NEJMicm066017			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	251LS	18199866				2022-12-28	WOS:000252375600009
J	Zachos, JC; Dickens, GR; Zeebe, RE				Zachos, James C.; Dickens, Gerald R.; Zeebe, Richard E.			An early Cenozoic perspective on greenhouse warming and carbon-cycle dynamics	NATURE			English	Article							EOCENE THERMAL MAXIMUM; CLIMATE SYSTEM; GLOBAL CARBON; PALEOCENE; METHANE; OCEAN; MECHANISM; HYDRATE		[Zachos, James C.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95060 USA; [Dickens, Gerald R.] Rice Univ, Dept Earth Sci, Houston, TX 77005 USA; [Zeebe, Richard E.] Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA	University of California System; University of California Santa Cruz; Rice University; University of Hawaii System; University of Hawaii Manoa	Zachos, JC (corresponding author), Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95060 USA.	jzachos@es.ucsc.edu; zeebe@hawaii.edu	Zachos, James C/A-7674-2008; Dickens, Gerald R/G-1222-2011	Zachos, James C/0000-0001-8439-1886; Dickens, Gerald/0000-0003-2869-4860				Archer D, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002625; Beerling DJ, 2007, PHILOS T R SOC A, V365, P1629, DOI 10.1098/rsta.2007.2037; Billups K, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000568; Bohaty SM, 2003, GEOLOGY, V31, P1017, DOI 10.1130/G19800.1; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Dickens GR, 2003, EARTH PLANET SC LETT, V213, P169, DOI 10.1016/S0012-821X(03)00325-X; Doney SC, 2007, ANNU REV ENV RESOUR, V32, P31, DOI 10.1146/annurev.energy.32.041706.124700; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Higgins JA, 2006, EARTH PLANET SC LETT, V245, P523, DOI 10.1016/j.epsl.2006.03.009; Huber M, 2001, GEOPHYS RES LETT, V28, P3481, DOI 10.1029/2001GL012943; Kurtz AC, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000908; Lourens LJ, 2005, NATURE, V435, P1083, DOI 10.1038/nature03814; Lowenstein TK, 2006, SCIENCE, V313, P1928, DOI 10.1126/science.1129555; Palike H, 2006, SCIENCE, V314, P1894, DOI 10.1126/science.1133822; Pancost RD, 2007, NATURE, V449, P332, DOI 10.1038/nature06012; Royer DL, 2006, GEOCHIM COSMOCHIM AC, V70, P5665, DOI 10.1016/j.gca.2005.11.031; Schmitz B, 2007, GEOLOGY, V35, P215, DOI 10.1130/G23261A.1; Sloan LC, 1998, GEOPHYS RES LETT, V25, P3517, DOI 10.1029/98GL02492; Sluijs A, 2007, DEEP-TIME PERSPECTIVES ON CLIMATE CHANGE: MARRYING THE SIGNAL FROM COMPUTER MODELS AND BIOLOGICAL PROXIES, P323; Svensen H, 2004, NATURE, V429, P542, DOI 10.1038/nature02566; Thomas DJ, 2002, GEOLOGY, V30, P1067, DOI 10.1130/0091-7613(2002)030<1067:WTFFTF>2.0.CO;2; Thomas E., 1996, Geological Society Special Publication, V101, P401, DOI 10.1144/GSL.SP.1996.101.01.20; WALKER JCG, 1981, J GEOPHYS RES-OCEANS, V86, P9776, DOI 10.1029/JC086iC10p09776; Wing SL, 2003, CAUSES CONSEQUENCES; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2005, SCIENCE, V308, P1611, DOI 10.1126/science.1109004; Zeebe RE, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001395	27	2136	2226	36	746	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2008	451	7176					279	283		10.1038/nature06588	http://dx.doi.org/10.1038/nature06588			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202643	Bronze			2022-12-28	WOS:000252432100035
J	Cheung, BMY				Cheung, Bernard M. Y.			Statins for people with diabetes	LANCET			English	Editorial Material							CORONARY-HEART-DISEASE; ATORVASTATIN; MELLITUS		Univ Birmingham, Dept Clin Pharmacol, Div Med Sci, Birmingham B15 2TH, W Midlands, England	University of Birmingham	Cheung, BMY (corresponding author), Univ Birmingham, Dept Clin Pharmacol, Div Med Sci, Birmingham B15 2TH, W Midlands, England.	b.cheung@bham.ac.uk	/E-9829-2010	/0000-0001-9106-7363				Cheung BMY, 2001, NEW ZEAL MED J, V114, P214; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; Knopp RH, 2006, DIABETES CARE, V29, P1478, DOI 10.2337/dc05-2415; Kumana CR, 1999, JAMA-J AM MED ASSOC, V282, P1899, DOI 10.1001/jama.282.20.1899; ONG KL, IN PRESS ANN EPIDEMI; PEDERSEN TR, 1994, LANCET, V344, P1383; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1	10	9	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 12	2008	371	9607					94	95		10.1016/S0140-6736(08)60081-1	http://dx.doi.org/10.1016/S0140-6736(08)60081-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	252ND	18191668				2022-12-28	WOS:000252452300005
J	Bianchi, AD; Kenzelmann, M; DeBeer-Schmitt, L; White, JS; Forgan, EM; Mesot, J; Zolliker, M; Kohlbrecher, J; Movshovich, R; Bauer, ED; Sarrao, JL; Fisk, Z; Petrovic, C; Eskildsen, MR				Bianchi, Andrea D.; Kenzelmann, Michel; DeBeer-Schmitt, Lisa; White, Jon S.; Forgan, Edward M.; Mesot, Joel; Zolliker, Markus; Kohlbrecher, Joachim; Movshovich, Roman; Bauer, Eric. D.; Sarrao, John L.; Fisk, Zachary; Petrovic, Cedomir; Eskildsen, Morten Ring			Superconducting vortices in CeCoIn5: Toward the Pauli-limiting field	SCIENCE			English	Article							QUANTUM CRITICAL-POINT; D-WAVE; LATTICE; STATE; CORE	Many superconducting materials allow the penetration of magnetic fields in a mixed state in which the superfluid is threaded by a regular lattice of Abrikosov vortices, each carrying one quantum of magnetic flux. The phenomenological Ginzburg- Landau theory, based on the concept of characteristic length scales, has generally provided a good description of the Abrikosov vortex lattice state. We conducted neutron- scattering measurements of the vortex lattice form factor in the heavy- fermion superconductor cerium- cobalt- indium ( CeCoIn5) and found that this form factor increases with increasing field- opposite to the expectations within the Abrikosov- Ginzburg- Landau paradigm. We propose that the anomalous field dependence of the form factor arises from Pauli paramagnetic effects around the vortex cores and from the proximity of the superconducting state to a quantum critical point.	[Bianchi, Andrea D.; Fisk, Zachary] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA; [Kenzelmann, Michel] ETH, Solid State Phys Lab, CH-8093 Zurich, Switzerland; [Kenzelmann, Michel; Mesot, Joel; Kohlbrecher, Joachim] ETH, CH-5232 Villigen, Switzerland; [Zolliker, Markus] Paul Scherrer Inst, Lab Dev & Methods, CH-5232 Villigen, Switzerland; [DeBeer-Schmitt, Lisa; Eskildsen, Morten Ring] Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA; [White, Jon S.; Forgan, Edward M.] Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England; [Movshovich, Roman; Bauer, Eric. D.; Sarrao, John L.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Petrovic, Cedomir] Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Dept, Upton, NY 11973 USA	University of California System; University of California Irvine; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Notre Dame; University of Birmingham; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Brookhaven National Laboratory	Bianchi, AD (corresponding author), Univ Montreal, Dept Phys, CP 6128, Montreal, PQ H3C 3J7, Canada.	andrea.bianchi@umontreal.ca	Kenzelmann, Michel/ABE-1645-2020; DeBeer-Schmitt, Lisa/I-3313-2015; Kohlbrecher, Joachim/C-8790-2011; Bianchi, Andrea D/E-9779-2010; Bianchi, Andrea/AAZ-8661-2021; White, Jonathan/G-2742-2010; Petrovic, Cedomir/A-8789-2009; Kenzelmann, Michel/A-8438-2008; Bauer, Eric D/D-7212-2011; Eskildsen, Morten Ring/E-7779-2011	DeBeer-Schmitt, Lisa/0000-0001-9679-3444; Kohlbrecher, Joachim/0000-0001-5879-6943; Bianchi, Andrea D/0000-0001-9340-6971; Bianchi, Andrea/0000-0001-9340-6971; White, Jonathan/0000-0001-7738-0150; Petrovic, Cedomir/0000-0001-6063-1881; Kenzelmann, Michel/0000-0001-7913-4826; Eskildsen, Morten Ring/0000-0001-5211-1771; Bauer, Eric/0000-0003-0017-1937; Movshovich, Roman/0000-0002-3667-634X				ABRIKOSOV AA, 1957, SOV PHYS JETP-USSR, V5, P1174; Amin MHS, 1998, PHYS REV B, V58, P5848, DOI 10.1103/PhysRevB.58.5848; Bianchi A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.257001; Bianchi A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.187004; Bianchi A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.137002; Brown SP, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.067004; CLEM JR, 1975, J LOW TEMP PHYS, V18, P427, DOI 10.1007/BF00116134; DeBeer-Schmitt L, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.167001; DeBeer-Schmitt L, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.127001; Eskildsen MR, 1998, NATURE, V393, P242, DOI 10.1038/30447; Eskildsen MR, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.187001; Forgan EM, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.167003; Franz M, 1996, PHYS REV B, V53, P5795, DOI 10.1103/PhysRevB.53.5795; FULDE P, 1964, PHYS REV A, V550, P135; Gurevich A, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.177009; Ichioka M, 1999, PHYS REV B, V59, P8902, DOI 10.1103/PhysRevB.59.8902; Ichioka M, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.064502; Kogan VG, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.134505; Kogan VG, 1997, PHYS REV B, V55, pR8693, DOI 10.1103/PhysRevB.55.R8693; LARKIN AI, 1965, ZH EKSP TEOR FIZ, V20, P762; Matsuda Y, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.051005; Nakai N, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.231004; Ormeno RJ, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.047005; Ozcan S, 2003, EUROPHYS LETT, V62, P412, DOI 10.1209/epl/i2003-00411-9; Petrovic C, 2001, J PHYS-CONDENS MAT, V13, pL337, DOI 10.1088/0953-8984/13/17/103; SCHELTEN J, 1971, PHYS STATUS SOLIDI B, V48, P619, DOI 10.1002/pssb.2220480219; Settai R, 2001, J PHYS-CONDENS MAT, V13, pL627, DOI 10.1088/0953-8984/13/27/103; Sonier JE, 2004, J PHYS-CONDENS MAT, V16, pS4499, DOI 10.1088/0953-8984/16/40/006; Tanatar MA, 2007, SCIENCE, V316, P1320, DOI 10.1126/science.1140762; Tayama T, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.180504; Vorontsov A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.237001	32	97	97	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2008	319	5860					177	180		10.1126/science.1150600	http://dx.doi.org/10.1126/science.1150600			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249RC	18187648	Green Published			2022-12-28	WOS:000252246400033
J	Nagamune, K; Hicks, LM; Fux, B; Brossier, F; Chini, EN; Sibley, LD				Nagamune, Kisaburo; Hicks, Leslie M.; Fux, Blima; Brossier, Fabien; Chini, Eduardo N.; Sibley, L. David			Abscisic acid controls calcium-dependent egress and development in Toxoplasma gondii	NATURE			English	Article							CYCLIC ADP-RIBOSE; MICRONEME SECRETION; BIOSYNTHESIS; PATHWAY; ACCUMULATION; REVEALS; STRAINS	Calcium controls a number of critical events, including motility, secretion, cell invasion and egress by apicomplexan parasites(1). Compared to animal(2) and plant cells(3), the molecular mechanisms that govern calcium signalling in parasites are poorly understood. Here we show that the production of the phytohormone abscisic acid ( ABA) controls calcium signalling within the apicomplexan parasite Toxoplasma gondii, an opportunistic human pathogen. In plants, ABA controls a number of important events, including environmental stress responses, embryo development and seed dormancy(4,5). ABA induces production of the second- messenger cyclic ADP ribose ( cADPR), which controls release of intracellular calcium stores in plants(6). cADPR also controls intracellular calcium release in the protozoan parasite T. gondii(7,8); however, previous studies have not revealed the molecular basis of this pathway(9). We found that addition of exogenous ABA induced formation of cADPR in T. gondii, stimulated calcium- dependent protein secretion, and induced parasite egress from the infected host cell in a density- dependent manner. Production of endogenous ABA within the parasite was confirmed by purification ( using high- performance liquid chromatography) and analysis ( by gas chromatography- mass spectrometry). Selective disruption of ABA synthesis by the inhibitor fluridone delayed egress and induced development of the slow- growing, dormant cyst stage of the parasite. Thus, ABA- mediated calcium signalling controls the decision between lytic and chronic stage growth, a developmental switch that is central in pathogenesis and transmission. The pathway for ABA production was probably acquired with an algal endosymbiont that was retained as a non- photosynthetic plastid known as the apicoplast. The plant- like nature of this pathway may be exploited therapeutically, as shown by the ability of a specific inhibitor of ABA synthesis to prevent toxoplasmosis in the mouse model.	[Nagamune, Kisaburo; Fux, Blima; Brossier, Fabien; Sibley, L. David] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Hicks, Leslie M.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Chini, Eduardo N.] Mayo Clin & Mayo Fdn, Dept Anesthesiol, Rochester, MN 55905 USA	Washington University (WUSTL); Donald Danforth Plant Science Center; Mayo Clinic	Sibley, LD (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	sibley@wustl.edu	Hicks, Leslie M/E-8015-2010; Fux, Blima/AAO-2941-2020; Sibley, L. David/C-4616-2008	Hicks, Leslie M/0000-0002-8008-3998; Fux, Blima/0000-0002-5038-3551	NIAID NIH HHS [R21 AI067051-02, R01 AI034036-16, R01 AI034036, R21 AI067051] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI067051, R01AI034036] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bothwell JHF, 2005, NEW PHYTOL, V166, P21, DOI 10.1111/j.1469-8137.2004.01312.x; Carruthers VB, 2000, J BIOL CHEM, V275, P14346, DOI 10.1074/jbc.275.19.14346; Chini EN, 2005, BIOCHEM J, V389, P269, DOI 10.1042/BJ20041971; COWAN AK, 1991, PLANT PHYSIOL, V97, P798, DOI 10.1104/pp.97.2.798; Almeida Julieta Andrea Silva de, 2005, Braz. J. Plant Physiol., V17, P391, DOI 10.1590/S1677-04202005000400007; ENDO T, 1982, EXP PARASITOL, V53, P179, DOI 10.1016/0014-4894(82)90059-5; Fux B, 2007, INFECT IMMUN, V75, P2580, DOI 10.1128/IAI.00085-07; HIRSCH R, 1989, BOT ACTA, V102, P326, DOI 10.1111/j.1438-8677.1989.tb00113.x; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Kobayashi M, 1997, PLANT GROWTH REGUL, V22, P79, DOI 10.1023/A:1005862809711; Leef J.L., 1999, Carotenoid synthesis inhibiting herbicides and fatty acid synthesis oxime herbicides as anti-apicomplexa protozoan parasite agents, Patent No. 847932; Liu XG, 2007, SCIENCE, V315, P1712, DOI 10.1126/science.1135882; Lovett JL, 2002, J BIOL CHEM, V277, P25870, DOI 10.1074/jbc.M202553200; Moreno SNJ, 2003, CURR OPIN MICROBIOL, V6, P359, DOI 10.1016/S1369-5274(03)00091-2; Moudy R, 2001, J BIOL CHEM, V276, P41492, DOI 10.1074/jbc.M106154200; Nagamune K, 2006, MOL BIOL EVOL, V23, P1613, DOI 10.1093/molbev/msl026; Puce S, 2004, J BIOL CHEM, V279, P39783, DOI 10.1074/jbc.M405348200; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Razem FA, 2006, NATURE, V439, P290, DOI 10.1038/nature04373; Rodrigues CO, 2002, J BIOL CHEM, V277, P48650, DOI 10.1074/jbc.M208990200; Saeij JPJ, 2005, INFECT IMMUN, V73, P695, DOI 10.1128/IAI.73.2.695-702.2005; Schwartz SH, 2003, PLANT PHYSIOL, V131, P1591, DOI 10.1104/pp.102.017921; Tian L, 2004, PHYSIOL PLANTARUM, V122, P314, DOI 10.1111/j.1399-3054.2004.00409.x; Walter RF, 2005, CURR ISSUES MOL BIOL, V7, P57, DOI 10.21775/cimb.007.057; Wu Y, 1997, SCIENCE, V278, P2126, DOI 10.1126/science.278.5346.2126; Xiong LM, 2003, PLANT PHYSIOL, V133, P29, DOI 10.1104/pp.103.025395; Zhang YW, 1999, MOL MICROBIOL, V31, P691, DOI 10.1046/j.1365-2958.1999.01210.x; Zhang YW, 2001, INFECT IMMUN, V69, P501, DOI 10.1128/IAI.69.1.501-507.2001; Zocchi E, 2001, P NATL ACAD SCI USA, V98, P14859, DOI 10.1073/pnas.261448698	30	169	178	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2008	451	7175					207	U11		10.1038/nature06478	http://dx.doi.org/10.1038/nature06478			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249GA	18185591	Green Accepted			2022-12-28	WOS:000252214400046
J	Axelrod, DA; Guidinger, MK; Finlayson, S; Schaubel, DE; Goodman, DC; Chobanian, M; Merion, RM				Axelrod, David A.; Guidinger, Mary K.; Finlayson, Samuel; Schaubel, Douglas E.; Goodman, David C.; Chobanian, Michael; Merion, Robert M.			Rates of solid-organ wait-listing, transplantation, and survival among residents of rural and urban areas	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CADAVERIC RENAL-TRANSPLANTATION; QUALITY-OF-LIFE; LIVER-TRANSPLANTATION; KIDNEY-TRANSPLANTATION; RACIAL-DIFFERENCES; UNITED-STATES; ACCESS; DIALYSIS; VETERANS; DISEASE	Context Disparities in access to organ transplantation exist for racial minorities, women, and patients with lower socioeconomic status or inadequate insurance. Rural residents represent another group that may have impaired access to transplant services. Objective To assess the association of rural residence with waiting list registration for heart, liver, and kidney transplant and rates of transplantation among wait- listed candidates. Design, Setting, and Patients Five- year US cohort of 174 630 patients who were wait- listed and who underwent heart, liver, or kidney transplantation between 1999 and 2004. Main Outcome Measures Rates of new waiting list registrations and transplants per million population for residents of 3 residential classifications ( rural/ small town population, < 10 000; micropolitan, 10 000- 50 000; and metropolitan > 50 000 or suburb of major city). Results Compared with urban residents, waiting list registration rates for rural/ small town residents were significantly lower for heart ( covariate- adjusted rate ratio [ RR]= 0.91; 95% confidence interval [ Cl], 0.86- 0.96; P <. 002), liver ( RR= 0.86; 95% Cl, 0.83- 0.89; P <. 001), and kidney transplants ( RR= 0.92; 95% Cl, 0.90- 0.95; P <. 001). Compared with residents in urban areas, rural/ small town residents had lower relative transplant rates for heart ( RR= 0.88; 95% Cl, 0.81- 0.94; P=. 004), liver ( RR= 0.80; 95% Cl, 0.77- 0.84; P < .001), and kidney transplantation ( covariate- adjusted RR= 0.90; 95% Cl, 0.88- 0.93; P <. 001). These disparities were consistent across national organ allocation regions. Significantly longer waiting times among rural patients wait- listed for heart transplantation were observed but not for liver and kidney transplantation. There were no significant differences in posttransplantation outcomes between groups. Conclusions Patients living in rural areas had a lower rate of wait- lisiting and transplant of solid organs, but did not experience significantly different outcomes following transplant. Differences in rates of wait- listing and transplant may be due to variations in the burden of disease between different patient groups or barriers to evaluation and waiting list entry for rural residents with organ failure.	[Axelrod, David A.; Finlayson, Samuel; Chobanian, Michael] Dartmouth Med Sch, Dept Surg, Lebanon, NH USA; [Guidinger, Mary K.; Merion, Robert M.] Arbor Res Collaborat Hlth, Sci Registry Transplant Recipients, Ann Arbor, MI USA; [Goodman, David C.] Dartmouth Med Sch, Dept Pediat, Lebanon, NH USA; [Schaubel, Douglas E.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Merion, Robert M.] Univ Michigan, Dept Surg, Div Transplantat, Ann Arbor, MI 48109 USA; [Goodman, David C.] Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA	Dartmouth College; Arbor Research Collaborative for Health; Dartmouth College; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Dartmouth College	Axelrod, DA (corresponding author), Dartmouth Hitchcock Med Ctr, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	david.axelrod@hitchcock.org	Goodman, David/AAG-7497-2020	Axelrod, David/0000-0001-5684-0613	PHS HHS [234-2005-37009C] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Alexander GC, 1998, JAMA-J AM MED ASSOC, V280, P1148, DOI 10.1001/jama.280.13.1148; Alexander GC, 2002, AM J KIDNEY DIS, V40, P824, DOI 10.1053/ajkd.2002.35695; Ayanian JZ, 2004, AM J KIDNEY DIS, V43, P350, DOI 10.1053/j.ajkd.2003.10.022; Ayanian JZ, 1999, NEW ENGL J MED, V341, P1661, DOI 10.1056/NEJM199911253412206; Bloembergen WE, 1997, AM J KIDNEY DIS, V30, P733, DOI 10.1016/S0272-6386(97)90076-7; Cass A, 2003, AM J KIDNEY DIS, V42, P1043, DOI 10.1016/j.ajkd.2003.07.006; Chan L, 2006, J RURAL HEALTH, V22, P140, DOI 10.1111/j.1748-0361.2006.00022.x; Epstein AM, 2000, NEW ENGL J MED, V343, P1537, DOI 10.1056/NEJM200011233432106; GASTON RS, 1993, JAMA-J AM MED ASSOC, V270, P1352, DOI 10.1001/jama.270.11.1352; HELD PJ, 1988, ARCH INTERN MED, V148, P2594, DOI 10.1001/archinte.148.12.2594; Julapalli VR, 2005, LIVER TRANSPLANT, V11, P1370, DOI 10.1002/lt.20434; Kasiske BL, 1998, J AM SOC NEPHROL, V9, P2142; Kinchen KS, 2002, ANN INTERN MED, V137, P479, DOI 10.7326/0003-4819-137-6-200209170-00007; McCormick PA, 2004, LIVER TRANSPLANT, V10, P1422, DOI 10.1002/lt.20276; Merion RM, 2005, AM J TRANSPLANT, V5, P307, DOI 10.1111/j.1600-6143.2004.00703.x; O'Hare AM, 2006, KIDNEY INT, V69, P343, DOI 10.1038/sj.ki.5000044; Roderick P, 2002, QJM-INT J MED, V95, P363, DOI 10.1093/qjmed/95.6.363; Schnitzler MA, 2005, AM J TRANSPLANT, V5, P2289, DOI 10.1111/j.1600-6143.2005.01021.x; Trang P, 2004, CELL MICROBIOL, V6, P499, DOI 10.1111/j.1462-5822.2004.00398.x; TuttleNewhall JE, 1997, TRANSPLANTATION, V63, P255, DOI 10.1097/00007890-199701270-00014; Weeks WB, 2006, J RURAL HEALTH, V22, P264, DOI 10.1111/j.1748-0361.2006.00043.x; Weeks WB, 2004, AM J PUBLIC HEALTH, V94, P1762, DOI 10.2105/AJPH.94.10.1762; Weeks WB, 2006, J RURAL HEALTH, V22, P204, DOI 10.1111/j.1748-0361.2006.00033.x; Weng FL, 2005, AM J KIDNEY DIS, V46, P734, DOI 10.1053/j.ajkd.2005.06.011; Winkelmayer WC, 2002, TRANSPLANTATION, V73, P1918, DOI 10.1097/00007890-200206270-00012; Wolfe RA, 2004, AM J TRANSPLANT, V4, P106, DOI 10.1111/j.1600-6135.2004.00402.x; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303	27	171	172	1	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2008	299	2					202	207		10.1001/jama.2007.50	http://dx.doi.org/10.1001/jama.2007.50			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UN	18182602	Bronze			2022-12-28	WOS:000252182600020
J	Goldenberg, RL; Culhane, JF; Iams, JD; Romero, R				Goldenberg, Robert L.; Culhane, Jennifer F.; Iams, Jay D.; Romero, Roberto			Preterm birth 1 - Epidemiology and causes of preterm birth	LANCET			English	Review							POLYMERASE-CHAIN-REACTION; FETAL INFLAMMATORY RESPONSE; AMNIOTIC-FLUID INFECTION; C-REACTIVE PROTEIN; BODY-MASS INDEX; INDICATED PRETERM; GESTATIONAL-AGE; UREAPLASMA-UREALYTICUM; DEPRESSIVE SYMPTOMS; BACTERIAL VAGINOSIS	This paper is the first in a three-part series on preterm. birth, which is the leading cause of perinatal morbidity and mortality in developed countries. Infants are born preterm at less than 37 weeks' gestational age after: (1) spontaneous labour with intact membranes, (2) preterm premature rupture of the membranes (PPROM), and (3) labour induction or Caesarean delivery for maternal or fetal indications. The frequency of preterm births is about 12-13% in the USA and 5-9% in many other developed countries; however, the rate of preterm, birth has increased in many locations, predominantly because of increasing indicated preterm births and preterm delivery of artificially conceived multiple pregnancies. Common reasons for indicated preterm. births include pre-eclampsia or eclampsia, and intrauterine growth restriction. Births that follow spontaneous preterm. labour and PPROM-together called spontaneous preterm births-are regarded as a syndrome resulting from multiple causes, including infection or inflammation, vascular disease, and uterine overdistension. Risk factors for spontaneous preterm births include a previous preterm birth, black race, periodontal disease, and low maternal body-mass index. A short cervical length and a raised cervical-vaginal fetal fibronectin concentration are the strongest predictors of spontaneous preterm birth.	[Goldenberg, Robert L.; Culhane, Jennifer F.] Drexel Univ, Coll Med, Dept Obstet & Gynecol, Philadelphia, PA 19102 USA; [Iams, Jay D.] Ohio State Univ, Dept Obstet & Gynecol, Columbus, OH 43210 USA; [Romero, Roberto] NICHHD, Perinatol Res Branch, NIH, Bethesda, MD 20892 USA; [Romero, Roberto] NICHHD, Perinatol Res Branch, NIH, Detroit, MI USA; [Romero, Roberto] Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI USA	Drexel University; University System of Ohio; Ohio State University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Wayne State University	Goldenberg, RL (corresponding author), Drexel Univ, Coll Med, Dept Obstet & Gynecol, 245 N 15th St,17th Floor,Room 17113, Philadelphia, PA 19102 USA.	rgoldenb@drexelmed.edu	Akın, Mustafa Senol/F-5143-2017; Romero, Roberto/A-5268-2019	Akın, Mustafa Senol/0000-0003-0055-8277; Romero, Roberto/0000-0002-4448-5121	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD002400] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD002400] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AMSTEL R, 1983, AM J MED, V74, P14; Ananth CV, 2006, J MATERN-FETAL NEO M, V19, P773, DOI 10.1080/14767050600965882; Ananth CV, 2006, AM J OBSTET GYNECOL, V195, P643, DOI 10.1016/j.ajog.2006.05.022; Ananth CV, 2005, OBSTET GYNECOL, V105, P1084, DOI 10.1097/01.AOG.0000158124.96300.c7; ANDERSON A B M, 1969, Journal of Obstetrics and Gynaecology of the British Commonwealth, V76, P196; Andres R L, 2000, Semin Neonatol, V5, P231, DOI 10.1053/siny.2000.0025; ANDREWS WW, 1995, AM J OBSTET GYNECOL, V173, P606, DOI 10.1016/0002-9378(95)90290-2; Andrews WW, 2005, AM J OBSTET GYNECOL, V193, P739, DOI 10.1016/j.ajog.2005.02.128; Andrews WW, 1995, INFECT AGENT DIS, V4, P196; Andrews WW, 2000, OBSTET GYNECOL, V95, P222, DOI 10.1016/S0029-7844(99)00483-4; Benowitz NL, 2000, TOB CONTROL, V9, P91, DOI 10.1136/tc.9.suppl_3.iii91; Bermudez EA, 2002, AM J CARDIOL, V89, P1117, DOI 10.1016/S0002-9149(02)02284-1; Brett KM, 1997, AM J PUBLIC HEALTH, V87, P199, DOI 10.2105/AJPH.87.2.199; Carroll SG, 1996, BRIT J OBSTET GYNAEC, V103, P54, DOI 10.1111/j.1471-0528.1996.tb09515.x; Cassell G., 1993, American Journal of Obstetrics and Gynecology, V168, P424; CASSELL GH, 1983, SEX TRANSM DIS, V10, P294; Challis JRG, 2001, BIOL NEONATE, V79, P163; Cnattingius S, 2004, NICOTINE TOB RES, V6, pS125, DOI 10.1080/14622200410001669187; Collins J W Jr, 1997, Ethn Health, V2, P117; Conde-Agudelo A, 2006, JAMA-J AM MED ASSOC, V295, P1809, DOI 10.1001/jama.295.15.1809; COPPER RL, 1990, AM J OBSTET GYNECOL, V162, P748, DOI 10.1016/0002-9378(90)91000-3; Copper RL, 1996, AM J OBSTET GYNECOL, V175, P1286, DOI 10.1016/S0002-9378(96)70042-X; Cotch MF, 1997, SEX TRANSM DIS, V24, P353, DOI 10.1097/00007435-199707000-00008; Crider KS, 2005, GENET MED, V7, P593, DOI 10.1097/01.gim.0000187223.69947.db; Dayan J, 2006, PSYCHOSOM MED, V68, P938, DOI 10.1097/01.psy.0000244025.20549.bd; Demissie K, 2001, AM J EPIDEMIOL, V154, P307, DOI 10.1093/aje/154.4.307; DONDERS GGG, 1993, GENITOURIN MED, V69, P98; Ebrahim SH, 2000, JAMA-J AM MED ASSOC, V283, P361, DOI 10.1001/jama.283.3.361; Engel SAM, 2005, EPIDEMIOLOGY, V16, P469, DOI 10.1097/01.ede.0000164539.09250.31; Farley TA, 2006, PAEDIATR PERINAT EP, V20, P188, DOI 10.1111/j.1365-3016.2006.00719.x; Fiscella K, 1996, PUBLIC HEALTH REP, V111, P104; Fiscella K, 1996, Obstet Gynecol Surv, V51, P60, DOI 10.1097/00006254-199601000-00022; Gardella C, 2004, AM J PERINAT, V21, P319, DOI 10.1055/s-2004-831884; GARFIELD RE, 1987, AM J OBSTET GYNECOL, V157, P1281, DOI 10.1016/S0002-9378(87)80315-0; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Gennaro S, 1997, BRAIN BEHAV IMMUN, V11, P201, DOI 10.1006/brbi.1997.0502; GIBBS RS, 1992, AM J OBSTET GYNECOL, V166, P1515, DOI 10.1016/0002-9378(92)91628-N; Goepfert AR, 2004, OBSTET GYNECOL, V104, P777, DOI 10.1097/01.AOG.0000139836.47777.6d; Goldenberg RL, 1998, NEW ENGL J MED, V339, P313, DOI 10.1056/NEJM199807303390506; Goldenberg RL, 2005, CLIN PERINATOL, V32, P523, DOI 10.1016/j.clp.2005.04.006; Goldenberg RL, 2005, AM J OBSTET GYNECOL, V192, pS36, DOI 10.1016/j.ajog.2005.02.015; Goldenberg RL, 2005, ARCH PEDIAT ADOL MED, V159, P89, DOI 10.1001/archpedi.159.1.89; Goldenberg RL, 1996, AM J OBSTET GYNECOL, V175, P1317, DOI 10.1016/S0002-9378(96)70048-0; Goldenberg RL, 1996, OBSTET GYNECOL, V87, P643, DOI 10.1016/0029-7844(96)00035-X; Goldenberg RL, 2003, J NUTR, V133, p1645S, DOI 10.1093/jn/133.5.1645S; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goldenberg RL, 1997, CLIN PERINATOL, V24, P23, DOI 10.1016/S0095-5108(18)30182-9; Goldenberg RL, 1996, JAMA-J AM MED ASSOC, V275, P1127, DOI 10.1001/jama.275.14.1127; GOLDENBERG RL, IN PRESS AM J OBSTET; Goldenberg RL, 2006, AM J OBSTET GYNECOL, V195, P792, DOI 10.1016/j.ajog.2006.05.050; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; Gomez R, 1997, PRETERM LABOR, P85; Gravett MG, 2007, J PROTEOME RES, V6, P89, DOI 10.1021/pr060149v; GRAY DJ, 1992, PRENATAL DIAG, V12, P111, DOI 10.1002/pd.1970120206; HAMILTON BE, 2006, BIRTHS PRELIMINARY D; HARDY JM, 1961, AM J PUBLIC HEALTH N, V51, P1182, DOI 10.2105/AJPH.51.8.1182; Hendler I, 2005, AM J OBSTET GYNECOL, V192, P882, DOI 10.1016/j.ajog.2004.09.021; HILLIER SL, 1995, CLIN INFECT DIS, V20, pS276, DOI 10.1093/clinids/20.Supplement_2.S276; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Hitti J, 1997, CLIN INFECT DIS, V24, P1228, DOI 10.1086/513669; Hoffman S, 1996, PAEDIATR PERINAT EP, V10, P380, DOI 10.1111/j.1365-3016.1996.tb00063.x; HORN P, 1955, OBSTET GYNECOL, V6, P121; HOROWITZ S, 1995, J REPROD MED, V40, P375; IAMS JD, 1995, AM J OBSTET GYNECOL, V172, P1097, DOI 10.1016/0002-9378(95)91469-2; Iams JD, 1996, NEW ENGL J MED, V334, P567, DOI 10.1056/NEJM199602293340904; Iams JD, 2002, NEW ENGL J MED, V346, P250, DOI 10.1056/NEJMoa002868; IAMS JD, IN PRESS LANCET; Jackson RA, 2004, OBSTET GYNECOL, V103, P551, DOI 10.1097/01.AOG.0000114989.84822.51; Jakobsson M, 2007, OBSTET GYNECOL, V109, P309, DOI 10.1097/01.AOG.0000253239.87040.23; Jalava J, 1996, BRIT J OBSTET GYNAEC, V103, P664, DOI 10.1111/j.1471-0528.1996.tb09835.x; Jeffcoat MK, 2001, J AM DENT ASSOC, V132, P875, DOI 10.14219/jada.archive.2001.0299; KNOX IC, 1950, AM J OBSTET GYNECOL, V59, P190, DOI 10.1016/0002-9378(50)90370-X; KROHN MA, 1995, J INFECT DIS, V171, P1475, DOI 10.1093/infdis/171.6.1475; Krupa FG, 2006, INT J GYNECOL OBSTET, V94, P5, DOI 10.1016/j.ijgo.2006.03.022; LAUNER LJ, 1990, BRIT J OBSTET GYNAEC, V97, P62, DOI 10.1111/j.1471-0528.1990.tb01718.x; Leitich H, 1999, AM J OBSTET GYNECOL, V181, P1465, DOI 10.1016/S0002-9378(99)70407-2; LIGGINS GC, 1977, CIBA F S, V47, P5; LOBEL M, 1992, HEALTH PSYCHOL, V11, P32, DOI 10.1037/0278-6133.11.1.32; Lu GC, 2001, OBSTET GYNECOL, V97, P225, DOI 10.1016/S0029-7844(00)01130-3; Macones GA, 2004, AM J OBSTET GYNECOL, V190, P1504, DOI 10.1016/j.ajog.2004.01.001; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; Meis PJ, 2003, NEW ENGL J MED, V348, P2379, DOI 10.1056/NEJMoa035140; MEIS PJ, 1995, AM J OBSTET GYNECOL, V173, P1231, DOI 10.1016/0002-9378(95)91360-2; Menon R, 2006, AM J OBSTET GYNECOL, V194, P1616, DOI 10.1016/j.ajog.2006.03.059; Mercer BM, 2000, AM J OBSTET GYNECOL, V183, P738, DOI 10.1067/mob.2000.106766; Mercer BM, 1999, AM J OBSTET GYNECOL, V181, P1216, DOI 10.1016/S0002-9378(99)70111-0; Moawad AH, 2002, AM J OBSTET GYNECOL, V186, P990, DOI 10.1067/mob.2002.121727; MOORE TR, 1994, OBSTET GYNECOL, V83, P517, DOI 10.1097/00006250-199404000-00006; MUELLERHEUBACH E, 1990, OBSTET GYNECOL, V75, P622; NAGEOTTE MP, 1988, AM J OBSTET GYNECOL, V158, P1254, DOI 10.1016/0002-9378(88)90353-5; Neggers Y, 2003, J NUTR, V133, p1737S, DOI 10.1093/jn/133.5.1737S; Newman RB, 2001, AM J OBSTET GYNECOL, V184, P438, DOI 10.1067/mob.2001.110312; Newman RB, 2006, AM J OBSTET GYNECOL, V195, P1564, DOI 10.1016/j.ajog.2006.03.063; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Offenbacher S, 1998, Ann Periodontol, V3, P233, DOI 10.1902/annals.1998.3.1.233; Offenbacher S, 1996, J PERIODONTOL, V67, P1103, DOI 10.1902/jop.1996.67.10s.1103; ORR ST, 1995, EPIDEMIOL REV, V17, P165, DOI 10.1093/oxfordjournals.epirev.a036172; Orr ST, 2002, AM J EPIDEMIOL, V156, P797, DOI 10.1093/aje/kwf131; Pompeii LA, 2005, OBSTET GYNECOL, V106, P1279, DOI 10.1097/01.AOG.0000189080.76998.f8; Porter TF, 1997, OBSTET GYNECOL, V90, P63, DOI 10.1016/S0029-7844(97)00215-9; Ramsey PS, 2003, CLIN PERINATOL, V30, P701, DOI 10.1016/S0095-5108(03)00109-X; RELMAN DA, 1990, NEW ENGL J MED, V323, P1573, DOI 10.1056/NEJM199012063232301; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P118, DOI 10.1111/j.1471-0528.2006.01150.x; Romero R, 1998, AM J OBSTET GYNECOL, V179, P186, DOI 10.1016/S0002-9378(98)70271-6; ROMERO R, 1988, AM J OBSTET GYNECOL, V159, P661, DOI 10.1016/S0002-9378(88)80030-9; ROMERO R, 1989, OBSTET GYNECOL, V73, P576; ROMERO R, 1989, AM J OBSTET GYNECOL, V161, P817, DOI 10.1016/0002-9378(89)90409-2; Russel P., 1979, AM J DIAG GYN OBSTET, V1, P127; SAIGAL S, IN PRESS LANCET; Saurel-Cubizolles MJ, 2004, J EPIDEMIOL COMMUN H, V58, P395, DOI 10.1136/jech.2003.008029; Schoenborn C A, 1993, Adv Data, P1; Scholl TO, 2005, AM J CLIN NUTR, V81, p1218S; Sfakianaki AK, 2006, J MATERN-FETAL NEO M, V19, P763, DOI 10.1080/14767050600949829; SHELDON J, 1993, CLIN CHEM, V39, P147; Slattery MM, 2002, LANCET, V360, P1489, DOI 10.1016/S0140-6736(02)11476-0; Smith GCS, 2003, BRIT MED J, V327, P313, DOI 10.1136/bmj.327.7410.313; Smith LK, 2007, ARCH DIS CHILD-FETAL, V92, pF11, DOI 10.1136/adc.2005.090308; Srinivas SK, 2006, AM J OBSTET GYNECOL, V195, P797, DOI 10.1016/j.ajog.2006.05.049; Steel JH, 2005, PEDIATR RES, V57, P404, DOI 10.1203/01.PDR.0000153869.96337.90; SWEET RL, 1987, AM J OBSTET GYNECOL, V156, P824, DOI 10.1016/0002-9378(87)90338-3; TAMURA T, 1992, AM J CLIN NUTR, V56, P365, DOI 10.1093/ajcn/56.2.365; Thompson JMD, 2006, PAEDIATR PERINAT EP, V20, P182, DOI 10.1111/j.1365-3016.2006.00711.x; Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P2167, DOI 10.1161/01.ATV.17.10.2167; Tu FF, 1998, OBSTET GYNECOL, V92, P446, DOI 10.1016/S0029-7844(98)00222-1; TUCKER JM, 1991, OBSTET GYNECOL, V77, P343; Wadhwa P D, 2001, Matern Child Health J, V5, P119, DOI 10.1023/A:1011353216619; Wadhwa PD, 2001, PAEDIATR PERINAT EP, V15, P17, DOI 10.1046/j.1365-3016.2001.00005.x; Wang XB, 2002, JAMA-J AM MED ASSOC, V287, P195, DOI 10.1001/jama.287.2.195; WATTS DH, 1992, OBSTET GYNECOL, V79, P351; Wenstrom KD, 1998, OBSTET GYNECOL, V92, P420, DOI 10.1016/S0029-7844(98)00210-5; Winkvist A, 1998, INT J EPIDEMIOL, V27, P248, DOI 10.1093/ije/27.2.248; Yoon BH, 2000, AM J OBSTET GYNECOL, V182, P675, DOI 10.1067/mob.2000.104207; Yoon BH, 2003, AM J OBSTET GYNECOL, V189, P919, DOI 10.1067/S0002-9378(03)00839-1; Yoon BH, 1999, AM J OBSTET GYNECOL, V181, P773, DOI 10.1016/S0002-9378(99)70299-1; Yoon BH, 1996, AM J OBSTET GYNECOL, V174, P1433, DOI 10.1016/S0002-9378(96)70585-9; ZUCKERMAN B, 1989, AM J OBSTET GYNECOL, V160, P1107, DOI 10.1016/0002-9378(89)90170-1; 2001, NAT GENET, V27, P227	138	4495	4701	16	597	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 5	2008	371	9606					75	84		10.1016/S0140-6736(08)60074-4	http://dx.doi.org/10.1016/S0140-6736(08)60074-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248YH	18177778	Bronze, Green Published			2022-12-28	WOS:000252192600033
J	Schlegel, T; Schuster, S				Schlegel, Thomas; Schuster, Stefan			Small circuits for large tasks: High-speed decision-making in archerfish	SCIENCE			English	Article							NEURAL BASIS; FISH LEARN; REPRESENTATION; OBJECT; MOTION	The enormous progress made in functional magnetic resonance imaging technology allows us to watch our brains engage in complex cognitive and social tasks. However, our understanding of what actually is computed in the underlying cellular networks is hindered by the vast numbers of neurons involved. Here, we describe a vertebrate system, shaped for top speed, in which a complex and plastic decision is performed by surprisingly small circuitry that can be studied at cellular resolution.	[Schlegel, Thomas; Schuster, Stefan] Univ Erlangen Nurnberg, Inst Zool 2, D-91058 Erlangen, Germany	University of Erlangen Nuremberg	Schuster, S (corresponding author), Univ Erlangen Nurnberg, Inst Zool 2, Staudtstr 5, D-91058 Erlangen, Germany.	sschuste@biologie.uni-erlangen.de		Schuster, Stefan/0000-0002-0873-8996				Berry MJ, 1999, NATURE, V398, P334, DOI 10.1038/18678; Canfield JG, 2007, J COMP PHYSIOL A, V193, P1055, DOI 10.1007/s00359-007-0258-2; Canfield JG, 2006, BRAIN BEHAV EVOLUT, V67, P188, DOI 10.1159/000091652; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; DILL LM, 1977, BEHAV ECOL SOCIOBIOL, V2, P169, DOI 10.1007/BF00361900; Fetcho JR, 2004, CURR OPIN NEUROBIOL, V14, P707, DOI 10.1016/j.conb.2004.10.008; Fetcho JR, 1997, CURR OPIN NEUROBIOL, V7, P832, DOI 10.1016/S0959-4388(97)80143-2; GUTHRIE DM, 1990, VISUAL NEUROSCI, V4, P367, DOI 10.1017/S0952523800004570; Hosoya T, 2005, NATURE, V436, P71, DOI 10.1038/nature03689; Korn H, 2005, NEURON, V47, P13, DOI 10.1016/j.neuron.2005.05.019; LENNIE P, 1981, VISION RES, V21, P815, DOI 10.1016/0042-6989(81)90180-2; Nelissen K, 2005, SCIENCE, V310, P332, DOI 10.1126/science.1115593; Olveczky BP, 2003, NATURE, V423, P401, DOI 10.1038/nature01652; Preuss T, 2006, J NEUROSCI, V26, P3454, DOI 10.1523/JNEUROSCI.5259-05.2006; Rossel S, 2002, J EXP BIOL, V205, P3321; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; SCHNAPF JL, 1987, NATURE, V325, P439, DOI 10.1038/325439a0; Schuster S, 2006, CURR BIOL, V16, P378, DOI 10.1016/j.cub.2005.12.037; Schuster S, 2004, CURR BIOL, V14, P1565, DOI 10.1016/j.cub.2004.08.050; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Wohl S, 2007, J EXP BIOL, V210, P311, DOI 10.1242/jeb.02646; Wohl S, 2006, J EXP BIOL, V209, P141, DOI 10.1242/jeb.01981; ZOTTOLI SJ, 1987, BRAIN RES, V401, P113, DOI 10.1016/0006-8993(87)91170-X	23	59	59	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2008	319	5859					104	106		10.1126/science.1149265	http://dx.doi.org/10.1126/science.1149265			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18174445				2022-12-28	WOS:000252084000042
J	Brandman, O; Liou, J; Park, WS; Meyer, T				Brandman, Onn; Liou, Jen; Park, Wei Sun; Meyer, Tobias			STIM2 is a feedback regulator that stabilizes basal cytosolic and endoplasmic reticulum Ca2+ levels	CELL			English	Article							STROMAL INTERACTION MOLECULE-1; PLASMA-MEMBRANE; CHANNEL FUNCTION; STORE DEPLETION; CRAC CHANNEL; CALCIUM; DISEASE; HOMEOSTASIS; ORAI1; SENSOR	Deviations in basal Ca2+ levels interfere with receptor-mediated Ca2+ signaling as well as endoplasmic reticulum ( ER) and mitochondrial function. While defective basal Ca2+ regulation has been linked to various diseases, the regulatory mechanism that controls basal Ca2+ is poorly understood. Here we performed an siRNA screen of the human signaling proteome to identify regulators of basal Ca2+ concentration and found STIM2 as the strongest positive regulator. In contrast to STIM1, a recently discovered signal transducer that triggers Ca2+ influx in response to receptor-mediated depletion of ER Ca2+ stores, STIM2 activated Ca2+ influx upon smaller decreases in ER Ca2+. STIM2, like STIM1, caused Ca2+ influx via activation of the plasma membrane Ca2+ channel Orai1. Our study places STIM2 at the center of a feedback module that keeps basal cytosolic and ER Ca2+ concentrations within tight limits.	[Brandman, Onn; Liou, Jen; Park, Wei Sun; Meyer, Tobias] Stanford Univ, Dept Chem & Syst Biol, Biox Clark Ctr W200, Stanford, CA 94305 USA	Stanford University	Brandman, O (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Biox Clark Ctr W200, Stanford, CA 94305 USA.	onn@stanford.edu; tobias1@stanford.edu	Liou, Jen/AAN-1105-2021	Meyer, Tobias/0000-0003-4339-3804	NCI NIH HHS [R33 CA083229-05] Funding Source: Medline; NIGMS NIH HHS [R01 GM030179, GM030179, R01 GM030179-26, R37 GM030179] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R33CA083229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030179, R01GM030179] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bezprozvanny I, 2004, BIOCHEM BIOPH RES CO, V322, P1310, DOI 10.1016/j.bbrc.2004.08.035; Brini M, 1999, MICROSC RES TECHNIQ, V46, P380, DOI 10.1002/(SICI)1097-0029(19990915)46:6<380::AID-JEMT6>3.0.CO;2-Y; Camello C, 2002, CELL CALCIUM, V32, P355, DOI 10.1016/S0143416002001926; Campanella M, 2004, BIOL RES, V37, P653; Dziadek MA, 2007, CELL CALCIUM, V42, P123, DOI 10.1016/j.ceca.2007.02.006; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guerini D, 2005, CELL CALCIUM, V38, P281, DOI 10.1016/j.ceca.2005.06.032; Kusters JMAM, 2005, BIOPHYS J, V89, P3741, DOI 10.1529/biophysj.105.062984; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Montero M, 2001, CELL CALCIUM, V30, P181, DOI 10.1054/ceca.2001.0224; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Periasamy M, 2007, MUSCLE NERVE, V35, P430, DOI 10.1002/mus.20745; Philipson KD, 2002, ANN NY ACAD SCI, V976, P1; Pinton P, 2006, CELL DEATH DIFFER, V13, P1409, DOI 10.1038/sj.cdd.4401960; Raza M, 2007, NEUROSCI LETT, V418, P77, DOI 10.1016/j.neulet.2007.03.005; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Schulman Ivonne Hernandez, 2005, Aging Clin Exp Res, V17, P40; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Spira ME, 2001, CELL MOL NEUROBIOL, V21, P591, DOI 10.1023/A:1015135617557; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Strehler EE, 2007, ANN NY ACAD SCI, V1099, P226, DOI 10.1196/annals.1387.023; Ter Keurs HEDJ, 2007, PHYSIOL REV, V87, P457, DOI 10.1152/physrev.00011.2006; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Thebault S, 2006, ADV CHRONIC KIDNEY D, V13, P110, DOI 10.1053/j.ackd.2006.01.002; Treves S, 2005, NEUROMUSCULAR DISORD, V15, P577, DOI 10.1016/j.nmd.2005.06.008; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yu R, 2000, J BIOL CHEM, V275, P23648, DOI 10.1074/jbc.M002684200; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec	37	516	531	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 28	2007	131	7					1327	1339		10.1016/j.cell.2007.11.039	http://dx.doi.org/10.1016/j.cell.2007.11.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GV	18160041	Green Accepted, Bronze			2022-12-28	WOS:000252217200021
J	Burton, BM; Marquis, KA; Sullivan, NL; Rapoport, TA; Rudner, DZ				Burton, Briana M.; Marquis, Kathleen A.; Sullivan, Nora L.; Rapoport, Tom A.; Rudner, David Z.			The ATPase SpoIIIE transports DNA across fused septal membranes during sporulation in Bacillus subtilis	CELL			English	Article							ASYMMETRIC CELL-DIVISION; ESCHERICHIA-COLI; GENE-EXPRESSION; CHROMOSOME SEGREGATION; BACTERIAL CONJUGATION; MOTHER CELL; SUBCELLULAR-LOCALIZATION; PROTEIN; FTSK; TRANSLOCASE	The FtsK/SpoIIIE family of ATP-dependent DNA transporters mediates proper chromosome segregation in dividing bacteria. In sporulating Bacillus subtilis cells, SpoIIIE translocates much of the circular chromosome from the mother cell into the forespore, but the molecular mechanism remains unclear. Using a new assay to monitor DNA transport, we demonstrate that the two arms of the chromosome are simultaneously pumped into the forespore. Up to 70 molecules of SpoIIIE are recruited to the site of DNA translocation and assemble into complexes that could contain 12 subunits. The fusion of the septal membranes during cytokinesis precedes DNA translocation and does not require SpoIIIE, as suggested by analysis of lipid dynamics, serial thin-section electron microscopy, and cell separation by protoplasting. These data support a model for DNA transport in which the transmembrane segments of FtsK/SpoIIIE form linked DNA-conducting channels across the two lipid bilayers of the septum.	[Burton, Briana M.; Rapoport, Tom A.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Marquis, Kathleen A.; Sullivan, Nora L.; Rudner, David Z.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Rapoport, Tom A.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Rapoport, TA (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	tom_rapoport@hms.harvard.edu; rudner@hms.harvard.edu			NIGMS NIH HHS [R01 GM073831, R01 GM073831-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073831] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aussel L, 2002, CELL, V108, P195, DOI 10.1016/S0092-8674(02)00624-4; Bartosik AA, 2005, ACTA BIOCHIM POL, V52, P1; Bath J, 2000, SCIENCE, V290, P995, DOI 10.1126/science.290.5493.995; Ben-Yehuda S, 2003, CURR BIOL, V13, P2196, DOI 10.1016/S0960-9822(03)00912-6; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; Bigot S, 2007, MOL MICROBIOL, V64, P1434, DOI 10.1111/j.1365-2958.2007.05755.x; Bigot S, 2006, NAT STRUCT MOL BIOL, V13, P1026, DOI 10.1038/nsmb1159; Britton RA, 1999, J BACTERIOL, V181, P5860, DOI 10.1128/JB.181.18.5860-5864.1999; Broder DH, 2006, CELL, V126, P917, DOI 10.1016/j.cell.2006.06.053; Cabezon E, 2006, RES MICROBIOL, V157, P299, DOI 10.1016/j.resmic.2005.12.002; Chary VK, 2003, J BACTERIOL, V185, P879, DOI 10.1128/JB.185.3.879-886.2003; Chen I, 2005, SCIENCE, V310, P1456, DOI 10.1126/science.1114021; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Corre J, 2005, MOL MICROBIOL, V56, P1539, DOI 10.1111/j.1365-2958.2005.04633.x; Dworkin J, 2001, CELL, V107, P339, DOI 10.1016/S0092-8674(01)00528-1; Errington J, 2001, NAT REV MOL CELL BIO, V2, P538, DOI 10.1038/35080005; Errington J, 2001, CURR OPIN MICROBIOL, V4, P660, DOI 10.1016/S1369-5274(01)00266-1; Frandsen N, 1999, GENE DEV, V13, P394, DOI 10.1101/gad.13.4.394; Gomis-Ruth FX, 2001, NATURE, V409, P637, DOI 10.1038/35054586; Gomis-Ruth FX, 2001, INT J BIOCHEM CELL B, V33, P839, DOI 10.1016/S1357-2725(01)00060-7; Gunton JE, 2007, MICROBIOL-SGM, V153, P428, DOI 10.1099/mic.0.2006/001297-0; Harwood C.R., 1990, MOL BIOL METHODS BAC; Hilbert DW, 2004, J BACTERIOL, V186, P1983, DOI 10.1128/JB.186.7.1983-1990.2004; HILLEN W, 1994, ANNU REV MICROBIOL, V48, P345, DOI 10.1146/annurev.mi.48.100194.002021; Iyer LM, 2004, NUCLEIC ACIDS RES, V32, P5260, DOI 10.1093/nar/gkh828; Khvorova A, 2000, J BACTERIOL, V182, P4425, DOI 10.1128/JB.182.16.4425-4429.2000; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Levy O, 2005, P NATL ACAD SCI USA, V102, P17618, DOI 10.1073/pnas.0508932102; Li ZH, 2001, P NATL ACAD SCI USA, V98, P12538, DOI 10.1073/pnas.221454798; Liu NJL, 2006, MOL MICROBIOL, V59, P1097, DOI 10.1111/j.1365-2958.2005.05004.x; Massey TH, 2006, MOL CELL, V23, P457, DOI 10.1016/j.molcel.2006.06.019; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; NESMEYANOVA MA, 1982, FEBS LETT, V142, P189, DOI 10.1016/0014-5793(82)80131-2; Pease PJ, 2005, SCIENCE, V307, P586, DOI 10.1126/science.1104885; Pogliano J, 1999, MOL MICROBIOL, V31, P1149, DOI 10.1046/j.1365-2958.1999.01255.x; Pogliano K, 1997, J BACTERIOL, V179, P3331, DOI 10.1128/jb.179.10.3331-3341.1997; Preble AM, 2001, GENETICS, V157, P163; Rudner DZ, 2002, P NATL ACAD SCI USA, V99, P8701, DOI 10.1073/pnas.132235899; Rudner DZ, 2002, GENE DEV, V16, P1007, DOI 10.1101/gad.977702; Sharp MD, 1999, P NATL ACAD SCI USA, V96, P14553, DOI 10.1073/pnas.96.25.14553; Sharp MD, 2002, SCIENCE, V295, P137, DOI 10.1126/science.1066274; Sharp MD, 2003, J BACTERIOL, V185, P2005, DOI 10.1128/JB.185.6.2005-2008.2003; SHARPE ME, 1995, P NATL ACAD SCI USA, V92, P8630, DOI 10.1073/pnas.92.19.8630; Wang ST, 2006, J MOL BIOL, V358, P16, DOI 10.1016/j.jmb.2006.01.059; WU LJ, 1995, GENE DEV, V9, P1316, DOI 10.1101/gad.9.11.1316; Wu LJ, 1998, MOL MICROBIOL, V27, P777, DOI 10.1046/j.1365-2958.1998.00724.x; WU LJ, 1994, SCIENCE, V264, P572, DOI 10.1126/science.8160014; Wu LJ, 1997, EMBO J, V16, P2161, DOI 10.1093/emboj/16.8.2161; YOUNGMAN PJ, 1983, P NATL ACAD SCI-BIOL, V80, P2305, DOI 10.1073/pnas.80.8.2305; Yu XC, 1998, J BACTERIOL, V180, P1296, DOI 10.1128/JB.180.5.1296-1304.1998; Zupancic ML, 2001, MOL MICROBIOL, V39, P1471, DOI 10.1046/j.1365-2958.2001.02331.x	51	98	99	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 28	2007	131	7					1301	1312		10.1016/j.cell.2007.11.009	http://dx.doi.org/10.1016/j.cell.2007.11.009			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GV	18160039	Bronze, Green Accepted			2022-12-28	WOS:000252217200019
J	Okada, T; Ohzeki, JI; Nakano, M; Yoda, K; Brinkley, WR; Larionov, V; Masumoto, H				Okada, Teruaki; Ohzeki, Jun-Ichirou; Nakano, Megumi; Yoda, Kinya; Brinkley, William R.; Larionov, Vladimir; Masumoto, Hiroshi			CENP-B controls centromere formation depending on the chromatin context	CELL			English	Article							ARTIFICIAL CHROMOSOME FORMATION; HISTONE H3 METHYLTRANSFERASE; ALPHA-SATELLITE ARRAY; DNA METHYLATION; NULL MICE; PROTEIN; COMPLEX; HETEROCHROMATIN; KINETOCHORE; IDENTIFICATION	The centromere is a chromatin region that serves as the spindle attachment point and directs accurate inheritance of eukaryotic chromosomes during cell divisions. However, the mechanism by which the centromere assembles and stabilizes at a specific genomic region is not clear. The de novo formation of a human/mammalian artificial chromosome (HAC/MAC) with a functional centromere assembly requires the presence of alpha-satellite DNA containing binding motifs for the centromeric CENP-B protein. We demonstrate here that de novo centromere assembly on HAC/MAC is dependent on CENP-B. In contrast, centromere formation is suppressed in cells expressing CENP-B when alpha-satellite DNA was integrated into a chromosomal site. Remarkably, on those integration sites CENP-B enhances histone H3-K9 trimethylation and DNA methylation, thereby stimulating heterochromatin formation. Thus, we propose that CENP-B plays a dual role in centromere formation, ensuring de novo formation on DNA lacking a functional centromere but preventing the formation of excess centromeres on chromosomes.	[Okada, Teruaki; Masumoto, Hiroshi] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Ohzeki, Jun-Ichirou; Nakano, Megumi; Larionov, Vladimir; Masumoto, Hiroshi] NCI, Mol Pharmacol Lab, Natl Inst Hlth, Bethesda, MD 20892 USA; [Yoda, Kinya] Nagoya Univ, Biosci & Biotechnol Ctr, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Brinkley, William R.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Nagoya University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Nagoya University; Baylor College of Medicine	Masumoto, H (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	g44478a@nucc.cc.nagoya-u.ac.jp			Intramural NIH HHS [NIH0011582802] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ando S, 2002, MOL CELL BIOL, V22, P2229, DOI 10.1128/MCB.22.7.2229-2241.2002; Chan GK, 2005, TRENDS CELL BIOL, V15, P589, DOI 10.1016/j.tcb.2005.09.010; Choo KHA, 2001, DEV CELL, V1, P165, DOI 10.1016/S1534-5807(01)00028-4; EARNSHAW WC, 1987, J CELL BIOL, V104, P817, DOI 10.1083/jcb.104.4.817; EARNSHAW WC, 1989, CHROMOSOMA, V98, P1, DOI 10.1007/BF00293329; Ebersole TA, 2000, HUM MOL GENET, V9, P1623, DOI 10.1093/hmg/9.11.1623; Edwards NS, 2005, MOL BIOL CELL, V16, P1800, DOI 10.1091/mbc.e04-09-0788; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Goshima G, 2003, J CELL BIOL, V160, P25, DOI 10.1083/jcb.200210005; Grimes BR, 2002, MOL THER, V5, P798, DOI 10.1006/mthe.2002.0612; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; Harrington JJ, 1997, NAT GENET, V15, P345, DOI 10.1038/ng0497-345; Howman EV, 2000, P NATL ACAD SCI USA, V97, P1148, DOI 10.1073/pnas.97.3.1148; Hudson DF, 1998, J CELL BIOL, V141, P309, DOI 10.1083/jcb.141.2.309; Ikeno M, 1998, NAT BIOTECHNOL, V16, P431, DOI 10.1038/nbt0598-431; Izuta H, 2006, GENES CELLS, V11, P673, DOI 10.1111/j.1365-2443.2006.00969.x; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Kapoor M, 1998, CHROMOSOMA, V107, P570, DOI 10.1007/s004120050343; KIPLING D, 1995, MOL CELL BIOL, V15, P4009; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Lam AL, 2006, P NATL ACAD SCI USA, V103, P4186, DOI 10.1073/pnas.0507947103; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; MASUMOTO H, 1989, J CELL BIOL, V109, P1963, DOI 10.1083/jcb.109.5.1963; Mejia JE, 2001, AM J HUM GENET, V69, P315, DOI 10.1086/321977; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; MURO Y, 1992, J CELL BIOL, V116, P585, DOI 10.1083/jcb.116.3.585; Nakagawa H, 2002, GENE DEV, V16, P1766, DOI 10.1101/gad.997702; Nakashima H, 2005, J CELL SCI, V118, P5885, DOI 10.1242/jcs.02702; Ohzeki J, 2002, J CELL BIOL, V159, P765, DOI 10.1083/jcb.200207112; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Okamoto Y, 2007, EMBO J, V26, P1279, DOI 10.1038/sj.emboj.7601584; Perez-Castro AV, 1998, DEV BIOL, V201, P135, DOI 10.1006/dbio.1998.9005; PLUTA AF, 1992, J CELL BIOL, V116, P1081, DOI 10.1083/jcb.116.5.1081; Spence JM, 2002, EMBO J, V21, P5269, DOI 10.1093/emboj/cdf511; SULLIVAN BA, 1995, HUM MOL GENET, V4, P2189, DOI 10.1093/hmg/4.12.2189; Sullivan BA, 2001, NAT REV GENET, V2, P584, DOI 10.1038/35084512; Sullivan KF, 2001, CURR OPIN GENET DEV, V11, P182, DOI 10.1016/S0959-437X(00)00177-5; Suzuki N, 2004, J BIOL CHEM, V279, P5934, DOI 10.1074/jbc.M306477200; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tanaka Y, 2005, J BIOL CHEM, V280, P41609, DOI 10.1074/jbc.M509666200; Tanaka Y, 2005, FEBS J, V272, P282, DOI 10.1111/j.1432-1033.2004.04406.x; Vafa O, 1999, CHROMOSOMA, V108, P367, DOI 10.1007/s004120050388; Warburton PE, 1997, CURR BIOL, V7, P901, DOI 10.1016/S0960-9822(06)00382-4; YODA K, 1992, J CELL BIOL, V119, P1413, DOI 10.1083/jcb.119.6.1413	45	173	179	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 28	2007	131	7					1287	1300		10.1016/j.cell.2007.10.045	http://dx.doi.org/10.1016/j.cell.2007.10.045			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GV	18160038	Bronze			2022-12-28	WOS:000252217200018
J	Cauley, JA; Hochberg, MC; Lui, LY; Palermo, L; Ensrud, KE; Hillier, TA; Nevitt, MC; Cummings, SR				Cauley, Jane A.; Hochberg, Marc C.; Lui, Li-Yung; Palermo, Lisa; Ensrud, Kristine E.; Hillier, Teresa A.; Nevitt, Michael C.; Cummings, Steven R.			Long-term risk of incident vertebral fractures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EUROPEAN PROSPECTIVE OSTEOPOROSIS; POSTMENOPAUSAL WOMEN; NONVERTEBRAL FRACTURES; OLDER WOMEN; EPIDEMIOLOGY; MORTALITY; TRIAL; MEN; POPULATION; PREDICTION	Context Vertebral fractures are the most common osteoporotic fracture. Women with low bone mineral density ( BMD) and prevalent vertebral fractures have a greater risk of incident vertebral fractures over the short- term, but their absolute risk of vertebral fracture over the long- term is uncertain. Objective To examine the absolute risk of incident vertebral fracture by BMD and prevalent vertebral fracture status over 15 years. Design, Setting, and Participants A total of 9704 white women were recruited at 4 US clinical centers and enrolled in the Study of Osteoporotic Fractures, a longitudinal cohort study. Of these, 2680 attended a clinic visit an average of 14.9 years after baseline; mean age of 68.8 years at entry and 83.8 years at follow- up. Mean Outcome Measure Incident vertebral fractures identified from lateral spinal radiographs defined as a decrease of at least 20% and 4 mm at any vertebral level. Prevalent vertebral fractures were identified on the baseline radiographs using vertebral morphometry. Bone mineral density was measured at the total hip and lumbar spine using dual- energy x- ray absorptiometry. Results Of the 2680 women, 487 ( 18.2%) had an incident vertebral fracture including 163 of the 394 ( 41.4%) with a prevalent vertebral fracture at baseline and 324 of the 2286 ( 14.2%) without a prevalent vertebral fracture at baseline ( odds ratio, 4.21; 95% confidence interval, 3.33- 5.34). Low BMD was associated with an increased risk of incident vertebral fracture ( odds ratio per 1 SD decrease in total hip BMD, 1.78 [ 95% confidence interval, 1.58- 2.00]). The absolute risk of vertebral fracture ranged from 56% among women with total hip BMD T score of - 2.5 or less and a prevalent vertebral fracture to 9% in women with normal BMD and no prevalent vertebral fracture. Conclusions Low BMD and prevalent vertebral fractures are independently related to new vertebral fractures over 15 years of follow- up. Women with a prevalent vertebral fracture have a substantially increased absolute risk of an incident fracture, especially if they have osteoporosis diagnosed by BMD.	Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; Univ Maryland, Med Ctr, Dept Med, Baltimore, MD 21201 USA; Calif Pacific Med Ctr, San Francisco Coordinating Ctr, San Francisco, CA USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Minneapolis VA Med Ctr, Dept Med, Minneapolis, MN USA; Kaiser Permanente Ctr Hlth Res NW Hawaii, Portland, OR USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Maryland; University of Maryland Baltimore; California Pacific Medical Center; California Pacific Medical Center Research Institute; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; Kaiser Permanente	Cauley, JA (corresponding author), Univ Pittsburgh, Dept Epidemiol, 130 DeSoto St,Crabtree A524, Pittsburgh, PA 15261 USA.	jcauley@edc.pitt.edu	Cauley, Jane A/N-4836-2015	Cauley, Jane A/0000-0003-0752-4408; Ensrud, Kristine/0000-0002-9069-3036	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035584, R01AR035583, R01AR035582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027576, R01AG005394, R01AG005407, R01AG027574] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR35583, AR35584, AR35582] Funding Source: Medline; NIA NIH HHS [R01 AG005407, 2 R01 AG005394-22A1, AG05407, AG05394, 2 R01 AG027574-22A1, R01 AG027576-22] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Black DM, 1999, J BONE MINER RES, V14, P90, DOI 10.1359/jbmr.1999.14.1.90; BLACK DM, 1995, J BONE MINER RES, V10, P890; Black DM, 1999, J BONE MINER RES, V14, P821, DOI 10.1359/jbmr.1999.14.5.821; BLACK DM, 1991, J BONE MINER RES, V6, P883; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Cauley JA, 2000, OSTEOPOROSIS INT, V11, P556, DOI 10.1007/s001980070075; COOPER C, 1993, BONE, V14, pS89; COOPER C, 1992, J BONE MINER RES, V7, P221, DOI 10.1002/jbmr.5650070214; CUMMINGS SR, 1995, J BONE MINER RES, V10, P518; Delmas PD, 2003, BONE, V33, P522, DOI 10.1016/S8756-3282(03)00241-2; Delmas PD, 2005, J BONE MINER RES, V20, P557, DOI 10.1359/JBMR.041214; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Genant HK, 2007, OSTEOPOROSIS INT, V18, P69, DOI 10.1007/s00198-006-0199-6; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; Jalava T, 2003, J BONE MINER RES, V18, P1254, DOI 10.1359/jbmr.2003.18.7.1254; Kado DM, 1999, ARCH INTERN MED, V159, P1215, DOI 10.1001/archinte.159.11.1215; Kado DM, 2003, OSTEOPOROSIS INT, V14, P589, DOI 10.1007/s00198-003-1412-5; Kanis JA, 2007, OSTEOPOROSIS INT, V18, P1033, DOI 10.1007/s00198-007-0343-y; Kaptoge S, 2006, OSTEOPOROSIS INT, V17, P1369, DOI 10.1007/s00198-005-0067-9; Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721; Lewiecki EM, 2006, J CLIN ENDOCR METAB, V91, P4215, DOI 10.1210/jc.2006-1178; Lindsay R, 2005, OSTEOPOROSIS INT, V16, P306, DOI 10.1007/s00198-004-1691-5; Looker AC, 1997, J BONE MINER RES, V12, P1761, DOI 10.1359/jbmr.1997.12.11.1761; Melton LJ, 1999, OSTEOPOROSIS INT, V10, P214, DOI 10.1007/s001980050218; Melton LJ, 1997, SPINE, V22, p2S, DOI 10.1097/00007632-199712151-00002; MELTON LJ, 1989, AM J EPIDEMIOL, V129, P1000, DOI 10.1093/oxfordjournals.aje.a115204; Nevitt MC, 2005, J BONE MINER RES, V20, P131, DOI 10.1359/JBMR.041003; Nevitt MC, 1998, ANN INTERN MED, V128, P793, DOI 10.7326/0003-4819-128-10-199805150-00001; Oleksik A, 2000, J BONE MINER RES, V15, P1384, DOI 10.1359/jbmr.2000.15.7.1384; Rockhill B, 2001, J NATL CANCER I, V93, P358, DOI 10.1093/jnci/93.5.358; ROSS PD, 1991, ANN INTERN MED, V114, P919, DOI 10.7326/0003-4819-114-11-919; Roy DK, 2003, OSTEOPOROSIS INT, V14, P19, DOI 10.1007/s00198-002-1317-8; Samelson EJ, 2006, J BONE MINER RES, V21, P1207, DOI 10.1359/JBMR.060513; Siris ES, 2006, OSTEOPOROSIS INT, V17, P565, DOI 10.1007/s00198-005-0027-4; Stone KL, 2003, J BONE MINER RES, V18, P1947, DOI 10.1359/jbmr.2003.18.11.1947; van der Klift M, 2004, J BONE MINER RES, V19, P1172, DOI 10.1359/JBMR.040215; Wainwright SA, 2005, J CLIN ENDOCR METAB, V90, P2787, DOI 10.1210/jc.2004-1568; Wasnich RD, 1996, BONE, V18, pS179, DOI 10.1016/8756-3282(95)00499-8	39	163	172	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2007	298	23					2761	2767		10.1001/jama.298.23.2761	http://dx.doi.org/10.1001/jama.298.23.2761			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242HK	18165669	Bronze			2022-12-28	WOS:000251716000021
J	Slot, KB; Berge, E; Dorman, P; Lewis, S; Dennis, M; Sandercock, P				Slot, Karsten Bruins; Berge, Eivind; Dorman, Paul; Lewis, Steff; Dennis, Martin; Sandercock, Peter		Oxfordshire Community Stroke Proje; Int Stroke Trial; Lothiar Stroke Register	Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies	BRITISH MEDICAL JOURNAL			English	Article							COMMUNITY-STROKE; CASE-FATALITY; ATRIAL-FIBRILLATION; RANDOMIZED-TRIAL; SIMPLE QUESTIONS; SUBTYPES; EPIDEMIOLOGY; PROJECT; REGISTRY; METHODOLOGY	Objective To estimate the impact on long term survival of functional status at six months after ischaemic stroke. Design Prospective cohort study. Settings Three cohorts: Oxfordshire community stroke project, Lothian stroke register, and the first international stroke trial (in the United Kingdom). Participants 7710 patients with ischaemic stroke registered between 1981 and 2000 and followed up for a maximum of 19 years. Main outcome measures Functional status at six months after stroke assessed with modified Rankin scale or "two simple questions." Mortality during follow-up. Survival analysis with Kaplan-Meier curves, log rank test, and Cox's regression model. Results In a combined analysis of all three cohorts, among patients who survived to assessment six months after the index stroke, the subsequent median length of survival among those independent in daily living and those dependent was 9.7 years (95% conifidence interval 8.9 to 10.6) and 6.0 years (5.7 to 6.4), respectively. In a combined analysis of the Oxfordshire and Lothian cohorts, subsequent median survival felt progressively from 12.9 years (10.0 to 15.9) for patients with. a Rankin score of 0-1 at six months after the stroke to 2.5 years (1.4 to 3.5) for patients with a Rankin score of 5. All previously stated differences in median survival were significant (log rank test P<0.001). The influence of functional outcome on survival remained significant (P<0.05) in each cohort after adjustment for relevant covariates (such as age, presence of atrial fibrillation, visible infarct on computed tomography, subtype of stroke) in a Cox's regression model. Conclusion Functional status six months after an ischaemic stroke is associated with long term survival. Early interventions that reduce dependency at six months might have positive effects on long term survival.	[Slot, Karsten Bruins; Berge, Eivind] Ullevaal Univ Hosp, Dept Internal Med, NO-0407 Oslo, Norway; [Dorman, Paul] Newcastle Gen Hosp, Dept Neurol, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; [Lewis, Steff; Dennis, Martin; Sandercock, Peter] Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland	University of Oslo; Newcastle General Hospital; University of Edinburgh	Slot, KB (corresponding author), Ullevaal Univ Hosp, Dept Internal Med, NO-0407 Oslo, Norway.	karsten.bruins.slot@medisin.uio.no		Sandercock, Peter/0000-0001-8484-0135; dennis, martin/0000-0003-1148-8972; Lewis, Steff/0000-0003-1210-2314				BAMFORD J, 1988, J NEUROL NEUROSUR PS, V51, P1373, DOI 10.1136/jnnp.51.11.1373; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; BONITA R, 1992, LANCET, V339, P342, DOI 10.1016/0140-6736(92)91658-U; Carolei A, 1997, STROKE, V28, P2500, DOI 10.1161/01.STR.28.12.2500; Carter KN, 2007, CEREBROVASC DIS, V23, P162, DOI 10.1159/000097054; Dennis M, 1997, CEREBROVASC DIS, V7, P22, DOI 10.1159/000108159; Dewey HM, 2003, CEREBROVASC DIS, V15, P133, DOI 10.1159/000067142; Di Carlo A, 2006, J NEUROL SCI, V244, P143, DOI 10.1016/j.jns.2006.01.016; Ellekjaer H, 1997, STROKE, V28, P2180, DOI 10.1161/01.STR.28.11.2180; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Gerzeli S, 2005, NEUROL SCI, V26, P72, DOI 10.1007/s10072-005-0439-0; HATTON TJ, 2003, EMIGRATION UK 1870 1; Jamrozik K, 1999, STROKE, V30, P2105, DOI 10.1161/01.STR.30.10.2105; Johansson B, 2000, STROKE, V31, P481, DOI 10.1161/01.STR.31.2.481; Jorgensen HS, 1996, STROKE, V27, P1765, DOI 10.1161/01.STR.27.10.1765; Kolominsky-Rabas PL, 2006, STROKE, V37, P1179, DOI 10.1161/01.STR.0000217450.21310.90; Kolominsky-Rabas PL, 2001, STROKE, V32, P2735, DOI 10.1161/hs1201.100209; LAURIA G, 1995, STROKE, V26, P1787, DOI 10.1161/01.STR.26.10.1787; Lin HJ, 1996, STROKE, V27, P1760, DOI 10.1161/01.STR.27.10.1760; LINDLEY RI, 1994, CEREBROVASC DIS, V4, P314, DOI 10.1159/000108501; *OFF NAT STAT, IMPL 2001 CENS REP; Samsa GP, 1999, J CLIN EPIDEMIOL, V52, P259, DOI 10.1016/S0895-4356(98)00151-6; Samsa GP, 2001, STROKE, V32, P669, DOI 10.1161/01.STR.32.3.669; Sandercock P, 1997, LANCET, V349, P1569; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Smadja D, 2001, STROKE, V32, P2741, DOI 10.1161/hs1201.099385; Spieler JF, 2004, CEREBROVASC DIS, V17, P134, DOI 10.1159/000075782; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Thrift AG, 2001, STROKE, V32, P1732, DOI 10.1161/01.STR.32.8.1732; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wilson JTL, 2005, STROKE, V36, P777, DOI 10.1161/01.STR.0000157596.13234.95	31	134	140	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 16	2008	336	7640					376	379		10.1136/bmj.39456.688333.BE	http://dx.doi.org/10.1136/bmj.39456.688333.BE			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268AP	18230644	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000253550600041
J	Dick, IE; Tadross, MR; Liang, HY; Tay, LH; Yang, WJ; Yue, DT				Dick, Ivy E.; Tadross, Michael R.; Liang, Haoya; Tay, Lai Hock; Yang, Wanjun; Yue, David T.			A modular switch for spatial Ca2+ selectivity in the calmodulin regulation of Ca-V channels	NATURE			English	Article							GATED CALCIUM-CHANNEL; CA2+-DEPENDENT INACTIVATION; BETA-SUBUNIT; FACILITATION; MECHANISMS; EXPRESSION; REVEALS; GAMMA; FRET	Ca2+/ calmodulin- dependent regulation of voltage- gated Ca(V)1 - 2 Ca2+ channels shows extraordinary modes of spatial Ca2+ decoding and channel modulation(1-6), vital for many biological functions(6-9). A single calmodulin ( CaM) molecule associates constitutively with the channel's carboxy- terminal tail(3,10-13), and Ca2+ binding to the C- terminal and N- terminal lobes of CaM can each induce distinct channel regulations(2,14). As expected from close channel proximity, the C- lobe responds to the roughly 100-mu M Ca2+ pulses driven by the associated channel(15,16), a behaviour defined as 'local Ca2+ selectivity'. Conversely, all previous observations have indicated that the N- lobe somehow senses the far weaker signals from distant Ca2+ sources(2,3,17,18). This 'global Ca2+ selectivity' satisfies a general signalling requirement, enabling a resident molecule to remotely sense cellular Ca2+ activity, which would otherwise be overshadowed by Ca2+ entry through the host channel(5,6). Here we show that the spatial Ca2+ selectivity of N- lobe CaM regulation is not invariably global but can be switched by a novel Ca2+/CaM- binding site within the amino terminus of channels ( NSCaTE, for N- terminal spatial Ca2+ transforming element). Native Ca(V)2.2 channels lack this element and show N- lobe regulation with a global selectivity. On the introduction of NSCaTE into these channels, spatial Ca2+ selectivity transforms from a global to local profile. Given this effect, we examined Ca(V)1.2/ Ca(V)1.3 channels, which naturally contain NSCaTE, and found that their N- lobe selectivity is indeed local. Disruption of this element produces a global selectivity, confirming the native function of NSCaTE. Thus, differences in spatial selectivity between advanced Ca(V)1 and Ca(V)2 channel isoforms are explained by the presence or absence of NSCaTE. Beyond functional effects, the position of NSCaTE on the channel's amino terminus indicates that CaM can bridge the amino terminus and carboxy terminus of channels. Finally, the modularity of NSCaTE offers practical means for understanding the basis of global Ca2+ selectivity(19).	[Dick, Ivy E.; Tadross, Michael R.; Liang, Haoya; Tay, Lai Hock; Yang, Wanjun; Yue, David T.] Johns Hopkins Univ, Sch Med, Calcium Signals Lab, Dept Biomed Engn, Baltimore, MD 21205 USA; [Dick, Ivy E.; Tadross, Michael R.; Liang, Haoya; Tay, Lai Hock; Yang, Wanjun; Yue, David T.] Johns Hopkins Univ, Sch Med, Calcium Signals Lab, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Yue, DT (corresponding author), Johns Hopkins Univ, Sch Med, Calcium Signals Lab, Dept Biomed Engn, Ross Bldg,Room 713,720 Rutland Ave, Baltimore, MD 21205 USA.	dyue@bme.jhu.edu		Dick, Ivy/0000-0002-7253-6846	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL076795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000023, P30DC005211] Funding Source: NIH RePORTER; NHLBI NIH HHS [R37 HL076795] Funding Source: Medline; NIDCD NIH HHS [T32 DC000023, P30 DC005211] Funding Source: Medline; NIMH NIH HHS [R01 MH065531] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Agler HL, 2005, NEURON, V46, P891, DOI 10.1016/j.neuron.2005.05.011; Alseikhan BA, 2002, P NATL ACAD SCI USA, V99, P17185, DOI 10.1073/pnas.262372999; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; Bootman MD, 2001, J CELL SCI, V114, P2213; Chaudhuri D, 2007, J GEN PHYSIOL, V129, P385, DOI 10.1085/jgp.200709749; DELEON M, 1995, SCIENCE, V270, P1502, DOI 10.1126/science.270.5241.1502; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Drum CL, 2002, NATURE, V415, P396, DOI 10.1038/415396a; Dunlap K, 2007, J GEN PHYSIOL, V129, P379, DOI 10.1085/jgp.200709786; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; EVANS J, 2003, BIOPHYS J A S, V84; Evans RM, 2006, TRENDS NEUROSCI, V29, P617, DOI 10.1016/j.tins.2006.08.006; Ivanina T, 2000, J BIOL CHEM, V275, P39846, DOI 10.1074/jbc.M005881200; KINCAID RL, 1988, METHOD ENZYMOL, V159, P605; Kobrinsky E, 2003, J BIOL CHEM, V278, P5021, DOI 10.1074/jbc.M211254200; Lee A, 2000, J NEUROSCI, V20, P6830, DOI 10.1523/JNEUROSCI.20-18-06830.2000; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Moosmang S, 2005, J NEUROSCI, V25, P9883, DOI 10.1523/JNEUROSCI.1531-05.2005; Mori MX, 2004, SCIENCE, V304, P432, DOI 10.1126/science.1093490; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Song LS, 1998, J PHYSIOL-LONDON, V512, P677, DOI 10.1111/j.1469-7793.1998.677bd.x; Stratton J, 2004, BIOPHYS J, V86, p317A; TADROSS MR, 2007, BIOPHYS J A S, V354; Tang ZZ, 2004, J BIOL CHEM, V279, P44335, DOI 10.1074/jbc.M407023200; Toescu EC, 2007, AGING CELL, V6, P267, DOI 10.1111/j.1474-9726.2007.00296.x; TOMLINSON WJ, 1993, NEUROPHARMACOLOGY, V32, P1117, DOI 10.1016/0028-3908(93)90006-O; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; WEI XY, 1991, J BIOL CHEM, V266, P21943; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; Xu JH, 2005, NEURON, V46, P633, DOI 10.1016/j.neuron.2005.03.024; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Yang PS, 2006, J NEUROSCI, V26, P10677, DOI 10.1523/JNEUROSCI.3236-06.2006; YANG PS, 2007, BIOPHYS J A S, V354	38	185	192	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2008	451	7180					830	U9		10.1038/nature06529	http://dx.doi.org/10.1038/nature06529			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	263BA	18235447	Green Accepted, Green Published			2022-12-28	WOS:000253191400043
J	Cheng, TL; Cohn, RD; Dover, GJ				Cheng, Tina L.; Cohn, Ronald D.; Dover, George J.			The genetics revolution and primary care pediatrics	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PERSONALIZED MEDICINE; OTITIS-MEDIA; POLYMORPHISMS; GENES		[Cheng, Tina L.; Dover, George J.] Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21287 USA; [Cohn, Ronald D.] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University	Cheng, TL (corresponding author), Johns Hopkins Univ, Dept Pediat, 200 N Wolfe St,Ste 2055, Baltimore, MD 21287 USA.	tcheng2@jhmi.edu	Cohn, Ronald/AAC-5835-2021		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K24HD052559] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS055879] Funding Source: NIH RePORTER; NICHD NIH HHS [1K24HD052559-01A2] Funding Source: Medline; NIMHD NIH HHS [P20 MD00165] Funding Source: Medline; NINDS NIH HHS [K08NS055879] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Armstrong K, 2005, JAMA-J AM MED ASSOC, V293, P1729, DOI 10.1001/jama.293.14.1729; BERG AO, 2005, IMPLICATIONS GENOMIC, P19; Botkin JR, 2006, PEDIATRICS, V117, P1793, DOI 10.1542/peds.2005-2547; Burke W, 2002, AM J EPIDEMIOL, V156, P311, DOI 10.1093/aje/kwf055; Burke W, 2007, JAMA-J AM MED ASSOC, V298, P1682, DOI 10.1001/jama.298.14.1682; Chesney Russell W, 2002, J Pediatr, V141, P453, DOI 10.1067/mpd.2002.128030; Childs B., 1999, GENETIC MED LOGIC DI; Emery J, 2001, BMJ-BRIT MED J, V322, P1027, DOI 10.1136/bmj.322.7293.1027; Emonts M, 2007, PEDIATRICS, V120, P814, DOI 10.1542/peds.2007-0524; Eriksson JG, 2007, J NUTR, V137, P1063, DOI 10.1093/jn/137.4.1063; Gardner P, 2006, PEDIATRICS, V118, P985, DOI 10.1542/peds.2005-2519; Ginsburg GS, 2001, TRENDS BIOTECHNOL, V19, P491, DOI 10.1016/S0167-7799(01)01814-5; Grosse SD, 2006, PEDIATRICS, V117, P923, DOI 10.1542/peds.2005-0553; Hall M, 2005, JAMA-J AM MED ASSOC, V293, P1783, DOI 10.1001/jama.293.14.1783; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lenfant C, 2003, NEW ENGL J MED, V349, P868, DOI 10.1056/NEJMsa035507; McGinnis JM, 2002, HEALTH AFFAIR, V21, P78, DOI 10.1377/hlthaff.21.2.78; Patel JA, 2006, PEDIATRICS, V118, P2273, DOI 10.1542/peds.2006-0764; Starfield B, 2002, EUR J PUBLIC HEALTH, V12, P51, DOI 10.1093/eurpub/12.1.51; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wolfberg AJ, 2006, NEW ENGL J MED, V355, P543, DOI 10.1056/NEJMp068079; Zerhouni Elias, 2006, VISION TRANSFORMING	22	16	17	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 30	2008	299	4					451	453		10.1001/jama.299.4.451	http://dx.doi.org/10.1001/jama.299.4.451			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	256JK	18230784				2022-12-28	WOS:000252724500024
J	Shortell, SM; Singer, SJ				Shortell, Stephen M.; Singer, Sara J.			Improving patient safety by taking systems seriously	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE; HOSPITALS		[Shortell, Stephen M.] Univ Calif Berkeley, Sch Publ Hlth, Div Hlth Policy & Management, Berkeley, CA 94720 USA; [Singer, Sara J.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Singer, Sara J.] Massachusetts Gen Hosp, Inst Hlth Policy, Boston, MA 02114 USA	University of California System; University of California Berkeley; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital	Shortell, SM (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Hlth Policy & Management, 50 Univ Hall, Berkeley, CA 94720 USA.	shortell@berkeley.edu	Singer, Sara/AAS-5317-2021	Singer, Sara/0000-0002-3374-1177				Batalden P B, 1993, Jt Comm J Qual Improv, V19, P424; Berwick DM, 2006, JAMA-J AM MED ASSOC, V295, P324, DOI 10.1001/jama.295.3.324; Carroll JS, 1998, J MANAGE STUD, V35, P699, DOI 10.1111/1467-6486.00116; Edmondson AC, 2003, J MANAGE STUD, V40, P1419, DOI 10.1111/1467-6486.00386; Edmondson AC, 2001, ADMIN SCI QUART, V46, P685, DOI 10.2307/3094828; Fargason C A Jr, 1992, QRB Qual Rev Bull, V18, P157; Frankel A, 2005, JT COMM J QUAL PATIE, V31, P423, DOI 10.1016/S1553-7250(05)31056-7; Frankel AS, 2006, HEALTH SERV RES, V41, P1690, DOI 10.1111/j.1475-6773.2006.00572.x; GABA DM, 2004, QUAL SAF HEALTH CARE, V13, P12; Gandhi TK, 2005, JT COMM J QUAL PATIE, V31, P614, DOI 10.1016/S1553-7250(05)31079-8; *I MED, 2004, PAT SAF ACH NEW STAN; Institute of Medicine, 2000, ERR IS HUM BUILD SAF; Katz-Navon T, 2005, ACAD MANAGE J, V48, P1075, DOI 10.5465/AMJ.2005.19573110; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; MILLER B, 2007, CENTURY CARING CHRON; Reason J, 2000, BMJ-BRIT MED J, V320, P768, DOI 10.1136/bmj.320.7237.768; Senge PM, 2006, 5 DISCIPLINE ART PRA; Singh H, 2007, ARCH INTERN MED, V167, P2030, DOI 10.1001/archinte.167.19.2030; Thomas EJ, 2003, CRIT CARE MED, V31, P956, DOI 10.1097/01.CCM.0000056183.89175.76; TUCKER A, 2007, 08015 HARV BUS SCH; Tucker AL, 2003, CALIF MANAGE REV, V45, P55, DOI 10.2307/41166165; WEICK KE, 1993, ADMIN SCI QUART, V38, P357, DOI 10.2307/2393372; WEINSTOCK A, 2007, MOD HEALTHC      SEP, P38; Wong DR, 2007, SURGERY, V141, P715, DOI 10.1016/j.surg.2007.01.017	24	74	77	2	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 30	2008	299	4					445	447		10.1001/jama.299.4.445	http://dx.doi.org/10.1001/jama.299.4.445			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	256JK	18230782				2022-12-28	WOS:000252724500022
J	Feng, J; Hennig, RG; Ashcroft, NW; Hoffmann, R				Feng, Ji; Hennig, Richard G.; Ashcroft, N. W.; Hoffmann, Roald			Emergent reduction of electronic state dimensionality in dense ordered Li-Be alloys	NATURE			English	Article							CRYSTAL-STRUCTURES; HIGH-PRESSURE; METALS; POTASSIUM; BEHAVIOR; ELEMENTS; LITHIUM; PHASES	High pressure is known to influence electronic structure and crystal packing, and can in some cases even induce compound formation between elements that do not bond under ambient conditions(1-3). Here we present a computational study showing that high pressure fundamentally alters the reactivity of the light elements lithium ( Li) and beryllium ( Be), which are the first of the metals in the condensed state and immiscible under normal conditions(4,5). We identify four stoichiometric LixBe1-x compounds that are stable over a range of pressures, and find that the electronic density of states of one of them displays a remarkable step-like feature near the bottom of the valence band and then remains almost constant with increasing energy. These characteristics are typical of a quasi- two- dimensional electronic structure, the emergence of which in a three- dimensional environment is rather unexpected. We attribute this observation to large size differences between the ionic cores of Li and Be: as the density increases, the Li cores start to overlap and thereby expel valence electrons into quasi- two- dimensional layers characterized by delocalized free- particle- like states in the vicinity of Be ions.	[Ashcroft, N. W.] Cornell Univ, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA; [Feng, Ji; Hoffmann, Roald] Cornell Univ, Baker Lab, Dept Chem & Biol Chem, Ithaca, NY 14853 USA; [Hennig, Richard G.] Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA; [Ashcroft, N. W.] Cornell Univ, Cornell Ctr Mat Res, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University; Cornell University	Ashcroft, NW (corresponding author), Cornell Univ, Atom & Solid State Phys Lab, Clark Hall, Ithaca, NY 14853 USA.	nwa@ccmr.cornell.edu; rh34@cornell.edu	Hennig, Richard/A-2978-2008; Muller, David/A-7745-2010; Feng, Ji/R-6676-2019; Feng, Ji/A-6956-2008; Feng, Ji/B-6775-2009	Hennig, Richard/0000-0003-4933-7686; Muller, David/0000-0003-4129-0473; Feng, Ji/0000-0003-1944-718X				Ackland GJ, 2004, NEW J PHYS, V6, DOI 10.1088/1367-2630/6/1/138; ASHCROFT NW, 1989, PHYS REV B, V39, P10552, DOI 10.1103/PhysRevB.39.10552; Atou T, 1996, J AM CHEM SOC, V118, P12104, DOI 10.1021/ja9627003; Corbett J. D., 1996, CHEM MET CLUST, P139; Degtyareva VF, 2006, PHYS-USP+, V49, P369, DOI 10.1070/PU2006v049n04ABEH005948; Feng J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.247002; Hanfland M, 2000, NATURE, V408, P174, DOI 10.1038/35041515; Hansen M., 1958, CONSTITUTION BINARY, V2nd ed., P1175; HOFFMANN R, 1963, J CHEM PHYS, V39, P1397, DOI 10.1063/1.1734456; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Kolmogorov AN, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.180501; Kraus W, 1996, J APPL CRYSTALLOGR, V29, P301, DOI 10.1107/S0021889895014920; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; MASSALSKI TB, 1986, BINARY ALLOY PHASE D, V1, P460; Mott NF, 1958, THEORY PROPERTIES ME, P152; Neaton JB, 1999, NATURE, V400, P141, DOI 10.1038/22067; Parker LJ, 1996, SCIENCE, V273, P95, DOI 10.1126/science.273.5271.95; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; PETTIFOR DG, 1986, J PHYS C SOLID STATE, V19, P285, DOI 10.1088/0022-3719/19/3/002; Pickard CJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.045504; Robert G, 2006, J PHYS IV, V134, P257, DOI 10.1051/jp4:2006134039; Tsvyashchenko AV, 1998, JETP LETT+, V68, P908, DOI 10.1134/1.567954; Vocadlo L, 1999, GEOPHYS RES LETT, V26, P1231, DOI 10.1029/1999GL900214; WATSON RE, 1984, PHYS REV B, V30, P1641, DOI 10.1103/PhysRevB.30.1641	26	93	93	3	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2008	451	7177					445	448		10.1038/nature06442	http://dx.doi.org/10.1038/nature06442			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	253YS	18216850	Bronze			2022-12-28	WOS:000252554100040
J	Fuerst, PG; Koizumi, A; Masland, RH; Burgess, RW				Fuerst, Peter G.; Koizumi, Amane; Masland, Richard H.; Burgess, Robert W.			Neurite arborization and mosaic spacing in the mouse retina require DSCAM	NATURE			English	Article							CELL-ADHESION MOLECULE; HOMOPHILIC INTERCELLULAR-ADHESION; AXON GUIDANCE; DROSOPHILA DSCAM; SELF-AVOIDANCE; DIVERSITY; NEURONS; SPECIFICITY; BINDING; SYSTEM	To establish functional circuitry, retinal neurons occupy spatial domains by arborizing their processes, which requires the self-avoidance of neurites from an individual cell, and by spacing their cell bodies, which requires positioning the soma and establishing a zone within which other cells of the same type are excluded(1). The mosaic patterns of distinct cell types form independently and overlap. The cues that direct these processes in the vertebrate retina are not known(2,3). Here we show that some types of retinal amacrine cells from mice with a spontaneous mutation in Down syndrome cell adhesion molecule ( Dscam), a gene encoding an immunoglobulin- superfamily member adhesion molecule(4,5), have defects in the arborization of processes and in the spacing of cell bodies. In the mutant retina, cells that would normally express Dscam have hyperfasciculated processes, preventing them from creating an orderly arbor. Also, their cell bodies are randomly distributed or pulled into clumps rather than being regularly spaced mosaics. Our results indicate that mouse DSCAM mediates isoneuronal self- avoidance for arborization and heteroneuronal self- avoidance within specific cell types to prevent fasciculation and to preserve mosaic spacing. These functions are analogous to those of Drosophila DSCAM ( ref. 6) and DSCAM2 ( ref. 7). DSCAM may function similarly in other regions of the mammalian nervous system, and this role may extend to other members of the mammalian Dscam gene family.	[Fuerst, Peter G.; Burgess, Robert W.] Jackson Lab, Bar Harbor, ME 04609 USA; [Koizumi, Amane; Masland, Richard H.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Jackson Laboratory; Harvard University; Massachusetts General Hospital	Burgess, RW (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	robert.burgess@jax.org	Koizumi, Amane/E-7771-2011	Burgess, Robert/0000-0002-9229-3407; Koizumi, Amane/0000-0003-1177-0185	NATIONAL EYE INSTITUTE [R03EY016031, F32EY015966] Funding Source: NIH RePORTER; NEI NIH HHS [F32 EY015966-02, R03 EY016031-03, F32 EY015966, R03 EY016031] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Agarwala KL, 2001, BIOCHEM BIOPH RES CO, V285, P760, DOI 10.1006/bbrc.2001.5214; Agarwala KL, 2000, MOL BRAIN RES, V79, P118, DOI 10.1016/S0169-328X(00)00108-X; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; Galli-Resta L, 2000, DEVELOPMENT, V127, P1509; GalliResta L, 1997, J NEUROSCI, V17, P7831; Hattori D, 2007, NATURE, V449, P223, DOI 10.1038/nature06099; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kong JH, 2005, J COMP NEUROL, V489, P293, DOI 10.1002/cne.20631; Lin B, 2004, NEURON, V43, P475, DOI 10.1016/j.neuron.2004.08.002; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Meijers R, 2007, NATURE, V449, P487, DOI 10.1038/nature06147; Millard SS, 2007, NATURE, V447, P720, DOI 10.1038/nature05855; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Novelli E, 2005, PROG BRAIN RES, V147, P141, DOI 10.1016/S0079-6123(04)47011-3; Raven MA, 2003, J COMP NEUROL, V461, P123, DOI 10.1002/cne.10693; Resta V, 2005, DEVELOPMENT, V132, P2873, DOI 10.1242/dev.01855; Rockhill RL, 2000, P NATL ACAD SCI USA, V97, P2303, DOI 10.1073/pnas.030413497; RODIECK RW, 1991, VISUAL NEUROSCI, V6, P95, DOI 10.1017/S095252380001049X; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Wojtowicz WM, 2007, CELL, V130, P1134, DOI 10.1016/j.cell.2007.08.026; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yamakawa K, 1998, HUM MOL GENET, V7, P227, DOI 10.1093/hmg/7.2.227; Yimlamai D, 2005, DEV BIOL, V279, P44, DOI 10.1016/j.ydbio.2004.12.001; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020	28	210	213	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2008	451	7177					470	U8		10.1038/nature06514	http://dx.doi.org/10.1038/nature06514			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	253YS	18216855	Green Accepted, Bronze			2022-12-28	WOS:000252554100046
J	Marroquin, OC; Selzer, F; Mulukutla, SR; Williams, DO; Vlachos, HA; Wilensky, RL; Tanguay, J; Holper, EM; Abbott, JD; Lee, JS; Smith, C; Anderson, WD; Kelsey, SF; Kip, KE				Marroquin, Oscar C.; Selzer, Faith; Mulukutla, Suresh R.; Williams, David O.; Vlachos, Helen A.; Wilensky, Robert L.; Tanguay, Jean-Francois; Holper, Elizabeth M.; Abbott, J. Dawn; Lee, Joon S.; Smith, Conrad; Anderson, William D.; Kelsey, Sheryl F.; Kip, Kevin E.			A comparison of bare-metal and drug-eluting stents for off-label indications	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; CORONARY-ARTERY LESIONS; SLOW-RELEASE; DOUBLE-BLIND; OUTCOMES; THROMBOSIS; SIRIUS; EFFICACY; DISEASE; COMPLEX	Background: Recent reports suggest that off-label use of drug-eluting stents is associated with an increased incidence of adverse events. Whether the use of bare-metal stents would yield different results is unknown. Methods: We analyzed data from 6551 patients in the National Heart, Lung, and Blood Institute Dynamic Registry according to whether they were treated with drug-eluting stents or bare-metal stents and whether use was standard or off-label. Patients were followed for 1 year for the occurrence of cardiovascular events and death. Off-label use was defined as use in restenotic lesions, lesions in a bypass graft, left main coronary artery disease, or ostial, bifurcated, or totally occluded lesions, as well as use in patients with a reference-vessel diameter of less than 2.5 mm or greater than 3.75 mm or a lesion length of more than 30 mm. Results: Off-label use occurred in 54.7% of all patients with bare-metal stents and 48.7% of patients with drug-eluting stents. As compared with patients with bare-metal stents, patients with drug-eluting stents had a higher prevalence of diabetes, hypertension, renal disease, previous percutaneous coronary intervention and coronary-artery bypass grafting, and multivessel coronary artery disease. One year after intervention, however, there were no significant differences in the adjusted risk of death or myocardial infarction in patients with drug-eluting stents as compared with those with bare-metal stents, whereas the risk of repeat revascularization was significantly lower among patients with drug-eluting stents. Conclusions: Among patients with off-label indications, the use of drug-eluting stents was not associated with an increased risk of death or myocardial infarction but was associated with a lower rate of repeat revascularization at 1 year, as compared with bare-metal stents. These findings support the use of drug-eluting stents for off-label indications.	[Marroquin, Oscar C.; Mulukutla, Suresh R.; Lee, Joon S.; Smith, Conrad; Anderson, William D.] Univ Pittsburgh, Med Ctr, Cardiovasc Inst, PUH, Pittsburgh, PA 15213 USA; [Selzer, Faith; Vlachos, Helen A.; Kelsey, Sheryl F.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15213 USA; [Williams, David O.; Abbott, J. Dawn] Rhode Isl Hosp, Providence, RI USA; [Wilensky, Robert L.] Hosp Univ Penn, Philadelphia, PA 19104 USA; [Tanguay, Jean-Francois] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Holper, Elizabeth M.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Kip, Kevin E.] Univ S Florida, Tampa, FL USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Lifespan Health Rhode Island; Rhode Island Hospital; University of Pennsylvania; Pennsylvania Medicine; Universite de Montreal; University of Texas System; University of Texas Southwestern Medical Center Dallas; State University System of Florida; University of South Florida	Marroquin, OC (corresponding author), Univ Pittsburgh, Med Ctr, Cardiovasc Inst, PUH, 200 Lothrop St,F392, Pittsburgh, PA 15213 USA.	marroquinoc@upmc.edu	Marroquin, Oscar C/F-2214-2015; Abbott, J/AAU-4065-2021	Marroquin, Oscar C/0000-0002-0909-0319; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL033292] Funding Source: NIH RePORTER; NHLBI NIH HHS [U01 HL033292, U01 HL033292-21, HL-33292-21, HL-33292-20, HL-33292-14, U01 HL033292-15, HL-33292-19, U01 HL033292-19, HL-33292-17, HL-33292-18, HL-33292-15, U01 HL033292-17, HL-33292-22, U01 HL033292-22, U01 HL033292-18, U01 HL033292-20, U01 HL033292-23, U01 HL033292-16, HL-33292-16] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Beohar N, 2007, JAMA-J AM MED ASSOC, V297, P1992, DOI 10.1001/jama.297.18.1992; *BOST SCI, TAXUS EXPR STENT SYS; Colombo A, 2003, CIRCULATION, V108, P788, DOI 10.1161/01.CIR.0000086926.62288.A6; *CORD, CYPHER SIR EL STENT; Dawkins KD, 2005, CIRCULATION, V112, P3306, DOI 10.1161/CIRCULATIONAHA.105.552190; Farb A, 2007, NEW ENGL J MED, V356, P984, DOI 10.1056/NEJMp068304; Grube E, 2003, CIRCULATION, V107, P38, DOI 10.1161/01.CIR.0000047700.58683.A1; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Schampaert E, 2004, J AM COLL CARDIOL, V43, P1110, DOI 10.1016/j.jacc.2004.01.024; Schofer J, 2003, LANCET, V362, P1093, DOI 10.1016/S0140-6736(03)14462-5; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Stone GW, 2005, JAMA-J AM MED ASSOC, V294, P1215, DOI 10.1001/jama.294.10.1215; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Weisz G, 2006, J AM COLL CARDIOL, V47, P1350, DOI 10.1016/j.jacc.2005.11.077; Williams DO, 2000, CIRCULATION, V102, P2945; Win HK, 2007, JAMA-J AM MED ASSOC, V297, P2001, DOI 10.1001/jama.297.18.2001	19	208	218	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2008	358	4					342	352		10.1056/NEJMoa0706258	http://dx.doi.org/10.1056/NEJMoa0706258			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253GY	18216354	Green Accepted, Bronze			2022-12-28	WOS:000252507900004
J	Raymond, PA; Oh, NH; Turner, RE; Broussard, W				Raymond, Peter A.; Oh, Neung-Hwan; Turner, R. Eugene; Broussard, Whitney			Anthropogenically enhanced fluxes of water and carbon from the Mississippi River	NATURE			English	Article							UNITED-STATES; STREAMFLOW TRENDS; NORTH-AMERICA; DIOXIDE; CO2; TRANSPORT; CHEMISTRY; BASEFLOW; INCREASE; QUALITY	The water and dissolved inorganic carbon exported by rivers are important net fluxes that connect terrestrial and oceanic water and carbon reservoirs(1). For most rivers, the majority of dissolved inorganic carbon is in the form of bicarbonate. The riverine bicarbonate flux originates mainly from the dissolution of rock minerals by soil water carbon dioxide, a process called chemical weathering, which controls the buffering capacity and mineral content of receiving streams and rivers(2). Here we introduce an unprecedented high- temporal- resolution, 100- year data set from the Mississippi River and couple it with sub- watershed and precipitation data to reveal that the large increase in bicarbonate flux that has occurred over the past 50 years ( ref. 3) is clearly anthropogenically driven. We show that the increase in bicarbonate and water fluxes is caused mainly by an increase in discharge from agricultural watersheds that has not been balanced by a rise in precipitation, which is also relevant to nutrient and pesticide fluxes to the Gulf of Mexico. These findings demonstrate that alterations in chemical weathering are relevant to improving contemporary biogeochemical budgets. Furthermore, land use change and management were arguably more important than changes in climate and plant CO2 fertilization to increases in riverine water and carbon export from this large region over the past 50 years.	[Raymond, Peter A.; Oh, Neung-Hwan] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Turner, R. Eugene] Louisiana State Univ, Coastal Ecol Inst, Baton Rouge, LA 70803 USA; [Broussard, Whitney] Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA	Yale University; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Raymond, PA (corresponding author), Yale Univ, Sch Forestry & Environm Studies, 21 Sachem St, New Haven, CT 06511 USA.	peter.raymond@yale.edu	Raymond, Peter A/C-4087-2009	Raymond, Peter A/0000-0002-8564-7860; Broussard, Whitney/0000-0001-6000-2751				[Anonymous], 2001, CLIMATE CHANGE 2001; Berner R.A., 2004, PHANEROZOIC CARBON C; BERNER RA, 1983, AM J SCI, V283, P641, DOI 10.2475/ajs.283.7.641; Betts RA, 2007, NATURE, V448, P1037, DOI 10.1038/nature06045; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Gaillardet J, 1999, CHEM GEOL, V159, P3, DOI 10.1016/S0009-2541(99)00031-5; Gedney N, 2006, NATURE, V439, P835, DOI 10.1038/nature04504; Hamilton SK, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002738; Jarvie HP, 1997, SCI TOTAL ENVIRON, V194, P285, DOI 10.1016/S0048-9697(96)05371-5; Jones JB, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017056; Kump LR, 2000, ANNU REV EARTH PL SC, V28, P611, DOI 10.1146/annurev.earth.28.1.611; Lins HF, 2005, PHYS GEOGR, V26, P489, DOI 10.2747/0272-3646.26.6.489; Lins HF, 1999, GEOPHYS RES LETT, V26, P227, DOI 10.1029/1998GL900291; Murdoch PS, 2006, ENVIRON MONIT ASSESS, V120, P1, DOI 10.1007/s10661-005-9028-1; Oh NH, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002565; PEREIRA WE, 1993, ENVIRON SCI TECHNOL, V27, P1542, DOI 10.1021/es00045a008; Raymond PA, 2003, SCIENCE, V301, P88, DOI 10.1126/science.1083788; Raymond PA, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002783; SABINE CL, 2004, GLOBAL CARBON CYCLE, pCH2; Schilling KE, 2005, AGR ECOSYST ENVIRON, V105, P433, DOI 10.1016/j.agee.2004.02.008; Shanley JB, 2002, HYDROL PROCESS, V16, P589, DOI 10.1002/hyp.312; Stoddard JL, 1999, NATURE, V401, P575, DOI 10.1038/44114; Striegl RG, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024413; Stumm W, 1996, AQUATIC CHEM; Szramek K, 2004, AQUAT GEOCHEM, V10, P99, DOI 10.1023/B:AQUA.0000038960.63501.5b; TURNER RE, 1991, BIOSCIENCE, V41, P140, DOI 10.2307/1311453; West TO, 2005, AGR ECOSYST ENVIRON, V108, P145, DOI 10.1016/j.agee.2005.01.002; Williams EL, 2007, GEOL SOC AM BULL, V119, P515, DOI 10.1130/B25967.1; Zhang YK, 2006, J HYDROL, V324, P412, DOI 10.1016/j.jhydrol.2005.09.033	29	381	409	11	262	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2008	451	7177					449	452		10.1038/nature06505	http://dx.doi.org/10.1038/nature06505			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	253YS	18216851	Bronze, Green Published			2022-12-28	WOS:000252554100041
J	Iezzoni, LI; Freedman, VA				Iezzoni, Lisa I.; Freedman, Vicki A.			Turning the disability tide - The importance of definitions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Iezzoni, Lisa I.] Massachusetts Gen Hosp, Inst Hlth Policy, Boston, MA 02114 USA; [Freedman, Vicki A.] Univ Med & Dent New Jersey, Sch Publ Hlth, Dept Hlth Syst & Policy, Newark, NJ 07103 USA	Harvard University; Massachusetts General Hospital; Rutgers State University New Brunswick; Rutgers State University Medical Center	Iezzoni, LI (corresponding author), Massachusetts Gen Hosp, Inst Hlth Policy, 50 Staniford St,Room 901B, Boston, MA 02114 USA.	liezzoni@partners.org			NIA NIH HHS [R01AG021516] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG021516] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALBERT SM, 2004, PUBLIC HLTH AGING IN; Alley DE, 2007, JAMA-J AM MED ASSOC, V298, P2020, DOI 10.1001/jama.298.17.2020; Bhattacharya J., 2006, WORKSH DIS AM NEW LO, P113; Cocchiarella L., 2001, GUIDES EVALUATION PE; Field MJ, 2007, FUTURE DISABILITY AM; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Fleischer D., 2001, DISABILITY RIGHTS MO; Freedman VA, 2002, JAMA-J AM MED ASSOC, V288, P3137, DOI 10.1001/jama.288.24.3137; Goffman E., 1963, BEHAV PUBLIC PLACES, P3; Gregg EW, 2007, JAMA-J AM MED ASSOC, V298, P2066, DOI 10.1001/jama.298.17.2066; *I MED COMM NAT AG, 1991, DIS AM NAT AG PREV; Linton Simi, 1998, CLAIMING DISABILITY; *NAT RES COUNC COM, 2002, DYN DIS MEAS MON DIS; Oliver M., 1996, UNDERSTANDING DISABI; Olkin R., 2001, WHAT PSYCHOTHERAPIST; Perrin JM, 2007, JAMA-J AM MED ASSOC, V297, P2755, DOI 10.1001/jama.297.24.2755; Shapiro Joseph P., 1994, NO PITY PEOPLE DISAB; *SOC SEC ADM OFF D, 2003, SOC SEC ADM PUBL; Stone D., 1984, DISABLED STATE; Ustun TB, 2003, HEALTH CARE FINANC R, V24, P77; Whiteneck G., 2006, WORKSH DIS AM NEW LO, P50; *WHO, 1997, ICIDH 2 INT CLASS IM; WHO, 2001, WHO INT CLASS FUNCT; World Health Organization, 1980, INT CLASS IMP DIS HA	24	66	65	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2008	299	3					332	334		10.1001/jama.299.3.332	http://dx.doi.org/10.1001/jama.299.3.332			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253DB	18212318				2022-12-28	WOS:000252497800025
J	Lewenstein, M; Sanpera, A				Lewenstein, Maciej; Sanpera, Anna			Physics - Probing quantum magnetism with cold atoms	SCIENCE			English	Editorial Material									[Lewenstein, Maciej; Sanpera, Anna] Inst Catalana Recerca & Estudis Avancats, E-08010 Barcelona, Spain; [Lewenstein, Maciej] Inst Ciencies Foton, E-08860 Castelldefels, Spain; [Sanpera, Anna] Univ Autonoma Barcelona, Fis Teor Grp, E-08193 Bellaterra, Spain	ICREA; Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); Autonomous University of Barcelona	Lewenstein, M (corresponding author), Inst Catalana Recerca & Estudis Avancats, E-08010 Barcelona, Spain.	maciej.lewenstein@icfo.es	Lewenstein, Maciej/I-1337-2014; Sanpera, Anna/L-3174-2014	Lewenstein, Maciej/0000-0002-0210-7800; Sanpera, Anna/0000-0002-8970-6127	ICREA Funding Source: Custom	ICREA(ICREA)		Altman E, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.013603; ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; ANDERSON PW, 1950, PHYS REV, V79, P350, DOI 10.1103/PhysRev.79.350; Damski B, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.053612; Eckert K, 2008, NAT PHYS, V4, P50, DOI 10.1038/nphys776; JIANG L, ARXIVORGABS07111365; Kramers HA, 1934, PHYSICA, V1, P182, DOI 10.1016/S0031-8914(34)90023-9; Lewenstein M, 2007, ADV PHYS, V56, P243, DOI 10.1080/00018730701223200; Mila F, 1998, PHYS REV LETT, V81, P2356, DOI 10.1103/PhysRevLett.81.2356; PAREDES B, ARXIVORGABS07113796; Trotzky S, 2008, SCIENCE, V319, P295, DOI 10.1126/science.1150841	11	12	12	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2008	319	5861					292	293		10.1126/science.1153723	http://dx.doi.org/10.1126/science.1153723			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252GY	18202282				2022-12-28	WOS:000252436200026
J	Mangale, VS; Hirokawa, KE; Satyaki, PRV; Gokulchandran, N; Chikbire, S; Subramanian, L; Shetty, AS; Martynoga, B; Paul, J; Mai, MV; Li, YQ; Flanagan, LA; Tole, S; Monuki, ES				Mangale, Vishakha S.; Hirokawa, Karla E.; Satyaki, Prasad R. V.; Gokulchandran, Nandini; Chikbire, Satyadeep; Subramanian, Lakshmi; Shetty, Ashwin S.; Martynoga, Ben; Paul, Jolly; Mai, Mark V.; Li, Yuqing; Flanagan, Lisa A.; Tole, Shubha; Monuki, Edwin S.			Lhx2 selector activity specifies cortical identity and suppresses hippocampal organizer fate	SCIENCE			English	Article							CAJAL-RETZIUS CELLS; CEREBRAL-CORTEX; DENTATE GYRUS; MOUSE HIPPOCAMPUS; GRANULE CELLS; EXPRESSION; DORSAL; GENE; DROSOPHILA; FOREBRAIN	The earliest step in creating the cerebral cortex is the specification of neuroepithelium to a cortical fate. Using mouse genetic mosaics and timed inactivations, we demonstrated that Lhx2 acts as a classic selector gene and essential intrinsic determinant of cortical identity. Lhx2 selector activity is restricted to an early critical period when stem cells comprise the cortical neuroepithelium, where it acts cell- autonomously to specify cortical identity and suppress alternative fates in a spatially dependent manner. Laterally, Lhx2 null cells adopt antihem identity, whereas medially they become cortical hem cells, which can induce and organize ectopic hippocampal fields. In addition to providing functional evidence for Lhx2 selector activity, these findings show that the cortical hem is a hippocampal organizer.	[Mangale, Vishakha S.; Satyaki, Prasad R. V.; Gokulchandran, Nandini; Chikbire, Satyadeep; Subramanian, Lakshmi; Shetty, Ashwin S.; Martynoga, Ben; Paul, Jolly; Tole, Shubha] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India; [Hirokawa, Karla E.; Monuki, Edwin S.] Univ Calif Irvine, Sch Biol Sci, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Mai, Mark V.] Swarthmore Coll, Dept Biol, Swarthmore, PA 19081 USA; [Li, Yuqing] Univ Alabama Birmingham, Sch Med, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA; [Flanagan, Lisa A.; Monuki, Edwin S.] Univ Calif Irvine, Sch Med, Dept Pathol & Lab Med, Irvine, CA 92697 USA	Tata Institute of Fundamental Research (TIFR); University of California System; University of California Irvine; Swarthmore College; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Irvine	Tole, S (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	stole@tifr.res.in; emonuki@uci.edu	Li, Yuqing/AAR-9383-2021; Mangale, Vishakha/AAQ-6403-2021; Li, Yuqing/G-1596-2011; shetty, Ashwin/AAV-3956-2021	Li, Yuqing/0000-0003-1211-5529; Li, Yuqing/0000-0003-1211-5529; shetty, Ashwin/0000-0002-2812-7674; Monuki, Edwin/0000-0001-5130-781X; Subramanian, Lakshmi/0000-0002-3504-4455; Mai, Mark/0000-0003-0346-5818; Hirokawa, Karla/0000-0002-9954-5515	NIA NIH HHS [AG23583, K01 AG023583] Funding Source: Medline; NIMH NIH HHS [MH02029, K08 MH002029] Funding Source: Medline; NINDS NIH HHS [NS07444, NS053511, T32 NS007444] Funding Source: Medline; Wellcome Trust [056684/Z/99/Z] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Ando H, 2005, DEV BIOL, V287, P456, DOI 10.1016/j.ydbio.2005.09.023; Assimacopoulos S, 2003, J NEUROSCI, V23, P6399; Badea TC, 2003, J NEUROSCI, V23, P2314; Bagri A, 2002, DEVELOPMENT, V129, P4249; BLAIR SS, 1994, DEVELOPMENT, V120, P1805; Bryja V, 2005, STEM CELLS, V23, P965, DOI 10.1634/stemcells.2004-0174; Bulchand S, 2001, MECH DEVELOP, V100, P165, DOI 10.1016/S0925-4773(00)00515-3; Cheng X, 2006, J NEUROSCI, V26, P7640, DOI 10.1523/JNEUROSCI.0714-06.2006; Currle DS, 2005, DEVELOPMENT, V132, P3549, DOI 10.1242/dev.01915; DIAZBENJUMEA FJ, 1993, CELL, V75, P741, DOI 10.1016/0092-8674(93)90494-B; Galceran J, 2000, DEVELOPMENT, V127, P469; GARCIABELLIDO A, 1975, CIBA F SYMP, P161, DOI DOI 10.1002/9780470720110.CH8; Gotz M, 1996, NEURON, V16, P551, DOI 10.1016/S0896-6273(00)80074-4; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hebert JM, 2002, NEURON, V35, P1029, DOI 10.1016/S0896-6273(02)00900-5; Irvine KD, 2001, ANNU REV CELL DEV BI, V17, P189, DOI 10.1146/annurev.cellbio.17.1.189; Jin XL, 2000, BIOCHEM BIOPH RES CO, V270, P978, DOI 10.1006/bbrc.2000.2532; Kiecker C, 2005, NAT REV NEUROSCI, V6, P553, DOI 10.1038/nrn1702; Kroll TT, 2005, P NATL ACAD SCI USA, V102, P7374, DOI 10.1073/pnas.0500819102; Lagutin OV, 2003, GENE DEV, V17, P368, DOI 10.1101/gad.1059403; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; Lee SMK, 2000, DEVELOPMENT, V127, P457; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Li GN, 2005, DEV NEUROSCI-BASEL, V27, P93, DOI 10.1159/000085980; Machon O, 2003, NEUROSCIENCE, V122, P129, DOI 10.1016/S0306-4522(03)00519-0; Machon O, 2007, DEV BIOL, V311, P223, DOI 10.1016/j.ydbio.2007.08.038; Monuki ES, 2001, NEURON, V32, P591, DOI 10.1016/S0896-6273(01)00504-9; Muzio L, 2005, J NEUROSCI, V25, P4435, DOI 10.1523/JNEUROSCI.4804-04.2005; Nagy A, 2003, MANIPULATING MOUSE E, P453; Porter FD, 1997, DEVELOPMENT, V124, P2935; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; RICKMANN M, 1987, J COMP NEUROL, V264, P449, DOI 10.1002/cne.902640403; Rincon-Limas DE, 1999, P NATL ACAD SCI USA, V96, P2165, DOI 10.1073/pnas.96.5.2165; Shimogori T, 2004, DEVELOPMENT, V131, P5639, DOI 10.1242/dev.01428; Shinozaki K, 2004, MECH DEVELOP, V121, P475, DOI 10.1016/j.mod.2004.03.013; Stoykova A, 2000, J NEUROSCI, V20, P8042; Stoykova A, 1997, DEVELOPMENT, V124, P3765; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Tole S, 2001, J NEUROSCI, V21, P1580, DOI 10.1523/JNEUROSCI.21-05-01580.2001; Tole S, 1997, DEVELOPMENT, V124, P4959; Yoshida M, 2006, DEVELOPMENT, V133, P537, DOI 10.1242/dev.02209; Zhao CJ, 2006, BRAIN RES, V1077, P48, DOI 10.1016/j.brainres.2006.01.042; Zhou CJ, 2004, J NEUROSCI, V24, P121, DOI 10.1523/JNEUROSCI.4071-03.2004	44	234	237	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2008	319	5861					304	309		10.1126/science.1151695	http://dx.doi.org/10.1126/science.1151695			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252GY	18202285	Green Accepted			2022-12-28	WOS:000252436200030
J	Allen, PA				Allen, Philip A.			From landscapes into geological history	NATURE			English	Article							SEDIMENT	Erosional and depositional landscapes are linked by the sediment- routing system. Observations over a wide range of timescales might show how these landscapes are translated into the narrative of geological history.	Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England	Imperial College London	Allen, PA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, S Kensington Campus, London SW7 2AZ, England.	philip.allen@imperial.ac.uk						Allen P, 2005, NATURE, V434, P961, DOI 10.1038/434961a; Allen P., 2005, BASIN ANAL PRINCIPLE; ALLEN PA, 1997, EARTH SURFACE PROCES; Braun J., 2006, QUANTITATIVE THERMOC; Braun J, 2006, GEOL SOC SPEC PUBL, V253, P307, DOI 10.1144/GSL.SP.2006.253.01.16; Castelltort S, 2003, SEDIMENT GEOL, V157, P3, DOI 10.1016/S0037-0738(03)00066-6; Fedele JJ, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2005JF000409; Leeder MR, 1997, EARTH SURF PROC LAND, V22, P229, DOI 10.1002/(SICI)1096-9837(199703)22:3<229::AID-ESP750>3.0.CO;2-F; Malmon DV, 2003, J GEOL, V111, P525, DOI 10.1086/376764; Metivier F, 1999, BASIN RES, V11, P293; MILLIMAN JD, 1983, J GEOL, V91, P1, DOI 10.1086/628741; MOLNAR P, 1990, NATURE, V346, P29, DOI 10.1038/346029a0; Squire RJ, 2006, EARTH PLANET SC LETT, V250, P116, DOI 10.1016/j.epsl.2006.07.032; Willett SD, 1999, J GEOPHYS RES-SOL EA, V104, P28957, DOI 10.1029/1999JB900248	14	279	350	4	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2008	451	7176					274	276		10.1038/nature06586	http://dx.doi.org/10.1038/nature06586			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202641	Bronze, Green Submitted			2022-12-28	WOS:000252432100033
J	Glantz, L; Roche, P; Annas, GJ				Glantz, Leonard; Roche, Patricia; Annas, George J.			Rules for donations to tissue banks - What next?.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Glantz, Leonard; Roche, Patricia; Annas, George J.] Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Glantz, L (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831; Roche, Patricia/0000-0001-7884-480X; Glantz, Leonard/0000-0003-4591-2305				Andrews L.B., 2001, BODY BAZAAR MARKET H; ANNAS GJ, 1993, JAMA-J AM MED ASSOC, V270, P2346, DOI 10.1001/jama.270.19.2346; ANNAS GJ, 1993, STANDARD CARE LAW AM, P167; ANNAS GJ, 1995, GENETIC PRIVACY ACT; *COMM GUID HUM EMB, 2005, GUID HUM EMBR STEM C, P9; Crichton M., 2006, NEXT; Department of Health and Human Services, 2004, GUID RES INV COD PRI; Goldman MA, 2007, NATURE, V445, P819, DOI 10.1038/445819a; Korobkin Russell, 2007, ARIZ LAW REV, V49, P45; Shuster E, 1997, NEW ENGL J MED, V337, P1436, DOI 10.1056/NEJM199711133372006; 2005, J LAW MED ETHICS, V33, P3	11	26	27	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2008	358	3					298	303		10.1056/NEJMhle074597	http://dx.doi.org/10.1056/NEJMhle074597			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	251LS	18199870	Green Submitted, Green Published			2022-12-28	WOS:000252375600014
J	Kroner, M; Govorov, AO; Remi, S; Biedermann, B; Seidl, S; Badolato, A; Petroff, PM; Zhang, W; Barbour, R; Gerardot, BD; Warburton, RJ; Karrai, K				Kroner, M.; Govorov, A. O.; Remi, S.; Biedermann, B.; Seidl, S.; Badolato, A.; Petroff, P. M.; Zhang, W.; Barbour, R.; Gerardot, B. D.; Warburton, R. J.; Karrai, K.			The nonlinear Fano effect	NATURE			English	Article							SINGLE QUANTUM-DOT; INTERFERENCE; EMISSION	The Fano effect(1) is ubiquitous in the spectroscopy of, for instance, atoms(1,2), bulk solids(3,4) and semiconductor heterostructures(5-7). It arises when quantum interference takes place between two competing optical pathways, one connecting the energy ground state and an excited discrete state, the other connecting the ground state with a continuum of energy states. The nature of the interference changes rapidly as a function of energy, giving rise to characteristically asymmetric lineshapes. The Fano effect is particularly important in the interpretation of electronic transport(5,6) and optical spectra(7,8) in semiconductors. Whereas Fano's original theory(1) applies to the linear regime at low power, at higher power a laser field strongly admixes the states and the physics becomes rich, leading, for example, to a remarkable interplay of coherent nonlinear transitions(9). Despite the general importance of Fano physics, this nonlinear regime has received very little attention experimentally, presumably because the classic autoionization processes(2), the original test-bed of Fano's ideas(1), occur in an inconvenient spectral region, the deep ultraviolet. Here we report experiments that access the nonlinear Fano regime by using semiconductor quantum dots, which allow both the continuum states to be engineered and the energies to be rescaled to the near infrared. We measure the absorption cross- section of a single quantum dot and discover clear Fano resonances that we can tune with the device design or even in situ with a voltage bias. In parallel, we develop a nonlinear theory applicable to solid- state systems with fast relaxation of carriers. In the nonlinear regime, the visibility of the Fano quantum interferences increases dramatically, affording a sensitive probe of continuum coupling. This could be a unique method to detect weak couplings of a two- level quantum system ( qubits), which should ideally be decoupled from all other states.	[Govorov, A. O.; Zhang, W.] Ohio Univ, Dept Phys & Astron, Athens, OH 45701 USA; [Kroner, M.; Remi, S.; Biedermann, B.; Seidl, S.; Karrai, K.] Univ Munich, Ctr Nanosci, D-80539 Munich, Germany; [Kroner, M.; Remi, S.; Biedermann, B.; Seidl, S.; Karrai, K.] Univ Munich, Dept Phys, D-80539 Munich, Germany; [Badolato, A.; Petroff, P. M.] Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA; [Barbour, R.; Gerardot, B. D.; Warburton, R. J.] Heriot Watt Univ, Sch Engn & Phys Sci, Edinburgh EH14 4AS, Midlothian, Scotland	University System of Ohio; Ohio University; University of Munich; University of Munich; University of California System; University of California Santa Barbara; Heriot Watt University	Govorov, AO (corresponding author), Ohio Univ, Dept Phys & Astron, Athens, OH 45701 USA.	govorov@helios.phy.ohiou.edu	Badolato, Antonio/E-9778-2015; Warburton, Richard/ABC-3609-2021; Gerardot, Brian D./AHB-1102-2022; Gerardot, Brian D/D-2418-2009	Gerardot, Brian D/0000-0002-0279-898X; Badolato, Antonio/0000-0001-8266-2902	EPSRC [EP/E037992/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E037992/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Alen B, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2354431; Atature M, 2007, NAT PHYS, V3, P101, DOI 10.1038/nphys521; BarAd S, 1997, PHYS REV LETT, V78, P1363, DOI 10.1103/PhysRevLett.78.1363; Bayer M, 2001, PHYS REV LETT, V86, P3168, DOI 10.1103/PhysRevLett.86.3168; CERDEIRA F, 1973, PHYS REV B, V8, P4734, DOI 10.1103/PhysRevB.8.4734; Faist J, 1997, NATURE, V390, P589, DOI 10.1038/37562; FANO U, 1961, PHYS REV, V124, P1866, DOI 10.1103/PhysRev.124.1866; Gammon D, 2002, PHYS TODAY, V55, P36, DOI 10.1063/1.1522165; Govorov AO, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.241307; Hase M, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.212301; Hennessy K, 2007, NATURE, V445, P896, DOI 10.1038/nature05586; Hogele A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.217401; KRONER M, IN PRESS PHYSICA E; Loudon R., 2000, QUANTUM THEORY LIGHT; MADDEN RP, 1963, PHYS REV LETT, V10, P516, DOI 10.1103/PhysRevLett.10.516; Peter E, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.067401; Reithmaier JP, 2004, NATURE, V432, P197, DOI 10.1038/nature02969; RZAZEWSKI K, 1981, PHYS REV LETT, V47, P408, DOI 10.1103/PhysRevLett.47.408; RZAZEWSKI K, 1983, PHYS REV A, V27, P2026, DOI 10.1103/PhysRevA.27.2026; Schmidt H, 1997, APPL PHYS LETT, V70, P3455, DOI 10.1063/1.119199; Seidl S, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.195339; Smith JM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.197402; Stufler S, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.121301; WAGNER J, 1985, PHYS REV B, V32, P8071, DOI 10.1103/PhysRevB.32.8071; Warburton RJ, 2000, NATURE, V405, P926, DOI 10.1038/35016030; Yoshie T, 2004, NATURE, V432, P200, DOI 10.1038/nature03119; Zhang W, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.146804; Zrenner A, 2002, NATURE, V418, P612, DOI 10.1038/nature00912	28	185	185	3	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2008	451	7176					311	314		10.1038/nature06506	http://dx.doi.org/10.1038/nature06506			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202652				2022-12-28	WOS:000252432100044
J	Plikus, MV; Mayer, JA; de la Cruz, D; Baker, RE; Maini, PK; Maxson, R; Chuong, CM				Plikus, Maksim V.; Mayer, Julie Ann; de la Cruz, Damon; Baker, Ruth E.; Maini, Philip K.; Maxson, Robert; Chuong, Cheng-Ming			Cyclic dermal BMP signalling regulates stem cell activation during hair regeneration	NATURE			English	Article							SELF-RENEWAL; SKIN; GROWTH; INDUCTION; FOLLICLES; NICHE; DIFFERENTIATION; MODULATION; ALOPECIA; HEDGEHOG	In the age of stem cell engineering it is critical to understand how stem cell activity is regulated during regeneration. Hairs are mini-organs that undergo cyclic regeneration throughout adult life(1,) and are an important model for organ regeneration. Hair stem cells located in the follicle bulge(2) are regulated by the surrounding microenvironment, or niche(3). The activation of such stem cells is cyclic, involving periodic beta-catenin activity(4-7). In the adult mouse, regeneration occurs in waves in a follicle population, implying coordination among adjacent follicles and the extrafollicular environment. Here we show that unexpected periodic expression of bone morphogenetic protein 2 ( Bmp2) and Bmp4 in the dermis regulates this process. This BMP cycle is out of phase with the WNT/beta-catenin cycle, thus dividing the conventional telogen into new functional phases: one refractory and the other competent for hair regeneration, characterized by high and low BMP signalling, respectively. Overexpression of noggin, a BMP antagonist, in mouse skin resulted in a markedly shortened refractory phase and faster propagation of the regenerative wave. Transplantation of skin from this mutant onto a wild- type host showed that follicles in donor and host can affect their cycling behaviours mutually, with the outcome depending on the equilibrium of BMP activity in the dermis. Administration of BMP4 protein caused the competent region to become refractory. These results show that BMPs may be the long- sought 'chalone' inhibitors of hair growth postulated by classical experiments. Taken together, results presented in this study provide an example of hierarchical regulation of local organ stem cell homeostasis by the inter- organ macro-environment. The expression of Bmp2 in subcutaneous adipocytes indicates physiological integration between these two thermoregulatory organs. Our findings have practical importance for studies using mouse skin as a model for carcinogenesis, intracutaneous drug delivery and stem cell engineering studies, because they highlight the acute need to differentiate supportive versus inhibitory regions in the host skin.	[Plikus, Maksim V.; Mayer, Julie Ann; de la Cruz, Damon; Chuong, Cheng-Ming] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Baker, Ruth E.; Maini, Philip K.] Math Inst, Ctr Math Biol, Oxford OX1 3LB, England; [Maini, Philip K.] Univ Oxford, Dept Biochem, Oxford Ctr Integrat Syst Biol, Oxford OX1 3QU, England; [Maxson, Robert] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA	University of Southern California; University of Oxford; University of Oxford; University of Southern California	Chuong, CM (corresponding author), Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA.	cmchuong@usc.edu		Baker, Ruth/0000-0002-6304-9333; Plikus, Maksim/0000-0002-8845-2559	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042177, R01AR047364] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR042177-13, R01 AR042177-14, R01 AR047364-06, R01 AR047364-05, R01 AR042177, R01 AR047364] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Botchkarev VA, 1999, NAT CELL BIOL, V1, P158, DOI 10.1038/11078; Botchkarev VA, 2001, FASEB J, V15, P2205, DOI 10.1096/fj.01-0207com; CHASE HB, 1954, PHYSIOL REV, V34, P113, DOI 10.1152/physrev.1954.34.1.113; DURWARD A, 1949, J ANAT, V83, P325; EBLING FJ, 1961, J EMBRYOL EXP MORPH, V9, P285; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Iguchi M, 2001, J INVEST DERMATOL, V117, P1349, DOI 10.1046/j.0022-202x.2001.01606.x; JOHNSON E, 1958, J ENDOCRINOL, V16, P351, DOI 10.1677/joe.0.0160351; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Lo Celso C, 2004, DEVELOPMENT, V131, P1787, DOI 10.1242/dev.01052; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Ma L, 2003, DEVELOPMENT, V130, P379, DOI 10.1242/dev.00201; Maurer M, 1997, AM J PATHOL, V150, P1433; Militzer K, 2001, CELLS TISSUES ORGANS, V168, P285, DOI 10.1159/000047845; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Oro AE, 2003, DEV BIOL, V255, P238, DOI 10.1016/S0012-1606(02)00042-8; PAUS R, 1990, BRIT J DERMATOL, V122, P777, DOI 10.1111/j.1365-2133.1990.tb06266.x; Plikus M, 2004, AM J PATHOL, V164, P1099, DOI 10.1016/S0002-9440(10)63197-5; PLIKUS MV, 2007, IN PRESS J INVEST DE; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; Sausville EA, 2006, CANCER RES, V66, P3351, DOI 10.1158/0008-5472.CAN-05-3627; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Suzuki N, 2003, P NATL ACAD SCI USA, V100, P9680, DOI 10.1073/pnas.1731184100; Wu P, 2004, INT J DEV BIOL, V48, P249, DOI 10.1387/ijdb.15272390; Zhang JW, 2006, STEM CELLS, V24, P2826, DOI 10.1634/stemcells.2005-0544; Zheng Y, 2005, J INVEST DERMATOL, V124, P867, DOI 10.1111/j.0022-202X.2005.23716.x	30	490	523	1	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2008	451	7176					340	U8		10.1038/nature06457	http://dx.doi.org/10.1038/nature06457			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202659	Green Accepted, Green Submitted			2022-12-28	WOS:000252432100051
J	Raymo, ME; Huybers, P				Raymo, Maureen E.; Huybers, Peter			Unlocking the mysteries of the ice ages	NATURE			English	Article							CLIMATE	Much progress has been made towards understanding what caused the waxing and the waning of the great ice sheets, but a complete theory of the ice ages is still elusive.	[Raymo, Maureen E.] Boston Univ, Dept Earth Sci, Boston, MA 02215 USA; [Huybers, Peter] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	Boston University; Harvard University	Raymo, ME (corresponding author), Boston Univ, Dept Earth Sci, 685 Commonwealth Ave, Boston, MA 02215 USA.	raymo@bu.edu	Raymo, Maureen E/A-1270-2012	Huybers, Peter/0000-0002-3734-8145				Clark PU, 1998, PALEOCEANOGRAPHY, V13, P1, DOI 10.1029/97PA02660; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Huybers P, 2006, SCIENCE, V313, P508, DOI 10.1126/science.1125249; HUYBERS PJ, IN PRESS PALEOCEANOG, pA3201; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; NAISH T, 2007, GEOTIMES         OCT, P30; PISIAS NG, 1981, EARTH PLANET SC LETT, V52, P450, DOI 10.1016/0012-821X(81)90197-7; Raymo ME, 2006, SCIENCE, V313, P492, DOI 10.1126/science.1123296	8	62	70	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2008	451	7176					284	285		10.1038/nature06589	http://dx.doi.org/10.1038/nature06589			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202644	Bronze			2022-12-28	WOS:000252432100036
J	Brochard, L				Brochard, Laurent			Sedation in the intensive-care unit: good and bad?	LANCET			English	Editorial Material							MECHANICAL VENTILATION		[Brochard, Laurent] Ctr Hosp Albert Chenevier Henri Mondor, AP HP, Med Intens Care Unit, Creteil, France; [Brochard, Laurent] INSERM, U841, F-94000 Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Brochard, L (corresponding author), Ctr Hosp Albert Chenevier Henri Mondor, AP HP, Med Intens Care Unit, Creteil, France.	laurent.brochard@hmn.aphp.fr						Cook DJ, 2001, CHEST, V120, p469S, DOI 10.1378/chest.120.6_suppl.469S; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Krishnan JA, 2004, AM J RESP CRIT CARE, V169, P673, DOI 10.1164/rccm.200306-761OC; THORENS JB, 1995, CRIT CARE MED, V23, P1807, DOI 10.1097/00003246-199511000-00004	5	11	12	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 12	2008	371	9607					95	97		10.1016/S0140-6736(08)60082-3	http://dx.doi.org/10.1016/S0140-6736(08)60082-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	252ND	18191669				2022-12-28	WOS:000252452300006
J	Ham, C				Ham, Chris			Incentives, priorities, and clinical integration in the NHS	LANCET			English	Editorial Material									Univ Birmingham, Hlth Serv Management Ctr, Birmingham B15 2RT, W Midlands, England	University of Birmingham	Ham, C (corresponding author), Univ Birmingham, Hlth Serv Management Ctr, Birmingham B15 2RT, W Midlands, England.	c.j.ham@bham.ac.uk						Audit Commission, 2007, PUTT COMM PRACT IMPL; Enthoven AC, 2002, BRIT MED J, V324, P143; Feachem RGA, 2002, BMJ-BRIT MED J, V324, P135, DOI 10.1136/bmj.324.7330.135; Ham C, 2007, CLIN INTEGRATED SYST; *HEALTHC COMM, 2007, IMPR HAV BEEN MAD SE; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; *SECR STAT HLTH, 2004, NHS IMPR PLAN PUTT; 2007, LANCET, V370, P1393	8	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 12	2008	371	9607					98	100		10.1016/S0140-6736(08)60084-7	http://dx.doi.org/10.1016/S0140-6736(08)60084-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	252ND	18191671				2022-12-28	WOS:000252452300008
J	Rosland, AM				Rosland, A. -M.			Assuming the worst	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BIAS					arosland@umich.edu		Rosland, Ann-Marie/0000-0002-5809-5861				Burgess D, 2007, J GEN INTERN MED, V22, P882, DOI 10.1007/s11606-007-0160-1; Green AR, 2007, J GEN INTERN MED, V22, P1231, DOI 10.1007/s11606-007-0258-5; Smedley B, 2002, UNEQUAL TREATMENT CO, P169	3	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2008	299	2					144	145		10.1001/jama.2007.54-b	http://dx.doi.org/10.1001/jama.2007.54-b			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UN	18182591				2022-12-28	WOS:000252182600001
J	Spruit, MA; Vanderhoven-Augustin, I; Janssen, PP; Wouters, EFM				Spruit, Martijn A.; Vanderhoven-Augustin, Ingrid; Janssen, Paul P.; Wouters, Emiel F. M.			Integration of pulmonary rehabilitation in COPD	LANCET			English	Editorial Material							DISEASE; MANAGEMENT		[Spruit, Martijn A.; Vanderhoven-Augustin, Ingrid; Janssen, Paul P.; Wouters, Emiel F. M.] Ctr Integrated Rehabil Organ Failure, NL-6085 NM Horn, Netherlands; [Wouters, Emiel F. M.] Univ Hosp Maastricht, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC)	Spruit, MA (corresponding author), Ctr Integrated Rehabil Organ Failure, NL-6085 NM Horn, Netherlands.	martijnspruit@proteion.nl	Wouters, Emiel/ABD-6200-2021					Baarends EM, 1997, EUR RESPIR J, V10, P2807, DOI 10.1183/09031936.97.10122807; Griffiths TL, 2001, THORAX, V56, P779, DOI 10.1136/thorax.56.10.779; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Jones Paul W, 2005, COPD, V2, P75; LACASSE Y, 2007, COCHRANE DB SYST REV, V3; Marquis Karine, 2005, J Cardiopulm Rehabil, V25, P226, DOI 10.1097/00008483-200507000-00010; Nici L, 2006, AM J RESP CRIT CARE, V173, P1390, DOI 10.1164/rccm.200508-1211ST; Redelmeier DA, 1997, AM J RESP CRIT CARE, V155, P1278, DOI 10.1164/ajrccm.155.4.9105067; Ries AL, 2007, CHEST, V131, p4S, DOI 10.1378/chest.06-2418; Rutten FH, 2005, EUR HEART J, V26, P1887, DOI 10.1093/eurheartj/ehi291; Spruit MA, 2007, SPORTS MED, V37, P501, DOI 10.2165/00007256-200737060-00004; Weitzenblum E, 2004, SLEEP MED REV, V8, P281, DOI 10.1016/j.smrv.2004.03.006; Wilt TJ, 2007, ANN INTERN MED, V147, P639, DOI 10.7326/0003-4819-147-9-200711060-00009; Wouters EFM, 2004, LANCET, V364, P883, DOI 10.1016/S0140-6736(04)16984-5	14	93	95	1	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 5	2008	371	9606					12	13		10.1016/S0140-6736(08)60048-3	http://dx.doi.org/10.1016/S0140-6736(08)60048-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248YH	18177760				2022-12-28	WOS:000252192600010
J	Ahel, I; Ahel, D; Matsusaka, T; Clark, AJ; Pines, J; Boulton, SJ; West, SC				Ahel, Ivan; Ahel, Dragana; Matsusaka, Takahiro; Clark, Allison J.; Pines, Jonathon; Boulton, Simon J.; West, Stephen C.			Poly(ADP-ribose)-binding zinc finger motifs in DNA repair/checkpoint proteins	NATURE			English	Article							VERTEBRATE SOMATIC-CELLS; DAMAGE CHECKPOINT; MAMMALIAN-CELLS; STRAND BREAKS; CHFR; ENTRY; POLY(ADP-RIBOSYL)ATION; POLYMERASE; RESPONSES; PROPHASE	Post- translational modification ( PTM) of proteins plays an important part in mediating protein interactions and/ or the recruitment of specific protein targets(1,2). PTM can be mediated by the addition of functional groups ( for example, acetylation or phosphorylation), peptides ( for example, ubiquitylation or sumoylation), or nucleotides ( for example, poly( ADP- ribosyl) ation). Poly( ADP- ribosyl) ation often involves the addition of long chains of ADP- ribose units, linked by glycosidic ribose - ribose bonds(3), and is critical for a wide range of processes, including DNA repair, regulation of chromosome structure, transcriptional regulation, mitosis and apoptosis(4). Here we identify a novel poly( ADP- ribose)- binding zinc finger ( PBZ) motif in a number of eukaryotic proteins involved in the DNA damage response and checkpoint regulation. The PBZ motif is also required for posttranslational poly( ADP- ribosyl) ation. We demonstrate interaction of poly( ADP- ribose) with this motif in two representative human proteins, APLF ( aprataxin PNK- like factor) and CHFR ( checkpoint protein with FHA and RING domains), and show that the actions of CHFR in the antephase checkpoint are abrogated by mutations in PBZ or by inhibition of poly( ADP- ribose) synthesis.	[Ahel, Dragana; Clark, Allison J.; Boulton, Simon J.] Canc Res UK London Res Inst, Clare Hall Labs, DNA Damage Response Lab, S Mimms EN6 3LD, Herts, England; [Ahel, Ivan; West, Stephen C.] Canc Res UK London Res Inst, Clare Hall Labs, Genet Recombinat Lab, S Mimms EN6 3LD, Herts, England; [Matsusaka, Takahiro; Pines, Jonathon] Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QR, England	Cancer Research UK; Cancer Research UK	Boulton, SJ (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, DNA Damage Response Lab, S Mimms EN6 3LD, Herts, England.	simon.boulton@cancer.org.uk; stephen.west@cancer.org.uk		Ahel, Ivan/0000-0002-9446-3756; Pines, Jonathon/0000-0002-5227-6004; West, Stephen/0000-0001-8848-9418				Bekker-Jensen S, 2007, J BIOL CHEM, V282, P19638, DOI 10.1074/jbc.C700060200; Bothos J, 2003, ONCOGENE, V22, P7101, DOI 10.1038/sj.onc.1206831; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Gagne JP, 2003, BIOCHEM J, V371, P331, DOI 10.1042/BJ20021675; Galande S, 1999, J BIOL CHEM, V274, P20521, DOI 10.1074/jbc.274.29.20521; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Iles N, 2007, MOL CELL BIOL, V27, P3793, DOI 10.1128/MCB.02269-06; Kang DM, 2002, J CELL BIOL, V156, P249, DOI 10.1083/jcb.200108016; Kanno SI, 2007, EMBO J, V26, P2094, DOI 10.1038/sj.emboj.7601663; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Leppard JB, 2003, MOL CELL BIOL, V23, P5919, DOI 10.1128/MCB.23.16.5919-5927.2003; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Matsusaka T, 2004, J CELL BIOL, V166, P507, DOI 10.1083/jcb.200401139; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; MINAGA T, 1983, J BIOL CHEM, V258, P5726; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Rieder CL, 1998, J CELL BIOL, V142, P1013, DOI 10.1083/jcb.142.4.1013; Rieder CL, 2000, COLD SPRING HARB SYM, V65, P369, DOI 10.1101/sqb.2000.65.369; Scolnick DM, 2000, NATURE, V406, P430, DOI 10.1038/35019108; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Walsh C., 2006, POSTRANSLATIONAL MOD; Yu XC, 2005, NAT GENET, V37, P401, DOI 10.1038/ng1538	26	305	316	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2008	451	7174					81	U12		10.1038/nature06420	http://dx.doi.org/10.1038/nature06420			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247KZ	18172500				2022-12-28	WOS:000252079300038
J	Graversen, RG; Mauritsen, T; Tjernstrom, M; Kallen, E; Svensson, G				Graversen, Rune G.; Mauritsen, Thorsten; Tjernstrom, Michael; Kallen, Erland; Svensson, Gunilla			Vertical structure of recent Arctic warming	NATURE			English	Article							SURFACE AIR-TEMPERATURE; CLIMATE-CHANGE; POLAR AMPLIFICATION; CIRCULATION	Near- surface warming in the Arctic has been almost twice as large as the global average over recent decades(1-5) - a phenomenon that is known as the 'Arctic amplification'. The underlying causes of this temperature amplification remain uncertain. The reduction in snow and ice cover that has occurred over recent decades(6,7) may have played a role(5,8). Climate model experiments indicate that when global temperature rises, Arctic snow and ice cover retreats, causing excessive polar warming(9-11). Reduction of the snow and ice cover causes albedo changes, and increased refreezing of sea ice during the cold season and decreases in sea- ice thickness both increase heat flux from the ocean to the atmosphere. Changes in oceanic and atmospheric circulation, as well as cloud cover, have also been proposed to cause Arctic temperature amplification(12-17). Here we examine the vertical structure of temperature change in the Arctic during the late twentieth century using reanalysis data. We find evidence for temperature amplification well above the surface. Snow and ice feedbacks cannot be the main cause of the warming aloft during the greater part of the year, because these feedbacks are expected to primarily affect temperatures in the lowermost part of the atmosphere, resulting in a pattern of warming that we only observe in spring. A significant proportion of the observed temperature amplification must therefore be explained by mechanisms that induce warming above the lowermost part of the atmosphere. We regress the Arctic temperature field on the atmospheric energy transport into the Arctic and find that, in the summer half- year, a significant proportion of the vertical structure of warming can be explained by changes in this variable. We conclude that changes in atmospheric heat transport may be an important cause of the recent Arctic temperature amplification.	[Graversen, Rune G.; Mauritsen, Thorsten; Tjernstrom, Michael; Kallen, Erland; Svensson, Gunilla] Univ Stockholm, Dept Meteorol, S-10691 Stockholm, Sweden	Stockholm University	Graversen, RG (corresponding author), Univ Stockholm, Dept Meteorol, S-10691 Stockholm, Sweden.	rune@misu.su.se	Graversen, Rune G/C-3956-2016; Tjernström, Michael/AAF-3481-2020; Mauritsen, Thorsten/G-5880-2013	Mauritsen, Thorsten/0000-0003-1418-4077; Tjernstrom, Michael/0000-0002-6908-7410; Graversen, Rune/0000-0003-4899-553X				Alexeev VA, 2005, CLIM DYNAM, V24, P655, DOI 10.1007/s00382-005-0018-3; Cavalieri DJ, 1997, SCIENCE, V278, P1104, DOI 10.1126/science.278.5340.1104; Chapman WL, 2007, J CLIMATE, V20, P609, DOI 10.1175/JCLI4026.1; Graversen RG, 2006, J CLIMATE, V19, P5422, DOI 10.1175/JCLI3906.1; Hansen J, 2007, ATMOS CHEM PHYS, V7, P2287, DOI 10.5194/acp-7-2287-2007; Hansen J, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD005776; Holland MM, 2003, CLIM DYNAM, V21, P221, DOI 10.1007/s00382-003-0332-6; Intrieri JM, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2000JC000439; Johannessen OM, 2004, TELLUS A, V56, P328, DOI 10.1111/j.1600-0870.2004.00060.x; Jones PD, 1999, REV GEOPHYS, V37, P173, DOI 10.1029/1999RG900002; MANABE S, 1975, J ATMOS SCI, V32, P3, DOI 10.1175/1520-0469(1975)032<0003:TEODTC>2.0.CO;2; Moritz RE, 2002, SCIENCE, V297, P1497, DOI 10.1126/science.1076522; OORT AH, 1983, ADV GEOPHYS, V25, P355; Polyakov IV, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL011111; Quadrelli R, 2004, J CLIMATE, V17, P3728, DOI 10.1175/1520-0442(2004)017<3728:ASLFFI>2.0.CO;2; Rigor IG, 2000, J CLIMATE, V13, P896, DOI 10.1175/1520-0442(2000)013<0896:VISATO>2.0.CO;2; Serreze MC, 2006, CLIMATIC CHANGE, V76, P241, DOI 10.1007/s10584-005-9017-y; Simon C., 2005, ARCTIC CLIMATE IMPAC; Solomon S., 2007, PHYS SCI BASIS WORKI; Stroeve JC, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021810; Thompson DWJ, 2001, SCIENCE, V293, P85, DOI 10.1126/science.1058958; Thompson DWJ, 1998, GEOPHYS RES LETT, V25, P1297, DOI 10.1029/98GL00950; TRENBERTH KE, 1991, J CLIMATE, V4, P707, DOI 10.1175/1520-0442(1991)004<0707:CDFGAC>2.0.CO;2; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; Wang XJ, 2005, J CLIMATE, V18, P2575, DOI 10.1175/JCLI3439.1; Wu QG, 2004, J CLIMATE, V17, P2139, DOI 10.1175/1520-0442(2004)017<2139:ACAOCT>2.0.CO;2	26	402	418	4	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2008	451	7174					53	U4		10.1038/nature06502	http://dx.doi.org/10.1038/nature06502			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247KZ	18172495				2022-12-28	WOS:000252079300031
J	Walsh, PC; DeWeese, TL; Eisenberger, MA				Walsh, Patrick C.; DeWeese, Theodore L.; Eisenberger, Mario A.			Localized prostate cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RADICAL RETROPUBIC PROSTATECTOMY; MODULATED RADIATION-THERAPY; POSITIVE SURGICAL MARGIN; RANDOMIZED-TRIAL; PREOPERATIVE NOMOGRAM; CONSENSUS CONFERENCE; PATHOLOGICAL STAGE; ANTIGEN LEVELS; PARTIN TABLES; RECURRENCE	A 68-year-old man presents with newly diagnosed prostate cancer. Over the past 3 years, his serum prostate- specific antigen ( PSA) level has been slowly and steadily increasing ( from 4.0 ng per milliliter to 4.3 ng per milliliter to 4.7 ng per milliliter). His digital rectal examination is normal; the prostate volume, estimated by means of ultrasonography, is 48 ml, and a needle- biopsy specimen reveals an adenocarcinoma with a Gleason score of 6 ( the sum of the numbers associated with the most common and second most common histologic patterns - in this case, 3 plus 3). The adenocarcinoma involves 10% of 1 of the 12 cores. The patient otherwise is well, is taking no medication, and has normal sexual function. How should his case be managed?	Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD 21287 USA; Johns Hopkins Med Inst, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA; Johns Hopkins Med Inst, Dept Urol Radiat Oncol & Mol Radiat Sci, Baltimore, MD 21287 USA; Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Walsh, PC (corresponding author), Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, 600 N Wolfe St,Phipps 554, Baltimore, MD 21287 USA.	pwalsh@jhmi.edu						Andriole GL, 2005, JNCI-J NATL CANCER I, V97, P433, DOI 10.1093/jnci/dji065; Augustin H, 2004, J UROLOGY, V171, P177, DOI 10.1097/01.ju.0000099827.77355.a7; Aus G, 2006, EUR UROL, V50, P927, DOI 10.1016/j.eururo.2006.07.011; Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739; Brown MW, 2007, PROSTATE CANCER P D, V10, P189, DOI 10.1038/sj.pcan.4500938; CARTER HB, 1992, JAMA-J AM MED ASSOC, V267, P2215, DOI 10.1001/jama.267.16.2215; Chuang AY, 2007, J UROLOGY, V178, P1306, DOI 10.1016/j.juro.2007.05.159; D'Amico AV, 2004, NEW ENGL J MED, V351, P125, DOI 10.1056/NEJMoa032975; Epstein JI, 2006, ADV ANAT PATHOL, V13, P57, DOI 10.1097/01.pap.0000202017.78917.18; Epstein JI, 1998, J UROLOGY, V160, P2407, DOI 10.1016/S0022-5347(01)62200-6; Etzioni R, 2002, J NATL CANCER I, V94, P981; Freedland SJ, 2006, UROLOGY, V67, P458, DOI 10.1016/j.urology.2005.12.026; Greene KL, 2004, J UROLOGY, V171, P2255, DOI 10.1097/01.ju.0000127733.01845.57; Gretzer MB, 2002, UROLOGY, V60, P1034, DOI 10.1016/S0090-4295(02)01997-0; Han M, 2003, J UROLOGY, V169, P517, DOI 10.1016/S0022-5347(05)63946-8; HAN M, 2007, J UROL S110, V177; Holmberg L, 2006, HEMATOL ONCOL CLIN N, V20, P845, DOI 10.1016/j.hoc.2006.03.007; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Klotz L, 2005, J CLIN ONCOL, V23, P8165, DOI 10.1200/JCO.2005.03.3134; Kundu SD, 2004, J UROLOGY, V172, P2227, DOI 10.1097/01.ju.0000145222.94455.73; Litwin MS, 2007, CANCER, V109, P2239, DOI 10.1002/cncr.22676; Makarov DV, 2007, UROLOGY, V69, P1095, DOI 10.1016/j.urology.2007.03.042; Mills N, 2006, CONTEMP CLIN TRIALS, V27, P413, DOI 10.1016/j.cct.2006.04.008; Morgan PB, 2007, INT J RADIAT ONCOL, V67, P1074, DOI 10.1016/j.ijrobp.2006.10.023; National Comprehensive Cancer Network (NCCN), 2007, CLIN PRACT GUID ONC; Nelson B, 2007, J UROLOGY, V177, P929, DOI 10.1016/j.juro.2006.10.070; Penson DF, 2005, J UROLOGY, V173, P1701, DOI 10.1097/01.ju.0000154637.38262.3a; Pollack A, 2002, INT J RADIAT ONCOL, V53, P1097, DOI 10.1016/S0360-3016(02)02829-8; Porter CR, 2006, J UROLOGY, V176, P569, DOI 10.1016/j.juro.2006.03.094; Postma R, 2007, EUR UROL, V52, P89, DOI 10.1016/j.eururo.2007.01.030; Roach M, 2006, INT J RADIAT ONCOL, V65, P965, DOI 10.1016/j.ijrobp.2006.04.029; Saranchuk JW, 2005, J CLIN ONCOL, V23, P4146, DOI 10.1200/JCO.2005.12.922; Stephenson AJ, 2006, JNCI-J NATL CANCER I, V98, P715, DOI 10.1093/jnci/djj190; Thompson I, 2007, J UROLOGY, V177, P2106, DOI 10.1016/j.juro.2007.03.003; Touijer K, 2005, J UROLOGY, V173, P765, DOI 10.1097/01.ju.0000146574.52402.d5; Vickers AJ, 2007, JNCI-J NATL CANCER I, V99, P1171, DOI 10.1093/jnci/djm060; Walsh PC, 2007, J UROLOGY, V177, P1632, DOI 10.1016/j.juro.2007.01.012; WALSH PC, 2007, DR P WALSHS GUIDE SU; Warlick C, 2006, JNCI-J NATL CANCER I, V98, P355, DOI 10.1093/jnci/djj072; WILT TJ, 1994, J UROLOGY, V152, P1910, DOI 10.1016/S0022-5347(17)32413-8; Zelefsky MJ, 2007, INT J RADIAT ONCOL, V67, P327, DOI 10.1016/j.ijrobp.2006.08.056; Zelefsky MJ, 2006, J UROLOGY, V176, P1415, DOI 10.1016/j.juro.2006.06.002; Zietman AL, 2005, JAMA-J AM MED ASSOC, V294, P1233, DOI 10.1001/jama.294.10.1233	43	121	126	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2007	357	26					2696	2705		10.1056/NEJMcp0706784	http://dx.doi.org/10.1056/NEJMcp0706784			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	245UO	18160689				2022-12-28	WOS:000251964500008
J	Wald, HL; Kramer, AM				Wald, Heidi L.; Kramer, Andrew M.			Nonpayment for harms resulting from medical care - Catheter-associated urinary tract infections	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NOSOCOMIAL INFECTIONS; PREVENTION; PHYSICIANS; FEEDBACK		Univ Colorado Denver, Div Hlth Care Policy & Res, Aurora, CO 80111 USA; Hlth Sci Ctr, Aurora, CO 80111 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Wald, HL (corresponding author), Univ Colorado Denver, Div Hlth Care Policy & Res, 13611 E Colfax Ave,Ste 100, Aurora, CO 80111 USA.	heidi.wald@uchsc.edu						Centers for Medicare and Medicaid Services (CMS) HHS, 2007, Fed Regist, V72, P47129; Coffey R, 2006, HCUP METHODS SERIES; Dumigan D G, 1998, Clin Perform Qual Health Care, V6, P172; DUNN S, 2000, MANAGEMENT SHORT TER; Goetz AM, 1999, AM J INFECT CONTROL, V27, P402, DOI 10.1016/S0196-6553(99)70005-2; HALEY RW, 1985, AM J EPIDEMIOL, V121, P159, DOI 10.1093/oxfordjournals.aje.a113988; HALEY RW, 1981, AM J MED, V70, P947, DOI 10.1016/0002-9343(81)90561-1; JAIN P, 1995, ARCH INTERN MED, V155, P1425, DOI 10.1001/archinte.155.13.1425; Jarvis WR, 1996, INFECT CONT HOSP EP, V17, P552; KRIEGER JN, 1983, J INFECT DIS, V148, P57, DOI 10.1093/infdis/148.1.57; Leatherman S, 2003, HEALTH AFFAIR, V22, P17, DOI 10.1377/hlthaff.22.2.17; MICHELSON JD, 1988, NEW ENGL J MED, V319, P321; Reilly L, 2006, AACN ADV CRIT CARE, V17, P272, DOI 10.1097/01256961-200607000-00007; Saint S, 2000, AM J MED, V109, P476, DOI 10.1016/S0002-9343(00)00531-3; Saint S, 2000, AM J INFECT CONTROL, V28, P68, DOI 10.1016/S0196-6553(00)90015-4; Topal J, 2005, AM J MED QUAL, V20, P121, DOI 10.1177/1062860605276074; WALD HL, IN PRESS ARCH SURG; Wong ES, GUIDELINE PREVENTION	18	110	110	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2007	298	23					2782	2784		10.1001/jama.298.23.2782	http://dx.doi.org/10.1001/jama.298.23.2782			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242HK	18165672				2022-12-28	WOS:000251716000024
J	Hosten, O; Kwiat, P				Hosten, Onur; Kwiat, Paul			Observation of the spin Hall effect of light via weak measurements	SCIENCE			English	Article							BERRY TOPOLOGICAL PHASE; ORBIT INTERACTION; REFLECTION; DYNAMICS; PHOTONS	We have detected a spin-dependent displacement perpendicular to the refractive index gradient for photons passing through an air-glass interface. The effect is the photonic version of the spin Hall effect in electronic systems, indicating the universality of the effect for particles of different nature. Treating the effect as a weak measurement of the spin projection of the photons, we used a preselection and postselection technique on the spin state to enhance the original displacement by nearly four orders of magnitude, attaining sensitivity to displacements of similar to 1 angstrom. The spin Hall effect can be used for manipulating photonic angular momentum states, and the measurement technique holds promise for precision metrology.	[Hosten, Onur; Kwiat, Paul] Univ Illinois, Dept Phys, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Hosten, O (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	hosten@uiuc.edu						AHARONOV Y, 1990, PHYS REV A, V41, P11, DOI 10.1103/PhysRevA.41.11; BERRY MV, 1984, PROC R SOC LON SER-A, V392, P45, DOI 10.1098/rspa.1984.0023; Bliokh KY, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.066609; Bliokh KY, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.043901; Bliokh KY, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.073903; Bliokh KY, 2004, PHYS LETT A, V333, P181, DOI 10.1016/j.physleta.2004.10.035; Bliokh KY, 2005, OPT COMMUN, V250, P321, DOI 10.1016/j.optcom.2005.03.020; Chang MC, 1996, PHYS REV B, V53, P7010, DOI 10.1103/PhysRevB.53.7010; CHIAO RY, 1986, PHYS REV LETT, V57, P933, DOI 10.1103/PhysRevLett.57.933; DOOGHIN AV, 1992, PHYS REV A, V45, P8204, DOI 10.1103/PhysRevA.45.8204; FEDOROV FI, 1955, DOKL AKAD NAUK SSSR+, V105, P465; GOOS F, 1947, ANN PHYS-BERLIN, V1, P333, DOI 10.1002/andp.19474360704; Gosselin P, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.084035; IMBERT C, 1972, PHYS REV D, V5, P787, DOI 10.1103/PhysRevD.5.787; Leyder C, 2007, NAT PHYS, V3, P628, DOI 10.1038/nphys676; LIBERMAN VS, 1992, PHYS REV A, V46, P5199, DOI 10.1103/PhysRevA.46.5199; Murakami S, 2003, SCIENCE, V301, P1348, DOI 10.1126/science.1087128; Onoda M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.083901; Onoda M, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.066610; Padgett M, 2004, PHYS TODAY, V57, P35, DOI 10.1063/1.1768672; Pillon F, 2004, APPL OPTICS, V43, P1863, DOI 10.1364/AO.43.001863; RITCHIE NWM, 1991, PHYS REV LETT, V66, P1107, DOI 10.1103/PhysRevLett.66.1107; Sinova J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.126603; Sundaram G, 1999, PHYS REV B, V59, P14915, DOI 10.1103/PhysRevB.59.14915; TOLLAKSEN J, 2007, J PHYS C SERIES, V70, P12015; TOMITA A, 1986, PHYS REV LETT, V57, P937, DOI 10.1103/PhysRevLett.57.937; Treps N, 2003, SCIENCE, V301, P940, DOI 10.1126/science.1086489; Wheeler J. A., 1983, QUANTUM THEORY MEASU; Wunderlich J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047204	29	1206	1231	19	314	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2008	319	5864					787	790		10.1126/science.1152697	http://dx.doi.org/10.1126/science.1152697			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18187623				2022-12-28	WOS:000252963000054
J	Minamino, T; Namba, K				Minamino, Tohru; Namba, Keiichi			Distinct roles of the FliI ATPase and proton motive force in bacterial flagellar protein export	NATURE			English	Article							III SECRETION; SALMONELLA-TYPHIMURIUM; ESCHERICHIA-COLI; CATALYTIC CYCLE; COMPONENTS; APPARATUS; OLIGOMERIZATION; SPECIFICITY; SIMILARITY; REGULATOR	Translocation of many soluble proteins across cell membranes occurs in an ATPase- driven manner. For construction of the bacterial flagellum responsible for motility, most of the components are exported by the flagellar protein export apparatus(1,2). The FliI ATPase is required for this export(3), and its ATPase activity is regulated by FliH(4); however, it is unclear how the chemical energy derived from ATP hydrolysis is used for the export process. Here we report that flagellar proteins of Salmonella enterica serovar Typhimurium are exported even in the absence of FliI. A fliH fliI double null mutant was weakly motile. Certain mutations in FlhA or FlhB, which form the core of the export gate, substantially improved protein export and motility of the double null mutant. Furthermore, proton motive force was essential for the export process. These results suggest that the FliH - FliI complex facilitates only the initial entry of export substrates into the gate, with the energy of ATP hydrolysis being used to disassemble and release the FliH - FliI complex from the protein about to be exported. The rest of the successive unfolding/ translocation process of the substrates is driven by proton motive force.	[Minamino, Tohru; Namba, Keiichi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Minamino, Tohru; Namba, Keiichi] JST, ICORP, Dynam NanoMachine Project, Suita, Osaka 5650871, Japan	Osaka University; Japan Science & Technology Agency (JST)	Namba, K (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.	keiichi@fbs.osaka-u.ac.jp	Namba, Keiichi/A-9406-2016					AIZAWA S, 1985, J BACTERIOL, V161, P836, DOI 10.1128/JB.161.3.836-849.1985; Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Aldridge P, 2003, MOL MICROBIOL, V49, P1333, DOI 10.1046/j.1365-2958.2003.03637.x; Auvray F, 2002, J MOL BIOL, V318, P941, DOI 10.1016/S0022-2836(02)00172-9; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Claret L, 2003, MOL MICROBIOL, V48, P1349, DOI 10.1046/j.1365-2958.2003.03506.x; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deiwick J, 1999, MOL MICROBIOL, V31, P1759, DOI 10.1046/j.1365-2958.1999.01312.x; EICHELBERG K, 1994, J BACTERIOL, V176, P4501, DOI 10.1128/JB.176.15.4501-4510.1994; Fan F, 1996, J BIOL CHEM, V271, P31981, DOI 10.1074/jbc.271.50.31981; GALPERIN MY, 1982, FEBS LETT, V143, P319, DOI 10.1016/0014-5793(82)80125-7; Gonzalez-Pedrajo B, 2002, MOL MICROBIOL, V45, P967, DOI 10.1046/j.1365-2958.2002.03047.x; Hirano T, 2003, J BACTERIOL, V185, P2485, DOI 10.1128/JB.185.8.2485-2492.2003; Imada K, 2007, P NATL ACAD SCI USA, V104, P485, DOI 10.1073/pnas.0608090104; Karlinsey JE, 2006, J BACTERIOL, V188, P103, DOI 10.1128/JB.188.1.103-114.2006; KUTSUKAKE K, 1990, J BACTERIOL, V172, P741, DOI 10.1128/jb.172.2.741-747.1990; Lane MC, 2006, J BIOL CHEM, V281, P508, DOI 10.1074/jbc.M507238200; Lee SH, 2004, MOL MICROBIOL, V51, P483, DOI 10.1046/j.1365-2958.2003.03840.x; Minamino T, 2000, MOL MICROBIOL, V37, P1494, DOI 10.1046/j.1365-2958.2000.02106.x; Minamino T, 1999, J BACTERIOL, V181, P1388, DOI 10.1128/JB.181.5.1388-1394.1999; Minamino T, 2004, J MOL MICROB BIOTECH, V7, P5, DOI 10.1159/000077865; Minamino T, 2003, J BACTERIOL, V185, P3983, DOI 10.1128/JB.185.13.3983-3988.2003; Minamino T, 2006, J MOL BIOL, V360, P510, DOI 10.1016/j.jmb.2006.05.010; Mori H, 2001, TRENDS MICROBIOL, V9, P494, DOI 10.1016/S0966-842X(01)02174-6; Namba K, 2001, GENES CELLS, V6, P1, DOI 10.1046/j.1365-2443.2001.00384.x; Pallen MJ, 2006, PROTEIN SCI, V15, P935, DOI 10.1110/ps.051958806; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; Thomas J, 2004, P NATL ACAD SCI USA, V101, P3945, DOI 10.1073/pnas.0307223101; van der Wolk JPW, 1997, EMBO J, V16, P7297, DOI 10.1093/emboj/16.24.7297; VOGLER AP, 1991, J BACTERIOL, V173, P3564, DOI 10.1128/jb.173.11.3564-3572.1991; Wilharm G, 2004, INFECT IMMUN, V72, P4004, DOI 10.1128/IAI.72.7.4004-4009.2004; YAMAGUCHI S, 1984, J GEN MICROBIOL, V130, P255; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830	34	219	221	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2008	451	7177					485	U12		10.1038/nature06449	http://dx.doi.org/10.1038/nature06449			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	253YS	18216858	Bronze			2022-12-28	WOS:000252554100049
J	Neil, SJD; Zang, T; Bieniasz, PD				Neil, Stuart J. D.; Zang, Trinity; Bieniasz, Paul D.			Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu	NATURE			English	Article							VIRUS TYPE-1 VPU; PROTEIN; RAFT; CD4; ENDOCYTOSIS; EXPRESSION; CELLS; GENE; NEF; GAG	Human cells possess an antiviral activity that inhibits the release of retrovirus particles, and other enveloped virus particles, and is antagonized by the HIV- 1 accessory protein, Vpu. This antiviral activity can be constitutively expressed or induced by interferon-alpha, and it consists of protein- based tethers, which we term 'tetherins', that cause retention of fully formed virions on infected cell surfaces. Using deductive constraints and gene expression analyses, we identify CD317 ( also called BST2 or HM1.24), a membrane protein of previously unknown function, as a tetherin. Specifically, CD317 expression correlated with, and induced, a requirement for Vpu during HIV- 1 and murine leukaemia virus particle release. Furthermore, in cells where HIV- 1 virion release requires Vpu expression, depletion of CD317 abolished this requirement. CD317 caused retention of virions on cell surfaces and, after endocytosis, in CD317- positive compartments. Vpu co- localized with CD317 and inhibited these effects. Inhibition of Vpu function and consequent mobilization of tetherin's antiviral activity is a potential therapeutic strategy in HIV/AIDS.	[Neil, Stuart J. D.; Zang, Trinity; Bieniasz, Paul D.] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA; [Neil, Stuart J. D.; Zang, Trinity; Bieniasz, Paul D.] Rockefeller Univ, Lab Retrovirol, New York, NY 10016 USA	Rockefeller University; Rockefeller University	Bieniasz, PD (corresponding author), Rockefeller Univ, Aaron Diamond AIDS Res Ctr, 455 1st Ave, New York, NY 10016 USA.	pbienias@adarc.org		Neil, Stuart/0000-0003-3306-5831				Bartee E, 2006, PLOS PATHOG, V2, P975, DOI 10.1371/journal.ppat.0020107; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; GERAGHTY RJ, 1994, J MED PRIMATOL, V23, P146, DOI 10.1111/j.1600-0684.1994.tb00115.x; GOTO T, 1994, BLOOD, V84, P1922; GOTTLINGER HG, 1993, P NATL ACAD SCI USA, V90, P7381, DOI 10.1073/pnas.90.15.7381; Harila K, 2006, J VIROL, V80, P3765, DOI 10.1128/JVI.80.8.3765-3772.2006; Harila K, 2007, VIROLOGY, V369, P299, DOI 10.1016/j.virol.2007.08.009; ISHIKAWA J, 1995, GENOMICS, V26, P527, DOI 10.1016/0888-7543(95)80171-H; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; KLIMKAIT T, 1990, J VIROL, V64, P621, DOI 10.1128/JVI.64.2.621-629.1990; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Lama J, 1999, CURR BIOL, V9, P622, DOI 10.1016/S0960-9822(99)80284-X; Muller B, 2004, J VIROL, V78, P10803, DOI 10.1128/JVI.78.19.10803-10813.2004; Neil SJD, 2007, CELL HOST MICROBE, V2, P193, DOI 10.1016/j.chom.2007.08.001; Neil Stuart J. D., 2006, PLoS Pathogens, V2, DOI 10.1371/jounral.ppat.0020039; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Ross TM, 1999, CURR BIOL, V9, P613, DOI 10.1016/S0960-9822(99)80283-8; STREBEL K, 1989, J VIROL, V63, P3784, DOI 10.1128/JVI.63.9.3784-3791.1989; TERWILLIGER EF, 1989, P NATL ACAD SCI USA, V86, P5163, DOI 10.1073/pnas.86.13.5163; Varthakavi V, 2003, P NATL ACAD SCI USA, V100, P15154, DOI 10.1073/pnas.2433165100; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992	22	1376	1430	2	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2008	451	7177					425	U1		10.1038/nature06553	http://dx.doi.org/10.1038/nature06553			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	253YS	18200009	Bronze			2022-12-28	WOS:000252554100036
J	Friedlingstein, P				Friedlingstein, Pierre			A steep road to climate stabilization	NATURE			English	Article									CEA Saclay, Inst Pierre Simon Laplace, Lab Climate & Environm Sci, F-91191 Gif Sur Yvette, France	UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS)	Friedlingstein, P (corresponding author), CEA Saclay, Inst Pierre Simon Laplace, Lab Climate & Environm Sci, F-91191 Gif Sur Yvette, France.	pierre.friedlingstein@lsce.ipsl.fr	Friedlingstein, Pierre/H-2700-2014	Friedlingstein, Pierre/0000-0003-3309-4739				Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Le Quere C, 2007, SCIENCE, V316, P1735, DOI 10.1126/science.1136188; Solomon S., 2007, PHYS SCI BASIS WORKI	4	33	34	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2008	451	7176					297	298		10.1038/nature06593	http://dx.doi.org/10.1038/nature06593			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202648	Bronze, Green Submitted			2022-12-28	WOS:000252432100040
J	Jaillon, O; Bouhouche, K; Gout, JF; Aury, JM; Noel, B; Saudemont, B; Nowacki, M; Serrano, V; Porcel, BM; Segurens, B; Le Mouel, A; Lepere, G; Schachter, V; Betermier, M; Cohen, J; Wincker, P; Sperling, L; Duret, L; Meyer, E				Jaillon, Olivier; Bouhouche, Khaled; Gout, Jean-Francois; Aury, Jean-Marc; Noel, Benjamin; Saudemont, Baptiste; Nowacki, Mariusz; Serrano, Vincent; Porcel, Betina M.; Segurens, Beatrice; Le Mouel, Anne; Lepere, Gersende; Schachter, Vincent; Betermier, Mireille; Cohen, Jean; Wincker, Patrick; Sperling, Linda; Duret, Laurent; Meyer, Eric			Translational control of intron splicing in eukaryotes	NATURE			English	Article							MESSENGER-RNA DECAY; NONSENSE-MEDIATED DECAY; PROTEIN-SYNTHESIS; GENOME BROWSER; INTERFERENCE; RECOGNITION	Most eukaryotic genes are interrupted by non- coding introns that must be accurately removed from pre- messenger RNAs to produce translatable mRNAs(1). Splicing is guided locally by short conserved sequences, but genes typically contain many potential splice sites, and the mechanisms specifying the correct sites remain poorly understood. In most organisms, short introns recognized by the intron definition mechanism(2) cannot be efficiently predicted solely on the basis of sequence motifs(3). In multicellular eukaryotes, long introns are recognized through exon definition(2) and most genes produce multiple mRNA variants through alternative splicing(4). The nonsense- mediated mRNA decay(5,6) ( NMD) pathway may further shape the observed sets of variants by selectively degrading those containing premature termination codons, which are frequently produced in mammals(7,8). Here we show that the tiny introns of the ciliate Paramecium tetraurelia are under strong selective pressure to cause premature termination of mRNA translation in the event of intron retention, and that the same bias is observed among the short introns of plants, fungi and animals. By knocking down the two P. tetraurelia genes encoding UPF1, a protein that is crucial in NMD, we show that the intrinsic efficiency of splicing varies widely among introns and that NMD activity can significantly reduce the fraction of unspliced mRNAs. The results suggest that, independently of alternative splicing, species with large intron numbers universally rely on NMD to compensate for suboptimal splicing efficiency and accuracy.	[Bouhouche, Khaled; Saudemont, Baptiste; Nowacki, Mariusz; Serrano, Vincent; Le Mouel, Anne; Lepere, Gersende; Meyer, Eric] Ecole Normale Super, Genet Mol Lab, F-75005 Paris, France; [Jaillon, Olivier; Aury, Jean-Marc; Noel, Benjamin; Porcel, Betina M.; Segurens, Beatrice; Schachter, Vincent; Wincker, Patrick] Genoscope CEA, F-91057 Evry, France; [Jaillon, Olivier; Aury, Jean-Marc; Noel, Benjamin; Porcel, Betina M.; Schachter, Vincent; Wincker, Patrick] CNRS, UMR 8030, F-91057 Evry, France; [Jaillon, Olivier; Aury, Jean-Marc; Noel, Benjamin; Porcel, Betina M.; Schachter, Vincent; Wincker, Patrick] Univ Evry, F-91057 Evry, France; [Bouhouche, Khaled; Saudemont, Baptiste; Nowacki, Mariusz; Serrano, Vincent; Le Mouel, Anne; Lepere, Gersende; Meyer, Eric] CNRS, UMR 8541, F-75005 Paris, France; [Bouhouche, Khaled; Betermier, Mireille; Cohen, Jean; Sperling, Linda] CNRS, Ctr Genet Mol, UPR 2167, F-91198 Gif Sur Yvette, France; [Bouhouche, Khaled; Betermier, Mireille; Cohen, Jean; Sperling, Linda] Univ Paris 11, F-91405 Orsay, France; [Bouhouche, Khaled; Betermier, Mireille; Cohen, Jean; Sperling, Linda] Univ Paris 06, F-75005 Paris, France; [Gout, Jean-Francois; Duret, Laurent] Univ Lyon 1, CNRS, UMR 5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Meyer, E (corresponding author), Ecole Normale Super, Genet Mol Lab, 46 Rue Ulm, F-75005 Paris, France.	emeyer@biologie.ens.fr	Sperling, Linda/C-9734-2014; Nowacki, Mariusz/E-4485-2011; Bouhouche, khaled/AGR-4456-2022; Aury, Jean-Marc/N-1621-2019; Jaillon, Olivier/GRY-6287-2022	Nowacki, Mariusz/0000-0003-4894-2905; Aury, Jean-Marc/0000-0003-1718-3010; Porcel, Betina/0000-0003-0169-5302; Sperling, Linda/0000-0002-7772-4774; Betermier, Mireille/0000-0002-5407-6292; Gout, Jean-Francois/0000-0002-4549-5647; Duret, Laurent/0000-0003-2836-3463; Meyer, Eric/0000-0002-3161-8597; lepere, gersende/0000-0002-4609-7587; Noel, Benjamin/0000-0002-5830-3253				Arciga-Reyes L, 2006, PLANT J, V47, P480, DOI 10.1111/j.1365-313X.2006.02802.x; Ashurst JL, 2005, NUCLEIC ACIDS RES, V33, pD459, DOI 10.1093/nar/gki135; Ast G, 2004, NAT REV GENET, V5, P773, DOI 10.1038/nrg1451; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Brogna S, 2002, MOL CELL, V10, P93, DOI 10.1016/S1097-2765(02)00565-8; Buhler M, 2002, EMBO REP, V3, P646, DOI 10.1093/embo-reports/kvf129; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; Dahlberg JE, 2004, CURR OPIN CELL BIOL, V16, P335, DOI 10.1016/j.ceb.2004.03.006; Domeier ME, 2000, SCIENCE, V289, P1928, DOI 10.1126/science.289.5486.1928; Galvani A, 2002, TRENDS GENET, V18, P11, DOI 10.1016/S0168-9525(01)02548-3; Garnier O, 2004, MOL CELL BIOL, V24, P7370, DOI 10.1128/MCB.24.17.7370-7379.2004; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Iborra FJ, 2004, J CELL SCI, V117, P5713, DOI 10.1242/jcs.01538; Iborra FJ, 2004, J CELL SCI, V117, P899, DOI 10.1242/jcs.00933; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Lim LP, 2001, P NATL ACAD SCI USA, V98, P11193, DOI 10.1073/pnas.201407298; Lynch M, 2006, MOL BIOL EVOL, V23, P450, DOI 10.1093/molbev/msj050; Maquat LE, 2002, GENE DEV, V16, P1743, DOI 10.1101/gad.1014502; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Miriami E, 2004, RNA, V10, P1, DOI 10.1261/rna.5112704; Mohn F, 2005, RNA, V11, P147, DOI 10.1261/rna.7182905; Mott R, 1997, COMPUT APPL BIOSCI, V13, P477; Nathanson L, 2003, RNA, V9, P9, DOI 10.1261/rna.2990203; Pan Q, 2006, GENE DEV, V20, P153, DOI 10.1101/gad.1382806; Romfo CM, 2000, MOL CELL BIOL, V20, P7955, DOI 10.1128/MCB.20.21.7955-7970.2000; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; RUSSELL CB, 1994, NUCLEIC ACIDS RES, V22, P1221, DOI 10.1093/nar/22.7.1221; Skouri F, 1997, MOL BIOL CELL, V8, P1063; Wachtel C, 2004, RNA, V10, P1740, DOI 10.1261/rna.7480804; Wang J, 2002, MOL CELL, V10, P951, DOI 10.1016/S1097-2765(02)00635-4; Wang J, 2002, SCIENCE, V297, P108, DOI 10.1126/science.1069757; [No title captured]; [No title captured]; [No title captured]	39	164	172	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2008	451	7176					359	U15		10.1038/nature06495	http://dx.doi.org/10.1038/nature06495			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202663	Green Published			2022-12-28	WOS:000252432100055
J	Sinclair, CA; Makin, JK				Sinclair, Craig A.; Makin, Jennifer K.			Medicine and the media - Sometimes it takes a loss of life to make a difference	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sinclair, Craig A.; Makin, Jennifer K.] Canc Council Victoria, Melbourne, Vic, Australia	Cancer Council Victoria	Sinclair, CA (corresponding author), Canc Council Victoria, Melbourne, Vic, Australia.	craig.sinclair@cancervic.org.au	Makin, Jen/AAE-6862-2020	Makin, Jen/0000-0001-7556-196X; Sinclair, Craig/0000-0002-6467-1191				Dobbinson S, 2006, EUR J CANCER PREV, V15, P424, DOI 10.1097/00008469-200610000-00007; 2007, AUST NZ J PUBLIC HLT, V31, P191	2	15	15	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 12	2008	336	7635					73	73		10.1136/bmj.39430.705752.94	http://dx.doi.org/10.1136/bmj.39430.705752.94			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253BX	18187723	Green Published			2022-12-28	WOS:000252494800026
J	Romani, L; Fallarino, F; De Luca, A; Montagnoli, C; D'Angelo, C; Zelante, T; Vacca, C; Bistoni, F; Fioretti, MC; Grohmann, U; Segal, BH; Puccetti, P				Romani, Luigina; Fallarino, Francesca; De Luca, Antonella; Montagnoli, Claudia; D'Angelo, Carmen; Zelante, Teresa; Vacca, Carmine; Bistoni, Francesco; Fioretti, Maria C.; Grohmann, Ursula; Segal, Brahm H.; Puccetti, Paolo			Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease	NATURE			English	Article							DELTA-T-CELLS; NF-KAPPA-B; DENDRITIC CELLS; INDOLEAMINE 2,3-DIOXYGENASE; IL-17 PRODUCTION; HOST-DEFENSE; GAMMA; IDO; TOLERANCE; INFECTION	Half a century ago, chronic granulomatous disease ( CGD) was first described as a disease fatally affecting the ability of children to survive infections. Various milestone discoveries have since been made, from an insufficient ability of patients' leucocytes to kill microbes to the underlying genetic abnormalities(1). In this inherited disorder, phagocytes lack NADPH oxidase activity and do not generate reactive oxygen species, most notably superoxide anion, causing recurrent bacterial and fungal infections. Patients with CGD also suffer from chronic inflammatory conditions, most prominently granuloma formation in hollow viscera. The precise mechanisms of the increased microbial pathogenicity have been unclear(2), and more so the reasons for the exaggerated inflammatory response(3-6). Here we show that a superoxide- dependent step in tryptophan metabolism along the kynurenine pathway is blocked in CGD mice with lethal pulmonary aspergillosis, leading to unrestrained V gamma 1(+) gamma delta T- cell reactivity, dominant production of interleukin ( IL)- 17, defective regulatory T- cell activity and acute inflammatory lung injury. Although beneficial effects are induced by IL- 17 neutralization or gamma delta T- cell contraction, complete cure and reversal of the hyperinflammatory phenotype are achieved by replacement therapy with a natural kynurenine distal to the blockade in the pathway. Effective therapy, which includes co-administration of recombinant interferon-gamma ( IFN-gamma), restores production of downstream immunoactive metabolites and enables the emergence of regulatory V gamma 4(+) gamma delta and Foxp3(+) alpha beta T cells. Therefore, paradoxically, the lack of reactive oxygen species contributes to the hyperinflammatory phenotype associated with NADPH oxidase deficiencies, through a dysfunctional kynurenine pathway of tryptophan catabolism. Yet, this condition can be reverted by reactivating the pathway downstream of the superoxide- dependent step.	[Romani, Luigina; Fallarino, Francesca; De Luca, Antonella; Montagnoli, Claudia; D'Angelo, Carmen; Zelante, Teresa; Vacca, Carmine; Bistoni, Francesco; Fioretti, Maria C.; Grohmann, Ursula; Puccetti, Paolo] Univ Perugia, Dept Expt Med, I-06126 Perugia, Italy; [Segal, Brahm H.] Roswell Pk Canc Inst, Div Infect Dis, Buffalo, NY 14263 USA	University of Perugia; Roswell Park Cancer Institute	Romani, L (corresponding author), Univ Perugia, Dept Expt Med, I-06126 Perugia, Italy.	iromani@unipg.it; plopcc@tin.it	Segal, Brahm/AAW-2706-2020; zelante, teresa/F-7933-2017; Vacca, Carmine/AAE-7046-2019; Romani, Luigina/O-9987-2018; Grohmann, Ursula/T-6545-2019; Fallarino, Francesca/O-3358-2013	zelante, teresa/0000-0002-7071-0302; Vacca, Carmine/0000-0002-3799-8164; Fallarino, Francesca/0000-0002-8501-2136; Puccetti, Paolo/0000-0001-6674-2128; Romani, Luigina/0000-0002-1356-525X; Grohmann, Ursula/0000-0001-7952-1850; DE LUCA, ANTONELLA/0000-0002-6866-5530				Andrew EM, 2005, J IMMUNOL, V175, P1741, DOI 10.4049/jimmunol.175.3.1741; Andrew EM, 2005, MICROBES INFECT, V7, P529, DOI 10.1016/j.micinf.2004.12.010; Assari Tracy, 2006, Med Immunol, V5, P4, DOI 10.1186/1476-9433-5-4; Belladonna ML, 2006, J IMMUNOL, V177, P130, DOI 10.4049/jimmunol.177.1.130; Bellocchio S, 2004, J IMMUNOL, V173, P7406, DOI 10.4049/jimmunol.173.12.7406; Born WK, 2006, CURR OPIN IMMUNOL, V18, P31, DOI 10.1016/j.coi.2005.11.007; Bylund J, 2007, EUR J IMMUNOL, V37, P1087, DOI 10.1002/eji.200636651; Chang YC, 1998, J CLIN INVEST, V101, P1843, DOI 10.1172/JCI2301; De Luca A, 2007, J IMMUNOL, V179, P5999, DOI 10.4049/jimmunol.179.9.5999; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Fallarino I, 2002, CELL DEATH DIFFER, V9, P1069, DOI 10.1038/sj.cdd.4401073; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Grohmann U, 2003, TRENDS IMMUNOL, V24, P242, DOI 10.1016/S1471-4906(03)00072-3; Grohmann U, 2007, NAT MED, V13, P579, DOI 10.1038/nm1563; Hizawa N, 2006, CLIN EXP ALLERGY, V36, P1109, DOI 10.1111/j.1365-2222.2006.02550.x; Hultqvist M, 2007, J IMMUNOL, V179, P1431, DOI 10.4049/jimmunol.179.3.1431; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; Jackson SH, 2001, J INTERF CYTOK RES, V21, P567, DOI 10.1089/10799900152547821; Kirby AC, 2007, J PATHOL, V212, P29, DOI 10.1002/path.2149; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Marciano BE, 2004, CLIN INFECT DIS, V39, P692, DOI 10.1086/422993; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Montagnoli C, 2006, J IMMUNOL, V176, P1712, DOI 10.4049/jimmunol.176.3.1712; Morgenstern DE, 1997, J EXP MED, V185, P207, DOI 10.1084/jem.185.2.207; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; PETERMAN GM, 1993, J IMMUNOL, V151, P6546; Platten M, 2005, SCIENCE, V310, P850, DOI 10.1126/science.1117634; Popov A, 2006, J CLIN INVEST, V116, P3160, DOI 10.1172/JCI28996; Puccetti P, 2007, NAT REV IMMUNOL, V7, P817, DOI 10.1038/nri2163; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Romani L, 2006, BLOOD, V108, P2265, DOI 10.1182/blood-2006-02-004762; Schwarcz R, 2002, J PHARMACOL EXP THER, V303, P1, DOI 10.1124/jpet.102.034439; Sharma MD, 2007, J CLIN INVEST, V117, P2570, DOI 10.1172/JCI31911; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; SPIEKERPOLET H, 1995, P NATL ACAD SCI USA, V92, P9348, DOI 10.1073/pnas.92.20.9348; Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870; Tramonti D, 2006, EUR J IMMUNOL, V36, P1729, DOI 10.1002/eji.200635959	39	436	449	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2008	451	7175					211	U12		10.1038/nature06471	http://dx.doi.org/10.1038/nature06471			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249GA	18185592				2022-12-28	WOS:000252214400047
J	Scharlemann, JPW; Laurance, WF				Scharlemann, Jorn P. W.; Laurance, William F.			Environmental science - How green are biofuels?	SCIENCE			English	Editorial Material							ENERGY; ETHANOL; DEFORESTATION; CLIMATE		[Scharlemann, Jorn P. W.; Laurance, William F.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama	Smithsonian Institution; Smithsonian Tropical Research Institute	Scharlemann, JPW (corresponding author), Smithsonian Trop Res Inst, Apartado 0843-03092, Balboa, Ancon, Panama.	jscharlemann@gmail.com; laurancew@si.edu	Scharlemann, Jorn/A-4737-2008; Laurance, William F/B-2709-2012	Scharlemann, Jorn/0000-0002-2834-6367; Laurance, William F/0000-0003-4430-9408				Adler PR, 2007, ECOL APPL, V17, P675, DOI 10.1890/05-2018; Bala G, 2007, P NATL ACAD SCI USA, V104, P6550, DOI 10.1073/pnas.0608998104; Crutzen P.J., 2007, ATMOS CHEM PHYS DISC, V7, P11191, DOI DOI 10.5194/ACPD-7-11191-2007; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Hill J, 2006, P NATL ACAD SCI USA, V103, P11206, DOI 10.1073/pnas.0604600103; Laurance WF, 1999, BIOL CONSERV, V91, P109, DOI 10.1016/S0006-3207(99)00088-9; Laurance WF, 2007, SCIENCE, V318, P1721; Melis A, 2001, PLANT PHYSIOL, V127, P740, DOI 10.1104/pp.127.3.740; Pacala S, 2004, SCIENCE, V305, P968, DOI 10.1126/science.1100103; Pimentel D, 2007, REV ENVIRON CONTAM T, V189, P25, DOI 10.1007/978-0-387-35368-5_2; Righelato R, 2007, SCIENCE, V317, P902, DOI 10.1126/science.1141361; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Ulgiati S, 2001, CRIT REV PLANT SCI, V20, P71, DOI 10.1080/20013591099191; Zah R, 2007, OKOBILANZ ENERGIEPRO	14	292	300	1	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2008	319	5859					43	44		10.1126/science.1153103	http://dx.doi.org/10.1126/science.1153103			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18174426				2022-12-28	WOS:000252084000020
J	Colaluca, IN; Tosoni, D; Nuciforo, P; Senic-Matuglia, F; Galimberti, V; Viale, G; Pece, S; Di Fiore, PP				Colaluca, Ivan N.; Tosoni, Daniela; Nuciforo, Paolo; Senic-Matuglia, Francesca; Galimberti, Viviana; Viale, Giuseppe; Pece, Salvatore; Di Fiore, Pier Paolo			NUMB controls p53 tumour suppressor activity	NATURE			English	Article							ASYMMETRIC CELL-DIVISION; BREAST-CANCER; NEGATIVE REGULATION; ENDOCYTIC PROTEIN; ALPHA-ADAPTIN; HISTONE H2AX; STEM-CELLS; MDM2; EXPRESSION; GENE	NUMB is a cell fate determinant, which, by asymmetrically partitioning at mitosis, controls cell fate choices by antagonising the activity of the plasma membrane receptor of the NOTCH family(1). NUMB is also an endocytic protein(2), and the NOTCH-NUMB counteraction has been linked to this function(3,4). There might be, however, additional functions of NUMB, as witnessed by its proposed role as a tumour suppressor in breast cancer(5). Here we describe a previously unknown function for human NUMB as a regulator of tumour protein p53 ( also known as TP53). NUMB enters in a tricomplex with p53 and the E3 ubiquitin ligase HDM2( also known as MDM2), thereby preventing ubiquitination and degradation of p53. This results in increased p53 protein levels and activity, and in regulation of p53- dependent phenotypes. In breast cancers there is frequent loss of NUMB expression(5). We show that, in primary breast tumour cells, this event causes decreased p53 levels and increased chemoresistance. In breast cancers, loss of NUMB expression causes increased activity of the receptor NOTCH5. Thus, in these cancers, a single event - loss of NUMB expression - determines activation of an oncogene ( NOTCH) and attenuation of the p53 tumour suppressor pathway. Biologically, this results in an aggressive tumour phenotype, as witnessed by findings that NUMB- defective breast tumours display poor prognosis. Our results uncover a previously unknown tumour suppressor circuitry.	[Colaluca, Ivan N.; Tosoni, Daniela; Nuciforo, Paolo; Senic-Matuglia, Francesca; Pece, Salvatore; Di Fiore, Pier Paolo] FIRC Inst Mol Oncol Fdn, IFOM, I-20139 Milan, Italy; [Colaluca, Ivan N.; Tosoni, Daniela; Galimberti, Viviana; Viale, Giuseppe; Pece, Salvatore; Di Fiore, Pier Paolo] European Inst Oncol, I-20141 Milan, Italy; [Viale, Giuseppe; Pece, Salvatore; Di Fiore, Pier Paolo] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, I-20122 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); University of Milan	Pece, S (corresponding author), FIRC Inst Mol Oncol Fdn, IFOM, Via Adamello 16, I-20139 Milan, Italy.	salvatore.pece@ifom-ieo-campus.it; pierpaolo.difiore@ifom-ieo-campus.it	高, 雨莉/HGU-8187-2022; GALIMBERTI, Viviana Enrica/AAS-3963-2020; Senic-Matuglia, Francesca/AAQ-3815-2020; Viale, Giuseppe/AAE-8921-2019; Nuciforo, Paolo/Q-2885-2019; colaluca, ivan nicola/AAB-2571-2019; Tosoni, Daniela/K-4524-2014; Pece, Salvatore/B-9609-2013; Di Fiore, Pier Paolo/K-2130-2012; Colaluca, Ivan Nicola/K-9776-2016	GALIMBERTI, Viviana Enrica/0000-0002-5036-7439; Pece, Salvatore/0000-0003-1764-3929; Di Fiore, Pier Paolo/0000-0002-2252-0950; Nuciforo, Paolo/0000-0003-1380-0990; Colaluca, Ivan Nicola/0000-0002-3371-112X	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Enari M, 2006, GENE DEV, V20, P1087, DOI 10.1101/gad.1381906; Fish KN, 2000, J CELL BIOL, V150, P145, DOI 10.1083/jcb.150.1.145; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hutterer A, 2005, EMBO REP, V6, P836, DOI 10.1038/sj.embor.7400500; Juven-Gershon T, 1998, MOL CELL BIOL, V18, P3974, DOI 10.1128/MCB.18.7.3974; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; MCCANN AH, 1995, BRIT J CANCER, V71, P981, DOI 10.1038/bjc.1995.189; MORNAND J, 1992, CELL, V69, P1237; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Pharoah PDP, 1999, BRIT J CANCER, V80, P1968, DOI 10.1038/sj.bjc.6690628; Rambhatla L, 2005, CANCER RES, V65, P3155, DOI 10.1158/0008-5472.CAN-04-3161; Reis T, 2004, CELL, V117, P253, DOI 10.1016/S0092-8674(04)00247-8; Roegiers F, 2004, CURR OPIN CELL BIOL, V16, P195, DOI 10.1016/j.ceb.2004.02.010; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Sharpless NE, 2004, J CLIN INVEST, V113, P160, DOI 10.1172/JCI200420761; SHERLEY JL, 1995, P NATL ACAD SCI USA, V92, P136, DOI 10.1073/pnas.92.1.136; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Silva J, 2003, J PATHOL, V199, P289, DOI 10.1002/path.1297; Silva J, 2001, ONCOGENE, V20, P4586, DOI 10.1038/sj.onc.1204617; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Veronesi U, 2003, NEW ENGL J MED, V349, P546, DOI 10.1056/NEJMoa012782; VESTEY SB, 1999, CURR OPIN GENE DEV, V9, P22; Vousden KH, 2005, CELL, V120, P7, DOI 10.1016/j.cell.2004.12.027; Woelk T, 2006, NAT CELL BIOL, V8, P1246, DOI 10.1038/ncb1484; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4	32	288	339	2	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2008	451	7174					76	U11		10.1038/nature06412	http://dx.doi.org/10.1038/nature06412			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247KZ	18172499				2022-12-28	WOS:000252079300037
J	Davies, HML; Manning, JR				Davies, Huw M. L.; Manning, James R.			Catalytic C-H functionalization by metal carbenoid and nitrenoid insertion	NATURE			English	Review							CARBON-HYDROGEN INSERTION; ENANTIOSELECTIVE SYNTHESIS; ORGANIC-SYNTHESIS; ASYMMETRIC-SYNTHESIS; ACTIVATION/COPE REARRANGEMENT; STEREOSELECTIVE-SYNTHESIS; BOND FUNCTIONALIZATION; OXIDATIVE CYCLIZATION; STRATEGIC REACTIONS; PROTECTED AMINES	Novel reactions that can selectively functionalize carbon - hydrogen bonds are of intense interest to the chemical community because they offer new strategic approaches for synthesis. A very promising 'carbon - hydrogen functionalization' method involves the insertion of metal carbenes and nitrenes into C - H bonds. This area has experienced considerable growth in the past decade, particularly in the area of enantioselective intermolecular reactions. Here we discuss several facets of these kinds of C - H functionalization reactions and provide a perspective on how this methodology has affected the synthesis of complex natural products and potential pharmaceutical agents.	[Davies, Huw M. L.; Manning, James R.] SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Davies, HML (corresponding author), SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA.	hdavies@buffalo.edu	Davies, Huw M. L./C-5598-2018	Davies, Huw M. L./0000-0001-6254-9398; Manning, James/0000-0002-2111-4723	NIDA NIH HHS [R01 DA006301-13, R01 DA015225-05, R01 DA015225] Funding Source: Medline; NIGMS NIH HHS [R01 GM080337, R01 GM080337-04] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA006301, R01DA015225] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Anada M, 1999, SYNLETT, P1775; ARNDTSEN BA, 1995, ACCOUNTS CHEM RES, V28, P154, DOI 10.1021/ar00051a009; Austin JF, 2002, J AM CHEM SOC, V124, P1172, DOI 10.1021/ja017255c; Axten JM, 1998, J ORG CHEM, V63, P9628, DOI 10.1021/jo982214t; Bergman RG, 2007, NATURE, V446, P391, DOI 10.1038/446391a; Boezio AA, 2005, ANGEW CHEM INT EDIT, V44, P6046, DOI 10.1002/anie.200502178; Cesati RR, 2004, J AM CHEM SOC, V126, P96; Crabtree RH, 2006, NATURE, V441, P165, DOI 10.1038/441165a; Dauban P, 2003, SYNLETT, P1571, DOI 10.1055/s-2003-41010; Davies HML, 2000, J AM CHEM SOC, V122, P3063, DOI 10.1021/ja994136c; Davies HML, 2003, CHEM REV, V103, P2861, DOI 10.1021/cr0200217; Davies HML, 2005, ANGEW CHEM INT EDIT, V44, P3518, DOI 10.1002/anie.200500554; Davies HML, 1996, J AM CHEM SOC, V118, P6897, DOI 10.1021/ja9604931; Davies HML, 2002, J MOL CATAL A-CHEM, V189, P125, DOI 10.1016/S1381-1169(02)00201-7; Davies HML, 2001, J ORGANOMET CHEM, V617, P47, DOI 10.1016/S0022-328X(00)00599-4; Davies HML, 2006, TETRAHEDRON-ASYMMETR, V17, P665, DOI 10.1016/j.tetasy.2006.01.023; Davies HML, 2006, J AM CHEM SOC, V128, P2485, DOI 10.1021/ja056877l; Davies HML, 2006, J AM CHEM SOC, V128, P1060, DOI 10.1021/ja057768+; Davies HML, 2005, J ORGANOMET CHEM, V690, P6111, DOI 10.1016/j.jorganchem.2005.08.026; Davies HML, 2005, ORG LETT, V7, P2293, DOI 10.1021/ol050018k; Davies HML, 2005, ANGEW CHEM INT EDIT, V44, P1733, DOI 10.1002/anie.200462227; Davies HML, 2004, J AM CHEM SOC, V126, P10862, DOI 10.1021/ja047185k; Davies HML, 2004, ORG LETT, V6, P1769, DOI 10.1021/ol0495467; Davies HML, 2004, P NATL ACAD SCI USA, V101, P5472, DOI 10.1073/pnas.0307556101; Davies HML, 2003, J AM CHEM SOC, V125, P6462, DOI 10.1021/ja0290072; Davies HML, 2003, J ORG CHEM, V68, P6126, DOI 10.1021/jo034533c; Davies HML, 2002, ANGEW CHEM INT EDIT, V41, P2197, DOI 10.1002/1521-3773(20020617)41:12<2197::AID-ANIE2197>3.0.CO;2-N; Davies HML, 2001, ORG LETT, V3, P3587, DOI 10.1021/ol0167255; Davies HML, 2001, J AM CHEM SOC, V123, P2070, DOI 10.1021/ja0035607; Davies HML, 2000, ORG LETT, V2, P4153, DOI 10.1021/ol006671j; Davies HML, 1999, TETRAHEDRON LETT, V40, P5287, DOI 10.1016/S0040-4039(99)01000-X; Davies HML, 1999, J AM CHEM SOC, V121, P6509, DOI 10.1021/ja9910715; Davies HML, 1999, ORG LETT, V1, P233, DOI 10.1021/ol9905699; Davies HML, 2006, TETRAHEDRON, V62, P10477, DOI 10.1016/j.tet.2006.05.086; Davies HML, 2006, ANGEW CHEM INT EDIT, V45, P6422, DOI 10.1002/anie.200601814; Davies HML, 2006, CHEM COMMUN, P3110, DOI 10.1039/b605047f; DEMONCEAU A, 1984, B SOC CHIM BELG, V93, P945; Deutsch HM, 1996, J MED CHEM, V39, P1201, DOI 10.1021/jm950697c; Diaz-Requejo MM, 2002, J AM CHEM SOC, V124, P896, DOI 10.1021/ja016798j; Dick AR, 2006, TETRAHEDRON, V62, P2439, DOI 10.1016/j.tet.2005.11.027; Doyle M.P., 1998, MODERN CATALYTIC MET; Doyle MP, 1998, CHEM REV, V98, P911, DOI 10.1021/cr940066a; Doyle MP, 2002, CHIRALITY, V14, P169, DOI 10.1002/chir.10060; DOYLE MP, 1993, J AM CHEM SOC, V115, P958, DOI 10.1021/ja00056a021; Dyker G, 1999, ANGEW CHEM INT EDIT, V38, P1699, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1698::AID-ANIE1698>3.0.CO;2-6; DYKER G, 2005, HDB C H TRANSFORMATI, V12; Espino CG, 2004, J AM CHEM SOC, V126, P15378, DOI 10.1021/ja0446294; Espino CG, 2001, ANGEW CHEM INT EDIT, V40, P598, DOI 10.1002/1521-3773(20010202)40:3<598::AID-ANIE598>3.0.CO;2-9; Espino CG, 2005, MODERN RHODIUM-CATALYZED ORGANIC REACTIONS, P379, DOI 10.1002/3527604693.ch17; Evans DA, 2003, J AM CHEM SOC, V125, P10780, DOI 10.1021/ja036985c; Ferreira EM, 2003, J AM CHEM SOC, V125, P9578, DOI 10.1021/ja035054y; Fiori KW, 2007, J AM CHEM SOC, V129, P562, DOI 10.1021/ja0650450; Fleming JJ, 2006, J AM CHEM SOC, V128, P3926, DOI 10.1021/ja0608545; Godula K, 2006, SCIENCE, V312, P67, DOI 10.1126/science.1114731; Grubbs R. H., 2003, HDB METATHESIS; Harrowven DC, 2005, ANGEW CHEM INT EDIT, V44, P1221, DOI 10.1002/anie.200462268; Heckrodt TJ, 2005, TOP CURR CHEM, V244, P1, DOI 10.1007/b96886; Hinman A, 2003, J AM CHEM SOC, V125, P11510, DOI 10.1021/ja0368305; Keating GM, 2002, DRUGS, V62, P1899, DOI 10.2165/00003495-200262130-00009; Kim AI, 2003, ANGEW CHEM INT EDIT, V42, P1267, DOI 10.1002/anie.200390325; Kim M, 2006, ORG LETT, V8, P1073, DOI 10.1021/ol052920y; King AO, 2004, TOP ORGANOMETAL CHEM, V6, P205; Kleeman A., 2001, PHARM SUBSTANCES, V4th; Labinger JA, 2002, NATURE, V417, P507, DOI 10.1038/417507a; Lebel H, 2005, J AM CHEM SOC, V127, P14198, DOI 10.1021/ja0552850; Lebel H, 2007, ORG LETT, V9, P639, DOI 10.1021/ol062953t; Liang CG, 2006, ANGEW CHEM INT EDIT, V45, P4641, DOI 10.1002/anie.200601248; Lipinski C, 2004, NATURE, V432, P855, DOI 10.1038/nature03193; LONGWELL L, 2007, IMS HLTH REPORTS GLO; Muller P, 2003, CHEM REV, V103, P2905, DOI 10.1021/cr020043t; Nicolaou KC, 1997, NATURE, V387, P268, DOI 10.1038/387268a0; Nicolaou KC, 2001, ANGEW CHEM INT EDIT, V40, P2482, DOI 10.1002/1521-3773(20010702)40:13<2482::AID-ANIE2482>3.0.CO;2-A; Panizzon L, 1944, HELV CHIM ACTA, V27, P1748, DOI 10.1002/hlca.194402701222; Reddy RP, 2006, ORG LETT, V8, P5013, DOI 10.1021/ol061742l; Saaby S, 2002, J ORG CHEM, V67, P4352, DOI 10.1021/jo0256787; Shilov AE, 1997, CHEM REV, V97, P2879, DOI 10.1021/cr9411886; Urbano J, 2005, ORGANOMETALLICS, V24, P1528, DOI 10.1021/om050024k; Waizumi N, 2003, J AM CHEM SOC, V125, P13022, DOI 10.1021/ja035898h; Waltz KM, 1997, SCIENCE, V277, P211, DOI 10.1126/science.277.5323.211; Wang JB, 1998, J ORG CHEM, V63, P8589, DOI 10.1021/jo981279t; WANG P, 1994, J AM CHEM SOC, V116, P3296, DOI 10.1021/ja00087a016; Wee AGH, 1997, J ORG CHEM, V62, P3324, DOI 10.1021/jo961484d; Wehn PM, 2002, J AM CHEM SOC, V124, P12950, DOI 10.1021/ja028139s; Yamawaki M, 2002, TETRAHEDRON LETT, V43, P9561, DOI 10.1016/S0040-4039(02)02432-2; YE T, 1994, CHEM REV, V94, P1091, DOI 10.1021/cr00028a010; Yu JQ, 2006, ORG BIOMOL CHEM, V4, P4041, DOI 10.1039/b611094k; Yu XQ, 2000, ORG LETT, V2, P2233, DOI 10.1021/ol000107r	87	1753	1771	13	380	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2008	451	7177					417	424		10.1038/nature06485	http://dx.doi.org/10.1038/nature06485			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	253YS	18216847	Green Accepted, Bronze			2022-12-28	WOS:000252554100035
J	Goodman, DC; Grumbach, K				Goodman, David C.; Grumbach, Kevin			Does having more physicians lead to better health system performance?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NEONATAL INTENSIVE-CARE; REGIONAL-VARIATIONS; QUALITY		[Goodman, David C.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch,Ctr Hlth Policy Res, Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH 03756 USA; [Grumbach, Kevin] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA	Dartmouth College; University of California System; University of California San Francisco	Grumbach, K (corresponding author), San Francisco Gen Hosp, Dept Family & Community Med, 1001 Potrero Ave, San Francisco, CA 94110 USA.	kgrumbach@fcm.ucsf.edu	Grumbach, Kevin/L-9222-2016; Goodman, David/AAG-7497-2020		NIA NIH HHS [P01 AG019783-06, P01 AG019783-08, P01 AG019783] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG019783] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Asch SM, 2006, NEW ENGL J MED, V354, P1147, DOI 10.1056/NEJMsa044464; *ASS AM MED COLL, MED SCH EXP PLANS RE; Baicker K, 2004, HEALTH AFFAIR, V23, pW4184, DOI 10.1377/hlthaff.W4.184; Cooper RA, 2002, HEALTH AFFAIR, V21, P140, DOI 10.1377/hlthaff.21.1.140; Cooper RA, 2003, HEALTH SERV RES, V38, P675, DOI 10.1111/1475-6773.00139; *COUNC GRAD MED ED, 1994, 4 COUNC GRAD MED ED; *COUNC GRAD MED ED, 16 COUNC GRAD MED ED; *COUNC GRAD MED ED, 14 COUNC GRAD MED ED; CROASDALE M, 2007, AM MED NEWS     1022; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Fisher ES, 2004, HEALTH AFFAIR, V23, pVAR19, DOI 10.1377/hlthaff.var.19; Goodman DC, 2006, HEALTH AFFAIR, V25, P521, DOI 10.1377/hlthaff.25.2.521; Goodman DC, 2002, NEW ENGL J MED, V346, P1538, DOI 10.1056/NEJMoa011921; Goodman DC, 2001, PEDIATRICS, V108, P426, DOI 10.1542/peds.108.2.426; GOODMAN DC, 2004, HLTH AFF MILLWOOD S, pVAR90; *HJ KAIS FAM FDN, KAIS HLTH SEC WATCH; Kenney G, 2007, HEALTH SERV RES, V42, P1520, DOI 10.1111/j.1475-6773.2007.00707.x; Komaromy M, 1996, NEW ENGL J MED, V334, P1305, DOI 10.1056/NEJM199605163342006; Krakauer H, 1996, HEALTH SERV RES, V31, P191; SHI LY, 1994, INT J HEALTH SERV, V24, P431, DOI 10.2190/BDUU-J0JD-BVEX-N90B; Sirovich BE, 2006, ANN INTERN MED, V144, P641, DOI 10.7326/0003-4819-144-9-200605020-00007; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Starfield B, 2005, HLTH AFF MILLWOOD S; WENNBERG DE, 2000, DARTMOUTH ATLAS CARD	25	63	64	1	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2008	299	3					335	337		10.1001/jama.299.3.335	http://dx.doi.org/10.1001/jama.299.3.335			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253DB	18212319				2022-12-28	WOS:000252497800026
J	Bhutta, ZA; Haider, BA				Bhutta, Zulfiqar A.; Haider, Batool Azra			Maternal micronutrient deficiencies in developing countries	LANCET			English	Editorial Material							SUPPLEMENTATION; PREGNANCY; WOMEN; VITAMIN; INFANTS		[Bhutta, Zulfiqar A.; Haider, Batool Azra] Aga Khan Univ, Dept Paediat & Child Hlth, Karachi 74800, Pakistan	Aga Khan University	Bhutta, ZA (corresponding author), Aga Khan Univ, Dept Paediat & Child Hlth, Karachi 74800, Pakistan.	zulfiqar.bhutta@aku.edu						Allen LH, 2005, AM J CLIN NUTR, V81, p1206S; Christian P, 2005, LANCET, V366, P711, DOI 10.1016/S0140-6736(05)67166-8; Fawzi WW, 2007, NEW ENGL J MED, V356, P1423, DOI 10.1056/NEJMoa064868; Gupta P, 2007, ARCH PEDIAT ADOL MED, V161, P58, DOI 10.1001/archpedi.161.1.58; Haider BA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004905; HOFMEYR GJ, 2006, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD001059.PUB2; Katz J, 2006, J NUTR, V136, P1389, DOI 10.1093/jn/136.5.1389; Mahomed K, 2007, COCHRANE DB SYST REV, V2; Martin H, 2007, PEDIATRICS, V119, P1152, DOI 10.1542/peds.2006-2706; *MICR IN, 2004, VIT MIN DEF PARTN DR; Osendarp SJM, 2001, LANCET, V357, P1080, DOI 10.1016/S0140-6736(00)04260-4; Ronnenberg AG, 2007, AM J EPIDEMIOL, V166, P304, DOI 10.1093/aje/kwm078; Shankar AH, 2008, LANCET, V371, P215, DOI 10.1016/S0140-6736(08)60133-6; *STATCOMPILER, 2007, DEM HLTH SURV; Thaver D, 2006, COCHRANE DB SYST REV, V2; Villamor E, 2005, AM J CLIN NUTR, V81, P880, DOI 10.1093/ajcn/81.4.880; *WHO DIV NUTR, 1995, WHONUT953; World Health Organization, 2007, WORLD HLTH STAT 2007	18	30	31	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 19	2008	371	9608					186	187		10.1016/S0140-6736(08)60116-6	http://dx.doi.org/10.1016/S0140-6736(08)60116-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	252UK	18207005				2022-12-28	WOS:000252471900009
J	Lin, CC; Chang, WH; Wang, TE; Chu, CH; Shih, SC				Lin, Ching-Chung; Chang, Wen-Hsiung; Wang, Tsang-En; Chu, Cheng-Hsin; Shih, Shou-Chuan			Why is this abdomen swollen?	LANCET			English	Editorial Material									[Lin, Ching-Chung; Chang, Wen-Hsiung; Wang, Tsang-En; Chu, Cheng-Hsin; Shih, Shou-Chuan] Mackay Mem Hosp, Mackay Med Nursing & Management Coll, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan	Mackay Junior College of Medicine, Nursing & Management; Mackay Memorial Hospital	Shih, SC (corresponding author), Mackay Mem Hosp, Mackay Med Nursing & Management Coll, Dept Internal Med, Div Gastroenterol, 92,Sec 2,Chung Shan N Rd, Taipei, Taiwan.	sschuan@ms2.mmh.org.tw	Wang, Tsang-En/GQH-7847-2022; Chu, Chu/T-6038-2019	Lin, Ching Chung/0000-0001-8917-5293				Krishnamurthy P, 2006, GASTROINTEST ENDOSC, V64, P464, DOI 10.1016/j.gie.2006.02.026; LOWENFELS AB, 1993, NEW ENGL J MED, V328, P1433, DOI 10.1056/NEJM199305203282001	2	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 19	2008	371	9608					274	274		10.1016/S0140-6736(08)60138-5	http://dx.doi.org/10.1016/S0140-6736(08)60138-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	252UK	18207022				2022-12-28	WOS:000252471900031
J	Toggweiler, JR; Russell, J				Toggweiler, J. R.; Russell, Joellen			Ocean circulation in a warming climate	NATURE			English	Article							ATMOSPHERIC CO2; STRATIFICATION; CYCLE; WIND	Climate models predict that the ocean's circulation will weaken in response to global warming, but the warming at the end of the last ice age suggests a different outcome.	[Toggweiler, J. R.] NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08542 USA; [Russell, Joellen] Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Arizona	Toggweiler, JR (corresponding author), NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08542 USA.	robbie.toggweiler@noaa.gov	Toggweiler, J. R./O-5883-2019	Toggweiler, J. R./0000-0001-6345-5756; Russell, Joellen/0000-0001-9937-6056				Aoki S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022220; Bindoff NL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P385; BROECKER WS, 1989, GEOCHIM COSMOCHIM AC, V53, P2465, DOI 10.1016/0016-7037(89)90123-3; de Boer AM, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2005PA001242; Francois R, 1997, NATURE, V389, P929, DOI 10.1038/40073; Gillett NP, 2003, NATURE, V422, P292, DOI 10.1038/nature01487; Gregory JM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023209; HURRELL JW, 1994, TELLUS A, V46, P325, DOI 10.1034/j.1600-0870.1994.t01-1-00007.x; Kuhlbrodt T, 2007, REV GEOPHYS, V45, DOI 10.1029/2004RG000166; Lynch-Stieglitz J, 2007, SCIENCE, V316, P66, DOI 10.1126/science.1137127; MANABE S, 1993, NATURE, V364, P215, DOI 10.1038/364215a0; Marchitto TM, 2007, SCIENCE, V316, P1456, DOI 10.1126/science.1138679; McCabe GJ, 2001, J CLIMATE, V14, P2763, DOI 10.1175/1520-0442(2001)014<2763:TINHSC>2.0.CO;2; Munk W, 1998, DEEP-SEA RES PT I, V45, P1977, DOI 10.1016/S0967-0637(98)00070-3; Russell JL, 2006, J CLIMATE, V19, P6382, DOI 10.1175/JCLI3984.1; Saenko OA, 2005, CLIM DYNAM, V25, P415, DOI 10.1007/s00382-005-0032-5; Sarmiento JL, 1998, NATURE, V393, P245, DOI 10.1038/30455; Shindell DT, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020724; Sigman DM, 2004, NATURE, V428, P59, DOI 10.1038/nature02357; Sikes EL, 2000, NATURE, V405, P555, DOI 10.1038/35014581; Thompson DWJ, 2002, SCIENCE, V296, P895, DOI 10.1126/science.1069270; TOGGWEILER JR, 1995, DEEP-SEA RES PT I, V42, P477, DOI 10.1016/0967-0637(95)00012-U; Toggweiler JR, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001154; Wunsch C, 1998, J PHYS OCEANOGR, V28, P2332, DOI 10.1175/1520-0485(1998)028<2332:TWDBTW>2.0.CO;2; Yin JH, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023684	25	240	253	3	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2008	451	7176					286	288		10.1038/nature06590	http://dx.doi.org/10.1038/nature06590			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202645	Bronze			2022-12-28	WOS:000252432100037
J	Fung, CH; Lim, YW; Mattke, S; Damberg, C; Shekelle, PG				Fung, Constance H.; Lim, Yee-Wei; Mattke, Soeren; Damberg, Cheryl; Shekelle, Paul G.			Systematic review: The evidence that publishing patient care performance data improves quality of care	ANNALS OF INTERNAL MEDICINE			English	Review							NEW-YORK-STATE; ARTERY-BYPASS-SURGERY; PAY-FOR-PERFORMANCE; HEALTH PLAN CHOICES; CARDIAC-SURGERY; HOSPITAL PERFORMANCE; CONSUMER REPORTS; MARKET SHARE; UNINTENDED CONSEQUENCES; MEDICAID BENEFICIARIES	Background: Previous reviews have shown inconsistent effects of publicly reported performance data on quality of care, but many new studies have become available in the 7 years since the last systematic review. Purpose: To synthesize the evidence for using publicly reported performance data to improve quality. Data Sources: Web of Science, MEDLINE, EconLit, and Wilson Business Periodicals (1999-2006) and independent review of articles (1986-1999) identified in a previous systematic review. Only sources published in English were included. Study Selection: Peer-reviewed articles assessing the effects of public release of performance data on selection of providers, quality improvement activity, clinical outcomes (effectiveness, patient safety, and patient-centeredness), and unintended consequences. Data Extraction: Data on study participants, reporting system or level, study design, selection of providers, quality improvement activity, outcomes, and unintended consequences were extracted. Data Synthesis: Forty-five articles published since 1986 (27 of which were published since 1999) evaluated the impact of public reporting on quality. Many focus on a select few reporting systems. Synthesis of data from 8 health plan-level studies suggests modest association between public reporting and plan selection. Synthesis of 11 studies, all hospital-level, suggests stimulation of quality improvement activity. Review of 9 hospital-level and 7 individual provider-level studies shows inconsistent association between public reporting and selection of hospitals and individual providers. Synthesis of 11 studies, primarily hospital-level, indicates inconsistent association between public reporting and improved effectiveness. Evidence on the impact of public reporting on patient safety and patient-centeredness is scant. Limitations: Heterogeneity made comparisons across studies challenging. Only peer-reviewed, English-language articles were included. Conclusion: Evidence is scant, particularly about individual providers and practices. Rigorous evaluation of many major public reporting systems is lacking. Evidence suggests that publicly releasing performance data stimulates quality improvement activity at the hospital level. The effect of public reporting on effectiveness, safety, and patient-centeredness remains uncertain.			Fung, CH (corresponding author), 10880 Wilshire Blvd,300, Los Angeles, CA 90024 USA.		Wilkins, Thad/G-2541-2010					*AG HEALTHC RES QU, 2004, NAT HEALTHC QUAL REP; *AG HEALTHC RES QU, CAHPS OV; Asch SM, 2004, ANN INTERN MED, V141, P938, DOI 10.7326/0003-4819-141-12-200412210-00010; Asch SM, 2006, NEW ENGL J MED, V354, P1147, DOI 10.1056/NEJMsa044464; Baker DW, 2003, MED CARE, V41, P729, DOI 10.1097/00005650-200306000-00006; Baker DW, 2002, MED CARE, V40, P879, DOI 10.1097/00005650-200210000-00006; Barry CA, 2000, BRIT MED J, V320, P1246, DOI 10.1136/bmj.320.7244.1246; Bates DW, 2001, J AM MED INFORM ASSN, V8, P299, DOI 10.1136/jamia.2001.0080299; Beaulieu ND, 2002, J HEALTH ECON, V21, P43, DOI 10.1016/S0167-6296(01)00126-6; Bentley J M, 1998, Jt Comm J Qual Improv, V24, P40; BERWICK DM, 1990, JAMA-J AM MED ASSOC, V263, P247, DOI 10.1001/jama.263.2.247; Berwick DM, 2003, MED CARE, V41, pI30; Bost J E, 2001, Manag Care Interface, V14, P50; Burack JH, 1999, ANN THORAC SURG, V68, P1195, DOI 10.1016/S0003-4975(99)00907-8; Centers for Medicare & Medicaid Services, HOSP COMP; Chassin MR, 2002, HEALTH AFFAIR, V21, P40, DOI 10.1377/hlthaff.21.4.40; Clough JD, 2002, AM J MED QUAL, V17, P47, DOI 10.1177/106286060201700202; Cochrane Effective Practice and Organisation of Care Review Group, 2002, DAT COLL CHECKL; Dranove D, 2003, J POLIT ECON, V111, P555, DOI 10.1086/374180; DZIUBAN SW, 1994, ANN THORAC SURG, V58, P1871, DOI 10.1016/0003-4975(94)91730-2; Farley DO, 2002, MED CARE RES REV, V59, P319, DOI 10.1177/1077558702059003005; Farley DO, 2002, HEALTH SERV RES, V37, P985, DOI 10.1034/j.1600-0560.2002.62.x; Ghali WA, 1997, JAMA-J AM MED ASSOC, V277, P379, DOI 10.1001/jama.277.5.379; GRADE Working Group, GRAD REC ASS DEV EV; Grimshaw J, 2003, QUAL SAF HEALTH CARE, V12, P298, DOI 10.1136/qhc.12.4.298; Grumbach K, 1998, NEW ENGL J MED, V339, P1516, DOI 10.1056/NEJM199811193392106; Handler JA, 2000, ACAD EMERG MED, V7, P1183, DOI 10.1111/j.1553-2712.2000.tb00462.x; Hannan EL, 1997, AM HEART J, V134, P55, DOI 10.1016/S0002-8703(97)70106-6; HANNAN EL, 1995, JAMA-J AM MED ASSOC, V273, P209, DOI 10.1001/jama.273.3.209; HANNAN EL, 1994, ANN THORAC SURG, V58, P1852, DOI 10.1016/0003-4975(94)91726-4; HANNAN EL, 1994, JAMA-J AM MED ASSOC, V271, P761, DOI 10.1001/jama.271.10.761; Harris KM, 2002, HEALTH SERV RES, V37, P551, DOI 10.1111/1475-6773.00037; Henley E, 2005, J FAM PRACTICE, V54, P609; Hibbard JH, 2003, HEALTH AFFAIR, V22, P84, DOI 10.1377/hlthaff.22.2.84; Hibbard JH, 2000, HEALTH AFFAIR, V19, P138, DOI 10.1377/hlthaff.19.5.138; Hibbard JH, 2005, HEALTH AFFAIR, V24, P1150, DOI 10.1377/hlthaff.24.4.1150; Hibbard JH, 1997, HEALTH AFFAIR, V16, P172, DOI 10.1377/hlthaff.16.6.172; Institute of Medicine, CROSS QUAL CHASM; Jha AK, 2006, HEALTH AFFAIR, V25, P844, DOI 10.1377/hlthaff.25.3.844; Jin GZ, 2006, J HEALTH ECON, V25, P248, DOI 10.1016/j.jhealeco.2005.06.002; Kaiser Family Foundation, 2004, NAT SURV CONS EXP PA; Kuperman G J, 2001, Jt Comm J Qual Improv, V27, P509; Lannon CM, 2001, PEDIATRICS, V107, P1473; Lansky D, 2002, HEALTH AFFAIR, V21, P52, DOI 10.1377/hlthaff.21.4.52; Lohr K., 1990, MED STRATEGY QUALITY; Longo DR, 1997, JAMA-J AM MED ASSOC, V278, P1579, DOI 10.1001/jama.278.19.1579; Luce JM, 1996, WESTERN J MED, V164, P410; Mannion Russell, 2005, J Health Serv Res Policy, V10, P18; Marshall MN, 2003, HEALTH AFFAIR, V22, P134, DOI 10.1377/hlthaff.22.3.134; Marshall MN, 2000, JAMA-J AM MED ASSOC, V283, P1866, DOI 10.1001/jama.283.14.1866; Marvel MK, 1999, JAMA-J AM MED ASSOC, V281, P283, DOI 10.1001/jama.281.3.283; McCormick D, 2002, JAMA-J AM MED ASSOC, V288, P1484, DOI 10.1001/jama.288.12.1484; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Mennemeyer ST, 1997, INQUIRY-J HEALTH CAR, V34, P117; Moscucci M, 2005, J AM COLL CARDIOL, V45, P1759, DOI 10.1016/j.jacc.2005.01.055; Mukamel DB, 2000, HEALTH SERV RES, V35, P319; Mukamel DB, 2004, INQUIRY-J HEALTH CAR, V41, P435, DOI 10.5034/inquiryjrnl_41.4.435; Mukamel DB, 1998, MED CARE, V36, P945, DOI 10.1097/00005650-199807000-00002; Mukamel DB, 2002, HEALTH SERV RES, V37, P1129, DOI 10.1111/1475-6773.10212; Narins CR, 2005, ARCH INTERN MED, V165, P83, DOI 10.1001/archinte.165.1.83; *NAT COMM QUAL ASS, 2005, STAT HEALTHC QUAL; *NCQA, NCQA HLTH PLAN REP C; *NJ DEP HLTH SEN S, 2005 HMO NJ PERF REP; Nugent WC, 1999, ANN THORAC SURG, V68, P1201; *NY STAT DEP HLTH, HEART DIS; *OFF INSP GEN JUN, EXT REV HOSP QUAL ST; Omoigui NA, 1996, CIRCULATION, V93, P27, DOI 10.1161/01.CIR.93.1.27; *PAC BUS GROUP HLT, VAL BAS PURCH; Peterson ED, 1998, J AM COLL CARDIOL, V32, P993, DOI 10.1016/S0735-1097(98)00332-5; Rainwater J A, 1998, Jt Comm J Qual Improv, V24, P31; Robinson S, 1997, JOINT COMM J QUAL IM, V23, P239, DOI 10.1016/S1070-3241(16)30313-3; Romano PS, 2004, MED CARE, V42, P367, DOI 10.1097/01.mlr.0000118872.33251.11; Rosenthal G E, 1998, Jt Comm J Qual Improv, V24, P347; Rosenthal G E, 1997, Am J Med Qual, V12, P103, DOI 10.1177/0885713X9701200204; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Scanlon DP, 2002, J HEALTH ECON, V21, P19, DOI 10.1016/S0167-6296(01)00111-4; Schauffler HH, 2001, ANNU REV PUBL HEALTH, V22, P69, DOI 10.1146/annurev.publhealth.22.1.69; Schneider EC, 1996, NEW ENGL J MED, V335, P251, DOI 10.1056/NEJM199607253350406; Schneider EC, 2001, QUAL HEALTH CARE, V10, P96, DOI 10.1136/qhc.10.2.96; Sofaer S, 2005, HEALTH SERV RES, V40, P2018, DOI 10.1111/j.1475-6773.2005.00473.x; Spranca M, 2000, HEALTH SERV RES, V35, P933; Tu JV, 2003, INT J QUAL HEALTH C, V15, P131, DOI 10.1093/intqhc/mzg015; *US C, 2006, NEXT GEN HLTH INF TO; *US DEP HHS, HOSP COMP; VLADECK BC, 1988, HEALTH AFFAIR, V7, P122, DOI 10.1377/hlthaff.7.1.122; Wedig GJ, 2002, J HEALTH ECON, V21, P1031, DOI 10.1016/S0167-6296(02)00075-9; Werner RM, 2005, CIRCULATION, V111, P1257, DOI 10.1161/01.CIR.0000157729.59754.09; Werner RM, 2005, JAMA-J AM MED ASSOC, V293, P1239, DOI 10.1001/jama.293.10.1239; [No title captured]	89	634	639	2	84	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2008	148	2					111	123		10.7326/0003-4819-148-2-200801150-00006	http://dx.doi.org/10.7326/0003-4819-148-2-200801150-00006			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	254NZ	18195336				2022-12-28	WOS:000252594600004
J	Carlin, JB; Darmstadt, GL; Hamer, DH; Weber, MW; Chowdhury, A; Saha, S; Deorari, A; Paul, V; Kumar, P; Narang, A; Zaidi, A; Bhutta, Z; Jeena, P; Yeboah-Antwi, K; Yobo, EA; Bartos, A; Mazzi, E; Bahl, R				Carlin, John B.; Darmstadt, Gary L.; Hamer, Davidson H.; Weber, Martin W.; Chowdhury, Azad; Saha, Samir; Deorari, Ashok; Paul, Vinod; Kumar, Praveen; Narang, Anil; Zaidi, Anita; Bhutta, Zulfiqar; Jeena, Prakash; Yeboah-Antwi, Kojo; Yobo, Emmanuel Ado; Bartos, Andres; Mazzi, Eduardo; Bahl, Rajiv		Young Infants Clinical Signs Study	Clinical signs that predict severe illness in children underage 2 months: a multicentre study	LANCET			English	Article							EPIDEMIOLOGIC PROFILE; VIRAL ETIOLOGY; SEPSIS; INFECTIONS; PNEUMONIA; BACTERIAL	Background Neonatal illness, particularly in the first week of life, is a leading cause of death worldwide. Improving identification of young infants who require referral for severe illness is of major public-health importance. Methods infants under 2 months of age brought with illness to health facilities in Bangladesh, Bolivia, Ghana, India, and South Africa were recruited in two age-groups: 0-6 days and 7-59 days. A trained health worker recorded Pakistan 31 symptoms and clinical signs. An expert paediatrician assessed each case independently for severe illness that required hospital admission. We examined the sensitivity, specificity, and odds ratio (OR) for each symptom and sign individually and combined into algorithms to assess their value for predicting severe illness, excluding jaundice. Findings 3177 children aged 0-6 days and 5712 infants aged 7-59 days were enrolled. 12 symptoms or signs predicted severe illness in the first week of life: history of difficulty feeding (OR 10 . 0, 95% CI, 6. 9-14 . 5), history of convulsions (15.4, 6.4-37 . 2), lethargy (3.5, 1.7-7. 1), movement only when stimulated (6.9, 3.0-15.5), respiratory rate of 60 breaths per minute or more (2-7, 1.9-3.8), grunting (2.9, 1.1-7.5), severe chest indrawing (8.9, 4. 0-20. 1), temperature of 37.5 degrees C or more (3.4, 2.4-4.9) or below 35.5 degrees C (9.2, 4. 6-18.6), prolonged capillary refill (10 . 5, 5.1-21.7), cyanosis (13.7, 1.6-116.5), and stiff limbs (15.1, 2.2-105.9). A decision rule requiring the presence of any one sign had high sensitivity (87%) and specificity (74%). After we reduced the algorithm to seven signs (history of difficulty feeding, history of convulsions, movement only when stimulated, respiratory rate of 60 breaths per minute or more, severe chest indrawing, temperature of 37.5 degrees C or more or below 35.5 degrees C), mainly on the basis of prevalence of each sign or symptom, sensitivity (85%) and specificity (75%) were much the same. These seven signs also did well in 7-59-day-old infants (sensitivity 74%, specificity 79%). Interpretation A single simple algorithm could be recommended for identifying severe illness in infants aged 0-2 months who are brought to health facilities. Further research is needed on screening newborn children for illness in the community during routine home visits.	[Carlin, John B.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Darmstadt, Gary L.] Johns Hopkins Univ, Baltimore, MD USA; [Hamer, Davidson H.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Weber, Martin W.; Bahl, Rajiv] WHO, CH-1211 Geneva, Switzerland; [Chowdhury, Azad; Saha, Samir] Dhaka Shishu Hosp, Dhaka, Bangladesh; [Deorari, Ashok; Paul, Vinod] All India Inst Med Sci, Delhi, India; [Kumar, Praveen; Narang, Anil] Postgrad Inst Med Educ & Res, Chandigarh 160012, India; [Zaidi, Anita; Bhutta, Zulfiqar] Aga Khan Univ, Karachi, Pakistan; [Jeena, Prakash] Univ KwaZulu Natal, Durban, South Africa; [Yeboah-Antwi, Kojo; Yobo, Emmanuel Ado] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana; [Bartos, Andres] Hosp Maternoinfantil, La Paz, Bolivia; [Mazzi, Eduardo] Hosp Nino, La Paz, Bolivia	Murdoch Children's Research Institute; Johns Hopkins University; Boston University; World Health Organization; All India Institute of Medical Sciences (AIIMS) New Delhi; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Aga Khan University; University of Kwazulu Natal; Kwame Nkrumah University Science & Technology	Weber, MW (corresponding author), WHO, Indonesia Country Off, Bina Mulia 1 Bldg,Jalan HR Rasuna Said Kav 10, Jakarta 12950, Indonesia.	weberm@who.or.id	C, Praveen Kumar/AAA-8227-2019; Weber, Martin/GPW-6095-2022; Darmstadt, Gary/AAU-7488-2020; Yeboah-Antwi, Kojo/AAI-8519-2020; Carlin, John B/B-3492-2012; Carlin, John/AAG-4332-2020; Hamer, Davidson Howes/J-2020-2019	Carlin, John B/0000-0002-2694-9463; Carlin, John/0000-0002-2694-9463; Hamer, Davidson Howes/0000-0002-4700-1495				Bang AT, 2005, PEDIATR INFECT DIS J, V24, P335, DOI 10.1097/01.inf.0000157094.43609.17; Deorari AK, 2007, INDIAN PEDIATR, V44, P739; Gatchalian SR, 1999, PEDIATR INFECT DIS J, V18, pS50, DOI 10.1097/00006454-199910001-00009; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lehmann D, 1999, PEDIATR INFECT DIS J, V18, pS42, DOI 10.1097/00006454-199910001-00008; Margolis P, 1999, PEDIATR INFECT DIS J, V18, pS23; Muhe L, 1999, PEDIATR INFECT DIS J, V18, pS56, DOI 10.1097/00006454-199910001-00010; Narang A, 2007, INDIAN PEDIATR, V44, P751; Tulloch J., 1999, Lancet (British edition), V354, P16, DOI 10.1016/S0140-6736(99)90252-0; Weber MW, 2003, PEDIATR INFECT DIS J, V22, P711, DOI 10.1097/01.inf.0000078163.80807.88; Weber MW, 1997, B WORLD HEALTH ORGAN, V75, P25; World Health Organization, PREGN CHILDB POSTP N; World Health Organization, 2006, WORLD HLTH STAT 2006; World Health Organization, 2005, WORLD HLTH REP 2005; YEBOAHANTWI K, IN PRESS ANN TROP PA; Zaidi AKM, 2005, LANCET, V365, P1175, DOI 10.1016/S0140-6736(05)71881-X	16	250	249	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 12	2008	371	9607					135	142						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	252ND	18191685				2022-12-28	WOS:000252452300028
J	Frossard, JL; Steer, ML; Pastor, CM				Frossard, Jean-Louis; Steer, Michael L.; Pastor, Catherine M.			Acute pancreatitis	LANCET			English	Review							ACUTE NECROTIZING PANCREATITIS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HEREDITARY PANCREATITIS; CONSERVATIVE TREATMENT; PARENTERAL-NUTRITION; ANTIBIOTIC-TREATMENT; CLINICAL-ASSESSMENT; DISEASE SEVERITY; CONTROLLED-TRIAL; STENT PLACEMENT	Acute pancreatitis is an inflammatory disease of the pancreas. Acute abdominal pain is the most common Symptom, and increased concentrations of serum amylase and lipase confirm the diagnosis. Pancreatic injury is mild in 80% of patients, who recover without complications. The remaining patients have a severe disease with local and systemic complications. Gallstone migration into the common bile duct and alcohol abuse are the most frequent causes of pancreatitis in adults. About 15-25% of pancreatitis episodes are of unknown origin. Treatment of mild disease is supportive, but severe episodes need management by a multidisciplinary team including gastroenterologists, interventional radiologists, intensivists, and surgeons. Improved understanding of pathophysiology and better assessments of disease severity should ameliorate the management and outcome of this complex disease.	[Frossard, Jean-Louis; Pastor, Catherine M.] Hop Univ Geneve, Div Gastroenterol, CH-1205 Geneva, Switzerland; [Steer, Michael L.] Tufts Univ New England Med Ctr, Dept Surg, Boston, MA USA	University of Geneva; Tufts Medical Center	Frossard, JL (corresponding author), Hop Univ Geneve, Div Gastroenterol, Rue Micheli du Crest 24, CH-1205 Geneva, Switzerland.	jean-louis.frossard@hcuge.ch		Pastor, Catherine/0000-0002-1551-3824	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031396] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK31396] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADISESHIAH M, 1983, WORLD J SURG, V7, P519, DOI 10.1007/BF01655943; Balachandra S, 2006, INT J CLIN PRACT, V60, P156, DOI 10.1111/j.1368-5031.2005.00645.x; BALTHAZAR EJ, 1990, RADIOLOGY, V174, P331, DOI 10.1148/radiology.174.2.2296641; Balthazar EJ, 2002, RADIOLOGY, V223, P603, DOI 10.1148/radiol.2233010680; Bank S, 1999, GASTROENTEROL CLIN N, V28, P571, DOI 10.1016/S0889-8553(05)70074-1; Baron TH, 1996, GASTROENTEROLOGY, V111, P755, DOI 10.1053/gast.1996.v111.pm8780582; Benifla M, 2003, J CLIN GASTROENTEROL, V37, P169, DOI 10.1097/00004836-200308000-00015; BERNARD C, 1856, LECONS PHYSL EXPT, V2, P278; BERRY AR, 1981, BRIT J SURG, V68, P870, DOI 10.1002/bjs.1800681212; BESS MA, 1980, JAMA-J AM MED ASSOC, V243, P246; Blum Arnon, 2005, Eur J Intern Med, V16, P473, DOI 10.1016/j.ejim.2005.03.005; BRADLEY EL, 1993, ARCH SURG-CHICAGO, V128, P586; Brown A, 2000, PANCREAS, V20, P367, DOI 10.1097/00006676-200005000-00005; BRUGGE WR, 2005, NEW ENGL J MED, V16, P1218; Buchler M, 1993, Curr Opin Gen Surg, P282; Buter A, 2002, BRIT J SURG, V89, P298, DOI 10.1046/j.0007-1323.2001.02025.x; CAPPELL MS, 1995, AM J MED, V98, P243, DOI 10.1016/S0002-9343(99)80370-2; Cheng CL, 2006, AM J GASTROENTEROL, V101, P139, DOI 10.1111/j.1572-0241.2006.00380.x; CLAVIEN PA, 1989, ANN SURG, V210, P614, DOI 10.1097/00000658-198911000-00008; Closa D, 1996, AM J PHYSIOL-GASTR L, V270, pG6, DOI 10.1152/ajpgi.1996.270.1.G6; COTTON PB, 1991, GASTROINTEST ENDOSC, V37, P383, DOI 10.1016/S0016-5107(91)70740-2; De Waele JJ, 2005, CRIT CARE, V9, pR452, DOI 10.1186/cc3754; DEFRANCES CJ, 2005, NATL HOSP DISCHARGE; Delcenserie R, 1996, PANCREAS, V13, P198; DELHAYE M, 1985, GASTROENTEROLOGY, V89, P951, DOI 10.1016/0016-5085(85)90193-3; Dholakia K, 2004, J CLIN GASTROENTEROL, V38, P81, DOI 10.1097/00004836-200401000-00017; Diehl AK, 1997, ARCH INTERN MED, V157, P1674, DOI 10.1001/archinte.157.15.1674; Draganov P, 2005, GASTROENTEROLOGY, V128, P756, DOI 10.1053/j.gastro.2005.01.037; Eachempati SR, 2002, ARCH SURG-CHICAGO, V137, P730, DOI 10.1001/archsurg.137.6.730; Eatock FC, 2005, AM J GASTROENTEROL, V100, P432, DOI 10.1111/j.1572-0241.2005.40587.x; Ellis I, 2001, PANCREATOLOGY, V1, P405, DOI 10.1159/000055840; FAN ST, 1993, NEW ENGL J MED, V328, P228, DOI 10.1056/NEJM199301283280402; Fazel A, 2005, PANCREAS, V30, P359, DOI 10.1097/01.mpa.0000160278.11086.89; Felley C, 2004, AIDS, V18, P1521, DOI 10.1097/01.aids.0000131356.52457.7a; Flasar MH, 2006, MED CLIN N AM, V90, P481, DOI 10.1016/j.mcna.2005.11.005; Folsch UR, 1997, NEW ENGL J MED, V336, P237, DOI 10.1056/NEJM199701233360401; FORTSON MR, 1995, AM J GASTROENTEROL, V90, P2134; Freeman ML, 1996, NEW ENGL J MED, V335, P909, DOI 10.1056/NEJM199609263351301; Freeny PC, 1998, AM J ROENTGENOL, V170, P969, DOI 10.2214/ajr.170.4.9530046; Frey CF, 2006, PANCREAS, V33, P336, DOI 10.1097/01.mpa.0000236727.16370.99; Frossard JL, 2003, AM J GASTROENTEROL, V98, P1516, DOI 10.1016/S0002-9270(03)00359-9; Frossard JL, 2002, FRONT BIOSCI-LANDMRK, V7, pD275, DOI 10.2741/frossard; Frossard JL, 1999, GASTROENTEROLOGY, V116, P694, DOI 10.1016/S0016-5085(99)70192-7; Frossard JL, 2001, GASTROEN CLIN BIOL, V25, P164; Frossard JL, 2001, AM J RESP CRIT CARE, V164, P162, DOI 10.1164/ajrccm.164.1.2008026; Frossard JL, 2000, GASTROINTEST ENDOSC, V51, P175, DOI 10.1016/S0016-5107(00)70414-7; FUNNELL IC, 1993, BRIT J SURG, V80, P484, DOI 10.1002/bjs.1800800426; FURUKAWA T, 1992, CANCER-AM CANCER SOC, V70, P1505, DOI 10.1002/1097-0142(19920915)70:6<1505::AID-CNCR2820700611>3.0.CO;2-D; Gelrud A, 2004, AM J GASTROENTEROL, V99, P1557, DOI 10.1111/j.1572-0241.2004.30834.x; Giannini G, 2005, INT J ARTIF ORGANS, V28, P1018, DOI 10.1177/039139880502801009; GIGGS JA, 1988, SOC SCI MED, V26, P79, DOI 10.1016/0277-9536(88)90047-0; Gloor B, 1998, J SURG RES, V80, P110, DOI 10.1006/jsre.1997.5289; Gorelick FS, 2003, PANCREAS, V27, P305, DOI 10.1097/00006676-200311000-00006; GRENDELL JH, 1990, GASTROENTEROL CLIN N, V19, P843; Halonen KI, 2002, CRIT CARE MED, V30, P1274, DOI 10.1097/00003246-200206000-00019; Harewood GC, 2005, GASTROINTEST ENDOSC, V62, P367, DOI 10.1016/j.gie.2005.04.020; Heinrich S, 2006, ANN SURG, V243, P154, DOI 10.1097/01.sla.0000197334.58374.70; Imrie CW, 1997, EUR J GASTROEN HEPAT, V9, P103, DOI 10.1097/00042737-199702000-00001; Isenmann R, 2004, GASTROENTEROLOGY, V126, P997, DOI 10.1053/j.gastro.2003.12.050; JAAKKOLA M, 1993, GUT, V34, P1255, DOI 10.1136/gut.34.9.1255; Johnson CD, 2005, GUT, V54, P1, DOI 10.1136/gut.200A.057026; Johnson CD, 2004, GUT, V53, P1340, DOI 10.1136/gut.2004.039883; Johnson JL, 2006, PHARMACOTHERAPY, V26, P414, DOI 10.1592/phco.26.3.414; JOHNSON MA, 2005, JOP, V8, P334; Karne S, 1999, SURG CLIN N AM, V79, P699, DOI 10.1016/S0039-6109(05)70036-0; Kemppainen E, 1998, ANN CHIR GYNAECOL, V87, P191; Kemppainen E, 1997, GUT, V41, P690, DOI 10.1136/gut.41.5.690; Kemppainen EA, 1997, NEW ENGL J MED, V336, P1788, DOI 10.1056/NEJM199706193362504; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kyriakidis AV, 2005, PANCREATOLOGY, V5, P201, DOI 10.1159/000085272; Lankisch PG, 1996, Z GASTROENTEROL, V34, P371; LANKISCH PG, 1995, GUT, V37, P565, DOI 10.1136/gut.37.4.565; Lankisch PG, 2001, AM J GASTROENTEROL, V96, P2081, DOI 10.1016/S0002-9270(01)02529-1; Lankisch PG, 1999, ACUTE PANCREATITIS N, P145; LeBodic L, 1996, HUM MOL GENET, V5, P549, DOI 10.1093/hmg/5.4.549; LEE SP, 1992, NEW ENGL J MED, V326, P589, DOI 10.1056/NEJM199202273260902; Liu TH, 2003, CRIT CARE MED, V31, P1026, DOI 10.1097/01.CCM.0000049951.77583.85; Lund H, 2006, SCAND J GASTROENTERO, V41, P234, DOI 10.1080/00365520510024133; MALKA D, 2001, GATROENTEROL CLIN BI, V25; Marik PE, 2004, BMJ-BRIT MED J, V328, P1407, DOI 10.1136/bmj.38118.593900.55; Matos C, 2006, BEST PRACT RES CL GA, V20, P157, DOI 10.1016/j.bpg.2005.09.003; Matull WR, 2006, J CLIN PATHOL, V59, P340, DOI 10.1136/jcp.2002.002923; Nathens AB, 2004, CRIT CARE MED, V32, P2524, DOI 10.1097/01.CCM.0000148222.09869.92; NEOPTOLEMOS JP, 1988, LANCET, V2, P979, DOI 10.1016/S0140-6736(88)90740-4; Nordback I, 2001, J GASTROINTEST SURG, V5, P113, DOI 10.1016/S1091-255X(01)80021-4; Norman JG, 1996, SURGERY, V120, P515, DOI 10.1016/S0039-6060(96)80072-9; Opie, 1901, J HOPKINS HOSP B, V12, P19; ORVAR K, 1994, ARCH INTERN MED, V154, P1755, DOI 10.1001/archinte.154.15.1755; Pagnoux C, 2005, MEDICINE, V84, P115, DOI 10.1097/01.md.0000158825.87055.0b; Papachristou GI, 2005, CLIN LAB MED, V25, P17, DOI 10.1016/j.cll.2004.12.003; Parenti DM, 1996, PANCREAS, V13, P356, DOI 10.1097/00006676-199611000-00005; Pastor CM, 2003, CHEST, V124, P2341, DOI 10.1378/chest.124.6.2341; Pazzi P, 2003, DIGEST LIVER DIS, V35, pS39, DOI 10.1016/S1590-8658(03)00093-8; PEDERZOLI P, 1993, SURG GYNECOL OBSTET, V176, P480; Perez A, 2005, AM J SURG, V190, P401, DOI 10.1016/j.amjsurg.2005.03.004; Pilleul F, 2005, J MAGN RESON IMAGING, V21, P237, DOI 10.1002/jmri.20254; Poch B, 1999, FEBS LETT, V461, P268, DOI 10.1016/S0014-5793(99)01470-2; RANSON JHC, 1977, J SURG RES, V22, P79, DOI 10.1016/0022-4804(77)90045-2; RANSON JHC, 1974, SURG GYNECOL OBSTET, V139, P69; RAVNIKGLAVAC M, 1996, PFLUGERS ARCH, V431, P191; RENNER IG, 1985, DIGEST DIS SCI, V30, P1005, DOI 10.1007/BF01308298; SAINIO V, 1995, LANCET, V346, P663, DOI 10.1016/S0140-6736(95)92280-6; SARLES H, 1965, GUT, V6, P545, DOI 10.1136/gut.6.6.545; Singh P, 2004, GASTROINTEST ENDOSC, V60, P544, DOI 10.1016/S0016-5107(04)02013-9; STERN CD, 1986, GUT, V27, P203, DOI 10.1136/gut.27.2.203; Sternby B, 1996, MAYO CLIN PROC, V71, P1138, DOI 10.4065/71.12.1138; SUGAWA C, 1987, AM J SURG, V153, P62, DOI 10.1016/0002-9610(87)90202-9; SWENSSON EE, 1981, AM J SURG, V142, P667, DOI 10.1016/0002-9610(81)90308-1; Tenner S, 1997, INT J PANCREATOL, V21, P105; TENNER S, 1994, AM J GASTROENTEROL, V89, P1863; TRAPNELL JE, 1975, BRIT MED J, V2, P179, DOI 10.1136/bmj.2.5964.179; Trivedi CD, 2005, J CLIN GASTROENTEROL, V39, P709, DOI 10.1097/01.mcg.0000173929.60115.b4; Uhl W, 2003, PANCREATOLOGY, V3, DOI 10.1159/000067684; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vriens PW, 2005, J AM COLL SURGEONS, V201, P497, DOI 10.1016/j.jamcollsurg.2005.06.269; Werlin SL, 2003, J PEDIATR GASTR NUTR, V37, P591, DOI 10.1097/00005176-200311000-00017; Werner J, 2005, GUT, V54, P426, DOI 10.1136/gut.2003.035907; Whitcomb DC, 2006, NEW ENGL J MED, V354, P2142, DOI 10.1056/NEJMcp054958; Whitcomb DC, 1999, GUT, V45, P317, DOI 10.1136/gut.45.3.317; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Whitcomb DC, 2005, DIGEST DIS, V23, P247, DOI 10.1159/000090172; Williams M, 1999, CRIT CARE MED, V27, P901, DOI 10.1097/00003246-199905000-00023; WILSON C, 1990, BRIT J SURG, V77, P1260, DOI 10.1002/bjs.1800771120; Windsor ACJ, 1998, GUT, V42, P431, DOI 10.1136/gut.42.3.431; WINSLET M, 1992, GUT, V33, P982, DOI 10.1136/gut.33.7.982; Yadav D, 2006, PANCREAS, V33, P323, DOI 10.1097/01.mpa.0000236733.31617.52	126	537	588	1	113	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 12	2008	371	9607					143	152		10.1016/S0140-6736(08)60107-5	http://dx.doi.org/10.1016/S0140-6736(08)60107-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	252ND	18191686				2022-12-28	WOS:000252452300029
J	Hertlein, C; Helden, L; Gambassi, A; Dietrich, S; Bechinger, C				Hertlein, C.; Helden, L.; Gambassi, A.; Dietrich, S.; Bechinger, C.			Direct measurement of critical Casimir forces	NATURE			English	Article							SPHERICAL-PARTICLES; LIGHT-SCATTERING; LIQUID-MIXTURES; SPHERES; AGGREGATION; SUSPENSIONS; FLUIDS; WALL	When fluctuating fields are confined between two surfaces, long- range forces arise. A famous example is the quantum electrodynamical Casimir force that results from zero- point vacuum fluctuations confined between two conducting metal plates(1). A thermodynamic analogue is the critical Casimir force: it acts between surfaces immersed in a binary liquid mixture close to its critical point and arises from the confinement of concentration fluctuations within the thin film of fluid separating the surfaces(2). So far, all experimental evidence for the existence of this effect has been indirect(3-5). Here we report the direct measurement of critical Casimir force between a single colloidal sphere and a flat silica surface immersed in a mixture of water and 2,6- lutidine near its critical point. We use total internal reflection microscopy to determine in situ the forces between the sphere and the surface, with femtonewton resolution(6). Depending on whether the adsorption preferences of the sphere and the surface for water and 2,6- lutidine are identical or opposite, we measure attractive and repulsive forces, respectively, that agree quantitatively with theoretical predictions and exhibit exquisite dependence on the temperature of the system. We expect that these features of critical Casimir forces may result in novel uses of colloids as model systems.	[Hertlein, C.; Helden, L.; Bechinger, C.] Univ Stuttgart, Inst Phys 2, D-70569 Stuttgart, Germany; [Gambassi, A.; Dietrich, S.] Max Planck Inst Met Res, D-70569 Stuttgart, Germany; [Gambassi, A.; Dietrich, S.] Univ Stuttgart, Inst Theoret & Angew Phys, D-70569 Stuttgart, Germany	University of Stuttgart; Max Planck Society; University of Stuttgart	Bechinger, C (corresponding author), Univ Stuttgart, Inst Phys 2, Pfaffenwaldring 57, D-70569 Stuttgart, Germany.	c.bechinger@physik.uni-stuttgart.de	Gambassi, Andrea/L-6353-2013	Gambassi, Andrea/0000-0003-3450-6125				Ball P, 2007, NATURE, V447, P772, DOI 10.1038/447772a; Bauer C, 2000, PHYS REV E, V62, P5324, DOI 10.1103/PhysRevE.62.5324; Bevan MA, 2000, J CHEM PHYS, V113, P1228, DOI 10.1063/1.481900; BEYSENS D, 1985, PHYS REV LETT, V54, P2123, DOI 10.1103/PhysRevLett.54.2123; Beysens D, 1999, J STAT PHYS, V95, P997, DOI 10.1023/A:1004506601807; Bieker T, 1998, PHYSICA A, V252, P85, DOI 10.1016/S0378-4371(97)00618-3; Casimir H. B. G., 1948, P KON NED AKAD WET, V51, P793; DOBBS HT, 1992, EUROPHYS LETT, V18, P439, DOI 10.1209/0295-5075/18/5/011; FISHER ME, 1978, CR ACAD SCI B PHYS, V287, P207; Fukuto M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.135702; GALLAGHER PD, 1992, PHYS REV A, V46, P2012, DOI 10.1103/PhysRevA.46.2012; GALLAGHER PD, 1992, PHYS REV A, V46, P7750, DOI 10.1103/PhysRevA.46.7750; Ganshin A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.075301; Garcia R, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.086101; GULARI E, 1972, J CHEM PHYS, V56, P6169, DOI 10.1063/1.1677169; Hanke A, 1998, PHYS REV LETT, V81, P1885, DOI 10.1103/PhysRevLett.81.1885; Helden L, 2006, APPL OPTICS, V45, P7299, DOI 10.1364/AO.45.007299; Krech M, 1999, J PHYS-CONDENS MAT, V11, pR391, DOI 10.1088/0953-8984/11/37/201; Mohideen U, 1998, PHYS REV LETT, V81, P4549, DOI 10.1103/PhysRevLett.81.4549; Prieve DC, 1999, ADV COLLOID INTERFAC, V82, P93, DOI 10.1016/S0001-8686(99)00012-3; Rafai S, 2007, PHYSICA A, V386, P31, DOI 10.1016/j.physa.2007.07.072; Rudhardt D, 1999, J PHYS-CONDENS MAT, V11, P10073, DOI 10.1088/0953-8984/11/50/303; Schlesener F, 2003, J STAT PHYS, V110, P981, DOI 10.1023/A:1022184508016; Vasilyev O, 2007, EPL-EUROPHYS LETT, V80, DOI 10.1209/0295-5075/80/60009	24	445	447	2	153	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2008	451	7175					172	175		10.1038/nature06443	http://dx.doi.org/10.1038/nature06443			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249GA	18185584	Green Submitted			2022-12-28	WOS:000252214400038
J	Wu, RR; Zhao, JP; Jin, H; Shao, P; Fang, MS; Guo, XF; He, YQ; Liu, YJ; Chen, JD; Li, LH				Wu, Ren-Rong; Zhao, Jing-Ping; Jin, Hua; Shao, Ping; Fang, Mao-Sheng; Guo, Xiao-Feng; He, Yi-Qun; Liu, Yi-Jun; Chen, Jin-Dong; Li, Le-Hua			Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ATYPICAL ANTIPSYCHOTICS; DOUBLE-BLIND; GLUCOSE; OLANZAPINE; THERAPY; HOMEOSTASIS; PREVENTION; CLOZAPINE; LIPIDS	Context Weight gain, a common adverse effect of antipsychotic medications, is associated with medical comorbidities in psychiatric patients. Objective To test the efficacy of lifestyle intervention and metformin alone and in combination for antipsychotic- induced weight gain and abnormalities in insulin sensitivity. Design, Setting, and Patients A randomized controlled trial ( October 2004-December 2006) involving 128 adult patients with schizophrenia in the Mental Health Institute of the Second Xiangya Hospital, Central South University, China. Participants who gained more than 10% of their predrug weight were assigned to 1 of 4 treatment groups. Interventions Patients continued their antipsychotic medication and were randomly assigned to 12 weeks of placebo, 750 mg/ d of metformin alone, 750 mg/ d of metformin and lifestyle intervention, or lifestyle intervention only. Main Outcome Measures Body mass index, waist circumference, insulin levels, and insulin resistance index. Results All 128 first- episode schizophrenia patients maintained relatively stable psychiatric improvement. The lifestyle- plus- metformin group had mean decreases in body mass index ( BMI) of 1.8 ( 95% confidence interval [ Cl], 1.3- 2.3), insulin resistance index of 3.6 ( 95% Cl, 2.7- 4.5), and waist circumference of 2.0 cm ( 95% Cl, 1.5- 2.4 cm). The metformin- alone group had mean decreases in BMI of 1.2 ( 95% Cl, 0.91.5), insulin resistance index of 3.5 ( 95% Cl, 2.7- 4.4), and waist circumference of 1.3 cm ( 95% Cl, 1.1- 1.5 cm). The lifestyle- plus- placebo group had mean decreases in BMI of 0.5 ( 95% Cl, 0.3- 0.8) and insulin resistance index of 1.0 ( 95% Cl, 0.5- 1.5). However, the placebo group had mean increases in BMI of 1.2 ( 95% Cl, 0.9- 1.5), insulin resistance index of 0.4 ( 95% Cl, 0.1- 0.7), and waist circumference of 2.2 cm ( 95% Cl, 1.7- 2.8 cm). The lifestyle- plus- metformin treatment was significantly superior to metformin alone and to lifestyle plus placebo for weight, BMI, and waist circumference reduction. Conclusions Lifestyle intervention and metformin alone and in combination demonstrated efficacy for antipsychotic- induced weight gain. Lifestyle intervention plus metformin showed the best effect on weight loss. Metformin alone was more effective in weight loss and improving insulin sensitivity than lifestyle intervention alone. Trial Registration clinicaltrials. gov Identifier: NCT00451399.	[Wu, Ren-Rong; Zhao, Jing-Ping; Shao, Ping; Fang, Mao-Sheng; Guo, Xiao-Feng; He, Yi-Qun; Liu, Yi-Jun; Chen, Jin-Dong; Li, Le-Hua] Cent S Univ, Xiangya Hosp 2, Mental Hlth Inst, Changsha 410011, Hunan, Peoples R China; [Jin, Hua] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA	Central South University; University of California System; University of California San Diego	Zhao, JP (corresponding author), Cent S Univ, Xiangya Hosp 2, Mental Hlth Inst, 139 Renmin Middle Rd, Changsha 410011, Hunan, Peoples R China.	wurenrong2005@yahoo.com.cn	zhao, jing/B-3868-2019; jin, hua/AAX-1569-2020	Wu, Renrong/0000-0003-1758-4738				Allison DB, 1999, AM J PSYCHIAT, V156, P1686; Allison DB, 2001, J CLIN PSYCHIAT, V62, P22; Alvarez-Jimenez M, 2006, J CLIN PSYCHIAT, V67, P1253, DOI 10.4088/JCP.v67n0812; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Andreasen N., 1984, SCALE ASSESSMENT POS; Aquila Ralph, 2000, Prim Care Companion J Clin Psychiatry, V2, P20; Baptista T, 2006, CAN J PSYCHIAT, V51, P192, DOI 10.1177/070674370605100310; Baptista T, 2007, SCHIZOPHR RES, V93, P99, DOI 10.1016/j.schres.2007.03.029; Barrett E, 2004, OBES RES, V12, P362; BERNSTEIN JG, 1987, ANN NY ACAD SCI, V499, P203, DOI 10.1111/j.1749-6632.1987.tb36212.x; Brar JS, 2005, J CLIN PSYCHIAT, V66, P205, DOI 10.4088/JCP.v66n0208; Colton Craig W, 2006, Prev Chronic Dis, V3, pA42; Eriksson KM, 2006, SCAND J PUBLIC HEALT, V34, P453, DOI 10.1080/14034940500489826; Evans S, 2005, AUST NZ J PSYCHIAT, V39, P479, DOI 10.1080/j.1440-1614.2005.01607.x; First M. B., 1997, STRUCTURED CLIN INTE; GUY W, 1976, ECDEU ASSESSMENT MAN, P341; Haffner SM, 1997, DIABETES CARE, V20, P1087, DOI 10.2337/diacare.20.7.1087; Hagg S, 1998, J CLIN PSYCHIAT, V59, P294, DOI 10.4088/JCP.v59n0604; Jin H, 2004, SCHIZOPHR RES, V71, P195, DOI 10.1016/j.schres.2004.03.024; Kitabchi AE, 2005, DIABETES, V54, P2404, DOI 10.2337/diabetes.54.8.2404; Klein DJ, 2006, AM J PSYCHIAT, V163, P2072, DOI 10.1176/appi.ajp.163.12.2072; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kroeze WK, 2003, NEUROPSYCHOPHARMACOL, V28, P519, DOI 10.1038/sj.npp.1300027; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Littrell KH, 2003, J NURS SCHOLARSHIP, V35, P237, DOI 10.1111/j.1547-5069.2003.00237.x; Matsui-Sakata Akiko, 2005, Drug Metab Pharmacokinet, V20, P368, DOI 10.2133/dmpk.20.368; Menza M, 2004, J CLIN PSYCHIAT, V65, P471; Meyer JM, 2004, SCHIZOPHR RES, V70, P1, DOI 10.1016/j.schres.2004.01.014; Miller BJ, 2006, PSYCHIAT SERV, V57, P1482, DOI 10.1176/appi.ps.57.10.1482; Morrison JA, 2002, AM J PSYCHIAT, V159, P655, DOI 10.1176/appi.ajp.159.4.655; Newcomer JW, 2005, CNS DRUGS, V19, P1; Rasouli N, 2007, AM J PHYSIOL-ENDOC M, V292, pE359, DOI 10.1152/ajpendo.00221.2006; ROTATORI AF, 1980, PSYCHOL REP, V46, P483, DOI 10.2466/pr0.1980.46.2.483; SCHAUER JE, 1987, AM J CARDIOL, V60, P1373, DOI 10.1016/0002-9149(87)90622-9; SHEN Q, 2003, CHIN J ENDOCRINOL ME, V19, P207; Smith RC, 2005, INT J NEUROPSYCHOPH, V8, P183, DOI 10.1017/S1461145705005110; Wirshing DA, 2002, J CLIN PSYCHIAT, V63, P856, DOI 10.4088/JCP.v63n1002; Wu RR, 2006, PSYCHOPHARMACOLOGY, V186, P572, DOI 10.1007/s00213-006-0384-5; XINMIN W, 2003, CHIN J NEW DRUGS CLI, V22, P175	39	268	287	4	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2008	299	2					185	193		10.1001/jama.2007.56-b	http://dx.doi.org/10.1001/jama.2007.56-b			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UN	18182600				2022-12-28	WOS:000252182600018
J	El Arifeen, S; Baqui, AH				El Arifeen, Shams; Baqui, Abdullah H.			Treating severe pneumonia in children: we can do better	LANCET			English	Editorial Material							INTEGRATED MANAGEMENT; ORAL AMOXICILLIN; EQUIVALENCY		[El Arifeen, Shams] Int Ctr Diarrhoeal Dis Res, Dhaka 1212, Bangladesh; [Baqui, Abdullah H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	International Centre for Diarrhoeal Disease Research (ICDDR); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	El Arifeen, S (corresponding author), Int Ctr Diarrhoeal Dis Res, Dhaka 1212, Bangladesh.	shams@icddrb.org		Arifeen, Shams/0000-0002-5372-5932				Addo-Yobo E, 2004, LANCET, V364, P1141, DOI 10.1016/S0140-6736(04)17100-6; Al Fadil SM, 2003, B WORLD HEALTH ORGAN, V81, P708; Bryce J, 2005, HEALTH POLICY PLANN, V20, pI5, DOI 10.1093/heapol/czi055; Bryce J, 2006, LANCET, V368, P1067, DOI 10.1016/S0140-6736(06)69339-2; Department of Child and Adolescent Health, 2005, HDB IMCI INT MAN CHI; El Arifeen S, 2004, LANCET, V364, P1595, DOI 10.1016/S0140-6736(04)17312-1; *GAVI ALL, 2007, PROGR ACH; Hazir T, 2008, LANCET, V371, P49, DOI 10.1016/S0140-6736(08)60071-9; Kalter HD, 2003, ACTA PAEDIATR, V92, P103; LEOWSKI J, IMPLEMENTATION ARI C; Peterson S, 2004, LANCET, V363, P1955, DOI 10.1016/S0140-6736(04)16411-8; *UNICEF, 2006, PNEUM FORG KILL HILD; World Health Organization (WHO), 1994, AC RESP INF CHILDR C	13	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 5	2008	371	9606					7	8		10.1016/S0140-6736(08)60045-8	http://dx.doi.org/10.1016/S0140-6736(08)60045-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248YH	18177757				2022-12-28	WOS:000252192600007
J	Gammon, BD; Gunarathne, A				Gammon, Brian D.; Gunarathne, Ashan			Let's reappraise recruiting South Asians to clinical trials	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gammon, Brian D.] Sandwell Gen Hosp, Sandwell Med Res Unit, Birmingham, W Midlands, England; [Gunarathne, Ashan] City Hosp, Univ Dept Med, Birmingham, W Midlands, England	University of Birmingham	Gammon, BD (corresponding author), Sandwell Gen Hosp, Sandwell Med Res Unit, Birmingham, W Midlands, England.	ashan@doctors.org.uk						Bham Z, 2005, ETHNIC DIS, V15, P548; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Vydelingum V, 2006, NURS INQ, V13, P23, DOI 10.1111/j.1440-1800.2006.00304.x; 2004, HLTH TECHNOL ASSESS, V8, P1; 1991, BMJ, V9, P560	5	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 5	2008	336	7634					46	46		10.1136/bmj.39416.697778.94	http://dx.doi.org/10.1136/bmj.39416.697778.94			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250UT	18174601	Green Published			2022-12-28	WOS:000252327500043
J	Yerushalmi, R; Gelmon, K				Yerushalmi, Rinat; Gelmon, Karen			Chemotherapy for oestrogen-receptor-negative breast cancer	LANCET			English	Editorial Material									[Yerushalmi, Rinat; Gelmon, Karen] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada	British Columbia Cancer Agency	Gelmon, K (corresponding author), British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada.	kgelmon@bccancer.bc.ca						ALBAIN K, SAN ANT BREAST CANC, P10; Bartlett JMS, 2007, J CLIN ONCOL, V25, P4423, DOI 10.1200/JCO.2007.11.0973; Clarke M, 2008, LANCET, V371, P29, DOI 10.1016/S0140-6736(08)60069-0; GOLDSTEIN L, 2007, SAN ANT BREAST CANC, P63; Martin M, 2005, NEW ENGL J MED, V352, P2302, DOI 10.1056/NEJMoa043681; Mitka M, 2003, JAMA-J AM MED ASSOC, V290, P27, DOI 10.1001/jama.290.1.27; MOOK S, 2007, SAN ANT BREAST CANC, P50; Mook Stella, 2007, Cancer Genomics & Proteomics, V4, P147; Paik S, 2007, ONCOLOGIST, V12, P631, DOI 10.1634/theoncologist.12-6-631; Tan DSP, 2008, BREAST CANCER RES TR, V111, P27, DOI 10.1007/s10549-007-9756-8; Tischkowitz M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-134; Wyld L, 2003, BRIT J SURG, V90, P388, DOI 10.1002/bjs.4124	12	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 5	2008	371	9606					4	5		10.1016/S0140-6736(08)60043-4	http://dx.doi.org/10.1016/S0140-6736(08)60043-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248YH	18177755				2022-12-28	WOS:000252192600005
J	Brecht, M; Schmitz, D				Brecht, Michael; Schmitz, Dietmar			Neuroscience - Rules of plasticity	SCIENCE			English	Editorial Material							SYNAPTIC PLASTICITY; CORTEX; MEMORY		[Brecht, Michael; Schmitz, Dietmar] Humboldt Univ, Bernstein Ctr Computat Neurosci, D-10115 Berlin, Germany; [Schmitz, Dietmar] Univ Med Berlin, Charite, Neurosci Res Ctr, D-10117 Berlin, Germany	Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Brecht, M (corresponding author), Humboldt Univ, Bernstein Ctr Computat Neurosci, D-10115 Berlin, Germany.	michael.brecht@bccn-berlin.de		Brecht, Michael/0000-0002-5387-0953; Schmitz, Dietmar/0000-0003-2741-5241				Abraham WC, 1997, PROG NEUROBIOL, V52, P303, DOI 10.1016/S0301-0082(97)00018-X; Clem RL, 2008, SCIENCE, V319, P101, DOI 10.1126/science.1143808; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997	7	6	6	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2008	319	5859					39	40		10.1126/science.1153231	http://dx.doi.org/10.1126/science.1153231			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18174422				2022-12-28	WOS:000252084000016
J	Marty, B; Palma, RL; Pepin, RO; Zimmermann, L; Schlutter, DJ; Burnard, PG; Westphal, AJ; Snead, CJ; Bajt, S; Becker, RH; Simones, JE				Marty, Bernard; Palma, Russell L.; Pepin, Robert O.; Zimmermann, Laurent; Schlutter, Dennis J.; Burnard, Peter G.; Westphal, Andrew J.; Snead, Christopher J.; Bajt, Sasa; Becker, Richard H.; Simones, Jacob E.			Helium and neon abundances and compositions in cometary matter	SCIENCE			English	Article							INTERPLANETARY DUST PARTICLES; NOBLE-GAS COMPONENT; ISOTOPIC COMPOSITIONS; STARDUST SPACECRAFT; EXCESS HE-3; SOLAR-WIND; P/WILD 2; ORIGIN; 81P/WILD-2; METEORITE	Materials trapped and preserved in comets date from the earliest history of the solar system. Particles captured by the Stardust spacecraft from comet 81P/Wild2 are indisputable cometary matter available for laboratory study. Here we report measurements of noble gases in Stardust material. Neon isotope ratios are within the range observed in "phase Q," a ubiquitous, primitive organic carrier of noble gases in meteorites. Helium displays He-3/He-4 ratios twice those in phase Q and in Jupiter's atmosphere. Abundances per gram are surprisingly large, suggesting implantation by ion irradiation. The gases are probably carried in high- temperature igneous grains similar to particles found in other Stardust studies. Collectively, the evidence points to gas acquisition in a hot, high ion- flux nebular environment close to the young Sun.	[Palma, Russell L.; Pepin, Robert O.; Schlutter, Dennis J.; Becker, Richard H.] Univ Minnesota, Sch Phys & Astron, Minneapolis, MN 55455 USA; [Marty, Bernard; Zimmermann, Laurent; Burnard, Peter G.] Nancy Univ, Ctr Rech Petrog & Geochim, F-54501 Vandoeuvre Les Nancy, France; [Palma, Russell L.; Simones, Jacob E.] Minnesota State Univ, Dept Phys & Astron, Mankato, MN 56001 USA; [Westphal, Andrew J.; Snead, Christopher J.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Bajt, Sasa] Lawrence Livermore Natl Lab, Inst Geophys & Planetary Phys, Livermore, CA 94550 USA	University of Minnesota System; University of Minnesota Twin Cities; Universite de Lorraine; Minnesota State Colleges & Universities; Minnesota State University Mankato; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Pepin, RO (corresponding author), Univ Minnesota, Sch Phys & Astron, Minneapolis, MN 55455 USA.	pepin001@umn.edu	Bajt, Sasa/G-2228-2010; Bajt, Sasa/O-4695-2019; 1.4, ALS Beamline/I-1886-2014	Bajt, Sasa/0000-0002-7163-7602; 				ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; Brownlee DE, 2004, SCIENCE, V304, P1764, DOI 10.1126/science.1097899; BROWNLEE DE, 2007, 38 LUN PLAN SCI C; Brownlee D, 2006, SCIENCE, V314, P1711, DOI 10.1126/science.1135840; Busemann H, 2000, METEORIT PLANET SCI, V35, P949, DOI 10.1111/j.1945-5100.2000.tb01485.x; Busemann H, 2002, METEORIT PLANET SCI, V37, P1865, DOI 10.1111/j.1945-5100.2002.tb01170.x; EBERHARDT P, 1972, 3RD P LUN SCI C HOUS, V2, P1821; Geiss J, 2004, SPACE SCI REV, V110, P307, DOI 10.1023/B:SPAC.0000023409.54469.40; Gounelle M, 2006, METEORIT PLANET SCI, V41, P135, DOI 10.1111/j.1945-5100.2006.tb00198.x; Grimberg A, 2007, SPACE SCI REV, V130, P293, DOI 10.1007/s11214-007-9150-1; HEBER VS, 2007, 38 LUN PLAN SCI C; Huss GR, 1996, GEOCHIM COSMOCHIM AC, V60, P3311, DOI 10.1016/0016-7037(96)00168-8; JAMBON A, 1986, GEOCHIM COSMOCHIM AC, V50, P401, DOI 10.1016/0016-7037(86)90193-6; JOSWIAK DJ, 2007, ESA PUBLICATION, P141; Lodders K, 1999, SPACE SCI REV, V90, P289, DOI 10.1023/A:1005226921031; MABRY JC, 2007, 38 LUN PLAN SCI C; Marrocchi Y, 2005, EARTH PLANET SC LETT, V236, P569, DOI 10.1016/j.epsl.2005.04.010; MATSUDA J, 1993, SCIENCE, V259, P788, DOI 10.1126/science.259.5096.788; McKeegan KD, 2006, SCIENCE, V314, P1724, DOI 10.1126/science.1135992; Messenger S, 2002, METEORIT PLANET SCI, V37, P1491, DOI 10.1111/j.1945-5100.2002.tb00806.x; NIER AO, 1993, METEORITICS, V28, P675, DOI 10.1111/j.1945-5100.1993.tb00639.x; OTT U, 1981, GEOCHIM COSMOCHIM AC, V45, P1751, DOI 10.1016/0016-7037(81)90009-0; OWEN T, 1992, NATURE, V358, P43, DOI 10.1038/358043a0; Palma RL, 2005, METEORIT PLANET SCI, V40, pA120; Pepin RO, 2000, METEORIT PLANET SCI, V35, P495, DOI 10.1111/j.1945-5100.2000.tb01431.x; Pepin RO, 2001, METEORIT PLANET SCI, V36, P1515, DOI 10.1111/j.1945-5100.2001.tb01843.x; Pepin RO, 2006, EARTH PLANET SC LETT, V252, P1, DOI 10.1016/j.epsl.2006.09.014; Sandford SA, 2006, SCIENCE, V314, P1720, DOI 10.1126/science.1135841; Sekanina Z, 2004, SCIENCE, V304, P1769, DOI 10.1126/science.1098388; SHELBY JE, 1971, PHYS REV B, V4, P2681, DOI 10.1103/PhysRevB.4.2681; WACKER JF, 1989, GEOCHIM COSMOCHIM AC, V53, P1421; Wood J. A., 1988, METEORITES EARLY SOL, P329; Zolensky ME, 2006, SCIENCE, V314, P1735, DOI 10.1126/science.1135842	35	55	55	3	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2008	319	5859					75	78		10.1126/science.1148001	http://dx.doi.org/10.1126/science.1148001			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18174437	Green Submitted			2022-12-28	WOS:000252084000033
J	Castelnovo, C; Moessner, R; Sondhi, SL				Castelnovo, C.; Moessner, R.; Sondhi, S. L.			Magnetic monopoles in spin ice	NATURE			English	Article							PYROCHLORE; DY2TI2O7; SYSTEMS; STATE	Electrically charged particles, such as the electron, are ubiquitous. In contrast, no elementary particles with a net magnetic charge have ever been observed, despite intensive and prolonged searches ( see ref. 1 for example). We pursue an alternative strategy, namely that of realizing them not as elementary but rather as emergent particles - that is, as manifestations of the correlations present in a strongly interacting many- body system. The most prominent examples of emergent quasiparticles are the ones with fractional electric charge e/3 in quantum Hall physics(2). Here we propose that magnetic monopoles emerge in a class of exotic magnets known collectively as spin ice(3-5): the dipole moment of the underlying electronic degrees of freedom fractionalises into monopoles. This would account for a mysterious phase transition observed experimentally in spin ice in a magnetic field(6,7), which is a liquid - gas transition of the magnetic monopoles. These monopoles can also be detected by other means, for example, in an experiment modelled after the Stanford magnetic monopole search(8).	[Castelnovo, C.; Moessner, R.] Univ Oxford, Rudolf Peierls Ctr Theoret Phys, Oxford OX1 3NP, England; [Moessner, R.] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; [Sondhi, S. L.] Princeton Univ, PCTP, Princeton, NJ 08544 USA; [Sondhi, S. L.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA	University of Oxford; Max Planck Society; Princeton University; Princeton University	Castelnovo, C (corresponding author), Univ Oxford, Rudolf Peierls Ctr Theoret Phys, S Parks Rd, Oxford OX1 3NP, England.	castel@physics.ox.ac.uk	Castro-Ríos, Katherin/AAJ-6151-2021; Taborda-Ocampo, Gonzalo/M-4634-2016; Torres, Ricardo A/K-4063-2014	Castro-Ríos, Katherin/0000-0003-2520-1696; Taborda-Ocampo, Gonzalo/0000-0003-4358-1506; Torres, Ricardo A/0000-0003-4583-9849				Aoki H, 2004, J PHYS SOC JPN, V73, P2851, DOI 10.1143/JPSJ.73.2851; Bramwell ST, 2001, SCIENCE, V294, P1495, DOI 10.1126/science.1064761; CABRERA B, 1982, PHYS REV LETT, V48, P1378, DOI 10.1103/PhysRevLett.48.1378; Dirac PAM, 1931, P R SOC LOND A-CONTA, V133, P60, DOI 10.1098/rspa.1931.0130; Fang Z, 2003, SCIENCE, V302, P92, DOI 10.1126/science.1089408; Fulde P, 2002, ANN PHYS-BERLIN, V11, P892, DOI 10.1002/1521-3889(200212)11:12<892::AID-ANDP892>3.0.CO;2-J; Harris MJ, 1997, PHYS REV LETT, V79, P2554, DOI 10.1103/PhysRevLett.79.2554; HEILMANN OJ, 1972, COMMUN MATH PHYS, V25, P190, DOI 10.1007/BF01877590; Henley CL, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.014424; Hermele M, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.064404; Higashinaka R, 2004, J PHYS SOC JPN, V73, P2845, DOI 10.1143/JPSJ.73.2845; Isakov SV, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.104418; Jackson J. D., 1975, CLASSICAL ELECTRODYN, P251; Kitaev AY, 2003, ANN PHYS-NEW YORK, V303, P2, DOI 10.1016/S0003-4916(02)00018-0; Kobelev V, 2002, J CHEM PHYS, V116, P7589, DOI 10.1063/1.1464827; Laughlin RB, 1999, REV MOD PHYS, V71, P863, DOI 10.1103/RevModPhys.71.863; Levin M, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.035122; Milton KA, 2006, REP PROG PHYS, V69, P1637, DOI 10.1088/0034-4885/69/6/R02; NAGLE JF, 1979, CHEM PHYS, V43, P317, DOI 10.1016/0301-0104(79)85200-3; RAJARAMAN R, 2001, FRACTIONAL CHARGE; Ramirez AP, 1999, NATURE, V399, P333, DOI 10.1038/20619; Ruff JPC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.097202; Saitoh E, 2004, NATURE, V432, P203, DOI 10.1038/nature03009; Siddharthan R, 1999, PHYS REV LETT, V83, P1854, DOI 10.1103/PhysRevLett.83.1854	25	1013	1019	9	297	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2008	451	7174					42	45		10.1038/nature06433	http://dx.doi.org/10.1038/nature06433			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247KZ	18172493	Green Submitted			2022-12-28	WOS:000252079300028
J	Xu, SZ; Sukumar, P; Zeng, FN; Li, J; Jairaman, A; English, A; Naylor, J; Ciurtin, C; Majeed, Y; Milligan, CJ; Bahnasi, YM; Al-Shawaf, E; Porter, KE; Jiang, LH; Emery, P; Sivaprasadarao, A; Beech, DJ				Xu, Shang-Zhong; Sukumar, Piruthivi; Zeng, Fanning; Li, Jing; Jairaman, Amit; English, Anne; Naylor, Jacqueline; Ciurtin, Coziana; Majeed, Yasser; Milligan, Carol J.; Bahnasi, Yahya M.; Al-Shawaf, Eman; Porter, Karen E.; Jiang, Lin-Hua; Emery, Paul; Sivaprasadarao, Asipu; Beech, David J.			TRPC channel activation by extracellular thioredoxin	NATURE			English	Article							RHEUMATOID-ARTHRITIS; OXIDATIVE STRESS; CATION CHANNELS; REDUCTASE; CELL; SUBUNIT; DISEASE; BRAIN	Mammalian homologues of Drosophila melanogaster transient receptor potential ( TRP) are a large family of multimeric cation channels that act, or putatively act, as sensors of one or more chemical factor(1,2). Major research objectives are the identification of endogenous activators and the determination of cellular and tissue functions of these channels. Here we show the activation of TRPC5 ( canonical TRP 5) homomultimeric and TRPC5-TRPC1 heteromultimeric channels(3-5) by extracellular reduced thioredoxin, which acts by breaking a disulphide bridge in the predicted extracellular loop adjacent to the ion- selectivity filter of TRPC5. Thioredoxin is an endogenous redox protein with established intracellular functions, but it is also secreted and its extracellular targets are largely unknown(6-9). Particularly high extracellular concentrations of thioredoxin are apparent in rheumatoid arthritis(8,10-12), an inflammatory joint disease that disables millions of people worldwide(13). We show that TRPC5 and TRPC1 are expressed in secretory fibroblast- like synoviocytes from patients with rheumatoid arthritis, that endogenous TRPC5 - TRPC1 channels of the cells are activated by reduced thioredoxin, and that blockade of the channels enhances secretory activity and prevents the suppression of secretion by thioredoxin. The data indicate the presence of a previously unrecognized ion- channel activation mechanism that couples extracellular thioredoxin to cell function.	[Xu, Shang-Zhong; Sukumar, Piruthivi; Zeng, Fanning; Li, Jing; Jairaman, Amit; Naylor, Jacqueline; Ciurtin, Coziana; Majeed, Yasser; Milligan, Carol J.; Bahnasi, Yahya M.; Al-Shawaf, Eman; Jiang, Lin-Hua; Sivaprasadarao, Asipu; Beech, David J.] Univ Leeds, Fac Biol Sci, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England; [Porter, Karen E.] Univ Leeds, Sch Med, Leeds LS2 9JT, W Yorkshire, England; [English, Anne; Emery, Paul] Chapel Allerton Hosp, Acad Unit Musculoskeletal Dis, Leeds LS7 4SA, W Yorkshire, England	University of Leeds; University of Leeds; Chapel Allerton Hospital; University of Leeds	Beech, DJ (corresponding author), Univ Leeds, Fac Biol Sci, Inst Membrane & Syst Biol, Garstang Bldg, Leeds LS2 9JT, W Yorkshire, England.	d.j.beech@leeds.ac.uk	Majeed, Yasser/ABG-3662-2021; Jiang, Lin-Hua/AAU-1078-2020; Naguib, Yahya/R-2949-2019; Coziana Ciurtin, C Ciurtin/ABA-3848-2021; Jiang, Lin-Hua/D-2030-2010; Xu, Shang-Zhong/P-2807-2015; emery, paul/B-3560-2013; Ciurtin, Coziana/P-1230-2018	Jiang, Lin-Hua/0000-0001-6398-0411; Naguib, Yahya/0000-0001-5851-7238; Coziana Ciurtin, C Ciurtin/0000-0002-8911-4113; Jiang, Lin-Hua/0000-0001-6398-0411; Xu, Shang-Zhong/0000-0002-7295-9347; Ciurtin, Coziana/0000-0002-8911-4113; Beech, David/0000-0002-7683-9422; Sivaprasadarao, Asipu/0000-0002-6755-3502; Sukumar, Piruthivi/0000-0002-3294-989X	BBSRC [BB/D524875/1] Funding Source: UKRI; Arthritis Research UK [18475] Funding Source: Medline; Biotechnology and Biological Sciences Research Council [BB/D524875/1] Funding Source: Medline; Wellcome Trust [083857, 077424] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Arthritis Research UK(Versus Arthritis); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Beech D. J., 2007, V179, P109; Burke-Gaffney A, 2005, TRENDS PHARMACOL SCI, V26, P398, DOI 10.1016/j.tips.2005.06.005; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Elliott DJS, 2004, EMBO J, V23, P4717, DOI 10.1038/sj.emboj.7600484; Flockerzi V., 2007, V179, P1; Jikimoto T, 2002, MOL IMMUNOL, V38, P765, DOI 10.1016/S0161-5890(01)00113-4; Jung S, 2003, J BIOL CHEM, V278, P3562, DOI 10.1074/jbc.M211484200; Lemarechal H, 2006, CLIN CHIM ACTA, V367, P156, DOI 10.1016/j.cca.2005.12.006; Lemarechal H, 2007, FREE RADICAL RES, V41, P688, DOI 10.1080/10715760701294468; Maurice MM, 1999, ARTHRITIS RHEUM, V42, P2430, DOI 10.1002/1529-0131(199911)42:11<2430::AID-ANR22>3.0.CO;2-6; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Plant TD, 2003, CELL CALCIUM, V33, P441, DOI 10.1016/S0143-4160(03)00055-1; Porter KE, 2002, J VASC SURG, V36, P150, DOI 10.1067/mva.2002.122029; Riccio A, 2002, MOL BRAIN RES, V109, P95, DOI 10.1016/S0169-328X(02)00527-2; RUBARTELLI A, 1992, J BIOL CHEM, V267, P24161; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; SMOLEN JS, 2007, LANCET          0613, DOI DOI 10.1016/S0140-6736(07)60784-3; Strubing C, 2003, J BIOL CHEM, V278, P39014, DOI 10.1074/jbc.M306705200; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Xu SZ, 2006, AM J PHYSIOL-HEART C, V291, pH2653, DOI 10.1152/ajpheart.00495.2006; Xu SZ, 2006, CIRC RES, V98, P1381, DOI 10.1161/01.RES.0000225284.36490.a2; Xu SZ, 2005, NAT BIOTECHNOL, V23, P1289, DOI 10.1038/nbt1148; Xu SZ, 2001, CIRC RES, V88, P84, DOI 10.1161/01.RES.88.1.84; Yoshida S, 1999, J IMMUNOL, V163, P351; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Zeng FN, 2004, J PHYSIOL-LONDON, V559, P739, DOI 10.1113/jphysiol.2004.065391	27	215	221	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2008	451	7174					69	U9		10.1038/nature06414	http://dx.doi.org/10.1038/nature06414			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247KZ	18172497	Green Accepted			2022-12-28	WOS:000252079300035
J	Ryu, JH; Kim, SH; Lee, HY; Bai, JY; Nam, YD; Bae, JW; Lee, DG; Shin, SC; Ha, EM; Lee, WJ				Ryu, Ji-Hwan; Kim, Sung-Hee; Lee, Hyo-Young; Bai, Jin Young; Nam, Young-Do; Bae, Jin-Woo; Lee, Dong Gun; Shin, Seung Chul; Ha, Eun-Mi; Lee, Won-Jae			Innate immune homeostasis by the homeobox gene Caudal and commensal-gut mutualism in Drosophila	SCIENCE			English	Article							ANTIMICROBIAL PEPTIDE GENES; HOST-DEFENSE; INFLAMMATION; EXPRESSION; INFECTION; EPITHELIA; PATHWAY; DISEASE	Although commensalism with gut microbiota exists in all metazoans, the host factors that maintain this homeostatic relationship remain largely unknown. We show that the intestinal homeobox gene Caudal regulates the commensal-gut mutualism by repressing nuclear factor kappa B-dependent antimicrobial peptide genes. Inhibition of Caudal expression in flies via RNA interference led to overexpression of antimicrobial peptides, which in turn altered the commensal population within the intestine. In particular, the dominance of one gut microbe, Gluconobacter sp. strain EW707, eventually led to gut cell apoptosis and host mortality. However, restoration of a healthy microbiota community and normal host survival in the Caudal-RNAi flies was achieved by reintroduction of the Caudal gene. These results reveal that a specific genetic deficiency within a host can profoundly influence the gut commensal microbial community and host physiology.	[Ryu, Ji-Hwan; Kim, Sung-Hee; Lee, Hyo-Young; Bai, Jin Young; Shin, Seung Chul; Ha, Eun-Mi; Lee, Won-Jae] Ewha Womans Univ, Div Mol Life Sci, Seoul 120750, South Korea; [Ryu, Ji-Hwan; Kim, Sung-Hee; Lee, Hyo-Young; Bai, Jin Young; Shin, Seung Chul; Ha, Eun-Mi; Lee, Won-Jae] Natl Creat Res Initiat Ctr Symbiosyst, Seoul 120750, South Korea; [Lee, Hyo-Young] Inst Pasteur, Lab BBMI, F-75724 Paris, France; [Nam, Young-Do; Bae, Jin-Woo] Korea Res Inst Biosci & Biotechnol, Biol Resource Ctr, Taejon 305806, South Korea; [Lee, Dong Gun] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Taegu 702701, South Korea; [Shin, Seung Chul] Yonsei Univ, Coll Med, Brain Korea Program 21, Seoul 120752, South Korea	Ewha Womans University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Kyungpook National University; Yonsei University; Yonsei University Health System	Lee, WJ (corresponding author), Ewha Womans Univ, Div Mol Life Sci, Seoul 120750, South Korea.	lwj@ewha.ac.kr	Bae, Jin-Woo/S-1955-2017	Bae, Jin-Woo/0000-0001-6433-5270; Nam, Young-Do/0000-0002-2660-3569				Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Dale C, 2006, CELL, V126, P453, DOI 10.1016/j.cell.2006.07.014; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Ferrandon D, 1998, EMBO J, V17, P1217, DOI 10.1093/emboj/17.5.1217; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Koropatnick TA, 2004, SCIENCE, V306, P1186, DOI 10.1126/science.1102218; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; MLODZIK M, 1987, CELL, V48, P465, DOI 10.1016/0092-8674(87)90197-8; Moreno E, 1999, NATURE, V400, P873, DOI 10.1038/23709; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Ryu JH, 2004, MOL CELL BIOL, V24, P172, DOI 10.1128/MCB.24.1.172-185.2004; Ryu JH, 2006, EMBO J, V25, P3693, DOI 10.1038/sj.emboj.7601233; Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002; Tingvall TO, 2001, EMBO REP, V2, P239; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Tzou P, 2000, IMMUNITY, V13, P737, DOI 10.1016/S1074-7613(00)00072-8; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xiao H, 2007, IMMUNITY, V26, P461, DOI 10.1016/j.immuni.2007.02.012; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590	28	570	596	9	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2008	319	5864					777	782		10.1126/science.1149357	http://dx.doi.org/10.1126/science.1149357			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18218863				2022-12-28	WOS:000252963000052
J	Schetter, AJ; Leung, SY; Sohn, JJ; Zanetti, KA; Bowman, ED; Yanaihara, N; Yuen, ST; Chan, TL; Kwong, DLW; Au, GKH; Liu, CG; Calin, GA; Croce, CM; Harris, CC				Schetter, Aaron J.; Leung, Suet Yi; Sohn, Jane J.; Zanetti, Krista A.; Bowman, Elise D.; Yanaihara, Nozomu; Yuen, Siu Tsan; Chan, Tsun Leung; Kwong, Dora L. W.; Au, Gordon K. H.; Liu, Chang-Gong; Calin, George A.; Croce, Carlo M.; Harris, Curtis C.			MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CANCER; DIFFERENTIATION; SIGNATURE; PATTERNS; ENCODES; RNA	Context MicroRNAs have potential as diagnostic biomarkers and therapeutic targets in cancer. No study has evaluated the association between microRNA expression patterns and colon cancer prognosis or therapeutic outcome. Objective To identify microRNA expression patterns associated with colon adenocarcinomas, prognosis, or therapeutic outcome. Design, Setting, and Patients MicroRNA microarray expression profiling of tumors and paired nontumorous tissues was performed on a US test cohort of 84 patients with incident colon adenocarcinoma, recruited between 1993 and 2002. We evaluated associations with tumor status, TNM staging, survival prognosis, and response to adjuvant chemotherapy. Associations were validated in a second, independent Chinese cohort of 113 patients recruited between 1991 and 2000, using quantitative reverse transcription polymerase chain reaction assays. The final date of follow- up was December 31, 2005, for the Maryland cohort and August 16, 2004, for the Hong Kong cohort. Main Outcome Measures MicroRNAs that were differentially expressed in tumors and microRNA expression patterns associated with survival using cancer-specific death as the end point. Results Thirty- seven microRNAs were differentially expressed in tumors from the test cohort. Selected for validation were miR- 20a, miR- 21, miR- 106a, miR- 181b, and miR- 203, and all 5 were enriched in tumors from the validation cohort ( P <. 001). Higher miR- 21 expression was present in adenomas ( P =.006) and in tumors with more advanced TNM staging ( P <. 001). In situ hybridization demonstrated miR- 21 to be expressed at high levels in colonic carcinoma cells. The 5- year cancer- specific survival rate was 57.5% for the Maryland cohort and was 49.5% for the Hong Kong cohort. High miR- 21 expression was associated with poor survival in both the training ( hazard ratio, 2.5; 95% confidence interval, 1.2- 5.2) and validation cohorts ( hazard ratio, 2.4; 95% confidence interval, 1.4- 3.9), independent of clinical covariates, including TNM staging, and was associated with a poor therapeutic outcome. Conclusions Expression patterns of microRNAs are systematically altered in colon adenocarcinomas. High miR- 21 expression is associated with poor survival and poor therapeutic outcome.	[Schetter, Aaron J.; Sohn, Jane J.; Zanetti, Krista A.; Bowman, Elise D.; Yanaihara, Nozomu; Harris, Curtis C.] NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Schetter, Aaron J.; Zanetti, Krista A.] NCI, Canc Prevent Fellowship Program, Off Prevent Oncol, NIH, Bethesda, MD 20892 USA; [Leung, Suet Yi; Yuen, Siu Tsan; Chan, Tsun Leung] Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Pokfulam, Hong Kong, Peoples R China; [Kwong, Dora L. W.; Au, Gordon K. H.] Univ Hong Kong, Queen Mary Hosp, Dept Clin Oncol, Pokfulam, Hong Kong, Peoples R China; [Liu, Chang-Gong; Croce, Carlo M.] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Calin, George A.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Hong Kong; University of Hong Kong; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Texas System; UTMD Anderson Cancer Center	Harris, CC (corresponding author), NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, Bldg 37,Room 3068A, Bethesda, MD 20892 USA.	Curtis_Harris@nih.gov	Young, Richard A/F-6495-2012; Leung, Suet Yi/C-4340-2009; Yuen, Siu/K-6311-2014; Calin, George/E-9390-2011; Vickers, Michael M/E-4095-2010; Leung, Suet Yi/T-9620-2019	Young, Richard A/0000-0001-8855-8647; Calin, George/0000-0001-6704-5615; Leung, Suet Yi/0000-0001-8614-4619	NATIONAL CANCER INSTITUTE [Z01BC010878, ZIABC010878, ZIABC005480, Z01BC005480] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 BC005480-22] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Aaltonen LA, 2000, PATHOLOGY GENETICS T, P130; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Brosens LAA, 2007, CURR MOL MED, V7, P29; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Georgantas RW, 2007, P NATL ACAD SCI USA, V104, P2750, DOI 10.1073/pnas.0610983104; Goldman E, 2006, ARCH MED RES, V37, P548, DOI 10.1016/j.arcmed.2005.09.013; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; HILL AB, 1971, STAT EVIDENCE INFERE; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kang HJ, 2005, DIS COLON RECTUM, V48, P1161, DOI 10.1007/s10350-004-0932-1; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mattes J, 2007, AM J RESP CELL MOL, V36, P8, DOI 10.1165/rcmb.2006-0227TR; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Michael MZ, 2003, MOL CANCER RES, V1, P882; Rodriguez-Bigas MA, 2006, HOLLAND FREI CANC ME, P1369; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Waldman SA, 2007, JAMA-J AM MED ASSOC, V297, P1923, DOI 10.1001/jama.297.17.1923; Wang CL, 2006, P NATL ACAD SCI USA, V103, P18680, DOI 10.1073/pnas.0609030103; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wurdinger T, 2007, PHARMACOGENOMICS J, V7, P297, DOI 10.1038/sj.tpj.6500429; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	43	1327	1472	1	114	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 30	2008	299	4					425	436		10.1001/jama.299.4.425	http://dx.doi.org/10.1001/jama.299.4.425			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	256JK	18230780	Green Accepted, Bronze			2022-12-28	WOS:000252724500020
J	Strand, AE; Pritchard, SG; McCormack, ML; Davis, MA; Oren, R				Strand, Allan E.; Pritchard, Seth G.; McCormack, M. Luke; Davis, Micheal A.; Oren, Ram			Irreconcilable differences: Fine-root life spans and soil carbon persistence	SCIENCE			English	Article							ELEVATED CO2; NITROGEN DEPOSITION; FOREST; TURNOVER; MORTALITY; SEQUESTRATION; MINIRHIZOTRON; TEMPERATURE; DYNAMICS	The residence time of fine- root carbon in soil is one of the least understood aspects of the global carbon cycle, and fine- root dynamics are one of the least understood aspects of plant function. Most recent studies of these belowground dynamics have used one of two methodological strategies. In one approach, based on analysis of carbon isotopes, the persistence of carbon is inferred; in the other, based on direct observations of roots with cameras, the longevity of individual roots is measured. We show that the contribution of fine roots to the global carbon cycle has been overstated because observations of root lifetimes systematically overestimate the turnover of fine- root biomass. On the other hand, isotopic techniques systematically underestimate the turnover of individual roots. These differences, by virtue of the separate processes or pools measured, are irreconcilable.	[Strand, Allan E.; Pritchard, Seth G.] Coll Charleston, Dept Biol, Charleston, SC 29424 USA; [McCormack, M. Luke] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Davis, Micheal A.] Univ So Mississippi, Dept Biol, Hattiesburg, MS 39406 USA; [Oren, Ram] Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA	College of Charleston; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Southern Mississippi; Duke University	Pritchard, SG (corresponding author), Coll Charleston, Dept Biol, Charleston, SC 29424 USA.	pritchards@cofc.edu	Oren, Ram/AAC-5326-2019	Oren, Ram/0000-0002-5654-1733; McCormack, Michael Luke/0000-0002-8300-5215				Eissenstat DM, 2000, NEW PHYTOL, V147, P33, DOI 10.1046/j.1469-8137.2000.00686.x; Fitter A, 2005, CURR BIOL, V15, pR185, DOI 10.1016/j.cub.2005.03.002; Guo DL, 2008, NEW PHYTOL, V177, P443, DOI 10.1111/j.1469-8137.2007.02242.x; Guo DL, 2004, OECOLOGIA, V140, P450, DOI 10.1007/s00442-004-1596-1; Hyvonen R, 2007, NEW PHYTOL, V173, P463, DOI 10.1111/j.1469-8137.2007.01967.x; Jackson RB, 1997, P NATL ACAD SCI USA, V94, P7362, DOI 10.1073/pnas.94.14.7362; Johnson MG, 2006, NEW PHYTOL, V170, P345, DOI 10.1111/j.1469-8137.2006.01658.x; Johnson MG, 2001, ENVIRON EXP BOT, V45, P263, DOI 10.1016/S0098-8472(01)00077-6; Joslin JD, 2006, NEW PHYTOL, V172, P523, DOI 10.1111/j.1469-8137.2006.01847.x; Lal R, 2005, FOREST ECOL MANAG, V220, P242, DOI 10.1016/j.foreco.2005.08.015; LUO Y, 2004, SCIENCE, V304, P945; Luo YQ, 2003, GLOBAL CHANGE BIOL, V9, P1118, DOI 10.1046/j.1365-2486.2003.00642.x; Matamala R, 2003, SCIENCE, V302, P1385, DOI 10.1126/science.1089543; Nadelhoffer KJ, 2000, NEW PHYTOL, V147, P131, DOI 10.1046/j.1469-8137.2000.00677.x; Norby RJ, 2004, P NATL ACAD SCI USA, V101, P9689, DOI 10.1073/pnas.0403491101; Phillips DL, 2006, GLOBAL CHANGE BIOL, V12, P61, DOI 10.1111/j.1365-2486.2005.01085.x; Phillips DL, 2006, OECOLOGIA, V148, P517, DOI 10.1007/s00442-006-0392-5; Richter DD, 1999, NATURE, V400, P56, DOI 10.1038/21867; Schlesinger WH, 2006, ECOL STU AN, V187, P197; Tierney GL, 2002, CAN J FOREST RES, V32, P1692, DOI [10.1139/x02-123, 10.1139/X02-123]; Tingey DT, 2005, FOREST ECOL MANAG, V204, P359, DOI 10.1016/j.foreco.2004.09.010; Trumbore SE, 2003, SCIENCE, V302, P1344, DOI 10.1126/science.1091841; Wells CE, 2002, AM J BOT, V89, P79, DOI 10.3732/ajb.89.1.79	23	175	185	5	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2008	319	5862					456	458		10.1126/science.1151382	http://dx.doi.org/10.1126/science.1151382			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254HB	18218895				2022-12-28	WOS:000252576600036
J	Nankivell, BJ; Murali, KM				Nankivell, Brian J.; Murali, Karumathil M.			Renal failure from vitamin C after transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Nankivell, Brian J.; Murali, Karumathil M.] Westmead Hosp, Sydney, NSW 2145, Australia	University of Sydney	Nankivell, BJ (corresponding author), Westmead Hosp, Sydney, NSW 2145, Australia.	brian_nankivell@wsahs.nsw.gov.au							0	13	15	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2008	358	4					E4	E4		10.1056/NEJMicm070984	http://dx.doi.org/10.1056/NEJMicm070984			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253GY	18216350				2022-12-28	WOS:000252507900011
J	Kump, LR				Kump, Lee R.			The rise of atmospheric oxygen	NATURE			English	Article							MASS-INDEPENDENT FRACTIONATION; SULFUR; EVOLUTION; EARTH	Clues from ancient rocks are helping to produce a coherent picture of how Earth's atmosphere changed from one that was almost devoid of oxygen to one that is one- fifth oxygen.	Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kump, LR (corresponding author), Penn State Univ, Dept Geosci, 535 Deike Bldg, University Pk, PA 16802 USA.	lkump@psu.edu	Kump, Lee/H-8287-2012					Anbar AD, 2007, SCIENCE, V317, P1903, DOI 10.1126/science.1140325; Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; Berner RA, 2003, ANNU REV EARTH PL SC, V31, P105, DOI 10.1146/annurev.earth.31.100901.141329; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; Catling DC, 2005, EARTH PLANET SC LETT, V237, P1, DOI 10.1016/j.epsl.2005.06.013; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; FARQUHAR J, 2007, NATURE, V448, P1033; Herman EK, 2005, GEOBIOLOGY, V3, P77, DOI 10.1111/j.1472-4669.2005.00048.x; Holland H. D., 1994, EARLY LIFE EARTH, V84, P237; Knauth P, 2006, NATURE, V442, P873, DOI 10.1038/442873a; Kopp RE, 2005, P NATL ACAD SCI USA, V102, P11131, DOI 10.1073/pnas.0504878102; Kump LR, 2007, NATURE, V448, P1033, DOI 10.1038/nature06058; Lovelock J.E., 1988, AGES GAIA; Ohmoto H, 2006, NATURE, V442, P908, DOI 10.1038/nature05044; Ono S, 2006, S AFR J GEOL, V109, P97, DOI 10.2113/gssajg.109.1-2.97; Pavlov AA, 2002, ASTROBIOLOGY, V2, P27, DOI 10.1089/153110702753621321; Rashby SE, 2007, P NATL ACAD SCI USA, V104, P15099, DOI 10.1073/pnas.0704912104; Scott AC, 2006, P NATL ACAD SCI USA, V103, P10861, DOI 10.1073/pnas.0604090103; WATSON A, 1978, BIOSYSTEMS, V10, P293, DOI 10.1016/0303-2647(78)90012-6; Zahnle K., 2006, GEOBIOLOGY, V4, P271, DOI 10.1111/j.1472-4669.2006.00085.x	21	288	317	6	206	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 17	2008	451	7176					277	278		10.1038/nature06587	http://dx.doi.org/10.1038/nature06587			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202642	Bronze			2022-12-28	WOS:000252432100034
J	Grol, R; Berwick, D; Wensing, M				Grol, Richard; Berwick, Donald; Wensing, Michel			On the trail of quality and safety in health care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SERVICES RESEARCH; IMPROVEMENT		[Grol, Richard; Wensing, Michel] Ctr Qual Care Res, NL-6500 HB Nijmegen, Netherlands; [Berwick, Donald] Inst Healthcare Improvement, Cambridge, MA 02138 USA	Radboud University Nijmegen; Institute for Healthcare Improvement	Grol, R (corresponding author), Ctr Qual Care Res, POB 9101,114, NL-6500 HB Nijmegen, Netherlands.	r.grol@kwazo.umcn.nl	Wensing, Michel/D-3998-2009; Grol, Richard/C-8523-2013; Wensing, Michel/H-8113-2014	Wensing, Michel/0000-0001-6569-8137				Berwick DM, 2005, HEALTH SERV RES, V40, P317, DOI 10.1111/j.1475-6773.2005.0n359.x; Dash P, 2003, BRIT MED J, V327, P1339, DOI 10.1136/bmj.327.7427.1339; Davidoff F, 2005, QUAL SAF HEALTH CARE, V14, P319, DOI 10.1136/qshc.2005.014787; Ferlie EB, 2001, MILBANK Q, V79, P281, DOI 10.1111/1468-0009.00206; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; GROL IR, 2005, IMPROVING PATIENT CA; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Grol R, 1997, BRIT MED J, V315, P418, DOI 10.1136/bmj.315.7105.418; Grol R BR, 2004, QUALITY IMPROVEMENT; Grol RPTM, 2007, MILBANK Q, V85, P93, DOI 10.1111/j.1468-0009.2007.00478.x; Institute of Medicine, 2006, PERF MEAS ACC IMPR; Leatherman Sheila, 2004, BMJ, V328, pE288, DOI 10.1136/bmj.328.7445.E288; Lomas J, 2003, BMJ-BRIT MED J, V327, P1301, DOI 10.1136/bmj.327.7427.1301; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Rosenberg RN, 2003, JAMA-J AM MED ASSOC, V289, P1305, DOI 10.1001/jama.289.10.1305; Schoen C, 2006, HEALTH AFFAIR, V25, pW457, DOI 10.1377/hlthaff.25.w457; Seddon ME, 2001, QUAL HEALTH CARE, V10, P152, DOI 10.1136/qhc.0100152..; Sung NS, 2003, JAMA-J AM MED ASSOC, V289, P1278, DOI 10.1001/jama.289.10.1278; TETROE J, IN PRESS MILBANK Q; van Roosmalen MS, 2007, QUAL SAF HEALTH CARE, V16, P105, DOI 10.1136/qshc.2006.018580	21	88	89	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 12	2008	336	7635					74	76		10.1136/bmj.39413.486944.AD	http://dx.doi.org/10.1136/bmj.39413.486944.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	253BX	18187724	Green Published			2022-12-28	WOS:000252494800027
J	Simini, F				Simini, Franco			Does improved detection of ill babies improve mortality?	LANCET			English	Editorial Material									Univ Republica, Montevideo 11600, Uruguay	Universidad de la Republica, Uruguay	Simini, F (corresponding author), Univ Republica, Montevideo 11600, Uruguay.	simini@fing.edu.uy	Simini, Franco/F-2528-2017	Simini, Franco/0000-0003-0241-8737				Bryce J, 2006, LANCET, V368, P1067, DOI 10.1016/S0140-6736(06)69339-2; Carlin JB, 2008, LANCET, V371, P135, DOI 10.1016/S0140-6736(08)60106-3; DEGROOT ANJA, 1993, INT J GYNECOL OBSTET, V40, P33, DOI 10.1016/0020-7292(93)90769-S; GUYATT G, 1992, JAMA-J AM MED ASSOC, V268, P2420, DOI 10.1001/jama.1992.03490170092032; KNOTTNERUS A, 1997, BRIT MED J, V315, P109; Somboonsook B, 1995, Med J Malaysia, V50, P212; Sotelo Figueiredo J M, 1993, Bol Oficina Sanit Panam, V114, P289; UN Millennium Project, 2005, INV DEV PRACT PLAN A	8	4	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 12	2008	371	9607					97	98		10.1016/S0140-6736(08)60083-5	http://dx.doi.org/10.1016/S0140-6736(08)60083-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	252ND	18191670				2022-12-28	WOS:000252452300007
J	Eulalio, A; Huntzinger, E; Izaurralde, E				Eulalio, Ana; Huntzinger, Eric; Izaurralde, Elisa			Getting to the root of miRNA-Mediated gene silencing	CELL			English	Article							MESSENGER-RNA DEGRADATION; TRANSLATION INITIATION; ZEBRAFISH MIR-430; LET-7 MICRORNA; HUMAN-CELLS; IN-VITRO; P-BODIES; DEADENYLATION; INHIBITION; COMPLEXES	MicroRNAs are similar to 22 nucleotide-long RNAs that silence gene expression posttranscriptionally by binding to the 3' untranslated regions of target mRNAs. Although much is known about their biogenesis and biological functions, the mechanisms allowing miRNAs to silence gene expression in animal cells are still under debate. Here, we discuss current models for miRNA-mediated gene silencing and formulate a hypothesis to reconcile differences.	[Eulalio, Ana; Huntzinger, Eric; Izaurralde, Elisa] Max Planck Inst Dev Biol, D-72077 Tubingen, Germany	Max Planck Society	Izaurralde, E (corresponding author), Max Planck Inst Dev Biol, Spemannstr, D-72077 Tubingen, Germany.	elisa.izaurralde@tuebingen.mpg.de	Eulalio, Ana/D-3083-2013; Huntzinger, Eric/J-6776-2012; Izaurralde, Elisa/G-3239-2012	Eulalio, Ana/0000-0002-7355-0674; Izaurralde, Elisa/0000-0001-7365-2649; Huntzinger, Eric/0000-0001-6126-4227				Aleman LM, 2007, RNA, V13, P385, DOI 10.1261/rna.352507; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Beitzinger M, 2007, RNA BIOL, V4, P76, DOI 10.4161/rna.4.2.4640; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Ding L, 2007, TRENDS CELL BIOL, V17, P411, DOI 10.1016/j.tcb.2007.06.003; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Eulalio A, 2007, GENE DEV, V21, P2558, DOI 10.1101/gad.443107; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Kiriakidou M, 2007, CELL, V129, P1141, DOI 10.1016/j.cell.2007.05.016; Leung AKL, 2007, CELL, V130, P581, DOI 10.1016/j.cell.2007.08.010; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Maroney PA, 2006, NAT STRUCT MOL BIOL, V13, P1102, DOI 10.1038/nsmb1174; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Mishima Y, 2006, CURR BIOL, V16, P2135, DOI 10.1016/j.cub.2006.08.086; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Rehwinkel J, 2006, MOL CELL BIOL, V26, P2965, DOI 10.1128/MCB.26.8.2965-2975.2006; Schmitter D, 2006, NUCLEIC ACIDS RES, V34, P4801, DOI 10.1093/nar/gkl646; Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563; Thermann R, 2007, NATURE, V447, P875, DOI 10.1038/nature05878; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Wakiyama M, 2007, GENE DEV, V21, P1857, DOI 10.1101/gad.1566707; Wang BB, 2006, MOL CELL, V22, P553, DOI 10.1016/j.molcel.2006.03.034; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Wu LG, 2005, MOL CELL BIOL, V25, P9198, DOI 10.1128/MCB.25.21.9198-9208.2005	33	770	840	1	125	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2008	132	1					9	14		10.1016/j.cell.2007.12.024	http://dx.doi.org/10.1016/j.cell.2007.12.024			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IL	18191211	Bronze			2022-12-28	WOS:000253427600006
J	Tolstoy, M; Waldhauser, F; Bohnenstiehl, DR; Weekly, RT; Kim, WY				Tolstoy, M.; Waldhauser, F.; Bohnenstiehl, D. R.; Weekly, R. T.; Kim, W. -Y.			Seismic identification of along-axis hydrothermal flow on the East Pacific Rise	NATURE			English	Article							RIDGE SPREADING CENTERS; MIDOCEAN RIDGE; SEA-FLOOR; OCEANIC-CRUST; MAGMA CHAMBER; HEAT-FLOW; 9-DEGREES-N; CALIFORNIA; BENEATH; FLUIDS	Hydrothermal circulation at the axis of mid- ocean ridges affects the chemistry of the lithosphere and overlying ocean, supports chemosynthetic biological communities and is responsible for significant heat transfer from the lithosphere to the ocean(1-3). It is commonly thought that flow in these systems is oriented across the ridge axis, with recharge occurring along off- axis faults(4-6), but the structure and scale of hydrothermal systems are usually inferred from thermal and geochemical models constrained by the geophysical setting(7-9), rather than direct observations. The presence of microearthquakes may shed light on hydrothermal pathways by revealing zones of thermal cracking where cold sea water extracts heat from hot crustal rocks, as well as regions where magmatic and tectonic stresses create fractures that increase porosity and permeability. Here we show that hypocentres beneath a well- studied hydrothermal vent field on the East Pacific Rise cluster in a vertical pipe- like zone near a small axial discontinuity, and in a band that lies directly above the axial magma chamber. The location of the shallow pipe- like cluster relative to the distribution and temperature of hydrothermal vents along this section of the ridge suggests that hydrothermal recharge may be concentrated there as a consequence of the permeability generated by tectonic fracturing. Furthermore, we interpret the band of seismicity above the magma chamber as a zone of hydrothermal cracking, which suggests that hydrothermal circulation may be strongly aligned along the ridge axis. We conclude that models that suggest that hydrothermal cells are oriented across- axis, with diffuse off- axis recharge zones, may not apply to the fast- spreading East Pacific Rise.	[Tolstoy, M.; Waldhauser, F.; Bohnenstiehl, D. R.; Weekly, R. T.; Kim, W. -Y.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Columbia University	Tolstoy, M (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, 61 Route 9W, Palisades, NY 10964 USA.	tolstoy@ldeo.columbia.edu		Weekly, Robert/0000-0003-2790-3704				[Anonymous], 2001, 01113 USGS; BAKUN WH, 1984, B SEISMOL SOC AM, V74, P1827; BOHNENSTIEHL DR, 2001, GEOCHEM GEOPHYS GEOS, V2; CORLISS JB, 1979, SCIENCE, V203, P1073, DOI 10.1126/science.203.4385.1073; Curewitz D, 1998, GEOPH MONOG SERIES, V106, P117; Dunn RA, 2000, J GEOPHYS RES-SOL EA, V105, P23537, DOI 10.1029/2000JB900210; Elderfield H, 1996, ANNU REV EARTH PL SC, V24, P191, DOI 10.1146/annurev.earth.24.1.191; FISHER AT, 2003, ENERGY MASS TRANSFER, V3, P29; Floyd JS, 2002, SCIENCE, V298, P1765, DOI 10.1126/science.1077950; HARDING AJ, 1993, J GEOPHYS RES-SOL EA, V98, P13925, DOI 10.1029/93JB00886; HAYMON RM, 1993, EARTH PLANET SC LETT, V119, P85, DOI 10.1016/0012-821X(93)90008-W; HAYMON RM, 1991, EARTH PLANET SC LETT, V104, P513, DOI 10.1016/0012-821X(91)90226-8; JOHNSON HP, 1993, GEOPHYS RES LETT, V20, P1875, DOI 10.1029/93GL00734; Kelley DS, 2002, ANNU REV EARTH PL SC, V30, P385, DOI 10.1146/annurev.earth.30.091201.141331; KENT GM, 1993, J GEOPHYS RES-SOL EA, V98, P13971, DOI 10.1029/93JB00706; KISSLING E, 1994, J GEOPHYS RES-SOL EA, V99, P19635, DOI 10.1029/93JB03138; Klein F. W., 2002, 02171 US GEOL SURV; LOWELL RP, 1995, J GEOPHYS RES-SOL EA, V100, P327, DOI 10.1029/94JB02222; LOWELL RP, 2002, J GEOPHYS RES, V107; Mcduff R. E., 1995, SEAFLOOR HYDROTHERMA, P357, DOI DOI 10.1029/GM091P0357; PURDY GM, 1992, NATURE, V355, P815, DOI 10.1038/355815a0; Ramondenc P, 2006, EARTH PLANET SC LETT, V245, P487, DOI 10.1016/j.epsl.2006.03.023; RUBIN KH, 1994, NATURE, V368, P841, DOI 10.1038/368841a0; SCHEIRER DS, 2006, GEOCHEM GEOPHYS GEOS, V7; Singh SC, 1999, GEOLOGY, V27, P219, DOI 10.1130/0091-7613(1999)027<0219:SEFAHL>2.3.CO;2; SLATER JG, 1980, REV GEOPHYSICS SPACE, V18, P269; STEIN CA, 1994, J GEOPHYS RES-SOL EA, V99, P3081, DOI 10.1029/93JB02222; Tolstoy M, 2006, SCIENCE, V314, P1920, DOI 10.1126/science.1133950; Tolstoy M, 1997, J GEOPHYS RES-SOL EA, V102, P3097, DOI 10.1029/96JB03226; VERA EE, 1990, J GEOPHYS RES-SOLID, V95, P15529, DOI 10.1029/JB095iB10p15529; Von Damm KL, 2004, GEOPH MONOG SERIES, V144, P245, DOI 10.1029/144GM16; VONDAMM KL, 2004, GEOPHYS MONOGR, V148, P187; Waldhauser F, 2000, B SEISMOL SOC AM, V90, P1353, DOI 10.1785/0120000006; WILCOCK WSD, 2002, J GEOPHYS RES, V107	34	111	115	2	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2008	451	7175					181	U7		10.1038/nature06424	http://dx.doi.org/10.1038/nature06424			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249GA	18185585				2022-12-28	WOS:000252214400040
J	Begg, CB; Haile, RW; Borg, A; Malone, KE; Concannon, P; Thomas, DC; Langholz, B; Bernstein, L; Olsen, JH; Lynch, CF; Anton-Culver, H; Capanu, M; Liang, XL; Hummer, AJ; Sima, C; Bernstein, JL				Begg, Colin B.; Haile, Robert W.; Borg, Ake; Malone, Kathleen E.; Concannon, Patrick; Thomas, Duncan C.; Langholz, Bryan; Bernstein, Leslie; Olsen, Jorgen H.; Lynch, Charles F.; Anton-Culver, Hoda; Capanu, Marinela; Liang, Xiaolin; Hummer, Amanda J.; Sima, Cami; Bernstein, Jonine L.			Variation of breast cancer risk among BRCA1/2 carriers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENOME-WIDE ASSOCIATION; FAMILY-HISTORY; MUTATION CARRIERS; ESTIMATING PENETRANCE; OVARIAN-CANCER; KIN-COHORT; SUSCEPTIBILITY; GENE; PREVALENCE; SERIES	Context The risk of breast cancer in BRCA1 and BRCA2 mutation carriers has been examined in many studies, but relatively little attention has been paid to the degree to which the risk may vary among carriers. Objectives To determine the extent to which risks for BRCA1 and BRCA2 carriers vary with respect to observable and unobservable characteristics. Design, Setting, and Participants Probands were identified from a population-based, case- control study ( Women's Environmental Cancer and Radiation Epidemiology [ WECARE]) of asynchronous contralateral breast cancer conducted during the period of January 2000 to July 2004. Participants previously diagnosed with contralateral breast cancer or unilateral breast cancer were genotyped for mutations in BRCA1 and BRCA2. All participants had their initial breast cancer diagnosed during the period of January 1985 to December 2000, before the age of 55 years. Main Outcome Measure Incidence of breast cancer in first- degree female relatives of the probands was examined and compared on the basis of proband characteristics and on the basis of variation between families. Results Among the 1394 participants with unilateral breast cancer, 73 ( 5.2%) were identified as carriers of deleterious mutations ( 42 with BRCA1 and 31 with BRCA2). Among the 704 participants with contralateral breast cancer, 108 ( 15.3%) were identified as carriers of deleterious mutations ( 67 with BRCA1 and 41 with BRCA2). Among relatives of carriers, risk was significantly associated with younger age at diagnosis in the proband ( P =. 04), and there was a trend toward higher risk for relatives of contralateral breast cancer vs unilateral breast cancer participants ( odds ratio, 1.4 [ 95% confidence interval, 0.8- 2.4]; P =. 28). In addition, there were significant differences in risk between carrier families after adjusting for these observed characteristics. Conclusion There exists broad variation in breast cancer risk among carriers of BRCA1 and BRCA2 mutations.	[Begg, Colin B.; Capanu, Marinela; Liang, Xiaolin; Hummer, Amanda J.; Sima, Cami; Bernstein, Jonine L.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Haile, Robert W.; Thomas, Duncan C.; Langholz, Bryan; Bernstein, Leslie] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [Borg, Ake] Univ Lund Hosp, Dept Oncol, S-22185 Lund, Sweden; [Malone, Kathleen E.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Concannon, Patrick] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA USA; [Olsen, Jorgen H.] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; [Lynch, Charles F.] Univ Iowa, Dept Epidemiol, Iowa City, IA USA; [Anton-Culver, Hoda] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA	Memorial Sloan Kettering Cancer Center; University of Southern California; Lund University; Skane University Hospital; Fred Hutchinson Cancer Center; University of Virginia; Danish Cancer Society; University of Iowa; University of California System; University of California Irvine	Begg, CB (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, 307 E 63rd St, New York, NY 10021 USA.	beggc@mskcc.org		Olsen, Jorgen Helge/0000-0001-9633-5662; Concannon, Patrick/0000-0002-5801-1859	NATIONAL CANCER INSTITUTE [R01CA097397, R01CA131010, R01CA098438, R01CA129639, U01CA083178] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA098438, CA097397, U01 CA083178-01, R01 CA129639, CA098438, R01 CA097397, R01 CA131010, R01 CA097397-01, R01 CA098438-01A1, CA083178, U01 CA083178] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahmed M, 2006, ONCOGENE, V25, P5906, DOI 10.1038/sj.onc.1209873; Andrieu N, 2006, JNCI-J NATL CANCER I, V98, P535, DOI 10.1093/jnci/djj132; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Antoniou AC, 2006, ONCOGENE, V25, P5898, DOI 10.1038/sj.onc.1209879; Antoniou AC, 2002, BRIT J CANCER, V86, P76, DOI 10.1038/sj.bjc.6600008; Antoniou AC, 2000, GENET EPIDEMIOL, V18, P173; Antoniou AC, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1630; Begg CB, 2002, J NATL CANCER I, V94, P1221; Bernstein JL, 2004, BREAST CANCER RES, V6, pR199, DOI 10.1186/bcr771; Bernstein JL, 2003, HUM MUTAT, V21, P542, DOI 10.1002/humu.10206; BONDY ML, 1994, J CLIN EPIDEMIOL, V47, P89, DOI 10.1016/0895-4356(94)90037-X; Chatterjee N, 2001, BIOMETRICS, V57, P245, DOI 10.1111/j.0006-341X.2001.00245.x; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; Cui JS, 2000, CANCER EPIDEM BIOMAR, V9, P805; Cullinane CA, 2005, INT J CANCER, V117, P988, DOI 10.1002/ijc.21273; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; GARBER JE, 1991, CANCER RES, V51, P6094; Gong G, 2003, GENET EPIDEMIOL, V24, P173, DOI 10.1002/gepi.10219; Hopper JL, 1999, CANCER EPIDEM BIOMAR, V8, P741; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; KHOURY MJ, 1988, AM J EPIDEMIOL, V127, P674, DOI 10.1093/oxfordjournals.aje.a114842; Lang AE, 1996, MOVEMENT DISORD, V11, P1, DOI 10.1002/mds.870110102; Langholz B, 1999, BIOMETRICS, V55, P1129, DOI 10.1111/j.0006-341X.1999.01129.x; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Mitchell G, 2006, CANCER RES, V66, P1866, DOI 10.1158/0008-5472.CAN-05-3368; Pharoah PDP, 1997, INT J CANCER, V71, P800, DOI 10.1002/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.3.CO;2-R; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Ponder BAJ, 2005, COLD SH Q B, V70, P35, DOI 10.1101/sqb.2005.70.029; Ponder BAJ, 2000, BRIT J CANCER, V83, P1301; Risch HA, 2001, AM J HUM GENET, V68, P700, DOI 10.1086/318787; Risch HA, 2006, JNCI-J NATL CANCER I, V98, P1694, DOI 10.1093/jnci/djj465; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; THOMAS DC, 2004, STAT METHODS GENETIC, P137; Thompson D, 2002, CANCER EPIDEM BIOMAR, V11, P329; Thorlacius S, 1998, LANCET, V352, P1337, DOI 10.1016/S0140-6736(98)03300-5; Warner E, 1999, J NATL CANCER I, V91, P1241, DOI 10.1093/jnci/91.14.1241; Whittemore AS, 2003, J NATL CANCER I, V95, P76, DOI 10.1093/jnci/95.1.76; Ziogas A, 2003, AM J PREV MED, V24, P190, DOI 10.1016/S0749-3797(02)00593-7	38	217	224	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2008	299	2					194	201		10.1001/jama.2007.55-a	http://dx.doi.org/10.1001/jama.2007.55-a			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UN	18182601	Green Accepted, Bronze			2022-12-28	WOS:000252182600019
J	Ibata, RA; Lewis, GF				Ibata, Rodrigo A.; Lewis, Geraint F.			Perspective - The cosmic web in our own backyard	SCIENCE			English	Editorial Material							MILKY-WAY; GALAXY; HALO; SIGNATURES; DISCOVERY; DARK; STARS	On the largest scales, matter is strung out on an intricate pattern known as the cosmic web. The tendrils of this web should reach right into our own cosmic backyard, lacing the Galactic halo with lumps of dark matter. The search for these lumps, lit up by stars that formed within them, is a major astronomical endeavor, although it has failed to find the huge expected population. Is this a dark matter crisis, or does it provide clues to the complexities of gas physics in the early universe? New technologies in the coming decade will reveal the answer.	[Ibata, Rodrigo A.] Observ Astron, F-67000 Strasbourg, France; [Lewis, Geraint F.] Univ Sydney, Sch Phys, Inst Astron, Sydney, NSW 2006, Australia	University of Sydney	Ibata, RA (corresponding author), Observ Astron, 11 Rue Univ, F-67000 Strasbourg, France.		Lewis, Geraint/F-9069-2015	Lewis, Geraint/0000-0003-3081-9319; Ibata, Rodrigo/0000-0002-3292-9709				Belokurov V, 2007, ASTROPHYS J, V654, P897, DOI 10.1086/509718; Braun R, 2004, ASTRON ASTROPHYS, V417, P421, DOI 10.1051/0004-6361:20034423; Bullock JS, 2000, ASTROPHYS J, V539, P517, DOI 10.1086/309279; Chapman SC, 2007, ASTROPHYS J, V662, pL79, DOI 10.1086/519377; Diemand J, 2005, NATURE, V433, P389, DOI 10.1038/nature03270; Freeman K, 2002, ANNU REV ASTRON ASTR, V40, P487, DOI 10.1146/annurev.astro.40.060401.093840; Ibata R, 2001, NATURE, V412, P49, DOI 10.1038/35083506; Ibata R, 2001, ASTROPHYS J, V551, P294, DOI 10.1086/320060; Johnston KV, 1996, ASTROPHYS J, V465, P278, DOI 10.1086/177418; Klypin A, 1999, ASTROPHYS J, V522, P82, DOI 10.1086/307643; KLYPIN AA, 1983, MON NOT R ASTRON SOC, V204, P891, DOI 10.1093/mnras/204.3.891; Majewski SR, 2007, ASTROPHYS J, V670, pL9, DOI 10.1086/524033; Martin NF, 2006, MON NOT R ASTRON SOC, V371, P1983, DOI 10.1111/j.1365-2966.2006.10823.x; Moore B, 2001, PHYS REV D, V64, DOI 10.1103/PhysRevD.64.063508; Navarro JF, 1997, ASTROPHYS J, V490, P493, DOI 10.1086/304888; Sales LV, 2007, MON NOT R ASTRON SOC, V379, P1464, DOI 10.1111/j.1365-2966.2007.12024.x; SMOOT GF, 1992, ASTROPHYS J, V396, pL1, DOI 10.1086/186504; Spergel DN, 2007, ASTROPHYS J SUPPL S, V170, P377, DOI 10.1086/513700; Springel V, 2005, NATURE, V435, P629, DOI 10.1038/nature03597; Venn KA, 2004, ASTRON J, V128, P1177, DOI 10.1086/422734; Willman B, 2005, ASTROPHYS J, V626, pL85, DOI 10.1086/431760; Yanny B, 2000, ASTROPHYS J, V540, P825, DOI 10.1086/309386	22	2	2	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2008	319	5859					50	52		10.1126/science.1152008	http://dx.doi.org/10.1126/science.1152008			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18174430				2022-12-28	WOS:000252084000024
J	Chan, PS; Krumholz, HM; Nichol, G; Nallamothu, BK				Chan, Paul S.; Krumholz, Harlan M.; Nichol, Graham; Nallamothu, Brahmajee K.		Amer Heart Assoc	Delayed time to defibrillation after in-hospital cardiac arrest	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AMERICAN-HEART-ASSOCIATION; HEALTH-CARE PROFESSIONALS; AUSTRALIAN RESUSCITATION COUNCIL; ADVANCED LIFE-SUPPORT; CARDIOPULMONARY-RESUSCITATION; RECOMMENDED GUIDELINES; UTSTEIN STYLE; STROKE FOUNDATION; TASK-FORCE; STATEMENT	Background: Expert guidelines advocate defibrillation within 2 minutes after an in-hospital cardiac arrest caused by ventricular arrhythmia. However, empirical data on the prevalence of delayed defibrillation in the United States and its effect on survival are limited. Methods: We identified 6789 patients who had cardiac arrest due to ventricular fibrillation or pulseless ventricular tachycardia at 369 hospitals participating in the National Registry of Cardiopulmonary Resuscitation. Using multivariable logistic regression, we identified characteristics associated with delayed defibrillation. We then examined the association between delayed defibrillation (more than 2 minutes) and survival to discharge after adjusting for differences in patient and hospital characteristics. Results: The overall median time to defibrillation was 1 minute (interquartile range, <1 to 3 minutes); delayed defibrillation occurred in 2045 patients (30.1%). Characteristics associated with delayed defibrillation included black race, noncardiac admitting diagnosis, and occurrence of cardiac arrest at a hospital with fewer than 250 beds, in an unmonitored hospital unit, and during after-hours periods (5 p.m. to 8 a.m. or weekends). Delayed defibrillation was associated with a significantly lower probability of surviving to hospital discharge (22.2%, vs. 39.3% when defibrillation was not delayed; adjusted odds ratio, 0.48; 95% confidence interval, 0.42 to 0.54; P<0.001). In addition, a graded association was seen between increasing time to defibrillation and lower rates of survival to hospital discharge for each minute of delay (P for trend <0.001). Conclusions: Delayed defibrillation is common and is associated with lower rates of survival after in-hospital cardiac arrest.	St Lukes Hosp, Mid Amer Heart Inst, Kansas City, MO 64111 USA; Univ Michigan, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT USA; Yale Univ, Sch Med, Dept Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06510 USA; Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; Univ Washington, Harborview Ctr Prehosp Emergency Care, Seattle, WA 98195 USA; Vet Affairs Ann Arbor Hlth Serv Res & Dev Ctr Exc, Ann Arbor, MI USA	Saint Luke's Hospital - Missouri; Saint Luke's Mid America Heart Institute; University of Michigan System; University of Michigan; Yale University; Yale University; Yale University; Yale University; Harborview Medical Center; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Chan, PS (corresponding author), St Lukes Hosp, Mid Amer Heart Inst, 5th Fl,4401 Wornall Rd, Kansas City, MO 64111 USA.	pchan@cc-pc.com	Nichol, Graham/Z-4996-2019; , Harlan/AAI-2875-2020		NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR017607] Funding Source: NIH RePORTER; NCRR NIH HHS [K12 RR017607-01] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Ballew KA, 1995, RESUSCITATION, V30, P203, DOI 10.1016/0300-9572(95)00894-2; Castren M, 2005, RESUSCITATION, V64, P293, DOI 10.1016/j.resuscitation.2004.08.017; CUMMINS RO, 1991, CIRCULATION, V83, P1832, DOI 10.1161/01.CIR.83.5.1832; Cummins RO, 1997, ANN EMERG MED, V29, P647, DOI 10.1016/S0196-0644(97)70255-5; Cummins RO, 1997, CIRCULATION, V95, P2213, DOI 10.1161/01.CIR.95.8.2213; Eisenberg MS, 2001, NEW ENGL J MED, V344, P1304, DOI 10.1056/NEJM200104263441707; Ewy GA, 2000, J AM COLL CARDIOL, V35, P830; Fredriksson M, 2006, RESUSCITATION, V68, P351, DOI 10.1016/j.resuscitation.2005.07.011; Hajbaghery MA, 2005, RESUSCITATION, V66, P317, DOI 10.1016/j.resuscitation.2005.04.004; Herlitz J, 2005, RESUSCITATION, V66, P159, DOI 10.1016/j.resuscitation.2005.03.018; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; JENNETT B, 1975, LANCET, V1, P480; Kaye W, 2005, RESUSCITATION, V65, P285, DOI 10.1016/j.resuscitation.2004.12.020; Nadkarni VM, 2006, JAMA-J AM MED ASSOC, V295, P50, DOI 10.1001/jama.295.1.50; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Skrifvars MB, 2003, RESUSCITATION, V56, P275, DOI 10.1016/S0300-9572(02)00373-8; ZARITSKY A, 1995, RESUSCITATION, V30, P95, DOI 10.1016/0300-9572(95)00884-V; ZARITSKY A, 1995, CIRCULATION, V92, P2006, DOI 10.1161/01.CIR.92.7.2006	18	414	427	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2008	358	1					9	17		10.1056/NEJMoa0706467	http://dx.doi.org/10.1056/NEJMoa0706467			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	246TW	18172170				2022-12-28	WOS:000252031200003
J	Cunningham, D; Starling, N; Rao, S; Iveson, T; Nicolson, M; Coxon, F; Middleton, G; Daniel, F; Oates, J; Norman, AR				Cunningham, David; Starling, Naureen; Rao, Sheela; Iveson, Timothy; Nicolson, Marianne; Coxon, Fareeda; Middleton, Gary; Daniel, Francis; Oates, Jacqueline; Norman, Andrew Richard		Natl Canc Res Inst United Kingdom	Capecitabine and oxaliplatin for advanced esophagogastric cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							METASTATIC COLORECTAL-CANCER; ORAL FLUOROPYRIMIDINE CARBAMATE; FLUOROURACIL PLUS LEUCOVORIN; ADVANCED GASTRIC-CANCER; PHASE-III; INTRAVENOUS FLUOROURACIL; 1ST-LINE THERAPY; SUPPORTIVE CARE; FINAL REPORT; CISPLATIN	Background: We evaluated capecitabine (an oral fluoropyrimidine) and oxaliplatin (a platinum compound) as alternatives to infused fluorouracil and cisplatin, respectively, for untreated advanced esophagogastric cancer. Methods: In a two-by-two design, we randomly assigned 1002 patients to receive triplet therapy with epirubicin and cisplatin plus either fluorouracil (ECF) or capecitabine (ECX) or triplet therapy with epirubicin and oxaliplatin plus either fluorouracil (EOF) or capecitabine (EOX). The primary end point was noninferiority in overall survival for the triplet therapies containing capecitabine as compared with fluorouracil and for those containing oxaliplatin as compared with cisplatin. Results: For the capecitabine-fluorouracil comparison, the hazard ratio for death in the capecitabine group was 0.86 (95% confidence interval [CI], 0.80 to 0.99); for the oxaliplatin-cisplatin comparison, the hazard ratio for the oxaliplatin group was 0.92 (95% CI, 0.80 to 1.10). The upper limit of the confidence intervals for both hazard ratios excluded the predefined noninferiority margin of 1.23. Median survival times in the ECF, ECX, EOF, and EOX groups were 9.9 months, 9.9 months, 9.3 months, and 11.2 months, respectively; survival rates at 1 year were 37.7%, 40.8%, 40.4%, and 46.8%, respectively. In the secondary analysis, overall survival was longer with EOX than with ECF, with a hazard ratio for death of 0.80 in the EOX group (95% CI, 0.66 to 0.97; P=0.02). Progression-free survival and response rates did not differ significantly among the regimens. Toxic effects of capecitabine and fluorouracil were similar. As compared with cisplatin, oxaliplatin was associated with lower incidences of grade 3 or 4 neutropenia, alopecia, renal toxicity, and thromboembolism but with slightly higher incidences of grade 3 or 4 diarrhea and neuropathy. Conclusions: Capecitabine and oxaliplatin are as effective as fluorouracil and cisplatin, respectively, in patients with previously untreated esophagogastric cancer. (Current Controlled Trials number, ISRCTN51678883.).	Royal Marsden Hosp Natl Hlth Serv Fdn Trust, Surrey, England; Royal Marsden Hosp Natl Hlth Serv Fdn Trust, London, England; Southampton Univ Hosp Natl Hlth Serv Trust, Southampton, Hants, England; Salisbury Hosp Natl Hlth Serv Fdn Trust, Salisbury, Wilts, England; Aberdeen Royal Infirm, Aberdeen, Scotland; No Ctr Canc Treatment, Newcastle Upon Tyne, Tyne & Wear, England; St Lukes Canc Ctr, Guildford, Surrey, England; Plymouth Oncol Ctr, Plymouth, Devon, England	Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of Southampton; University Hospital Southampton NHS Foundation Trust; Salisbury District Hospital; University of Aberdeen	Cunningham, D (corresponding author), Royal Marsden Hosp Natl Hlth Serv Fdn Trust, Surrey, England.			Middleton, Gary/0000-0001-5695-3474; Cunningham, David/0000-0001-5158-1069; Iveson, Timothy/0000-0002-4681-2712; Starling, Naureen/0000-0002-1496-6792				AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; ALBATRAN S, 2006, J CLIN ONCOL, V24, pS18; Borner MM, 2002, EUR J CANCER, V38, P349, DOI 10.1016/S0959-8049(01)00371-9; Budman DR, 1998, J CLIN ONCOL, V16, P1795, DOI 10.1200/JCO.1998.16.5.1795; CASSIDY J, 2007, J CLIN ONCOL S, V25, pS18; Cho EK, 2005, ONCOLOGY-BASEL, V68, P333, DOI 10.1159/000086972; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Dank M, 2005, J CLIN ONCOL, V23, p308S; Diaz-Rubio E, 2007, J CLIN ONCOL, V25, P4224, DOI 10.1200/JCO.2006.09.8467; Evans TRJ, 2002, ANN ONCOL, V13, P1469, DOI 10.1093/annonc/mdf243; Glimelius B, 1997, ANN ONCOL, V8, P163, DOI 10.1023/A:1008243606668; Hoff PM, 2001, J CLIN ONCOL, V19, P2282, DOI 10.1200/JCO.2001.19.8.2282; Kang Y, 2006, J CLIN ONCOL, V24, p183S; Liu G, 1997, J CLIN ONCOL, V15, P110, DOI 10.1200/JCO.1997.15.1.110; Miwa M, 1998, EUR J CANCER, V34, P1274, DOI 10.1016/S0959-8049(98)00058-6; MURAD AM, 1993, CANCER, V72, P37, DOI 10.1002/1097-0142(19930701)72:1<37::AID-CNCR2820720109>3.0.CO;2-P; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Porschen R, 2007, J CLIN ONCOL, V25, P4217, DOI 10.1200/JCO.2006.09.2684; PYRHONEN S, 1995, BRIT J CANCER, V71, P587, DOI 10.1038/bjc.1995.114; Ross P, 2002, J CLIN ONCOL, V20, P1996, DOI 10.1200/JCO.2002.08.105; Sumpter K, 2005, BRIT J CANCER, V92, P1976, DOI 10.1038/sj.bjc.6602572; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Twelves C, 2005, NEW ENGL J MED, V352, P2696, DOI 10.1056/NEJMoa043116; Van Cutsem E, 2001, J CLIN ONCOL, V19, P4097, DOI 10.1200/JCO.2001.19.21.4097; Van Cutsem E, 2006, J CLIN ONCOL, V24, P4991, DOI 10.1200/JCO.2006.06.8429; Wagner AD, 2006, J CLIN ONCOL, V24, P2903, DOI 10.1200/JCO.2005.05.0245; Webb A, 1997, J CLIN ONCOL, V15, P261, DOI 10.1200/JCO.1997.15.1.261	27	1686	1764	0	63	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2008	358	1					36	46		10.1056/NEJMoa073149	http://dx.doi.org/10.1056/NEJMoa073149			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	246TW	18172173				2022-12-28	WOS:000252031200006
J	Nutt, SL				Nutt, Stephen L.			B-cell identity - Commitment is not forever	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PAX5		Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute	Nutt, SL (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.		Nutt, Stephen L/C-9256-2013	Nutt, Stephen L/0000-0002-0020-6637				Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2	5	6	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2008	358	1					82	83		10.1056/NEJMcibr0707112	http://dx.doi.org/10.1056/NEJMcibr0707112			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	246TW	18172181				2022-12-28	WOS:000252031200014
J	Kuhn, CD; Geiger, SR; Baumli, S; Gartmann, M; Gerber, J; Jennebach, S; Mielke, T; Tschochner, H; Beckmann, R; Cramer, P				Kuhn, Claus-D.; Geiger, Sebastian R.; Baumli, Sonja; Gartmann, Marco; Gerber, Jochen; Jennebach, Stefan; Mielke, Thorsten; Tschochner, Herbert; Beckmann, Roland; Cramer, Patrick			Functional architecture of RNA polymerase I	CELL			English	Article							INTRINSIC TRANSCRIPT CLEAVAGE; SACCHAROMYCES-CEREVISIAE; ELECTRON-MICROSCOPY; PREINITIATION COMPLEX; ELONGATION COMPLEX; III SUBUNITS; H ACTIVITY; YEAST; INITIATION; TERMINATION	Synthesis of ribosomal RNA (rRNA) by RNA polymerase (Pol) I is the first step in ribosome biogenesis and a regulatory switch in eukaryotic cell growth. Here we report the 12 angstrom cryoelectron microscopic structure for the complete 14-subunit yeast Pol I, a homology model for the core enzyme, and the crystal structure of the subcomplex A14/43. In the resulting hybrid structure of Pol I, A14/43, the clamp, and the dock domain contribute to a unique surface interacting with promoter-specific initiation factors. The Pol I-specific subunits A49 and A34.5 form a heterodimer near the enzyme funnel that acts as a built-in elongation factor and is related to the Pol II-associated factor TFIIF. In contrast to Pol II, Pol I has a strong intrinsic 3'-RNA cleavage activity, which requires the C-terminal domain of subunit A12.2 and, apparently, enables ribosomal RNA proofreading and 3'-end trimming.	[Kuhn, Claus-D.; Geiger, Sebastian R.; Baumli, Sonja; Gartmann, Marco; Jennebach, Stefan; Beckmann, Roland; Cramer, Patrick] Univ Munich, Dept Chem & Biochem, Gene Ctr Munich, D-81377 Munich, Germany; [Kuhn, Claus-D.; Geiger, Sebastian R.; Baumli, Sonja; Gartmann, Marco; Jennebach, Stefan; Beckmann, Roland; Cramer, Patrick] Univ Munich, Dept Chem & Biochem, Ctr Integrated Prot Sci CIPSM, D-81377 Munich, Germany; [Gerber, Jochen; Tschochner, Herbert] Univ Regensburg, Inst Biochem Genet & Mikrobiol, D-93053 Regensburg, Germany; [Mielke, Thorsten] Max Planck Inst Mol Genet, D-14195 Berlin, Germany	University of Munich; University of Munich; University of Regensburg; Max Planck Society	Cramer, P (corresponding author), Univ Munich, Dept Chem & Biochem, Gene Ctr Munich, Feodor Lynen Str 25, D-81377 Munich, Germany.	cramer@LMB.uni-muenchen.de	Kuhn, Claus D./U-3438-2019	Kuhn, Claus D./0000-0002-4244-3219				Alic N, 2007, P NATL ACAD SCI USA, V104, P10400, DOI 10.1073/pnas.0704116104; Armache KJ, 2005, J BIOL CHEM, V280, P7131, DOI 10.1074/jbc.M413038200; BARTHOLOMEW B, 1993, MOL CELL BIOL, V13, P942, DOI 10.1128/MCB.13.2.942; Bischler N, 2002, EMBO J, V21, P4136, DOI 10.1093/emboj/cdf392; Bric A, 2004, J BIOL CHEM, V279, P31259, DOI 10.1074/jbc.M311828200; Brueckner F, 2007, SCIENCE, V315, P859, DOI 10.1126/science.1135400; Brun I, 1997, EMBO J, V16, P5730, DOI 10.1093/emboj/16.18.5730; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUDISA N, 1995, EUR J BIOCHEM, V230, P788; Chedin S, 1998, GENE DEV, V12, P3857, DOI 10.1101/gad.12.24.3857; Chen HT, 2003, MOL CELL, V12, P437, DOI 10.1016/S1097-2765(03)00306-X; Chen HT, 2007, NAT STRUCT MOL BIOL, V14, P696, DOI 10.1038/nsmb1272; Chen JZ, 2007, J STRUCT BIOL, V157, P168, DOI 10.1016/j.jsb.2006.06.001; Chung WH, 2003, MOL CELL, V12, P1003, DOI 10.1016/S1097-2765(03)00387-3; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; De Carlo S, 2003, J MOL BIOL, V329, P891, DOI 10.1016/S0022-2836(03)00510-2; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; EDWARDS AM, 1991, J BIOL CHEM, V266, P71; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fath S, 2000, J CELL BIOL, V149, P575, DOI 10.1083/jcb.149.3.575; Fernandez-Tornero C, 2007, MOL CELL, V25, P813, DOI 10.1016/j.molcel.2007.02.016; Ferri ML, 2000, MOL CELL BIOL, V20, P488, DOI 10.1128/MCB.20.2.488-495.2000; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gadal O, 1997, MOL CELL BIOL, V17, P1787, DOI 10.1128/MCB.17.4.1787; Gaiser F, 2000, J MOL BIOL, V302, P1119, DOI 10.1006/jmbi.2000.4110; GERBER J, 2007, IN RPESS NUCL ACIDS, DOI DOI 10.1093/NAR/GKM1093; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; HIGUCHI H, 1988, J MUSCLE RES CELL M, V9, P491, DOI 10.1007/BF01738754; Hsieh YJ, 1999, MOL CELL BIOL, V19, P7697; Hu P, 2002, MOL CELL BIOL, V22, P8044, DOI 10.1128/MCB.22.22.8044-8055.2002; HUET J, 1976, NATURE, V261, P431, DOI 10.1038/261431a0; HUET J, 1975, P NATL ACAD SCI USA, V72, P3034, DOI 10.1073/pnas.72.8.3034; HUET J, 1977, J BIOL CHEM, V252, P8848; IBORRA F, 1979, J BIOL CHEM, V254, P920; Imazawa Y, 2005, J BIOL CHEM, V280, P11467, DOI 10.1074/jbc.M411150200; Jasiak AJ, 2006, MOL CELL, V23, P71, DOI 10.1016/j.molcel.2006.05.013; JOHNSON TL, 1994, CELL, V77, P217, DOI 10.1016/0092-8674(94)90314-X; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; KUHN A, 1989, GENE DEV, V3, P224, DOI 10.1101/gad.3.2.224; Labhart P, 1997, J BIOL CHEM, V272, P9055; Landrieux E, 2006, EMBO J, V25, P118, DOI 10.1038/sj.emboj.7600915; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LILJELUND P, 1992, P NATL ACAD SCI USA, V89, P9302, DOI 10.1073/pnas.89.19.9302; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Maniatis F.a.S., 1982, MOL CLONING LAB MANU; Meinhart A, 2003, J BIOL CHEM, V278, P48267, DOI 10.1074/jbc.M307874200; Meka H, 2003, NUCLEIC ACIDS RES, V31, P4391, DOI 10.1093/nar/gkg652; Milkereit P, 1997, BIOL CHEM, V378, P1433, DOI 10.1515/bchm.1997.378.12.1433; Milkereit P, 1998, EMBO J, V17, P3692, DOI 10.1093/emboj/17.13.3692; Moss T, 2007, CELL MOL LIFE SCI, V64, P29, DOI 10.1007/s00018-006-6278-1; ORLOVA M, 1995, P NATL ACAD SCI USA, V92, P4596, DOI 10.1073/pnas.92.10.4596; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Penczek PA, 2006, J STRUCT BIOL, V154, P184, DOI 10.1016/j.jsb.2005.12.013; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Peyroche E, 2002, P NATL ACAD SCI USA, V99, P14670, DOI 10.1073/pnas.232580799; Peyroche G, 2000, EMBO J, V19, P5473, DOI 10.1093/emboj/19.20.5473; Prescott EM, 2004, P NATL ACAD SCI USA, V101, P6068, DOI 10.1073/pnas.0401393101; Russell J, 2006, BIOCHEM SOC SYMP, V73, P203; SADHALE PP, 1994, MOL CELL BIOL, V14, P6164, DOI 10.1128/MCB.14.9.6164; Schneider DA, 2007, MOL CELL, V26, P217, DOI 10.1016/j.molcel.2007.04.007; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SCHULTZ P, 1993, EMBO J, V12, P2601, DOI 10.1002/j.1460-2075.1993.tb05920.x; Siaut M, 2003, MOL CELL BIOL, V23, P195, DOI 10.1128/MCB.23.1.195-205.2003; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THUILLIER V, 1995, EMBO J, V14, P351, DOI 10.1002/j.1460-2075.1995.tb07009.x; Todone F, 2001, MOL CELL, V8, P1137, DOI 10.1016/S1097-2765(01)00379-3; Tschochner H, 1996, P NATL ACAD SCI USA, V93, P12914, DOI 10.1073/pnas.93.23.12914; Van Mullem V, 2002, MOL MICROBIOL, V43, P1105; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Weilbaecher RG, 2003, J BIOL CHEM, V278, P24189, DOI 10.1074/jbc.M211197200; WHITEHALL SK, 1994, J BIOL CHEM, V269, P2299; Wind M, 2000, BIOESSAYS, V22, P327, DOI 10.1002/(SICI)1521-1878(200004)22:4<327::AID-BIES3>3.0.CO;2-4; Yamamoto K, 2004, MOL CELL BIOL, V24, P6338, DOI 10.1128/MCB.24.14.6338-6349.2004; Yuan XJ, 2002, EMBO REP, V3, P1082, DOI 10.1093/embo-reports/kvf212	77	155	175	2	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 28	2007	131	7					1260	1272		10.1016/j.cell.2007.10.051	http://dx.doi.org/10.1016/j.cell.2007.10.051			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GV	18160037	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000252217200016
J	Hinkov, V; Haug, D; Fauque, B; Bourges, P; Sidis, Y; Ivanov, A; Bernhard, C; Lin, CT; Keimer, B				Hinkov, V.; Haug, D.; Fauque, B.; Bourges, P.; Sidis, Y.; Ivanov, A.; Bernhard, C.; Lin, C. T.; Keimer, B.			Electronic liquid crystal state in the high-temperature superconductor YBa2Cu3O6.45	SCIENCE			English	Article							MAGNETIC EXCITATIONS; SPIN EXCITATIONS; PHASE-DIAGRAM; LA2-XSRXCUO4; FIELD	Electronic phases with symmetry properties matching those of conventional liquid crystals have recently been discovered in transport experiments on semiconductor heterostructures and metal oxides at millikelvin temperatures. We report the spontaneous onset of a one- dimensional, incommensurate modulation of the spin system in the high- transition- temperature superconductor YBa2Cu3O6.45 upon cooling below similar to 150 kelvin, whereas static magnetic order is absent above 2 kelvin. The evolution of this modulation with temperature and doping parallels that of the in- plane anisotropy of the resistivity, indicating an electronic nematic phase that is stable over a wide temperature range. The results suggest that soft spin fluctuations are a microscopic route toward electronic liquid crystals and that nematic order can coexist with high- temperature superconductivity in underdoped cuprates.	[Hinkov, V.; Haug, D.; Lin, C. T.; Keimer, B.] Max Planck Inst Festkorperforsch, D-70569 Stuttgart, Germany; [Fauque, B.; Bourges, P.; Sidis, Y.] CEA Saclay, CNRS, Lab Leon Brillouin, F-91191 Gif Sur Yvette, France; [Ivanov, A.] Inst Max Von Laue Paul Langevin, F-38042 Grenoble 9, France; [Bernhard, C.] Univ Fribourg, Dept Phys, CH-1700 Fribourg, Switzerland; [Bernhard, C.] Univ Fribourg, FriMat Ctr Nanomat, CH-1700 Fribourg, Switzerland	Max Planck Society; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut Laue-Langevin (ILL); University of Fribourg; University of Fribourg	Hinkov, V (corresponding author), Max Planck Inst Festkorperforsch, Heisenbergstr 1, D-70569 Stuttgart, Germany.	v.hinkov@fkf.mpg.de	Hinkov, Vladimir/D-1495-2016	Bourges, Philippe/0000-0001-9494-0789; Keimer, Bernhard/0000-0001-5220-9023; Bernhard, Christian/0000-0002-9957-3487				Abbamonte P, 2005, NAT PHYS, V1, P155, DOI 10.1038/nphys178; Ando Y, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.137005; Borzi RA, 2007, SCIENCE, V315, P214, DOI 10.1126/science.1134796; CHOU FC, 1993, PHYS REV LETT, V71, P2323, DOI 10.1103/PhysRevLett.71.2323; Christensen NB, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.197003; Cooper KB, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.241313; Cvetkovic V, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.045701; Dai PC, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.054525; Doiron-Leyraud N, 2007, NATURE, V447, P565, DOI 10.1038/nature05872; Fong HF, 2000, PHYS REV B, V61, P14773, DOI 10.1103/PhysRevB.61.14773; Fujita M, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.104517; Fujita M, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.064505; Hayden SM, 2004, NATURE, V429, P531, DOI 10.1038/nature02576; Hinkov V, 2007, NAT PHYS, V3, P780, DOI 10.1038/nphys720; Hinkov V, 2004, NATURE, V430, P650, DOI 10.1038/nature02774; Kao YJ, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.024502; KEIMER B, 1992, PHYS REV B, V46, P14034, DOI 10.1103/PhysRevB.46.14034; Kohsaka Y, 2007, SCIENCE, V315, P1380, DOI 10.1126/science.1138584; Kotov VN, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.184519; Lake B, 2002, NATURE, V415, P299, DOI 10.1038/415299a; Lee YS, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.014518; Liang RX, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.180505; Marchetti PA, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.214514; MILLIS AJ, PREPRINT; Niedermayer C, 1998, PHYS REV LETT, V80, P3843, DOI 10.1103/PhysRevLett.80.3843; Oganesyan V, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.195109; STERNLIEB BJ, 1990, PHYS REV B, V41, P8866, DOI 10.1103/PhysRevB.41.8866; Stock C, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.100504; Stock C, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.014502; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Yamase H, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.214517	32	401	402	6	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2008	319	5863					597	600		10.1126/science.1152309	http://dx.doi.org/10.1126/science.1152309			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	257AQ	18187621	Green Submitted			2022-12-28	WOS:000252772000034
J	Collaco, JM; Vanscoy, L; Bremer, L; McDougal, K; Blackman, SM; Bowers, A; Naughton, K; Jennings, J; Ellen, J; Cutting, GR				Collaco, J. Michael; Vanscoy, Lori; Bremer, Lindsay; McDougal, Kathryn; Blackman, Scott M.; Bowers, Amanda; Naughton, Kathleen; Jennings, Jacky; Ellen, Jonathan; Cutting, Garry R.			Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; PASSIVE SMOKING; SOCIOECONOMIC-STATUS; CHILDREN; EXPOSURE; POLYMORPHISMS; ASSOCIATION; DECLINE; MODIFIERS; SEVERITY	Context Disease variation can be substantial even in conditions with a single gene etiology such as cystic fibrosis ( CF). Simultaneously studying the effects of genes and environment may provide insight into the causes of variation. Objective To determine whether secondhand smoke exposure is associated with lung function and other outcomes in individuals with CF, whether socioeconomic status affects the relationship between secondhand smoke exposure and lung disease severity, and whether specific gene- environment interactions influence the effect of secondhand smoke exposure on lung function. Design, Setting, and Participants Retrospective assessment of lung function, stratified by environmental and genetic factors. Data were collected by the US Cystic Fibrosis Twin and Sibling Study with missing data supplemented by the Cystic Fibrosis Foundation Data Registry. All participants were diagnosed with CF, were recruited between October 2000 and October 2006, and were primarily from the United States. Main Outcome Measures Disease- specific cross- sectional and longitudinal measures of lung function. Results Of 812 participants with data on secondhand smoke in the home, 188 ( 23.2%) were exposed. Of 780 participants with data on active maternal smoking during gestation, 129 ( 16.5%) were exposed. Secondhand smoke exposure in the home was associated with significantly lower cross- sectional ( 9.8 percentile point decrease; P <. 001) and longitudinal lung function ( 6.1 percentile point decrease; P=. 007) compared with those not exposed. Regression analysis demonstrated that socioeconomic status did not confound the adverse effect of secondhand smoke exposure on lung function. Interaction between gene variants and secondhand smoke exposure resulted in significant percentile point decreases in lung function, namely in CFTR non- Delta F508 homozygotes ( 12.8 percentile point decrease; P=. 001), TGF beta 1-509 TT homozygotes ( 22.7 percentile point decrease; P=. 006), and TGF beta 1 codon 10 CC homozygotes ( 20.3 percentile point decrease; P=. 005). Conclusions Any exposure to secondhand smoke adversely affects both cross-sectional and longitudinal measures of lung function in individuals with CF. Variations in the gene that causes CF ( CFTR) and a CF- modifier gene ( TGF beta 1) amplify the negative effects of secondhand smoke exposure.	[Collaco, J. Michael; Vanscoy, Lori; Bremer, Lindsay; McDougal, Kathryn; Blackman, Scott M.; Bowers, Amanda; Naughton, Kathleen; Jennings, Jacky; Ellen, Jonathan; Cutting, Garry R.] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA	Johns Hopkins University	Cutting, GR (corresponding author), Johns Hopkins Univ, Sch Med, Inst Med Genet, 733 N Broadway,Broadway Res Bldg,Ste 551, Baltimore, MD 21205 USA.	gcutting@jhmi.edu		Blackman, Scott/0000-0002-4532-6421; Jennings PhD MPH, Jacky/0000-0002-3789-5122	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068927] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL68927, R01 HL068927-06A1, R01 HL068927] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arkwright PD, 2000, THORAX, V55, P459, DOI 10.1136/thorax.55.6.459; Beydon N, 2002, AM J RESP CRIT CARE, V166, P1099, DOI 10.1164/rccm.200205-421OC; Blackman SM, 2006, GASTROENTEROLOGY, V131, P1030, DOI 10.1053/j.gastro.2006.07.016; BOYER PH, 1955, PEDIATRICS, V16, P778; Brazova J, 2006, CLIN IMMUNOL, V121, P350, DOI 10.1016/j.clim.2006.08.015; Buranawuti K, 2007, J MED GENET, V44, P209, DOI 10.1136/jmg.2006.046318; CAMPBELL PW, 1992, J PEDIATR-US, V120, P261, DOI 10.1016/S0022-3476(05)80438-X; Cantin AM, 2006, AM J RESP CRIT CARE, V173, P1139, DOI 10.1164/rccm.200508-1330OC; Celedon JC, 2004, HUM MOL GENET, V13, P1649, DOI 10.1093/hmg/ddh171; Corey M, 1997, J PEDIATR-US, V131, P809, DOI 10.1016/S0022-3476(97)70025-8; Drumm ML, 2005, NEW ENGL J MED, V353, P1443, DOI 10.1056/NEJMoa051469; Duffy DL, 1997, AM J HUM GENET, V61, pA197; Festini F, 2005, J PEDIATR-US, V147, P316, DOI 10.1016/j.jpeds.2005.04.031; GILLJAM H, 1990, RESP MED, V84, P289, DOI 10.1016/S0954-6111(08)80055-8; Hollingshead A.B., 1975, 4 FACTOR INDEX SOCIA; Kohler E, 1999, HUM EXP TOXICOL, V18, P212, DOI 10.1191/096032799678839932; Konstan MW, 2007, J PEDIATR-US, V151, P134, DOI 10.1016/j.jpeds.2007.03.006; KOVESI T, 1993, AM REV RESPIR DIS, V148, P1266, DOI 10.1164/ajrccm/148.5.1266; Kulich M, 2005, AM J RESP CRIT CARE, V172, P885, DOI 10.1164/rccm.200410-1335OC; Li HL, 2007, HUM GENET, V121, P529, DOI 10.1007/s00439-007-0337-z; Mak JCW, 2006, J ALLERGY CLIN IMMUN, V117, P92, DOI 10.1016/j.jaci.2005.08.049; Moritsugu KP, 2007, AM J PREV MED, V32, P542, DOI 10.1016/j.amepre.2007.02.026; Muller AE, 1999, EUR J PEDIATR, V158, P264, DOI 10.1007/s004310051065; O'Connor GT, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.4.e333; Pulleyn LJ, 2001, HUM GENET, V109, P623, DOI 10.1007/s00439-001-0617-y; Rosenstein BJ, 1998, J PEDIATR-US, V132, P589, DOI 10.1016/S0022-3476(98)70344-0; RUBIN BK, 1990, NEW ENGL J MED, V323, P782, DOI 10.1056/NEJM199009203231203; Salam MT, 2007, AM J RESP CRIT CARE, V176, P1192, DOI 10.1164/rccm.200704-561OC; Schechter MS, 1998, J PEDIATR-US, V132, P260, DOI 10.1016/S0022-3476(98)70442-1; Schechter MS, 2001, AM J RESP CRIT CARE, V163, P1331, DOI 10.1164/ajrccm.163.6.9912100; Schluchter MD, 2002, STAT MED, V21, P1271, DOI 10.1002/sim.1104; Silverman ES, 2004, AM J RESP CRIT CARE, V169, P214, DOI 10.1164/rccm.200307-973OC; SMYTH A, 1994, ARCH DIS CHILD, V71, P353, DOI 10.1136/adc.71.4.353; Smyth A, 2001, PEDIATR PULM, V31, P133, DOI 10.1002/1099-0496(200102)31:2<133::AID-PPUL1021>3.0.CO;2-8; Strausbaugh SD, 2007, CLIN CHEST MED, V28, P279, DOI 10.1016/j.ccm.2007.02.011; Su ZG, 2005, ACTA PHARMACOL SIN, V26, P714, DOI 10.1111/j.1745-7254.2005.00084.x; *US BUR CENS, CENS DAT 2000; *US CDCP, BOD MASS IND Z SCOR; Vanscoy LL, 2007, AM J RESP CRIT CARE, V175, P1036, DOI 10.1164/rccm.200608-1164OC; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Wu L, 2004, THORAX, V59, P126, DOI 10.1136/thorax.2003.005769	41	103	104	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 30	2008	299	4					417	424		10.1001/jama.299.4.417	http://dx.doi.org/10.1001/jama.299.4.417			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	256JK	18230779	Green Accepted, Bronze			2022-12-28	WOS:000252724500019
J	Brown, LD				Brown, Lawrence D.			The amazing noncollapsing US Health care system - Is reform finally at hand?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Columbia Univ, Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY 10027 USA	Columbia University	Brown, LD (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY 10027 USA.								0	22	22	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2008	358	4					325	327		10.1056/NEJMp0708600	http://dx.doi.org/10.1056/NEJMp0708600			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	253GY	18216351				2022-12-28	WOS:000252507900001
J	Katz, MH				Katz, Mitchell H.			Golden gate to health care for all? San Francisco's new universal-acess program	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									San Francisco Dept Publ Hlth, San Francisco, CA 94143 USA	San Francisco Department of Public Health	Katz, MH (corresponding author), San Francisco Dept Publ Hlth, San Francisco, CA 94143 USA.							Blumberg LJ, 2007, HEALTH AFFAIR, V26, pW463, DOI 10.1377/hlthaff.26.4.w463; Grumbach K, 2002, JAMA-J AM MED ASSOC, V288, P889, DOI 10.1001/jama.288.7.889; *UCLA CTR HLTH POL, CAL HLTH INT SURV CH	3	16	16	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2008	358	4					327	329		10.1056/NEJMp0706590	http://dx.doi.org/10.1056/NEJMp0706590			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	253GY	18216352				2022-12-28	WOS:000252507900002
J	Paul, K; Erhardt, M; Hirano, T; Blair, DF; Hughes, KT				Paul, Koushik; Erhardt, Marc; Hirano, Takanori; Blair, David F.; Hughes, Kelly T.			Energy source of flagellar type III secretion	NATURE			English	Article							PROTON MOTIVE FORCE; SALMONELLA-TYPHIMURIUM; NEGATIVE REGULATOR; ESCHERICHIA-COLI; EXPORT APPARATUS; ATPASE; FLII; FLGM; COMPONENTS; PROTEINS	Bacterial flagella contain a specialized secretion apparatus that functions to deliver the protein subunits that form the filament and other structures to outside the membrane(1). This apparatus is related to the injectisome used by many gram- negative pathogens and symbionts to transfer effector proteins into host cells; in both systems this export mechanism is termed 'type III' secretion(2,3). The flagellar secretion apparatus comprises a membrane- embedded complex of about five proteins, and soluble factors, which include export- dedicated chaperones and an ATPase, FliI, that was thought to provide the energy for export(1,4). Here we show that flagellar secretion in Salmonella enterica requires the proton motive force ( PMF) and does not require ATP hydrolysis by FliI. The export of several flagellar export substrates was prevented by treatment with the protonophore CCCP, with no accompanying decrease in cellular ATP levels. Weak swarming motility and rare flagella were observed in a mutant deleted for FliI and for the non-flagellar type- III secretion ATPases InvJ and SsaN. These findings show that the flagellar secretion apparatus functions as a proton-driven protein exporter and that ATP hydrolysis is not essential for type III secretion.	[Paul, Koushik; Erhardt, Marc; Hirano, Takanori; Blair, David F.; Hughes, Kelly T.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Blair, DF (corresponding author), Univ Utah, Dept Biol, 257 South 1400 East, Salt Lake City, UT 84112 USA.	blair@bioscience.utah.edu; hughes@biology.utah.edu		Erhardt, Marc/0000-0001-6292-619X				Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Aldridge P, 2006, MOL MICROBIOL, V60, P630, DOI 10.1111/j.1365-2958.2006.05135.x; BAKKER EP, 1983, BIOCHIM BIOPHYS ACTA, V730, P379, DOI 10.1016/0005-2736(83)90355-3; Blocker A, 2003, P NATL ACAD SCI USA, V100, P3027, DOI 10.1073/pnas.0535335100; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Davis R., 1980, ADV BACTERIAL GENETI; DREYFUS G, 1993, J BACTERIOL, V175, P3131, DOI 10.1128/JB.175.10.3131-3138.1993; Evans LDB, 2006, P NATL ACAD SCI USA, V103, P17474, DOI 10.1073/pnas.0605197103; Fan F, 1996, J BIOL CHEM, V271, P31981, DOI 10.1074/jbc.271.50.31981; Fraser GM, 2003, J BACTERIOL, V185, P5546, DOI 10.1128/JB.185.18.5546-5554.2003; GALPERIN MY, 1982, FEBS LETT, V143, P319, DOI 10.1016/0014-5793(82)80125-7; GILLEN KL, 1991, J BACTERIOL, V173, P2301, DOI 10.1128/JB.173.7.2301-2310.1991; GILLEN KL, 1991, J BACTERIOL, V173, P6453, DOI 10.1128/jb.173.20.6453-6459.1991; Hensel M, 1997, MOL MICROBIOL, V24, P155, DOI 10.1046/j.1365-2958.1997.3271699.x; HUGHES KT, 1993, SCIENCE, V262, P1277, DOI 10.1126/science.8235660; Karlinsey JE, 1998, J BACTERIOL, V180, P5384, DOI 10.1128/JB.180.20.5384-5397.1998; Komoriya K, 1999, MOL MICROBIOL, V34, P767, DOI 10.1046/j.1365-2958.1999.01639.x; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; Lee HJ, 2006, J BACTERIOL, V188, P3308, DOI 10.1128/JB.188.9.3308-3316.2006; LINO T, 1974, Journal of Supramolecular Structure, V2, P372, DOI 10.1002/jss.400020226; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Minamino T, 2000, MOL MICROBIOL, V37, P1494, DOI 10.1046/j.1365-2958.2000.02106.x; Minamino T, 2003, J BACTERIOL, V185, P1190, DOI 10.1128/JB.185.4.1190-1194.2003; Rosu V, 2006, J BACTERIOL, V188, P5196, DOI 10.1128/JB.00299-06; Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200; VOGLER AP, 1991, J BACTERIOL, V173, P3564, DOI 10.1128/jb.173.11.3564-3572.1991; Wilharm G, 2004, INFECT IMMUN, V72, P4004, DOI 10.1128/IAI.72.7.4004-4009.2004	27	237	240	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2008	451	7177					489	U13		10.1038/nature06497	http://dx.doi.org/10.1038/nature06497			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	253YS	18216859	Bronze			2022-12-28	WOS:000252554100050
J	Trivedi, AN; Rakowski, W; Ayanian, JZ				Trivedi, Amal N.; Rakowski, William; Ayanian, John Z.			Effect of cost sharing on screening mammography in medicare health plans	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SERVICES TASK-FORCE; OLDER WOMEN; MAINTENANCE ORGANIZATION; INSURANCE EXPERIMENT; CARE; IMPACT; BENEFICIARIES; COPAYMENTS; EMERGENCY; BENEFITS	Background: Policies that increase patients' share of health care expenses decrease the use of discretionary health services but also may reduce the use of important preventive care such as mammography. Methods: We reviewed coverage for mammography within 174 Medicare managed-care plans from 2001 through 2004. Among 550,082 individual-level observations for 366,475 women between the ages of 65 and 69 years, we compared rates of biennial breast-cancer screening in plans requiring cost sharing for mammography with screening rates in plans with full coverage. We also performed a longitudinal analysis of screening rates in plans that changed from full coverage to cost sharing for mammography as compared with rates in matched control plans that did not institute cost sharing. Results: The number of plans with cost sharing for mammography, which we defined as requiring a copayment of more than $10 or coinsurance of more than 10% for screening mammography, increased from 3 in 2001 (representing 0.5% of women) to 21 in 2004 (11.4% of women). Biennial screening rates were 8.3 percentage points lower in cost-sharing plans than in plans with full coverage, a difference that persisted in adjusted analyses (P<0.001). The effect of cost sharing was magnified among women residing in areas of lower income or educational levels (P<0.001 for each interaction). Screening rates decreased by 5.5 percentage points in plans that instituted cost sharing and increased by 3.4 percentage points in matched control plans that retained full coverage (P<0.001 for the adjusted analysis). Conclusions: Relatively small copayments were associated with significantly lower mammography rates among women who should undergo screening mammography according to accepted clinical guidelines. For effective preventive services such as mammography, exempting elderly adults from cost sharing may be warranted.	[Trivedi, Amal N.; Rakowski, William] Brown Univ, Warren Alpert Med Sch, Dept Community Hlth, Providence, RI 02912 USA; [Trivedi, Amal N.] Providence Vet Affairs Med Ctr, Target Res Enhancement Program, Providence, RI USA; [Ayanian, John Z.] Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA; [Ayanian, John Z.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Ayanian, John Z.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Trivedi, AN (corresponding author), Brown Univ, Warren Alpert Med Sch, Dept Community Hlth, Box G-S121, Providence, RI 02912 USA.	amal_trivedi@brown.edu			AHRQ HHS [5T32-HS-000020-20] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000020] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		ACHMAN L, 2002, TRENDS MEDICARE CHOI; BECK RG, 1980, MED CARE, V18, P787, DOI 10.1097/00005650-198008000-00001; Bloom SA, 2000, MED CARE, V38, P187, DOI 10.1097/00005650-200002000-00008; BLUSTEIN J, 1995, NEW ENGL J MED, V332, P1138, DOI 10.1056/NEJM199504273321706; BREEN N, 1994, MILBANK Q, V72, P431, DOI 10.2307/3350265; Breen N, 2007, CANCER-AM CANCER SOC, V109, P2405, DOI 10.1002/cncr.22723; BRIAN EW, 1974, MED CARE, V12, P1; Chandra A., 2007, 12972 NAT BUR EC RES; CHERKIN DC, 1989, MED CARE, V27, P1036, DOI 10.1097/00005650-198911000-00005; Chernew ME, 2007, HEALTH AFFAIR, V26, pW195, DOI 10.1377/hlthaff.26.2.w195; Claxton G, 2006, HEALTH AFFAIR, V25, pW476, DOI 10.1377/hlthaff.25.w476; *CTR MED MED SERV, 2003, BIENN NAT STAT MAMM; ELLIS RP, 1993, J ECON PERSPECT, V7, P135, DOI 10.1257/jep.7.4.135; FOX SA, 1991, ARCH INTERN MED, V151, P50, DOI 10.1001/archinte.151.1.50; Goldman DP, 2003, HEALTH AFFAIR, V22, P194, DOI 10.1377/hlthaff.22.3.194; GORDON NP, 1993, J NATL CANCER I, V85, P566, DOI 10.1093/jnci/85.7.566; Gornick ME, 1996, NEW ENGL J MED, V335, P791, DOI 10.1056/NEJM199609123351106; Gross DJ, 1999, HEALTH SERV RES, V34, P241; Hendrick RE, 2005, AM J ROENTGENOL, V184, P433, DOI 10.2214/ajr.184.2.01840433; *HLTH CAR FIN ADM, MED HEDIS 3 0 1998 D; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; Iglehart JK, 2002, NEW ENGL J MED, V347, P956, DOI 10.1056/NEJMhpr022143; *INTERSTUDY PUBL, 2001, INTERSTUDY COMP EDG; KEELER EB, 1985, JAMA-J AM MED ASSOC, V254, P1926; Kelaher M, 2000, PREV MED, V31, P658, DOI 10.1006/pmed.2000.0759; KIEFE CI, 1994, ARCH INTERN MED, V154, P1217, DOI 10.1001/archinte.154.11.1217; LINDFORS KK, 1995, JAMA-J AM MED ASSOC, V274, P881, DOI 10.1001/jama.274.11.881; Lindfors KK, 1996, JAMA-J AM MED ASSOC, V275, P112; Lohr K N, 1986, Med Care, V24, pS1; LURIE N, 1989, AM J PUBLIC HEALTH, V79, P1677; LURIE N, 1989, AM J PUBLIC HEALTH, V79, P640, DOI 10.2105/AJPH.79.5.640; Magid DJ, 1997, NEW ENGL J MED, V336, P1722, DOI 10.1056/NEJM199706123362406; Mandelblatt J, 2003, ANN INTERN MED, V139, P835, DOI 10.7326/0003-4819-139-10-200311180-00011; *NCI, SCREEN MAMM QUEST AN; Neumann PJ, 2005, NEW ENGL J MED, V353, P1516, DOI 10.1056/NEJMsb050564; Neumann PJ, 2002, AM J PREV MED, V23, P276, DOI 10.1016/S0749-3797(02)00516-0; NEWHOUSE JP, 1981, NEW ENGL J MED, V305, P1501, DOI 10.1056/NEJM198112173052504; PAULY MV, 1968, AM ECON REV, V58, P531; Rice T, 2004, MED CARE RES REV, V61, P415, DOI 10.1177/1077558704269498; Robinson JC, 2004, JAMA-J AM MED ASSOC, V291, P1880, DOI 10.1001/jama.291.15.1880; RODDY PC, 1986, MED CARE, V24, P873, DOI 10.1097/00005650-198609000-00009; RUBIN RJ, 1995, NEW ENGL J MED, V333, P733; Selby JV, 1996, NEW ENGL J MED, V334, P635, DOI 10.1056/NEJM199603073341006; Smith RA, 2003, CA-CANCER J CLIN, V53, P141, DOI 10.3322/canjclin.53.3.141; Trivedi AN, 2005, NEW ENGL J MED, V353, P692, DOI 10.1056/NEJMsa051207; *US CANC STAT WORK, 2005, US CANC STAT 1999 20; ZWEIFEL P, 2000, HDB HLTH EC, P409; 2007, MMWR MORB MORTAL WKL, V56, P49; 2004, MEDICARE PREVENTIVE	49	162	163	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2008	358	4					375	383		10.1056/NEJMsa070929	http://dx.doi.org/10.1056/NEJMsa070929			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	253GY	18216358				2022-12-28	WOS:000252507900008
J	Abdel-Ghafar, AN; Chotpitayasunondh, T; Gao, ZC; Hayden, FG; Hien, ND; de Jong, MD; Naghdaliyev, A; Peiris, JSM; Shindo, N; Soeroso, S; Uyeki, TM				Abdel-Ghafar, Abdel-Nasser; Chotpitayasunondh, Tawee; Gao, Zhancheng; Hayden, Frederick G.; Hien, Nguyen Duc; de Jong, Menno D.; Naghdaliyev, Azim; Peiris, J. S. Malik; Shindo, Nahoko; Soeroso, Santoso; Uyeki, Timothy M.		2nd World Hlth Org Consultation	Update on Avian Influenza A (H5N1) virus infection in humans	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CYTOKINE RESPONSES; HEMAGGLUTININ; TRANSMISSION; VACCINE; SUSCEPTIBILITY; INACTIVATION; PATHOGENESIS; IMMUNITY; THERAPY; BIRDS		[Hayden, Frederick G.; Shindo, Nahoko] WHO, Dept Epidem & Pandem Alert & Response, Global Influenza Program, CH-1211 Geneva 27, Switzerland; [Abdel-Ghafar, Abdel-Nasser] Minist Hlth & Populat, Cairo, Egypt; [Chotpitayasunondh, Tawee] Queen Sirikit Natl Inst Child Hlth, Bangkok, Thailand; [Gao, Zhancheng] Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China; [Hayden, Frederick G.] Univ Virginia, Charlottesville, VA USA; [Hien, Nguyen Duc] Natl Inst Infect & Trop Dis, Hanoi, Vietnam; [de Jong, Menno D.] Hosp Trop Dis, Oxford Univ Clin Res Unit, Ho Chi Minh City, Vietnam; [Naghdaliyev, Azim] Abulfaz Karayev Childrens Hosp 2, Baku, Azerbaijan; [Peiris, J. S. Malik] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Soeroso, Santoso] Natl Infect Dis Hosp, Jakarta, Indonesia; [Uyeki, Timothy M.] Ctr Dis Control & Prevent, Atlanta, GA USA	World Health Organization; Egyptian Knowledge Bank (EKB); Ministry of Health & Population - Egypt; Peking University; University of Virginia; University of Hong Kong; Centers for Disease Control & Prevention - USA	Hayden, FG (corresponding author), WHO, Dept Epidem & Pandem Alert & Response, Global Influenza Program, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.	haydenf@who.int	Peiris, Joseph/C-4380-2009					[Anonymous], 2007, WHO GEN TECH REP; [Anonymous], 2021, HUM INF AV INFL AH5N; Areechokchai Darin, 2006, MMWR Suppl, V55, P3; BARRETT N, 2007, 9 INT S RESP VIR INF; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; Buchy P, 2007, J CLIN VIROL, V39, P164, DOI 10.1016/j.jcv.2007.04.010; Chan KH, 2007, J CLIN VIROL, V38, P169, DOI 10.1016/j.jcv.2006.11.010; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; De Benedictis P, 2007, ZOONOSES PUBLIC HLTH, V54, P51, DOI 10.1111/j.1863-2378.2007.01029.x; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dinh PN, 2006, EMERG INFECT DIS, V12, P1841; Ducatez MF, 2006, NATURE, V442, P37, DOI 10.1038/442037a; Fielding R, 2007, EMERG INFECT DIS, V13, P1065, DOI 10.3201/eid1307.061031; Gauthier-Clerc M, 2007, IBIS, V149, P202, DOI 10.1111/j.1474-919X.2007.00699.x; GOJI N, 2006, 44 ANN M IDSA TOR OC, P64; Govorkova EA, 2007, ANTIMICROB AGENTS CH, V51, P1414, DOI 10.1128/AAC.01312-06; Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3; Hatta M, 2007, PLOS PATHOG, V3, P1374, DOI 10.1371/journal.ppat.0030133; Hurt AC, 2007, ANTIVIR RES, V73, P228, DOI 10.1016/j.antiviral.2006.10.004; Ilyushina NA, 2007, ANTIVIR THER, V12, P363; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Le QM, 2005, NATURE, V438, P754, DOI 10.1038/438754b; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Leschnik M, 2007, EMERG INFECT DIS, V13, P243, DOI 10.3201/eid1302.060608; Lin JT, 2006, LANCET, V368, P991, DOI 10.1016/S0140-6736(06)69294-5; Lu XH, 2006, VACCINE, V24, P6588, DOI 10.1016/j.vaccine.2006.05.039; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; McKimm-Breschkin JL, 2007, EMERG INFECT DIS, V13, P1354, DOI 10.3201/eid1309.070164; MORRISON D, IN PRESS PLOS CLIN T; Mumford E, 2007, FOOD NUTR BULL, V28, pS357, DOI 10.1177/15648265070282S215; Nefkens I, 2007, J CLIN VIROL, V39, P27, DOI 10.1016/j.jcv.2007.02.005; Ng WF, 2006, HUM PATHOL, V37, P381, DOI 10.1016/j.humpath.2006.01.015; Nicholls JM, 2007, NAT MED, V13, P147, DOI 10.1038/nm1529; Olsen SJ, 2005, EMERG INFECT DIS, V11, P1799; Oner AF, 2006, NEW ENGL J MED, V355, P2179, DOI 10.1056/NEJMoa060601; Ortiz JR, 2007, EMERG INFECT DIS, V13, P294, DOI 10.3201/eid1302.061052; Park AW, 2007, LANCET INFECT DIS, V7, P543, DOI 10.1016/S1473-3099(07)70186-X; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Pitzer VE, 2007, EMERG INFECT DIS, V13, P1074, DOI 10.3201/eid1307.061538; Rice EW, 2007, EMERG INFECT DIS, V13, P1568, DOI 10.3201/eid1310.070323; SAAD MD, 2007, OPT CONTR INFL C TOR, P228; Salomon R, 2007, P NATL ACAD SCI USA, V104, P12479, DOI 10.1073/pnas.0705289104; Sedyaningsih ER, 2007, J INFECT DIS, V196, P522, DOI 10.1086/519692; SEDYANINGSIH ER, 2007, OPT CONTR INFL 6 C T, P329; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; Songserm T, 2006, EMERG INFECT DIS, V12, P1744, DOI 10.3201/eid1211.060542; Stephenson I, 2005, J INFECT DIS, V191, P1210, DOI 10.1086/428948; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06; Thiry E, 2007, VET MICROBIOL, V122, P25, DOI 10.1016/j.vetmic.2006.12.021; Uiprasertkui M, 2007, EMERG INFECT DIS, V13, P708, DOI 10.3201/eid1305.060572; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; Vong S, 2006, EMERG INFECT DIS, V12, P1542, DOI 10.3201/eid1210.060424; Wang M, 2006, EMERG INFECT DIS, V12, P1773, DOI 10.3201/eid1211.060675; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; *WHO, 2007, ANT GEN CHAR H5N1 VI; *WHO, 2006, WHO RAP ADV GUID PHA; *WHO, 2006, NEW ENGL J MED, V354, P884; *WHO, 2006, AV INFL SIT IND UPD; *WHO, SUMM 2 WHO CONS CLIN; *WHO, 2007, 3 WHO M EV PAND INFL; *WHO, 2007, WKLY EPIDEMIOL REC, V82, P41; Winker K, 2007, EMERG INFECT DIS, V13, P547, DOI 10.3201/eid1304.061072; World Health Organization, COLL PRES SHIPP SPEC; World Health Organization, CUM NUMB CONF HUM CA; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yen HL, 2005, J INFECT DIS, V192, P665, DOI 10.1086/432008; Yu HJ, 2006, LANCET, V367, P84, DOI 10.1016/S0140-6736(05)67894-4; Yu HJ, 2007, EMERG INFECT DIS, V13, P1061, DOI 10.3201/eid1307.061557; 2007, WKLY EPIDEMIOL REC, V81, P183	77	663	707	1	109	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2008	358	3					261	273						13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	251LS	18199865	Bronze, Green Published			2022-12-28	WOS:000252375600007
J	Magee, CC; Coggins, MP; Foster, CS; Muse, VV; Colvin, RB				Magee, Colm C.; Coggins, Matthew P.; Foster, C. Stephen; Muse, Victorine V.; Colvin, Robert B.			A woman with postpartum visual loss, shortness of breath, and renal failure - Postpartum renal failure due to thrombotic microangiopathy, associated with antiphospholipid antibodies	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERNATIONAL CONSENSUS STATEMENT; CLASSIFICATION CRITERIA; NORMAL-PREGNANCY; POST-PARTUM; PREECLAMPSIA; MANIFESTATIONS; ENDOTHELIOSIS; EXPRESSION; DISEASE; UPDATE		[Magee, Colm C.] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA; [Coggins, Matthew P.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Muse, Victorine V.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Colvin, Robert B.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Magee, Colm C.; Coggins, Matthew P.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Foster, C. Stephen] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; [Muse, Victorine V.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Colvin, Robert B.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Foster, C. Stephen] Immunol & Uveitis Fdn, Cambridge, MA USA; [Foster, C. Stephen] Massachusetts Eye Res & Surg Inst, Cambridge, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Magee, CC (corresponding author), Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA.							ABRAMSON SB, 1992, AM J REPROD IMMUNOL, V28, P183, DOI 10.1111/j.1600-0897.1992.tb00787.x; Asherson RA, 2003, LUPUS, V12, P530, DOI 10.1191/0961203303lu394oa; Asherson RA, 2001, MEDICINE, V80, P355, DOI 10.1097/00005792-200111000-00002; Bates SA, 2004, CHEST, V126, p627S, DOI 10.1378/chest.126.3_suppl.627S; BRANCH DW, 1992, OBSTET GYNECOL, V80, P614; BUYON JP, 1986, AM J MED, V81, P194, DOI 10.1016/0002-9343(86)90251-2; Cervera R, 2002, ARTHRITIS RHEUM-US, V46, P1019, DOI 10.1002/art.10187; EPSTEIN FH, 1973, NEW ENGL J MED, V288, P93; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Erkan D, 2003, ANN RHEUM DIS, V62, P530, DOI 10.1136/ard.62.6.530; Espinosa G, 2004, ANN RHEUM DIS, V63, P730, DOI 10.1136/ard.2003.007245; Frangie C, 2007, LANCET ONCOL, V8, P177, DOI 10.1016/S1470-2045(07)70037-2; GABER LW, 1994, BAILLIERE CLIN OB GY, V8, P443, DOI 10.1016/S0950-3552(05)80330-X; IHLE BU, 1987, BRIT MED J, V294, P79, DOI 10.1136/bmj.294.6564.79; Joyama S, 2001, AM J KIDNEY DIS, V37, part. no.; Miserocchi E, 2001, AM J OPHTHALMOL, V131, P451, DOI 10.1016/S0002-9394(00)00884-9; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Nochy D, 1999, J AM SOC NEPHROL, V10, P507; Nochy D, 2002, J NEPHROL, V15, P446; PIETTE JC, 1994, SEMIN ARTHRITIS RHEU, V23, P357, DOI 10.1016/0049-0172(94)90086-8; ROBSON JS, 1968, Q J MED, V37, P423; Rubenstein E, 2006, J RHEUMATOL, V33, P355; SPARGO B, 1959, ARCH PATHOL, V68, P593; Strevens H, 2003, BJOG-INT J OBSTET GY, V110, P831, DOI 10.1111/j.1471-0528.2003.02162.x	24	5	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2008	358	3					275	289		10.1056/NEJMcpc0707557	http://dx.doi.org/10.1056/NEJMcpc0707557			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	251LS	18199867				2022-12-28	WOS:000252375600011
J	Asghar, R; Banajeh, S; Egas, J; Hibberd, P; Iqbal, I; Katep-Bwalya, M; Kundi, Z; Law, P; MacLeod, W; Maulen-Radovan, I; Mino, G; Saha, S; Sempertegui, F; Simon, J; Santosham, M; Singhi, S; Thea, DM; Qazi, S				Asghar, Rai; Banajeh, Salem; Egas, Josefina; Hibberd, Patricia; Iqbal, Imran; Katep-Bwalya, Mary; Kundi, Zafarullah; Law, Paul; MacLeod, William; Maulen-Radovan, Irene; Mino, Greta; Saha, Samir; Sempertegui, Fernando; Simon, Jonathon; Santosham, Mathuram; Singhi, Sunit; Thea, Donald M.; Qazi, Shamim		SPEAR Study Grp	Chloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2-59 months in low resource settings: multicentre randomised controlled trial (SPEAR study)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RESPIRATORY-TRACT INFECTION; HAEMOPHILUS-INFLUENZAE; ANTIMICROBIAL RESISTANCE; STREPTOCOCCUS-PNEUMONIAE; CASE-MANAGEMENT; CLINICAL SIGNS; RISK-FACTORS; PENICILLIN; MORTALITY; PAKISTAN	Objective To evaluate whether five days'treatment with injectable ampicillin plus gentamicin compared with chloramphenicol reduces treatment failure in children aged 2-59 months with community acquired very severe pneumonia in tow resource settings. Design Open label randonnised controlled trial. Setting Inpatient wards within tertiary care hospitals in Bangladesh, Ecuador, India, Mexico, Pakistan, Yemen, and Zambia. Participants Children aged 2-59 months with WHO defined very severe pneumonia. Intervention Chloramphenicol versus a combination of ampicillin plus gentamicin. Main outcome measures Primary outcome measure was treatment failure at five days. Secondary outcomes were treatment failure defined similarly among all participants evaluated at 48 hours and at 10 and 21 days. Results More children failed treatment with chloramphenicol at day 5 (16% v 11%; relative risk 1.43, 95% confidence interval 1.03 to 1.97) and also by days 10 and 21. Overall, 112 bacterial isolates were obtained from blood and lung aspirates in 110 children (11.5%), with the most common organisms being Staphylococcus aureus (n=47) and Streptococcus pneumoniae (n=22). In subgroup analysis, bacteraemia with any organism increased the risk of treatment failure at 21 days in the chloramphenicol group (2.09, 1.41 to 3.10) but not in the ampicillin plus gentamicin group (1.12, 0.59 to 2.13). Similarly, isolation of S pneumoniae increased the risk of treatment failure at day 21 (4.06, 2.73 to 6.03) and death (5.80, 2.62 to 12.85) in the chloramphenicol group but not in the ampicillin plus gentamicin group. No difference was found in treatment failure for children with S aureus bacteraemia in the two groups, but the power to detect a difference in this subgroup analysis was low. Independent predictors of treatment failure by multivariate analysis were hypoxaemia (oxygen saturation <90%), receiving chloramphenicol, being female, and poor immunisation status. Conclusion Injectable ampicillin plus gentamicin is superior to injectable chloramphenicol for the treatment of community acquired very severe pneumonia in children aged 2-59 months in low resource settings. Trial registration Current Controlled Trials ISRCTN39543942.	[MacLeod, William; Simon, Jonathon; Thea, Donald M.] Boston Univ, Sch Publ Hlth, Ctr Int Hlth & Dev, Boston, MA 02118 USA; [Asghar, Rai; Kundi, Zafarullah] Rawalpindi Gen Hosp, Rawalpindi, Pakistan; [Banajeh, Salem] Al Sabeen Hosp, Sanaa, Yemen; [Egas, Josefina; Sempertegui, Fernando] Corp Ecuatoriana Biotecnol, Quito, Ecuador; [Hibberd, Patricia] Tufts Univ, New England Med Ctr, Clin Res Inst, Boston, MA 02111 USA; [Iqbal, Imran] Nishter Hosp, Multan, Pakistan; [Katep-Bwalya, Mary] Univ Teaching Hosp, Lusaka, Zambia; [Law, Paul; Santosham, Mathuram] Johns Hopkins Bloomberg Univ, Dept Int Hlth, Baltimore, MD USA; [Maulen-Radovan, Irene] Inst Nacl Pediat, Div Invest, Mexico City, DF, Mexico; [Mino, Greta] Childrens Hosp, Guayaquil, Ecuador; [Saha, Samir] Dhaka Shishu Hosp, Dhaka, Bangladesh; [Singhi, Sunit] Postgrad Inst Med Educ & Res, Chandigarh 160012, India; [Qazi, Shamim] WHO, Dept Child & Adolescent Hlth & Dev, CH-1211 Geneva, Switzerland	Boston University; Rawalpindi Medical College; Tufts Medical Center; Tufts University; University of Zambia; Johns Hopkins University; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; University of Geneva; World Health Organization	Thea, DM (corresponding author), Boston Univ, Sch Publ Hlth, Ctr Int Hlth & Dev, Boston, MA 02118 USA.	dthea@bu.edu		MacLeod, William/0000-0001-8003-8874; Hibberd, Patricia/0000-0002-7455-8117; Thea, Donald/0000-0002-6933-1030				Addo-Yobo E, 2004, LANCET, V364, P1141, DOI 10.1016/S0140-6736(04)17100-6; BAHL R, 1995, ANN TROP PAEDIATR, V15, P173, DOI 10.1080/02724936.1995.11747768; Bahwere P, 2001, Int J Infect Dis, V5, P180, DOI 10.1016/S1201-9712(01)90067-0; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Chintu C, 2004, LANCET, V364, P1865, DOI 10.1016/S0140-6736(04)17442-4; Deeks SL, 1999, PEDIATRICS, V103, P409, DOI 10.1542/peds.103.2.409; Deivanayagam N, 1996, Indian Pediatr, V33, P813; Duke T, 1999, LANCET, V353, P2210, DOI 10.1016/S0140-6736(99)02389-2; Duke T, 2002, LANCET, V359, P474, DOI 10.1016/S0140-6736(02)07677-8; DYKE T, 1994, BRIT MED J, V308, P119, DOI 10.1136/bmj.308.6921.119; FORREST KV, 2003, MANUAL CLIN MICROBIO; FRIEDLAND IR, 1992, LANCET, V339, P405, DOI 10.1016/0140-6736(92)90087-J; GRATTEN M, 1980, LANCET, V2, P192; KHALIQUE N, 1993, J ROY SOC HEALTH, V113, P247, DOI 10.1177/146642409311300507; KLUGMAN KP, 2002, EUR RESPIR J, V36, P3; Likitnukul Sasithorn, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P672; Lozano JM, 2001, INT J TUBERC LUNG D, V5, P496; MASTRO TD, 1993, PEDIATR INFECT DIS J, V12, P824, DOI 10.1097/00006454-199310000-00006; MASTRO TD, 1991, LANCET, V337, P156, DOI 10.1016/0140-6736(91)90813-5; MISHRA S, 1993, J TROP PEDIATRICS, V39, P288, DOI 10.1093/tropej/39.5.288; Muhe L, 1999, TROP MED INT HEALTH, V4, P421, DOI 10.1046/j.1365-3156.1999.00417.x; MULHOLLAND EK, 1995, PEDIATR INFECT DIS J, V14, P959, DOI 10.1097/00006454-199511000-00007; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; ONYANGO FE, 1993, BRIT MED J, V306, P612, DOI 10.1136/bmj.306.6878.612; Ostroff SM, 1996, CLIN INFECT DIS, V23, P1069, DOI 10.1093/clinids/23.5.1069; PALLARES R, 1995, NEW ENGL J MED, V333, P474, DOI 10.1056/NEJM199508243330802; Pepin J, 2001, T ROY SOC TROP MED H, V95, P410, DOI 10.1016/S0035-9203(01)90199-3; Qazi SA, 1996, B WORLD HEALTH ORGAN, V74, P501; QAZI SA, 1995, REDUCTION ACUTE RESP, P1; Rios A M, 1999, Rev Panam Salud Publica, V5, P69, DOI 10.1590/S1020-49891999000200001; Ruffini DD, 2002, AIDS, V16, P105, DOI 10.1097/00002030-200201040-00013; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; Sehgal V, 1997, Indian Pediatr, V34, P213; SHANN F, 1989, PEDIATR INFECT DIS J, V8, P852, DOI 10.1097/00006454-198912000-00005; SHANN F, 1984, LANCET, V2, P537; SHANN F, 1985, LANCET, V2, P684; SHANN F, 1986, PEDIATR INFECT DIS J, V5, P247, DOI 10.1097/00006454-198603000-00017; Shann F, 2001, LANCET, V357, P2070, DOI 10.1016/S0140-6736(00)05226-0; SPOONER V, 1989, J TROP PEDIATRICS, V35, P295, DOI 10.1093/tropej/35.6.295; Straus WL, 1998, LANCET, V352, P270, DOI 10.1016/S0140-6736(97)10294-X; Thomas K, 1998, PEDIATR INFECT DIS J, V17, pS172; TUPASI TE, 1990, REV INFECT DIS, V12, pS929; *WHO, 2000, FOOD BORN DIS FOC HL, P1; WHO, 1990, AC RESP INF CHILDR C; *WHO, 2004, WHOARI9120; *WHO PROGR CONTR A, 1991, WHOARI9120 PROGR CON; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; World Health Organization, 2005, WORLD HLTH REP 2005	49	63	65	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 12	2008	336	7635					80	84		10.1136/bmj.39421.435949.BE	http://dx.doi.org/10.1136/bmj.39421.435949.BE			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253BX	18182412	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000252494800029
J	Bornemann, A; Norris, RD; Friedrich, O; Beckmann, B; Schouten, S; Damste, JSS; Vogel, J; Hofmann, P; Wagner, T				Bornemann, Andre; Norris, Richard D.; Friedrich, Oliver; Beckmann, Britta; Schouten, Stefan; Damste, Jaap S. Sinninghe; Vogel, Jennifer; Hofmann, Peter; Wagner, Thomas			Isotopic evidence for glaciation during the Cretaceous supergreenhouse	SCIENCE			English	Article							RECORD; TEMPERATURES; CALCITE; WESTERN; CURVE	The Turonian ( 93.5 to 89.3 million years ago) was one of the warmest periods of the Phanerozoic eon, with tropical sea surface temperatures over 35 degrees C. High- amplitude sea- level changes and positive delta O-18 excursions in marine limestones suggest that glaciation events may have punctuated this episode of extreme warmth. New delta O-18 data from the tropical Atlantic show synchronous shifts similar to 91.2 million years ago for both the surface and deep ocean that are consistent with an approximately 200,000- year period of glaciation, with ice sheets of about half the size of the modern Antarctic ice cap. Even the prevailing supergreenhouse climate was not a barrier to the formation of large ice sheets, calling into question the common assumption that the poles were always ice- free during past periods of intense global warming.	[Bornemann, Andre; Norris, Richard D.; Friedrich, Oliver; Vogel, Jennifer] Univ Calif San Diego, Scripps Inst Oceanog, Geosci Res Div, La Jolla, CA 92093 USA; [Bornemann, Andre] Univ Leipzig, Inst Geophys & Geol, D-04103 Leipzig, Germany; [Friedrich, Oliver] Natl Ocean Ctr, Sch Ocean & Earth Sci, Southampton SO14 3ZH, Hants, England; [Beckmann, Britta; Hofmann, Peter] Univ Cologne, Inst Geol & Mineral, D-50674 Cologne, Germany; [Schouten, Stefan; Damste, Jaap S. Sinninghe] Netherlands Inst Sea Res, Dept Marine Biogeochem & Toxicol, NL-1790 AB Den Burg, Netherlands; [Wagner, Thomas] Univ Newcastle, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of California System; University of California San Diego; Scripps Institution of Oceanography; Leipzig University; NERC National Oceanography Centre; University of Cologne; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Newcastle University - UK	Bornemann, A (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Geosci Res Div, 9500 Gilman Dr, La Jolla, CA 92093 USA.	a.bornemann@uni-leipzig.de	Bornemann, André/A-4145-2009; Damste, Jaap S Sinninghe/F-6128-2011; Wagner, Thomas/F-8734-2011; Bornemann, André/N-7239-2019	Bornemann, André/0000-0003-4341-2366; Damste, Jaap S Sinninghe/0000-0002-8683-1854; Bornemann, André/0000-0003-4341-2366; Hofmann, Peter/0000-0002-9796-0352; Wagner, Thomas/0000-0001-5006-625X				[Anonymous], 2002, R SOC NZ B; ANTONOV J, 1998, WORLD OCEAN ATLAS 19, V1; Arthur M.A., 1979, DEEP DRILLING RESULT, P375, DOI [10.1029/me003p0375, DOI 10.1029/ME003P0375]; Bice KL, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001203; Bice KL, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000848; Bornemann A, 2007, MAR MICROPALEONTOL, V65, P32, DOI 10.1016/j.marmicro.2007.05.005; Coxall HK, 2005, NATURE, V433, P53, DOI 10.1038/nature03135; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; FAIRBANKS RG, 1978, QUATERNARY RES, V10, P181, DOI 10.1016/0033-5894(78)90100-X; Forster A, 2007, GEOLOGY, V35, P919, DOI 10.1130/G23874A.1; GALE AS, 1996, GEOL SOC SP, P177; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; HANCOCK J M, 1989, Proceedings of the Geologists' Association, V100, P565; HARDENBOL J, 1998, MESOZOIC CENOZOIC SE, V60, P3, DOI DOI 10.2110/PEC.98.02.0003CS; Herman AB, 1996, NATURE, V380, P330, DOI 10.1038/380330a0; Huber BT, 2002, GEOLOGY, V30, P123, DOI 10.1130/0091-7613(2002)030<0123:DSPROE>2.0.CO;2; Huybrechts P, 2000, ANN GLACIOL-SER, V30, P52, DOI 10.3189/172756400781820778; Jarvis I, 2006, GEOL MAG, V143, P561, DOI 10.1017/S0016756806002421; Miller KG, 2005, MAR GEOL, V217, P215, DOI 10.1016/j.margeo.2005.02.007; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Pearson PN, 2001, NATURE, V413, P481, DOI 10.1038/35097000; Sageman BB, 1997, J SEDIMENT RES, V67, P286; Sahagian D, 1996, AAPG BULL, V80, P1433; Schouten S, 2002, EARTH PLANET SC LETT, V204, P265, DOI 10.1016/S0012-821X(02)00979-2; Stoll HM, 2000, GEOL SOC AM BULL, V112, P308, DOI 10.1130/0016-7606(2000)112<308:HSIRFT>2.0.CO;2; tenBrink US, 1997, J GEOPHYS RES-SOL EA, V102, P27603, DOI 10.1029/97JB02483; Voigt S, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001015; Voigt S, 2000, J GEOL SOC LONDON, V157, P737, DOI 10.1144/jgs.157.4.737; Wilson PA, 2002, GEOLOGY, V30, P607, DOI 10.1130/0091-7613(2002)030<0607:TTCGHU>2.0.CO;2; Wuchter C, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001041	30	201	210	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2008	319	5860					189	192		10.1126/science.1148777	http://dx.doi.org/10.1126/science.1148777			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249RC	18187651				2022-12-28	WOS:000252246400037
J	Tavazoie, SF; Alarcon, C; Oskarsson, T; Padua, D; Wang, QQ; Bos, PD; Gerald, WL; Massague, J				Tavazoie, Sohail F.; Alarcon, Claudio; Oskarsson, Thordur; Padua, David; Wang, Qiongqing; Bos, Paula D.; Gerald, William L.; Massague, Joan			Endogenous human microRNAs that suppress breast cancer metastasis	NATURE			English	Article							EXPRESSION PROFILES; CELLS; BETA; DIFFERENTIATION; SIGNATURES; INVASION; TUMORS; GENES; SOX-4; CORE	A search for general regulators of cancer metastasis has yielded a set of microRNAs for which expression is specifically lost as human breast cancer cells develop metastatic potential. Here we show that restoring the expression of these microRNAs in malignant cells suppresses lung and bone metastasis by human cancer cells in vivo. Of these microRNAs, miR- 126 restoration reduces overall tumour growth and proliferation, whereas miR- 335 inhibits metastatic cell invasion. miR- 335 regulates a set of genes whose collective expression in a large cohort of human tumours is associated with risk of distal metastasis. miR- 335 suppresses metastasis and migration through targeting of the progenitor cell transcription factor SOX4 and extracellular matrix component tenascin C. Expression of miR- 126 and miR- 335 is lost in the majority of primary breast tumours from patients who relapse, and the loss of expression of either microRNA is associated with poor distal metastasis- free survival. miR- 335 and miR- 126 are thus identified as metastasis suppressor microRNAs in human breast cancer.	[Tavazoie, Sohail F.; Alarcon, Claudio; Oskarsson, Thordur; Padua, David; Wang, Qiongqing; Bos, Paula D.; Massague, Joan] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Tavazoie, Sohail F.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Gerald, William L.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	massaguj@mskcc.org	Oskarsson, Thordur/HBP-9601-2022; Vickers, Michael M/E-4095-2010	Oskarsson, Thordur/0000-0002-0983-6969; Massague, Joan/0000-0001-9324-8408; Padua, David/0000-0003-2549-9939	NATIONAL CANCER INSTITUTE [P30CA008748, P01CA094060] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA008748, P01 CA094060, P01 CA094060-06A10002] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Chan CS, 2005, PLOS COMPUT BIOL, V1, P564, DOI 10.1371/journal.pcbi.0010069; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Egeblad M, 2007, DEV DYNAM, V236, P1683, DOI 10.1002/dvdy.21159; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; GRAHAM DK, 1995, ONCOGENE, V10, P2349; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hoser M, 2007, J NEUROSCI, V27, P5495, DOI 10.1523/JNEUROSCI.1384-07.2007; Ilunga K, 2004, INT J EXP PATHOL, V85, P373, DOI 10.1111/j.0959-9673.2004.00406.x; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lyu MS, 1996, MAMM GENOME, V7, P501, DOI 10.1007/s003359900151; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Nevins JR, 2007, NAT REV GENET, V8, P601, DOI 10.1038/nrg2137; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Orend G, 2006, CANCER LETT, V244, P143, DOI 10.1016/j.canlet.2006.02.017; Schilham MW, 1997, EUR J IMMUNOL, V27, P1292, DOI 10.1002/eji.1830270534; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; VANDEWETERING M, 1993, EMBO J, V12, P3847, DOI 10.1002/j.1460-2075.1993.tb06063.x; Varadi A, 2005, MOL BIOL CELL, V16, P2670, DOI 10.1091/mbc.e04-11-1001; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670	33	1507	1668	1	221	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2008	451	7175					147	U3		10.1038/nature06487	http://dx.doi.org/10.1038/nature06487			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249GA	18185580	Green Accepted			2022-12-28	WOS:000252214400033
J	McLellan, F; Horton, R; Mullan, Z; Palmer, J				McLellan, Faith; Horton, Richard; Mullan, Zoe; Palmer, Joanna			Introducing The art of medicine	LANCET			English	Editorial Material									[McLellan, Faith; Horton, Richard; Mullan, Zoe; Palmer, Joanna] The Lancet, New York, NY 10010 USA; [McLellan, Faith; Horton, Richard; Mullan, Zoe; Palmer, Joanna] The Lancet, London, England		McLellan, F (corresponding author), The Lancet, New York, NY 10010 USA.			McLellan, Faith/0000-0003-0744-1450					0	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 5	2008	371	9606					14	14		10.1016/S0140-6736(08)60049-5	http://dx.doi.org/10.1016/S0140-6736(08)60049-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248YH	18177761				2022-12-28	WOS:000252192600011
J	Tyrer, P; Oliver-Africano, PC; Ahmed, Z; Bouras, N; Cooray, S; Deb, S; Murphy, D; Hare, M; Meade, M; Reece, B; Kramo, K; Bhaumik, S; Harley, D; Regan, A; Thomas, D; Rao, B; North, B; Eliahoo, J; Karatela, S; Soni, A; Crawford, M				Tyrer, Peter; Oliver-Africano, Patricia C.; Ahmed, Zed; Bouras, Nick; Cooray, Sherva; Deb, Shoumitro; Murphy, Declan; Hare, Monica; Meade, Michael; Reece, Ben; Kramo, Kofi; Bhaumik, Sabyasachi; Harley, David; Regan, Adrienne; Thomas, David; Rao, Bharti; North, Bernard; Eliahoo, Joseph; Karatela, Shamshad; Soni, Anju; Crawford, Mike			Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial	LANCET			English	Article							LEARNING-DISABILITIES; ADULTS; PREVALENCE; PEOPLE; HEALTH; RELIABILITY; DISORDERS; EFFICACY; CHILDREN; SCALE	Background Aggressive challenging behaviour is frequently reported in adults with intellectual disability and it is often treated with antipsychotic drugs. However, no adequate evidence base for this practice exists. We compared flexible doses of haloperidol (a typical, first-generation antipsychotic drug), risperidone (an atypical, second-generation antipsychotic), and placebo, in the treatment of this behaviour. Methods 86 non-psychotic patients presenting with aggressive challenging behaviour from ten centres in England and Wales, and one in Queensland, Australia, were randomly assigned to haloperidol (n=28), risperidone (n=29), or placebo (n=29). Clinical assessments of aggression, aberrant behaviour, quality of life, adverse drug effects, and carer uplift (positive feelings about the care of the disabled person) and burden, together with total costs, were recorded at 4, 12, and 26 weeks. The primary outcome was change in aggression after 4 weeks' treatment, which was recorded with the modified overt aggression scale (MOAS). Analysis was by intention to treat. This study is registered as ISRCTN 11736448. Findings 80 patients had adherence of 80% or more to prescribed drug. Aggression decreased substantially with all three treatments by 4 weeks, with the placebo group showing the greatest change (median decrease in MOAS score after 4 weeks=9 [95% CI 5-14] for placebo, 79% from baseline; 7 [4-14] for risperidone, 58% from baseline; 6.5 [5-14] for haloperidol, 65% from baseline; p=0.06). Furthermore, although no important differences between the treatments were recorded, including adverse effects, patients given placebo showed no evidence at any time points of worse response than did patients assigned to either of the antipsychotic drugs. Interpretation Antipsychotic drugs should no longer be regarded as an acceptable routine treatment for aggressive challenging behaviour in people with intellectual disability.	[Tyrer, Peter; Oliver-Africano, Patricia C.; Meade, Michael; Reece, Ben; Kramo, Kofi; Rao, Bharti; Crawford, Mike] Univ London Imperial Coll Sci Technol & Med, Dept Psychol Med, London W6 8RP, England; [Ahmed, Zed; Hare, Monica] Cardiff Univ, Welsh Ctr Learning Disabil Clin Studies, Cardiff, Wales; [Bouras, Nick] Guys Hosp, Estia Ctr, Inst Psychiat, Kings Coll London,Mental Hlth Learning Disabil Ct, London SE1 9RT, England; [Cooray, Sherva] Cent N W London Fdn NHS Trust, Kingsbury Community Unit, London, England; [Deb, Shoumitro] Univ Birmingham, Queen Elizabeth Psychiat Hosp, Dept Psychiat, Birmingham, W Midlands, England; [Murphy, Declan] Inst Psychiat, Sect Brain Maturat, London, England; [Bhaumik, Sabyasachi] Leicester Frith Hosp, Leicestershire Partnership NHS Trust, Leicester, Leics, England; [Harley, David; Karatela, Shamshad] Univ Queensland, Sch Populat Hlth, QCIDD, Brisbane, Qld, Australia; [Regan, Adrienne] Harrow Primary Care NHS Trust, Stanmore, Middx, England; [Thomas, David] N E London Mental Hlth NHS Trust, Redbridge Learning Disabil Serv, Barkingside, Essex, England; [North, Bernard; Eliahoo, Joseph] Univ London Imperial Coll Sci Technol & Med, Stat Advisory Serv, London, England; [Soni, Anju] W London Mental Hlth NHS Trust, Hammersmith & Fulham Mental Hlth Unit, London, England	Imperial College London; Cardiff University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Birmingham; University of London; King's College London; Leicestershire Partnership NHS Trust; University of Queensland; Imperial College London	Tyrer, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Psychol Med, St Dunstans Rd, London W6 8RP, England.	p.tyrer@imperial.ac.uk	Karatela, Shamshad/G-5086-2018; Harley, David/B-4910-2017; Harley, David O/C-1326-2010	Karatela, Shamshad/0000-0001-7425-7229; Harley, David/0000-0001-6691-5420; Crawford, Mike/0000-0003-3137-5772; Murphy, Declan/0000-0002-6664-7451; Deb, Shoumitro/0000-0002-1300-8103	National Institute for Health Research [01/07/02] Funding Source: researchfish; Department of Health [01/07/02] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		Alexander J, 2004, BRIT J PSYCHIAT, V185, P63, DOI 10.1192/bjp.185.1.63; AMAN MG, 1985, AM J MENT DEF, V89, P485; Ashcroft R, 2001, J MED ETHICS, V27, P338; BAIR HV, 1955, ARCH NEURO PSYCHIATR, V74, P363, DOI 10.1001/archneurpsyc.1955.02330160013003; BEECHAM J, 1995, EC EVALUATION MENTAL, P61; BRANFORD D, 1994, J INTELL DISABIL RES, V38, P577; Brylewski J, 2007, COCHRANE DB SYST REV, V3; Cooper SA, 2007, BRIT J PSYCHIAT, V190, P27, DOI 10.1192/bjp.bp.106.022483; Corbett J. A., 1979, PSYCHIAT ILLNESS MEN, P11; Einfeld SL, 2001, ADV PSYCHIAT TREATME, V7, P43, DOI DOI 10.1192/APT.7.1.43; Gagiano C, 2005, PSYCHOPHARMACOLOGY, V179, P629, DOI 10.1007/s00213-004-2093-2; Guy W, 1976, DHEW PUBLICATION, VADM 76-338, P217; Haessler F, 2007, BRIT J PSYCHIAT, V190, P447, DOI 10.1192/bjp.bp.105.016535; LINAKER OM, 1990, BRIT J PSYCHIAT, V156, P525, DOI 10.1192/bjp.156.4.525; Lingjaerde O, 1987, Acta Psychiatr Scand Suppl, V334, P1; LUND J, 1985, ACTA PSYCHIAT SCAND, V72, P563, DOI 10.1111/j.1600-0447.1985.tb02655.x; McCracken JT, 2002, NEW ENGL J MED, V347, P314, DOI 10.1056/NEJMoa013171; MCGROTHER CW, 2007, LEICESTERSHIRE LEARN; Oliver PC, 2007, J APPL RES INTELLECT, V20, P368, DOI 10.1111/j.1468-3148.2006.00346.x; Prosser H, 1998, J INTELL DISABIL RES, V42, P264, DOI 10.1046/j.1365-2788.1998.00146.x; PRUCHNO RA, 1990, RES AGING, V12, P57, DOI 10.1177/0164027590121003; Qureshi H., 1992, MENT HANDICAP RES, V5, P130, DOI [10.1111/j.1468-3148.1992.tb00041.x, DOI 10.1111/J.1468-3148.1992.TB00041.X]; Robertson J, 2000, J INTELL DISABIL RES, V44, P666, DOI 10.1046/j.1365-2788.2000.00307.x; Schalock R., 1993, QUALITY LIFE QUESTIO; Smith S, 1996, BRIT J PSYCHIAT, V169, P219, DOI 10.1192/bjp.169.2.219; SORGI P, 1991, J NEUROPSYCHIAT, V3, P552; Taylor JL, 2002, J APPL RES INTELLECT, V15, P151, DOI 10.1046/j.1468-3148.2002.00109.x; VANDENBORRE R, 1993, ACTA PSYCHIAT SCAND, V87, P167; Xenitidis KI, 1999, J INTELL DISABIL RES, V43, P128, DOI 10.1046/j.1365-2788.1999.00184.x	29	217	217	0	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 5	2008	371	9606					57	63		10.1016/S0140-6736(08)60072-0	http://dx.doi.org/10.1016/S0140-6736(08)60072-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248YH	18177776				2022-12-28	WOS:000252192600031
J	Malone, JH; Michalak, P				Malone, John H.; Michalak, P.			Physiological sex predicts hybrid sterility regardless of genotype	SCIENCE			English	Article							RULE		[Malone, John H.; Michalak, P.] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA	University of Texas System; University of Texas Arlington	Michalak, P (corresponding author), Univ Texas Arlington, Dept Biol, Box 19498, Arlington, TX 76019 USA.	michalak@uta.edu						Coyne J. A., 2004, SPECIATION, P283; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; KOBEL HR, 1996, BIOL XENOPUS, P391; Malone JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000781; Malone JH, 2006, J MOL EVOL, V63, P427, DOI 10.1007/s00239-005-0263-4; Wu CI, 1996, TRENDS ECOL EVOL, V11, P281, DOI 10.1016/0169-5347(96)10033-1; WU CI, 1993, AM NAT, V142, P187, DOI 10.1086/285534; Zhang Y, 2007, CURR OPIN GENET DEV, V17, P113, DOI 10.1016/j.gde.2007.02.002	8	27	27	2	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2008	319	5859					59	59		10.1126/science.1148231	http://dx.doi.org/10.1126/science.1148231			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18174434				2022-12-28	WOS:000252084000028
J	Sussan, TE; Yang, AN; Li, F; Ostrowski, MC; Reeves, RH				Sussan, Thomas E.; Yang, Annan; Li, Fu; Ostrowski, Michael C.; Reeves, Roger H.			Trisomy represses Apc(Min)-mediated tumours in mouse models of Down's syndrome	NATURE			English	Article							INTESTINAL NEOPLASIA; CANCER INCIDENCE; MAJOR MODIFIER; MORTALITY; GROWTH; GENE; ANGIOGENESIS; LOCUS	Epidemiological studies spanning more than 50 yr reach conflicting conclusions as to whether there is a lower incidence of solid tumours in people with trisomy 21 ( Down's syndrome)(1,2). We used mouse models of Down's syndrome and of cancer in a biological approach to investigate the relationship between trisomy and the incidence of intestinal tumours. Apc(Min)-mediated tumour number was determined in aneuploid mouse models Ts65Dn, Ts1Rhr and Ms1Rhr. Trisomy for orthologues of about half of the genes on chromosome 21 ( Hsa21) in Ts65Dn mice or just 33 of these genes in Ts1Rhr mice resulted in a significant reduction in the number of intestinal tumours. In Ms1Rhr, segmental monosomy for the same 33 genes that are triplicated in Ts1Rhr resulted in an increased number of tumours. Further studies demonstrated that the Ets2 gene contributed most of the dosage- sensitive effect on intestinal tumour number. The action of Ets2 as a repressor when it is overexpressed differs from tumour suppression, which requires normal gene function to prevent cellular transformation. Upregulation of Ets2 and, potentially, other genes involved in this kind of protective effect may provide a prophylactic effect in all individuals, regardless of ploidy.	[Sussan, Thomas E.; Yang, Annan; Reeves, Roger H.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Sussan, Thomas E.; Yang, Annan; Reeves, Roger H.] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; [Li, Fu; Ostrowski, Michael C.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	Johns Hopkins University; Johns Hopkins University; University System of Ohio; Ohio State University	Reeves, RH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	rreeves@jhmi.edu	Li, Fu/E-7072-2011; Ostrowski, Michael/H-3108-2011	Sussan, Thomas/0000-0002-5240-4299; Ostrowski, Michael/0000-0003-2948-6297	NCI NIH HHS [P01 CA097189, R01 CA053271] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA053271, P01CA097189] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Day SM, 2005, DEV MED CHILD NEUROL, V47, P171, DOI 10.1017/S0012162205000319; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; Gardiner K, 2003, GENE, V318, P137, DOI 10.1016/S0378-1119(03)00769-8; Goldacre MJ, 2004, ARCH DIS CHILD, V89, P1014, DOI 10.1136/adc.2003.046219; Hill DA, 2003, ARCH INTERN MED, V163, P705, DOI 10.1001/archinte.163.6.705; Hsu T, 2004, J CELL BIOCHEM, V91, P896, DOI 10.1002/jcb.20012; *JACKS LAB, GEN PROT APC; MACPHEE M, 1995, CELL, V81, P957, DOI 10.1016/0092-8674(95)90015-2; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; Moore DS, 2005, AM STAT, V59, P1, DOI 10.1198/000313005X20745; Olson LE, 2004, SCIENCE, V306, P687, DOI 10.1126/science.1098992; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Patja K, 2006, INT J CANCER, V118, P1769, DOI 10.1002/ijc.21518; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Roberts RB, 2002, P NATL ACAD SCI USA, V99, P1521, DOI 10.1073/pnas.032678499; Satge D, 1998, AM J MED GENET, V78, P207, DOI 10.1002/(SICI)1096-8628(19980707)78:3<207::AID-AJMG1>3.3.CO;2-Q; Smith JL, 2000, MOL CELL BIOL, V20, P8026, DOI 10.1128/MCB.20.21.8026-8034.2000; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Wolvetang EJ, 2003, NEUROBIOL DIS, V14, P349, DOI 10.1016/S0969-9961(03)00107-4; Yamada Y, 2007, CANCER SCI, V98, P6, DOI 10.1111/j.1349-7006.2006.00348.x; Yang QH, 2002, LANCET, V359, P1019, DOI 10.1016/S0140-6736(02)08092-3	21	125	131	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2008	451	7174					73	U10		10.1038/nature06446	http://dx.doi.org/10.1038/nature06446			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247KZ	18172498				2022-12-28	WOS:000252079300036
J	Pletcher, MJ; Kertesz, SG; Kohn, MA; Gonzales, R				Pletcher, Mark J.; Kertesz, Stefan G.; Kohn, Michael A.; Gonzales, Ralph			Trends in opioid prescribing by race/ethnicity for patients seeking care in US emergency departments	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEDICAL-CARE; CANCER PAIN; NONMEDICAL USE; DISPARITIES; ETHNICITY; ANALGESIA; PRESCRIPTION; PHYSICIAN; RACE; FRACTURES	Context National quality improvement initiatives implemented in the late 1990s were followed by substantial increases in opioid prescribing in the United States, but it is unknown whether opioid prescribing for treatment of pain in the emergency department has increased and whether differences in opioid prescribing by race/ethnicity have decreased. Objectives To determine Whether opioid prescribing in emergency departments has increased, whether non-Hispanic white patients are more likely to receive an opioid than other racial/ethnic groups, and whether differential prescribing by race/ethnicity has diminished since 2000. Design and Setting Pain-related visits to US emergency departments were identified using reason-for-visit and physician diagnosis codes from 13 years (1993-2005) of the National Hospital Ambulatory Medical Care Survey. Main Outcome Measure Prescription of an opioid analgesic. Results Pain-related visits accounted for 156729 of 374891 (42%) emergency department visits. Opioid prescribing for pain- related visits increased from 23 % (95 % confidence interval [Cl], 21%-24%) in 1993 to 37% (95% Cl, 34%-39%) in 2005 (P<.001 for trend), and this trend was more pronounced in 2001-2005 (P=.02). Overall years, white patients with pain were more likely to receive an opioid (31 %)than black (23%), Hispanic (24%), or Asian/other patients (28%) (P<.001 for trend), and differences did not diminish over time (P=.44), with opioid prescribing rates of 40% for white patients and 32 % for all other patients in 2005. Differential prescribing by race/ethnicity was evident for all types of pain visits, was more pronounced with increasing pain severity, and was detectable for long-bone fracture and nephrolithiasis as well as among children. Statistical adjustment for pain severity and other factors did not substantially attenuate these differences, with white patients remaining significantly more likely to receive an opioid prescription than black patients (adjusted odds ratio, 0.66; 95% Cl, 0.62-0.70), Hispanic patients (0.67; 95% Cl, 0.63-0.72), and Asian/other patients (0.79; 95% Cl, 0.67-0.93). Conclusion Opioid prescribing for patients making a pain-related visit to the emergency department increased after national quality improvement initiatives in the late 1990s, but differences in opioid prescribing by race/ethnicity have not diminished.	[Pletcher, Mark J.; Kohn, Michael A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94107 USA; [Pletcher, Mark J.; Gonzales, Ralph] Univ Calif San Francisco, Dept Med, Div Gen Internal Med, San Francisco, CA 94107 USA; [Kertesz, Stefan G.] Univ Alabama, Div Prevent Med, Birmingham, AL USA; [Kertesz, Stefan G.] Vet Affairs Med Ctr, Deep S Ctr Effectiveness, Birmingham, AL USA; [Kohn, Michael A.] Mills Peninsula Med Ctr, Emergency Dept, Burlingame, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Pletcher, MJ (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, 185 Berry St,Ste 5700, San Francisco, CA 94107 USA.	mpletcher@epi.ucsf.edu		Kertesz, Stefan/0000-0001-6101-8421	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R03HS016238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K23DA015487] Funding Source: NIH RePORTER; AHRQ HHS [R03 HS016238] Funding Source: Medline; NIDA NIH HHS [K23DA015487] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Betancourt JR, 2004, NEW ENGL J MED, V351, P953, DOI 10.1056/NEJMp048033; Campana D, 2004, INT J MULTIPHAS FLOW, V30, P431, DOI 10.1016/j.ijmultiphaseflow.2004.03.007; Choi DMA, 2000, BRIT MED J, V320, P980, DOI 10.1136/bmj.320.7240.980; Cooper LA, 2006, J GEN INTERN MED, V21, pS21, DOI 10.1111/j.1525-1497.2006.00305.x; Epstein AM, 2001, NEW ENGL J MED, V344, P1471, DOI 10.1056/NEJM200105103441911; FRIEDLAND LR, 1994, ANN EMERG MED, V23, P203, DOI 10.1016/S0196-0644(94)70031-1; Fry Margaret, 2002, Emerg Med (Fremantle), V14, P249, DOI 10.1046/j.1442-2026.2002.00339.x; Fry Margaret, 2004, Accid Emerg Nurs, V12, P136, DOI 10.1016/j.aaen.2004.02.006; Fuentes EF, 2002, ACAD EMERG MED, V9, P910, DOI 10.1197/aemj.9.9.910; Heins Alan, 2006, J Opioid Manag, V2, P335; Heins JK, 2006, J EMERG NURS, V32, P219, DOI 10.1016/j.jen.2006.01.010; Hostetler MA, 2002, AM J EMERG MED, V20, P139, DOI 10.1053/ajem.2002.33002; Kalauokalani D, 2007, PAIN MED, V8, P17, DOI 10.1111/j.1526-4637.2007.00170.x; Karpman RR, 1997, CLIN ORTHOP RELAT R, P270; Lanser P, 2001, Healthc Benchmarks, V8, P68; Lanser P, 2001, HEALTHC BENCHMARKS, V8, P62; Lee WW, 2001, AM J EMERG MED, V19, P549, DOI 10.1053/ajem.2001.28038; MAX MB, 1995, JAMA-J AM MED ASSOC, V274, P1874, DOI 10.1001/jama.1995.03530230060032; Miner J, 2006, ACAD EMERG MED, V13, P140, DOI 10.1197/j.aem.2005.08.008; Rupp T, 2004, ANN EMERG MED, V43, P494, DOI 10.1016/j.annemergmed.2003.11.019; Schneider D, 1979, VITAL HLTH STAT, V2, pi; Sehgal AR, 2003, JAMA-J AM MED ASSOC, V289, P996, DOI 10.1001/jama.289.8.996; Simoni-Wastila L, 2004, SUBST USE MISUSE, V39, P1, DOI 10.1081/JA-120027764; Singer AJ, 2002, J BURN CARE REHABIL, V23, P361, DOI 10.1097/00004630-200211000-00001; Tamayo-Sarver JH, 2003, AM J PUBLIC HEALTH, V93, P2067, DOI 10.2105/AJPH.93.12.2067; Tamayo-Sarver JH, 2004, ANN EMERG MED, V43, P483, DOI 10.1016/j.annemergmed.2003.10.043; Tamayo-Sarver JH, 2003, ACAD EMERG MED, V10, P1239, DOI 10.1197/S1069-6563903)00494-9; Todd KH, 2000, ANN EMERG MED, V35, P11, DOI 10.1016/S0196-0644(00)70099-0; TODD KH, 1994, JAMA-J AM MED ASSOC, V271, P925, DOI 10.1001/jama.271.12.925; Todd KH, 2007, J PAIN, V8, P460, DOI 10.1016/j.jpain.2006.12.005; Vallerand AH, 2005, PAIN MED, V6, P242, DOI 10.1111/j.1526-4637.2005.05038.x; Walls CA, 2002, ACAD EMERG MED, V9, P1140, DOI 10.1111/j.1553-2712.2002.tb01568.x; Yen K, 2003, ANN EMERG MED, V42, P41, DOI 10.1067/mem.2003.230; Zacny J, 2003, DRUG ALCOHOL DEPEN, V69, P215, DOI 10.1016/S0376-8716(03)00003-6; Zechnich AD, 1996, ACAD EMERG MED, V3, P312, DOI 10.1111/j.1553-2712.1996.tb03443.x	35	556	557	0	32	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2008	299	1					70	78		10.1001/jama.2007.64	http://dx.doi.org/10.1001/jama.2007.64			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247BL	18167408	Bronze			2022-12-28	WOS:000252052000018
J	Dixit, R; Ross, JL; Goldman, YE; Holzbaur, ELF				Dixit, Ram; Ross, Jennifer L.; Goldman, Yale E.; Holzbaur, Erika L. F.			Differential regulation of dynein and kinesin motor proteins by tau	SCIENCE			English	Article							CYTOPLASMIC DYNEIN; ALZHEIMERS-DISEASE; MICROTUBULES; TRANSPORT; NEURODEGENERATION; VESICLES	Dynein and kinesin motor proteins transport cellular cargoes toward opposite ends of microtubule tracks. In neurons, microtubules are abundantly decorated with microtubule- associated proteins ( MAPs) such as tau. Motor proteins thus encounter MAPs frequently along their path. To determine the effects of tau on dynein and kinesin motility, we conducted single- molecule studies of motor proteins moving along tau- decorated microtubules. Dynein tended to reverse direction, whereas kinesin tended to detach at patches of bound tau. Kinesin was inhibited at about a tenth of the tau concentration that inhibited dynein, and the microtubule- binding domain of tau was sufficient to inhibit motor activity. The differential modulation of dynein and kinesin motility suggests that MAPs can spatially regulate the balance of microtubule- dependent axonal transport.	[Dixit, Ram; Ross, Jennifer L.; Goldman, Yale E.; Holzbaur, Erika L. F.] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Dixit, Ram; Ross, Jennifer L.; Goldman, Yale E.; Holzbaur, Erika L. F.] Univ Penn, Penn Muscle Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Holzbaur, ELF (corresponding author), Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA.	holzbaur@mail.med.upenn.edu	Ross, Jennifer L/D-7208-2012	Ross, Jennifer L/0000-0002-4838-3798	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR051174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048661] Funding Source: NIH RePORTER; NIAMS NIH HHS [P01 AR051174, P01 AR051174-050002, P01-AR-051174] Funding Source: Medline; NIGMS NIH HHS [R01 GM048661, GM-48661, R01 GM048661-16] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ackmann M, 2000, J BIOL CHEM, V275, P30335, DOI 10.1074/jbc.M002590200; Andreadis A, 2006, PROG MOLEC, V44, P89; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Black MM, 1996, J NEUROSCI, V16, P3601; BRAAK H, 1994, ACTA NEUROPATHOL, V87, P554; Chevalier-Larsen E, 2006, BBA-MOL BASIS DIS, V1762, P1094, DOI 10.1016/j.bbadis.2006.04.002; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Kempf M, 1996, J NEUROSCI, V16, P5583; KHATOON S, 1992, J NEUROCHEM, V59, P750, DOI 10.1111/j.1471-4159.1992.tb09432.x; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Konzack S, 2007, J NEUROSCI, V27, P9916, DOI 10.1523/JNEUROSCI.0927-07.2007; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Seitz A, 2002, EMBO J, V21, P4896, DOI 10.1093/emboj/cdf503; Trinczek B, 1999, J CELL SCI, V112, P2355; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; Vershinin M, 2007, P NATL ACAD SCI USA, V104, P87, DOI 10.1073/pnas.0607919104; Wang ZH, 1999, CELL STRUCT FUNCT, V24, P373, DOI 10.1247/csf.24.373	20	684	706	1	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2008	319	5866					1086	1089		10.1126/science.1152993	http://dx.doi.org/10.1126/science.1152993			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264SW	18202255	Green Accepted			2022-12-28	WOS:000253311700042
J	Dial, KP; Jackson, BE; Segre, P				Dial, Kenneth P.; Jackson, Brandon E.; Segre, Paolo			A fundamental avian wing-stroke provides a new perspective on the evolution of flight	NATURE			English	Article							MANEUVERING FLIGHT; WIDE-RANGE; ORIGIN; AERODYNAMICS; KINEMATICS; BIRDS	The evolution of avian flight remains one of biology's major controversies, with a long history of functional interpretations of fossil forms given as evidence for either an arboreal or cursorial origin of flight. Despite repeated emphasis on the 'wing-stroke' as a necessary avenue of investigation for addressing the evolution of flight(1-4), no empirical data exist on wing-stroke dynamics in an experimental evolutionary context. Here we present the first comparison of wing-stroke kinematics of the primary locomotor modes (descending flight and incline flap- running) that lead to level- flapping flight in juvenile ground birds throughout development (Fig. 1). We offer results that are contrary both to popular perception and inferences from other studies(5-7). Starting shortly after hatching and continuing through adulthood, ground birds use a wing- stroke confined to a narrow range of less than 20 degrees, when referenced to gravity, that directs aerodynamic forces about 40 degrees above horizontal, permitting a 180 degrees range in the direction of travel. Based on our results, we put forth an ontogenetic- transitional wing hypothesis that posits that the incremental adaptive stages leading to the evolution of avian flight correspond behaviourally and morphologically to transitional stages observed in ontogenetic forms.	[Dial, Kenneth P.; Jackson, Brandon E.; Segre, Paolo] Univ Montana, Div Biol Sci, Flight Lab, Missoula, MT 59812 USA	University of Montana System; University of Montana	Dial, KP (corresponding author), Univ Montana, Div Biol Sci, Flight Lab, 32 Campus Dr, Missoula, MT 59812 USA.	kdial@mso.umt.edu	Jackson, Brandon/H-3869-2012; Segre, Paolo/A-7865-2011					Bundle MW, 2003, J EXP BIOL, V206, P4553, DOI 10.1242/jeb.00673; Dial KP, 2006, BIOSCIENCE, V56, P437, DOI 10.1641/0006-3568(2006)056[0437:WUIHAW]2.0.CO;2; Dial KP, 2003, SCIENCE, V299, P402, DOI 10.1126/science.1078237; FEDUCCIA A, 1979, SCIENCE, V203, P1021, DOI 10.1126/science.203.4384.1021; Garner JP, 1999, P ROY SOC B-BIOL SCI, V266, P1259, DOI 10.1098/rspb.1999.0772; Gatesy SM, 2005, PALEOBIOLOGY, V31, P382, DOI 10.1666/0094-8373(2005)031[0382:TOOTAF]2.0.CO;2; Gauthier J., 1985, P185; Hedrick TL, 2007, J EXP BIOL, V210, P1897, DOI 10.1242/jeb.002055; Hedrick TL, 2002, J EXP BIOL, V205, P1389; JENKINS FA, 1993, AM J SCI, V293A, P253, DOI 10.2475/ajs.293.A.253; Jones TD, 2000, NATURE, V406, P716, DOI 10.1038/35021041; Norberg U.M., 1985, P293; Ostrom J.H., 1976, Smithsonian Contributions to Paleobiology, VNo. 27, P1; PADIAN K, 1985, PALAEONTOLOGY, V28, P413; Padian K, 2005, NATURE, V438, pE3, DOI 10.1038/nature04354; Padian K, 1998, SCI AM, V278, P38, DOI 10.1038/scientificamerican0298-38; Park KJ, 2001, J EXP BIOL, V204, P2741; SPEAKMAN JR, 1995, NATURE, V374, P221, DOI 10.1038/374221b0; Tobalske BW, 2007, J EXP BIOL, V210, P1742, DOI 10.1242/jeb.001701; Tobalske BW, 1996, J EXP BIOL, V199, P263; Warrick DR, 1998, J EXP BIOL, V201, P655; Witmer Lawrence M., 2002, P3; Xu X, 2004, NATURE, V431, P680, DOI 10.1038/nature02855; [No title captured]; [No title captured]	25	67	69	2	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2008	451	7181					985	U3		10.1038/nature06517	http://dx.doi.org/10.1038/nature06517			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264TK	18216784	Green Published			2022-12-28	WOS:000253313100047
J	Rauch, A; Thiel, CT; Schindler, D; Wick, U; Crow, YJ; Ekici, AB; van Essen, AJ; Goecke, TO; Al-Gazali, L; Chrzanowska, KH; Zweier, C; Brunner, HG; Becker, K; Curry, CJ; Dallapiccola, B; Devriendt, K; Dorfler, A; Kinning, E; Megarbane, A; Meinecke, P; Semple, RK; Spranger, S; Toutain, A; Trembath, RC; Voss, E; Wilson, L; Hennekam, R; de Zegher, F; Dorr, HG; Reis, A				Rauch, Anita; Thiel, Christian T.; Schindler, Detlev; Wick, Ursula; Crow, Yanick J.; Ekici, Arif B.; van Essen, Anthonie J.; Goecke, Timm O.; Al-Gazali, Lihadh; Chrzanowska, Krystyna H.; Zweier, Christiane; Brunner, Han G.; Becker, Kristin; Curry, Cynthia J.; Dallapiccola, Bruno; Devriendt, Koenraad; Doerfler, Arnd; Kinning, Esther; Megarbane, Andre; Meinecke, Peter; Semple, Robert K.; Spranger, Stephanie; Toutain, Annick; Trembath, Richard C.; Voss, Egbert; Wilson, Louise; Hennekam, Raoul; de Zegher, Francis; Doerr, Helmuth-Guenther; Reis, Andre			Mutations in the pericentrin (PCNT) gene cause primordial dwarfism	SCIENCE			English	Article							II MOPD-II; CALMODULIN-BINDING PROTEIN; HOMO-FLORESIENSIS; CLINICAL REPORT; BRAIN; ANEUPLOIDY; HOMININ; STROKE; LB1	Fundamental processes influencing human growth can be revealed by studying extreme short stature. Using genetic linkage analysis, we find that biallelic loss- of- function mutations in the centrosomal pericentrin ( PCNT) gene on chromosome 21q22.3 cause microcephalic osteodysplastic primordial dwarfism type II ( MOPD II) in 25 patients. Adults with this rare inherited condition have an average height of 100 centimeters and a brain size comparable to that of a 3- month- old baby, but are of near- normal intelligence. Absence of PCNT results in disorganized mitotic spindles and missegregation of chromosomes. Mutations in related genes are known to cause primary microcephaly ( MCPH1, CDK5RAP2, ASPM, and CENPJ).	[Rauch, Anita; Thiel, Christian T.; Wick, Ursula; Ekici, Arif B.; Zweier, Christiane; Reis, Andre] Univ Erlangen Nurnberg, Inst Human Genet, Univ Hosp Erlangen, D-8520 Erlangen, Germany; [Schindler, Detlev] Univ Wurzburg, Dept Human Genet, D-8700 Wurzburg, Germany; [Crow, Yanick J.] St James Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [van Essen, Anthonie J.] Univ Groningen, Dept Genet, Univ Med Ctr Groningen, Groningen, Netherlands; [Goecke, Timm O.] Univ Dusseldorf, Inst Humangenet & Anthropol, Dusseldorf, Germany; [Al-Gazali, Lihadh] United Arab Emirates Univ, Fac Med, Al Ain, U Arab Emirates; [Chrzanowska, Krystyna H.] Childrens Mem Hlth Inst, Dept Med Genet, Warsaw, Poland; [Brunner, Han G.] Radboud Univ Nijmegen, Dept Human Genet, Nijmegen Ctr Mol Life Sci, Nijmegen Med Ctr, Nijmegen, Netherlands; [Becker, Kristin] Glan Clwyd Gen Hosp, N Wales Clin Genet Serv, Rhyl, Wales; [Becker, Kristin] Univ Wales Hosp, Inst Med Genet, Cardiff, Wales; [Curry, Cynthia J.] Genet Med Cent Calif, Fresno, CA USA; [Curry, Cynthia J.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Dallapiccola, Bruno] San Giovanni Rotondo & CSS Mendel Inst, IRCCS, Rome, Italy; [Dallapiccola, Bruno] Univ Roma La Sapienza, Dept Expt Med & Pathol, Rome, Italy; [Devriendt, Koenraad] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; [Doerfler, Arnd] Univ Erlangen Nurnberg, Dept Neuroradiol, Univ Hosp Erlangen, Erlangen, Germany; [Kinning, Esther] Leicester Royal Infirm, Dept Clin Genet, Leicester, Leics, England; [Megarbane, Andre] Univ St Joseph, Unite Genet Med, Fac Med, Beirut, Lebanon; [Meinecke, Peter] Altonaer Kinderkrankenhaus, Abt Med Genet, Hamburg, Germany; [Semple, Robert K.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 2QQ, England; [Spranger, Stephanie] Praxis Humangenet, Bremen, Germany; [Toutain, Annick] Bretonneau Univ Hosp, Dept Genet, Tours, France; [Trembath, Richard C.] Kings Coll London, Dept Med & Mol Genet, Sch Med, London WC2R 2LS, England; [Voss, Egbert] Cnopfs Pediat Hosp, Nurnberg, Germany; [Wilson, Louise; Hennekam, Raoul] Great Ormond St Hosp Sick Children, Dept Clin Genet, London WC1N 3JH, England; [Hennekam, Raoul] UCL, Inst Child Hlth, Clin & Mol Genet Unit, London, England; [Hennekam, Raoul] Univ Amsterdam, Dept Paediat, Amsterdam, Netherlands; [de Zegher, Francis] Katholieke Univ Leuven, Dept Woman & Child, Louvain, Belgium; [Doerr, Helmuth-Guenther] Univ Erlangen Nurnberg, Dept Pediat & Adolescent Med, Erlangen, Germany	University of Erlangen Nuremberg; University of Wurzburg; Saint James's University Hospital; University of Leeds; University of Groningen; Heinrich Heine University Dusseldorf; United Arab Emirates University; Children's Memorial Health Institute; Radboud University Nijmegen; Cardiff University; University of California System; University of California San Francisco; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; Sapienza University Rome; KU Leuven; University of Erlangen Nuremberg; University of Leicester; Saint Joseph University Beirut; University of Hamburg; University Medical Center Hamburg-Eppendorf; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; CHU Tours; University of London; King's College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of Amsterdam; KU Leuven; University of Erlangen Nuremberg	Rauch, A (corresponding author), Univ Erlangen Nurnberg, Inst Human Genet, Univ Hosp Erlangen, D-8520 Erlangen, Germany.	Anita.Rauch@humgenet.uni-erlangen.de	Zweier, Christiane/F-2202-2015; O'Rahilly, Stephen/ABF-6509-2020; Crow, Yanick J/N-6120-2014; Rauch, Anita/C-5568-2014; Megarbane, Andre/ABD-5574-2021; Brunner, Han/C-9928-2013; Semple, Robert/AAB-2948-2019; Thiel, Christian T/H-8964-2012; Ekici, Arif B/C-3971-2013; Reis, André/D-2309-2009; Dallapiccola, Bruno/K-8692-2016	Zweier, Christiane/0000-0001-8002-2020; O'Rahilly, Stephen/0000-0003-2199-4449; Crow, Yanick J/0000-0001-7211-7564; Rauch, Anita/0000-0003-2930-3163; Thiel, Christian T/0000-0003-3817-7277; Ekici, Arif B/0000-0001-6099-7066; Reis, André/0000-0002-6301-6363; Semple, Robert Kenneth/0000-0001-6539-3069; Trembath, Richard/0000-0003-0550-3400; Chrzanowska, Krystyna/0000-0003-3888-0624; Toutain, Annick/0000-0002-5999-5300; Dallapiccola, Bruno/0000-0002-5031-1013	Wellcome Trust [062346/Z/00/Z, 080952/Z/06/Z] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Argue D, 2006, J HUM EVOL, V51, P360, DOI 10.1016/j.jhevol.2006.04.013; Brancati F, 2005, AM J MED GENET A, V139A, P212, DOI 10.1002/ajmg.a.31009; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Culotta E, 2007, SCIENCE, V317, P740, DOI 10.1126/science.317.5839.740; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Falk D, 2006, SCIENCE, V312, DOI 10.1126/science.1124972; Falk D, 2005, SCIENCE, V310, DOI 10.1126/science.1117062; Falk D, 2005, SCIENCE, V308, P242, DOI 10.1126/science.1109727; Falk D, 2007, P NATL ACAD SCI USA, V104, P2513, DOI 10.1073/pnas.0609185104; Flory MR, 2000, P NATL ACAD SCI USA, V97, P5919, DOI 10.1073/pnas.97.11.5919; Hall JG, 2006, AM J MED GENET A, V140A, P1356, DOI 10.1002/ajmg.a.31301; Hall JG, 2004, AM J MED GENET A, V130A, P55, DOI 10.1002/ajmg.a.30203; Hall MN, 2004, CELL GROWTH CONTROL; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; MAJEWSKI F, 1982, AM J MED GENET, V12, P23, DOI 10.1002/ajmg.1320120104; Martin RD, 2006, SCIENCE, V312, DOI 10.1126/science.1121144; Martin RD, 2006, ANAT REC PART A, V288A, P1123, DOI 10.1002/ar.a.20389; Muller H, 2006, SCIENCE, V314, P654, DOI 10.1126/science.1132834; Richards GD, 2006, J EVOLUTION BIOL, V19, P1744, DOI 10.1111/j.1420-9101.2006.01179.x; Stirling DA, 1996, J CELL SCI, V109, P1297; Stirling DA, 2000, BBA-MOL CELL RES, V1499, P85, DOI 10.1016/S0167-4889(00)00110-5; Takahashi M, 2002, MOL BIOL CELL, V13, P3235, DOI 10.1091/mbc.E02-02-0112; Tocheri MW, 2007, SCIENCE, V317, P1743, DOI 10.1126/science.1147143; Weber J, 2005, SCIENCE, V310, DOI 10.1126/science.1114789; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	27	290	298	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2008	319	5864					816	819		10.1126/science.1151174	http://dx.doi.org/10.1126/science.1151174			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18174396				2022-12-28	WOS:000252963000063
J	Greenleaf, WJ; Frieda, KL; Foster, DAN; Woodside, MT; Block, SM				Greenleaf, William J.; Frieda, Kirsten L.; Foster, Daniel A. N.; Woodside, Michael T.; Block, Steven M.			Direct observation of hierarchical folding in single riboswitch aptamers	SCIENCE			English	Article							ADENINE-SENSING RIBOSWITCH; GENE-EXPRESSION; LIGAND-BINDING; NUCLEIC-ACID; INDUCED FIT; KINETICS; RNA; TRANSCRIPTION; EQUALITY; DOMAIN	Riboswitches regulate genes through structural changes in ligand- binding RNA aptamers. With the use of an optical- trapping assay based on in situ transcription by a molecule of RNA polymerase, single nascent RNAs containing pbuE adenine riboswitch aptamers were unfolded and refolded. Multiple folding states were characterized by means of both force- extension curves and folding trajectories under constant force by measuring the molecular contour length, kinetics, and energetics with and without adenine. Distinct folding steps correlated with the formation of key secondary or tertiary structures and with ligand binding. Adenine- induced stabilization of the weakest helix in the aptamer, the mechanical switch underlying regulatory action, was observed directly. These results provide an integrated view of hierarchical folding in an aptamer, demonstrating how complex folding can be resolved into constituent parts, and supply further insights into tertiary structure formation.	[Foster, Daniel A. N.; Woodside, Michael T.] Univ Alberta, Dept Phys, Edmonton, AB T6G 2G7, Canada; [Greenleaf, William J.; Block, Steven M.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Frieda, Kirsten L.] Stanford Univ, Biophys Program, Stanford, CA 94305 USA; [Block, Steven M.] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Woodside, Michael T.] Natl Res Council Canada, Natl Inst Nanotechnol, Edmonton, AB T6G 2M9, Canada	University of Alberta; Stanford University; Stanford University; Stanford University; National Research Council Canada	Woodside, MT (corresponding author), Univ Alberta, Dept Phys, Edmonton, AB T6G 2G7, Canada.	michael.woodside@nrc.ca; sblock@stanford.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM057035, R01GM057035, P01GM066275] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM057035, GM057035, R01 GM057035-12, GM066275] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Coppins RL, 2007, CURR OPIN MICROBIOL, V10, P176, DOI 10.1016/j.mib.2007.03.006; Dalal RV, 2006, MOL CELL, V23, P231, DOI 10.1016/j.molcel.2006.06.023; Dudko OK, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.108101; Gilbert SD, 2006, J MOL BIOL, V359, P754, DOI 10.1016/j.jmb.2006.04.003; Greenleaf WJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.208102; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Lemay JF, 2006, CHEM BIOL, V13, P857, DOI 10.1016/j.chembiol.2006.06.010; Li PTX, 2006, P NATL ACAD SCI USA, V103, P15847, DOI 10.1073/pnas.0607202103; Liphardt J, 2002, SCIENCE, V296, P1832, DOI 10.1126/science.1071152; Mandal M, 2004, NAT STRUCT MOL BIOL, V11, P29, DOI 10.1038/nsmb710; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; Noeske J, 2005, P NATL ACAD SCI USA, V102, P1372, DOI 10.1073/pnas.0406347102; Noeske J, 2007, NUCLEIC ACIDS RES, V35, P572, DOI 10.1093/nar/gkl1094; Onoa B, 2003, SCIENCE, V299, P1892, DOI 10.1126/science.1081338; Ottink OM, 2007, RNA, V13, P2202, DOI 10.1261/rna.635307; Saenger W., 1984, PRINCIPLES NUCL ACID; Seol Y, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.118102; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Tinoco I, 2002, BIOPHYS CHEM, V101, P513, DOI 10.1016/S0301-4622(02)00177-1; Wickiser JK, 2005, MOL CELL, V18, P49, DOI 10.1016/j.molcel.2005.02.032; Wickiser JK, 2005, BIOCHEMISTRY-US, V44, P13404, DOI 10.1021/bi051008u; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Woodside MT, 2006, SCIENCE, V314, P1001, DOI 10.1126/science.1133601; Woodside MT, 2006, P NATL ACAD SCI USA, V103, P6190, DOI 10.1073/pnas.0511048103	27	313	317	4	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2008	319	5863					630	633		10.1126/science.1151298	http://dx.doi.org/10.1126/science.1151298			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	257AQ	18174398	Green Accepted			2022-12-28	WOS:000252772000044
J	Gawande, A; Denno, DW; Truog, RD; Waisel, D				Gawande, Atul; Denno, Deborah W.; Truog, Robert D.; Waisel, David			Perspective roundtable: Physicians and execution - Highlights from a discussion of lethal injection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gawande, Atul; Truog, Robert D.; Waisel, David] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Gawande, Atul] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Gawande, Atul] Brigham & Womens Hosp, Boston, MA 02115 USA; [Denno, Deborah W.] Fordham Univ, Sch Law, Bronx, NY 10458 USA	Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Fordham University	Gawande, A (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.			Waisel, David/0000-0002-5307-4092; Gawande, Atul/0000-0002-1824-9176					0	17	17	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2008	358	5					448	451		10.1056/NEJMp0800378	http://dx.doi.org/10.1056/NEJMp0800378			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	256IW	18216349				2022-12-28	WOS:000252722900002
J	Burgert, R; Schnockel, H; Grubisic, A; Li, X; Stokes, ST; Bowen, KH; Gantefor, GF; Kiran, B; Jena, P				Burgert, R.; Schnoeckel, H.; Grubisic, A.; Li, X.; Stokes, S. T.; Bowen, K. H.; Gantefor, G. F.; Kiran, B.; Jena, P.			Spin conservation accounts for aluminum cluster anion reactivity pattern with O-2	SCIENCE			English	Article							SIMPLE METAL-CLUSTERS; OXYGEN; OXIDATION; PHYSICS; MODEL; IONS	The reactivity pattern of small (similar to 10 to 20 atoms) anionic aluminum clusters with oxygen has posed a long- standing puzzle. Those clusters with an odd number of atoms tend to react much more slowly than their even- numbered counterparts. We used Fourier transform ion cyclotron resonance mass spectrometry to show that spin conservation straightforwardly accounts for this trend. The reaction rate of odd- numbered clusters increased appreciably when singlet oxygen was used in place of ground- state ( triplet) oxygen. Conversely, monohydride clusters AlnH-, in which addition of the hydrogen atom shifts the spin state by converting formerly open- shell structures to closed- shell ones ( and vice versa), exhibited an opposing trend: The odd- n hydride clusters reacted more rapidly with triplet oxygen. These findings are supported by theoretical simulations and highlight the general importance of spin selection rules in mediating cluster reactivity.	[Burgert, R.; Schnoeckel, H.] Univ Karlsruhe, Inst Inorgan Chem, D-76128 Karlsruhe, Germany; [Grubisic, A.; Li, X.; Stokes, S. T.; Bowen, K. H.] Johns Hopkins Univ, Dept Chem, Baltimore, MD 21218 USA; [Grubisic, A.; Li, X.; Stokes, S. T.; Bowen, K. H.] Johns Hopkins Univ, Dept Mat Sci, Baltimore, MD 21218 USA; [Gantefor, G. F.] Univ Konstanz, Dept Phys, D-78457 Constance, Germany; [Kiran, B.] McNeese State Univ, Dept Chem, Lake Charles, LA 70605 USA; [Jena, P.] Virginia Commonwealth Univ, Dept Phys, Richmond, VA 23284 USA	Helmholtz Association; Karlsruhe Institute of Technology; Johns Hopkins University; Johns Hopkins University; University of Konstanz; University of Louisiana System; McNeese State University; Virginia Commonwealth University	Schnockel, H (corresponding author), Univ Karlsruhe, Inst Inorgan Chem, Kaiserstr 12, D-76128 Karlsruhe, Germany.	schnoeckel@chemie.uni-karlsruhe.de	Li, Xuelong/Z-3785-2019; Li, Xiang/F-4539-2012; Ganteför, Gerd/AAU-2721-2021; Grubisic, Andrej/P-2717-2014; Li, Xiang/G-3886-2011; Li, Xuelong/ABF-3381-2020; li, xiang/GWM-6319-2022	Ganteför, Gerd/0000-0003-4591-6381; Grubisic, Andrej/0000-0001-8236-0007; Jena, Purusottam/0000-0002-2316-859X				ADAM W, 1981, CHEM UNSERER ZEIT, V15, P190, DOI 10.1002/ciuz.19810150604; Ahlrichs R, 1999, PHYS CHEM CHEM PHYS, V1, P13, DOI 10.1039/a807713d; AHLRICHS R, 1986, J AM CHEM SOC, V108, P3596, DOI 10.1021/ja00273a008; Ashman C, 2000, CHEM PHYS LETT, V324, P137, DOI 10.1016/S0009-2614(00)00569-8; Behler J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.036104; Bergeron DE, 2004, SCIENCE, V304, P84, DOI 10.1126/science.1093902; BRACK M, 1993, REV MOD PHYS, V65, P677, DOI 10.1103/RevModPhys.65.677; Burgert R, 2006, ANGEW CHEM INT EDIT, V45, P1476, DOI 10.1002/anie.200502957; Burgert R, 2006, J AM CHEM SOC, V128, P7904, DOI 10.1021/ja060613x; Chase MW, 1998, J PHYS CHEM REF DATA, V9, DOI [10.18434/T42S31, DOI 10.18434/T42S31]; DEHEER WA, 1993, REV MOD PHYS, V65, P611, DOI 10.1103/RevModPhys.65.611; Frisch M.J., 2016, GAUSSIAN16 REV B01; Greer A, 2006, ACCOUNTS CHEM RES, V39, P797, DOI 10.1021/ar050191g; HETTICH RL, 1989, J AM CHEM SOC, V111, P8582, DOI 10.1021/ja00205a004; JARROLD MF, 1988, CHEM PHYS LETT, V144, P311, DOI 10.1016/0009-2614(88)87160-4; LEUCHTNER RE, 1991, J CHEM PHYS, V94, P1093, DOI 10.1063/1.460716; LEUCHTNER RE, 1989, J CHEM PHYS, V91, P2753, DOI 10.1063/1.456988; Li X, 1998, PHYS REV LETT, V81, P1909, DOI 10.1103/PhysRevLett.81.1909; Li X, 2007, SCIENCE, V315, P356, DOI 10.1126/science.1133767; Martin TP, 1996, PHYS REP, V273, P199, DOI 10.1016/0370-1573(95)00083-6; Mednikov EG, 2007, J AM CHEM SOC, V129, P11619, DOI 10.1021/ja073945q; Okabe H., 1978, PHOTOCHEMISTRY SMALL, P431; Peslherbe GH, 2000, J PHYS CHEM A, V104, P10556, DOI 10.1021/jp0012146; Reber AC, 2007, J AM CHEM SOC, V129, P16098, DOI 10.1021/ja075998d; Schwarz H, 2004, INT J MASS SPECTROM, V237, P75, DOI 10.1016/j.ijms.2004.06.006	25	147	149	3	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2008	319	5862					438	442		10.1126/science.1148643	http://dx.doi.org/10.1126/science.1148643			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254HB	18218890				2022-12-28	WOS:000252576600030
J	Buesseler, KO; Doney, SC; Karl, DM; Boyd, PW; Caldeira, K; Chai, F; Coale, KH; de Baar, HJW; Falkowski, PG; Johnson, KS; Lampitt, RS; Michaels, AF; Naqvi, SWA; Smetacek, V; Takeda, S; Watson, AJ				Buesseler, Ken O.; Doney, Scott C.; Karl, David M.; Boyd, Philip W.; Caldeira, Ken; Chai, Fei; Coale, Kenneth H.; de Baar, Hein J. W.; Falkowski, Paul G.; Johnson, Kenneth S.; Lampitt, Richard S.; Michaels, Anthony F.; Naqvi, S. W. A.; Smetacek, Victor; Takeda, Shigenobu; Watson, Andrew J.			Environment - Ocean iron fertilization - Moving forward in a sea of uncertainty	SCIENCE			English	Editorial Material									[Buesseler, Ken O.; Doney, Scott C.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Karl, David M.] Univ Hawaii, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA; [Boyd, Philip W.] Univ Otago, Natl Inst Water & Atmospher Res, Ctr Chem & Phys Oceanog, Dept Chem, Dunedin, New Zealand; [Caldeira, Ken] Carnegie Inst, Dept Global Ecol, Stanford, CA USA; [Chai, Fei] Univ Maine, Sch Marine Sci, Orono, ME USA; [Coale, Kenneth H.] Moss Landing Marine Labs, Moss Landing, CA 95039 USA; [de Baar, Hein J. W.] Royal Netherlands Inst Res, Isle Texel, Netherlands; [Falkowski, Paul G.] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08903 USA; [Johnson, Kenneth S.] Monterey Bay Aquarium Res Inst, Moss Landing, CA USA; [Lampitt, Richard S.] Natl Oceanog Ctr, Southampton, Hants, England; [Michaels, Anthony F.] Univ So Calif, Wrigley Inst Environm Studies, Los Angeles, CA USA; [Naqvi, S. W. A.] Natl Inst Oceanog, Goa, India; [Smetacek, Victor] Alfred Wegener Inst Polar & Marine Res, D-2850 Bremerhaven, Germany; [Takeda, Shigenobu] Univ Tokyo, Dept Aquat Biosci, Tokyo, Japan; [Watson, Andrew J.] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England	Woods Hole Oceanographic Institution; University of Hawaii System; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Otago; Carnegie Institution for Science; University of Maine System; University of Maine Orono; Moss Landing Marine Laboratories; Rutgers State University New Brunswick; Monterey Bay Aquarium Research Institute; NERC National Oceanography Centre; University of Southern California; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute of Oceanography (NIO); Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Tokyo; University of East Anglia	Buesseler, KO (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.	kbuesseler@whoi.edu	Caldeira, Ken/E-7914-2011; Karl, David/AFP-3837-2022; Johnson, Kenneth S/F-9742-2011; Doney, Scott C/F-9247-2010; Boyd, Philip W/J-7624-2014	Caldeira, Ken/0000-0002-4591-643X; Johnson, Kenneth S/0000-0001-5513-5584; Doney, Scott C/0000-0002-3683-2437; Boyd, Philip W/0000-0001-7850-1911; Watson, Andrew/0000-0002-9654-8147; Takeda, Shigenobu/0000-0002-4997-1583; Karl, David/0000-0002-6660-6721	NERC [soc010008] Funding Source: UKRI; Natural Environment Research Council [soc010008] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; DEBAAR JHW, 2005, J GEOPHYS RES, V110, DOI UNSP C09816; Dilling L, 2003, ANNU REV ENV RESOUR, V28, P521, DOI 10.1146/annurev.energy.28.011503.163443; Pacala S, 2004, SCIENCE, V305, P968, DOI 10.1126/science.1100103	4	124	127	5	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2008	319	5860					162	162		10.1126/science.1154305	http://dx.doi.org/10.1126/science.1154305			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249RC	18187642				2022-12-28	WOS:000252246400024
J	Hunter, DJ; Khoury, MJ; Drazen, JM				Hunter, David J.; Khoury, Muin J.; Drazen, Jeffrey M.			Letting the genome out of the bottle - Will we get our wish?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MEDICINE		[Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Khoury, Muin J.] Ctr Dis Control & Prevent, Natl Off Publ Hlth Genom, Atlanta, GA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Centers for Disease Control & Prevention - USA	Hunter, DJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.		Drazen, Jeffrey M/E-5841-2012	Drazen, Jeffrey/0000-0003-2715-9890				Haddow JE, 2004, HUMAN GENOME EPIDEMI, P217; Khoury MJ, 2007, GENET MED, V9, P665, DOI 10.1097/GIM.0b013e31815699d0; Wald NJ, 1999, BMJ-BRIT MED J, V319, P1562, DOI 10.1136/bmj.319.7224.1562; Ware JH, 2006, NEW ENGL J MED, V355, P2615, DOI 10.1056/NEJMp068249	4	293	298	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2008	358	2					105	107		10.1056/NEJMp0708162	http://dx.doi.org/10.1056/NEJMp0708162			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249CJ	18184955				2022-12-28	WOS:000252204200001
J	Lloyd, CE; Barnett, AH				Lloyd, Cathy E.; Barnett, Anthony H.			Physical activity and risk of diabetes	LANCET			English	Editorial Material							EXERCISE; INTERVENTION; UK		[Barnett, Anthony H.] Univ Birmingham, Birmingham B9 5SS, W Midlands, England; [Lloyd, Cathy E.] Open Univ, Fac Hlth & Social Care, Milton Keynes MK7 6AA, Bucks, England; [Barnett, Anthony H.] Heart England NHS Fdn Trust, Birmingham B9 5SS, W Midlands, England	University of Birmingham; Open University - UK; Heart of England NHS Foundation Trust	Barnett, AH (corresponding author), Univ Birmingham, Birmingham B9 5SS, W Midlands, England.	anthony.barnett@heartofengland.nhs.uk		Lloyd, Cathy/0000-0002-8863-3069				Barnett AH, 2006, DIABETOLOGIA, V49, P2234, DOI 10.1007/s00125-006-0325-1; Dugdill L, 2005, ERGONOMICS, V48, P1390, DOI 10.1080/00140130500101544; Gibbs HD, 2004, J HUM NUTR DIET, V17, P191, DOI 10.1111/j.1365-277X.2004.00517.x; Hamman RF, 2006, DIABETES CARE, V29, P2102, DOI 10.2337/dc06-0560; Harrison RA, 2005, J PUBLIC HEALTH-UK, V27, P25, DOI 10.1093/pubmed/fdh197; Isaacs AJ, 2007, HEALTH TECHNOL ASSES, V11, P1; Kinmonth AL, 2008, LANCET, V371, P41, DOI 10.1016/S0140-6736(08)60070-7; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; LLOYD CE, 2007, PROMOTING PUBLIC HLT, P140; National Institute for Health & Clinical Excellence, 2006, 4 COMM US METH INCR; Silink M, 2007, PRACT DIAB INT, V24, P387	11	4	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 5	2008	371	9606					5	7		10.1016/S0140-6736(08)60044-6	http://dx.doi.org/10.1016/S0140-6736(08)60044-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248YH	18177756				2022-12-28	WOS:000252192600006
J	Taylor, AL; Gostin, LO; Pagonis, KA				Taylor, Allyn L.; Gostin, Lawrence O.; Pagonis, Katrina A.			Ensuring effective pain treatment - A national and global perspective	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DEVELOPING-COUNTRIES; PALLIATIVE CARE; MANAGEMENT; AVAILABILITY; DISPARITIES; PHARMACIES		[Taylor, Allyn L.; Gostin, Lawrence O.; Pagonis, Katrina A.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						Brennan F, 2007, ANESTH ANALG, V105, P205, DOI 10.1213/01.ane.0000268145.52345.55; De Lima Liliana, 2004, J Palliat Med, V7, P97, DOI 10.1089/109662104322737368; Farmer P, 2005, PATHOLOGIES POWER HL; Fishman SM, 2004, PAIN MED, V5, P309, DOI 10.1111/j.1526-4637.2004.04049.x; Forbes Karen, 2006, J Pain Palliat Care Pharmacother, V20, P33, DOI 10.1300/J354v20n03_08; Green CR, 2003, PAIN MED, V4, P277, DOI 10.1046/j.1526-4637.2003.03034.x; Green CR, 2005, J PAIN, V6, P689, DOI 10.1016/j.jpain.2005.06.002; Joranson DE, 2007, J PAIN SYMPTOM MANAG, V33, P527, DOI 10.1016/j.jpainsymman.2007.02.013; Koshy RC, 1998, SUPPORT CARE CANCER, V6, P430, DOI 10.1007/s005200050190; Kuehn BM, 2007, JAMA-J AM MED ASSOC, V297, P249, DOI 10.1001/jama.297.3.249; MCNEIL DG, 2007, NY TIMES        0910, pA15; Morrison RS, 2000, NEW ENGL J MED, V342, P1023, DOI 10.1056/NEJM200004063421406; Mosoiu D, 2007, J PAIN SYMPTOM MANAG, V33, P610, DOI 10.1016/j.jpainsymman.2007.02.023; Pletcher MJ, 2008, JAMA-J AM MED ASSOC, V299, P70, DOI 10.1001/jama.2007.64; Stjernsward J, 2007, J PUBLIC HEALTH POL, V28, P42, DOI 10.1057/palgrave.jphp.3200115; Sullivan LW, 2005, PAIN MED, V6, P5, DOI 10.1111/j.1526-4637.2005.05016.x; Todd KH, 2000, ANN EMERG MED, V35, P11, DOI 10.1016/S0196-0644(00)70099-0; *U WISC PAIN POL S, 2006, SINGL CONV NARC DRUG; Webster R, 2007, J PUBLIC HEALTH POL, V28, P28, DOI 10.1057/palgrave.jphp.3200097; Won AB, 2004, J AM GERIATR SOC, V52, P867, DOI 10.1111/j.1532-5415.2004.52251.x	20	22	22	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2008	299	1					89	91		10.1001/jama.2007.25	http://dx.doi.org/10.1001/jama.2007.25			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247BL	18167410				2022-12-28	WOS:000252052000021
J	Miller, K; Wang, ML; Gralow, J; Dickler, M; Cobleigh, M; Perez, EA; Shenkier, T; Cella, D; Davidson, NE				Miller, Kathy; Wang, Molin; Gralow, Julie; Dickler, Maura; Cobleigh, Melody; Perez, Edith A.; Shenkier, Tamara; Cella, David; Davidson, Nancy E.			Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOTHELIAL GROWTH-FACTOR; COMBINED BIOLOGICAL THERAPY; QUALITY-OF-LIFE; RESISTANCE; ANGIOGENESIS; TARGET; CELLS; TRIAL	Background: In an open-label, randomized, phase 3 trial, we compared the efficacy and safety of paclitaxel with that of paclitaxel plus bevacizumab, a monoclonal antibody against vascular endothelial growth factor, as initial treatment for metastatic breast cancer. Methods: We randomly assigned patients to receive 90 mg of paclitaxel per square meter of body-surface area on days 1, 8, and 15 every 4 weeks, either alone or with 10 mg of bevacizumab per kilogram of body weight on days 1 and 15. The primary end point was progression-free survival; overall survival was a secondary end point. Results: From December 2001 through May 2004, a total of 722 patients were enrolled. Paclitaxel plus bevacizumab significantly prolonged progression-free survival as compared with paclitaxel alone (median, 11.8 vs. 5.9 months; hazard ratio for progression, 0.60; P<0.001) and increased the objective response rate (36.9% vs. 21.2%, P<0.001). The overall survival rate, however, was similar in the two groups (median, 26.7 vs. 25.2 months; hazard ratio, 0.88; P=0.16). Grade 3 or 4 hypertension (14.8% vs. 0.0%, P<0.001), proteinuria (3.6% vs. 0.0%, P<0.001), headache (2.2% vs. 0.0%, P=0.008), and cerebrovascular ischemia (1.9% vs. 0.0%, P=0.02) were more frequent in patients receiving paclitaxel plus bevacizumab. Infection was more common in patients receiving paclitaxel plus bevacizumab (9.3% vs. 2.9%, P<0.001), but febrile neutropenia was uncommon (<1% overall). Conclusions: Initial therapy of metastatic breast cancer with paclitaxel plus bevacizumab prolongs progression-free survival, but not overall survival, as compared with paclitaxel alone. (ClinicalTrials.gov number, NCT00028990.).	Indiana Univ, Ctr Canc, Indiana Canc Pavil, Indianapolis, IN 46202 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Puget Sound Oncol Consortium, Seattle, WA USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA; Mayo Clin, Jacksonville, FL 32224 USA; British Columbia Canc Agcy, Vancouver Canc Ctr, Vancouver, BC V5Z 4E6, Canada; Evanston NW Healthcare, Evanston, IL USA; Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL USA; Johns Hopkins Kimmel Comprehens Canc Ctr, Baltimore, MD USA	Indiana University System; Indiana University-Purdue University Indianapolis; Harvard University; Dana-Farber Cancer Institute; Memorial Sloan Kettering Cancer Center; Rush University; Mayo Clinic; British Columbia Cancer Agency; NorthShore University Health System; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Johns Hopkins University; Johns Hopkins Medicine	Miller, K (corresponding author), Indiana Univ, Ctr Canc, Indiana Canc Pavil, 535 Barnhill Dr,RT473, Indianapolis, IN 46202 USA.	kathmill@iupui.edu		Cobleigh, Melody/0000-0001-6385-4693	NATIONAL CANCER INSTITUTE [U10CA016116, U10CA021115, U10CA066636, U10CA049883, U10CA023318] Funding Source: NIH RePORTER; NCI NIH HHS [CA49883, CA66636, CA16116, CA21115, CA23318] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brady MJ, 1997, J CLIN ONCOL, V15, P974, DOI 10.1200/JCO.1997.15.3.974; BROUTYBOYE D, 1995, CANCER RES, V55, P1633; Cobleigh MA, 2001, BREAST CANCER RES TR, V69, P301; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Fitzmaurice GM, 2001, STAT MED, V20, P1009, DOI 10.1002/sim.718; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; GASPARINI G, 1999, BREAST CANC MOL GENE, P347; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hari M, 2006, MOL CANCER THER, V5, P270, DOI 10.1158/1535-7163.MCT-05-0190; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; JENNISON C, 1989, J R STAT SOC B, V51, P305; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kerbel RS, 2001, CANCER METAST REV, V20, P79, DOI 10.1023/A:1013172910858; Miller KD, 2003, ANN ONCOL, V14, P20, DOI 10.1093/annonc/mdg033; Miller KD, 2005, J CLIN ONCOL, V23, P792, DOI 10.1200/JCO.2005.05.098; Miller KD, 2001, J CLIN ONCOL, V19, P1195, DOI 10.1200/JCO.2001.19.4.1195; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Pegram M, 2006, BREAST CANCER RES TR, V100, pS28; Pegram MD, 2002, SEMIN ONCOL, V29, P29, DOI 10.1053/sonc.2002.34053; Relf M, 1997, CANCER RES, V57, P963; Sandler A, 2007, NEW ENGL J MED, V356, P318; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Skillings JR, 2005, J CLIN ONCOL, V23, p196S; Sledge G, 2007, J CLIN ONCOL, V25; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Sweeney CJ, 2001, CANCER RES, V61, P3369; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Wagner LI, 2006, BREAST CANCER RES TR, V100, pS239	30	2447	2575	1	199	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2007	357	26					2666	2676		10.1056/NEJMoa072113	http://dx.doi.org/10.1056/NEJMoa072113			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	245UO	18160686	Bronze			2022-12-28	WOS:000251964500005
J	Shulman, LN; Hitt, RA; Ferry, JA				Shulman, Lawrence N.; Hitt, Rachel A.; Ferry, Judith A.			A pregnant woman with swelling of the left breast and shortness of breath - Diffuse large-B-cell lymphoma, consistent with primary mediastinal large-B-cell lymphoma, with involvement of breast and ovary	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MALIGNANT-LYMPHOMA; HODGKIN-LYMPHOMA; FEMALE BREAST; CANCER; EXPERIENCE; CHEMOTHERAPY; EXPRESSION; MULTICENTER; MANAGEMENT; CARCINOMA		[Shulman, Lawrence N.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Shulman, Lawrence N.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Hitt, Rachel A.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Ferry, Judith A.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Shulman, Lawrence N.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Hitt, Rachel A.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Ferry, Judith A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Shulman, LN (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.							Abou-Elella AA, 1999, J CLIN ONCOL, V17, P784, DOI 10.1200/JCO.1999.17.3.784; ADDIS BJ, 1986, HISTOPATHOLOGY, V10, P379, DOI 10.1111/j.1365-2559.1986.tb02491.x; ALSHARABATI M, 1991, CANCER, V67, P2579, DOI 10.1002/1097-0142(19910515)67:10<2579::AID-CNCR2820671030>3.0.CO;2-H; Antic N, 2000, MED ONCOL, V17, P233, DOI 10.1007/BF02780535; Berry DL, 1999, J CLIN ONCOL, V17, P855, DOI 10.1200/JCO.1999.17.3.855; Bonnier P, 1997, INT J CANCER, V72, P720, DOI 10.1002/(SICI)1097-0215(19970904)72:5<720::AID-IJC3>3.0.CO;2-U; Calaminici M, 2004, HISTOPATHOLOGY, V45, P619, DOI 10.1111/j.1365-2559.2004.01969.x; CazalsHatem D, 1996, AM J SURG PATHOL, V20, P877, DOI 10.1097/00000478-199607000-00012; COHEN PL, 1991, CANCER-AM CANCER SOC, V67, P1359, DOI 10.1002/1097-0142(19910301)67:5<1359::AID-CNCR2820670515>3.0.CO;2-4; de Leval L, 2001, AM J SURG PATHOL, V25, P1277, DOI 10.1097/00000478-200110000-00008; Domchek SM, 2002, CANCER-AM CANCER SOC, V94, P6, DOI 10.1002/cncr.10163; Fadiora S O, 2005, West Afr J Med, V24, P280; Gelb AB, 1996, CANCER-AM CANCER SOC, V78, P304, DOI 10.1002/(SICI)1097-0142(19960715)78:2<304::AID-CNCR18>3.0.CO;2-#; Gholam D, 2003, LEUKEMIA LYMPHOMA, V44, P1173, DOI 10.1080/1042819031000079195; Giacalone PL, 1999, CANCER-AM CANCER SOC, V86, P2266, DOI 10.1002/(SICI)1097-0142(19991201)86:11<2266::AID-CNCR14>3.0.CO;2-7; GIARDINI R, 1992, CANCER-AM CANCER SOC, V69, P725, DOI 10.1002/1097-0142(19920201)69:3<725::AID-CNCR2820690320>3.0.CO;2-C; HARRIS NL, 1994, BLOOD, V84, P1361; HUGH JC, 1990, CANCER-AM CANCER SOC, V66, P2602, DOI 10.1002/1097-0142(19901215)66:12<2602::AID-CNCR2820661224>3.0.CO;2-U; JACOBS C, 1981, ANN INTERN MED, V95, P669, DOI 10.7326/0003-4819-95-6-669; JAFFE ES, 2001, WHO CLASSIFICATION T, V3, P351; JEON HJ, 1992, CANCER-AM CANCER SOC, V70, P2451, DOI 10.1002/1097-0142(19921115)70:10<2451::AID-CNCR2820701011>3.0.CO;2-B; Joos S, 1996, BLOOD, V87, P1571, DOI 10.1182/blood.V87.4.1571.bloodjournal8741571; Kirkpatrick AW, 1996, CAN J SURG, V39, P333; KIRN D, 1993, J CLIN ONCOL, V11, P1336, DOI 10.1200/JCO.1993.11.7.1336; Kuper-Hommel MJJ, 2003, ANN HEMATOL, V82, P397, DOI 10.1007/s00277-003-0664-7; LAMOVEC J, 1987, CANCER-AM CANCER SOC, V60, P3033, DOI 10.1002/1097-0142(19871215)60:12<3033::AID-CNCR2820601230>3.0.CO;2-A; Lazzarino M, 1997, J CLIN ONCOL, V15, P1646, DOI 10.1200/JCO.1997.15.4.1646; LICHTENSTEIN AK, 1980, AM J MED, V68, P509, DOI 10.1016/0002-9343(80)90294-6; LIPSHULTZ SE, 1995, NEW ENGL J MED, V332, P1738, DOI 10.1056/NEJM199506293322602; Loibl S, 2006, CANCER-AM CANCER SOC, V106, P237, DOI 10.1002/cncr.21610; Loughrey MB, 2004, J CLIN PATHOL, V57, P1213, DOI 10.1136/jcp.2004.018994; MEYER JE, 1980, RADIOLOGY, V135, P623, DOI 10.1148/radiology.135.3.7384445; PETREK JA, 1991, CANCER-AM CANCER SOC, V67, P869, DOI 10.1002/1097-0142(19910215)67:4<869::AID-CNCR2820670402>3.0.CO;2-Q; Ring AE, 2005, J CLIN ONCOL, V23, P4192, DOI 10.1200/JCO.2005.03.038; Rodig SJ, 2007, AM J SURG PATHOL, V31, P106, DOI 10.1097/01.pas.0000213334.40358.0e; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Savage KJ, 2006, ANN ONCOL, V17, P123, DOI 10.1093/annonc/mdj030; Savage KJ, 2003, BLOOD, V102, P3871, DOI 10.1182/blood-2003-06-1841; STEINERSALZ D, 1985, CANCER, V56, P2087, DOI 10.1002/1097-0142(19851015)56:8<2087::AID-CNCR2820560834>3.0.CO;2-X; Todeschini G, 2004, BRIT J CANCER, V90, P372, DOI 10.1038/sj.bjc.6601460; TURCHI JJ, 1988, CANCER-AM CANCER SOC, V61, P435, DOI 10.1002/1097-0142(19880201)61:3<435::AID-CNCR2820610305>3.0.CO;2-F; Wong WW, 2002, J SURG ONCOL, V80, P19, DOI 10.1002/jso.10084; Zinzani PL, 2002, HAEMATOLOGICA, V87, P1258	43	11	11	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2008	358	5					513	523		10.1056/NEJMcpc0707921	http://dx.doi.org/10.1056/NEJMcpc0707921			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	256IW	18234756				2022-12-28	WOS:000252722900011
J	Frank, B; Serpell, MG; Hughes, J; Matthews, JNS; Kapur, D				Frank, B.; Serpell, M. G.; Hughes, J.; Matthews, J. N. S.; Kapur, D.			Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study	BRITISH MEDICAL JOURNAL			English	Article							CONTROLLED-TRIAL; POSTHERPETIC NEURALGIA; DELTA-9-TETRAHYDROCANNABINOL; COMBINATION; EFFICACY	Objective To compare the analgesic efficacy and side effects of the synthetic cannabinoid nabilone with those of the weak opioid dihydrocodeine for chronic neuropathic pain. Design Randomised, double blind, crossover trial of 14 weeks' duration comparing dihydrocodeine and nabilone. Setting Outpatient units of three hospitals in the United Kingdom. Participants 96 patients with chronic neuropathic pain, aged 23-84 years. Main outcome measures The primary outcome was difference between nabilone and dihydrocodeine in pain, as measured by the mean visual analogue score computed over the last two weeks of each treatment period. Secondary outcomes were changes in mood, quality of life, steep, and psychometric function. Side effects were measured by a questionnaire. Intervention Patients received a maximum daily dose of 240 mg dihydrocodeine or 2 mg nabilone at the end of each escalating treatment period of 6 weeks. Treatment periods were separated by a 2 week washout period. Results Mean baseline visual analogue score was 69.6 mm (range 29.4-95.2) on a 0-100 mm scale. 73 patients were included in the available case analysis and 64 patients in the per protocol analysis. The mean score was 6.0 mm longer for nabilone than for dihydrocodeine (95% confidence interval 1.4 to 10.5) in the available case analysis and 5.6 mm (10.3 to 0.8) in the per protocol analysis. Side effects were more frequent with nabilone. Conclusion Dihydrococleine provided better pain relief than the synthetic cannabinoid nabilone and had slightly fewer side effects, although no major adverse events occurred for either drug. Trial registration Current Controlled Trials ISRCTNI5330757.	[Frank, B.] Royal Victoria Infirm, Pain Management Unit, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Serpell, M. G.] Gartnavel Royal Hosp, Univ Dept Anaesthesia & Pain Management, Glasgow G12 0YN, Lanark, Scotland; [Hughes, J.] James Cook Univ Hosp, Dept Anaesthesia, Middlesbrough TS4 3BW, Cleveland, England; [Matthews, J. N. S.] Univ Newcastle, Sch Math & Stat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Kapur, D.] Flinders Med Ctr, Pain Management Unit, Bedford Pk, SA 5155, Australia	Newcastle University - UK; Gartnavel Royal Hospital; James Cook University Hospital; Newcastle University - UK; Flinders Medical Centre	Frank, B (corresponding author), Royal Victoria Infirm, Pain Management Unit, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	bernhard.frank@ncl.ac.uk	Hughes, John/AAD-2889-2019; Matthews, John N S/H-7502-2013; Côté, Mathieu/A-6735-2008	Matthews, John N S/0000-0003-2559-037X; Frank, Bernhard/0000-0001-5405-4942				Armitage P., 2002, STAT METHODS MED RES; Berman JS, 2004, PAIN, V112, P299, DOI 10.1016/j.pain.2004.09.013; Campbell FA, 2001, BMJ-BRIT MED J, V323, P13, DOI 10.1136/bmj.323.7303.13; Edwards JE, 2000, COCHRANE DB SYST REV; Finnerup NB, 2005, PAIN, V118, P289, DOI 10.1016/j.pain.2005.08.013; FRANK B, 2001, ANN SCI M PAIN SOC 2, P95; Gardner EL, 2005, PHARMACOL BIOCHEM BE, V81, P263, DOI 10.1016/j.pbb.2005.01.032; Hamann W, 1999, LANCET, V353, P560, DOI 10.1016/S0140-6736(98)05429-4; Jenkinson C, 1999, J EPIDEMIOL COMMUN H, V53, P46, DOI 10.1136/jech.53.1.46; Luporini G, 1998, EUR RESPIR J, V12, P97, DOI 10.1183/09031936.98.12010097; McQuay H J, 1998, Health Technol Assess, V2, P1; Naef M, 2003, PAIN, V105, P79, DOI 10.1016/S0304-3959(03)00163-5; Notcutt WG, 1997, PHARM SCI, V3, P551; NOYES R, 1975, J CLIN PHARMACOL, V15, P139, DOI 10.1002/j.1552-4604.1975.tb02348.x; Pertwee RG, 2000, EXPERT OPIN INV DRUG, V9, P1553, DOI 10.1517/13543784.9.7.1553; Raja SN, 2002, NEUROLOGY, V59, P1015, DOI 10.1212/WNL.59.7.1015; Rog DJ, 2005, NEUROLOGY, V65, P812, DOI 10.1212/01.wnl.0000176753.45410.8b; Rowbotham M, 1998, JAMA-J AM MED ASSOC, V280, P1837, DOI 10.1001/jama.280.21.1837; RUBIN A, 1977, CLIN PHARMACOL THER, V22, P85; Ware J.E., 2000, SF 36 HLTH SURVEY MA; Webb JA, 2001, BRIT J CLIN PHARMACO, V52, P35, DOI 10.1046/j.0306-5251.2001.01414.x; Wilder-Smith CH, 2001, PAIN, V91, P23, DOI 10.1016/S0304-3959(00)00414-0; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	23	130	132	1	18	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 26	2008	336	7637					199	201		10.1136/bmj.39429.619653.80	http://dx.doi.org/10.1136/bmj.39429.619653.80			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259KT	18182416	Bronze, Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000252938900043
J	Baker, MB; Peter, T				Baker, Marcia B.; Peter, Thomas			Small-scale cloud processes and climate	NATURE			English	Article							MICROPHYSICS	Clouds constitute the largest single source of uncertainty in climate prediction. A better understanding of small- scale cloud processes could shed light on the role of clouds in the climate system.	[Baker, Marcia B.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Peter, Thomas] ETH, Inst Atmospher & Climate Sci, CH-8092 Zurich, Switzerland	University of Washington; University of Washington Seattle; Swiss Federal Institutes of Technology Domain; ETH Zurich	Baker, MB (corresponding author), Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA.	marcia@ess.washington.edu	Peter, Thomas/B-2529-2018	Peter, Thomas/0000-0002-7218-7156				ALBRECHT BA, 1989, SCIENCE, V245, P1227, DOI 10.1126/science.245.4923.1227; Baker MB, 1997, SCIENCE, V276, P1072, DOI 10.1126/science.276.5315.1072; CHARLSON RJ, 1994, SCI AM, V270, P48, DOI 10.1038/scientificamerican0294-48; Collins W, 2007, SCI AM, V297, P64, DOI 10.1038/scientificamerican0807-64; Koop T, 2000, NATURE, V406, P611, DOI 10.1038/35020537; Lohmann U, 2007, B AM METEOROL SOC, V88, P243, DOI 10.1175/BAMS-88-2-243; Solomon S., 2007, PHYS SCI BASIS WORKI; TWOMEY S, 1977, J ATMOS SCI, V34, P1149, DOI 10.1175/1520-0469(1977)034<1149:TIOPOT>2.0.CO;2	8	129	135	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2008	451	7176					299	300		10.1038/nature06594	http://dx.doi.org/10.1038/nature06594			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202649	Bronze			2022-12-28	WOS:000252432100041
J	Birmingham, CL; Canadien, V; Kaniuk, NA; Steinberg, BE; Higgins, DE; Brumell, JH				Birmingham, Cheryl L.; Canadien, Veronica; Kaniuk, Natalia A.; Steinberg, Benjamin E.; Higgins, Darren E.; Brumell, John H.			Listeriolysin O allows Listeria monocytogenes replication in macrophage vacuoles	NATURE			English	Article							PHOSPHOLIPASES-C; LYSOSOME FUSION; CELLS; INFECTION; PH; PATHOGENESIS; MATURATION; AUTOPHAGY; SURVIVAL; PROTEIN	Listeria monocytogenes is an intracellular bacterial pathogen that replicates rapidly in the cytosol of host cells during acute infection(1). Surprisingly, these bacteria were found to occupy vacuoles in liver granuloma macrophages during persistent infection of severe combined immunodeficient ( SCID) mice(2). Here we show that L. monocytogenes can replicate in vacuoles within macrophages. In livers of SCID mice infected for 21 days, we observed bacteria in large LAMP1(+) compartments that we termed spacious Listeria- containing phagosomes ( SLAPs). SLAPs were also observed in vitro, and were found to be non- acidic and non-degradative compartments that are generated in an autophagy-dependent manner. The replication rate of bacteria in SLAPs was found to be reduced compared to the rate of those in the cytosol. Listeriolysin O ( LLO, encoded by hly), a pore- forming toxin essential for L. monocytogenes virulence(1), was necessary and sufficient for SLAP formation. A L. monocytogenes mutant with low LLO expression was impaired for phagosome escape but replicated slowly in SLAPs over a 72 h period. Therefore, our studies reveal a role for LLO in promoting L. monocytogenes replication in vacuoles and suggest a mechanism by which this pathogen can establish persistent infection in host macrophages.	[Birmingham, Cheryl L.; Canadien, Veronica; Kaniuk, Natalia A.; Steinberg, Benjamin E.; Brumell, John H.] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Birmingham, Cheryl L.; Brumell, John H.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Steinberg, Benjamin E.; Brumell, John H.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Higgins, Darren E.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Harvard University; Harvard Medical School	Brumell, JH (corresponding author), Hosp Sick Children, Cell Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	john.brumell@sickkids.ca	Birmingham, Cheryl/AAF-6649-2020					Alberti-Segui C, 2007, CELL MICROBIOL, V9, P179, DOI 10.1111/j.1462-5822.2006.00780.x; Beauregard KE, 1997, J EXP MED, V186, P1159, DOI 10.1084/jem.186.7.1159; Bhardwaj V, 1998, J IMMUNOL, V160, P376; Birmingham CL, 2007, AUTOPHAGY, V3, P442, DOI 10.4161/auto.4450; BISHOP DK, 1987, J IMMUNOL, V139, P2005; Brumell JH, 2001, CELL MICROBIOL, V3, P75, DOI 10.1046/j.1462-5822.2001.00087.x; CAMILLI A, 1993, MOL MICROBIOL, V8, P143, DOI 10.1111/j.1365-2958.1993.tb01211.x; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cheng LW, 2003, CELL MICROBIOL, V5, P875, DOI 10.1046/j.1462-5822.2003.00327.x; DECHASTELLIER C, 1994, INFECT IMMUN, V62, P543, DOI 10.1128/IAI.62.2.543-553.1994; del Cerro-Vadillo E, 2006, J IMMUNOL, V176, P1321, DOI 10.4049/jimmunol.176.3.1321; Dramsi S, 1998, INFECT IMMUN, V66, P4461; GORDON AH, 1980, NATURE, V286, P79, DOI 10.1038/286079a0; Hackam DJ, 1997, J BIOL CHEM, V272, P29810, DOI 10.1074/jbc.272.47.29810; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Henry R, 2006, CELL MICROBIOL, V8, P107, DOI 10.1111/j.1462-5822.2005.00604.x; Jankowski A, 2002, J BIOL CHEM, V277, P6059, DOI 10.1074/jbc.M110059200; JONES S, 1994, INFECT IMMUN, V62, P5608, DOI 10.1128/IAI.62.12.5608-5613.1994; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Kayal S, 2006, FEMS MICROBIOL REV, V30, P514, DOI 10.1111/j.1574-6976.2006.00021.x; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; Myers JT, 2003, J IMMUNOL, V171, P5447, DOI 10.4049/jimmunol.171.10.5447; NATO F, 1991, INFECT IMMUN, V59, P4641, DOI 10.1128/IAI.59.12.4641-4646.1991; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Perrin AJ, 2004, CURR BIOL, V14, P806, DOI 10.1016/j.cub.2004.04.033; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; Shaughnessy LM, 2006, CELL MICROBIOL, V8, P781, DOI 10.1111/j.1462-5822.2005.00665.x; Skoble J, 2000, J CELL BIOL, V150, P527, DOI 10.1083/jcb.150.3.527; SMITH GA, 1995, INFECT IMMUN, V63, P4231, DOI 10.1128/IAI.63.11.4231-4237.1995; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33	32	230	239	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2008	451	7176					350	U13		10.1038/nature06479	http://dx.doi.org/10.1038/nature06479			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202661				2022-12-28	WOS:000252432100053
J	Duffy, TS				Duffy, Thomas S.			Mineralogy at the extremes	NATURE			English	Article							POST-PEROVSKITE PHASE; LOWERMOST-MANTLE; BOUNDARY; MGSIO3		Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	Princeton University	Duffy, TS (corresponding author), Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA.	duffy@princeton.edu	Duffy, Thomas S/C-9140-2017	Duffy, Thomas S/0000-0002-5357-1259				Badro J, 2003, SCIENCE, V300, P789, DOI 10.1126/science.1081311; Duffy TS, 2005, REP PROG PHYS, V68, P1811, DOI 10.1088/0034-4885/68/8/R03; Garnero EJ, 2000, ANNU REV EARTH PL SC, V28, P509, DOI 10.1146/annurev.earth.28.1.509; Hernlund JW, 2005, NATURE, V434, P882, DOI 10.1038/nature03472; Jeanloz R, 2007, P NATL ACAD SCI USA, V104, P9172, DOI 10.1073/pnas.0608170104; Lay T, 2006, SCIENCE, V314, P1272, DOI 10.1126/science.1133280; Murakami M, 2004, SCIENCE, V304, P855, DOI 10.1126/science.1095932; Oganov AR, 2005, Z KRISTALLOGR, V220, P531, DOI 10.1524/zkri.220.5.531.65079; Oganov AR, 2004, NATURE, V430, P445, DOI 10.1038/nature02701; RODI F, 1965, Z ANORG ALLG CHEM, V336, P17, DOI 10.1002/zaac.19653360104; Scandolo S, 2003, AM SCI, V91, P516, DOI 10.1511/2003.6.516; van der Hilst RD, 2007, SCIENCE, V315, P1813, DOI 10.1126/science.1137867; Wookey J, 2005, NATURE, V438, P1004, DOI 10.1038/nature04345	13	15	17	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2008	451	7176					269	270		10.1038/nature06584	http://dx.doi.org/10.1038/nature06584			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202639	Bronze			2022-12-28	WOS:000252432100031
J	Ebert, BL; Pretz, J; Bosco, J; Chang, CY; Tamayo, P; Galili, N; Raza, A; Root, DE; Attar, E; Ellis, SR; Golub, TR				Ebert, Benjamin L.; Pretz, Jennifer; Bosco, Jocelyn; Chang, Cindy Y.; Tamayo, Pablo; Galili, Naomi; Raza, Azra; Root, David E.; Attar, Eyal; Ellis, Steven R.; Golub, Todd R.			Identification of RPS14 as a 5q(-) syndrome gene by RNA interference screen	NATURE			English	Article							CANCER; DELETION	Somatic chromosomal deletions in cancer are thought to indicate the location of tumour suppressor genes, by which a complete loss of gene function occurs through biallelic deletion, point mutation or epigenetic silencing, thus fulfilling Knudson's two- hit hypothesis(1). In many recurrent deletions, however, such biallelic inactivation has not been found. One prominent example is the 5q(-) syndrome, a subtype of myelodysplastic syndrome characterized by a defect in erythroid differentiation(2). Here we describe an RNA-mediated interference ( RNAi)- based approach to discovery of the 5q(-) disease gene. We found that partial loss of function of the ribosomal subunit protein RPS14 phenocopies the disease in normal haematopoietic progenitor cells, and also that forced expression of RPS14 rescues the disease phenotype in patient- derived bone marrow cells. In addition, we identified a block in the processing of pre- ribosomal RNA in RPS14- deficient cells that is functionally equivalent to the defect in Diamond- Blackfan anaemia, linking the molecular pathophysiology of the 5q(-) syndrome to a congenital syndrome causing bone marrow failure. These results indicate that the 5q(-) syndrome is caused by a defect in ribosomal protein function and suggest that RNAi screening is an effective strategy for identifying causal haploinsufficiency disease genes.	[Ebert, Benjamin L.; Pretz, Jennifer; Bosco, Jocelyn; Chang, Cindy Y.; Tamayo, Pablo; Root, David E.; Golub, Todd R.] MIT, Broad Inst, Cambridge, MA 02142 USA; [Ebert, Benjamin L.; Pretz, Jennifer; Bosco, Jocelyn; Chang, Cindy Y.; Tamayo, Pablo; Root, David E.; Golub, Todd R.] Harvard Univ, Cambridge, MA 02142 USA; [Ebert, Benjamin L.; Golub, Todd R.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Ebert, Benjamin L.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Hematol, Boston, MA 02115 USA; [Galili, Naomi; Raza, Azra] Univ Massachusetts, Sch Med, Div Hematol Oncol, Worcester, MA 01655 USA; [Attar, Eyal] Massachusetts Gen Hosp, Dept Med, Div Hematol Oncol, Boston, MA 02114 USA; [Ellis, Steven R.] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40292 USA; [Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts General Hospital; University of Louisville; Howard Hughes Medical Institute	Golub, TR (corresponding author), MIT, Broad Inst, Cambridge, MA 02142 USA.	golub@broad.mit.edu			NATIONAL CANCER INSTITUTE [T32CA009172] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082945, R01HL079583, K08HL078818] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [T32 CA009172] Funding Source: Medline; NHLBI NIH HHS [R01 HL082945, K08 HL078818, R01 HL079583] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boultwood J, 2002, BLOOD, V99, P4638, DOI 10.1182/blood.V99.12.4638; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; Ebert BL, 2005, BLOOD, V105, P4620, DOI 10.1182/blood-2004-08-3313; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; FIYGARE J, 2007, BLOOD, V109, P860; Fodde R, 2002, SCIENCE, V298, P761, DOI 10.1126/science.1077707; Gazda HT, 2006, AM J HUM GENET, V79, P1110, DOI 10.1086/510020; Giagounidis AAN, 2006, CLIN CANCER RES, V12, P5, DOI 10.1158/1078-0432.CCR-05-1437; Gnatenko DV, 2003, BLOOD, V101, P2285, DOI 10.1182/blood-2002-09-2797; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Heaney ML, 1999, NEW ENGL J MED, V340, P1649, DOI 10.1056/NEJM199905273402107; Horrigan SK, 2000, BLOOD, V95, P2372, DOI 10.1182/blood.V95.7.2372.007k20_2372_2377; Joslin JM, 2007, BLOOD, V110, P719, DOI 10.1182/blood-2007-01-068809; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; List A, 2006, NEW ENGL J MED, V355, P1456, DOI 10.1056/NEJMoa061292; Liu JM, 2006, BLOOD, V107, P4583, DOI 10.1182/blood-2005-12-4831; Liu TX, 2007, NAT MED, V13, P78, DOI 10.1038/nm1512; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; QUESENBERRY PJ, 2005, WILLIAMS HEMATOLOGY, P153; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; RAZA A, 1995, BLOOD, V86, P268, DOI 10.1182/blood.V86.1.268.bloodjournal861268; Stegmaier K, 2004, NAT GENET, V36, P257, DOI 10.1038/ng1305; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang H, 2001, MOL CELL BIOL, V21, P8671, DOI 10.1128/MCB.21.24.8671-8683.2001; VANDENBERGHE H, 1974, NATURE, V251, P437, DOI 10.1038/251437a0; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030	28	670	700	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2008	451	7176					335	U7		10.1038/nature06494	http://dx.doi.org/10.1038/nature06494			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202658	Green Submitted, Green Accepted			2022-12-28	WOS:000252432100050
J	Roll-Mecak, A; Vale, RD				Roll-Mecak, Antonina; Vale, Ronald D.			Structural basis of microtubule severing by the hereditary spastic paraplegia protein spastin	NATURE			English	Article							ATP-DEPENDENT OLIGOMERIZATION; DISASSEMBLES MICROTUBULES; ALPHA-TUBULIN; KATANIN; RECOGNITION; SCATTERING; HOMOLOG; BINDING; INVIVO; DOMAIN	Spastin, the most common locus for mutations in hereditary spastic paraplegias(1), and katanin are related microtubule- severing AAA ATPases(2-6) involved in constructing neuronal(7-10) and non-centrosomal(7,11) microtubule arrays and in segregating chromosomes(12,13). The mechanism by which spastin and katanin break and destabilize microtubules is unknown, in part owing to the lack of structural information on these enzymes. Here we report the X- ray crystal structure of the Drosophila spastin AAA domain and provide a model for the active spastin hexamer generated using small- angle X- ray scattering combined with atomic docking. The spastin hexamer forms a ring with a prominent central pore and six radiating arms that may dock onto the microtubule. Helices unique to the microtubule- severing AAA ATPases surround the entrances to the pore on either side of the ring, and three highly conserved loops line the pore lumen. Mutagenesis reveals essential roles for these structural elements in the severing reaction. Peptide and antibody inhibition experiments further show that spastin may dismantle microtubules by recognizing specific features in the carboxy- terminal tail of tubulin. Collectively, our data support a model in which spastin pulls the C terminus of tubulin through its central pore, generating a mechanical force that destabilizes tubulin- tubulin interactions within the microtubule lattice. Our work also provides insights into the structural defects in spastin that arise from mutations identified in hereditary spastic paraplegia patients.	[Roll-Mecak, Antonina; Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Roll-Mecak, Antonina; Vale, Ronald D.] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Vale, RD (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 600 16th St, San Francisco, CA 94158 USA.	vale@cmp.ucsf.edu		Roll-Mecak, Antonina/0000-0003-2621-7307	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS057934] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NINDS NIH HHS [K99 NS057934-02, K99 NS057934-01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Burk DH, 2001, PLANT CELL, V13, P807, DOI 10.1105/tpc.13.4.807; Evans KJ, 2005, J CELL BIOL, V168, P599, DOI 10.1083/jcb.200409058; Fonknechten N, 2000, HUM MOL GENET, V9, P637, DOI 10.1093/hmg/9.4.637; Frickey T, 2004, J STRUCT BIOL, V146, P2, DOI 10.1016/j.jsb.2003.11.020; Guinier  A., 1995, SMALL ANGLE SCATTERI; GUNDERSEN GG, 1984, CELL, V38, P779, DOI 10.1016/0092-8674(84)90273-3; Hartman JJ, 1999, SCIENCE, V286, P782, DOI 10.1126/science.286.5440.782; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Lee S, 2007, MOL CELL, V25, P261, DOI 10.1016/j.molcel.2007.01.002; Lu CG, 2004, MOL BIOL CELL, V15, P142, DOI 10.1091/mbc.E03-06-0418; Matsushita-Ishiodori Y, 2007, BIOCHEM BIOPH RES CO, V359, P157, DOI 10.1016/j.bbrc.2007.05.086; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; RODRIGUEZ JA, 1979, BIOCHEM BIOPH RES CO, V89, P893, DOI 10.1016/0006-291X(79)91862-X; Roll-Mecak A, 2005, CURR BIOL, V15, P650, DOI 10.1016/j.cub.2005.02.029; Roll-Mecak A, 2006, J CELL BIOL, V175, P849, DOI 10.1083/jcb.200611149; Salinas S, 2005, J NEUROCHEM, V95, P1411, DOI 10.1111/j.1471-4159.2005.03472.x; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Sherwood NT, 2004, PLOS BIOL, V2, P2094, DOI 10.1371/journal.pbio.0020429; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Srayko M, 2000, GENE DEV, V14, P1072; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tarrade A, 2006, HUM MOL GENET, V15, P3544, DOI 10.1093/hmg/ddl431; Trotta N, 2004, CURR BIOL, V14, P1135, DOI 10.1016/j.cub.2004.06.058; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WEHLAND J, 1983, J CELL BIOL, V97, P1467, DOI 10.1083/jcb.97.5.1467; White SR, 2007, J CELL BIOL, V176, P995, DOI 10.1083/jcb.200610072; Wood JD, 2006, HUM MOL GENET, V15, P2763, DOI 10.1093/hmg/ddl212; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843; Zhang D, 2007, J CELL BIOL, V177, P231, DOI 10.1083/jcb.200612011	34	232	241	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2008	451	7176					363	U16		10.1038/nature06482	http://dx.doi.org/10.1038/nature06482			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202664	Green Accepted			2022-12-28	WOS:000252432100056
J	Matson, JL; Wilkins, J				Matson, Johnny L.; Wilkins, Jonathan			Antipsychotic drugs for aggression in intellectual disability	LANCET			English	Editorial Material							CHALLENGING BEHAVIOR		[Matson, Johnny L.; Wilkins, Jonathan] Louisiana State Univ, Dept Psychol, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Matson, JL (corresponding author), Louisiana State Univ, Dept Psychol, Baton Rouge, LA 70803 USA.	johnmatson@aol.com						BRYLEWSKI J, 2004, COCHRANE DB SYST REV, V4, DOI UNSP CD000030; Geddes J, 2000, BRIT MED J, V321, P1371, DOI 10.1136/bmj.321.7273.1371; Machalicek W, 2007, RES AUTISM SPECT DIS, V1, P229, DOI 10.1016/j.rasd.2006.10.005; Matson JL, 2001, J PSYCHOPATHOL BEHAV, V23, P3, DOI 10.1023/A:1011083221991; MATSON JL, 2007, J DEV PHYS DISABIL; Matson JL, 2007, RES DEV DISABIL, V28, P353, DOI 10.1016/j.ridd.2006.01.005; McGillivray J, 2005, J DEV PHYS DISABIL, V17, P311, DOI 10.1007/s10882-005-6614-7; PLOTKIN R, 1979, STANFORD LAW REV, V31, P637, DOI 10.2307/1228421; Tyrer P, 2008, LANCET, V371, P57, DOI 10.1016/S0140-6736(08)60072-0	9	72	72	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 5	2008	371	9606					9	10		10.1016/S0140-6736(08)60046-X	http://dx.doi.org/10.1016/S0140-6736(08)60046-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248YH	18177758				2022-12-28	WOS:000252192600008
J	Jonsson, TJ; Johnson, LC; Lowther, WT				Jonsson, Thomas J.; Johnson, Lynnette C.; Lowther, W. Todd			Structure of the sulphiredoxin-peroxiredoxin complex reveals an essential repair embrace	NATURE			English	Article							CYSTEINE-SULFINIC ACID; 2-CYS PEROXIREDOXIN; OXIDATIVE STRESS; CRYSTAL-STRUCTURE; REDUCTION; SULFIREDOXIN; PEROXIDASE; MECHANISM; STATE; H2O2	Typical 2-Cys peroxiredoxins ( Prxs) have an important role in regulating hydrogen peroxide-mediated cell signalling(1). In this process, Prxs can become inactivated through the hyperoxidation of an active site Cys residue to Cys sulphinic acid. The unique repair of this moiety by sulphiredoxin ( Srx) restores peroxidase activity and terminates the signal(2). The hyperoxidized form of Prx exists as a stable decameric structure with each active site buried. Therefore, it is unclear how Srx can access the sulphinic acid moiety. Here we present the 2.6 angstrom crystal structure of the human Srx - PrxI complex. This complex reveals the complete unfolding of the carboxy terminus of Prx, and its unexpected packing onto the backside of Srx away from the Srx active site. Binding studies and activity analyses of site- directed mutants at this interface show that the interaction is required for repair to occur. Moreover, rearrangements in the Prx active site lead to a juxtaposition of the Prx Gly- Gly- Leu- Gly and Srx ATP- binding motifs, providing a structural basis for the first step of the catalytic mechanism. The results also suggest that the observed interactions may represent a common mode for other proteins to bind to Prxs.	[Jonsson, Thomas J.; Johnson, Lynnette C.; Lowther, W. Todd] Wake Forest Univ, Bowman Gray Sch Med, Ctr Struct Biol, Winston Salem, NC 27157 USA; [Jonsson, Thomas J.; Johnson, Lynnette C.; Lowther, W. Todd] Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Lowther, WT (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Ctr Struct Biol, Med Ctr Blvd, Winston Salem, NC 27157 USA.	tlowther@wfubmc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072866] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM072866, R01 GM072866-03] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Bozonet SM, 2005, J BIOL CHEM, V280, P23319, DOI 10.1074/jbc.M502757200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Harris JR, 2001, BBA-PROTEIN STRUCT M, V1547, P221, DOI 10.1016/S0167-4838(01)00184-4; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; Hong SK, 2006, FREE RADICAL BIO MED, V40, P275, DOI 10.1016/j.freeradbiomed.2005.08.029; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jeong W, 2006, J BIOL CHEM, V281, P14400, DOI 10.1074/jbc.M511082200; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Jonsson TJ, 2005, BIOCHEMISTRY-US, V44, P8634, DOI 10.1021/bi050131i; Jung H, 2001, J BIOL CHEM, V276, P15504, DOI 10.1074/jbc.M009620200; Kang SW, 2005, TRENDS MOL MED, V11, P571, DOI 10.1016/j.molmed.2005.10.006; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Koo KH, 2002, ARCH BIOCHEM BIOPHYS, V397, P312, DOI 10.1006/abbi.2001.2700; Lee DY, 2006, BIOCHEMISTRY-US, V45, P15301, DOI 10.1021/bi061824h; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Moon JC, 2005, J BIOL CHEM, V280, P28775, DOI 10.1074/jbc.M505362200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Parsonage D, 2005, BIOCHEMISTRY-US, V44, P10583, DOI 10.1021/bi050448i; Phalen TJ, 2006, J CELL BIOL, V175, P779, DOI 10.1083/jcb.200606005; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Sayed AA, 2004, J BIOL CHEM, V279, P26159, DOI 10.1074/jbc.M401748200; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Xiao NZ, 2005, FEBS J, V272, P3929, DOI 10.1111/j.1742-4658.2005.04809.x	36	109	112	5	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2008	451	7174					98	U16		10.1038/nature06415	http://dx.doi.org/10.1038/nature06415			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247KZ	18172504	Green Accepted			2022-12-28	WOS:000252079300042
J	Merks, JHM; Ozgen, HM; Koster, J; Zwinderman, AH; Caron, HN; Hennekam, RCM				Merks, Johannes H. M.; Ozgen, Heval M.; Koster, Jan; Zwinderman, Aeilko H.; Caron, Huib N.; Hennekam, Raoul C. M.			Prevalence and patterns of morphological abnormalities in patients with childhood cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYELOID-LEUKEMIA; MINOR ANOMALIES; FRASER-SYNDROME; MILD ERRORS; MUTATIONS; CHILDREN; GENE; MORPHOGENESIS; MALIGNANCY; PROTEIN	Context Constitutional gene defects predispose to cancer in children. Such tumor predisposition syndromes can be recognized by specific patterns of morphological abnormalities. Objectives To assess the prevalence of morphological abnormalities in a large cohort of patients with childhood cancer and to identify new tumor predisposition syndromes. Design, Setting, and Participants Patients were recruited from Emma Children's Hospital, Academic Medical Center, Amsterdam, the Netherlands, between January 2000 and March 2003. A total of 1073 patients underwent a physical examination directed at 683 morphological abnormalities. The patient cohort consisted of 898 long-term survivors of childhood cancer and 175 newly diagnosed pediatric patients with cancer. The control group consisted of 1007 schoolchildren examined in an identical way. Mean ages of patients and controls were 21.2 and 10.4 years, respectively. Main Outcome Measures Prevalence and patterns of morphological abnormalities in patients compared with controls. To prevent age bias, only age-independent abnormalities were used for overall prevalence analysis. Patients younger than 9 years were excluded from the pattern analysis. The sample was restricted to white patients to prevent ethnicity bias. Results Morphological abnormalities were significantly more prevalent in pediatric patients with cancer. Major abnormalities were present in 26.8% of patients vs 15.5% of controls (P<.001) and minor anomalies in 65.1 % of patients vs 56.2% of controls (P<.001). Three or more minor anomalies were detected in 15.2% of patients vs 8.3% in controls (P<.001). Forty-two patients were diagnosed with an established tumor predisposition syndrome. Multivariate analyses showed 14 morphological abnormalities to occur significantly more often in the patient group. For 2 of these (blepharophimosis and asymmetric lower limbs), we identified statistically significant patterns of co-occurring morphological abnormalities suggestive of new tumor predisposition syndromes. Thirty-four patients fit 1 of the 2 novel tumor predisposition patterns. Conclusions Pediatric patients with cancer show a significantly higher prevalence of morphological abnormalities compared with controls. Specific patterns of morphological abnormalities indicate possible unrecognized tumor predisposition syndromes, but validation in an independent sample is needed.	[Merks, Johannes H. M.; Caron, Huib N.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat Oncol, NL-1105 AZ Amsterdam, Netherlands; [Ozgen, Heval M.; Hennekam, Raoul C. M.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; [Ozgen, Heval M.] Univ Med Ctr, Wilhelmina Childrens Hosp, Dept Pediat Psychiat, Utrecht, Netherlands; [Hennekam, Raoul C. M.] UCL, Great Ormond St Hosp Children, Inst Child Hlth, London, England; [Koster, Jan] Univ Amsterdam, Acad Med Ctr, Dept Human Genet, NL-1105 AZ Amsterdam, Netherlands; [Zwinderman, Aeilko H.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Merks, JHM (corresponding author), Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat Oncol, Floor F8,Room 245,Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.h.merks@amc.uva.nl	Ozgen, mihriban/H-6635-2018; Ozgen, Heval/J-2056-2019; Koster, Jan/C-5934-2008	Ozgen, mihriban/0000-0002-8933-7122; Ozgen, Heval/0000-0002-8933-7122; Koster, Jan/0000-0002-0890-7585				Aase JM, 1990, DIAGNOSTIC DYSMORPHO; Altmann AE, 1998, BRIT J CANCER, V78, P1244, DOI 10.1038/bjc.1998.662; ANTHONY S, 2003, AANGEBOREN AFWIJKING; BARR FG, 1993, NAT GENET, V3, P113, DOI 10.1038/ng0293-113; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CLUITMANS TLM, 2002, GEZONDHEIDSPROFIEL K; FEKETE G, 1987, Orvosi Hetilap, V128, P725; Frias J L, 1996, Adv Pediatr, V43, P27; Geenen MM, 2007, JAMA-J AM MED ASSOC, V297, P2705, DOI 10.1001/jama.297.24.2705; Gorlin RJ., 2001, SYNDROMES HEAD NECK, DOI 10.17245/jdapm.2019.19.5.261; Kobayashi N, 1968, Paediatr Univ Tokyo, V16, P31; LECESSIE S, 1992, APPL STAT-J ROY ST C, V41, P191; MARDEN PM, 1964, J PEDIATR-US, V64, P357, DOI 10.1016/S0022-3476(64)80188-8; McGregor L, 2003, NAT GENET, V34, P203, DOI 10.1038/ng1142; Mehes K, 1998, AM J MED GENET, V75, P22, DOI 10.1002/(SICI)1096-8628(19980106)75:1<22::AID-AJMG6>3.3.CO;2-D; MEHES K, 1985, EUR J PEDIATR, V144, P243, DOI 10.1007/BF00451951; MEHES K, 1994, FAMILY INVESTIGATION, P177; Merks JHM, 2005, AM J MED GENET A, V134A, P132, DOI 10.1002/ajmg.a.30603; Merks JHM, 2003, AM J MED GENET A, V123A, P211, DOI 10.1002/ajmg.a.20249; Merks JHM, 2006, AM J MED GENET A, V140A, P2091, DOI 10.1002/ajmg.a.31355; MIYOSHI H, 1991, P NATL ACAD SCI USA, V88, P10431, DOI 10.1073/pnas.88.23.10431; Nakamura T, 1996, NAT GENET, V12, P154, DOI 10.1038/ng0296-154; OPITZ JM, 1985, EUR J PEDIATR, V144, P252, DOI 10.1007/BF00451953; Roganovic J, 2002, MED PEDIATR ONCOL, V38, P128, DOI 10.1002/mpo.1288.abs; Stiller CA, 2006, EUR J CANCER, V42, P1952, DOI 10.1016/j.ejca.2006.05.017; Stiller CA, 2004, ONCOGENE, V23, P6429, DOI 10.1038/sj.onc.1207717; STOJIMIROVIC E, 1981, Srpski Arkhiv za Tselokupno Lekarstvo, V109, P1275; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; VANLIER A, 2005, STERFTE NOORDHOLLAND; Villavicencio EH, 2000, AM J HUM GENET, V67, P1047, DOI 10.1016/S0002-9297(07)62934-6; WINTER RM, 1990, CLIN GENET, V37, P494; Winter RM, 2001, LONDON DYSMORPHOLOGY	33	47	48	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2008	299	1					61	69		10.1001/jama.2007.66	http://dx.doi.org/10.1001/jama.2007.66			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247BL	18167407	Bronze			2022-12-28	WOS:000252052000017
J	Hsia, KC; Stavropoulos, P; Blobel, G; Hoelz, A				Hsia, Kuo-Chiang; Stavropoulos, Pete; Blobel, Guenter; Hoelz, Andre			Architecture of a coat for the nuclear pore membrane	CELL			English	Article							MESSENGER-RNA EXPORT; BIOGENESIS PATHWAY; NUP107-160 COMPLEX; PROTEOMIC ANALYSIS; NUCLEOPORINS; KINETOCHORES; NUP145P; IMPORT; NUP133; TOOL	The symmetric core of the nuclear pore complex can be considered schematically as a series of concentric cylinders. A peripheral cylinder coating the pore membrane contains the previously characterized, elongated heptamer that harbors Sec13-Nup145C in its middle section. Strikingly, Sec13-Nup145C crystallizes as a hetero-octamer in two space groups. Oligomerization of Sec13-Nup145C was confirmed biochemically. Importantly, the numerous interacting surfaces in the hetero-octamer are evolutionarily highly conserved, further underlining the physiological relevance of the oligomerization. The hetero-octamer forms a slightly curved, yet rigid rod of sufficient length to span the entire height of the proposed membrane-adjacent cylinder. In concordance with the dimensions and symmetry of the nuclear pore complex core, we suggest that the cylinder is constructed of four antiparallel rings, each ring being composed of eight heptamers arranged in a head-to-tail fashion. Our model proposes that the hetero-octamer would vertically traverse and connect the four stacked rings.	[Hsia, Kuo-Chiang; Stavropoulos, Pete; Blobel, Guenter; Hoelz, Andre] Rockefeller Univ, Howard Hughes Med Inst, Cell Biol Lab, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Blobel, G (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Cell Biol Lab, 1230 York Ave, New York, NY 10021 USA.	blobel@rockefeller.edu; hoelza@rockefeller.edu	Hsia, Kuo-Chiang/AAS-8056-2021; Hoelz, Andre/AAB-6978-2021	Hsia, Kuo-Chiang/0000-0002-4409-6732; 	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117360] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCRR NIH HHS [P41 RR015301-05S10101] Funding Source: Medline; NIGMS NIH HHS [R01 GM117360] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen NPC, 2001, J BIOL CHEM, V276, P29268, DOI 10.1074/jbc.M102629200; Bai SW, 2004, MOL CELL BIOL, V24, P6379, DOI 10.1128/MCB.24.14.6379-6392.2004; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Belgareh N, 2001, J CELL BIOL, V154, P1147, DOI 10.1083/jcb.200101081; Berke IC, 2004, J CELL BIOL, V167, P591, DOI 10.1083/jcb.200408109; Bickford LC, 2004, CURR OPIN STRUC BIOL, V14, P147, DOI 10.1016/j.sbi.2004.02.002; Boehmer T, 2003, P NATL ACAD SCI USA, V100, P981, DOI 10.1073/pnas.252749899; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; Dockendorff TC, 1997, MOL CELL BIOL, V17, P906, DOI 10.1128/MCB.17.2.906; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Fahrenkrog B, 2004, TRENDS BIOCHEM SCI, V29, P175, DOI 10.1016/j.tibs.2004.02.006; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Fontoura BMA, 1999, J CELL BIOL, V144, P1097, DOI 10.1083/jcb.144.6.1097; Glavy JS, 2007, P NATL ACAD SCI USA, V104, P3811, DOI 10.1073/pnas.0700058104; Gurkan C, 2006, NAT REV MOL CELL BIO, V7, P727, DOI 10.1038/nrm2025; Hoelz A, 2004, NATURE, V432, P815, DOI 10.1038/432815a; Hoelz A, 2003, MOL CELL, V11, P1241, DOI 10.1016/S1097-2765(03)00171-0; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P163; LAFORTELLE ED, 1997, METHOD ENZYMOL, V276, P476; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lederkremer GZ, 2001, P NATL ACAD SCI USA, V98, P10704, DOI 10.1073/pnas.191359398; Loiodice I, 2004, MOL BIOL CELL, V15, P3333, DOI 10.1091/mbc.E03-12-0878; Lutzmann M, 2005, J BIOL CHEM, V280, P18442, DOI 10.1074/jbc.M412787200; Lutzmann M, 2002, EMBO J, V21, P387, DOI 10.1093/emboj/21.3.387; Melcak I, 2007, SCIENCE, V315, P1729, DOI 10.1126/science.1135730; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Salama NR, 1997, MOL BIOL CELL, V8, P205, DOI 10.1091/mbc.8.2.205; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Saxena K, 1996, BIOCHEMISTRY-US, V35, P15215, DOI 10.1021/bi961616x; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; Siniossoglou S, 2000, J CELL BIOL, V149, P41, DOI 10.1083/jcb.149.1.41; Stavropoulos P, 2006, NAT STRUCT MOL BIOL, V13, P626, DOI 10.1038/nsmb1113; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; Teixeira MT, 1997, EMBO J, V16, P5086, DOI 10.1093/emboj/16.16.5086; Vasu S, 2001, J CELL BIOL, V155, P339, DOI 10.1083/jcb.200108007; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Wyatt PJ, 1997, INSTRUM SCI TECHNOL, V25, P1, DOI 10.1080/10739149709351443; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4	51	102	105	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 28	2007	131	7					1313	1326		10.1016/j.cell.2007.11.038	http://dx.doi.org/10.1016/j.cell.2007.11.038			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GV	18160040	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000252217200020
J	Nakashiba, T; Young, JZ; McHugh, TJ; Buhl, DL; Tonegawa, S				Nakashiba, Toshiaki; Young, Jennie Z.; McHugh, Thomas J.; Buhl, Derek L.; Tonegawa, Susumu			Transgenic inhibition of synaptic transmission reveals role of CA3 output in hippocampal learning	SCIENCE			English	Article							NMDA RECEPTORS; ENTORHINAL CORTEX; NOVELTY DETECTION; IN-VIVO; MEMORY; NEURONS; STORAGE; RECALL; INACTIVATION; SUPPRESSION	The hippocampus is an area of the brain involved in learning and memory. It contains parallel excitatory pathways referred to as the trisynaptic pathway ( which carries information as follows: entorhinal cortex --> dentate gyrus --> CA3 --> CA1 --> entorhinal cortex) and the monosynaptic pathway ( entorhinal cortex --> CA1 --> entorhinal cortex). We developed a generally applicable tetanus toxin - based method for transgenic mice that permits inducible and reversible inhibition of synaptic transmission and applied it to the trisynaptic pathway while preserving transmission in the monosynaptic pathway. We found that synaptic output from CA3 in the trisynaptic pathway is dispensable and the short monosynaptic pathway is sufficient for incremental spatial learning. In contrast, the full trisynaptic pathway containing CA3 is required for rapid one- trial contextual learning, for pattern completion based memory recall, and for spatial tuning of CA1 cells.	[Nakashiba, Toshiaki; Young, Jennie Z.; McHugh, Thomas J.; Buhl, Derek L.; Tonegawa, Susumu] MIT, Dept Biol, RIKEN MIT Neurosci Res Ctr, Howard Hughes Med Inst,Picower Inst Learning & Me, Cambridge, MA 02139 USA; [Nakashiba, Toshiaki; Young, Jennie Z.; McHugh, Thomas J.; Buhl, Derek L.; Tonegawa, Susumu] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN; Massachusetts Institute of Technology (MIT)	Tonegawa, S (corresponding author), MIT, Dept Biol, RIKEN MIT Neurosci Res Ctr, Howard Hughes Med Inst,Picower Inst Learning & Me, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tonegawa@mit.edu	McHugh, Thomas J/A-6693-2010; McHugh, Thomas/M-6159-2019; Buhl, Derek/AAV-3911-2021	McHugh, Thomas J/0000-0002-1243-5189; McHugh, Thomas/0000-0002-1243-5189; Buhl, Derek/0000-0003-4433-7150	NIMH NIH HHS [R01-MH078821, P50-MH58880] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078821, P50MH058880] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; FANSELOW MS, 1990, ANIM LEARN BEHAV, V18, P264, DOI 10.3758/BF03205285; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Harms KJ, 2005, J COMP NEUROL, V490, P72, DOI 10.1002/cne.20635; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; Karpova AY, 2005, NEURON, V48, P727, DOI 10.1016/j.neuron.2005.11.015; Kumaran D, 2007, HIPPOCAMPUS, V17, P735, DOI 10.1002/hipo.20326; Lerchner W, 2007, NEURON, V54, P35, DOI 10.1016/j.neuron.2007.02.030; Lisman JE, 2001, HIPPOCAMPUS, V11, P551; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; McClelland JL, 1996, HIPPOCAMPUS, V6, P654; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; Nishimura-Akiyoshi S, 2007, P NATL ACAD SCI USA, V104, P14801, DOI 10.1073/pnas.0706919104; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; Rolls ET, 2006, PROG NEUROBIOL, V79, P1, DOI 10.1016/j.pneurobio.2006.04.005; Roozendaal B, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn766; Rudy JW, 1999, BEHAV NEUROSCI, V113, P867, DOI 10.1037/0735-7044.113.5.867; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Scoville WB, 2000, J NEUROPSYCH CLIN N, V12, P103; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Witter M., 2004, RAT NERVOUS SYSTEM, V3, P635, DOI [10.1016/B978-012547638-6/50022-5, DOI 10.1016/B978-012547638-6/50022-5]; Yamamoto M, 2003, J NEUROSCI, V23, P6759; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	34	345	347	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 29	2008	319	5867					1260	1264		10.1126/science.1151120	http://dx.doi.org/10.1126/science.1151120			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18218862				2022-12-28	WOS:000253530600049
J	Cummings, KJ; Kreiss, K				Cummings, Kristin J.; Kreiss, Kathleen			Contingent workers and contingent health - Risks of a modern economy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TEMPORARY EMPLOYMENT; SAFETY; EXPOSURE; INDUSTRY; INJURY		[Cummings, Kristin J.; Kreiss, Kathleen] NIOSH, Div Resp Dis Studies, Ctr Dis Control & Prevent, Morgantown, WV 26505 USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Cummings, KJ (corresponding author), NIOSH, Div Resp Dis Studies, Ctr Dis Control & Prevent, 1095 Willowdale Rd,MS 2800, Morgantown, WV 26505 USA.	cvx5@cdc.gov						Aiken LH, 1997, AM J PUBLIC HEALTH, V87, P103, DOI 10.2105/AJPH.87.1.103; APPLEBAUM E, 1992, NEW POLICIES PART TI, P1; Aronsson G, 1999, WORK EMPLOY SOC, V13, P439, DOI 10.1177/09500179922118024; Benach J, 2004, EUR J PUBLIC HEALTH, V14, P314, DOI 10.1093/eurpub/14.3.314; Benach J, 2000, AM J PUBLIC HEALTH, V90, P1316, DOI 10.2105/AJPH.90.8.1316; Benavides FG, 2006, OCCUP ENVIRON MED, V63, P416, DOI 10.1136/oem.2005.022301; Bohle P, 2004, REV SAUDE PUBL, V38, P19, DOI 10.1590/S0034-89102004000700004; Cummings KJ, 2006, ARCH ENVIRON OCCUP H, V61, P101, DOI 10.3200/AEOH.61.3.101-108; Glazner JE, 1998, AM J IND MED, V34, P105, DOI 10.1002/(SICI)1097-0274(199808)34:2<105::AID-AJIM2>3.0.CO;2-W; Hipple S, 2001, MON LABOR REV, V124, P3; Kivimaki M, 2003, AM J EPIDEMIOL, V158, P663, DOI 10.1093/aje/kwg185; KOCHAN TA, 1994, HUM RESOURCE MANAGE, V33, P55, DOI 10.1002/hrm.3930330105; Kreiss K, 2007, AM J RESP CRIT CARE, V176, P427, DOI 10.1164/rccm.200706-837ED; Mayhew C, 2002, SOCIOL HEALTH ILL, V24, P261, DOI 10.1111/1467-9566.00294; Morris J A, 1999, AAOHN J, V47, P470; Parker SK, 2002, PERS PSYCHOL, V55, P689, DOI 10.1111/j.1744-6570.2002.tb00126.x; Robertson R, 2006, GAO06656; Rousseau DM, 1997, CALIF MANAGE REV, V39, P103, DOI 10.2307/41165889; SCHROEDER P, 1995, WASH LEE L REV, V52, P731; Shane S., 2007, NY TIMES        0204; Silverstein B, 2002, AM J IND MED, V41, P149, DOI 10.1002/ajim.10054; Thebaud-Mony A, 1999, Int J Occup Environ Health, V5, P296; Valenzuela Abel., 2006, COMER DAY LABOR US; Virtanen M, 2005, INT J EPIDEMIOL, V34, P610, DOI 10.1093/ije/dyi024	24	61	61	2	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 30	2008	299	4					448	450		10.1001/jama.299.4.448	http://dx.doi.org/10.1001/jama.299.4.448			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	256JK	18230783				2022-12-28	WOS:000252724500023
J	Luguet, A; Pearson, DG; Nowell, GM; Dreher, ST; Coggon, JA; Spetsius, ZV; Parman, SW				Luguet, Ambre; Pearson, D. Graham; Nowell, Geoff M.; Dreher, Scott T.; Coggon, Judith A.; Spetsius, Zdislav V.; Parman, Stephen W.			Enriched Pt-Re-Os isotope systematics in plume lavas explained by metasomatic sulfides	SCIENCE			English	Article							CORE-MANTLE INTERACTION; OS-186-OS-187 SYSTEMATICS; OCEANIC-CRUST; INNER-CORE; PERIDOTITES; GEOCHEMISTRY; KOMATIITES; EVOLUTION; PRESSURE; BENEATH	To explain the elevated osmium isotope ( (Os-187Os)-Os-186) signatures in oceanic basalts, the possibility of material flux from the metallic core into the crust has been invoked. This hypothesis conflicts with theoretical constraints on Earth's thermal and dynamic history. To test the veracity and uniqueness of elevated Os-186-Os-187 in tracing core- mantle exchange, we present highly siderophile element analyses of pyroxenites, eclogites plus their sulfides, and new Os-186/Os-188 measurements on pyroxenites and platinum- rich alloys. Modeling shows that involvement in the mantle source of either bulk pyroxenite or, more likely, metasomatic sulfides derived from either pyroxenite or peridotite melts can explain the Os-186-Os-187 signatures of oceanic basalts. This removes the requirement for core- mantle exchange and provides an effective mechanism for generating Os isotope diversity in basalt source regions.	[Luguet, Ambre; Pearson, D. Graham; Nowell, Geoff M.; Dreher, Scott T.; Coggon, Judith A.; Parman, Stephen W.] Univ Durham, Dept Earth Sci, No Ctr Isotop & Elemental Tracing, Durham DH1 3LE, England; [Spetsius, Zdislav V.] ALROSA Joint Stock Co, Yakutian Res & Design Inst Diamond Min Ind, Mirny 678170, Yakutia, Russia	Durham University	Luguet, A (corresponding author), Univ Bonn, Mineral Petrol Inst, Poppelsdorfer Schloss, D-53115 Bonn, Germany.	ambre.luguet@durham.ac.uk	Pearson, Graham/AAN-5507-2020	Nowell, Geoff/0000-0003-3229-128X; luguet, ambre/0000-0002-4899-8776				Alard O, 2005, NATURE, V436, P1005, DOI 10.1038/nature03902; Baker JA, 2004, EARTH PLANET SC LETT, V220, P277, DOI 10.1016/S0012-821X(04)00059-7; Borisov A, 2000, AM MINERAL, V85, P1665; Brandon AD, 1999, EARTH PLANET SC LETT, V174, P25, DOI 10.1016/S0012-821X(99)00251-4; Brandon AD, 2005, EARTH PLANET SC LETT, V232, P211, DOI 10.1016/j.epsl.2005.01.034; Brandon AD, 2003, EARTH PLANET SC LETT, V206, P411, DOI 10.1016/S0012-821X(02)01101-9; Griffin WL, 2004, CHEM GEOL, V208, P89, DOI 10.1016/j.chemgeo.2004.04.007; Hofmann A.W., 2003, TREAT GEOCHEM, V2, P61, DOI DOI 10.1016/B0-08-043751-6/02123-X; Labrosse S, 2001, EARTH PLANET SC LETT, V190, P111, DOI 10.1016/S0012-821X(01)00387-9; LORAND JP, 1989, J PETROL, V30, P987, DOI 10.1093/petrology/30.4.987; Luguet A, 2001, EARTH PLANET SC LETT, V189, P285, DOI 10.1016/S0012-821X(01)00357-0; Luguet A, 2004, CHEM GEOL, V208, P175, DOI 10.1016/j.chemgeo.2004.04.011; MACGREGOR ID, 1986, J GEOPHYS RES-SOLID, V91, P14063, DOI 10.1029/JB091iB14p14063; Mavrogenes JA, 1999, GEOCHIM COSMOCHIM AC, V63, P1173, DOI 10.1016/S0016-7037(98)00289-0; Meibom A, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002602; Nimmo F, 2004, GEOPHYS J INT, V156, P363, DOI 10.1111/j.1365-246X.2003.02157.x; Pearson DG, 2007, NATURE, V449, P202, DOI 10.1038/nature06122; Pearson DG, 2004, CHEM GEOL, V208, P29, DOI 10.1016/j.chemgeo.2004.04.005; Pearson DG, 2004, J PETROL, V45, P439, DOI 10.1093/petrology/egg102; PEARSON DG, 1995, GEOCHIM COSMOCHIM AC, V59, P959, DOI 10.1016/00167-0379(50)00143-; Puchtel IS, 2005, EARTH PLANET SC LETT, V237, P118, DOI 10.1016/j.epsl.2005.04.023; Schersten A, 2004, NATURE, V427, P234, DOI 10.1038/nature02221; Smith AD, 2003, J GEODYN, V36, P469, DOI 10.1016/S0264-3707(02)00108-4; Sobolev AV, 2007, SCIENCE, V316, P412, DOI 10.1126/science.1138113; Sobolev AV, 2005, NATURE, V434, P590, DOI 10.1038/nature03411; Van Orman JA, 2006, GEOCHIM COSMOCHIM AC, V70, pA666, DOI 10.1016/j.gca.2006.06.1244; Walker RJ, 2005, EARTH PLANET SC LETT, V230, P211, DOI 10.1016/j.epsl.2004.11.009; Walker RJ, 1997, GEOCHIM COSMOCHIM AC, V61, P4799, DOI 10.1016/S0016-7037(97)00270-6; Yaxley GM, 1998, SCHWEIZ MINER PETROG, V78, P243	29	110	115	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2008	319	5862					453	456		10.1126/science.1149868	http://dx.doi.org/10.1126/science.1149868			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254HB	18218894				2022-12-28	WOS:000252576600035
J	Bose, D; Philipp, S				Bose, Dirk; Philipp, Sebastian			High-resolution imaging of myocardial bridging	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bose, Dirk; Philipp, Sebastian] W German Heart Ctr Essen, D-45147 Essen, Germany		Bose, D (corresponding author), W German Heart Ctr Essen, D-45147 Essen, Germany.	sebastian.philipp@uk-essen.de							0	6	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2008	358	4					392	392		10.1056/NEJMicm072887	http://dx.doi.org/10.1056/NEJMicm072887			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253GY	18216360				2022-12-28	WOS:000252507900010
J	Cherry, JD				Cherry, James D.			Croup	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RACEMIC EPINEPHRINE; BACTERIAL TRACHEITIS; ORAL DEXAMETHASONE; STEROID TREATMENT; LARYNGOTRACHEITIS; CHILDREN; LARYNGOTRACHEOBRONCHITIS; THERAPY; TRIAL; BUDESONIDE		[Cherry, James D.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Cherry, James D.] Univ Calif Los Angeles, Mattel Childrens Hosp, Div Infect Dis, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Cherry, JD (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, 10833 Le Conte Ave,MDCC 22-442, Los Angeles, CA 90095 USA.	jcherry@mednet.ucla.edu						[Anonymous], 2007, GUID DIAGN MAN CROUP; Ausejo M, 1999, BRIT MED J, V319, P595, DOI 10.1136/bmj.319.7210.595; Bjornson CL, 2005, PEDIATR EMERG CARE, V21, P863, DOI 10.1097/01.pec.0000190225.04986.e0; Bjornson CL, 2004, NEW ENGL J MED, V351, P1306, DOI 10.1056/NEJMoa033534; BURTON DM, 1992, INT J PEDIATR OTORHI, V23, P171, DOI 10.1016/0165-5876(92)90053-R; *CAN PAED SOC, 1992, CMAJ, V147, P429; *CAN PAED SOC, 1993, CMAJ, V148, P492; Cetinkaya F, 2004, INT J PEDIATR OTORHI, V68, P453, DOI 10.1016/j.ijporl.2003.11.017; Cherry James D, 2005, Pediatr Infect Dis J, V24, pS198, DOI 10.1097/01.inf.0000188156.23182.eb; Cherry James D., 1993, P654, DOI 10.1017/CHOL9780521332866.092; CHERRY JD, 1979, J PEDIATR-US, V94, P352, DOI 10.1016/S0022-3476(79)80883-5; CHERRY JD, 1981, CURRENT CLIN TOPICS, P1; CORNELI HM, 1992, AM FAM PHYSICIAN, V46, P683; DAVISON FW, 1959, JAMA-J AM MED ASSOC, V171, P1301, DOI 10.1001/jama.1959.03010280025006; DAVISON FW, 1950, PA MED J, V53, P250; DENNY FW, 1983, PEDIATRICS, V71, P871; DUDIN AA, 1990, PEDIATR INFECT DIS J, V9, P293, DOI 10.1097/00006454-199004000-00015; Feigin RD, 2004, TXB PEDIAT INFECT DI, V5th, P252; Fitzgerald DA, 2006, PAEDIATR RESPIR REV, V7, P73, DOI 10.1016/j.prrv.2005.09.002; FOGEL JM, 1982, J PEDIATR-US, V101, P1028, DOI 10.1016/S0022-3476(82)80039-5; GARDNER HG, 1973, PEDIATRICS, V52, P52; Geelhoed GC, 1996, ANN EMERG MED, V28, P621, DOI 10.1016/S0196-0644(96)70084-7; Geelhoed GC, 2005, PEDIATR EMERG CARE, V21, P359, DOI 10.1097/01.pec.0000166724.99555.de; HALL CB, 2004, TXB PEDIAT INFECT DI, P2270; Hopkins A, 2006, PEDIATRICS, V118, P1418, DOI 10.1542/peds.2006-0692; Johnson DW, 1996, ARCH PEDIAT ADOL MED, V150, P349, DOI 10.1001/archpedi.1996.02170290015002; JONES R, 1979, JAMA-J AM MED ASSOC, V242, P721, DOI 10.1001/jama.242.8.721; KAIRYS SW, 1989, PEDIATRICS, V83, P683; KASIAN GF, 1989, CAN MED ASSOC J, V140, P46; KELLEY PB, 1992, AM J EMERG MED, V10, P181, DOI 10.1016/0735-6757(92)90204-B; Moore M, 2006, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CDC002870.PUB2; Myers C, 2006, PEDIATR INFECT DIS J, V25, P753, DOI 10.1097/01.inf.0000227822.76682.1c; Orton HB, 1941, ARCHIV OTOLARYNGOL, V33, P926; Ottolini MG, 2002, J INFECT DIS, V186, P1713, DOI 10.1086/345834; PRENDERGAST M, 1994, AM J EMERG MED, V12, P613, DOI 10.1016/0735-6757(94)90024-8; Prevention and control of tuberculosis in correctional and detention facilities: recommendations from CDC, 2006, MMWR RECOMM REP, V55, P1; RICHARDS L, 1938, ANN OTO RHINOL LARYN, V47, P326; Russel K, 2003, COCHRANE DB SYST REV, V4; Scolnik D, 2006, JAMA-J AM MED ASSOC, V295, P1274, DOI 10.1001/jama.295.11.1274; Segal AO, 2005, PEDIATRICS, V116, P51, DOI 10.1542/peds.2004-1892; Sparrow A, 2006, ARCH DIS CHILD, V91, P580, DOI 10.1136/adc.2005.089516; SUPER DM, 1989, J PEDIATR-US, V115, P323, DOI 10.1016/S0022-3476(89)80095-2; SZPUNAR J, 1971, ARCHIV OTOLARYNGOL, V93, P173; TAUSSIG LM, 1975, AM J DIS CHILD, V129, P790, DOI 10.1001/archpedi.1975.02120440016004; Tenenbein M, 2005, PEDIATRICS, V116, P230, DOI 10.1542/peds.2005-0676; WAISMAN Y, 1992, PEDIATRICS, V89, P302; Weber JE, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.6.e96; WELLIVER RC, 1985, PEDIATR RES, V19, P716, DOI 10.1203/00006450-198507000-00016; Welliver RC, 1995, SEMIN PEDIAT INFECT, V6, P90; WESTLEY CR, 1978, AM J DIS CHILD, V132, P484, DOI 10.1001/archpedi.1978.02120300044008; 2006, MMWR MORB MORTAL WKL, V55, P800	51	66	69	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2008	358	4					384	391		10.1056/NEJMcp072022	http://dx.doi.org/10.1056/NEJMcp072022			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253GY	18216359				2022-12-28	WOS:000252507900009
J	Torre-Amione, G; Anker, SD; Bourge, RC; Colucci, WS; Greenberg, BH; Hildebrandt, P; Keren, A; Motro, M; Moye, LA; Otterstad, JE; Pratt, CM; Ponikowski, P; Rouleau, JL; Sestier, F; Winkelmann, BR; Young, JB				Torre-Amione, Guillermo; Anker, Stefan D.; Bourge, Robert C.; Colucci, Wilson S.; Greenberg, Barry H.; Hildebrandt, Per; Keren, Andre; Motro, Michael; Moye, Lemuel A.; Otterstad, Jan Erik; Pratt, Craig M.; Ponikowski, Piotr; Rouleau, Jean Lucien; Sestier, Francois; Winkelmann, Bernhard R.; Young, James B.		Adv Chronic Heart Failure Clinical	Results of a non-specific immunomodulation therapy on chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial	LANCET			English	Article							IMMUNE-MODULATION THERAPY; NECROSIS-FACTOR-ALPHA; LEFT-VENTRICULAR DYSFUNCTION; DILATED CARDIOMYOPATHY; CYTOKINE PRODUCTION; APOPTOTIC CELLS; IMMUNOGLOBULIN; ETANERCEPT	Background Evidence suggests that inflammatory mediators contribute to development and progression of chronic heart failure. We therefore tested the hypothesis that immunomodulation might counteract this pathophysiological mechanism in patients. Methods We did a double-blind, placebo-controlled study of a device-based non-specific immunomodulation therapy (IMT) in patients with New York Heart Association (NYHA) functional class II-IV chronic heart failure, left ventricular (LV) systolic dysfunction, and hospitalisation for heart failure or intravenous drug therapy in an outpatient setting within the past 12 months. Patients were randomly assigned to receive IMT (n=1213) or placebo (n=1213) by intragluteal injection on days 1, 2, 14, and every 28 days thereafter. Primary endpoint was the composite of time to death from any cause or first hospitalisation for cardiovascular reasons. The study continued until 828 primary endpoint events had accrued and all study patients had been treated for at least 22 weeks. Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00111969. Findings During a mean follow-up of 10 . 2 months, there were 399 primary events in the IMT group and 429 in the placebo group (hazard ratio 0 . 92; 95% CI 0 . 80-1.05; p=0 . 22). In two prespecified subgroups of patients-those with no history of previous myocardial infarction (n=919) and those with NYHA II heart failure (n=689)-IMT was associated with a 26% (0.74; 0 . 57-0 . 95; p=0.02) and a 39% (0.61; 95% CI 0 . 46-0.80; p=0 . 0003) reduction in the risk of primary endpoint events, respectively. Interpretation Non-specific immunomodulation may have a role as a potential treatment for a large segment of the heart failure population, which includes patients without a history of myocardial infarction (irrespective of their functional NYHA class) and patients within NYHA class II.	[Torre-Amione, Guillermo; Pratt, Craig M.] Methodist Hosp, Methodist DeBakey Heart Ctr, Heart Transplant Program, Houston, TX 77030 USA; [Anker, Stefan D.] Charite Univ Med Berlin, Berlin, Germany; [Bourge, Robert C.] Univ Alabama, Birmingham, AL USA; [Colucci, Wilson S.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Greenberg, Barry H.] Univ Calif San Diego, Med Ctr, San Diego, CA 92103 USA; [Hildebrandt, Per] Frederiksberg Univ Hosp, Frederiksberg, Denmark; [Keren, Andre] Hadassah Univ Hosp, IL-91120 Jerusalem, Israel; [Motro, Michael] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; [Moye, Lemuel A.] Univ Texas Houston, Hlth Sci Ctr, Houston, TX USA; [Otterstad, Jan Erik] Hosp Vestfold, Tonsberg, Norway; [Ponikowski, Piotr] Mil Hosp, Wroclaw, Poland; [Rouleau, Jean Lucien] Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada; [Sestier, Francois] Univ Montreal, Ctr Hosp, Ctr Rech, Hotel Dieu, Montreal, PQ, Canada; [Winkelmann, Bernhard R.] Kardiol Gemeinschaftspraxis, Frankfurt, Germany; [Young, James B.] Cleveland Clin, Cleveland, OH 44106 USA	The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Alabama System; University of Alabama Birmingham; Boston University; University of California System; University of California San Diego; Hebrew University of Jerusalem; Chaim Sheba Medical Center; University of Texas System; University of Texas Health Science Center Houston; Universite de Montreal; Laval University; Universite de Montreal; Cleveland Clinic Foundation	Torre-Amione, G (corresponding author), Methodist Hosp, Methodist DeBakey Heart Ctr, Heart Transplant Program, 6550 Fannin,Suite 1901, Houston, TX 77030 USA.	gtorre@tmhs.org	Ponikowski, Piotr/O-6454-2015	Ponikowski, Piotr/0000-0002-3391-7064; Torre-Amione, Guillermo/0000-0001-9950-0416; Colucci, Wilson/0000-0002-0576-9420				Aukrust P, 1999, AM J CARDIOL, V83, P376, DOI 10.1016/S0002-9149(98)00872-8; Babaei S, 2002, ATHEROSCLEROSIS, V162, P45, DOI 10.1016/S0021-9150(01)00680-3; Bolton AE, 2005, AM J CARDIOL, V95, p24C, DOI 10.1016/j.amjcard.2005.03.009; Bozkurt B, 1998, CIRCULATION, V97, P1382, DOI 10.1161/01.CIR.97.14.1382; Castoldi G, 2007, CLIN SCI, V113, P103, DOI 10.1042/CS20060338; Chung ES, 2003, CIRCULATION, V107, P3133, DOI 10.1161/01.CIR.0000077913.60364.D2; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Gullestad L, 2001, CIRCULATION, V103, P220; Hunt SA, 2005, J AM COLL CARDIOL, V46, P1116, DOI [DOI 10.1016/j.jacc.2005.08.023, DOI 10.1016/J.JACC.2005.08.023]; Kubota T, 1997, CIRC RES, V81, P627, DOI 10.1161/01.RES.81.4.627; Mann DL, 2004, CIRCULATION, V109, P1594, DOI 10.1161/01.CIR.0000124490.27666.B2; Mann DL, 2002, CIRC RES, V91, P988, DOI 10.1161/01.RES.0000043825.01705.1B; MATSUMORI A, 1994, BRIT HEART J, V72, P561; Moye L. A, 2006, STAT REASONING MED I; Nolan Y, 2002, NEUROIMMUNOMODULAT, V10, P40, DOI 10.1159/000064413; OLIN JW, 2006, AM COLL CARD 55 ANN; PARRILLO JE, 1989, NEW ENGL J MED, V321, P1061, DOI 10.1056/NEJM198910193211601; Ramasubbu Kumudha, 2006, Congest Heart Fail, V12, P153; Rector TS, 1987, HEART FAIL, V3, P198; Shivji G M, 2000, J Cutan Med Surg, V4, P132; Staudt A, 2001, CIRCULATION, V103, P2681; Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204; Torre-Amione G, 2004, J AM COLL CARDIOL, V44, P1181, DOI 10.1016/j.jacc.2004.06.047; Torre-Amione G, 2007, TRANSPLANTATION, V84, P480, DOI 10.1097/01.tp.0000276990.78659.77; Torre-Amione G, 2007, CAN J CARDIOL, V23, P369, DOI 10.1016/S0828-282X(07)70770-5; TorreAmione G, 1996, J AM COLL CARDIOL, V27, P1201, DOI 10.1016/0735-1097(95)00589-7; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022	27	132	140	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 19	2008	371	9608					228	236		10.1016/S0140-6736(08)60134-8	http://dx.doi.org/10.1016/S0140-6736(08)60134-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	252UK	18207018				2022-12-28	WOS:000252471900026
J	Harjes, CE; Rocheford, TR; Bai, L; Brutnell, TP; Kandianis, CB; Sowinski, SG; Stapleton, AE; Vallabhaneni, R; Williams, M; Wurtzel, ET; Yan, JB; Buckler, ES				Harjes, Carlos E.; Rocheford, Torbert R.; Bai, Ling; Brutnell, Thomas P.; Kandianis, Catherine Bermudez; Sowinski, Stephen G.; Stapleton, Ann E.; Vallabhaneni, Ratnakar; Williams, Mark; Wurtzel, Eleanore T.; Yan, Jianbing; Buckler, Edward S.			Natural genetic variation in lycopene epsilon cyclase tapped for maize biofortification	SCIENCE			English	Article							VITAMIN-A-DEFICIENCY; LINKAGE DISEQUILIBRIUM; Y1 GENE; CAROTENOIDS; BETA; FORTIFICATION; BIOSYNTHESIS; REVEALS	Dietary vitamin A deficiency causes eye disease in 40 million children each year and places 140 to 250 million at risk for health disorders. Many children in sub- Saharan Africa subsist on maize- based diets. Maize displays considerable natural variation for carotenoid composition, including vitamin A precursors alpha-carotene, beta-carotene, and beta-cryptoxanthin. Through association analysis, linkage mapping, expression analysis, and mutagenesis, we show that variation at the lycopene epsilon cyclase (lcyE) locus alters flux down alpha-carotene versus beta-carotene branches of the carotenoid pathway. Four natural lcyE polymorphisms explained 58% of the variation in these two branches and a threefold difference in provitamin A compounds. Selection of favorable lcyE alleles with inexpensive molecular markers will now enable developing- country breeders to more effectively produce maize grain with higher provitamin A levels.	[Rocheford, Torbert R.; Kandianis, Catherine Bermudez] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Harjes, Carlos E.; Buckler, Edward S.] Cornell Univ, Inst Genom Divers, Ithaca, NY 14853 USA; [Bai, Ling; Brutnell, Thomas P.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Sowinski, Stephen G.; Williams, Mark] DuPont Crop Genet Res, Wilmington, DE 19880 USA; [Stapleton, Ann E.] Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28403 USA; [Vallabhaneni, Ratnakar; Wurtzel, Eleanore T.] CUNY Herbert H Lehman Coll, Dept Biol Sci, Bronx, NY 10468 USA; [Vallabhaneni, Ratnakar; Wurtzel, Eleanore T.] CUNY Grad Sch & Univ Ctr, New York, NY 10016 USA; [Yan, Jianbing] CIMMYT, Mexico City 06600, DF, Mexico; [Buckler, Edward S.] ARS, USDA, Plant Soil & Nutr Res Unit, Ithaca, NY 14853 USA; [Buckler, Edward S.] Cornell Univ, Dept Genet & Plant Breeding, Ithaca, NY 14853 USA	University of Illinois System; University of Illinois Urbana-Champaign; Cornell University; Cornell University; Boyce Thompson Institute for Plant Research; DuPont; University of North Carolina; University of North Carolina Wilmington; City University of New York (CUNY) System; Lehman College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) Graduate School; CGIAR; International Maize & Wheat Improvement Center (CIMMYT); United States Department of Agriculture (USDA); Cornell University	Rocheford, TR (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	trochefo@uiuc.edu; esb33@cornell.edu	Brutnell, Thomas/M-2840-2013; Buckler, Edward/GPS-4932-2022; Buckler, Edward/L-7651-2019	Brutnell, Thomas/0000-0002-3581-8211; Buckler, Edward/0000-0002-3100-371X; Stapleton, Ann/0000-0001-7242-2673; Wurtzel, Eleanore/0000-0002-9186-3260	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008225, SC1GM081160] Funding Source: NIH RePORTER; NIGMS NIH HHS [SC1 GM081160, SC1 GM081160-01, SC1 GM081160-02, S06-GM08225] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asins MJ, 2002, PLANT BREEDING, V121, P281, DOI 10.1046/j.1439-0523.2002.730285.x; Buckner B, 1996, GENETICS, V143, P479; Cunningham FX, 1996, PLANT CELL, V8, P1613, DOI 10.1105/tpc.8.9.1613; Dary O, 2002, J NUTR, V132, p2927S, DOI 10.1093/jn/132.9.2927S; DellaPenna D, 2006, ANNU REV PLANT BIOL, V57, P711, DOI 10.1146/annurev.arplant.56.032604.144301; Diretto G, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-13; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002; Graham RD, 2001, ADV AGRON, V70, P77, DOI 10.1016/S0065-2113(01)70004-1; Howe JA, 2006, J NUTR, V136, P2562, DOI 10.1093/jn/136.10.2562; Li FQ, 2007, PLANT PHYSIOL, V144, P1181, DOI 10.1104/PP.107.098996; Li S, 2007, J AGR FOOD CHEM, V55, P10744, DOI 10.1021/jf071815v; Low JW, 2007, J NUTR, V137, P1320; Matthews PD, 2008, CHEM FUNCT PROP FOOD, P347; Mora JO, 2003, J NUTR, V133, p2990S, DOI 10.1093/jn/133.9.2990S; Palaisa K, 2004, P NATL ACAD SCI USA, V101, P9885, DOI 10.1073/pnas.0307839101; Pecker I, 1996, PLANT MOL BIOL, V30, P807, DOI 10.1007/BF00019013; Pogson B, 1996, PLANT CELL, V8, P1627, DOI 10.1105/tpc.8.9.1627; Pogson BJ, 2000, PHILOS T ROY SOC B, V355, P1395, DOI 10.1098/rstb.2000.0701; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; STEVENS RA, IN PRESS FOOD POLICY; Underwood BA, 2004, J NUTR, V134, p231S, DOI 10.1093/jn/134.1.231S; van Lieshout M, 2005, AM J CLIN NUTR, V81, P943, DOI 10.1093/ajcn/81.4.943; West CE, 2000, NUTR REV, V58, P341, DOI 10.1111/j.1753-4887.2000.tb01831.x; Wong JC, 2004, THEOR APPL GENET, V108, P349, DOI 10.1007/s00122-003-1436-4; YU B, 2007, TRANSGENIC RES, DOI DOI 10.1007/S11248; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702	27	533	577	0	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2008	319	5861					330	333		10.1126/science.1150255	http://dx.doi.org/10.1126/science.1150255			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252GY	18202289	Green Accepted			2022-12-28	WOS:000252436200038
J	Paller, AS; Siegfried, EC; Langley, RG; Gottlieb, AB; Pariser, D; Landells, I; Hebert, AA; Eichenfield, LF; Patel, V; Creamer, K; Jahreis, A				Paller, Amy S.; Siegfried, Elaine C.; Langley, Richard G.; Gottlieb, Alice B.; Pariser, David; Landells, Ian; Hebert, Adelaide A.; Eichenfield, Lawrence F.; Patel, Vaishali; Creamer, Kara; Jahreis, Angelika		Etanercept Pediat Psoriasis Study	Etanercept treatment for children and adolescents with plaque psoriasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SUICIDAL IDEATION; THERAPY; TRIAL; RISK; MONOTHERAPY; DEPRESSION; EFFICACY; OBESITY; SAFETY	Background: Etanercept, a soluble tumor necrosis factor receptor, has been shown to lessen disease severity in adult patients with psoriasis. We assessed the efficacy and safety of etanercept in children and adolescents with moderate-to-severe plaque psoriasis. Methods: In this 48-week study, 211 patients with psoriasis (4 to 17 years of age) were initially randomly assigned to a double-blind trial of 12 once-weekly subcutaneous injections of placebo or 0.8 mg of etanercept per kilogram of body weight (to a maximum of 50 mg), followed by 24 weeks of once-weekly open-label etanercept. At week 36, 138 patients underwent a second randomization to placebo or etanercept to investigate the effects of withdrawal and retreatment. The primary end point was 75% or greater improvement from baseline in the psoriasis area-and-severity index (PASI 75) at week 12. Secondary end points included PASI 50, PASI 90, physician's global assessment of clear or almost clear of disease, and safety assessments. Results: At week 12, 57% of patients receiving etanercept achieved PASI 75, as compared with 11% of those receiving placebo (P<0.001). A significantly higher proportion of patients in the etanercept group than in the placebo group had PASI 50 (75% vs. 23%), PASI 90 (27% vs. 7%), and a physician's global assessment of clear or almost clear (53% vs. 13%) at week 12 (P<0.001). At week 36, after 24 weeks of open-label etanercept, rates of PASI 75 were 68% and 65% for patients initially assigned to etanercept and placebo, respectively. During the withdrawal period from week 36 to week 48, response was lost by 29 of 69 patients (42%) assigned to placebo at the second randomization. Four serious adverse events (including three infections) occurred in three patients during treatment with open-label etanercept; all resolved without sequelae. Conclusions: Etanercept significantly reduced disease severity in children and adolescents with moderate-to-severe plaque psoriasis. (ClinicalTrials.gov number, NCT00078819.).	[Paller, Amy S.] Childrens Mem Hosp, Chicago, IL 60614 USA; [Paller, Amy S.] Northwestern Univ, Sch Med, Chicago, IL USA; [Siegfried, Elaine C.] St Louis Univ, Cardinal Glennon Childrens Hosp, St Louis, MO USA; [Langley, Richard G.] Dalhousie Med Sch, Halifax, NS, Canada; [Gottlieb, Alice B.] Tufts Univ New England Med Ctr, Boston, MA USA; [Pariser, David] Eastern Virginia Med Sch, Norfolk, VA 23501 USA; [Pariser, David] Virginia Clin Res, Norfolk, VA USA; [Landells, Ian] Nexus Clin Res, St John, NF, Canada; [Hebert, Adelaide A.] Univ Texas Houston, Dermatol Clin Res Ctr, Houston, TX USA; [Eichenfield, Lawrence F.] Rady Childrens Hosp, San Diego, CA USA; [Eichenfield, Lawrence F.] Univ Calif San Diego, San Diego, CA 92103 USA; [Patel, Vaishali; Creamer, Kara; Jahreis, Angelika] Amgen Inc, Thousand Oaks, CA USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Saint Louis University; Dalhousie University; Tufts Medical Center; Eastern Virginia Medical School; University of Texas System; University of Texas Health Science Center Houston; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; Amgen	Paller, AS (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Dermatol, 676 N St Clair St,Suite 1600, Chicago, IL 60611 USA.	apaller@northwestern.edu		Paller, Amy/0000-0001-6187-6549				Brecher AR, 2003, J AM ACAD DERMATOL, V49, P171, DOI 10.1067/S0190-9622(03)01564-0; *CDCP, 2003, BMI BOD MASS IND BMI; FREDRIKSSON T, 1978, DERMATOLOGICA, V157, P238, DOI 10.1159/000250839; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Gottlieb AB, 2003, ARCH DERMATOL, V139, P1627, DOI 10.1001/archderm.139.12.1627; Gupta MA, 1998, BRIT J DERMATOL, V139, P846; GUPTA MA, 1993, INT J DERMATOL, V32, P188, DOI 10.1111/j.1365-4362.1993.tb02790.x; HENSELER T, 1995, J AM ACAD DERMATOL, V32, P982, DOI 10.1016/0190-9622(95)91336-X; Herron MD, 2005, ARCH DERMATOL, V141, P1527, DOI 10.1001/archderm.141.12.1527; *IMM, ENBR ET PRESCR INF; Lebwohl M, 1998, J AM ACAD DERMATOL, V39, P464, DOI 10.1016/S0190-9622(98)70325-1; Leonardi CL, 2003, NEW ENGL J MED, V349, P2014, DOI 10.1056/NEJMoa030409; LEWISJONES MS, 1995, BRIT J DERMATOL, V132, P942; Lewkowicz Debra, 2004, Dermatol Ther, V17, P364, DOI 10.1111/j.1396-0296.2004.04039.x; Lovell DJ, 2006, ARTHRITIS RHEUM, V54, P1987, DOI 10.1002/art.21885; LOVELL DJ, 2007, ANN RHEUM DIS S2, V66; Mallbris Lotus, 2006, Curr Rheumatol Rep, V8, P355, DOI 10.1007/s11926-006-0065-8; McGowan JW, 2005, ARCH DERMATOL, V141, P1601, DOI 10.1001/archderm.141.12.1601; Morris A, 2001, PEDIATR DERMATOL, V18, P188, DOI 10.1046/j.1525-1470.2001.018003188.x; *NAT CTR HLTH STAT, 2001, CLIN GROWTH CHARTS; Nestorov I, 2006, BRIT J CLIN PHARMACO, V62, P435, DOI 10.1111/j.1365-2125.2006.02581.x; Papp KA, 2005, BRIT J DERMATOL, V152, P1304, DOI 10.1111/j.1365-2133.2005.06688.x; Raychaudhuri SP, 2000, PEDIATR DERMATOL, V17, P174, DOI 10.1046/j.1525-1470.2000.01746.x; Sommer DM, 2006, ARCH DERMATOL RES, V298, P321, DOI 10.1007/s00403-006-0703-z; Stern RS, 1996, J PEDIATR-US, V129, P915, DOI 10.1016/S0022-3476(96)70039-2; STROBER B, 2006, 64 ANN M AM AC DERM; Tyring S, 2006, LANCET, V367, P29, DOI 10.1016/S0140-6736(05)67763-X; Uyanik BS, 2002, CLIN CHEM LAB MED, V40, P65, DOI 10.1515/CCLM.2002.013; VANELTEREN P, 1960, B INT STATIST INST, V37, P351; Wakkee M, 2007, ATHEROSCLEROSIS, V190, P1, DOI 10.1016/j.atherosclerosis.2006.07.011	30	298	308	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2008	358	3					241	251		10.1056/NEJMoa066886	http://dx.doi.org/10.1056/NEJMoa066886			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	251LS	18199863				2022-12-28	WOS:000252375600005
J	Yin, P; Choi, HMT; Calvert, CR; Pierce, NA				Yin, Peng; Choi, Harry M. T.; Calvert, Colby R.; Pierce, Niles A.			Programming biomolecular self-assembly pathways	NATURE			English	Article							DNA; DESIGN; HYBRIDIZATION; DEVICES; ENZYME; TRACK; FUEL	In nature, self- assembling and disassembling complexes of proteins and nucleic acids bound to a variety of ligands perform intricate and diverse dynamic functions. In contrast, attempts to rationally encode structure and function into synthetic amino acid and nucleic acid sequences have largely focused on engineering molecules that self- assemble into prescribed target structures, rather than on engineering transient system dynamics(1,2). To design systems that perform dynamic functions without human intervention, it is necessary to encode within the biopolymer sequences the reaction pathways by which self- assembly occurs. Nucleic acids show promise as a design medium for engineering dynamic functions, including catalytic hybridization(3-6), triggered self- assembly(7) and molecular computation(8,9). Here, we program diverse molecular self- assembly and disassembly pathways using a 'reaction graph' abstraction to specify complementarity relationships between modular domains in a versatile DNA hairpin motif. Molecular programs are executed for a variety of dynamic functions: catalytic formation of branched junctions, autocatalytic duplex formation by a cross- catalytic circuit, nucleated dendritic growth of a binary molecular 'tree', and autonomous locomotion of a bipedal walker.	[Yin, Peng; Choi, Harry M. T.; Calvert, Colby R.; Pierce, Niles A.] CALTECH, Dept Bioengn, Pasadena, CA 91125 USA; [Yin, Peng] CALTECH, Dept Comp Sci, Pasadena, CA 91125 USA; [Pierce, Niles A.] CALTECH, Dept Appl & Computat Math, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology	Pierce, NA (corresponding author), CALTECH, Dept Bioengn, Pasadena, CA 91125 USA.	niles@caltech.edu	Pierce, Niles A/F-6535-2010	Choi, Harry/0000-0002-1530-0773				Asbury CL, 2005, CURR OPIN CELL BIOL, V17, P89, DOI 10.1016/j.ceb.2004.12.002; Bath J, 2005, ANGEW CHEM INT EDIT, V44, P4358, DOI 10.1002/anie.200501262; Bois JS, 2005, NUCLEIC ACIDS RES, V33, P4090, DOI 10.1093/nar/gki721; Butterfoss GL, 2006, ANNU REV BIOPH BIOM, V35, P49, DOI 10.1146/annurev.biophys.35.040405.102046; Dirks RM, 2004, P NATL ACAD SCI USA, V101, P15275, DOI 10.1073/pnas.0407024101; Dirks RM, 2004, NUCLEIC ACIDS RES, V32, P1392, DOI 10.1093/nar/gkh291; Dirks RM, 2007, SIAM REV, V49, P65, DOI 10.1137/060651100; Feldkamp U, 2006, ANGEW CHEM INT EDIT, V45, P1856, DOI 10.1002/anie.200502358; Flamm C, 2000, RNA, V6, P325, DOI 10.1017/S1355838200992161; Green SJ, 2006, BIOPHYS J, V91, P2966, DOI 10.1529/biophysj.106.084681; Hansma HG, 1996, BIOPHYS J, V70, P1933, DOI 10.1016/S0006-3495(96)79757-6; Lee DH, 1996, NATURE, V382, P525, DOI 10.1038/382525a0; Levy M, 2003, P NATL ACAD SCI USA, V100, P6416, DOI 10.1073/pnas.1130145100; Li YG, 2004, NAT MATER, V3, P38, DOI 10.1038/nmat1045; Paul N, 2002, P NATL ACAD SCI USA, V99, P12733, DOI 10.1073/pnas.202471099; Pei R, 2006, J AM CHEM SOC, V128, P12693, DOI 10.1021/ja058394n; Robertson A, 2000, CHEM SOC REV, V29, P141, DOI 10.1039/a803602k; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Rothemund PWK, 2004, PLOS BIOL, V2, P2041, DOI 10.1371/journal.pbio.0020424; Seelig G, 2006, J AM CHEM SOC, V128, P12211, DOI 10.1021/ja0635635; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Tian Y, 2005, ANGEW CHEM INT EDIT, V44, P4355, DOI 10.1002/anie.200500703; Turberfield AJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.118102; Venkataraman S, 2007, NAT NANOTECHNOL, V2, P490, DOI 10.1038/nnano.2007.225; VONKIEDROWSKI G, 1986, ANGEW CHEM INT EDIT, V25, P932, DOI 10.1002/anie.198609322; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yin P, 2004, ANGEW CHEM INT EDIT, V43, P4906, DOI 10.1002/anie.200460522; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Zhang DY, 2007, SCIENCE, V318, P1121, DOI 10.1126/science.1148532	32	1066	1123	57	912	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2008	451	7176					318	U4		10.1038/nature06451	http://dx.doi.org/10.1038/nature06451			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202654				2022-12-28	WOS:000252432100046
J	Perillo, B; Ombra, MN; Bertoni, A; Cuozzo, C; Sacchetti, S; Sasso, A; Chiariotti, L; Malorni, A; Abbondanza, C; Avvedimento, EV				Perillo, Bruno; Ombra, Maria Neve; Bertoni, Alessandra; Cuozzo, Concetta; Sacchetti, Silvana; Sasso, Annarita; Chiariotti, Lorenzo; Malorni, Antonio; Abbondanza, Ciro; Avvedimento, Enrico V.			DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression	SCIENCE			English	Article							RECEPTOR-REGULATED TRANSCRIPTION; HISTONE; LSD1; PROMOTER; CELLS	Modifications at the N- terminal tails of nucleosomal histones are required for efficient transcription in vivo. We analyzed how H3 histone methylation and demethylation control expression of estrogen- responsive genes and show that a DNA- bound estrogen receptor directs transcription by participating in bending chromatin to contact the RNA polymerase II recruited to the promoter. This process is driven by receptor- targeted demethylation of H3 lysine 9 at both enhancer and promoter sites and is achieved by activation of resident LSD1 demethylase. Localized demethylation produces hydrogen peroxide, which modifies the surrounding DNA and recruits 8- oxoguanine- DNA glycosylase 1 and topoisomerase II beta, triggering chromatin and DNA conformational changes that are essential for estrogen- induced transcription. Our data show a strategy that uses controlled DNA damage and repair to guide productive transcription.	[Perillo, Bruno; Ombra, Maria Neve; Malorni, Antonio] CNR, Ist Sci Alimentaz, I-83100 Avellino, Italy; [Bertoni, Alessandra; Sasso, Annarita; Chiariotti, Lorenzo; Avvedimento, Enrico V.] Univ Naples Federico 2, Dipartimento Biol & Patol Cellulare & Mol L Calif, I-80131 Naples, Italy; [Cuozzo, Concetta; Sacchetti, Silvana] Ctr Ingn Genet CEINGE, Naples Oncogenom Ctr, I-80131 Naples, Italy; [Abbondanza, Ciro] Univ Naples 2, Dipartimento Patol Gen, I-80138 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); University of Naples Federico II; Universita della Campania Vanvitelli	Perillo, B (corresponding author), CNR, Ist Sci Alimentaz, I-83100 Avellino, Italy.	perillo@unina.it; avvedim@unina.it	Hu, Ruogu/B-2203-2008; Chiariotti, Lorenzo/AAC-5262-2022	OMBRA, MARIA NEVE/0000-0002-2437-9276; ABBONDANZA, Ciro/0000-0001-5346-4835; Perillo, Bruno/0000-0001-8935-0370; CHIARIOTTI, Lorenzo/0000-0001-6097-4171	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Doisneau-Sixou SF, 2003, ENDOCR-RELAT CANCER, V10, P179, DOI 10.1677/erc.0.0100179; Felty Q, 2005, BIOCHEMISTRY-US, V44, P6900, DOI 10.1021/bi047629p; Forneris F, 2005, FEBS LETT, V579, P2203, DOI 10.1016/j.febslet.2005.03.015; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; KROEGER PE, 1993, J BIOL CHEM, V268, P16449; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Perillo B, 2000, MOL CELL BIOL, V20, P2890, DOI 10.1128/MCB.20.8.2890-2901.2000; Rajapakse N, 2005, ENVIRON MOL MUTAGEN, V45, P397, DOI 10.1002/em.20104; RoldanArjona T, 1997, P NATL ACAD SCI USA, V94, P8016, DOI 10.1073/pnas.94.15.8016; RUSSO MT, 2004, CANCER RES, V64, P1111; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shanmugam M, 1999, MOL CELL ENDOCRINOL, V148, P109, DOI 10.1016/S0303-7207(98)00229-9; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Vaute O, 2002, NUCLEIC ACIDS RES, V30, P475, DOI 10.1093/nar/30.2.475; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; YOUNG RL, 1993, MOL CELL BIOL, V13, P3686, DOI 10.1128/MCB.13.6.3686; Zhang H, 2006, EMBO J, V25, P4223, DOI 10.1038/sj.emboj.7601306	25	396	407	2	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2008	319	5860					202	206		10.1126/science.1147674	http://dx.doi.org/10.1126/science.1147674			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249RC	18187655				2022-12-28	WOS:000252246400041
J	Kamerow, D				Kamerow, Douglas			Waiting for the genetic revolution - Will 2008 be the year that genomics delivers on its promises?	BRITISH MEDICAL JOURNAL			English	Editorial Material												dkamerow@bmj.com		Kamerow, Douglas/0000-0001-7000-9957					0	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 5	2008	336	7634					22	22		10.1136/bmj.39437.453102.0F	http://dx.doi.org/10.1136/bmj.39437.453102.0F			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250UT	18174596	Green Published			2022-12-28	WOS:000252327500029
J	Bowman, JM				Bowman, Joel M.			Chemistry - Beyond Born-Oppenheimer	SCIENCE			English	Editorial Material							APPROXIMATION		Emory Univ, Dept Chem, Atlanta, GA 30322 USA	Emory University	Bowman, JM (corresponding author), Emory Univ, Dept Chem, 1515 Pierce Dr, Atlanta, GA 30322 USA.	jmbowma@emory.edu						Alexander MH, 2002, SCIENCE, V296, P715, DOI 10.1126/science.1070472; Capecehi G, 2004, PHYS CHEM CHEM PHYS, V6, P4975, DOI 10.1039/b411385c; Che L, 2007, SCIENCE, V317, P1061, DOI 10.1126/science.1144984; Chu TS, 2007, J PHYS CHEM A, V111, P8286, DOI 10.1021/jp075173q; Dong F, 2001, J CHEM PHYS, V115, P1197, DOI 10.1063/1.1378834; Garand E, 2008, SCIENCE, V319, P72, DOI 10.1126/science.1150602; Jasper AW, 2006, ACCOUNTS CHEM RES, V39, P101, DOI 10.1021/ar040206v; LANDAU LD, 1976, QUANTUM MECH, P265; Maiti B, 2004, J PHYS CHEM A, V108, P8772, DOI 10.1021/jp049143o; Manolopoulos DE, 2002, SCIENCE, V296, P664, DOI 10.1126/science.1071814; Neumark DM, 2005, PHYS CHEM CHEM PHYS, V7, P433, DOI 10.1039/b417886f	11	12	12	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2008	319	5859					40	41		10.1126/science.1152504	http://dx.doi.org/10.1126/science.1152504			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18174423				2022-12-28	WOS:000252084000017
J	Jan, YN; Jan, L				Jan, Yuh-Nung; Jan, Lily			Seymour Benzer (1921-2007) - Retrospective	SCIENCE			English	Biographical-Item									[Jan, Yuh-Nung; Jan, Lily] Univ Calif San Francisco, Dept Physiol, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Jan, Yuh-Nung; Jan, Lily] Univ Calif San Francisco, Dept Biochem, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Jan, Yuh-Nung; Jan, Lily] Univ Calif San Francisco, Dept Biophys, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Jan, YN (corresponding author), Univ Calif San Francisco, Dept Physiol, Howard Hughes Med Inst, Box 0444, San Francisco, CA 94143 USA.	yuhnung.jan@ucsf.edu; lily.jan@ucsf.edu		Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498					0	6	6	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2008	319	5859					45	45		10.1126/science.1154050	http://dx.doi.org/10.1126/science.1154050			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18174427				2022-12-28	WOS:000252084000021
J	Atsumi, S; Hanai, T; Liao, JC				Atsumi, Shota; Hanai, Taizo; Liao, James C.			Non-fermentative pathways for synthesis of branched-chain higher alcohols as biofuels	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; AMINO-ACIDS; CLOSTRIDIUM-ACETOBUTYLICUM; MOLECULAR CHARACTERIZATION; ISOLEUCINE BIOSYNTHESIS; DECARBOXYLASE; METABOLISM; GENE; 1,3-PROPANEDIOL	Global energy and environmental problems have stimulated increased efforts towards synthesizing biofuels from renewable resources(1-3). Compared to the traditional biofuel, ethanol, higher alcohols offer advantages as gasoline substitutes because of their higher energy density and lower hygroscopicity. In addition, branched- chain alcohols have higher octane numbers compared with their straight- chain counterparts. However, these alcohols cannot be synthesized economically using native organisms. Here we present a metabolic engineering approach using Escherichia coli to produce higher alcohols including isobutanol, 1-butanol, 2- methyl- 1- butanol, 3- methyl- 1- butanol and 2- phenylethanol from glucose, a renewable carbon source. This strategy uses the host's highly active amino acid biosynthetic pathway and diverts its 2- keto acid intermediates for alcohol synthesis. In particular, we have achieved high- yield, high- specificity production of isobutanol from glucose. The strategy enables the exploration of biofuels beyond those naturally accumulated to high quantities in microbial fermentation.	[Atsumi, Shota; Hanai, Taizo; Liao, James C.] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA; [Liao, James C.] Univ Calif Los Angeles, UCLA DOE Inst Genom & Proteom, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles	Liao, JC (corresponding author), Univ Calif Los Angeles, Dept Chem & Biomol Engn, 5531 Boelter Hall,420 Westwood Plaza, Los Angeles, CA 90095 USA.	liaoj@seas.ucla.edu		Atsumi, Shota/0000-0002-5782-4196; Liao, James/0000-0002-4580-7276				Alper H, 2006, SCIENCE, V314, P1565, DOI 10.1126/science.1131969; Barbirato F, 1996, APPL ENVIRON MICROB, V62, P1448, DOI 10.1128/AEM.62.4.1448-1451.1996; BOGOSIAN G, 1989, J BIOL CHEM, V264, P531; CALHOUN DH, 1973, J BIOL CHEM, V248, P3511; CHARON NW, 1974, J BACTERIOL, V117, P203, DOI 10.1128/JB.117.1.203-211.1974; de la Plaza M, 2004, FEMS MICROBIOL LETT, V238, P367, DOI 10.1016/j.femsle.2004.07.057; Dickinson JR, 1998, J BIOL CHEM, V273, P25751, DOI 10.1074/jbc.273.40.25751; Dickinson JR, 1997, J BIOL CHEM, V272, P26871, DOI 10.1074/jbc.272.43.26871; Dickinson JR, 2000, J BIOL CHEM, V275, P10937, DOI 10.1074/jbc.275.15.10937; Dickinson JR, 2003, J BIOL CHEM, V278, P8028, DOI 10.1074/jbc.M211914200; Farmer WR, 2000, NAT BIOTECHNOL, V18, P533, DOI 10.1038/75398; FLINT DH, 1993, J BIOL CHEM, V268, P14732; GOLLOP N, 1990, J BACTERIOL, V172, P3444, DOI 10.1128/jb.172.6.3444-3449.1990; HOHMANN S, 1991, J BACTERIOL, V173, P7963, DOI 10.1128/jb.173.24.7963-7969.1991; Howell DM, 1999, J BACTERIOL, V181, P331, DOI 10.1128/JB.181.1.331-333.1999; Ingram LO, 1999, BIOTECHNOL PROGR, V15, P855, DOI 10.1021/bp9901062; Khosla C, 2003, NAT REV DRUG DISCOV, V2, P1019, DOI 10.1038/nrd1256; Konig S, 1998, BBA-PROTEIN STRUCT M, V1385, P271, DOI 10.1016/S0167-4838(98)00074-0; LIN YL, 1983, APPL ENVIRON MICROB, V45, P966, DOI 10.1128/AEM.45.3.966-973.1983; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; MIWA K, 1983, AGR BIOL CHEM TOKYO, V47, P2329, DOI 10.1080/00021369.1983.10865958; NAIR RV, 1994, J BACTERIOL, V176, P871, DOI 10.1128/jb.176.3.871-885.1994; Pitera DJ, 2007, METAB ENG, V9, P193, DOI 10.1016/j.ymben.2006.11.002; RUSSELL DW, 1983, J BIOL CHEM, V258, P2674; SENTHESHANMUGANATHAN S, 1958, BIOCHEM J, V69, P210, DOI 10.1042/bj0690210; SENTHESHANMUGANATHAN S, 1960, BIOCHEM J, V74, P568, DOI 10.1042/bj0740568; Vuralhan Z, 2003, APPL ENVIRON MICROB, V69, P4534, DOI 10.1128/AEM.69.8.4534-4541.2003; WOODS DR, 1995, TRENDS BIOTECHNOL, V13, P259, DOI 10.1016/S0167-7799(00)88960-X; Xu H, 2004, J BACTERIOL, V186, P5400, DOI 10.1128/JB.186.16.5400-5409.2004; Zhu MM, 2002, BIOTECHNOL PROGR, V18, P694, DOI 10.1021/bp020281+	30	1384	1621	28	739	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2008	451	7174					86	U13		10.1038/nature06450	http://dx.doi.org/10.1038/nature06450			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247KZ	18172501				2022-12-28	WOS:000252079300039
J	Sierra-Johnson, J; Romero-Corral, A; Lopez-Jimenez, F				Sierra-Johnson, Justo; Romero-Corral, Abel; Lopez-Jimenez, Francisco			Utility of different lipid measures to predict coronary heart disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Sierra-Johnson, Justo] Karolinska Inst, Dept Med, Atherosclerosis Res Unit, Stockholm, Sweden; [Romero-Corral, Abel; Lopez-Jimenez, Francisco] Mayo Clin & Mayo Fdn, Dept Internal Med, Div Cardiovasc Dis, Rochester, MN 55905 USA	Karolinska Institutet; Mayo Clinic	Sierra-Johnson, J (corresponding author), Karolinska Inst, Dept Med, Atherosclerosis Res Unit, Stockholm, Sweden.	jusier@ki.se	Shah, Nirav R./B-6622-2008	Shah, Nirav R./0000-0003-2044-7865				Ingelsson E, 2007, JAMA-J AM MED ASSOC, V298, P776, DOI 10.1001/jama.298.7.776; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Thompson A, 2006, J INTERN MED, V259, P481, DOI 10.1111/j.1365-2796.2006.01644.x	3	6	6	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2008	299	1					35	35		10.1001/jama.2007.3	http://dx.doi.org/10.1001/jama.2007.3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247BL	18167403				2022-12-28	WOS:000252052000011
J	Wendler, P; Shorter, J; Plisson, C; Cashikar, AG; Lindquist, S; Saibil, HR				Wendler, Petra; Shorter, James; Plisson, Celia; Cashikar, Anil G.; Lindquist, Susan; Saibil, Helen R.			Atypical AAA+ subunit packing creates an expanded cavity for disaggregation by the protein-remodeling factor Hsp104	CELL			English	Editorial Material							SACCHAROMYCES-CEREVISIAE HSP104; TERMINAL ATPASE DOMAIN; PLUS CHAPERONE CLPB; CRYSTAL-STRUCTURE; BINDING DOMAIN; SUBSTRATE RECOGNITION; AGGREGATED PROTEINS; HUNTINGTONS-DISEASE; ELECTRON-MICROSCOPY; NUCLEOTIDE-BINDING	Hsp104, a yeast protein-remodeling factor of the AAA+ (ATPases associated with various cellular activities) superfamily, and its homologs in bacteria and plants mediate cell recovery after severe stress by disaggregating denatured proteins through a poorly understood mechanism. Here, we present cryo-electron microscopy maps and domain fitting of Hsp104 hexamers, revealing an unusual arrangement of AAA+ modules with the prominent coiled-coil domain intercalated between the AAA+ domains. This packing results in a greatly expanded cavity, which is capped at either end by N- and C-terminal domains. The fitted structures as well as mutation of conserved coiled-coil arginines suggest that the coiled-coil domain plays a major role in the extraction of proteins from aggregates, providing conserved residues for key functions in ATP hydrolysis and potentially for substrate interaction. The large cavity could enable the uptake of polypeptide loops without a requirement for exposed N or C termini.	[Wendler, Petra; Plisson, Celia; Saibil, Helen R.] Univ London Birkbeck Coll, Dept Crystallog, London WC1E 7HX, England; [Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Cashikar, Anil G.] Med Coll Georgia, Augusta, GA 30912 USA; [Shorter, James] Univ Penn, Sch Med, Dept Biochem & Biophys, Stellar Chance Labs 805B, Philadelphia, PA 19104 USA	University of London; Birkbeck University London; Massachusetts Institute of Technology (MIT); Whitehead Institute; University System of Georgia; Augusta University; University of Pennsylvania	Saibil, HR (corresponding author), Univ London Birkbeck Coll, Dept Crystallog, Malet St, London WC1E 7HX, England.	h.saibil@mail.cryst.bbk.ac.uk	Shorter, James/ABE-7307-2020; Cashikar, Anil G/F-5968-2011; Wendler, Petra/C-9056-2014; Shorter, James/E-8207-2011; Plisson-Chastang, Celia/AAB-3629-2019; Wendler, Petra/X-5799-2019	Shorter, James/0000-0001-5269-8533; Wendler, Petra/0000-0002-8285-2199; Cashikar, Anil/0000-0002-3671-684X; Plisson-Chastang, Celia/0000-0002-8439-8428	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025874, R01GM025874] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM025874, R01 GM025874] Funding Source: Medline; Wellcome Trust [070776, 079605] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Cashikar AG, 2002, MOL CELL, V9, P751, DOI 10.1016/S1097-2765(02)00499-9; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Ditzel L, 1998, CELL, V93, P125, DOI 10.1016/S0092-8674(00)81152-6; Doyle SM, 2007, NAT STRUCT MOL BIOL, V14, P114, DOI 10.1038/nsmb1198; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; GILBERT PFC, 1972, PROC R SOC SER B-BIO, V182, P89, DOI 10.1098/rspb.1972.0068; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Guo FS, 2002, J BIOL CHEM, V277, P46743, DOI 10.1074/jbc.M207796200; Haslberger T, 2007, MOL CELL, V25, P247, DOI 10.1016/j.molcel.2006.11.008; Hattendorf DA, 2002, P NATL ACAD SCI USA, V99, P2732, DOI 10.1073/pnas.261693199; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; Hung GC, 2006, GENETICS, V173, P611, DOI 10.1534/genetics.106.056820; Huyton T, 2003, J STRUCT BIOL, V144, P337, DOI 10.1016/j.jsb.2003.10.007; Ishikawa T, 2004, J STRUCT BIOL, V146, P180, DOI 10.1016/j.jsb.2003.11.018; Karata K, 1999, J BIOL CHEM, V274, P26225, DOI 10.1074/jbc.274.37.26225; Kurahashi H, 2007, MOL MICROBIOL, V63, P1669, DOI 10.1111/j.1365-2958.2007.05629.x; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Lee S, 2007, MOL CELL, V25, P261, DOI 10.1016/j.molcel.2007.01.002; Lee U, 2005, PLANT CELL, V17, P559, DOI 10.1105/tpc.104.027540; Lum R, 2004, J BIOL CHEM, V279, P29139, DOI 10.1074/jbc.M403777200; Massey TH, 2006, MOL CELL, V23, P457, DOI 10.1016/j.molcel.2006.06.019; Matveeva EA, 2002, BIOCHEMISTRY-US, V41, P530, DOI 10.1021/bi015632s; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; Mogk A, 2003, J BIOL CHEM, V278, P17615, DOI 10.1074/jbc.M209686200; Moriyama H, 2000, MOL CELL BIOL, V20, P8916, DOI 10.1128/MCB.20.23.8916-8922.2000; Neuwald AF, 1999, GENOME RES, V9, P27; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; PARSELL DA, 1994, J BIOL CHEM, V269, P4480; Perrin V, 2007, MOL THER, V15, P903, DOI 10.1038/mt.sj.6300141; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Queitsch C, 2000, PLANT CELL, V12, P479, DOI 10.1105/tpc.12.4.479; Ranson NA, 2006, NAT STRUCT MOL BIOL, V13, P147, DOI 10.1038/nsmb1046; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; SANCHEZ Y, 1993, J BACTERIOL, V175, P6484, DOI 10.1128/jb.175.20.6484-6491.1993; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Schirmer EC, 2004, MOL BIOL CELL, V15, P2061, DOI 10.1091/mbc.E02-08-0502; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; Schirmer EC, 2001, P NATL ACAD SCI USA, V98, P914, DOI 10.1073/pnas.031568098; Schirmer EC, 1998, J BIOL CHEM, V273, P15546, DOI 10.1074/jbc.273.25.15546; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Tkach JM, 2004, J BIOL CHEM, V279, P35692, DOI 10.1074/jbc.M400782200; Vacher C, 2005, HUM MOL GENET, V14, P3425, DOI 10.1093/hmg/ddi372; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Watanabe Y, 2005, J BIOL CHEM, V280, P24562, DOI 10.1074/jbc.M414623200; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Xia D, 2004, J STRUCT BIOL, V146, P166, DOI 10.1016/j.jsb.2003.11.025; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944	57	100	102	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 28	2007	131	7					1366	1377		10.1016/j.cell.2007.10.047	http://dx.doi.org/10.1016/j.cell.2007.10.047			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GV	18160044	Green Published, hybrid			2022-12-28	WOS:000252217200024
J	Plaisier, E; Gribouval, O; Alamowitch, S; Mougenot, B; Prost, C; Verpont, MC; Marro, B; Desmettre, T; Cohen, SY; Roullet, E; Dracon, M; Fardeau, M; Van Agtmael, T; Kerjaschki, D; Antignac, C; Ronco, P				Plaisier, Emmanuelle; Gribouval, Olivier; Alamowitch, Sonia; Mougenot, Beatrice; Prost, Catherine; Verpont, Marie Christine; Marro, Beatrice; Desmettre, Thomas; Cohen, Salomon Yves; Roullet, Etienne; Dracon, Michel; Fardeau, Michel; Van Agtmael, Tom; Kerjaschki, Dontscho; Antignac, Corinne; Ronco, Pierre			COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POLYCYSTIC KIDNEY-DISEASE; RETINAL ARTERIOLAR TORTUOSITY; INTRACRANIAL ANEURYSMS; COLLAGEN-IV; EXPRESSION; STROKE; DYSGENESIS; MATRIX; GENE; WALL	Background: COL4A3, COL4A4, and COL4A5 are the only collagen genes that have been implicated in inherited nephropathies in humans. However, the causative genes for a number of hereditary multicystic kidney diseases, myopathies with cramps, and heritable intracranial aneurysms remain unknown. Methods: We characterized the renal and extrarenal phenotypes of subjects from three families who had an autosomal dominant hereditary angiopathy with nephropathy, aneurysms, and muscle cramps (HANAC), which we propose is a syndrome. Linkage studies involving microsatellite markers flanking the COL4A1-COL4A2 locus were performed, followed by sequence analysis of COL4A1 complementary DNA extracted from skin-fibroblast specimens from the subjects. Results: We identified three closely located glycine mutations in exons 24 and 25 of the gene COL4A1, which encodes procollagen type IV alpha 1. The clinical renal manifestations of the HANAC syndrome in these families include hematuria and bilateral, large cysts. Histologic analysis revealed complex basement-membrane defects in kidney and skin. The systemic angiopathy of the HANAC syndrome appears to affect both small vessels and large arteries. Conclusions: COL4A1 may be a candidate gene in unexplained familial syndromes with autosomal dominant hematuria, cystic kidney disease, intracranial aneurysms, and muscle cramps.	Univ Paris 06, INSERM, U702, F-75020 Paris, France; Hop Tenon, Assistance Publ Hop Paris, Unite Mixte Rech Sci 702, F-75970 Paris, France; Hop Tenon, Assistance Publ Hop Paris, Unite Mixte Rech Sci 582, F-75970 Paris, France; Hop Avicenne, Paris, France; Hop La Pitie Salpetriere, Paris, France; Hop Necker Enfants Malad, Paris, France; INSERM, U574, Paris, France; Paris 15, Ctr Ophthalmol, Paris, France; INSERM, U582, Paris, France; Univ Paris 05, Fac Med Rene Descartes, Unite Mixte Rech Sci 574, Paris, France; Univ Lille 2, Lille, France; Ctr Hosp Reg Univ Lille, F-59037 Lille, France; Univ Edinburgh, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; Med Univ Vienna, Clin Inst Pathol, Vienna, Austria	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; University of Edinburgh; Medical University of Vienna	Plaisier, E (corresponding author), Hop Tenon, Dept Nephrol, 4 Rue Chine, F-75020 Paris, France.	emmanuelle.plaisier@tnn.aphp.fr	Ronco, Pierre/AAC-8390-2022; ANTIGNAC, Corinne/H-8945-2017; Gribouval, Olivier/A-7689-2015	ANTIGNAC, Corinne/0000-0002-9934-4940; Gribouval, Olivier/0000-0003-0238-8224; Van Agtmael, Tom/0000-0003-4282-449X	MRC [G0601268] Funding Source: UKRI; Medical Research Council [G0601268] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Breedveld G, 2006, J MED GENET, V43, P490, DOI 10.1136/jmg.2005.035584; CHYATTE D, 1990, NEUROSURGERY, V26, P939, DOI 10.1227/00006123-199006000-00003; Gould DB, 2005, SCIENCE, V308, P1167, DOI 10.1126/science.1109418; Gould DB, 2006, NEW ENGL J MED, V354, P1489, DOI 10.1056/NEJMoa053727; Gould DB, 2007, HUM MOL GENET, V16, P798, DOI 10.1093/hmg/ddm024; Gupta MC, 1997, J CELL BIOL, V137, P1185, DOI 10.1083/jcb.137.5.1185; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Joly D, 2003, AM J PATHOL, V163, P1791, DOI 10.1016/S0002-9440(10)63539-0; KATZ SK, 1989, ANN CLIN LAB SCI, V19, P352; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Miner JH, 1998, CURR OPIN NEPHROL HY, V7, P13; Ophoff RA, 2001, AM J HUM GENET, V69, P447, DOI 10.1086/321975; Pepin M, 2000, NEW ENGL J MED, V342, P673, DOI 10.1056/NEJM200003093421001; Petrini S, 2005, MOL CELL NEUROSCI, V30, P408, DOI 10.1016/j.mcn.2005.08.005; Plaisier E, 2005, KIDNEY INT, V67, P2354, DOI 10.1111/j.1523-1755.2005.00341.x; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Regele HM, 2000, J AM SOC NEPHROL, V11, P403, DOI 10.1681/ASN.V113403; Rossetti S, 2003, LANCET, V361, P2196, DOI 10.1016/S0140-6736(03)13773-7; Ruigrok YM, 2005, LANCET NEUROL, V4, P179, DOI 10.1016/S1474-4422(05)01015-X; Ruigrok YM, 2006, HUM MOL GENET, V15, P3361, DOI 10.1093/hmg/ddl412; Shannon MB, 2006, J AM SOC NEPHROL, V17, P1913, DOI 10.1681/ASN.2005121298; Skirgaudas M, 1996, NEUROSURGERY, V39, P537, DOI 10.1097/00006123-199609000-00021; Vahedi K, 2003, NEUROLOGY, V60, P57, DOI 10.1212/WNL.60.1.57; Van Agtmael T, 2005, HUM MOL GENET, V14, P3161, DOI 10.1093/hmg/ddi348; van der Knaap MS, 2006, ANN NEUROL, V59, P504, DOI 10.1002/ana.20715; Wiberg C, 2001, J BIOL CHEM, V276, P18947, DOI 10.1074/jbc.M100625200	26	223	227	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2007	357	26					2687	2695		10.1056/NEJMoa071906	http://dx.doi.org/10.1056/NEJMoa071906			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	245UO	18160688	Bronze			2022-12-28	WOS:000251964500007
J	Yin, W; Basu, A; Zhang, JX; Rabbani, A; Meltzer, DO; Alexander, GC				Yin, Wesley; Basu, Anirban; Zhang, James X.; Rabbani, Atonu; Meltzer, David O.; Alexander, G. Caleb			The effect of the medicare Part D prescription benefit on drug utilization and expenditures	ANNALS OF INTERNAL MEDICINE			English	Article							COVERAGE	Background: information about the effect of the Medicare Part D Prescription Drug Benefit on drug utilization and expenditures is limited. Objective: To estimate changes in prescription utilization and out-of-pocket expenditures attributable to Part D among a sample of persons eligible for the benefit. Design: Generalized estimating equations were used to estimate changes in expenditures and utilization among beneficiaries. A control group was included to control for secular trends unrelated to the Part D benefit. Setting: National pharmacy chain representing approximately 15% of all U.S. retail pharmacy sales. Participants: Persons age 66 to 79 years (those eligible for Part D) and a control group of persons age 60 to 63 years (those ineligible for Part D). The final sample represented approximately 5.1 million unique beneficiaries and 1.8 million unique control individuals. Measurements: Prescription utilization (measured in pill-days) and out-of-pocket expenditures, as determined from pharmacy claims from September 2004 to April 2007. Results: During the penalty-free Part D enrollment period (January 2006 to May 2006), average monthly drug utilization increased by 1.1% (95% CI, 0.5% to 1.7%; P< 0.001) and out-of-pocket expenditures decreased by 8.8% (CI, 6.6% to 11.0%; P < 0.001). After enrollment stabilized (June 2006 to April 2007), average monthly drug utilization increased by 5.9% (CI, 5.1% to 6.7%; P < 0.001) and out-of-pocket expenditures decreased by 13.1 % (CI, 9.6% to 16.6%; P = 0.003). Compared with eligible non-enrollees, enrollees had higher out-of-pocket expenditures and utilization at baseline but experienced significantly larger decreases in expenditures and increases in utilization after enrollment. Limitations: Analyses were limited to claims within 1 pharmacy chain. The effect of the "doughnut hole" and the effect of changes on clinical outcomes were not evaluated. Conclusion: The Medicare Part D prescription benefit resulted in modest increases in average drug utilization and decreases in average out-of-pocket expenditures among Part D beneficiaries. Further research is needed to examine patterns among other beneficiaries and to evaluate the effect of these changes on health outcomes.	[Alexander, G. Caleb] Univ Chicago, Chicago, IL 60637 USA; Harvard Univ, Robert Wood Johnson Scholars Hlth Policy Program, Cambridge, MA 02138 USA; Univ Chicago, Harris Sch Publ Policy, Ctr Hlth & Social Sci, Chicago, IL 60637 USA; MacLean Ctr Clin Med Eth, Chicago, IL USA; Univ Illinois, Chicago Sch Pharm, Chicago, IL USA; Virginia Commonwealth Univ, Richmond, VA USA	University of Chicago; Harvard University; Robert Wood Johnson Foundation (RWJF); University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Virginia Commonwealth University	Alexander, GC (corresponding author), Univ Chicago, 5841 S Maryland,MC 2007, Chicago, IL 60637 USA.	galexand@uchicago.edu	Zhang, James/HHS-8616-2022; Zhang, James X./AFN-7901-2022; Meltzer, David/C-2926-2009; Rabbani, Atonu/R-3033-2017	Zhang, James X./0000-0002-6251-0474; Meltzer, David/0000-0003-2790-7393; Rabbani, Atonu/0000-0002-3821-4106	AHRQ HHS [K08 HS15699-01A1] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS015699] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Bach PB, 2006, NEW ENGL J MED, V354, P2312, DOI 10.1056/NEJMp068108; Berkowitz SA, 2007, JAMA-J AM MED ASSOC, V297, P868, DOI 10.1001/jama.297.8.868; Cline RR, 2003, AAPS PHARMSCI, V5; *CTR MED MED SERV, MED DRUG PLANS STRON; Doherty RB, 2004, ANN INTERN MED, V141, P391, DOI 10.7326/0003-4819-141-5-200409070-00100; Gaynor M, 2006, 12758 NBER; Geronimus AT, 1998, AM J EPIDEMIOL, V148, P475; Heiss F, 2006, HEALTH AFFAIR, V25, pW344, DOI 10.1377/hlthaff.25.w344; HOLLAND PW, 1986, J AM STAT ASSOC, V81, P945, DOI 10.2307/2289064; *KAIS FAM FDN, 2006, CHARTP SEN EARL EXP; *KAIS FAM FDN, 2006, PUBL KAIS FAM FDN, V7453; *KAIS FAM FDN, 2006, PUBL KAIS FAM FDN, V7201; KHAN N, 2007, 12848 NBER; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Lichtenberg FR, 2007, HEALTH AFFAIR, V26, P1735, DOI 10.1377/hlthaff.26.6.1735; Manning WG, 1998, J HEALTH ECON, V17, P283, DOI 10.1016/S0167-6296(98)00025-3; Manning WG, 2005, J HEALTH ECON, V24, P465, DOI 10.1016/j.jhealeco.2004.09.011; Pauly MV, 2004, HEALTH AFFAIR, V23, P113, DOI 10.1377/hlthaff.23.1.113; RUBIN DB, 1974, J EDUC PSYCHOL, V66, P688, DOI 10.1037/h0037350; Stuart B, 2006, MED CARE, V44, P243, DOI 10.1097/01.mlr.0000199652.15293.fc	20	145	145	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2008	148	3					169	177		10.7326/0003-4819-148-3-200802050-00200	http://dx.doi.org/10.7326/0003-4819-148-3-200802050-00200			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	258DX	18180465				2022-12-28	WOS:000252849700001
J	Vaia, R; Baur, J				Vaia, Richard; Baur, Jeffery			Adaptive composites	SCIENCE			English	Editorial Material							POLYMER		[Vaia, Richard; Baur, Jeffery] USAF, Mat & Mfg Directorate, Res Lab, Wright Patterson AFB, OH 45433 USA	United States Department of Defense; United States Air Force; US Air Force Research Laboratory	Vaia, R (corresponding author), USAF, Mat & Mfg Directorate, Res Lab, Wright Patterson AFB, OH 45433 USA.	richard.vaia@wpafb.af.mil; jeffery.baur@wpafb.af.mil						Barrett CJ, 2007, SOFT MATTER, V3, P1249, DOI 10.1039/b705619b; Buckley PR, 2006, IEEE T BIO-MED ENG, V53, P2075, DOI 10.1109/TBME.2006.877113; Cao AY, 2005, SCIENCE, V310, P1307, DOI 10.1126/science.1118957; Ebron VH, 2006, SCIENCE, V311, P1580, DOI 10.1126/science.1120182; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Koerner H, 2004, NAT MATER, V3, P115, DOI 10.1038/nmat1059; Kousourakis A, 2006, COMPOS STRUCT, V75, P610, DOI 10.1016/j.compstruct.2006.04.086; Kramer RM, 2007, NAT MATER, V6, P533, DOI 10.1038/nmat1930; Leo D.J., ENG ANAL SMART MAT S, P1; Mathger LM, 2007, CELL TISSUE RES, V329, P179, DOI 10.1007/s00441-007-0384-8; *NASA, 2007, NASA TECH BRIEFS, V31, P20; Nelson EC, 2007, SCIENCE, V318, P924, DOI 10.1126/science.1148009; Pfeifer R, 2007, SCIENCE, V318, P1088, DOI 10.1126/science.1145803; STOY K, 2004, P 2004 IEEE RSJ INT, V2, P2062; Toohey KS, 2007, NAT MATER, V6, P581, DOI 10.1038/nmat1934; Yakobson BI, 2006, J NANOPART RES, V8, P105, DOI 10.1007/s11051-005-8335-3	16	111	113	3	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2008	319	5862					420	421		10.1126/science.1152931	http://dx.doi.org/10.1126/science.1152931			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254HB	18218885				2022-12-28	WOS:000252576600026
J	Warner, TD; Mitchell, JA				Warner, Timothy D.; Mitchell, Jane A.			COX-2 selectivity alone does not define the cardiovascular risks associated with non-steroidal anti-inflammatory drugs	LANCET			English	Editorial Material							PLATELET-FUNCTION; INHIBITION; IBUPROFEN; NAPROXEN; CYCLO-OXYGENASE-2; METAANALYSIS; LUMIRACOXIB; VOLUNTEERS; DICLOFENAC; KETOROLAC		[Warner, Timothy D.] Barts & London, Queen Marys Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England; [Mitchell, Jane A.] Imperial Coll Sch Med, Royal Brompton Hosp, Unit Crit Care Med, London, England	University of London; Queen Mary University London; Imperial College London; Royal Brompton Hospital	Warner, TD (corresponding author), Barts & London, Queen Marys Sch Med & Dent, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England.	t.d.warner@qmul.ac.uk	Mitchell, Jane A/A-1991-2009; Warner, Timothy D/A-1980-2009	Warner, Timothy D/0000-0003-3988-4408	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Antman EM, 2007, CIRCULATION, V115, P1634, DOI 10.1161/CIRCULATIONAHA.106.181424; CRONBERG S, 1984, SCAND J HAEMATOL, V33, P155; Farkouh ME, 2007, ANN RHEUM DIS, V66, P764, DOI 10.1136/ard.2006.066001; Farkouh ME, 2004, LANCET, V364, P675, DOI 10.1016/S0140-6736(04)16894-3; Flavahan NA, 2007, TRENDS PHARMACOL SCI, V28, P106, DOI 10.1016/j.tips.2007.01.003; Graham DJ, 2005, LANCET, V365, P475, DOI 10.1016/S0140-6736(05)17864-7; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Grosser T, 2006, THROMB HAEMOSTASIS, V96, P393, DOI 10.1160/TH06-08-0444; Hawkey CJ, 2006, J CARDIOVASC PHARM, V47, pS72, DOI 10.1097/00005344-200605001-00013; Henry D, 1996, BRIT MED J, V312, P1563, DOI 10.1136/bmj.312.7046.1563; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; Mitchell JA, 2006, NAT REV DRUG DISCOV, V5, P75, DOI 10.1038/nrd1929; Mitchell JA, 2006, FASEB J, V20, P2468, DOI 10.1096/fj.06-6615com; Niemi TT, 1997, ACTA ANAESTH SCAND, V41, P1353, DOI 10.1111/j.1399-6576.1997.tb04657.x; Reinhart DJ, 2000, DRUG SAFETY, V22, P487, DOI 10.2165/00002018-200022060-00007; SCHAFER AI, 1995, J CLIN PHARMACOL, V35, P209, DOI 10.1002/j.1552-4604.1995.tb04050.x; Topper JN, 1996, P NATL ACAD SCI USA, V93, P10417, DOI 10.1073/pnas.93.19.10417; Van Hecken A, 2000, J CLIN PHARMACOL, V40, P1109; Vane JR, 2000, LANCET, V356, P1373, DOI 10.1016/S0140-6736(00)02837-3; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; White WB, 2007, HYPERTENSION, V49, P408, DOI 10.1161/01.HYP.0000258106.74139.25	22	109	118	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 19	2008	371	9608					270	273		10.1016/S0140-6736(08)60137-3	http://dx.doi.org/10.1016/S0140-6736(08)60137-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	252UK	18207021				2022-12-28	WOS:000252471900030
J	Arnold, PL; Patel, D; Wilson, C; Love, JB				Arnold, Polly L.; Patel, Dipti; Wilson, Claire; Love, Jason B.			Reduction and selective oxo group silylation of the uranyl dication	NATURE			English	Article							PENTAVALENT-URANYL; OXYGENATION REACTIONS; ACTIVE-SITES; COMPLEXES; URANIUM; COORDINATION; REACTIVITY; CHEMISTRY; LIGANDS; BASE	Uranium occurs in the environment predominantly as the uranyl dication [UO2](2+). Its solubility renders this species a problematic contaminant(1-3) which is, moreover, chemically extraordinarily robust owing to strongly covalent U-O bonds(4). This feature manifests itself in the uranyl dication showing little propensity to partake in the many oxo group functionalizations and redox reactions typically seen with [CrO2](2+), [MoO2](2+) and other transition metal analogues(5-9). As a result, only a few examples of [UO2](2+) with functionalized oxo groups are known. Similarly, it is only very recently that the isolation and characterization of the singly reduced, pentavalent uranyl cation [UO2](+) has been reported(10-12). Here we show that placing the uranyl dication within a rigid and well-defined molecular framework while keeping the environment anaerobic allows simultaneous single- electron reduction and selective covalent bond formation at one of the two uranyl oxo groups. The product of this reaction is a pentavalent and monofunctionalized [O = U = OR](+) cation that can be isolated in the presence of transition metal cations. This finding demonstrates that under appropriate reaction conditions, the uranyl oxo group will readily undergo radical reactions commonly associated only with transition metal oxo groups. We expect that this work might also prove useful in probing the chemistry of the related but highly radioactive plutonyl and neptunyl analogues found in nuclear waste.	[Arnold, Polly L.; Patel, Dipti; Love, Jason B.] Univ Edinburgh, Sch Chem, Edinburgh EH9 3JJ, Midlothian, Scotland; [Wilson, Claire] Rigaku Europe, Sevenoaks TN15 6QY, Kent, England	University of Edinburgh; Rigaku Corporation	Arnold, PL (corresponding author), Univ Edinburgh, Sch Chem, W Mains Rd, Edinburgh EH9 3JJ, Midlothian, Scotland.	Polly.Arnold@ed.ac.uk; Jason.Love@ed.ac.uk	Arnold, Polly/E-6229-2011	Arnold, Polly/0000-0001-6410-5838	EPSRC [EP/D050782/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/D050782/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Amme M, 2005, J NUCL MATER, V341, P209, DOI 10.1016/j.jnucmat.2005.02.004; Arnold PL, 2004, INORG CHEM, V43, P8206, DOI 10.1021/ic0487070; Arnold PL, 2006, J AM CHEM SOC, V128, P9610, DOI 10.1021/ja0634167; Berthet JC, 2006, CHEM COMMUN, P3184, DOI 10.1039/b605710a; Burdet F, 2006, J AM CHEM SOC, V128, P16512, DOI 10.1021/ja067445t; Burns CJ, 2000, INORG CHEM, V39, P5464, DOI 10.1021/ic0003168; Castro-Rodriguez I, 2003, J AM CHEM SOC, V125, P4565, DOI 10.1021/ja028342n; Costes JP, 1998, CHEM-EUR J, V4, P1616, DOI 10.1002/(SICI)1521-3765(19980904)4:9<1616::AID-CHEM1616>3.0.CO;2-A; COTTON FA, 1984, INORG CHEM, V23, P4211, DOI 10.1021/ic00193a023; Denning RG, 2007, J PHYS CHEM A, V111, P4125, DOI 10.1021/jp071061n; Docrat TI, 1999, INORG CHEM, V38, P1879, DOI 10.1021/ic9814423; Donahue JP, 1998, J AM CHEM SOC, V120, P12869, DOI 10.1021/ja982914f; Hay PJ, 2000, J PHYS CHEM A, V104, P6259, DOI 10.1021/jp000519h; Jin N, 2007, J AM CHEM SOC, V129, P12416, DOI 10.1021/ja0761737; Kannan S, 2006, J AM CHEM SOC, V128, P14024, DOI 10.1021/ja065822w; Kuhn FE, 2006, CHEM REV, V106, P2455, DOI 10.1021/cr040703p; Limberg C, 2003, ANGEW CHEM INT EDIT, V42, P5932, DOI 10.1002/anie.200300578; Lorber C, 1998, J AM CHEM SOC, V120, P8102, DOI 10.1021/ja981015o; LOVLEY DR, 1991, NATURE, V350, P413, DOI 10.1038/350413a0; Mayer JM, 1998, ACCOUNTS CHEM RES, V31, P441, DOI 10.1021/ar970171h; Nam W, 2007, ACCOUNTS CHEM RES, V40, P522, DOI 10.1021/ar700027f; Natrajan L, 2006, J AM CHEM SOC, V128, P7152, DOI 10.1021/ja0609809; O'Grady E, 2002, J CHEM SOC DALTON, P1233, DOI 10.1039/b109696f; Reilly SD, 2006, INORG CHEM, V45, P1839, DOI 10.1021/ic051760j; ROSEN RK, 1990, J AM CHEM SOC, V112, P4588, DOI 10.1021/ja00167a092; Sarsfield MJ, 2004, INORG CHEM, V43, P3170, DOI 10.1021/ic035349c; Sarsfield MJ, 2004, J AM CHEM SOC, V126, P1036, DOI 10.1021/ja039101y; Suzuki Y, 2002, NATURE, V419, P134, DOI 10.1038/419134a; Wander MCF, 2006, J PHYS CHEM A, V110, P9691, DOI 10.1021/jp062325t; Zi GF, 2005, ORGANOMETALLICS, V24, P4251, DOI 10.1021/om050406q	30	239	241	0	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2008	451	7176					315	U3		10.1038/nature06467	http://dx.doi.org/10.1038/nature06467			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202653	Green Accepted			2022-12-28	WOS:000252432100045
J	Goldberg, RB; Holman, R; Drucker, DJ				Goldberg, Ronald B.; Holman, Rury; Drucker, Daniel J.			Management of type 2 diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRIPLE ORAL-THERAPY; RANDOMIZED-TRIAL; INSULIN GLARGINE; PLUS METFORMIN; SULFONYLUREA; PIOGLITAZONE; EXENATIDE; FAILURE		[Goldberg, Ronald B.] Univ Miami, Miller Sch Med, Diabet Res Inst, Div Endocrinol Diabet & Metab, Miami, FL 33152 USA; [Holman, Rury] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Diabet Trials Unit, Oxford, England; [Drucker, Daniel J.] Univ Toronto, Mt Sinai Hosp, Banting & Best Diabet Ctr, Toronto, ON M5G 1X5, Canada	University of Miami; University of Oxford; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Goldberg, RB (corresponding author), Univ Miami, Miller Sch Med, Diabet Res Inst, Div Endocrinol Diabet & Metab, Miami, FL 33152 USA.							Aljabri K, 2004, AM J MED, V116, P230, DOI 10.1016/j.amjmed.2003.07.023; [Anonymous], 1996, DIABETES; Dorkhan M, 2006, J INTERN MED, V260, P125, DOI 10.1111/j.1365-2796.2006.01665.x; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Heine RJ, 2005, ANN INTERN MED, V143, P559, DOI 10.7326/0003-4819-143-8-200510180-00006; HOLMAN RR, 1987, DIABETIC MED, V4, P457, DOI 10.1111/j.1464-5491.1987.tb00909.x; Kendall DM, 2005, DIABETES CARE, V28, P1083, DOI 10.2337/diacare.28.5.1083; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Nathan DM, 2006, DIABETOLOGIA, V49, P2816, DOI 10.1007/s00125-006-0415-0; Nauck MA, 2007, DIABETOLOGIA, V50, P259, DOI 10.1007/s00125-006-0510-2; Nyback-Nakell A, 2007, DIABETIC MED, V24, P1424, DOI 10.1111/j.1464-5491.2007.02286.x; Rosenstock J, 2006, DIABETES CARE, V29, P554, DOI 10.2337/diacare.29.03.06.dc05-0695; Schwartz AV, 2006, J CLIN ENDOCR METAB, V91, P3349, DOI 10.1210/jc.2005-2226; Schwartz S, 2003, DIABETES CARE, V26, P2238, DOI 10.2337/diacare.26.8.2238; TURNER RC, 1995, DIABETES, V44, P1249	15	17	20	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2008	358	3					293	297						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	251LS	18199869				2022-12-28	WOS:000252375600013
J	Gruber, N; Galloway, JN				Gruber, Nicolas; Galloway, James N.			An Earth-system perspective of the global nitrogen cycle	NATURE			English	Article							CARBON-CYCLE; DENITRIFICATION; TERRESTRIAL	With humans having an increasing impact on the planet, the interactions between the nitrogen cycle, the carbon cycle and climate are expected to become an increasingly important determinant of the Earth system.	[Gruber, Nicolas] ETH, Inst Biogeochem & Pollutant Dynam, Environm Phys Grp, CH-8092 Zurich, Switzerland; [Galloway, James N.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Virginia	Gruber, N (corresponding author), ETH, Inst Biogeochem & Pollutant Dynam, Environm Phys Grp, Univ Str 16, CH-8092 Zurich, Switzerland.	nicolas.gruber@env.ethz.ch	Galloway, James N/C-2769-2013; Gruber, Nicolas/B-7013-2009	Galloway, James N/0000-0001-7676-8698; Gruber, Nicolas/0000-0002-2085-2310				Altabet MA, 2002, NATURE, V415, P159, DOI 10.1038/415159a; [Anonymous], [No title captured]; AUSTIN AT, 2003, INTERACTIONS MAJOR B; Ramos JBE, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002898; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; Codispoti LA., 2006, BIOGEOSCI DISCUSS, V3, P1203, DOI DOI 10.5194/BGD-3-1203-2006; Deutsch C, 2007, NATURE, V445, P163, DOI 10.1038/nature05392; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Fluckiger J, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002122; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Galloway JN, 2003, BIOSCIENCE, V53, P341, DOI 10.1641/0006-3568(2003)053[0341:TNC]2.0.CO;2; Gruber N., 2004, OCEAN CARBON CYCLE C, VIV, P97, DOI [10.1007/978-1-4020-2087-2_4, DOI 10.1007/978-1-4020-2087-2_4]; GRUBER N, IN PRESS NITROGEN MA, pCH1; Hyvonen R, 2008, BIOGEOCHEMISTRY, V89, P121, DOI 10.1007/s10533-007-9121-3; Rabalais NN, 2002, AMBIO, V31, P102, DOI 10.1579/0044-7447-31.2.102; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Sarmiento JL, 2002, PHYS TODAY, V55, P30, DOI 10.1063/1.1510279; Schimel DS, 2001, NATURE, V414, P169, DOI 10.1038/35102500; Seitzinger S, 2006, ECOL APPL, V16, P2064, DOI 10.1890/1051-0761(2006)016[2064:DALAWA]2.0.CO;2; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444	23	1929	2111	157	1670	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2008	451	7176					293	296		10.1038/nature06592	http://dx.doi.org/10.1038/nature06592			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202647	Bronze			2022-12-28	WOS:000252432100039
J	Knabl, J; Witschi, R; Hosl, K; Reinold, H; Zeilhofer, UB; Ahmadi, S; Brockhaus, J; Sergejeva, M; Hess, A; Brune, K; Fritschy, JM; Rudolph, U; Mohler, H; Zeilhofer, HU				Knabl, Julia; Witschi, Robert; Hoesl, Katharina; Reinold, Heiko; Zeilhofer, Ulrike B.; Ahmadi, Seifollah; Brockhaus, Johannes; Sergejeva, Marina; Hess, Andreas; Brune, Kay; Fritschy, Jean-Marc; Rudolph, Uwe; Moehler, Hanns; Zeilhofer, Hanns Ulrich			Reversal of pathological pain through specific spinal GABA(A) receptor subtypes	NATURE			English	Article							SUPERFICIAL DORSAL HORN; PERIPHERAL-NERVE INJURY; NEUROPATHIC PAIN; ANION GRADIENT; RAT; HYPERALGESIA; CORD; INHIBITION; NEURONS; BENZODIAZEPINES	Inflammatory diseases and neuropathic insults are frequently accompanied by severe and debilitating pain, which can become chronic and often unresponsive to conventional analgesic treatment(1,2). A loss of synaptic inhibition in the spinal dorsal horn is considered to contribute significantly to this pain pathology(3-7). Facilitation of spinal gamma-aminobutyric acid ( GABA) ergic neurotransmission through modulation of GABA(A) receptors should be able to compensate for this loss(8,9). With the use of GABA(A)-receptor point- mutated knock- in mice in which specific GABA(A) receptor subtypes have been selectively rendered insensitive to benzodiazepine- site ligands(10-12), we show here that pronounced analgesia can be achieved by specifically targeting spinal GABA(A) receptors containing the alpha 2 and/ or alpha 3 subunits. We show that their selective activation by the non- sedative ('alpha 1- sparing') benzodiazepine- site ligand L- 838,417 ( ref. 13) is highly effective against inflammatory and neuropathic pain yet devoid of unwanted sedation, motor impairment and tolerance development. L- 838,417 not only diminished the nociceptive input to the brain but also reduced the activity of brain areas related to the associative- emotional components of pain, as shown by functional magnetic resonance imaging in rats. These results provide a rational basis for the development of subtype- selective GABAergic drugs for the treatment of chronic pain, which is often refractory to classical analgesics.	[Knabl, Julia; Hoesl, Katharina; Reinold, Heiko; Zeilhofer, Ulrike B.; Ahmadi, Seifollah; Sergejeva, Marina; Hess, Andreas; Brune, Kay; Zeilhofer, Hanns Ulrich] Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, D-91054 Erlangen, Germany; [Witschi, Robert; Brockhaus, Johannes; Fritschy, Jean-Marc; Rudolph, Uwe; Moehler, Hanns; Zeilhofer, Hanns Ulrich] Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland; [Moehler, Hanns; Zeilhofer, Hanns Ulrich] ETH, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland; [Rudolph, Uwe] Harvard Univ, Sch Med, McLean Hosp, Dept Psychiat,Lab Genet Neuropharmacol, Belmont, MA 02478 USA; [Moehler, Hanns] Collegium Helveticum, CH-8092 Zurich, Switzerland	University of Erlangen Nuremberg; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Harvard University; McLean Hospital	Zeilhofer, HU (corresponding author), Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, D-91054 Erlangen, Germany.	zeilhofer@pharma.uzh.ch	Zeilhofer, Hanns Ulrich/A-4600-2008	Zeilhofer, Hanns Ulrich/0000-0001-6954-4629; Fritschy, Jean-Marc/0000-0002-8552-3702				Ahmadi S, 2002, NAT NEUROSCI, V5, P34, DOI 10.1038/nn778; Ator NA, 2005, CNS SPECTRUMS, V10, P31, DOI 10.1017/S1092852900009883; Barnard EA, 1998, PHARMACOL REV, V50, P291; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bohlhalter S, 1996, J NEUROSCI, V16, P283, DOI 10.1523/jneurosci.16-01-00283.1996; BONETTI EP, 1988, PHARMACOL BIOCHEM BE, V31, P733, DOI 10.1016/0091-3057(88)90259-6; Brooks J, 2005, J ANAT, V207, P19, DOI 10.1111/j.1469-7580.2005.00428.x; BUSHNELL MC, 2006, WALL MELZACKS TXB PA, P107; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Crestani F, 2002, P NATL ACAD SCI USA, V99, P8980, DOI 10.1073/pnas.142288699; Depner UB, 2003, EUR J NEUROSCI, V17, P2381, DOI 10.1046/j.1460-9568.2003.02676.x; Dias R, 2005, J NEUROSCI, V25, P10682, DOI 10.1523/JNEUROSCI.1166-05.2005; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; Enna SJ, 2006, ADV PHARMACOL, V54, P1, DOI 10.1016/S1054-3589(06)54001-3; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; HARRIS JA, 1995, BEHAV NEUROSCI, V109, P295, DOI 10.1037/0735-7044.109.2.295; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Hess A, 2007, EUR J PAIN, V11, P109, DOI 10.1016/j.ejpain.2006.01.005; Jasmin L, 2003, NATURE, V424, P316, DOI 10.1038/nature01808; Keller AF, 2001, J NEUROSCI, V21, P7871, DOI 10.1523/JNEUROSCI.21-20-07871.2001; Low K, 2000, SCIENCE, V290, P131, DOI 10.1126/science.290.5489.131; MA W, 1993, J COMP NEUROL, V338, P337, DOI 10.1002/cne.903380303; Malan TP, 2002, ANESTHESIOLOGY, V96, P1161, DOI 10.1097/00000542-200205000-00020; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Moore KA, 2002, J NEUROSCI, V22, P6724, DOI 10.1523/jneurosci.22-15-06724.2002; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933; Sandkuhler J, 2000, PAIN, V88, P113, DOI 10.1016/S0304-3959(00)00424-3; Scholz J, 2005, J NEUROSCI, V25, P7317, DOI 10.1523/JNEUROSCI.1526-05.2005; Scott-Stevens P, 2005, BIOPHARM DRUG DISPOS, V26, P13, DOI 10.1002/bdd.423; van Rijnsoever C, 2004, J NEUROSCI, V24, P6785, DOI 10.1523/JNEUROSCI.1067-04.2004; WIELAND HA, 1992, J BIOL CHEM, V267, P1426; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Zeilhofer HU, 1997, J PHYSIOL-LONDON, V503, P67, DOI 10.1111/j.1469-7793.1997.067bi.x	38	335	346	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2008	451	7176					330	U6		10.1038/nature06493	http://dx.doi.org/10.1038/nature06493			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202657				2022-12-28	WOS:000252432100049
J	Boyd, PW; Mackie, D				Boyd, Philip W.; Mackie, Douglas			Comment on the Southern Ocean biological response to aeolian iron deposition	SCIENCE			English	Editorial Material							PHYTOPLANKTON; DUST		[Boyd, Philip W.; Mackie, Douglas] Univ Otago, Natl Inst Water, Dunedin, New Zealand; [Boyd, Philip W.; Mackie, Douglas] Univ Otago, Atmospher Res Ctr Chem & Phys Oceanog, Dept Chem, Dunedin, New Zealand	University of Otago; University of Otago	Boyd, PW (corresponding author), Univ Otago, Natl Inst Water, Dunedin, New Zealand.	pboyd@alkali.otago.ac.nz	Boyd, Philip W/J-7624-2014	Boyd, Philip W/0000-0001-7850-1911				Abraham ER, 2000, NATURE, V407, P727, DOI 10.1038/35037555; Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; Boyd PW, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002494; Boyd PW, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2002GB002020; Cassar N, 2007, SCIENCE, V317, P1067, DOI 10.1126/science.1144602; Chin M, 2000, J GEOPHYS RES-ATMOS, V105, P24689, DOI 10.1029/2000JD900385; Fan SM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024852; Frew RD, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002558; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; Kraemer SM, 2005, REV MINERAL GEOCHEM, V59, P53, DOI 10.2138/rmg.2005.59.4; Meskhidze N, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018035; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P	12	18	18	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2008	319	5860								10.1126/science.1149884	http://dx.doi.org/10.1126/science.1149884			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249RC	18187641				2022-12-28	WOS:000252246400020
J	Georgescu, RE; Kim, SS; Yurieva, O; Kuriyan, J; Kong, XP; O'Donnell, M				Georgescu, Roxana E.; Kim, Seung-Sup; Yurieva, Olga; Kuriyan, John; Kong, Xiang-Peng; O'Donnell, Mike			Structure of a sliding clamp on DNA	CELL			English	Article							CELL NUCLEAR ANTIGEN; POLYMERASE-III HOLOENZYME; ESCHERICHIA-COLI; PROCESSIVITY-CLAMP; CRYSTAL-STRUCTURE; REPLICATION; BETA; SUBUNIT; REPAIR; MECHANISM	The structure of the E. coli beta clamp polymerase processivity factor has been solved in complex with primed DNA. Interestingly, the clamp directly binds the DNA duplex and also forms a crystal contact with the ssDNA template strand, which binds into the protein-binding pocket of the clamp. We demonstrate that these clamp-DNA interactions function in clamp loading, perhaps by inducing the ring to close around DNA. Clamp binding to template ssDNA may also serve to hold the clamp at a primed site after loading or during switching of multiple factors on the clamp. Remarkably, the DNA is highly tilted as it passes through the b ring. The pronounced 22 degrees angle of DNA through b may enable DNA to switch between multiple factors bound to a single clamp simply by alternating from one protomer of the ring to the other.	[Georgescu, Roxana E.; Yurieva, Olga; O'Donnell, Mike] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; [Kim, Seung-Sup; Kong, Xiang-Peng] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; [Kuriyan, John] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Kuriyan, John] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; [Kuriyan, John] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Kuriyan, John] Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA USA	Howard Hughes Medical Institute; Rockefeller University; New York University; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	O'Donnell, M (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	odonnel@mail.rockefeller.edu	Georgescu, Roxana/B-9943-2011	Kong, Xiang-Peng/0000-0001-5773-2681; O'Donnell, Michael/0000-0001-9002-4214	NIGMS NIH HHS [GM45547, R37 GM038839-17, R37 GM038839, R01 GM045547, GM70841, R01 GM038839, R37 GM038839-18, GM38839, R01 GM070841, R37 GM038839-19, R37 GM038839-16] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045547, R01GM070841, R01GM038839, R37GM038839] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson SG, 2007, J BIOL CHEM, V282, P7035, DOI 10.1074/jbc.M610136200; Argiriadi MA, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-2; Bloom LB, 2006, CRIT REV BIOCHEM MOL, V41, P179, DOI 10.1080/10409230600648751; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bunting KA, 2003, EMBO J, V22, P5883, DOI 10.1093/emboj/cdg568; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Burnouf DY, 2004, J MOL BIOL, V335, P1187, DOI 10.1016/j.jmb.2003.11.049; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Dalrymple BP, 2001, P NATL ACAD SCI USA, V98, P11627, DOI 10.1073/pnas.191384398; de Saro FJL, 2003, EMBO J, V22, P6408, DOI 10.1093/emboj/cdg603; Dionne I, 2003, MOL CELL, V11, P275, DOI 10.1016/S1097-2765(02)00824-9; Dohrmann PR, 2005, J MOL BIOL, V350, P228, DOI 10.1016/j.jmb.2005.04.065; Ellison V, 2003, PLOS BIOL, V1, P231, DOI 10.1371/journal.pbio.0000033; Fujii S, 2004, EMBO J, V23, P4342, DOI 10.1038/sj.emboj.7600438; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Indiani C, 2005, MOL CELL, V19, P805, DOI 10.1016/j.molcel.2005.08.011; Ivanov I, 2006, NUCLEIC ACIDS RES, V34, P6023, DOI 10.1093/nar/gkl744; Jeruzalmi D, 2001, CELL, V106, P417, DOI 10.1016/S0092-8674(01)00462-7; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Matsumiya S, 2001, PROTEIN SCI, V10, P17, DOI 10.1110/ps.36401; Maul RW, 2007, MOL MICROBIOL, V65, P811, DOI 10.1111/j.1365-2958.2007.05828.x; McHenry CS, 2003, MOL MICROBIOL, V49, P1157, DOI 10.1046/j.1365-2958.2003.03645.x; McInerney P, 2004, J BIOL CHEM, V279, P21543, DOI 10.1074/jbc.M401649200; Naktinis V, 1996, CELL, V84, P137, DOI 10.1016/S0092-8674(00)81000-4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; Snyder AK, 2004, J BIOL CHEM, V279, P4386, DOI 10.1074/jbc.M310430200; STUKENBERG PT, 1994, CELL, V78, P877, DOI 10.1016/S0092-8674(94)90662-9; Sutton MD, 2001, P NATL ACAD SCI USA, V98, P8342, DOI 10.1073/pnas.111036998; Sutton MD, 2005, MOL MICROBIOL, V55, P1751, DOI 10.1111/j.1365-2958.2005.04500.x; Sutton MD, 2006, DNA REPAIR, V5, P312, DOI 10.1016/j.dnarep.2005.10.011; Sutton MD, 2004, J BACTERIOL, V186, P6738, DOI 10.1128/JB.186.20.6738-6748.2004; Sutton MD, 2000, ANNU REV GENET, V34, P479, DOI 10.1146/annurev.genet.34.1.479; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.3.CO;2-R; Yao N, 2000, J BIOL CHEM, V275, P1421, DOI 10.1074/jbc.275.2.1421	40	163	164	1	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 11	2008	132	1					43	54		10.1016/j.cell.2007.11.045	http://dx.doi.org/10.1016/j.cell.2007.11.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IL	18191219	Bronze, Green Accepted			2022-12-28	WOS:000253427600014
J	Nakatsukasa, K; Huyer, G; Michaelis, S; Brodsky, JL				Nakatsukasa, Kunio; Huyer, Gregory; Michaelis, Susan; Brodsky, Jeffrey L.			Dissecting the ER-Associated degradation of a misfolded polytopic membrane protein	CELL			English	Article							RETICULUM-ASSOCIATED DEGRADATION; TRANSMEMBRANE CONDUCTANCE REGULATOR; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; UBIQUITIN-LIGASE; MOLECULAR CHAPERONES; CYSTIC-FIBROSIS; SACCHAROMYCES-CEREVISIAE; IN-VIVO; PROTEASOME	It remains unclear how misfolded membrane proteins are selected and destroyed during endoplasmic reticulum-associated degradation (ERAD). For example, chaperones are thought to solubilize aggregation-prone motifs, and some data suggest that these proteins are degraded at the ER. To better define how membrane proteins are destroyed, the ERAD of Ste6p*, a 12 transmembrane protein, was reconstituted. We found that specific Hsp70/40s act before ubiquitination and facilitate Ste6p* association with an E3 ubiquitin ligase, suggesting an active role for chaperones. Furthermore, polyubiquitination was a prerequisite for retrotranslocation, which required the Cdc48 complex and ATP. Surprisingly, the substrate was soluble, and extraction was independent of a ubiquitin chain extension enzyme (Ufd2p). However, Ufd2p increased the degree of ubiquitination and facilitated degradation. These data indicate that polytopic membrane proteins can be extracted from the ER, and define the point of action of chaperones and the requirement for Ufd2p during membrane protein quality control.	[Nakatsukasa, Kunio; Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Huyer, Gregory; Michaelis, Susan] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University	Brodsky, JL (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	jbrodsky@pitt.edu			NIGMS NIH HHS [R01 GM075061-02, GM75061, R01 GM051508, R01 GM075061, R01 GM075061-01A1, GM51508] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075061, R01GM051508] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahner A, 2007, MOL BIOL CELL, V18, P806, DOI 10.1091/mbc.E06-05-0458; Akiyama Y, 2003, J BIOL CHEM, V278, P18146, DOI 10.1074/jbc.M302152200; Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Arteaga MF, 2006, P NATL ACAD SCI USA, V103, P11178, DOI 10.1073/pnas.0604816103; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Becker J, 1996, MOL CELL BIOL, V16, P4378; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; Carlson EJ, 2006, EMBO J, V25, P4557, DOI 10.1038/sj.emboj.7601307; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; DESHAIES RJ, 1995, EMBO J, V14, P303, DOI 10.1002/j.1460-2075.1995.tb07004.x; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Gardner RG, 2001, MOL CELL BIOL, V21, P4276, DOI 10.1128/MCB.21.13.4276-4291.2001; Gardner RG, 1999, EMBO J, V18, P5994, DOI 10.1093/emboj/18.21.5994; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Gnann A, 2004, MOL BIOL CELL, V15, P4125, DOI 10.1091/mbc.e04-01-0024; Han S, 2007, J BIOL CHEM, V282, P26140, DOI 10.1074/jbc.M701969200; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; HERSHKO A, 1985, BIOCHEM BIOPH RES CO, V128, P1079, DOI 10.1016/0006-291X(85)91050-2; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Kota J, 2007, J CELL BIOL, V176, P617, DOI 10.1083/jcb.200612100; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; Loayza D, 1998, MOL BIOL CELL, V9, P2767, DOI 10.1091/mbc.9.10.2767; Mayer TU, 1998, EMBO J, V17, P3251, DOI 10.1093/emboj/17.12.3251; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Meusser B, 2004, MOL CELL, V14, P247, DOI 10.1016/S1097-2765(04)00212-6; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Nishikawa S, 2005, J BIOCHEM, V137, P551, DOI 10.1093/jb/mvi068; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Piwko W, 2006, NAT STRUCT MOL BIOL, V13, P691, DOI 10.1038/nsmb1122; Plemper RK, 1998, J BIOL CHEM, V273, P32848, DOI 10.1074/jbc.273.49.32848; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Wigley WC, 1999, J CELL BIOL, V145, P481; Xiong XM, 1999, J BIOL CHEM, V274, P2616, DOI 10.1074/jbc.274.5.2616; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303	57	206	208	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 11	2008	132	1					101	112		10.1016/j.cell.2007.11.023	http://dx.doi.org/10.1016/j.cell.2007.11.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IL	18191224	Green Accepted, Bronze			2022-12-28	WOS:000253427600019
J	Schreiber, H; Rowley, DA				Schreiber, Hans; Rowley, Donald A.			Cancer - Quo vadis, specificity?	SCIENCE			English	Editorial Material							METHYLCHOLANTHRENE; SARCOMAS; HOST		[Schreiber, Hans; Rowley, Donald A.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Chicago	Schreiber, H (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	hszz@midway.uchicago.edu						BASOMBRIO MA, 1970, CANCER RES, V30, P2458; Kiberstis PA, 2006, SCIENCE, V312, P1157, DOI 10.1126/science.312.5777.1157; KLEIN G, 1960, CANCER RES, V20, P1561; Ludewig B, 2000, J EXP MED, V191, P795, DOI 10.1084/jem.191.5.795; Miettinen M, 2006, ADV EXP MED BIOL, V587, P99; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Mumberg D, 1996, Semin Immunol, V8, P289, DOI 10.1006/smim.1996.0037; Savage PA, 2008, SCIENCE, V319, P215, DOI 10.1126/science.1148886; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Worley BS, 2001, CANCER RES, V61, P6868; Yu ZY, 2004, J CLIN INVEST, V114, P551, DOI 10.1172/JCI200421695	12	4	4	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2008	319	5860					164	165		10.1126/science.1153713	http://dx.doi.org/10.1126/science.1153713			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249RC	18187644				2022-12-28	WOS:000252246400026
J	Boukai, AI; Bunimovich, Y; Tahir-Kheli, J; Yu, JK; Goddard, WA; Heath, JR				Boukai, Akram I.; Bunimovich, Yuri; Tahir-Kheli, Jamil; Yu, Jen-Kan; Goddard, William A., III; Heath, James R.			Silicon nanowires as efficient thermoelectric materials	NATURE			English	Article							THERMAL-CONDUCTIVITY; PHONON DRAG; POWER; TRANSPORT; FIGURE	Thermoelectric materials interconvert thermal gradients and electric fields for power generation or for refrigeration(1,2). Thermoelectrics currently find only niche applications because of their limited efficiency, which is measured by the dimensionless parameter ZT - a function of the Seebeck coefficient or thermoelectric power, and of the electrical and thermal conductivities. Maximizing ZT is challenging because optimizing one physical parameter often adversely affects another(3). Several groups have achieved significant improvements in ZT through multi- component nanostructured thermoelectrics(4-6), such as Bi2Te3/Sb2Te3 thin- film superlattices, or embedded PbSeTe quantum dot superlattices. Here we report efficient thermoelectric performance from the single- component system of silicon nanowires for cross- sectional areas of 10 nm x 20 nm and 20 nm x 20 nm. By varying the nanowire size and impurity doping levels, ZT values representing an approximately 100- fold improvement over bulk Si are achieved over a broad temperature range, including ZT approximate to 1 at 200 K. Independent measurements of the Seebeck coefficient, the electrical conductivity and the thermal conductivity, combined with theory, indicate that the improved efficiency originates from phonon effects. These results are expected to apply to other classes of semiconductor nanomaterials.	[Boukai, Akram I.; Bunimovich, Yuri; Tahir-Kheli, Jamil; Yu, Jen-Kan; Goddard, William A., III; Heath, James R.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Heath, JR (corresponding author), CALTECH, Div Chem & Chem Engn, MC 127-72,1200 E Calif Blvd, Pasadena, CA 91125 USA.	heath@caltech.edu	Yu, Jen-Kan/E-6405-2011	Bunimovich, Yuri/0000-0002-7920-8781				BEHNEN E, 1990, J APPL PHYS, V67, P287, DOI 10.1063/1.345250; Boukai A, 2006, ADV MATER, V18, P864, DOI 10.1002/adma.200502194; CAHILL DG, 1992, PHYS REV B, V46, P6131, DOI 10.1103/PhysRevB.46.6131; Chen G, 2003, INT MATER REV, V48, P45, DOI 10.1179/095066003225010182; GEBALLE TH, 1955, PHYS REV, V98, P940, DOI 10.1103/PhysRev.98.940; GUREVICH L, 1946, ZH EKSP TEOR FIZ+, V16, P193; Harman TC, 2002, SCIENCE, V297, P2229, DOI 10.1126/science.1072886; HERRING C, 1954, PHYS REV, V96, P1163, DOI 10.1103/PhysRev.96.1163; HICKS LD, 1993, PHYS REV B, V47, P16631, DOI 10.1103/PhysRevB.47.16631; Hsu KF, 2004, SCIENCE, V303, P818, DOI 10.1126/science.1092963; Humphrey TE, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.096601; LANDAU LD, 1986, THEORY ELASTICITY, P138; Li DY, 2003, APPL PHYS LETT, V83, P2934, DOI 10.1063/1.1616981; Lifshitz R, 2000, PHYS REV B, V61, P5600, DOI 10.1103/PhysRevB.61.5600; Lin YM, 2002, APPL PHYS LETT, V81, P2403, DOI 10.1063/1.1503873; Mac Donald D., 1962, THERMOELECTRICITY IN; Mahan G, 1997, PHYS TODAY, V50, P42, DOI 10.1063/1.881752; Mahan GD, 1996, P NATL ACAD SCI USA, V93, P7436, DOI 10.1073/pnas.93.15.7436; Majumdar A, 2004, SCIENCE, V303, P777, DOI 10.1126/science.1093164; Maranganti R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.195504; Melosh NA, 2003, SCIENCE, V300, P112, DOI 10.1126/science.1081940; Morales AM, 1998, SCIENCE, V279, P208, DOI 10.1126/science.279.5348.208; PEARSON WB, 1961, SOV PHYS-SOL STATE, V3, P1024; Shi L, 2003, J HEAT TRANS-T ASME, V125, P881, DOI 10.1115/1.1597619; Small JP, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.256801; TRZCINSKI R, 1986, PHYS REV LETT, V56, P1086, DOI 10.1103/PhysRevLett.56.1086; Venkatasubramanian R, 2001, NATURE, V413, P597, DOI 10.1038/35098012; Wang DW, 2006, SMALL, V2, P1153, DOI 10.1002/smll.200600249; WEBER L, 1991, APPL PHYS A-MATER, V53, P136, DOI 10.1007/BF00323873; Zener C, 1937, PHYS REV, V52, P0230, DOI 10.1103/PhysRev.52.230	30	2273	2329	23	1483	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2008	451	7175					168	171		10.1038/nature06458	http://dx.doi.org/10.1038/nature06458			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249GA	18185583				2022-12-28	WOS:000252214400037
J	Pelliccia, A; Di Paolo, FM; Quattrini, FM; Basso, C; Culasso, F; Popoli, G; De Luca, R; Spataro, A; Biffi, A; Thiene, G; Maron, BJ				Pelliccia, Antonio; Di Paolo, Fernando M.; Quattrini, Filippo M.; Basso, Cristina; Culasso, Franco; Popoli, Gloria; De Luca, Rosanna; Spataro, Antonio; Biffi, Alessandro; Thiene, Gaetano; Maron, Barry J.			Outcomes in athletes with marked ECG repolarization abnormalities	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							T-WAVE ABNORMALITIES; LEFT-VENTRICULAR HYPERTROPHY; BINDING PROTEIN-C; SUDDEN-DEATH; HEART; ELECTROCARDIOGRAMS; CARDIOMYOPATHY; DIAGNOSIS; PATTERNS; SPORTS	Background: Young, trained athletes may have abnormal 12-lead electrocardiograms (ECGs) without evidence of structural cardiac disease. Whether such ECG patterns represent the initial expression of underlying cardiac disease with potential long-term adverse consequences remains unresolved. We assessed long-term clinical outcomes in athletes with ECGs characterized by marked repolarization abnormalities. Methods: From a database of 12,550 trained athletes, we identified 81 with diffusely distributed and deeply inverted T waves (>= 2 mm in at least three leads) who had no apparent cardiac disease and who had undergone serial clinical, ECG, and echocardiographic studies for a mean (+/-SD) of 9+/-7 years (range, 1 to 27). Comparisons were made with 229 matched control athletes with normal ECGs from the same database. Results: Of the 81 athletes with abnormal ECGs, 5 (6%) ultimately proved to have cardiomyopathies, including one who died suddenly at the age of 24 years from clinically undetected arrhythmogenic right ventricular cardiomyopathy. Of the 80 surviving athletes, clinical and phenotypic features of hypertrophic cardiomyopathy developed in 3 after 12+/-5 years (at the ages of 27, 32, and 50 years), including 1 who had an aborted cardiac arrest. The fifth athlete demonstrated dilated cardiomyopathy after 9 years of follow-up. In contrast, none of the 229 athletes with normal ECGs had a cardiac event or received a diagnosis of cardiomyopathy 9+/-3 years after initial evaluation (P=0.001). Conclusions: Markedly abnormal ECGs in young and apparently healthy athletes may represent the initial expression of underlying cardiomyopathies that may not be evident until many years later and that may ultimately be associated with adverse outcomes. Athletes with such ECG patterns merit continued clinical surveillance.	[Pelliccia, Antonio; Di Paolo, Fernando M.; Quattrini, Filippo M.; De Luca, Rosanna; Spataro, Antonio; Biffi, Alessandro] Italian Natl Olymp Comm, Inst Sports Med & Sci, I-00197 Rome, Italy; [Basso, Cristina; Thiene, Gaetano] Univ Padua, Sch Med, Inst Pathol, Padua, Italy; [Culasso, Franco] Univ Roma La Sapienza, Dept Expt Med, Rome, Italy; [Popoli, Gloria] Univ Modena & Reggio Emilia, Dept Diagnost & Lab Serv & Forens Med, Modena, Italy; [Maron, Barry J.] Minneapolis Heart Inst Fdn, Hypertroph Cardiomyopathy Ctr, Minneapolis, MN USA	University of Padua; Sapienza University Rome; Universita di Modena e Reggio Emilia; Minneapolis Heart Institute Foundation	Pelliccia, A (corresponding author), Italian Natl Olymp Comm, Inst Sports Med & Sci, Via Campi Sport 46, I-00197 Rome, Italy.	ant.pelliccia@libero.it		QUATTRINI, Filippo Maria/0000-0001-5309-140X; Spataro, Antonio/0000-0002-7727-665X; basso, cristina/0000-0002-0195-9753				Antzelevitch C, 2003, J AM COLL CARDIOL, V41, P1665, DOI 10.1016/S0735-1097(03)00310-3; ARMITAGE P, 1994, STAT METHODS MED RES, P277; BALADY GJ, 1984, AM J CARDIOL, V53, P1339, DOI 10.1016/0002-9149(84)90090-0; BJORNSTAD H, 1993, CARDIOLOGY, V82, P66, DOI 10.1159/000175856; Corrado D, 2003, J AM COLL CARDIOL, V42, P1959, DOI 10.1016/j.jacc.2003.03.002; DOUGLAS PS, 1988, AM HEART J, V116, P784, DOI 10.1016/0002-8703(88)90338-9; GAVAZZI A, 1993, AM HEART J, V125, P410; HANNEPAPARO N, 1971, AM HEART J, V81, P743, DOI 10.1016/0002-8703(71)90078-0; HUSTON TP, 1985, NEW ENGL J MED, V313, P24, DOI 10.1056/NEJM198507043130106; LICHTMAN J, 1973, ARCH INTERN MED, V132, P763, DOI 10.1001/archinte.132.5.763; Maron BJ, 2006, CIRCULATION, V114, P1633, DOI 10.1161/CIRCULATIONAHA.106.613562; Maron BJ, 2004, J AM COLL CARDIOL, V44, P2125, DOI 10.1016/j.jacc.2004.08.052; MARON BJ, 1983, AM J CARDIOL, V51, P189, DOI 10.1016/S0002-9149(83)80034-4; Maron BJ, 2003, J AM COLL CARDIOL, V42, P882, DOI 10.1016/S0735-1097(03)00855-6; MARON BJ, 1995, CIRCULATION, V91, P1596, DOI 10.1161/01.CIR.91.5.1596; Maron BJ, 2001, J AM COLL CARDIOL, V38, P315, DOI 10.1016/S0735-1097(01)01386-9; MCKENNA WJ, 1994, BRIT HEART J, V71, P215; Niimura H, 1998, NEW ENGL J MED, V338, P1248, DOI 10.1056/NEJM199804303381802; NISHIMURA T, 1981, J ELECTROCARDIOL, V14, P357, DOI 10.1016/S0022-0736(81)81008-4; OAKLEY DG, 1982, AM J CARDIOL, V50, P985, DOI 10.1016/0002-9149(82)90406-4; Pelliccia A, 2000, CIRCULATION, V102, P278; PELLICCIA A, 1991, NEW ENGL J MED, V324, P295, DOI 10.1056/NEJM199101313240504; PELLICCIA A, 1995, AM J CARDIOL, V75, P827, DOI 10.1016/S0002-9149(99)80421-4; PELLICCIA A, 1993, AM J CARDIOL, V72, P978, DOI 10.1016/0002-9149(93)91120-7; Pelliccia A, 1999, ANN INTERN MED, V130, P23, DOI 10.7326/0003-4819-130-1-199901050-00005; Pelliccia A, 2006, EUR HEART J, V27, P2196, DOI 10.1093/eurheartj/ehl137; ROESKE WR, 1976, CIRCULATION, V53, P286, DOI 10.1161/01.CIR.53.2.286; Serra-Grima R, 2000, J AM COLL CARDIOL, V36, P1310, DOI 10.1016/S0735-1097(00)00853-6; SHARMA S, 1999, BRIT J SPORT MED, V33, P39; THIENE G, 1988, NEW ENGL J MED, V318, P129, DOI 10.1056/NEJM198801213180301; VENERANDO A, 1964, J Sports Med Phys Fitness, V4, P135; ZEHENDER M, 1990, AM HEART J, V119, P1378, DOI 10.1016/S0002-8703(05)80189-9; ZEPPILLI P, 1980, AM HEART J, V100, P213, DOI 10.1016/0002-8703(80)90117-9	33	211	219	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2008	358	2					152	161		10.1056/NEJMoa060781	http://dx.doi.org/10.1056/NEJMoa060781			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249CJ	18184960				2022-12-28	WOS:000252204200006
J	Vinther, J; Van Roy, P; Briggs, DEG				Vinther, Jakob; Van Roy, Peter; Briggs, Derek E. G.			Machaeridians are Palaeozoic armoured annelids	NATURE			English	Article								The systematic affinities of several Palaeozoic skeletal taxa were only resolved when their soft- tissue morphology was revealed by the discovery of exceptionally preserved specimens. The conodonts provide a classic example, their tooth- like elements having been assigned to various invertebrate and vertebrate groups for more than 125 years until the discovery of their soft tissues revealed them to be crown- group vertebrates(1). Machaeridians, which are virtually ubiquitous as shell plates in benthic marine shelly assemblages ranging from Early Ordovician ( Late Tremadoc) to Carboniferous(2), have proved no less enigmatic. The Machaeridia comprise three distinct families of worm- like animals, united by the possession of a dorsal skeleton of calcite plates that is rarely found articulated. Since they were first described 150 years ago(3) machaeridians have been allied with barnacles(4,5), echinoderms(6,7), molluscs(3,8-10) or annelids(9,11,12). Here we describe a new machaeridian with preserved soft parts, including parapodia and chaetae, from the Upper Tremadoc of Morocco, demonstrating the annelid affinity of the group. This discovery shows that a lineage of annelids evolved a dorsal skeleton of calcareous plates early in their history; it also resolves the affinities of a group of problematic Palaeozoic invertebrates previously known only from isolated elements and occasional skeletal assemblages.	[Vinther, Jakob; Briggs, Derek E. G.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Van Roy, Peter] Univ Ghent, Dept Soil Sci & Geol, B-9000 Ghent, Belgium	Yale University; Ghent University	Briggs, DEG (corresponding author), Yale Univ, Dept Geol & Geophys, POB 208109, New Haven, CT 06520 USA.	derek.briggs@yale.edu	Vinther, Jakob/GZG-4679-2022	Vinther, Jakob/0000-0002-3584-9616; Van Roy, Peter/0000-0001-5330-8402				ADRAIN JM, 1991, PALAEONTOLOGY, V34, P637; ADRAIN JM, 1992, ALCHERINGA, V16, P15, DOI 10.1080/03115519208619031; Alessandrello Anna, 2004, Memorie della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano, V32, P1; [Anonymous], 1998, FOSSILS HUNSR CK SLA; BENGTSON S, 1970, LETHAIA, V3, P363, DOI 10.1111/j.1502-3931.1970.tb00829.x; BENGTSON S, 1978, THALASSIA JUGOSLAVIC, V12, P1; BISCHOFF GCO, 1975, SENCKENBERG LETH, V57, P1; BRIGGS DEG, 1992, SCIENCE, V256, P1285, DOI 10.1126/science.1598571; CHAUVEL J., 1967, B SOC GEOLOGIQUE MIN, P73; DE KONINCK L., 1857, B LACADEMIE SCI BELG, V3, P190; Destombes J., 1985, LOWER PALAEOZOIC ROC, V4, P91; DZIK J, 1986, PROBLEMATIC FOSSIL T, P116; Eibye-Jacobsen D, 2004, LETHAIA, V37, P317, DOI 10.1080/00241160410002027; EVANS KR, 1990, J PALEONTOL, V64, P692, DOI 10.1017/S0022336000018928; Farrell UC, 2007, P ROY SOC B-BIOL SCI, V274, P499, DOI 10.1098/rspb.2006.0063; Hints O, 2004, CRIT MOM PERSP EARTH, P223; Hints O, 2007, PALAEOGEOGR PALAEOCL, V245, P95, DOI 10.1016/j.palaeo.2006.02.029; Holmer LE, 2002, PALAEONTOLOGY, V45, P875, DOI 10.1111/1475-4983.00265; Jell PA, 1979, ALCHERINGA, V3, P253, DOI 10.1080/03115517908527797; KOBAYASHI T, 1976, P JPN ACAD, V52, P371, DOI 10.2183/pjab1945.52.371; Li GX, 2004, J PALEONTOL, V78, P900, DOI 10.1666/0022-3360(2004)078<0900:TAMTFT>2.0.CO;2; MORRIS SC, 1995, PHILOS T ROY SOC B, V347, P305, DOI 10.1098/rstb.1995.0029; Pope J.K., 1975, Bulletins of American Paleontology, V67, P385; Rouse Greg W., 2002, POLYCHAETES; Schrank E., 1978, Geschiebe-Sammler, V11, P5; Sigwart JD, 2007, P R SOC B, V274, P2413, DOI 10.1098/rspb.2007.0701; Westheide W, 1997, J NAT HIST, V31, P1, DOI 10.1080/00222939700770011; Withers T. H., 1926, CATALOGUE MACHAERIDI, Vxv, P1; Wolburg J., 1938, Palaeontologische Zeitschrift, V20, P289; WOODWARD H, 1865, Q J GEOL SOC LOND, V21, P486	30	78	80	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2008	451	7175					185	188		10.1038/nature06474	http://dx.doi.org/10.1038/nature06474			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249GA	18185586				2022-12-28	WOS:000252214400041
J	Mitchell, EW				Mitchell, Edward W.			The ethics of passer-by diagnosis	LANCET			English	Editorial Material							EMERGENCIES; PHYSICIAN		[Mitchell, Edward W.] Univ Oxford, Sch Med, John Radcliffe Hosp, Oxford, England	University of Oxford	Mitchell, EW (corresponding author), Univ Oxford Pembroke Coll, Oxford OX1 1DW, England.	ed.mitchell@pmb.ox.ac.uk		Mitchell, Edward/0000-0002-3842-6045				*AM MED ASS, 2006, COD MED ETH AM MED A; Beauchamp T L, 2012, PRINCIPLES BIOMEDICA; Brochez L, 2001, J AM ACAD DERMATOL, V44, P979, DOI 10.1067/mjd.2001.113442; BUTLER S, 1872, EREWHON, P72; CHUN RWM, 1973, JAMA-J AM MED ASSOC, V225, P1603, DOI 10.1001/jama.225.13.1603; Dowdall N, 2000, BRIT MED J, V321, P1336, DOI 10.1136/bmj.321.7272.1336; General Medical Council, 2006, GOOD MED PRACT; Glover J, 1977, CAUSING DEATH SAVING; Grimes DA, 2002, LANCET, V359, P881, DOI 10.1016/S0140-6736(02)07948-5; Gross CP, 1998, J GEN INTERN MED, V13, P491, DOI 10.1046/j.1525-1497.1998.00141.x; Gruen RL, 2004, JAMA-J AM MED ASSOC, V291, P94, DOI 10.1001/jama.291.1.94; HUGHES R, 1998, TIME            0413; Leavitt FJ, 2005, J MED ETHICS, V31, P689, DOI 10.1136/jme.2004.010769; Noddings N., 1984, HAPPINESS ED; Tronto J, 1993, MORAL BOUNDARIES; Williams K, 2001, Oxf J Leg Stud, V21, P393, DOI 10.1093/ojls/21.3.393	16	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 5	2008	371	9606					85	87		10.1016/S0140-6736(08)60075-6	http://dx.doi.org/10.1016/S0140-6736(08)60075-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248YH	18177779				2022-12-28	WOS:000252192600034
J	Shen, B; Dong, L; Xiao, SH; Kowalewski, M				Shen, Bing; Dong, Lin; Xiao, Shuhai; Kowalewski, Michal			The Avalon explosion: Evolution of Ediacara morphospace	SCIENCE			English	Article							MORPHOLOGICAL DISPARITY; STANLY COUNTY; FOSSILS; BODY; BIOTAS; ORIGIN; SHALE; AREA; SEA	Ediacara fossils [ 575 to 542 million years ago ( Ma)] represent Earth's oldest known complex macroscopic life forms, but their morphological history is poorly understood. A comprehensive quantitative analysis of these fossils indicates that the oldest Ediacara assemblage- the Avalon assemblage ( 575 to 565 Ma)- already encompassed the full range of Ediacara morphospace. A comparable morphospace range was occupied by the subsequent White Sea ( 560 to 550 Ma) and Nama ( 550 to 542 Ma) assemblages, although it was populated differently. In contrast, taxonomic richness increased in the White Sea assemblage and declined in the Nama assemblage. These diversity changes, occurring while morphospace range remained relatively constant, led to inverse shifts in morphological variance. The Avalon morphospace expansion mirrors the Cambrian explosion, and both events may reflect similar underlying mechanisms.	[Shen, Bing; Dong, Lin; Xiao, Shuhai; Kowalewski, Michal] Virginia Polytech Inst & State Univ, Dept Geosci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Xiao, SH (corresponding author), Virginia Polytech Inst & State Univ, Dept Geosci, Blacksburg, VA 24061 USA.	xiao@vt.edu	Kowalewski, Michal/B-4263-2008; Shen, Bing/D-5355-2009; Xiao, Shuhai/A-2190-2009	Kowalewski, Michal/0000-0002-8575-4711; Shen, Bing/0000-0002-7955-0704; Xiao, Shuhai/0000-0003-4655-2663				Amthor JE, 2003, GEOLOGY, V31, P431, DOI 10.1130/0091-7613(2003)031<0431:EOCANA>2.0.CO;2; BOWRING SA, 1993, SCIENCE, V261, P1293, DOI 10.1126/science.11539488; BRIGGS DEG, 1992, SCIENCE, V256, P1670, DOI 10.1126/science.256.5064.1670; Canfield DE, 2007, SCIENCE, V315, P92, DOI 10.1126/science.1135013; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Dzik J, 2003, INTEGR COMP BIOL, V43, P114, DOI 10.1093/icb/43.1.114; FARMER J, 1992, GEOL MAG, V129, P181, DOI 10.1017/S001675680000827X; Fike DA, 2006, NATURE, V444, P744, DOI 10.1038/nature05345; FOOTE M, 1992, P NATL ACAD SCI USA, V89, P7325, DOI 10.1073/pnas.89.16.7325; FOOTE M, 1992, SCIENCE, V258, P1816, DOI 10.1126/science.258.5089.1816; FOOTE M, 1993, PALEOBIOLOGY, V19, P185, DOI 10.1017/S0094837300015864; FOOTE M, 1994, PALEOBIOLOGY, V20, P320, DOI 10.1017/S009483730001280X; Gehling JG, 2005, EVOLVING FORM AND FUNCTION: FOSSILS AND DEVELOPMENT, P43; GIBSON GG, 1984, GEOLOGY, V12, P387, DOI 10.1130/0091-7613(1984)12<387:EFFTCS>2.0.CO;2; GOULD SJ, 1991, PALEOBIOLOGY, V17, P411, DOI 10.1017/S0094837300010745; Grazhdankin D, 2004, PALEOBIOLOGY, V30, P203, DOI 10.1666/0094-8373(2004)030<0203:PODITE>2.0.CO;2; Grazhdankin D, 2002, PALAEONTOLOGY, V45, P57, DOI 10.1111/1475-4983.00227; GROIZINGER JP, 1995, SCIENCE, V270, P598; Hagadorn JW, 2000, J PALEONTOL, V74, P349, DOI 10.1666/0022-3360(2000)074<0349:EFFTSG>2.0.CO;2; HOFMANN HJ, 1991, CAN J EARTH SCI, V28, P1541, DOI 10.1139/e91-138; Huntley JW, 2006, PRECAMBRIAN RES, V144, P52, DOI 10.1016/j.precamres.2005.11.003; Marshall CR, 2006, ANNU REV EARTH PL SC, V34, P355, DOI 10.1146/annurev.earth.33.031504.103001; Martin MW, 2000, SCIENCE, V288, P841, DOI 10.1126/science.288.5467.841; Narbonne GM, 2005, ANNU REV EARTH PL SC, V33, P421, DOI 10.1146/annurev.earth.33.092203.122519; Narbonne GM, 2003, GEOLOGY, V31, P27, DOI 10.1130/0091-7613(2003)031<0027:LASTOC>2.0.CO;2; NARBONNE GM, 1987, PALAEONTOLOGY, V30, P647; Peterson KJ, 2005, P NATL ACAD SCI USA, V102, P9547, DOI 10.1073/pnas.0503660102; Smith AG, 2001, PERS PALEOB, P11; SOKOLOV BS, 1990, VENDIAN SYSTEM, V1; SUN WG, 1986, PRECAMBRIAN RES, V31, P361, DOI 10.1016/0301-9268(86)90040-9; Waggoner B, 2003, INTEGR COMP BIOL, V43, P104, DOI 10.1093/icb/43.1.104; Weaver PG, 2006, PRECAMBRIAN RES, V150, P123, DOI 10.1016/j.precamres.2006.07.002; Xiao SH, 2005, P NATL ACAD SCI USA, V102, P10227, DOI 10.1073/pnas.0502176102; Xiao SH, 2002, J PALEONTOL, V76, P347, DOI 10.1666/0022-3360(2002)076<0347:MCCIAT>2.0.CO;2	34	114	124	3	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2008	319	5859					81	84		10.1126/science.1150279	http://dx.doi.org/10.1126/science.1150279			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18174439				2022-12-28	WOS:000252084000035
J	Piao, SL; Ciais, P; Friedlingstein, P; Peylin, P; Reichstein, M; Luyssaert, S; Margolis, H; Fang, JY; Barr, A; Chen, AP; Grelle, A; Hollinger, DY; Laurila, T; Lindroth, A; Richardson, AD; Vesala, T				Piao, Shilong; Ciais, Philippe; Friedlingstein, Pierre; Peylin, Philippe; Reichstein, Markus; Luyssaert, Sebastiaan; Margolis, Hank; Fang, Jingyun; Barr, Alan; Chen, Anping; Grelle, Achim; Hollinger, David Y.; Laurila, Tuomas; Lindroth, Anders; Richardson, Andrew D.; Vesala, Timo			Net carbon dioxide losses of northern ecosystems in response to autumn warming	NATURE			English	Article							ATMOSPHERIC CO2; SEASONAL CYCLE; CLIMATE-CHANGE; FOREST; UNCERTAINTY; SENSITIVITY; EXCHANGE; BALANCE; SCHEME	The carbon balance of terrestrial ecosystems is particularly sensitive to climatic changes in autumn and spring(1-4), with spring and autumn temperatures over northern latitudes having risen by about 1.1 degrees C and 0.8 degrees C, respectively, over the past two decades(5). A simultaneous greening trend has also been observed, characterized by a longer growing season and greater photosynthetic activity(6,7). These observations have led to speculation that spring and autumn warming could enhance carbon sequestration and extend the period of net carbon uptake in the future(8). Here we analyse interannual variations in atmospheric carbon dioxide concentration data and ecosystem carbon dioxide fluxes. We find that atmospheric records from the past 20 years show a trend towards an earlier autumn- to- winter carbon dioxide build- up, suggesting a shorter net carbon uptake period. This trend cannot be explained by changes in atmospheric transport alone and, together with the ecosystem flux data, suggest increasing carbon losses in autumn. We use a process- based terrestrial biosphere model and satellite vegetation greenness index observations to investigate further the observed seasonal response of northern ecosystems to autumnal warming. We find that both photosynthesis and respiration increase during autumn warming, but the increase in respiration is greater. In contrast, warming increases photosynthesis more than respiration in spring. Our simulations and observations indicate that northern terrestrial ecosystems may currently lose carbon dioxide in response to autumn warming, with a sensitivity of about 0.2 PgC degrees C-1, offsetting 90% of the increased carbon dioxide uptake during spring. If future autumn warming occurs at a faster rate than in spring, the ability of northern ecosystems to sequester carbon may be diminished earlier than previously suggested(9,10).	[Piao, Shilong; Ciais, Philippe; Friedlingstein, Pierre] CNRS, CEA, UMR, LSCE, F-91191 Gif Sur Yvette, France; [Peylin, Philippe] LBI, F-78026 Thiverval Grignon, France; [Reichstein, Markus] Max Planck Inst Biogeochem, D-07701 Jena, Germany; [Luyssaert, Sebastiaan] Univ Antwerp, Dept Biol, B-2610 Antwerp, Belgium; [Margolis, Hank] Univ Laval, Fac Foresterie & Geomat, Ste Foy, PQ G1K 7P4, Canada; [Fang, Jingyun] Peking Univ, Dept Ecol, Beijing 100871, Peoples R China; [Barr, Alan] Environm Canada, Div Climate Res, Saskatoon, SK S7N 3H5, Canada; [Chen, Anping] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Grelle, Achim] Swedish Univ Agr Sci, Dept Ecol, SE-75007 Uppsala, Sweden; [Hollinger, David Y.] US Forest Serv, USDA, No Res Stn, Durham, NH 03824 USA; [Laurila, Tuomas] Finnish Meteorol Inst, FIN-00101 Helsinki, Finland; [Lindroth, Anders] Lund Univ, Dept Phys Geog & Ecosyst Anal, SE-22362 Lund, Sweden; [Richardson, Andrew D.] Univ New Hampshire, Complex Syst Res Ctr, Durham, NH 03824 USA; [Vesala, Timo] Univ Helsinki, Dept Phys Sci, FIN-00014 Helsinki, Finland	UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Max Planck Society; University of Antwerp; Laval University; Peking University; Environment & Climate Change Canada; Princeton University; Swedish University of Agricultural Sciences; United States Department of Agriculture (USDA); United States Forest Service; Finnish Meteorological Institute; Lund University; University System Of New Hampshire; University of New Hampshire; University of Helsinki	Piao, SL (corresponding author), CNRS, CEA, UMR, LSCE, Batiment 709,CE, F-91191 Gif Sur Yvette, France.	slpiao@lsce.ipsl.fr; philippe.ciais@lsce.ipsl.fr	Ciais, Philippe/A-6840-2011; Luyssaert, Sebastiaan/F-6684-2011; Friedlingstein, Pierre/H-2700-2014; Barr, Alan/H-9939-2014; Barr, Alan George/AAX-2129-2020; Chen, Anping/H-9960-2014; Vesala, Timo/C-3795-2017; Lindroth, Anders/N-4697-2014; Richardson, Andrew/F-5691-2011; Hollinger, David Y/G-7185-2012; Reichstein, Markus/A-7494-2011; Fang, Jingyun/A-4282-2009	Ciais, Philippe/0000-0001-8560-4943; Luyssaert, Sebastiaan/0000-0003-1121-1869; Friedlingstein, Pierre/0000-0003-3309-4739; Chen, Anping/0000-0003-2085-3863; Vesala, Timo/0000-0002-4852-7464; Lindroth, Anders/0000-0002-7669-784X; Richardson, Andrew/0000-0002-0148-6714; Reichstein, Markus/0000-0001-5736-1112; Peylin, Philippe/0000-0001-9335-6994; Barr, Alan/0000-0003-2717-218X				Angert A, 2005, P NATL ACAD SCI USA, V102, P10823, DOI 10.1073/pnas.0501647102; Aubinet M, 2000, ADV ECOL RES, V30, P113, DOI 10.1016/S0065-2504(08)60018-5; Bergeron O, 2007, GLOBAL CHANGE BIOL, V13, P89, DOI 10.1111/j.1365-2486.2006.01281.x; Black TA, 2000, GEOPHYS RES LETT, V27, P1271, DOI 10.1029/1999GL011234; Churkina G, 2005, GLOBAL CHANGE BIOL, V11, P1777, DOI 10.1111/j.1365-2486.2005.001012.x; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; *GLOBALVIEW CO2, 2004, COOP ATM DAT INT PRO; Goulden ML, 1998, SCIENCE, V279, P214, DOI 10.1126/science.279.5348.214; Heimann M, 1998, GLOBAL BIOGEOCHEM CY, V12, P1, DOI 10.1029/97GB01936; Hourdin F, 1999, MON WEATHER REV, V127, P822, DOI 10.1175/1520-0493(1999)127<0822:TUOFVM>2.0.CO;2; IPCC (Intergovernmental Panel on Climate Change), 2007, CLIM CHANG 2007 PHYS; Keeling CD, 1996, NATURE, V382, P146, DOI 10.1038/382146a0; Krinner G, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2003GB002199; Linderholm HW, 2006, AGR FOREST METEOROL, V137, P1, DOI 10.1016/j.agrformet.2006.03.006; MARLAND G, 2007, GLOBAL REGIONAL NATL; MARTI O, 2006, NEW ISPL CLIMATE SYS; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Morgenstern K, 2004, AGR FOREST METEOROL, V123, P201, DOI 10.1016/j.agrformet.2003.12.003; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; MYNENI RB, 2003, NDVI VERSION 3 BASED; Papale D, 2006, BIOGEOSCIENCES, V3, P571, DOI 10.5194/bg-3-571-2006; Piao SL, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028205; Randerson JT, 1999, GEOPHYS RES LETT, V26, P2765, DOI 10.1029/1999GL900500; RICHARDSON C, 1984, MODEL GENERATING DAI; Schwartz MD, 2006, GLOBAL CHANGE BIOL, V12, P343, DOI 10.1111/j.1365-2486.2005.01097.x; Shahgedanova M, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005213; SITCH S, IN PRESS GLOB CHANGE; Takasu Y, 1999, ELECTROCHEM SOLID ST, V2, P1, DOI 10.1149/1.1390714; Tanja S, 2003, GLOBAL CHANGE BIOL, V9, P1410, DOI 10.1046/j.1365-2486.2003.00597.x; THONING KW, 1989, J GEOPHYS RES-ATMOS, V94, P8549, DOI 10.1029/JD094iD06p08549; TIEDTKE M, 1989, MON WEATHER REV, V117, P1779, DOI 10.1175/1520-0493(1989)117<1779:ACMFSF>2.0.CO;2; VAN LEER B, 1977, J COMPUT PHYS, V23, P276, DOI [10.1016/0021-9991(77)90095-X, 10.1016/0021-9991(77)90094-8]	35	775	862	53	753	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 3	2008	451	7174					49	U3		10.1038/nature06444	http://dx.doi.org/10.1038/nature06444			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247KZ	18172494	Green Submitted			2022-12-28	WOS:000252079300030
J	Chekanova, JA; Gregory, BD; Reverdatto, SV; Chen, H; Kumar, R; Hooker, T; Yazaki, J; Li, P; Skiba, N; Peng, Q; Alonso, J; Brukhin, V; Grossniklaus, U; Ecker, JR; Belostotsky, DA				Chekanova, Julia A.; Gregory, Brian D.; Reverdatto, Sergei V.; Chen, Huaming; Kumar, Ravi; Hooker, Tanya; Yazaki, Junshi; Li, Pinghua; Skiba, Nikolai; Peng, Qian; Alonso, Jose; Brukhin, Vladimir; Grossniklaus, Ueli; Ecker, Joseph R.; Belostotsky, Dmitry A.			Genome-wide high-resolution mapping of exosome substrates reveals hidden features in the Arabidopsis transcriptome	CELL			English	Article							MESSENGER-RNA; RIBOSOMAL-RNA; QUALITY-CONTROL; SACCHAROMYCES-CEREVISIAE; DECAPPING COMPLEX; DNA METHYLATION; YEAST EXOSOME; DEGRADATION; PROTEIN; SUBUNIT	The exosome complex plays a central and essential role in RNA metabolism. However, comprehensive studies of exosome substrates and functional analyses of its subunits are lacking. Here, we demonstrate that as opposed to yeast and metazoans the plant exosome core possesses an unanticipated functional plasticity and present a genome-wide atlas of Arabidopsis exosome targets. Additionally, our study provides evidence for widespread polyadenylation- and exosome-mediated RNA quality control in plants, reveals unexpected aspects of stable structural RNA metabolism, and uncovers numerous novel exosome substrates. These include a select subset of mRNAs, miRNA processing intermediates, and hundreds of noncoding RNAs, the vast majority of which have not been previously described and belong to a layer of the transcriptome that can only be visualized upon inhibition of exosome activity. These first genome-wide maps of exosome substrates will aid in illuminating new fundamental components and regulatory mechanisms of eukaryotic transcriptomes.	[Gregory, Brian D.; Yazaki, Junshi; Peng, Qian; Alonso, Jose; Ecker, Joseph R.] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Gregory, Brian D.; Chen, Huaming; Yazaki, Junshi; Ecker, Joseph R.] Salk Inst Biol Studies, Genome Anal Lab, La Jolla, CA 92037 USA; [Chekanova, Julia A.; Kumar, Ravi; Hooker, Tanya; Belostotsky, Dmitry A.] Univ Missouri, Sch Biol Sci, Kansas City, MO 64110 USA; [Chekanova, Julia A.; Reverdatto, Sergei V.; Li, Pinghua; Belostotsky, Dmitry A.] SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA; [Skiba, Nikolai] Harvard Univ, Sch Med, Howe Lab Ophthalmol, Boston, MA 02114 USA; [Peng, Qian] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92037 USA; [Brukhin, Vladimir; Grossniklaus, Ueli] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Brukhin, Vladimir; Grossniklaus, Ueli] Univ Zurich, Zurich Basel Plant Sci Ctr, CH-8008 Zurich, Switzerland	Salk Institute; Salk Institute; University of Missouri System; University of Missouri Kansas City; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Harvard University; Harvard Medical School; University of California System; University of California San Diego; University of Zurich; University of Zurich	Ecker, JR (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	ecker@salk.edu; belostotskyd@umkc.edu	Grossniklaus, Ueli/A-2736-2012; Ecker, Joseph R/B-9144-2008; Alonso, Jose M/K-6826-2014; Yazaki, Junshi/B-1557-2012; Gregory, Brian D/G-2890-2010; Grossniklaus, Ueli/E-9995-2016; Brukhin, Vladimir/F-9779-2015	Ecker, Joseph R/0000-0001-5799-5895; Alonso, Jose M/0000-0001-7087-1571; Grossniklaus, Ueli/0000-0002-0522-8974; Brukhin, Vladimir/0000-0003-1836-0437; Yazaki, Junshi/0000-0002-0697-8320; Chen, Huaming/0000-0001-5289-7882; Chekanova, Julia/0000-0002-2214-8896				Akama K, 1997, FEBS LETT, V417, P213, DOI 10.1016/S0014-5793(97)01288-X; Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Allmang C, 2000, NUCLEIC ACIDS RES, V28, P1684, DOI 10.1093/nar/28.8.1684; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Baker RE, 1998, GENETICS, V149, P73; Barneche F, 2000, J BIOL CHEM, V275, P27212; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Brouwer R, 2001, J BIOL CHEM, V276, P6177, DOI 10.1074/jbc.M007603200; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Chekanova JA, 2000, J BIOL CHEM, V275, P33158, DOI 10.1074/jbc.M005493200; Chekanova JA, 2002, NUCLEIC ACIDS RES, V30, P695, DOI 10.1093/nar/30.3.695; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Das B, 2003, MOL CELL BIOL, V23, P5502, DOI 10.1128/MCB.23.16.5502-5515.2003; Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Estevez AM, 2003, J BIOL CHEM, V278, P34943, DOI 10.1074/jbc.M305333200; Estevez AM, 2001, EMBO J, V20, P3831, DOI 10.1093/emboj/20.14.3831; Goeres DC, 2007, PLANT CELL, V19, P1549, DOI 10.1105/tpc.106.047621; Graham AC, 2006, MOL BIOL CELL, V17, P1399, DOI 10.1091/mbc.e05-08-0805; Hooker TS, 2007, PLANT CELL, V19, P904, DOI 10.1105/tpc.106.049304; Houalla R, 2006, YEAST, V23, P439, DOI 10.1002/yea.1369; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; Kadaba S, 2006, RNA, V12, P508, DOI 10.1261/rna.2305406; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kopcewicz KA, 2007, MOL CELL BIOL, V27, P2821, DOI 10.1128/MCB.02159-06; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Libri D, 2002, MOL CELL BIOL, V22, P8254, DOI 10.1128/MCB.22.23.8254-8266.2002; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Liu QS, 2007, CELL, V131, P188, DOI 10.1016/j.cell.2007.09.019; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Mayer C, 2006, MOL CELL, V22, P351, DOI 10.1016/j.molcel.2006.03.028; Meyers BC, 2004, NAT BIOTECHNOL, V22, P1006, DOI 10.1038/nbt992; Mitchell P, 2003, MOL CELL BIOL, V23, P6982, DOI 10.1128/MCB.23.19.6982-6992.2003; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Peng WT, 2003, CELL, V113, P919, DOI 10.1016/S0092-8674(03)00466-5; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Torchet C, 2002, MOL CELL, V9, P1285, DOI 10.1016/S1097-2765(02)00544-0; van Hoof A, 2000, EMBO J, V19, P1357, DOI 10.1093/emboj/19.6.1357; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Xu J, 2006, PLANT CELL, V18, P3386, DOI 10.1105/tpc.106.047605; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2004, CURR BIOL, V14, P1214, DOI 10.1016/j.cub.2004.06.055; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	54	257	271	0	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 28	2007	131	7					1340	1353		10.1016/j.cell.2007.10.056	http://dx.doi.org/10.1016/j.cell.2007.10.056			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GV	18160042	Bronze			2022-12-28	WOS:000252217200022
J	Reddy, VY; Reynolds, MR; Neuzil, P; Richardson, AW; Taborsky, M; Jongnarangsin, K; Kralovec, S; Sediva, L; Ruskin, JN; Josephson, ME				Reddy, Vivek Y.; Reynolds, Matthew R.; Neuzil, Petr; Richardson, Allison W.; Taborsky, Milos; Jongnarangsin, Krit; Kralovec, Stepan; Sediva, Lucie; Ruskin, Jeremy N.; Josephson, Mark E.			Prophylactic catheter ablation for the prevention of defibrillator therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	27th Annual Scientific Session of the Heart-Rhythm-Society	MAY 17-20, 2006	Boston, MA	Heart Rhythm Soc			IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; VENTRICULAR-TACHYCARDIA; MYOCARDIAL-INFARCTION; SINUS RHYTHM; DRUG-THERAPY; SOTALOL; SHOCKS; CARDIOMYOPATHY; ORIGIN; TRIAL	Background: For patients who have a ventricular tachyarrhythmic event, implantable cardioverter-defibrillators (ICDs) are a mainstay of therapy to prevent sudden death. However, ICD shocks are painful, can result in clinical depression, and do not offer complete protection against death from arrhythmia. We designed this randomized trial to examine whether prophylactic radiofrequency catheter ablation of arrhythmogenic ventricular tissue would reduce the incidence of ICD therapy. Methods: Eligible patients with a history of a myocardial infarction underwent defibrillator implantation for spontaneous ventricular tachycardia or fibrillation. The patients did not receive antiarrhythmic drugs. Patients were randomly assigned to defibrillator implantation alone or defibrillator implantation with adjunctive catheter ablation (64 patients in each group). Ablation was performed with the use of a substrate-based approach in which the myocardial scar is mapped and ablated while the heart remains predominantly in sinus rhythm. The primary end point was survival free from any appropriate ICD therapy. Results: The mortality rate 30 days after ablation was zero, and there were no significant changes in ventricular function or functional class during the mean (+/-SD) follow-up period of 22.5+/-5.5 months. Twenty-one patients assigned to defibrillator implantation alone (33%) and eight patients assigned to defibrillator implantation plus ablation (12%) received appropriate ICD therapy (antitachycardia pacing or shocks) (hazard ratio in the ablation group, 0.35; 95% confidence interval, 0.15 to 0.78, P=0.007). Among these patients, 20 in the control group (31%) and 6 in the ablation group (9%) received shocks (P=0.003). Mortality was not increased in the group assigned to ablation as compared with the control group (9% vs. 17%, P=0.29). Conclusions: In this randomized trial, prophylactic substrate-based catheter ablation reduced the incidence of ICD therapy in patients with a history of myocardial infarction who received ICDs for the secondary prevention of sudden death. (Current Controlled Trials number, ISRCTN62488166.).	Beth Israel Deaconess Med Ctr, Harvard Thorndike Electrophysiol Inst, Div Cardiovasc, Boston, MA 02215 USA; Massachusetts Gen Hosp, Cardiac Arrhythmia Serv, Boston, MA 02114 USA; Beth Israel Deaconess Med Ctr, Arrhythmia Serv, Boston, MA 02215 USA; Homolka Hosp, Cardiac Arrhythmia Serv, Prague, Czech Republic	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Na Homolce Hospital	Josephson, ME (corresponding author), Beth Israel Deaconess Med Ctr, Harvard Thorndike Electrophysiol Inst, Div Cardiovasc, 185 Pilgrim Rd, Boston, MA 02215 USA.	mjoseph2@bidmc.harvard.edu		Reddy, Vivek/0000-0002-5638-4993	NHLBI NIH HHS [K23 HL077171-04, K23 HL077171, K23 HL68064, K23 HL068064] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL068064, K23HL077171] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson KP, 2005, J INTERV CARD ELECTR, V14, P71, DOI 10.1007/s10840-005-4547-9; Arenal A, 2003, J AM COLL CARDIOL, V41, P81, DOI 10.1016/S0735-1097(02)02623-2; Bilge AK, 2006, PACE, V29, P619, DOI 10.1111/j.1540-8159.2006.00409.x; CASSIDY DM, 1984, CIRCULATION, V69, P1103, DOI 10.1161/01.CIR.69.6.1103; Connolly SJ, 2006, JAMA-J AM MED ASSOC, V295, P165, DOI 10.1001/jama.295.2.165; Credner SC, 1998, J AM COLL CARDIOL, V32, P1909, DOI 10.1016/S0735-1097(98)00495-1; Epstein AE, 1998, J AM COLL CARDIOL, V31, p118A, DOI 10.1016/S0735-1097(97)84220-9; Goldberger JJ, 2006, J AM COLL CARDIOL, V48, P1228, DOI 10.1016/j.jacc.2006.05.053; Goldberger Z, 2006, JAMA-J AM MED ASSOC, V295, P809, DOI 10.1001/jama.295.7.809; GUIRAUDON G, 1978, ANN THORAC SURG, V26, P438, DOI 10.1016/S0003-4975(10)62923-2; Hohnloser SH, 2004, NEW ENGL J MED, V351, P2481, DOI 10.1056/NEJMoa041489; Josephson ME, 2003, J CARDIOVASC ELECTR, V14, P1134, DOI 10.1046/j.1540-8167.2003.03322.x; Kamphuis HCM, 2003, EUROPACE, V5, P381, DOI 10.1016/S1099-5129(03)00078-3; KIENZLE MG, 1984, CIRCULATION, V70, P957, DOI 10.1161/01.CIR.70.6.957; Krishnan SC, 2000, PACE, V23, P1295, DOI 10.1111/j.1540-8159.2000.tb00948.x; Marchlinski FE, 2000, CIRCULATION, V101, P1288, DOI 10.1161/01.CIR.101.11.1288; Mazur A, 2001, J AM COLL CARDIOL, V37, P1100, DOI 10.1016/S0735-1097(01)01106-8; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; Moss AJ, 2004, CIRCULATION, V110, P3760, DOI 10.1161/01.CIR.0000150390.04704.B7; Pacifico A, 1998, AM J CARDIOL, V82, P875, DOI 10.1016/S0002-9149(98)00495-0; Pacifico A, 1999, NEW ENGL J MED, V340, P1855, DOI 10.1056/NEJM199906173402402; Reddy VY, 2003, J AM COLL CARDIOL, V41, P2228, DOI 10.1016/S0735-1097(03)00492-3; Sears SF, 2003, CLIN CARDIOL, V26, P107, DOI 10.1002/clc.4960260303; Seidl K, 1998, AM J CARDIOL, V82, P744, DOI 10.1016/S0002-9149(98)00478-0; Stevenson WG, 2005, CURR OPIN CARDIOL, V20, P42; Villacastin J, 1996, CIRCULATION, V93, P753, DOI 10.1161/01.CIR.93.4.753	26	570	592	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2007	357	26					2657	2665		10.1056/NEJMoa065457	http://dx.doi.org/10.1056/NEJMoa065457			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	245UO	18160685	Green Accepted			2022-12-28	WOS:000251964500004
J	Steinbrook, R				Steinbrook, Robert			One step forward, two steps back - Will there ever be an AIDS vaccine?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRIAL					rsteinbrook@attglobal.net						Cohen Jon, 2001, SHOTS DARK WAYWARD S; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; *HIV VACC MICR RES, 2006, ADD IT ALL HIV VACC; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748	5	99	106	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2007	357	26					2653	2655		10.1056/NEJMp0708117	http://dx.doi.org/10.1056/NEJMp0708117			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	245UO	18160684				2022-12-28	WOS:000251964500003
J	Hampton, T				Hampton, Tracy			7-country survey of patients: - US adults most unhappy with health care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2007	298	23					2730	2731		10.1001/jama.298.23.2730	http://dx.doi.org/10.1001/jama.298.23.2730			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242HK	18165660				2022-12-28	WOS:000251716000003
J	Fathi, A; Erni, D				Fathi, Ali-Reza; Erni, Dominique			Calcified hematoma of the skull	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fathi, Ali-Reza; Erni, Dominique] Univ Hosp Bern, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern	Fathi, A (corresponding author), Univ Hosp Bern, CH-3010 Bern, Switzerland.	ar.fathi@gmx.net							0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2008	358	5					E5	E5		10.1056/NEJMicm074915	http://dx.doi.org/10.1056/NEJMicm074915			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	256IW	18234749				2022-12-28	WOS:000252722900010
J	Sheeran, J				Sheeran, Josette			The challenge of hunger	LANCET			English	Editorial Material									UN, World Food Programme, I-00148 Rome, Italy		Sheeran, J (corresponding author), UN, World Food Programme, I-00148 Rome, Italy.	nancy.roman@wfp.org						Collier P.., 2007, RISK MANAGEMENT ACCO; *FOOD AGR ORG UN, 2006, STAT FOOD INS WORLD; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; *UN EC COMM LAT AM, 2007, COST HAMBR IMP EC SO; United Nations, 2000, MILL DEV GOALS REP 2	5	20	20	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 19	2008	371	9608					180	181		10.1016/S0140-6736(07)61870-4	http://dx.doi.org/10.1016/S0140-6736(07)61870-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	252UK	18207568				2022-12-28	WOS:000252471900005
J	Gratten, J; Wilson, AJ; McRae, AF; Beraldi, D; Visscher, PM; Pemberton, JM; Slate, J				Gratten, J.; Wilson, A. J.; McRae, A. F.; Beraldi, D.; Visscher, P. M.; Pemberton, J. M.; Slate, J.			A localized negative genetic correlation constrains microevolution of coat color in wild sheep	SCIENCE			English	Article							SELECTION; EVOLUTION; DISEQUILIBRIUM; POPULATION; PHENOTYPE; GROWTH; TYRP1	The evolutionary changes that occur over a small number of generations in natural populations often run counter to what is expected on the basis of the heritability of traits and the selective forces acting upon them. In Soay sheep, dark coat color is associated with large size, which is heritable and positively correlated with fitness, yet the frequency of dark sheep has decreased. This unexpected microevolutionary trend is explained by genetic linkage between the causal mutation underlying the color polymorphism and quantitative trait loci with antagonistic effects on size and fitness. As a consequence, homozygous dark sheep are large, but have reduced fitness relative to phenotypically indistinguishable dark heterozygotes and light sheep. This result demonstrates the importance of understanding the genetic basis of fitness variation when making predictions about the microevolutionary consequences of selection.	[Gratten, J.; Slate, J.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Wilson, A. J.; Beraldi, D.; Pemberton, J. M.] Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; [McRae, A. F.; Visscher, P. M.] Queensland Inst Med Res, Brisbane, Qld 4029, Australia	University of Sheffield; University of Edinburgh; QIMR Berghofer Medical Research Institute	Gratten, J (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.		Wilson, Alastair/F-3118-2010; McRae, Allan F/J-2644-2014; Visscher, Peter/ABB-6151-2020; Pemberton, Josephine M/F-3100-2010; Gratten, Jacob/G-1485-2011; Slate, Jon/D-2925-2012	McRae, Allan F/0000-0001-5286-5485; Visscher, Peter/0000-0002-2143-8760; Gratten, Jacob/0000-0003-1293-409X; Slate, Jon/0000-0003-3356-5123; Wilson, Alastair/0000-0002-5045-2051; Beraldi, Dario/0000-0003-1504-5212	Natural Environment Research Council [NER/T/S/2002/00189, NE/D008883/1, NE/F001371/1] Funding Source: researchfish; NERC [NE/F001371/1, NE/D008883/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		[Anonymous], ISLAND SURVIVORS ECO; Clutton-Brock T.H., 2004, SOAY SHEEP DYNAMICS; CluttonBrock TH, 1997, PHILOS T R SOC B, V352, P839, DOI 10.1098/rstb.1997.0064; Coltman DW, 2003, MOL ECOL, V12, P733, DOI 10.1046/j.1365-294X.2003.01762.x; Coltman DW, 1999, AM NAT, V154, P730, DOI 10.1086/303274; Coulson T, 2006, P ROY SOC B-BIOL SCI, V273, P547, DOI 10.1098/rspb.2005.3357; ELWES HJ, 1912, SCOTT NATURALIST, V1, P25; Gratten J, 2007, P ROY SOC B-BIOL SCI, V274, P619, DOI 10.1098/rspb.2006.3762; Hernandez-Sanchez J, 2003, GENETICS, V164, P637; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.2307/2408842; Merila J, 2001, GENETICA, V112, P199, DOI 10.1023/A:1013391806317; Murisier F, 2006, DEV BIOL, V298, P644, DOI 10.1016/j.ydbio.2006.05.011; Nachman MW, 2003, P NATL ACAD SCI USA, V100, P5268, DOI 10.1073/pnas.0431157100; Roff D.A., 1997, EVOLUTIONARY QUANTIT; Slate J, 2002, GENETICS, V160, P1587; Smyth IM, 2006, P NATL ACAD SCI USA, V103, P3704, DOI 10.1073/pnas.0600199103; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Wilson AJ, 2007, EVOL ECOL, V21, P337, DOI 10.1007/s10682-006-9106-z; Wilson AJ, 2005, J EVOLUTION BIOL, V18, P405, DOI 10.1111/j.1420-9101.2004.00824.x; Wilson AJ, 2005, EVOLUTION, V59, P451; Yagyu H, 2002, J BIOL CHEM, V277, P10037, DOI 10.1074/jbc.M109966200; ZDARSKY E, 1990, GENETICS, V126, P443	23	91	92	0	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2008	319	5861					318	320		10.1126/science.1151182	http://dx.doi.org/10.1126/science.1151182			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252GY	18202287				2022-12-28	WOS:000252436200034
J	Long, MD; Silver, PG				Long, Maureen D.; Silver, Paul G.			The subduction zone flow field from seismic anisotropy: A global view	SCIENCE			English	Article							LATTICE-PREFERRED ORIENTATION; TRENCH-PARALLEL ANISOTROPY; MANTLE FLOW; PLATE MOTIONS; BENEATH; ARC; MARIANA; WEDGE; WATER	Although the morphologies of subducting slabs have been relatively well characterized, the character of the mantle flow field that accompanies subduction remains poorly understood. To analyze this pattern of flow, we compiled observations of seismic anisotropy, as manifested by shear wave splitting. Data from 13 subduction zones reveal systematic variations in both mantle- wedge and subslab anisotropy with the magnitude of trench migration velocity | V-t|. These variations can be explained by flow along the strike of the trench induced by trench motion. This flow dominates beneath the slab, where its magnitude scales with | V-t|. In the mantle wedge, this flow interacts with classical corner flow produced by the convergence velocity V-c; their relative influence is governed by the relative magnitude of | V-t| and V-c.	[Long, Maureen D.; Silver, Paul G.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA	Carnegie Institution for Science	Long, MD (corresponding author), Carnegie Inst Sci, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA.	long@dtm.ciw.edu	Long, Maureen D/A-1383-2009	Long, Maureen D/0000-0003-1936-3840				Behn MD, 2007, SCIENCE, V317, P108, DOI 10.1126/science.1141269; CHRISTENSEN NI, 1984, GEOPHYS J ROY ASTR S, V76, P89, DOI 10.1111/j.1365-246X.1984.tb05025.x; Currie CA, 2004, GEOPHYS J INT, V157, P341, DOI 10.1111/j.1365-246X.2004.02175.x; Fouch MJ, 1996, J GEOPHYS RES-SOL EA, V101, P15987, DOI 10.1029/96JB00881; Hall CE, 2000, J GEOPHYS RES-SOL EA, V105, P28009, DOI 10.1029/2000JB900297; Heuret A, 2005, PHYS EARTH PLANET IN, V149, P31, DOI 10.1016/j.pepi.2004.08.022; HUSSON L, 2007, MEM GEOSCI MONTPELLI, V41, P169; Jung H, 2006, TECTONOPHYSICS, V421, P1, DOI 10.1016/j.tecto.2006.02.011; Jung H, 2001, SCIENCE, V293, P1460, DOI 10.1126/science.1062235; Kaminski E, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000222; Kincaid C, 2003, NATURE, V425, P58, DOI 10.1038/nature01923; Kneller EA, 2005, EARTH PLANET SC LETT, V237, P781, DOI 10.1016/j.epsl.2005.06.049; Kneller EA, 2007, NATURE, V450, P1222, DOI 10.1038/nature06429; Levin V, 2004, GEOPHYS J INT, V158, P1009, DOI 10.1111/j.1365-246X.2004.02352.x; Long MD, 2007, GEOPHYS J INT, V170, P839, DOI 10.1111/j.1365-246X.2007.03464.x; Long MD, 2006, PHYS EARTH PLANET IN, V155, P300, DOI 10.1016/j.pepi.2006.01.003; Long MD, 2005, PHYS EARTH PLANET IN, V151, P206, DOI 10.1016/j.pepi.2005.03.003; Mehl L, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002233; Morgan JP, 2007, TERRA NOVA, V19, P167, DOI 10.1111/j.1365-3121.2007.00737.x; Nakajima J, 2004, EARTH PLANET SC LETT, V225, P365, DOI 10.1016/j.epsl.2004.06.011; Polet J, 2000, J GEOPHYS RES-SOL EA, V105, P6287, DOI 10.1029/1999JB900326; Pozgay SH, 2007, GEOPHYS J INT, V170, P371, DOI 10.1111/j.1365-246X.2007.03433.x; RUSSO RM, 1994, SCIENCE, V263, P1105, DOI 10.1126/science.263.5150.1105; Savage MK, 1999, REV GEOPHYS, V37, P65, DOI 10.1029/98RG02075; Silver PG, 1996, ANNU REV EARTH PL SC, V24, P385, DOI 10.1146/annurev.earth.24.1.385; Smith GP, 2001, SCIENCE, V292, P713, DOI 10.1126/science.1058763; Syracuse EM, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001045; ZHANG SQ, 1995, NATURE, V375, P774, DOI 10.1038/375774a0	28	295	304	6	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2008	319	5861					315	318		10.1126/science.1150809	http://dx.doi.org/10.1126/science.1150809			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252GY	18202286				2022-12-28	WOS:000252436200033
J	Asbury, CL				Asbury, Charles L.			XMAP215: A tip tracker that really moves	CELL			English	Editorial Material							PLUS-END-TRACKING; XENOPUS EGGS; MICROTUBULES; MECHANISMS; EB1	XMAP215 is a microtubule plus-end binding protein implicated in modulating microtubule dynamics. In this issue, Brouhard et al. ( 2008) propose a new mechanism to explain how XMAP215 promotes microtubule growth. They report that XMAP215 moves with the growing microtubule plus ends where it catalyzes the addition of tubulin subunits.	[Asbury, Charles L.] Univ Washington, Dept Phys & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Asbury, CL (corresponding author), Univ Washington, Dept Phys & Biophys, Box 357290, Seattle, WA 98195 USA.	casbury@u.washington.edu			NIGMS NIH HHS [R01 GM079373-01, R01 GM079373-02, R01 GM079373-03, R01 GM079373-04, R01 GM079373] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079373] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Al-Bassam J, 2006, J CELL BIOL, V172, P1009, DOI 10.1083/jcb.200511010; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; BROUHARD GJ, 2008, CELL; Cassimeris L, 2001, J CELL SCI, V114, P3025; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Shirasu-Hiza M, 2003, J CELL BIOL, V161, P349, DOI 10.1083/jcb.200211095; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; VASQUEZ RJ, 1994, J CELL BIOL, V127, P985, DOI 10.1083/jcb.127.4.985	12	6	7	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 11	2008	132	1					19	20		10.1016/j.cell.2007.12.019	http://dx.doi.org/10.1016/j.cell.2007.12.019			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IL	18191214	Bronze, Green Accepted			2022-12-28	WOS:000253427600009
J	Beller, S; Bender, A				Beller, Sieghard; Bender, Andrea			The limits of counting: Numerical cognition between evolution and culture	SCIENCE			English	Article							SYSTEMS; NUMBER; LANGUAGE; WORDS	Number words that, in principle, allow all kinds of objects to be counted ad infinitum are one basic requirement for complex numerical cognition. Accordingly, short or object- specific counting sequences in a language are often regarded as earlier steps in the evolution from premathematical conceptions to greater abstraction. We present some instances from Melanesia and Polynesia, whose short or object- specific sequences originated from the same extensive and abstract sequence. Furthermore, the object- specific sequences can be shown to be cognitively advantageous for calculations without notation because they use larger counting units, thereby abbreviating higher numbers, enhancing the counting process, and extending the limits of counting. These results expand our knowledge both regarding numerical cognition and regarding the evolution of numeration systems.	[Beller, Sieghard; Bender, Andrea] Univ Freiburg, Dept Psychol, D-79085 Freiburg, Germany	University of Freiburg	Bender, A (corresponding author), Univ Freiburg, Dept Psychol, D-79085 Freiburg, Germany.	bender@psychologie.uni-freiburg.de						Ascher M, 1991, ETHNOMATHEMATICS MUL; Bellwood P.S., 1987, POLYNESIANS PREHISTO; Bender A, 2006, J POLYNESIAN SOC, V115, P7; Bender A, 2007, J COGN CULT, V7, P213, DOI 10.1163/156853707X208495; Bender A, 2006, OCEAN LINGUIST, V45, P380, DOI 10.1353/ol.2007.0000; Churchward C.M., 1941, NEW FIJIAN GRAMMAR; DEHAENE S, 1992, COGNITION, V44, P1, DOI 10.1016/0010-0277(92)90049-N; Dehaene S., 2011, NUMBER SENSE MIND CR; Everett DL, 2005, CURR ANTHROPOL, V46, P621, DOI 10.1086/431525; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Fuson K. C., 1991, LANGUAGE MATH ED, P211; Geary DC, 1996, CHILD DEV, V67, P2022, DOI 10.2307/1131607; Gordon P, 2004, SCIENCE, V306, P496, DOI 10.1126/science.1094492; Green R. C., 2002, ASIAN PERSPECT, V41, P213, DOI DOI 10.1353/ASI.2003.0006; Holzknecht Susanne, 1986, PAPERS NEW GUINEA LI, V24, P77; IFRAH G, 1985, ONE ZERO UNIVERSAL H; Kirch P.V., 1984, EVOLUTION POLYNESIAN; KLIX F, 1993, ERWACHENDES DENKEN G; Lean G., 1992, COUNTING SYSTEMS PAP; Lynch J., 2002, OCEANIC LANGUAGES; Menninger Karl., 1969, NUMBER WORDS NUMBER; MILLER KF, 1995, PSYCHOL SCI, V6, P56, DOI 10.1111/j.1467-9280.1995.tb00305.x; NICKERSON RS, 1988, HUM FACTORS, V30, P181, DOI 10.1177/001872088803000206; Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085; TRYON DT, 1995, COMP AUSTRONESIAN DI; WASSMANN J, 1994, J CROSS CULT PSYCHOL, V25, P78, DOI 10.1177/0022022194251005; Wiese H, 2003, NUMBERS LANGUAGE HUM; Wiese H, 2007, LINGUA, V117, P758, DOI 10.1016/j.lingua.2006.03.001; ZHANG JJ, 1995, COGNITION, V57, P271, DOI 10.1016/0010-0277(95)00674-3	29	58	60	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2008	319	5860					213	215		10.1126/science.1148345	http://dx.doi.org/10.1126/science.1148345			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	249RC	18187658				2022-12-28	WOS:000252246400044
J	Hewitt, C; Mitchell, N; Torgerson, D				Hewitt, Catherine; Mitchell, Natasha; Torgerson, David			Research methodology - Heed the data when results are not significant	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; TERM		[Hewitt, Catherine; Mitchell, Natasha; Torgerson, David] Univ York, Dept Hlth Sci, York Trials Unit, York YO10 5DD, N Yorkshire, England	University of York - UK	Torgerson, D (corresponding author), Univ York, Dept Hlth Sci, York Trials Unit, York YO10 5DD, N Yorkshire, England.	djt6@york.ac.uk	Mitchell, Natasha/GXH-2160-2022; Torgerson, David/L-4566-2019	Torgerson, David/0000-0002-1667-4275; Hewitt, Catherine Elizabeth/0000-0002-0415-3536				Ciliberto H, 2005, BMJ-BRIT MED J, V330, P1109, DOI 10.1136/bmj.38427.404259.8F; Craig TK, 2004, BMJ-BRIT MED J, V329, P1067, DOI 10.1136/bmj.38246.594873.7C; Dodd JM, 2006, BMJ-BRIT MED J, V332, P509, DOI 10.1136/bmj.38729.513819.63; Jespersen CM, 2006, BRIT MED J, V332, P22, DOI 10.1136/bmj.38666.653600.55; Kaptchuk TJ, 2003, BRIT MED J, V326, P1453, DOI 10.1136/bmj.326.7404.1453; Laurant MGH, 2004, BMJ-BRIT MED J, V328, P927, DOI 10.1136/bmj.38041.493519.EE; Meyer G, 2003, BRIT MED J, V326, P76, DOI 10.1136/bmj.326.7380.76; Sanders J, 2006, BMJ-BRIT MED J, V333, P117, DOI 10.1136/bmj.38878.833241.7C; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226; Watson M, 2005, BMJ-BRIT MED J, V330, P178, DOI 10.1136/bmj.38309.664444.8F	10	34	35	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 5	2008	336	7634					23	25		10.1136/bmj.39379.359560.AD	http://dx.doi.org/10.1136/bmj.39379.359560.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250UT	18174597	Green Published			2022-12-28	WOS:000252327500030
J	Fletcher, LN; Irwin, PGJ; Orton, GS; Teanby, NA; Achterberg, RK; Bjoraker, GL; Read, PL; Simon-Miller, AA; Howett, C; de Kok, R; Bowles, N; Calcutt, SB; Hesman, B; Flasar, FM				Fletcher, L. N.; Irwin, P. G. J.; Orton, G. S.; Teanby, N. A.; Achterberg, R. K.; Bjoraker, G. L.; Read, P. L.; Simon-Miller, A. A.; Howett, C.; de Kok, R.; Bowles, N.; Calcutt, S. B.; Hesman, B.; Flasar, F. M.			Temperature and composition of Saturn's polar hot spots and hexagon	SCIENCE			English	Article							HUBBLE-SPACE-TELESCOPE; ATMOSPHERIC DYNAMICS; CLOUD STRUCTURE; CASSINI/CIRS; PHOSPHINE; IMAGES; SYSTEM; WAVE	Saturn's poles exhibit an unexpected symmetry in hot, cyclonic polar vortices, despite huge seasonal differences in solar flux. The cores of both vortices are depleted in phosphine gas, probably resulting from subsidence of air into the troposphere. The warm cores are present throughout the upper troposphere and stratosphere at both poles. The thermal structure associated with the marked hexagonal polar jet at 77 degrees N has been observed for the first time. Both the warm cyclonic belt at 79 degrees N and the cold anticyclonic zone at 75 degrees N exhibit the hexagonal structure.	[Fletcher, L. N.; Irwin, P. G. J.; Teanby, N. A.; Read, P. L.; Howett, C.; de Kok, R.; Bowles, N.; Calcutt, S. B.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [Orton, G. S.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Achterberg, R. K.; Bjoraker, G. L.; Simon-Miller, A. A.; Hesman, B.; Flasar, F. M.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	University of Oxford; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Fletcher, LN (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Parks Rd, Oxford OX1 3PU, England.	fletcher@atm.ox.ac.uk	Flasar, F Michael/C-8509-2012; Orton, Glenn/AAD-9862-2020; Bjoraker, Gordon L/D-5032-2012; de Kok, Remco/U-5637-2019; Read, Peter Leonard/AAS-2773-2020; Simon, Amy/C-8020-2012; Fletcher, Leigh/D-6093-2011	Simon, Amy/0000-0003-4641-6186; Fletcher, Leigh/0000-0001-5834-9588; Irwin, Patrick Gerard Joseph/0000-0002-6772-384X; Teanby, Nicholas/0000-0003-3108-5775; de Kok, Remco/0000-0001-6906-2662; Calcutt, Simon/0000-0002-0102-3170; Achterberg, Richard/0000-0002-7643-7626	STFC [ST/F007957/1, PP/D000866/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/F007957/1, PP/D000866/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		ALLISON M, 1990, SCIENCE, V247, P1061, DOI 10.1126/science.247.4946.1061; CALDWELL J, 1993, SCIENCE, V260, P326, DOI 10.1126/science.260.5106.326; Flasar FM, 2004, SPACE SCI REV, V115, P169, DOI 10.1007/s11214-004-1454-9; Fletcher LN, 2007, ICARUS, V189, P457, DOI 10.1016/j.icarus.2007.02.006; Fletcher LN, 2007, ICARUS, V188, P72, DOI 10.1016/j.icarus.2006.10.029; GODFREY DA, 1988, ICARUS, V76, P335, DOI 10.1016/0019-1035(88)90075-9; Gurnett DA, 2007, SCIENCE, V316, P442, DOI 10.1126/science.1138562; INGERSOLL AP, 1990, SCIENCE, V248, P308, DOI 10.1126/science.248.4953.308; Irwin PGJ, 2004, ICARUS, V172, P37, DOI 10.1016/j.icarus.2003.09.027; Karkoschka E, 2005, ICARUS, V179, P195, DOI 10.1016/j.icarus.2005.05.016; Orton GS, 2007, ASTRON ASTROPHYS, V473, pL5, DOI 10.1051/0004-6361:20078277; Orton GS, 2005, SCIENCE, V307, P696, DOI 10.1126/science.1105730; Perez-Hoyos S, 2005, ICARUS, V176, P155, DOI 10.1016/j.icarus.2005.01.014; Sanchez-Lavega A, 2006, ICARUS, V184, P524, DOI 10.1016/j.icarus.2006.05.020; Sanchez-Lavega A, 2002, ICARUS, V160, P216, DOI 10.1006/icar.2002.6947; SANCHEZLAVEGA A, 1993, SCIENCE, V260, P329, DOI 10.1126/science.260.5106.329; SanchezLavega A, 1997, ICARUS, V128, P322, DOI 10.1006/icar.1997.5761; SMITH BA, 1982, SCIENCE, V215, P504, DOI 10.1126/science.215.4532.504; Taylor FW, 1980, J GEOPHYS RES-SPACE, V85, P7963, DOI 10.1029/JA085iA13p07963; Vasavada AR, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002563; VENNE DE, 1982, J ATMOS SCI, V39, P1026; [No title captured]	23	93	93	3	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2008	319	5859					79	81		10.1126/science.1149514	http://dx.doi.org/10.1126/science.1149514			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18174438				2022-12-28	WOS:000252084000034
J	Ezzie, ME; Janssen, WJ; O'Brien, JM; Fox, CC; Schwarz, MI				Ezzie, Michael E.; Janssen, William J.; O'Brien, James M.; Fox, Charity C.; Schwarz, Marvin I.			Failure to respond	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							THYMOMA; IMMUNODEFICIENCY		Ohio State Univ, Dept Med, Div Pulm Crit Care Allergy & Sleep Med, Columbus, OH 43210 USA; Natl Jewish Med & Res Ctr, Dept Med, Denver, CO USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA	Ohio State University; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Ezzie, ME (corresponding author), Ohio State Univ, Dept Med, Div Pulm Crit Care Allergy & Sleep Med, 201 Davis HLRI,473 W 12th Ave, Columbus, OH 43210 USA.	michael.ezzie@osumc.edu	O'Brien, James M/A-2624-2009					Croskerry P, 2002, ACAD EMERG MED, V9, P1184, DOI 10.1111/j.1553-2712.2002.tb01574.x; Kelleher P, 2003, J CLIN PATHOL, V56, P12, DOI 10.1136/jcp.56.1.12; MAGGI G, 1991, ANN THORAC SURG, V51, P152, DOI 10.1016/0003-4975(91)90478-9; MITCHELL EB, 1983, CLIN LAB HAEMATOL, V5, P253; RA G., 1954, B U MINNESOTA HOSP M, P1; SOUADJIAN JV, 1974, ARCH INTERN MED, V134, P374, DOI 10.1001/archinte.134.2.374; Tarr PE, 2001, MEDICINE, V80, P123, DOI 10.1097/00005792-200103000-00005; Yale SH, 1996, MAYO CLIN PROC, V71, P5, DOI 10.4065/71.1.5	8	5	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2008	358	1					70	74		10.1056/NEJMcps067266	http://dx.doi.org/10.1056/NEJMcps067266			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	246TW	18172177				2022-12-28	WOS:000252031200010
J	Emmelot-Vonk, MH; Verhaar, HJJ; Pour, HRN; Aleman, A; Lock, TMTW; Bosch, JLHR; Grobbee, DE; van der Schouw, YT				Emmelot-Vonk, Marielle H.; Verhaar, Harald J. J.; Pour, Hamid R. Nakhai; Aleman, Andre; Lock, Tycho M. T. W.; Bosch, J. L. H. Ruud; Grobbee, Diederick E.; van der Schouw, Yvonne T.			Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; HORMONE-BINDING GLOBULIN; SENSITIVITY CHECK INDEX; LATE-ONSET HYPOGONADISM; REPLACEMENT THERAPY; METABOLIC SYNDROME; INSULIN SENSITIVITY; ALZHEIMER-DISEASE; PROSTATE-CANCER; MUSCLE STRENGTH	Context Serum testosterone levels decline significantly with aging. Testosterone supplementation to older men might beneficially affect the aging processes. Objective To investigate the effect of testosterone supplementation on functional mobility, cognitive function, bone mineral density, body composition, plasma lipids, quality of life, and safety parameters in older men with low normal testosterone levels. Design, Setting, and Participants Double-blind, randomized, placebo-controlled trial of 237 healthy men between the ages of 60 and 80 years with a testosterone level lower than 13.7 nmol/L conducted from January 2004 to April 2005 at a university medical center in the Netherlands. Intervention Participants were randomly assigned to receive 80 mg of testosterone undecenoate or a matching placebo twice daily for 6 months. Main Outcome Measures Functional mobility (Stanford Health Assessment questionnaire, timed get up and go test, isometric handgrip strength, isometric leg extensor strength), cognitive function (8 different cognitive instruments), bone mineral density of the hip and lumbar spine (dual-energy x-ray absorptiometry scanning), body composition (total body dual-energy x-ray absorptiometry and abdominal ultrasound of fat mass), metabolic risk factors (fasting plasma lipids, glucose, and insulin), quality of life (Short-Form Health 36 Survey and the Questions on Life Satisfaction Modules), and safety parameters (serum prostate-specific antigen level, ultrasonographic prostate volume, International Prostate Symptom score, serum levels of creatinine, aspartate aminotransferase, alanine aminotransferase, gamma-glutamyltransferase, hemoglobin, and hematocrit). Results A total of 207 men completed the study. During the study, lean body mass increased and fat mass decreased in the testosterone group compared with the placebo group but these factors were not accompanied by an increase of functional mobility or muscle strength. Cognitive function and bone mineral density did not change. Insulin sensitivity improved but high-density lipoprotein cholesterol decreased; by the end of the study, 47.8% in the testosterone group vs 35.5% in the placebo group had the metabolic syndrome (P=.07). Quality-of -life measures were no different except for one hormone-related quality-of-life measure that improved. No negative effects on prostate safety were detected. Conclusion Testosterone supplementation during 6 months to older men with a low normal testosterone concentration did not affect functional status or cognition but increased lean body mass and had mixed metabolic effects. Trial Registration isrctn.org Identifier: ISRCTN23688581.	[Emmelot-Vonk, Marielle H.; Verhaar, Harald J. J.; Pour, Hamid R. Nakhai] Univ Med Ctr Utrecht, Dept Geriatr Med, NL-3508 GA Utrecht, Netherlands; [Lock, Tycho M. T. W.; Bosch, J. L. H. Ruud] Univ Med Ctr Utrecht, Dept Urol, NL-3508 GA Utrecht, Netherlands; [Emmelot-Vonk, Marielle H.; Pour, Hamid R. Nakhai; Grobbee, Diederick E.; van der Schouw, Yvonne T.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [Aleman, Andre] Univ Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Groningen	Emmelot-Vonk, MH (corresponding author), Univ Med Ctr Utrecht, Dept Geriatr Med, POB 85500,Room B05-256, NL-3508 GA Utrecht, Netherlands.	m.h.emmelotvonk@umcutrecht.nl	Aleman, Andre/E-1341-2012; Grobbee, Diederick/C-7651-2014; van der Schouw, Yvonne T./F-8327-2014	Grobbee, Diederick/0000-0003-4472-4468; van der Schouw, Yvonne T./0000-0002-4605-435X				Badia X, 1997, EUR UROL, V31, P129; BAILLIE SP, 1992, AGE AGEING, V21, P139, DOI 10.1093/ageing/21.2.139; Barrett-Connor E, 1999, J CLIN ENDOCR METAB, V84, P3681, DOI 10.1210/jc.84.10.3681; Benton A., 1983, CONTRIBUTION NEUROPS; Bhasin S, 2003, J ANDROL, V24, P299; Bhasin S, 1997, J CLIN ENDOCR METAB, V82, P1659, DOI 10.1210/jc.82.6.1659; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Boyanov M A, 2003, Aging Male, V6, P1; Cherrier MM, 2001, NEUROLOGY, V57, P80, DOI 10.1212/WNL.57.1.80; Cherrier MM, 2005, NEUROLOGY, V64, P2063, DOI 10.1212/01.WNL.0000165995.98986.F1; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; *COMM ASS NEED CLI, 2004, REPL THER TEST AG CL; Curran MJ, 1999, UROLOGY, V53, P423, DOI 10.1016/S0090-4295(98)00348-3; Ferrando AA, 2002, AM J PHYSIOL-ENDOC M, V282, pE601, DOI 10.1152/ajpendo.00362.2001; Gaylis FD, 2005, J UROLOGY, V174, P534, DOI 10.1097/01.ju.0000165166.36280.60; Gouras GK, 2000, P NATL ACAD SCI USA, V97, P1202, DOI 10.1073/pnas.97.3.1202; Hamilton A, 1994, J Hand Ther, V7, P163; Hanninen T, 1996, AGE AGEING, V25, P201, DOI 10.1093/ageing/25.3.201; Haren MT, 2005, MATURITAS, V50, P124, DOI 10.1016/j.maturitas.2004.05.002; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Herschbach P, 2001, EUR J ENDOCRINOL, V145, P255, DOI 10.1530/eje.0.1450255; Houwing NS, 2003, PHARMACOTHERAPY, V23, P1257, DOI 10.1592/phco.23.12.1257.32707; Hrebicek J, 2002, J CLIN ENDOCR METAB, V87, P144, DOI 10.1210/jc.87.1.144; HUBER D, 1988, PHARMACOPSYCHIATRY, V21, P453, DOI 10.1055/s-2007-1017050; Isidori AM, 2005, CLIN ENDOCRINOL, V63, P280, DOI 10.1111/j.1365-2265.2005.02339.x; JANOWSKY JS, 1994, BEHAV NEUROSCI, V108, P325, DOI 10.1037/0735-7044.108.2.325; Janowsky JS, 2006, NEUROSCIENCE, V138, P1015, DOI 10.1016/j.neuroscience.2005.09.007; Kapoor D, 2006, EUR J ENDOCRINOL, V154, P899, DOI 10.1530/eje.1.02166; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kenny AM, 2002, J GERONTOL A-BIOL, V57, pM321, DOI 10.1093/gerona/57.5.M321; Kenny AM, 2001, J GERONTOL A-BIOL, V56, pM266, DOI 10.1093/gerona/56.5.M266; Kenny AM, 2004, J GERONTOL A-BIOL, V59, P75; Kupelian V, 2006, J CLIN ENDOCR METAB, V91, P843, DOI 10.1210/jc.2005-1326; Laaksonen DE, 2004, DIABETES CARE, V27, P1036, DOI 10.2337/diacare.27.5.1036; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; LEE F, 1985, PROSTATE, V7, P117, DOI 10.1002/pros.2990070202; LEZAK MD, 1995, NEUROPSYCHOLOGIAL AS; Lu PH, 2006, ARCH NEUROL-CHICAGO, V63, P177, DOI 10.1001/archneur.63.2.nct50002; Ly LP, 2001, J CLIN ENDOCR METAB, V86, P4078, DOI 10.1210/jc.86.9.4078; Marks LS, 2006, JAMA-J AM MED ASSOC, V296, P2351, DOI 10.1001/jama.296.19.2351; Moffat SD, 2004, NEUROLOGY, V62, P188, DOI 10.1212/WNL.62.2.188; Moffat SD, 2002, J CLIN ENDOCR METAB, V87, P5001, DOI 10.1210/jc.2002-020419; Moncada I, 2006, AGING MALE, V9, P189, DOI 10.1080/13685530601003180; Morley JE, 2001, J LAB CLIN MED, V137, P231, DOI 10.1067/mlc.2001.113504; Muller M, 2005, NEUROLOGY, V64, P866, DOI 10.1212/01.WNL.0000153072.54068.E3; Nieschlag E, 2006, J ANDROL, V27, P135, DOI 10.2164/jandrol.05047; Orwoll E, 2006, ARCH INTERN MED, V166, P2124, DOI 10.1001/archinte.166.19.2124; Ottenbacher KJ, 2006, J AM GERIATR SOC, V54, P1666, DOI 10.1111/j.1532-5415.2006.00938.x; Papasozomenos SC, 2002, P NATL ACAD SCI USA, V99, P1140, DOI 10.1073/pnas.032646799; Park N C, 2003, Aging Male, V6, P86, DOI 10.1080/713604766; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Pour HRN, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-24; Reitan RM, 1985, HALSTEAD REITAN NEUR; Rhoden EL, 2004, NEW ENGL J MED, V350, P482, DOI 10.1056/NEJMra022251; Rhodes T, 1999, J UROLOGY, V161, P1174, DOI 10.1016/S0022-5347(01)61621-5; Samson MM, 2000, AGE AGEING, V29, P235, DOI 10.1093/ageing/29.3.235; Schaap LA, 2005, CLIN ENDOCRINOL, V63, P152, DOI 10.1111/j.1365-2265.2005.02315.x; Schatzl G, 2001, PROSTATE, V47, P52; Schnabel PG, 2007, CLIN ENDOCRINOL, V66, P579, DOI 10.1111/j.1365-2265.2007.02781.x; Scuteri A, 2005, DIABETES CARE, V28, P882, DOI 10.2337/diacare.28.4.882; SIEGERT CEH, 1984, CLIN RHEUMATOL, V3, P305, DOI 10.1007/BF02032335; Sih R, 1997, J CLIN ENDOCR METAB, V82, P1661, DOI 10.1210/jc.82.6.1661; Silverman I, 1999, PSYCHONEUROENDOCRINO, V24, P813, DOI 10.1016/S0306-4530(99)00031-1; Snyder PJ, 1999, J CLIN ENDOCR METAB, V84, P2647, DOI 10.1210/jc.84.8.2647; STANLEY HL, 1991, J AM GERIATR SOC, V39, P766, DOI 10.1111/j.1532-5415.1991.tb02698.x; TENOVER JS, 1992, J CLIN ENDOCR METAB, V75, P1092, DOI 10.1210/jc.75.4.1092; Tirassa P, 1997, J NEUROSCI RES, V47, P198, DOI 10.1002/(SICI)1097-4547(19970115)47:2<198::AID-JNR8>3.0.CO;2-A; Tracz MJ, 2006, J CLIN ENDOCR METAB, V91, P2011, DOI 10.1210/jc.2006-0036; Tremblay AJ, 2004, CLIN BIOCHEM, V37, P785, DOI 10.1016/j.clinbiochem.2004.03.008; VANDENBERG SG, 1978, PERCEPT MOTOR SKILL, V47, P599, DOI 10.2466/pms.1978.47.2.599; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; Whitsel EA, 2001, AM J MED, V111, P261, DOI 10.1016/S0002-9343(01)00833-6; Wittert GA, 2003, J GERONTOL A-BIOL, V58, P618; Yaffe K, 2002, J AM GERIATR SOC, V50, P707, DOI 10.1046/j.1532-5415.2002.50166.x; ZMUDA JM, 1993, METABOLISM, V42, P446, DOI 10.1016/0026-0495(93)90101-S	77	368	379	0	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2008	299	1					39	52		10.1001/jama.2007.51	http://dx.doi.org/10.1001/jama.2007.51			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247BL	18167405	Bronze			2022-12-28	WOS:000252052000015
J	Blakely, T; Tobias, M; Atkinson, J				Blakely, Tony; Tobias, Martin; Atkinson, June			Inequalities in mortality during and after restructuring of the New Zealand economy: repeated cohort studies	BRITISH MEDICAL JOURNAL			English	Article							SOCIOECONOMIC INEQUALITIES; CHANGING RELATION; PRESTON; DISEASE; HEALTH; TRENDS; LEVEL; RATES; EDUCATION; DECLINE	Objectives To determine whether disparities between income and mortality changed during a period of major structural and macroeconomic reform and to estimate the changing contribution of different diseases to these disparities. Design Repeated cohort studies. Data sources 1981, 1986, 1991, 1996, and 2001 censuses linked to mortality data. Population Total New Zealand population, ages 1-74 years. Methods Mortality rates standardised for age and ethnicity were calculated for each census cohort by level of household income. Standardised rate differences and rate ratios, and slope and relative indices of inequality (SII and RII), were calculated to measure disparities on both absolute and relative scales. Results All cause mortality rates declined over the 25 year study period in all groups stratified by sex, age, and income, except for 25-44 year olds of both sexes on low incomes among whom there was little change. In all age groups pooled, relative inequalities increased from 1981-4 to 1996-9 (RIIs increased from 1.85 (95% confidence interval 1.67 to 2.04) to 2.54 (2.29 to 2.82) for mates and from 1.54 (1.35 to 1.76) to 2.12 (1.88 to 2.39) for females), then stabilised in 2001-4 (RIIs of 2.60 (2.34 to 2.89) and 2.18 (1.93 to 2.45), respectively). Absolute inequalities were stable overtime, with a possible fall from 1996-9 to 2001-4. Cardiovascular disease was the major contributor to the observed disparities between income and mortality but decreased in importance from 45% in 1981-4 to 33% in 2001-4 for males and from 50% to 29% for females. The corresponding contribution of cancer increased from 16% to 22% for mates and from 12% to 25% for females. Conclusions During and after restructuring of the economy disparities in mortality between income groups in New Zealand increased in relative terms (but not in absolute terms), but it is difficult to confidently draw a causal,link with structural reforms. The contribution of different causes of death to this inequality changed over time, indicating a need to re-prioritise health policy accordingly.	[Blakely, Tony; Atkinson, June] Univ Otago, Hlth Inequal Res Programme, Wellington, New Zealand; [Tobias, Martin] Minist Hlth, Wellington, New Zealand	University of Otago	Blakely, T (corresponding author), Univ Otago, Hlth Inequal Res Programme, POB 7343, Wellington, New Zealand.	tony.blakely@otago.ac.nz						Belich J., 2001, PARADISE REFORGED HI; Blakely T, 2006, SOC SCI MED, V62, P2024, DOI 10.1016/j.socscimed.2005.08.059; Blakely T, 2002, INT J EPIDEMIOL, V31, P1246, DOI 10.1093/ije/31.6.1246; Blakely T, 2005, INT J EPIDEMIOL, V34, P1054, DOI 10.1093/ije/dyi172; Blakely T, 2002, NZ CENSUS MORTALITY, P258; Blakely T, 2007, TRACKING DISPARITY T; Bloom DE, 2007, INT J EPIDEMIOL, V36, P498, DOI 10.1093/ije/dym079; BOSTON J, 1999, REDESIGNING WELFARE; Capewell S, 2000, CIRCULATION, V102, P1511, DOI 10.1161/01.CIR.102.13.1511; Cheyne C, 1997, SOCIAL POLICY AOTEAR; Cutler D, 2006, J ECON PERSPECT, V20, P97, DOI 10.1257/jep.20.3.97; Fawcett J, 2005, EUR J EPIDEMIOL, V20, P683, DOI 10.1007/s10654-005-7923-y; Fawcett J, 2007, J EPIDEMIOL COMMUN H, V61, P59, DOI 10.1136/jech.2005.044016; FAWCETT J, 2005, THESIS U OTAGO OTAGO; Fawcett J, 2002, 5 NZCMS, P92; Forster M., 2005, OECD SOCIAL EMPLOYME; Hayes LJ, 2002, J EPIDEMIOL COMMUN H, V56, P762, DOI 10.1136/jech.56.10.762; Jensen J., 1988, INCOME EQUIVALENCES; Khang YH, 2005, INT J EPIDEMIOL, V34, P1291, DOI 10.1093/ije/dyi224; Kunitz SJ, 2007, INT J EPIDEMIOL, V36, P491, DOI 10.1093/ije/dym076; Lahelma E, 2002, SOC SCI MED, V55, P609, DOI 10.1016/S0277-9536(01)00191-5; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; Leon DA, 2007, INT J EPIDEMIOL, V36, P500, DOI 10.1093/ije/dym081; Mackenbach JP, 2007, INT J EPIDEMIOL, V36, P496, DOI 10.1093/ije/dym080; Mackenbach JP, 2003, INT J EPIDEMIOL, V32, P830, DOI 10.1093/ije/dyg209; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; McKeown Thomas, 1976, MODERN RISE POPULATI; Men T, 2003, BRIT MED J, V327, P964, DOI 10.1136/bmj.327.7421.964; *MIN SOC POL, 2007, SOC REP IND SOC WELL; MURRAY CJL, 1993, SOC SCI MED, V36, P143, DOI 10.1016/0277-9536(93)90206-J; Plavinski SL, 2003, BRIT MED J, V326, P1240, DOI 10.1136/bmj.326.7401.1240; Preston SH, 2007, INT J EPIDEMIOL, V36, P502, DOI 10.1093/ije/dym082; PRESTON SH, 1975, POP STUD-J DEMOG, V29, P231, DOI 10.2307/2173509; Ruhm C. J., 1996, 5570 NAT BUR EC RES; Shkolnikov V, 2001, LANCET, V357, P917, DOI 10.1016/S0140-6736(00)04212-4; Starfield B, 2007, J EPIDEMIOL COMMUN H, V61, P1038, DOI 10.1136/jech.2006.054627; Tobias Martin, 2006, N Z Med J, V119, pU1932; Unal B, 2005, BMJ-BRIT MED J, V331, P614, DOI 10.1136/bmj.38561.633345.8F; WHITE C, 2003, HLTH STAT Q, V20, P25	39	83	83	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 16	2008	336	7640					371	375		10.1136/bmj.39455.596181.25	http://dx.doi.org/10.1136/bmj.39455.596181.25			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	268AP	18218998	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000253550600040
J	Hirata, A; Klein, BJ; Murakami, KS				Hirata, Akira; Klein, Brianna J.; Murakami, Katsuhiko S.			The X-ray crystal structure of RNA polymerase from Archaea	NATURE			English	Article							TRANSCRIPTION FACTORS; ANGSTROM RESOLUTION; INITIATION; SUBUNIT; TRANSLATION; MACHINERY; MECHANISM; COMPLEX; SYSTEM; ENZYME	The transcription apparatus in Archaea can be described as a simplified version of its eukaryotic RNA polymerase ( RNAP) II counterpart, comprising an RNAPII- like enzyme as well as two general transcription factors, the TATA- binding protein ( TBP) and the eukaryotic TFIIB orthologue TFB1,2. It has been widely understood that precise comparisons of cellular RNAP crystal structures could reveal structural elements common to all enzymes and that these insights would be useful in analysing components of each enzyme that enable it to perform domain- specific gene expression. However, the structure of archaeal RNAP has been limited to individual subunits(3,4). Here we report the first crystal structure of the archaeal RNAP from Sulfolobus solfataricus at 3.4 angstrom resolution, completing the suite of multi- subunit RNAP structures from all three domains of life. We also report the high-resolution ( at 1.76 angstrom) crystal structure of the D/ L subcomplex of archaeal RNAP and provide the first experimental evidence of any RNAP possessing an iron - sulphur ( Fe - S) cluster, which may play a structural role in a key subunit of RNAP assembly. The striking structural similarity between archaeal RNAP and eukaryotic RNAPII highlights the simpler archaeal RNAP as an ideal model system for dissecting the molecular basis of eukaryotic transcription.	[Hirata, Akira; Klein, Brianna J.; Murakami, Katsuhiko S.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Murakami, KS (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	kum14@psu.edu		Murakami, Katsuhiko/0000-0003-2244-0501	NIGMS NIH HHS [R01 GM071897, R01 GM071897-04] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071897] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Armache KJ, 2005, J BIOL CHEM, V280, P7131, DOI 10.1074/jbc.M413038200; Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Bell SD, 1998, TRENDS MICROBIOL, V6, P222, DOI 10.1016/S0966-842X(98)01281-5; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Chlenov M, 2005, J MOL BIOL, V353, P138, DOI 10.1016/j.jmb.2005.07.073; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Ebright RH, 2000, J MOL BIOL, V304, P687, DOI 10.1006/jmbi.2000.4309; Fernandez-Tornero C, 2007, MOL CELL, V25, P813, DOI 10.1016/j.molcel.2007.02.016; Geiduschek EP, 2005, MOL MICROBIOL, V56, P1397, DOI 10.1111/j.1365-2958.2005.04627.x; Goede B, 2006, J BIOL CHEM, V281, P30581, DOI 10.1074/jbc.M605209200; ISHIHAMA A, 1976, RNA POLYMERASE, P485; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murakami K, 1997, P NATL ACAD SCI USA, V94, P11274, DOI 10.1073/pnas.94.21.11274; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Naji S, 2007, J BIOL CHEM, V282, P11047, DOI 10.1074/jbc.M611674200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouhammouch M, 2004, J BIOL CHEM, V279, P51719, DOI 10.1074/jbc.C400446200; Rodriguez-Monge L, 1998, TRENDS BIOCHEM SCI, V23, P169, DOI 10.1016/S0968-0004(98)01203-1; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Todone F, 2001, MOL CELL, V8, P1137, DOI 10.1016/S1097-2765(01)00379-3; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Werner F, 2005, MOL CELL BIOL, V25, P8344, DOI 10.1128/MCB.25.18.8344-8355.2005; Werner F, 2002, MOL CELL, V10, P635, DOI 10.1016/S1097-2765(02)00629-9; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yee A, 2000, P NATL ACAD SCI USA, V97, P6311, DOI 10.1073/pnas.97.12.6311; ZALENSKAYA K, 1990, GENE, V89, P7, DOI 10.1016/0378-1119(90)90199-2; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; ZILLIG W, 1976, RNA POLYMERASE, P101	35	156	173	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2008	451	7180					851	U12		10.1038/nature06530	http://dx.doi.org/10.1038/nature06530			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	263BA	18235446	Green Accepted			2022-12-28	WOS:000253191400047
J	Bhutta, ZA; Ahmed, T; Black, RE; Cousens, S; Dewey, K; Giugliani, E; Haider, BA; Kirkwood, B; Morris, SS; Sachdev, HPS; Shekar, M				Bhutta, Zulfiqar A.; Ahmed, Tahmeed; Black, Robert E.; Cousens, Simon; Dewey, Kathryn; Giugliani, Elsa; Haider, Botool A.; Kirkwood, Betty; Morris, Saul S.; Sachdev, H. P. S.; Shekar, Meera		Maternal & Child Undernutr Study G	Maternal and Child Undernutrition 3 - What works? Interventions for maternal and child undernutrition and survival	LANCET			English	Review							VITAMIN-A SUPPLEMENTATION; RANDOMIZED CONTROLLED-TRIAL; IRON-DEFICIENCY ANEMIA; ROUTINE PROPHYLACTIC SUPPLEMENTATION; ENHANCE MICRONUTRIENT ADEQUACY; RESPIRATORY-TRACT INFECTIONS; FEEDING PROMOTION PROGRAM; LOW-INCOME POPULATION; DEVELOPING-COUNTRIES; YOUNG-CHILDREN	We reviewed interventions that affect maternal and child undernutrition and nutrition-related outcomes. These interventions included promotion of breastfeeding; strategies to promote complementary feeding, with or without provision of food supplements; micronutrient interventions; general supportive strategies to improve family and community nutrition; and reduction of disease burden (promotion of handwashing and strategies to reduce the burden of malaria in pregnancy). We showed that although strategies for breastfeeding promotion have a large effect on survival, their effect on stunting is small. In populations with sufficient food, education about complementary feeding increased height-for-age Z score by 0 . 25 (95% CI 0 . 01-0 . 49), whereas provision of food supplements (with or without education) in populations with insufficient food increased the height-for-age Z score by 0 .41 (0.0 5-0.76). Management of severe acute malnutrition according to WHO guidelines reduced the case-fatality rate by 55% (risk ratio 0 . 45, 0.32-0.62), and recent studies suggest that newer commodities, such as ready-to-use therapeutic foods, can be used to manage severe acute malnutrition in community settings. Effective micronutrient interventions for pregnant women included supplementation with iron folate (which increased haemoglobin at term by 12 g/L 2.93-21.07) and micronutrients (which reduced the risk of low birthweight at term by 16% (relative risk 0. 84,0.74-0.95). Recommended micronutrient interventions for children included strategies for supplementation of vitamin A (in the neonatal period and late infancy), preventive zinc supplements, iron supplements for children in areas where malaria is not endemic, and universal promotion of iodised salt. We used a cohort model to assess the potential effect of these interventions on mothers and children in the 36 countries that have 90% of children with stunted linear growth. The model showed that existing interventions that were designed to improve nutrition and prevent related disease could reduce stunting at 36 months by 36%; mortality between birth and 36 months by about 25%; and disability-adjusted life-years associated with stunting severe wasting, intrauterine growth restriction, and micronutrient deficiencies by about 25%. To eliminate stunting in the longer term, these interventions should be supplemented by improvements in the underlying determinants of undernutrition, such as poverty, poor education, disease burden, and lack of women's empowerment.	[Bhutta, Zulfiqar A.; Haider, Botool A.] Aga Khan Univ, Dept Paediat & Child Hlth, Karachi, Pakistan; [Ahmed, Tahmeed] Ctr Hlth & Populat Res, Dhaka, Bangladesh; [Black, Robert E.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Cousens, Simon; Kirkwood, Betty; Morris, Saul S.] London Sch Hyg & Trop Med, London WC1, England; [Dewey, Kathryn] Univ Calif Davis, Davis, CA 95616 USA; [Giugliani, Elsa] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil; [Sachdev, H. P. S.] Sitaram Bhartia Inst Sci & Res, New Delhi, India; [Shekar, Meera] World Bank, Washington, DC 20433 USA	Aga Khan University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of London; London School of Hygiene & Tropical Medicine; University of California System; University of California Davis; Universidade Federal do Rio Grande do Sul; Sitaram Bhartia Institute of Science & Research; The World Bank	Bhutta, ZA (corresponding author), Aga Khan Univ, Dept Paediat & Child Hlth, Karachi, Pakistan.	zulfiqar.bhutta@aku.edup	Giugliani, Elsa Regina Justo/Y-9236-2019; Hallal, Pedro C/A-3249-2011	Hallal, Pedro C/0000-0003-1470-6461; Kirkwood, Betty/0000-0001-5274-6072; Black, Robert/0000-0001-9926-7984; Sachdev, Harshpal Singh/0000-0002-4956-9391; Morris, Saul/0000-0002-9372-7342	MRC [MC_U147585821, G0400519] Funding Source: UKRI; Medical Research Council [MC_U147585821, U1475000003, G0400519] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Adish AA, 1999, LANCET, V353, P712, DOI 10.1016/S0140-6736(98)04450-X; Adu-Afarwuah S, 2007, AM J CLIN NUTR, V86, P412, DOI 10.1093/ajcn/86.2.412; Aggarwal R, 2007, PEDIATRICS, V119, P1120, DOI 10.1542/peds.2006-3481; Ahmed T, 1999, LANCET, V353, P1919, DOI 10.1016/S0140-6736(98)07499-6; ALLEN LH, 2001, ASIAN DEV BANK ADB N, V5; Alvarado-M. Reynaldo, 1996, Food and Nutrition Bulletin, V17, P49; Ambrus JL, 2004, EXP BIOL MED, V229, P464, DOI 10.1177/153537020422900603; Andang'o PEA, 2007, LANCET, V369, P1799, DOI 10.1016/S0140-6736(07)60817-4; Anderson AK, 2005, ARCH PEDIAT ADOL MED, V159, P836, DOI 10.1001/archpedi.159.9.836; Arnesen T, 2004, HEALTH POLICY, V70, P137, DOI 10.1016/j.healthpol.2003.08.004; Ashworth A, 2004, LANCET, V363, P1110, DOI 10.1016/S0140-6736(04)15894-7; ASHWORTH A, IN PRESS MATERN CHIL; Ashworth A, 2006, FOOD NUTR BULL, V27, pS24, DOI 10.1177/15648265060273S303; BALLOT DE, 1989, AM J CLIN NUTR, V49, P162, DOI 10.1093/ajcn/49.1.162; Baqui AH, 2002, BRIT MED J, V325, P1059, DOI 10.1136/bmj.325.7372.1059; BARRETO ML, 1994, LANCET, V344, P228, DOI 10.1016/S0140-6736(94)92998-X; BARROS FC, 1995, ACTA PAEDIATR, V84, P1221, DOI 10.1111/j.1651-2227.1995.tb13537.x; BEATON GH, 1993, 13 UN ADM COMM COORD; BEHRMAN J, 2001, 104 IFPRI FOOD CONS; Berti PR, 2004, PUBLIC HEALTH NUTR, V7, P599, DOI 10.1079/PHN2003595; Bhandari N, 2003, LANCET, V361, P1418, DOI 10.1016/S0140-6736(03)13134-0; Bhandari N, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e86; Bhandari N, 2001, J NUTR, V131, P1946, DOI 10.1093/jn/131.7.1946; Bhutta ZA, 1999, J PEDIATR-US, V135, P689, DOI 10.1016/S0022-3476(99)70086-7; Bhutta ZA, 2000, AM J CLIN NUTR, V72, P1516; Bimenya Gabriel S, 2002, Afr Health Sci, V2, P63; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Borigato EVM, 1998, J NUTR, V128, P855, DOI 10.1093/jn/128.5.855; BRENT NB, 1995, ARCH PEDIAT ADOL MED, V149, P798, DOI 10.1001/archpedi.1995.02170200088014; Briend A, 2006, FOOD NUTR BULL, V27, pS3, DOI 10.1177/15648265060273S301; Britton C, 2007, COCHRANE DB SYST REV, V1, P1; Brooks WA, 2005, LANCET, V366, P999, DOI 10.1016/S0140-6736(05)67109-7; Brown KH, 2002, AM J CLIN NUTR, V75, P1062, DOI 10.1093/ajcn/75.6.1062; BURKHALTER BR, 1991, INT J GYNECOL OBSTET, V34, P353, DOI 10.1016/0020-7292(91)90604-4; Caulfield Laura E., 1999, Food and Nutrition Bulletin, V20, P183; Caulfield LE, 2004, AM J CLIN NUTR, V80, P193; Ceesay SM, 1997, BMJ-BRIT MED J, V315, P786, DOI 10.1136/bmj.315.7111.786; CHANG KC, 1982, CLIN ALLERGY, V12, P369, DOI 10.1111/j.1365-2222.1982.tb02541.x; Chapman DJ, 2004, ARCH PEDIAT ADOL MED, V158, P897, DOI 10.1001/archpedi.158.9.897; Christian P, 2007, P MICR FOR CONS CONT, P129; Christofides A, 2006, MATERN CHILD NUTR, V2, P169, DOI 10.1111/j.1740-8709.2006.00060.x; Ciliberto MA, 2005, AM J CLIN NUTR, V81, P864, DOI 10.1093/ajcn/81.4.864; Cobra C, 1997, J NUTR, V127, P574, DOI 10.1093/jn/127.4.574; Collins S, 2006, LANCET, V368, P1992, DOI 10.1016/S0140-6736(06)69443-9; Conde-Agudelo A, 2006, JAMA-J AM MED ASSOC, V295, P1809, DOI 10.1001/jama.295.15.1809; Conde-Agudelo A, 2007, AM J OBSTET GYNECOL, V196, P297, DOI 10.1016/j.ajog.2006.05.055; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; Curtis V, 2003, LANCET INFECT DIS, V3, P275, DOI 10.1016/S1473-3099(03)00606-6; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Dary O, 2002, J NUTR, V132, p2927S, DOI 10.1093/jn/132.9.2927S; Deen JL, 2003, B WORLD HEALTH ORGAN, V81, P237; Dennis CL, 2002, CAN MED ASSOC J, V166, P21; Dewey KG, 2007, MATERN CHILD NUTR, V3, P151, DOI 10.1111/j.1740-8709.2007.00092.x; Dickson R, 2000, BMJ-BRIT MED J, V320, P1697, DOI 10.1136/bmj.320.7251.1697; Edmond KM, 2006, PEDIATRICS, V117, pE380, DOI 10.1542/peds.2005-1496; Elnagar B, 1997, INT J FOOD SCI NUTR, V48, P119, DOI 10.3109/09637489709006971; Faber M, 2002, AM J CLIN NUTR, V76, P1048, DOI 10.1093/ajcn/76.5.1048; Falbo Ana Rodrigues, 2006, Cad. Saúde Pública, V22, P561, DOI 10.1590/S0102-311X2006000300011; Fawzi WW, 2007, NEW ENGL J MED, V356, P1423, DOI 10.1056/NEJMoa064868; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; FRANK DA, 1987, PEDIATRICS, V80, P845; Froozani MD, 1999, B WORLD HEALTH ORGAN, V77, P381; Gamble C, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003755.pub2, 10.1002/14651858.CD001031.pub2]; Garner P, 2000, ARCH DIS CHILD, V82, P197, DOI 10.1136/adc.82.3.197; Geerligs PDP, 2003, J HUM NUTR DIET, V16, P275, DOI 10.1046/j.1365-277X.2003.00447.x; Geerligs PP, 2003, TROP MED INT HEALTH, V8, P310, DOI 10.1046/j.1365-3156.2003.01023.x; Geerligs PP, 2002, PUBLIC HEALTH NUTR, V5, P619, DOI 10.1079/PHN2002341; Gera T, 2007, J PEDIATR GASTR NUTR, V44, P468, DOI 10.1097/01.mpg.0000243440.85452.38; Gibson RS, 2003, J NUTR, V133, p3992S, DOI 10.1093/jn/133.11.3992S; GILLESPIE S, 15 ACC SCN UN ADM CO; Giovannini M, 2006, J PEDIATR GASTR NUTR, V42, P306, DOI 10.1097/01.mpg.0000189363.07040.4b; GLASSMAN A, 2006, EC SECTOR STUDIES SE; Golkowski F, 2003, J Endocrinol Invest, V26, P11; Graffy J, 2004, BRIT MED J, V328, P26, DOI 10.1136/bmj.328.7430.26; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; GROSSMAN LK, 1990, AM J DIS CHILD, V144, P471, DOI 10.1001/archpedi.1990.02150280093019; Grotto I, 2003, J PEDIATR-US, V142, P297, DOI 10.1067/mpd.2003.116; Gulani A, 2007, BMJ-BRIT MED J, V334, P1095, DOI 10.1136/bmj.39150.510475.AE; Guldan GS, 2000, J NUTR, V130, P1204, DOI 10.1093/jn/130.5.1204; Gupta P, 2007, ARCH PEDIAT ADOL MED, V161, P58, DOI 10.1001/archpedi.161.1.58; Haider BA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004905; Haider R, 1996, B WORLD HEALTH ORGAN, V74, P173; HERNANDEZ O, 1995, ASSESSMENT IMPACT NA; HILL Z, 2004, FAMILY COMMUNITY PRA; Hirve S, 2007, INDIAN PEDIATR, V44, P91; *HLTH DEV AG, 2005, GRAD EV REC PUBL HLT; HOFMEYR GJ, 2006, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD001059.PUB2; Humphrey JH, 1996, J PEDIATR-US, V128, P489, DOI 10.1016/S0022-3476(96)70359-1; HUTTON EK, 2007, JAMA-J AM MED ASSOC, V297, P1257; Iannotti LL, 2006, AM J CLIN NUTR, V84, P1261, DOI 10.1093/ajcn/84.6.1261; Iliff PJ, 2005, AIDS, V19, P699, DOI 10.1097/01.aids.0000166093.16446.c9; JONES DA, 1985, ARCH DIS CHILD, V60, P772, DOI 10.1136/adc.60.8.772; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Klemm R, 2007, P MICR FOR CONS CONT; Kramer MS, 2003, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD000032; Krause VM, 1998, J NUTR, V128, P860, DOI 10.1093/jn/128.5.860; Kristjansson EA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004676.pub2; Kugelman A, 2007, AM J PERINAT, V24, P307, DOI 10.1055/s-2007-981434; KUHN L, 2007, 14 C RETR OPP INF CR; Kusic Z, 2005, COLLEGIUM ANTROPOL, V29, P9; Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900; Lainez Villabona B, 2005, An Pediatr (Barc), V63, P14; LANGER A, 1996, EXCLUSIVE BREASTFEED; Larocque R, 2006, TROP MED INT HEALTH, V11, P1485, DOI 10.1111/j.1365-3156.2006.01706.x; Lartey A, 1999, AM J CLIN NUTR, V70, P391; Leroy JL, 2007, J NUTR, V137, P2311, DOI 10.1093/jn/137.10.2311; Lira PIC, 1998, AM J CLIN NUTR, V68, p418S, DOI 10.1093/ajcn/68.2.418S; Long KZ, 2006, AM J CLIN NUTR, V83, P693, DOI 10.1093/ajcn.83.3.693; Luby SP, 2005, LANCET, V366, P225, DOI 10.1016/S0140-6736(05)66912-7; LUTTER CK, IN PRESS J NUTR; MABERLY GF, 1981, LANCET, V2, P1270; Mahomed K, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000230.pub3; Malaba LC, 2005, AM J CLIN NUTR, V81, P454, DOI 10.1093/ajcn.81.2.454; Maluccio J, 2005, 141 IFPRI; Menon P, 2007, J NUTR, V137, P1023, DOI 10.1093/jn/137.4.1023; MESNARD A, 2005, EVALUATION FAMILIAS; Moore SE, 2004, AM J CLIN NUTR, V80, P453, DOI 10.1093/ajcn/80.2.453; Morrell CJ, 2000, BRIT MED J, V321, P593, DOI 10.1136/bmj.321.7261.593; Morrow AL, 1999, LANCET, V353, P1226, DOI 10.1016/S0140-6736(98)08037-4; MUHILAL, 1988, AM J CLIN NUTR, V48, P1271, DOI 10.1093/ajcn/48.5.1271; NADIGER HA, 1980, BRIT J NUTR, V43, P45, DOI 10.1079/BJN19800063; NEYZI O, 1988, RESULTS ED INTERVENT; Njagi JK, 2002, THESIS U NAIROBI; *NUTR COMM PROJ, 1995, HOND NAT BREASTF PRO; Obatolu VA, 2003, NUTRITION, V19, P174, DOI 10.1016/S0899-9007(02)01102-4; Oelofse A, 2003, INT J FOOD SCI NUTR, V54, P399, DOI [10.1080/0963748031000092161, 10.1080/096374803767755841]; OLAIZFERNANDEZ G, 2006, ENC NAC SAL NUTR 200; PALTI H, 1988, ISRAEL J MED SCI, V24, P342; Pena-Rosas JP, 2006, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858; Penny ME, 2005, LANCET, V365, P1863, DOI 10.1016/S0140-6736(05)66426-4; PHAROAH POD, 1987, INT J EPIDEMIOL, V16, P68, DOI 10.1093/ije/16.1.68; PICHARD E, 1992, ANN PEDIATR-PARIS, V39, P71; Portier L, 2000, INT J PLASTICITY, V16, P303, DOI 10.1016/S0749-6419(99)00056-X; Pretell EA, 2004, THYROID, V14, P590, DOI 10.1089/1050725041692909; Pugh LC, 2002, BIRTH-ISS PERINAT C, V29, P95, DOI 10.1046/j.1523-536X.2002.00169.x; Quinlivan JA, 2003, LANCET, V361, P893, DOI 10.1016/S0140-6736(03)12770-5; Rahmathullah L, 2003, BMJ-BRIT MED J, V327, P254, DOI 10.1136/bmj.327.7409.254; Ramakrishnan U, 1999, J NUTR, V129, p544S, DOI 10.1093/jn/129.2.544S; Reid M, 2004, J NUTR, V134, P3004, DOI 10.1093/jn/134.11.3004; RIVERA A, 1993, PROMOTION LACTATIONA; Roberfroid D, 2005, TROP MED INT HEALTH, V10, P1121, DOI 10.1111/j.1365-3156.2005.01498.x; Rodriguez-Garcia R, 1990, J Obstet Gynecol Neonatal Nurs, V19, P431, DOI 10.1111/j.1552-6909.1990.tb01662.x; Rollins N, 2006, LANCET, V368, P1236, DOI 10.1016/S0140-6736(06)69514-7; RUEL MT, IN PRESS LANCET; Rutstein SO, 2005, INT J GYNECOL OBSTET, V89, pS7, DOI 10.1016/j.ijgo.2004.11.012; Salama P, 2004, LANCET, V364, P1801, DOI 10.1016/S0140-6736(04)17405-9; Santos I, 2001, J NUTR, V131, P2866, DOI 10.1093/jn/131.11.2866; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Sazawal S, 2007, LANCET, V369, P927, DOI 10.1016/S0140-6736(07)60452-8; Sazawal S, 2007, BMJ-BRIT MED J, V334, P140, DOI 10.1136/bmj.39035.482396.55; Sazawal S, 2006, LANCET INFECT DIS, V6, P374, DOI 10.1016/S1473-3099(06)70495-9; Schroeder D. G., 2002, FOOD NUTR BULL, V23, P50, DOI [10.1177/15648265020234s208, DOI 10.1177/15648265020234S108, 10.1177/15648265020234S208]; Sebotsa MLD, 2005, NUTRITION, V21, P20, DOI 10.1016/j.nut.2004.09.005; Selwitz Robert H, LANCET, V369, P51, DOI [10.1016/s0140-6736(07)60031-2, DOI 10.1016/S0140-6736(07)60031-2, DOI 10.1016/S0140-6736(07)61690-0]; Semba Richard D., 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P120; Sempertegui F, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.1.e1; SEMPERTEGUI F, 55 ANN M AM SOC TROP; Sharieff W, 2006, PUBLIC HEALTH NUTR, V9, P336, DOI 10.1079/PHN2006841; Sheikholeslam R, 2004, East Mediterr Health J, V10, P844; SHWE TN, 2003, P 9 AS C NUTR; SOLOMONS NW, 1993, NUTR REV, V51, P327, DOI 10.1111/j.1753-4887.1993.tb03758.x; SQUATRITO S, 1986, J CLIN ENDOCR METAB, V63, P368, DOI 10.1210/jcem-63-2-368; STECKEL RH, 2002, HIST STAT US MILLENN; Stein AD, 2004, PEDIATRICS, V113, pE270, DOI 10.1542/peds.113.3.e270; Stoltzfus RJ., 2004, COMP QUANTIFICATION, pp. 163; *SUMMIT STUD GROUP, IN PRESS LANCET; Temple V, 2005, J PUBLIC HEALTH-UK, V27, P45, DOI 10.1093/pubmed/fdh199; ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603; ter Kuile FO, 2003, AM J TROP MED HYG, V68, P50, DOI 10.4269/ajtmh.2003.68.50; THILLY CH, 1978, J CLIN ENDOCR METAB, V47, P354, DOI 10.1210/jcem-47-2-354; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; Thuy PV, 2003, AM J CLIN NUTR, V78, P284, DOI 10.1093/ajcn/78.2.284; THUY PV, 2005, J NUTR, V135, P2596; Tielsch JM, 2006, LANCET, V367, P144, DOI 10.1016/S0140-6736(06)67963-4; Torlesse H, 2001, T ROY SOC TROP MED H, V95, P195, DOI 10.1016/S0035-9203(01)90164-6; *UNICEF, 2007, STAT WORLDS CHILDR; UNICEF/WHO/UNU, 1999, COMP MULT SUPPL US P; *USAID, 2007, DEM HLTH SURV 2007; VALDES V, 1993, J TROP PEDIATRICS, V39, P142, DOI 10.1093/tropej/39.3.142; VALDES V, 1994, 3 DAY LACTATION COUR; VAN DE, 2002, COCHRANE DB SYST REV, V4; Van Rheenen P, 2004, ANN TROP PAEDIATR, V24, P3, DOI 10.1179/027249304225013286; van Rheenen P, 2007, TROP MED INT HEALTH, V12, P603, DOI 10.1111/j.1365-3156.2007.01835.x; van Stuijvenberg ME, 2006, BRIT J NUTR, V95, P532, DOI 10.1079/BJN20051669; Vandale-Toney S, 1992, Salud Publica Mex, V34, P25; Victora CG, 1998, J NUTR, V128, P1134, DOI 10.1093/jn/128.7.1134; Victora CG, 2005, LANCET, V366, P1460, DOI 10.1016/S0140-6736(05)67599-X; VICTORA CG, 2008, LANCET          0117, DOI DOI 10.1016/S0140-6736(07)61692-4; Villalpando S, 2006, J NUTR, V136, P2633, DOI 10.1093/jn/136.10.2633; Villamor E, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.1.e6; WALTER T, 1993, AM J CLIN NUTR, V57, P190, DOI 10.1093/ajcn/57.2.190; West KP, 1999, BMJ-BRIT MED J, V318, P570, DOI 10.1136/bmj.318.7183.570; *WHO, 1999, WHO TECHN REP SER, V854, P161; *WHO COLL STUD TEA, 2000, LANCET, V355, P1104; *WHO WFP UNSCN UNI, 2007, COMM BAS MAN SEV AC; Wiles L S, 1984, JOGN Nurs, V13, P253, DOI 10.1111/j.1552-6909.1984.tb01136.x; Wilkinson D, 1996, J TROP PEDIATRICS, V42, P114, DOI 10.1093/tropej/42.2.114; WINIKOFF B, 1993, AM J PUBLIC HEALTH, V83, P1052, DOI 10.2105/AJPH.83.7.1052; *WORLD BANK, 2005, REP NUTR CENTR DEV; Wu T, 2002, Cochrane Database Syst Rev, pCD003204; Yeudall F, 2005, PUBLIC HEALTH NUTR, V8, P826, DOI 10.1079/PHN2005744; Zhao Jinkou, 2004, Food and Nutrition Bulletin, V25, P337; Zimmermann MB, 2003, THYROID, V13, P199, DOI 10.1089/105072503321319512; Zimmermann MB, 2006, AM J CLIN NUTR, V84, P580, DOI 10.1093/ajcn/84.3.580; Zlotkin S, 2003, B WORLD HEALTH ORGAN, V81, P108; Zlotkin S, 2001, AM J CLIN NUTR, V74, P791; Zwane AP, 2007, 140 CID	208	1189	1208	4	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 2	2008	371	9610					417	440		10.1016/S0140-6736(07)61693-6	http://dx.doi.org/10.1016/S0140-6736(07)61693-6			24	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	260ED	18206226				2022-12-28	WOS:000252992700032
J	Krasopoulos, G; Brister, SJ; Beattie, WS; Buchanan, MR				Krasopoulos, George; Brister, Stephanie J.; Beattie, W. Scott; Buchanan, Michael R.			Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INCREASED PLATELET SENSITIVITY; LOW-DOSE ASPIRIN; MYOCARDIAL-INFARCTION; ACETYLSALICYLIC-ACID; CORONARY; CLOPIDOGREL; BYPASS; STROKE; ASA; NONRESPONSIVENESS	Objective To determine if there is a relation between aspirin "resistance" and clinical outcomes in patients with cardiovascular disease. Design Systematic review and meta-anatysis. Data source Electronic literature search without language restrictions of four databases and hand search of bibliographies for other relevant articles. Review methods Inclusion criteria included a test for platelet responsiveness and clinical outcomes. Aspirin resistance was assessed, using a variety of platelet function assays. Results 20 studies totalling 2930 patients with cardiovascular disease were identified. Most studies used aspirin regimens, ranging from 75-325 mg daily, and six studies included adjunct antiplatelet therapy. Compliance was confirmed directly in 14 studies and by telephone or interviews in three. Information was insufficient to assess compliance in three studies. Overall, 810 patients (28%) were classified as aspirin resistant. A cardiovascular related event occurred in 41% of patients (odds ratio 3.85, 95% confidence interval 3.08 to 4.80), death in 5.7% (5.99, 2.28 to 15.72), and an acute coronary syndrome in 39.4% (4.06, 2.96 to 5.56). Aspirin resistant patients did not benefit from other antiplatelet treatment. Conclusion Patients who are resistant to aspirin are at a greater risk of clinically important cardiovascular morbidity long term than patients who are sensitive to aspirin.	[Buchanan, Michael R.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4L8, Canada; [Krasopoulos, George; Brister, Stephanie J.] Toronto Gen Hosp, Univ Hlth Network, Div Cardiovasc Surg, Toronto, ON, Canada; [Beattie, W. Scott] Toronto Gen Hosp, Univ Hlth Network, Dept Anaesthesiol, Toronto, ON, Canada	McMaster University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Buchanan, MR (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4L8, Canada.	mbuchan@mcmaster.ca	Beattie, William Scott/A-4352-2008					Abaci A, 2006, PLATELETS, V17, P7, DOI 10.1080/09537100500163358; ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Andersen K, 2002, THROMB RES, V108, P37, DOI 10.1016/S0049-3848(02)00405-X; Angiolillo DJ, 2006, AM J CARDIOL, V97, P38, DOI 10.1016/i.amicard.2005.07.106; Berrouschot J, 2006, ACTA NEUROL SCAND, V113, P31, DOI 10.1111/j.1600-0404.2005.00419.x; Borna C, 2005, THROMB J, V3, DOI 10.1186/1477-9560-3-10; Buchanan MR, 2006, CAN J CARDIOL, V22, P149, DOI 10.1016/S0828-282X(06)70255-0; BUCHANAN MR, 1995, CAN J CARDIOL, V11, P221; Buchanan MR, 2000, CAN J CARDIOL, V16, P1385; BUTT RW, 1983, THROMB RES, V29, P469, DOI 10.1016/0049-3848(83)90253-0; Cattaneo M, 2004, ARTERIOSCL THROM VAS, V24, P1980, DOI 10.1161/01.ATV.0000145980.39477.a9; Chen WH, 2005, AM J CARDIOL, V96, P760, DOI 10.1016/j.amjcard.2005.04.056; Chen WH, 2004, J AM COLL CARDIOL, V43, P1122, DOI 10.1016/j.jacc.2003.12.034; Cotter G, 2004, AM HEART J, V147, P293, DOI 10.1016/j.ahj.2003.07.011; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eikelboom JW, 2002, CIRCULATION, V105, P1650, DOI 10.1161/01.CIR.0000013777.21160.07; Faraday N, 2004, PLATELETS, V15, P9, DOI 10.1080/09537100310001644006; Frelinger AL, 2006, CIRCULATION, V113, P2888, DOI 10.1161/CIRCULATIONAHA.105.596627; GROTEMEYER KH, 1993, THROMB RES, V71, P397, DOI 10.1016/0049-3848(93)90164-J; Grundmann K, 2003, J NEUROL, V250, P63, DOI 10.1007/s00415-003-0954-y; Gum PA, 2003, J AM COLL CARDIOL, V41, P961, DOI 10.1016/S0735-1097(02)03014-0; Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83; Heindl B, 2001, N-S ARCH PHARMACOL, V363, P233, DOI 10.1007/s002100000349; HELGASON CM, 1994, STROKE, V25, P2331, DOI 10.1161/01.STR.25.12.2331; HELGASON CM, 1993, STROKE, V24, P345, DOI 10.1161/01.STR.24.3.345; Hennekens CH, 2004, CIRCULATION, V110, P1706, DOI 10.1161/01.CIR.0000142056.69970.DB; Hobikoglu GF, 2005, TOHOKU J EXP MED, V207, P59, DOI 10.1620/tjem.207.59; Hovens MMC, 2007, AM HEART J, V153, P175, DOI 10.1016/j.ahj.2006.10.040; Kawakami Y, 2000, DES MONOMERS POLYM, V3, P1, DOI 10.1163/156855500750198681; Kawasaki T, 2000, STROKE, V31, P591, DOI 10.1161/01.STR.31.3.591; Kuliczkowski Wiktor, 2005, Kardiol Pol, V62, P14; Lee PY, 2005, AM J MED, V118, P723, DOI 10.1016/j.amjmed.2005.03.041; Macaskill P, 2001, STAT MED, V20, P641, DOI 10.1002/sim.698; Macchi L, 2002, THROMB RES, V107, P45, DOI 10.1016/S0049-3848(02)00210-4; McCabe DJH, 2005, PLATELETS, V16, P269, DOI 10.1080/09537100400020567; MCKENNA JV, 1989, PROST LEUKOT MED, V36, P171; Mueller MR, 1997, THROMB HAEMOSTASIS, V78, P1003; PARMUKCU B, 2007, BLOOD COAGUL FIBRIN, V18, P187; Patrono C, 2003, J THROMB HAEMOST, V1, P1710, DOI 10.1046/j.1538-7836.2003.00284.x; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; Poston RS, 2006, J THORAC CARDIOV SUR, V131, P122, DOI 10.1016/j.jtcvs.2005.08.058; Quinn MJ, 2004, J AM COLL CARDIOL, V43, P972, DOI 10.1016/j.jacc.2003.09.059; Snoep JD, 2007, ARCH INTERN MED, V167, P1593, DOI 10.1001/archinte.167.15.1593; STEJSKAL D, 2004, VNITRNI LEKARSTVI, V8, P591; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Taylor DW, 1999, LANCET, V353, P2179, DOI 10.1016/S0140-6736(99)05388-X; Yilmaz MB, 2005, THROMB RES, V115, P25, DOI 10.1016/j.thromres.2004.07.004; Zhang Yan, 2005, Zhonghua Xinxueguanbing Zazhi, V33, P695; Zimmermann N, 2003, CIRCULATION, V108, P542, DOI 10.1161/01.CIR.0000081770.51929.5A	49	580	625	1	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2008	336	7637					195	198H		10.1136/bmj.39430.529549.BE	http://dx.doi.org/10.1136/bmj.39430.529549.BE			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259KT	18202034	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000252938900042
J	Janin, J				Janin, Joel			Biochemistry - Dicey assemblies	SCIENCE			English	Editorial Material									[Janin, Joel] Univ Paris Sud, Inst Biochim & Biophys Mol & Cellulaire, CNRS, UMR 8619, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Janin, J (corresponding author), Univ Paris Sud, Inst Biochim & Biophys Mol & Cellulaire, CNRS, UMR 8619, Bat 430, F-91405 Orsay, France.	joel.janin@u-psud.fr	Janin, Joel/I-2958-2012					Bennett MJ, 2006, STRUCTURE, V14, P811, DOI 10.1016/j.str.2006.03.011; BORCHERT TV, 1994, P NATL ACAD SCI USA, V91, P1515, DOI 10.1073/pnas.91.4.1515; Grueninger D, 2008, SCIENCE, V319, P206, DOI 10.1126/science.1150421; Linderstrom-Lang K, 1959, ENZYMES, P443; Lukatsky DB, 2007, J MOL BIOL, V365, P1596, DOI 10.1016/j.jmb.2006.11.020; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1	7	5	5	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2008	319	5860					165	166		10.1126/science.1152930	http://dx.doi.org/10.1126/science.1152930			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249RC	18187645				2022-12-28	WOS:000252246400027
J	Savage, PA; Vosseller, K; Kang, CH; Larimore, K; Riedel, E; Wojnoonski, K; Jungbluth, AA; Allison, JP				Savage, Peter A.; Vosseller, Keith; Kang, Chulho; Larimore, Kevin; Riedel, Elyn; Wojnoonski, Kathleen; Jungbluth, Achim A.; Allison, James P.			Recognition of a ubiquitous self antigen by prostate cancer-infiltrating CD8(+) T lymphocytes	SCIENCE			English	Article							TRANSGENIC MOUSE; MELANOMA; CELLS; MODEL	Substantial evidence exists that many tumors can be specifically recognized by CD8(+) T lymphocytes. The definition of antigens targeted by these cells is paramount for the development of effective immunotherapeutic strategies for treating human cancers. In a screen for endogenous tumor- associated T cell responses in a primary mouse model of prostatic adenocarcinoma, we identified a naturally arising CD8(+) T cell response that is reactive to a peptide derived from histone H4. Despite the ubiquitous nature of histones, T cell recognition of histone H4 peptide was specifically associated with the presence of prostate cancer in these mice. Thus, the repertoire of antigens recognized by tumor- infiltrating T cells is broader than previously thought and includes peptides derived from ubiquitous self antigens that are normally sequestered from immune detection.	[Savage, Peter A.; Wojnoonski, Kathleen; Allison, James P.] Mem Sloan Kettering Canc Ctr, Dept Immunol, Howard Hughes Med Inst, New York, NY 10021 USA; [Savage, Peter A.; Wojnoonski, Kathleen; Allison, James P.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr Canc Immunotherapy, New York, NY 10021 USA; [Vosseller, Keith] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA; [Kang, Chulho] Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA; [Larimore, Kevin] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Riedel, Elyn] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Jungbluth, Achim A.] Ludwig Inst Canc Res, New York Branch, New York, NY 10021 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Drexel University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Memorial Sloan Kettering Cancer Center; Ludwig Institute for Cancer Research	Allison, JP (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Immunol, Howard Hughes Med Inst, 1275 York Ave, New York, NY 10021 USA.	allisonj@mskcc.org		Allison, James/0000-0001-8980-5697				Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Foster BA, 1997, CANCER RES, V57, P3325; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Kaplan-Lefko PJ, 2003, PROSTATE, V55, P219, DOI 10.1002/pros.10215; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Mortarini R, 2003, CANCER RES, V63, P2535; PANNETIER C, 1993, P NATL ACAD SCI USA, V90, P4319, DOI 10.1073/pnas.90.9.4319; Romero P, 2006, ADV IMMUNOL, V92, P187, DOI 10.1016/S0065-2776(06)92005-7; Rosenberg SA, 2001, NATURE, V411, P380, DOI 10.1038/35077246; VandenEynde BJ, 1997, CURR OPIN IMMUNOL, V9, P684, DOI 10.1016/S0952-7915(97)80050-7; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; Zippelius A, 2004, CANCER RES, V64, P2865, DOI 10.1158/0008-5472.CAN-03-3066	13	81	82	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2008	319	5860					215	220		10.1126/science.1148886	http://dx.doi.org/10.1126/science.1148886			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249RC	18187659				2022-12-28	WOS:000252246400045
J	Clark, S				Clark, Stephanie			Waiting times for scoliosis surgery	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Clark, S (corresponding author), The Lancet, London NW1 7BY, England.							AHN H, 2007, 42 ANN M SCOL RES SO, P45; DABKE HV, 2007, 42 ANN M SCOL RES SO, P46	2	8	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 5	2008	371	9606					10	11		10.1016/S0140-6736(08)60047-1	http://dx.doi.org/10.1016/S0140-6736(08)60047-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248YH	18177759				2022-12-28	WOS:000252192600009
J	Logan, SAE; MacMahon, E				Logan, Sarah A. E.; MacMahon, Eithne			Viral meningitis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CENTRAL-NERVOUS-SYSTEM; CEREBROSPINAL-FLUID; ASEPTIC-MENINGITIS; VIRUS; INFECTIONS; MANIFESTATIONS; EPIDEMIOLOGY; ENGLAND; DNA		[Logan, Sarah A. E.; MacMahon, Eithne] Guys & St Thomas NHS Fdn Trust, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust	MacMahon, E (corresponding author), Guys & St Thomas NHS Fdn Trust, London SE1 7EH, England.	eithne.macmahon@gstt.nhs.uk		Logan, Sarah/0000-0001-8527-450X				[Anonymous], INFECT CENTRAL NERVO; [Anonymous], 2001, FIELDS VIROLOGY; BERGSTROM T, 1990, J INFECT DIS, V162, P322, DOI 10.1093/infdis/162.2.322; BOUFASSA F, 1995, J INFECT DIS, V171, P1190, DOI 10.1093/infdis/171.5.1190; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Cassady KA., 2004, INFECT CENTRAL NERVO, V44, P57; COREY L, 1983, ANN INTERN MED, V98, P958, DOI 10.7326/0003-4819-98-6-958; Davison KL, 2003, ARCH DIS CHILD, V88, P662, DOI 10.1136/adc.88.8.662; ECHEVARRIA JM, 1994, J MED VIROL, V43, P331, DOI 10.1002/jmv.1890430403; Gupta RK, 2005, BMJ-BRIT MED J, V330, P1132, DOI 10.1136/bmj.330.7500.1132; Hasbun R, 2001, NEW ENGL J MED, V345, P1727, DOI 10.1056/NEJMoa010399; Health Protection Agency, 2007, HLTH PROTECTION REPO, V1, P4; KULHANJIAN JA, 1992, NEW ENGL J MED, V326, P916, DOI 10.1056/NEJM199204023261403; Kupila L, 2006, NEUROLOGY, V66, P75, DOI 10.1212/01.wnl.0000191407.81333.00; *MEN RES FDN, EARL MAN SUSP BAC ME; Negrini B, 2000, PEDIATRICS, V105, P316, DOI 10.1542/peds.105.2.316; O'Sullivan CE, 2003, MAYO CLIN PROC, V78, P1347, DOI 10.4065/78.11.1347; Ramers C, 2000, JAMA-J AM MED ASSOC, V283, P2680, DOI 10.1001/jama.283.20.2680; RANTAKALLIO P, 1986, SCAND J INFECT DIS, V18, P287, DOI 10.3109/00365548609032339; Read SJ, 1999, J CLIN MICROBIOL, V37, P1352, DOI 10.1128/JCM.37.5.1352-1355.1999; Rotbart HA, 1998, CLIN INFECT DIS, V27, P896, DOI 10.1086/517162; Sawyer MH, 2004, INFECT CENTRAL NERVO, V3rd, P75; Shalabi M, 2006, CLIN INFECT DIS, V43, P1194, DOI 10.1086/508281; Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368; Tunkel AR, 2005, MANDELL DOUGLAS BENN, V6th, P1083; Vyse AJ, 2000, SEX TRANSM INFECT, V76, P183, DOI 10.1136/sti.76.3.183	26	117	122	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 5	2008	336	7634					36	40		10.1136/bmj.39409.673657.AE	http://dx.doi.org/10.1136/bmj.39409.673657.AE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250UT	18174598	Bronze, Green Published			2022-12-28	WOS:000252327500040
J	Folco, HD; Pidoux, AL; Urano, T; Allshire, RC				Folco, Hernan Diego; Pidoux, Alison L.; Urano, Takeshi; Allshire, Robin C.			Heterochromatin and RNAi are required to establish CENP-A chromatin at centromeres	SCIENCE			English	Article							FISSION YEAST; CHROMOSOME SEGREGATION; LYSINE-9 METHYLATION; PROTEIN; RITS; PROPAGATION; DISTINCT; DOMAINS; COMPLEX; ACTS	Heterochromatin is defined by distinct posttranslational modifications on histones, such as methylation of histone H3 at lysine 9 ( H3K9), which allows heterochromatin protein 1 ( HP1)- related chromodomain proteins to bind. Heterochromatin is frequently found near CENP-A chromatin, which is the key determinant of kinetochore assembly. We have discovered that the RNA interference ( RNAi)- directed heterochromatin flanking the central kinetochore domain at fission yeast centromeres is required to promote CENP- A(Cnp1) and kinetochore assembly over the central domain. The H3K9 methyltransferase Clr4 ( Suv39); the ribonuclease Dicer, which cleaves heterochromatic double- stranded RNA to small interfering RNA ( siRNA); Chp1, a component of the RNAi effector complex ( RNA- induced initiation of transcriptional gene silencing; RITS); and Swi6 ( HP1) are required to establish CENP-A(Cnp1) chromatin on naive templates. Once assembled, CENP-A(Cnp1) chromatin is propagated by epigenetic means in the absence of heterochromatin. Thus, another, potentially conserved, role for centromeric RNAi- directed heterochromatin has been identified.	[Folco, Hernan Diego; Pidoux, Alison L.; Allshire, Robin C.] Univ Edinburgh, Sch Biol Sci, Inst Cell Biol, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Urano, Takeshi] Nagoya Univ, Grad Sch Med, Dept Biochem 2, Nagoya, Aichi 4668550, Japan	University of Edinburgh; Nagoya University	Allshire, RC (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Cell Biol, Wellcome Trust Ctr Cell Biol, 6-34 Swann Bldg, Edinburgh EH9 3JR, Midlothian, Scotland.	robin.allshire@ed.ac.uk		Allshire, Robin/0000-0002-8005-3625; Urano, Takeshi/0000-0003-3383-3554	Wellcome Trust [065061/Z, 065061] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; BAUM M, 1994, MOL BIOL CELL, V5, P747, DOI 10.1091/mbc.5.7.747; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Liu XK, 2005, EMBO J, V24, P2919, DOI 10.1038/sj.emboj.7600762; MARSCHALL LG, 1995, J CELL BIOL, V128, P445, DOI 10.1083/jcb.128.4.445; Morris CA, 2007, CELL, V128, P647, DOI 10.1016/j.cell.2007.02.002; Mythreye K, 2003, J CELL BIOL, V160, P833, DOI 10.1083/jcb.200211116; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Partridge JF, 2000, GENE DEV, V14, P783; Pidoux AL, 2005, PHILOS T R SOC B, V360, P569, DOI 10.1098/rstb.2004.1611; Pidoux AL, 2003, J CELL BIOL, V161, P295, DOI 10.1083/jcb.200212110; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Saffery R, 2003, MOL CELL, V12, P509, DOI 10.1016/S1097-2765(03)00279-X; SAITOH H, 1992, CELL, V70, P115, DOI 10.1016/0092-8674(92)90538-N; Saitoh S, 1997, CELL, V90, P131, DOI 10.1016/S0092-8674(00)80320-7; Sullivan BA, 2004, NAT STRUCT MOL BIOL, V11, P1076, DOI 10.1038/nsmb845; Sullivan BA, 2001, NAT REV GENET, V2, P584, DOI 10.1038/35084512; TAKAHASHI K, 1992, MOL BIOL CELL, V3, P819, DOI 10.1091/mbc.3.7.819; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Verdel A, 2005, FEBS LETT, V579, P5872, DOI 10.1016/j.febslet.2005.08.083; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973	27	222	227	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2008	319	5859					94	97		10.1126/science.1150944	http://dx.doi.org/10.1126/science.1150944			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18174443	Green Accepted			2022-12-28	WOS:000252084000039
J	Nicastro, F; Mathur, S; Elvis, M				Nicastro, Fabrizio; Mathur, Smita; Elvis, Martin			Missing baryons and the warm-hot intergalactic medium	SCIENCE			English	Editorial Material							X-RAY FOREST; PROBE WMAP OBSERVATIONS; XMM-NEWTON	Stars and gas in galaxies, hot intracluster medium, and intergalactic photo- ionized gas make up at most half of the baryons that are expected to be present in the universe. The majority of baryons are still missing and are expected to be hidden in a web of warm- hot intergalactic medium. This matter was shock- heated during the collapse of density perturbations that led to the formation of the relaxed structures that we see today. Finding the missing baryons and thereby producing a complete inventory of possibly the only detectable component of the energy- mass budget of the universe is crucial to validate or invalidate our standard cosmological model.	[Nicastro, Fabrizio; Elvis, Martin] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Nicastro, Fabrizio] Ist Nazl Astrofis, Osservatorio Astron Roma, I-00040 Rome, Italy; [Mathur, Smita] Ohio State Univ, Columbus, OH 43210 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Istituto Nazionale Astrofisica (INAF); University System of Ohio; Ohio State University	Nicastro, F (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	fnicastro@cfa.harvard.edu		Nicastro, Fabrizio/0000-0002-6896-1364				Bennett CL, 2003, ASTROPHYS J SUPPL S, V148, P1, DOI 10.1086/377253; Cen RY, 2006, ASTROPHYS J, V650, P573, DOI 10.1086/506506; Cen RY, 2006, ASTROPHYS J, V650, P560, DOI 10.1086/506505; Danforth CW, 2005, ASTROPHYS J, V624, P555, DOI 10.1086/429285; Kaastra JS, 2006, ASTROPHYS J, V652, P189, DOI 10.1086/507835; Kirkman D, 2003, ASTROPHYS J SUPPL S, V149, P1, DOI 10.1086/378152; Nicastro F, 2005, ASTROPHYS J, V629, P700, DOI 10.1086/431270; Nicastro F, 2005, NATURE, V433, P495, DOI 10.1038/nature03245; PFENNIGER D, 1994, ASTRON ASTROPHYS, V285, P94; Piro L, 2006, PROC SPIE, V6266, DOI 10.1117/12.670401; Rasmussen AP, 2007, ASTROPHYS J, V656, P129, DOI 10.1086/509865; Rauch M, 1998, ANNU REV ASTRON ASTR, V36, P267, DOI 10.1146/annurev.astro.36.1.267; Richter P, 2006, ASTRON ASTROPHYS, V445, P827, DOI 10.1051/0004-6361:20053636; Spergel DN, 2003, ASTROPHYS J SUPPL S, V148, P175, DOI 10.1086/377226; Stocke JT, 2006, ASTROPHYS J, V641, P217, DOI 10.1086/500386; Weinberg DH, 1997, ASTROPHYS J, V490, P564, DOI 10.1086/304893; Williams RJ, 2006, ASTROPHYS J, V642, pL95, DOI 10.1086/504635	17	54	55	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2008	319	5859					55	57		10.1126/science.1151400	http://dx.doi.org/10.1126/science.1151400			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18174432	Green Submitted			2022-12-28	WOS:000252084000026
J	Lee, JA; Carvalho, CMB; Lupski, JR				Lee, Jennifer A.; Carvalho, Claudia M. B.; Lupski, James R.			A DNA replication mechanism for generating nonrecurrent rearrangements associated with genomic disorders	CELL			English	Article							PELIZAEUS-MERZBACHER-DISEASE; PROTEOLIPID PROTEIN GENE; FAMILIAL PARKINSONS-DISEASE; SEVERE MENTAL-RETARDATION; GERM-CELL APOPTOSIS; COPY-NUMBER; LOCUS DUPLICATION; ESCHERICHIA-COLI; MAJOR CAUSE; MECP2 GENE	The prevailing mechanism for recurrent and some nonrecurrent rearrangements causing genomic disorders is nonallelic homologous recombination (NAHR) between region-specific low-copy repeats (LCRs). For other nonrecurrent rearrangements, nonhomologous end joining (NHEJ) is implicated. Pelizaeus-Merzbacher disease (PMD) is an X-linked dysmyelinating disorder caused most frequently (60%-70%) by nonrecurrent duplication of the dosage-sensitive proteolipid protein 1 (PLP1) gene but also by nonrecurrent deletion or point mutations. Many PLP1 duplication junctions are refractory to breakpoint sequence analysis, an observation inconsistent with a simple recombination mechanism. Our current analysis of junction sequences in PMD patients confirms the occurrence of simple tandem PLP1 duplications but also uncovers evidence for sequence complexity at some junctions. These data are consistent with a replication-based mechanism that we term FoSTeS, for replication Fork Stalling and Template Switching. We propose that complex duplication and deletion rearrangements associated with PMD, and potentially other nonrecurrent rearrangements, may be explained by this replication-based mechanism.	[Lee, Jennifer A.; Carvalho, Claudia M. B.; Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	jlupski@bcm.tmc.edu			NICHD NIH HHS [HD024064, P01 HD39422] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bacolla A, 2004, J BIOL CHEM, V279, P47411, DOI 10.1074/jbc.R400028200; Blanco-Rodriguez J, 2002, J ANDROL, V23, P484; Blanco-Rodriguez J, 2002, J ANDROL, V23, P182; Cabrejo L, 2006, BRAIN, V129, P2966, DOI 10.1093/brain/awl237; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen JM, 2005, HUM MUTAT, V26, P362, DOI 10.1002/humu.20230; del Gaudio D, 2006, GENET MED, V8, P784, DOI 10.1097/01.gim.0000250502.28516.3c; Dumas L, 2007, GENOME RES, V17, P1266, DOI 10.1101/gr.6557307; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Goldfless SJ, 2006, MOL CELL, V21, P595, DOI 10.1016/j.molcel.2006.01.025; GORDON AJE, 1995, GENETICS, V140, P411; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Inoue K, 1999, ANN NEUROL, V45, P624, DOI 10.1002/1531-8249(199905)45:5<624::AID-ANA11>3.3.CO;2-T; Inoue K, 2002, AM J HUM GENET, V71, P838, DOI 10.1086/342728; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kosynider B, 2007, DNA REPAIR, V6, P1850, DOI 10.1016/j.dnarep.2007.07.014; Koszul R, 2004, EMBO J, V23, P234, DOI 10.1038/sj.emboj.7600024; Lee JA, 2006, ANN NEUROL, V59, P398, DOI 10.1002/ana.20732; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Lee JA, 2006, HUM MOL GENET, V15, P2250, DOI 10.1093/hmg/ddl150; Lupski J.R., 2006, GENOMIC DISORDERS TH; Lupski JR, 2007, NEW ENGL J MED, V356, P1169, DOI 10.1056/NEJMcibr067658; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Meins M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.023804; Mimault C, 1999, AM J HUM GENET, V65, P360, DOI 10.1086/302483; Narayanan V, 2006, CELL, V125, P1283, DOI 10.1016/j.cell.2006.04.042; Nishioka K, 2006, ANN NEUROL, V59, P298, DOI 10.1002/ana.20753; Ohno S., 1970, EVOLUTION GENE DUPLI; OHSHIMA A, 1992, P NATL ACAD SCI USA, V89, P1016, DOI 10.1073/pnas.89.3.1016; Padiath QS, 2006, NAT GENET, V38, P1114, DOI 10.1038/ng1872; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Potocki L, 2007, AM J HUM GENET, V80, P633, DOI 10.1086/512864; PRIGENT C, 1994, MOL CELL BIOL, V14, P310, DOI 10.1128/MCB.14.1.310; RASKIND WH, 1991, AM J HUM GENET, V49, P1355; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Shaw CJ, 2005, HUM GENET, V116, P1, DOI 10.1007/s00439-004-1204-9; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sistermans EA, 1998, NEUROLOGY, V50, P1749, DOI 10.1212/WNL.50.6.1749; Slack A, 2006, PLOS GENET, V2, P385, DOI 10.1371/journal.pgen.0020048; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; Toffolatti L, 2002, GENOMICS, V80, P523, DOI 10.1006/geno.2002.6861; TRINH TQ, 1991, NATURE, V352, P544, DOI 10.1038/352544a0; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Vissers LELM, 2007, HUM GENET, V121, P697, DOI 10.1007/s00439-007-0359-6; Wojciechowska M, 2005, J BIOL CHEM, V280, P941, DOI 10.1074/jbc.M410427200; Wolf NI, 2005, BRAIN, V128, P743, DOI 10.1093/brain/awh409; Woodward KJ, 2005, AM J HUM GENET, V77, P966, DOI 10.1086/498048	50	630	660	1	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 28	2007	131	7					1235	1247		10.1016/j.cell.2007.11.037	http://dx.doi.org/10.1016/j.cell.2007.11.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GV	18160035	Bronze			2022-12-28	WOS:000252217200014
J	Guzzo, L; Pierleoni, M; Meneux, B; Branchini, E; Le Fevre, O; Marinoni, C; Garilli, B; Blaizot, J; De Lucia, G; Pollo, A; McCracken, HJ; Bottini, D; Le Brun, V; Maccagni, D; Picat, JP; Scaramella, R; Scodeggio, M; Tresse, L; Vettolani, G; Zanichelli, A; Adami, C; Arnouts, S; Bardelli, S; Bolzonella, M; Bongiorno, A; Cappi, A; Charlot, S; Ciliegi, P; Contini, T; Cucciati, O; de la Torre, S; Dolag, K; Foucaud, S; Franzetti, P; Gavignaud, I; Ilbert, O; Iovino, A; Lamareille, F; Marano, B; Mazure, A; Memeo, P; Merighi, R; Moscardini, L; Paltani, S; Pello, R; Perez-Montero, E; Pozzetti, L; Radovich, M; Vergani, D; Zamorani, G; Zucca, E				Guzzo, L.; Pierleoni, M.; Meneux, B.; Branchini, E.; Le Fevre, O.; Marinoni, C.; Garilli, B.; Blaizot, J.; De Lucia, G.; Pollo, A.; McCracken, H. J.; Bottini, D.; Le Brun, V.; Maccagni, D.; Picat, J. P.; Scaramella, R.; Scodeggio, M.; Tresse, L.; Vettolani, G.; Zanichelli, A.; Adami, C.; Arnouts, S.; Bardelli, S.; Bolzonella, M.; Bongiorno, A.; Cappi, A.; Charlot, S.; Ciliegi, P.; Contini, T.; Cucciati, O.; de la Torre, S.; Dolag, K.; Foucaud, S.; Franzetti, P.; Gavignaud, I.; Ilbert, O.; Iovino, A.; Lamareille, F.; Marano, B.; Mazure, A.; Memeo, P.; Merighi, R.; Moscardini, L.; Paltani, S.; Pello, R.; Perez-Montero, E.; Pozzetti, L.; Radovich, M.; Vergani, D.; Zamorani, G.; Zucca, E.			A test of the nature of cosmic acceleration using galaxy redshift distortions	NATURE			English	Article							VLT DEEP SURVEY; CLUSTER ABUNDANCE; DENSITY; CONSTRAINTS; EVOLUTION; OMEGA(M); MODELS; SPACE; BIAS	Observations of distant supernovae indicate that the Universe is now in a phase of accelerated expansion(1,2) the physical cause of which is a mystery(3). Formally, this requires the inclusion of a term acting as a negative pressure in the equations of cosmic expansion, accounting for about 75 per cent of the total energy density in the Universe. The simplest option for this 'dark energy' corresponds to a 'cosmological constant', perhaps related to the quantum vacuum energy. Physically viable alternatives invoke either the presence of a scalar field with an evolving equation of state, or extensions of general relativity involving higher- order curvature terms or extra dimensions(4-8). Although they produce similar expansion rates, different models predict measurable differences in the growth rate of large- scale structure with cosmic time(9). A fingerprint of this growth is provided by coherent galaxy motions, which introduce a radial anisotropy in the clustering pattern reconstructed by galaxy redshift surveys(10). Here we report a measurement of this effect at a redshift of 0.8. Using a new survey of more than 10,000 faint galaxies(11,12), we measure the anisotropy parameter beta=0.70 +/- 0.26, which corresponds to a growth rate of structure at that time of f = 0.9 +/- 0.36. This is consistent with the standard cosmological- constant model with low matter density and flat geometry, although the error bars are still too large to distinguish among alternative origins for the accelerated expansion. The correct origin could be determined with a further factor-of-ten increase in the sampled volume at similar redshift.	[Guzzo, L.; Cucciati, O.; Iovino, A.] INAF, Osservatorio Astron Brera, I-23807 Merate, LC, Italy; [Guzzo, L.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Guzzo, L.; Pierleoni, M.; Blaizot, J.; De Lucia, G.; Dolag, K.] Max Planck Inst Astrophys, D-85748 Garching, Germany; [Guzzo, L.] European So Observ, D-85748 Garching, Germany; [Meneux, B.; Garilli, B.; Bottini, D.; Maccagni, D.; Scodeggio, M.; Franzetti, P.; Memeo, P.; Vergani, D.] INAF, IASF, I-20133 Milan, Italy; [Branchini, E.] Univ Roma 3, Dipartimento Fis, I-00146 Rome, Italy; [Le Fevre, O.; Pollo, A.; Le Brun, V.; Tresse, L.; Adami, C.; Arnouts, S.; de la Torre, S.; Mazure, A.] Univ Aix Marseille 1, Lab Astrophys Marseille, CNRS, UMR6110, F-13376 Marseille 12, France; [Marinoni, C.] Univ Aix Marseille 1, Ctr Phys Theor, CNRS, UMR 6207, F-13288 Marseille, France; [Pollo, A.] Andrzej Soltan Inst Nucl Res, PL-00681 Warsaw, Poland; [McCracken, H. J.; Charlot, S.] Inst Astrophys, UMR 7095, F-75014 Paris, France; [McCracken, H. J.] LERMA, Observ Paris, F-75014 Paris, France; [Picat, J. P.; Contini, T.; Pello, R.; Perez-Montero, E.] Observ Midi Pyrenees, Astrophys Lab, UMR 5572, F-31400 Toulouse, France; [Scaramella, R.; Vettolani, G.; Zanichelli, A.] INAF, IRA, I-40129 Bologna, Italy; [Scaramella, R.] INAF, Osservatorio Astron Roma, I-00040 Monte Porzio Catone, Italy; [Bardelli, S.; Bolzonella, M.; Cappi, A.; Ciliegi, P.; Lamareille, F.; Merighi, R.; Pozzetti, L.; Zamorani, G.; Zucca, E.] INAF, Osservatorio Astron Bologna, I-40127 Bologna, Italy; [Bongiorno, A.; Marano, B.; Moscardini, L.] Univ Bologna, Dipartimento Astron, I-40127 Bologna, Italy; [Cucciati, O.] Univ Milano Bicocca, Dipartimento Fis, I-20126 Milan, Italy; [Foucaud, S.] Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England; [Gavignaud, I.] Astrophys Inst Potsdam, D-14482 Potsdam, Germany; [Ilbert, O.] Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; [Moscardini, L.] Ist Nazl Fis Nucl, Sez Bologna, I-40127 Bologna, Italy; [Paltani, S.] Observ Geneva, CH-1290 Sauverny, Switzerland; [Paltani, S.] Integral Sci Data Ctr, CH-1290 Versoix, Switzerland; [Radovich, M.] INAF, Osservatorio Astron Capodimonte, I-80131 Naples, Italy	Istituto Nazionale Astrofisica (INAF); Max Planck Society; Max Planck Society; European Southern Observatory; Istituto Nazionale Astrofisica (INAF); Roma Tre University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; National Centre for Nuclear Research; Soltan Institute for Nuclear Studies; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); University of Bologna; University of Milano-Bicocca; University of Nottingham; University of Hawaii System; Istituto Nazionale di Fisica Nucleare (INFN); University of Geneva; University of Geneva; Istituto Nazionale Astrofisica (INAF)	Guzzo, L (corresponding author), INAF, Osservatorio Astron Brera, Via Bianchi 46, I-23807 Merate, LC, Italy.	luigi.guzzo@brera.inaf.it	Merighi, Roberto/Q-3993-2019; Pello, Roser/G-4754-2010; Ilbert, Olivier/AAK-4578-2020; Bardelli, Sandro/O-9369-2015; Vergani, Daniela/Z-3026-2019; Contini, Thierry/AAQ-1509-2021; branchini, enzo/L-8385-2017; Pozzetti, Lucia/ABC-8644-2021; Guzzo, Luigi/R-4939-2017; McCracken, Henry Joy/AAA-1489-2019; Zucca, Elena/O-9396-2015; Cappi, Alberto/O-9391-2015; Le Fevre, Olivier/G-7389-2011; Merighi, Roberto/O-9360-2015; Bolzonella, Micol/O-9495-2015	Merighi, Roberto/0000-0003-2490-1834; Ilbert, Olivier/0000-0002-7303-4397; Bardelli, Sandro/0000-0002-8900-0298; branchini, enzo/0000-0002-0808-6908; Guzzo, Luigi/0000-0001-8264-5192; McCracken, Henry Joy/0000-0002-9489-7765; Zucca, Elena/0000-0002-5845-8132; Cappi, Alberto/0000-0002-9200-7167; Merighi, Roberto/0000-0003-2490-1834; Bolzonella, Micol/0000-0003-3278-4607; Franzetti, Paolo/0000-0002-6986-0127; Ciliegi, Paolo/0000-0002-0447-4620; Perez Montero, Enrique/0000-0003-3985-4882; bottini, dario/0000-0001-6917-041X; Contini, Thierry/0000-0003-0275-938X; Iovino, Angela/0000-0001-6958-0304; Radovich, Mario/0000-0002-3585-866X; Zanichelli, Alessandra/0000-0002-2893-023X; Pozzetti, Lucia/0000-0001-7085-0412; Zamorani, Giovanni/0000-0002-2318-301X; Tresse, Laurence/0000-0001-8776-0958; Bongiorno, Angela/0000-0002-0101-6624; Pollo, Agnieszka/0000-0003-3358-0665; Scodeggio, Marco/0000-0002-2282-5850; Moscardini, Lauro/0000-0002-3473-6716; Scaramella, Roberto/0000-0003-2229-193X; Vergani, Daniela/0000-0003-0898-2216; Garilli, Bianca/0000-0001-7455-8750				ALCOCK C, 1979, NATURE, V281, P358, DOI 10.1038/281358a0; Amendola L, 2005, MON NOT R ASTRON SOC, V357, P429, DOI 10.1111/j.1365-2966.2004.08558.x; Amendola L, 2000, MON NOT R ASTRON SOC, V312, P521, DOI 10.1046/j.1365-8711.2000.03165.x; Borgani S, 2001, ASTROPHYS J, V561, P13, DOI 10.1086/323214; Capozziello S, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.043503; Carroll SM, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.043528; Cooray A, 2004, PHYS REV D, V69, DOI 10.1103/PhysRevD.69.027301; DAVIS M, 1983, ASTROPHYS J, V267, P465, DOI 10.1086/160884; De Lucia G, 2007, MON NOT R ASTRON SOC, V375, P2, DOI 10.1111/j.1365-2966.2006.11287.x; Dvali G, 2000, PHYS LETT B, V485, P208, DOI 10.1016/S0370-2693(00)00669-9; GARILLI B, UNPUB ASTRON ASTROPH; Hamilton AJS, 1998, ASTROPHYS SPACE SC L, V231, P185; Hawkins E, 2003, MON NOT R ASTRON SOC, V346, P78, DOI 10.1046/j.1365-2966.2003.07063.x; KAISER N, 1987, MON NOT R ASTRON SOC, V227, P1; Le Fevre O, 2005, ASTRON ASTROPHYS, V439, P845, DOI 10.1051/0004-6361:20041960; Linder EV, 2005, PHYS REV D, V72, DOI 10.1103/PhysRevD.72.043529; LUE R, 2004, PHYS REV D, V69, P4015; Marinoni C, 2005, ASTRON ASTROPHYS, V442, P801, DOI 10.1051/0004-6361:20052966; Peacock JA, 2001, NATURE, V410, P169, DOI 10.1038/35065528; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; Ross NP, 2007, MON NOT R ASTRON SOC, V381, P573, DOI 10.1111/j.1365-2966.2007.12289.x; Schuecker P, 2003, ASTRON ASTROPHYS, V398, P867, DOI 10.1051/0004-6361:20021715; Spergel DN, 2007, ASTROPHYS J SUPPL S, V170, P377, DOI 10.1086/513700; Turner MS, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.111015; Wang L, 1998, ASTROPHYS J, V508, P483, DOI 10.1086/306436; WETTERICH C, 1995, ASTRON ASTROPHYS, V301, P321	28	523	524	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2008	451	7178					541	544		10.1038/nature06555	http://dx.doi.org/10.1038/nature06555			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256OQ	18235494				2022-12-28	WOS:000252739900034
J	Rokas, A				Rokas, Antonis			Genomics - Lining up to avoid bias	SCIENCE			English	Editorial Material							SEQUENCE ALIGNMENT; PHYLOGENY		Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Rokas, A (corresponding author), Vanderbilt Univ, Dept Biol Sci, VU Stn B 35-1634, Nashville, TN 37235 USA.	antonis.rokas@vanderbilt.edu	Rokas, Antonis/A-9775-2008	Rokas, Antonis/0000-0002-7248-6551				Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Fleissner R, 2005, SYST BIOL, V54, P548, DOI 10.1080/10635150590950371; Kumar S, 2007, GENOME RES, V17, P127, DOI 10.1101/gr.5232407; Lunter G, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-83; Lutzoni F, 2000, SYST BIOL, V49, P628, DOI 10.1080/106351500750049743; Morrison DA, 1997, MOL BIOL EVOL, V14, P428, DOI 10.1093/oxfordjournals.molbev.a025779; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Suchard MA, 2006, BIOINFORMATICS, V22, P2047, DOI 10.1093/bioinformatics/btl175; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532	9	7	7	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2008	319	5862					416	417		10.1126/science.1153156	http://dx.doi.org/10.1126/science.1153156			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254HB	18218881				2022-12-28	WOS:000252576600022
J	Errami, M; Garner, H				Errami, Mounir; Garner, Harold			A tale of two citations	NATURE			English	Editorial Material									[Errami, Mounir] Univ Texas SW Med Ctr Dallas, Div Translat Res Dept, Dallas, TX 75390 USA; [Garner, Harold] Univ Texas SW Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Errami, M (corresponding author), Univ Texas SW Med Ctr Dallas, Div Translat Res Dept, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.							ERRAMI M, 2007, NUCLEIC ACIDS RES, V35; Errami M, 2008, BIOINFORMATICS, V24, P243, DOI 10.1093/bioinformatics/btm574; Martinson BC, 2005, NATURE, V435, P737, DOI 10.1038/435737a; Sorokina D, 2006, IEEE DATA MINING, P1070	4	128	133	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2008	451	7177					397	399		10.1038/451397a	http://dx.doi.org/10.1038/451397a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	253YS	18216832	Bronze			2022-12-28	WOS:000252554100021
J	Holmboe, ES; Lipner, R; Greiner, A				Holmboe, Eric S.; Lipner, Rebecca; Greiner, Ann			Assessing quality of care - Knowledge matters	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SPECIALTY BOARD CERTIFICATION; PHYSICIAN; OUTCOMES; THERAPY; ADULTS		[Holmboe, Eric S.; Lipner, Rebecca; Greiner, Ann] Amer Board Internal Med, Philadelphia, PA 19106 USA	American Board of Internal Medicine	Holmboe, ES (corresponding author), Amer Board Internal Med, 510 Walnut St,Ste 1700, Philadelphia, PA 19106 USA.	eholmboe@abim.org						Blank L, 2003, ANN INTERN MED, V138, P839, DOI 10.7326/0003-4819-138-10-200305200-00012; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Bordage G, 1999, ACAD MED, V74, pS138, DOI 10.1097/00001888-199910000-00065; Brennan TA, 2004, JAMA-J AM MED ASSOC, V292, P1038, DOI 10.1001/jama.292.9.1038; Chen J, 2006, J GEN INTERN MED, V21, P238, DOI 10.1111/j.1525-1497.2006.00326.x; Choudhry NK, 2005, ANN INTERN MED, V142, P260, DOI 10.7326/0003-4819-142-4-200502150-00008; DAY SC, 1988, P ANN C RES MED ED, V27, P139; Downing SM, 2006, HDB TEST DEV; Eva KW, 2002, ACAD MED, V77, pS1, DOI 10.1097/00001888-200210001-00002; Fisher ES, 2003, NEW ENGL J MED, V349, P1665, DOI 10.1056/NEJMe038149; Graber ML, 2005, ARCH INTERN MED, V165, P1493, DOI 10.1001/archinte.165.13.1493; Gruppen LD, 2002, INT HDB RES MED ED, P205; Hanson KL, 2001, J URBAN HEALTH, V78, P112, DOI 10.1093/jurban/78.1.112; *I HEALTHC IMPR, 2000, ID DES CLIN OFF PRAC; Institute of Medicine, 2001, CROSSING QUALITY CHA; KROENKE K, 1989, AM J MED, V86, P262, DOI 10.1016/0002-9343(89)90293-3; Masoudi FA, 2005, CIRCULATION, V112, P39, DOI 10.1161/CIRCULATIONAHA.104.527549; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; MOLD JW, 1986, NEW ENGL J MED, V314, P512, DOI 10.1056/NEJM198602203140809; Nelson Eugene C, 2002, Jt Comm J Qual Improv, V28, P472; Norcini JJ, 2000, ACAD MED, V75, P1193, DOI 10.1097/00001888-200012000-00016; Pham HH, 2005, JAMA-J AM MED ASSOC, V294, P473, DOI 10.1001/jama.294.4.473; Prystowsky JB, 2002, SURGERY, V132, P663, DOI 10.1067/msy.2002.127550; Sharp LK, 2002, ACAD MED, V77, P534, DOI 10.1097/00001888-200206000-00011; Silber JH, 2002, ANESTHESIOLOGY, V96, P1044, DOI 10.1097/00000542-200205000-00004	25	55	56	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2008	299	3					338	340		10.1001/jama.299.3.338	http://dx.doi.org/10.1001/jama.299.3.338			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253DB	18212320				2022-12-28	WOS:000252497800027
J	Saigal, S; Doyle, LW				Saigal, Saroj; Doyle, Lex W.			Preterm birth 3 - An overview of mortality and sequelae of preterm birth from infancy to adulthood	LANCET			English	Review							QUALITY-OF-LIFE; NEONATAL INTENSIVE-CARE; SCHOOL-AGED CHILDREN; 28 WEEKS GESTATION; FOLLOW-UP PROJECT; WEIGHT INFANTS; CEREBRAL-PALSY; HEALTH-CARE; NEURODEVELOPMENTAL OUTCOMES; FUNCTIONAL LIMITATIONS	Survival rates have greatly improved in recent years for infants of borderline viability; however, these infants remain at risk of developing a wide array of complications, not only in the neonatal unit, but also in the long term. Morbidity is inversely related to gestational age; however, there is no gestational age, including term, that is wholly exempt. Neurodevelopmental disabilities and recurrent health problems take a toll in early childhood. Subsequently hidden disabilities such as school difficulties and behavioural problems become apparent and persist into adolescence. Reassuringly, however, most children born very preterm adjust remarkably well during their transition into adulthood. Because mortality rates have fallen, the focus for perinatal interventions is to develop strategies to reduce long-term morbidity, especially the prevention of brain injury and abnormal brain development. In addition, follow-up to middle age and beyond is warranted to identify the risks, especially for cardiovascular and metabolic disorders that are likely to be experienced by preterm survivors.	[Saigal, Saroj] McMaster Univ, Med Ctr, Dept Paediat, Hamilton, ON L8S 4J9, Canada; [Doyle, Lex W.] Royal Womens Hosp, Melbourne, Vic, Australia; [Doyle, Lex W.] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Doyle, Lex W.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Doyle, Lex W.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia	McMaster University; University of Melbourne; University of Melbourne; Murdoch Children's Research Institute	Saigal, S (corresponding author), McMaster Univ, Med Ctr, Dept Paediat, 1200 Main St W,Room 4G40, Hamilton, ON L8S 4J9, Canada.	saigal@mcmaster.ca	Doyle, Lex/AAJ-5205-2021; Fahimifar, Sepideh/M-5303-2019	Doyle, Lex/0000-0002-7667-7312; 				Albrecht GL, 1999, SOC SCI MED, V48, P977, DOI 10.1016/S0277-9536(98)00411-0; Alexander G R, 1999, Matern Child Health J, V3, P225, DOI 10.1023/A:1022381506823; Alexander GR, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e61; Allen MC, 2000, PAEDIATR PERINAT EP, V14, P152, DOI 10.1046/j.1365-3016.2000.00255.x; Anderson P, 2003, JAMA-J AM MED ASSOC, V289, P3264, DOI 10.1001/jama.289.24.3264; Anderson PJ, 2004, PEDIATRICS, V114, P50, DOI 10.1542/peds.114.1.50; [Anonymous], 1997, Arch Dis Child Fetal Neonatal Ed, V77, pF91; Aylward GP, 2005, J DEV BEHAV PEDIATR, V26, P427, DOI 10.1097/00004703-200512000-00008; BARKER DJP, 1995, EUR J CLIN INVEST, V25, P457, DOI 10.1111/j.1365-2362.1995.tb01730.x; BHUSHAN V, 1993, PEDIATRICS, V91, P1094; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Bjerager M, 1995, ACTA PAEDIATR, V84, P1339, DOI 10.1111/j.1651-2227.1995.tb13565.x; Bohin S, 1999, EARLY HUM DEV, V55, P9, DOI 10.1016/S0378-3782(99)00003-1; Botting N, 1998, DEV MED CHILD NEUROL, V40, P652; Botting N, 1997, J CHILD PSYCHOL PSYC, V38, P931, DOI 10.1111/j.1469-7610.1997.tb01612.x; Breslau N, 2000, BIOL PSYCHIAT, V47, P1005, DOI 10.1016/S0006-3223(99)00312-1; BRESLAU N, 1994, ARCH PEDIAT ADOL MED, V148, P377, DOI 10.1001/archpedi.1994.02170040043007; Chow LC, 2003, PEDIATRICS, V111, P339, DOI 10.1542/peds.111.2.339; CHURCHILL DN, 1987, CLIN INVEST MED, V10, P14; Cifuentes J, 2002, PEDIATRICS, V109, P745, DOI 10.1542/peds.109.5.745; Colver AF, 2000, ARCH DIS CHILD-FETAL, V83, pF7, DOI 10.1136/fn.83.1.F7; Cooke RWI, 2004, ARCH DIS CHILD, V89, P201, DOI 10.1136/adc.2003.030197; Cooke RWI, 1999, ARCH DIS CHILD-FETAL, V80, pF115, DOI 10.1136/fn.80.2.F115; CRONIN CMG, 1995, ARCH PEDIAT ADOL MED, V149, P151, DOI 10.1001/archpedi.1995.02170140033005; Darlow BA, 2003, ARCH DIS CHILD-FETAL, V88, pF23, DOI 10.1136/fn.88.1.F23; Davidoff MJ, 2006, SEMIN PERINATOL, V30, P8, DOI 10.1053/j.semperi.2006.01.009; Davis NM, 2007, DEV MED CHILD NEUROL, V49, P325, DOI 10.1111/j.1469-8749.2007.00325.x; Davis NM, 2001, DEV MED CHILD NEUROL, V43, P191, DOI 10.1017/S0012162201000366; Delobel-Ayoub M, 2006, PEDIATRICS, V117, P1996, DOI 10.1542/peds.2005-2310; den Ouden AL, 2000, TIJDSCHR KINDERGENEE, V68, P241; Dinesen SJ, 2001, ARCH DIS CHILD-FETAL, V85, pF165, DOI 10.1136/fn.85.3.F165; Dolk H, 2006, DEV MED CHILD NEUROL, V48, P406, DOI 10.1017/S0012162206000909; Doyle LW, 2006, PEDIATRICS, V118, P108, DOI 10.1542/peds.2005-2522; Doyle Lex W, 2003, Semin Neonatol, V8, P137, DOI 10.1016/S1084-2756(02)00221-X; Doyle LW, 2005, ARCH DIS CHILD-FETAL, V90, pF484, DOI 10.1136/adc.2004.063362; Doyle LW, 2004, EARLY HUM DEV, V80, P103, DOI 10.1016/j.earlhumdev.2004.05.009; Doyle LW, 2004, MED J AUSTRALIA, V181, P136, DOI 10.5694/j.1326-5377.2004.tb06203.x; Doyle LW, 2004, ARCH DIS CHILD, V89, P347, DOI 10.1136/adc.2002.025924; Doyle LW, 2004, PEDIATRICS, V113, P505, DOI 10.1542/peds.113.3.505; Doyle LW, 2004, PEDIATRICS, V113, P510, DOI 10.1542/peds.113.3.510; Doyle LW, 1997, J PAEDIATR CHILD H, V33, P161; Doyle LW, 1999, MED J AUSTRALIA, V170, P528, DOI 10.5694/j.1326-5377.1999.tb127877.x; Doyle LW, 2000, J PAEDIATR CHILD H, V36, P7, DOI 10.1046/j.1440-1754.2000.00452.x; Doyle LW, 2003, PEDIATRICS, V111, P252, DOI 10.1542/peds.111.2.252; Doyle LW, 2001, PEDIATRICS, V108, P134, DOI 10.1542/peds.108.1.134; Doyle LW, 2001, ARCH DIS CHILD-FETAL, V85, pF159, DOI 10.1136/fn.85.3.F159; DOYLE LW, 1996, SEMIN NEONATOL, V1, P257; Draper ES, 1999, BRIT MED J, V319, P1093, DOI 10.1136/bmj.319.7217.1093; Drotar D, 2006, PEDIATRICS, V117, P2006, DOI 10.1542/peds.2005-2118; Elgen I, 2002, ARCH DIS CHILD-FETAL, V87, pF128, DOI 10.1136/fn.87.2.F128; Emsley HCA, 1998, ARCH DIS CHILD-FETAL, V78, pF99, DOI 10.1136/fn.78.2.F99; Ericson A, 1998, ARCH DIS CHILD-FETAL, V78, pF171, DOI 10.1136/fn.78.3.F171; Escobar GJ, 2006, ARCH DIS CHILD-FETAL, V91, pF238, DOI 10.1136/adc.2005.087031; Escobar GJ, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.1.e2; Farooqi A, 2006, PEDIATRICS, V118, pE1452, DOI 10.1542/peds.2006-1069; Farooqi A, 2006, PEDIATRICS, V118, pE1466, DOI 10.1542/peds.2006-1070; Finken MJJ, 2006, PEDIATR RES, V59, P604, DOI 10.1203/01.pdr.0000203096.13266.eb; Finnstrom O, 1998, ACTA PAEDIATR, V87, P1055, DOI 10.1080/080352598750031374; Finnstrom O, 1997, ACTA PAEDIATR, V86, P503, DOI 10.1111/j.1651-2227.1997.tb08921.x; Ford GW, 2000, ARCH PEDIAT ADOL MED, V154, P778, DOI 10.1001/archpedi.154.8.778; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Goyen TA, 1998, DEV MED CHILD NEUROL, V40, P76, DOI 10.1111/j.1469-8749.1998.tb15365.x; Gultom E, 1997, AUST NZ J OBSTET GYN, V37, P56, DOI 10.1111/j.1479-828X.1997.tb02218.x; Hack M, 2005, JAMA-J AM MED ASSOC, V294, P318, DOI 10.1001/jama.294.3.318; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; Hack M, 2005, PEDIATR RES, V58, P677, DOI 10.1203/01.PDR.0000180551.93470.56; Hack M, 2004, PEDIATRICS, V114, P932, DOI 10.1542/peds.2003-1017-L; Hack M, 1996, ARCH PEDIAT ADOL MED, V150, P1122, DOI 10.1001/archpedi.1996.02170360012002; Hack M, 2003, PEDIATRICS, V112, pE30, DOI 10.1542/peds.112.1.e30; Hack M, 2000, Semin Neonatol, V5, P89, DOI 10.1053/siny.1999.0001; HACK M, 1994, NEW ENGL J MED, V331, P753, DOI 10.1056/NEJM199409223311201; Hack M, 2000, PEDIATRICS, V106, P554, DOI 10.1542/peds.106.3.554; HACK M, 2007, IN PRESS J PEDIAT; Hadders-Algra M, 2002, DEV MED CHILD NEUROL, V44, P561; Hagan R, 1996, BRIT J OBSTET GYNAEC, V103, P239, DOI 10.1111/j.1471-0528.1996.tb09712.x; Hagberg B, 2001, ACTA PAEDIATR, V90, P271, DOI 10.1080/080352501300067532; Hakansson S, 2004, PEDIATRICS, V114, P58, DOI 10.1542/peds.114.1.58; Harrison H, 2001, J CLIN ETHIC, V12, P239; Hille ETM, 2001, LANCET, V357, P1641, DOI 10.1016/S0140-6736(00)04818-2; Hintz SR, 2005, PEDIATRICS, V115, P1645, DOI 10.1542/peds.2004-2215; HO S, 2005, NEOREVIEWS, V6, pE1; Huddy CLJ, 2001, ARCH DIS CHILD-FETAL, V85, pF23, DOI 10.1136/fn.85.1.F23; Jackson K, 2001, ACTA PAEDIATR, V90, P213; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Joffe S, 1999, PEDIATRICS, V104, P894, DOI 10.1542/peds.104.4.894; Kamper J, 2004, ACTA PAEDIATR, V93, P225, DOI 10.1080/08035250310022298; Keijzer-Veen MG, 2005, PEDIATRICS, V116, P725, DOI 10.1542/peds.2005-0309; Kinney HC, 2006, SEMIN PERINATOL, V30, P81, DOI 10.1053/j.semperi.2006.02.006; KITCHEN WH, 1991, J PEDIATR-US, V118, P761; KITCHEN WH, 1992, AM J DIS CHILD, V146, P40, DOI 10.1001/archpedi.1992.02160130042019; Kramer MS, 2000, JAMA-J AM MED ASSOC, V284, P843, DOI 10.1001/jama.284.7.843; Larroque B, 2004, ARCH DIS CHILD-FETAL, V89, P139, DOI 10.1136/adc.2002.020396; Lefebvre F, 2005, ACTA PAEDIATR, V94, P733, DOI 10.1080/08035250510025987; Lorenz JM, 2001, PEDIATRICS, V108, P1269, DOI 10.1542/peds.108.6.1269; Markestad T, 2005, PEDIATRICS, V115, P1289, DOI 10.1542/peds.2004-1482; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; MCCORMICK MC, 1993, J PEDIATR-US, V122, P360, DOI 10.1016/S0022-3476(05)83417-1; MCCORMICK MC, 1995, FUTURE CHILD, V5, P162, DOI 10.2307/1602513; Mikkola K, 2005, PEDIATRICS, V116, P1391, DOI 10.1542/peds.2005-0171; Moore M, 2006, J PEDIATR PSYCHOL, V31, P1024, DOI 10.1093/jpepsy/jsj075; O'Connor AR, 2002, PEDIATRICS, V109, P12, DOI 10.1542/peds.109.1.12; O'Shea TM, 1998, PEDIATRICS, V101, P642, DOI 10.1542/peds.101.4.642; Pharoah POD, 1998, ARCH DIS CHILD-FETAL, V79, pF21, DOI 10.1136/fn.79.1.F21; Platt MJ, 2007, LANCET, V369, P43, DOI 10.1016/S0140-6736(07)60030-0; Powls A, 1996, ARCH DIS CHILD-FETAL, V75, pF152, DOI 10.1136/fn.75.3.F152; Raju TNK, 2006, PEDIATR RES, V60, P775, DOI 10.1203/01.pdr.0000246074.73342.1e; Rees S, 2005, EARLY HUM DEV, V81, P753, DOI 10.1016/j.earlhumdev.2005.07.004; Reijneveld SA, 2006, ARCH DIS CHILD-FETAL, V91, pF423, DOI 10.1136/adc.2006.093674; Rijken M, 2003, PEDIATRICS, V112, P351, DOI 10.1542/peds.112.2.351; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Saigal S, 2000, PEDIATRICS, V105, P569, DOI 10.1542/peds.105.3.569; Saigal S, 2000, J PEDIATR-US, V137, P701, DOI 10.1067/mpd.2000.109001; SAIGAL S, 1991, J PEDIATR-US, V118, P751, DOI 10.1016/S0022-3476(05)80043-5; Saigal S, 2000, PEDIATRICS, V105, P325, DOI 10.1542/peds.105.2.325; Saigal S, 2006, JAMA-J AM MED ASSOC, V295, P667, DOI 10.1001/jama.295.6.667; Saigal S, 2003, PEDIATRICS, V111, P969, DOI 10.1542/peds.111.5.969; Saigal S, 2003, PEDIATRICS, V112, P943, DOI 10.1542/peds.112.4.943; Saigal S, 1999, JAMA-J AM MED ASSOC, V281, P1991, DOI 10.1001/jama.281.21.1991; SAIGAL S, 1989, J PEDIATR-US, V114, P839, DOI 10.1016/S0022-3476(89)80150-7; Saigal S, 1996, JAMA-J AM MED ASSOC, V276, P453, DOI 10.1001/jama.276.6.453; Saigal S, 2001, PEDIATRICS, V108, P407, DOI 10.1542/peds.108.2.407; SAIGAL S, 2007, PEDIATRICS, V119; Saigal S, 2006, PEDIATR RES, V60, P751, DOI 10.1203/01.pdr.0000246201.93662.8e; Saigal S, 2006, PEDIATRICS, V118, P1140, DOI 10.1542/peds.2006-0119; Samuelson JL, 2002, PAEDIATR PERINAT EP, V16, P305, DOI 10.1046/j.1365-3016.2002.00450.x; Singer LT, 1999, JAMA-J AM MED ASSOC, V281, P799, DOI 10.1001/jama.281.9.799; Soll RF, 1998, BIOL NEONATE, V74, P35, DOI 10.1159/000047033; STANLEY FJ, 1992, BRIT MED J, V304, P1658, DOI 10.1136/bmj.304.6843.1658; Stoelhorst GMSJ, 2005, PEDIATRICS, V115, P396, DOI 10.1542/peds.2004-1497; Sutton L, 1999, PAEDIATR PERINAT EP, V13, P288; Sykes DH, 1997, J CHILD PSYCHOL PSYC, V38, P315, DOI 10.1111/j.1469-7610.1997.tb01516.x; Taylor HG, 2000, CHILD DEV, V71, P1495, DOI 10.1111/1467-8624.00242; Taylor HG, 2004, J INT NEUROPSYCH SOC, V10, P149, DOI 10.1017/S1355617704102038; Taylor HG, 2001, ARCH PEDIAT ADOL MED, V155, P155, DOI 10.1001/archpedi.155.2.155; Therien JM, 2004, DEV MED CHILD NEUROL, V46, P816, DOI 10.1017/S0012162204001434; Tin W, 1997, BMJ-BRIT MED J, V314, P107, DOI 10.1136/bmj.314.7074.107; Tommiska V, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.1.e2; Tommiska V, 2007, PEDIATRICS, V119, P29, DOI 10.1542/peds.2006-1472; Vanhaesebrouck P, 2004, PEDIATRICS, V114, P663, DOI 10.1542/peds.2003-0903-L; Vincer MJ, 2006, PEDIATRICS, V118, pE1621, DOI 10.1542/peds.2006-1522; Vohr BR, 2005, PEDIATRICS, V116, P635, DOI 10.1542/peds.2004-2247; Wang ML, 2004, PEDIATRICS, V114, P372, DOI 10.1542/peds.114.2.372; Wilson-Costello D, 2005, PEDIATRICS, V115, P997, DOI 10.1542/peds.2004-0221; Wilson-Costello D, 2007, PEDIATRICS, V119, P37, DOI 10.1542/peds.2006-1416; Winter S, 2002, PEDIATRICS, V110, P1220, DOI 10.1542/peds.110.6.1220; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601; Wood NS, 2003, ARCH DIS CHILD-FETAL, V88, pF492, DOI 10.1136/fn.88.6.F492	147	1790	1841	6	208	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 19	2008	371	9608					261	269		10.1016/S0140-6736(08)60136-1	http://dx.doi.org/10.1016/S0140-6736(08)60136-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	252UK	18207020				2022-12-28	WOS:000252471900029
J	Ward, VB				Ward, Veronica Bridget			Pregnancy plus - Eating disorders in pregnancy	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BULIMIA-NERVOSA; WOMEN; DEPRESSION; OUTCOMES; IMPACT; BIRTH				Ward, VB (corresponding author), 10 Nicholson Rd, Oxford OX3 0HW, England.	ward_veronica@hotmail.com						[Anonymous], 2004, EAT DIS COR INT TREA; Baird DT, 2006, HUM REPROD UPDATE, V12, P193, DOI 10.1093/humupd/dmk003; *BEAT EAT DIS, INF HELP ALL ASP EAT; Blais MA, 2000, INT J EAT DISORDER, V27, P140, DOI 10.1002/(SICI)1098-108X(200003)27:2<140::AID-EAT2>3.0.CO;2-E; Cooper P. J., 1995, BULIMIA NERVOSA BING; Crow SJ, 2002, AM J PSYCHIAT, V159, P1048, DOI 10.1176/appi.ajp.159.6.1048; Ekeus C, 2006, BJOG-INT J OBSTET GY, V113, P925, DOI 10.1111/j.1471-0528.2006.01012.x; Fairburn CG., 1995, OVERCOMING BINGE EAT; Franko DL, 2000, OBSTET GYNECOL, V95, P942, DOI 10.1016/S0029-7844(00)00792-4; FREEMAN C, 2001, OVERCOMING ANOREXIA; HOEK HW, 1991, PSYCHOL MED, V21, P455, DOI 10.1017/S0033291700020560; Kouba S, 2005, OBSTET GYNECOL, V105, P255, DOI 10.1097/01.AOG.0000148265.90984.c3; Larsson G, 2003, EUR EAT DISORD REV, V11, P116, DOI 10.1002/erv.497; Mazzeo SE, 2006, INT J EAT DISORDER, V39, P202, DOI 10.1002/eat.20243; McCabe R. E., 2003, OVERCOMING BULIMIA W; Morgan JF, 2006, PSYCHOSOM MED, V68, P487, DOI 10.1097/01.psy.0000221265.43407.89; Morgan JF, 1999, BRIT J PSYCHIAT, V174, P135, DOI 10.1192/bjp.174.2.135; Newton MS, 2006, J PSYCHOSOM OBST GYN, V27, P5, DOI 10.1080/01674820500451517; Rocco PL, 2005, J PSYCHOSOM RES, V59, P175, DOI 10.1016/j.jpsychores.2005.03.002; Schmidt U., 1993, GETTING BETTER BITE; *SOM FISH, WEBS DED RAIS AW PRO; STEIN A, 1994, J CHILD PSYCHOL PSYC, V35, P733, DOI 10.1111/j.1469-7610.1994.tb01218.x; Treasure J., 1997, ANOREXIA NERVOSA SUR; Waugh E, 1999, INT J EAT DISORDER, V25, P123, DOI 10.1002/(SICI)1098-108X(199903)25:2&lt;123::AID-EAT1&gt;3.0.CO;2-B	24	36	36	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 12	2008	336	7635					93	96		10.1136/bmj.39393.689595.BE	http://dx.doi.org/10.1136/bmj.39393.689595.BE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	253BX	18187726	Green Published			2022-12-28	WOS:000252494800032
J	Lee, KPK; Dey, M; Neculai, D; Cao, C; Dever, TE; Sicheri, F				Lee, Kenneth P. K.; Dey, Madhusudan; Neculai, Dante; Cao, Chune; Dever, Thomas E.; Sicheri, Frank			Structure of the dual enzyme ire1 reveals the basis for catalysis and regulation in nonconventional RNA splicing	CELL			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM; MESSENGER-RNA; MYCOBACTERIUM-TUBERCULOSIS; CRYSTAL-STRUCTURE; TRANSMEMBRANE PROTEIN; 2-5A-DEPENDENT RNASE; KINASE-ACTIVITY; ACTIVATION; CLEAVAGE	Ire1 is an ancient transmembrane sensor of ER stress with dual protein kinase and ribonuclease activities. In response to ER stress, Ire1 catalyzes the splicing of target mRNAs in a spliceosome-independent manner. We have determined the crystal structure of the dual catalytic region of Ire1at 2.4 angstrom resolution, revealing the fusion of a domain, which we term the KEN domain, to the protein kinase domain. Dimerization of the kinase domain composes a large catalytic surface on the KEN domain which carries out ribonuclease function. We further show that signal induced trans-autophosphorylation of the kinase domain permits unfettered binding of nucleotide, which in turn promotes dimerization to compose the ribonuclease active site. Comparison of Ire1 to a topologically disparate ribonuclease reveals the convergent evolution of their catalytic mechanism. These findings provide a basis for understanding the mechanism of action of RNaseL and other pseudokinases, which represent 10% of the human kinome.	[Lee, Kenneth P. K.; Sicheri, Frank] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Syst Biol, Toronto, ON M5G 1X5, Canada; [Lee, Kenneth P. K.; Neculai, Dante; Sicheri, Frank] Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; [Dey, Madhusudan; Cao, Chune; Dever, Thomas E.] Natl Inst Child Hlth & Human Dev, Lab Gene Regulat & Dev, Bethesda, MD 20892 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Sicheri, F (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Syst Biol, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	sicheri@mshri.on.ca	Neculai, Dante/M-2884-2013; Longo, Kenneth A/A-5631-2010; Dever, Thomas/GSE-0966-2022; Neculai, Dante/A-9923-2011; Sicheri, Frank/F-8856-2013	Neculai, Dante/0000-0001-8887-9168; Dever, Thomas/0000-0001-7120-9678	Intramural NIH HHS [Z01 HD001010-13] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001010] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Carrasco DR, 2007, CANCER CELL, V11, P349, DOI 10.1016/j.ccr.2007.02.015; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Debreczeni JE, 2003, ACTA CRYSTALLOGR D, V59, P393, DOI 10.1107/S0907444902020917; Dey M, 2005, CELL, V122, P901, DOI 10.1016/j.cell.2005.06.041; DONG BH, 1995, J BIOL CHEM, V270, P4133, DOI 10.1074/jbc.270.8.4133; DONG BH, 1994, J BIOL CHEM, V269, P14153; Dong BH, 2001, RNA, V7, P361, DOI 10.1017/S1355838201002230; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FLOYDSMITH G, 1981, SCIENCE, V212, P1030, DOI 10.1126/science.6165080; Gay LM, 2006, J MOL BIOL, V360, P409, DOI 10.1016/j.jmb.2006.05.015; Gonzalez TN, 1999, EMBO J, V18, P3119, DOI 10.1093/emboj/18.11.3119; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Greenstein AE, 2007, J BIOL CHEM, V282, P11427, DOI 10.1074/jbc.M610193200; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Kimata Y, 2004, J CELL BIOL, V167, P445, DOI 10.1083/jcb.200405153; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; MADEJ T, 1995, PROTEINS, V23, P356, DOI 10.1002/prot.340230309; Mori K, 2003, TRAFFIC, V4, P519, DOI 10.1034/j.1600-0854.2003.00112.x; MORI K, 1993, CELL, V74, P743; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Ortiz-Lombardia M, 2003, J BIOL CHEM, V278, P13094, DOI 10.1074/jbc.M300660200; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Welihinda AA, 1996, J BIOL CHEM, V271, P18181, DOI 10.1074/jbc.271.30.18181; Xue S, 2006, SCIENCE, V312, P906, DOI 10.1126/science.1126629; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Young TA, 2003, NAT STRUCT BIOL, V10, P168, DOI 10.1038/nsb897; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	41	253	268	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 11	2008	132	1					89	100		10.1016/j.cell.2007.10.057	http://dx.doi.org/10.1016/j.cell.2007.10.057			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IL	18191223	Bronze, Green Accepted			2022-12-28	WOS:000253427600018
J	Bitterman, Y; Mukamel, R; Malach, R; Fried, I; Nelken, I				Bitterman, Y.; Mukamel, R.; Malach, R.; Fried, I.; Nelken, I.			Ultra-fine frequency tuning revealed in single neurons of human auditory cortex	NATURE			English	Article							RECEPTIVE-FIELDS; DISCRIMINATION; RESPONSES; MODEL; ORGANIZATION; TONES; CUES	Just- noticeable differences of physical parameters are often limited by the resolution of the peripheral sensory apparatus. Thus, two- point discrimination in vision is limited by the size of individual photoreceptors. Frequency selectivity is a basic property of neurons in the mammalian auditory pathway(1,2). However, just- noticeable differences of frequency are substantially smaller than the bandwidth of the peripheral sensors(3). Here we report that frequency tuning in single neurons recorded from human auditory cortex in response to random- chord stimuli is far narrower than that typically described in any other mammalian species ( besides bats), and substantially exceeds that attributed to the human auditory periphery. Interestingly, simple spectral filter models failed to predict the neuronal responses to natural stimuli, including speech and music. Thus, natural sounds engage additional processing mechanisms beyond the exquisite frequency tuning probed by the random- chord stimuli.	[Bitterman, Y.; Nelken, I.] Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, IL-91904 Jerusalem, Israel; [Bitterman, Y.; Nelken, I.] Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel; [Mukamel, R.] Univ Calif Los Angeles, David Geffen Sch Med, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90095 USA; [Mukamel, R.; Fried, I.] Univ Calif Los Angeles, David Geffen Sch Med, Div Neurosurg, Los Angeles, CA 90095 USA; [Mukamel, R.; Fried, I.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Malach, R.] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Fried, I.] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Funct Neurosurg Unit, IL-69978 Tel Aviv, Israel; [Fried, I.] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Nelken, I (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, IL-91904 Jerusalem, Israel.	ifried@mednet.ucla.edu; israel@cc.huji.ac.il	Nelken, Israel/B-7753-2011; bitterman, yael/GRS-6144-2022; Mukamel, Roy/AAV-2900-2021	Nelken, Israel/0000-0002-6645-107X; Mukamel, Roy/0000-0001-9359-8950; bitterman, yael/0000-0002-4153-3888	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033221] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS033221, R01 NS033221-10] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Banai K, 2004, AUDIOL NEURO-OTOL, V9, P328, DOI 10.1159/000081282; Banai K, 2006, CEREB CORTEX, V16, P1718, DOI 10.1093/cercor/bhj107; Benasich AA, 2002, BEHAV BRAIN RES, V136, P31, DOI 10.1016/S0166-4328(02)00098-0; Bleeck S, 2004, ACTA ACUST UNITED AC, V90, P781; deCharms RC, 1998, SCIENCE, V280, P1439, DOI 10.1126/science.280.5368.1439; Ehret G, 1997, J COMP PHYSIOL A, V181, P635, DOI 10.1007/s003590050146; EHRET G, 1988, BRAIN RES REV, V13, P139, DOI 10.1016/0165-0173(88)90018-5; EVANS EF, 1977, PSYCHOPHYSICS PHYSL, P185; Fried I, 1999, J NEUROSURG, V91, P697, DOI 10.3171/jns.1999.91.4.0697; Gaese BH, 2001, J NEUROPHYSIOL, V86, P1062, DOI 10.1152/jn.2001.86.2.1062; Heinz MG, 2001, NEURAL COMPUT, V13, P2273, DOI 10.1162/089976601750541804; Howard MA, 1996, BRAIN RES, V724, P260, DOI 10.1016/0006-8993(96)00315-0; Hsu A, 2004, NETWORK-COMP NEURAL, V15, P91, DOI 10.1088/0954-898X/15/2/002; McArthur GM, 2005, BRAIN LANG, V94, P260, DOI 10.1016/j.bandl.2005.01.002; Miller LM, 2002, J NEUROPHYSIOL, V87, P516, DOI 10.1152/jn.00395.2001; MOORE B, 1982, INTRO PSYCHOL HEARIN, P74; Moshitch D, 2006, J NEUROPHYSIOL, V95, P3756, DOI 10.1152/jn.00822.2005; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Nelken I, 2002, SPR HDB AUD, V15, P358; Qin L, 2003, NEUROSCI RES, V46, P145, DOI 10.1016/S0168-0102(03)00034-8; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Read HL, 2001, P NATL ACAD SCI USA, V98, P8042, DOI 10.1073/pnas.131591898; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2315, DOI 10.1152/jn.2000.83.4.2315; Schnupp JWH, 2001, NATURE, V414, P200, DOI 10.1038/35102568; SCHWARZ DWF, 1990, J NEUROPHYSIOL, V64, P282, DOI 10.1152/jn.1990.64.1.282; Theunissen FE, 2000, J NEUROSCI, V20, P2315; Theunissen FE, 2001, NETWORK-COMP NEURAL, V12, P289, DOI 10.1088/0954-898X/12/3/304; Tramo MJ, 2002, J NEUROPHYSIOL, V87, P122, DOI 10.1152/jn.00104.1999; Woolley SMN, 2006, J NEUROSCI, V26, P2499, DOI 10.1523/JNEUROSCI.3731-05.2006	29	124	124	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2008	451	7175					197	U9		10.1038/nature06476	http://dx.doi.org/10.1038/nature06476			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249GA	18185589	Green Accepted			2022-12-28	WOS:000252214400044
J	Woolf, SH				Woolf, Steven H.			The meaning of translational research and why it matters	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							QUALITY; HEALTH		[Woolf, Steven H.] Virginia Commonwealth Univ, Dept Family Med, Richmond, VA 23298 USA; [Woolf, Steven H.] Virginia Commonwealth Univ, Dept Epidemiol, Richmond, VA 23298 USA; [Woolf, Steven H.] Virginia Commonwealth Univ, Dept Community Hlth, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Woolf, SH (corresponding author), Virginia Commonwealth Univ, Dept Family Med, 1200 E Broad St,POB 980251, Richmond, VA 23298 USA.	swoolf@vcu.edu						Adegbola RA, 2005, LANCET, V366, P144, DOI 10.1016/S0140-6736(05)66788-8; Cochrane Collaboration, COCHR EFF PRACT ORG; Davidoff F, 2005, QUAL SAF HEALTH CARE, V14, P319, DOI 10.1136/qshc.2005.014787; Fixsen D.L., 2005, FMHI PUBLICATION, V231; Fontanarosa PB, 2002, JAMA-J AM MED ASSOC, V287, P1728, DOI 10.1001/jama.287.13.1728; Institute of Medicine, 2001, CROSSING QUALITY CHA; KEMER JF, 2006, J CONTIN ED HLTH PRO, V26, P72; Kerner JF, 2005, CANCER CAUSE CONTROL, V16, P27, DOI 10.1007/s10552-005-0488-y; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Mold James W, 2005, Ann Fam Med, V3 Suppl 1, pS12, DOI 10.1370/afm.303; Moses H, 2005, JAMA-J AM MED ASSOC, V294, P1333, DOI 10.1001/jama.294.11.1333; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Sung NS, 2003, JAMA-J AM MED ASSOC, V289, P1278, DOI 10.1001/jama.289.10.1278; TRAVIS K, 2007, SCIENCE         0817; Westfall JM, 2007, JAMA-J AM MED ASSOC, V297, P403, DOI 10.1001/jama.297.4.403; Woolf SH, 2005, ANN FAM MED, V3, P545, DOI 10.1370/afm.406; Woolf SH, 2007, JAMA-J AM MED ASSOC, V297, P523, DOI 10.1001/jama.297.5.523; Zaza S, 2005, GUIDE COMMUNITY PREV	18	1125	1179	4	155	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2008	299	2					211	213		10.1001/jama.2007.26	http://dx.doi.org/10.1001/jama.2007.26			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UN	18182604				2022-12-28	WOS:000252182600022
J	Faucher-Giguere, CA; Lidz, A; Hernquist, L				Faucher-Giguere, Claude-Andre; Lidz, Adam; Hernquist, Lars			Perspective - Numerical simulations unravel the cosmic web	SCIENCE			English	Editorial Material							LYMAN-ALPHA FOREST; ABSORPTION-LINES; POWER SPECTRUM; HYDROGEN; DENSITY	The universe is permeated by a network of filaments, sheets, and knots collectively forming a "cosmic web." The discovery of the cosmic web, especially through its signature of absorption of light from distant sources by neutral hydrogen in the intervening intergalactic medium, exemplifies the interplay between theory and experiment that drives science and is one of the great examples in which numerical simulations have played a key and decisive role. We recount the milestones in our understanding of cosmic structure; summarize its impact on astronomy, cosmology, and physics; and look ahead by outlining the challenges faced as we prepare to probe the cosmic web at new wavelengths.	[Faucher-Giguere, Claude-Andre; Lidz, Adam; Hernquist, Lars] Harvard Univ, Dept Astron, Cambridge, MA 02138 USA	Harvard University	Faucher-Giguere, CA (corresponding author), Harvard Univ, Dept Astron, 60 Garden St, Cambridge, MA 02138 USA.	cgiguere@cfa.harvard.edu	Faucher-Giguere, Claude-Andre/AAC-5298-2019	Lidz, Adam/0000-0002-3950-9598				BAHCALL JN, 1965, ASTROPHYS J, V142, P1677, DOI 10.1086/148460; BAHCALL JN, 1969, ASTROPHYS J, V156, pL7, DOI 10.1086/180337; BERGERON J, 1986, ASTRON ASTROPHYS, V155, pL8; Bond JR, 1996, NATURE, V380, P603, DOI 10.1038/380603a0; BURBIDGE EM, 1966, ASTROPHYS J, V144, P447, DOI 10.1086/148629; Cen RY, 1999, ASTROPHYS J, V514, P1, DOI 10.1086/306949; Croft RAC, 1998, ASTROPHYS J, V495, P44, DOI 10.1086/305289; Dave R, 2001, ASTROPHYS J, V552, P473, DOI 10.1086/320548; Goldreich P., 1976, Comments on Astrophysics. Comments on Modern Physics: Part C, V6, P133; GUNN JE, 1965, ASTROPHYS J, V142, P1633, DOI 10.1086/148444; Hernquist L, 1996, ASTROPHYS J, V457, pL51, DOI 10.1086/309899; KATZ N, 1996, APJ, V457, P57; McDonald P, 2005, ASTROPHYS J, V635, P761, DOI 10.1086/497563; McQuinn M, 2007, MON NOT R ASTRON SOC, V377, P1043, DOI 10.1111/j.1365-2966.2007.11489.x; OSTRIKER JP, 1983, ASTROPHYS J, V268, pL63, DOI 10.1086/184030; Rauch M, 1998, ANNU REV ASTRON ASTR, V36, P267, DOI 10.1146/annurev.astro.36.1.267; Rauch M, 1997, ASTROPHYS J, V489, P7, DOI 10.1086/304765; REES MJ, 1986, MON NOT R ASTRON SOC, V218, pP25, DOI 10.1093/mnras/218.1.25P; SARGENT WLW, 1980, ASTROPHYS J SUPPL S, V42, P41, DOI 10.1086/190644; SCHEUER PAG, 1965, NATURE, V207, P963, DOI 10.1038/207963a0; SCHMIDT M, 1965, ASTROPHYS J, V141, P1295, DOI 10.1086/148217; Seljak U, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.191303; Seljak U, 2006, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2006/10/014; SHKLOVSK.IS, 1965, SOV ASTRON, V8, P638; SMOOT GF, 1992, ASTROPHYS J, V396, pL1, DOI 10.1086/186504; Spergel DN, 2003, ASTROPHYS J SUPPL S, V148, P175, DOI 10.1086/377226; Viel M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.071301; WHITE SDM, 1983, ASTROPHYS J, V274, pL1, DOI 10.1086/184139; Zahn O, 2007, ASTROPHYS J, V654, P12, DOI 10.1086/509597; ZELDOVICH YB, 1970, ASTRON ASTROPHYS, V5, P84	30	11	11	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2008	319	5859					52	55		10.1126/science.1151476	http://dx.doi.org/10.1126/science.1151476			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18174431	Green Submitted			2022-12-28	WOS:000252084000025
J	Garand, E; Zhou, J; Manolopoulos, DE; Alexander, MH; Neumark, DM				Garand, Etienne; Zhou, Jia; Manolopoulos, David E.; Alexander, Millard H.; Neumark, Daniel M.			Nonadiabatic interactions in the Cl+H-2 reaction probed by CIH2- and CID2- photoelectron imaging	SCIENCE			English	Article							BORN-OPPENHEIMER APPROXIMATION; POTENTIAL-ENERGY SURFACES; CHLORINE ATOM REACTION; SPIN-ORBIT REACTIVITY; TRANSITION-STATE; F+H-2 REACTION; SPECTROSCOPY; PHOTODETACHMENT; DYNAMICS; IONS	The degree of electronic and nuclear coupling in the Cl + H-2 reaction has become a vexing problem in chemical dynamics. We report slow electron velocity- map imaging (SEVI) spectra of ClH2- and ClD2-. These spectra probe the reactant valley of the neutral reaction potential energy surface, where nonadiabatic transitions responsible for reactivity of the Cl excited spin- orbit state with H-2 would occur. The SEVI spectra reveal progressions in low- frequency Cl center dot H-2 bending and stretching modes, and are compared to simulations with and without nonadiabatic couplings between the Cl spin- orbit states. Although nonadiabatic effects are small, their inclusion improves agreement with experiment. This comparison validates the theoretical treatment, especially of the nonadiabatic effects, in this critical region of the Cl + H-2 reaction, and suggests strongly that these effects are minor.	[Manolopoulos, David E.] Univ Oxford, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England; [Garand, Etienne; Zhou, Jia; Neumark, Daniel M.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Alexander, Millard H.] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA; [Alexander, Millard H.] Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA; [Neumark, Daniel M.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Chem Sci, Berkeley, CA 94720 USA	University of Oxford; University of California System; University of California Berkeley; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Manolopoulos, DE (corresponding author), Univ Oxford, Phys & Theoret Chem Lab, S Parks Rd, Oxford OX1 3QZ, England.	david.manolopoulos@chem.ox.ac.uk; mha@umd.edu; dneumark@berkeley.edu	Manolopoulos, David/AAV-1276-2021; Neumark, Daniel M/B-9551-2009	Neumark, Daniel M/0000-0002-3762-9473; Manolopoulos, David/0000-0002-7111-0763; Garand, Etienne/0000-0001-5062-5453				Alagia M, 1996, SCIENCE, V273, P1519, DOI 10.1126/science.273.5281.1519; Alexander MH, 2004, FARADAY DISCUSS, V127, P59, DOI 10.1039/b314189f; Alexander MH, 2003, J CHEM PHYS, V118, P9637, DOI 10.1063/1.1533034; ALEXANDER MH, 1994, J CHEM PHYS, V101, P2887, DOI 10.1063/1.468431; Alexander MH, 2002, SCIENCE, V296, P715, DOI 10.1126/science.1070472; Alexander MH, 2000, J CHEM PHYS, V113, P11084, DOI 10.1063/1.1326850; AQUILANTI V, 1980, J CHEM PHYS, V73, P1165, DOI 10.1063/1.440270; Aquilanti V, 2001, J PHYS CHEM A, V105, P2401, DOI 10.1021/jp003782r; Bilodeau RC, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.143001; BRADFORTH SE, 1993, J CHEM PHYS, V99, P6345, DOI 10.1063/1.465873; CAPECCHI G, 2001, PHYS CHEM CHEM PHYS, V6, P1975; CHANDLER DW, 1987, J CHEM PHYS, V87, P1445, DOI 10.1063/1.453276; Che L, 2007, SCIENCE, V317, P1061, DOI 10.1126/science.1144984; DAGDIGIAN PJ, 1987, CHEM REV, V87, P1, DOI 10.1021/cr00077a001; Dong F, 2001, J CHEM PHYS, V115, P1197, DOI 10.1063/1.1378834; DONOVAN RJ, 1970, CHEM REV, V70, P489, DOI 10.1021/cr60266a003; Eppink ATJB, 1997, REV SCI INSTRUM, V68, P3477, DOI 10.1063/1.1148310; Even U, 2000, J CHEM PHYS, V112, P8068, DOI 10.1063/1.481405; Ferguson MJ, 2002, J CHEM PHYS, V117, P8181, DOI 10.1063/1.1518998; HOLMGREN SL, 1977, J CHEM PHYS, V67, P4414, DOI 10.1063/1.434572; Lee SH, 1999, J CHEM PHYS, V111, P6253, DOI 10.1063/1.479930; Manolopoulos DE, 2004, PHYS CHEM CHEM PHYS, V6, P4984, DOI 10.1039/b411391h; MANOLOPOULOS DE, 1993, SCIENCE, V262, P1852, DOI 10.1126/science.262.5141.1852; Neumark DM, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2216709; Neumark DM, 2005, PHYS CHEM CHEM PHYS, V7, P433, DOI 10.1039/b417886f; NIKITIN EE, 1974, THEORY ELEMENTARY AT; Osterwalder A, 2004, J CHEM PHYS, V121, P6317, DOI 10.1063/1.1787491; Shiu W, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.103201; Skouteris D, 1999, SCIENCE, V286, P1713, DOI 10.1126/science.286.5445.1713; WIGNER EP, 1948, PHYS REV, V73, P1002, DOI 10.1103/PhysRev.73.1002; Zhang BL, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1871894; Zhou J, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2748399	32	63	63	2	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2008	319	5859					72	75		10.1126/science.1150602	http://dx.doi.org/10.1126/science.1150602			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18174436				2022-12-28	WOS:000252084000032
J	Morris, SS; Cogill, B; Uauy, R				Morris, Saul S.; Cogill, Bruce; Uauy, Ricardo		Maternal & Child Undernutr Study G	Maternal and Child Undernutrition 5 - Effective international action against undernutrition: why has it proven so difficult and what can be done to accelerate progress?	LANCET			English	Article							HEALTH; EMERGENCY; PRIORITIES; PROGRAMS; QUALITY	Many transnational organisations work to support efforts to eliminate maternal and child undernutrition in high-burden countries. Financial, intellectual, and personal linkages bind these organisations loosely together as components of an international nutrition system. In this paper, we argue that such a system should deliver in four functional areas: stewardship, mobilisation of financial resources, direct provision of nutrition services at times of natural disaster or conflict, and human and institutional resource strengthening. We review quantitative and qualitative data from various sources to assess the performance of the system in each of these areas, and find substantial shortcomings. Fragmentation, lack of an evidence base for prioritised action, institutional inertia, and failure to join up with promising developments in parallel sectors are recurrent themes. Many of these weaknesses can be attributed to systemic problems affecting most organisations working in the field; these are analysed using a problem tree approach. We also make recommendations to overcome some of the most important problems, and we propose five priority actions for the development of a new international architecture.	[Morris, Saul S.; Uauy, Ricardo] Univ London London Sch Hyg & Trop Med, Nutr & Publ Hlth Intervent Res Unit, London WC1E 7HT, England; [Uauy, Ricardo] Int Union Nutr Sci, New York, NY USA; [Cogill, Bruce] UNICEF, New York, NY USA	University of London; London School of Hygiene & Tropical Medicine; UNICEF	Uauy, R (corresponding author), Univ London London Sch Hyg & Trop Med, Nutr & Publ Hlth Intervent Res Unit, Keppel St, London WC1E 7HT, England.	Ricardo.Uauy@LSHTM.ac.uk	Hallal, Pedro C/A-3249-2011	Hallal, Pedro C/0000-0003-1470-6461; Morris, Saul/0000-0002-9372-7342; Kirkwood, Betty/0000-0001-5274-6072	Medical Research Council [G0400519, MC_U147585821, G0400519(71108), U.1475.00.004.00005.01 (85821)] Funding Source: Medline; Medical Research Council [U1475000003] Funding Source: researchfish; MRC [G0400519, MC_U147585821] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AGBLE R, 2005, PANAFRICAN NUTR INIT; Allen L, 2006, GUIDELINES FOOD FORT; [Anonymous], 2005, HUMANITARIAN RESPONS; AusAID, 2005, AUSGUIDELINE 3 3 LOG; BARRETT CB, 2002, 200243 CORN U; Barrett CB, 2005, FOOD AID 50 YEARS RE; BATE R, 2006, AM INTEREST, V1, P113; BERG E, 1993, RETHINKING TECHNICAL; Berruios R., 2000, CONTRACTING DEV ROLE; BHUTTA ZA, 2008, LANCET          0117, DOI DOI 10.1016/S0140-6736(07)61693-6; Bonnard P, 2002, REPORT FOOD AID FOOD; Bouis Howarth E., 2000, Food and Nutrition Bulletin, V21, P374; BRYCE J, 2008, LANCET          0117, DOI DOI 10.1016/S0140-6736(07)61694-8; Bryce J, 2006, LANCET, V368, P817, DOI 10.1016/S0140-6736(06)69299-4; Copeland R, 2002, FOOD NUTR TECHNICAL; Deitchler M, 2007, INT J EPIDEMIOL, V36, P858, DOI 10.1093/ije/dym092; DIAO XE, 2005, 84 MTID INT FOOD POL; Dixit A, 2002, J HUM RESOUR, V37, P696, DOI 10.2307/3069614; *DRN ADE BAAST ECO, 2005, JOINT EV EFF IMP EN; DUFFIELD A, REV PUBLISHED LIT IM; Easterly W., 2002, J POLICY REFORM, V5, P223, DOI DOI 10.1080/1384128032000096823; *EM NUTR NETW, IMPR EFF EM FOOD NJU; *FAO WORLD FOOD PR, 1997, TCPIRQ6713 FAO WORLD; Heaver R, 2006, GOOD WORK BUT NOT EN; Hofmann C.-A., 2004, 17 HPG OV DEV I; HOOGENDOORN A, 2005, OEDE20064 WORLD FOOD; *INT BAB ACT NETW, 2000, BREAK RUL STRETCH RU; *INT HLTH PARTN, GLOB COMP ACH HLTH M; JACOBSTEIN R, 2001, MIDTERM REV MOST PRO; KENNEDY E, 2002, MIDTERM PERFORMANCE; Laxminarayan R, 2006, LANCET, V367, P1193, DOI 10.1016/S0140-6736(06)68440-7; *LEAD EDG GROUP, INT IN IMP EV; Leroy JL, 2007, AM J PUBLIC HEALTH, V97, P219, DOI 10.2105/AJPH.2005.083287; Llanos A, 2008, PUBLIC HEALTH NUTR, V11, P466, DOI 10.1017/S1368980007000730; Maleta K., 2004, J PEDIAT GASTROENTER, V38, P143; Maluccio J, 2005, 141 IFPRI; Marchione TJ, 2002, J NUTR, V132, p2104S, DOI 10.1093/jn/132.7.2104S; MASON F, 2003, REV ADV CHALLENGES N; Maxwell D, 2003, DISASTERS, V27, P72, DOI 10.1111/1467-7717.00220; Mcmichael A.J., 2003, ATL HLTH CLIM; *MEST ASS CAN, 2006, STAK PERC AN 10 YEAR; Mukuria A.G., 2006, INFANT YOUNG CHILD F; Myatt M, 2005, B WORLD HEALTH ORGAN, V83, P20; National Academies Committee on Facilitating Interdisciplinary Research (CFIR) and Committee on Science Engineering and Public Policy (COSEPUP), 2005, FAC INT RES; Nielsen J, 2004, AM J CLIN NUTR, V80, P1036, DOI 10.1093/ajcn/80.4.1036; *OECD DEV ASS COMM, 2004, AN AID SUPP HIV AIDS; *ORG EC COOP DEV, 2006, DEV EFF FOOD AID DOE; *ORG EC COOP DEV, PEER REV DAC MEMB; Pelletier D. L., 1999, Agriculture and Human Values, V16, P401, DOI 10.1023/A:1007651801471; PELLETIER DL, 2002, NUTR FDN DEV; Pielemeier John, 2003, ASSESSMENT BASIC SUP; Prinzo ZW, 2002, P NUTR SOC, V61, P251, DOI 10.1079/PNS2002151; Robertson SE, 2006, SOC SCI MED, V63, P1648, DOI 10.1016/j.socscimed.2006.04.011; Salama P, 2004, LANCET, V364, P1801, DOI 10.1016/S0140-6736(04)17405-9; Saltman RB, 2000, B WORLD HEALTH ORGAN, V78, P732; Selwitz Robert H, LANCET, V369, P51, DOI [10.1016/s0140-6736(07)60031-2, DOI 10.1016/S0140-6736(07)60031-2, DOI 10.1016/S0140-6736(07)61690-0]; Shrimpton R, 2002, UNICEF NUTR PORTFOLI; Simondon KB, 1996, AM J CLIN NUTR, V64, P537, DOI 10.1093/ajcn/64.4.537; Skoufias E., 2005, 139 IFPRI; Slaughter S., 2004, ACAD CAPITALISM NEW; Smith L.C., 2000, EXPLAINING CHILD MAL; Sphere Project, HUM CHART MIN STAND; Spiegel PB, 2004, JAMA-J AM MED ASSOC, V292, P613, DOI 10.1001/jama.292.5.613; STODDARD A, 2003, EXTERNAL REV INTERAG; *UN, 2001, A56326 UN GEN ASS; *UN FAO, WORLD FOOD SUMM PLAN; *UN INT SECR INT S, 2006, GLOB SURV EARL WARN; *UN INT STAND COMM, NUTR CLUST; *UNICEF, GOALS CHILDR DEV 199; UNICEF data, 2006, PROGR CHILDR REP CAR; UNICEF WHO, 2003, GLOB STRAT INF YOUNG; *US GOV ACC OFF, 2007, FOOD ASS VAR CHALL I; Vautier F, 1999, TROP MED INT HEALTH, V4, P875, DOI 10.1046/j.1365-3156.1999.00495.x; VICTORA CG, 2008, LANCET          0117, DOI DOI 10.1016/S0140-6736(07)61692-4; *WHO, 2006, A5920 WHO WORLD HOLT; *WHO, MICR DEF INF SYST; WHO, 2003, INF YOUNG CHILD FEED; *WHO DEP IMM, 2007, WHO VACC POS PAP; WHO/FAO, 2005, UND COD AL; World Bank, 2012, WORLD DEV IND GLOB D; World Health Organization, 2000, WORLD HLTH REP 2000; World Health Organization, GLOB DAT BOD MASS IN; Young H, 2004, LANCET, V364, P1899, DOI 10.1016/S0140-6736(04)17447-3; 1997, FOOD NUTR B, V18, P4	84	157	161	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 16	2008	371	9612					608	621		10.1016/S0140-6736(07)61695-X	http://dx.doi.org/10.1016/S0140-6736(07)61695-X			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263FI	18206225				2022-12-28	WOS:000253202600028
J	Brass, AL; Dykxhoorn, DM; Benita, Y; Yan, N; Engelman, A; Xavier, RJ; Lieberman, J; Elledge, SJ				Brass, Abraham L.; Dykxhoorn, Derek M.; Benita, Yair; Yan, Nan; Engelman, Alan; Xavier, Ramnik J.; Lieberman, Judy; Elledge, Stephen J.			Identification of host proteins required for HIV infection through a functional genomic screen	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; N-LINKED GLYCOSYLATION; ENDOPLASMIC-RETICULUM; NUCLEAR IMPORT; SNARE TLG1P; LATE GOLGI; COMPLEX; GLYCOPROTEINS; TRANSPORT; CXCR4	HIV- 1 exploits multiple host proteins during infection. We performed a large- scale small interfering RNA screen to identify host factors required by HIV- 1 and identified more than 250 HIV- dependency factors ( HDFs). These proteins participate in a broad array of cellular functions and implicate new pathways in the viral life cycle. Further analysis revealed previously unknown roles for retrograde Golgi transport proteins ( Rab6 and Vps53) in viral entry, a karyopherin ( TNPO3) in viral integration, and the Mediator complex ( Med28) in viral transcription. Transcriptional analysis revealed that HDF genes were enriched for high expression in immune cells, suggesting that viruses evolve in host cells that optimally perform the functions required for their life cycle. This effort illustrates the power with which RNA interference and forward genetics can be used to expose the dependencies of human pathogens such as HIV, and in so doing identify potential targets for therapy.	[Brass, Abraham L.; Elledge, Stephen J.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Brigham & Womens Hosp,Dept Genet,Ctr Genet & Geno, Boston, MA 02115 USA; [Brass, Abraham L.; Xavier, Ramnik J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Dykxhoorn, Derek M.; Yan, Nan; Lieberman, Judy] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Dykxhoorn, Derek M.; Yan, Nan; Lieberman, Judy] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Benita, Yair; Xavier, Ramnik J.] Harvard Univ, Sch Med, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Engelman, Alan] Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Aids, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Elledge, SJ (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Brigham & Womens Hosp,Dept Genet,Ctr Genet & Geno, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu	Dykxhoorn, Derek M/D-1357-2015; Abrams, William R/A-5782-2008; Lieberman, Judy/A-2717-2015; Benita, Yair/E-3094-2012		Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [U19-AI056900, P30 AI060354, AI062773, AI052014] Funding Source: Medline; NIDDK NIH HHS [P30 DK040561-13, P30 DK040561] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062773, R01AI052014, U19AI056900, P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allemand E, 2002, MOL BIOL CELL, V13, P2436, DOI 10.1091/mbc.E02-02-0102; Ashida H, 2006, J BIOL CHEM, V281, P896, DOI 10.1074/jbc.M511311200; Balzarini J, 2007, NAT REV MICROBIOL, V5, P583, DOI 10.1038/nrmicro1707; BLOUGH HA, 1986, BIOCHEM BIOPH RES CO, V141, P33, DOI 10.1016/S0006-291X(86)80330-8; Chabot DJ, 2000, J VIROL, V74, P4404, DOI 10.1128/JVI.74.9.4404-4413.2000; Conde R, 2003, YEAST, V20, P1189, DOI 10.1002/yea.1032; Conibear E, 2000, MOL BIOL CELL, V11, P305, DOI 10.1091/mbc.11.1.305; Del Nery E, 2006, TRAFFIC, V7, P394, DOI 10.1111/j.1600-0854.2006.00395.x; Erkmann JA, 2005, MOL BIOL CELL, V16, P2960, DOI 10.1091/mbc.E04-11-1023; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Folkman J, 2006, EXP CELL RES, V312, P594, DOI 10.1016/j.yexcr.2005.11.015; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; Girod A, 1999, NAT CELL BIOL, V1, P423, DOI 10.1038/15658; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Harel A, 2003, MOL CELL, V11, P853, DOI 10.1016/S1097-2765(03)00116-3; Hug P, 2000, J VIROL, V74, P6377, DOI 10.1128/JVI.74.14.6377-6385.2000; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kim YG, 2006, CELL, V127, P817, DOI 10.1016/j.cell.2006.09.029; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; Luo ZL, 2003, J BIOL CHEM, V278, P791, DOI 10.1074/jbc.M209120200; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Murray JL, 2005, J VIROL, V79, P11742, DOI 10.1128/JVI.79.18.11742-11751.2005; Nehete PN, 2002, ANTIVIR RES, V56, P233, DOI 10.1016/S0166-3542(02)00130-4; Puri A, 2004, AIDS, V18, P849, DOI 10.1097/00002030-200404090-00002; Quenneville NR, 2006, MOL BIOL CELL, V17, P1859, DOI 10.1091/mbc.E05-11-1002; Sabri N, 2007, J CELL BIOL, V178, P557, DOI 10.1083/jcb.200612135; Siniossoglou S, 2000, EMBO J, V19, P4885, DOI 10.1093/emboj/19.18.4885; Siniossoglou S, 2002, J BIOL CHEM, V277, P48318, DOI 10.1074/jbc.M209428200; Siniossoglou S, 2001, EMBO J, V20, P5991, DOI 10.1093/emboj/20.21.5991; Ungar D, 2006, TRENDS CELL BIOL, V16, P113, DOI 10.1016/j.tcb.2005.12.004; Wang JB, 2004, VIROLOGY, V324, P140, DOI 10.1016/j.virol.2004.03.005; Wolk T, 2006, MED MICROBIOL IMMUN, V195, P165, DOI 10.1007/s00430-006-0016-z	35	1101	1155	2	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2008	319	5865					921	926		10.1126/science.1152725	http://dx.doi.org/10.1126/science.1152725			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	262RM	18187620				2022-12-28	WOS:000253165700037
J	Lutz, W; Sanderson, W; Scherbov, S				Lutz, Wolfgang; Sanderson, Warren; Scherbov, Sergei			The coming acceleration of global population ageing	NATURE			English	Article							DEMOGRAPHY; LIMITS	The future paths of population ageing result from specific combinations of declining fertility and increasing life expectancies in different parts of the world(1). Here we measure the speed of population ageing by using conventional measures and new ones that take changes in longevity into account for the world as a whole and for 13 major regions. We report on future levels of indicators of ageing and the speed at which they change. We show how these depend on whether changes in life expectancy are taken into account. We also show that the speed of ageing is likely to increase over the coming decades and to decelerate in most regions by mid-century. All our measures indicate a continuous ageing of the world's population throughout the century. The median age of the world's population increases from 26.6 years in 2000 to 37.3 years in 2050 and then to 45.6 years in 2100, when it is not adjusted for longevity increase. When increases in life expectancy are taken into account(2,3), the adjusted median age rises from 26.6 in 2000 to 31.1 in 2050 and only to 32.9 in 2100, slightly less than what it was in the China region in 2005. There are large differences in the regional patterns of ageing. In North America, the median age adjusted for life expectancy change falls throughout almost the entire century, whereas the conventional median age increases significantly. Our assessment of trends in ageing is based on new probabilistic population forecasts. The probability that growth in the world's population will end during this century is 88%, somewhat higher than previously assessed(4). After mid- century, lower rates of population growth are likely to coincide with slower rates of ageing.	[Lutz, Wolfgang; Sanderson, Warren; Scherbov, Sergei] Int Inst Appl Syst Anal, World Populat Program, A-2361 Laxenburg, Austria; [Lutz, Wolfgang; Scherbov, Sergei] Austrian Acad Sci, Vienna Inst Demog, A-1040 Vienna, Austria; [Sanderson, Warren] SUNY Stony Brook, Dept Econ, Stony Brook, NY 11794 USA; [Sanderson, Warren] SUNY Stony Brook, Dept Hist, Stony Brook, NY 11794 USA	International Institute for Applied Systems Analysis (IIASA); Austrian Academy of Sciences; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Lutz, W (corresponding author), Int Inst Appl Syst Anal, World Populat Program, Schlosspl 1, A-2361 Laxenburg, Austria.	lutz@iiasa.ac.at	Scherbov, Sergey/F-3158-2019; Sanderson, Warren/R-3398-2019	Scherbov, Sergey/0000-0001-5902-3790; Scherbov, Sergei/0000-0002-0881-1073; Lutz, Wolfgang/0000-0001-7975-8145; Sanderson, Warren/0000-0002-2205-948X				Bongaarts J, 2006, POPUL DEV REV, V32, P605, DOI 10.1111/j.1728-4457.2006.00144.x; Carnes BA, 2007, POPUL DEV REV, V33, P367, DOI 10.1111/j.1728-4457.2007.00172.x; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Harper S., 2006, AGEING SOC MYTHS CHA; HERSCH L, 1944, DEMOGRAPHIE ACTUELLE; Keilman N., 1997, J STAT STOCKHOLM, V13, P245; LEE RD, 1992, J AM STAT ASSOC, V87, P659, DOI 10.2307/2290201; Lutz W, 2001, NATURE, V412, P543, DOI 10.1038/35087589; Lutz W, 2004, END WORLD POPULATION, P17; MANTON KG, 1991, POPUL DEV REV, V17, P603, DOI 10.2307/1973599; National Research Council, 2000, 6 BILL FOR WORLDS PO; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Panush N, 1996, EUR J POPUL, V12, P27, DOI 10.1007/BF01797164; RYDER NB, 1975, POPUL INDEX, V41, P3, DOI 10.2307/2734140; Sanderson WC, 2007, DEMOGR RES, V16, P27, DOI 10.4054/DemRes.2007.16.2; Sanderson WC, 2005, NATURE, V435, P811, DOI 10.1038/nature03593; Scherbov Sergei, 2007, VIENNA YB POPULATION, V5, P37, DOI DOI 10.1553/POPULATIONYEARBOOK2007S37; UN, 2004, WORLD POP 2300; United Nations, 2007, WORLD POP AG 2007	19	800	822	9	204	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2008	451	7179					716	719		10.1038/nature06516	http://dx.doi.org/10.1038/nature06516			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259HD	18204438				2022-12-28	WOS:000252929500041
J	Ishii, HA; Bradley, JP; Dai, ZR; Chi, MF; Kearsley, AT; Burchell, MJ; Browning, ND; Molster, F				Ishii, Hope A.; Bradley, John P.; Dai, Zu Rong; Chi, Miaofang; Kearsley, Anton T.; Burchell, Mark J.; Browning, Nigel D.; Molster, Frank			Comparison of comet 81P/Wild 2 dust with interplanetary dust from comets	SCIENCE			English	Article							STARDUST; MINERALOGY; SAMPLES; GRAINS	The Stardust mission returned the first sample of a known outer solar system body, comet 81P/Wild 2, to Earth. The sample was expected to resemble chondritic porous interplanetary dust particles because many, and possibly all, such particles are derived from comets. Here, we report that the most abundant and most recognizable silicate materials in chondritic porous interplanetary dust particles appear to be absent from the returned sample, indicating that indigenous outer nebula material is probably rare in 81P/Wild 2. Instead, the sample resembles chondritic meteorites from the asteroid belt, composed mostly of inner solar nebula materials. This surprising finding emphasizes the petrogenetic continuum between comets and asteroids and elevates the astrophysical importance of stratospheric chondritic porous interplanetary dust particles as a precious source of the most cosmically primitive astromaterials.	[Ishii, Hope A.; Bradley, John P.; Dai, Zu Rong; Chi, Miaofang; Browning, Nigel D.] Lawrence Livermore Natl Lab, Inst Geophys & Planetary Phys, Livermore, CA 94550 USA; [Chi, Miaofang; Browning, Nigel D.] Univ Calif Davis, Dept Chem Engn & Mat Sci, Davis, CA 95616 USA; [Kearsley, Anton T.] Nat Hist Museum, Dept Mineral, London SW7 5BD, England; [Burchell, Mark J.] Univ Kent, Sch Phys Sci, Canterbury CT2 7NH, Kent, England; [Molster, Frank] NWO, NL-2593 HW The Hague, Netherlands	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Davis; Natural History Museum London; University of Kent	Ishii, HA (corresponding author), Lawrence Livermore Natl Lab, Inst Geophys & Planetary Phys, Livermore, CA 94550 USA.	hope.ishii@llnl.gov	Dai, Zurong/E-6732-2010; Chi, Miaofang/Y-3603-2019; Chi, Miaofang/Q-2489-2015	Chi, Miaofang/0000-0003-0764-1567; Chi, Miaofang/0000-0003-0764-1567; Browning, Nigel/0000-0003-0491-251X; Ishii, Hope/0000-0002-7976-5078; Dai, Zurong/0000-0002-4209-8718; Burchell, Mark/0000-0002-2680-8943	Science and Technology Facilities Council [ST/F003153/1] Funding Source: researchfish; STFC [ST/F003153/1] Funding Source: UKRI	Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Bradley JP, 2005, TREATISE GEOCHEM, V1, P689; BRADLEY JP, 1994, SCIENCE, V265, P925, DOI 10.1126/science.265.5174.925; BRADLEY JP, 1983, NATURE, V301, P473, DOI 10.1038/301473a0; Brownlee D.E., 1995, LUNAR PLANET SCI, P183; Brownlee DE, 2000, METEORIT PLANET SCI, V35, pA35; Brownlee DE, 2005, TREATISE GEOCHEM, V1, P663; Brownlee D, 2006, SCIENCE, V314, P1711, DOI 10.1126/science.1135840; CHI M, 2007, LUNAR PLANET SCI, V38, P2010; Dai ZR, 2001, GEOCHIM COSMOCHIM AC, V65, P3601, DOI 10.1016/S0016-7037(01)00692-5; Festou C.M., 2004, COMETS 2; FRAUNDORF P, 1981, LUNAR PLANET SCI, V12, P292; Hsieh HH, 2006, SCIENCE, V312, P561, DOI 10.1126/science.1125150; Joswiak DJ, 2007, METEORIT PLANET SCI, V42, pA78; Kearsley AT, 2007, METEORIT PLANET SCI, V42, P191, DOI 10.1111/j.1945-5100.2007.tb00227.x; Keller LP, 2006, SCIENCE, V314, P1728, DOI 10.1126/science.1135796; Keller LP, 2000, J GEOPHYS RES-SPACE, V105, P10397, DOI 10.1029/1999JA900395; KELLER LP, 1994, ANAL INTERPLANETARY, P51; Krolikowska M, 2006, ASTRON ASTROPHYS, V448, P401, DOI 10.1051/0004-6361:20053756; Matrajt G, 2007, METEORIT PLANET SCI, V42, pA99; McKeegan KD, 2006, SCIENCE, V314, P1724, DOI 10.1126/science.1135992; Messenger S, 2003, SCIENCE, V300, P105, DOI 10.1126/science.1080576; Messenger S, 2000, NATURE, V404, P968, DOI 10.1038/35010053; NGUYEN AN, 2007, LUNAR PLANET SCI, V38, P2332; Noguchi T, 2007, METEORIT PLANET SCI, V42, P357, DOI 10.1111/j.1945-5100.2007.tb00239.x; WEISBERG M, 2006, EOS, V87; WOOD JA, 1989, NASA C PUB, P61; Zolensky ME, 2006, SCIENCE, V314, P1735, DOI 10.1126/science.1135842	28	205	205	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2008	319	5862					447	450		10.1126/science.1150683	http://dx.doi.org/10.1126/science.1150683			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254HB	18218892				2022-12-28	WOS:000252576600033
J	de Moya, MA; Reisner, AT; LaMuraglia, GM; Kalva, SP				de Moya, Marc A.; Reisner, Andrew T.; LaMuraglia, Glenn M.; Kalva, Sanjeeva P.			A man with sudden onset of abdominal pain and hypotension - Celiac-artery stenosis and multiple aneurysms of the pancreaticoduodenal arcade, with rupture	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IRREVERSIBLE HEMORRHAGIC SHOCK; DAMAGE CONTROL RESUSCITATION; FLUID RESUSCITATION; VOLUME REPLACEMENT; CARDIAC MECHANISM; FLOW-RATE; COAGULOPATHY; MANAGEMENT; PRESSURE; TRAUMA		[de Moya, Marc A.] Massachusetts Gen Hosp, Div Trauma Emergency Surg & Surg Crit Care, Boston, MA 02114 USA; [LaMuraglia, Glenn M.] Massachusetts Gen Hosp, Div Vasc & Endovasc Surg, Boston, MA 02114 USA; [Reisner, Andrew T.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Kalva, Sanjeeva P.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [de Moya, Marc A.; LaMuraglia, Glenn M.] Harvard Univ, Sch Med, Gen Surg Serv, Cambridge, MA 02138 USA; [Reisner, Andrew T.] Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; [Kalva, Sanjeeva P.] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	de Moya, MA (corresponding author), Massachusetts Gen Hosp, Div Trauma Emergency Surg & Surg Crit Care, Boston, MA 02114 USA.							Alam HB, 2006, SCAND J SURG, V95, P136, DOI 10.1177/145749690609500302; [Anonymous], 2000, MANUAL EMERGENCY AIR, V1, P8; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; CAPONE AC, 1995, J AM COLL SURGEONS, V180, P49; Coll DP, 1998, ANN VASC SURG, V12, P286, DOI 10.1007/s100169900155; CROWELL JW, 1961, AM J PHYSIOL, V201, P893, DOI 10.1152/ajplegacy.1961.201.5.893; CROWELL JW, 1962, AM J PHYSIOL, V203, P248, DOI 10.1152/ajplegacy.1962.203.2.248; de Perrot M, 1999, ANN SURG, V229, P416, DOI 10.1097/00000658-199903000-00016; DELAROCHE MRP, 1993, ANN EMERG MED, V22, P1551, DOI 10.1016/S0196-0644(05)81257-0; Ducasse E, 2004, J VASC SURG, V39, P906, DOI 10.1016/j.jvs.2003.09.049; DULA DJ, 1981, J TRAUMA, V21, P480; Dutton RP, 2002, J TRAUMA, V52, P1141, DOI 10.1097/00005373-200206000-00020; HADDY FJ, 1965, AM J PHYSIOL, V208, P169, DOI 10.1152/ajplegacy.1965.208.1.169; Hess JR, 2006, TRANSFUSION, V46, P685, DOI 10.1111/j.1537-2995.2006.00816.x; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; HYMAN SA, 1991, ANESTH ANALG, V73, P573; Kalva SP, 2007, EUR J VASC ENDOVASC, V33, P670, DOI 10.1016/j.ejvs.2006.12.021; Kohane IS, 1996, J AM MED INFORM ASSN, V3, P191, DOI 10.1136/jamia.1996.96310633; KOWALENKO T, 1992, J TRAUMA, V33, P349, DOI 10.1097/00005373-199209000-00003; Landry DW, 2001, NEW ENGL J MED, V345, P588, DOI 10.1056/NEJMra002709; Mandl KD, 2001, BMJ-BRIT MED J, V322, P283, DOI 10.1136/bmj.322.7281.283; MATEER JR, 1983, ANN EMERG MED, V12, P149, DOI 10.1016/S0196-0644(83)80556-3; MCGOWAN P, 1995, BRIT J ANAESTH, V75, P777, DOI 10.1093/bja/75.6.777; MILLIKAN JS, 1984, J TRAUMA, V24, P428, DOI 10.1097/00005373-198405000-00010; Moore EE, 1996, AM J SURG, V172, P405, DOI 10.1016/S0002-9610(96)00216-4; PRIST R, 1994, SHOCK, V1, P188, DOI 10.1097/00024382-199403000-00006; STERN SA, 1993, ANN EMERG MED, V22, P155, DOI 10.1016/S0196-0644(05)80195-7; URETSKY BF, 1977, AM J CARDIOL, V40, P498, DOI 10.1016/0002-9149(77)90062-5; WILSON RF, 1992, AM SURGEON, V58, P535	29	4	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2008	358	2					178	186		10.1056/NEJMcpc0707327	http://dx.doi.org/10.1056/NEJMcpc0707327			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249CJ	18184964				2022-12-28	WOS:000252204200011
J	Percy, MJ; Furlow, PW; Lucas, GS; Li, XP; Lappin, TRJ; McMullin, MF; Lee, FS				Percy, Melanie J.; Furlow, Paul W.; Lucas, Guy S.; Li, Xiping; Lappin, Terence R. J.; McMullin, Mary Frances; Lee, Frank S.			A gain-of-function mutation in the HIF2A gene in familial erythrocytosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HYPOXIA-INDUCIBLE FACTOR; CONGENITAL POLYCYTHEMIA; OXYGEN HOMEOSTASIS; IN-VIVO; ERYTHROPOIETIN; MICE; FACTOR-1-ALPHA; HYDROXYLATION; INACTIVATION; PHD2	Hypoxia-inducible factor (HIF) alpha, which has three isoforms, is central to the continuous balancing of the supply and demand of oxygen throughout the body. HIF-alpha is a transcription factor that modulates a wide range of processes, including erythropoiesis, angiogenesis, and cellular metabolism. We describe a family with erythrocytosis and a mutation in the HIF2A gene, which encodes the HIF-2 alpha protein. Our functional studies indicate that this mutation leads to stabilization of the HIF-2 alpha protein and suggest what wild-type HIF-2 alpha regulates erythropoietin production in adults.	[Percy, Melanie J.] Belfast City Hosp, Dept Haematol, Belfast BT9 7AB, Antrim, North Ireland; [Lappin, Terence R. J.; McMullin, Mary Frances] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Furlow, Paul W.; Li, Xiping; Lee, Frank S.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Stellar Chance Labs 605, Philadelphia, PA 19104 USA; [Lucas, Guy S.] Manchester Royal Infirm, Manchester M13 9WL, Lancs, England	Belfast City Hospital; Queens University Belfast; University of Pennsylvania; University of Manchester	Percy, MJ (corresponding author), Belfast City Hosp, Dept Haematol, Floor C,Tower Block,Lisburn Rd, Belfast BT9 7AB, Antrim, North Ireland.	melanie.percy@belfasttrust.hscni.net; franklee@mail.med.upenn.edu	McMullin, Mary F/AAF-6472-2020; McMullin, Mary Frances/AAG-6078-2021	McMullin, Mary Frances/0000-0002-0773-0204; Furlow, Paul/0000-0002-0754-4962; Lee, Frank/0000-0003-2511-1834	NATIONAL CANCER INSTITUTE [R01CA090261] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA090261-05, R01 CA090261] Funding Source: Medline; PHS HHS [R01 C090261] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ang SO, 2002, NAT GENET, V32, P614, DOI 10.1038/ng1019; Bunn HF, 2007, BLOOD, V109, P868, DOI 10.1182/blood-2006-08-019083; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Grimm C, 2002, NAT MED, V8, P718, DOI 10.1038/nm723; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Huang JH, 2007, BIOCHEM J, V401, P341, DOI 10.1042/BJ20060635; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; Kim WY, 2006, EMBO J, V25, P4650, DOI 10.1038/sj.emboj.7601300; Lee FS, 2006, CELL CYCLE, V5, P941, DOI 10.4161/cc.5.9.2723; McMullin MF, 2005, BRIT J HAEMATOL, V130, P174, DOI 10.1111/j.1365-2141.2005.05535.x; Pastore YD, 2003, BLOOD, V101, P1591, DOI 10.1182/blood-2002-06-1843; Percy MJ, 2007, BLOOD, V110, P2193, DOI 10.1182/blood-2007-04-084434; Percy MJ, 2006, P NATL ACAD SCI USA, V103, P654, DOI 10.1073/pnas.0508423103; Percy MJ, 2003, BLOOD, V102, P1097, DOI 10.1182/blood-2002-10-3246; Percy MJ, 1998, BRIT J HAEMATOL, V100, P407, DOI 10.1046/j.1365-2141.1998.00550.x; Rankin EB, 2005, MOL CELL BIOL, V25, P3163, DOI 10.1128/MCB.25.8.3163-3172.2005; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Scortegagna M, 2003, BLOOD, V102, P1634, DOI 10.1182/blood-2003-02-0448; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88; Yoon D, 2006, J BIOL CHEM, V281, P25703, DOI 10.1074/jbc.M602329200; Yu AY, 1999, J CLIN INVEST, V103, P691, DOI 10.1172/JCI5912	25	237	262	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2008	358	2					162	168		10.1056/NEJMoa073123	http://dx.doi.org/10.1056/NEJMoa073123			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249CJ	18184961	Green Accepted			2022-12-28	WOS:000252204200007
J	Sanai, N; Mirzadeh, Z; Berger, MS				Sanai, Nader; Mirzadeh, Zaman; Berger, Mitchel S.			Functional outcome after language mapping for glioma resection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CENTRAL-NERVOUS-SYSTEM; LOW-GRADE; PROGNOSTIC-FACTORS; CORTICAL LOCALIZATION; MOTOR CORTEX; BRAIN-TUMORS; ASTROCYTOMAS; ADULTS; REORGANIZATION; COMPLICATIONS	Background: Language sites in the cortex of the brain vary among patients. Language mapping while the patient is awake is an intraoperative technique designed to minimize language deficits associated with brain-tumor resection. Methods: To study language function after brain-tumor resection with language mapping, we examined 250 consecutive patients with gliomas. Positive language sites (i.e., language regions in the cortex of the brain, 1 cm by 1 cm, which were temporarily inactivated by means of a bipolar electrode) were identified and categorized into cortical language maps. The tumors were resected up to 1 cm from the cortical areas where intraoperative stimulation produced a disturbance in language. Our resection strategy did not require identification of the stimulation-induced language sites within the field of exposure. Results: A total of 145 of the 250 patients (58.0%) had at least one site with an intraoperative stimulation-induced speech arrest, 82 patients had anomia, and 23 patients had alexia. Overall, 3094 of 3281 cortical sites (94.3%) were not associated with stimulation-induced language deficits. A total of 159 patients (63.6%) had intact speech preoperatively. One week after surgery, baseline language function remained in 194 patients (77.6%), it worsened in 21 patients (8.4%), and 35 patients (14.0%) had new speech deficits. However, 6 months after surgery, only 4 of 243 surviving patients (1.6%) had a persistent language deficit. Cortical maps generated with intraoperative language data also showed surprising variability in language localization within the dominant hemisphere. Conclusions: Craniotomies tailored to limit cortical exposure, even without localization of positive language sites, permit most gliomas to be aggressively resected without language deficits. The composite language maps generated in our study suggest that our current models of human language organization insufficiently account for observed language function.	Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Brain Tumor Res Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Sanai, N (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 505 Parnassus Ave,M-779, San Francisco, CA 94143 USA.	sanain@neurosurg.ucsf.edu						BERKER EA, 1986, ARCH NEUROL-CHICAGO, V43, P1065, DOI 10.1001/archneur.1986.00520100069017; Brell M, 2000, ACTA NEUROCHIR, V142, P739, DOI 10.1007/s007010070088; Brown PD, 2005, NEUROSURGERY, V57, P495, DOI 10.1227/01.NEU.0000170562.25335.C7; Buckner JC, 2001, CANCER-AM CANCER SOC, V92, P420, DOI 10.1002/1097-0142(20010715)92:2<420::AID-CNCR1338>3.0.CO;2-3; Chang SM, 2003, J NEUROSURG, V98, P1175, DOI 10.3171/jns.2003.98.6.1175; CHOLLET F, 1991, ANN NEUROL, V29, P63, DOI 10.1002/ana.410290112; CIRIC I, 1987, NEUROSURGERY, V21, P21, DOI 10.1227/00006123-198707000-00005; DEVAUX BC, 1993, J NEUROSURG, V78, P767, DOI 10.3171/jns.1993.78.5.0767; Duffau H, 1999, ACTA NEUROCHIR, V141, P1157, DOI 10.1007/s007010050413; Fandino J, 1999, J NEUROSURG, V91, P238, DOI 10.3171/jns.1999.91.2.0238; Farias ST, 2005, AM J NEURORADIOL, V26, P2492; GRADY MS, 1989, J NEUROSURG, V71, P534, DOI 10.3171/jns.1989.71.4.0534; HAGLUND MM, 1994, NEUROSURGERY, V34, P567, DOI 10.1227/00006123-199404000-00001; Herholz K, 1996, NEUROIMAGE, V3, P185, DOI 10.1006/nimg.1996.0020; Kowalczuk A, 1997, NEUROSURGERY, V41, P1028, DOI 10.1097/00006123-199711000-00004; Leighton C, 1997, J CLIN ONCOL, V15, P1294, DOI 10.1200/JCO.1997.15.4.1294; Nicolato A, 1995, SURG NEUROL, V44, P208, DOI 10.1016/0090-3019(95)00184-0; OJEMANN G, 1989, J NEUROSURG, V71, P316, DOI 10.3171/jns.1989.71.3.0316; Ojemann G. A., 1990, SEMINARS NEUROSCIENC, V2, P297; OJEMANN GA, 1978, BRAIN LANG, V6, P239, DOI 10.1016/0093-934X(78)90061-5; OJEMANN GA, 1979, J NEUROSURG, V50, P164, DOI 10.3171/jns.1979.50.2.0164; OJEMANN GA, 1991, J NEUROSCI, V11, P2281; Ojemann JG, 1996, NEUROSURGERY, V39, P253, DOI 10.1097/00006123-199608000-00003; Peraud A, 1998, ACTA NEUROCHIR, V140, P1213, DOI 10.1007/s007010050241; PHILIPPON JH, 1993, NEUROSURGERY, V32, P554; Sartorius CJ, 1998, J NEUROSURG, V88, P349, DOI 10.3171/jns.1998.88.2.0349; Sawaya R, 1998, NEUROSURGERY, V42, P1044, DOI 10.1097/00006123-199805000-00054; Scerrati M, 1996, J NEUROL NEUROSUR PS, V61, P291, DOI 10.1136/jnnp.61.3.291; SEITZ RJ, 1995, NEUROREPORT, V6, P742, DOI 10.1097/00001756-199503270-00009; Skirboll SS, 1996, NEUROSURGERY, V38, P678, DOI 10.1227/00006123-199604000-00008; Stark AM, 2005, SURG NEUROL, V63, P162, DOI 10.1016/j.surneu.2004.01.028; Taylor MD, 1999, J NEUROSURG, V90, P35, DOI 10.3171/jns.1999.90.1.0035; Tortosa A, 2003, CANCER, V97, P1063, DOI 10.1002/cncr.11120; Vorster S J, 1998, Neurosurg Focus, V4, pe2; WEDER B, 1994, NEUROREPORT, V5, P457, DOI 10.1097/00001756-199401120-00022; Wunderlich G, 1998, NEUROSURGERY, V42, P18, DOI 10.1097/00006123-199801000-00005	36	679	711	0	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2008	358	1					18	27		10.1056/NEJMoa067819	http://dx.doi.org/10.1056/NEJMoa067819			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	246TW	18172171				2022-12-28	WOS:000252031200004
J	Huang, B; Wang, WQ; Bates, M; Zhuang, XW				Huang, Bo; Wang, Wenqin; Bates, Mark; Zhuang, Xiaowei			Three-dimensional super-resolution imaging by stochastic optical reconstruction microscopy	SCIENCE			English	Article							FLUORESCENCE NANOSCOPY; AXIAL RESOLUTION; LOCALIZATION; TRACKING; PROBES; ENDOCYTOSIS; PRECISION; MOLECULES; EMITTERS; CELLS	Recent advances in far- field fluorescence microscopy have led to substantial improvements in image resolution, achieving a near- molecular resolution of 20 to 30 nanometers in the two lateral dimensions. Three- dimensional ( 3D) nanoscale- resolution imaging, however, remains a challenge. We demonstrated 3D stochastic optical reconstruction microscopy ( STORM) by using optical astigmatism to determine both axial and lateral positions of individual fluorophores with nanometer accuracy. Iterative, stochastic activation of photoswitchable probes enables high- precision 3D localization of each probe, and thus the construction of a 3D image, without scanning the sample. Using this approach, we achieved an image resolution of 20 to 30 nanometers in the lateral dimensions and 50 to 60 nanometers in the axial dimension. This development allowed us to resolve the 3D morphology of nanoscopic cellular structures.	[Huang, Bo; Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Huang, Bo; Zhuang, Xiaowei] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Wang, Wenqin; Zhuang, Xiaowei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Bates, Mark] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Harvard University	Zhuang, XW (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.	zhuang@chemistry.harvard.edu	Wang, Wenqin/E-9418-2012; Huang, Bo/D-4854-2009	Bates, Mark/0000-0003-0668-5277	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068518] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [GM 068518, R01 GM068518, R01 GM068518-05] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARAK LS, 1981, J CELL BIOL, V90, P595, DOI 10.1083/jcb.90.3.595; Bates M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108101; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bock H, 2007, APPL PHYS B-LASERS O, V88, P161, DOI 10.1007/s00340-007-2729-0; Chen I, 2005, CURR OPIN BIOTECH, V16, P35, DOI 10.1016/j.copbio.2004.12.003; Egner A, 2005, TRENDS CELL BIOL, V15, P207, DOI 10.1016/j.tcb.2005.02.003; Egner A, 2007, BIOPHYS J, V93, P3285, DOI 10.1529/biophysj.107.112201; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Gustafsson MGL, 1999, J MICROSC-OXFORD, V195, P10, DOI 10.1046/j.1365-2818.1999.00576.x; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Hell SW, 2003, NAT BIOTECHNOL, V21, P1347, DOI 10.1038/nbt895; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Holtzer L, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2437066; KAO HP, 1994, BIOPHYS J, V67, P1291, DOI 10.1016/S0006-3495(94)80601-0; Moerner WE, 1999, SCIENCE, V283, P1670, DOI 10.1126/science.283.5408.1670; Nagorni M, 1998, J STRUCT BIOL, V123, P236, DOI 10.1006/jsbi.1998.4037; Prabhat P, 2006, PROC SPIE, V6090, DOI 10.1117/12.644343; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sharonov A, 2006, P NATL ACAD SCI USA, V103, P18911, DOI 10.1073/pnas.0609643104; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Speidel M, 2003, OPT LETT, V28, P69, DOI 10.1364/OL.28.000069; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Toprak E, 2007, NANO LETT, V7, P2043, DOI 10.1021/nl0709120; Torok P, 1997, OPT COMMUN, V137, P127, DOI 10.1016/S0030-4018(96)00771-7; van Oijen AM, 1998, CHEM PHYS LETT, V292, P183, DOI 10.1016/S0009-2614(98)00673-3; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	31	1855	1949	43	1203	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2008	319	5864					810	813		10.1126/science.1153529	http://dx.doi.org/10.1126/science.1153529			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18174397	Green Submitted, Green Accepted			2022-12-28	WOS:000252963000061
J	Silverman, N; Paquette, N				Silverman, Neal; Paquette, Nicholas			Immunology - The right resident bugs	SCIENCE			English	Editorial Material							DROSOPHILA; MODEL; FLORA		[Silverman, Neal; Paquette, Nicholas] Univ Massachusetts, Sch Med, Div Infect Dis, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Silverman, N (corresponding author), Univ Massachusetts, Sch Med, Div Infect Dis, Worcester, MA 01605 USA.	neal.silverman@umassmed.edu		Silverman, Neal/0000-0002-4259-456X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060025] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Basset A, 2000, P NATL ACAD SCI USA, V97, P3376, DOI 10.1073/pnas.070357597; Cox CR, 2007, INFECT IMMUN, V75, P1565, DOI 10.1128/IAI.01496-06; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Guarner F, 2005, CURR OPIN GASTROEN, V21, P414; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Lengyel JA, 2002, DEV BIOL, V243, P1, DOI 10.1006/dbio.2002.0577; Liehl P, 2006, PLOS PATHOG, V2, P551, DOI 10.1371/journal.ppat.0020056; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; Ren C, 2007, CELL METAB, V6, P144, DOI 10.1016/j.cmet.2007.06.006; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Senger K, 2006, P NATL ACAD SCI USA, V103, P15957, DOI 10.1073/pnas.0607608103; Stiefel Usha, 2004, Curr Infect Dis Rep, V6, P420, DOI 10.1007/s11908-004-0060-z	12	9	10	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2008	319	5864					734	735		10.1126/science.1154209	http://dx.doi.org/10.1126/science.1154209			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18218861				2022-12-28	WOS:000252963000027
J	Brownstein, CA; Brownstein, JS				Brownstein, Catherine A.; Brownstein, John S.			Estimating excess mortality in post-invasion Iraq	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Brownstein, Catherine A.] Yale Univ, Dept Genet, New Haven, CT 06520 USA; [Brownstein, John S.] Childrens Hosp, Informat Program, Boston, MA 02115 USA; [Brownstein, John S.] Harvard Univ, Sch Med, Boston, MA USA	Yale University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Brownstein, CA (corresponding author), Yale Univ, Dept Genet, New Haven, CT 06520 USA.		Brownstein, John S/A-1438-2011	Brownstein, Catherine/0000-0002-7371-0340				Brown V, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-9; Burnham G, 2006, LANCET, V368, P1421, DOI 10.1016/S0140-6736(06)69491-9; Giles J, 2007, NATURE, V446, P6, DOI 10.1038/446006a	3	9	9	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2008	358	5					445	447		10.1056/NEJMp0709003	http://dx.doi.org/10.1056/NEJMp0709003			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	256IW	18184951				2022-12-28	WOS:000252722900001
J	Sokol, DK				Sokol, Daniel K.			How far would you go? A little exaggeration or white lie on a job application form is OK, isn't it? Absolutely not	BRITISH MEDICAL JOURNAL			English	Editorial Material									St Georges Univ London, London, England	St Georges University London	Sokol, DK (corresponding author), St Georges Univ London, London, England.	daniel.sokol@talk21.com							0	0	0	1	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 26	2008	336	7637					190	190		10.1136/bmj.39468.616736.0F	http://dx.doi.org/10.1136/bmj.39468.616736.0F			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259KT	18219040	Green Published			2022-12-28	WOS:000252938900040
J	Yamagata, M; Sanes, JR				Yamagata, Masahito; Sanes, Joshua R.			Dscam and Sidekick proteins direct lamina-specific synaptic connections in vertebrate retina	NATURE			English	Article							CELL-ADHESION MOLECULE; HOMOPHILIC INTERCELLULAR-ADHESION; CHOLINE-ACETYLTRANSFERASE; MAMMALIAN RETINA; DROSOPHILA DSCAM; AXON GUIDANCE; DIVERSITY; SYSTEM; TRANSPOSITION; SEGREGATION	Synaptic circuits in the retina transform visual input gathered by photoreceptors into messages that retinal ganglion cells ( RGCs) send to the brain. Processes of retinal interneurons ( amacrine and bipolar cells) form synapses on dendrites of RGCs in the inner plexiform layer ( IPL). The IPL is divided into at least 10 parallel sublaminae; subsets of interneurons and RGCs arborize and form synapses in just one or a few of them(1-3). These lamina- specific circuits determine the visual features to which RGC subtypes respond(3-5). Here we show that four closely related immunoglobulin superfamily ( IgSF) adhesion molecules - Dscam ( Down's syndrome cell adhesion molecule), DscamL ( refs 6 - 9), Sidekick- 1 and Sidekick- 2 ( ref. 10) - are expressed in chick by non- overlapping subsets of interneurons and RGCs that form synapses in distinct IPL sublaminae. Moreover, each protein is concentrated within the appropriate sublaminae and each mediates homophilic adhesion. Loss- and gain- of- function studies in vivo indicate that these IgSF members participate in determining the IPL sublaminae in which synaptic partners arborize and connect. Thus, vertebrate Dscams, like Drosophila Dscams(11-19), play roles in neural connectivity. Together, our results on Dscams and Sidekicks suggest the existence of an IgSF code for laminar specificity in retina and, by implication, in other parts of the central nervous system.	[Yamagata, Masahito; Sanes, Joshua R.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Yamagata, Masahito; Sanes, Joshua R.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Sanes, JR (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	sanesj@mcb.harvard.edu	Yamagata, Masahito/H-6695-2016	Yamagata, Masahito/0000-0001-8193-2931				Agarwala KL, 2001, BIOCHEM BIOPH RES CO, V285, P760, DOI 10.1006/bbrc.2001.5214; Agarwala KL, 2000, MOL BRAIN RES, V79, P118, DOI 10.1016/S0169-328X(00)00108-X; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Cajal SR., 1893, CELLULE, V9, P119; Chang K, 2006, NAT METHODS, V3, P707, DOI 10.1038/NMETH923; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Hughes SH, 2004, FOLIA BIOL-PRAGUE, V50, P107; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; INUZUKA H, 1991, NEURON, V7, P69, DOI 10.1016/0896-6273(91)90075-B; JOHNSON CD, 1986, J NEUROCHEM, V46, P968, DOI 10.1111/j.1471-4159.1986.tb13064.x; Kidd T, 2007, NEURON, V54, P350, DOI 10.1016/j.neuron.2007.04.018; Li X, 2001, MOL GENET GENOMICS, V266, P190, DOI 10.1007/s004380100525; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Millard SS, 2007, NATURE, V447, P720, DOI 10.1038/nature05855; Pang JJ, 2002, J NEUROSCI, V22, P4693, DOI 10.1523/JNEUROSCI.22-11-04693.2002; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; SPIRA AW, 1987, J COMP NEUROL, V260, P526, DOI 10.1002/cne.902600406; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Wohrn JCP, 1998, J COMP NEUROL, V396, P20; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yamagata M, 2006, MOL CELL NEUROSCI, V33, P296, DOI 10.1016/j.mcn.2006.08.001; Yamakawa K, 1998, HUM MOL GENET, V7, P227, DOI 10.1093/hmg/7.2.227; Yimlamai D, 2005, DEV BIOL, V279, P44, DOI 10.1016/j.ydbio.2004.12.001; Zeng Y, 2005, METHOD ENZYMOL, V392, P371, DOI 10.1016/S0076-6879(04)92022-8; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zipursky SL, 2006, TRENDS BIOCHEM SCI, V31, P581, DOI 10.1016/j.tibs.2006.08.003	33	294	301	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2008	451	7177					465	U6		10.1038/nature06469	http://dx.doi.org/10.1038/nature06469			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	253YS	18216854	Bronze			2022-12-28	WOS:000252554100045
J	Graff, MJL; Adang, EMM; Vernooij-Dassen, MJM; Dekker, J; Jonsson, L; Thijssen, M; Hoefnagels, WHL; Rikkert, MGMO				Graff, Maud J. L.; Adang, Eddy M. M.; Vernooij-Dassen, Myrra J. M.; Dekker, Joost; Jonsson, L.; Thijssen, Marjolein; Hoefnagels, Willibrord H. L.; Rikkert, Marcel G. M. Olde			Community occupational therapy for older patients with dementia and their care givers: cost effectiveness study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ALZHEIMERS-DISEASE; CONTROLLED-TRIAL; RATING-SCALE; CAREGIVERS; HOME; DETERMINANTS; INDIVIDUALS; PREVALENCE; ILLNESS; PEOPLE	Objective To assess the cost effectiveness of community based occupational therapy compared with usual care in older patients with dementia and their care givers from a societal viewpoint. Design Cost effectiveness study alongside a single blind randomised controlled trial. Setting Memory clinic, day clinic of a geriatrics department, and participants' homes. Patients 135 patients aged >= 65 with mild to moderate dementia living in the community and their primary care givers. Intervention 10 sessions of occupational therapy over five weeks, including cognitive and behavioural interventions, to train patients in the use of aids to compensate for cognitive decline and caregivers in coping behaviours and supervision. Main outcome measures Incremental cost effectiveness ratio expressed as the difference in mean total care costs per successful treatment (that is, a combined patient and care giver outcome measure of clinically relevant improvement on process, performance, and competence scales) at three months after randomisation. Bootstrap methods used to determine confidence intervals for these measures. Results The intervention cost (euro)1183 (848; pound $1738) (95% confidence interval (euro)1128 (808; pound $1657) to (euro)1239 (888; pound $1820)) per patient and primary care giver unit at three months. Visits to general practitioners and hospital doctors cost the same in both groups but total mean costs were (euro)1748 (1279; pound $2621) lower in the intervention group, with the main cost savings in informal care. There was a significant difference in proportions of successful treatments of 36% at three months. The number needed to treat for successful treatment at three months was 2.8 (2.7 to 2.9). Conclusions Community occupational therapy intervention for patients with dementia and their care givers is successful and cost effective, especially in terms of informal care giving.	[Graff, Maud J. L.; Thijssen, Marjolein] Radboud Univ Nijmegen Med Ctr, Dept Occupat Therapy 897, Alzheimer Ctr Nijmegen, NL-6500 HB Nijmegen, Netherlands; [Adang, Eddy M. M.] Radboud Univ Nijmegen Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assessment, NL-6500 HB Nijmegen, Netherlands; [Graff, Maud J. L.; Vernooij-Dassen, Myrra J. M.; Thijssen, Marjolein] Radboud Univ Nijmegen Med Ctr, Dept Qual Care Res, Alzheimer Ctr Nijmegen, NL-6500 HB Nijmegen, Netherlands; [Dekker, Joost] Free Univ Med Ctr Amsterdam, Dept Rehabil Med, Amsterdam, Netherlands; [Jonsson, L.] Karolinska Inst, Neurotec Dept, Div Geriatr Epidemiol, Stockholm, Sweden; [Hoefnagels, Willibrord H. L.; Rikkert, Marcel G. M. Olde] Radboud Univ Nijmegen Med Ctr, Dept Geriatr 925, Alzheimer Ctr Nijmegen, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Karolinska Institutet; Radboud University Nijmegen	Graff, MJL (corresponding author), Radboud Univ Nijmegen Med Ctr, Dept Occupat Therapy 897, Alzheimer Ctr Nijmegen, POB 9101, NL-6500 HB Nijmegen, Netherlands.	m.graff@pmd.umcn.nl	Jönsson, Linus/G-2253-2017; Graff, M.J.L./L-4333-2015; Vernooij-Dassen, M.J.F.J./H-8107-2014; Adang, E.M.M./L-4169-2015; Rikkert, M.G.M. Olde/H-8078-2014; Rikkert, Marcel Olde/D-9773-2012	Jönsson, Linus/0000-0001-5751-6292; Rikkert, M.G.M. Olde/0000-0003-1397-1677; Dekker, Joost/0000-0003-2027-0027				APA, 1994, DIAGN STAT MAN MENT; Brink TL., 1982, CLIN GERON, V1, P37, DOI [10.1300/J018v01n01_06, DOI 10.1300/J018V01N01_06]; Brodaty H, 1991, Int Psychogeriatr, V3, P11, DOI 10.1017/S1041610291000479; Burgener SC, 1998, GERIATR NURS, V19, P121, DOI 10.1016/S0197-4572(98)90055-6; COEN J, 1998, J HLTH GAIN, V2, P5; Drummond MF, 2015, METHODS EC EVALUATIO; *DUTCH HLTH COUNC, 2002, 200204 DUTCH HLTH CO; *DUTCH OCC THER AS, 2006, RICHTL DECL VERR EER; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fisher A. G., 2003, ASSESSMENT MOTOR PRO; Gitlin LN, 2005, J GERONTOL A-BIOL, V60, P368, DOI 10.1093/gerona/60.3.368; Gitlin LN, 2001, GERONTOLOGIST, V41, P4, DOI 10.1093/geront/41.1.4; Graff M.J.L., 2006, DEMENTIA, V5, P503, DOI [10.1177/1471301206069918, DOI 10.1177/1471301206069918]; Graff MJL, 2007, J GERONTOL A-BIOL, V62, P1002, DOI 10.1093/gerona/62.9.1002; Graff MJL, 2006, BMJ-BRIT MED J, V333, P1196, DOI 10.1136/bmj.39001.688843.BE; Graff MJ, 2000, NED TIJDSCHR ERGOTHE, V28, P169; Graff MJL, 2003, OTJR-OCCUP PART HEAL, V23, P155, DOI 10.1177/153944920302300403; Hay J, 2002, J AM GERIATR SOC, V50, P1381, DOI 10.1046/j.1532-5415.2002.50359.x; Jepson C, 1999, Image J Nurs Sch, V31, P115, DOI 10.1111/j.1547-5069.1999.tb00444.x; Jonsson L, 2006, INT J GERIATR PSYCH, V21, P449, DOI 10.1002/gps.1489; KARLSSON G, 1998, HLTH EC DEMENTIA; Knapp M, 2006, BRIT J PSYCHIAT, V188, P574, DOI 10.1192/bjp.bp.105.010561; Maynard A, 2007, BMJ-BRIT MED J, V334, P594, DOI 10.1136/bmj.39132.363356.80; Meerding WJ, 1998, BRIT MED J, V317, P111, DOI 10.1136/bmj.317.7151.111; MELIS RJF, IN PRESS GERONTOL A; MELIS RJF, IN PRESS J GERONTO A; MILLER MD, 1992, PSYCHIAT RES, V41, P237, DOI 10.1016/0165-1781(92)90005-N; Oostenbrink J, 2004, HANDLEIDING KOSTENON; Polder J J, 2006, KOSTEN ZIEKTEN NEDER; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; REISBERG B, 1983, PSYCHOPHARMACOL BULL, V19, P702; *RIVM, 2006, VOLKSG TOEK VERK 200; Rockwood K., 2006, TRIAL DESIGNS OUTCOM; *RVZ, 2006, ARB ZORGVR ACHT; Siemonsma PC, 1997, CLIN REHABIL, V11, P273, DOI 10.1177/026921559701100402; Steultjens EMJ, 2004, AGE AGEING, V33, P453, DOI 10.1093/ageing/afh174; TERI L, 1992, PSYCHOL AGING, V7, P622, DOI 10.1037/0882-7974.7.4.622; Teunisse S, 1997, Int Psychogeriatr, V9 Suppl 1, P155, DOI 10.1017/S1041610297004845; Teunisse S., 1997, CLINIMETRICS DEMENTI; VernooijDassen MJFJ, 1996, SOC SCI MED, V43, P41, DOI 10.1016/0277-9536(95)00332-0; Wimo A, 2006, DEMENT GERIATR COGN, V21, P175, DOI 10.1159/000090733; Wimo A, 2003, ALZ DIS ASSOC DIS, V17, P63, DOI 10.1097/00002093-200304000-00002; Wimo A, 1998, HLTH EC DEMENTIA	43	170	172	0	37	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 19	2008	336	7636					134	138		10.1136/bmj.39408.481898.BE	http://dx.doi.org/10.1136/bmj.39408.481898.BE			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	257SS	18171718	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000252819400031
J	Valiela, I; Fox, SE				Valiela, Ivan; Fox, Sophia E.			Ecology - Managing coastal wetlands	SCIENCE			English	Editorial Material							FORESTS MITIGATED TSUNAMI		[Valiela, Ivan; Fox, Sophia E.] Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA; [Valiela, Ivan; Fox, Sophia E.] Boston Univ, Marine Program, Marine Biol Lab, Woods Hole, MA 02543 USA	Marine Biological Laboratory - Woods Hole; Boston University; Marine Biological Laboratory - Woods Hole	Valiela, I (corresponding author), Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA.	ivaliela@mbl.edu; sefox@mbl.edu						Barbier EB, 2003, CONTEMP ECON POLICY, V21, P59, DOI 10.1093/cep/21.1.59; Barbier EB, 2008, SCIENCE, V319, P321, DOI 10.1126/science.1150349; Barbier EB, 2007, ECON POLICY, P178, DOI 10.1111/j.1468-0327.2007.00174.x; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Duarte C M, 2007, GLOBAL LOSS COASTAL; Kathiresan K, 2005, ESTUAR COAST SHELF S, V65, P601, DOI 10.1016/j.ecss.2005.06.022; Kerr AM, 2006, ESTUAR COAST SHELF S, V67, P539, DOI 10.1016/j.ecss.2005.12.012; SMITH T, 2007, 19 BIENN C EST RES F; Turner RE, 1992, STEMMING TIDE COASTA, P97; Valiela I., 2006, GLOBAL COASTAL CHANG; Vermaat JE, 2007, ESTUAR COAST SHELF S, V75, P564, DOI 10.1016/j.ecss.2007.08.009; Vermaat JE, 2006, ESTUAR COAST SHELF S, V69, P1, DOI 10.1016/j.ecss.2006.04.019	12	22	23	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2008	319	5861					290	291		10.1126/science.1153477	http://dx.doi.org/10.1126/science.1153477			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252GY	18202280				2022-12-28	WOS:000252436200024
J	Kanamori, H				Kanamori, Hiroo			Earthquake physics and real-time seismology	NATURE			English	Article							SLIP	The past few decades have witnessed significant progress in our understanding of the physics and complexity of earthquakes. This has implications for hazard mitigation.	CALTECH, Seismol Lab, Pasadena, CA 91125 USA	California Institute of Technology	Kanamori, H (corresponding author), CALTECH, Seismol Lab, Pasadena, CA 91125 USA.	hiroo@gps.caltech.edu						ABERCROMBIE R, 2007, GEOPHYSICAL MONOGRAP, V170; Ammon CJ, 2008, NATURE, V451, P561, DOI 10.1038/nature06521; Dragert H, 2001, SCIENCE, V292, P1525, DOI 10.1126/science.1060152; Gasparini P, 2007, EARTHQUAKE EARLY WAR; HEATON TH, 1995, SCIENCE, V267, P206, DOI 10.1126/science.267.5195.206; Ide S, 1997, J GEOPHYS RES-SOL EA, V102, P27379, DOI 10.1029/97JB02675; Kanamori H, 2005, ANNU REV EARTH PL SC, V33, P195, DOI 10.1146/annurev.earth.33.092203.122626; Kanamori H, 2004, P JPN ACAD B-PHYS, V80, P297, DOI 10.2183/pjab.80.297; Obara K, 2002, SCIENCE, V296, P1679, DOI 10.1126/science.1070378; OLSEN KB, 1995, SCIENCE, V270, P1628, DOI 10.1126/science.270.5242.1628; RICE JR, 2007, TECTONIC FAULTS AGEN, P446; SCHWARTZ SY, IN PRESS TREATISE GE; WALD DJ, 1994, B SEISMOL SOC AM, V84, P668; Wald DJ., 1999, EARTHQ SPECTRA, V15, P537, DOI [10.1193/1.1586057, DOI 10.1193/1.1586057]; WIELANDT E, 1982, B SEISMOL SOC AM, V72, P2349	15	18	23	3	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2008	451	7176					271	273		10.1038/nature06585	http://dx.doi.org/10.1038/nature06585			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202640	Bronze			2022-12-28	WOS:000252432100032
J	Mikosch, J; Trippel, S; Eichhorn, C; Otto, R; Lourderaj, U; Zhang, JX; Hase, WL; Weidemuller, M; Wester, R				Mikosch, J.; Trippel, S.; Eichhorn, C.; Otto, R.; Lourderaj, U.; Zhang, J. X.; Hase, W. L.; Weidemueller, M.; Wester, R.			Imaging nucleophilic substitution dynamics	SCIENCE			English	Article							GAS-PHASE S(N)2; DISPLACEMENT-REACTIONS; ENERGY DISPOSAL; ION; EXCITATION; CL-+CH3BR; PRODUCTS; KINETICS; COMPLEX; HALIDES	Anion- molecule nucleophilic substitution ( SN2) reactions are known for their rich reaction dynamics, caused by a complex potential energy surface with a submerged barrier and by weak coupling of the relevant rotational- vibrational quantum states. The dynamics of the SN2 reaction of Cl- + CH3I were uncovered in detail by using crossed molecular beam imaging. As a function of the collision energy, the transition from a complex- mediated reaction mechanism to direct backward scattering of the I- product was observed experimentally. Chemical dynamics calculations were performed that explain the observed energy transfer and reveal an indirect roundabout reaction mechanism involving CH3 rotation.	[Mikosch, J.; Trippel, S.; Eichhorn, C.; Otto, R.; Weidemueller, M.; Wester, R.] Univ Freiburg, Inst Phys, D-79104 Freiburg, Germany; [Lourderaj, U.; Zhang, J. X.; Hase, W. L.] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA	University of Freiburg; Texas Tech University System; Texas Tech University	Wester, R (corresponding author), Univ Freiburg, Inst Phys, Hermann Herder Str 3, D-79104 Freiburg, Germany.	roland.wester@physik.uni-freiburg.de	Wester, Roland/J-6293-2012; Weidemüller, Matthias/N-2232-2014; Trippel, Sebastian/J-7825-2015	Wester, Roland/0000-0001-7935-6066; Weidemüller, Matthias/0000-0001-5639-5126; Trippel, Sebastian/0000-0002-1895-3868; Lourderaj, Upakarasamy/0000-0002-5550-9694; Hase, William/0000-0002-0560-5100				Angel LA, 2003, J AM CHEM SOC, V125, P1014, DOI 10.1021/ja021003+; Ayotte P, 1999, J AM CHEM SOC, V121, P6950, DOI 10.1021/ja990814j; Boudaiffa B, 2000, SCIENCE, V287, P1658, DOI 10.1126/science.287.5458.1658; Chabinyc ML, 1998, SCIENCE, V279, P1882, DOI 10.1126/science.279.5358.1882; CHESNAVICH WJ, 1977, J CHEM PHYS, V66, P2306, DOI 10.1063/1.434292; Craig SL, 1997, SCIENCE, V276, P1536, DOI 10.1126/science.276.5318.1536; DEPUY CH, 1990, J AM CHEM SOC, V112, P8650, DOI 10.1021/ja00180a003; Glukhovtsev MN, 1996, J AM CHEM SOC, V118, P6273, DOI 10.1021/ja953665n; GRAUL ST, 1994, J AM CHEM SOC, V116, P3875, DOI 10.1021/ja00088a024; HASE WL, 1994, SCIENCE, V266, P998, DOI 10.1126/science.266.5187.998; Hennig C, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1924407; HU WP, 1994, J PHYS CHEM-US, V98, P1049, DOI 10.1021/j100055a001; Laerdahl JK, 2002, INT J MASS SPECTROM, V214, P277, DOI 10.1016/S1387-3806(01)00575-9; LeGarrec JL, 1997, J CHEM PHYS, V107, P1021, DOI 10.1063/1.474431; Lin JJ, 2003, SCIENCE, V300, P966, DOI 10.1126/science.1083672; Lourderaj U, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2437214; Merceron-Saffon N, 2003, SCIENCE, V301, P1223, DOI 10.1126/science.1086860; Mikosch J, 2006, PHYS CHEM CHEM PHYS, V8, P2990, DOI 10.1039/b603109a; OLMSTEAD WN, 1977, J AM CHEM SOC, V99, P4219, DOI 10.1021/ja00455a002; Schmatz S, 2004, CHEMPHYSCHEM, V5, P600, DOI 10.1002/cphc.200301043; Sun LP, 2002, SCIENCE, V296, P875, DOI 10.1126/science.1068053; Tonner DS, 2000, J AM CHEM SOC, V122, P8783, DOI 10.1021/ja000881+; VANORDEN SL, 1991, ORG MASS SPECTROM, V26, P1003, DOI 10.1002/oms.1210261118; VIGGIANO AA, 1992, J AM CHEM SOC, V114, P10477, DOI 10.1021/ja00052a050; Vollhardt K.P.C., 2007, ORGANIC CHEM STRUCTU; WADT WR, 1985, J CHEM PHYS, V82, P284, DOI 10.1063/1.448800; Wang YF, 2003, J CHEM PHYS, V118, P2688, DOI 10.1063/1.1535890; Wester R, 2003, J CHEM PHYS, V119, P10032, DOI 10.1063/1.1618220	29	277	278	6	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2008	319	5860					183	186		10.1126/science.1150238	http://dx.doi.org/10.1126/science.1150238			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249RC	18187650				2022-12-28	WOS:000252246400035
J	Roden, DM				Roden, Dan M.			Long-QT syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TORSADES-DE-POINTES; T-WAVE PATTERNS; CARDIAC-ARRHYTHMIAS; POTASSIUM CHANNEL; GENE; MUTATIONS; GENOTYPE; THERAPY; RISK; FLECAINIDE		[Roden, Dan M.] Vanderbilt Univ, Sch Med, Oates Inst Expt Therapeut, Dept Med, Nashville, TN 37232 USA; [Roden, Dan M.] Vanderbilt Univ, Sch Med, Oates Inst Expt Therapeut, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Roden, DM (corresponding author), Vanderbilt Univ, Sch Med, Oates Inst Expt Therapeut, Dept Med, 1285 Med Res Bldg 5, Nashville, TN 37232 USA.	dan.roden@vanderbilt.edu	Roden, Dan/ABD-5412-2021		NHLBI NIH HHS [HL65962, HL49989, U01 HL065962] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049989, U01HL065962, U19HL065962] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arnestad M, 2007, CIRCULATION, V115, P361, DOI 10.1161/CIRCULATIONAHA.106.658021; Benhorin J, 2000, CIRCULATION, V101, P1698; Brink PA, 2005, CIRCULATION, V112, P2602, DOI 10.1161/CIRCULATIONAHA.105.572453; Choi G, 2004, CIRCULATION, V110, P2119, DOI 10.1161/01.CIR.0000144471.98080.CA; Daubert JP, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2007.01.025; Hobbs JB, 2006, JAMA-J AM MED ASSOC, V296, P1249, DOI 10.1001/jama.296.10.1249; Hofman N, 2007, EUR HEART J, V28, P575, DOI 10.1093/eurheartj/ehl355; Imboden M, 2006, NEW ENGL J MED, V355, P2744, DOI 10.1056/NEJMoa042786; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Kimbrough J, 2001, CIRCULATION, V104, P557, DOI 10.1161/hc3001.093501; Koopmann TT, 2006, HEART RHYTHM, V3, P52, DOI 10.1016/j.hrthm.2005.10.014; Lehtonen A, 2007, HEART RHYTHM, V4, P603, DOI 10.1016/j.hrthm.2007.01.019; Li H, 1998, CIRCULATION, V97, P1264, DOI 10.1161/01.CIR.97.13.1264; Makita N, 2007, CIRCULATION, V116, P490; Maron BJ, 2003, NEW ENGL J MED, V349, P1064, DOI 10.1056/NEJMra022783; Moss AJ, 2005, ANN NONINVAS ELECTRO, V10, P59, DOI 10.1111/j.1542-474X.2005.00077.x; Moss AJ, 2005, J CLIN INVEST, V115, P2018, DOI 10.1172/JCI25537; Moss AJ, 2002, CIRCULATION, V105, P794, DOI 10.1161/hc0702.105124; MOSS AJ, 1985, CIRCULATION, V71, P17, DOI 10.1161/01.CIR.71.1.17; Moss AJ, 2000, CIRCULATION, V101, P616, DOI 10.1161/01.CIR.101.6.616; MOSS AJ, 1995, CIRCULATION, V92, P2929, DOI 10.1161/01.CIR.92.10.2929; MOSS AJ, 1971, NEW ENGL J MED, V285, P903, DOI 10.1056/NEJM197110142851607; Moss AJ, 2007, CIRCULATION, V115, P2481, DOI 10.1161/CIRCULATIONAHA.106.665406; Paulussen ADC, 2004, J MOL MED, V82, P182, DOI 10.1007/s00109-003-0522-z; Priori SG, 2000, CIRCULATION, V102, P945, DOI 10.1161/01.CIR.102.9.945; Priori SG, 2004, JAMA-J AM MED ASSOC, V292, P1341, DOI 10.1001/jama.292.11.1341; Priori SG, 2003, NEW ENGL J MED, V348, P1866, DOI 10.1056/NEJMoa022147; Priori SG, 1999, CIRCULATION, V99, P529, DOI 10.1161/01.CIR.99.4.529; Roden DM, 2004, TRENDS CARDIOVAS MED, V14, P112, DOI 10.1016/j.tcm.2004.01.001; Sauer AJ, 2007, J AM COLL CARDIOL, V49, P329, DOI 10.1016/j.jacc.2006.08.057; SCHWARTZ PJ, 1975, AM HEART J, V89, P378, DOI 10.1016/0002-8703(75)90089-7; SCHWARTZ PJ, 1995, CIRCULATION, V92, P3381, DOI 10.1161/01.CIR.92.12.3381; Schwartz PJ, 2001, CIRCULATION, V103, P89; Schwartz PJ, 2003, J CARDIOVASC ELECTR, V14, P1120, DOI 10.1046/j.1540-8167.2003.03339.x; Schwartz PJ, 2004, CIRCULATION, V109, P1826, DOI 10.1161/01.CIR.0000125523.14403.1E; SCHWARTZ PJ, 1993, CIRCULATION, V88, P782, DOI 10.1161/01.CIR.88.2.782; Seth R, 2007, J AM COLL CARDIOL, V49, P1092, DOI 10.1016/j.jacc.2006.09.054; Shimizu W, 2003, J AM COLL CARDIOL, V41, P633, DOI 10.1016/S0735-1097(02)02850-4; Taggart NW, 2007, CIRCULATION, V115, P2613, DOI 10.1161/CIRCULATIONAHA.106.661082; Tan HNL, 2006, CIRCULATION, V114, P2096, DOI 10.1161/CIRCULATIONAHA.106.642694; Tester DJ, 2006, HEART RHYTHM, V3, P815, DOI 10.1016/j.hrthm.2006.03.016; Tester DJ, 2006, J AM COLL CARDIOL, V47, P764, DOI 10.1016/j.jacc.2005.09.056; Van Langen IM, 2003, J MED GENET, V40, P141, DOI 10.1136/jmg.40.2.141; Vincent GM, 2004, J AM COLL CARDIOL, V44, P1283, DOI 10.1016/j.jacc.2004.06.045; Viskin S, 2005, HEART RHYTHM, V2, P569, DOI 10.1016/j.hrthm.2005.02.011; Vyas H, 2006, CIRCULATION, V113, P1385, DOI 10.1161/CIRCULATIONAHA.105.600445; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Wilde AAM, 1999, J AM COLL CARDIOL, V33, P327, DOI 10.1016/S0735-1097(98)00578-6; Yang P, 2002, CIRCULATION, V105, P1943, DOI 10.1161/01.CIR.0000014448.19052.4C; Zareba W, 1998, NEW ENGL J MED, V339, P960, DOI 10.1056/NEJM199810013391404; Zhang L, 2000, CIRCULATION, V102, P2849; Zipes DP, 2006, CIRCULATION, V114, pE385, DOI 10.1161/CIRCULATIONAHA.106.178233	52	287	298	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2008	358	2					169	176		10.1056/NEJMcp0706513	http://dx.doi.org/10.1056/NEJMcp0706513			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249CJ	18184962				2022-12-28	WOS:000252204200008
J	Brisson, JA; Nuzhdin, SV				Brisson, Jennifer A.; Nuzhdin, Sergey V.			Rarity of males in pea aphids results in mutational decay	SCIENCE			English	Article							SELECTION; EVOLUTION; GENOME		[Brisson, Jennifer A.; Nuzhdin, Sergey V.] Univ Calif Davis, Sect Ecol & Evolut, Davis, CA 95616 USA	University of California System; University of California Davis	Brisson, JA (corresponding author), Univ Calif Davis, Sect Ecol & Evolut, Davis, CA 95616 USA.	jabrisson@ucdavis.edu		Brisson, Jennifer/0000-0001-7000-0709				Brisson JA, 2007, EVOL DEV, V9, P338, DOI 10.1111/j.1525-142X.2007.00170.x; Civetta A, 1999, GENOME, V42, P1033, DOI 10.1139/gen-42-6-1033; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; MORAN NA, 1992, ANNU REV ENTOMOL, V37, P321, DOI 10.1146/annurev.en.37.010192.001541; Subramanian S, 2004, GENETICS, V168, P373, DOI 10.1534/genetics.104.028944; VIA S, 1992, ENTOMOL EXP APPL, V65, P119, DOI 10.1007/BF00221362; von Dohlen CD, 2006, MOL PHYLOGENET EVOL, V38, P316, DOI 10.1016/j.ympev.2005.04.035	7	20	21	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2008	319	5859					58	58		10.1126/science.1147919	http://dx.doi.org/10.1126/science.1147919			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18174433	Green Published			2022-12-28	WOS:000252084000027
J	Beebe, K; Mock, M; Merriman, E; Schimmel, P				Beebe, Kirk; Mock, Marissa; Merriman, Eve; Schimmel, Paul			Distinct domains of tRNA synthetase recognize the same base pair	NATURE			English	Article							HAEMOPHILUS-INFLUENZAE YBAK; AMINO-ACID; ESCHERICHIA-COLI; MAJOR DETERMINANT; CRYSTAL-STRUCTURE; CELL VIABILITY; GENETIC-CODE; DISCRIMINATION; IDENTITY; MISTRANSLATION	Synthesis of proteins containing errors ( mistranslation) is prevented by aminoacyl transfer RNA synthetases through their accurate aminoacylation of cognate tRNAs and their ability to correct occasional errors of aminoacylation by editing reactions(1-5). A principal source of mistranslation comes from mistaking glycine or serine for alanine, which can lead to serious cell and animal pathologies, including neurodegeneration(3). A single specific GNU base pair ( G3 center dot U70) marks a tRNA for aminoacylation by alanyl-tRNA synthetase(6-9). Mistranslation occurs when glycine or serine is joined to the G3 center dot U70- containing tRNAs, and is prevented by the editing activity that clears the mischarged amino acid. Previously it was assumed that the specificity for recognition of tRNA(Ala) for editing was provided by the same structural determinants as used for aminoacylation. Here we show that the editing site of alanyl-tRNA synthetase, as an artificial recombinant fragment, targets mischarged tRNA(Ala) using a structural motif unrelated to that for aminoacylation so that, remarkably, two motifs ( one for aminoacylation and one for editing) in the same enzyme independently can provide determinants for tRNA(Ala) recognition. The structural motif for editing is also found naturally in genome-encoded protein fragments that are widely distributed in evolution(10-12). These also recognize mischarged tRNA(Ala). Thus, through evolution, three different complexes with the same tRNA can guard against mistaking glycine or serine for alanine.	[Beebe, Kirk; Mock, Marissa; Merriman, Eve; Schimmel, Paul] Scripps Res Inst, Dept Mol Biol & Chem, La Jolla, CA 92037 USA; [Beebe, Kirk; Mock, Marissa; Merriman, Eve; Schimmel, Paul] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Schimmel, P (corresponding author), Scripps Res Inst, Dept Mol Biol & Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	schimmel@scripps.edu						Ahel I, 2003, P NATL ACAD SCI USA, V100, P15422, DOI 10.1073/pnas.2136934100; An S, 2005, J BIOL CHEM, V280, P34465, DOI 10.1074/jbc.M507550200; An SG, 2004, J BIOL CHEM, V279, P42359, DOI 10.1074/jbc.C400304200; Beebe K, 2003, J BIOL CHEM, V278, P45056, DOI 10.1074/jbc.M307080200; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; Beebe K, 2007, ANAL BIOCHEM, V368, P111, DOI 10.1016/j.ab.2007.05.013; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; Dock-Bregeon AC, 2000, CELL, V103, P877, DOI 10.1016/S0092-8674(00)00191-4; Doring V, 2001, SCIENCE, V292, P501, DOI 10.1126/science.1057718; Fukunaga R, 2007, ACTA CRYSTALLOGR D, V63, P390, DOI 10.1107/S090744490605640X; HOU YM, 1989, BIOCHEMISTRY-US, V28, P6800, DOI 10.1021/bi00443a003; HOU YM, 1988, NATURE, V333, P140, DOI 10.1038/333140a0; JASIN M, 1983, NATURE, V306, P441, DOI 10.1038/306441a0; Karkhanis VA, 2006, J BIOL CHEM, V281, P33217, DOI 10.1074/jbc.M607406200; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; MCCLAIN WH, 1988, SCIENCE, V241, P1804, DOI 10.1126/science.2459773; Nangle LA, 2002, J BIOL CHEM, V277, P45729, DOI 10.1074/jbc.M208093200; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; Pauling L., 1957, FESTSCHRIFT ARTHUR S, P597; PUTNEY SD, 1981, SCIENCE, V213, P1497, DOI 10.1126/science.7025207; REGAN L, 1987, SCIENCE, V235, P1651, DOI 10.1126/science.2435005; Roy H, 2004, EMBO J, V23, P4639, DOI 10.1038/sj.emboj.7600474; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; Sankaranarayanan R, 2000, NAT STRUCT BIOL, V7, P461; Schimmel P, 2001, COLD SPRING HARB SYM, V66, P161, DOI 10.1101/sqb.2001.66.161; Sokabe M, 2005, P NATL ACAD SCI USA, V102, P11669, DOI 10.1073/pnas.0502119102; Swairjo MA, 2004, MOL CELL, V13, P829, DOI 10.1016/S1097-2765(04)00126-1; TSUI WC, 1981, NUCLEIC ACIDS RES, V9, P4627, DOI 10.1093/nar/9.18.4627; Waas WF, 2007, BIOCHEMISTRY-US, V46, P12062, DOI 10.1021/bi7007454	29	61	68	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2008	451	7174					90	U14		10.1038/nature06454	http://dx.doi.org/10.1038/nature06454			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247KZ	18172502				2022-12-28	WOS:000252079300040
J	Dando, PR				Dando, Paul R.			Alan J. Southward (1928-2007) - Obituary	NATURE			English	Biographical-Item									Bangor Univ, Sch Ocean Sci, Menai Bridge LL59 5AB, Gwynedd, Wales	Bangor University	Dando, PR (corresponding author), Bangor Univ, Sch Ocean Sci, Menai Bridge LL59 5AB, Gwynedd, Wales.	oss109@bangor.ac.uk		Dando, Paul/0000-0002-1291-5414	NERC [MBA010001] Funding Source: UKRI; Natural Environment Research Council [MBA010001] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2008	451	7174					28	28		10.1038/451028a	http://dx.doi.org/10.1038/451028a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247KZ	18172490	Bronze			2022-12-28	WOS:000252079300024
J	Paukstelis, PJ; Chen, JH; Chase, E; Lambowitz, AM; Golden, BL				Paukstelis, Paul J.; Chen, Jui-Hui; Chase, Elaine; Lambowitz, Alan M.; Golden, Barbara L.			Structure of a tyrosyl-tRNA synthetase splicing factor bound to a group I intron RNA	NATURE			English	Article							NEUROSPORA-CRASSA; CATALYTIC CORE; CRYSTAL-STRUCTURE; CYT-18 PROTEIN; TETRAHYMENA RIBOZYME; TERTIARY STRUCTURE; P4-P6 DOMAIN; BINDING; DEFECTS; PROGRAM	The 'RNA world' hypothesis holds that during evolution the structural and enzymatic functions initially served by RNA were assumed by proteins, leading to the latter's domination of biological catalysis. This progression can still be seen in modern biology, where ribozymes, such as the ribosome and RNase P, have evolved into protein- dependent RNA catalysts ('RNPzymes'). Similarly, group I introns use RNA- catalysed splicing reactions, but many function as RNPzymes bound to proteins that stabilize their catalytically active RNA structure(1,2). One such protein, the Neurospora crassa mitochondrial tyrosyl- tRNA synthetase ( TyrRS; CYT- 18), is bifunctional and both aminoacylates mitochondrial tRNA(Tyr) and promotes the splicing of mitochondrial group I introns(3). Here we determine a 4.5-angstrom co-crystal structure of the Twort orf142-I2 group I intron ribozyme bound to splicing-active, carboxy- terminally truncated CYT- 18. The structure shows that the group I intron binds across the two subunits of the homodimeric protein with a newly evolved RNA- binding surface distinct from that which binds tRNA(Tyr). This RNA binding surface provides an extended scaffold for the phosphodiester backbone of the conserved catalytic core of the intron RNA, allowing the protein to promote the splicing of a wide variety of group I introns. The group I intron- binding surface includes three small insertions and additional structural adaptations relative to non- splicing bacterial TyrRSs, indicating a multistep adaptation for splicing function. The co- crystal structure provides insight into how CYT- 18 promotes group I intron splicing, how it evolved to have this function, and how proteins could have incrementally replaced RNA structures during the transition from an RNA world to an RNP world.	[Paukstelis, Paul J.; Lambowitz, Alan M.] Univ Texas Austin, Sch Biol Sci, Dept Chem & Biochem, Inst Mol & Cellular Biol, Austin, TX 78712 USA; [Paukstelis, Paul J.; Lambowitz, Alan M.] Univ Texas Austin, Sch Biol Sci, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Chen, Jui-Hui; Chase, Elaine; Golden, Barbara L.] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Lambowitz, AM (corresponding author), Univ Texas Austin, Sch Biol Sci, Dept Chem & Biochem, Inst Mol & Cellular Biol, Austin, TX 78712 USA.	lambowitz@mail.utexas.edu; barbgolden@purdue.edu	Paukstelis, Paul/D-6320-2011; Paukstelis, Paul/C-9599-2009	Golden, Barbara/0000-0002-9741-882X				Adams PL, 2004, NATURE, V430, P45, DOI 10.1038/nature02642; AKINS RA, 1987, CELL, V50, P331, DOI 10.1016/0092-8674(87)90488-0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caprara MG, 1996, J MOL BIOL, V257, P512, DOI 10.1006/jmbi.1996.0182; Caprara MG, 1996, CELL, V87, P1135, DOI 10.1016/S0092-8674(00)81807-3; Caprara MG, 2001, J MOL BIOL, V308, P165, DOI 10.1006/jmbi.2001.4581; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; Chen X, 2000, J MOL BIOL, V301, P265, DOI 10.1006/jmbi.2000.3963; Chen X, 2004, RNA, V10, P634, DOI 10.1261/rna.5212604; DeLaBarre B, 2006, ACTA CRYSTALLOGR D, V62, P923, DOI 10.1107/S0907444906012650; Galagan JE, 2005, GENOME RES, V15, P1620, DOI 10.1101/gr.3767105; Golden BL, 2005, NAT STRUCT MOL BIOL, V12, P82, DOI 10.1038/nsmb868; Guo F, 2004, MOL CELL, V16, P351, DOI 10.1016/S1097-2765(04)00592-1; GUO QB, 1992, GENE DEV, V6, P1357, DOI 10.1101/gad.6.8.1357; KAMPER U, 1992, MOL CELL BIOL, V12, P499; Kleinjung J, 2005, NUCLEIC ACIDS RES, V33, pW342, DOI 10.1093/nar/gki369; LAMBOWITZ AM, 1990, TRENDS BIOCHEM SCI, V15, P440, DOI 10.1016/0968-0004(90)90283-H; Lambowitz AM., 1999, GROUP GROUP 2 RIBOZY, P451; Landthaler M, 1999, P NATL ACAD SCI USA, V96, P7005, DOI 10.1073/pnas.96.12.7005; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; MOHR G, 1992, CELL, V69, P483, DOI 10.1016/0092-8674(92)90449-M; MOHR G, 1994, NATURE, V370, P147, DOI 10.1038/370147a0; Mohr G, 2001, J MOL BIOL, V307, P75, DOI 10.1006/jmbi.2000.4460; Myers CA, 1996, J MOL BIOL, V262, P87, DOI 10.1006/jmbi.1996.0501; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paukstelis PJ, 2005, MOL CELL, V17, P417, DOI 10.1016/j.molcel.2004.12.026; SELKER EU, 1990, ANNU REV GENET, V24, P579, DOI 10.1146/annurev.ge.24.120190.003051; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Waldsich C, 2002, GENE DEV, V16, P2300, DOI 10.1101/gad.231302; Webb AE, 2001, J MOL BIOL, V309, P1087, DOI 10.1006/jmbi.2001.4714; Weeks KM, 1996, SCIENCE, V271, P345, DOI 10.1126/science.271.5247.345; Yaremchuk A, 2002, EMBO J, V21, P3829, DOI 10.1093/emboj/cdf373	34	66	71	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2008	451	7174					94	U15		10.1038/nature06413	http://dx.doi.org/10.1038/nature06413			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247KZ	18172503				2022-12-28	WOS:000252079300041
J	Hopewell, S; Clarke, M; Moher, D; Wager, E; Middleton, P; Altman, DG; Schulz, KF				Hopewell, Sally; Clarke, Mike; Moher, David; Wager, Elizabeth; Middleton, Philippa; Altman, Douglas G.; Schulz, Kenneth F.		CONSORT Grp	CONSORT for reporting randomised trials in journal and conference abstracts	LANCET			English	Editorial Material							EXTENSION		[Hopewell, Sally; Clarke, Mike] UK Cochrane Ctr, Oxford OX2 7LG, England; [Clarke, Mike] Trinity Coll Dublin, Sch Nursing & Midwifery, Dublin, Ireland; [Moher, David] Childrens Hosp Eastern Ontario, Res Inst, Chalmers Res Grp, Ottawa, ON K1H 8L1, Canada; [Moher, David] Univ Ottawa, Fac Med, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Middleton, Philippa] Univ Adelaide, Discipline Obstet & Gynaecol, Adelaide, SA, Australia; [Hopewell, Sally; Altman, Douglas G.] Univ Oxford Wolfson Coll, Ctr Stat Med, Oxford OX2 6UD, England; [Schulz, Kenneth F.] Family Hlth Int, Durham, NC USA	Cochrane Centre; Trinity College Dublin; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Adelaide; University of Oxford	Hopewell, S (corresponding author), UK Cochrane Ctr, Summertown Pavil, Oxford OX2 7LG, England.	shopewell@cochrane.co.uk	Harding, Richard/G-9729-2012	Moher, David/0000-0003-2434-4206; Hopewell, Sally/0000-0002-6881-6984; Wager, Elizabeth/0000-0002-4202-7813				Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; *CONSORT, 2007, CONSORT EXT ABSTR; HAYNES RB, 1987, ANN INTERN MED, V106, P598; Hopewell S, 2008, PLOS MED, V5, P48, DOI 10.1371/journal.pmed.0050020; *INT COMM MED J ED, 2006, UN REQ MAN SUBM BIOM; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; *PLOS MED ED, 2006, PLOS MED, V3, pE252; Scherer RW, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000005.pub3, 10.1002/14651858.MR000005.pub4]; Schriger DL, 2006, ANN EMERG MED, V48, P743, DOI 10.1016/j.annemergmed.2006.03.028	11	291	289	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2008	371	9609					281	283		10.1016/S0140-6736(07)61835-2	http://dx.doi.org/10.1016/S0140-6736(07)61835-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254VQ	18221781				2022-12-28	WOS:000252616500007
J	Hoernle, K; Abt, DL; Fischer, KM; Nichols, H; Hauff, F; Abers, GA; van den Bogaard, P; Heydolph, K; Alvarado, G; Protti, M; Strauch, W				Hoernle, Kaj; Abt, David L.; Fischer, Karen M.; Nichols, Holly; Hauff, Folkmar; Abers, Geoffrey A.; van den Bogaard, Paul; Heydolph, Ken; Alvarado, Guillermo; Protti, Marino; Strauch, Wilfried			Arc-parallel flow in the mantle wedge beneath Costa Rica and Nicaragua	NATURE			English	Article							SEISMIC ANISOTROPY; ELASTIC-CONSTANTS; HISTORY; ASTHENOSPHERE; OLIVINE; VOLCANO; MA	Resolving flow geometry in the mantle wedge is central to understanding the thermal and chemical structure of subduction zones, subducting plate dehydration, and melting that leads to arc volcanism, which can threaten large populations and alter climate through gas and particle emission. Here we show that isotope geochemistry and seismic velocity anisotropy provide strong evidence for trench- parallel flow in the mantle wedge beneath Costa Rica and Nicaragua. This finding contradicts classical models, which predict trench- normal flow owing to the overlying wedge mantle being dragged downwards by the subducting plate. The isotopic signature of central Costa Rican volcanic rocks is not consistent with its derivation from the mantle wedge(1-3) or eroded fore- arc complexes(4) but instead from seamounts of the Galapagos hotspot track on the subducting Cocos plate. This isotopic signature decreases continuously from central Costa Rica to northwestern Nicaragua. As the age of the isotopic signature beneath Costa Rica can be constrained and its transport distance is known, minimum northwestward flow rates can be estimated ( 63 - 190 mm yr(-1)) and are comparable to the magnitude of subducting Cocos plate motion (similar to 85 mm yr(-1)). Trench- parallel flow needs to be taken into account in models evaluating thermal and chemical structure and melt generation in subduction zones.	[Hoernle, Kaj; Nichols, Holly; van den Bogaard, Paul; Heydolph, Ken] Univ Kiel, SFB 574, D-24148 Kiel, Germany; [Hoernle, Kaj; Hauff, Folkmar; van den Bogaard, Paul] Univ Kiel, Leibniz Inst Marine Sci, IFM GEOMAR, D-24148 Kiel, Germany; [Abt, David L.; Fischer, Karen M.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Abers, Geoffrey A.] Boston Univ, Dept Earth Sci, Boston, MA 02215 USA; [Alvarado, Guillermo] ICE, OSIVAM, Heredia 1000, Costa Rica; [Protti, Marino] Univ Nacl, Observ Vulcanol & Sismol Costa Rica, Heredia 3000, Costa Rica; [Strauch, Wilfried] Inst Nicaraguense Estud Terr, Managua, Nicaragua	University of Kiel; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Kiel; Brown University; Boston University; Universidad Nacional Costa Rica	Hoernle, K (corresponding author), Univ Kiel, SFB 574, Wischhofstr 1-3, D-24148 Kiel, Germany.	khoernle@ifm-geomar.de	Hoernle, Kaj/AAF-9500-2021; Hauff, Folkmar/AAG-3630-2021	Hauff, Folkmar/0000-0001-9503-9714; Protti, Marino/0000-0001-9818-0051; Strauch, Wilfried/0000-0003-4074-9780				Abramson EH, 1997, J GEOPHYS RES-SOL EA, V102, P12253, DOI 10.1029/97JB00682; Abratis M, 2001, GEOLOGY, V29, P127, DOI 10.1130/0091-7613(2001)029<0127:RCSWFA>2.0.CO;2; ABT DL, UNPUB GEOPHYS J INT; Alvarado G., 2007, CENTRAL AM GEOLOGY R; ANDERSON M, UNPUB EARTH PLANET S; ANDERSON OL, 1995, MINERAL PHYS CRYSTAL, P64; Basu A, 1996, EARTH PROCESSES READ, V95, P429, DOI DOI 10.1029/GM095P0429; Behn MD, 2007, SCIENCE, V317, P108, DOI 10.1126/science.1141269; CARR MJ, 1990, CONTRIB MINERAL PETR, V105, P369, DOI 10.1007/BF00286825; DEFANT MJ, 1991, CONTRIB MINERAL PETR, V106, P309, DOI 10.1007/BF00324560; Feigenson MD, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000621; Fischer KM, 2000, J GEOPHYS RES-SOL EA, V105, P16181, DOI 10.1029/1999JB900441; FRISILLO AL, 1972, J GEOPHYS RES, V77, P6360, DOI 10.1029/JB077i032p06360; Goss AR, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001163; Hall CE, 2000, J GEOPHYS RES-SOL EA, V105, P28009, DOI 10.1029/2000JB900297; Hauff F, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/1999GC000020; HERRSTROM EA, 1995, GEOLOGY, V23, P617, DOI 10.1130/0091-7613(1995)023<0617:VILCAW>2.3.CO;2; Hoernle K, 2004, GEOLOGY, V32, P697, DOI 10.1130/G20574.1; Hoernle K, 2000, GEOLOGY, V28, P435, DOI 10.1130/0091-7613(2000)28<435:EOCSZI>2.0.CO;2; Hoernle K, 2002, GEOLOGY, V30, P795, DOI 10.1130/0091-7613(2002)030<0795:MHMOTG>2.0.CO;2; Hoernle K., 1991, SCHWEIZ MINER PETROG, V71, P3, DOI DOI 10.5169/seals-54342; Holtzman BK, 2003, SCIENCE, V301, P1227, DOI 10.1126/science.1087132; Jung H, 2001, SCIENCE, V293, P1460, DOI 10.1126/science.1062235; Kimura G., 1997, P OCEAN DRILLING PRO, DOI [10.2973/odp.proc.ir.170.1997, DOI 10.2973/ODP.PROC.IR.170.1997]; Kneller EA, 2005, EARTH PLANET SC LETT, V237, P781, DOI 10.1016/j.epsl.2005.06.049; Kneller EA, 2007, NATURE, V450, P1222, DOI 10.1038/nature06429; Levin V, 2004, GEOPHYS J INT, V158, P1009, DOI 10.1111/j.1365-246X.2004.02352.x; Long MD, 2005, PHYS EARTH PLANET IN, V151, P206, DOI 10.1016/j.pepi.2005.03.003; MacMillan I, 2004, TECTONOPHYSICS, V392, P325, DOI 10.1016/j.tecto.2004.04.014; Nakajima J, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025053; Patino LC, 2000, CONTRIB MINERAL PETR, V138, P265, DOI 10.1007/s004100050562; Pozgay SH, 2007, GEOPHYS J INT, V170, P371, DOI 10.1111/j.1365-246X.2007.03433.x; REAGAN MK, 1989, J GEOPHYS RES-SOLID, V94, P4619, DOI 10.1029/JB094iB04p04619; SILVER PG, 1991, J GEOPHYS RES-SOL EA, V96, P16429, DOI 10.1029/91JB00899; Smith GP, 2001, SCIENCE, V292, P713, DOI 10.1126/science.1058763; Turner HL, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027586; Werner R, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2003GC000576	37	176	186	3	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2008	451	7182					1094	U4		10.1038/nature06550	http://dx.doi.org/10.1038/nature06550			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	266RB	18223639				2022-12-28	WOS:000253453600039
J	Raizen, DM; Zimmerman, JE; Maycock, MH; Ta, UD; You, YJ; Sundaram, MV; Pack, AI				Raizen, David M.; Zimmerman, John E.; Maycock, Matthew H.; Ta, Uyen D.; You, Young-Jai; Sundaram, Meera V.; Pack, Allan I.			Lethargus is a Caenorhabditis elegans sleep-like state	NATURE			English	Article							DEPENDENT PROTEIN-KINASE; C-ELEGANS; DROSOPHILA-MELANOGASTER; NEMATODE; BEHAVIOR; REST	There are fundamental similarities between sleep in mammals and quiescence in the arthropod Drosophila melanogaster, suggesting that sleep- like states are evolutionarily ancient(1-3). The nematode Caenorhabditis elegans also has a quiescent behavioural state during a period called lethargus, which occurs before each of the four moults(4). Like sleep, lethargus maintains a constant temporal relationship with the expression of the C. elegans Period homologue LIN-42 ( ref. 5). Here we show that quiescence associated with lethargus has the additional sleep- like properties of reversibility, reduced responsiveness and homeostasis. We identify the cGMP-dependent protein kinase ( PKG) gene egl- 4 as a regulator of sleep-like behaviour, and show that egl- 4 functions in sensory neurons to promote the C. elegans sleep- like state. Conserved effects on sleep- like behaviour of homologous genes in C. elegans and Drosophila suggest a common genetic regulation of sleep- like states in arthropods and nematodes. Our results indicate that C. elegans is a suitable model system for the study of sleep regulation. The association of this C. elegans sleep- like state with developmental changes that occur with larval moults suggests that sleep may have evolved to allow for developmental changes.	[Raizen, David M.; Zimmerman, John E.; Maycock, Matthew H.; Ta, Uyen D.; Pack, Allan I.] Univ Penn, Sch Med, Ctr Sleep & Resp Neurobiol, Philadelphia, PA 19104 USA; [Raizen, David M.; Ta, Uyen D.] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Sundaram, Meera V.] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Pack, Allan I.] Univ Penn, Sch Med, Dept Med, Div Sleep Med, Philadelphia, PA 19104 USA; [You, Young-Jai] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Texas System; University of Texas Southwestern Medical Center Dallas	Raizen, DM (corresponding author), Univ Penn, Sch Med, Ctr Sleep & Resp Neurobiol, 3400 Spruce St, Philadelphia, PA 19104 USA.	raizen@mail.med.upenn.edu	PhD/K-3106-2019; Raizen, David/ABB-1478-2020	you, young/0000-0002-5716-5418; Pack, Allan/0000-0002-2879-0484; Sundaram, Meera/0000-0002-2940-8750				AVERY L, 1993, GENETICS, V133, P897; Barger AJ, 1998, J NEUROSCI, V18, P2871; Borbely A A, 1982, Hum Neurobiol, V1, P195; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Chao MY, 2004, P NATL ACAD SCI USA, V101, P15512, DOI 10.1073/pnas.0403369101; Charlie NK, 2006, GENETICS, V173, P111, DOI 10.1534/genetics.105.054007; Ewer John, 2002, P1; Frand AR, 2005, PLOS BIOL, V3, P1719, DOI 10.1371/journal.pbio.0030312; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Fujiwara M, 2002, NEURON, V36, P1091, DOI 10.1016/S0896-6273(02)01093-0; Hallam SJ, 1998, NATURE, V395, P78, DOI 10.1038/25757; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hendricks JC, 2001, NAT NEUROSCI, V4, P1108, DOI 10.1038/nn743; Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628; Jeon M, 1999, SCIENCE, V286, P1141, DOI 10.1126/science.286.5442.1141; KALDERON D, 1989, J BIOL CHEM, V264, P10738; L'Etoile ND, 2002, NEURON, V36, P1079, DOI 10.1016/S0896-6273(02)01066-8; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; PEREIRA HS, 1993, P NATL ACAD SCI USA, V90, P5044, DOI 10.1073/pnas.90.11.5044; Raizen DM, 2006, GENETICS, V173, P177, DOI 10.1534/genetics.106.057380; RANKIN CH, 1991, J COMP PHYSIOL A, V169, P59; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; SINGH RN, 1978, NEMATOLOGICA, V24, P63, DOI 10.1163/187529278X00074; TRACHSEL L, 1991, PHYSIOL BEHAV, V49, P575, DOI 10.1016/0031-9384(91)90283-T; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; Van Buskirk C, 2007, NAT NEUROSCI, V10, P1300, DOI 10.1038/nn1981; WHITE JG, 1978, NATURE, V271, P764, DOI 10.1038/271764a0; WICKS SR, 1995, J NEUROSCI, V15, P2434, DOI 10.1523/JNEUROSCI.15-03-02434.1995	30	307	319	4	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2008	451	7178					569	U6		10.1038/nature06535	http://dx.doi.org/10.1038/nature06535			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256OQ	18185515				2022-12-28	WOS:000252739900041
J	Zheng, AY; Lawhorn, JK; Lumley, T; Freeman, S				Zheng, Alex Y.; Lawhorn, Janessa K.; Lumley, Thomas; Freeman, Scott			Assessment - Application of Bloom's taxonomy debunks the "MCAT myth"	SCIENCE			English	Editorial Material							EDUCATION		[Zheng, Alex Y.; Lawhorn, Janessa K.; Freeman, Scott] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Lumley, Thomas] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Freeman, S (corresponding author), Univ Washington, Dept Biol, Box 355320, Seattle, WA 98195 USA.	srf991@u.washington.edu						*AAMC, 2007, 2007 MCAT ESS; Alberts B, 2005, CELL, V123, P739, DOI 10.1016/j.cell.2005.11.014; Anderson L-W, 1994, BLOOMS TAXONOMY 40 Y; Bissell AN, 2006, BIOSCIENCE, V56, P66, DOI 10.1641/0006-3568(2006)056[0066:ANMFAC]2.0.CO;2; Bloom B. S., 1956, HDB 1 COGNITIVE DOMA; Cooke M, 2006, NEW ENGL J MED, V355, P1339, DOI 10.1056/NEJMra055445; Donnon T, 2007, ACAD MED, V82, P100, DOI 10.1097/01.ACM.0000249878.25186.b7; Farley J K, 1989, Nurse Educ, V14, P10, DOI 10.1097/00006223-198911000-00003; Hoffman K, 2006, ACAD MED, V81, P617, DOI 10.1097/01.ACM.0000232411.97399.c6; KNECHT KT, 2001, AM J PHARM EDUC, V65, P4; Krathwohl DR, 2002, THEOR PRACT, V41, P212, DOI 10.1207/s15430421tip4104_2; Kuncel NR, 2007, SCIENCE, V315, P1080, DOI 10.1126/science.1136618; Labov Jay B, 2005, Cell Biol Educ, V4, P7, DOI 10.1187/cbe.04-11-0053; Masters JC, 2001, J NURS EDUC, V40, P25; Morgan D. L., 2005, 20059 COLL BOARD; National Research Council (NRC), 2002, LEARN UND IMPR ADV S; National Research Council (NRC), 2003, BIO 2010 TRANSF UND; Whitcomb ME, 2006, ACAD MED, V81, P413, DOI 10.1097/01.ACM.0000222262.85760.13; Wood William B, 2002, Cell Biol Educ, V1, P123, DOI 10.1187/cbe.02-09-0038	19	64	65	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2008	319	5862					414	415		10.1126/science.1147852	http://dx.doi.org/10.1126/science.1147852			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254HB	18218880				2022-12-28	WOS:000252576600021
J	Hannan, EL; Wu, CT; Walford, G; Culliford, AT; Gold, JP; Smith, CR; Higgins, RSD; Carlson, RE; Jones, RH				Hannan, Edward L.; Wu, Chuntao; Walford, Gary; Culliford, Alfred T.; Gold, Jeffrey P.; Smith, Craig R.; Higgins, Robert S. D.; Carlson, Russell E.; Jones, Robert H.			Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; TAXUS-IV TRIAL; SLOW-RELEASE; BARE-METAL; CLINICAL-OUTCOMES; PROPENSITY SCORE; STANDARD STENT; SIROLIMUS; IMPLANTATION; METAANALYSIS	Background: Numerous studies have compared the outcomes of two competing interventions for multivessel coronary artery disease: coronary-artery bypass grafting (CABG) and coronary stenting. However, little information has become available since the introduction of drug-eluting stents. Methods: We identified patients with multivessel disease who received drug-eluting stents or underwent CABG in New York State between October 1, 2003, and December 31, 2004, and we compared adverse outcomes (death, death or myocardial infarction, or repeat revascularization) through December 31, 2005, after adjustment for differences in baseline risk factors among the patients. Results: In comparison with treatment with a drug-eluting stent, CABG was associated with lower 18-month rates of death and of death or myocardial infarction both for patients with three-vessel disease and for patients with two-vessel disease. Among patients with three-vessel disease who underwent CABG, as compared with those who received a stent, the adjusted hazard ratio for death was 0.80 (95% confidence interval [CI], 0.65 to 0.97) and the adjusted survival rate was 94.0% versus 92.7% (P=0.03); the adjusted hazard ratio for death or myocardial infarction was 0.75 (95% CI, 0.63 to 0.89) and the adjusted rate of survival free from myocardial infarction was 92.1% versus 89.7% (P<0.001). Among patients with two-vessel disease who underwent CABG, as compared with those who received a stent, the adjusted hazard ratio for death was 0.71 (95% CI, 0.57 to 0.89) and the adjusted survival rate was 96.0% versus 94.6% (P=0.003); the adjusted hazard ratio for death or myocardial infarction was 0.71 (95% CI, 0.59 to 0.87) and the adjusted rate of survival free from myocardial infarction was 94.5% versus 92.5% (P<0.001). Patients undergoing CABG also had lower rates of repeat revascularization. Conclusions: For patients with multivessel disease, CABG continues to be associated with lower mortality rates than does treatment with drug-eluting stents and is also associated with lower rates of death or myocardial infarction and repeat revascularization.	[Hannan, Edward L.; Wu, Chuntao] SUNY Albany, Albany, NY 12222 USA; [Walford, Gary] St Josephs Hosp, Syracuse, NY USA; [Culliford, Alfred T.] NYU Med Ctr, New York, NY 10016 USA; [Gold, Jeffrey P.] Med Univ Ohio, Toledo, OH USA; [Smith, Craig R.] Columbia Presbyterian Med Ctr, New York, NY 10032 USA; [Higgins, Robert S. D.] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Carlson, Russell E.] Mercy Hosp, Buffalo, NY USA; Duke Univ, Med Ctr, Durham, NC USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; New York University; Columbia University; NewYork-Presbyterian Hospital; Rush University; Duke University	Hannan, EL (corresponding author), SUNY Albany, Sch Publ Hlth, Dept Hlth Policy Management & Behav, 1 Univ Pl, Rensselaer, NY 12144 USA.	elh03@health.state.ny.us	Higgins, Robert/AGZ-7064-2022					Allison P. D., 1995, SURVIVAL ANAL USING; Ardissino D, 2004, JAMA-J AM MED ASSOC, V292, P2727, DOI 10.1001/jama.292.22.2727; Bavry AA, 2005, J AM COLL CARDIOL, V45, P941, DOI 10.1016/j.jacc.2004.11.064; Bavry AA, 2006, AM J MED, V119, P1056, DOI 10.1016/j.amjmed.2006.01.023; Colombo A, 2003, CIRCULATION, V108, P788, DOI 10.1161/01.CIR.0000086926.62288.A6; D'Agostino RB, 2007, JAMA-J AM MED ASSOC, V297, P314, DOI 10.1001/jama.297.3.314; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; Ghali WA, 2001, JAMA-J AM MED ASSOC, V286, P1494, DOI 10.1001/jama.286.12.1494; Goy JJ, 2000, MAYO CLIN PROC, V75, P1116, DOI 10.4065/75.11.1116; Grube E, 2003, CIRCULATION, V107, P38, DOI 10.1161/01.CIR.0000047700.58683.A1; Hannan EL, 2005, NEW ENGL J MED, V352, P2174, DOI 10.1056/NEJMoa040316; Hermiller JB, 2005, J AM COLL CARDIOL, V45, P1172, DOI 10.1016/j.jacc.2004.10.075; Holmes DR, 2004, CIRCULATION, V109, P634, DOI 10.1161/01.CIR.0000112572.57794.22; Indolfi C, 2005, AM J CARDIOL, V95, P1146, DOI 10.1016/j.amjcard.2005.01.040; Katritsis DG, 2005, AM J CARDIOL, V95, P640, DOI 10.1016/j.amjcard.2004.10.041; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Ong ATL, 2005, J AM COLL CARDIOL, V45, P947, DOI 10.1016/j.jacc.2004.09.079; Regar E, 2002, CIRCULATION, V106, P1949, DOI 10.1161/01.CIR.0000034045.36219.12; Rodriguez A, 2001, J AM COLL CARDIOL, V37, P51, DOI 10.1016/S0735-1097(00)01052-4; Rodriguez A, 2001, J AM COLL CARDIOL, V37, P973; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Serruys PW, 2001, NEW ENGL J MED, V344, P1117, DOI 10.1056/NEJM200104123441502; Sigwart U, 2002, LANCET, V360, P965; Stone GW, 2005, JAMA-J AM MED ASSOC, V294, P1215, DOI 10.1001/jama.294.10.1215; Stone GW, 2004, CIRCULATION, V109, P1942, DOI 10.1161/01.CIR.0000127110.49192.72; Tanabe K, 2003, CIRCULATION, V107, P559, DOI 10.1161/01.CIR.0000048184.96491.8A; 2006, WASHINGTON POST 1207; 2006, NY TIMES        1213	30	391	428	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2008	358	4					331	341		10.1056/NEJMoa071804	http://dx.doi.org/10.1056/NEJMoa071804			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253GY	18216353				2022-12-28	WOS:000252507900003
J	Vandermeer, J; Perfecto, I; Philpott, SM				Vandermeer, John; Perfecto, Ivette; Philpott, Stacy M.			Clusters of ant colonies and robust criticality in a tropical agroecosystem	NATURE			English	Article							SELF-ORGANIZATION; PATTERN; SCALE; MUTUALISM; PREY	Although sometimes difficult to measure at large scales, spatial pattern is important in natural biological spaces as a determinant of key ecological properties such as species diversity, stability, resiliency and others(1-6). Here we demonstrate, at a large spatial scale, that a common species of tropical arboreal ant forms clusters of nests through a combination of local satellite colony formation and density- dependent control by natural enemies, mainly a parasitic fly. Cluster sizes fall off as a power law consistent with a so-called robust critical state(7). This endogenous cluster formation at a critical state is a unique example of an insect population forming a non- random pattern at a large spatial scale. Furthermore, because the species is a keystone of a larger network that contributes to the ecosystem function of pest control, this is an example of how spatial dynamics at a large scale can affect ecosystem service at a local level.	[Vandermeer, John] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Vandermeer, John; Perfecto, Ivette] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Philpott, Stacy M.] Univ Toledo, Dept Environm Sci, Toledo, OH 43606 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University System of Ohio; University of Toledo	Vandermeer, J (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Kraus Nat Sci Bldg, Ann Arbor, MI 48109 USA.	jvander@umich.edu	Philpott, Stacy/M-3486-2019; Philpott, Stacy M/F-2330-2011	Philpott, Stacy/0000-0002-8338-3806; Philpott, Stacy M/0000-0002-8338-3806				Ball P., 1999, SELF MADE TAPESTRY P; CZARAN T, 1992, TRENDS ECOL EVOL, V7, P38, DOI 10.1016/0169-5347(92)90103-I; Durrett R, 1998, THEOR POPUL BIOL, V53, P30, DOI 10.1006/tpbi.1997.1338; FORMAN RTT, 1987, LANDSCAPE ECOLOGY; Gurney WSC, 2000, B MATH BIOL, V62, P61, DOI 10.1006/bulm.1999.0130; HASSELL MP, 1994, NATURE, V370, P290, DOI 10.1038/370290a0; Kefi S, 2007, NATURE, V449, P213, DOI 10.1038/nature06111; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Maron JL, 1997, SCIENCE, V278, P1619, DOI 10.1126/science.278.5343.1619; Pascual M, 2005, TRENDS ECOL EVOL, V20, P88, DOI 10.1016/j.tree.2004.11.012; Pascual M, 2002, PHILOS T ROY SOC B, V357, P657, DOI 10.1098/rstb.2001.0983; PERFECTO I, IN PRESS ECOLOGY; Perfecto I, 2006, AGR ECOSYST ENVIRON, V117, P218, DOI 10.1016/j.agee.2006.04.007; Philpott SM, 2004, OIKOS, V105, P141, DOI 10.1111/j.0030-1299.2004.12889.x; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; Roy Manojit, 2003, Complexity, V8, P19, DOI 10.1002/cplx.10096; TURNER SJ, 1990, ECOL STUD, V82, P17; Vandermeer J, 2006, SCIENCE, V311, P1000, DOI 10.1126/science.1121432; VANDERMEER J, UNPUB J AGR SCI; Wootton JT, 2001, NATURE, V413, P841, DOI 10.1038/35101595	20	93	97	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2008	451	7177					457	U3		10.1038/nature06477	http://dx.doi.org/10.1038/nature06477			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	253YS	18216853	Bronze, Green Published			2022-12-28	WOS:000252554100043
J	Romanowicz, B				Romanowicz, Barbara			Using seismic waves to image Earth's internal structure	NATURE			English	Article							VELOCITY STRUCTURE; SHEAR VELOCITY; MANTLE; HETEROGENEITIES; TOMOGRAPHY; DYNAMICS; SURFACE; BENEATH		[Romanowicz, Barbara] Univ Calif Berkeley, Berkeley Seismol Lab, Berkeley, CA 94720 USA; [Romanowicz, Barbara] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Romanowicz, B (corresponding author), Univ Calif Berkeley, Berkeley Seismol Lab, 215 McCone Hall, Berkeley, CA 94720 USA.	barbara.romanowicz@gmail.com	Romanowicz, barbara A/H-6726-2017	Romanowicz, barbara A/0000-0002-6208-6044				AKI K, 1977, J GEOPHYS RES, V82, P277, DOI 10.1029/JB082i002p00277; Bostock MG, 2002, NATURE, V417, P536, DOI 10.1038/417536a; DZIEWONSKI AM, 1977, J GEOPHYS RES, V82, P239, DOI 10.1029/JB082i002p00239; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Forsyth DW, 1998, SCIENCE, V280, P1235, DOI 10.1126/science.280.5367.1235; Gu YJ, 2001, J GEOPHYS RES-SOL EA, V106, P11169, DOI 10.1029/2001JB000340; Hirose K, 2006, REV GEOPHYS, V44, DOI 10.1029/2005RG000186; Kawakatsu H, 2007, SCIENCE, V316, P1468, DOI 10.1126/science.1140855; Kerr RA, 2006, SCIENCE, V313, P1726, DOI 10.1126/science.313.5794.1726; Komatitsch D, 2002, SCIENCE, V298, P1737, DOI 10.1126/science.1076024; Lay T, 1998, NATURE, V392, P461, DOI 10.1038/33083; Megnin C, 2000, GEOPHYS J INT, V143, P709, DOI 10.1046/j.1365-246X.2000.00298.x; Ritsema J, 1999, SCIENCE, V286, P1925, DOI 10.1126/science.286.5446.1925; Romanowicz B, 2003, ANNU REV EARTH PL SC, V31, P303, DOI 10.1146/annurev.earth.31.091602.113555; Shapiro NM, 2005, SCIENCE, V307, P1615, DOI 10.1126/science.1108339; van der Hilst RD, 2007, SCIENCE, V315, P1813, DOI 10.1126/science.1137867; Wen LX, 2001, EARTH PLANET SC LETT, V194, P83, DOI 10.1016/S0012-821X(01)00550-7	17	46	50	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2008	451	7176					266	268		10.1038/nature06583	http://dx.doi.org/10.1038/nature06583			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202638	Bronze			2022-12-28	WOS:000252432100030
J	Stevenson, DJ				Stevenson, David J.			A planetary perspective on the deep Earth	NATURE			English	Article							ACCRETION	Earth is an engine, tending to obliterate some of the evidence of events that are distant in time, but a memory is retained in its chemistry, its isotopes, the presence of the Moon, perhaps also in geophysical observables such as the temperature of the core and the nature of the mantle immediately above the core, and maybe even in the existence of plate tectonics and life. The remarkable growth in the study and understanding of Earth has happened in parallel with a spectacular era of planetary exploration, relevant astronomical discoveries and computational and theoretical advances, all of which help us to place Earth and its interior in a perspective that integrates the Earth sciences with extraterrestrial studies and basic sciences such as condensed- matter physics. However, progress on the biggest challenges in understanding the deep Earth continues to rely mainly on looking down rather than looking up.	CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	California Institute of Technology	Stevenson, DJ (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	djs@gps.caltech.edu						Boyet M, 2005, SCIENCE, V309, P576, DOI 10.1126/science.1113634; Canup RM, 2004, ANNU REV ASTRON ASTR, V42, P441, DOI 10.1146/annurev.astro.41.082201.113457; Chambers JE, 2004, EARTH PLANET SC LETT, V223, P241, DOI 10.1016/j.epsl.2004.04.031; HALLIDAY AN, 2007, TREATISE GEOPHYS, V9, P13; Mosenfelder JL, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004364; Nimmo F, 2007, TREATISE GEOPHYS, V9, P217, DOI DOI 10.1016/B978-044452748-6/00147-4; Ogihara M, 2007, ICARUS, V188, P522, DOI 10.1016/j.icarus.2006.12.006; Pahlevan K, 2007, EARTH PLANET SC LETT, V262, P438, DOI 10.1016/j.epsl.2007.07.055; Raymond SN, 2006, SCIENCE, V313, P1413, DOI 10.1126/science.1130461; Rubie D. C., 2015, TREATISE GEOPHYS, V9, P43, DOI DOI 10.1016/B978-044452748-6.00140-1; Solomatov V. S., 2007, TREATISE GEOPHYS, V9, P91, DOI DOI 10.1016/B978-044452748-6.00141-3); Stixrude L, 2005, SCIENCE, V310, P297, DOI 10.1126/science.1116952; Touboul M, 2007, NATURE, V450, P1206, DOI 10.1038/nature06428; Udry S, 2007, ASTRON ASTROPHYS, V469, pL43, DOI 10.1051/0004-6361:20077612; Wilde SA, 2001, NATURE, V409, P175, DOI 10.1038/35051550	17	38	44	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2008	451	7176					261	265		10.1038/nature06582	http://dx.doi.org/10.1038/nature06582			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202637	Bronze			2022-12-28	WOS:000252432100029
J	Chadda, R; Mayor, S				Chadda, Rahul; Mayor, Satyajit			PTRF triggers a cave in	CELL			English	Editorial Material							PROTEIN; DOMAINS; ADIPOCYTES; CAVEOLIN-1	Caveolae are small membrane invaginations important for cell signaling that are characterized by the presence of caveolin proteins. Hill et al. (2008) have now identified PTRF as a new constituent of the caveolar coat. In the absence of PTRF, caveolae flatten and caveolin-1 is released into the cell membrane, where it is rapidly internalized and degraded.	[Chadda, Rahul; Mayor, Satyajit] Natl Ctr Biol Sci, Bangalore 560005, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Mayor, S (corresponding author), Natl Ctr Biol Sci, Bangalore 560005, Karnataka, India.	mayor@ncbs.res.in	Chadda, Rahul/AAM-2085-2020					Aboulaich N, 2004, BIOCHEM J, V383, P237, DOI 10.1042/BJ20040647; Foti M, 2007, P NATL ACAD SCI USA, V104, P1242, DOI 10.1073/pnas.0610523104; HILL MM, 2008, CELL, V30; Jansa P, 1998, EMBO J, V17, P2855, DOI 10.1093/emboj/17.10.2855; Machleidt T, 2000, J CELL BIOL, V148, P17, DOI 10.1083/jcb.148.1.17; MONIER S, 1995, MOL BIOL CELL, V6, P911, DOI 10.1091/mbc.6.7.911; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; Nixon SJ, 2007, J CELL SCI, V120, P2151, DOI 10.1242/jcs.003830; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Tagawa A, 2005, J CELL BIOL, V170, P769, DOI 10.1083/jcb.200506103; Wanaski SP, 2003, BIOCHEMISTRY-US, V42, P42, DOI 10.1021/bi012097n	12	24	24	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 11	2008	132	1					23	24		10.1016/j.cell.2007.12.021	http://dx.doi.org/10.1016/j.cell.2007.12.021			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IL	18191216	Bronze			2022-12-28	WOS:000253427600011
J	Nariya, H; Inouye, M				Nariya, Hirofumi; Inouye, Masayori			MazF, an mRNA interferase, mediates programmed cell death during multicellular Myxococcus development	CELL			English	Article							SER/THR KINASE CASCADE; ESCHERICHIA-COLI; XANTHUS DEVELOPMENT; PROTEIN-SYNTHESIS; GENES; SPORULATION; BACTERIA; 6-PHOSPHOFRUCTOKINASE; IDENTIFICATION; MUTANTS	In prokaryotes, the toxin-antitoxin systems are thought to play important roles in growth regulation under stress conditions. In the E. coli MazE-MazF system, MazF toxin functions as an mRNA interferase cleaving mRNAs at ACA sequences to inhibit protein synthesis leading to cell growth arrest. Myxococcus xanthus is a bacterium displaying multicellular fruiting body development during which approximately 80% of cells undergo obligatory cell lysis. Here, we demonstrate that M. xanthus has a solitary mazF gene that lacks a cotranscribed antitoxin gene. The mazF deletion results in elimination of the obligatory cell death during development causing dramatic reduction in spore formation. Surprisingly, MrpC, a key developmental regulator, functions as a MazF antitoxin and a mazF transcription activator. Transcription of mrpC and mazF is negatively regulated via MrpC phosphorylation by a Ser/Thr kinase cascade. These findings reveal the regulated deployment of a toxin gene for developmental programmed cell death in bacteria.	[Nariya, Hirofumi; Inouye, Masayori] Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Inouye, M (corresponding author), Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA.	inouye@umdnj.edu						Berleman JE, 2007, J BACTERIOL, V189, P5675, DOI 10.1128/JB.00544-07; CAMPOS JM, 1978, J MOL BIOL, V119, P167, DOI 10.1016/0022-2836(78)90431-X; Dworkin M, 1996, MICROBIOL REV, V60, P70, DOI 10.1128/MMBR.60.1.70-102.1996; Engelberg-Kulka H, 2005, J CELL SCI, V118, P4327, DOI 10.1242/jcs.02619; Engelberg-Kulka H, 2003, SCIENCE, V301, P467, DOI 10.1126/science.1088051; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; HAGEN DC, 1978, DEV BIOL, V64, P284, DOI 10.1016/0012-1606(78)90079-9; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; INOUYE M, 1979, P NATL ACAD SCI USA, V76, P209, DOI 10.1073/pnas.76.1.209; James P, 1996, GENETICS, V144, P1425; Julien B, 2000, P NATL ACAD SCI USA, V97, P9098, DOI 10.1073/pnas.97.16.9098; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Kimura Y, 2002, J BACTERIOL, V184, P3578, DOI 10.1128/JB.184.13.3578-3585.2002; Kolodkin-Gal I, 2007, SCIENCE, V318, P652, DOI 10.1126/science.1147248; Komano T, 2000, MOL MICROBIOL, V35, P1348, DOI 10.1046/j.1365-2958.2000.01769.x; KROOS L, 1986, DEV BIOL, V117, P252, DOI 10.1016/0012-1606(86)90368-4; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Lioy VS, 2006, MICROBIOL-SGM, V152, P2365, DOI 10.1099/mic.0.28950-0; LIU YC, 1990, BIOTECHNIQUES, V9, P558; Marianovsky I, 2001, J BIOL CHEM, V276, P5975, DOI 10.1074/jbc.M008832200; Miller J.H., 1972, EXPT MOL GENETICS CO; MORRISON CE, 1979, J BACTERIOL, V140, P1036, DOI 10.1128/JB.140.3.1036-1042.1979; MUNOZDORADO J, 1991, CELL, V67, P995, DOI 10.1016/0092-8674(91)90372-6; Nariya H, 2005, MOL MICROBIOL, V58, P367, DOI 10.1111/j.1365-2958.2005.04826.x; Nariya H, 2005, MOL MICROBIOL, V56, P1314, DOI 10.1111/j.1365-2958.2005.04619.x; Nariya H, 2003, MOL MICROBIOL, V49, P517, DOI 10.1046/j.1365-2958.2003.03572.x; Nariya H, 2006, MOL MICROBIOL, V60, P1205, DOI 10.1111/j.1365-2958.2006.05178.x; NORIOKA N, 1995, J BACTERIOL, V177, P4179, DOI 10.1128/jb.177.14.4179-4182.1995; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pellegrini O, 2005, MOL MICROBIOL, V56, P1139, DOI 10.1111/j.1365-2958.2005.04606.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd, ed.; Shimazu T, 2007, GENE DEV, V21, P929, DOI 10.1101/gad.1522007; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Sun H, 2001, J BACTERIOL, V183, P4786, DOI 10.1128/JB.183.16.4786-4795.2001; Suzuki M, 2005, MOL CELL, V18, P253, DOI 10.1016/j.molcel.2005.03.011; Tojo N, 1996, J BACTERIOL, V178, P4004, DOI 10.1128/jb.178.14.4004-4011.1996; Tsilibaris V, 2007, J BACTERIOL, V189, P6101, DOI 10.1128/JB.00527-07; Ueki T, 1996, GENE, V183, P153, DOI 10.1016/S0378-1119(96)00546-X; Ueki T, 2003, P NATL ACAD SCI USA, V100, P8782, DOI 10.1073/pnas.1533026100; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhu L, 2006, J BIOL CHEM, V281, P18638, DOI 10.1074/jbc.M512693200; ZUKER M, 1989, METHOD ENZYMOL, V180, P262	44	187	195	3	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2008	132	1					55	66		10.1016/j.cell.2007.11.044	http://dx.doi.org/10.1016/j.cell.2007.11.044			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IL	18191220	Bronze			2022-12-28	WOS:000253427600015
J	Richardson, E; Marone, C				Richardson, Eliza; Marone, Chris			Geophysics - What triggers tremor?	SCIENCE			English	Editorial Material							CASCADIA SUBDUCTION ZONE; NON-VOLCANIC TREMOR; EPISODIC TREMOR; NONVOLCANIC TREMOR; EARTHQUAKES; SLIP; SEISMICITY; JAPAN; FAULTS; TIDES		[Richardson, Eliza; Marone, Chris] Ist Nazl Geofis & Vulcanol, Rome, Italy; [Richardson, Eliza; Marone, Chris] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	Istituto Nazionale Geofisica e Vulcanologia (INGV); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Richardson, E (corresponding author), Ist Nazl Geofis & Vulcanol, Rome, Italy.	eliza@geosc.psu.edu						Abercrombie RE, 2005, GEOPHYS J INT, V162, P406, DOI 10.1111/j.1365-246X.2005.02579.x; BEROZA GC, 1990, J GEOPHYS RES-SOLID, V95, P2485, DOI 10.1029/JB095iB03p02485; Brudzinski MR, 2007, GEOLOGY, V35, P907, DOI 10.1130/G23740A.1; BURTINI L, 2007, GEOLOGY, V35, P183; Cochran ES, 2004, SCIENCE, V306, P1164, DOI 10.1126/science.1103961; Gomberg J, 2008, SCIENCE, V319, P173, DOI 10.1126/science.1149164; Harrington RM, 2006, B SEISMOL SOC AM, V96, P871, DOI 10.1785/0120050076; Ide S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028890; Kasahara J, 2002, SCIENCE, V297, P348, DOI 10.1126/science.1074601; McGuire JJ, 2005, NATURE, V434, P457, DOI 10.1038/nature03377; McNutt SR, 2005, ANNU REV EARTH PL SC, V33, P461, DOI 10.1146/annurev.earth.33.092203.122459; Miller MM, 2002, SCIENCE, V295, P2423, DOI 10.1126/science.1071193; Nadeau RM, 2005, SCIENCE, V307, P389, DOI 10.1126/science.1107142; Obara K, 2002, SCIENCE, V296, P1679, DOI 10.1126/science.1070378; Obara K., 2004, GEOPHYS RES LETT, V31; RICE JR, 1983, PURE APPL GEOPHYS, V121, P187, DOI 10.1007/BF02590135; Richardson E, 2002, B SEISMOL SOC AM, V92, P1766, DOI 10.1785/0120000226; Rogers G, 2003, SCIENCE, V300, P1942, DOI 10.1126/science.1084783; Roy M, 1996, J GEOPHYS RES-SOL EA, V101, P13919, DOI 10.1029/96JB00529; Rubinstein JL, 2008, SCIENCE, V319, P186, DOI 10.1126/science.1150558; Rubinstein JL, 2007, NATURE, V448, P579, DOI 10.1038/nature06017; Savage HM, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2005JB004238; Shelly DR, 2007, NATURE, V446, P305, DOI 10.1038/nature05666; Shelly DR, 2006, NATURE, V442, P188, DOI 10.1038/nature04931; Tolstoy M, 2002, GEOLOGY, V30, P503, DOI 10.1130/0091-7613(2002)030<0503:BOTSTC>2.0.CO;2	25	5	5	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2008	319	5860					166	167		10.1126/science.1152877	http://dx.doi.org/10.1126/science.1152877			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249RC	18187646				2022-12-28	WOS:000252246400028
J	Yeung, T; Gilbert, GE; Shi, J; Silvius, J; Kapus, A; Grinstein, S				Yeung, Tony; Gilbert, Gary E.; Shi, Jialan; Silvius, John; Kapus, Andras; Grinstein, Sergio			Membrane phosphatidylserine regulates surface charge and protein localization	SCIENCE			English	Article							PLASMA-MEMBRANE; ELECTROSTATIC SWITCH; BINDING; LACTADHERIN; ASSOCIATION; APOPTOSIS; K-RAS4B; DOMAIN	Electrostatic interactions with negatively charged membranes contribute to the subcellular targeting of proteins with polybasic clusters or cationic domains. Although the anionic phospholipid phosphatidylserine is comparatively abundant, its contribution to the surface charge of individual cellular membranes is unknown, partly because of the lack of reagents to analyze its distribution in intact cells. We developed a biosensor to study the subcellular distribution of phosphatidylserine and found that it binds the cytosolic leaflets of the plasma membrane, as well as endosomes and lysosomes. The negative charge associated with the presence of phosphatidylserine directed proteins with moderately positive charge to the endocytic pathway. More strongly cationic proteins, normally associated with the plasma membrane, relocalized to endocytic compartments when the plasma membrane surface charge decreased on calcium influx.	[Yeung, Tony; Grinstein, Sergio] Hosp Sick Children, Div Cell Biol, Toronto, ON M5G 1X8, Canada; [Gilbert, Gary E.; Shi, Jialan] Harvard Univ, Dept Vet Affairs, Brigham & Womens Hosp, Dept Med,VA Boston Healthcare Syst,Sch Med, Boston, MA 02115 USA; [Silvius, John] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Kapus, Andras] Univ Toronto, St Michaels Hosp, Keenan Res Ctr, Li Ka Sheng Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Kapus, Andras] Univ Toronto, Dept Surg, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Harvard University; Brigham & Women's Hospital; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System; McGill University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Grinstein, S (corresponding author), Hosp Sick Children, Div Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	sga@sickkids.ca		Shi, Jialan/0000-0001-5642-5436; Yeung, Tony/0000-0002-1970-5751				Andersen MH, 2000, BIOCHEMISTRY-US, V39, P6200, DOI 10.1021/bi992221r; ATKINSON K, 1980, J BIOL CHEM, V255, P6653; Balasubramanian K, 2007, J BIOL CHEM, V282, P18357, DOI 10.1074/jbc.M700202200; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; GILBERT GE, 1990, J BIOL CHEM, V265, P815; Gilbert GE, 2002, J BIOL CHEM, V277, P6374, DOI 10.1074/jbc.M104732200; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Leventis R, 1998, BIOCHEMISTRY-US, V37, P7640, DOI 10.1021/bi973077h; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Murray D, 1998, BIOCHEMISTRY-US, V37, P2145, DOI 10.1021/bi972012b; Roy MO, 2000, BIOCHEMISTRY-US, V39, P8298, DOI 10.1021/bi000512q; Shi JL, 2004, BBA-BIOMEMBRANES, V1667, P82, DOI 10.1016/j.bbamem.2004.09.006; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551	17	728	752	5	185	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2008	319	5860					210	213		10.1126/science.1152066	http://dx.doi.org/10.1126/science.1152066			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249RC	18187657				2022-12-28	WOS:000252246400043
J	Voss, D; Coontz, R				Voss, David; Coontz, Robert			Warp and woof - Introduction	SCIENCE			English	Editorial Material																			0	0	0	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2008	319	5859					46	46		10.1126/science.319.5859.46	http://dx.doi.org/10.1126/science.319.5859.46			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18174428				2022-12-28	WOS:000252084000022
J	Budetti, PP				Budetti, Peter P.			Market justice and US Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; INSURANCE; INDUSTRY		Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Dept Hlth Policy & Adm, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Budetti, PP (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Dept Hlth Policy & Adm, 801 NE 13th St,Room CHB343A, Oklahoma City, OK 73104 USA.	peter-budetti@ouhsc.edu						Angell M, 2004, CAN MED ASSOC J, V171, P1451, DOI 10.1503/cmaj.1041594; [Anonymous], 1988, FUT PUBL HLTH; *ASS AM MED COLL, 2007, US MED SCH APPL STUD; Centers for Medicare and Medicaid Services, 1960, NAT HLTH EXP TYP SER; Claxton G, 1997, HEALTH AFFAIR, V16, P9, DOI 10.1377/hlthaff.16.2.9; Conrad P, 2004, J HEALTH SOC BEHAV, V45, P158; Davis K, 2007, SLOWING GROWTH US HL; DeBakey ME, 2006, AM J SURG, V191, P145, DOI 10.1016/j.amjsurg.2005.09.016; DENAVASWALT C, 2007, P60233 US CENS BUR; Dorfman L, 2005, HEALTH EDUC BEHAV, V32, P320, DOI 10.1177/1090198105275046; Enthoven AC, 2006, HEALTH AFFAIR, V25, P1538, DOI 10.1377/hlthaff.25.6.1538; HOY EW, 1986, TRENDS GROWTH MAJOR; *KAIS FAM FDN HLTH, EMPL HLTH BEN 2007 A; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Mullan F, 2005, NEW ENGL J MED, V353, P1810, DOI 10.1056/NEJMsa050004; Needleman J, 1997, HEALTH AFFAIR, V16, P187, DOI 10.1377/hlthaff.16.2.187; Quadagno J, 2004, J HEALTH SOC BEHAV, V45, P25; Robinson JC, 2006, HEALTH AFFAIR, V25, P1475, DOI 10.1377/hlthaff.25.6.1475; Robinson JC, 2004, HEALTH AFFAIR, V23, P11, DOI 10.1377/hlthaff.23.6.11; SALKEVER DS, 1976, MILBANK FUND Q, V54, P185, DOI 10.2307/3349587; Schoen C, 2006, HEALTH AFFAIR, V25, pW457, DOI 10.1377/hlthaff.25.w457; SCOFEA LA, 1994, MON LABOR REV, V117, P3; Thorpe KE, 2005, HEALTH AFFAIR, V24, P1436, DOI 10.1377/hlthaff.24.6.1436; *US BUR CENS, 1971, STAT ABSTR US 1971; *US DEP HEW, 1964, HLTH INS COV US JUL	25	12	12	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2008	299	1					92	94		10.1001/jama.2007.27	http://dx.doi.org/10.1001/jama.2007.27			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247BL	18167411				2022-12-28	WOS:000252052000022
J	Tanabe, KK; Lemoine, A; Finkelstein, DM; Kawasaki, H; Fujii, T; Chung, RT; Lauwers, GY; Kulu, Y; Muzikansky, A; Kuruppu, D; Lanuti, M; Goodwin, JM; Azoulay, D; Fuchs, BC				Tanabe, Kenneth K.; Lemoine, Antoinette; Finkelstein, Dianne M.; Kawasaki, Hiroshi; Fujii, Tsutomu; Chung, Raymond T.; Lauwers, Gregory Y.; Kulu, Yakup; Muzikansky, Alona; Kuruppu, Darshini; Lanuti, Michael; Goodwin, Jonathan M.; Azoulay, Daniel; Fuchs, Bryan C.			Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EGF GENE; EXPRESSION; CANCER; LIVER; RESPONSIVENESS; HEPATOCYTES; ASSOCIATION; INHIBITOR; GEFITINIB; MELANOMA	Context Overexpression of epidermal growth factor (EGF) in the liver induces transformation to hepatocellular carcinoma in animal models. Polymorphisms in the EGF gene modulate EGF levels. Objective To assess the relationship among human EGF gene single-nucleotide polymorphism, EGF expression, and risk of hepatocellular carcinoma. Design, Setting, and Participants Molecular mechanisms linking the 61*G allele polymorphism to EGF expression were examined in human hepatocellular carcinoma cell lines and human liver tissue. A case-control study involving 207 patients with cirrhosis was conducted at the Massachusetts General Hospital (1999-2006) and a validation case-control study involving 121 patients with cirrhosis was conducted at Hopital Paul Brousse (1993-2006). Restriction fragment-length polymorphism was used to determine the EGF gene polymorphism genotype. Logistic regression analysis was used to assess the association between the EGF polymorphism and hepatocellular carcinoma risk. Main Outcome Measures Mechanisms by which the EGF gene polymorphism modulates EGF levels and associations among EGF gene polymorphism, EGF levels, and hepatocellular carcinoma. Results Transcripts from the EGF 61*G allele exhibited more than a 2-fold longer half-life than those from the 61*A allele, and EGF secretion was 2.3-fold higher in G/G hepatocellular carcinoma cell lines than A/A cell lines. Serum EGF levels were 1.8-fold higher in G/G patients than A/A patients, and liver EGF levels were 2.4-fold higher in G/G patients than A/A patients. Among the 207 patients with cirrhosis in the Massachusetts study population, 59 also had hepatocellular carcinoma. Analysis of the distribution of allelic frequencies revealed that there was a 4-fold odds of hepatocellular carcinoma in G/G patients compared with A/A patients in the Massachusetts study population (odds ratio, 4.0; 95% confidence interval [0], 1.6-9.6; P=.002). Logistic regression analysis demonstrated that the number of copies of G was significantly associated with hepatocellular carcinoma after adjusting for age, sex, race, etiology, and severity of cirrhosis (G/G or A/G vs A/A; hazard ratio, 3.49; 95% Cl, 1.29-9.44; P=.01). The significant association was validated in the French patients with alcoholic cirrhosis and hepatocellular carcinoma. Conclusion The EGF gene polymorphism genotype is associated with risk for development of hepatocellular carcinoma in liver cirrhosis through modulation of EGF levels.	[Tanabe, Kenneth K.; Kawasaki, Hiroshi; Fujii, Tsutomu; Kulu, Yakup; Kuruppu, Darshini; Fuchs, Bryan C.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Surg Oncol, Boston, MA 02114 USA; [Finkelstein, Dianne M.; Muzikansky, Alona] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Biostat, Boston, MA 02114 USA; [Chung, Raymond T.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med,Gastrointestinal Unit, Boston, MA 02114 USA; [Lauwers, Gregory Y.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Lanuti, Michael; Goodwin, Jonathan M.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Thorac Surg, Boston, MA 02114 USA; [Lemoine, Antoinette; Azoulay, Daniel] Hop Paul Brousse, Assistance Publ Hop Paris, Ctr Chirurg Hepatobiliaire, Villejuif, France; Univ Paris 11, Fac Pharm, F-92290 Chatenay Malabry, France; INSERM, U602, Villejuif, France	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm)	Tanabe, KK (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Surg Oncol, Yawkey 7-924,55 Fruit St, Boston, MA 02114 USA.	ktanabe@partners.org	Azoulay, Daniel/Q-7887-2018; Fujii, Tsutomu/M-4838-2014		NATIONAL CANCER INSTITUTE [P30CA006516, P01CA111519, R01CA076183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI006993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK078772] Funding Source: NIH RePORTER; NCI NIH HHS [2P30 CA06516-43, 5P01CA111519, P30 CA006516, 2R01CA76183] Funding Source: Medline; NIAID NIH HHS [AI06993] Funding Source: Medline; NIDDK NIH HHS [DK078772] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amend KL, 2004, CANCER RES, V64, P2668, DOI 10.1158/0008-5472.CAN-03-3855; Berrahmoune H, 2007, J INVEST DERMATOL, V127, P969, DOI 10.1038/sj.jid.5700650; Bhowmick DA, 2004, CANCER RES, V64, P1220, DOI 10.1158/0008-5472.CAN-03-3137; BLANC P, 1992, GASTROENTEROLOGY, V102, P1340; Borlak J, 2005, ONCOGENE, V24, P1809, DOI 10.1038/sj.onc.1208196; CARPENTER G, 1979, ANNU REV BIOCHEM, V48, P193, DOI 10.1146/annurev.bi.48.070179.001205; COHEN S, 1962, J BIOL CHEM, V237, P1555; Ding CM, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-8; FISHER DA, 1990, ENDOCR REV, V11, P418, DOI 10.1210/edrv-11-3-418; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; HOFFMANN B, 1989, J CELL PHYSIOL, V139, P654, DOI 10.1002/jcp.1041390328; *IARC, 2004, MON EV CARC RISKS HU, V59; Komuves LG, 2000, J HISTOCHEM CYTOCHEM, V48, P821, DOI 10.1177/002215540004800610; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; MULLHAUPT B, 1994, J BIOL CHEM, V269, P19667; OKA Y, 1983, J CLIN INVEST, V72, P249, DOI 10.1172/JCI110964; PARK JG, 1995, INT J CANCER, V62, P276, DOI 10.1002/ijc.2910620308; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; ROBERTS AB, 1985, NATURE, V315, P237, DOI 10.1038/315237a0; Rosenthal N, 1998, NEW ENGL J MED, V338, P122, DOI 10.1056/NEJM199801083380210; Saffroy R, 2004, CARCINOGENESIS, V25, P1443, DOI 10.1093/carcin/bgh147; SAINSBURY JRC, 1985, LANCET, V1, P364; Schiffer E, 2005, HEPATOLOGY, V41, P307, DOI 10.1002/hep.20538; Shahbazi M, 2002, LANCET, V359, P397, DOI 10.1016/S0140-6736(02)07600-6; SINGLETARY SE, 1987, CANCER RES, V47, P403; STERN DF, 1987, SCIENCE, V235, P321, DOI 10.1126/science.3492043; STOSCHECK CM, 1986, CANCER RES, V46, P1030; Thomas MB, 2005, J CLIN ONCOL, V23, P2892, DOI 10.1200/JCO.2005.03.196; TONJES RR, 1995, ONCOGENE, V10, P765; Yoon SS, 2000, FASEB J, V14, P301, DOI 10.1096/fasebj.14.2.301; Yoon SS, 1998, ANN SURG, V228, P366, DOI 10.1097/00000658-199809000-00009	33	172	175	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2008	299	1					53	60		10.1001/jama.2007.65	http://dx.doi.org/10.1001/jama.2007.65			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247BL	18167406	Bronze			2022-12-28	WOS:000252052000016
J	Marine, JE				Marine, Joseph E.			Catheter ablation therapy for supraventricular arrhythmias	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PARKINSON-WHITE-SYNDROME; PAROXYSMAL ATRIAL-FIBRILLATION; NODAL REENTRANT TACHYCARDIA; PULMONARY VEIN ISOLATION; RADIOFREQUENCY ABLATION; ATRIOVENTRICULAR JUNCTION; INTRACARDIAC ECHOCARDIOGRAPHY; VENTRICULAR-FIBRILLATION; ASYMPTOMATIC PATIENTS; CONDUCTION SYSTEM	The supraventricular arrhythmias include a wide spectrum of disorders including, in descending order of frequency, atrial fibrillation, atrial flutter, atrioventricular nodal reentry, Wolff- Parkinson- White syndrome, and atrial tachycardia. While not life- threatening in most cases, they may cause important symptoms, such as palpitations, chest discomfort, breathlessness, anxiety, and syncope, which significantly impair quality of life. Medical therapy has variable efficacy, and most patients are not rendered free of symptoms. Research over the past several decades has revealed fundamental mechanisms involved in the initiation and maintenance of all of these arrhythmias. Knowledge of mechanisms has in turn led to highly effective surgical and catheter-based treatments. Atrial fibrillation remains a therapeutic challenge but is also yielding to investigation and therapeutic efforts. The supraventricular arrhythmias and their treatment are described in this report.	Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA	Johns Hopkins University	Marine, JE (corresponding author), Johns Hopkins Bayview Med Ctr, 4940 Eastern Ave,A-1 E, Baltimore, MD 21224 USA.	jmarine2@jhmi.edu						Al-Khatib SM, 1999, AM HEART J, V138, P403, DOI 10.1016/S0002-8703(99)70140-7; Blomstrom-Lundqvist C, 2003, CIRCULATION, V108, P1871, DOI 10.1161/01.CIR.0000091380.04100.84; Calkins H, 1999, CIRCULATION, V99, P262, DOI 10.1161/01.CIR.99.2.262; CALKINS H, 1991, NEW ENGL J MED, V324, P1612, DOI 10.1056/NEJM199106063242302; Calkins H, 2007, HEART RHYTHM, V4, P816, DOI 10.1016/j.hrthm.2007.04.005; Cappato R, 2005, CIRCULATION, V111, P1100, DOI 10.1161/01.CIR.0000157153.30978.67; Cheema A, 2006, J CARDIOVASC ELECTR, V17, P1080, DOI 10.1111/j.1540-8167.2006.00569.x; Chen SA, 1999, CIRCULATION, V100, P1879, DOI 10.1161/01.CIR.100.18.1879; COBB FR, 1968, CIRCULATION, V38, P1018, DOI 10.1161/01.CIR.38.6.1018; COX JL, 1995, J THORAC CARDIOV SUR, V110, P473, DOI 10.1016/S0022-5223(95)70244-X; Cummings JE, 2006, ANN INTERN MED, V144, P572, DOI 10.7326/0003-4819-144-8-200604180-00007; Dong J, 2006, J CARDIOVASC ELECTR, V17, P459, DOI 10.1111/j.1540-8167.2006.00425.x; FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; FELD GK, 1992, CIRCULATION, V86, P1233, DOI 10.1161/01.CIR.86.4.1233; FLEGEL KM, 1987, LANCET, V1, P526; Friedman PL, 2004, HEART RHYTHM, V1, P129, DOI 10.1016/j.hrthm.2004.02.022; Fuster V, 2006, J AM COLL CARDIOL, V48, P854, DOI 10.1016/j.jacc.2006.07.009; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Gepstein L, 1997, CIRCULATION, V95, P1611; Glatter KA, 1999, CIRCULATION, V99, P1034, DOI 10.1161/01.CIR.99.8.1034; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Goldschlager N, 2007, HEART RHYTHM, V4, P1250, DOI 10.1016/j.hrthm.2007.07.020; Haines D, 2004, J CARDIOVASC ELECTR, V15, pS2, DOI 10.1046/j.1540-8167.2004.15102.x; Haissaguerre M, 2000, AM J CARDIOL, V86, p9K, DOI 10.1016/S0002-9149(00)01186-3; Haissaguerre M, 1996, J CARDIOVASC ELECTR, V7, P1132, DOI 10.1111/j.1540-8167.1996.tb00492.x; Haissaguerre M, 2000, CIRCULATION, V101, P1409, DOI 10.1161/01.CIR.101.12.1409; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Hsu LF, 2005, PACE, V28, pS106, DOI 10.1111/j.1540-8159.2005.00062.x; HUANG SK, 1987, J AM COLL CARDIOL, V9, P349, DOI 10.1016/S0735-1097(87)80388-1; JACKMAN WM, 1991, NEW ENGL J MED, V324, P1605, DOI 10.1056/NEJM199106063242301; Jalife J, 1998, J CARDIOVASC ELECTR, V9, pS2; KALBFLEISCH SJ, 1993, J AM COLL CARDIOL, V21, P85, DOI 10.1016/0735-1097(93)90720-L; KANNEL WB, 1983, AM HEART J, V106, P389, DOI 10.1016/0002-8703(83)90208-9; Kay GN, 1998, J INTERV CARD ELECTR, V2, P121, DOI 10.1023/A:1009795330454; Kistler PM, 2006, J AM COLL CARDIOL, V48, P1010, DOI 10.1016/j.jacc.2006.03.058; KLEIN GJ, 1986, AM J CARDIOL, V57, P587, DOI 10.1016/0002-9149(86)90840-4; KLEIN GJ, 1979, NEW ENGL J MED, V301, P1080, DOI 10.1056/NEJM197911153012003; LANGBERG JJ, 1993, CIRCULATION, V87, P1551, DOI 10.1161/01.CIR.87.5.1551; Lewis T, 1920, HEART-J STUD CIRC, V7, P191; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; Marine JE, 2005, PROG CARDIOVASC DIS, V48, P178, DOI 10.1016/j.pcad.2005.06.011; Marrouche NF, 2003, CIRCULATION, V107, P2710, DOI 10.1161/01.CIR.0000070541.83326.15; McCarthy P M, 2000, Semin Thorac Cardiovasc Surg, V12, P25; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; MOE GK, 1964, AM HEART J, V67, P200, DOI 10.1016/0002-8703(64)90371-0; MONTOYA PT, 1991, EUR HEART J, V12, P144; NATHAN H, 1966, CIRCULATION, V34, P412, DOI 10.1161/01.CIR.34.3.412; OLGIN JE, 1995, CIRCULATION, V92, P1839, DOI 10.1161/01.CIR.92.7.1839; Oral H, 2003, CIRCULATION, V108, P2355, DOI 10.1161/01.CIR.0000095796.45180.88; Oral H, 2006, NEW ENGL J MED, V354, P934, DOI 10.1056/NEJMoa050955; Ouyang FF, 2004, CIRCULATION, V110, P2090, DOI 10.1161/01.CIR.0000144459.37455.EE; PACKER DL, 1992, CIRCULATION, V85, P574, DOI 10.1161/01.CIR.85.2.574; Pappone C, 2003, NEW ENGL J MED, V349, P1803, DOI 10.1056/NEJMoa035345; Pappone C, 2001, CIRCULATION, V104, P2539, DOI 10.1161/hc4601.098517; Pappone C, 2000, CIRCULATION, V102, P2619; Paydak H, 1998, CIRCULATION, V98, P315, DOI 10.1161/01.CIR.98.4.315; POTY H, 1995, CIRCULATION, V92, P1389; Qureshi AM, 2003, CIRCULATION, V108, P1336, DOI 10.1161/01.CIR.0000086322.21781.6A; Roy D, 2000, NEW ENGL J MED, V342, P913, DOI 10.1056/NEJM200003303421302; Saad EB, 2003, CIRCULATION, V108, P3102, DOI 10.1161/01.CIR.0000104569.96907.7F; Saito T, 2000, J CARDIOVASC ELECTR, V11, P888, DOI 10.1111/j.1540-8167.2000.tb00068.x; Schaff H V, 2000, Semin Thorac Cardiovasc Surg, V12, P30; Scheinman M, 2003, PACE, V26, P789, DOI 10.1046/j.1460-9592.2003.00139.x; SCHEINMAN MM, 1982, JAMA-J AM MED ASSOC, V248, P851, DOI 10.1001/jama.248.7.851; Singh BN, 2005, NEW ENGL J MED, V352, P1861, DOI 10.1056/NEJMoa041705; STRICKBERGER SA, 1993, J CARDIOVASC ELECTR, V4, P526; SWARTZ JF, 1994, CIRCULATION, V90, P335; Tsai CF, 1999, CIRCULATION, V100, P768, DOI 10.1161/01.CIR.100.7.768; Wazni OM, 2005, JAMA-J AM MED ASSOC, V293, P2634, DOI 10.1001/jama.293.21.2634; Wellens HJ, 2005, CIRCULATION, V112, P2201, DOI 10.1161/CIRCULATIONAHA.104.483321; Wolff L, 1930, AM HEART J, V5, P685, DOI 10.1016/S0002-8703(30)90086-5; Wood MA, 2000, CIRCULATION, V101, P1138, DOI 10.1161/01.CIR.101.10.1138; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328	73	11	12	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2007	298	23					2768	2778		10.1001/jama.298.23.2768	http://dx.doi.org/10.1001/jama.298.23.2768			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242HK	18165670				2022-12-28	WOS:000251716000022
J	Hanyu-Nakamura, K; Sonobe-Nojima, H; Tanigawa, A; Lasko, P; Nakamura, A				Hanyu-Nakamura, Kazuko; Sonobe-Nojima, Hiroko; Tanigawa, Akie; Lasko, Paul; Nakamura, Akira			Drosophila Pgc protein inhibits P-TEFb recruitment to chromatin in primordial germ cells	NATURE			English	Article							RNA-POLYMERASE-II; HEAT-SHOCK; C-ELEGANS; TRANSCRIPTION ELONGATION; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; NONCODING RNA; HIV-1 TAT; IN-VIVO; KINASE	Germ cells are the only cells that transmit genetic information to the next generation, and they therefore must be prevented from differentiating inappropriately into somatic cells(1). A common mechanism by which germline progenitors are protected from differentiation- inducing signals is a transient and global repression of RNA polymerase II ( RNAPII)- dependent transcription(1). In both Drosophila and Caenorhabditis elegans embryos, the repression of messenger RNA transcription during germ cell specification correlates with an absence of phosphorylation of Ser 2 residues in the carboxy- terminal domain of RNAPII ( hereafter called CTD)(2), a critical modification for transcriptional elongation(3). Here we show that, in Drosophila embryos, a small protein encoded by polar granule component ( pgc) is essential for repressing CTD Ser 2 phosphorylation in newly formed pole cells, the germline progenitors. Ectopic Pgc expression in somatic cells is sufficient to repress CTD Ser 2 phosphorylation. Furthermore, Pgc interacts, physically and genetically, with positive transcription elongation factor b ( P- TEFb), the CTD Ser 2 kinase complex, and prevents its recruitment to transcription sites. These results indicate that Pgc is a cell- type- specific P- TEFb inhibitor that has a fundamental role in Drosophila germ cell specification. In C. elegans embryos, PIE- 1 protein segregates to germline blastomeres, and is thought to repress mRNA transcription through interaction with P- TEFb(4-7). Thus, inhibition of P- TEFb is probably a common mechanism during germ cell specification in the disparate organisms C. elegans and Drosophila.	[Hanyu-Nakamura, Kazuko; Sonobe-Nojima, Hiroko; Tanigawa, Akie; Nakamura, Akira] RIKEN, Ctr Dev Biol, Lab Germline Dev, Kobe, Hyogo 6500047, Japan; [Lasko, Paul] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	RIKEN; McGill University	Nakamura, A (corresponding author), RIKEN, Ctr Dev Biol, Lab Germline Dev, Kobe, Hyogo 6500047, Japan.	akiran@cdb.riken.jp	Lasko, Paul/C-6761-2014; Nakamura, Akira/V-6869-2019	Lasko, Paul/0000-0002-4037-3501; Nakamura, Akira/0000-0001-6506-9146	NICHD NIH HHS [R01 HD036631, R01 HD036631-10] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036631] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Agata Y, 2001, J EXP MED, V193, P873, DOI 10.1084/jem.193.7.873; Alekseyenko AA, 2006, GENE DEV, V20, P848, DOI 10.1101/gad.1400206; Barboric M, 2005, PLOS BIOL, V3, P200, DOI 10.1371/journal.pbio.0030076; Batchelder C, 1999, GENE DEV, V13, P202, DOI 10.1101/gad.13.2.202; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Deshpande G, 2004, DEVELOPMENT, V131, P1247, DOI 10.1242/dev.01004; Eissenberg JC, 2007, MOL GENET GENOMICS, V277, P101, DOI 10.1007/s00438-006-0164-2; Extavour CG, 2003, DEVELOPMENT, V130, P5869, DOI 10.1242/dev.00804; Larochelle S, 1998, GENE DEV, V12, P370, DOI 10.1101/gad.12.3.370; Lis JT, 2000, GENE DEV, V14, P792; MACDONALD PM, 1988, NATURE, V336, P595, DOI 10.1038/336595a0; Martinho RG, 2004, CURR BIOL, V14, P159, DOI 10.1016/j.cub.2003.12.036; Mello CC, 1996, NATURE, V382, P710, DOI 10.1038/382710a0; Michels AA, 2003, MOL CELL BIOL, V23, P4859, DOI 10.1128/MCB.23.14.4859-4869.2003; Nakamura A, 1996, SCIENCE, V274, P2075, DOI 10.1126/science.274.5295.2075; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Ni ZY, 2004, MOL CELL, V13, P55, DOI 10.1016/S1097-2765(03)00526-4; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Peng JM, 1998, J BIOL CHEM, V273, P13855, DOI 10.1074/jbc.273.22.13855; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Seydoux G, 1997, DEVELOPMENT, V124, P2191; Seydoux G, 1996, NATURE, V382, P713, DOI 10.1038/382713a0; Seydoux G, 2006, CELL, V127, P891, DOI 10.1016/j.cell.2006.11.016; Shim EY, 2002, GENE DEV, V16, P2135, DOI 10.1101/gad.999002; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Zhang F, 2003, GENE DEV, V17, P748, DOI 10.1101/gad.1068203; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	33	149	153	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2008	451	7179					730	U7		10.1038/nature06498	http://dx.doi.org/10.1038/nature06498			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HD	18200011	Green Accepted			2022-12-28	WOS:000252929500044
J	Greenhalgh, RM; Powell, JT				Greenhalgh, Roger M.; Powell, Janet T.			Endovascular repair of abdominal aortic aneurysm	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FOLLOW-UP; RUPTURE RATE; MANAGEMENT; MORTALITY; OUTCOMES; SURGERY; INTERVENTIONS; SURVEILLANCE; ASSOCIATION; PREVALENCE	A 72- year- old man who was a previous smoker had had transient ischemic attacks that were successfully managed with the use of carotid endarterectomy. Since about 10% of patients with cerebral arterial disease have occult abdominal aortic aneurysms, 1 abdominal ultrasonography was performed, which revealed an infrarenal abdominal aortic aneurysm 5.7 cm in diameter. Computed tomography ( CT) confirmed the diagnosis. The patient was assessed for the feasibility of open repair of the aneurysm under general anesthesia. Electrocardiography showed an old myocardial infarction; the forced expiratory volume in 1 second was within the normal range, at 2.4 liters per second, and the serum creatinine level was 86 mu mol per liter. The patient was taking an angiotensin- converting - enzyme inhibitor for hypertension, as well as low- dose aspirin. The patient was considered fit for open repair on the basis of his medical condition, but review of his CT scan also indicated anatomical suitability for endovascular repair. This raised the question of whether the repair should be completed by means of the endovascular method or the open method.	[Greenhalgh, Roger M.; Powell, Janet T.] Charing Cross Hosp, Imperial Coll London, Vasc Surg Res Grp, London W6 8RF, England	Imperial College London	Greenhalgh, RM (corresponding author), Charing Cross Hosp, Imperial Coll London, Vasc Surg Res Grp, Fulham Palace Rd, London W6 8RF, England.	r.greenhalgh@imperial.ac.uk	Bozzani, Antonio/Y-8427-2019; Powell, Janet/AAW-8669-2021	Bozzani, Antonio/0000-0003-3274-6248; Powell, Janet/0000-0002-3905-1468				BAIRD PA, 1995, LANCET, V346, P601, DOI 10.1016/S0140-6736(95)91436-6; Becquemin JP, 2004, J VASC SURG, V39, P298, DOI 10.1016/j.jvs.2003.09.043; Blankensteijn JD, 2005, NEW ENGL J MED, V352, P2398, DOI 10.1056/NEJMoa051255; Bown MJ, 2002, BRIT J SURG, V89, P714, DOI 10.1046/j.1365-2168.2002.02122.x; Brewster DC, 2006, ANN SURG, V244, P426, DOI 10.1097/01.sla.0000234893.88045.dc; Brown LC, 2007, BRIT J SURG, V94, P709, DOI 10.1002/bjs.5776; Brown LC, 1999, ANN SURG, V230, P289, DOI 10.1097/00000658-199909000-00002; Cotroneo AR, 2006, RADIOL MED, V111, P597, DOI 10.1007/s11547-006-0054-z; Elkouri Stephane, 2004, Vasc Endovascular Surg, V38, P401, DOI 10.1177/153857440403800502; Golledge J, 2007, EUR J VASC ENDOVASC, V34, P267, DOI 10.1016/j.ejvs.2007.03.006; Greenhalgh RM, 2005, LANCET, V365, P2179, DOI 10.1016/S0140-6736(05)66627-5; Greenhalgh RM, 2004, LANCET, V364, P843, DOI 10.1016/S0140-6736(04)16979-1; Greenhalgh RM, 2005, LANCET, V365, P2187, DOI 10.1016/S0140-6736(05)66628-7; Hackam DG, 2006, LANCET, V368, P659, DOI 10.1016/S0140-6736(06)69250-7; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Jones WB, 2007, J VASC SURG, V46, P434, DOI 10.1016/j.jvs.2007.05.002; Larzon T, 2005, J ENDOVASC THER, V12, P548, DOI 10.1583/04-1469.1; Lederle FA, 2002, JAMA-J AM MED ASSOC, V287, P2968, DOI 10.1001/jama.287.22.2968; Lederle FA, 2002, NEW ENGL J MED, V346, P1437, DOI 10.1056/NEJMoa012573; MACSWEENEY STR, 1993, BRIT J SURG, V80, P582, DOI 10.1002/bjs.1800800510; Maldonado Thomas S, 2007, Vasc Endovascular Surg, V41, P192, DOI 10.1177/1538574407300915; Moore R, 2007, J VASC SURG, V45, P443, DOI 10.1016/j.jvs.2006.11.047; Newman AB, 2001, ANN INTERN MED, V134, P182, DOI 10.7326/0003-4819-134-3-200102060-00008; Ockert S, 2007, J ENDOVASC THER, V14, P324, DOI 10.1583/06-2065.1; Parmer SS, 2006, J VASC SURG, V43, P19, DOI 10.1016/j.jvs.2005.09.025; Powell JT, 2007, BRIT J SURG, V94, P702, DOI 10.1002/bjs.5778; Powell JT, 2008, ANN SURG, V247, P173, DOI 10.1097/SLA.0b013e3181557d2a; Powell JT, 2003, NEW ENGL J MED, V348, P1895, DOI 10.1056/NEJMcp012641; Prinssen M, 2007, J VASC SURG, V46, P883, DOI 10.1016/j.jvs.2007.07.033; Rutherford Robert B, 2004, Semin Vasc Surg, V17, P294, DOI 10.1053/j.semvascsurg.2004.09.009; Schouten O, 2006, EUR J VASC ENDOVASC, V32, P21, DOI 10.1016/j.ejvs.2005.12.024; SCOTT RAP, 1991, BRIT J SURG, V78, P1122, DOI 10.1002/bjs.1800780929; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Sukhija R, 2006, AM J CARDIOL, V97, P279, DOI 10.1016/j.amjcard.2005.08.033; Tang T, 2003, EUR J VASC ENDOVASC, V26, P299, DOI 10.1053/ejvs.2002.1928; van Marrewijk C, 2002, J VASC SURG, V35, P461, DOI 10.1067/mva.2002.118823; Wilmink TBM, 1999, J VASC SURG, V30, P1099, DOI 10.1016/S0741-5214(99)70049-2	37	80	85	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2008	358	5					494	501		10.1056/NEJMct0707524	http://dx.doi.org/10.1056/NEJMct0707524			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	256IW	18234753				2022-12-28	WOS:000252722900007
J	Segal, E; Raveh-Sadka, T; Schroeder, M; Unnerstall, U; Gaul, U				Segal, Eran; Raveh-Sadka, Tali; Schroeder, Mark; Unnerstall, Ulrich; Gaul, Ulrike			Predicting expression patterns from regulatory sequence in Drosophila segmentation	NATURE			English	Article							TRANSCRIPTION-FACTOR BINDING; COOPERATIVE DNA-BINDING; GENE-EXPRESSION; MORPHOGEN GRADIENT; DIRECT REPRESSION; DEPENDENT MANNER; IN-VIVO; EMBRYO; MELANOGASTER; POLARITY	The establishment of complex expression patterns at precise times and locations is key to metazoan development, yet a mechanistic understanding of the underlying transcription control networks is still missing. Here we describe a novel thermodynamic model that computes expression patterns as a function of cis- regulatory sequence and of the binding- site preferences and expression of participating transcription factors. We apply this model to the segmentation gene network of Drosophila melanogaster and find that it predicts expression patterns of cis- regulatory modules with remarkable accuracy, demonstrating that positional information is encoded in the regulatory sequence and input factor distribution. Our analysis reveals that both strong and weaker binding sites contribute, leading to high occupancy of the module DNA, and conferring robustness against mutation; short- range homotypic clustering of weaker sites facilitates cooperative binding, which is necessary to sharpen the patterns. Our computational framework is generally applicable to most protein - DNA interaction systems.	[Segal, Eran; Raveh-Sadka, Tali] Weizmann Inst Sci, Dept Appl Math & Comp Sci, IL-76100 Rehovot, Israel; [Schroeder, Mark; Unnerstall, Ulrich; Gaul, Ulrike] Rockefeller Univ, Lab Dev Neurogenet, New York, NY 10065 USA	Weizmann Institute of Science; Rockefeller University	Segal, E (corresponding author), Weizmann Inst Sci, Dept Appl Math & Comp Sci, IL-76100 Rehovot, Israel.	eran@weizmann.ac.il; gaul@mail.rockefeller.edu	Segal, Eran/AAF-4855-2019	Segal, Eran/0000-0002-6859-1164				Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Arnosti DN, 1996, EMBO J, V15, P3659, DOI 10.1002/j.1460-2075.1996.tb00735.x; Arnosti DN, 1996, DEVELOPMENT, V122, P205; Berman BP, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r61; Biggin Mark D., 2001, Functional and Integrative Genomics, V1, P223, DOI 10.1007/s101420000021; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Carr A, 1999, EMBO J, V18, P1598, DOI 10.1093/emboj/18.6.1598; Crauk O, 2005, CURR BIOL, V15, P1888, DOI 10.1016/j.cub.2005.09.046; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; Ephrussi A, 2004, CELL, V116, P143, DOI 10.1016/S0092-8674(04)00037-6; Furriols M, 2003, EMBO J, V22, P1947, DOI 10.1093/emboj/cdg224; Granek JA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r87; Gray S, 1996, GENE DEV, V10, P700, DOI 10.1101/gad.10.6.700; HOCH M, 1991, EMBO J, V10, P2267, DOI 10.1002/j.1460-2075.1991.tb07763.x; HOCH M, 1992, SCIENCE, V256, P94, DOI 10.1126/science.1348871; JACKLE H, 1992, J CELL SCI, P39; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Janssens H, 2006, NAT GENET, V38, P1159, DOI 10.1038/ng1886; LANGELAND JA, 1994, DEVELOPMENT, V120, P2945; LaRosee A, 1997, EMBO J, V16, P4403, DOI 10.1093/emboj/16.14.4403; Lebrecht D, 2005, P NATL ACAD SCI USA, V102, P13176, DOI 10.1073/pnas.0506462102; MEINHARDT H, 1986, J CELL SCI, P357; Myasnikova E, 2001, BIOINFORMATICS, V17, P3, DOI 10.1093/bioinformatics/17.1.3; NASIADKA A, 2002, ADV DEV BIOL BIOCH, P155; Ochoa-Espinosa A, 2005, P NATL ACAD SCI USA, V102, P4960, DOI 10.1073/pnas.0500373102; PTASHNE M, 2002, GENES SIGNALS, P26; Rajewsky N, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-30; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; RiveraPomar R, 1996, TRENDS GENET, V12, P478, DOI 10.1016/0168-9525(96)10044-5; RIVERAPOMAR R, 1995, NATURE, V376, P253, DOI 10.1038/376253a0; SAUER F, 1995, EMBO J, V14, P4773, DOI 10.1002/j.1460-2075.1995.tb00159.x; Schroeder MD, 2004, PLOS BIOL, V2, P1396, DOI 10.1371/journal.pbio.0020271; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; SIMPSONBROSE M, 1994, CELL, V78, P855, DOI 10.1016/S0092-8674(94)90622-X; SMALL S, 1991, GENE DEV, V5, P827, DOI 10.1101/gad.5.5.827; STANOJEVIC D, 1991, SCIENCE, V254, P1385, DOI 10.1126/science.1683715; STJOHNSTON D, 1992, CELL, V68, P201; STORMO GD, 1989, P NATL ACAD SCI USA, V86, P1183, DOI 10.1073/pnas.86.4.1183; Sutrias-Grau M, 2004, MOL CELL BIOL, V24, P5953, DOI 10.1128/MCB.24.13.5953-5966.2004; Tanay A, 2006, GENOME RES, V16, P962, DOI 10.1101/gr.5113606; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Vashee S, 1998, CURR BIOL, V8, P452, DOI 10.1016/S0960-9822(98)70179-4; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zinzen RP, 2006, CURR BIOL, V16, P1358, DOI 10.1016/j.cub.2006.05.044	48	347	358	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2008	451	7178					535	U1		10.1038/nature06496	http://dx.doi.org/10.1038/nature06496			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256OQ	18172436				2022-12-28	WOS:000252739900033
J	Williams, D; Davison, J				Williams, David; Davison, John			Pregnancy plus - Chronic kidney disease in pregnancy	BRITISH MEDICAL JOURNAL			English	Article							MATERNAL OUTCOMES; WOMEN; FETAL		[Williams, David] UCL Hosp, Inst Womens Hlth, EGA Obstet Hosp, London WC1E 6DH, England; [Davison, John] Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Davison, John] Univ Newcastle, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	University College London Hospitals NHS Foundation Trust; University of London; University College London; Newcastle University - UK; Newcastle University - UK	Williams, D (corresponding author), UCL Hosp, Inst Womens Hlth, EGA Obstet Hosp, London WC1E 6DH, England.	d.williams@uclh.nhs.uk	Williams, David/AFW-0581-2022	Williams, David/0000-0002-8186-9124				Coomarasamy A, 2003, OBSTET GYNECOL, V101, P1319, DOI 10.1016/S0029-7844(03)00169-8; CUNNINGHAM FG, 1990, AM J OBSTET GYNECOL, V163, P453, DOI 10.1016/0002-9378(90)91175-C; Davison John, 1995, P226; Fischer MJ, 2004, AM J KIDNEY DIS, V43, P415, DOI 10.1053/j.ajkd.2003.10.041; Imbasciati E, 2007, AM J KIDNEY DIS, V49, P753, DOI 10.1053/j.ajkd.2007.03.022; Jones DC, 1996, NEW ENGL J MED, V335, P226, DOI 10.1056/NEJM199607253350402; Jungers P, 1996, KIDNEY INT, V50, P593, DOI 10.1038/ki.1996.354; JUNGERS P, 1995, LANCET, V346, P1122, DOI 10.1016/S0140-6736(95)91798-5; Jungers P, 1997, CLIN NEPHROL, V47, P281; Williams D, 2006, HIGH RISK PREGNANCY, P1098	10	165	185	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 26	2008	336	7637					211	215		10.1136/bmj.39406.652986.BE	http://dx.doi.org/10.1136/bmj.39406.652986.BE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259KT	18219043	Green Published			2022-12-28	WOS:000252938900046
J	Jenkins, R; Burton, AM				Jenkins, R.; Burton, A. M.			100% accuracy in automatic face recognition	SCIENCE			English	Article									[Jenkins, R.; Burton, A. M.] Univ Glasgow, Dept Psychol, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Jenkins, R (corresponding author), Univ Glasgow, Dept Psychol, Glasgow G12 8QQ, Lanark, Scotland.	rob@psy.gla.ac.uk	Burton, Mike/A-9491-2008; Jenkins, Rob/C-5289-2008	Burton, Mike/0000-0002-2035-2084; 				Burton AM, 2005, COGNITIVE PSYCHOL, V51, P256, DOI 10.1016/j.cogpsych.2005.06.003; Galton F. J., 1878, NATURE, V18, P97, DOI DOI 10.1038/018097A0; Hancock PJB, 2000, TRENDS COGN SCI, V4, P330, DOI 10.1016/S1364-6613(00)01519-9; Zhao W, 2003, ACM COMPUT SURV, V35, P399, DOI 10.1145/954339.954342	4	93	98	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2008	319	5862					435	435		10.1126/science.1149656	http://dx.doi.org/10.1126/science.1149656			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254HB	18218889				2022-12-28	WOS:000252576600028
J	Wong, KM; Suchard, MA; Huelsenbeck, JP				Wong, Karen M.; Suchard, Marc A.; Huelsenbeck, John P.			Alignment uncertainty and genomic analysis	SCIENCE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SACCHAROMYCES GENOMES; PHYLOGENY ESTIMATION; DNA-SEQUENCES; SELECTION; ELEMENTS; GENES	The statistical methods applied to the analysis of genomic data do not account for uncertainty in the sequence alignment. Indeed, the alignment is treated as an observation, and all of the subsequent inferences depend on the alignment being correct. This may not have been too problematic for many phylogenetic studies, in which the gene is carefully chosen for, among other things, ease of alignment. However, in a comparative genomics study, the same statistical methods are applied repeatedly on thousands of genes, many of which will be difficult to align. Using genomic data from seven yeast species, we show that uncertainty in the alignment can lead to several problems, including different alignment methods resulting in different conclusions.	[Huelsenbeck, John P.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Wong, Karen M.] Univ Calif San Diego, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA; [Suchard, Marc A.] Univ Calif Los Angeles, Dept Biomath, Los Angeles, CA 90095 USA	University of California System; University of California Berkeley; University of California System; University of California San Diego; University of California System; University of California Los Angeles	Huelsenbeck, JP (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	johnh@berkeley.edu	Suchard, Marc A/A-9703-2008; Huelsenbeck, John P/C-6398-2013		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069801] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM069801, GM-069801] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Cliften PF, 2001, GENOME RES, V11, P1175, DOI 10.1101/gr.182901; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; GRAYBEAL A, 1994, SYST BIOL, V43, P174, DOI 10.2307/2413460; Hein J, 2003, P NATL ACAD SCI USA, V100, P14960, DOI 10.1073/pnas.2036252100; Holmes I, 2001, BIOINFORMATICS, V17, P803, DOI 10.1093/bioinformatics/17.9.803; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; LAKE JA, 1991, MOL BIOL EVOL, V8, P378; Lutzoni F, 2000, SYST BIOL, V49, P628, DOI 10.1080/106351500750049743; Morgenstern B, 1999, BIOINFORMATICS, V15, P211, DOI 10.1093/bioinformatics/15.3.211; Morrison DA, 1997, MOL BIOL EVOL, V14, P428, DOI 10.1093/oxfordjournals.molbev.a025779; Mugridge NB, 2000, MOL BIOL EVOL, V17, P1842, DOI 10.1093/oxfordjournals.molbev.a026285; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Redelings BD, 2005, SYST BIOL, V54, P401, DOI 10.1080/10635150590947041; Redelings BD, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-40; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Stoye J, 1998, GENE, V211, pGC45, DOI 10.1016/S0378-1119(98)00097-3; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THORNE JL, 1991, J MOL EVOL, V33, P114, DOI 10.1007/BF02193625; Yang ZH, 2000, GENETICS, V155, P431	23	261	264	4	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2008	319	5862					473	476		10.1126/science.1151532	http://dx.doi.org/10.1126/science.1151532			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254HB	18218900				2022-12-28	WOS:000252576600041
J	Blendon, RJ; Altman, DE; Deane, C; Benson, JM; Brodie, M; Buhr, T				Blendon, Robert J.; Altman, Drew E.; Deane, Claudia; Benson, John M.; Brodie, Mollyann; Buhr, Tami			Health care in the 2008 presidential primaries	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TELEPHONE SURVEY; NONRESPONSE; ELECTION		[Blendon, Robert J.; Benson, John M.; Buhr, Tami] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Blendon, Robert J.] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA; [Altman, Drew E.; Deane, Claudia; Brodie, Mollyann] Kaiser Family Fdn, Menlo Pk, CA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Blendon, RJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave,4th Fl, Boston, MA 02115 USA.	rblendon@hsph.harvard.edu						ABRAMOWITZ AI, 1989, J POLIT, V51, P977, DOI 10.2307/2131544; ABRAMSON PR, 1992, AM POLIT SCI REV, V86, P55, DOI 10.2307/1964015; American Association for Public Opinion Research, 2006, STAND DEF FIN DISP C, V4th; Bartels LM., 1988, PRESIDENTIAL PRIMARI; Blendon RJ, 2003, J HEALTH COMMUN, V8, P83, DOI 10.1080/10810730390224884; Blendon RJ, 2006, NEW ENGL J MED, V355, P1928, DOI 10.1056/NEJMsr066042; *CBS NEWS NY TIM, 2007, US HLTH CAR POL; *CBS NEWS NY TIM P, 2007, PRES C 2008 CAMP; *CBS NEWS POLL, 2007, HLTH CAR DEM PRES CA; Commonwealth of Massachusetts, 2006, ACT PROV ACC AFF QUA; COOK C, 2006, 2008 PRESIDENTIAL WI, V32; Curtin R, 2000, PUBLIC OPIN QUART, V64, P413, DOI 10.1086/318638; DANIEL WW, 1991, BIOSTATISTICS FDN AN, P225; *KAIS FAM FDN, 2008 PRES CAND HLTH; Kaiser Family Foundation/Harvard School of Public Health, 2006, PUBL HLTH CAR AG NEW; Keeter S, 2000, PUBLIC OPIN QUART, V64, P125, DOI 10.1086/317759; Keeter S, 2006, PUBLIC OPIN QUART, V70, P759, DOI 10.1093/poq/nfl035; *LOS ANG TIM BLOOM, 2007, PUBL PESS EC MOST PI; Pew Research Center for the People and the Press, 2006, CELL PHON CHALL SURV; *ROP CTR PUBL OP R, 2007, ABC NEWS WASH POST P; *ROP CTR PUBL OP R, 2007, KAIS FAM FDN POLL; *ROP CTR PUBL OP R, 2007, HARV SCH PUBL HLTH R; Traugott MW, 2001, PUBLIC OPIN QUART, V65, P389, DOI 10.1086/322850; VOSS DS, 1995, PUBLIC OPIN QUART, V59, P98, DOI 10.1086/269461; *WA POST KAIS FAM, 2007, SURV POL IND	25	15	15	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2008	358	4					414	422		10.1056/NEJMsr0708410	http://dx.doi.org/10.1056/NEJMsr0708410			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	253GY	18216365	Bronze			2022-12-28	WOS:000252507900017
J	Jagsi, R				Jagsi, Reshma			How deep the bias	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												rjagsi@med.umich.edu		Jagsi, Reshma/0000-0001-6562-1228					0	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2008	299	3					259	260		10.1001/jama.299.3.259	http://dx.doi.org/10.1001/jama.299.3.259			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253DB	18212304				2022-12-28	WOS:000252497800001
J	Burkle, FM				Burkle, Frederick M., Jr.			Measuring humanitarian assistance in conflicts	LANCET			English	Editorial Material									Harvard Univ, Harvard Humanitarian Initiat, Cambridge, MA 02138 USA	Harvard University	Burkle, FM (corresponding author), Harvard Univ, Harvard Humanitarian Initiat, Cambridge, MA 02138 USA.	fburkle@hhi.harvard.edu	Burkle, Frederick/AAE-5423-2020					BONEVENTRE EV, 2008, MILITARY REV     JAN, P66; BOSS LP, 1994, JAMA-J AM MED ASSOC, V272, P371, DOI 10.1001/jama.272.5.371; Burkle F. M., 2006, DISASTER MED, P333; Burkle F M Jr, 1995, Prehosp Disaster Med, V10, P48; *DEP DEF, 2005, MIL SUPP STAB SEC TR; Macrae J, 1997, DISASTERS, V21, P223, DOI 10.1111/1467-7717.00058; Patrick S., 2007, PENTAGON GLOBAL DEV; POWELL C, 2001, NAT FOR POL C LEAD N; REAVES EJ, 2007, THESIS U HLTH SCI BE	9	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 19	2008	371	9608					189	190		10.1016/S0140-6736(08)60118-X	http://dx.doi.org/10.1016/S0140-6736(08)60118-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	252UK	18207007				2022-12-28	WOS:000252471900011
J	Heimann, M; Reichstein, M				Heimann, Martin; Reichstein, Markus			Terrestrial ecosystem carbon dynamics and climate feedbacks	NATURE			English	Article							TEMPERATURE; SOIL; DECOMPOSITION	Recent evidence suggests that, on a global scale, terrestrial ecosystems will provide a positive feedback in a warming world, albeit of uncertain magnitude.	[Heimann, Martin; Reichstein, Markus] Max Planck Inst Biogeochem, D-07745 Jena, Germany	Max Planck Society	Heimann, M (corresponding author), Max Planck Inst Biogeochem, Hans Knoll Str 10, D-07745 Jena, Germany.	martin.heimann@bgc-jena.mpg.de	Reichstein, Markus/A-7494-2011; Heimann, Martin/H-7807-2016	Reichstein, Markus/0000-0001-5736-1112; Heimann, Martin/0000-0001-6296-5113				Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Farquhar GD, 2003, SCIENCE, V299, P1997, DOI 10.1126/science.1080681; Fontaine S, 2004, ECOL LETT, V7, P314, DOI 10.1111/j.1461-0248.2004.00579.x; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Hyvonen R, 2007, NEW PHYTOL, V173, P463, DOI 10.1111/j.1469-8137.2007.01967.x; KHVOROSTYANOV DV, IN PRESS TELLUS; Kirschbaum MUF, 2006, SOIL BIOL BIOCHEM, V38, P2510, DOI 10.1016/j.soilbio.2006.01.030; Knapp AK, 2002, SCIENCE, V298, P2202, DOI 10.1126/science.1076347; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Reichstein M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027880; Sabine CL, 2004, SCOPE SER, V62, P17; SAIESKA SR, 2003, SCIENCE, V302, P1554; Sitch S, 2007, NATURE, V448, P791, DOI 10.1038/nature06059; Wahlen M., 2001, EXCHANGES ATMOSPHERI; Wolter K., 1998, WEATHER, V53, P315, DOI DOI 10.1002/J.1477-8696.1998.TB06408.X	18	996	1096	44	751	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2008	451	7176					289	292		10.1038/nature06591	http://dx.doi.org/10.1038/nature06591			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202646	Bronze			2022-12-28	WOS:000252432100038
J	Schatton, T; Murphy, GF; Frank, NY; Yamaura, K; Waaga-Gasser, AM; Gasser, M; Zhan, Q; Jordan, S; Duncan, LM; Weishaupt, C; Fuhlbrigge, RC; Kupper, TS; Sayegh, MH; Frank, MH				Schatton, Tobias; Murphy, George F.; Frank, Natasha Y.; Yamaura, Kazuhiro; Waaga-Gasser, Ana Maria; Gasser, Martin; Zhan, Qian; Jordan, Stefan; Duncan, Lyn M.; Weishaupt, Carsten; Fuhlbrigge, Robert C.; Kupper, Thomas S.; Sayegh, Mohamed H.; Frank, Markus H.			Identification of cells initiating human melanomas	NATURE			English	Article							ACUTE MYELOID-LEUKEMIA; MALIGNANT-MELANOMA; STEM-CELLS; CANCER-CELLS; EXPRESSION; CHEMORESISTANCE; GENE	Tumour- initiating cells capable of self- renewal and differentiation, which are responsible for tumour growth, have been identified in human haematological malignancies(1,2) and solid cancers(3-6). If such minority populations are associated with tumour progression in human patients, specific targeting of tumour- initiating cells could be a strategy to eradicate cancers currently resistant to systemic therapy. Here we identify a subpopulation enriched for human malignant- melanoma- initiating cells ( MMIC) defined by expression of the chemoresistance mediator ABCB5 ( refs 7, 8) and show that specific targeting of this tumorigenic minority population inhibits tumour growth. ABCB5(+) tumour cells detected in human melanoma patients show a primitive molecular phenotype and correlate with clinical melanoma progression. In serial human- to-mouse xenotransplantation experiments, ABCB5(+) melanoma cells possess greater tumorigenic capacity than ABCB5(-) bulk populations and re- establish clinical tumour heterogeneity. In vivo genetic lineage tracking demonstrates a specific capacity of ABCB5(+) sub-populations for self- renewal and differentiation, because ABCB5(+) cancer cells generate both ABCB5(+) and ABCB5(-) progeny, whereas ABCB5(-) tumour populations give rise, at lower rates, exclusively to ABCB5(-) cells. In an initial proof- of- principle analysis, designed to test the hypothesis that MMIC are also required for growth of established tumours, systemic administration of a monoclonal antibody directed at ABCB5, shown to be capable of inducing antibody- dependent cell- mediated cytotoxicity in ABCB5(+) MMIC, exerted tumour- inhibitory effects. Identification of tumour- initiating cells with enhanced abundance in more advanced disease but susceptibility to specific targeting through a defining chemoresistance determinant has important implications for cancer therapy.	[Schatton, Tobias; Frank, Natasha Y.; Yamaura, Kazuhiro; Jordan, Stefan; Sayegh, Mohamed H.; Frank, Markus H.] Childrens Hosp, Transplantat Res Ctr, Boston, MA 02115 USA; [Schatton, Tobias; Murphy, George F.; Frank, Natasha Y.; Yamaura, Kazuhiro; Zhan, Qian; Jordan, Stefan; Sayegh, Mohamed H.; Frank, Markus H.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Frank, Natasha Y.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Waaga-Gasser, Ana Maria; Gasser, Martin] Univ Wurzburg, Dept Surg, D-97080 Wurzburg, Germany; [Duncan, Lyn M.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Weishaupt, Carsten; Fuhlbrigge, Robert C.; Kupper, Thomas S.] Brigham & Womens Hosp, Dept Dermatol, Harvard Skin Dis Res Ctr, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Wurzburg; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Frank, MH (corresponding author), Childrens Hosp, Transplantat Res Ctr, 300 Longwood Ave, Boston, MA 02115 USA.	mfrank@rics.bwh.harvard.edu	Schatton, Tobias/N-9898-2018; Jordan, Stefan/AAI-1073-2021; Jordan, Stefan/G-6243-2011; Jordan, Stefan/AAH-8261-2021; Frank, Markus/O-1625-2014	Schatton, Tobias/0000-0003-1386-680X; Jordan, Stefan/0000-0001-9330-1715; Jordan, Stefan/0000-0001-9330-1715; Jordan, Stefan/0000-0001-9330-1715; Sayegh, Mohamed/0000-0002-2847-588X; Frank, Markus/0000-0002-1312-0488	NATIONAL CANCER INSTITUTE [R01CA113796] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR042689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS051349] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA113796-01A1, R01 CA113796] Funding Source: Medline; NHLBI NIH HHS [R01 HL084815, R01 HL084815-17] Funding Source: Medline; NIAMS NIH HHS [P30 AR042689-159006, P30 AR042689] Funding Source: Medline; NINDS NIH HHS [K08 NS051349] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Arce C, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000098; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; FLORENES VA, 1994, CANCER RES, V54, P354; Frank NY, 2006, J CELL BIOL, V175, P99, DOI 10.1083/jcb.200511036; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; Frank NY, 2003, J BIOL CHEM, V278, P47156, DOI 10.1074/jbc.M308700200; Hazenbos WLW, 1998, J IMMUNOL, V161, P3026; Hendrix MJC, 2003, ONCOGENE, V22, P3070, DOI 10.1038/sj.onc.1206447; Huang Y, 2004, CANCER RES, V64, P4294, DOI 10.1158/0008-5472.CAN-03-3884; Kanazawa J, 2000, CANCER IMMUNOL IMMUN, V49, P253, DOI 10.1007/s002620000101; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Klein WM, 2007, MODERN PATHOL, V20, P102, DOI 10.1038/modpathol.3800720; KROESEN BJ, 1992, J IMMUNOL METHODS, V156, P47, DOI 10.1016/0022-1759(92)90009-I; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Rahmanto YS, 2007, CARCINOGENESIS, V28, P2172, DOI 10.1093/carcin/bgm096; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Topczewska JM, 2006, NAT MED, V12, P925, DOI 10.1038/nm1448; van Kempen LCLT, 2000, AM J PATHOL, V156, P769, DOI 10.1016/S0002-9440(10)64943-7	30	1061	1128	2	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2008	451	7176					345	U11		10.1038/nature06489	http://dx.doi.org/10.1038/nature06489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202660	Green Accepted			2022-12-28	WOS:000252432100052
J	Reinhardt, UE; Cheng, TM				Reinhardt, Uwe E.; Cheng, Tsung-Mei			Humbled in Taiwan	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Reinhardt, Uwe E.; Cheng, Tsung-Mei] Princeton Univ, Int Forum, Princeton, NJ 08544 USA	Princeton University	Reinhardt, UE (corresponding author), Princeton Univ, Int Forum, Princeton, NJ 08544 USA.	reinhard@princeton.edu							0	25	26	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 12	2008	336	7635					72	72		10.1136/bmj.39450.473380.0F	http://dx.doi.org/10.1136/bmj.39450.473380.0F			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253BX	18187722	Green Published			2022-12-28	WOS:000252494800025
J	Sheldon, T				Sheldon, Tony			More than a quick fix	BRITISH MEDICAL JOURNAL			English	Editorial Material							HEROIN; PRESCRIPTION; ADDICTS; TRIALS					Tonysheldon5@cs.com						Fischer B, 2007, J URBAN HEALTH, V84, P552, DOI 10.1007/s11524-007-9198-y; GOSSOP M, 1994, SUCHT, V5, P325; HARTNOLL RL, 1980, ARCH GEN PSYCHIAT, V37, P877; Rehm J, 2001, LANCET, V358, P1417, DOI 10.1016/S0140-6736(01)06529-1; Satel SL, 1999, J SUBST ABUSE TREAT, V17, P331; UCHTENHAGEN A, 1997, PROGRAMME MED PRESCR; van den Brink W, 2003, BRIT MED J, V327, P310, DOI 10.1136/bmj.327.7410.310; Voth EA, 2004, BMJ-BRIT MED J, V328, P229, DOI 10.1136/bmj.328.7433.229	8	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 12	2008	336	7635					68	69		10.1136/bmj.39434.460694.AD	http://dx.doi.org/10.1136/bmj.39434.460694.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253BX	18187719	Green Published			2022-12-28	WOS:000252494800023
J	Brouhard, GJ; Stear, JH; Noetzel, TL; Al-Bassam, J; Kinoshita, K; Harrison, SC; Howard, J; Hyman, AA				Brouhard, Gary J.; Stear, Jeffrey H.; Noetzel, Tim L.; Al-Bassam, Jawdat; Kinoshita, Kazuhisa; Harrison, Stephen C.; Howard, Jonathon; Hyman, Anthony A.			XMAP215 is a processive microtubule polymerase	CELL			English	Article							XENOPUS EGG EXTRACTS; SPINDLE POLE ORGANIZATION; PLUS-END; FISSION YEAST; STRUCTURAL BASIS; ATP HYDROLYSIS; PROTEIN; DYNAMICS; ACTIN; TUBULIN	Fast growth of microtubules is essential for rapid assembly of the microtubule cytoskeleton during cell proliferation and differentiation. XMAP215 belongs to a conserved family of proteins that promote microtubule growth. To determine how XMAP215 accelerates growth, we developed a single-molecule assay to visualize directly XMAP215-GFP interacting with dynamic microtubules. XMAP215 binds free tubulin in a 1: 1 complex that interacts with the microtubule lattice and targets the ends by a diffusion-facilitated mechanism. XMAP215 persists at the plus end for many rounds of tubulin subunit addition in a form of "tip tracking.'' These results show that XMAP215 is a processive polymerase that directly catalyzes the addition of up to 25 tubulin dimers to the growing plus end. Under some circumstances XMAP215 can also catalyze the reverse reaction, namely microtubule shrinkage. The similarities between XMAP215 and formins, actin polymerases, suggest that processive tip tracking is a common mechanism for stimulating the growth of cytoskeletal polymers.	[Brouhard, Gary J.; Stear, Jeffrey H.; Noetzel, Tim L.; Howard, Jonathon; Hyman, Anthony A.] Max Planck Inst Mol Cell Bio & Genet, Dresden, Germany; [Al-Bassam, Jawdat; Harrison, Stephen C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Kinoshita, Kazuhisa] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan	Max Planck Society; Harvard University; Harvard Medical School; Kyoto University	Howard, J (corresponding author), Max Planck Inst Mol Cell Bio & Genet, Dresden, Germany.	howard@mpi-cbg.de; hyman@mpi-cbg.de	Hyman, Anthony A/B-3917-2017; Howard, Jonathon/J-7492-2016; Howard, Jonathon/D-4229-2011; Brouhard, Gary/AAZ-7789-2021; Hyman, Tony/F-1923-2011	Hyman, Anthony A/0000-0003-3664-154X; Howard, Jonathon/0000-0003-0086-1196; Howard, Jonathon/0000-0003-0086-1196; Kinoshita, Kazuhisa/0000-0002-0882-4296; Stear, Jeffrey/0000-0002-2255-8297	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM078023, F32GM074723] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR040593-10, R01 AR040593, R01 AR40593] Funding Source: Medline; NIGMS NIH HHS [F32 GM078023-01, F32 GM074723-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Al-Bassam J, 2006, J CELL BIOL, V172, P1009, DOI 10.1083/jcb.200511010; Al-Bassam J, 2007, STRUCTURE, V15, P355, DOI 10.1016/j.str.2007.01.012; Ali MY, 2007, P NATL ACAD SCI USA, V104, P4332, DOI 10.1073/pnas.0611471104; Arnal I, 2000, J CELL BIOL, V149, P767, DOI 10.1083/jcb.149.4.767; Ashford AJ, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P205; Brittle AL, 2005, EMBO J, V24, P1387, DOI 10.1038/sj.emboj.7600629; Cassimeris L, 2004, MOL BIOL CELL, V15, P1580, DOI 10.1091/mbc.E03-07-0544; Cassimeris L, 2001, J CELL SCI, V114, P3025; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; Garcia MA, 2001, EMBO J, V20, P3389, DOI 10.1093/emboj/20.13.3389; Gard DL, 2004, INT REV CYTOL, V239, P179, DOI 10.1016/S0074-7696(04)39004-2; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; GARD DL, 1987, J CELL BIOL, V105, P2191, DOI 10.1083/jcb.105.5.2191; Gergely F, 2003, GENE DEV, V17, P336, DOI 10.1101/gad.245603; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Goshima G, 2005, CURR BIOL, V15, P1979, DOI 10.1016/j.cub.2005.09.054; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Hestermann A, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-24; HILLER G, 1978, CELL, V14, P795, DOI 10.1016/0092-8674(78)90335-5; HOWARD J, 1993, METHOD CELL BIOL, V39, P105, DOI 10.1016/S0091-679X(08)60164-8; Howard J., 2001, MECH MOTOR PROTEINS; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Kinoshita K, 2002, TRENDS CELL BIOL, V12, P267, DOI 10.1016/S0962-8924(02)02295-X; Kinoshita K, 2001, SCIENCE, V294, P1340, DOI 10.1126/science.1064629; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kwok BH, 2006, NAT CHEM BIOL, V2, P480, DOI 10.1038/nchembio812; Lee MJ, 2001, NAT CELL BIOL, V3, P643, DOI 10.1038/35083033; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; Matthews LR, 1998, J CELL BIOL, V141, P1159, DOI 10.1083/jcb.141.5.1159; Nakaseko Y, 2001, CURR BIOL, V11, P537, DOI 10.1016/S0960-9822(01)00155-5; Niethammer P, 2007, PLOS BIOL, V5, P190, DOI 10.1371/journal.pbio.0050029; NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338; OHKURA H, 1988, EMBO J, V7, P1465, DOI 10.1002/j.1460-2075.1988.tb02964.x; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Parsons SF, 1997, CELL MOTIL CYTOSKEL, V36, P1; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Romero S, 2007, J BIOL CHEM, V282, P8435, DOI 10.1074/jbc.M609886200; Sato M, 2007, NATURE, V447, P334, DOI 10.1038/nature05773; Schurmann G, 2001, MOL BIOL CELL, V12, P1765, DOI 10.1091/mbc.12.6.1765; Severin F, 2001, J CELL BIOL, V153, P435, DOI 10.1083/jcb.153.2.435; Shirasu-Hiza M, 2003, J CELL BIOL, V161, P349, DOI 10.1083/jcb.200211095; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Spittle C, 2000, J BIOL CHEM, V275, P20748, DOI 10.1074/jbc.M002597200; Srayko M, 2005, DEV CELL, V9, P223, DOI 10.1016/j.devcel.2005.07.003; Srayko M, 2003, CURR BIOL, V13, P1506, DOI 10.1016/S0960-9822(03)00597-9; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Tournebize R, 2000, NAT CELL BIOL, V2, P13, DOI 10.1038/71330; van Breugel M, 2003, J CELL BIOL, V161, P359, DOI 10.1083/jcb.200211097; VASQUEZ RJ, 1994, J CELL BIOL, V127, P985, DOI 10.1083/jcb.127.4.985; Vasquez RJ, 1999, CELL MOTIL CYTOSKEL, V43, P310, DOI 10.1002/(SICI)1097-0169(1999)43:4<310::AID-CM4>3.3.CO;2-A; Wang ZH, 2000, BIOPHYS J, V78, P1955, DOI 10.1016/S0006-3495(00)76743-9; Westermann S, 2006, NATURE, V440, P565, DOI 10.1038/nature04409; Whittington AT, 2001, NATURE, V411, P610, DOI 10.1038/35079128	57	362	366	5	49	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2008	132	1					79	88		10.1016/j.cell.2007.11.043	http://dx.doi.org/10.1016/j.cell.2007.11.043			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IL	18191222	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000253427600017
J	Kang, JS; Tian, JH; Pan, PY; Zald, P; Li, C; Deng, C; Sheng, ZH				Kang, Jian-Sheng; Tian, Jin-Hua; Pan, Ping-Yue; Zald, Philip; Li, Cuiling; Deng, Chuxia; Sheng, Zu-Hang			Docking of axonal mitochondria by syntaphilin controls their mobility and affects short-term facilitation	CELL			English	Article							TRANSPORT; PROTEIN; MICROTUBULES; ORGANELLES; SYNAPSES; NEURONS; MILTON; TRANSMISSION; POTENTIATION; CYTOSKELETON	Proper distribution of mitochondria within axons and at synapses is critical for neuronal function. While one-third of axonal mitochondria are mobile, a large proportion remains in a stationary phase. However, the mechanisms controlling mitochondrial docking within axons remain elusive. Here, we report a role for axon-targeted syntaphilin (SNPH) in mitochondrial docking through its interaction with microtubules. Axonal mitochondria that contain exogenously or endogenously expressed SNPH lose mobility. Deletion of the mouse snph gene results in a substantially higher proportion of axonal mitochondria in the mobile state and reduces the density of mitochondria in axons. The snph mutant neurons exhibit enhanced short-term facilitation during prolonged stimulation, probably by affecting calcium signaling at presynaptic boutons. This phenotype is fully rescued by reintroducing the snph gene into the mutant neurons. These findings demonstrate a molecular mechanism for controlling mitochondrial docking in axons that has a physiological impact on synaptic function.	[Kang, Jian-Sheng; Tian, Jin-Hua; Pan, Ping-Yue; Zald, Philip; Sheng, Zu-Hang] NINDS, NIH, Porter Neurosci Res Ctr, Synapt Funct Sect, Bethesda, MD 20892 USA; [Pan, Ping-Yue] Shanghai Jiao Tong Univ, Sch Med, Dept Neurobiol, Shanghai 200030, Peoples R China; [Li, Cuiling; Deng, Chuxia] NIDDK, NIH, Genet Dev & Dis Branch, Mammalian Genet Sect, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Shanghai Jiao Tong University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Sheng, ZH (corresponding author), NINDS, NIH, Porter Neurosci Res Ctr, Synapt Funct Sect, Bldg 35,Rm 4B203, Bethesda, MD 20892 USA.	shengz@ninds.nih.gov	deng, chuxia/N-6713-2016	Kang, Jian-Sheng/0000-0002-2603-9718; Pan, Pingyue/0000-0002-2805-6810	Intramural NIH HHS [Z01 NS002946-11] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003029, Z01NS002946] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aiello GL, 2000, J NEUROSCI METH, V103, P145, DOI 10.1016/S0165-0270(00)00308-3; BELLES B, 1987, PFLUG ARCH EUR J PHY, V409, P582, DOI 10.1007/BF00584657; BENSHALOM G, 1985, J NEUROCYTOL, V14, P943, DOI 10.1007/BF01224806; BERTHOLD CH, 1993, J NEUROCYTOL, V22, P925, DOI 10.1007/BF01218351; Billups B, 2002, J NEUROSCI, V22, P5840; Cai Q, 2005, J CELL BIOL, V170, P959, DOI 10.1083/jcb.200506042; Chada SR, 2004, CURR BIOL, V14, P1272, DOI 10.1016/j.cub.2004.07.027; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Das S, 2003, MOL BRAIN RES, V116, P38, DOI 10.1016/S0169-328X(03)00212-2; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Gorska-Andrzejak J, 2003, J COMP NEUROL, V463, P372, DOI 10.1002/cne.10750; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; Hirokawa N, 2004, EXP CELL RES, V301, P50, DOI 10.1016/j.yexcr.2004.08.010; HIROKAWA N, 1982, J CELL BIOL, V94, P129, DOI 10.1083/jcb.94.1.129; Hollenbeck, 1996, FRONT BIOSCI, V1, pD91; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Hubley MJ, 1996, BBA-GEN SUBJECTS, V1291, P115, DOI 10.1016/0304-4165(96)00053-0; JONAS E, 1993, CYTOSKELETON, V24, P245; Lao GF, 2000, NEURON, V25, P191, DOI 10.1016/S0896-6273(00)80882-X; LETERRIER JF, 1994, MICROSC RES TECHNIQ, V27, P233, DOI 10.1002/jemt.1070270305; Levy M, 2003, J BIOL CHEM, V278, P17727, DOI 10.1074/jbc.M212878200; Ligon LA, 2000, J COMP NEUROL, V427, P340, DOI 10.1002/1096-9861(20001120)427:3<340::AID-CNE2>3.0.CO;2-Y; LINDEN M, 1989, J BIOENERG BIOMEMBR, V21, P507, DOI 10.1007/BF00762522; Mattson MP, 2007, NEUROCHEM RES, V32, P707, DOI 10.1007/s11064-006-9170-3; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Moore D.S., 1993, INTRO PRACTICE STAT; MORRIS RL, 1993, J CELL SCI, V104, P917; PANNESE E, 1986, CELL TISSUE RES, V245, P1; PRICE RL, 1991, BRAIN RES, V540, P209, DOI 10.1016/0006-8993(91)90509-T; Rapaport D, 2003, EMBO REP, V4, P948, DOI 10.1038/sj.embor.embor937; REYNOLDS IJ, 2004, SCI STKE, V251, pPE46; Rowland KC, 2000, J NEUROSCI, V20, P9135; Safieddine S, 2002, MOL CELL NEUROSCI, V20, P343, DOI 10.1006/mcne.2002.1120; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; SMITH DS, 1977, J CELL SCI, V27, P255; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Su QN, 2004, NAT CELL BIOL, V6, P941, DOI 10.1038/ncb1169; Tang YG, 1997, NEURON, V18, P483, DOI 10.1016/S0896-6273(00)81248-9; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; WERTH JL, 1994, J NEUROSCI, V14, P348; Yang F, 2003, J CELL BIOL, V163, P511, DOI 10.1083/jcb.200307027	43	390	399	1	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 11	2008	132	1					137	148		10.1016/j.cell.2007.11.024	http://dx.doi.org/10.1016/j.cell.2007.11.024			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IL	18191227	Green Accepted, Bronze			2022-12-28	WOS:000253427600022
J	Coombes, R				Coombes, Rebecca			Profile - Face of the future - Plastic surgeon Peter Butler	BRITISH MEDICAL JOURNAL			English	Editorial Material												rcoombes@bmj.com							0	6	6	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 5	2008	336	7634					18	19		10.1136/bmj.39433.451424.AD	http://dx.doi.org/10.1136/bmj.39433.451424.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250UT	18174594	Green Published			2022-12-28	WOS:000252327500027
J	Randhawa, S; Lee, AG				Randhawa, Sandeep; Lee, Andrew G.			Medical mystery: Cloud surrounding the optic disks	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA	University of Iowa	Randhawa, S (corresponding author), Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA.	andrew-lee@uiowa.edu	Lee, Andrew/GVU-2817-2022						0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2008	358	1					69	69		10.1056/NEJMicm070278	http://dx.doi.org/10.1056/NEJMicm070278			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	246TW	18172176				2022-12-28	WOS:000252031200009
J	Tosteson, ANA; Stout, NK; Fryback, DG; Acharyya, S; Herman, BA; Hannah, LG; Pisano, ED				Tosteson, Anna N. A.; Stout, Natasha K.; Fryback, Dennis G.; Acharyya, Suddhasatta; Herman, Benjamin A.; Hannah, Lucy G.; Pisano, Etta D.			Cost-effectiveness of digital mammography breast cancer screening	ANNALS OF INTERNAL MEDICINE			English	Article							FILM MAMMOGRAPHY; HORMONE-THERAPY; DENSITY; TRENDS; RISK; AGE	Background: The DMIST (Digital Mammography Imaging Screening Trial) reported improved breast cancer detection with digital mammography compared with film mammography in selected population subgroups, but it did not assess the economic value of digital relative to film mammography screening. Objective: To evaluate the cost-effectiveness of digital mammography screening for breast cancer. Design: Validated, discrete-event simulation model. Data Sources: Data from DMIST and publicly available U.S. data. Target Population: U.S. women age 40 years or older. Time Horizon: Lifetime. Perspective: Societal and Medicare. Intervention: All-film mammography screening; all-digital mammography screening; and targeted digital mammography screening, which is age-targeted digital mammography (for women <50 years of age) and age- and density-targeted digital mammography (for women <50 years of age or women >= 50 years of age with dense breasts). Outcome Measures: Cost per quality-adjusted life-year (QALY) gained. Results of Base-Case Analysis: All-digital mammography screening cost $331 000 (95% Cl, $268 000 to $403 000) per QALY gained relative to all-film mammography screening but was more costly and less effective than targeted digital mammography screening. Targeted digital mammography screening resulted in more screen-detected cases of cancer and fewer deaths from cancer than either all-film or all-digital mammography screening, with cost-effectiveness estimates ranging from $26 500 (Cl, $21 000 to $33 000) per QALY gained for age-targeted digital mammography to $84 500 (Cl, $75 000 to $93 000) per QALY gained for age-and density-targeted digital mammography. In the Medicare population, the cost-effectiveness of density-targeted digital mammography screening varied from a base-case estimate of $97 000 (Cl, $77 000 to $131 000) to $257 000 per QALY gained (Cl, $91 000 to $536 000) in the alternative-case analyses, in which the sensitivity of film mammography was increased and the sensitivity of digital mammography in women with nondense breasts was decreased. Results of Sensitivity Analysis: Results were sensitive to the cost of digital mammography and to the prevalence of dense breasts. Limitations: Results were dependent on model assumptions and DMIST findings. Conclusion: Relative to film mammography, screening for breast cancer by using all-digital mammography is not cost-effective. Age-targeted screening with digital mammography seems cost-effective, whereas density-targeted screening strategies are more costly and of uncertain value, particularly among women age 65 years or older.	[Tosteson, Anna N. A.; Stout, Natasha K.; Fryback, Dennis G.; Acharyya, Suddhasatta; Herman, Benjamin A.; Hannah, Lucy G.; Pisano, Etta D.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Lebanon, NH 03756 USA; [Tosteson, Anna N. A.; Stout, Natasha K.; Fryback, Dennis G.; Acharyya, Suddhasatta; Herman, Benjamin A.; Hannah, Lucy G.; Pisano, Etta D.] Dartmouth Inst Hlth Policy, Lebanon, NH USA; [Tosteson, Anna N. A.; Stout, Natasha K.; Fryback, Dennis G.; Acharyya, Suddhasatta; Herman, Benjamin A.; Hannah, Lucy G.; Pisano, Etta D.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Tosteson, Anna N. A.; Stout, Natasha K.; Fryback, Dennis G.; Acharyya, Suddhasatta; Herman, Benjamin A.; Hannah, Lucy G.; Pisano, Etta D.] Univ Wisconsin, Madison, WI USA; [Tosteson, Anna N. A.; Stout, Natasha K.; Fryback, Dennis G.; Acharyya, Suddhasatta; Herman, Benjamin A.; Hannah, Lucy G.; Pisano, Etta D.] Brown Univ, Providence, RI 02912 USA; [Tosteson, Anna N. A.; Stout, Natasha K.; Fryback, Dennis G.; Acharyya, Suddhasatta; Herman, Benjamin A.; Hannah, Lucy G.; Pisano, Etta D.] Univ N Carolina, Chapel Hill, NC USA	Dartmouth College; Harvard University; Harvard T.H. Chan School of Public Health; University of Wisconsin System; University of Wisconsin Madison; Brown University; University of North Carolina; University of North Carolina Chapel Hill	Tosteson, ANA (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	anna.tosteson@dartmouth.edu			NATIONAL CANCER INSTITUTE [U10CA080098, U01CA080098, U10CA079778, U01CA088211, U01CA079778] Funding Source: NIH RePORTER; NCI NIH HHS [U01 CA088211, CA79778, U01 CA080098, U10 CA079778, CA80098, CA88211, U01 CA088211-01, U01 CA080098-01, U01 CA079778-01, U10 CA080098, U01 CA079778] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		American College of Radiology, 2003, BREAST IM REP DAT SY; Anderson WF, 2007, J CLIN ONCOL, V25, P3923, DOI 10.1200/JCO.2007.11.6079; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Boyd NF, 2005, LANCET ONCOL, V6, P798, DOI 10.1016/S1470-2045(05)70390-9; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; BREEN N, 1994, AM J PUBLIC HEALTH, V84, P62, DOI 10.2105/AJPH.84.1.62; BROWN ML, 1993, BREAST CANCER RES TR, V25, P113, DOI 10.1007/BF00662136; Clarke M, 1998, LANCET, V351, P1451; Cronin KA, 2005, CANCER CAUSE CONTROL, V16, P701, DOI 10.1007/s10552-005-0693-8; *EARLY BREAST CANC, 1998, LANCET, V362, P930; Early Breast Cancer Trialists' Collaborative G, 2002, COCHRANE DB SYST REV; Fryback Dennis G, 2006, J Natl Cancer Inst Monogr, P37, DOI 10.1093/jncimonographs/lgj007; Glass AG, 2007, JNCI-J NATL CANCER I, V99, P1152, DOI 10.1093/jnci/djm059; Glueck DH, 2007, ACAD RADIOL, V14, P670, DOI 10.1016/j.acra.2007.02.011; Gold MR, 1996, COST EFFECTIVENESS H; Hanmer J, 2006, MED DECIS MAKING, V26, P391, DOI 10.1177/0272989X06290497; Holford Theodore R, 2006, J Natl Cancer Inst Monogr, P19, DOI 10.1093/jncimonographs/lgj016; Kerlikowske K, 1999, JAMA-J AM MED ASSOC, V282, P2156, DOI 10.1001/jama.282.22.2156; Kerlikowske K, 2007, JNCI-J NATL CANCER I, V99, P1335, DOI 10.1093/jnci/djm111; Kerlikowske K, 2007, NEW ENGL J MED, V356, P297, DOI 10.1056/NEJMe068244; LAUPACIS A, 1992, CAN MED ASSOC J, V146, P473; Lewin JM, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.3.1790671; Lewin JM, 2001, RADIOLOGY, V218, P873, DOI 10.1148/radiology.218.3.r01mr29873; LINDFORS KK, 1995, JAMA-J AM MED ASSOC, V274, P881, DOI 10.1001/jama.274.11.881; Mandelblatt J, 2003, ANN INTERN MED, V139, P835, DOI 10.7326/0003-4819-139-10-200311180-00011; Mariotto A, 2002, J NATL CANCER I, V94, P1626; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Pisano ED, 2005, RADIOLOGY, V236, P404, DOI 10.1148/radiol.2362050440; PISANO ED, 2007, IN PRESS RADIOLOGY; Plevritis SK, 2006, JAMA-J AM MED ASSOC, V295, P2374, DOI 10.1001/jama.295.20.2374; Ravdin PM, 2007, NEW ENGL J MED, V356, P1670, DOI 10.1056/NEJMsr070105; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Skaane P, 2003, RADIOLOGY, V229, P877, DOI 10.1148/radiol.2293021171; Stout NK, 2006, JNCI-J NATL CANCER I, V98, P774, DOI 10.1093/jnci/djj210; TAPLIN SH, 1995, J NATL CANCER I, V87, P417, DOI 10.1093/jnci/87.6.417; Titus-Ernstoff L, 2006, CANCER CAUSE CONTROL, V17, P1281, DOI 10.1007/s10552-006-0071-1; *US CENS BUR, 2005, INC EXP WEALTH STAT; *US DEP LAB, 2005, BUR LAB STAT EMPL CO; *US DEP LAB BER LA, 2006, CONS PRIC IND	39	118	119	0	24	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	2008	148	1					1	10		10.7326/0003-4819-148-1-200801010-00002	http://dx.doi.org/10.7326/0003-4819-148-1-200801010-00002			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248JJ	18166758	Green Accepted			2022-12-28	WOS:000252149300001
J	Victora, CG; Adair, L; Fall, C; Hallal, PC; Martorell, R; Richter, L; Sachdev, HS				Victora, Cesar G.; Adair, Linda; Fall, Caroline; Hallal, Pedro C.; Martorell, Reynaldo; Richter, Linda; Sachdev, Harshpal Singh		Maternal & Child Undernutr Study	Maternal and child undernutrition 2 - Maternal and child undernutrition: consequences for adult health and human capital	LANCET			English	Review							SYSTOLIC BLOOD-PRESSURE; LONG-TERM CONSEQUENCES; BREAST-CANCER RISK; LOW-BIRTH-WEIGHT; BODY-MASS INDEX; CATCH-UP GROWTH; IMPAIRED GLUCOSE-TOLERANCE; ISCHEMIC-HEART-DISEASE; FETAL ORIGINS; NUTRITIONAL SUPPLEMENTATION	In this paper we review the associations between maternal and child undernutrition with human capital and risk of adult diseases in low-income and middle-income countries. We analysed data from five long-standing prospective cohort studies from Brazil, Guatemala, India, the Philippines, and South Africa and noted that indices of maternal and child undernutrition (maternal height, birthweight, intrauterine growth restriction, and weight, height, and body-mass index at 2 years according to the new WHO growth standards) were related to adult outcomes (height, schooling, income or assets, offspring birthweight, body-mass index, glucose concentrations, blood pressure). We undertook systematic reviews of studies from low-income and middle-income countries for these outcomes and for indicators related to blood lipids, cardiovascular disease, lung and immune function, cancers, osteoporosis, and mental illness. Undernutrition was strongly associated, both in the review of published work and in new analyses, with shorter adult height, less schooling, reduced economic productivity, and-for women-lower offspring birthweight. Associations with adult disease indicators were not so clear-cut. Increased size at birth and in childhood were positively associated with adult body-mass index and to a lesser extent with blood pressure values, but not with blood glucose concentrations. In our new analyses and in published work, lower birthweight and undernutrition in childhood were risk factors for high glucose concentrations, blood pressure, and harmful lipid profiles once adult body-mass index and height were adjusted for, suggesting that rapid postnatal weight gain-especially after infancy-is linked to these conditions. The review of published works indicates that there is insufficient information about long-term changes in immune function, blood lipids, or osteoporosis indicators. Birthweight is positively associated with lung function and with the incidence of some cancers, and undernutrition could be associated with mental illness. We noted that height-for-age at 2 years was the best predictor of human capital and that undernutrition is associated with lower human capital. We conclude that damage suffered in early life leads to permanent impairment, and might also affect future generations. Its prevention will probably bring about important health, educational, and economic benefits. Chronic diseases are especially common in undernourished children who experience rapid weight gain after infancy.	[Victora, Cesar G.; Hallal, Pedro C.] Univ Fed Pelotas, BR-96001970 Pelotas, Brazil; [Fall, Caroline] Univ Southampton, MRC, Epidemiol Resource Ctr, Southampton, Hants, England; [Sachdev, Harshpal Singh] Sitaram Bhartia Inst Sci & Res, New Delhi, India; [Martorell, Reynaldo] Emory Univ, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Adair, Linda] Univ N Carolina, Chapel Hill, NC USA; [Richter, Linda] Human Sci Res Council, Durban, South Africa	Universidade Federal de Pelotas; University of Southampton; Sitaram Bhartia Institute of Science & Research; Emory University; University of North Carolina; University of North Carolina Chapel Hill; Human Sciences Research Council-South Africa	Victora, CG (corresponding author), Univ Fed Pelotas, CP 464, BR-96001970 Pelotas, Brazil.	cvictora@terra.com.br	Victora, Cesar Gomes/Y-2455-2019; Victora, Cesar G/D-4476-2013; Hallal, Pedro C/A-3249-2011; Martorell, Reynaldo/I-2539-2012; Fahimifar, Sepideh/M-5303-2019	Victora, Cesar Gomes/0000-0002-2465-2180; Victora, Cesar G/0000-0002-2465-2180; Hallal, Pedro C/0000-0003-1470-6461; Kirkwood, Betty/0000-0001-5274-6072; Fall, Caroline/0000-0003-4402-5552; Sachdev, Harshpal Singh/0000-0002-4956-9391	Medical Research Council [G0400519(71108), MC_U147585821, U.1475.00.004.00005.01 (85821), G0400519] Funding Source: Medline; Wellcome Trust [082554] Funding Source: Medline; MRC [G0400519, MC_U147585821] Funding Source: UKRI; Medical Research Council [U1475000003] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Adair L, 2005, ANNU REV NUTR, V25, P407, DOI 10.1146/annurev.nutr.25.050304.092538; Adair LS, 2007, AM J HUM BIOL, V19, P327, DOI 10.1002/ajhb.20587; Adair LS, 2003, HYPERTENSION, V41, P451, DOI 10.1161/01.HYP.0000054212.23528.B2; Adair LS, 2001, CIRCULATION, V104, P1034, DOI 10.1161/hc3401.095037; Alderman H, 2006, OXFORD ECON PAP, V58, P450, DOI 10.1093/oep/gpl008; Armitage JA, 2004, J PHYSIOL-LONDON, V561, P355, DOI 10.1113/jphysiol.2004.072009; Bailey SM, 2007, AM J HUM BIOL, V19, P603, DOI 10.1002/ajhb.20704; Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6; Barker D J, 1997, Rev Reprod, V2, P105, DOI 10.1530/ror.0.0020105; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Barker DJP, 2005, ARCH DIS CHILD, V90, P272, DOI 10.1136/adc.2003.033464; Barker DJP, 2003, INT J EPIDEMIOL, V32, P876, DOI 10.1093/ije/dyg293; Barker DJP, 2002, TRENDS ENDOCRIN MET, V13, P364, DOI 10.1016/S1043-2760(02)00689-6; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; BARKER DJP, 1986, LANCET, V1, P1077; Behrman JR, 2004, REV ECON STAT, V86, P586, DOI 10.1162/003465304323031139; Belizan JM, 1997, BMJ-BRIT MED J, V315, P281, DOI 10.1136/bmj.315.7103.281; Bennet L, 2006, ADV EXP MED BIOL, V573, P204; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; BHUTTA ZA, 2008, LANCET; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Boyko EJ, 2000, DIABETES CARE, V23, P1260, DOI 10.2337/diacare.23.9.1260; BRENNER BM, 1988, AM J HYPERTENS, V1, P335, DOI 10.1093/ajh/1.4.335; BRISCOE J, 1991, AM J EPIDEMIOL, V133, P185; Brown JL, 1996, SCI AM, V274, P38, DOI 10.1038/scientificamerican0296-38; Campbell DM, 1996, BRIT J OBSTET GYNAEC, V103, P273, DOI 10.1111/j.1471-0528.1996.tb09718.x; Chen YY, 2007, J HEALTH ECON, V26, P659, DOI 10.1016/j.jhealeco.2006.12.006; Cheung YB, 2000, HYPERTENSION, V36, P795, DOI 10.1161/01.HYP.36.5.795; Cheung YF, 2000, LANCET, V355, P1157, DOI 10.1016/S0140-6736(00)02068-7; Choi CS, 2000, DIABETES RES CLIN PR, V49, P53, DOI 10.1016/S0168-8227(00)00131-5; Clark PM, 1998, OBSTET GYNECOL, V91, P103, DOI 10.1016/S0029-7844(97)00581-4; Cole TJ, 2000, P NUTR SOC, V59, P317, DOI 10.1017/S0029665100000355; Coly AN, 2006, J NUTR, V136, P2412, DOI 10.1093/jn/136.9.2412; Conlisk AJ, 2004, J NUTR, V134, P890, DOI 10.1093/jn/134.4.890; Cooper C, 2006, OSTEOPOROSIS INT, V17, P337, DOI 10.1007/s00198-005-2039-5; Crimmins EM, 2001, SOC SCI MED, V52, P1629, DOI 10.1016/S0277-9536(00)00273-2; Daniels MC, 2004, J NUTR, V134, P1439, DOI 10.1093/jn/134.6.1439; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dodic M., 2003, Archives of Physiology and Biochemistry, V111, P61, DOI 10.1076/apab.111.1.61.15144; Ellison G T, 1997, Curationis, V20, P36; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; FALL CH, 2006, EARLY LIFE ORIGINS H; Fall CHD, 1998, DIABETIC MED, V15, P220, DOI 10.1002/(SICI)1096-9136(199803)15:3<220::AID-DIA544>3.0.CO;2-O; Fisher D, 2006, INT J EPIDEMIOL, V35, P1196, DOI 10.1093/ije/dyl130; Fogel R. W., 2002, NUTR PHYSL CAPITAL E; Forman MR, 2005, CANCER INVEST, V23, P609, DOI 10.1080/07357900500283093; GIGANTE DP, IN PRESS EUR J CLIN; GODFREY KM, 1994, BRIT J OBSTET GYNAEC, V101, P398, DOI 10.1111/j.1471-0528.1994.tb11911.x; Grajeda Ruben, 2005, Food and Nutrition Bulletin, V26, pS15; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; HAAS JD, 1995, J NUTR, V125, pS1078; Hack M, 1998, EUR J CLIN NUTR, V52, pS65; Haeffner LSB, 2002, ANN HUM BIOL, V29, P627, DOI 10.1080/03014460210145847; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Harder T, 2007, AM J EPIDEMIOL, V165, P849, DOI 10.1093/aje/kwk071; Harding R, 2006, DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE, P336, DOI 10.1017/CBO9780511544699.026; Hardy R, 2006, EUR J PUBLIC HEALTH, V16, P21, DOI 10.1093/eurpub/cki171; Hillier TA, 2007, DIABETES CARE, V30, P2287, DOI 10.2337/dc06-2361; HODDINOTT J, IN PRESS LANCET; Horta B, 2006, EVIDENCE LONG TERM E; Huxley R, 2004, JAMA-J AM MED ASSOC, V292, P2755, DOI 10.1001/jama.292.22.2755; Huxley R, 2002, LANCET, V360, P659, DOI 10.1016/S0140-6736(02)09834-3; Huxley R, 2007, AM J CLIN NUTR, V85, P1244, DOI 10.1093/ajcn/85.5.1244; Huxley RR, 2000, J HYPERTENS, V18, P815, DOI 10.1097/00004872-200018070-00002; Joseph KS, 1996, EPIDEMIOL REV, V18, P158, DOI 10.1093/oxfordjournals.epirev.a017923; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Krishnaswamy K, 2002, NUTR REV, V60, pS35, DOI 10.1301/00296640260130713; Kumaran K, 2000, HEART, V83, P272, DOI 10.1136/heart.83.3.272; Kynast-Wolf G, 2006, INT J EPIDEMIOL, V35, P427, DOI 10.1093/ije/dyi150; Landon J, 2006, DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE, P370, DOI 10.1017/CBO9780511544699.028; Lauren L, 2003, INT J EPIDEMIOL, V32, P862, DOI 10.1093/ije/dyg201; Law CM, 1996, J HYPERTENS, V14, P935; Lawlor DA, 2005, THORAX, V60, P851, DOI 10.1136/thx.2005.042408; Lawlor DA, 2005, CURR OPIN NEPHROL HY, V14, P259, DOI 10.1097/01.mnh.0000165893.13620.2b; Lawlor DA, 2002, AM J EPIDEMIOL, V156, P1100, DOI 10.1093/aje/kwf154; Lawlor DA, 2007, AM J EPIDEMIOL, V165, P1405, DOI 10.1093/aje/kwm028; Leary S, 2006, ACTA OBSTET GYN SCAN, V85, P1066, DOI 10.1080/00016340600697306; LEON DA, 1999, FETAL ORIGINS CARDIO; Levitt NS, 2000, J CLIN ENDOCR METAB, V85, P4611, DOI 10.1210/jc.85.12.4611; Li HJ, 2003, PEDIATRICS, V112, P1156, DOI 10.1542/peds.112.5.1156; Li HJ, 2003, AM J CLIN NUTR, V77, P1498, DOI 10.1093/ajcn/77.6.1498; Lima RD, 2005, CHEST, V128, P2400, DOI 10.1378/chest.128.4.2400; Lucas A, 1999, BRIT MED J, V319, P245, DOI 10.1136/bmj.319.7204.245; Lucas A, 1996, BRIT J NUTR, V76, P605, DOI 10.1079/BJN19960066; Lumey L H, 1993, Paediatr Perinat Epidemiol, V7, P354, DOI 10.1111/j.1365-3016.1993.tb00415.x; Mackenzie HS, 1996, KIDNEY INT, pS30; MACKENZIE HS, 1995, AM J KIDNEY DIS, V26, P91, DOI 10.1016/0272-6386(95)90161-2; Malcolm JC, 2006, DIABETIC MED, V23, P565, DOI 10.1111/j.1464-5491.2006.01840.x; Maluccio J., 2006, IMPACT EXPT NUTR INT; Maluccio J. A., 2006, 0614 MIDDL COLL; MARTORELL R, 1994, EUR J CLIN NUTR, V48, pS45; Martorell R., 2005, POLICY PROGRAM IMPLI; Martorell Reynaldo, 2005, Food and Nutrition Bulletin, V26, pS5; Martyn CN, 1997, LANCET, V350, P953, DOI 10.1016/S0140-6736(96)10508-0; Matthews SG, 2002, TRENDS ENDOCRIN MET, V13, P373, DOI 10.1016/S1043-2760(02)00690-2; McClellan JM, 2006, JAMA-J AM MED ASSOC, V296, P582, DOI 10.1001/jama.296.5.582; McDade TW, 2001, AM J CLIN NUTR, V74, P543; Mi J, 2000, ANN INTERN MED, V132, P253, DOI 10.7326/0003-4819-132-4-200002150-00002; Michels KB, 2006, INT J CANCER, V119, P2007, DOI 10.1002/ijc.22004; Monteiro POA, 2005, OBES REV, V6, P143, DOI 10.1111/j.1467-789X.2005.00183.x; Moore SE, 2004, AM J CLIN NUTR, V80, P453, DOI 10.1093/ajcn/80.2.453; Moore SE, 2004, INT J EPIDEMIOL, V33, P137, DOI 10.1093/ije/dyh007; Moore SE, 2001, DIABETIC MED, V18, P646, DOI 10.1046/j.1464-5491.2001.00565.x; Moore SE, 1997, NATURE, V388, P434, DOI 10.1038/41245; Moore SE, 1999, INT J EPIDEMIOL, V28, P1088, DOI 10.1093/ije/28.6.1088; Moore SE, 2006, P NUTR SOC, V65, P311, DOI 10.1079/PNS2006503; Newsome CA, 2003, DIABETIC MED, V20, P339, DOI 10.1046/j.1464-5491.2003.00871.x; Normand SLT, 1999, STAT MED, V18, P321, DOI 10.1002/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P; Okasha M, 2003, BREAST CANCER RES TR, V78, P223, DOI 10.1023/A:1022988918755; Okasha M, 2002, BEST PRACT RES CL EN, V16, P225, DOI 10.1053/beem.2002.0204; Ong KK, 2006, ACTA PAEDIATR, V95, P904, DOI 10.1080/08035250600719754; Owen CG, 2003, PEDIATRICS, V111, P1081, DOI 10.1542/peds.111.5.1081; Ozanne SE, 1999, P NUTR SOC, V58, P615, DOI 10.1017/S0029665199000804; Ozanne SE, 2001, BRIT MED BULL, V60, P143, DOI 10.1093/bmb/60.1.143; Park SK, 2006, INT J CANCER, V119, P2136, DOI 10.1002/ijc.21974; Pitcher JB, 2006, EARLY LIFE ORIGINS H; Pollitt E., 1996, Social Policy Report, V10, P1; Prentice AM, 2005, ARCH DIS CHILD, V90, P429, DOI 10.1136/adc.2004.059030; PROOS LA, 1993, ACTA PAEDIATR, V82, P641, DOI 10.1111/j.1651-2227.1993.tb18031.x; Psacharopoulos G., 2004, EDUC ECON, V12, P111, DOI [DOI 10.1080/0964529042000239140, 10.1080/0964529042000239140]; Ramakrishnan U, 1999, J NUTR, V129, p544S, DOI 10.1093/jn/129.2.544S; Richter LM, 2004, PAEDIATR PERINAT EP, V18, P290, DOI 10.1111/j.1365-3016.2004.00572.x; RIVERA JA, 1995, J NUTR, V125, pS1068; Rogers I, 2003, INT J OBESITY, V27, P755, DOI 10.1038/sj.ijo.0802316; Roseboom T, 2006, EARLY HUM DEV, V82, P485, DOI 10.1016/j.earlhumdev.2006.07.001; Roseboom TJ, 2001, PAEDIATR PERINAT EP, V15, P220, DOI 10.1046/j.1365-3016.2001.00336.x; Roseboom TJ, 2001, J HYPERTENS, V19, P29, DOI 10.1097/00004872-200101000-00004; Sachdev HS, 2005, AM J CLIN NUTR, V82, P456, DOI 10.1093/ajcn/82.2.456; Sanderson M, 2002, BRIT J CANCER, V86, P84, DOI 10.1038/sj.bjc.6600009; Schroeder DG, 1999, AM J EPIDEMIOL, V149, P177, DOI 10.1093/oxfordjournals.aje.a009784; Shaheen S, 1997, BRIT MED BULL, V53, P58; Shiell AW, 2001, HYPERTENSION, V38, P1282, DOI 10.1161/hy1101.095332; Shrimpton R, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e75; Singh GR, 2003, MED J AUSTRALIA, V179, P532, DOI 10.5694/j.1326-5377.2003.tb05679.x; St Clair D, 2005, JAMA-J AM MED ASSOC, V294, P557, DOI 10.1001/jama.294.5.557; Staal WG, 2000, AM J PSYCHIAT, V157, P416, DOI 10.1176/appi.ajp.157.3.416; Stein AD, 2003, AM J CLIN NUTR, V78, P162, DOI 10.1093/ajcn/78.1.162; Stein AD, 2002, J NUTR, V132, P2208, DOI 10.1093/jn/132.8.2208; Stein AD, 2006, AM J EPIDEMIOL, V164, P1160, DOI 10.1093/aje/kwj328; Stein CE, 1996, LANCET, V348, P1269, DOI 10.1016/S0140-6736(96)04547-3; Stein CE, 1997, THORAX, V52, P895, DOI 10.1136/thx.52.10.895; Thomas D, 1997, J ECONOMETRICS, V77, P159, DOI 10.1016/S0304-4076(96)01811-8; Tian JY, 2006, EUR J ENDOCRINOL, V155, P601, DOI 10.1530/eje.1.02265; Tu YK, 2006, J HUM HYPERTENS, V20, P646, DOI 10.1038/sj.jhh.1002044; Tu YK, 2005, AM J EPIDEMIOL, V161, P27, DOI 10.1093/aje/kwi002; Uauy R, 2005, J NUTR, V135, p2934S, DOI 10.1093/jn/135.12.2934S; Uauy R, 2002, PUBLIC HEALTH NUTR, V5, P223, DOI 10.1079/PHN2001297; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Vickers MH, 2003, AM J PHYSIOL-REG I, V285, pR271, DOI 10.1152/ajpregu.00051.2003; Victora CG, 2007, ACTA PAEDIATR, V96, P296, DOI 10.1111/j.1651-2227.2007.00110.x; Victora Cesar G., 2003, Cad. Saúde Pública, V19, P1241, DOI 10.1590/S0102-311X2003000500003; Victora CG, 2005, ACTA PAEDIATR, V94, P1656, DOI 10.1080/08035250500252658; Victora CG, 2001, INT J EPIDEMIOL, V30, P1325, DOI 10.1093/ije/30.6.1325; Walker SP, 2007, INT J OBESITY, V31, P347, DOI 10.1038/sj.ijo.0803383; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011; WHO, 2001, WORLD HLTH REPORT 20; WILLIAMS RL, 1982, OBSTET GYNECOL, V59, P624; Woods LL, 2000, CURR OPIN NEPHROL HY, V9, P419, DOI 10.1097/00041552-200007000-00014; Woods LL, 2001, PEDIATR RES, V49, P460, DOI 10.1203/00006450-200104000-00005; World Bank, 2006, REP NUTR CENTR DEV S; Yajnik CS, 2003, INT J OBESITY, V27, P173, DOI 10.1038/sj.ijo.802219	166	2091	2160	2	224	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2008	371	9609					340	357		10.1016/S0140-6736(07)61692-4	http://dx.doi.org/10.1016/S0140-6736(07)61692-4			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254VQ	18206223	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000252616500030
J	Zhang, CL; Zou, YH; He, WM; Gage, FH; Evans, RM				Zhang, Chun-Li; Zou, Yuhua; He, Weimin; Gage, Fred H.; Evans, Ronald M.			A role for adult TLX-positive neural stem cells in learning and behaviour	NATURE			English	Article							NUCLEAR RECEPTOR TLX; ENHANCED SYNAPTIC PLASTICITY; GENERATED GRANULE CELLS; HIPPOCAMPAL NEUROGENESIS; DENTATE GYRUS; TAILLESS GENE; MICE; MEMORY; MOUSE; PROLIFERATION	Neurogenesis persists in the adult brain and can be regulated by a plethora of external stimuli, such as learning, memory, exercise, environment and stress(1). Although newly generated neurons are able to migrate and preferentially incorporate into the neural network(2-5), how these cells are molecularly regulated and whether they are required for any normal brain function are unresolved questions(6). The adult neural stem cell pool is composed of orphan nuclear receptor TLX- positive cells(7). Here, using genetic approaches in mice, we demonstrate that TLX ( also called NR2E1) regulates adult neural stem cell proliferation in a cell- autonomous manner by controlling a defined genetic network implicated in cell proliferation and growth. Consequently, specific removal of TLX from the adult mouse brain through inducible recombination results in a significant reduction of stem cell proliferation and a marked decrement in spatial learning. In contrast, the resulting suppression of adult neurogenesis does not affect contextual fear conditioning, locomotion or diurnal rhythmic activities, indicating a more selective contribution of newly generated neurons to specific cognitive functions.	[Zhang, Chun-Li; Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Zhang, Chun-Li; Zou, Yuhua; He, Weimin; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute; Salk Institute	Evans, RM (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu; evans@salk.edu	Evans, Ronald/AAF-4001-2019	Evans, Ronald/0000-0002-9986-5965				Bush TG, 1998, CELL, V93, P189, DOI 10.1016/S0092-8674(00)81571-8; Cho YH, 1999, BEHAV BRAIN RES, V98, P77; Crawley Jacqueline N., 2007, WHATS WRONG MY MOUSE; Forni PE, 2006, J NEUROSCI, V26, P9593, DOI 10.1523/JNEUROSCI.2815-06.2006; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; MONAGHAN AP, 1995, DEVELOPMENT, V121, P839; Monaghan AP, 1997, NATURE, V390, P515, DOI 10.1038/37364; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Prickaerts J, 2004, NEUROBIOL LEARN MEM, V81, P1, DOI 10.1016/j.nlm.2003.09.001; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Roy K, 2002, PHYSIOL BEHAV, V77, P595, DOI 10.1016/S0031-9384(02)00902-2; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Wang S, 2000, J NEUROBIOL, V42, P248, DOI 10.1002/(SICI)1097-4695(20000205)42:2<248::AID-NEU8>3.3.CO;2-A; Whishaw IQ, 1996, PHYSIOL BEHAV, V60, P1191, DOI 10.1016/S0031-9384(96)00176-X; Wiltgen BJ, 2006, J NEUROSCI, V26, P5484, DOI 10.1523/JNEUROSCI.2685-05.2006; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; YU RT, 1994, NATURE, V370, P375, DOI 10.1038/370375a0; Zhang CL, 2006, GENE DEV, V20, P1308, DOI 10.1101/gad.1413606	31	412	433	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 21	2008	451	7181					1004	U7		10.1038/nature06562	http://dx.doi.org/10.1038/nature06562			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264TK	18235445				2022-12-28	WOS:000253313100051
J	Xie, J; Brayne, C; Matthews, FE				Xie, Jing; Brayne, Carol; Matthews, Fiona E.		Med Res Council	Survival times in people with dementia: analysis from population based cohort study with 14 year follow-up	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; AGED 65; MORTALITY; PREDICTORS; COMMUNITY; IMPACT; CANADIANS; DECLINE; DEATH	Objectives To provide estimates of survival after onset of dementia by age, sex, self reported health, disability, and severity of cognitive impairment. Design Analysis of participants from prospective population based cohort study in 1991-2003, with follow-up of dementia status in all individuals after two and six years (in one Centre) and 10 years and in subsamples additionally at six and eight years and mortality until 2005. Setting Multicentre population based study in England and Wales: two rural and three urban centres. Participants 438 participants who developed dementia from a population based study of 13 004 individuals aged 65 years and over drawn from primary care population registers. Main outcome measures Sociodemographic factors, cognitive function, specific health conditions, and self reported health collected at each interview. Cox's proportional hazards regression models were used to identify predictors of mortality from the selected variables in people who received diagnosis of dementia according the study's criteria. Results By December 2005, 356 of the 438 (81%) participants who developed dementia during the study had died. Estimated median survival time from onset of dementia to death was 4.1 years (interquartile range 2.5-7.6) for men and 4.6 years (2.9-7.0) for women. There was a difference of nearly seven years in survival between the younger old and the oldest people with dementia: 10.7 (25th centile 5.6) for ages 65-69; 5.4 (interquartile range 3.4-8.3) for ages 70-79; 4.3 (2.8-7.0) for ages 80-89, and 3.8 (2.3-5.2) years for ages >= 90. Significant factors that predicted mortality in the presence of dementia during the follow-up included sex, age of onset, and disability. Conclusion These analyses give a population based estimated median survival for incident dementia of 4.5 years. Such estimates can be used for prognosis and planning for patients, carers, service providers, and policy makers.	[Xie, Jing; Brayne, Carol] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 0SR, England; [Matthews, Fiona E.] Inst Publ Hlth, MRC, Biostat Unit, Cambridge, England	University of Cambridge; MRC Biostatistics Unit; University of Cambridge	Brayne, C (corresponding author), Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 0SR, England.	carol.brayne@medschl.cam.ac.uk	Dewey, Michael E/E-2049-2010; Brayne, Carol/AAA-4285-2020; Matthews, Fiona/O-6932-2015; xie, jing/GRY-1689-2022	Dewey, Michael E/0000-0002-7522-3677; Brayne, Carol/0000-0001-5307-663X; Matthews, Fiona/0000-0002-1728-2388; 	Medical Research Council [MC_U105292687, G9901400] Funding Source: Medline; MRC [MC_U105292687, G9901400] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aguero-Torres H, 1998, J AM GERIATR SOC, V46, P444, DOI 10.1111/j.1532-5415.1998.tb02464.x; Baldereschi M, 1999, NEUROLOGY, V52, P709, DOI 10.1212/WNL.52.4.709; Boersma F, 1999, INT J GERIATR PSYCH, V14, P748, DOI 10.1002/(SICI)1099-1166(199909)14:9<748::AID-GPS3>3.0.CO;2-H; Brayne C, 2006, PLOS MED, V3, P1922, DOI 10.1371/journal.pmed.0030397; COMASHERRERA A, 2003, 1728 PERS SOC SERV R; COPELAND JRM, 1986, PSYCHOL MED, V16, P89, DOI 10.1017/S0033291700057779; Dewey ME, 2001, INT J GERIATR PSYCH, V16, P751, DOI 10.1002/gps.397.abs; Fernando MS, 2004, J NEUROL SCI, V226, P13, DOI 10.1016/j.jns.2004.09.004; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fitzpatrick AL, 2005, J NEUROL SCI, V229, P43, DOI 10.1016/j.jns.2004.11.022; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freels S, 2002, NEUROLOGY, V59, P1146, DOI 10.1212/WNL.59.8.1146; Geerlings MI, 1999, PSYCHOL MED, V29, P1219, DOI 10.1017/S0033291799008867; Guehne U, 2006, DEMENT GERIATR COGN, V21, P403, DOI 10.1159/000092846; GUEROTORRES H, 1999, J CLIN EPIDEMIOL, V52, P737; Gussekloo J, 1997, BRIT MED J, V315, P1053, DOI 10.1136/bmj.315.7115.1053; Helmer C, 2001, AM J EPIDEMIOL, V154, P642, DOI 10.1093/aje/154.7.642; Ishizaki T, 2006, ARCH GERONTOL GERIAT, V42, P47, DOI 10.1016/j.archger.2005.06.001; Juva K, 2000, NEUROLOGY, V54, P412, DOI 10.1212/WNL.54.2.412; Knopman DS, 2003, ARCH NEUROL-CHICAGO, V60, P85, DOI 10.1001/archneur.60.1.85; Koopmans RTCM, 2003, J AM GERIATR SOC, V51, P184, DOI 10.1046/j.1532-5415.2003.51056.x; Landi F, 1999, DEMENT GERIATR COGN, V10, P121, DOI 10.1159/000017112; Larson EB, 2004, ANN INTERN MED, V140, P501, DOI 10.7326/0003-4819-140-7-200404060-00008; Matthews F, 2005, PLOS MED, V2, P753, DOI 10.1371/journal.pmed.0020193; Matthews FE, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-185; MOLSA PK, 1995, ACTA NEUROL SCAND, V91, P159; Neale R, 2001, INT J EPIDEMIOL, V30, P1383, DOI 10.1093/ije/30.6.1383; Noale M, 2003, DEMENT GERIATR COGN, V16, P7, DOI 10.1159/000069987; Ostbye T, 1999, J AM GERIATR SOC, V47, P1249, DOI 10.1111/j.1532-5415.1999.tb05207.x; Ostbye T, 1999, NEUROLOGY, V53, P521, DOI 10.1212/WNL.53.3.521; VANDIJK PTM, 1991, J AM GERIATR SOC, V39, P603, DOI 10.1111/j.1532-5415.1991.tb03602.x; Waring SC, 2005, ALZ DIS ASSOC DIS, V19, P178, DOI 10.1097/01.wad.0000189033.35579.2d	32	250	252	1	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2008	336	7638					258	262		10.1136/bmj.39433.616678.25	http://dx.doi.org/10.1136/bmj.39433.616678.25			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	261TM	18187696	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000253102900038
J	Seidel, HS; Rockman, MV; Kruglyak, L				Seidel, Hannah S.; Rockman, Matthew V.; Kruglyak, Leonid			Widespread genetic incompatibility in C. elegans maintained by balancing selection	SCIENCE			English	Article							EFFECT SELFISH GENES; CAENORHABDITIS-ELEGANS; LINKAGE DISEQUILIBRIUM; NATURAL-POPULATIONS; MEIOTIC DRIVE; POLYMORPHISM; SEGREGATION; RESISTANCE; DISTORTION; DYNAMICS	Natural selection is expected to eliminate genetic incompatibilities from interbreeding populations. We have discovered a globally distributed incompatibility in the primarily selfing species Caenorhabditis elegans that has been maintained despite its negative consequences for fitness. Embryos homozygous for a naturally occurring deletion of the zygotically acting gene zeel- 1 arrest if their sperm parent carries an incompatible allele of a second, paternal- effect locus, peel- 1. The two interacting loci are tightly linked, with incompatible alleles occurring in linkage disequilibrium in two common haplotypes. These haplotypes exhibit elevated sequence divergence, and population genetic analyses of this region indicate that natural selection is preserving both haplotypes in the population. Our data suggest that long- term maintenance of a balanced polymorphism has permitted the incompatibility to persist despite gene flow across the rest of the genome.	[Seidel, Hannah S.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University	Seidel, HS (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	hseidel@princeton.edu; mrockman@princeton.edu; leonid@genomics.princeton.edu			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059520] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG004321-01, R01 HG004321] Funding Source: Medline; NIGMS NIH HHS [GM071508] Funding Source: Medline; NIMH NIH HHS [R37 MH059520] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ahringer J., 2006, REVERSE GENETICS; Atlan A, 1997, EVOLUTION, V51, P1886, DOI 10.1111/j.1558-5646.1997.tb05111.x; Barriere A, 2005, CURR BIOL, V15, P1176, DOI 10.1016/j.cub.2005.06.022; Barriere A, 2007, GENETICS, V176, P999, DOI 10.1534/genetics.106.067223; BEEMAN RW, 1992, SCIENCE, V256, P89, DOI 10.1126/science.1566060; Beeman RW, 1999, HEREDITY, V82, P529, DOI 10.1038/sj.hdy.6885150; Browning H, 1996, DEVELOPMENT, V122, P391; Charlesworth D, 2006, PLOS GENET, V2, P379, DOI 10.1371/journal.pgen.0020064; Cutter AD, 2006, GENETICS, V172, P171, DOI 10.1534/genetics.105.048207; Denver DR, 2003, MOL BIOL EVOL, V20, P393, DOI 10.1093/molbev/msg044; Denver DR, 2004, NATURE, V430, P679, DOI 10.1038/nature02697; Fishman L, 2005, GENETICS, V169, P347, DOI 10.1534/genetics.104.032789; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gonczy P., 2005, ASYMMETRIC CELL DIVI; Haber M, 2005, MOL BIOL EVOL, V22, P160, DOI 10.1093/molbev/msh264; Hodgkin J, 1997, GENETICS, V146, P149; Hurst GDD, 2001, NAT REV GENET, V2, P597, DOI 10.1038/35084545; Koch R, 2000, GENOME RES, V10, P1690, DOI 10.1101/gr.GR-1471R; L'Hernault S. W, 2006, SPERMATOGENESIS, DOI 10. 1895/wormbook. 1. 85. 1; Orr HA, 2000, BIOESSAYS, V22, P1085, DOI 10.1002/1521-1878(200012)22:12&lt;1085::AID-BIES6&gt;3.0.CO;2-G; Orr HA, 2005, GENETICS, V169, P671, DOI 10.1534/genetics.104.033274; Reed FA, 2005, EVOLUTION, V59, P1280, DOI 10.1111/j.0014-3820.2005.tb01778.x; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Sivasundar A, 2005, CURR BIOL, V15, P1598, DOI 10.1016/j.cub.2005.08.034; Sivasundar A, 2003, GENETICS, V163, P147; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; Swan KA, 2002, GENOME RES, V12, P1100, DOI 10.1101/gr.208902; Thomas JH, 2006, GENOME RES, V16, P1017, DOI 10.1101/gr.5089806; Thomas JH, 2006, GENETICS, V172, P127, DOI 10.1534/genetics.104.040030; Tian DC, 2002, P NATL ACAD SCI USA, V99, P11525, DOI 10.1073/pnas.172203599; Vasudevan S, 2007, EMBO REP, V8, P279, DOI 10.1038/sj.embor.7400895; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	34	180	187	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2008	319	5863					589	594		10.1126/science.1151107	http://dx.doi.org/10.1126/science.1151107			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	257AQ	18187622	Green Accepted			2022-12-28	WOS:000252772000032
J	Bouchard, LS; Burt, SR; Anwar, MS; Kovtunov, KV; Koptyug, IV; Pines, A				Bouchard, Louis-S.; Burt, Scott R.; Anwar, M. Sabieh; Kovtunov, Kirill V.; Koptyug, Igor V.; Pines, Alexander			NMR imaging of catalytic hydrogenation in microreactors with the use of para-hydrogen	SCIENCE			English	Article							INDUCED POLARIZATION; MRI; VISUALIZATION; FUTURE	Catalysis is vital to industrial chemistry, and the optimization of catalytic reactors attracts considerable resources. It has proven challenging to correlate the active regions in heterogeneous catalyst beds with morphology and to monitor multistep reactions within the bed. We demonstrate techniques, using magnetic resonance imaging and para- hydrogen ( p-H-2) polarization, that allow direct visualization of gas- phase flow and the density of active catalyst in a packed- bed microreactor, as well as control over the dynamics of the polarized state in space and time to facilitate the study of subsequent reactions. These procedures are suitable for characterizing reactors and reactions in microfluidic devices where low sensitivity of conventional magnetic resonance would otherwise be the limiting factor.	[Bouchard, Louis-S.; Burt, Scott R.; Pines, Alexander] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Bouchard, Louis-S.; Burt, Scott R.; Pines, Alexander] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Anwar, M. Sabieh] Lahore Univ Management & Sci, Sch Sci & Engn, Lahore 54792, Pakistan; [Kovtunov, Kirill V.; Koptyug, Igor V.] Int Tomog Ctr, Novosibirsk 630090, Russia	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Lahore University of Management Sciences; International Tomography Center, Siberian Branch of Russian Academy of Sciences	Bouchard, LS (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA.	louis.bouchard@gmail.com; pines@berkeley.edu	Kovtunov, Kirill/T-7871-2019; Koptyug, Igor/F-6470-2014; Kovtunov, Kirill/K-7943-2017	Koptyug, Igor/0000-0003-3480-7649; Kovtunov, Kirill/0000-0001-7577-9619; Anwar, Muhammad Sabieh/0000-0001-5039-8828				Ahmed-Omer B, 2007, ORG BIOMOL CHEM, V5, P733, DOI 10.1039/b615072a; Ahola S, 2006, LAB CHIP, V6, P90, DOI 10.1039/b510708c; Anwar MS, 2007, ANAL CHEM, V79, P2806, DOI 10.1021/ac062327+; Bauer T, 2005, CHEM ENG SCI, V60, P3101, DOI 10.1016/j.ces.2004.12.041; Belder D, 2006, ANAL BIOANAL CHEM, V385, P416, DOI 10.1007/s00216-006-0428-z; Bogdan AR, 2007, ANGEW CHEM INT EDIT, V46, P1698, DOI 10.1002/anie.200603854; Bouchard LS, 2007, ANGEW CHEM INT EDIT, V46, P4064, DOI 10.1002/anie.200700830; Bowers C. R, 2007, ENCY NUCL MAGNETIC R, DOI 10.1002/9780470034590.emrstm0489; BOWERS CR, 1986, PHYS REV LETT, V57, P2645, DOI 10.1103/PhysRevLett.57.2645; Callaghan, 1993, PRINCIPLES NUCL MAGN; Carravetta M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.153003; Ciobanu L, 2003, ANGEW CHEM INT EDIT, V42, P4669, DOI 10.1002/anie.200351901; Craighead H, 2006, NATURE, V442, P387, DOI 10.1038/nature05061; Haake M, 1996, J AM CHEM SOC, V118, P8688, DOI 10.1021/ja960067f; Haswell SJ, 2001, CHEM COMMUN, P391, DOI 10.1039/b008496o; Kobayashi J, 2004, SCIENCE, V304, P1305, DOI 10.1126/science.1096956; Koptyug IV, 2007, CATAL TODAY, V126, P37, DOI 10.1016/j.cattod.2006.10.001; Koptyug IV, 2007, J AM CHEM SOC, V129, P5580, DOI 10.1021/ja068653o; Koptyug IV, 2005, J MAGN RESON, V175, P21, DOI 10.1016/j.jmr.2005.03.005; KOVTUNOV KV, IN PRESS ANGEW CHEM; Kuppers M, 2002, APPL MAGN RESON, V22, P235, DOI 10.1007/BF03166106; LAUTERBUR PC, 1973, NATURE, V242, P190, DOI 10.1038/242190a0; Lysova AA, 2005, J AM CHEM SOC, V127, P11916, DOI 10.1021/ja053456v; Lysova AA, 2007, CHEM ENG J, V130, P101, DOI 10.1016/j.cej.2006.06.014; Mewes D, 1999, CHEM ENG SCI, V54, P4729, DOI 10.1016/S0009-2509(99)00190-6; Natterer J, 1997, PROG NUCL MAG RES SP, V31, P293, DOI 10.1016/S0079-6565(97)00007-1; Parker DJ, 1996, MEAS SCI TECHNOL, V7, P287, DOI 10.1088/0957-0233/7/3/009; Sederman AJ, 2005, CATAL LETT, V103, P1, DOI 10.1007/s10562-005-7522-2; SHAKA AJ, 1988, J MAGN RESON, V77, P274, DOI 10.1016/0022-2364(88)90178-3; Tayebi D, 2001, CHEM ENG COMMUN, V186, P57; Watts P, 2005, CHEM ENG TECHNOL, V28, P290, DOI 10.1002/ceat.200407124; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Yuen EHL, 2002, APPL CATAL A-GEN, V232, P29, DOI 10.1016/S0926-860X(02)00064-9	33	172	173	2	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2008	319	5862					442	445		10.1126/science.1151787	http://dx.doi.org/10.1126/science.1151787			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254HB	18218891				2022-12-28	WOS:000252576600031
J	Karpova, TS; Kim, MJ; Spriet, C; Nalley, K; Stasevich, TJ; Kherrouche, Z; Heliot, L; McNally, JG				Karpova, Tatiana S.; Kim, Min J.; Spriet, Corentin; Nalley, Kip; Stasevich, Timothy J.; Kherrouche, Zoulika; Heliot, Laurent; McNally, James G.			Concurrent fast and slow cycling of a transcriptional activator at an endogenous promoter	SCIENCE			English	Article							IN-VIVO; RECEPTOR; DYNAMICS; RECRUITMENT; EXCHANGE; RSC; DNA	For gene regulation, some transcriptional activators bind periodically to promoters with either a fast (similar to 1 minute) or a slow (similar to 15 to 90 minutes) cycle. It is uncertain whether the fast cycle occurs on natural promoters, and the function of either cycle in transcription remains unclear. We report that fast and slow cycling can occur simultaneously on an endogenous yeast promoter and that slow cycling in this system reflects an oscillation in the fraction of accessible promoters rather than the recruitment and release of stably bound transcriptional activators. This observation, combined with single- cell measurements of messenger RNA ( mRNA) production, argues that fast cycling initiates transcription and that slow cycling regulates the quantity of mRNA produced. These findings counter the prevailing view that slow cycling initiates transcription.	[Karpova, Tatiana S.; Kim, Min J.; Nalley, Kip; Stasevich, Timothy J.; McNally, James G.] NCI, Ctr Canc Res, Core Imaging Facil, Lab Receptor Biol & Gene Express,NIH, Bethesda, MD 20892 USA; [Spriet, Corentin; Heliot, Laurent] Lille Univ Sci & Technol, Interdisciplinary Res Inst, CNRS, USR 3078, F-59021 Lille, France; [Kherrouche, Zoulika] Inst Pasteur, UMR 8161, Inst Biol Lille, F-59021 Lille, France	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	McNally, JG (corresponding author), NCI, Ctr Canc Res, Core Imaging Facil, Lab Receptor Biol & Gene Express,NIH, 41 Lib Dr, Bethesda, MD 20892 USA.	mcnallyj@exchange.nih.gov	KHERROUCHE, Zoulika/L-6549-2019; Spriet, Corentin/ABE-4215-2021; KHERROUCHE, Zoulika/HHN-0213-2022	Spriet, Corentin/0000-0002-5805-3426; Karpova, Tatiana/0000-0001-6025-2128	NATIONAL CANCER INSTITUTE [Z01BC010561, ZIABC010561] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Angus-Hill ML, 2001, MOL CELL, V7, P741, DOI 10.1016/S1097-2765(01)00219-2; Barrow J, 2006, FEBS LETT, V580, P711, DOI 10.1016/j.febslet.2005.12.061; Belmont AS, 1998, TRENDS CELL BIOL, V8, P121, DOI 10.1016/S0962-8924(97)01211-7; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; Bullitt E, 1997, CELL, V89, P1077, DOI 10.1016/S0092-8674(00)80295-0; Burakov D, 2002, J BIOL CHEM, V277, P14359, DOI 10.1074/jbc.C200099200; Fowler Amy M, 2004, Sci STKE, V2004, ppe51, DOI 10.1126/stke.2562004pe51; FURST P, 1988, CELL, V55, P705, DOI 10.1016/0092-8674(88)90229-2; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Karpova TS, 2004, EMBO REP, V5, P1064, DOI 10.1038/sj.embor.7400281; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Metivier R, 2006, EMBO REP, V7, P161, DOI 10.1038/sj.embor.7400626; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Nalley K, 2006, NATURE, V442, P1054, DOI 10.1038/nature05067; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Rayasam GV, 2005, MOL CELL BIOL, V25, P2406, DOI 10.1128/MCB.25.6.2406-2418.2005; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sharp ZD, 2006, J CELL SCI, V119, P4101, DOI 10.1242/jcs.03161; WELCH JW, 1983, MOL CELL BIOL, V3, P1353, DOI 10.1128/MCB.3.8.1353; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025	22	113	115	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2008	319	5862					466	469		10.1126/science.1150559	http://dx.doi.org/10.1126/science.1150559			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254HB	18218898				2022-12-28	WOS:000252576600039
J	Alexander, SI; Smith, N; Hu, M; Verran, D; Shun, A; Dorney, S; Smith, A; Webster, B; Shaw, PJ; Lammi, A; Stormon, MO				Alexander, Stephen I.; Smith, Neil; Hu, Min; Verran, Deborah; Shun, Albert; Dorney, Stuart; Smith, Arabella; Webster, Boyd; Shaw, Peter John; Lammi, Ahti; Stormon, Michael O.			Brief report: Chimerism and tolerance in a recipient of a deceased-donor liver transplant	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; VERSUS-HOST-DISEASE; LIVING-DONOR; GRAFT; MICROCHIMERISM; RECONSTITUTION; INDUCTION; REJECTION; ALLOGRAFT	Complete hematopoietic chimerism and tolerance of a liver allograft from a deceased male donor developed in a 9- year- old girl, with no evidence of graft- versus- host disease 17 months after transplantation. The tolerance was preceded by a period of severe hemolysis, reflecting partial chimerism that was refractory to standard therapies. The hemolysis resolved after the gradual withdrawal of all immunosuppressive therapy.	[Alexander, Stephen I.; Hu, Min] Univ Sydney, Ctr Kidney Res, Sydney, NSW 2006, Australia; [Alexander, Stephen I.; Smith, Neil; Shun, Albert; Dorney, Stuart; Smith, Arabella; Webster, Boyd; Shaw, Peter John; Lammi, Ahti; Stormon, Michael O.] Univ Sydney, Childrens Hosp Westmead, Sydney, NSW 2006, Australia; [Alexander, Stephen I.; Smith, Neil; Shun, Albert; Dorney, Stuart; Smith, Arabella; Webster, Boyd; Shaw, Peter John; Lammi, Ahti; Stormon, Michael O.] Univ Sydney, Dept Paediat & Child Hlth, Sydney, NSW 2006, Australia; [Verran, Deborah; Shun, Albert; Dorney, Stuart; Stormon, Michael O.] Australian Natl Liver Transplant Unit, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of Sydney	Stormon, MO (corresponding author), Childrens Hosp Westmead, Dept Gastroenterol, Locked Bag 4001, Sydney, NSW 2145, Australia.	michaes6@chw.edu.au	shaw, peter John/D-8255-2011; Verran, Deborah/V-3954-2019	shaw, peter John/0000-0003-0101-4482; 				ABUELMAGD KM, 1991, TRANSPLANT P, V23, P3190; Andreoni KA, 2004, NEW ENGL J MED, V350, P2624, DOI 10.1056/NEJM200406173502522; Cavazzana-Calvo M, 2007, BLOOD, V109, P4575, DOI 10.1182/blood-2006-07-029090; COLLINS RH, 1993, NEW ENGL J MED, V328, P762, DOI 10.1056/NEJM199303183281104; Domiati-Saad R, 2005, AM J TRANSPLANT, V5, P2968, DOI 10.1111/j.1600-6143.2005.01110.x; Donckier V, 2004, TRANSPL IMMUNOL, V13, P139, DOI 10.1016/j.trim.2004.05.004; Gilroy RK, 2004, BLOOD, V103, P1171, DOI 10.1182/blood-2003-04-1187; Kraus AB, 2003, EXP HEMATOL, V31, P609, DOI 10.1016/S0301-472X(03)00082-1; Kurtz J, 2004, BLOOD, V103, P4336, DOI 10.1182/blood-2003-08-2642; Li Y, 2004, AM J TRANSPLANT, V4, P2118, DOI 10.1111/j.1600-6143.2004.00611.x; Manilay JO, 1998, TRANSPLANTATION, V66, P96, DOI 10.1097/00007890-199807150-00015; Mocarski ES, 2004, CELL MICROBIOL, V6, P707, DOI 10.1111/j.1462-5822.2004.00425.x; Nikolic B, 1997, CURR OPIN IMMUNOL, V9, P634, DOI 10.1016/S0952-7915(97)80042-8; Ponchel F, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-18; Savage WJ, 2001, BONE MARROW TRANSPL, V28, P463, DOI 10.1038/sj.bmt.1703176; SCHLITT HJ, 1994, NEW ENGL J MED, V330, P646, DOI 10.1056/NEJM199403033300919; Schlitt HJ, 1997, TRANSPL P, V29, P82, DOI 10.1016/S0041-1345(96)00016-4; Sivasai KSR, 1997, TRANSPLANTATION, V64, P427, DOI 10.1097/00007890-199708150-00010; STARZL TE, 1992, LANCET, V339, P1579, DOI 10.1016/0140-6736(92)91840-5; STARZL TE, 1992, LANCET, V340, P876, DOI 10.1016/0140-6736(92)93286-V; Wang ECY, 2002, P NATL ACAD SCI USA, V99, P7570, DOI 10.1073/pnas.112680099; Wekerle T, 1999, TRANSPLANTATION, V68, P459, DOI 10.1097/00007890-199908270-00001; Werkele T, 2000, NAT MED, V6, P464, DOI 10.1038/74731; Whitington PF, 1996, TRANSPLANTATION, V62, P1516, DOI 10.1097/00007890-199611270-00025	24	124	139	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2008	358	4					369	374		10.1056/NEJMoa0707255	http://dx.doi.org/10.1056/NEJMoa0707255			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253GY	18216357				2022-12-28	WOS:000252507900007
J	Feng, SH; Martinez, C; Gusmaroli, G; Wang, Y; Zhou, JL; Wang, F; Chen, LY; Yu, L; Iglesias-Pedraz, JM; Kircher, S; Schafer, E; Fu, XD; Fan, LM; Deng, XW				Feng, Suhua; Martinez, Cristina; Gusmaroli, Giuliana; Wang, Yu; Zhou, Junli; Wang, Feng; Chen, Liying; Yu, Lu; Iglesias-Pedraz, Juan M.; Kircher, Stefan; Schaefer, Eberhard; Fu, Xiangdong; Fan, Liu-Min; Deng, Xing Wang			Coordinated regulation of Arabidopsis thaliana development by light and gibberellins	NATURE			English	Article							PHYTOCHROME INTERACTING FACTOR-3; TRANSCRIPTION FACTOR; SEED-GERMINATION; PROTEIN; PIF3; AFFINITY; DEGRADATION; RECEPTOR; PATHWAY; BINDING	Light and gibberellins ( GAs) mediate many essential and partially overlapping plant developmental processes. DELLA proteins are GA- signalling repressors that block GA- induced development(1). GA induces degradation of DELLA proteins via the ubiquitin/ proteasome pathway(2), but light promotes accumulation of DELLA proteins by reducing GA levels(3). It was proposed that DELLA proteins restrain plant growth largely through their effect on gene expression(4,5). However, the precise mechanism of their function in coordinating GA signalling and gene expression remains unknown. Here we characterize a nuclear protein interaction cascade mediating transduction of GA signals to the activity regulation of a light- responsive transcription factor. In the absence of GA, nuclear- localized DELLA proteins accumulate to higher levels, interact with phytochrome- interacting factor 3 ( PIF3, a bHLH- type transcription factor) and prevent PIF3 from binding to its target gene promoters and regulating gene expression, and therefore abrogate PIF3- mediated light control of hypocotyl elongation. In the presence of GA, GID1 proteins ( GA receptors) elevate their direct interaction with DELLA proteins in the nucleus, trigger DELLA protein's ubiquitination and proteasome- mediated degradation, and thus release PIF3 from the negative effect of DELLA proteins.	[Feng, Suhua; Martinez, Cristina; Gusmaroli, Giuliana; Deng, Xing Wang] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Feng, Suhua; Zhou, Junli; Wang, Feng; Chen, Liying; Yu, Lu; Deng, Xing Wang] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Wang, Yu; Fan, Liu-Min; Deng, Xing Wang] Peking Univ, Coll Life Sci, Peking Yale Joint Ctr Plant Mol Genet & Agrobiote, Beijing 100871, Peoples R China; [Wang, Yu; Fan, Liu-Min; Deng, Xing Wang] Peking Univ, Coll Life Sci, Natl Lab Prot Engn & Plant Genet Engn, Beijing 100871, Peoples R China; [Iglesias-Pedraz, Juan M.] CSIC, Ctr Nacl Biotecnol, Dept Genet Mol Plantas, E-28049 Madrid, Spain; [Kircher, Stefan; Schaefer, Eberhard] Univ Freiburg, Inst Biol Bot 2, D-79104 Freiburg, Germany; [Fu, Xiangdong] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100080, Peoples R China	Yale University; National Institute of Biological Sciences, Beijing; Peking University; Peking University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of Freiburg; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Deng, XW (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	xingwang.deng@yale.edu	Pedraz, Juan Manuel Iglesias/AAH-6067-2019; Deng, Xing Wang/ABF-4107-2020; Iglesias-Pedraz, Juan Manuel/U-7205-2017; Iglesias Pedraz, Juan Manuel/AAH-6075-2019; Hernandez, Cristina Martinez/L-1703-2014	Iglesias-Pedraz, Juan Manuel/0000-0003-0070-8116; Iglesias Pedraz, Juan Manuel/0000-0003-0070-8116; Hernandez, Cristina Martinez/0000-0001-7061-062X; Kircher, Stefan/0000-0002-8351-567X	NIGMS NIH HHS [R01 GM047850-12, R37 GM047850-17, R37 GM047850, R01 GM047850] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047850, R01GM047850] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Achard P, 2007, PLANT PHYSIOL, V143, P1163, DOI 10.1104/pp.106.092254; Al-Sady B, 2006, MOL CELL, V23, P439, DOI 10.1016/j.molcel.2006.06.011; Alabadi D, 2004, PLANT PHYSIOL, V134, P1050, DOI 10.1104/pp.103.035451; Bauer D, 2004, PLANT CELL, V16, P1433, DOI 10.1105/tpc.021568; Bolle C, 2004, PLANTA, V218, P683, DOI 10.1007/s00425-004-1203-z; Cao DN, 2006, PLANT PHYSIOL, V142, P509, DOI 10.1104/pp.106.082289; de Lucas M, 2008, NATURE, V451, P480, DOI 10.1038/nature06520; Dill A, 2004, PLANT CELL, V16, P1392, DOI 10.1105/tpc.020958; Feng SH, 2004, PLANT CELL, V16, P1870, DOI 10.1105/tpc.021949; Feng SH, 2003, PLANT CELL, V15, P1083, DOI 10.1105/tpc.010207; Fleet CM, 2005, CURR OPIN PLANT BIOL, V8, P77, DOI 10.1016/j.pbi.2004.11.015; Fu XD, 2004, PLANT CELL, V16, P1406, DOI 10.1105/tpc.021386; Griffiths J, 2006, PLANT CELL, V18, P3399, DOI 10.1105/tpc.106.047415; Itoh H, 2002, PLANT CELL, V14, P57, DOI 10.1105/tpc.010319; Itoh H, 2003, TRENDS PLANT SCI, V8, P492, DOI 10.1016/j.tplants.2003.08.002; Jiao YL, 2005, PLANT CELL, V17, P3239, DOI 10.1105/tpc.105.035840; Kim JY, 2003, PLANT CELL, V15, P2399, DOI 10.1105/tpc.014498; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; Martinez-Garcia JF, 2000, SCIENCE, V288, P859, DOI 10.1126/science.288.5467.859; Monte E, 2004, P NATL ACAD SCI USA, V101, P16091, DOI 10.1073/pnas.0407107101; Nakajima M, 2006, PLANT J, V46, P880, DOI 10.1111/j.1365-313X.2006.02748.x; Ni M, 1999, NATURE, V400, P781, DOI 10.1038/23500; Ogawa M, 2003, PLANT CELL, V15, P1591, DOI 10.1105/tpc.011650; Oh E, 2004, PLANT CELL, V16, P3045, DOI 10.1105/tpc.104.025163; Park E, 2004, PLANT CELL PHYSIOL, V45, P968, DOI 10.1093/pcp/pch125; Penfield S, 2005, CURR BIOL, V15, P1998, DOI 10.1016/j.cub.2005.11.010; Rubio V, 2005, PLANT J, V41, P767, DOI 10.1111/j.1365-313X.2004.02328.x; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Willige BC, 2007, PLANT CELL, V19, P1209, DOI 10.1105/tpc.107.051441; Zhu YX, 2000, P NATL ACAD SCI USA, V97, P13419, DOI 10.1073/pnas.230433797	32	724	804	13	281	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2008	451	7177					475	U9		10.1038/nature06448	http://dx.doi.org/10.1038/nature06448			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	253YS	18216856	Green Accepted, Bronze			2022-12-28	WOS:000252554100047
J	Hart, JT				Hart, Julian Tudor			A few lessons in screening for Gordon Brown	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												julian@tudorhart.freeserve.co.uk						HART JT, 1991, BMJ-BRIT MED J, V302, P1509, DOI 10.1136/bmj.302.6791.1509; 2008, BMJ, V336, P62	2	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 19	2008	336	7636					123	123		10.1136/bmj.39461.502581.59	http://dx.doi.org/10.1136/bmj.39461.502581.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	257SS	18202064	Green Published			2022-12-28	WOS:000252819400027
J	Steinert, Y				Steinert, Yvonne			Teaching rounds - The "problem" junior: whose problem is it?	BRITISH MEDICAL JOURNAL			English	Editorial Material							PROBLEM RESIDENTS; MEDICINE RESIDENCY; NATIONAL-SURVEY; WORKING		McGill Univ, Lady Meredith House, Fac Med, Ctr Med Educ, Montreal, PQ H3A 1A3, Canada	McGill University	Steinert, Y (corresponding author), McGill Univ, Lady Meredith House, Fac Med, Ctr Med Educ, 1110 Pine Ave W, Montreal, PQ H3A 1A3, Canada.	yvonne.steinert@mcgill.ca						Gordon M J, 1993, Fam Med, V25, P637; Grams G D, 1992, Fam Med, V24, P197; Howell JB, 1984, PHYS STRESS HDB COPI; Ikkos G, 2000, HOSP MED, V61, P348, DOI 10.12968/hosp.2000.61.5.1335; Peterkin AD, 1991, STAYING HUMAN RESIDE; Rankin JW, 1986, EVALUATE RESIDENTS; Reamy BV, 2006, FAM MED, V38, P252; ROBACK HB, 1989, AM J PSYCHIAT, V146, P96; Rose TG, 1989, BECOMING FAMILY PHYS; Shapiro J, 1987, Fam Med, V19, P368; Steinert Y, 2001, MED TEACH, V23, P284; STEINZOR RI, 1993, URBAN LAWYER, V25, P627; Vaughn LM, 1998, TEACH LEARN MED, V10, P217, DOI 10.1207/S15328015TLM1004_4; Winter RO, 2002, FAM MED, V34, P190; Yao DC, 2000, JAMA-J AM MED ASSOC, V284, P1099, DOI 10.1001/jama.284.9.1099; Yao DC, 2001, J GEN INTERN MED, V16, P486, DOI 10.1046/j.1525-1497.2001.016007486.x	16	25	26	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 19	2008	336	7636					150	153		10.1136/bmj.39308.610081.AD	http://dx.doi.org/10.1136/bmj.39308.610081.AD			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	257SS	18202068	Green Submitted, Green Published			2022-12-28	WOS:000252819400035
J	Hong, DL; Gupta, R; Ancliff, P; Atzberger, A; Brown, J; Soneji, S; Green, J; Colman, S; Piacibello, W; Buckle, V; Tsuzuki, S; Greaves, M; Enver, T				Hong, Dengli; Gupta, Rajeev; Ancliff, Philip; Atzberger, Ann; Brown, John; Soneji, Shamit; Green, Joanne; Colman, Sue; Piacibello, Wanda; Buckle, Veronica; Tsuzuki, Shinobu; Greaves, Mel; Enver, Tariq			Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia	SCIENCE			English	Article							STEM-CELLS; IDENTIFICATION; LESSONS	Understanding cancer pathogenesis requires knowledge of not only the specific contributory genetic mutations but also the cellular framework in which they arise and function. Here we explore the clonal evolution of a form of childhood precursor- B cell acute lymphoblastic leukemia that is characterized by a chromosomal translocation generating a TEL- AML1 fusion gene. We identify a cell compartment in leukemic children that can propagate leukemia when transplanted in mice. By studying a monochorionic twin pair, one preleukemic and one with frank leukemia, we establish the lineal relationship between these "cancer- propagating" cells and the preleukemic cell in which the TEL- AML1 fusion first arises or has functional impact. Analysis of TEL- AML1- transduced cord blood cells suggests that TEL- AML1 functions as a first- hit mutation by endowing this preleukemic cell with altered self- renewal and survival properties.	[Hong, Dengli; Gupta, Rajeev; Atzberger, Ann; Brown, John; Soneji, Shamit; Green, Joanne; Buckle, Veronica; Enver, Tariq] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC,Mol Haematol Unit, Oxford OX3 9DS, England; [Ancliff, Philip] Great Ormond St Hosp Sick Children, Dept Haematol, London WC1N 3JH, England; [Ancliff, Philip] UCL, Inst Child Hlth, Dept Mol Haematol & Canc Biol, London WC1N 3JH, England; [Tsuzuki, Shinobu] Aichi Canc Res Inst, Div Mol Med, Nagoya, Aichi 4648681, Japan; [Piacibello, Wanda] Inst Canc Res & Treatment, Div Res Med Oncol, I-10060 Turin, Italy; [Colman, Sue; Greaves, Mel] Inst Canc Res, Sect Haematooncol, Sutton SM2 5NG, Surrey, England	University of Oxford; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Aichi Cancer Center; University of London; Institute of Cancer Research - UK	Enver, T (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC,Mol Haematol Unit, Oxford OX3 9DS, England.	tenver@gwmail.jr2.ox.ac.uk		Tsuzuki, Shinobu/0000-0002-3209-3550; Hong, Dengli/0000-0001-5251-0297; Gupta, Rajeev/0000-0001-9573-0505	MRC [MC_U137961143, MC_U137973817] Funding Source: UKRI; Medical Research Council [MC_U137961143, MC_U137973817] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Greaves MF, 2003, BLOOD, V102, P2321, DOI 10.1182/blood-2002-12-3817; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Shurtleff SA, 1995, LEUKEMIA, V9, P1985; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004	9	287	303	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2008	319	5861					336	339		10.1126/science.1150648	http://dx.doi.org/10.1126/science.1150648			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252GY	18202291				2022-12-28	WOS:000252436200040
J	Takacs, CM; Baird, JR; Hughes, EG; Kent, SS; Benchabane, H; Paik, R; Ahmed, Y				Takacs, Carter M.; Baird, Jason R.; Hughes, Edward G.; Kent, Sierra S.; Benchabane, Hassina; Paik, Raehum; Ahmed, Yashi			Dual positive and negative regulation of Wingless signaling by adenomatous polyposis coli	SCIENCE			English	Article							TUMOR-SUPPRESSOR PROTEIN; CATENIN-TCF COMPLEX; BETA-CATENIN; DROSOPHILA APC2; AXIN; ARMADILLO; PATHWAY; HOMOLOG; ACTIVATION; MUTATION	Understanding cancer pathogenesis requires knowledge of not only the specific contributory genetic mutations but also the cellular framework in which they arise and function. Here we explore the clonal evolution of a form of childhood precursor- B cell acute lymphoblastic leukemia that is characterized by a chromosomal translocation generating a TEL- AML1 fusion gene. We identify a cell compartment in leukemic children that can propagate leukemia when transplanted in mice. By studying a monochorionic twin pair, one preleukemic and one with frank leukemia, we establish the lineal relationship between these "cancer- propagating" cells and the preleukemic cell in which the TEL- AML1 fusion first arises or has functional impact. Analysis of TEL- AML1- transduced cord blood cells suggests that TEL- AML1 functions as a first- hit mutation by endowing this preleukemic cell with altered self- renewal and survival properties.	[Takacs, Carter M.; Baird, Jason R.; Hughes, Edward G.; Kent, Sierra S.; Benchabane, Hassina; Paik, Raehum; Ahmed, Yashi] Dartmouth Med Sch, Dept Genet, Hanover, NH 03755 USA; [Takacs, Carter M.; Baird, Jason R.; Hughes, Edward G.; Kent, Sierra S.; Benchabane, Hassina; Paik, Raehum; Ahmed, Yashi] Dartmouth Med Sch, Norris Cotton Canc Ctr, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Ahmed, Y (corresponding author), Dartmouth Med Sch, Dept Genet, Hanover, NH 03755 USA.	yfa@dartmouth.edu			NATIONAL CANCER INSTITUTE [R01CA105038, K08CA078532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM122222] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA105038, KO8CA078532, R01 CA105038] Funding Source: Medline; NIGMS NIH HHS [R01 GM122222] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Ahmed Y, 1998, CELL, V93, P1171, DOI 10.1016/S0092-8674(00)81461-0; Ahmed Y, 2002, DEVELOPMENT, V129, P1751; Akong K, 2002, DEV BIOL, V250, P91, DOI 10.1006/dbio.2002.0776; Albuquerque C, 2002, HUM MOL GENET, V11, P1549, DOI 10.1093/hmg/11.13.1549; BAKER NE, 1988, DEVELOPMENT, V102, P489; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Farr GH, 2000, J CELL BIOL, V148, P691, DOI 10.1083/jcb.148.4.691; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Hayashi S, 1997, P NATL ACAD SCI USA, V94, P242, DOI 10.1073/pnas.94.1.242; Hoier EF, 2000, GENE DEV, V14, P874; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Lamlum H, 1999, NAT MED, V5, P1071, DOI 10.1038/12511; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; McCartney BM, 1999, J CELL BIOL, V146, P1303, DOI 10.1083/jcb.146.6.1303; McCartney BM, 2001, NAT CELL BIOL, V3, P933, DOI 10.1038/ncb1001-933; McCartney BM, 2006, DEVELOPMENT, V133, P2407, DOI 10.1242/dev.02398; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; PEIFER M, 1991, DEVELOPMENT, V111, P1029; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Schneikert J, 2007, HUM MOL GENET, V16, P199, DOI 10.1093/hmg/ddl464; SHARMA RP, 1976, DEV BIOL, V48, P461, DOI 10.1016/0012-1606(76)90108-1; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Tomlinson A, 2003, DEV CELL, V5, P799, DOI 10.1016/S1534-5807(03)00326-5; Vleminckx K, 1997, J CELL BIOL, V136, P411, DOI 10.1083/jcb.136.2.411; Wernet MF, 2003, CELL, V115, P267, DOI 10.1016/S0092-8674(03)00848-1; Yu X, 1999, NAT CELL BIOL, V1, P144, DOI 10.1038/11064	36	47	50	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2008	319	5861					333	336		10.1126/science.1151232	http://dx.doi.org/10.1126/science.1151232			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252GY	18202290				2022-12-28	WOS:000252436200039
J	Allen, KJ; Gurrin, LC; Constantine, CC; Osborne, NJ; Delatycki, MB; Nicoll, AJ; McLaren, CE; Bahlo, M; Nisselle, AE; Vulpe, CD; Anderson, GJ; Southey, MC; Giles, GG; English, DR; Hopper, JL; Olynyk, JK; Powell, LW; Gertig, DM				Allen, Katrina J.; Gurrin, Lyle C.; Constantine, Clare C.; Osborne, Nicholas J.; Delatycki, Martin B.; Nicoll, Amanda J.; McLaren, Christine E.; Bahlo, Melanie; Nisselle, Amy E.; Vulpe, Chris D.; Anderson, Gregory J.; Southey, Melissa C.; Giles, Graham G.; English, Dallas R.; Hopper, John L.; Olynyk, John K.; Powell, Lawrie W.; Gertig, Dorota M.			Iron-overload-related disease in HFE hereditary hemochromatosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICAL EXPRESSION; AFRICAN-AMERICANS; POPULATION; ASSOCIATION; MANAGEMENT; DIAGNOSIS; MUTATION; FIBROSIS	Background: Most persons who are homozygous for C282Y, the HFE allele most commonly asssociated with hereditary hemochromatosis, have elevated levels of serum ferritin and transferrin saturation. Diseases related to iron overload develop in some C282Y homozygotes, but the extent of the risk is controversial. Methods: We assessed HFE mutations in 31,192 persons of northern European descent between the ages of 40 and 69 years who participated in the Melbourne Collaborative Cohort Study and were followed for an average of 12 years. In a random sample of 1438 subjects stratified according to HFE genotype, including all 203 C282Y homozygotes (of whom 108 were women and 95 were men), we obtained clinical and biochemical data, including two sets of iron measurements performed 12 years apart. Disease related to iron overload was defined as documented iron overload and one or more of the following conditions: cirrhosis, liver fibrosis, hepatocellular carcinoma, elevated aminotransferase levels, physician-diagnosed symptomatic hemochromatosis, and arthropathy of the second and third metacarpophalangeal joints. Results: The proportion of C282Y homozygotes with documented iron-overload-related disease was 28.4% (95% confidence interval [CI], 18.8 to 40.2) for men and 1.2% (95% CI, 0.03 to 6.5) for women. Only one non-C282Y homozygote (a compound heterozygote) had documented iron-overload-related disease. Male C282Y homozygotes with a serum ferritin level of 1000 microg per liter or more were more likely to report fatigue, use of arthritis medicine, and a history of liver disease than were men who had the wild-type gene. Conclusions: In persons who are homozygous for the C282Y mutation, iron-overload-related disease developed in a substantial proportion of men but in a small proportion of women.	[Allen, Katrina J.; Osborne, Nicholas J.; Delatycki, Martin B.; Nisselle, Amy E.] Univ Melbourne, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Gurrin, Lyle C.; Constantine, Clare C.; Osborne, Nicholas J.; Giles, Graham G.; English, Dallas R.; Hopper, John L.; Gertig, Dorota M.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Allen, Katrina J.; Delatycki, Martin B.; Nisselle, Amy E.] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Southey, Melissa C.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Nicoll, Amanda J.] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Bahlo, Melanie] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Anderson, Gregory J.; Powell, Lawrie W.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Anderson, Gregory J.; Powell, Lawrie W.] Univ Queensland, Brisbane, Qld, Australia; [Giles, Graham G.; English, Dallas R.] Canc Council Victoria, Melbourne, Vic, Australia; [Olynyk, John K.] Univ Western Australia, Perth, WA 6009, Australia; [Olynyk, John K.] Western Australian Inst Med Res, Perth, WA, Australia; [McLaren, Christine E.] Univ Calif Irvine, Irvine, CA USA; [Vulpe, Chris D.] Univ Calif Berkeley, Berkeley, CA 94720 USA	Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Royal Melbourne Hospital; Walter & Eliza Hall Institute; QIMR Berghofer Medical Research Institute; University of Queensland; Cancer Council Victoria; University of Western Australia; University of Western Australia; University of California System; University of California Irvine; University of California System; University of California Berkeley	Allen, KJ (corresponding author), Royal Childrens Hosp, Dept Gastroenterol, Flemington Rd, Parkville, Vic 3052, Australia.	katie.allen@rch.org.au	, Amy/M-3622-2019; Anderson, Gregory J/G-4148-2013; English, Dallas/AAH-5005-2019; Delatycki, Martin B/A-5409-2013; Gertig, Dorota/Z-1087-2019; Osborne, Nicholas/D-2086-2011; Vulpe, Chris/AAF-9170-2020; Allen, Katrina/I-4361-2018	, Amy/0000-0002-8908-5906; Anderson, Gregory J/0000-0002-8814-5866; English, Dallas/0000-0001-7828-8188; Osborne, Nicholas/0000-0002-6700-2284; Vulpe, Chris/0000-0001-5134-8929; Allen, Katrina/0000-0002-1921-4493; Gurrin, Lyle/0000-0001-7052-1969; Olynyk, John/0000-0003-0417-3411; Southey, Melissa/0000-0002-6313-9005; Bahlo, Melanie/0000-0001-5132-0774; Giles, Graham/0000-0003-4946-9099; Nicoll, Amanda/0000-0002-1855-2757	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061885] Funding Source: NIH RePORTER; NIDDK NIH HHS [1-RO1-DK061885-01A2] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams P, 2000, J HEPATOL, V33, P487, DOI 10.1016/S0168-8278(01)80874-6; Adams PC, 2007, LANCET, V370, P1855, DOI 10.1016/S0140-6736(07)61782-6; Adams PC, 2005, NEW ENGL J MED, V352, P1769, DOI 10.1056/NEJMoa041534; Ajioka RS, 2003, BLOOD, V101, P3351, DOI 10.1182/blood-2002-11-3453; Allen KJ, 2002, LANCET, V360, P412, DOI 10.1016/S0140-6736(02)09583-1; Andersen RV, 2004, BLOOD, V103, P2914, DOI 10.1182/blood-2003-10-3564; Barton JC, 2005, BLOOD CELL MOL DIS, V34, P38, DOI 10.1016/j.bcmd.2004.08.022; Beutler E, 2002, LANCET, V359, P211, DOI 10.1016/S0140-6736(02)07447-0; Beutler E, 2003, BLOOD CELL MOL DIS, V31, P305, DOI 10.1016/S1079-9796(03)00165-7; Bulaj ZJ, 2000, NEW ENGL J MED, V343, P1529, DOI 10.1056/NEJM200011233432104; Delatycki MB, 2005, LANCET, V366, P314, DOI 10.1016/S0140-6736(05)63012-7; EDWARDS CQ, 1993, NEW ENGL J MED, V328, P1616; Falize L, 2006, HEPATOLOGY, V44, P472, DOI 10.1002/hep.21260; Giles G G, 2002, IARC Sci Publ, V156, P69; Gochee PA, 2002, GASTROENTEROLOGY, V122, P646, DOI 10.1016/S0016-5085(02)80116-0; Gochee PA, 2002, GASTROENTEROLOGY, V122, P1191; Guyader D, 1998, GASTROENTEROLOGY, V115, P929, DOI 10.1016/S0016-5085(98)70265-3; Niederau C, 1996, GASTROENTEROLOGY, V110, P1107, DOI 10.1053/gast.1996.v110.pm8613000; Olynyk JK, 1999, NEW ENGL J MED, V341, P718, DOI 10.1056/NEJM199909023411002; Olynyk JK, 2004, MAYO CLIN PROC, V79, P309, DOI 10.4065/79.3.309; Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573; Pietrangelo A, 2006, ANNU REV NUTR, V26, P251, DOI 10.1146/annurev.nutr.26.061505.111226; Powell LW, 2006, ARCH INTERN MED, V166, P294, DOI 10.1001/archinte.166.3.294; River CA, 2007, BLOOD CELL MOL DIS, V38, P247, DOI 10.1016/j.bcmd.2006.12.002; Tavill AS, 2001, HEPATOLOGY, V33, P1321, DOI 10.1053/jhep.2001.24783; Whitlock EP, 2006, ANN INTERN MED, V145, P209, DOI 10.7326/0003-4819-145-3-200608010-00009; Worwood M, 2005, BLOOD REV, V19, P69, DOI 10.1016/j.blre.2004.03.003	27	485	502	2	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2008	358	3					221	230		10.1056/NEJMoa073286	http://dx.doi.org/10.1056/NEJMoa073286			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	251LS	18199861				2022-12-28	WOS:000252375600003
J	Deana, A; Celesnik, H; Belasco, JG				Deana, Atilio; Celesnik, Helena; Belasco, Joel G.			The bacterial enzyme RppH triggers messenger RNA degradation by 5' pyrophosphate removal	NATURE			English	Article							ESCHERICHIA-COLI K1; NUDIX HYDROLASE; RIBOSOMAL PROTEIN-S20; RIBONUCLEASE-E; STEM-LOOP; IN-VIVO; GENE; CLEAVAGE; STABILIZATION; ABILITY	The long- standing assumption that messenger RNA ( mRNA) degradation in Escherichia coli begins with endonucleolytic cleavage has been challenged by the recent discovery that RNA decay can be triggered by a prior non- nucleolytic event that marks transcripts for rapid turnover: the rate- determining conversion of the 5' terminus from a triphosphate to a monophosphate(1). This modification creates better substrates for the endonuclease RNase E, whose cleavage activity at internal sites is greatly enhanced when the RNA 5' end is monophosphorylated(2,3). Moreover, it suggests an explanation for the influence of 5' termini on the endonucleolytic cleavage of primary transcripts, which are triphosphorylated(4-) (8). However, no enzyme capable of removing pyrophosphate from RNA 5' ends has been identified in any bacterial species. Here we show that the E. coli protein RppH ( formerly NudH/Y gdP) is the RNA pyrophosphohydrolase that initiates mRNA decay by this 5'- end- dependent pathway. In vitro, RppH efficiently removes pyrophosphate from the 5' end of triphosphorylated RNA, irrespective of the identity of the 5'- terminal nucleotide. In vivo, it accelerates the degradation of hundreds of E. coli transcripts by converting their triphosphorylated 5' ends to a more labile mono-phosphorylated state that can stimulate subsequent ribonuclease cleavage. That the action of the pyrophosphohydrolase is impeded when the 5' end is structurally sequestered by a stem- loop helps to explain the stabilizing influence of 5'- terminal base pairing on mRNA lifetimes. Together, these findings suggest a possible basis for the effect of RppH and its orthologues on the invasiveness of bacterial pathogens. Interestingly, this master regulator of 5'- end-dependent mRNA degradation in E. coli not only catalyses a process functionally reminiscent of eukaryotic mRNA decapping but also bears an evolutionary relationship to the eukaryotic decapping enzyme Dcp2.	[Deana, Atilio; Celesnik, Helena; Belasco, Joel G.] NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Deana, Atilio; Celesnik, Helena; Belasco, Joel G.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	New York University; New York University	Belasco, JG (corresponding author), NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY 10016 USA.	belasco@saturn.med.nyu.edu		Deana, Atilio/0000-0003-1804-1823	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035769] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM035769] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnold TE, 1998, RNA, V4, P319; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Badger JL, 2000, MOL MICROBIOL, V36, P174, DOI 10.1046/j.1365-2958.2000.01840.x; Baker KE, 2003, MOL MICROBIOL, V47, P75, DOI 10.1046/j.1365-2958.2003.03292.x; Bessman MJ, 2001, J BIOL CHEM, V276, P37834; BOUVET P, 1992, NATURE, V360, P488, DOI 10.1038/360488a0; Bricker AL, 1999, J BACTERIOL, V181, P3587, DOI 10.1128/JB.181.11.3587-3590.1999; Celesnik H, 2007, MOL CELL, V27, P79, DOI 10.1016/j.molcel.2007.05.038; Coleman TM, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh007; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dunckley T, 1999, EMBO J, V18, P5411, DOI 10.1093/emboj/18.19.5411; Edelstein PH, 2005, INFECT IMMUN, V73, P6567, DOI 10.1128/IAI.73.10.6567-6576.2005; EMORY SA, 1992, GENE DEV, V6, P135, DOI 10.1101/gad.6.1.135; EMORY SA, 1990, J BACTERIOL, V172, P4472, DOI 10.1128/jb.172.8.4472-4481.1990; Feng YN, 2000, P NATL ACAD SCI USA, V97, P6415, DOI 10.1073/pnas.120173797; Ismail TM, 2003, J BIOL CHEM, V278, P32602, DOI 10.1074/jbc.M305994200; Jiang XQ, 2004, P NATL ACAD SCI USA, V101, P9211, DOI 10.1073/pnas.0401382101; Jiang XQ, 2000, J BACTERIOL, V182, P2468, DOI 10.1128/JB.182.9.2468-2475.2000; Lee K, 2002, MOL MICROBIOL, V43, P1445, DOI 10.1046/j.1365-2958.2002.02848.x; MACKIE GA, 1992, J BIOL CHEM, V267, P1054; Mackie GA, 1998, NATURE, V395, P720, DOI 10.1038/27246; MACKIE GA, 1991, J BACTERIOL, V173, P2488, DOI 10.1128/jb.173.8.2488-2497.1991; MACKIE GA, 1983, J BIOL CHEM, V258, P7840; Mackie GA, 2000, J BIOL CHEM, V275, P25069, DOI 10.1074/jbc.C000363200; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Mildvan AS, 2005, ARCH BIOCHEM BIOPHYS, V433, P129, DOI 10.1016/j.abb.2004.08.017; MITCHELL SJ, 1995, INFECT IMMUN, V63, P1552, DOI 10.1128/IAI.63.4.1552-1562.1995; MUHLRAD D, 1994, GENE DEV, V8, P855, DOI 10.1101/gad.8.7.855; Ow MC, 2003, MOL MICROBIOL, V49, P607, DOI 10.1046/j.1365-2958.2003.03587.x; Tock MR, 2000, J BIOL CHEM, V275, P8726, DOI 10.1074/jbc.275.12.8726; Wang ZR, 2002, P NATL ACAD SCI USA, V99, P12663, DOI 10.1073/pnas.192445599	31	302	309	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2008	451	7176					355	U14		10.1038/nature06475	http://dx.doi.org/10.1038/nature06475			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202662				2022-12-28	WOS:000252432100054
J	Yoshino, T; Manthilake, G; Matsuzaki, T; Katsura, T				Yoshino, Takashi; Manthilake, Geeth; Matsuzaki, Takuya; Katsura, Tomoo			Dry mantle transition zone inferred from the conductivity of wadsleyite and ringwoodite	NATURE			English	Article							ELECTRICAL-CONDUCTIVITY; PACIFIC-OCEAN; C-RESPONSES; BENEATH; WATER; OLIVINE; HYDROGEN; REGION; PHASE	The Earth's mantle transition zone could potentially store a large amount of water, as the minerals wadsleyite and ringwoodite incorporate a significant amount of water in their crystal structure(1,2). The water content in the transition zone can be estimated from the electrical conductivities of hydrous wadsleyite and ringwoodite, although such estimates depend on accurate knowledge of the two conduction mechanisms in these minerals ( small polaron and proton conductions), which early studies have failed to distinguish between(3,4). Here we report the electrical conductivity of these two minerals obtained by high- pressure multi- anvil experiments. We found that the small polaron conductions of these minerals are substantially lower than previously estimated. The contributions of proton conduction are small at temperatures corresponding to the mantle transition zone and the conductivity of wadsleyite is considerably lower than that of ringwoodite for both mechanisms. The dry model mantle shows considerable conductivity jumps associated with the olivine- wadsleyite, wadsleyite- ringwoodite and post- spinel transitions. Such a dry model explains well the currently available conductivity- depth profiles(5) obtained from geoelectromagnetic studies. We therefore conclude that there is no need to introduce a significant amount of water in the mantle transition to satisfy electrical conductivity constraints.	[Yoshino, Takashi; Manthilake, Geeth; Matsuzaki, Takuya; Katsura, Tomoo] Okayama Univ, Inst Study Earths Interior, Tottori 6820193, Japan	Okayama University	Yoshino, T (corresponding author), Okayama Univ, Inst Study Earths Interior, Tottori 6820193, Japan.	tyoshino@misasa.okayama-u.ac.jp	Manthilake, Geeth/AAO-8616-2020; Katsura, Tomoo/A-7483-2010; Katsura, Tomoo/ABC-1899-2021; YOSHINO, Takashi/B-1899-2011	Manthilake, Geeth/0000-0001-8161-081X; Katsura, Tomoo/0000-0001-7857-5101; Katsura, Tomoo/0000-0001-7857-5101; YOSHINO, Takashi/0000-0002-5422-7396				BAHR K, 1993, GEOPHYS RES LETT, V20, P2937, DOI 10.1029/93GL02134; BANKS RJ, 1969, GEOPHYS J ROY ASTR S, V17, P457, DOI 10.1111/j.1365-246X.1969.tb00252.x; DEBYE PP, 1954, PHYS REV, V93, P693, DOI 10.1103/PhysRev.93.693; Fuji-ta K, 2004, GEOPHYS J INT, V157, P79, DOI 10.1111/j.1365-246X.2004.02165.x; Hae R, 2006, EARTH PLANET SC LETT, V243, P141, DOI 10.1016/j.epsl.2005.12.035; Hirschmann M, 2006, NATURE, V439, pE3, DOI 10.1038/nature04528; Huang XG, 2005, NATURE, V434, P746, DOI 10.1038/nature03426; INOUE T, 1994, PHYS EARTH PLANET IN, V85, P237, DOI 10.1016/0031-9201(94)90116-3; KARATO S, 1990, NATURE, V347, P272, DOI 10.1038/347272a0; Katsura T, 1998, NATURE, V395, P493, DOI 10.1038/26736; KATURA T, 2004, J GEOPHYS RES, V109, DOI DOI 10.1029/2003JB002438; Kohlstedt DL, 1996, CONTRIB MINERAL PETR, V123, P345, DOI 10.1007/s004100050161; Kuvshinov A, 2005, GEOPHYS J INT, V160, P505, DOI 10.1111/j.1365-246X.2005.02477.x; LIZZARALDE D, 1995, J GEOPHYS RES, V100, P17837; McCammon C, 2005, SCIENCE, V308, P807, DOI 10.1126/science.1110532; Neal SL, 2000, J GEOPHYS RES-SOL EA, V105, P8229, DOI 10.1029/1999JB900447; Olsen N, 1998, GEOPHYS J INT, V133, P298, DOI 10.1046/j.1365-246X.1998.00503.x; PATTERSON MS, 1982, B MINERAL, V105, P20; SCHULTZ A, 1993, GEOPHYS RES LETT, V20, P2941, DOI 10.1029/93GL02833; Tarits P, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019277; Utada H, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016092; Xu YS, 1998, SCIENCE, V280, P1415, DOI 10.1126/science.280.5368.1415; Xu YS, 2000, PHYS EARTH PLANET IN, V118, P149, DOI 10.1016/S0031-9201(99)00135-1; Yoshino T, 2006, NATURE, V443, P973, DOI 10.1038/nature05223	24	170	192	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2008	451	7176					326	329		10.1038/nature06427	http://dx.doi.org/10.1038/nature06427			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202656				2022-12-28	WOS:000252432100048
J	Alleyne, G; Aninat, E; de Ferranti, D; de Quadros, C; Chen, L; Freire, M; Guerrero, R; Langer, A; Rodriguez, JGM				Alleyne, George; Aninat, Eduardo; de Ferranti, David; de Quadros, Ciro; Chen, Lincoln; Freire, Maria; Guerrero, Rodrigo; Langer, Ana; Martin Rodriguez, Jose Gerardo			Instituto Carso de la Salud: a boost for health philanthropy	LANCET			English	Editorial Material									[Chen, Lincoln] China Med Board, Cambridge, MA 02138 USA; [Alleyne, George] Pan Amer Hlth Org, Washington, DC USA; [Aninat, Eduardo] Anisal Economistas & Assoc Isapres Chile, Santiago, Chile; [de Ferranti, David] Brookings Inst, Global Financing Initiat, Washington, DC 20036 USA; [de Quadros, Ciro] Albert B Sabin Vaccine Inst, Washington, DC USA; [Freire, Maria] Global Alliance TB Drug Dev, New York, NY USA; [Guerrero, Rodrigo] VallenPaz, Cali, Colombia; [Langer, Ana] EngenderHlth, New York, NY USA; [Martin Rodriguez, Jose Gerardo] World Federat Neurosurg Soc, Madrid, Spain	Pan American Health Organization; Brookings Institution	Chen, L (corresponding author), China Med Board, Cambridge, MA 02138 USA.	lcchen@fas.harvard.edu		Guerrero Velasco, Rodrigo/0000-0002-4683-7987				Frenk J, 2006, LANCET, V368, P954, DOI 10.1016/S0140-6736(06)69376-8	1	5	4	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 12	2008	371	9607					100	101		10.1016/S0140-6736(08)60085-9	http://dx.doi.org/10.1016/S0140-6736(08)60085-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	252ND	18191672				2022-12-28	WOS:000252452300009
J	Hill, MM; Bastiani, M; Luetterforst, R; Kirkham, M; Kirkham, A; Nixon, SJ; Walser, P; Abankwa, D; Oorschot, VMJ; Martin, S; Hancock, JF; Parton, RG				Hill, Michelle M.; Bastiani, Michele; Luetterforst, Robert; Kirkham, Matthew; Kirkham, Annika; Nixon, Susan J.; Walser, Piers; Abankwa, Daniel; Oorschot, Viola M. J.; Martin, Sally; Hancock, John F.; Parton, Robert G.			PTRF-Cavin, a conserved cytoplasmic protein required for Caveola formation and function	CELL			English	Article							PLASMA-MEMBRANE; BINDING PROTEIN; GOLGI-COMPLEX; MEDIATED ENDOCYTOSIS; CELL-SURFACE; MICE SHOW; CHOLESTEROL; EXPRESSION; MUSCLE; TRAFFICKING	Caveolae are abundant cell-surface organelles involved in lipid regulation and endocytosis. We used comparative proteomics to identify PTRF ( also called Cav-p60, Cavin) as a putative caveolar coat protein. PTRF-Cavin selectively associates with mature caveolae at the plasma membrane but not Golgi-localized caveolin. In prostate cancer PC3 cells, and during development of zebrafish notochord, lack of PTRF-Cavin expression correlates with lack of caveolae, and caveolin resides on flat plasma membrane. Expression of PTRF-Cavin in PC3 cells is sufficient to cause formation of caveolae. Knockdown of PTRF-Cavin reduces caveolae density, both in mammalian cells and in the zebrafish. Caveolin remains on the plasma membrane in PTRF-Cavin knockdown cells but exhibits increased lateral mobility and accelerated lysosomal degradation. We conclude that PTRF-Cavin is required for caveola formation and sequestration of mobile caveolin into immobile caveolae.	[Hill, Michelle M.; Bastiani, Michele; Luetterforst, Robert; Kirkham, Matthew; Kirkham, Annika; Nixon, Susan J.; Walser, Piers; Abankwa, Daniel; Oorschot, Viola M. J.; Martin, Sally; Hancock, John F.; Parton, Robert G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Hill, Michelle M.; Bastiani, Michele; Luetterforst, Robert; Kirkham, Matthew; Kirkham, Annika; Nixon, Susan J.; Walser, Piers; Oorschot, Viola M. J.; Martin, Sally; Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Parton, RG (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	r.parton@imb.uq.edu.au	Hill, Michelle Mei Chih/G-4417-2010; Parton, Robert G/C-5673-2009; Bastiani, Michele/J-1823-2014; Kirkham, Matthew/I-5458-2012; Martin, Sally/A-7150-2010; Nixon, Susan/D-4588-2017	Hill, Michelle Mei Chih/0000-0003-1134-0951; Parton, Robert G/0000-0002-7494-5248; Bastiani, Michele/0000-0001-6752-4157; Martin, Sally/0000-0001-9294-5404; Kirkham, Matthew/0000-0003-0920-5355; Abankwa, Daniel/0000-0003-2769-0745; Hancock, John/0000-0003-0542-4710; Nixon, Susan/0000-0003-0346-9683	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066717] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM066717-04, R01 GM066717] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aboulaich N, 2004, BIOCHEM J, V383, P237, DOI 10.1042/BJ20040647; BURGENER R, 1990, BIOCHEM J, V269, P729, DOI 10.1042/bj2690729; Clayton AHA, 2004, J MICROSC-OXFORD, V213, P1, DOI 10.1111/j.1365-2818.2004.01265.x; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Fang PK, 2006, AM J PATHOL, V169, P2209, DOI 10.2353/ajpath.2006.060562; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Galbiati F, 2001, J BIOL CHEM, V276, P21425, DOI 10.1074/jbc.M100828200; Gustincich S, 1999, GENOMICS, V57, P120, DOI 10.1006/geno.1998.5733; Hagiwara Y, 2000, HUM MOL GENET, V9, P3047, DOI 10.1093/hmg/9.20.3047; Hailstones D, 1998, J LIPID RES, V39, P369; Izumi Y, 1997, J BIOL CHEM, V272, P7381, DOI 10.1074/jbc.272.11.7381; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Monier S, 1996, FEBS LETT, V388, P143, DOI 10.1016/0014-5793(96)00519-4; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; Nichols BJ, 2002, NAT CELL BIOL, V4, P374, DOI 10.1038/ncb787; Nixon SJ, 2007, J CELL SCI, V120, P2151, DOI 10.1242/jcs.003830; Parolini I, 1999, J BIOL CHEM, V274, P25718, DOI 10.1074/jbc.274.36.25718; Parton RG, 2002, J BIOL CHEM, V277, P46769, DOI 10.1074/jbc.M205683200; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; PARTON RG, 1994, J HISTOCHEM CYTOCHEM, V42, P155, DOI 10.1177/42.2.8288861; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Pol A, 2005, MOL BIOL CELL, V16, P2091, DOI 10.1091/mbc.E04-08-0737; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Razani B, 2002, MOL CELL BIOL, V22, P2329, DOI 10.1128/MCB.22.7.2329-2344.2002; Tagawa A, 2005, J CELL BIOL, V170, P769, DOI 10.1083/jcb.200506103; Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317; Vinten J, 2001, CELL TISSUE RES, V305, P99, DOI 10.1007/s004410100389; Vinten J, 2005, BBA-BIOMEMBRANES, V1717, P34, DOI 10.1016/j.bbamem.2005.09.013; Voldstedlund M, 2001, CELL TISSUE RES, V306, P265, DOI 10.1007/s004410100439; Voldstedlund M, 2003, ACTA PHYSIOL SCAND, V179, P179, DOI 10.1046/j.1365-201X.2003.01183.x; Wanaski SP, 2003, BIOCHEMISTRY-US, V42, P42, DOI 10.1021/bi012097n; WAY M, 1995, FEBS LETT, V376, P108, DOI 10.1016/0014-5793(95)01256-7; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004	38	510	521	1	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 11	2008	132	1					113	124		10.1016/j.cell.2007.11.042	http://dx.doi.org/10.1016/j.cell.2007.11.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IL	18191225	Bronze, Green Accepted			2022-12-28	WOS:000253427600020
J	Hochbaum, AI; Chen, RK; Delgado, RD; Liang, WJ; Garnett, EC; Najarian, M; Majumdar, A; Yang, PD				Hochbaum, Allon I.; Chen, Renkun; Delgado, Raul Diaz; Liang, Wenjie; Garnett, Erik C.; Najarian, Mark; Majumdar, Arun; Yang, Peidong			Enhanced thermoelectric performance of rough silicon nanowires	NATURE			English	Article							THERMAL-CONDUCTIVITY; ARRAYS; NANOSTRUCTURES; SCATTERING; DEVICES; GROWTH; LAYERS; MERIT; SI	Approximately 90 per cent of the world's power is generated by heat engines that use fossil fuel combustion as a heat source and typically operate at 30 - 40 per cent efficiency, such that roughly 15 terawatts of heat is lost to the environment. Thermoelectric modules could potentially convert part of this low- grade waste heat to electricity. Their efficiency depends on the thermoelectric figure of merit ZT of their material components, which is a function of the Seebeck coefficient, electrical resistivity, thermal conductivity and absolute temperature. Over the past five decades it has been challenging to increase ZT > 1, since the parameters of ZT are generally interdependent(1). While nanostructured thermoelectric materials can increase ZT > 1 ( refs 2 - 4), the materials ( Bi, Te, Pb, Sb, and Ag) and processes used are not often easy to scale to practically useful dimensions. Here we report the electrochemical synthesis of large- area, wafer- scale arrays of rough Si nanowires that are 20-300 nm in diameter. These nanowires have Seebeck coefficient and electrical resistivity values that are the same as doped bulk Si, but those with diameters of about 50 nm exhibit 100- fold reduction in thermal conductivity, yielding ZT = 0.6 at room temperature. For such nanowires, the lattice contribution to thermal conductivity approaches the amorphous limit for Si, which cannot be explained by current theories. Although bulk Si is a poor thermoelectric material, by greatly reducing thermal conductivity without much affecting the Seebeck coefficient and electrical resistivity, Si nanowire arrays show promise as high- performance, scalable thermoelectric materials.	[Chen, Renkun; Majumdar, Arun] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA; [Hochbaum, Allon I.; Delgado, Raul Diaz; Liang, Wenjie; Garnett, Erik C.; Yang, Peidong] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Najarian, Mark; Majumdar, Arun; Yang, Peidong] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Majumdar, Arun; Yang, Peidong] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Majumdar, A (corresponding author), Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA.	majumdar@me.berkeley.edu; p_yang@berkeley.edu	Chen, Renkun/J-2400-2014; Vasilica, Andrei V/F-2185-2010; Garnett, Erik C/A-6847-2009	Chen, Renkun/0000-0001-7526-4981; Garnett, Erik C/0000-0002-9158-8326; Hochbaum, Allon/0000-0002-5377-8065; Majumdar, Arunava/0000-0003-4226-9705				ASEGHI M, 1976, J HEAT TRANSF, pCH1; ASHCROFT NW, 1976, SOLID STATE PHYS, pCH1; Asheghi M, 1998, J HEAT TRANS-T ASME, V120, P30, DOI 10.1115/1.2830059; Asheghi M, 1997, APPL PHYS LETT, V71, P1798, DOI 10.1063/1.119402; BRINSON ME, 1970, J PHYS PART C SOLID, V3, P483, DOI 10.1088/0022-3719/3/3/001; CAHILL DG, 1992, PHYS REV B, V46, P6131, DOI 10.1103/PhysRevB.46.6131; CAHILL DG, 1987, PHYS REV B, V35, P4067, DOI 10.1103/PhysRevB.35.4067; Harman TC, 2002, SCIENCE, V297, P2229, DOI 10.1126/science.1072886; Hochbaum AI, 2005, NANO LETT, V5, P457, DOI 10.1021/nl047990x; Hsu KF, 2004, SCIENCE, V303, P818, DOI 10.1126/science.1092963; Ju YS, 1999, APPL PHYS LETT, V74, P3005, DOI 10.1063/1.123994; Kim W, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.045901; Li DY, 2003, APPL PHYS LETT, V83, P2934, DOI 10.1063/1.1616981; Majumdar A, 2004, SCIENCE, V303, P777, DOI 10.1126/science.1093164; Mingo N, 2003, NANO LETT, V3, P1713, DOI 10.1021/nl034721i; NOLAS GS, 2001, THERMOELECTRICS, pCH3; Peng KQ, 2005, ANGEW CHEM INT EDIT, V44, P2737, DOI 10.1002/anie.200462995; Peng KQ, 2003, ADV FUNCT MATER, V13, P127, DOI 10.1002/adfm.200390018; Peng KQ, 2002, ADV MATER, V14, P1164, DOI 10.1002/1521-4095(20020816)14:16<1164::AID-ADMA1164>3.0.CO;2-E; Rowe D.M., 1995, CRC HDB THERMOELECTR; Ruf T, 2000, SOLID STATE COMMUN, V115, P243, DOI 10.1016/S0038-1098(00)00172-1; SAHA S, 2006, P ASME, P15668; Shi L, 2003, J HEAT TRANS-T ASME, V125, P881, DOI 10.1115/1.1597619; Sze S. M, 1981, PHYSICS SEMICONDUCTO; Touloukian Y. S., 1970, THERMOPHYSICAL PROPE, V1, P333; Venkatasubramanian R, 2001, NATURE, V413, P597, DOI 10.1038/35098012; WEBER L, 1991, APPL PHYS A-MATER, V53, P136, DOI 10.1007/BF00323873; Zou J, 2001, J APPL PHYS, V89, P2932, DOI 10.1063/1.1345515	28	3390	3464	40	2339	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2008	451	7175					163	U5		10.1038/nature06381	http://dx.doi.org/10.1038/nature06381			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249GA	18185582				2022-12-28	WOS:000252214400036
J	Silver, PG; Behn, MD				Silver, Paul G.; Behn, Mark D.			Intermittent plate tectonics?	SCIENCE			English	Article							EPISODIC CONTINENTAL GROWTH; EVOLUTION; LAURENTIA; SUPERCONTINENTS; CONVECTION; MAGMATISM; HISTORY; HEAT	Although it is commonly assumed that subduction has operated continuously on Earth without interruption, subduction zones are routinely terminated by ocean closure and supercontinent assembly. Under certain circumstances, this could lead to a dramatic loss of subduction, globally. Closure of a Pacific- type basin, for example, would eliminate most subduction, unless this loss were compensated for by comparable subduction initiation elsewhere. Given the evidence for Pacific- type closure in Earth's past, the absence of a direct mechanism for termination/ initiation compensation, and recent data supporting a minimum in subduction flux in the Mesoproterozoic, we hypothesize that dramatic reductions or temporary cessations of subduction have occurred in Earth's history. Such deviations in the continuity of plate tectonics have important consequences for Earth's thermal and continental evolution.	[Silver, Paul G.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; [Behn, Mark D.] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA	Carnegie Institution for Science; Woods Hole Oceanographic Institution	Silver, PG (corresponding author), Carnegie Inst Sci, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA.		Behn, Mark D/F-5813-2012	Behn, Mark D/0000-0002-2001-1335				Anderson JL, 2005, LITHOS, V80, P45, DOI 10.1016/j.lithos.2004.05.008; ANDERSON JL, 1989, LITHOS, V23, P19, DOI 10.1016/0024-4937(89)90021-2; BRADLEY DC, 2007, EOS, V88; Cagnioncle AM, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2007JB004934; Casey J.F., 1984, GEOLOGICAL SOC SPECI, V13, P269, DOI [10.1144/GSL.SP.1984.013.01.22, DOI 10.1144/GSL.SP.1984.013.01.22]; Clift P, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000127; Collerson KD, 1999, SCIENCE, V283, P1519, DOI 10.1126/science.283.5407.1519; Condie KC, 1998, EARTH PLANET SC LETT, V163, P97, DOI 10.1016/S0012-821X(98)00178-2; Condie KC, 2000, TECTONOPHYSICS, V322, P153, DOI 10.1016/S0040-1951(00)00061-5; Dalziel IWD, 2000, J GEOL, V108, P499, DOI 10.1086/314418; Davies G.F., 1999, DYNAMIC EARTH PLATES; DEMETS C, 1990, GEOPHYS J INT, V101, P425, DOI 10.1111/j.1365-246X.1990.tb06579.x; Doblas M, 2002, GEOLOGY, V30, P839, DOI 10.1130/0091-7613(2002)030<0839:MIBTWA>2.0.CO;2; ENGEL AEJ, 1974, GEOL SOC AM BULL, V85, P843, DOI 10.1130/0016-7606(1974)85<843:CEAGTA>2.0.CO;2; Gerbault M, 2000, EARTH PLANET SC LETT, V178, P165, DOI 10.1016/S0012-821X(00)00054-6; Gurnis M, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000681; Hamilton WB, 1998, PRECAMBRIAN RES, V91, P143, DOI 10.1016/S0301-9268(98)00042-4; Hawkesworth CJ, 2006, NATURE, V443, P811, DOI 10.1038/nature05191; HOFFMAN PF, 1989, GEOLOGY, V17, P135, DOI 10.1130/0091-7613(1989)017<0135:SOLSFG>2.3.CO;2; HOFFMAN PF, 1991, SCIENCE, V252, P1409, DOI 10.1126/science.252.5011.1409; Karlstrom KE, 2001, PRECAMBRIAN RES, V111, P5, DOI 10.1016/S0301-9268(01)00154-1; Kemp AIS, 2006, NATURE, V439, P580, DOI 10.1038/nature04505; Korenaga J, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL016982; Korenaga J, 2006, GEOPHYS MONOGR SER, V164, P7, DOI 10.1029/164GM03; Kramers JD, 1997, CHEM GEOL, V139, P75, DOI 10.1016/S0009-2541(97)00027-2; Li ZX, 2008, PRECAMBRIAN RES, V160, P179, DOI 10.1016/j.precamres.2007.04.021; Murphy JB, 2005, INT GEOL REV, V47, P591, DOI 10.2747/0020-6814.47.6.591; O'Neill C, 2007, EARTH PLANET SC LETT, V262, P552, DOI 10.1016/j.epsl.2007.04.056; Parman SW, 2007, NATURE, V446, P900, DOI 10.1038/nature05691; Rino S, 2004, PHYS EARTH PLANET IN, V146, P369, DOI 10.1016/j.pepi.2003.09.024; Sleep NH, 2000, J GEOPHYS RES-PLANET, V105, P17563, DOI 10.1029/2000JE001240; STEIN CA, 1992, NATURE, V359, P123, DOI 10.1038/359123a0; Stern RJ, 2007, CHINESE SCI BULL, V52, P578, DOI 10.1007/s11434-007-0073-8; Stern RJ, 2005, GEOLOGY, V33, P557, DOI 10.1130/G21365.1; Stern RJ, 2004, EARTH PLANET SC LETT, V226, P275, DOI 10.1016/j.epsl.2004.08.007; WILSON JT, 1966, NATURE, V211, P676, DOI 10.1038/211676a0	36	141	144	6	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2008	319	5859					85	88		10.1126/science.1148397	http://dx.doi.org/10.1126/science.1148397			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18174440				2022-12-28	WOS:000252084000036
J	Wells, DA; Ross, JS; Detsky, AS				Wells, David A.; Ross, Joseph S.; Detsky, Allan S.			What is different about the market for health care?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CONTROLLED TRIAL; MEDICAL-CARE; INSURANCE; COMMONS; ADULTS; PLANS		Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; Mt Sinai Sch Med, Dept Geriatr, New York, NY USA; Mt Sinai Sch Med, Dept Adult Dev, New York, NY USA; Mt Sinai Sch Med, Dept Med, New York, NY USA; James J Peters Vet Adm Med Ctr, Hlth Serv Res & Dev Serv Targeted Res Enhancement, Bronx, NY USA; James J Peters Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Bronx, NY USA; Univ Toronto, Dept Hlth Policy, Toronto, ON, Canada; Univ Toronto, Dept Management, Toronto, ON, Canada; Univ Toronto, Dept Evaluat & Med, Toronto, ON, Canada; Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Detsky, AS (corresponding author), Mt Sinai Hosp, Dept Med, 600 Univ Ave,Room 427, Toronto, ON M5G 1X5, Canada.	allan.detsky@uhn.on.ca		Ross, Joseph/0000-0002-9218-3320				ARROW KJ, 1963, AM ECON REV, V53, P941; BROOK RH, 1983, NEW ENGL J MED, V309, P1426, DOI 10.1056/NEJM198312083092305; Detsky AS, 1978, EC FDN NATL HLTH POL; Dhalla I, 2007, CAN MED ASSOC J, V177, P51, DOI 10.1503/cmaj.061064; ENTHOVEN AC, 1978, NEW ENGL J MED, V298, P709, DOI 10.1056/NEJM197803302981304; FELDSTEIN MS, 1973, J POLIT ECON, V81, P251, DOI 10.1086/260027; Fendrick AM, 2007, J GEN INTERN MED, V22, P890, DOI 10.1007/s11606-007-0188-2; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; HIATT HH, 1975, NEW ENGL J MED, V293, P235, DOI 10.1056/NEJM197507312930506; Lohr K, 1986, MED CARE S, V24, pS31; NEWHOUSE JP, 1981, NEW ENGL J MED, V305, P1501, DOI 10.1056/NEJM198112173052504; Newhouse JP, 1993, FREE ALL LESSONS RAN; Oberlander J, 2001, CAN MED ASSOC J, V164, P1583; Rosenthal MB, 2007, JAMA-J AM MED ASSOC, V298, P2281, DOI 10.1001/jama.298.19.2281; Rosenthal MB, 2007, JAMA-J AM MED ASSOC, V297, P740, DOI 10.1001/jama.297.7.740; Ross JS, 2006, JAMA-J AM MED ASSOC, V295, P2027, DOI 10.1001/jama.295.17.2027; SIU AL, 1986, NEW ENGL J MED, V315, P1259, DOI 10.1056/NEJM198611133152005; Wodchis WP, 2007, JAMA-J AM MED ASSOC, V298, P1797, DOI 10.1001/jama.298.15.1797; Woolhandler S, 2007, J GEN INTERN MED, V22, P879, DOI 10.1007/s11606-007-0187-3	19	17	17	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2007	298	23					2785	2787		10.1001/jama.298.23.2785	http://dx.doi.org/10.1001/jama.298.23.2785			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242HK	18165673				2022-12-28	WOS:000251716000025
J	Galloe, AM; Thuesen, L; Kelbaek, H; Thayssen, P; Rasmussen, K; Hansen, PR; Bligaard, N; Saunamaki, K; Junker, A; Aaroe, J; Abildgaard, U; Ravkilde, J; Engstrom, T; Jensen, JS; Andersen, HR; Botker, HE; Galatius, S; Kristensen, SD; Madsen, JK; Krusell, LR; Abildstrom, SZ; Stephansen, GB; Lassen, JF				Galloe, Anders M.; Thuesen, Leif; Kelbaek, Henning; Thayssen, Per; Rasmussen, Klaus; Hansen, Peter R.; Bligaard, Niels; Saunamaki, Kari; Junker, Anders; Aaroe, Jens; Abildgaard, Ulrik; Ravkilde, Jan; Engstrom, Thomas; Jensen, Jan S.; Andersen, Henning R.; Botker, Hans E.; Galatius, Soren; Kristensen, Steen D.; Madsen, Jan K.; Krusell, Lars R.; Abildstrom, Steen Z.; Stephansen, Ghita B.; Lassen, Jens F.		SORT OUT II Investigators	Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice - The SORT OUT II Randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-ARTERY-DISEASE; INTRAVASCULAR ULTRASOUND; INTERVENTION; METAANALYSIS; ANGIOGRAPHY; RESTENOSIS; OUTCOMES; LESIONS	Context Approval of drug- eluting coronary stents was based on results of relatively small trials of selected patients; however, in routine practice, stents are used in a broader spectrum of patients. Objective To compare the first 2 commercially available drug- eluting stents sirolimus- eluting and paclitaxel- eluting - for prevention of symptom- driven clinical end points, using a study design reflecting everyday clinical practice. Design, Setting, and Patients Randomized, blinded trial conducted August 2004 to January 2006 at 5 university hospitals in Denmark. Patients were 2098 men and women ( mean [ SD] age, 63.6 [ 10.8] years) treated with percutaneous coronary intervention ( PCI) and randomized to receive either sirolimus- eluting ( n = 1065) or paclitaxel-eluting ( n = 1033) stents. Indications for PCI included ST- segment elevation myocardial infarction ( STEMI), non- STEMI or unstable angina pectoris, and stable angina. Main Outcome Measures The primary end point was a composite clinical end point of major adverse cardiac events, defined as either cardiac death, acute myocardial infarction, target lesion revascularization, or target vessel revascularization. Secondary end points included individual components of the composite end point, all- cause mortality, and stent thrombosis. Results The sirolimus- and the paclitaxel- eluting stent groups did not differ significantly in major adverse cardiac events ( 98 [ 9.3%] vs 114 [ 11.2%]; hazard ratio, 0.83 [ 95% confidence interval, 0.63- 1.08]; P=. 16) or in any of the secondary end points. The stent thrombosis rates were 27 ( 2.5%) and 30 ( 2.9%) ( hazard ratio, 0.87 [ 95% confidence interval, 0.52- 1.46]; P=. 60), respectively. Conclusion In this practical randomized trial, there were no significant differences in clinical outcomes between patients receiving sirolimus- and paclitaxel- eluting stents. Trial Registration clinicaltrials. gov Identifier: NCT00388934.	[Galloe, Anders M.; Hansen, Peter R.; Bligaard, Niels; Abildgaard, Ulrik; Engstrom, Thomas; Jensen, Jan S.; Galatius, Soren; Madsen, Jan K.; Abildstrom, Steen Z.; Stephansen, Ghita B.] Univ Copenhagen, Gentofte Univ Hosp, Dept Cardiol, Copenhagen, Denmark; [Kelbaek, Henning; Saunamaki, Kari] Univ Copenhagen, Copenhagen Univ Hosp, Rigshosp, Dept Cardiol, Copenhagen, Denmark; [Thuesen, Leif; Ravkilde, Jan; Andersen, Henning R.; Botker, Hans E.; Kristensen, Steen D.; Krusell, Lars R.; Lassen, Jens F.] Univ Aarhus, Skejby Hosp, Dept Cardiol, Aarhus, Denmark; [Rasmussen, Klaus; Aaroe, Jens] Univ Aarhus, Aalborg Univ Hosp, Dept Cardiol, Aarhus, Denmark; [Thayssen, Per; Junker, Anders] Univ So Denmark, Odense Univ Hosp, Dept Cardiol, Odense, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University; University of Southern Denmark; Odense University Hospital	Galloe, AM (corresponding author), Gentofte Univ Hosp, Dept Cardiol P, Niels Andersens Vej 65, DK-2900 Copenhagen, Denmark.	anders@galloe.dk	Hansen, Peter Riis/AAR-7659-2020; Lassen, Jens Flensted/AAY-2127-2021	Lassen, Jens Flensted/0000-0001-7972-9192; Saunamaki, Kari/0000-0001-5953-5243; Engstrom, Thomas/0000-0001-5436-9194; Hansen, Peter Riis/0000-0002-9056-535X; Botker, Hans Erik/0000-0001-6358-8962				Anderson HV, 2000, CIRCULATION, V102, P2910; Cervinka P, 2006, CATHETER CARDIO INTE, V67, P846, DOI 10.1002/ccd.20755; Dibra A, 2005, NEW ENGL J MED, V353, P663, DOI 10.1056/NEJMoa044372; Goy JJ, 2005, J AM COLL CARDIOL, V45, P308, DOI 10.1016/j.jacc.2004.10.062; Harrington RA, 2007, JAMA-J AM MED ASSOC, V297, P2028, DOI 10.1001/jama.297.18.2028; KALSER C, 2005, LANCET, V366, P921; Kastrati A, 2005, JAMA-J AM MED ASSOC, V293, P165, DOI 10.1001/jama.293.2.165; Kereiakes DJ, 2005, J AM COLL CARDIOL, V45, P1206, DOI 10.1016/j.jacc.2005.01.005; Kim YH, 2006, CIRCULATION, V114, P2148, DOI 10.1161/CIRCULATIONAHA.106.666396; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Mehilli J, 2006, EUR HEART J, V27, P260, DOI 10.1093/eurheartj/ehi721; Morice MC, 2006, JAMA-J AM MED ASSOC, V295, P895, DOI 10.1001/jama.295.8.895; Petronio AS, 2007, J AM COLL CARDIOL, V49, P539, DOI 10.1016/j.jacc.2006.09.042; Ruygrok PN, 1999, J AM COLL CARDIOL, V34, P1507, DOI 10.1016/S0735-1097(99)00380-0; Schomig A, 2007, J AM COLL CARDIOL, V50, P1373, DOI 10.1016/j.jacc.2007.06.047; Smith SC, 2006, J AM COLL CARDIOL, V47, P216, DOI 10.1016/j.jacc.2005.11.025; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; ten Berg JM, 2001, J AM COLL CARDIOL, V38, P1061, DOI 10.1016/S0735-1097(01)01476-0; Windecker S, 2005, NEW ENGL J MED, V353, P653, DOI 10.1056/NEJMoa051175; Zhang Q, 2006, CHINESE MED J-PEKING, V119, P165, DOI 10.1097/00029330-200601020-00013	20	106	107	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 30	2008	299	4					409	416		10.1001/jama.299.4.409	http://dx.doi.org/10.1001/jama.299.4.409			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	256JK	18230778	Bronze			2022-12-28	WOS:000252724500018
J	Herzfeld, C				Herzfeld, Charles			How the change agent has changed	NATURE			English	Editorial Material																			0	0	0	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2008	451	7177					403	404		10.1038/451403a	http://dx.doi.org/10.1038/451403a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	253YS	18216838	Bronze			2022-12-28	WOS:000252554100026
J	Scandling, JD; Busque, S; Dejbakhsh-Jones, S; Benike, C; Millan, MT; Shizuru, JA; Hoppe, RT; Lowsky, R; Engleman, EG; Strober, S				Scandling, John D.; Busque, Stephan; Dejbakhsh-Jones, Sussan; Benike, Claudia; Millan, Maria T.; Shizuru, Judith A.; Hoppe, Richard T.; Lowsky, Robert; Engleman, Edgar G.; Strober, Samuel			Brief report: Tolerance and chimerism after renal and hematopoietic-cell transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TOTAL LYMPHOID IRRADIATION; VERSUS-HOST-DISEASE; MIXED CHIMERISM; IMMUNE TOLERANCE; T-CELLS; SUBSETS; EXPRESSION; GENERATION; ALLOGRAFTS; EFFECTOR	We describe a recipient of combined kidney and hematopoietic-cell transplants from an HLA-matched donor. A post-transplantation conditioning regimen of total lymphoid irradiation and antithymocyte globulin allowed engraftment of the donor's hematopoietic cells. The patient had persistent mixed chimerism, and the function of the kidney allograft has been normal for more than 28 months since discontinuation of all immunosuppressive drugs. Adverse events requiring hospitalization ware limited to a 2-day episode of fever with neutropenia. The patient has had neither rejection episodes nor clinical manifestations of graft-versus-host disease.	[Scandling, John D.; Dejbakhsh-Jones, Sussan; Shizuru, Judith A.; Lowsky, Robert; Strober, Samuel] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Busque, Stephan; Millan, Maria T.] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA; [Benike, Claudia; Engleman, Edgar G.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Hoppe, Richard T.] Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Strober, S (corresponding author), Stanford Univ, Sch Med, Dept Med, Ctr Clin Sci Res Bldg,Suite 2215,269 W Campus Dr, Stanford, CA 94305 USA.	sstrober@stanford.edu	Busque, Stephan/AAB-6555-2020		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL075462] Funding Source: NIH RePORTER; NHLBI NIH HHS [1P01HL-075462] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ENGLEMAN EG, 1983, J IMMUNOL, V130, P2623; Field EH, 2001, PHILOS T R SOC B, V356, P739, DOI 10.1098/rstb.2001.0851; Fudaba Y, 2006, AM J TRANSPLANT, V6, P2121, DOI 10.1111/j.1600-6143.2006.01434.x; Hayamizu K, 1999, TRANSPLANTATION, V68, P1036, DOI 10.1097/00007890-199910150-00023; Higuchi M, 2002, J IMMUNOL, V169, P5564, DOI 10.4049/jimmunol.169.10.5564; KANSAS GS, 1985, J IMMUNOL, V134, P2995; KAPLAN HS, 1966, CANCER RES, V26, P1268; Lawsky R, 2006, NEW ENGL J MED, V354, P884; Lowsky R, 2005, NEW ENGL J MED, V353, P1321, DOI 10.1056/NEJMoa050642; MEHTADAMANI A, 1994, J IMMUNOL, V153, P996; Millan TLT, 2002, TRANSPLANTATION, V73, P1386, DOI 10.1097/00007890-200205150-00005; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Sempowski GD, 2001, J IMMUNOL, V166, P2808, DOI 10.4049/jimmunol.166.4.2808; STROBER S, 1984, J IMMUNOL, V132, P1013; STROBER S, 1989, NEW ENGL J MED, V321, P28, DOI 10.1056/NEJM198907063210106; Sykes M, 2001, PHILOS T R SOC B, V356, P707, DOI 10.1098/rstb.2001.0853; Sykes M, 2001, IMMUNITY, V14, P417, DOI 10.1016/S1074-7613(01)00122-4; Takahashi T, 2006, J IMMUNOL, V176, P211, DOI 10.4049/jimmunol.176.1.211	19	379	418	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2008	358	4					362	368		10.1056/NEJMoa074191	http://dx.doi.org/10.1056/NEJMoa074191			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253GY	18216356				2022-12-28	WOS:000252507900006
J	Barnett, CF; Hsue, PY; Machado, RF				Barnett, Christopher F.; Hsue, Priscilla Y.; Machado, Roberto F.			Pulmonary hypertension - An increasingly recognized complication of hereditary hemolytic anemias and HIV infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SICKLE-CELL-DISEASE; ARTERIAL-HYPERTENSION; NITRIC-OXIDE; GROWTH-FACTOR; RISK-FACTOR; THERAPY; HEMOGLOBIN; EXPRESSION; SURVIVAL; DEATH	Modern health care has greatly increased longevity for patients with congenital hemolytic anemias ( such as sickle cell disease and thalassemia) and human immunodeficiency virus ( HIV) infection. It is estimated that 10% of patients with hemoglobinopathies and 0.5% of patients with HIV infection develop moderate to severe pulmonary hypertension. Pulmonary hypertension is a relentlessly progressive disease leading to right heart failure and death. Worldwide, there are an estimated 30 million patients with sickle cell disease or thalassemia and 40 million patients with HIV disease. Considering the prevalence of pulmonary vascular disease in these populations, sickle cell disease and HIV disease may be the most common causes of pulmonary hypertension worldwide. In this review, the available data on epidemiology, hemodynamics, mechanisms, and therapeutic strategies for these diseases are summarized. Because therapy is likely to reduce morbidity and prolong survival, efforts to screen, diagnose, and treat these patients represent a global health opportunity.	[Barnett, Christopher F.; Machado, Roberto F.] NHLBI, Pulm & Vasc Med Branch, NIH, Ctr Clin, Bethesda, MD 20892 USA; [Barnett, Christopher F.; Machado, Roberto F.] NHLBI, Dept Crit Care Med, Ctr Clin, NIH, Bethesda, MD 20892 USA; [Hsue, Priscilla Y.] Univ Calif San Francisco, Div Cardiol, San Francisco, CA 94143 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Heart Lung & Blood Institute (NHLBI); University of California System; University of California San Francisco	Machado, RF (corresponding author), NHLBI, Pulm & Vasc Med Branch, NIH, Ctr Clin, Bldg 10-CRC,Room 5-5140, Bethesda, MD 20892 USA.	robertom@nhlbi.nih.gov	Barnett, Christopher/AAD-9872-2022	Barnett, Christopher/0000-0003-1095-5794; Machado, Roberto/0000-0002-3722-5954				Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; Aessopos A, 2004, EUR J HAEMATOL, V73, P359, DOI 10.1111/j.1600-0609.2004.00304.x; Anthi A, 2007, AM J RESP CRIT CARE, V175, P1272, DOI 10.1164/rccm.200610-1498OC; Ascherl G, 1999, BLOOD, V93, P4232; Ataga KI, 2006, BRIT J HAEMATOL, V134, P109, DOI 10.1111/j.1365-2141.2006.06110.x; Atichartakarn V, 2003, INT J HEMATOL, V78, P139, DOI 10.1007/BF02983382; Atichartakarn V, 2002, BRIT J HAEMATOL, V118, P893, DOI 10.1046/j.1365-2141.2002.03711.x; Badesch DB, 2007, CHEST, V131, P1917, DOI 10.1378/chest.06-2674; BARNETT CF, 2006, P AM THORAC SOC, V3, pA61; Barst RJ, 2004, AM J RESP CRIT CARE, V169, P441, DOI 10.1164/rccm.200307-957OC; BARST RJ, 1994, ANN INTERN MED, V121, P409, DOI 10.7326/0003-4819-121-6-199409150-00003; Caldwell RL, 2006, J LEUKOCYTE BIOL, V79, P192, DOI 10.1189/jlb.0405194; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Channick RN, 1996, CHEST, V109, P1545, DOI 10.1378/chest.109.6.1545; Chin KM, 2006, CHEST, V130, P1657, DOI 10.1378/chest.130.6.1657; Cool CD, 2003, NEW ENGL J MED, V349, P1113, DOI 10.1056/NEJMoa035115; De Castro LM, 2004, BLOOD, V104, p462A, DOI 10.1182/blood.V104.11.1663.1663; Derchi G, 2005, HAEMATOLOGICA, V90, P452; Ergul S, 2004, AM J HEMATOL, V76, P245, DOI 10.1002/ajh.20107; Fauci AS, 1996, ANN INTERN MED, V124, P654, DOI 10.7326/0003-4819-124-7-199604010-00006; GALDWIN MT, 2005, HEMATOL-AM SOC HEMAT, P51; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; HAGGER D, 1995, BLOOD COAGUL FIBRIN, V6, P93, DOI 10.1097/00001721-199504000-00001; HSUE P, 2005, CIRCULATION S2, V112, P97; Humbert M, 1998, EUR RESPIR J, V11, P554; Ieong M. H., 2006, Clinical Pulmonary Medicine, V13, P194, DOI 10.1097/01.cpm.0000218606.74161.d4; Kanmogne GD, 2005, BIOCHEM BIOPH RES CO, V333, P1107, DOI 10.1016/j.bbrc.2005.05.198; Kisanuki A, 1997, THROMB RES, V85, P95, DOI 10.1016/S0049-3848(96)00226-5; Machado R, 2007, ADV PULM HYPERTENS, V6, P16; Machado RF, 2005, BRIT J HAEMATOL, V130, P445, DOI 10.1111/j.1365-2141.2005.05625.x; Machado RF, 2005, BRIT J HAEMATOL, V129, P449, DOI 10.1111/j.1365-2141.2005.05432.x; Machado RF, 2007, BRIT J HAEMATOL, V136, P319, DOI 10.1111/j.1365-2141.2006.06417.x; Machado RF, 2006, JAMA-J AM MED ASSOC, V296, P310, DOI 10.1001/jama.296.3.310; MARECKI JC, 2006, P AM THORAC SOC, V3, pA476; Marecki JC, 2006, AM J RESP CRIT CARE, V174, P437, DOI 10.1164/rccm.200601-005OC; McGoon M, 2004, CHEST, V126, p14S, DOI 10.1378/chest.126.1_suppl.14S; Mehta NJ, 2000, CHEST, V118, P1133, DOI 10.1378/chest.118.4.1133; METTE SA, 1992, AM REV RESPIR DIS, V145, P1196, DOI 10.1164/ajrccm/145.5.1196; Morris CR, 2005, JAMA-J AM MED ASSOC, V294, P81, DOI 10.1001/jama.294.1.81; Morris CR, 2003, AM J RESP CRIT CARE, V168, P63, DOI 10.1164/rccm.200208-967OC; Morse JH, 1996, AM J RESP CRIT CARE, V153, P1299, DOI 10.1164/ajrccm.153.4.8616557; Nath KA, 2004, MICROCIRCULATION, V11, P179, DOI 10.1080/10739680490278592; Nicastri E, 2005, EMERG INFECT DIS, V11, P1480, DOI 10.3201/eid1109.0408801480; Nunes H, 2003, AM J RESP CRIT CARE, V167, P1433, DOI 10.1164/rccm.200204-330OC; Opravil M, 1997, AM J RESP CRIT CARE, V155, P990, DOI 10.1164/ajrccm.155.3.9117037; Pellicelli AM, 2004, ACTA CARDIOL, V59, P323, DOI 10.2143/AC.59.3.2005190; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; ROSENKRANZ S, 2005, C RETROVIR OPPORTUNI, V12, P874; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Sachdev V, 2007, J AM COLL CARDIOL, V49, P472, DOI 10.1016/j.jacc.2006.09.038; Simonneau G, 2004, J AM COLL CARDIOL, V43, p5S, DOI 10.1016/j.jacc.2004.02.037; SITBON OL, 2006, P AM THORAC SOC, V3, pA57; Steinberg MH, 2003, JAMA-J AM MED ASSOC, V289, P1645, DOI 10.1001/jama.289.13.1645; Villagra J, 2007, BLOOD, V110, P2166, DOI 10.1182/blood-2006-12-061697; *WHO UN JOINT PROG, 2006, AIDS EP UPD; Zuber JP, 2004, CLIN INFECT DIS, V38, P1178, DOI 10.1086/383037	56	63	65	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2008	299	3					324	331		10.1001/jama.299.3.324	http://dx.doi.org/10.1001/jama.299.3.324			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253DB	18212317				2022-12-28	WOS:000252497800024
J	D'Amico, AV; Chen, MH; Renshaw, AA; Loffredo, M; Kantoff, PW				D'Amico, Anthony V.; Chen, Ming-Hui; Renshaw, Andrew A.; Loffredo, Marian; Kantoff, Philip W.			Androgen suppression and radiation vs radiation alone for prostate cancer - A randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RADICAL PROSTATECTOMY; DEPRIVATION THERAPY; COMPETING RISK; ONCOLOGY-GROUP; RADIOTHERAPY; COMORBIDITY; CANDIDATES; SURVIVAL; LIFE	Context Comorbidities may increase the negative effects of specific anticancer treatments such as androgen suppression therapy ( AST). Objectives To compare 6 months of AST and radiation therapy ( RT) to RT alone and to assess the interaction between level of comorbidity and all- cause mortality. Design, Setting, and Patients At academic and community- based medical centers in Massachusetts, between December 1, 1995, and April 15, 2001, 206 men with localized but unfavorable- risk prostate cancer were randomized to receive RT alone or RT and AST combined. All- cause mortality estimates stratified by randomized treatment group and further stratified in a postrandomization analysis by the Adult Comorbidity Evaluation 27 comorbidity score were compared using a log- rank test. Main Outcome Measure Time to all- cause mortality. Results As of January 15, 2007, with a median follow- up of 7.6 ( range, 0.5- 11.0) years, 74 deaths have occurred. A significant increase in the risk of all- cause mortality ( 44 vs 30 deaths; hazard ratio [ HR], 1.8; 95% confidence interval [ CI], 1.1- 2.9; P=. 01) was observed in men randomized to RT compared with RT and AST. However, the increased risk in all- cause mortality appeared to apply only to men randomized to RT with no or minimal comorbidity ( 31 vs 11 deaths; HR, 4.2; 95% CI, 2.1- 8.5; P <. 001). Among men with moderate or severe comorbidity, those randomized to RT alone vs RT and AST did not have an increased risk of all- cause mortality ( 13 vs 19 deaths; HR, 0.54; 95% CI, 0.27- 1.10; P=. 08). Conclusions The addition of 6 months of AST to RT resulted in increased overall survival in men with localized but unfavorable- risk prostate cancer. This result may pertain only to men without moderate or severe comorbidity, but this requires further assessment in a clinical trial specifically designed to assess this interaction. Trial Registration clinicaltrials. gov Identifier: NCT00116220	[D'Amico, Anthony V.; Loffredo, Marian] Brigham & Womens Hosp, Dept Radiat Oncol, Boston, MA 02115 USA; [Renshaw, Andrew A.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Kantoff, Philip W.] Brigham & Womens Hosp, Dept Med Oncol, Boston, MA 02115 USA; [D'Amico, Anthony V.; Renshaw, Andrew A.; Loffredo, Marian; Kantoff, Philip W.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Chen, Ming-Hui] Univ Connecticut, Dept Stat, Storrs, CT 06269 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; University of Connecticut	D'Amico, AV (corresponding author), Brigham & Womens Hosp, Dept Radiat Oncol, 75 Francis St,L-2 Level, Boston, MA 02115 USA.	adamico@partners.org		Kantoff, Philip/0000-0001-7275-0597				Agresti A, 2002, INTRO CATEGORICAL DA, P16; Bolla M, 1997, NEW ENGL J MED, V337, P295, DOI 10.1056/NEJM199707313370502; Bolla M, 2002, LANCET, V360, P103, DOI 10.1016/S0140-6736(02)09408-4; Braga-Basaria M, 2006, J CLIN ONCOL, V24, P3979, DOI 10.1200/JCO.2006.05.9741; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; D'Amico AV, 2007, J CLIN ONCOL, V25, P2420, DOI 10.1200/JCO.2006.09.3369; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; D'Amico AV, 2004, JAMA-J AM MED ASSOC, V292, P821, DOI 10.1001/jama.292.7.821; Denham JW, 2005, LANCET ONCOL, V6, P841, DOI 10.1016/S1470-2045(05)70348-X; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; EAHRS OH, 1992, AM JOINT COMMITTEE C; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; GAYNOR JJ, 1993, J AM STAT ASSOC, V88, P400, DOI 10.2307/2290318; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Johnson A, 2001, J REGISTRY MANAGE, V28, P125; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Keating NL, 2006, J CLIN ONCOL, V24, P4448, DOI 10.1200/JCO.2006.06.2497; Klein JP, 2003, SURVIVAL ANAL TECHNI, P243; Neter J, 1983, APPL LINEAR REGRESSI, P150; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Piccirillo JF, 2004, JAMA-J AM MED ASSOC, V291, P2441, DOI 10.1001/jama.291.20.2441; Piccirillo JF, 2003, J REGISTRY MANAGEMEN, V30, P8; Pilepich MV, 2001, INT J RADIAT ONCOL, V50, P1243, DOI 10.1016/S0360-3016(01)01579-6; Shipley WU, 2002, INT J RADIAT ONCOL, V54, P1302, DOI 10.1016/S0360-3016(02)03052-3; Walz J, 2007, J CLIN ONCOL, V25, P3576, DOI 10.1200/JCO.2006.10.3820; Walz J, 2007, INT J RADIAT ONCOL, V69, P88, DOI 10.1016/j.ijrobp.2007.02.022	27	545	554	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2008	299	3					289	295		10.1001/jama.299.3.289	http://dx.doi.org/10.1001/jama.299.3.289			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253DB	18212313	Bronze			2022-12-28	WOS:000252497800020
J	Haubek, D; Ennibi, OK; Poulsen, K; Vaeth, M; Poulsen, S; Kilian, M				Haubek, Dorte; Ennibi, Oum-Keltoum; Poulsen, Knud; Vaeth, Michael; Poulsen, Sven; Kilian, Mogens			Risk of aggressive periodontitis in adolescent carriers of the JP2 clone of Aggregatibacter (Actinobacillus) actinomycetemcomitans in Morocco: a prospective longitudinal cohort study	LANCET			English	Article							EARLY-ONSET PERIODONTITIS; HIGHLY TOXIC CLONE; JUVENILE PERIODONTITIS; LOCALIZED JUVENILE; POPULATION-STRUCTURE; DISEASE; CHILDREN; STRAINS; PLAQUE; MICROBIOLOGY	Background Periodontitis is a loss of supporting connective tissue and alveolar bone around teeth, and if it occurs in an aggressive form it can lead to tooth loss before the age of 20 years. Although the cause of periodontitis in general remains elusive, a particular clone (JP2) of the gram-negative rod Aggregatibacter (Actinobacillus) actinomycetemcomitans is considered a possible aetiological agent of the aggressive form in adolescents living in or originating from north and west Africa, where the disease is highly prevalent. We did a population-based longitudinal study of adolescents to assess the role of the JP2 clone in the initiation of aggressive periodontitis. Methods A total of 700 adolescents from public schools in Rabat, Morocco, were enrolled in the study. We used PCR to detect A actinomycetemcomitans in plaque samples (taken from molar and incisor sites) and to differentiate between the JP2 clone and other non-JP2 genotypes of the bacterium. 18 individuals were found to already have periodontitis and were excluded. The 682 periodontally healthy adolescents (mean age 12.5 years; SD 1 . 0) were classified according to their A actinomycetemcomitans carrier status at baseline. After 2 years, 428 (62. 8%) individuals returned for re-examination, which included recording of periodontal attachment loss measured from the cemento-enamel junction to the bottom of the periodontal pockets of all teeth present. Findings Individuals who carried the JP2 clone of A actinomycetemcomitans alone (relative risk 18 . 0; 95% CI 7.8-41.2, p<0 . 0001) or together with non-JP2 clones of A actinomycetemcomitans (12.4; 5.2-29.9, p<0 . 0001) had a significantly increased risk of periodontal attachment loss. A much less pronounced disease risk was found in those carrying non-JP2 clones only (3 . 0; 1. 3-7. 1, p=0 . 012). Interpretation The JP2 clone of A actinomycetemcomitans is likely to be an important aetiological agent in initiation of periodontal attachment loss in children and adolescents. Co-occurrence of non-JP2 clones of A actinomycetemcomitans reduces the risk of development of periodontitis, suggesting competition for the ecological niche between the JP2 and non-JP2 clones of this species.	[Haubek, Dorte; Poulsen, Sven] Aarhus Univ, Fac Hlth Sci, Dept Community Oral Hlth & Pediat Dent, DK-8000 Aarhus C, Denmark; [Poulsen, Knud; Kilian, Mogens] Aarhus Univ, Inst Med Microbiol & Immunol, DK-8000 Aarhus C, Denmark; [Vaeth, Michael] Aarhus Univ, Dept Biostat, DK-8000 Aarhus C, Denmark; [Ennibi, Oum-Keltoum] Univ Rabat, Fac Dent, Dept Periodontol, Rabat, Morocco	Aarhus University; Aarhus University; Aarhus University; Mohammed V University in Rabat	Haubek, D (corresponding author), Aarhus Univ, Fac Hlth Sci, Dept Community Oral Hlth & Pediat Dent, Vennelyst Blvd, DK-8000 Aarhus C, Denmark.	dhaubek@odont.au.dk	Ennibi, Oumkeltoum/AAT-4626-2020; Vaeth, Michael/T-6882-2017	Kilian, Mogens/0000-0002-5861-0472; Vaeth, Michael/0000-0002-0134-5006; ENNIBI, OUMKELTOUM/0000-0002-1224-9124				Albandar JM, 2002, PERIODONTOL 2000, V29, P153, DOI 10.1034/j.1600-0757.2002.290108.x; BROGAN JM, 1994, INFECT IMMUN, V62, P501, DOI 10.1128/IAI.62.2.501-508.1994; Bueno LC, 1998, J PERIODONTOL, V69, P998, DOI 10.1902/jop.1998.69.9.998; Cortelli JR, 2005, J CLIN PERIODONTOL, V32, P860, DOI 10.1111/j.1600-051X.2005.00777.x; Guthmiller JM, 2001, CRIT REV ORAL BIOL M, V12, P116, DOI 10.1177/10454411010120020201; Haraszthy VI, 2000, J PERIODONTOL, V71, P912, DOI 10.1902/jop.2000.71.6.912; Haubek D, 1997, J CLIN MICROBIOL, V35, P3037, DOI 10.1128/JCM.35.12.3037-3042.1997; Haubek D, 2004, J DENT RES, V83, P767, DOI 10.1177/154405910408301006; Haubek D, 2002, J CLIN PERIODONTOL, V29, P657, DOI 10.1034/j.1600-051X.2002.290711.x; Haubek D, 1996, J CLIN MICROBIOL, V34, P1576, DOI 10.1128/JCM.34.6.1576-1578.1996; Haubek D, 2001, J DENT RES, V80, P1580, DOI 10.1177/00220345010800062001; Haubek D, 2007, INFECT IMMUN, V75, P3080, DOI 10.1128/IAI.01734-06; HORMAND J, 1979, J CLIN PERIODONTOL, V6, P407; Jenkins WMM, 2001, PERIODONTOL 2000, V26, P16, DOI 10.1034/j.1600-0757.2001.2260102.x; Kaplan JB, 2002, J CLIN MICROBIOL, V40, P1181, DOI 10.1128/JCm.40.4.1181-1187.2002; Kilian M, 2006, PERIODONTOL 2000, V42, P158, DOI 10.1111/j.1600-0757.2006.00159.x; Kimura S, 2002, J PERIODONTOL, V73, P20, DOI 10.1902/jop.2002.73.1.20; Listgarten Max A, 2003, Ann Periodontol, V8, P182, DOI 10.1902/annals.2003.8.1.182; Lopez R, 2003, COMMUNITY DENT ORAL, V31, P136, DOI 10.1034/j.1600-0528.2003.00022.x; Marsh PD, 2005, J CLIN PERIODONTOL, V32, P7, DOI 10.1111/j.1600-051X.2005.00790.x; Norskov-Lauritsen N, 2006, INT J SYST EVOL MICR, V56, P2135, DOI 10.1099/ijs.0.64207-0; Paster BJ, 2006, PERIODONTOL 2000, V42, P80, DOI 10.1111/j.1600-0757.2006.00174.x; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Poulsen K, 2003, J CLIN MICROBIOL, V41, P4829, DOI 10.1128/JCM.41.10.4829-4832.2003; POULSEN K, 1994, MICROBIOL-UK, V140, P2049, DOI 10.1099/13500872-140-8-2049; Sanz M, 2004, J CLIN PERIODONTOL, V31, P1034, DOI 10.1111/j.1600-051X.2004.00609.x; SAXEN L, 1980, J CLIN PERIODONTOL, V7, P1, DOI 10.1111/j.1600-051X.1980.tb01944.x; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Van der Velden U, 2006, J CLIN PERIODONTOL, V33, P540, DOI 10.1111/j.1600-051X.2006.00953.x; Zambon JJ, 1996, J PERIODONTOL, V67, P282, DOI 10.1902/jop.1996.67.3s.282	30	236	241	1	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 19	2008	371	9608					237	242		10.1016/S0140-6736(08)60135-X	http://dx.doi.org/10.1016/S0140-6736(08)60135-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	252UK	18207019				2022-12-28	WOS:000252471900027
J	Claseem, A; Snow, V; Shekelle, P; Casey, DE; Cross, JT; Owens, DK				Claseem, Amir; Snow, Vincenza; Shekelle, Paul; Casey, Donald E., Jr.; Cross, J. Thomas, Jr.; Owens, Douglas K.		Clinical Efficacy Assessment Sub	Evidence-based interventions to improve the palliative care of pain, dyspnea, and depression at the end of life: A clinical practice guideline from the American college of physicians	ANNALS OF INTERNAL MEDICINE			English	Article							HOME-BASED INTERVENTION; QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; CONGESTIVE-HEART-FAILURE; CANCER-PATIENTS; UNPLANNED READMISSIONS; ETHICS CONSULTATIONS; FAMILY SATISFACTION; CAREGIVER BURDEN; MANAGEMENT	Recommendation 1: in patients with serious illness at the end of life, clinicians should regularly assess patients for pain, dyspnea, and depression. (Grade: strong recommendation, moderate quality of evidence.) Recommendation 2: In patients with serious illness at the end of life, clinicians should use therapies of proven effectiveness to manage pain. For patients with cancer, this includes nonsteroidal anti-inflammatory drugs, opioids, and bisphosphonates. (Grade: strong recommendation, moderate quality of evidence.) Recommendation 3: In patients with serious illness at the end of life, clinicians should use therapies of proven effectiveness to manage dyspnea, which include opioids in patients with unrelieved dyspnea and oxygen for short-term relief of hypoxemia. (Grade: strong recommendation, moderate quality of evidence.) Recommendation 4: In patients with serious illness at the end of life, clinicians should use therapies of proven effectiveness to manage depression. For patients with cancer, this includes tricyclic antidepressants, selective serotonin reuptake inhibitors, or psychosocial intervention. (Grade: strong recommendation, moderate quality of evidence.) Recommendation 5: Clinicians should ensure that advance care planning, including completion of advance directives, occurs for all patients with serious illness. (Grade: strong recommendation, low quality of evidence.).	[Claseem, Amir] American Coll Phys, Philadelphia, PA 19106 USA		Claseem, A (corresponding author), American Coll Phys, 190 N Independence Mail W, Philadelphia, PA 19106 USA.	aqaseem@acponline.org	Casey, Donald/AFM-6658-2022	Casey, Donald/0000-0002-3820-598X				Abernethy AP, 2003, BRIT MED J, V327, P523, DOI 10.1136/bmj.327.7414.523; Acton Gayle J, 2002, Annu Rev Nurs Res, V20, P149; Acton GJ, 2001, RES NURS HEALTH, V24, P349, DOI 10.1002/nur.1036; Adams K., 2003, PRIORITY AREAS NATL; Baker R, 2000, J AM GERIATR SOC, V48, pS61, DOI 10.1111/j.1532-5415.2000.tb03143.x; Bruera E, 2003, PALLIATIVE MED, V17, P659, DOI 10.1191/0269216303pm826oa; Burgio L, 2003, GERONTOLOGIST, V43, P568, DOI 10.1093/geront/43.4.568; Burns R, 2003, GERONTOLOGIST, V43, P547, DOI 10.1093/geront/43.4.547; CARR D, 2002, AHRQ PUBLICATION; Casarett D, 2005, JAMA-J AM MED ASSOC, V294, P211, DOI 10.1001/jama.294.2.211; Detmar SB, 2002, JAMA-J AM MED ASSOC, V288, P3027, DOI 10.1001/jama.288.23.3027; Eisdorfer C, 2003, GERONTOLOGIST, V43, P521, DOI 10.1093/geront/43.4.521; Field MJ, 1997, APPROACHING DEATH IM; Gitlin LN, 2003, PSYCHOL AGING, V18, P361, DOI 10.1037/0882-7974.18.3.361; Gitlin LN, 2003, GERONTOLOGIST, V43, P532, DOI 10.1093/geront/43.4.532; Grande GE, 2000, PALLIATIVE MED, V14, P375, DOI 10.1191/026921600701536200; Grande GE, 1997, PALLIATIVE MED, V11, P202, DOI 10.1177/026921639701100304; GUO B, 2004, ADV DIRECTIVES END O; Gysels M., 2004, IMPROVING SUPPORTIVE; Hanson LC, 1997, ANN INTERN MED, V126, P381, DOI 10.7326/0003-4819-126-5-199703010-00007; Hanson LC, 1997, J AM GERIATR SOC, V45, P1339, DOI 10.1111/j.1532-5415.1997.tb02933.x; HIGGINSON IJ, 2000, ROLE PALLIATIVE CARE; Jennings AL, 2002, THORAX, V57, P939, DOI 10.1136/thorax.57.11.939; Jordhoy MS, 2001, J CLIN ONCOL, V19, P3884, DOI 10.1200/JCO.2001.19.18.3884; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Knols R, 2005, J CLIN ONCOL, V23, P3830, DOI 10.1200/JCO.2005.02.148; Latimer EJ, 1998, J PAIN SYMPTOM MANAG, V16, P41, DOI 10.1016/S0885-3924(98)00027-X; Lee H, 2005, EUR J PAIN, V9, P437, DOI 10.1016/j.ejpain.2004.10.004; Lorenz K, 2006, AHRQ PUBLICATION, V06-E001; Lorenz KA, 2008, ANN INTERN MED, V148, P147, DOI 10.7326/0003-4819-148-2-200801150-00010; Mahoney DF, 2003, GERONTOLOGIST, V43, P556, DOI 10.1093/geront/43.4.556; McAlister FA, 2004, J AM COLL CARDIOL, V44, P810, DOI 10.1016/j.jacc.2004.05.055; Morrison RS, 2005, J AM GERIATR SOC, V53, P290, DOI 10.1111/j.1532-5415.2005.53116.x; Patrick DL, 2003, ANN INTERN MED, V139, P410, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00006; Rabow MW, 2004, ARCH INTERN MED, V164, P83, DOI 10.1001/archinte.164.1.83; Ram FSF, 2004, BMJ-BRIT MED J, V329, P315, DOI 10.1136/bmj.38159.650347.55; Riegel B, 2002, ARCH INTERN MED, V162, P705, DOI 10.1001/archinte.162.6.705; Ringdal GI, 2004, PALLIATIVE MED, V18, P108, DOI 10.1191/0269216304pm878oa; Ringdal GI, 2002, J PAIN SYMPTOM MANAG, V24, P53, DOI 10.1016/S0885-3924(02)00417-7; Roffe L, 2005, PSYCHO-ONCOLOGY, V14, P607, DOI 10.1002/pon.889; Schneiderman LJ, 2000, CRIT CARE MED, V28, P3920, DOI 10.1097/00003246-200012000-00033; Schneiderman LJ, 2003, JAMA-J AM MED ASSOC, V290, P1166, DOI 10.1001/jama.290.9.1166; SHUKLA V, 2006, 65 CAN COORD OFF HLT; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Sorensen S, 2002, GERONTOLOGIST, V42, P356, DOI 10.1093/geront/42.3.356; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; Stewart S, 1999, LANCET, V354, P1077, DOI 10.1016/S0140-6736(99)03428-5; Stewart S, 1999, ARCH INTERN MED, V159, P257, DOI 10.1001/archinte.159.3.257; Stewart S, 1998, ARCH INTERN MED, V158, P1067, DOI 10.1001/archinte.158.10.1067; Teno JM, 2001, J PAIN SYMPTOM MANAG, V22, P752, DOI 10.1016/S0885-3924(01)00331-1; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; Wenrich MD, 2003, J PAIN SYMPTOM MANAG, V25, P236, DOI 10.1016/S0885-3924(02)00694-2; WILSON DM, 2004, SYSTEMATIC REV END L; Windham BG, 2003, AM J MANAG CARE, V9, P447	54	133	136	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2008	148	2					141	146		10.7326/0003-4819-148-2-200801150-00009	http://dx.doi.org/10.7326/0003-4819-148-2-200801150-00009			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	254NZ	18195338				2022-12-28	WOS:000252594600007
J	Grueninger, D; Treiber, N; Ziegler, MOP; Koetter, JWA; Schulze, MS; Schulz, GE				Grueninger, Dirk; Treiber, Nora; Ziegler, Mathias O. P.; Koetter, Jochen W. A.; Schulze, Monika-Sarah; Schulz, Georg E.			Designed protein-protein association	SCIENCE			English	Article							CONFORMATIONAL ENTROPY; SPECIFICITY; RECOGNITION; CRYSTALLIZATION; PRINCIPLES; INTERFACES; MECHANISM; CRYSTALS; DOCKING	The analysis of natural contact interfaces between protein subunits and between proteins has disclosed some general rules governing their association. We have applied these rules to produce a number of novel assemblies, demonstrating that a given protein can be engineered to form contacts at various points of its surface. Symmetry plays an important role because it defines the multiplicity of a designed contact and therefore the number of required mutations. Some of the proteins needed only a single side- chain alteration in order to associate to a higher- order complex. The mobility of the buried side chains has to be taken into account. Four assemblies have been structurally elucidated. Comparisons between the designed contacts and the results will provide useful guidelines for the development of future architectures.	[Grueninger, Dirk; Treiber, Nora; Ziegler, Mathias O. P.; Koetter, Jochen W. A.; Schulze, Monika-Sarah; Schulz, Georg E.] Univ Freiburg, Inst Organ Chem & Biochem, D-79104 Freiburg, Germany	University of Freiburg	Schulz, GE (corresponding author), Univ Freiburg, Inst Organ Chem & Biochem, Albertstr 21, D-79104 Freiburg, Germany.	georg.schulz@ocbc.uni-freiburg.de						Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Cerutti DS, 2006, PROTEIN SCI, V15, P1579, DOI 10.1110/ps.051985106; Chevalier BS, 2002, MOL CELL, V10, P895, DOI 10.1016/S1097-2765(02)00690-1; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; Claus MT, 2005, BIOCHEMISTRY-US, V44, P8620, DOI 10.1021/bi050485+; Cole C, 2002, PROTEIN SCI, V11, P2860, DOI 10.1110/ps.0222702; Derewenda ZS, 2004, STRUCTURE, V12, P529, DOI 10.1016/j.str.2004.03.008; Faller M, 2004, SCIENCE, V303, P1189, DOI 10.1126/science.1094114; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; Halperin I, 2002, PROTEINS, V47, P409, DOI 10.1002/prot.10115; Kessler D, 2004, J MOL BIOL, V342, P183, DOI 10.1016/j.jmb.2004.07.028; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kroemer M, 2003, BIOCHEMISTRY-US, V42, P10560, DOI 10.1021/bi0349266; Lo Conte L, 1999, J MOL BIOL, V285, P2177; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Ofran Y, 2003, J MOL BIOL, V325, P377, DOI 10.1016/S0022-2836(02)01223-8; Ogihara NL, 2001, P NATL ACAD SCI USA, V98, P1404, DOI 10.1073/pnas.98.4.1404; Padilla JE, 2001, P NATL ACAD SCI USA, V98, P2217, DOI 10.1073/pnas.041614998; Pautsch A, 1999, PROTEINS, V34, P167, DOI 10.1002/(SICI)1097-0134(19990201)34:2<167::AID-PROT2>3.3.CO;2-8; Schueler-Furman O, 2005, SCIENCE, V310, P638, DOI 10.1126/science.1112160; Schweizer A, 2007, STRUCTURE, V15, P625, DOI 10.1016/j.str.2007.03.014; Shifman JM, 2002, J MOL BIOL, V323, P417, DOI 10.1016/S0022-2836(02)00881-1; Smyth DR, 2003, PROTEIN SCI, V12, P1313, DOI 10.1110/ps.0243403; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Wiesmann C, 1997, ACTA CRYSTALLOGR D, V53, P274, DOI 10.1107/S0907444996014977	26	114	118	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2008	319	5860					206	209		10.1126/science.1150421	http://dx.doi.org/10.1126/science.1150421			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249RC	18187656				2022-12-28	WOS:000252246400042
J	Snape, MD; Perrett, KP; Ford, KJ; John, TM; Pace, D; Yu, LM; Langley, JM; McNeil, S; Dull, PM; Ceddia, F; Anemona, A; Halperin, SA; Dobson, S; Pollard, AJ				Snape, Matthew D.; Perrett, Kirsten P.; Ford, Karen J.; John, Tessa M.; Pace, David; Yu, Ly-Mee; Langley, Joanne M.; McNeil, Shelley; Dull, Peter M.; Ceddia, Francesca; Anemona, Alessandra; Halperin, Scott A.; Dobson, Simon; Pollard, Andrew J.			Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONJUGATE VACCINE; DISEASE; COMPLICATIONS	Context Immunization with a meningococcal tetravalent ( serogroup ACWY) glycoconjugate vaccine is recommended for all US adolescents. However, the currently licensed vaccine is poorly immunogenic in infancy, when the highest rates of disease are observed. Objective To determine the immunogenicity of a novel tetravalent CRM197-conjugated meningococcal vaccine ( MenACWY) in infants. Design, Setting, and Participants Randomized, open- label, controlled study of 225 UK and 196 Canadian 2- month- olds from August 2004 to September 2006. Intervention UK infants received a primary course of MenACWY ( at 2, 3, and 4 months or 2 and 4 months) or Neisseria meningitidis serogroup C monovalent meningococcal glycoconjugate vaccine ( MenC) ( at 2 and 4 months). All received MenACWY at 12 months. Canadian infants received MenACWY at 2, 4, and 6 months or 2 and 4 months; at 12 months they received MenACWY, a plain tetravalent polysaccharide vaccine, or no vaccine. Main Outcome Measure Percentage of infants with a human complement serum bactericidal activity (hSBA) titer >= 1: 4 after a primary course of MenACWY and after a 12- month booster. Safety and reactogenicity of MenACWY were also assessed. Results According to the prespecified per- protocol analysis, the percentages ( 95% Cls) of MenACWY 2-, 3-, and 4- month recipients with hSBA titers >= 1: 4 after primary immunization were serogroup A, 93% ( 84%- 98%); C, 96% ( 89%- 99%); W- 135, 97% ( 90%- 100%); and Y, 94% ( 86%- 98%). With a post hoc intention- to- treat analysis with imputed values for missing data, these values were unchanged for serogroups C and Y; for serogroup A, values were 92% ( 84%- 97%), and for W- 135, 97% ( 91%- 99%). For the per- protocol analysis of MenACWY 2-, 4-, and 6- month recipients, the percentages ( 95% Cls) of responders were A, 81%( 71%- 89%); C, 98%( 92%- 100%); W- 135,99% ( 93%- 100%); and Y, 98% ( 92%- 100%). With the imputed value analysis, these values were A, 83% ( 74%- 89%); C, 98% ( 93%- 99%); W- 135, 99% ( 94%- 100%); and Y, 98% ( 92%- 99%). At least 84% of MenACWY 2- and 4- month recipients achieved hSBA titers >= 1: 4 for serogroups C, W- 135, and Y after primary immunization, as did at least 60% for serogroup A ( per- protocol and imputation analysis). At least 95% of primary and booster MenACWY recipients achieved hSBA titers >= 1: 4 for serogroups C, W- 135, and Y at 13 months, as did at least 84% for serogroup A ( per- protocol and imputation analysis). During the primary immunization course, postimmunization pain on leg movement was observed in 2% of UK Men ACWY 2- and 4- month recipients and4% of MenC 2- and 4- month recipients; a temperature of 38 C or greater was observed in 4% and 2% in these groups, respectively. Conclusion MenACWY is well tolerated and immunogenic in infancy. Trial Registration clinicaltrials. gov Identifier: NCT00262002.	[Snape, Matthew D.; Perrett, Kirsten P.; Ford, Karen J.; John, Tessa M.; Pace, David; Pollard, Andrew J.] Univ Oxford, Oxford Vaccine Grp, Oxford OX1 2JD, England; [Yu, Ly-Mee] Ctr Stat Med, Oxford, England; [Langley, Joanne M.; McNeil, Shelley; Halperin, Scott A.] Dalhousie Univ, Canadian Ctr Vaccinol, Halifax, NS, Canada; [Langley, Joanne M.; Halperin, Scott A.] IWK Hlth Ctr, Halifax, NS, Canada; [McNeil, Shelley] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada; [Dull, Peter M.; Ceddia, Francesca; Anemona, Alessandra] Novartis Vaccines & Diagnost, Siena, Italy; [Dobson, Simon] British Columbia Childrens Hosp, Vaccine Evaluat Ctr, Vancouver, BC V6H 3V4, Canada	University of Oxford; University of Oxford; Dalhousie University; Dalhousie University; Queen Elizabeth II Health Sciences Centre; Novartis; BC Childrens Hospital; University of British Columbia	Snape, MD (corresponding author), Churchill Hosp, CCVTM, Oxford Vaccine Grp, Old Rd, Oxford OX3 7LJ, England.	matthew.snape@paediatrics.ox.ac.uk	Perrett, Kirsten/P-8813-2019; Yu, LM/J-4284-2012; Pace, David/AAO-8928-2021	Perrett, Kirsten/0000-0002-5683-996X; Pace, David/0000-0002-3275-1189; Snape, Matthew/0000-0003-0531-5426; McNeil, Shelly/0000-0001-5444-4166; Langley, Joanne/0000-0003-3270-7345; Yu, Ly-Mee/0000-0003-0331-7364; Halperin, Scott/0000-0003-0525-589X				AlMazrou Y, 2005, INFECT IMMUN, V73, P2932, DOI 10.1128/IAI.73.5.2932-2939.2005; Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P794; Bilukha O, 2007, PEDIATR INFECT DIS J, V26, P371, DOI 10.1097/01.inf.0000259996.95965.ef; Erickson L, 1998, CLIN INFECT DIS, V26, P1159, DOI 10.1086/520303; Erickson LJ, 2001, CLIN INFECT DIS, V33, P737, DOI 10.1086/322587; *FOOD DRUG ADM, 2007, PROD APPR INF MEN PO; HASSANKING MKA, 1988, J INFECTION, V16, P55, DOI 10.1016/S0163-4453(88)96117-8; LEE LH, FDA CLIN BRIEFING DO; National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1; PERRETT KP, 2006, INF DIS SOC AM OCT T; Rennels M, 2004, PEDIATR INFECT DIS J, V23, P429, DOI 10.1097/01.inf.0000126297.28952.f8; Rosenstein NE, 1999, J INFECT DIS, V180, P1894, DOI 10.1086/315158; Snape MD, 2005, LANCET INFECT DIS, V5, P21, DOI 10.1016/S1473-3099(04)01251-4; Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1; Vu DM, 2006, J INFECT DIS, V193, P821, DOI 10.1086/500512; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774	16	165	182	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2008	299	2					173	184		10.1001/jama.2007.29-c	http://dx.doi.org/10.1001/jama.2007.29-c			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UN	18182599				2022-12-28	WOS:000252182600017
J	Goldfarb, S				Goldfarb, Stanley			Update in nephrology	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ACUTE-RENAL-FAILURE; PLASMA-EXCHANGE; MULTIPLE-MYELOMA; KIDNEY; METAANALYSIS; NEPHROPATHY; MANAGEMENT; RADIOLOGY; COMMITTEE; DISEASE		Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Goldfarb, S (corresponding author), Univ Penn, Sch Med, Stemmler Hall,Suite 100,3450 Hamilton Walk, Philadelphia, PA 19104 USA.	stanley.goldfarb@uphs.upenn.edu						Balk E, 2006, ANN INTERN MED, V145, P901, DOI 10.7326/0003-4819-145-12-200612190-00143; Boudville N, 2006, ANN INTERN MED, V145, P185, DOI 10.7326/0003-4819-145-3-200608010-00006; Clark WF, 2005, ANN INTERN MED, V143, P777, DOI 10.7326/0003-4819-143-11-200512060-00005; Gertz MA, 2005, ANN INTERN MED, V143, P835, DOI 10.7326/0003-4819-143-11-200512060-00013; GROBNER T, 2006, NEPHROL DIAL TRANSPL; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Ho KM, 2006, BMJ-BRIT MED J, V333, P420, DOI 10.1136/bmj.38902.605347.7C; Holden A, 2006, KIDNEY INT, V70, P948, DOI 10.1038/sj.ki.5001671; Hou FF, 2006, NEW ENGL J MED, V354, P131, DOI 10.1056/NEJMoa053107; Kuo PH, 2007, RADIOLOGY, V242, P647, DOI 10.1148/radiol.2423061640; Marenzi G, 2006, NEW ENGL J MED, V354, P2773, DOI 10.1056/NEJMoa054209; PASQUALI S, 1985, INT J ARTIF ORGANS, V8, P27; White CJ, 2006, CIRCULATION, V114, P1892, DOI 10.1161/CIRCULATIONAHA.106.178777; ZUCCHELLI P, 1988, KIDNEY INT, V33, P1175, DOI 10.1038/ki.1988.127	14	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	2008	148	1					49	54		10.7326/0003-4819-148-1-200801010-00007	http://dx.doi.org/10.7326/0003-4819-148-1-200801010-00007			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248JJ	18166760				2022-12-28	WOS:000252149300005
J	Bonneau, R; Facciotti, MT; Reiss, DJ; Schmid, AK; Pan, M; Kaur, A; Thorsson, V; Shannon, P; Johnson, MH; Bare, JC; Longabaugh, W; Vuthoori, M; Whitehead, K; Madar, A; Suzuki, L; Mori, T; Chang, DE; DiRuggiero, J; Johnson, CH; Hood, L; Baliga, NS				Bonneau, Richard; Facciotti, Marc T.; Reiss, David J.; Schmid, Amy K.; Pan, Min; Kaur, Amardeep; Thorsson, Vesteinn; Shannon, Paul; Johnson, Michael H.; Bare, J. Christopher; Longabaugh, William; Vuthoori, Madhavi; Whitehead, Kenia; Madar, Aviv; Suzuki, Lena; Mori, Tetsuya; Chang, Dong-Eun; DiRuggiero, Jocelyne; Johnson, Carl H.; Hood, Leroy; Baliga, Nitin S.			A predictive model for transcriptional control of physiology in a free living cell	CELL			English	Article							SYSTEMS-BIOLOGY; REGULATORY NETWORK; ESCHERICHIA-COLI; GENOME-SCALE; DE-NOVO; DATABASE; GENES; RADIATION; NRC-1; EXPRESSION	The environment significantly influences the dynamic expression and assembly of all components encoded in the genome of an organism into functional biological networks. We have constructed a model for this process in Halobacterium salinarum NRC-1 through the data-driven discovery of regulatory and functional interrelationships among similar to 80% of its genes and key abiotic factors in its hypersaline environment. Using relative changes in 72 transcription factors and 9 environmental factors (EFs) this model accurately predicts dynamic transcriptional responses of all these genes in 147 newly collected experiments representing completely novel genetic backgrounds and environments-suggesting a remarkable degree of network completeness. Using this model we have constructed and tested hypotheses critical to this organism's interaction with its changing hypersaline environment. This study supports the claim that the high degree of connectivity within biological and EF networks will enable the construction of similar models for any organism from relatively modest numbers of experiments.	[Facciotti, Marc T.; Reiss, David J.; Schmid, Amy K.; Pan, Min; Kaur, Amardeep; Thorsson, Vesteinn; Shannon, Paul; Johnson, Michael H.; Bare, J. Christopher; Longabaugh, William; Vuthoori, Madhavi; Whitehead, Kenia; Hood, Leroy; Baliga, Nitin S.] Inst Syst Biol, Seattle, WA 98103 USA; [Bonneau, Richard; Madar, Aviv] NYU, Ctr Genome & Syst Biol, New York, NY 10003 USA; [DiRuggiero, Jocelyne] Univ Maryland, College Pk, MD 20742 USA; [Suzuki, Lena; Mori, Tetsuya; Chang, Dong-Eun; Johnson, Carl H.] Vanderbilt Univ, Nashville, TN 37240 USA; [Bonneau, Richard] NYU, Dept Comp Sci, Courant Inst Math Sci, New York, NY 10003 USA; [Baliga, Nitin S.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Baliga, Nitin S.] Univ Washington, Dept Mol & Cellular Biol, Seattle, WA 98195 USA	Institute for Systems Biology (ISB); New York University; University System of Maryland; University of Maryland College Park; Vanderbilt University; New York University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Baliga, NS (corresponding author), Inst Syst Biol, Seattle, WA 98103 USA.	nbaliga@systemsbiology.org	Bonneau, Richard/GZL-2900-2022; Madar, Aviv/D-1023-2013; Bonneau, Richard/ABD-6737-2021; Madar, Aviv/AAO-1540-2020; Facciotti, Marc/AAF-9227-2020	Facciotti, Marc/0000-0003-4453-3274; baliga, nitin/0000-0001-9157-5974; Bare, J. Christopher/0000-0003-1006-1491; Mori, Tetsuya/0000-0001-6036-5261	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067152, R37GM067152, P50GM076547] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM067152, P50GM076547, R37 GM067152, R01GM067152] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baliga NS, 2004, GENOME RES, V14, P1025, DOI 10.1101/gr.1993504; Baliga NS, 2002, P NATL ACAD SCI USA, V99, P14913, DOI 10.1073/pnas.192558999; Baliga NS, 1999, J BACTERIOL, V181, P2513, DOI 10.1128/JB.181.8.2513-2518.1999; Baliga NS, 2001, P NATL ACAD SCI USA, V98, P2521, DOI 10.1073/pnas.051632498; Barrett CL, 2005, P NATL ACAD SCI USA, V102, P19103, DOI 10.1073/pnas.0505231102; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Bonneau R, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r52; Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; Bowers PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r35; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Eichenberger P, 2004, PLOS BIOL, V2, P1664, DOI 10.1371/journal.pbio.0020328; Facciotti MT, 2007, P NATL ACAD SCI USA, V104, P4630, DOI 10.1073/pnas.0611663104; Facciotti MT, 2004, CURR GENOMICS, V5, P527, DOI 10.2174/1389202043348850; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Grant WD, 2004, PHILOS T R SOC B, V359, P1249, DOI 10.1098/rstb.2004.1502; Hayete B, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100118; Hofacker A, 2004, MICROBIOL-SGM, V150, P1829, DOI 10.1099/mic.0.27078-0; Ideker T, 2000, J COMPUT BIOL, V7, P805, DOI 10.1089/10665270050514945; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kaur A, 2006, GENOME RES, V16, P841, DOI 10.1101/gr.5189606; Kirschner MW, 2005, CELL, V121, P503, DOI 10.1016/j.cell.2005.05.005; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kottemann M, 2005, EXTREMOPHILES, V9, P219, DOI 10.1007/s00792-005-0437-4; LANYI JK, 1980, J SUPRAMOL STR CELL, V13, P83, DOI 10.1002/jss.400130108; Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Masuda N, 2003, MOL MICROBIOL, V48, P699, DOI 10.1046/j.1365-2958.2003.03477.x; Muller JA, 2005, J BACTERIOL, V187, P1659, DOI 10.1128/JB.187.5.1659-1667.2005; Ng WV, 2000, P NATL ACAD SCI USA, V97, P12176, DOI 10.1073/pnas.190337797; Oren A, 1999, MICROBIOL MOL BIOL R, V63, P334, DOI 10.1128/MMBR.63.2.334-348.1999; PEEL JL, 1962, J BIOL CHEM, V237, pP263; Reiss DJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-280; Ruepp A, 1996, J BACTERIOL, V178, P4942, DOI 10.1128/jb.178.16.4942-4947.1996; Schmid AK, 2007, GENOME RES, V17, P1399, DOI 10.1101/gr.6728007; Shannon PT, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-176; Sintchak MD, 2002, NAT STRUCT BIOL, V9, P293, DOI 10.1038/nsb774; Sussman JL, 1998, ACTA CRYSTALLOGR D, V54, P1078, DOI 10.1107/S0907444998009378; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Thorsson V, 2005, STAT APPL GENET MOL, V4; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Whitehead K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100091	41	230	238	2	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 28	2007	131	7					1354	1365		10.1016/j.cell.2007.10.053	http://dx.doi.org/10.1016/j.cell.2007.10.053			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GV	18160043	Bronze			2022-12-28	WOS:000252217200023
J	Epstein, AE; Kirklin, JK				Epstein, Andrew E.; Kirklin, James K.			Mapping the atrioventricular node	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Alabama, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Epstein, AE (corresponding author), Univ Alabama, Birmingham, AL 35294 USA.	aepstein@uab.edu							0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2007	357	26					2706	2706		10.1056/NEJMicm072508	http://dx.doi.org/10.1056/NEJMicm072508			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	245UO	18160690				2022-12-28	WOS:000251964500009
J	Zheng, SL; Sun, JL; Wiklund, F; Smith, S; Stattin, P; Li, G; Adami, HO; Hsu, FC; Zhu, Y; Balter, K; Kader, AK; Turner, AR; Liu, WN; Bleecker, ER; Meyers, DA; Duggan, D; Carpten, JD; Chang, BL; Isaacs, WB; Xu, JF; Gronberg, H				Zheng, S. Lilly; Sun, Jielin; Wiklund, Fredrik; Smith, Shelly; Stattin, Par; Li, Ge; Adami, Hans-Olov; Hsu, Fang-Chi; Zhu, Yi; Balter, Katarina; Kader, A. Karim; Turner, Aubrey R.; Liu, Wennuan; Bleecker, Eugene R.; Meyers, Deborah A.; Duggan, David; Carpten, John D.; Chang, Bao-Li; Isaacs, William B.; Xu, Jianfeng; Gronberg, Henrik			Cumulative association of five genetic variants with prostate cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHROMOSOME 8Q24; RISK LOCUS; COMMON	Background Single-nucleotide polymorphisms (SNPs) in five chromosomal regions -- three at 8q24 and one each at 17q12 and 17q24.3 -- have been associated with prostate cancer. Each SNP has only a moderate association, but when SNPs are combined, the association may be stronger. Methods We evaluated 16 SNPs from five chromosomal regions in a Swedish population (2893 subjects with prostate cancer and 1781 control subjects) and assessed the individual and combined association of the SNPs with prostate cancer. Results Multiple SNPs in each of the five regions were associated with prostate cancer in single SNP analysis. When the most significant SNP from each of the five regions was selected and included in a multivariate analysis, each SNP remained significant after adjustment for other SNPs and family history. Together, the five SNPs and family history were estimated to account for 46% of the cases of prostate cancer in the Swedish men we studied. The five SNPs plus family history had a cumulative association with prostate cancer (P for trend, 3.93x10(-28)). In men who had any five or more of these factors associated with prostate cancer, the odds ratio for prostate cancer was 9.46 (P=1.29x10(-8)), as compared with men without any of the factors. The cumulative effect of these variants and family history was independent of serum levels of prostate-specific antigen at diagnosis. Conclusions SNPs in five chromosomal regions plus a family history of prostate cancer have a cumulative and significant association with prostate cancer.	[Zheng, S. Lilly; Sun, Jielin; Smith, Shelly; Li, Ge; Hsu, Fang-Chi; Zhu, Yi; Turner, Aubrey R.; Liu, Wennuan; Bleecker, Eugene R.; Meyers, Deborah A.; Chang, Bao-Li; Xu, Jianfeng] Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genome, Winston Salem, NC 27157 USA; [Hsu, Fang-Chi] Wake Forest Univ, Bowman Gray Sch Med, Dept Biostat Sci, Winston Salem, NC 27157 USA; [Kader, A. Karim] Wake Forest Univ, Bowman Gray Sch Med, Dept Urol, Winston Salem, NC 27157 USA; [Wiklund, Fredrik; Adami, Hans-Olov; Balter, Katarina; Gronberg, Henrik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Stattin, Par] Univ Umea Hosp, Dept Urol, S-90185 Umea, Sweden; [Adami, Hans-Olov] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Duggan, David; Carpten, John D.] Translat Genom Res Inst, Phoenix, AZ USA; [Isaacs, William B.] Johns Hopkins Med Inst, Baltimore, MD 21205 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Karolinska Institutet; Umea University; Harvard University; Harvard T.H. Chan School of Public Health; Translational Genomics Research Institute; Johns Hopkins University; Johns Hopkins Medicine	Xu, JF (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genome, Med Ctr Blvd, Winston Salem, NC 27157 USA.	wisaacs@jhmi.edu; jxu@wfubmc.edu			NCI NIH HHS [PC051264, CA95052, CA58236, CA112517, CA105055, CA106523] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA095052, R01CA112517, R01CA105055, P50CA058236, R01CA106523] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Gronberg H, 2003, LANCET, V361, P859, DOI 10.1016/S0140-6736(03)12713-4; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; GUNDMUNDSSON J, 2007, NAT GENET, V39, P977; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Hunter DJ, 2007, NEW ENGL J MED, V357, P436, DOI 10.1056/NEJMp078120; Johns LE, 2003, BJU INT, V91, P789, DOI 10.1046/j.1464-410X.2003.04232.x; LILIENFELD AM, 1980, FDN EPIDEMIOLOGY, P301; Lindstrom S, 2006, CANCER RES, V66, P11077, DOI 10.1158/0008-5472.CAN-06-3024; Schumacher FR, 2007, CANCER RES, V67, P2951, DOI 10.1158/0008-5472.CAN-06-3591; Severi G, 2007, CANCER EPIDEM BIOMAR, V16, P610, DOI 10.1158/1055-9965.EPI-06-0872; Suuriniemi M, 2007, CANCER EPIDEM BIOMAR, V16, P809, DOI 10.1158/1055-9965.EPI-06-1049; Wang L, 2007, CANCER RES, V67, P2944, DOI 10.1158/0008-5472.CAN-06-3186; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zheng SL, 2007, JNCI-J NATL CANCER I, V99, P1525, DOI 10.1093/jnci/djm169	16	496	509	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2008	358	9					910	919		10.1056/NEJMoa075819	http://dx.doi.org/10.1056/NEJMoa075819			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266JD	18199855	Bronze			2022-12-28	WOS:000253430200006
J	Chen, Y; Yang, YT; van Overbeek, M; Donigian, JR; Baciu, P; de Lange, T; Lei, M				Chen, Yong; Yang, Yuting; van Overbeek, Megan; Donigian, Jill R.; Baciu, Paul; de Lange, Titia; Lei, Ming			A shared docking motif in TRF1 and TRF2 used for differential recruitment of telomeric proteins	SCIENCE			English	Article							DNA; COMPLEX; TIN2; POLYMERASE; INTERACTS; APOLLO	Mammalian telomeres are protected by a six- protein complex: shelterin. Shelterin contains two closely related proteins ( TRF1 and TRF2), which recruit various proteins to telomeres. We dissect the interactions of TRF1 and TRF2 with their shared binding partner ( TIN2) and other shelterin accessory factors. TRF1 recognizes TIN2 using a conserved molecular surface in its TRF homology ( TRFH) domain. However, this same surface does not act as a TIN2 binding site in TRF2, and TIN2 binding to TRF2 is mediated by a region outside the TRFH domain. Instead, the TRFH docking site of TRF2 binds a shelterin accessory factor ( Apollo), which does not interact with the TRFH domain of TRF1. Conversely, the TRFH domain of TRF1, but not of TRF2, interacts with another shelterin- associated factor: PinX1.	[Chen, Yong; Yang, Yuting; Baciu, Paul; Lei, Ming] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [van Overbeek, Megan; Donigian, Jill R.; de Lange, Titia] Rockefeller Univ, Cell Biol & Genet Lab, New York, NY 10065 USA	University of Michigan System; University of Michigan; Rockefeller University	Lei, M (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	leim@umich.edu	Chen, Yong/AAF-9915-2020; de Lange, Titia/B-8263-2011; chen, Yong/F-3938-2010	Chen, Yong/0000-0001-5857-6086; de Lange, Titia/0000-0002-9267-367X; 				Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Court R, 2005, EMBO REP, V6, P39, DOI 10.1038/sj.embor.7400314; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Fairall L, 2001, MOL CELL, V8, P351, DOI 10.1016/S1097-2765(01)00321-5; Fotiadou P, 2004, CANCER RES, V64, P3830, DOI 10.1158/0008-5472.CAN-04-0136; Kim S, 2004, J BIOL CHEM, V279, P43799, DOI 10.1074/jbc.M408650200; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Lee TH, 2006, J BIOL CHEM, V281, P759, DOI 10.1074/jbc.M509855200; Lenain C, 2006, CURR BIOL, V16, P1303, DOI 10.1016/j.cub.2006.05.021; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Nishikawa T, 2001, STRUCTURE, V9, P1237, DOI 10.1016/S0969-2126(01)00688-8; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; van Overbeek M, 2006, CURR BIOL, V16, P1295, DOI 10.1016/j.cub.2006.05.022; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	17	186	195	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2008	319	5866					1092	1096		10.1126/science.1151804	http://dx.doi.org/10.1126/science.1151804			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264SW	18202258				2022-12-28	WOS:000253311700044
J	Fudge, N; Wolfe, CDA; McKevitt, C				Fudge, Nina; Wolfe, Charles D. A.; McKevitt, Christopher			Assessing the promise of user involvement in health service development: ethnographic study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SOCIAL-MOVEMENTS; PARTICIPATION; DELIVERY; PEOPLE; IMPACT; POWER	Objectives To understand how the policy of user involvement is interpreted in health service organisations and to identify factors that influence how user involvement is put into practice. Design Ethnographic study using participant observation, interviews, and collection of documentary evidence. Setting A multiagency modernisation programme to improve stroke services in two London boroughs. Participants Service users, National Health Service managers, and clinicians. Results User involvement in the programme was initiated and led by professionals. Professionals determined the areas of service improvement service users could participate in. A wide range of activities were considered "user involvement," from patient satisfaction surveys to service users delivering peer support. Involvement tended to be most active in the least technical areas and areas with least input from clinicians. Factors that might explain this included organisational structure, the vagueness of the concept of user involvement, the value attributed to service users' experiential knowledge, and variations in professional and service user understandings of and commitment to involvement. The gains of involvement were harder to identify in terms of impact on services. More evident were the personal gains for those involved: satisfaction of feeling listened to by professionals, social opportunities of meeting others in a similar situation, and increased knowledge about stroke and services available. Conclusions User involvement may not automatically lead to improved service quality. Healthcare professionals and service users understand and practise user involvement in different ways according to individual ideologies, circumstances, and needs. Given the resource implications of undertaking user involvement in service development there is a need for critical debate on the purpose of such involvement as well as better evidence of the benefits claimed for it.	[Fudge, Nina; Wolfe, Charles D. A.; McKevitt, Christopher] Kings Coll London, Div Hlth & Social Care Res, London SE1 3QD, England; [Wolfe, Charles D. A.] Guys & St Thomas NHS Fdn Trust, Natl Inst Hlth Res Comprehens Biomed Res Ctr, London, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Fudge, N (corresponding author), Kings Coll London, Div Hlth & Social Care Res, London SE1 3QD, England.	nina.fudge@kcl.ac.uk	mckevitt, christopher/AAN-7271-2021	Wolfe, Charles/0000-0001-8264-0981; Fudge, Nina/0000-0002-7161-4355; MCKEVITT, CHRISTOPHER/0000-0002-5290-4613	National Institute for Health Research [RP-PG-0407-10184] Funding Source: researchfish; Department of Health [RP-PG-0407-10184] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		[Anonymous], 1988, BRIT MED J, V297, P126; *ASS PUBL HLTH OBS, 2006, COMM HLTH PROF LAMB; *ASS PUBL HLTH OBS, 2006, COMM HLTH PROF SOUTH; Beresford P, 2007, HEALTH SOC CARE COMM, V15, P306, DOI 10.1111/j.1365-2524.2007.00688.x; Brown P, 2004, SOCIOL HEALTH ILL, V26, P679, DOI 10.1111/j.0141-9889.2004.00413.x; Contandriopoulos D, 2004, SOC SCI MED, V58, P321, DOI 10.1016/S0277-9536(03)00164-3; Crawford MJ, 2003, ACTA PSYCHIAT SCAND, V107, P410, DOI 10.1034/j.1600-0447.2003.00049.x; Crawford MJ, 2002, BRIT MED J, V325, P1263, DOI 10.1136/bmj.325.7375.1263; DAVIES CA, 1999, RELFEXIVE ETHNOGRAPH; DAYKIN N, 2004, CRITICAL PUBLIC HLTH, V14, P277; *DEP HLTH, 2001, SHIFT BAL POW NEXT S; Department of Health, 2005, CREAT PAT LED NHS; Farrell C., 2004, PATIENT PUBLIC INVOL; FLETCHER G, 2003, OBSTET GYNAECOLOGIST, V5, P218; Florin D, 2004, BRIT MED J, V328, P159, DOI 10.1136/bmj.328.7432.159; Hammersley M., 1995, ETHNOGRAPHY PRINCIPL; Harrison S, 2002, HEALTH SOC CARE COMM, V10, P63, DOI 10.1046/j.1365-2524.2002.00342.x; Hodge S, 2005, CRIT SOC POLICY, V25, P164, DOI 10.1177/0261018305051324; Kolker ES, 2004, SOCIOL HEALTH ILL, V26, P820, DOI 10.1111/j.0141-9889.2004.00420.x; Lambert H, 2002, BRIT MED J, V325, P210, DOI 10.1136/bmj.325.7357.210; Low JTS, 1999, SOC SCI MED, V49, P711, DOI 10.1016/S0277-9536(99)00194-X; Milewa T, 1999, SOCIOL HEALTH ILL, V21, P445, DOI 10.1111/1467-9566.00166; Murphy E., 2003, QUALITATIVE METHODS; National Audit Office, 2005, RED BRAIN DAM FAST A; Nilsen ES, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004563.pub2; Roy CM, 2001, AIDS CARE, V13, P421, DOI 10.1080/09540120120057950; Rutter D, 2004, SOC SCI MED, V58, P1973, DOI 10.1016/S0277-9536(03)00401-5; Savage J, 2000, BMJ-BRIT MED J, V321, P1400, DOI 10.1136/bmj.321.7273.1400; Simpson EL, 2002, BRIT MED J, V325, P1265, DOI 10.1136/bmj.325.7375.1265; St John of God Health Care, 2019, OUR VIS; Wellard Sally, 2003, Int J Nurs Pract, V9, P255, DOI 10.1046/j.1440-172X.2003.00429.x; Wilson T, 2005, BMJ-BRIT MED J, V330, P657, DOI 10.1136/bmj.330.7492.657; Wolfe CDA, 2000, BRIT MED BULL, V56, P275, DOI 10.1258/0007142001903120	33	107	107	1	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2008	336	7639					313	+		10.1136/bmj.39456.552257.BE	http://dx.doi.org/10.1136/bmj.39456.552257.BE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	266LR	18230646	Green Submitted, Green Published			2022-12-28	WOS:000253437400032
J	Richards, T				Richards, Tessa			Olympic challenges - Will moves to improve air quality in Beijing push the climate change agenda?	BRITISH MEDICAL JOURNAL			English	Editorial Material												trichards@bmj.com							0	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 26	2008	336	7637					189	189		10.1136/bmj.39468.630741.47	http://dx.doi.org/10.1136/bmj.39468.630741.47			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259KT	18219039	Green Published			2022-12-28	WOS:000252938900039
J	Goldston, D				Goldston, David			Shattered illusions	NATURE			English	Editorial Material											Goldston, D (corresponding author), Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA.	partyofonecolumn@gmail.com						Goldston D, 2007, NATURE, V449, P962, DOI 10.1038/449962a; Hand E, 2008, NATURE, V451, P2, DOI 10.1038/451002a	2	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2008	451	7177					387	387		10.1038/451387a	http://dx.doi.org/10.1038/451387a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	253YS	18216824				2022-12-28	WOS:000252554100012
J	Buttgereit, F; Doering, G; Schaeffler, A; Witte, S; Sierakowski, S; Gromnica-Ihle, E; Jeka, S; Krueger, K; Szechinski, J; Alten, R				Buttgereit, Frank; Doering, Gisela; Schaeffler, Achim; Witte, Stephan; Sierakowski, Stanislaw; Gromnica-Ihle, Erika; Jeka, Slawomir; Krueger, Klaus; Szechinski, Jacek; Alten, Rieke			Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial	LANCET			English	Article							CIRCADIAN-RHYTHMS; GLUCOCORTICOID TREATMENT; MECHANISMS; DISEASES; HORMONES; THERAPY	Background Circadian rhythms are changed in patients with rheumatoid arthritis. A new modified-release delivery system has been developed which adapts the release of the administered glucocorticoid to the circadian rhythms of endogenous cortisol and disease symptoms to improve the benefit-risk ratio of glucocorticoid therapy in rheumatoid arthritis. We aimed to assess the efficacy and safety of a new modified-release prednisone tablet compared with immediate-release prednisone in patients with this disease. Methods In a 12-week, multicentre, randomised, double-blind trial, 288 patients with active rheumatoid arthritis were randomly assigned to either a modified-release prednisone tablet (n=144) or to an immediate-release prednisone tablet (n=144). The modified-release tablet was taken at bedtime and prednisone was released with a delay of 4 h after ingestion. This treatment was compared with morning administration of immediate-release prednisone as an active comparator. The primary outcome measure was duration of morning stiffness of the joints. Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00146640. Findings The mean relative change in duration of morning stiffness of the joints from baseline to end of treatment was significantly higher with modified-release prednisone than with immediate-release prednisone (-22.7% vs-0.4%; difference=22. 4% [95% CI 0.49-44.30]; p=0.045). Patients in the prednisone modified-release group achieved a mean reduction of 44.0 (SD 136.6) min compared with baseline. The absolute difference between the treatment groups was 29.2 min (95% CI -2 . 59 to 61. 9) in favour of modified-release prednisone (p=0.072). The safety profile did not differ between treatments. Interpretation Modified-release prednisone is well tolerated, convenient to administer, and produces a clinically relevant reduction of morning stiffness of the joints in addition to all known therapeutic effects of immediate-release prednisone.	[Buttgereit, Frank] Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, D-10117 Berlin, Germany; [Doering, Gisela] Merck KGaA, Darmstadt, Germany; [Schaeffler, Achim; Witte, Stephan] Nitec Pharma GmbH, Mannheim, Germany; [Sierakowski, Stanislaw] Ctr Miriada, Prywatny Gabinet Specialistyc, Bialystok, Poland; [Gromnica-Ihle, Erika] Immanuel Krankenhaus, Berlin, Germany; [Jeka, Slawomir] Clin Trials Off, Torun, Poland; [Krueger, Klaus] Praxiszentrum St Bonifatius, Munich, Germany; [Szechinski, Jacek] Katedra & Klin Reumatol & Chorob Wewnetrznych AM, Wroclaw, Poland; [Alten, Rieke] Charite Teaching Hosp, Schlosspk Klin, Dept Internal Med, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Merck KGaA; Wroclaw Medical University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Buttgereit, F (corresponding author), Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, Charitepl 1, D-10117 Berlin, Germany.	frank.buttgereit@charite.de	Jeka, Sławomir/W-6677-2019; Alten, Rieke/M-1045-2019	Buttgereit, Frank/0000-0003-2534-550X				Aletaha D, 2006, ANN RHEUM DIS, V65, P227, DOI 10.1136/ard.2005.038513; Aletaha D, 2006, ARTHRITIS RHEUM-US, V54, P2784, DOI 10.1002/art.22052; Almawi WY, 2001, MOD ASP IMMUNOBIOL, V2, P78; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; ARVIDSON NG, 1994, ANN RHEUM DIS, V53, P521, DOI 10.1136/ard.53.8.521; Arvidson NG, 1997, ANN RHEUM DIS, V56, P27, DOI 10.1136/ard.56.1.27; Bijlsma JWJ, 2005, RHEUM DIS CLIN N AM, V31, P1, DOI 10.1016/j.rdc.2004.10.003; Buttgereit F, 2005, LANCET, V365, P801; Buttgereit F, 2004, ARTHRITIS RHEUM-US, V50, P3408, DOI 10.1002/art.20583; Buttgereit F, 2002, ANN RHEUM DIS, V61, P718, DOI 10.1136/ard.61.8.718; Buttgereit F, 2005, SCAND J RHEUMATOL, V34, P14, DOI 10.1080/03009740510017706; Caplan L, 2007, J RHEUMATOL, V34, P696; Cutolo M, 2006, ANN RHEUM DIS, V65, P1438, DOI 10.1136/ard.2006.051979; Cutolo M, 2005, ANN NY ACAD SCI, V1051, P372, DOI 10.1196/annals.1361.079; Cutolo M, 2005, AUTOIMMUN REV, V4, P497, DOI 10.1016/j.autrev.2005.04.019; Cutolo M, 2005, RHEUM DIS CLIN N AM, V31, P115, DOI 10.1016/j.rdc.2004.09.005; Cutolo M, 2003, ANN RHEUM DIS, V62, P593, DOI 10.1136/ard.62.7.593; Da Silva JAP, 2006, ANN RHEUM DIS, V65, P285, DOI 10.1136/ard.2005.038638; Davis JM, 2007, ARTHRITIS RHEUM-US, V56, P820, DOI 10.1002/art.22418; *EUR MED AG, 2003, CPMPEWP55695 EUR MED; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; HENCH PS, 1950, ARCH INTERN MED, V85, P545, DOI 10.1001/archinte.1950.00230100002001; Hoes JN, 2007, ANN RHEUM DIS, V66, P1560, DOI 10.1136/ard.2007.072157; KIRWAN J, 2007, COCHRANE DB SYST REV, V4; Kirwan J, 2007, CURR OPIN RHEUMATOL, V19, P233, DOI 10.1097/BOR.0b013e3280d6471a; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; SCOTT DL, 1993, EULAR HDB STANDARD M, P1; Soubrier M, 2006, J RHEUMATOL, V33, P1243; Straub RH, 2007, ARTHRITIS RHEUM, V56, P399, DOI 10.1002/art.22368; Thiele K, 2005, ARTHRIT RHEUM-ARTHR, V53, P740, DOI 10.1002/art.21467; VACCA A, 1992, J EXP MED, V175, P637, DOI 10.1084/jem.175.3.637; Ware J, 1994, SF 36 PHYS MENT HLTH; Yazici Y, 2004, J RHEUMATOL, V31, P1723	34	253	261	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 19	2008	371	9608					205	214		10.1016/S0140-6736(08)60132-4	http://dx.doi.org/10.1016/S0140-6736(08)60132-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	252UK	18207016				2022-12-28	WOS:000252471900024
J	Wee, B; Reynolds, JH; Bleetman, A				Wee, Bernard; Reynolds, John H.; Bleetman, Anthony			Rational imaging - Imaging after trauma to the neck	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							C-SPINE RULE; CERVICAL-SPINE; CLEARANCE; CRITERIA; INJURY; RISK	Plain radiography is often used to image the neck after trauma, but computed tomography and magnetic resonance imaging provide further useful information and should be considered.	[Wee, Bernard; Reynolds, John H.] Birmingham Heartlands Hosp, Heart England NHS Fdn Trust, Dept Radiol, Birmingham B9 5SS, W Midlands, England; [Bleetman, Anthony] Heart England NHS Fdn Trust, Dept Emergency Med, Birmingham B9 5SS, W Midlands, England	Heart of England NHS Foundation Trust; University of Birmingham; Heart of England NHS Foundation Trust	Reynolds, JH (corresponding author), Birmingham Heartlands Hosp, Heart England NHS Fdn Trust, Dept Radiol, Birmingham B9 5SS, W Midlands, England.	john.reynolds@heartofengland.nhs.uk						Berrington de Gonzalez A, 2004, LANCET, V363, P345, DOI 10.1016/S0140-6736(04)15433-0; DAVIS JW, 1993, J TRAUMA, V34, P342, DOI 10.1097/00005373-199303000-00006; Goradia D, 2007, AM J NEURORADIOL, V28, P209; Griffen MM, 2003, J TRAUMA, V55, P222, DOI 10.1097/01.TA.0000083332.93868.E2; Hoffman JR, 2000, NEW ENGL J MED, V343, P94, DOI 10.1056/NEJM200007133430203; Katzberg RW, 1999, RADIOLOGY, V213, P203, DOI 10.1148/radiology.213.1.r99oc40203; Klein GR, 1999, SPINE, V24, P771, DOI 10.1097/00007632-199904150-00007; *NIH CLIN EXC, 2007, 56 NIH CLIN EXC; Rybicki F, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.4.1790933; Sanchez B, 2005, J TRAUMA, V59, P179, DOI 10.1097/01.TA.0000171449.94650.81; Stiell IG, 2003, NEW ENGL J MED, V349, P2510, DOI 10.1056/NEJMoa031375; Stiell IG, 2001, JAMA-J AM MED ASSOC, V286, P1841, DOI 10.1001/jama.286.15.1841	12	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 19	2008	336	7636					154	157		10.1136/bmj.39433.663715.BE	http://dx.doi.org/10.1136/bmj.39433.663715.BE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	257SS	18202069	Green Published			2022-12-28	WOS:000252819400036
J	O'Dell, CR; Townsley, LK				O'Dell, C. R.; Townsley, Leisa K.			Astronomy - Orion continues to surprise	SCIENCE			English	Editorial Material							NEBULA		[O'Dell, C. R.] Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA; [Townsley, Leisa K.] Penn State Univ, Dept Astron & Astrophys, University Pk, PA 16802 USA	Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	O'Dell, CR (corresponding author), Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA.	cr.odell@vanderbilt.edu; townsley@astro.psu.edu						Gudel M, 2008, SCIENCE, V319, P309, DOI 10.1126/science.1149926; LEITHERER C, 1988, ASTROPHYS J, V326, P356, DOI 10.1086/166097; O'Dell CR, 2001, ANNU REV ASTRON ASTR, V39, P99, DOI 10.1146/annurev.astro.39.1.99; ODELL CR, 2003, ORION NEBULA; Townsley LK, 2003, ASTROPHYS J, V593, P874, DOI 10.1086/376692	5	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2008	319	5861					289	290		10.1126/science.1153476	http://dx.doi.org/10.1126/science.1153476			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252GY	18202279				2022-12-28	WOS:000252436200023
J	Nield, T				Nield, Ted			A tribe of jobbing ditchers	NATURE			English	Editorial Material												ted.nield@geolsoc.org.uk							0	1	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2008	451	7176					258	260		10.1038/nature06581	http://dx.doi.org/10.1038/nature06581			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202636				2022-12-28	WOS:000252432100028
J	McNamara, JM; Barta, Z; Fromhage, L; Houston, AI				McNamara, John M.; Barta, Zoltan; Fromhage, Lutz; Houston, Alasdair I.			The coevolution of choosiness and cooperation	NATURE			English	Article							PRISONERS-DILEMMA; EVOLUTION; DIVORCE; RECIPROCITY; CONFLICT; ALTRUISM; BEHAVIOR; MODELS; PARENT	Explaining the rise and maintenance of cooperation is central to our understanding of biological systems(1,2) and human societies(3,4). When an individual's cooperativeness is used by other individuals as a choice criterion, there can be competition to be more generous than others, a situation called competitive altruism(5). The evolution of cooperation between non- relatives can then be driven by a positive feedback between increasing levels of cooperativeness and choosiness(6). Here we use evolutionary simulations to show that, in a situation where individuals have the opportunity to engage in repeated pairwise interactions, the equilibrium degree of cooperativeness depends critically on the amount of behavioural variation that is being maintained in the population by processes such as mutation. Because our model does not invoke complex mechanisms such as negotiation behaviour, it can be applied to a wide range of species. The results suggest an important role of lifespan in the evolution of cooperation.	[Fromhage, Lutz; Houston, Alasdair I.] Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England; [McNamara, John M.] Univ Bristol, Dept Math, Bristol BS8 1TW, Avon, England; [Barta, Zoltan] Univ Debrecen, Dept Evolutionary Zool, H-4010 Debrecen, Hungary	University of Bristol; University of Bristol; University of Debrecen	Fromhage, L (corresponding author), Univ Bristol, Sch Biol Sci, Woodland Rd, Bristol BS8 1UG, Avon, England.	lutzfromhage@web.de	Fromhage, Lutz/B-2936-2009	Fromhage, Lutz/0000-0001-5560-6673; Barta, Zoltan/0000-0002-7121-9865				Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Brown M, 2004, ECONOMETRICA, V72, P747, DOI 10.1111/j.1468-0262.2004.00511.x; DAWES RM, 1980, ANNU REV PSYCHOL, V31, P169, DOI 10.1146/annurev.ps.31.020180.001125; Doebeli M, 2004, SCIENCE, V306, P859, DOI 10.1126/science.1101456; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; ENQUIST M, 1993, ANIM BEHAV, V45, P747, DOI 10.1006/anbe.1993.1089; ENS BJ, 1993, ANIM BEHAV, V45, P1199, DOI 10.1006/anbe.1993.1142; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Hamilton IM, 2005, P ROY SOC B-BIOL SCI, V272, P2259, DOI 10.1098/rspb.2005.3248; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Houston A.I., 1985, P471; Houston AI, 2005, TRENDS ECOL EVOL, V20, P33, DOI 10.1016/j.tree.2004.10.008; Hruschka DJ, 2006, J THEOR BIOL, V239, P1, DOI 10.1016/j.jtbi.2005.07.006; Killingback T, 2002, AM NAT, V160, P421, DOI 10.1086/342070; Maynard Smith J., 1982, pi; McNamara JM, 1996, AM NAT, V147, P609, DOI 10.1086/285869; McNamara JM, 2004, NATURE, V428, P745, DOI 10.1038/nature02432; McNamara JM, 2003, BEHAV ECOL, V14, P301, DOI 10.1093/beheco/14.3.301; MCNAMARA JM, 1992, ANIM BEHAV, V43, P641, DOI 10.1016/0003-3472(92)90086-O; McNamara JM, 1999, PHILOS T R SOC B, V354, P223, DOI 10.1098/rstb.1999.0374; Moody AT, 2005, BEHAV ECOL SOCIOBIOL, V57, P224, DOI 10.1007/s00265-004-0856-8; PARKER GA, 1985, ANIM BEHAV, V33, P519, DOI 10.1016/S0003-3472(85)80075-0; QUELLER DC, 1985, NATURE, V318, P366, DOI 10.1038/318366a0; Roberts G, 1998, P ROY SOC B-BIOL SCI, V265, P427, DOI 10.1098/rspb.1998.0312; Sherratt TN, 1998, J THEOR BIOL, V193, P167, DOI 10.1006/jtbi.1998.0703; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Triefenbach F, 1998, ANIM BEHAV, V55, P1263, DOI 10.1006/anbe.1997.0690; Trivers R. L., 1985, SOCIAL EVOLUTION; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850	30	158	161	2	57	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 10	2008	451	7175					189	192		10.1038/nature06455	http://dx.doi.org/10.1038/nature06455			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249GA	18185587				2022-12-28	WOS:000252214400042
J	Morens, DM; Fauci, AS				Morens, David M.; Fauci, Anthony S.			Dengue and hemorrhagic fever - A potential threat to public health in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SHOCK SYNDROME; PUERTO-RICO; INFECTION; TYPE-2; THAILAND; DISEASE; RISK		[Morens, David M.; Fauci, Anthony S.] NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Morens, DM (corresponding author), NIAID, NIH, Bldg 31,Room 7A-03, Bethesda, MD 20892 USA.	dmorens@niaid.nih.gov						Abelz A., 2007, Morbidity and Mortality Weekly Report, V56, P785; Ayala A., 2006, Morbidity and Mortality Weekly Report, V55, P700; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Bock G., 2006, NEW TREATMENT STRATE; Effler PV, 2005, EMERG INFECT DIS, V11, P742; Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6; HALSTEAD SB, 1969, AM J TROP MED HYG, V18, P997, DOI 10.4269/ajtmh.1969.18.997; HALSTEAD SB, 1978, ASIAN J INFECTIOUS D, V2, P85; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; MORENS DM, 1991, AM J TROP MED HYG, V45, P644, DOI 10.4269/ajtmh.1991.45.644; MORENS DM, 1994, CLIN INFECT DIS, V19, P500, DOI 10.1093/clinids/19.3.500; MORENS DM, 1986, AM J TROP MED HYG, V35, P197, DOI 10.4269/ajtmh.1986.35.197; MORENS DM, 1987, AM J TROP MED HYG, V36, P424, DOI 10.4269/ajtmh.1987.36.424; NIMMANNITYA S, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P392; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; Rigau-Perez JG, 2006, CLIN INFECT DIS, V42, P1241, DOI 10.1086/501355; SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932; TABACHNICK W J, 1991, American Entomologist, V37, P14; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; *WHO, 1999, WHO REG PUBL, V29	22	124	131	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2008	299	2					214	216		10.1001/jama.2007.31-a	http://dx.doi.org/10.1001/jama.2007.31-a			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UN	18182605				2022-12-28	WOS:000252182600023
J	Clarke, M; Coates, AS; Darby, SC; Davies, C; Gelber, RD; Godwin, I; Goldhirsch, A; Gray, R; Peto, R; Pritchard, KI; Wood, WC				Clarke, M.; Coates, A. S.; Darby, S. C.; Davies, C.; Gelber, R. D.; Godwin, I.; Goldhirsch, A.; Gray, R.; Peto, R.; Pritchard, K. I.; Wood, W. C.		EBCTCG	Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials	LANCET			English	Article							CYTOTOXIC CHEMOTHERAPY; ENDOCRINE THERAPY	Background The long-term effects of adjuvant polychemotherapy regimens in oestrogen-receptor-poor (ER-poor) breast cancer, and the extent to which these effects are modified by age or tamoxifen use, can be assessed by an updated meta-analysis of individual patient data from randomised trials. Methods Collaborative meta-analyses of individual patient data for about 6000 women with ER-poor breast cancer in 46 trials of polychemotherapy versus not (non-taxane-based polychemotherapy, typically about six cycles; trial start dates 1975-96, median 1984) and about 14000 women with ER-poor breast cancer in 50 trials of tamoxifen versus not (some trials in the presence and some in the absence of polychemotherapy; trial start dates 1972-93, median 1982). Findings In women with ER-poor breast cancer, polychemotherapy significantly reduced recurrence, breast cancer mortality; and death from any cause, in those younger than 50 years and those aged 50-69 years at entry into trials of polychemotherapy versus not. In those aged younger than 50 years (1907 women, 15% node-positive), the 10-year risks were: recurrence 33% versus 45% (ratio of 10-year risks 0 . 73, 2p<0.00001), breast cancer mortality 24% versus 32% (ratio 0 . 73, 2p=0.0002), and death from any cause 25% versus 33% (ratio 0 . 75, 2p=0. 0003). In women aged 50-69 years (3965 women, 58% node-positive), the 10-year risks were: recurrence 42% versus 52% (ratio 0 . 82, 2p<0 . 00001), breast cancer mortality 36% versus 42% (ratio 0 . 86, 2p=0. 0004), and death from any cause 39% versus 45% (ratio 0 . 87, 2p=0. 0009). Few were aged 70 years or older. Tamoxifen had little effect on recurrence or death in women who were classified in these trials as having ER-poor disease, and did not significantly modify the effects of polychemotherapy. Interpretation In women who had ER-poor breast cancer, and were either younger than 50 years or between 50 and 69 years, these older adjuvant polychemotherapy regimens were safe (ie, had little effect on mortality from causes other than breast cancer) and produced substantial and definite reductions in the 10-year risks of recurrence and death. Current and future chemotherapy regimens could well yield larger proportional reductions in breast cancer mortality.	[Davies, C.] ATLAS Trial Collaborat Study Grp, Oxford, England; [Clarke, M.; Darby, S. C.; Davies, C.; Godwin, I.; Gray, R.; Peto, R.] CTSU, EBCTCG Secretariat, Oxford OX3 7LF, England; [Gray, R.; Wood, W. C.] Eastern Cooperat Oncol Grp, Boston, MA USA; [Coates, A. S.; Gelber, R. D.; Goldhirsch, A.] Int Breast Canc Study Grp Ludwig, Bern, Switzerland; [Pritchard, K. I.] Natl Canc Inst Canada, Clin Trials Grp, Kingston, ON, Canada; [Pritchard, K. I.] Ontario Clin Oncol Grp, Hamilton, ON, Canada; [Goldhirsch, A.] Swiss Grp Clin Canc Res, Bern, Switzerland; [Goldhirsch, A.] OSAKO, St Gallen, Switzerland; [Pritchard, K. I.] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada	University of Oxford; University of Oxford; International Breast Cancer Study Group; Queens University - Canada; Canadian Cancer Trials Group; Swiss Group for Clinical Cancer Research (SAKK); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Clarke, M (corresponding author), CTSU, EBCTCG Secretariat, Richard Doll Bldg, Oxford OX3 7LF, England.	bc.overview@ctsu.ox.ac.uk	GORI, Stefania/N-8827-2016; GORI, Stefania/AAB-4802-2022; Pritchard, Kathleen I/I-2184-2014	GORI, Stefania/0000-0001-6320-405X; GORI, Stefania/0000-0001-6320-405X; Pritchard, Kathleen I/0000-0003-0758-9666; Bergh, Jonas/0000-0001-5526-1847; Wang, Xiang/0000-0002-1522-9532; Gray, Richard/0000-0003-4440-574X; Valentini, Miriam/0000-0002-1421-6975	MRC [MC_U137686850] Funding Source: UKRI; Medical Research Council [MC_U137686850] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ABE O, 1992, LANCET, V339, P71; Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Abe O, 1998, LANCET, V352, P930; Anderson WF, 2006, BREAST CANCER RES TR, V100, P121, DOI 10.1007/s10549-006-9231-y; [Anonymous], 1992, Lancet, V339, P1; CHANG JC, 1981, CANCER-AM CANCER SOC, V48, P2503, DOI 10.1002/1097-0142(19811201)48:11<2503::AID-CNCR2820481126>3.0.CO;2-T; Clahsen PC, 1997, J CLIN ONCOL, V15, P2526, DOI 10.1200/JCO.1997.15.7.2526; Coates AS, 1998, LANCET, V352, P1783, DOI 10.1016/S0140-6736(05)79861-5; Colleoni M, 2001, J CLIN ONCOL, V19, P4141, DOI 10.1200/JCO.2001.19.21.4141; *EARL BREAST CANC, 1990, TREATM EARL BREAST C, V1; GOLDHIRSCH A, 1989, NEW ENGL J MED, V320, P491; KIANG DT, 1980, CANCER, V46, P2814, DOI 10.1002/1097-0142(19801215)46:12+<2814::AID-CNCR2820461415>3.0.CO;2-D; KIANG DT, 1978, NEW ENGL J MED, V299, P1330, DOI 10.1056/NEJM197812142992403; LIPPMAN ME, 1978, NEW ENGL J MED, V298, P1223, DOI 10.1056/NEJM197806012982203; OSBORNE CK, 1989, J CLIN ONCOL, V7, P710, DOI 10.1200/JCO.1989.7.6.710; ROSENBAUM C, 1980, CANCER, V46, P2919, DOI 10.1002/1097-0142(19801215)46:12+<2919::AID-CNCR2820461434>3.0.CO;2-X; RUBENS RD, 1980, CANCER, V46, P2922, DOI 10.1002/1097-0142(19801215)46:12+<2922::AID-CNCR2820461435>3.0.CO;2-D; YOUNG PCM, 1980, CANCER-AM CANCER SOC, V46, P2961, DOI 10.1002/1097-0142(19801215)46:12+<2961::AID-CNCR2820461444>3.0.CO;2-E	18	201	208	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 5	2008	371	9606					29	40						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248YH	18177773				2022-12-28	WOS:000252192600028
J	Horton, R				Horton, Richard			Resuscitating Homo academicus	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.								0	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 5	2008	371	9606					3	3		10.1016/S0140-6736(08)60042-2	http://dx.doi.org/10.1016/S0140-6736(08)60042-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248YH	18177754				2022-12-28	WOS:000252192600004
J	Moore, EE; Knudson, MM; Schwab, CW; Trunkey, DD; Johannigman, JA; Holcomb, JB				Moore, Ernest E.; Knudson, M. Margaret; Schwab, C. William; Trunkey, Donald D.; Johannigman, Jay A.; Holcomb, John B.			Military-civilian collaboration in trauma care and the senior visiting surgeon program	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OPERATION IRAQI FREEDOM; RECOMBINANT-FACTOR-VIIA; COMBAT CASUALTY CARE; US ARMY; UNITED-STATES; EXPERIENCE; TERRORISM; CENTERS; INJURY; THROMBOEMBOLISM		Univ Colorado, Denver Hlth Med Ctr, Dept Surg, Denver, CO 80202 USA; Univ Calif San Francisco, San Francisco Gen Hosp, Dept Surg, San Francisco, CA USA; Univ Cincinnati, Dept Surg, Cincinnati, OH 45267 USA; Oregon Hlth & Sci Univ, Dept Surg, Portland, OR USA; Univ Penn, Med Ctr, Dept Surg, Philadelphia, PA 19104 USA; Brooke Army Med Ctr, USA, Inst Surg Res, Ft Sam Houston, TX 78234 USA	Denver Health Medical Center; University of Colorado System; University of Colorado Denver; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University System of Ohio; University of Cincinnati; Oregon Health & Science University; University of Pennsylvania; San Antonio Military Medical Center; United States Department of Defense; United States Army	Moore, EE (corresponding author), Univ Colorado, Denver Hlth Med Ctr, Dept Surg, Denver, CO 80202 USA.			holcomb, john/0000-0001-8312-9157				Aharonson-Daniel L, 2006, ANN SURG, V244, P1018, DOI 10.1097/01.sla.0000225355.06362.0f; American College of Surgeons Committee on Trauma, 2006, RES OPT CAR INJ PAT; Boffard KD, 2005, J TRAUMA, V59, P8, DOI 10.1097/01.TA.0000171453.37949.B7; Branas CC, 2005, JAMA-J AM MED ASSOC, V293, P2626, DOI 10.1001/jama.293.21.2626; Bruce Sandra, 2003, Crit Care Nurs Clin North Am, V15, P149, DOI 10.1016/S0899-5885(02)00080-1; Chambers LW, 2006, J TRAUMA, V60, P1155, DOI 10.1097/01.ta.0000220340.91356.7e; Champion HR, 2006, J AM COLL SURGEONS, V203, P951, DOI 10.1016/j.jamcollsurg.2006.08.019; Chung KK, 2006, J BURN CARE RES, V27, P606, DOI 10.1097/01.BCR.0000235466.57137.f2; CHUNG KK, IN PRESS J TRAUMA; Cothren CC, 2007, J TRAUMA, V62, P834, DOI 10.1097/TA.0b013e31803c7632; Crommett John W, 2002, Respir Care Clin N Am, V8, P105, DOI 10.1016/S1078-5337(02)00019-9; DeBakey ME, 1996, MIL MED, V161, P711, DOI 10.1093/milmed/161.12.711; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; *GEN ACC OFF, 1998, PUBL GAO; Griffith ME, 2007, INFECT CONT HOSP EP, V28, P720, DOI 10.1086/518966; Holcomb JB, 2006, J TRAUMA, V60, P397, DOI 10.1097/01.ta.0000203581.75241.f1; Holcomb JB, 2005, J TRAUMA, V59, P990, DOI 10.1097/01.ta.0000188010.65920.26; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Kapur GB, 2005, J TRAUMA, V59, P1436, DOI 10.1097/01.ta.0000197853.49084.3c; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Knuth TE, 1998, MIL MED, V163, P608, DOI 10.1093/milmed/163.9.608; Knuth TE, 1996, MIL MED, V161, P137, DOI 10.1093/milmed/161.3.137; Lapostolle F, 2001, NEW ENGL J MED, V345, P779, DOI 10.1056/NEJMoa010378; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Maier RV, 2005, J TRAUMA, V59, P762, DOI 10.1097/01.ta.0000177656.85206.cd; Mattox K, 2001, CRIT CARE, V5, P323, DOI 10.1186/cc1062; NISKA RW, 2005, ADV DATA, P3641; Patel TH, 2004, J TRAUMA, V57, P201, DOI 10.1097/01.TA.0000133638.30269.38; Perkins JG, 2007, J TRAUMA, V62, P1095, DOI 10.1097/TA.0b013e31804798a4; Perkins RM, 2007, CLIN J AM SOC NEPHRO, V2, P313, DOI 10.2215/CJN.03070906; Pruitt BA, 2006, ANN SURG, V243, P715, DOI 10.1097/01.sla.0000220038.66466.b5; Rasmussen TE, 2006, J TRAUMA, V61, P8, DOI 10.1097/01.ta.0000220668.84405.17; Sariego Jack, 2006, Disaster Manag Response, V4, P114, DOI 10.1016/j.dmr.2006.09.001; Schreiber MA, 2002, J SURG RES, V104, P8, DOI 10.1006/jsre.2002.6391; Schwab CW, 2007, J TRAUMA, V62, P1, DOI 10.1097/TA.0b013e31802f734a; Slater MS, 1997, ARCH SURG-CHICAGO, V132, P1059; TRUNKEY DD, 1992, J TRAUMA, V32, P526, DOI 10.1097/00005373-199204000-00018; TRUNKEY DD, IN PRESS ARCH SURG	38	44	45	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2007	357	26					2723	2727		10.1056/NEJMsr073207	http://dx.doi.org/10.1056/NEJMsr073207			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	245UO	18160694				2022-12-28	WOS:000251964500014
J	Belmaker, RH; Agam, G				Belmaker, R. H.; Agam, Galila			Mechanisms of disease: Major depressive disorder	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							GAMMA-AMINOBUTYRIC-ACID; MAGNETIC-RESONANCE SPECTROSCOPY; NATIONAL COMORBIDITY SURVEY; MESSENGER-RNA EXPRESSION; FORCED-SWIM TEST; MOOD-DISORDERS; ANTIDEPRESSANT DRUGS; PREFRONTAL CORTEX; HIPPOCAMPAL NEUROGENESIS; NONHUMAN-PRIMATES		Ben Gurion Univ Negev, Beer Sheva, Israel	Ben Gurion University	Belmaker, RH (corresponding author), Beersheba Mental Hlth Ctr, POB 4600, Beer Sheva, Israel.	belmaker@bgu.ac.il	Penninx, Brenda WJH/S-7627-2017; Yan, Shuo/B-8381-2009; Pariante, Carmine Maria/B-1297-2011	Penninx, Brenda WJH/0000-0001-7779-9672; Pariante, Carmine Maria/0000-0002-9132-5091; Otte, Christian/0000-0002-4051-997X; Mohr, David/0000-0002-5443-7596; Gold, Stefan/0000-0001-5188-4799	Medical Research Council [G108/603, MR/N029488/1] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Angelucci F, 2005, MOL PSYCHIATR, V10, P345, DOI 10.1038/sj.mp.4001637; Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Avissar S, 1997, AM J PSYCHIAT, V154, P211; Barbon A, 2006, BIOL PSYCHIAT, V59, P713, DOI 10.1016/j.biopsych.2005.10.018; Bauer M, 2002, MOL PSYCHIATR, V7, P140, DOI 10.1038/sj.mp.4000963; Beasley CL, 2005, BIPOLAR DISORD, V7, P449, DOI 10.1111/j.1399-5618.2005.00239.x; Belmaker RH, 2004, NEW ENGL J MED, V351, P476, DOI 10.1056/NEJMra035354; BERSUDSKY Y, IN PRESS BIPOLAR DIS; Bhagwagar Z, 2007, BIOL PSYCHIAT, V61, P806, DOI 10.1016/j.biopsych.2006.08.048; Bhansali P, 2007, J NEUROSCI, V27, P1467, DOI 10.1523/JNEUROSCI.4632-06.2007; Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; Blendy JA, 2006, BIOL PSYCHIAT, V59, P1144, DOI 10.1016/j.biopsych.2005.11.003; BOUCHARD TJ, 1994, SCIENCE, V264, P1700, DOI 10.1126/science.8209250; Boyle MP, 2005, P NATL ACAD SCI USA, V102, P473, DOI 10.1073/pnas.0406458102; Brambilla P, 2003, MOL PSYCHIATR, V8, P721, DOI 10.1038/sj.mp.4001362; Brown ES, 2004, BIOL PSYCHIAT, V55, P1, DOI 10.1016/S0006-3223(03)00473-6; Bunney WE, 2000, NEUROPSYCHOPHARMACOL, V22, P335, DOI 10.1016/S0893-133X(99)00145-1; Burke HM, 2005, PSYCHONEUROENDOCRINO, V30, P846, DOI 10.1016/j.psyneuen.2005.02.010; Carroll BJ, 2007, ACTA PSYCHIAT SCAND, V115, P90, DOI 10.1111/j.1600-0447.2007.00967.x; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Castren E, 2005, NAT REV NEUROSCI, V6, P241, DOI 10.1038/nrn1629; CHANG A, 2002, POSTMORTEM BRAIN PSY, P341; Chen B, 2001, BIOL PSYCHIAT, V50, P260, DOI 10.1016/S0006-3223(01)01083-6; Choudary PV, 2005, P NATL ACAD SCI USA, V102, P15653, DOI 10.1073/pnas.0507901102; Conti AC, 2002, J NEUROSCI, V22, P3262, DOI 10.1523/JNEUROSCI.22-08-03262.2002; Cooper-Kazaz R, 2007, ARCH GEN PSYCHIAT, V64, P679, DOI 10.1001/archpsyc.64.6.679; Coupland NJ, 2005, BIOL PSYCHIAT, V57, P1526, DOI 10.1016/j.biopsych.2005.02.027; CRYNS K, IN PRESS NEUROPSYCHO; Dantzer R, 1999, MOL PSYCHIATR, V4, P328, DOI 10.1038/sj.mp.4000572; de Pablos RM, 2006, J NEUROSCI, V26, P5709, DOI 10.1523/JNEUROSCI.0802-06.2006; Desouza LA, 2005, MOL CELL NEUROSCI, V29, P414, DOI 10.1016/j.mcn.2005.03.010; Dziedzicka-Wasylewska M, 2006, NEUROPSYCHOPHARMACOL, V31, P2424, DOI 10.1038/sj.npp.1301064; Einat H, 2006, BEHAV BRAIN RES, V173, P153, DOI 10.1016/j.bbr.2006.06.006; Flores BH, 2006, NEUROPSYCHOPHARMACOL, V31, P628, DOI 10.1038/sj.npp.1300884; Folstein M, 2007, AM J PSYCHIAT, V164, P861, DOI 10.1176/appi.ajp.164.6.861; Frodl T, 2007, ARCH GEN PSYCHIAT, V64, P410, DOI 10.1001/archpsyc.64.4.410; George MS, 2007, TRANSCRANIAL MAGNETI; Gershon AA, 2007, BIOL PSYCHIAT, V61, P145, DOI 10.1016/j.biopsych.2006.05.031; Gingrich JA, 2002, CNS NEUROL DISORD-DR, V1, P449, DOI 10.2174/1568007023339003; GOSHEN I, IN PRESS MOL PSYCHIA; Hasler G, 2005, BIOL PSYCHIAT, V58, P969, DOI 10.1016/j.biopsych.2005.05.017; Hasler G, 2007, ARCH GEN PSYCHIAT, V64, P193, DOI 10.1001/archpsyc.64.2.193; Hastings RS, 2004, NEUROPSYCHOPHARMACOL, V29, P952, DOI 10.1038/sj.npp.1300371; Hedlund PB, 2005, BIOL PSYCHIAT, V58, P831, DOI 10.1016/j.biopsych.2005.05.012; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Henn FA, 2004, BIOL PSYCHIAT, V56, P146, DOI 10.1016/j.biopsych.2004.04.011; Hines LM, 2006, J NEUROSCI, V26, P12609, DOI 10.1523/JNEUROSCI.1040-06.2006; HOLICK KA, IN PRESS NEUROPSYCHO; Holmans P, 2007, AM J PSYCHIAT, V164, P248, DOI 10.1176/appi.ajp.164.2.248; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Janowsky DS, 2013, MED PSYCHIATRY, P67; Johansson C, 2003, NEUROPSYCHOPHARMACOL, V28, P734, DOI 10.1038/sj.npp.1300121; Kable JW, 2000, J PHARMACOL EXP THER, V293, P1; Karege F, 2005, MOL BRAIN RES, V136, P29, DOI 10.1016/j.molbrainres.2004.12.020; Karege F, 2005, BIOL PSYCHIAT, V57, P1068, DOI 10.1016/j.biopsych.2005.01.008; Kendler KS, 2006, AM J PSYCHIAT, V163, P115, DOI 10.1176/appi.ajp.163.1.115; Kendler KS, 2000, ARCH GEN PSYCHIAT, V57, P953, DOI 10.1001/archpsyc.57.10.953; Kendler KS, 1999, ARCH GEN PSYCHIAT, V56, P322, DOI 10.1001/archpsyc.56.4.322; Kendler KS, 2000, ARCH GEN PSYCHIAT, V57, P94, DOI 10.1001/archpsyc.57.1.94; Kennedy SE, 2006, ARCH GEN PSYCHIAT, V63, P1199, DOI 10.1001/archpsyc.63.11.1199; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kozlovsky N, 2007, INT J NEUROPSYCHOPH, V10, P741, DOI 10.1017/S1461145707007560; Lambert G, 2000, ARCH GEN PSYCHIAT, V57, P787, DOI 10.1001/archpsyc.57.8.787; Lee R, 2005, AM J PSYCHIAT, V162, P995, DOI 10.1176/appi.ajp.162.5.995; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lesch KP, 2002, MOL GENETICS HUMAN P, P109; LESPERANCE F, 2007, JAMA-J AM MED ASSOC, V298, P40; Lesperance F, 2007, JAMA-J AM MED ASSOC, V297, P367, DOI 10.1001/jama.297.4.367; Lewy AJ, 2006, P NATL ACAD SCI USA, V103, P7414, DOI 10.1073/pnas.0602425103; Lopez-Rodriguez F, 2004, NEUROPSYCHOPHARMACOL, V29, P1105, DOI 10.1038/sj.npp.1300406; Louis C, 2006, NEUROPSYCHOPHARMACOL, V31, P2180, DOI 10.1038/sj.npp.1301036; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; MacMaster FP, 2006, BIOL PSYCHIAT, V60, P862, DOI 10.1016/j.biopsych.2006.04.013; MacQueen GM, 2003, P NATL ACAD SCI USA, V100, P1387, DOI 10.1073/pnas.0337481100; Mann JJ, 2005, NEW ENGL J MED, V353, P1819, DOI 10.1056/NEJMra050730; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Merali Z, 2004, J NEUROSCI, V24, P1478, DOI 10.1523/JNEUROSCI.4734-03.2004; Meyer JH, 2006, ARCH GEN PSYCHIAT, V63, P1209, DOI 10.1001/archpsyc.63.11.1209; Milak MS, 2005, ARCH GEN PSYCHIAT, V62, P397, DOI 10.1001/archpsyc.62.4.397; Monteggia LM, 2007, BIOL PSYCHIAT, V61, P187, DOI 10.1016/j.biopsych.2006.03.021; Muller N, 2006, MOL PSYCHIATR, V11, P680, DOI 10.1038/sj.mp.4001805; Nabkasorn C, 2006, EUR J PUBLIC HEALTH, V16, P179, DOI 10.1093/eurpub/cki159; Nemets B, 2002, AM J PSYCHIAT, V159, P477, DOI 10.1176/appi.ajp.159.3.477; Ordway GA, 2003, BIOL PSYCHIAT, V53, P315, DOI 10.1016/S0006-3223(02)01728-6; Overstreet DH, 2005, NEUROSCI BIOBEHAV R, V29, P739, DOI 10.1016/j.neubiorev.2005.03.015; Perel P, 2007, BMJ-BRIT MED J, V334, P197, DOI 10.1136/bmj.39048.407928.BE; Perera TD, 2007, J NEUROSCI, V27, P4894, DOI 10.1523/JNEUROSCI.0237-07.2007; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Pitchot W, 2005, BIOL PSYCHIAT, V58, P854, DOI 10.1016/j.biopsych.2005.05.042; Pizzagalli DA, 2004, MOL PSYCHIATR, V9, P393, DOI 10.1038/sj.mp.4001469; Popik P, 2003, BRIT J PHARMACOL, V139, P1196, DOI 10.1038/sj.bjp.0705359; Potter GG, 2007, NEUROPSYCHOPHARMACOL, V32, P2135, DOI 10.1038/sj.npp.1301339; Rajkowska G, 2000, BIOL PSYCHIAT, V48, P766, DOI 10.1016/S0006-3223(00)00950-1; Rajkowska G, 2007, NEUROPSYCHOPHARMACOL, V32, P471, DOI 10.1038/sj.npp.1301234; Rakic P, 2002, NAT REV NEUROSCI, V3, P65, DOI 10.1038/nrn700; Reagan LP, 2004, P NATL ACAD SCI USA, V101, P2179, DOI 10.1073/pnas.0307294101; Ruhe HG, 2007, MOL PSYCHIATR, V12, P331, DOI 10.1038/sj.mp.4001949; Sanacora G, 2004, ARCH GEN PSYCHIAT, V61, P705, DOI 10.1001/archpsyc.61.7.705; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Schmidt PJ, 2005, ARCH GEN PSYCHIAT, V62, P154, DOI 10.1001/archpsyc.62.2.154; Schramm NL, 2001, J NEUROSCI, V21, P4875, DOI 10.1523/JNEUROSCI.21-13-04875.2001; Seeman P, 2005, MOL PSYCHIATR, V10, P877, DOI 10.1038/sj.mp.4001682; Shimon H, 1997, AM J PSYCHIAT, V154, P1148; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Shytle RD, 2002, MOL PSYCHIATR, V7, P525, DOI 10.1038/sj.mp.4001035; Spalletta G, 2006, MOL PSYCHIATR, V11, P984, DOI 10.1038/sj.mp.4001879; Strome EM, 2002, P NATL ACAD SCI USA, V99, P15749, DOI 10.1073/pnas.232480899; Strous RD, 2003, ARCH GEN PSYCHIAT, V60, P133, DOI 10.1001/archpsyc.60.2.133; Sullivan GM, 2006, BIOL PSYCHIAT, V60, P500, DOI 10.1016/j.biopsych.2005.11.022; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Svenningsson P, 2006, SCIENCE, V311, P77, DOI 10.1126/science.1117571; Taylor CB, 2005, ARCH GEN PSYCHIAT, V62, P792, DOI 10.1001/archpsyc.62.7.792; Taylor MJ, 2006, ARCH GEN PSYCHIAT, V63, P1217, DOI 10.1001/archpsyc.63.11.1217; Torregrossa MM, 2006, BRAIN RES, V1069, P172, DOI 10.1016/j.brainres.2005.11.005; Tremblay LK, 2002, ARCH GEN PSYCHIAT, V59, P409, DOI 10.1001/archpsyc.59.5.409; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Valdizan EM, 2003, BIOL PSYCHIAT, V54, P1457, DOI 10.1016/S0006-3223(03)00589-4; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H., 1987, TREATING RESISTANT D, P279; Wakefield JC, 2007, ARCH GEN PSYCHIAT, V64, P433, DOI 10.1001/archpsyc.64.4.433; Warner-Schmidt JL, 2007, P NATL ACAD SCI USA, V104, P4647, DOI 10.1073/pnas.0610282104; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; WEBER MM, 1988, INT CLIN PSYCHOPHARM, V3, P255, DOI 10.1097/00004850-198807000-00007; Weisstaub NV, 2006, SCIENCE, V313, P536, DOI 10.1126/science.1123432; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zhang XD, 2004, SCIENCE, V305, P217, DOI 10.1126/science.1097540; Zhang XD, 2005, NEURON, V45, P11, DOI 10.1016/j.neuron.2004.12.014	131	1308	1370	11	273	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2008	358	1					55	68		10.1056/NEJMra073096	http://dx.doi.org/10.1056/NEJMra073096			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	246TW	27629598				2022-12-28	WOS:000252031200008
